PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	El-Kadi, AM; Bros-Facer, V; Deng, WH; Philpott, A; Stoddart, E; Banks, G; Jackson, GS; Fisher, EMC; Duchen, MR; Greensmith, L; Moore, AL; Hafezparast, M				El-Kadi, Ali Morsi; Bros-Facer, Virginie; Deng, Wenhan; Philpott, Amelia; Stoddart, Eleanor; Banks, Gareth; Jackson, Graham S.; Fisher, Elizabeth M. C.; Duchen, Michael R.; Greensmith, Linda; Moore, Anthony L.; Hafezparast, Majid			The Legs at odd angles (Loa) Mutation in Cytoplasmic Dynein Ameliorates Mitochondrial Function in SOD1(G93A) Mouse Model for Motor Neuron Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FAST AXONAL-TRANSPORT; LINKED SOD1 MUTANTS; SUPEROXIDE-DISMUTASE; DEGENERATION; DYSFUNCTION; SURVIVAL; DEFECTS; CELLS; ONSET	Amyotrophic lateral sclerosis (ALS) is a debilitating and fatal late-onset neurodegenerative disease. Familial cases of ALS (FALS) constitute similar to 10% of all ALS cases, and mutant superoxide dismutase 1 (SOD1) is found in 15-20% of FALS. SOD1 mutations confer a toxic gain of unknown function to the protein that specifically targets the motor neurons in the cortex and the spinal cord. We have previously shown that the autosomal dominant Legs at odd angles (Loa) mutation in cytoplasmic dynein heavy chain (Dync1h1) delays disease onset and extends the life span of transgenic mice harboring human mutant SOD1(G93A). In this study we provide evidence that despite the lack of direct interactions between mutant SOD1 and either mutant or wild-type cytoplasmic dynein, the Loa mutation confers significant reductions in the amount of mutant SOD1 protein in the mitochondrial matrix. Moreover, we show that the Loa mutation ameliorates defects in mitochondrial respiration and membrane potential observed in SOD1(G93A) motor neuron mitochondria. These data suggest that the Loa mutation reduces the vulnerability of mitochondria to the toxic effects of mutant SOD1, leading to improved mitochondrial function in SOD1(G93A) motor neurons.	[El-Kadi, Ali Morsi; Deng, Wenhan; Philpott, Amelia; Stoddart, Eleanor; Moore, Anthony L.; Hafezparast, Majid] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Bros-Facer, Virginie; Greensmith, Linda] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Banks, Gareth; Jackson, Graham S.; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Duchen, Michael R.] UCL Div Biosci, London WC1B 6BT, England	University of Sussex; University of London; University College London; University of London; University College London; University of London; University College London	Hafezparast, M (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	m.hafezparast@sussex.ac.uk	Hafezparast, Majid/N-8292-2019; duchen, michael/A-2116-2009; Fisher, Elizabeth MC/C-2168-2008; Hafezparast, Majid/H-6728-2018	Hafezparast, Majid/0000-0002-5262-7150; duchen, michael/0000-0003-2548-4294; Fisher, Elizabeth MC/0000-0003-2850-9936; Jackson, Graham/0000-0002-3125-2011; Banks, Gareth/0000-0002-8647-667X	Medical Research Council; Biotechnology and Biological Sciences Research Council; Amyotrophic Lateral Sclerosis Association and Robert Packard Center for ALS Research at Johns Hopkins; Brain Research Trust; Wellcome Trust; University of Sussex; BBSRC [BB/D012309/1] Funding Source: UKRI; MRC [MC_U123170362, G0500288, G0500865, G0601943] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D012309/1] Funding Source: researchfish; Medical Research Council [G0500865, G0601943, MC_U123170362, G0500288, G0601943B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Amyotrophic Lateral Sclerosis Association and Robert Packard Center for ALS Research at Johns Hopkins; Brain Research Trust; Wellcome Trust(Wellcome Trust); University of Sussex; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (to M. H., A. M. E.-K., and E. S.), the Biotechnology and Biological Sciences Research Council (to M. H., W. D., and A. L. M.), the Amyotrophic Lateral Sclerosis Association and Robert Packard Center for ALS Research at Johns Hopkins (to M. H., L. G., E. M. C. F., and V. B.-F.), the Brain Research Trust (to L. G.), The Wellcome Trust (to G. B. and E. M. C. F.), and the University of Sussex (to A. P.).	Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BREUER AC, 1987, NEUROLOGY, V37, P738, DOI 10.1212/WNL.37.5.738; Brill LB, 2000, METHODS, V22, P307, DOI 10.1006/meth.2000.1083; Brown RH, 1995, CURR OPIN NEUROBIOL, V5, P841, DOI 10.1016/0959-4388(95)80114-6; Browne SE, 1998, J NEUROCHEM, V71, P281; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hafezparast M, 2002, LANCET NEUROL, V1, P215, DOI 10.1016/S1474-4422(02)00100-X; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1998, CELL MOTIL CYTOSKEL, V41, P154, DOI 10.1002/(SICI)1097-0169(1998)41:2<154::AID-CM6>3.0.CO;2-E; Rao MV, 2003, NEUROCHEM RES, V28, P1041, DOI 10.1023/A:1023259207015; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw PJ, 1999, BMJ-BRIT MED J, V318, P1118, DOI 10.1136/bmj.318.7191.1118; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang J, 2007, J BIOL CHEM, V282, P345, DOI 10.1074/jbc.M604503200; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	60	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18627	18639		10.1074/jbc.M110.129320	http://dx.doi.org/10.1074/jbc.M110.129320			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382740	Green Published, hybrid			2022-12-25	WOS:000278453900056
J	Feng, QY; Baird, D; Yoo, S; Antonyak, M; Cerione, RA				Feng, Qiyu; Baird, Dan; Yoo, Sungsoo; Antonyak, Marc; Cerione, Richard A.			Phosphorylation of the Cool-1/beta-Pix Protein Serves as a Regulatory Signal for the Migration and Invasive Activity of Src-transformed Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; P85 BETA-PIX; P21-ACTIVATED KINASE; RHO-GTPASES; MENTAL-RETARDATION; GIT1 FUNCTIONS; ACTIN; FAMILY; ACTIVATION; MECHANISMS	Previously we showed that Cool-1 (Cloned out of library-1)/beta-Pix (Pak-interactive exchange factor) is phosphorylated at a specific tyrosine residue (Tyr-442) in a Src-dependent manner and serves as a dual function guanine nucleotide exchange factor (GEF)/signaling-effector for Cdc42 that is essential for transformation by Src. Here, we show that knocking-down Cool-1 or overexpressing a Cool-1 mutant that contains substitutions within its Dbl homology domain and is defective for GEF activity, inhibits Src-promoted cell migration. Similarly, the expression of a Cool-1 mutant containing a tyrosine to phenylalanine substitution at position 442, making it incapable of being phosphorylated in response to serum, epidermal growth factor (EGF), or Src, also causes a significant inhibition of the migration and invasive activity of cells expressing oncogenic Src. We further demonstrate that the phosphorylation of Cool-1 at Tyr-442 weakens its ability to bind to one of its primary interaction-partners, Cat-1 (Cool-associated tyrosine phosphosubstrate-1)/Git-1 (G protein-coupled receptor kinase-interactor-1), thus making Cat more accessible for binding to paxillin. This enables cells to alternate between states where they contain large numbers of focal complexes (i.e. conditions favoring Cool-1-Cat interactions) versus reduced numbers of focal complexes (conditions favoring Cat-paxillin interactions). Overall, these findings show that the phosphorylation-dephosphorylation cycle of Cool-1 at Tyr-442 can serve as a key regulatory signal for focal complex assembly-disassembly, and consequently, for the migration and invasive activity of Src-transformed cells.	[Feng, Qiyu; Baird, Dan; Yoo, Sungsoo; Antonyak, Marc; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			National Institutes of Health [GM047458, GM61762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R01GM061762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM047458 and GM61762.	Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Castellano F, 2001, EMBO J, V20, P5603, DOI 10.1093/emboj/20.20.5603; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 2005, EXP CELL RES, V307, P315, DOI 10.1016/j.yexcr.2005.03.028; Lee Juliet, 1993, Trends in Cell Biology, V3, P366, DOI 10.1016/0962-8924(93)90084-E; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matafora V, 2001, J CELL SCI, V114, P4509; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sheetz Michael P., 1994, Seminars in Cell Biology, V5, P149, DOI 10.1006/scel.1994.1019; Shin EY, 2004, J BIOL CHEM, V279, P1994, DOI 10.1074/jbc.M307330200; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; VAN AL, 1997, GENE DEV, V11, P2295; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996	51	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18806	18816		10.1074/jbc.M109.098079	http://dx.doi.org/10.1074/jbc.M109.098079			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375009	Green Published, hybrid			2022-12-25	WOS:000278453900071
J	Tanco, S; Zhang, X; Morano, C; Aviles, FX; Lorenzo, J; Fricker, LD				Tanco, Sebastian; Zhang, Xin; Morano, Cain; Xavier Aviles, Francesc; Lorenzo, Julia; Fricker, Lloyd D.			Characterization of the Substrate Specificity of Human Carboxypeptidase A4 and Implications for a Role in Extracellular Peptide Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-BRAIN; CANCER; INHIBITION; NEUROTENSIN; ACID; METALLOCARBOXYPEPTIDASES; ACTIVATION; MECHANISM; PATHWAY; MATRIX	CPA4 (carboxypeptidase A4) is a member of the metallocarboxypeptidase family. CPA4 was originally found in a screen of mRNAs up-regulated by sodium butyrate-induced differentiation of cancer cells. Further studies suggested a relation between CPA4 and prostate cancer aggressiveness. In the present study, we determined that CPA4 is secreted from cells as a soluble proenzyme (pro-CPA4) that can be activated by endoproteases, such as trypsin. Three complementary approaches were used to study the substrate specificity of CPA4; kinetic analysis was performed using a new series of chromogenic substrates and some biologically relevant peptides, the cleavage of synthetic peptides was tested individually, and the cleavage of a mixture of > 100 mouse brain peptides was examined using a quantitative peptidomics mass spectrometry-based approach. CPA4 was able to cleave hydrophobic C-terminal residues with a preference for Phe, Leu, Ile, Met, Tyr, and Val. However, not all peptides with C-terminal hydrophobic residues were cleaved, indicating the importance of additional residues within the peptide. Aliphatic, aromatic, and basic residues in the P1 position have a positive influence on the cleavage specificity. In contrast, acidic residues, Pro, and Gly have a negative influence in the P1 position. Some of the peptides identified as CPA4 substrates (such as neurotensin, granins, and opioid peptides) have been previously shown to function in cell proliferation and differentiation, potentially explaining the link between CPA4 and cancer aggressiveness. Taken together, these studies suggest that CPA4 functions in neuropeptide processing and regulation in the extracellular environment.	[Tanco, Sebastian; Xavier Aviles, Francesc; Lorenzo, Julia] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain; [Tanco, Sebastian; Xavier Aviles, Francesc; Lorenzo, Julia] Univ Autonoma Barcelona, Dept Bioquim, Bellaterra 08193, Barcelona, Spain; [Zhang, Xin; Morano, Cain; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Autonomous University of Barcelona; Autonomous University of Barcelona; Yeshiva University; Albert Einstein College of Medicine	Lorenzo, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain.	julia.lorenzo@uab.es; lloyd.fricker@einstein.yu.edu	Lorenzo, Julia/E-9015-2011; Aviles, Francesc Xavier/F-3482-2019; Tanco, Sebastian Martin/R-2528-2016; Avilés, Francesc Xavier/A-2664-2015	Lorenzo, Julia/0000-0001-5659-6008; Aviles, Francesc Xavier/0000-0002-1399-6789; Tanco, Sebastian Martin/0000-0003-2130-4401; Avilés, Francesc Xavier/0000-0002-1399-6789	National Institutes of Health [DK-51271, DA-04494]; European Commission [FP7-Health-2009-241919-LIVIMODE]; Spanish Ministry of Science and Technology [BIO2007-68046-C02]; Xarxa de Referencia en Biotecnologia (Generalitat de Catalunya); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xarxa de Referencia en Biotecnologia (Generalitat de Catalunya)(Generalitat de Catalunya); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grants DK-51271 and DA-04494 (to L. D. F.). This work was also supported by European Commission Grant FP7-Health-2009-241919-LIVIMODE (to F. X. A.), by Spanish Ministry of Science and Technology Grant BIO2007-68046-C02 (to F. X. A.), and by Xarxa de Referencia en Biotecnologia (Generalitat de Catalunya).	Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; Bentley L, 2003, J MED GENET, V40, P249, DOI 10.1136/jmg.40.4.249; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BLUMBERG S, 1975, BIOCHEMISTRY-US, V14, P2410, DOI 10.1021/bi00682a022; BYERS LD, 1973, BIOCHEMISTRY-US, V12, P2070, DOI 10.1021/bi00735a008; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Davila-Garcia M I, 1990, Adv Exp Med Biol, V265, P75; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Escobar ML, 1997, BRAIN RES, V751, P330, DOI 10.1016/S0006-8993(96)01373-X; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia-Castellanos R, 2005, CELL MOL LIFE SCI, V62, P1996, DOI 10.1007/s00018-005-5174-4; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Grishin AM, 2008, PROTEIN ENG DES SEL, V21, P545, DOI 10.1093/protein/gzn031; Hamstra DA, 1999, HUM GENE THER, V10, P235, DOI 10.1089/10430349950019020; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Huang HJ, 1999, CANCER RES, V59, P2981; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kayashima T, 2003, HUM GENET, V112, P220, DOI 10.1007/s00439-002-0891-3; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leung LLK, 2008, MOL IMMUNOL, V45, P4080, DOI 10.1016/j.molimm.2008.07.010; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Mosca A, 2005, J Endocrinol Invest, V28, P141; Myers RM, 2009, ACS CHEM BIOL, V4, P503, DOI 10.1021/cb900038e; Nagakawa O, 2001, INT J UROL, V8, P65, DOI 10.1046/j.1442-2042.2001.00250.x; Novikova EG, 2000, J BIOL CHEM, V275, P4865, DOI 10.1074/jbc.275.7.4865; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pallares I, 2008, ACTA CRYSTALLOGR D, V64, P784, DOI 10.1107/S0907444908013474; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; PETERSON LM, 1982, ANAL BIOCHEM, V125, P420, DOI 10.1016/0003-2697(82)90024-0; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; Ross PL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-69; RYAN CA, 1974, J BIOL CHEM, V249, P5495; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Vias M, 2007, PROSTATE, V67, P190, DOI 10.1002/pros.20518; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; WHITE D, 2004, Patent No. 2004007001; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; ZHANG FM, 1991, J BIOL CHEM, V266, P24606; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	50	48	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18385	18396		10.1074/jbc.M109.060350	http://dx.doi.org/10.1074/jbc.M109.060350			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385563	hybrid, Green Published			2022-12-25	WOS:000278453900032
J	Bugge, A; Siersbaek, M; Madsen, MS; Gondor, A; Rougier, C; Mandrup, S				Bugge, Anne; Siersbaek, Majken; Madsen, Maria S.; Gondor, Anita; Rougier, Carole; Mandrup, Susanne			A Novel Intronic Peroxisome Proliferator-activated Receptor gamma Enhancer in the Uncoupling Protein (UCP) 3 Gene as a Regulator of Both UCP2 and-3 Expression in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN-ADIPOSE-TISSUE; FATTY-ACID OXIDATION; UP-REGULATION; SKELETAL-MUSCLE; THYROID-HORMONE; MESSENGER-RNA; AGONISTS; BINDING; THIAZOLIDINEDIONES; TRANSACTIVATION	Uncoupling Proteins (UCPs) are integral ion channels residing in the inner mitochondrial membrane. UCP2 is ubiquitously expressed, while UCP3 is found primarily in muscles and adipose tissue. Although the exact molecular mechanism of action is controversial, it is generally agreed that both homologues function to facilitate mitochondrial fatty acid oxidation. UCP2 and -3 expression is activated by the peroxisome proliferator-activated receptors (PPARs), but so far no PPAR response element has been reported in the vicinity of the Ucp2 and Ucp3 genes. Using genome-wide profiling of PPAR gamma occupancy in 3T3-L1 adipocytes we demonstrate that PPAR gamma associates with three chromosomal regions in the vicinity of the Ucp3 locus and weakly with a site in intron 1 of the Ucp2 gene. These sites are isolated from the nearest neighboring sites by >900 kb. The most prominent PPAR gamma binding site in the Ucp2 and Ucp3 loci is located in intron 1 of the Ucp3 gene and is the only site that facilitates PPAR gamma transactivation of a heterologous promoter. This site furthermore transactivates the endogenous Ucp3 promoter, and using chromatin conformation capture we show that it loops out to specifically interact with the Ucp2 promoter and intron 1. Our data indicate that PPAR gamma transactivation of both UCP2 and -3 is mediated through this novel enhancer in Ucp3 intron 1.	[Bugge, Anne; Siersbaek, Majken; Madsen, Maria S.; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Gondor, Anita] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Rougier, Carole] Uppsala Univ, Dept Genet & Dev, SE-75105 Uppsala, Sweden	University of Southern Denmark; Karolinska Institutet; Uppsala University	Mandrup, S (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	s.mandrup@bmb.sdu.dkmailto	Mandrup, Susanne/B-6693-2008	Bugge, Anne/0000-0001-5885-4541; Gondor, Anita/0000-0002-1523-4411; Siersbaek, Majken/0000-0003-1030-182X; Mandrup, Susanne/0000-0002-0961-5787	Danish Natural Science Research Foundation; Novo Nordisk Foundation; NordForsk; Novo Scholarship program	Danish Natural Science Research Foundation(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NordForsk; Novo Scholarship program	This work has been supported in part by grants from the Danish Natural Science Research Foundation, the Novo Nordisk Foundation, and grants from NordForsk given to the Nordic Center of Excellence MitoHealth.; Supported by the Novo Scholarship program.	Acin A, 1999, BIOCHEM BIOPH RES CO, V258, P278, DOI 10.1006/bbrc.1999.0530; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Aubert J, 1997, BIOCHEM BIOPH RES CO, V238, P606, DOI 10.1006/bbrc.1997.7348; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Bugge A, 2009, MOL ENDOCRINOL, V23, P794, DOI 10.1210/me.2008-0236; Camirand A, 1998, ENDOCRINOLOGY, V139, P428, DOI 10.1210/en.139.1.428; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chevillotte E, 2001, J BIOL CHEM, V276, P10853, DOI 10.1074/jbc.M008010200; Emilsson V, 2000, METABOLISM, V49, P1610, DOI 10.1053/meta.2000.18692; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fromme T, 2009, PHYSIOL GENOMICS, V38, P54, DOI 10.1152/physiolgenomics.00249.2007; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Helledie T, 2000, J LIPID RES, V41, P1740; Helledie T, 2002, J BIOL CHEM, V277, P26821, DOI 10.1074/jbc.M111295200; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Jucker BM, 2000, J BIOL CHEM, V275, P39279, DOI 10.1074/jbc.M007760200; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Matsuda J, 1998, DIABETES, V47, P1809, DOI 10.2337/diabetes.47.11.1809; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Orlicky DJ, 2001, J LIPID RES, V42, P910; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Rieusset J, 1999, BIOCHEM BIOPH RES CO, V265, P265, DOI 10.1006/bbrc.1999.1657; Schrauwen P, 2003, FASEB J, V17, P2272, DOI 10.1096/fj.03-0515fje; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Son C, 2001, ENDOCRINOLOGY, V142, P4189, DOI 10.1210/en.142.10.4189; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tu N, 2000, LIFE SCI, V67, P2267, DOI 10.1016/S0024-3205(00)00802-X; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Weigle DS, 1998, DIABETES, V47, P298, DOI 10.2337/diabetes.47.2.298; Yoshitomi H, 1999, BIOCHEM J, V340, P397, DOI 10.1042/0264-6021:3400397; Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com	44	46	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17310	17317		10.1074/jbc.M110.120584	http://dx.doi.org/10.1074/jbc.M110.120584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360005	Green Published, hybrid			2022-12-25	WOS:000278133400008
J	Lee, M; Tazzari, V; Giustarini, D; Rossi, R; Sparatore, A; Del Soldato, P; McGeer, E; McGeer, PL				Lee, Moonhee; Tazzari, Valerio; Giustarini, Daniela; Rossi, Ranieri; Sparatore, Anna; Del Soldato, Piero; McGeer, Edith; McGeer, Patrick L.			Effects of Hydrogen Sulfide-releasing L-DOPA Derivatives on Glial Activation POTENTIAL FOR TREATING PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MONOAMINE-OXIDASE-B; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; LEVODOPA; ASTROCYTES; CELLS; INFLAMMATION; NSAIDS; INHIBITION	The main lesion in Parkinson disease (PD) is loss of substantia nigra dopaminergic neurons. Levodopa (L-DOPA) is the most widely used therapy, but it does not arrest disease progression. Some possible contributing factors to the continuing neuronal loss are oxidative stress, including oxidation of L-DOPA, and neurotoxins generated by locally activated microglia and astrocytes. A possible method of reducing these factors is to produce L-DOPA hybrid compounds that have antioxidant and anti-inflammatory properties. Here we demonstrate the properties of four such L-DOPA hybrids based on coupling L-DOPA to four different hydrogen sulfide-donating compounds. The donors themselves were shown to be capable of conversion by isolated mitochondria to H2S or equivalent SH- ions. This capability was confirmed by in vivo results, showing a large increase in intracerebral dopamine and glutathione after iv administration in rats. When human microglia, astrocytes, and SH-SY5Y neuroblastoma cells were treated with these donating agents, they all accumulated H2S intracellularly as did their derivatives coupled to L-DOPA. The donating agents and the L-DOPA hybrids reduced the release of tumor necrosis factor-alpha, interleukin-6, and nitric oxide from stimulated microglia, astrocytes as well as the THP-1 and U373 cell lines. They also demonstrated a neuroprotective effect by reducing the toxicity of supernatants from these stimulated cells to SH-SY5Y cells. L-DOPA itself was without effect in any of these assays. The H2S-releasing L-DOPA hybrid molecules also inhibited MAO B activity. They may be useful for the treatment of PD because of their significant anti-inflammatory, antioxidant, and neuroprotective properties.	[Lee, Moonhee; McGeer, Edith; McGeer, Patrick L.] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [Tazzari, Valerio; Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, I-20133 Milan, Italy; [Giustarini, Daniela; Rossi, Ranieri] Univ Siena, Dept Evolutionary Biol, Lab Pharmacol & Toxicol, I-53100 Siena, Italy; [Del Soldato, Piero] CTG Pharma, I-20131 Milan, Italy	University of British Columbia; University of Milan; University of Siena	McGeer, PL (corresponding author), Univ British Columbia, Kinsmen Lab Neurol Res, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	mcgeerpl@interchange.ubc.ca	Rossi, Ranieri/C-8743-2011; Sparatore, Anna/J-8634-2015; Giustarini, Daniela/AAV-6629-2021	Rossi, Ranieri/0000-0002-0187-4530; Sparatore, Anna/0000-0003-2135-2649; Giustarini, Daniela/0000-0003-4929-5316	Pacific Alzheimer Research Foundation	Pacific Alzheimer Research Foundation	This research was supported by the Pacific Alzheimer Research Foundation.	Adelaere B., 1989, SULFUR LETT, V10, P31; Asanuma M, 2008, CURR PHARM DESIGN, V14, P1428, DOI 10.2174/138161208784480153; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Damier P, 1996, NEUROLOGY, V46, P1262, DOI 10.1212/WNL.46.5.1262; DARTIGUES B, 1980, EUR J MED CHEM, V15, P405; Drukarch B, 2006, J NEURAL TRANSM, V113, P593, DOI 10.1007/s00702-005-0350-0; Esposito E, 2007, EXP NEUROL, V205, P295, DOI 10.1016/j.expneurol.2007.02.008; Eto K, 2002, J NEUROSCI, V22, P3386; FAHN S, 1991, AM J CLIN NUTR, V53, pS380, DOI 10.1093/ajcn/53.1.380S; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Giustarini D, 2009, FEBS J, V276, P4946, DOI 10.1111/j.1742-4658.2009.07197.x; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; HU LF, 2010, AGING CELL IN PRESS; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Klegeris A, 1999, NEUROPHARMACOLOGY, V38, P1017, DOI 10.1016/S0028-3908(99)00014-3; Klegeris A, 2000, EXP NEUROL, V166, P458, DOI 10.1006/exnr.2000.7517; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Kostrzewa RM, 2002, AMINO ACIDS, V23, P57, DOI 10.1007/s00726-001-0110-x; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; LEE M, 2010, FASEB J IN PRESS; Lee M, 2010, GLIA, V58, P103, DOI 10.1002/glia.20905; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Lowicka E, 2007, PHARMACOL REP, V59, P4; LOZACH N, 1950, B SOC CHIM FR, P1243; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Muzzi C, 2008, BIOMED PHARMACOTHER, V62, P253, DOI 10.1016/j.biopha.2007.10.018; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nagatsu T, 2006, J NEURAL TRANSM-SUPP, P53; Postuma RB, 2004, NEUROLOGY, V63, P886, DOI 10.1212/01.WNL.0000137886.74175.5A; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Wahner AD, 2007, NEUROLOGY, V69, P1836, DOI 10.1212/01.wnl.0000279519.99344.ad; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zoccolella S, 2009, MOVEMENT DISORD, V24, P1028, DOI 10.1002/mds.22511	47	84	97	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17318	17328		10.1074/jbc.M110.115261	http://dx.doi.org/10.1074/jbc.M110.115261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368333	Green Published, hybrid			2022-12-25	WOS:000278133400009
J	Rajagopal, V; Gurjar, M; Levin, MK; Patel, SS				Rajagopal, Vaishnavi; Gurjar, Madhura; Levin, Mikhail K.; Patel, Smita S.			The Protease Domain Increases the Translocation Stepping Efficiency of the Hepatitis C Virus NS3-4A Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ATP-DEPENDENT TRANSLOCATION; ESCHERICHIA-COLI; RNA HELICASE; NONSTRUCTURAL PROTEIN-3; DISPLACE STREPTAVIDIN; PHOSPHATE RELEASE; FLUORESCENT-PROBE; KINETIC-ANALYSIS; STEADY-STATE	Hepatitis C virus (HCV) NS3 protein has two enzymatic activities of helicase and protease that are essential for viral replication. The helicase separates the strands of DNA and RNA duplexes using the energy from ATP hydrolysis. To understand how ATP hydrolysis is coupled to helicase movement, we measured the single turnover helicase translocation-dissociation kinetics and the pre-steady-state Pi release kinetics on single-stranded RNA and DNA substrates of different lengths. The parameters of stepping were determined from global fitting of the two types of kinetic measurements into a computational model that describes translocation as a sequence of coupled hydrolysis-stepping reactions. Our results show that the HCV helicase moves with a faster rate on single stranded RNA than on DNA. The HCV helicase steps on the RNA or DNA one nucleotide at a time, and due to imperfect coupling, not every ATP hydrolysis event produces a successful step. Comparison of the helicase domain (NS3h) with the protease-helicase (NS3-4A) shows that the most significant contribution of the protease domain is to improve the translocation stepping efficiency of the helicase. Whereas for NS3h, only 20% of the hydrolysis events result in translocation, the coupling for NS3-4A is near-perfect 93%. The presence of the protease domain also significantly reduces the stepping rate, but it doubles the processivity. These effects of the protease domain on the helicase can be explained by an improved allosteric cross-talk between the ATP- and nucleic acid-binding sites achieved by the overall stabilization of the helicase domain structure.	[Levin, Mikhail K.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Levin, MK (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA.	svarneticist@gmail.com; patelss@umdnj.edu	Rajagopal, Vaishnavi/E-5272-2012		National Institutes of Health [GM55310]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55310.	Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Beran RKF, 2009, J VIROL, V83, P3268, DOI 10.1128/JVI.01849-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Donmez I, 2008, EMBO J, V27, P1718, DOI 10.1038/emboj.2008.100; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Evans Jared D, 2006, Hepatology, V43, P615, DOI 10.1002/hep.21096; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Fischer CJ, 2004, J MOL BIOL, V344, P1265, DOI 10.1016/j.jmb.2004.10.004; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Garai A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061910; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Gwack Y, 1997, EUR J BIOCHEM, V250, P47, DOI 10.1111/j.1432-1033.1997.00047.x; HAHM B, 1995, J VIROL, V69, P2534, DOI 10.1128/JVI.69.4.2534-2539.1995; Howe AYM, 1999, PROTEIN SCI, V8, P1332, DOI 10.1110/ps.8.6.1332; Johnson CL, 2007, J BIOL CHEM, V282, P10792, DOI 10.1074/jbc.M610361200; Khu YL, 2004, BIOCHEM J, V384, P401, DOI 10.1042/BJ20040858; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Levin Mikhail K., 2009, V500, P335, DOI 10.1007/978-1-59745-525-1_12; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; LEVIN MK, 2002, MOL MOTORS; Liu DJ, 2001, J MOL BIOL, V314, P543, DOI 10.1006/jmbi.2001.5146; Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; MATLOCK DL, BIOCHEMISTRY, V49, P2097; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; Murayama A, 2007, J VIROL, V81, P8030, DOI 10.1128/JVI.02088-06; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Porter DJT, 1998, J BIOL CHEM, V273, P14247, DOI 10.1074/jbc.273.23.14247; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Sillanpaa M, 2008, J GEN VIROL, V89, P432, DOI 10.1099/vir.0.83316-0; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Wardell AD, 1999, J GEN VIROL, V80, P701, DOI 10.1099/0022-1317-80-3-701; Webb MR, 2007, MOL BIOSYST, V3, P249, DOI 10.1039/b614154d; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; YOUNG MC, 1994, J MOL BIOL, V235, P1436, DOI 10.1006/jmbi.1994.1099; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100	73	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17821	17832		10.1074/jbc.M110.114785	http://dx.doi.org/10.1074/jbc.M110.114785			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363755	Green Published, hybrid			2022-12-25	WOS:000278133400060
J	Tang, YF; Urs, S; Boucher, J; Bernaiche, T; Venkatesh, D; Spicer, DB; Vary, CPH; Liaw, L				Tang, Yuefeng; Urs, Sumithra; Boucher, Joshua; Bernaiche, Tyler; Venkatesh, Deepak; Spicer, Douglas B.; Vary, Calvin P. H.; Liaw, Lucy			Notch and Transforming Growth Factor-beta (TGF beta) Signaling Pathways Cooperatively Regulate Vascular Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RBP-J-KAPPA; INTRACELLULAR DOMAIN; DEPENDENT PATHWAY; ACTIN EXPRESSION; ALPHA-ACTIN; CROSS-TALK; IN-VITRO; INHIBITION; MYOCARDIN; APOPTOSIS	Notch and transforming growth factor-beta (TGF beta) play pivotal roles during vascular development and the pathogenesis of vascular disease. The interaction of these two pathways is not fully understood. The present study utilized primary human smooth muscle cells (SMC) to examine molecular cross-talk between TGF beta 1 and Notch signaling on contractile gene expression. Activation of Notch signaling using Notch intracellular domain or Jagged1 ligand induced smooth muscle alpha-actin (SM actin), smooth muscle myosin heavy chain, and calponin1, and the expression of Notch downstream effectors hairy-related transcription factors. Similarly, TGF beta 1 treatment of human aortic smooth muscle cells induced SM actin, calponin1, and smooth muscle protein 22-alpha (SM22 alpha) in a dose-and time-dependent manner. Hairy-related transcription factor proteins, which antagonize Notch activity, also suppressed the TGF beta 1-induced increase in SMC markers, suggesting a general mechanism of inhibition. We found that Notch and TGF beta 1 cooperatively activate SMC marker transcripts and protein through parallel signaling axes. Although the intracellular domain of Notch4 interacted with phosphoSmad2/3 in SMC, this interaction was not observed with Notch1 or Notch2. However, we found that CBF1 co-immunoprecipitated with phosphoSmad2/3, suggesting a mechanism to link canonical Notch signaling to phosphoSmad activity. Indeed, the combination of Notch activation and TGF beta 1 treatment led to synergistic activation of a TGF beta-responsive promoter. This increase corresponded to increased levels of phosphoSmad2/3 interaction at Smad consensus binding sites within the SM actin, calponin1, and SM22 alpha promoters. Thus, Notch and TGF beta coordinately induce a molecular and functional contractile phenotype by co-regulation of Smad activity at SMC promoters.	[Tang, Yuefeng; Urs, Sumithra; Boucher, Joshua; Bernaiche, Tyler; Venkatesh, Deepak; Spicer, Douglas B.; Vary, Calvin P. H.; Liaw, Lucy] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	Maine Medical Center	Liaw, L (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	liawl@mmc.org	Tang, Yuefeng/J-9770-2012		National Institutes of Health, National Center for Research Resources [R01 HL070865, P20RR15555]; Founders Affiliate of the American Heart Association; Graduate School of Biomedical Sciences at University of Maine, Orono, ME; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555, P20RR018789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083151, R01HL070865] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Founders Affiliate of the American Heart Association(American Heart Association); Graduate School of Biomedical Sciences at University of Maine, Orono, ME; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL070865 (to L. L.) and P20RR15555 from the National Center for Research Resources (to R. E. Friesel and L. L.).; Supported by a predoctoral fellowship from the Founders Affiliate of the American Heart Association.; Supported by a fellowship from the Graduate School of Biomedical Sciences at University of Maine, Orono, ME.	Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Herrmann J, 2007, BBA-MOL BASIS DIS, V1772, P1250, DOI 10.1016/j.bbadis.2007.10.006; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hung SC, 2006, CELL TISSUE RES, V324, P457, DOI 10.1007/s00441-006-0156-x; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; King IN, 2006, BIOCHEM BIOPH RES CO, V345, P446, DOI 10.1016/j.bbrc.2006.04.097; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Ono Y, 2007, J CELL PHYSIOL, V210, P358, DOI 10.1002/jcp.20838; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozbun LL, 2005, BBA-GENE STRUCT EXPR, V1728, P163, DOI 10.1016/j.bbaexp.2005.02.010; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Rao P, 2003, MOL CELL BIOL, V23, P6694, DOI 10.1128/MCB.23.18.6694-6701.2003; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	41	109	114	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17556	17563		10.1074/jbc.M109.076414	http://dx.doi.org/10.1074/jbc.M109.076414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368328	Green Published, hybrid			2022-12-25	WOS:000278133400034
J	Haferkamp, S; Haase, W; Pascal, AA; van Amerongen, H; Kirchhoff, H				Haferkamp, Silvia; Haase, Winfried; Pascal, Andrew A.; van Amerongen, Herbert; Kirchhoff, Helmut			Efficient Light Harvesting by Photosystem II Requires an Optimized Protein Packing Density in Grana Thylakoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-TRANSFER; PHOTOSYNTHETIC MEMBRANES; EXCITATION-ENERGY; HIGHER-PLANTS; CHARGE SEPARATION; COMPLEXES; ORGANIZATION; CHLOROPLAST; MODEL; IDENTIFICATION	A recently developed technique for dilution of the naturally high protein packing density in isolated grana membranes was applied to study the dependence of the light harvesting efficiency of photosystem (PS) II on macromolecular crowding. Slight dilution of the protein packing from 80% area fraction to the value found in intact grana thylakoids (70%) leads to an improved functionality of PSII (increased antenna size, enhanced connectivity between reaction centers). Further dilution induces a functional disconnection of light-harvesting complex (LHC) II from PSII. It is concluded that efficient light harvesting by PSII requires an optimal protein packing density in grana membranes that is close to 70%. We hypothesize that the decreased efficiency in overcrowded isolated grana thylakoids is caused by excited state quenching in LHCII, which has previously been correlated with neoxanthin distortion. Resonance Raman spectroscopy confirms this increase in neoxanthin distortion in overcrowded grana as compared with intact thylakoids. Furthermore, analysis of the changes in the antenna size in highly diluted membranes indicates a lipid-induced dissociation of up to two trimeric LHCII from PSII, leaving one trimer connected. This observation supports a hierarchy of LHCII-binding sites on PSII.	[Kirchhoff, Helmut] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Haase, Winfried] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Pascal, Andrew A.] CEA, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [van Amerongen, Herbert] Wageningen Univ, Biophys Lab, NL-6700 ET Wageningen, Netherlands	Washington State University; Max Planck Society; CEA; UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research	Kirchhoff, H (corresponding author), Washington State Univ, Inst Biol Chem, POB 646340, Pullman, WA 99164 USA.	kirchhh@wsu.edu	pascal, andrew a/B-6186-2014; Kirchhoff, Helmut/AAN-6695-2020; van Amerongen, Herbert/J-9483-2016	pascal, andrew a/0000-0002-1844-6065; Kirchhoff, Helmut/0000-0001-5874-3681; van Amerongen, Herbert/0000-0002-9783-2895				Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; ANDERSON JM, 1986, ANNU REV PLANT PHYS, V37, P93, DOI 10.1146/annurev.arplant.37.1.93; Andreeva A, 2003, J PHOTOCH PHOTOBIO B, V70, P153, DOI 10.1016/S1011-1344(03)00075-7; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; *BLANK, 2002, MOL MECH PHOT; Broess K, 2006, BIOPHYS J, V91, P3776, DOI 10.1529/biophysj.106.085068; Bumba L, 2003, PHOTOSYNTH RES, V77, P1, DOI 10.1023/A:1024927631196; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Duchene S, 2000, LIPIDS, V35, P739, DOI 10.1007/s11745-000-0580-4; Eijckelhoff C, 1997, PHOTOSYNTH RES, V52, P69, DOI 10.1023/A:1005834006985; FORSTER T, 1949, Z NATURFORSCH A, V4, P321; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; Haferkamp S, 2008, PHOTOSYNTH RES, V95, P129, DOI 10.1007/s11120-007-9253-2; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; Kirchhoff H, 2004, BIOCHEMISTRY-US, V43, P14508, DOI 10.1021/bi048473w; Kirchhoff H, 2004, BIOCHEMISTRY-US, V43, P9204, DOI 10.1021/bi0494626; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kirchhoff H, 2007, BBA-BIOENERGETICS, V1767, P1180, DOI 10.1016/j.bbabio.2007.05.009; LAVERGNE J, 1995, BIOPHYS J, V68, P2474, DOI 10.1016/S0006-3495(95)80429-7; MELIS A, 1976, PHOTOCHEM PHOTOBIOL, V23, P343, DOI 10.1111/j.1751-1097.1976.tb07259.x; Miloslavina Y, 2006, BIOCHEMISTRY-US, V45, P2436, DOI 10.1021/bi052248c; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; SIEGEL CO, 1981, J CELL BIOL, V91, P113, DOI 10.1083/jcb.91.1.113; STAEHELIN LA, 1996, OXYGENIC PHOTOSYNTHE, P11; Sturgis JN, 1997, J PHYS CHEM B, V101, P7227, DOI 10.1021/jp963363n; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; WEBB MS, 1989, BIOCHIM BIOPHYS ACTA, V984, P41, DOI 10.1016/0005-2736(89)90340-4; WILLIAMS WP, 1998, LIPIDS PHOTOSYNTHES, P145	43	81	82	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17020	17028		10.1074/jbc.M109.077750	http://dx.doi.org/10.1074/jbc.M109.077750			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360011	Green Published, hybrid			2022-12-25	WOS:000277982600065
J	Terada, K; Oike, Y				Terada, Kazutoyo; Oike, Yuichi			Multiple Molecules of Hsc70 and a Dimer of DjA1 Independently Bind to an Unfolded Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SIGMA(32); NEWLY SYNTHESIZED PROTEINS; HEAT-SHOCK PROTEINS; CRYSTAL-STRUCTURE; PEPTIDE-BINDING; SUBSTRATE-SPECIFICITY; HSP70 CHAPERONES; DNAK CHAPERONE; REACTION CYCLE; HSP40	Protein folding is a prominent chaperone function of the Hsp70 system. Refolding of an unfolded protein is efficiently mediated by the Hsc70 system with either type 1 DnaJ protein, DjA1 or DjA2, and a nucleotide exchange factor. A surface plasmon resonance technique was applied to investigate substrate recognition by the Hsc70 system and demonstrated that multiple Hsc70 proteins and a dimer of DjA1 initially bind independently to an unfolded protein. The association rate of the Hsc70 was faster than that of DjA1 under folding-compatible conditions. The Hsc70 binding involved a conformational change, whereas the DjA1 binding was bivalent and substoichiometric. Consistently, we found that the bound C-14-labeled Hsc70 to the unfolded protein became more resistant to tryptic digestion. The gel filtration and cross-linking experiments revealed the predominant presence of the DjA1 dimer. Furthermore, the Hsc70 and DjA1 bound to distinct sets of peptide array sequences. All of these findings argue against the generality of the widely proposed hypothesis that the DnaJ-bound substrate is targeted and transferred to Hsp70. Instead, these results suggest the importance of the bivalent binding of DjA1 dimer that limits unfavorable transitions of substrate conformations in protein folding.	[Terada, Kazutoyo; Oike, Yuichi] Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Kumamoto 8608556, Japan	Kumamoto University	Terada, K (corresponding author), Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Honjo 1-1-1, Kumamoto 8608556, Japan.	terada@gpo.kumamoto-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19058010, 20590287]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants 19058010 and 20590287 from the Ministry of Education, Science, Sports and Culture of Japan (to K. T.).	Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; GRAGEROV A, 1994, J MOL BIOL, V241, P133, DOI 10.1006/jmbi.1994.1482; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jiang RF, 1997, J BIOL CHEM, V272, P6141, DOI 10.1074/jbc.272.10.6141; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Nagata H, 1998, BIOCHEMISTRY-US, V37, P6924, DOI 10.1021/bi980164g; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Uchiyama Y, 2006, J BIOCHEM, V140, P805, DOI 10.1093/jb/mvj212; WEBER K, 1969, J BIOL CHEM, V244, P4406; WICKNER SH, 1990, P NATL ACAD SCI USA, V87, P2690, DOI 10.1073/pnas.87.7.2690; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	42	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16789	16797		10.1074/jbc.M110.101501	http://dx.doi.org/10.1074/jbc.M110.101501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363747	Green Published, hybrid			2022-12-25	WOS:000277982600042
J	Yu, ZW; Xu, XH; Xiang, ZH; Zhou, JF; Zhang, ZH; Hu, C; He, C				Yu, Zhongwang; Xu, Xiaohui; Xiang, Zhenghua; Zhou, Jianfeng; Zhang, Zhaohuan; Hu, Chun; He, Cheng			Nitrated alpha-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; PROTEIN TRANSDUCTION; TYROSINE NITRATION; LEWY BODIES; D2 RECEPTOR; MOUSE MODEL; CELL-DEATH; IN-VITRO	Background: The pathology of Parkinson's disease (PD) is characterized by the degeneration of the nigrostriatal dopaminergic pathway, as well as the formation of intraneuronal inclusions known as Lewy bodies and Lewy neurites in the substantia nigra. Accumulations of nitrated alpha-synuclein are demonstrated in the signature inclusions of Parkinson's disease. However, whether the nitration of alpha-synuclein is relevant to the pathogenesis of PD is unknown. Methodology/Principal Findings: In this study, effect of nitrated alpha-synuclein to dopaminergic (DA) neurons was determined by delivering nitrated recombinant TAT-alpha-synuclein intracellular. We provide evidence to show that the nitrated alpha-synuclein was toxic to cultured dopaminergic SHSY-5Y neurons and primary mesencephalic DA neurons to a much greater degree than unnitrated alpha-synuclein. Moreover, we show that administration of nitrated alpha-synuclein to the substantia nigra pars compacta of rats caused severe reductions in the number of DA neurons therein, and led to the down-regulation of D2R in the striatum in vivo. Furthermore, when administered to the substantia nigra of rats, nitrated alpha-synuclein caused PD-like motor dysfunctions, such as reduced locomotion and motor asymmetry, however unmodified alpha-synuclein had significantly less severe behavioral effects. Conclusions/Significance: Our results provide evidence that alpha-synuclein, principally in its nitrated form, induce DA neuron death and may be a major factor in the etiology of PD.	[Yu, Zhongwang] Second Mil Med Univ, Inst Neurosci, Changzheng Hosp, Neurosci Res Ctr, Shanghai, Peoples R China; Second Mil Med Univ, Key Lab Mol Neurobiol Minister Educ, Changzheng Hosp, Neurosci Res Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Yu, ZW (corresponding author), Second Mil Med Univ, Inst Neurosci, Changzheng Hosp, Neurosci Res Ctr, Shanghai, Peoples R China.	chenghe@smmu.edu.cn		Yu, Zhong-wang/0000-0002-8212-0158; Xu, Xiao-Hui/0000-0001-7608-4114	National Key Basic Research Program [2006CB500702]; Ministry of Science and Technology of China [2007CB947100]; National 863 Program [2006AA02A114]; National Natural Science Foundation of China [30530240, 30770657]; Shanghai Metropolitan Fund for Research and Development [07DJ14005]	National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Metropolitan Fund for Research and Development	This study was supported by the National Key Basic Research Program (2006CB500702), the Ministry of Science and Technology of China (2007CB947100), the National 863 Program (2006AA02A114), the National Natural Science Foundation of China (30530240, 30770657), and the Shanghai Metropolitan Fund for Research and Development (07DJ14005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Aoyama K, 2000, ANN NEUROL, V47, P524, DOI 10.1002/1531-8249(200004)47:4<524::AID-ANA19>3.0.CO;2-5; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Beyer K, 2004, NEUROPATH APPL NEURO, V30, P601, DOI 10.1111/j.1365-2990.2004.00572.x; Beyer K, 2008, NEUROGENETICS, V9, P15, DOI 10.1007/s10048-007-0106-0; Bixby M, 2005, LIFE SCI, V77, P345, DOI 10.1016/j.lfs.2004.11.030; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cai GP, 2000, J NEUROSCI, V20, P1849; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung CY, 2007, J NEUROSCI, V27, P8314, DOI 10.1523/JNEUROSCI.1972-07.2007; Cole NB, 2008, CURR ALZHEIMER RES, V5, P599, DOI 10.2174/156720508786898523; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; CUNHA CD, 2008, BEHAV BRAIN RES, V189, P364; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Daveu C, 1997, NITRIC OXIDE-BIOL CH, V1, P234, DOI 10.1006/niox.1997.0123; de Oliveira MR, 2009, PROG NEURO-PSYCHOPH, V33, P353, DOI 10.1016/j.pnpbp.2008.12.020; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee SJ, 2006, J BIOL CHEM, V281, P2215, DOI 10.1074/jbc.M509509200; Liberatore GT, 1999, NAT MED, V5, P1403; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Mihm MJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-11-j0003.2001; NITSCH C, 1995, SYNAPSE, V19, P247, DOI 10.1002/syn.890190404; Norris EH, 2003, J BIOL CHEM, V278, P27230, DOI 10.1074/jbc.M212436200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tao L, 2006, CIRCULATION, V114, P1395, DOI 10.1161/CIRCULATIONAHA.106.625061; Tieu K, 2003, IUBMB LIFE, V55, P329, DOI 10.1080/1521654032000114320; Turnbull S, 2001, FREE RADICAL BIO MED, V30, P1163, DOI 10.1016/S0891-5849(01)00513-5; Uversky VN, 2005, MOL BRAIN RES, V134, P84, DOI 10.1016/j.molbrainres.2004.11.014; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P553, DOI 10.1089/ars.2006.1524; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Yu S, 2007, NEUROSCIENCE, V145, P539, DOI 10.1016/j.neuroscience.2006.12.028; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhen XC, 2002, MOL PHARMACOL, V62, P1356, DOI 10.1124/mol.62.6.1356	63	77	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9956	10.1371/journal.pone.0009956	http://dx.doi.org/10.1371/journal.pone.0009956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386702	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482000003
J	Amrit, FRG; Boehnisch, CML; May, RC				Amrit, Francis R. G.; Boehnisch, Claudia M. L.; May, Robin C.			Phenotypic Covariance of Longevity, Immunity and Stress Resistance in the Caenorhabditis Nematodes	PLOS ONE			English	Article							LIFE-SPAN; SALMONELLA-TYPHIMURIUM; MODEL HOST; ELEGANS; DAF-16; MUTANTS; LONG; GENE; EVOLUTION; TARGETS	Background: Ageing, immunity and stresstolerance are inherent characteristics of all organisms. In animals, these traits are regulated, at least in part, by forkhead transcription factors in response to upstream signals from the Insulin/Insulin-like growth factor signalling (IIS) pathway. In the nematode Caenorhabditis elegans, these phenotypes are molecularly linked such that activation of the forkhead transcription factor DAF-16 both extends lifespan and simultaneously increases immunity and stress resistance. It is known that lifespan varies significantly among the Caenorhabditis species but, although DAF-16 signalling is highly conserved, it is unclear whether this phenotypic linkage occurs in other species. Here we investigate this phenotypic covariance by comparing longevity, stress resistance and immunity in four Caenorhabditis species. Methodology/Principal Findings: We show using phenotypic analysis of DAF-16 influenced phenotypes that among four closely related Caenorhabditis nematodes, the gonochoristic species (Caenorhabditis remanei and Caenorhabditis brenneri) have diverged significantly with a longer lifespan, improved stress resistance and higher immunity than the hermaphroditic species (C. elegans and Caenorhabditis briggsae). Interestingly, we also observe significant differences in expression levels between the daf-16 homologues in these species using Real-Time PCR, which positively correlate with the observed phenotypes. Finally, we provide additional evidence in support of a role for DAF-16 in regulating phenotypic coupling by using a combination of wildtype isolates, constitutively active daf-16 mutants and bioinformatic analysis. Conclusions: The gonochoristic species display a significantly longer lifespan (p<0.0001) and more robust immune and stress response (p<0.0001, thermal stress; p<0.01, heavy metal stress; p<0.0001, pathogenic stress) than the hermaphroditic species. Our data suggests that divergence in DAF-16 mediated phenotypes may underlie many of the differences observed between these four species of Caenorhabditis nematodes. These findings are further supported by the correlative higher daf-16 expression levels among the gonochoristic species and significantly higher lifespan, immunity and stress tolerance in the constitutively active daf-16 hermaphroditic mutants.	[Amrit, Francis R. G.; Boehnisch, Claudia M. L.; May, Robin C.] Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham, W Midlands, England	University of Birmingham	Amrit, FRG (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham, W Midlands, England.	r.c.may@bham.ac.uk	Amrit, Francis/AAU-1222-2021; May, Robin Charles/ABA-9266-2021	Amrit, Francis/0000-0003-1928-3234; May, Robin Charles/0000-0001-5364-1838	BBSRC [BB/F000138/1]; Darwin Trust of Edinburgh; MRC; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/F000138/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Darwin Trust of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was made possible with financial support from the BBSRC (BB/F000138/1) and the Darwin Trust of Edinburgh. Work in the May Laboratory is supported by the BBSRC, MRC and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; BERG MCW, 2006, GENETICS, V173, P677; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; FODOR A, 1983, NEMATOLOGICA, V29, P203, DOI 10.1163/187529283X00456; FRIEDMAN DB, 1988, GENETICS, V118, P75; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Galbadage T, 2008, MECH AGEING DEV, V129, P507, DOI 10.1016/j.mad.2008.04.012; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hope IA., 1999, C ELEGANS PRACTICAL; HUANG DW, 2008, RESOURCES, V4, P44; Inoue T, 2007, GENETICS, V177, P809, DOI 10.1534/genetics.107.078857; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiontke K, 2006, ECOLOGY CAENORHABDIT; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X; McCulloch D, 2003, AGING CELL, V2, P165, DOI 10.1046/j.1474-9728.2003.00047.x; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Partridge L, 2002, CURR BIOL, V12, pR544, DOI 10.1016/S0960-9822(02)01048-5; Patel MN, 2002, P NATL ACAD SCI USA, V99, P769, DOI 10.1073/pnas.012511099; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Riddle DL, 1997, C ELEGANS; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; van Helden J, 2000, NUCLEIC ACIDS RES, V28, P1000; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]	56	27	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9978	10.1371/journal.pone.0009978	http://dx.doi.org/10.1371/journal.pone.0009978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20369008	Green Submitted, gold, Green Published			2022-12-25	WOS:000276418200049
J	de Souza, D; Kelly-Hope, L; Lawson, B; Wilson, M; Boakye, D				de Souza, Dziedzom; Kelly-Hope, Louise; Lawson, Bernard; Wilson, Michael; Boakye, Daniel			Environmental Factors Associated with the Distribution of Anopheles gambiae s.s in Ghana; an Important Vector of Lymphatic Filariasis and Malaria	PLOS ONE			English	Article							WEST-AFRICA; GENETIC DIFFERENTIATION; INSECTICIDE RESISTANCE; ECOLOGICAL ZONES; MOLECULAR-FORMS; BORNE DISEASE; COMPLEX; ABUNDANCE; IRRIGATION; KENYA	Anopheles gambiae s.s mosquitoes are important vectors of lymphatic filariasis (LF) and malaria in Ghana. To better understand their ecological aspects and influence on disease transmission, we examined the spatial distribution of the An. gambiae (M and S) molecular forms and associated environmental factors, and determined their relationship with disease prevalence. Published and current data available on the An. gambiae species in Ghana were collected in a database for analysis, and the study sites were georeferenced and mapped. Using the An. gambiae s.s sites, environmental data were derived from climate, vegetation and remote-sensed satellite sources, and disease prevalence data from existing LF and malaria maps in the literature. The data showed that An. gambiae M and S forms were sympatric in most locations. However, the S form predominated in the central region, while the Mformpredominated in the northern and coastal savanna regions. Bivariate and multiple regression analyses identified temperature as a key factor distinguishing their distributions. An. gambiae M was significantly correlated with LF, and 2.5 to 3 times more prevalent in the high LF zone than low to medium zones. There were no significant associations between high prevalence An. gambiae s.s locations and malaria. The distribution of the An. gambiae M and S forms and the diseases they transmit in Ghana appear to be distinct, driven by different environmental factors. This study provides useful baseline information for disease control, and future work on the An. gambiae s.s in Ghana.	[de Souza, Dziedzom; Wilson, Michael; Boakye, Daniel] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [de Souza, Dziedzom; Lawson, Bernard] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana; [Kelly-Hope, Louise] Univ Liverpool, Ctr Neglected Trop Dis, Liverpool L69 3BX, Merseyside, England	University of Ghana; Kwame Nkrumah University Science & Technology; University of Liverpool	de Souza, D (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana.	dboakye@noguchi.mimcom.org	de Souza, Dziedzom/ABC-8432-2021	de Souza, Dziedzom/0000-0001-5000-6177; Kelly-Hope, Louise/0000-0002-3330-7629	JRS Biodiversity Foundation	JRS Biodiversity Foundation	This study was supported by the JRS Biodiversity Foundation (http://www.jrsbdf.org/v2/home.asp) grant to Prof Boakye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoulaye D, 2003, J MED ENTOMOL, V40, P195, DOI 10.1603/0022-2585-40.2.195; Afari Edwin A., 1995, Afr J Health Sci, V2, P312; Appawu MA, 2001, AFR ENTOMOL, V9, P59; Appawu MA, 2001, TROP MED INT HEALTH, V6, P511, DOI 10.1046/j.1365-3156.2001.00737.x; APPAWU MA, 1994, ACTA TROP, V56, P15, DOI 10.1016/0001-706X(94)90036-1; Bayoh MN, 2001, MED VET ENTOMOL, V15, P267, DOI 10.1046/j.0269-283x.2001.00298.x; Boakye DA, 2004, ANN TROP MED PARASIT, V98, P501, DOI 10.1179/000349804225003514; Calzetta M, 2008, AM J TROP MED HYG, V78, P169, DOI 10.4269/ajtmh.2008.78.169; Carnevale P, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P273; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coluzzi M., 1993, Parassitologia (Rome), V35, P23; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Dunyo SK, 1996, T ROY SOC TROP MED H, V90, P634, DOI 10.1016/S0035-9203(96)90414-9; Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUNTER JM, 1992, SOC SCI MED, V35, P627, DOI 10.1016/0277-9536(92)90001-7; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; *IRI, 2008, IRI LDEO CLIM DAT LI; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kelly-Hope LA, 2006, TROP MED INT HEALTH, V11, P129, DOI 10.1111/j.1365-3156.2005.01558.x; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kirby MJ, 2009, ACTA TROP, V109, P118, DOI 10.1016/j.actatropica.2008.09.025; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Lariviere M, 1966, Bull Soc Med Afr Noire Lang Fr, V11, P670; Lenhart Audrey, 2007, Filaria J, V6, P14, DOI 10.1186/1475-2883-6-14; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Love T, 2002, CLIMATE PREDICTION C; Molyneux DH, 2003, T ROY SOC TROP MED H, V97, P129, DOI 10.1016/S0035-9203(03)90097-6; Muturi EJ, 2007, J MED ENTOMOL, V44, P336, DOI 10.1603/0022-2585(2007)44[336:MSSAPF]2.0.CO;2; Ndiath MO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-136; *NOAA, 2008, DAILY DIAGN GROUND Q; *NOAA, 2008, DAILY DIAGN AB GROUN; *NOAA, 2008, NCEP CPC FEWS AFR DA; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; *USGS, 2008, NORM DIFF VEG IND LA; WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121; WHO, 2004, WHOCDSCPEPVC200410; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29; DIRECTORY CITIES TOW	46	68	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9927	10.1371/journal.pone.0009927	http://dx.doi.org/10.1371/journal.pone.0009927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360950	Green Published, Green Accepted, gold			2022-12-25	WOS:000276163100019
J	Scott, JJ; Budsberg, KJ; Suen, G; Wixon, DL; Balser, TC; Currie, CR				Scott, Jarrod J.; Budsberg, Kevin J.; Suen, Garret; Wixon, Devin L.; Balser, Teri C.; Currie, Cameron R.			Microbial Community Structure of Leaf-Cutter Ant Fungus Gardens and Refuse Dumps	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACID; CUTTING ANTS; SOIL; BACTERIA; POPULATION; DYNAMICS; BIOMASS; NESTS; LIPOPOLYSACCHARIDES; METAGENOMICS	Background: Leaf-cutter ants use fresh plant material to grow a mutualistic fungus that serves as the ants' primary food source. Within fungus gardens, various plant compounds are metabolized and transformed into nutrients suitable for ant consumption. This symbiotic association produces a large amount of refuse consisting primarily of partly degraded plant material. A leaf-cutter ant colony is thus divided into two spatially and chemically distinct environments that together represent a plant biomass degradation gradient. Little is known about the microbial community structure in gardens and dumps or variation between lab and field colonies. Methodology/Principal Findings: Using microbial membrane lipid analysis and a variety of community metrics, we assessed and compared the microbiota of fungus gardens and refuse dumps from both laboratory-maintained and field-collected colonies. We found that gardens contained a diverse and consistent community of microbes, dominated by Gram-negative bacteria, particularly gamma-Proteobacteria and Bacteroidetes. These findings were consistent across lab and field gardens, as well as host ant taxa. In contrast, dumps were enriched for Gram-positive and anaerobic bacteria. Broad-scale clustering analyses revealed that community relatedness between samples reflected system component (gardens/dumps) rather than colony source (lab/field). At finer scales samples clustered according to colony source. Conclusions/Significance: Here we report the first comparative analysis of the microbiota from leaf-cutter ant colonies. Our work reveals the presence of two distinct communities: one in the fungus garden and the other in the refuse dump. Though we find some effect of colony source on community structure, our data indicate the presence of consistently associated microbes within gardens and dumps. Substrate composition and system component appear to be the most important factor in structuring the microbial communities. These results thus suggest that resident communities are shaped by the plant degradation gradient created by ant behavior, specifically their fungiculture and waste management.	[Scott, Jarrod J.; Budsberg, Kevin J.; Suen, Garret; Balser, Teri C.; Currie, Cameron R.] Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Scott, Jarrod J.; Suen, Garret; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Scott, Jarrod J.; Currie, Cameron R.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Budsberg, Kevin J.; Balser, Teri C.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Wixon, Devin L.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Scott, JJ (corresponding author), Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	currie@bact.wisc.edu	Suen, Garret/AAF-2080-2019	Suen, Garret/0000-0002-6170-711X; Scott, Jarrod/0000-0001-9863-1318; Wixon, Devin/0000-0002-5206-4650	National Science Foundation [DEB-0747002, MCB-0702025, MCB-0731822]; DOE Great Lakes Bioenergy Research Center [DE-FC02-07ER64494]; Direct For Biological Sciences [0747002] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); DOE Great Lakes Bioenergy Research Center(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation [grants DEB-0747002 (to CRC), MCB-0702025 (to CRC and TCB), and MCB-0731822 (to CRC)] and the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494, to (CRC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baath E, 2003, MICROBIAL ECOL, V45, P373, DOI 10.1007/s00248-003-2002-y; BACCI M, 1995, BRAZ J MED BIOL RES, V28, P79; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Belt T., 1874, NATURALIST NICARAGUA; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bull ID, 2000, NATURE, V405, P175, DOI 10.1038/35012061; Carreiro SC, 1997, ANTON LEEUW INT J G, V71, P243, DOI 10.1023/A:1000182108648; Colwell R. K., 2006, ESTIMATES VERSION 8; CRAVEN SE, 1970, SCIENCE, V169, P184, DOI 10.1126/science.169.3941.184; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Epstein E., 1997, SCI COMPOSTING; Farji-Brener AG, 2000, BIOTROPICA, V32, P120, DOI 10.1646/0006-3606(2000)032[0120:TIOWTD]2.0.CO;2; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fritze H, 2000, EUR J SOIL SCI, V51, P565, DOI 10.1046/j.1365-2389.2000.00346.x; Frostegard A, 1997, APPL ENVIRON MICROB, V63, P2224; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hallmann C, 2008, NAT GEOSCI, V1, P588, DOI 10.1038/ngeo260; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; HENDRICK D, 2005, MANUAL SOIL ANAL MON, P251; Herz H, 2007, BIOTROPICA, V39, P476, DOI 10.1111/j.1744-7429.2007.00283.x; Herz H, 2007, BIOTROPICA, V39, P482, DOI 10.1111/j.1744-7429.2007.00284.x; Holldobler B., 1990, pi; Hudson TM, 2009, SOIL BIOL BIOCHEM, V41, P1088, DOI 10.1016/j.soilbio.2009.02.014; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Keith-Roach MJ, 2002, BIOGEOCHEMISTRY, V60, P77, DOI 10.1023/A:1016553225977; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Little AEF, 2003, NATURWISSENSCHAFTEN, V90, P558, DOI 10.1007/s00114-003-0480-x; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Mentzer JL, 2006, PLANT SOIL, V284, P85, DOI 10.1007/s11104-006-0032-1; Midi I, 2001, SHERLOCK MICROBIAL I; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; MOSER JOHN C., 1963, ANN ENTOMOL SOC AMER, V56, P286, DOI 10.1093/aesa/56.3.286; Oravecz O, 2004, FOLIA MICROBIOL, V49, P83, DOI 10.1007/BF02931652; Petersen SO, 2002, SOIL SCI SOC AM J, V66, P826, DOI 10.2136/sssaj2002.0826; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Poulsen M, 2003, NATURWISSENSCHAFTEN, V90, P406, DOI 10.1007/s00114-003-0450-3; Ramsey PW, 2006, PEDOBIOLOGIA, V50, P275, DOI 10.1016/j.pedobi.2006.03.003; ROCKWOOD LL, 1976, ECOLOGY, V57, P48, DOI 10.2307/1936397; *SAS I INC, 2007, JMP; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Smithwick EAH, 2005, SOIL BIOL BIOCHEM, V37, P1546, DOI 10.1016/j.soilbio.2005.01.016; Srinivasan BS, 2005, NAT BIOTECHNOL, V23, P691, DOI 10.1038/nbt1098; Sternberg LD, 2007, P ROY SOC B-BIOL SCI, V274, P315, DOI 10.1098/rspb.2006.3746; SUEN G, 2010, INSECT HERBIVO UNPUB; Suen G, 2006, J BACTERIOL, V188, P7999, DOI 10.1128/JB.01195-06; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Weber N. A., 1972, GARDENING ANTS ATTIN; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; Wirth R, 2003, HERBIVORY LEAF CUTTI, P230; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zar, 2011, BIOSTAT ANAL; ZELLES L, 1992, SOIL BIOL BIOCHEM, V24, P317, DOI 10.1016/0038-0717(92)90191-Y; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	61	65	69	6	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9922	10.1371/journal.pone.0009922	http://dx.doi.org/10.1371/journal.pone.0009922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360970	gold, Green Published, Green Submitted			2022-12-25	WOS:000276163100015
J	Kalogeropoulos, M; Varanasi, SS; Olstad, OK; Sanderson, P; Gautvik, VT; Reppe, S; Francis, RM; Gautvik, KM; Birch, MA; Datta, HK				Kalogeropoulos, Michail; Varanasi, Satya S.; Olstad, Ole K.; Sanderson, Paul; Gautvik, Vigdis T.; Reppe, Sjur; Francis, Roger M.; Gautvik, Kaare M.; Birch, Mark A.; Datta, Harish K.			Zic1 transcription factor in bone: neural developmental protein regulates mechanotransduction in osteocytes	FASEB JOURNAL			English	Article						mechanical stress; fluid flow; shear stress; mechanosensors	MECHANICAL STRAIN; GENE-EXPRESSION; CILIA; SKELETOGENESIS; POLYCYSTIN-1; OSTEOGENESIS; DROSOPHILA; RESPONSES; PATHWAYS; ABLATION	A transcriptome analysis compared gene expression in human bone biopsy samples taken from lumbar spine and iliac crest, sites that experience high and low levels of mechanical stress, respectively. The analysis revealed that the zinc finger protein of cerebellum (Zic) family member transcription factor Zic1 was the most up-regulated gene in the lumbar spine (202-fold; P<10(-7)) in comparison with the iliac crest. Software analysis of differential gene expression in the biopsy samples identified the ciliary-related proteins PATCH1 and GLI-Kruppel family members Gli1 and Gli3 as part of a potential molecular network associated with Zic1. RT-PCR confirmed the expression of Zic1, Gli1, and Gli3 and other related key signaling mediators in osteoblastic cells and osteocytes in vitro. Zic1 was immunolocalized in the cytosol and nucleus of the murine osteocyte cell line MLO-Y4 and osteoblast-like cells MC3T3-E1 and in primary rat osteoblasts. MLO-Y4 cells subjected to prolonged oscillatory fluid flow showed increased localization of Zic1 in the nucleus with diminished levels in the cytosol, but no such changes were seen in MC3T3-E1 cells. A shear stress-induced increase in T-cell factor/lymphoid enhancer factor transcriptional activity was abolished by Zic1 gene silencing. These results suggest that Zic1, perhaps together with Gli1 and Gli3, may act as a link between mechanosensing and Wnt signaling. We conclude that Zic1, a neural developmental transcription factor, plays an important role in shear flow mechanotransduction in osteocytes.-Kalogeropoulos, M., Varanasi, S. S., Olstad, O. K., Sanderson, P., Gautvik, V. T., Reppe, S., Francis, R. M., Gautvik, K. M., Birch, M. A., Datta, H. K. Zic1 transcription factor in bone: neural developmental protein regulates mechanotransduction in osteocytes. FASEB J. 24, 2893-2903 (2010). www.fasebj.org	[Kalogeropoulos, Michail; Varanasi, Satya S.; Birch, Mark A.; Datta, Harish K.] Newcastle Univ, Sch Med, ICM, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Francis, Roger M.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Olstad, Ole K.; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Clin Chem, Oslo, Norway; [Sanderson, Paul] Newcastle Upon Tyne NHS Fdn Trust Hosp, Dept Orthopaed Surg, Newcastle Upon Tyne, Tyne & Wear, England; [Gautvik, Vigdis T.; Reppe, Sjur; Gautvik, Kaare M.] Lovisenberg Deacon Hosp, Dept Clin Chem, Oslo, Norway; [Gautvik, Kaare M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	Newcastle University - UK; Newcastle University - UK; University of Oslo; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Oslo	Datta, HK (corresponding author), Newcastle Univ, Sch Med, ICM, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	h.k.datta@ncl.ac.uk	Datta, Harish/AAN-5621-2020		European Union [FP6-502491]; Newcastle University	European Union(European Commission); Newcastle University	The authors are grateful to the participants who volunteered for the study, and gratefully acknowledge the contribution of the nursing and theater staff of Newcastle General and Freeman Hospitals. H.K.D. thanks Professor Lynda Bonewald (University of Missouri-Kansas Ciy, Kansas City, MO, USA) for the gift of MLO-Y4 cells. The work was supported by a grant from the European Union, project OSTEOGENE (FP6-502491) under FP6 (K.M.G. and H.K.D.), and from Newcastle University (H.K.D. and M.B.).	Al-oanzi ZH, 2006, CLIN CHEM, V52, P248, DOI 10.1373/clinchem.2005.059568; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Bonewald L., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P331; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DATTA HK, 2009, 31 ANN M AM SOC BON; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Inoue T, 2007, DEV BIOL, V306, P669, DOI 10.1016/j.ydbio.2007.04.003; Kamel MA, 2006, J BONE MINER RES, V21, pS92; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kraiss LW, 2000, AM J PHYSIOL-HEART C, V278, pH1537, DOI 10.1152/ajpheart.2000.278.5.H1537; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Mannion AF, 2000, SPINE, V25, P842, DOI 10.1097/00007632-200004010-00013; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Reppe S, 2007, AM J PHYSIOL-ENDOC M, V292, pE1465, DOI 10.1152/ajpendo.00487.2006; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519; Sprowson AP, 2008, J ORTHOP RES, V26, P1256, DOI 10.1002/jor.20606; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Vezeridis PS, 2006, BIOCHEM BIOPH RES CO, V348, P1082, DOI 10.1016/j.bbrc.2006.07.146; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Yang WC, 2009, BONE, V44, P32, DOI 10.1016/j.bone.2008.08.133; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068; SKELETAL SITE RELATE	49	31	32	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2893	2903		10.1096/fj.09-148908	http://dx.doi.org/10.1096/fj.09-148908			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354137				2022-12-25	WOS:000285005400029
J	Eliades, A; Papadantonakis, N; Ravid, K				Eliades, Alexia; Papadantonakis, Nikolaos; Ravid, Katya			New Roles for Cyclin E in Megakaryocytic Polyploidization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMITOTIC CELL-CYCLE; DNA-REPLICATION; MOLECULAR-MECHANISMS; PLATELET PRODUCTION; TRANSGENIC MICE; RE-REPLICATION; G1 CYCLIN; S PHASE; C-MYC; EXPRESSION	Megakaryocytes are platelet precursor cells that undergo endomitosis. During this process, repeated rounds of DNA synthesis are characterized by lack of late anaphase and cytokinesis. Physiologically, the majority of the polyploid megakaryocytes in the bone marrow are cell cycle arrested. As previously reported, cyclin E is essential for megakaryocyte polyploidy; however, it has remained unclear whether up-regulated cyclin E is an inducer of polyploidy in vivo. We found that cyclin E is up-regulated upon stimulation of primary megakaryocytes by thrombopoietin. Transgenic mice in which elevated cyclin E expression is targeted to megakaryocytes display an increased ploidy profile. Examination of S phase markers, specifically proliferating cell nuclear antigen, cyclin A, and 5-bromo-2-deoxyuridine reveals that cyclin E promotes progression to S phase and cell cycling. Interestingly, analysis of Cdc6 and Mcm2 indicates that cyclin E mediates its effect by promoting the expression of components of the pre-replication complex. Furthermore, we show that up-regulated cyclin E results in the up-regulation of cyclin B1 levels, suggesting an additional mechanism of cyclin E-mediated ploidy increase. These findings define a key role for cyclin E in promoting megakaryocyte entry into S phase and hence, increase in the number of cell cycling cells and in augmenting polyploidization.	[Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Whitaker Cardiovasc Inst,CVI,Dept Med, Boston, MA 02118 USA; [Eliades, Alexia; Papadantonakis, Nikolaos; Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Whitaker Cardiovasc Inst,Dept Biochem, Boston, MA 02118 USA; [Papadantonakis, Nikolaos] Univ Crete, Sch Med, Grad Program Mol Basis Human Dis, Iraklion 71003, Greece	Boston University; Boston University; University of Crete	Ravid, K (corresponding author), Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Whitaker Cardiovasc Inst,CVI,Dept Med, W-601,700 Albany St, Boston, MA 02118 USA.	kravid@bu.edu		Ravid, Katya/0000-0002-9918-3024; Eliades, Alexia/0000-0001-8459-7163	National Institutes of Health NHLBI [HL80442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080442] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grant HL80442 (to K. R.).	Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Arata Y, 2000, J BIOL CHEM, V275, P6337, DOI 10.1074/jbc.275.9.6337; Balduini CL, 2004, SEMIN THROMB HEMOST, V30, P513, DOI 10.1055/s-2004-835672; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carow CE, 2001, J CELL PHYSIOL, V188, P291, DOI 10.1002/jcp.1120; Datta NS, 1998, CELL GROWTH DIFFER, V9, P639; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Early A, 2004, PHILOS T R SOC B, V359, P31, DOI 10.1098/rstb.2003.1362; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Garcia P, 1996, ONCOGENE, V13, P695; Garcia P, 2000, ONCOGENE, V19, P1820, DOI 10.1038/sj.onc.1203494; Geddis AE, 2004, BLOOD, V104, P1017, DOI 10.1182/blood-2004-02-0419; Geddis AE, 2006, CELL CYCLE, V5, P538, DOI 10.4161/cc.5.5.2537; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Gudas JM, 1999, MOL CELL BIOL, V19, P612; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Italiano JE, 2007, J THROMB HAEMOST, V5, P18, DOI 10.1111/j.1538-7836.2007.02487.x; Iwabe K, 1998, BRIT J HAEMATOL, V102, P812, DOI 10.1046/j.1365-2141.1998.00819.x; Kaushansky K, 1999, BIOESSAYS, V21, P353, DOI 10.1002/(SICI)1521-1878(199904)21:4<353::AID-BIES12>3.0.CO;2-P; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Keck JM, 2007, J CELL BIOL, V178, P371, DOI 10.1083/jcb.200703202; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McCrann DJ, 2008, BLOOD, V111, P4092, DOI 10.1182/blood-2007-11-122150; McCrann DJ, 2009, BLOOD, V114, P1243, DOI 10.1182/blood-2008-12-195883; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Nguyen HG, 2005, BLOOD, V106, P1559, DOI 10.1182/blood-2005-02-0638; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Papadantonakis N, 2008, CELL CYCLE, V7, P2352, DOI 10.4161/cc.6325; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; PAULUS JM, 1970, BLOOD-J HEMATOL, V35, P298, DOI 10.1182/blood.V35.3.298.298; RAVID K, 1991, P NATL ACAD SCI USA, V88, P1521, DOI 10.1073/pnas.88.4.1521; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Roy L, 2001, BLOOD, V97, P2238, DOI 10.1182/blood.V97.8.2238; Sun S, 2001, HAEMATOLOGICA, V86, P17; Thompson A, 1996, J BIOL CHEM, V271, P22976, DOI 10.1074/jbc.271.38.22976; Tomer A, 2004, BLOOD, V104, P2722, DOI 10.1182/blood-2004-02-0769; Tsuruga H, 1997, BIOCHEM BIOPH RES CO, V236, P118, DOI 10.1006/bbrc.1997.6865; Vitrat N, 1998, BLOOD, V91, P3711; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; WANG ZY, 1995, BLOOD, V86, P3783, DOI 10.1182/blood.V86.10.3783.bloodjournal86103783; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Zariwala M, 1998, ONCOGENE, V17, P2787, DOI 10.1038/sj.onc.1202505; Zhang Y, 2004, BLOOD, V103, P3717, DOI 10.1182/blood-2003-09-3365; Zhang Y, 1998, J BIOL CHEM, V273, P1387, DOI 10.1074/jbc.273.3.1387; Zhang Y, 1996, J BIOL CHEM, V271, P4266; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	57	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18909	18917		10.1074/jbc.M110.102145	http://dx.doi.org/10.1074/jbc.M110.102145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392692	hybrid, Green Published			2022-12-25	WOS:000278453900081
J	He, C; Nora, GP; Schneider, EL; Kerr, ID; Hansell, E; Hirata, K; Gonzalez, D; Sajid, M; Boyd, SE; Hruz, P; Cobo, ER; Le, C; Liu, WT; Eckmann, L; Dorrestein, PC; Houpt, ER; Brinen, LS; Craik, CS; Roush, WR; McKerrow, J; Reed, SL				He, Chen; Nora, George P.; Schneider, Eric L.; Kerr, Iain D.; Hansell, Elizabeth; Hirata, Ken; Gonzalez, David; Sajid, Mohammed; Boyd, Sarah E.; Hruz, Petr; Cobo, Eduardo R.; Le, Christine; Liu, Wei-ting; Eckmann, Lars; Dorrestein, Pieter C.; Houpt, Eric R.; Brinen, Linda S.; Craik, Charles S.; Roush, William R.; McKerrow, James; Reed, Sharon L.			A Novel Entamoeba histolytica Cysteine Proteinase, EhCP4, Is Key for Invasive Amebiasis and a Therapeutic Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOZOAN PARASITE; TRANSCRIPTION FACTOR; GAL/GALNAC LECTIN; GENE-EXPRESSION; PROTEASES; CELLS; IDENTIFICATION; INHIBITION; PURIFICATION; COMPARTMENTS	Entamoeba histolytica cysteine proteinases (EhCPs) play a key role in disrupting the colonic epithelial barrier and the innate host immune response during invasion of E. histolytica, the protozoan cause of human amebiasis. EhCPs are encoded by 50 genes, of which ehcp4 (ehcp-a4) is the most up-regulated during invasion and colonization in a mouse cecal model of amebiasis. Up-regulation of ehcp4 in vivo correlated with our finding that co-culture of E. histolytica trophozoites with mucin-producing T84 cells increased ehcp4 expression up to 6-fold. We have expressed recombinant EhCP4, which was autocatalytically activated at acidic pH but had highest proteolytic activity at neutral pH. In contrast to the other amebic cysteine proteinases characterized so far, which have a preference for arginine in the P2 position, EhCP4 displayed a unique preference for valine and isoleucine at P2. This preference was confirmed by homology modeling, which revealed a shallow, hydrophobic S2 pocket. Endogenous EhCP4 localized to cytoplasmic vesicles, the nuclear region, and perinuclear endoplasmic reticulum (ER). Following co-culture with colonic cells, EhCP4 appeared in acidic vesicles and was released extracellularly. A specific vinyl sulfone inhibitor, WRR605, synthesized based on the substrate specificity of EhCP4, inhibited the recombinant enzyme in vitro and significantly reduced parasite burden and inflammation in the mouse cecal model. The unique expression pattern, localization, and biochemical properties of EhCP4 could be exploited as a potential target for drug design.	[Reed, Sharon L.] Univ Calif San Diego, Med Ctr, Div Infect Dis, Dept Pathol, San Diego, CA 92103 USA; [He, Chen; Hirata, Ken; Cobo, Eduardo R.; Reed, Sharon L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Nora, George P.; Roush, William R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Schneider, Eric L.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Kerr, Iain D.; Brinen, Linda S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Hansell, Elizabeth; Sajid, Mohammed; McKerrow, James] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94158 USA; [Gonzalez, David; Liu, Wei-ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-233 ZA Leiden, Netherlands; [Boyd, Sarah E.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia; [Boyd, Sarah E.] La Trobe Univ, Biosci Res Ctr, Bundoora, Vic 3086, Australia; [Hruz, Petr; Le, Christine; Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Houpt, Eric R.] Univ Virginia, Dept Internal Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; La Trobe University; La Trobe University; University of California System; University of California San Diego; University of Virginia	Reed, SL (corresponding author), Univ Calif San Diego, Med Ctr, Div Infect Dis, Dept Pathol, 200 W Arbor Dr, San Diego, CA 92103 USA.	slreed@ucsd.edu	Cobo, Eduardo R/AAF-2656-2021; Dorrestein, Pieter/D-5012-2012; Hruz, Petr/F-1406-2011; Boyd, Sarah E/I-9047-2012; Dorrestein, Pieter/ABF-2930-2020	Cobo, Eduardo R/0000-0001-5450-7673; Hruz, Petr/0000-0003-2767-0445; Boyd, Sarah/0000-0002-7264-8602	National Institutes of Health [1-UO1-AI077822, R01 CA128765]; University of California, San Diego; University of California, San Francisco; NATIONAL CANCER INSTITUTE [R01CA128765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); University of California, San Francisco(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1-UO1-AI077822 (to S.L.R., J.M., and W.R.R.) and R01 CA128765 (to E.L.S. and C.S.C.).; We are grateful for the technical support and the initial cecum-passed E. histolytica trophozoites from S. Stroup and Dr. X. T. Guo (University of Virginia). We thank the mouse surgery supporting team, G. Hwang, Y. Anderson, J. Scholtz, and H. Yoo (University of California, San Diego). We thank Dr. J. Engel (University of California, San Francisco) and J. Steinauer and Dr. L. Ellies (University of California, San Diego) for technical advice and support of microscopy; Dr. M. Diccianni (University of California, San Diego) for fluorescence scan; Dr. M. Ramos and Dr. S. Melendez-Lopez (Universidad Autonoma de Baja California, Mexico) for general advice; and Dr. S. J. Bark (University of California, San Diego) for identification of the purified recombinant EhCP4 antigen for antibody production. In addition, we thank Dr. C. Davis for critical review of the manuscript.	Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Beck DL, 2005, EUKARYOT CELL, V4, P722, DOI 10.1128/EC.4.4.722-732.2005; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; BEYNON R, 2001, PROTEOLYTIC ENZYMES, P144; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Brinen LS, 2000, ARCH MED RES, V31, pS63, DOI 10.1016/S0188-4409(00)00154-5; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Bruchhaus I, 1996, MOL MICROBIOL, V22, P255, DOI 10.1046/j.1365-2958.1996.00111.x; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Gilchrist CA, 1998, INFECT IMMUN, V66, P2383, DOI 10.1128/IAI.66.5.2383-2386.1998; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Gottke MU, 1998, J EUKARYOT MICROBIOL, V45, p17S, DOI 10.1111/j.1550-7408.1998.tb04519.x; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Hellberg A, 2002, PROTEIN EXPRES PURIF, V24, P131, DOI 10.1006/prep.2001.1548; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; KEENE WE, 1986, J EXP MED, V163, P536, DOI 10.1084/jem.163.3.536; KELSALL BL, 1993, J INFECT DIS, V168, P1319, DOI 10.1093/infdis/168.5.1319; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Lauwaet T, 2003, J BIOL CHEM, V278, P22650, DOI 10.1074/jbc.M300142200; LihBrody L, 1996, DIGEST DIS SCI, V41, P2078, DOI 10.1007/BF02093613; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; Maubach G, 2008, MOL BIOL CELL, V19, P4238, DOI 10.1091/mbc.E08-03-0291; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Melendez-Lopez SG, 2007, EUKARYOT CELL, V6, P1130, DOI 10.1128/EC.00094-07; Mitra BN, 2007, CELL MICROBIOL, V9, P2112, DOI 10.1111/j.1462-5822.2007.00941.x; Mitra BN, 2006, EXP PARASITOL, V114, P57, DOI 10.1016/j.exppara.2006.02.009; Moncada D, 2003, INFECT IMMUN, V71, P838, DOI 10.1128/IAI.71.2.838-844.2003; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Pizzorno MC, 2001, BBA-MOL BASIS DIS, V1536, P31, DOI 10.1016/S0925-4439(01)00032-1; Que XC, 2003, INFECT IMMUN, V71, P1274, DOI 10.1128/IAI.71.3.1274-1280.2003; Que XC, 2002, MOL BIOCHEM PARASIT, V119, P23, DOI 10.1016/S0166-6851(01)00387-5; Quintas-Granados LI, 2009, PROTEIN EXPRES PURIF, V63, P26, DOI 10.1016/j.pep.2008.09.006; REED SL, 1989, J IMMUNOL, V143, P189; REED SL, 1995, J IMMUNOL, V155, P266; Roush WR, 2001, BIOORG MED CHEM LETT, V11, P2759, DOI 10.1016/S0960-894X(01)00566-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato D, 2006, FEBS LETT, V580, P5306, DOI 10.1016/j.febslet.2006.08.081; Screen M, 2008, DEVELOPMENT, V135, P3311, DOI 10.1242/dev.025627; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Teixeira JE, 2008, EUKARYOT CELL, V7, P1222, DOI 10.1128/EC.00007-08; Tillack M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-170; Tran VQ, 1998, J INFECT DIS, V177, P508, DOI 10.1086/517388; Zhang Z, 2000, MOL MICROBIOL, V37, P542, DOI 10.1046/j.1365-2958.2000.02037.x	55	52	52	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18516	18527		10.1074/jbc.M109.086181	http://dx.doi.org/10.1074/jbc.M109.086181			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378535	Green Published, hybrid			2022-12-25	WOS:000278453900045
J	Choi, YS; Wu, K; Jeong, K; Lee, D; Jeon, YH; Choi, BS; Pan, ZQ; Ryu, KS; Cheong, C				Choi, Yun-Seok; Wu, Kenneth; Jeong, Kwiwan; Lee, Daeyoup; Jeon, Young Ho; Choi, Byong-Seok; Pan, Zhen-Qiang; Ryu, Kyoung-Seok; Cheong, Chaejoon			The Human Cdc34 Carboxyl Terminus Contains a Non-covalent Ubiquitin Binding Activity That Contributes to SCF-dependent Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; POLYUBIQUITIN CHAINS; LIGASE; CULLIN; NEDD8; COMPLEX; UBC3; TAIL; DEGRADATION; ACTIVATION	Cdc34 is an E2 ubiquitin-conjugating enzyme that functions in conjunction with SCF (Skp1.Cullin1.F-box) E3 ubiquitin ligase to catalyze covalent attachment of polyubiquitin chains to a target protein. Here we identified direct interactions between the human Cdc34 C terminus and ubiquitin using NMR chemical shift perturbation assays. The ubiquitin binding activity was mapped to two separate Cdc34 C-terminal motifs (UBS1 and UBS2) that comprise residues 206-215 and 216-225, respectively. UBS1 and UBS2 bind to ubiquitin in the proximity of ubiquitin Lys(48) and C-terminal tail, both of which are key sites for conjugation. When bound to ubiquitin in one orientation, the Cdc34 UBS1 aromatic residues (Phe(206), Tyr(207), Tyr(210), and Tyr(211)) are probably positioned in the vicinity of ubiquitin C-terminal residue Val(70). Replacement of UBS1 aromatic residues by glycine or of ubiquitin Val70 by alanine decreased UBS1-ubiquitin affinity interactions. UBS1 appeared to support the function of Cdc34 in vivo because human Cdc34(1-215) but not Cdc34(1-200) was able to complement the growth defect by yeast Cdc34 mutant strain. Finally, reconstituted I kappa B alpha ubiquitination analysis revealed a role for each adjacent pair of UBS1 aromatic residues (Phe(206)/Tyr(207), Tyr(210)/Tyr(211)) in conjugation, with Tyr(210) exhibiting the most pronounced catalytic function. Intriguingly, Cdc34 Tyr(210) was required for the transfer of the donor ubiquitin to a receptor lysine on either I kappa B alpha ora ubiquitin in a manner that depended on the neddylated RING subcomplex of the SCF. Taken together, our results identified a new ubiquitin binding activity within the human Cdc34 C terminus that contributes to SCF-dependent ubiquitination.	[Wu, Kenneth; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Choi, Yun-Seok; Jeon, Young Ho; Ryu, Kyoung-Seok; Cheong, Chaejoon] Korea Basic Sci Inst, Div Magnet Resonance, Ochang Eup 363883, Chungcheongbuk, South Korea; [Choi, Yun-Seok; Jeon, Young Ho; Ryu, Kyoung-Seok; Cheong, Chaejoon] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 350333, South Korea; [Jeong, Kwiwan; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, Byong-Seok] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Icahn School of Medicine at Mount Sinai; Korea Basic Science Institute (KBSI); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Pan, ZQ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu; ksryu@kbsi.re.kr; cheong@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022; Choi, Byong-Seok/C-1937-2011; Jeon, Young Ho/F-4483-2011; Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823	National Institutes of Health [GM61051, CA095634]; Korea Basic Science Institute [T3022E, T29221]; NCI, National Institutes of Health [T32 CA078207]; NATIONAL CANCER INSTITUTE [R01CA095634, T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Basic Science Institute; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61051 and CA095634 (to Z.-Q.P.). This work was also supported by the NMR Research Programs of the Korea Basic Science Institute (Grants T3022E (to K.-S.R.) and T29221 (to Y.H.J.)).; Supported by NCI, National Institutes of Health, Postdoctoral Training Grant T32 CA078207.	Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Choi YS, 2009, FEBS LETT, V583, P3323, DOI 10.1016/j.febslet.2009.09.034; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; PICKART CM, 1992, J BIOL CHEM, V267, P14418; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; PRENDERGAST JA, 1995, J BIOL CHEM, V270, P9347, DOI 10.1074/jbc.270.16.9347; PTAK C, 1994, J BIOL CHEM, V269, P26539; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105	32	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17754	17762		10.1074/jbc.M109.090621	http://dx.doi.org/10.1074/jbc.M109.090621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353940	Green Published, hybrid			2022-12-25	WOS:000278133400053
J	Inforzato, A; Baldock, C; Jowitt, TA; Holmes, DF; Lindstedt, R; Marcellini, M; Rivieccio, V; Briggs, DC; Kadler, KE; Verdoliva, A; Bottazzi, B; Mantovani, A; Salvatori, G; Day, AJ				Inforzato, Antonio; Baldock, Clair; Jowitt, Thomas A.; Holmes, David F.; Lindstedt, Ragnar; Marcellini, Marcella; Rivieccio, Vincenzo; Briggs, David C.; Kadler, Karl E.; Verdoliva, Antonio; Bottazzi, Barbara; Mantovani, Alberto; Salvatori, Giovanni; Day, Anthony J.			The Angiogenic Inhibitor Long Pentraxin PTX3 Forms an Asymmetric Octamer with Two Binding Sites for FGF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; FIBROBLAST-GROWTH-FACTOR; INNATE IMMUNITY; BIOLOGICAL MACROMOLECULES; NITRITE REDUCTASE; GENOMIC STRUCTURE; COILED COILS; RECOGNITION; SCATTERING; INFLAMMATION	The inflammation-associated long pentraxin PTX3 plays key roles in innate immunity, female fertility, and vascular biology (e.g. it inhibits FGF2 (fibroblast growth factor 2)-mediated angiogenesis). PTX3 is composed of multiple protomers, each composed of distinct N- and C-terminal domains; however, it is not known how these are organized or contribute to its functional properties. Here, biophysical analyses reveal that PTX3 is composed of eight identical protomers, associated through disulfide bonds, forming an elongated and asymmetric, molecule with two differently sized domains interconnected by a stalk. The N-terminal region of the protomer provides the main structural determinant underlying this quaternary organization, supporting formation of a disulfide-linked tetramer and a dimer of dimers (a non-covalent tetramer), giving rise to the asymmetry of the molecule. Furthermore, the PTX3 octamer is shown to contain two FGF2 binding sites, where it is the tetramers that act as the functional units in ligand recognition. Thus, these studies provide a unifying model of the PTX3 oligomer, explaining both its quaternary organization and how this is required for its anti-angiogenic function.	[Inforzato, Antonio; Baldock, Clair; Jowitt, Thomas A.; Holmes, David F.; Briggs, David C.; Kadler, Karl E.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Lindstedt, Ragnar; Marcellini, Marcella; Salvatori, Giovanni] Sigma Tau Ind Farmaceut Riunite SpA, I-00040 Pomezia, Italy; [Rivieccio, Vincenzo; Verdoliva, Antonio] Tecnogen SpA, I-81030 Loc La Fagianeria, Piana Monte Ver, Italy; [Bottazzi, Barbara; Mantovani, Alberto] Ist Clin Humanitas, I-20089 Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dipartimento Med Traslaz, I-20089 Rozzano, Italy	University of Manchester; IRCCS Humanitas Research Hospital; University of Milan	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk	Inforzato, Antonio/K-6954-2012; Inforzato, Antonio/ABG-4513-2020; Briggs, David/F-1199-2010; Mantovani, Alberto/HCI-7449-2022; KADLER, KARL/ABI-2403-2020; Day, Anthony/O-1658-2015; bottazzi, barbara/ABH-9274-2020	Inforzato, Antonio/0000-0001-8110-0027; Mantovani, Alberto/0000-0001-5578-236X; KADLER, KARL/0000-0003-4977-4683; Day, Anthony/0000-0002-1415-3134; bottazzi, barbara/0000-0002-1930-9257; Jowitt, Thomas/0000-0002-4045-0933; Baldock, Clair/0000-0003-3497-1959; Briggs, David/0000-0002-9793-7339	Sigma-Tau; Tecnogen; Arthritis Research UK [16539]; Medical Research Council [G0701180]; European Research Council; Fondazione Italiana per la Ricerca sul Cancro; Fondazione "Humanitas" per la Ricerca; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; MRC [G0701180] Funding Source: UKRI	Sigma-Tau; Tecnogen; Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione "Humanitas" per la Ricerca; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Sigma-Tau, Tecnogen, Arthritis Research UK Grant 16539, Medical Research Council Grant G0701180, and European Research Council Project HIIS.; Recipient of Fondazione Italiana per la Ricerca sul Cancro and Fondazione "Humanitas" per la Ricerca fellowships.	Aquilina JA, 2003, BIOCHEM J, V375, P323, DOI 10.1042/BJ20030541; Bamford VA, 2002, BIOCHEMISTRY-US, V41, P2921, DOI 10.1021/bi015765d; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2006, J LEUKOCYTE BIOL, V79, P909, DOI 10.1189/jlb.1005557; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Camozzi M, 2006, J BIOL CHEM, V281, P22605, DOI 10.1074/jbc.M601023200; Cotena A, 2007, J IMMUNOL, V179, P6311, DOI 10.4049/jimmunol.179.9.6311; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Einsle O, 2000, J BIOL CHEM, V275, P39608, DOI 10.1074/jbc.M006188200; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Introna M, 1996, BLOOD, V87, P1862; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kishore U, 2001, Results Probl Cell Differ, V33, P225; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEALI D, 2010, J CELL MOL IN PRESS; LEE GW, 1993, J IMMUNOL, V150, P1804; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Omeis IA, 1996, GENOMICS, V36, P543, DOI 10.1006/geno.1996.0503; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Rivieccio V, 2007, PROTEIN EXPRES PURIF, V51, P49, DOI 10.1016/j.pep.2006.07.009; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Ruprecht J, 2001, PROG BIOPHYS MOL BIO, V75, P121, DOI 10.1016/S0079-6107(01)00004-9; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shrive AK, 1999, J MOL BIOL, V290, P997, DOI 10.1006/jmbi.1999.2956; SQUIRES CH, 1988, J BIOL CHEM, V263, P16297; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Yadav MK, 2006, BIOCHEMISTRY-US, V45, P4463, DOI 10.1021/bi060092q	53	88	90	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17681	17692		10.1074/jbc.M109.085639	http://dx.doi.org/10.1074/jbc.M109.085639			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363749	Green Published, hybrid			2022-12-25	WOS:000278133400046
J	Natarajan, M; August, A; Henderson, AJ				Natarajan, Malini; August, Avery; Henderson, Andrew J.			Combinatorial Signals from CD28 Differentially Regulate Human Immunodeficiency Virus Transcription in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LONG-TERMINAL REPEAT; KINASE-C-THETA; HIV-1 GENE-EXPRESSION; P-TEFB; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNOLOGICAL SYNAPSE; HISTONE ACETYLATION; CYTOPLASMIC TAIL; 7SK SNRNA	Activation through the T-cell receptor and the costimulatory receptor CD28 supports efficient HIV transcription as well as reactivation of latent provirus. To characterize critical signals associated with CD28 that regulate HIV-1 transcription, we generated a library of chimeric CD28 receptors that harbored different combinations of key tyrosine residues in the cytoplasmic tail, Tyr-173, Tyr-188, Tyr-191, and Tyr-200. We found that Tyr-191 and Tyr-200 induce HIV-1 transcription via the activation of NF-kappa B and its recruitment to the HIV-long terminal repeat. Tyr-188 modifies positive and negative signals associated with CD28. Importantly, signaling through Tyr-188, Tyr-191, and Tyr-200 is required to overcome the inhibition posed by Tyr-173. CD28 also regulates P-TEFb activity, which is necessary for HIV-1 transcription processivity, by limiting the release of P-TEFb from the HEXIM1-7SK inhibitory complex in response to T-cell receptor signaling. Our studies reveal that CD28 regulates HIV-1 provirus transcription through a complex interplay of positive and negative signals that may be manipulated to control HIV-1 transcription and replication.	Penn State Univ, Intercoll Grad Degree Program Immunol & Infect Di, University Pk, PA 16802 USA; [August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Natarajan, Malini; Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis,Ctr HIV AIDS Care & Res, Boston, MA 02118 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University	Henderson, AJ (corresponding author), Boston Univ, Sch Med, Dept Med, Evans Biomed Res Ctr 648, 650 Albany St, Boston, MA 02118 USA.	andrew.henderson@bmc.org		Henderson, Andrew/0000-0002-9299-5302	National Institutes of Health, NIAID [AI062467]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI062467, R01AI062467] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI062467 (to A. J. H.) from NIAID.	ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Bagasra O, 2006, EXPERT OPIN BIOL TH, V6, P1135, DOI 10.1517/14712598.6.11.1135; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bieniasz PD, 1999, P NATL ACAD SCI USA, V96, P7791, DOI 10.1073/pnas.96.14.7791; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brooks DG, 2003, P NATL ACAD SCI USA, V100, P12955, DOI 10.1073/pnas.2233345100; Burke B, 2007, J VIROL, V81, P7424, DOI 10.1128/JVI.02838-06; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Cook JA, 2003, J BIOL CHEM, V278, P35812, DOI 10.1074/jbc.M302878200; Cook JA, 2002, J IMMUNOL, V169, P254, DOI 10.4049/jimmunol.169.1.254; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dienz O, 2003, J IMMUNOL, V170, P365, DOI 10.4049/jimmunol.170.1.365; Dodson LF, 2009, MOL CELL BIOL, V29, P3710, DOI 10.1128/MCB.01869-08; Duverger A, 2009, J VIROL, V83, P3078, DOI 10.1128/JVI.02058-08; Gogishvili T, 2008, EUR J IMMUNOL, V38, P2528, DOI 10.1002/eji.200838223; GRUTERS RA, 1991, EUR J IMMUNOL, V21, P167, DOI 10.1002/eji.1830210125; Gummuluru S, 1999, J VIROL, V73, P5422, DOI 10.1128/JVI.73.7.5422-5430.1999; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; King PD, 1997, J IMMUNOL, V158, P580; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Marinari B, 2002, EUR J IMMUNOL, V32, P447, DOI 10.1002/1521-4141(200202)32:2<447::AID-IMMU447>3.0.CO;2-5; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pumfery A, 2003, CURR HIV RES, V1, P343, DOI 10.2174/1570162033485186; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Sadowski I, 2008, CURR HIV RES, V6, P286, DOI 10.2174/157016208785132563; Sadra A, 2004, P NATL ACAD SCI USA, V101, P11422, DOI 10.1073/pnas.0403792101; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; Teng JMC, 1996, TISSUE ANTIGENS, V48, P255, DOI 10.1111/j.1399-0039.1996.tb02643.x; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang SD, 2004, MICROBES INFECT, V6, P759, DOI 10.1016/j.micinf.2004.03.007; Ward SG, 1996, BIOCHEM J, V318, P361, DOI 10.1042/bj3180361; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Zhang J, 2000, J BIOL CHEM, V275, P34314, DOI 10.1074/jbc.M006804200; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200	62	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17338	17347		10.1074/jbc.M109.085324	http://dx.doi.org/10.1074/jbc.M109.085324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368329	hybrid, Green Published			2022-12-25	WOS:000278133400011
J	Kim, HJ; Yamaguchi, S; Li, Q; So, I; Muallem, S				Kim, Hyun Jin; Yamaguchi, Soichiro; Li, Qin; So, Insuk; Muallem, Shmuel			Properties of the TRPML3 Channel Pore and Its Stable Expansion by the Varitint-Waddler-causing Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X RECEPTOR CHANNELS; CONSTITUTIVE ACTIVITY; IONIC SELECTIVITY; CELL DEGENERATION; ORGANIC CATIONS; MOUSE; DEAFNESS; CA2+; TRAFFICKING; PERMEATION	TRPML3 is a H+-regulated Ca2+ channel that shuttles between intracellular compartments and the plasma membrane. The A419P mutation causes the varitint-waddler phenotype as a result of gain-of-function (GOF). The mechanism by which A419P leads to GOF is not known. Here, we show that the TRPML3 pore is dynamic when conducting Ca2+ to change its conductance and permeability, which appears to be mediated by trapping Ca2+ within the pore. The pore properties can be restored by strong depolarization or by conducting Na+ through the pore. The A419P mutation results in expanded channel pore with altered permeability that limits modulation of the pore by Ca2+. This effect is specific for the A419P mutation and is not reproduced by other GOF mutations, including A419G, H283A, and proline mutations in the fifth transmembrane domain. These findings describe a novel mode of a transient receptor potential channel behavior and suggest that pore expansion by the A419P mutation may contribute to the varitint-waddler phenotype.	[So, Insuk] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Seoul National University (SNU); University of Texas System; University of Texas Southwestern Medical Center Dallas		shmuel.muallem@utsouthwestern.edu	So, Insuk/J-2762-2012; Yamaguchi, Soichiro/Q-8563-2019		National Institutes of Health [DE12309, DK38938]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DE12309 and DK38938 and the Ruth S. Harrell Professorship in Medical Research.	Atiba-Davies M, 2007, BBA-MOL BASIS DIS, V1772, P1028, DOI 10.1016/j.bbadis.2007.01.007; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cuajungco MP, 2008, PFLUG ARCH EUR J PHY, V457, P463, DOI 10.1007/s00424-008-0523-4; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; SABOVCIK R, 1995, J GEN PHYSIOL, V106, P149, DOI 10.1085/jgp.106.2.149; Samways DSK, 2008, J BIOL CHEM, V283, P31274, DOI 10.1074/jbc.C800131200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104	25	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16513	16520		10.1074/jbc.M109.078204	http://dx.doi.org/10.1074/jbc.M109.078204			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20378547	hybrid, Green Published			2022-12-25	WOS:000277982600013
J	Powell, E; Wang, YD; Shapiro, DJ; Xu, W				Powell, Emily; Wang, Yidan; Shapiro, David J.; Xu, Wei			Differential Requirements of Hsp90 and DNA for the Formation of Estrogen Receptor Homodimers and Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; RESPONSE ELEMENTS; STEROID-RECEPTORS; ALPHA; LIGAND; BETA; HORMONE; TARGET; DIMERIZATION; INHIBITOR	The two estrogen receptor (ER) subforms, ER alpha and ER beta, are capable of forming DNA-binding homodimers and heterodimers. Although binding to DNA is thought to stabilize ER dimers, how ER alpha/alpha, ER beta/beta, and ER alpha/beta dimerization is regulated by DNA and the chaperone protein Hsp90 is poorly understood. Using our highly optimized bioluminescence resonance energy transfer assays in conjunction with assays for transcriptional activation of ERs, we determined that DNA binding appears to play a minor role in the stabilization of ER dimers, especially in the case of ER beta/beta homodimers. These findings suggest that ER dimers form before they associate with chromatin and that DNA binding plays a minor role in stabilizing ER dimers. Additionally, although Hsp90 is essential for the proper dimerization of ER beta/beta and ER alpha/beta, it is not required for the proper dimerization of ER alpha/alpha. Despite this, Hsp90 is critical for the estrogen-dependent transcriptional activity of the ER beta/beta homodimer. Thus, Hsp90 is implicated as an important regulator of distinct aspects of ER alpha and ER beta action.	[Powell, Emily; Wang, Yidan; Xu, Wei] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Shapiro, David J.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign	Xu, W (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Rm 421A,1400 Univ Ave, Madison, WI 53706 USA.	wxu@oncology.wisc.edu	wang, yidan/G-4566-2013		National Institutes of Health [RO1 CA125387, RO3 MH089442, RO1 DK071909, T32 CA009135]; NATIONAL CANCER INSTITUTE [T32CA009135, R01CA125387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH089442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA125387 and RO3 MH089442 (to W. X.), RO1 DK071909 (to D.J.S.), and T32 CA009135 (to E. P.).	Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Bagatell R, 2001, CLIN CANCER RES, V7, P2076; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; Beliakoff J, 2003, CLIN CANCER RES, V9, P4961; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Drysdale MJ, 2006, CURR OPIN DRUG DISC, V9, P483; Egorin MJ, 2002, CANCER CHEMOTH PHARM, V49, P7, DOI 10.1007/s00280-001-0380-8; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Gougelet A, 2005, J STEROID BIOCHEM, V94, P71, DOI 10.1016/j.jsbmb.2005.01.018; GREEN S, 1989, CANCER RES, V49, pS2282; GREEN S, 1988, EMBO J, V7, P3037, DOI 10.1002/j.1460-2075.1988.tb03168.x; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hergenrother PJ, 2006, CURR OPIN CHEM BIOL, V10, P213, DOI 10.1016/j.cbpa.2006.04.005; HIRST MA, 1992, P NATL ACAD SCI USA, V89, P5527, DOI 10.1073/pnas.89.12.5527; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Koterba Kristen L, 2006, Nucl Recept Signal, V4, pe021; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Kuntz MA, 1997, J BIOL CHEM, V272, P27949, DOI 10.1074/jbc.272.44.27949; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Michelini E, 2004, ANAL CHEM, V76, P7069, DOI 10.1021/ac048914h; MURDOCH FE, 1995, BIOCHEMISTRY-US, V34, P9144, DOI 10.1021/bi00028a025; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Putt KS, 2004, ANAL BIOCHEM, V333, P256, DOI 10.1016/j.ab.2004.04.032; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Saji S, 2005, CANCER CHEMOTH PHARM, V56, pS21, DOI 10.1007/s0028-005-0107-3; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Sun J, 1999, ENDOCRINOLOGY, V140, P800, DOI 10.1210/en.140.2.800; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; WHITE R, 1991, J STEROID BIOCHEM, V40, P333, DOI 10.1016/0960-0760(91)90199-F; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	42	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16125	16134		10.1074/jbc.M110.104356	http://dx.doi.org/10.1074/jbc.M110.104356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20353944	Green Published, hybrid			2022-12-25	WOS:000277715900050
J	O'Donovan, KJ; Diedler, J; Couture, GC; Fak, JJ; Darnell, RB				O'Donovan, Kevin J.; Diedler, Jennifer; Couture, Graeme C.; Fak, John J.; Darnell, Robert B.			The Onconeural Antigen cdr2 Is a Novel APC/C Target that Acts in Mitosis to Regulate C-Myc Target Genes in Mammalian Tumor Cells	PLOS ONE			English	Article							PARANEOPLASTIC CEREBELLAR DEGENERATION; ANAPHASE-PROMOTING COMPLEX; GENOMIC TARGETS; PROTEIN-KINASE; GRANULE CELLS; KEN BOX; EXPRESSION; IDENTIFICATION; CYCLE; DIFFERENTIATION	Cdr2 is a tumor antigen expressed in a high percentage of breast and ovarian tumors and is the target of a naturally occurring tumor immune response in patients with paraneoplastic cerebellar degeneration, but little is known of its regulation or function in cancer cells. Here we find that cdr2 is cell cycle regulated in tumor cells with protein levels peaking in mitosis. As cells exit mitosis, cdr2 is ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) and rapidly degraded by the proteasome. Previously we showed that cdr2 binds to the oncogene c-myc, and here we extend this observation to show that cdr2 and c-myc interact to synergistically regulate c-myc-dependent transcription during passage through mitosis. Loss of cdr2 leads to functional consequences for dividing cells, as they show aberrant mitotic spindle formation and impaired proliferation. Conversely, cdr2 overexpression is able to drive cell proliferation in tumors. Together, these data indicate that the onconeural antigen cdr2 acts during mitosis in cycling cells, at least in part through interactions with c-myc, to regulate a cascade of actions that may present new targeting opportunities in gynecologic cancer.	[O'Donovan, Kevin J.] Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY USA; Rockefeller Univ, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donovan, KJ (corresponding author), Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088	NIH [R01 CA85784]; NATIONAL CANCER INSTITUTE [R01CA085784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH grant R01 CA85784. RBD is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Balamurugan K, 2009, ONCOGENE, V28, P3274, DOI 10.1038/onc.2009.186; BANKER G, 1998, CULTURING NERVE CELL, V12; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Corradi JP, 1997, J NEUROSCI, V17, P1406; Dang CV, 1999, MOL CELL BIOL, V19, P1; Darnell JC, 2000, CANCER RES, V60, P2136; DARNELL RB, 1985, MOL CELL BIOL, V5, P3157, DOI 10.1128/MCB.5.11.3157; Darnell RB, 2006, SEMIN ONCOL, V33, P270, DOI 10.1053/j.seminoncol.2006.03.008; Delcuve GP, 2008, J CELL BIOCHEM, V105, P1, DOI 10.1002/jcb.21806; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FATHALLAHSHAYKH H, 1991, P NATL ACAD SCI USA, V88, P3451, DOI 10.1073/pnas.88.8.3451; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fletcher CF, 1997, GENOMICS, V45, P313, DOI 10.1006/geno.1997.4925; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Gatti G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005442; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; JORDAN MA, 1992, J CELL SCI, V102, P401; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kimmelman AC, 2002, MOL CELL BIOL, V22, P5946, DOI 10.1128/MCB.22.16.5946-5961.2002; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Liu D, 2000, ONCOGENE, V19, P5964, DOI 10.1038/sj.onc.1203992; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; O'Donovan KJ, 1999, MOL CELL BIOL, V19, P4711; O'Donovan KJ, 1998, J NEUROCHEM, V70, P1241; Okano HJ, 1999, GENE DEV, V13, P2087, DOI 10.1101/gad.13.16.2087; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfleger CM, 2000, GENE DEV, V14, P655; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Roberts WK, 2004, CURR OPIN IMMUNOL, V16, P616, DOI 10.1016/j.coi.2004.07.009; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; SAKAI K, 1990, ANN NEUROL, V28, P692, DOI 10.1002/ana.410280515; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Santomasso BD, 2007, P NATL ACAD SCI USA, V104, P19073, DOI 10.1073/pnas.0704336104; SETH A, 1993, MOL CELL BIOL, V13, P4125, DOI 10.1128/MCB.13.7.4125; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; WAKAMATSU Y, 1993, NEURON, V10, P1, DOI 10.1016/0896-6273(93)90236-K; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	61	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10045	10.1371/journal.pone.0010045	http://dx.doi.org/10.1371/journal.pone.0010045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383333	Green Published, gold, Green Submitted			2022-12-25	WOS:000276454000010
J	Stegmann, CM; Luhrmann, R; Wahl, MC				Stegmann, Christian M.; Luehrmann, Reinhard; Wahl, Markus C.			The Crystal Structure of PPIL1 Bound to Cyclosporine A Suggests a Binding Mode for a Linear Epitope of the SKIP Protein	PLOS ONE			English	Article							CYCLOPHILIN; COREGULATOR; SPLICEOSOME; MOLECULES; INSIGHTS; SNW/SKIP; COMPLEX	Background: The removal of introns from pre-mRNA is carried out by a large macromolecular machine called the spliceosome. The peptidyl-prolyl cis/trans isomerase PPIL1 is a component of the human spliceosome and binds to the spliceosomal SKIP protein via a binding site distinct from its active site. Principal Findings: Here, we have studied the PPIL1 protein and its interaction with SKIP biochemically and by X-ray crystallography. A minimal linear binding epitope derived from the SKIP protein could be determined using a peptide array. A 36-residue region of SKIP centred on an eight-residue epitope suffices to bind PPIL1 in pull-down experiments. The crystal structure of PPIL1 in complex with the inhibitor cyclosporine A (CsA) was obtained at a resolution of 1.15 angstrom and exhibited two bound Cd2+ ions that enabled SAD phasing. PPIL1 residues that have previously been implicated in binding of SKIP are involved in the coordination of Cd2+ ions in the present crystal structure. Employing the present crystal structure, the determined minimal binding epitope and previously published NMR data [1], a molecular docking study was performed. In the docked model of the PPIL1-SKIP interaction, a proline residue of SKIP is buried in a hydrophobic pocket of PPIL1. This hydrophobic contact is encircled by several hydrogen bonds between the SKIP peptide and PPIL1. Conclusion: We characterized a short, linear epitope of SKIP that is sufficient to bind the PPIL1 protein. Our data indicate that this SKIP peptide could function in recruiting PPIL1 into the core of the spliceosome. We present a molecular model for the binding mode of SKIP to PPIL1 which emphasizes the versatility of cyclophilin-type PPIases to engage in additional interactions with other proteins apart from active site contacts despite their limited surface area.	[Stegmann, Christian M.; Luehrmann, Reinhard; Wahl, Markus C.] Max Planck Inst Biophys Chem, Gottingen, Germany; [Stegmann, Christian M.; Wahl, Markus C.] Free Univ Berlin, Max Planck Inst Biophys Chem, AG Strukturbiochem, Inst Chem & Biochem, D-1000 Berlin, Germany	Max Planck Society; Free University of Berlin; Max Planck Society	Stegmann, CM (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	mwahl@gwdg.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307	German National Academic Foundation; VW Foundation [VW I/81 649]; Max Planck Society	German National Academic Foundation; VW Foundation(Volkswagen); Max Planck Society(Max Planck Society)	C. M. S. was supported by a fellowship of the German National Academic Foundation (Studienstiftung). This research was supported by a grant from the VW Foundation (VW I/81 649) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mesa A, 2008, FEBS LETT, V582, P2345, DOI 10.1016/j.febslet.2008.06.006; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; REES DC, 1983, J MOL BIOL, V168, P367, DOI 10.1016/S0022-2836(83)80024-2; Reidt U, 2003, J MOL BIOL, V331, P45, DOI 10.1016/S0022-2836(03)00684-3; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skruzny M, 2001, BBA-GENE STRUCT EXPR, V1521, P146, DOI 10.1016/S0167-4781(01)00301-3; Stegmann CM, 2009, ANGEW CHEM INT EDIT, V48, P5207, DOI 10.1002/anie.200900481; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thai V, 2008, J MOL BIOL, V378, P71, DOI 10.1016/j.jmb.2007.08.051; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang XS, 2010, J BIOL CHEM, V285, P4951, DOI 10.1074/jbc.M109.087528; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200	26	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10013	10.1371/journal.pone.0010013	http://dx.doi.org/10.1371/journal.pone.0010013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368803	Green Submitted, gold, Green Published			2022-12-25	WOS:000276419900013
J	Gaiteri, C; Guilloux, JP; Lewis, DA; Sibille, E				Gaiteri, Chris; Guilloux, Jean-Philippe; Lewis, David A.; Sibille, Etienne			Altered Gene Synchrony Suggests a Combined Hormone-Mediated Dysregulated State in Major Depression	PLOS ONE			English	Article								Coordinated gene transcript levels across tissues (denoted "gene synchrony") reflect converging influences of genetic, biochemical and environmental factors; hence they are informative of the biological state of an individual. So could brain gene synchrony also integrate the multiple factors engaged in neuropsychiatric disorders and reveal underlying pathologies? Using bootstrapped Pearson correlation for transcript levels for the same genes across distinct brain areas, we report robust gene transcript synchrony between the amygdala and cingulate cortex in the human postmortem brain of normal control subjects (n = 14; Control/Permutated data, p<0.000001). Coordinated expression was confirmed across distinct prefrontal cortex areas in a separate cohort (n = 19 subjects) and affected different gene sets, potentially reflecting regional network- and function-dependent transcriptional programs. Genewise regional transcript coordination was independent of age-related changes and array technical parameters. Robust shifts in amygdala-cingulate gene synchrony were observed in subjects with major depressive disorder (MDD, denoted here "depression") (n = 14; MDD/Permutated data, p<0.000001), significantly affecting between 100 and 250 individual genes (10-30% false discovery rate). Biological networks and signal transduction pathways corresponding to the identified gene set suggested putative dysregulated functions for several hormone-type factors previously implicated in depression (insulin, interleukin-1, thyroid hormone, estradiol and glucocorticoids; p<0.01 for association with depression-related networks). In summary, we showed that coordinated gene expression across brain areas may represent a novel molecular probe for brain structure/function that is sensitive to disease condition, suggesting the presence of a distinct and integrated hormone-mediated corticolimbic homeostatic, although maladaptive and pathological, state in major depression.	[Gaiteri, Chris; Guilloux, Jean-Philippe; Lewis, David A.; Sibille, Etienne] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Gaiteri, Chris; Lewis, David A.; Sibille, Etienne] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Guilloux, Jean-Philippe] Univ Paris 11, Fac Pharm, EA 3544, F-92290 Chatenay Malabry, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UDICE-French Research Universities; Universite Paris Saclay	Gaiteri, C (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	sibilleel@upmc.edu	JP, Guilloux/Z-5069-2019; Guilloux, Jean-Philippe/B-3726-2015; Lewis, David A/G-4053-2014	JP, Guilloux/0000-0003-0982-3751; Guilloux, Jean-Philippe/0000-0003-0982-3751; Lewis, David A/0000-0002-3225-6778; Gaiteri, Chris/0000-0001-7838-8664	National Institute of Mental Health [MH077159, MH084060, MH084053]; University of Pittsburgh Institute for Clinical Research Education; Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, TL1TR000145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077159, K02MH084060, P50MH084053] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Pittsburgh Institute for Clinical Research Education; Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the following grants from the National Institute of Mental Health (NIMH): MH077159 (E.S.), MH084060 (E.S.) and MH084053 (D.A.L.), and by a fellowship from the University of Pittsburgh Institute for Clinical Research Education and the Clinical and Translational Science (C.G.). The funding agency had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health.	Altar CA, 2008, BIOL PSYCHIAT, V64, P1077, DOI 10.1016/j.biopsych.2008.08.031; BAUER M, 2003, CURR PSYCHIAT REP, V53, P163; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Galfalvy HC, 2003, BMC BIOINFORMATICS, V4, P1, DOI 10.1186/1471-2105-4-37; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hsiung S, 2003, J NEUROCHEM, V87, P182, DOI 10.1046/j.1471-4159.2003.01987.x; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; LEWIS DA, 1983, ARCH GEN PSYCHIAT, V40, P167; Matthews SC, 2008, J AFFECT DISORDERS, V111, P13, DOI 10.1016/j.jad.2008.05.022; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Sibille E, 2009, AM J PSYCHIAT, V166, P1011, DOI 10.1176/appi.ajp.2009.08121760; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Sliwerska E, 2007, BIOL PSYCHIAT, V61, P13, DOI 10.1016/j.biopsych.2006.01.023; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; WARDEN D, 2007, CURR PSYCHIAT REP, V96, P449	38	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9970	10.1371/journal.pone.0009970	http://dx.doi.org/10.1371/journal.pone.0009970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376317	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000276418200043
J	Macia, L; Viltart, O; Delacre, M; Sachot, C; Heliot, L; Di Santo, JP; Wolowczuk, I				Macia, Laurence; Viltart, Odile; Delacre, Myriam; Sachot, Christelle; Heliot, Laurent; Di Santo, James P.; Wolowczuk, Isabelle			Interleukin-7, a New Cytokine Targeting the Mouse Hypothalamic Arcuate Nucleus: Role in Body Weight and Food Intake Regulation	PLOS ONE			English	Article							NERVOUS-SYSTEM CONTROL; IL-7; MICE; OBESITY; NEURONS; CELLS; BCL-2; LEADS; MTOR; STAT	Body weight is controlled through peripheral (white adipose tissue) and central (mainly hypothalamus) mechanisms. We have recently obtained evidence that overexpression of interleukin (IL)-7, a critical cytokine involved in lymphopoiesis, can protect against the development of diet-induced obesity in mice. Here we assessed whether IL-7 mediated its effects by modulating hypothalamic function. Acute subcutaneous injection of IL-7 prevented monosodium glutamate-induced obesity, this being correlated with partial protection against cell death in the hypothalamic arcuate nucleus (ARC). Moreover, we showed that IL-7 activated hypothalamic areas involved in regulation of feeding behavior,as indicated by induction of the activation marker c-Fos in neural cells located in the ventromedial part of the ARC and by inhibition of food intake after fasting. Both chains of the IL-7 receptor (IL-7R alpha and gamma c) were expressed in the ARC and IL-7 injection induced STAT-3 phosphorylation in this area. Finally, we established that IL-7 modulated the expression of neuropeptides that tune food intake, with a stimulatory effect on the expression of pro-opiomelanocortin and an inhibitory effect on agouti-related peptide expression in accordance with IL-7 promoting anorectic effects. These results suggest that the immunomodulatory cytokine IL-7 plays an important and unappreciated role in hypothalamic body weight regulation.	[Macia, Laurence; Viltart, Odile; Delacre, Myriam; Sachot, Christelle; Heliot, Laurent; Wolowczuk, Isabelle] Univ Lille Nord France, Lille, France; [Macia, Laurence; Viltart, Odile; Delacre, Myriam; Wolowczuk, Isabelle] Inst Pasteur, Lab Neuroimmunoendocrinol, F-59019 Lille, France; [Macia, Laurence; Viltart, Odile; Delacre, Myriam; Wolowczuk, Isabelle] Inst Pasteur, IFR 142, F-59019 Lille, France; [Viltart, Odile; Sachot, Christelle] USTL, INSERM, U837, JPARC, Lille, France; [Heliot, Laurent] USTL, Interdisciplinary Res Inst, CNRS, USR 3078, Villeneuve Dascq, France; [Di Santo, James P.] Inst Pasteur, Cytokines & Lymphoid Dev Unit, Paris, France; [Di Santo, James P.] INSERM, U668, Paris, France	Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Macia, L (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurobiol Res Program, Darlinghurst, NSW 2010, Australia.	Isabelle.Wolowczuk@ibl.fr	Macia, laurence/D-5983-2016; Di Santo, James P/M-4298-2014	Macia, laurence/0000-0003-0835-851X; Di Santo, James P/0000-0002-7146-1862; wolowczuk, isabelle/0000-0001-6692-6904	Centre National de la Recherche Scientifique (CNRS); Pasteur Institute in Lille; French Ministry for Research and Education	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute in Lille; French Ministry for Research and Education	This work was in part supported by the Centre National de la Recherche Scientifique (CNRS), the Pasteur Institute in Lille, and the French Ministry for Research and Education (to L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; Chou WC, 2006, BLOOD, V108, P3005, DOI 10.1182/blood-2006-05-024430; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cui H, 2006, FASEB J, V20, P2654, DOI 10.1096/fj.06-5989fje; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; INGRAM DK, 1982, J GEN PSYCHOL, V106, P233; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lee JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001639; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Liu X, 1999, MOL BRAIN RES, V71, P210, DOI 10.1016/S0169-328X(99)00186-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; MEISTER B, 1989, EXP BRAIN RES, V76, P343; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; PAXINOS G, 2005, NEW CORONAL SET, P209; Rosenthal LA, 1997, CELL IMMUNOL, V181, P172, DOI 10.1006/cimm.1997.1208; Roye O, 1998, J IMMUNOL, V161, P4161; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WILES MV, 1992, EUR J IMMUNOL, V22, P1037, DOI 10.1002/eji.1830220424; Williams IR, 1997, J IMMUNOL, V159, P3044; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	45	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9953	10.1371/journal.pone.0009953	http://dx.doi.org/10.1371/journal.pone.0009953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376352	gold, Green Published, Green Submitted			2022-12-25	WOS:000276418200029
J	Schreuder, M; Blankertz, B; Tangermann, M				Schreuder, Martijn; Blankertz, Benjamin; Tangermann, Michael			A New Auditory Multi-Class Brain-Computer Interface Paradigm: Spatial Hearing as an Informative Cue	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; P300; P3A; COMMUNICATION; LOCALIZATION; PROBABILITY; ATTENTION; MEMORY	Most P300-based brain-computer interface (BCI) approaches use the visual modality for stimulation. For use with patients suffering from amyotrophic lateral sclerosis (ALS) this might not be the preferable choice because of sight deterioration. Moreover, using a modality different from the visual one minimizes interference with possible visual feedback. Therefore, a multi-class BCI paradigm is proposed that uses spatially distributed, auditory cues. Ten healthy subjects participated in an offline oddball task with the spatial location of the stimuli being a discriminating cue. Experiments were done in free field, with an individual speaker for each location. Different inter-stimulus intervals of 1000 ms, 300 ms and 175 ms were tested. With averaging over multiple repetitions, selection scores went over 90% for most conditions, i.e., in over 90% of the trials the correct location was selected. One subject reached a 100% correct score. Corresponding information transfer rates were high, up to an average score of 17.39 bits/minute for the 175 ms condition (best subject 25.20 bits/minute). When presenting the stimuli through a single speaker, thus effectively canceling the spatial properties of the cue, selection scores went down below 70% for most subjects. We conclude that the proposed spatial auditory paradigm is successful for healthy subjects and shows promising results that may lead to a fast BCI that solely relies on the auditory sense.	[Schreuder, Martijn; Blankertz, Benjamin; Tangermann, Michael] Berlin Inst Technol, Machine Learning Dept, Berlin, Germany; [Blankertz, Benjamin] Fraunhofer FIRST, Intelligent Data Anal Grp, Berlin, Germany	Technical University of Berlin; Fraunhofer Gesellschaft; Fraunhofer Institute Center Schloss Birlinghoven	Schreuder, M (corresponding author), Berlin Inst Technol, Machine Learning Dept, Berlin, Germany.	martijn@cs.tu-berlin.de	Schreuder, Martijn/E-2476-2013; Tangermann, Michael/ABE-4178-2020	Tangermann, Michael/0000-0001-6729-0290; Blankertz, Benjamin/0000-0002-2437-4846; Schreuder, Evert-Jan Martijn/0000-0002-7239-9909	European Information and Communication Technologies (ICT) Programme Project [FP7-224631, 216886]; Deutsche Forschungsgemeinschaft (DFG) [MU 987/3-1]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01IB001A, 01GQ0850]; European Community [ICT-216886]	European Information and Communication Technologies (ICT) Programme Project; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Community(European Commission)	This work was partly supported by the European Information and Communication Technologies (ICT) Programme Project FP7-224631 and 216886, by grants of the Deutsche Forschungsgemeinschaft (DFG) (MU 987/3-1) and Bundesministerium fur Bildung und Forschung (BMBF) (FKZ 01IB001A, 01GQ0850) and by the FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence, ICT-216886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1908, BIOMETRIKA, V6, P1; Bayliss JD, 2004, CYBERPSYCHOL BEHAV, V7, P694, DOI 10.1089/cpb.2004.7.694; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer AM, 2008, P 4 INT BRAIN COMP I, P280; Brungart DS, 1999, J ACOUST SOC AM, V106, P1956, DOI 10.1121/1.427943; Chatterjee A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-40; CINCOTTI F, 2007, COMPUT INTELL NEUROS; Conroy MA, 2007, J PSYCHOPHYSIOL, V21, P22, DOI 10.1027/0269-8803.21.1.22; Deouell LY, 2006, EUR J NEUROSCI, V24, P1488, DOI 10.1111/j.1460-9568.2006.05025.x; DESAIN P, 2006, P 3 INT BRAIN COMP I, P98; Duda R.O., 2006, PATTERN CLASSIFICATI; Farquhar J., 2008, P 4 INT BCI WORKSH T, P50; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Green M D, 1966, SIGNAL DETECTION THE; Hill N.J., 2005, ADV NEURAL INFORM PR, V17, P569; Hinterberger T, 2004, EXP BRAIN RES, V154, P521, DOI 10.1007/s00221-003-1690-3; Kanoh S, 2008, IEEE ENG MED BIO, P642, DOI 10.1109/IEMBS.2008.4649234; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lenhardt A, 2008, IEEE T NEUR SYS REH, V16, P121, DOI 10.1109/TNSRE.2007.912816; M³ller K-R., 2004, BIOMED TECH, V49, P11, DOI [DOI 10.13109/9783666351419.11, 10.13109/9783666351419.11]; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; Muller-Putz GR, 2006, IEEE T NEUR SYS REH, V14, P30, DOI 10.1109/TNSRE.2005.863842; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Rader SK, 2008, CLIN NEUROPHYSIOL, V119, P1176, DOI 10.1016/j.clinph.2008.01.014; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Teder-Salejarvi WA, 1998, PERCEPT PSYCHOPHYS, V60, P1228, DOI 10.3758/BF03206172; Teder-Salejarvi WA, 1999, COGNITIVE BRAIN RES, V8, P213, DOI 10.1016/S0926-6410(99)00023-3; TOMIAKA R, 2008, P 4 INT BRAIN COMP I, P232; TREDER M, 2009, BBCI WORKSH ADV NEUR; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	46	193	199	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9813	10.1371/journal.pone.0009813	http://dx.doi.org/10.1371/journal.pone.0009813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368976	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200004
J	Tajima, S; Okada, M				Tajima, Satohiro; Okada, Masato			Discriminating Natural Image Statistics from Neuronal Population Codes	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; BAND-LIMITED CONTRAST; AMPLITUDE SPECTRA; RECEPTIVE-FIELD; CONTEXTUAL MODULATION; PERCEIVED CONTRAST; CORTICAL-NEURONS; SIMPLE CELLS; FACILITATION	The power law provides an efficient description of amplitude spectra of natural scenes. Psychophysical studies have shown that the forms of the amplitude spectra are clearly related to human visual performance, indicating that the statistical parameters in natural scenes are represented in the nervous system. However, the underlying neuronal computation that accounts for the perception of the natural image statistics has not been thoroughly studied. We propose a theoretical framework for neuronal encoding and decoding of the image statistics, hypothesizing the elicited population activities of spatial-frequency selective neurons observed in the early visual cortex. The model predicts that frequency-tuned neurons have asymmetric tuning curves as functions of the amplitude spectra falloffs. To investigate the ability of this neural population to encode the statistical parameters of the input images, we analyze the Fisher information of the stochastic population code, relating it to the psychophysically measured human ability to discriminate natural image statistics. The nature of discrimination thresholds suggested by the computational model is consistent with experimental data from previous studies. Of particular interest, a reported qualitative disparity between performance in fovea and parafovea can be explained based on the distributional difference over preferred frequencies of neurons in the current model. The threshold shows a peak at a small falloff parameter when the neuronal preferred spatial frequencies are narrowly distributed, whereas the threshold peak vanishes for a neural population with a more broadly distributed frequency preference. These results demonstrate that the distributional property of neuronal stimulus preference can play a crucial role in linking microscopic neurophysiological phenomena and macroscopic human behaviors.	[Tajima, Satohiro; Okada, Masato] Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan; [Tajima, Satohiro] NHK Japan Broadcasting Corp, Nagano Stn, Nagano, Japan; [Okada, Masato] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	University of Tokyo; NHK Japan Broadcasting Corp; RIKEN	Tajima, S (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan.	tajima@mns.k.u-tokyo.ac.jp	Tajima, Satohiro/I-7100-2013	Tajima, Satohiro/0000-0002-9597-1381	Ministry of Education, Culture, Sports, Science and Technology of Japan [20650019];  [18079003];  [20240020]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was partially supported by Grants-in-Aid for Scientific Research on Priority Areas (Grant No. 18079003), Grants-in-Aid for Scientific Research (A) (Grant No. 20240020) and Grants-in-Aid for Exploratory Research (Grant No. 20650019) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; BEX PJ, 2007, J VIS, V7; Billock VA, 2000, PHYSICA D, V137, P379, DOI 10.1016/S0167-2789(99)00197-9; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; BRADY N, 1995, VISION RES, V35, P739, DOI 10.1016/0042-6989(94)00172-I; Brady N, 1997, PERCEPTION, V26, P1089, DOI 10.1068/p261089; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Carandini M, 1997, J NEUROSCI, V17, P8621; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Dayan P., 2001, THEORETICAL NEUROSCI; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FIELD DJ, 1986, PROC R SOC SER B-BIO, V228, P379, DOI 10.1098/rspb.1986.0060; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Hansen BC, 2003, NETWORK-COMP NEURAL, V14, P501, DOI 10.1088/0954-898X/14/3/307; Hansen BC, 2006, J VISION, V6, P696, DOI 10.1167/6.7.3; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KNILL DC, 1990, J OPT SOC AM A, V7, P1113, DOI 10.1364/JOSAA.7.001113; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Liu RuoWei, 2008, China Vegetables, P1; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Meese TS, 2007, J VISION, V7, DOI 10.1167/7.4.7; Mizobe K, 2001, VISUAL NEUROSCI, V18, P377, DOI 10.1017/S0952523801183045; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Parraga CA, 2005, VISION RES, V45, P3145, DOI 10.1016/j.visres.2005.08.006; Parraga CA, 2000, PERCEPTION, V29, P1101, DOI 10.1068/p2904; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Snowden RJ, 1998, VISION RES, V38, P1935, DOI 10.1016/S0042-6989(97)00379-9; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; TADMOR Y, 1994, VISION RES, V34, P541, DOI 10.1016/0042-6989(94)90167-8; Thomson MGA, 1997, J OPT SOC AM A, V14, P2081, DOI 10.1364/JOSAA.14.002081; Tolhurst DJ, 1997, PERCEPTION, V26, P1011, DOI 10.1068/p261011; Tolhurst DJ, 1997, VISION RES, V37, P3203, DOI 10.1016/S0042-6989(97)00119-3; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zemel RS, 1999, ADV NEUR IN, V11, P174; Zipser K, 1996, J NEUROSCI, V16, P7376	61	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9704	10.1371/journal.pone.0009704	http://dx.doi.org/10.1371/journal.pone.0009704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360849	Green Published, gold, Green Submitted			2022-12-25	WOS:000275969500001
J	Zeng, J; Parvanova, IA; Howard, JC				Zeng, Jia; Parvanova, Iana Angelova; Howard, Jonathan C.			A Dedicated Promoter Drives Constitutive Expression of the Cell-Autonomous Immune Resistance GTPase, Irga6 (IIGP1) in Mouse Liver	PLOS ONE			English	Article								Background: In general, immune effector molecules are induced by infection. Methodology and Principal Findings: However, strong constitutive expression of the cell-autonomous resistance GTPase, Irga6 (IIGP1), was found in mouse liver, contrasting with previous evidence that expression of this protein is exclusively dependent on induction by IFN gamma. Constitutive and IFN gamma-inducible expression of Irga6 in the liver were shown to be dependent on transcription initiated from two independent untranslated 5' exons, which splice alternatively into the long exon encoding the full-length protein sequence. Irga6 is expressed constitutively in freshly isolated hepatocytes and is competent in these cells to accumulate on the parasitophorous vacuole membrane of infecting Toxoplasma gondii tachyzoites. Conclusions and Significance: The role of constitutive hepatocyte expression of Irga6 in resistance to parasites invading from the gut via the hepatic portal system is discussed.			Zeng, J (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Therapeut, Leeds, W Yorkshire, England.	j.howard@uni-koeln.de		Howard, Jonathan/0000-0003-2756-5143				Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boehm U, 1998, J IMMUNOL, V161, P6715; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; CLAYTON DF, 1985, MOL CELL BIOL, V5, P2623, DOI 10.1128/MCB.5.10.2623; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; HUNN JP, 2008, EMBO J; Jiang GQ, 1997, J BIOL CHEM, V272, P1218, DOI 10.1074/jbc.272.2.1218; Kaiser F, 2004, J CELL SCI, V117, P1747, DOI 10.1242/jcs.01039; Kawakubo K, 1999, VIROLOGY, V264, P106, DOI 10.1006/viro.1999.9995; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Liesenfeld O, 1999, IMMUNOBIOLOGY, V201, P229, DOI 10.1016/S0171-2985(99)80063-1; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; MELZER T, 2008, INFECT IMMUN; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; PARVANOVA I, 2005, ANAL ROLE P47 GTPASE; Samadani U, 1996, GENE EXPRESSION, V6, P23; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6787	10.1371/journal.pone.0006787	http://dx.doi.org/10.1371/journal.pone.0006787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	20368812	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000029
J	Rosenberg, D; Kartvelishvily, E; Shleper, M; Klinker, CMC; Bowser, MT; Wolosker, H				Rosenberg, Dina; Kartvelishvily, Elena; Shleper, Maria; Klinker, Chanda M. C.; Bowser, Michael T.; Wolosker, Herman			Neuronal release of D-serine: a physiological pathway controlling extracellular D-serine concentration	FASEB JOURNAL			English	Article						serine racemase; neurotransmission; microdialysis; NMDA receptor	METHYL-D-ASPARTATE; RAT-BRAIN; RECEPTOR AGONISTS; GLUTAMATE; RACEMASE; NMDA; LOCALIZATION; TRANSPORTER; GLYCINE; ASC-1	D-Serine is thought to be a glia-derived transmitter that activates N-methyl D-aspartate receptors (NMDARs) in the brain. Here, we investigate the pathways for D-serine release using primary cultures, brain slices, and in vivo microdialysis. In contrast with the notion that D-serine is exclusively released from astrocytes, we found that D-serine is released by neuronal depolarization both in vitro and in vivo. Veratridine (50 mu M) or depolarization by 40 mM KCl elicits a significant release of endogenous D-serine from primary neuronal cultures. Controls with astrocyte cultures indicate that glial cells are insensitive to veratridine, but release D-serine mainly by the opening of volume-regulated anion channels. In cortical slices perfused with veratridine, endogenous D-serine release is 10-fold higher than glutamate receptor-evoked release. Release of D-serine from slices does not require internal or external Ca2+, suggesting a nonvesicular release mechanism. To confirm the neuronal origin of D-serine, we selectively loaded neurons in cortical slices with D-[H-3] serine or applied D-alanine, which specifically releases D-serine from neurons. Depolarization with veratridine promotes D-serine release in vivo monitored by high temporal resolution microdialysis of the striatum. Our data indicate that the neuronal pool of D-serine plays a major role in D-serine dynamics, with implications for the regulation of NMDAR transmission. Rosenberg, D., Kartvelishvily, E., Shleper, M., Klinker, C. M. C., Bowser, M. T., Wolosker, H. Neuronal release of D-serine: a physiological pathway controlling extracellular D-serine concentration. FASEB J. 24, 2951-2961 (2010). www.fasebj.org	[Rosenberg, Dina; Kartvelishvily, Elena; Shleper, Maria; Wolosker, Herman] Technion Israel Inst Technol, Dept Biochem, B Rappaport Fac Med, IL-31096 Haifa, Israel; [Klinker, Chanda M. C.; Bowser, Michael T.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Wolosker, H (corresponding author), Technion Israel Inst Technol, Dept Biochem, B Rappaport Fac Med, IL-31096 Haifa, Israel.	hwolosker@tx.technion.ac.il	Bowser, Michael/HCI-4724-2022	Wolosker, Herman/0000-0001-5508-9194	Israel Science Foundation; Rappaport Institute of Medical Research; NARSAD; The Sternheim Research Fund; The L. Aronberg Research Fund in Neurology; ISF-Legacy Heritage Fund; Ministry of Health; U.S. National Institutes of Health [GM 063533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043304] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Rappaport Institute of Medical Research; NARSAD(NARSAD); The Sternheim Research Fund; The L. Aronberg Research Fund in Neurology; ISF-Legacy Heritage Fund; Ministry of Health; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Israel Science Foundation, the Rappaport Institute of Medical Research, NARSAD, The Sternheim Research Fund, The L. Aronberg Research Fund in Neurology, the ISF-Legacy Heritage Fund, and the Ministry of Health to H.W.; and from the U.S. National Institutes of Health (GM 063533) to M.T.B.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; BAUGHMAN RW, 1981, J NEUROSCI, V1, P427; Ciriacks CM, 2006, NEUROSCI LETT, V393, P200, DOI 10.1016/j.neulet.2005.09.080; Ciriacks CM, 2004, ANAL CHEM, V76, P6582, DOI 10.1021/ac0490651; Danysz W, 1998, PHARMACOL REV, V50, P597; DE MJ, 2002, P NATL ACAD SCI USA, V99, P14542; Dun Y, 2008, J NEUROCHEM, V104, P970, DOI 10.1111/j.1471-4159.2007.05015.x; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; GONZALEZALVEAR GM, 1994, J PHARMACOL EXP THER, V271, P212; Gustafson EC, 2007, J NEUROPHYSIOL, V98, P122, DOI 10.1152/jn.00057.2006; HAAS J, 1991, GLIA, V4, P111, DOI 10.1002/glia.440040113; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; Hashimoto A, 2000, BRAIN RES BULL, V53, P347, DOI 10.1016/S0361-9230(00)00357-9; Helboe L, 2003, EUR J NEUROSCI, V18, P2227, DOI 10.1046/j.1460-9568.2003.02966.x; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; KIRPEKAR SM, 1979, P NATL ACAD SCI USA, V76, P2081, DOI 10.1073/pnas.76.4.2081; Klinker CC, 2007, ANAL CHEM, V79, P8747, DOI 10.1021/ac071433o; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; LEVI G, 1992, J NEUROCHEM, V58, P1943, DOI 10.1111/j.1471-4159.1992.tb10073.x; Matsuo H, 2004, NEUROSCI LETT, V358, P123, DOI 10.1016/j.neulet.2004.01.014; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mongin AA, 2005, AM J PHYSIOL-CELL PH, V288, pC204, DOI 10.1152/ajpcell.00330.2004; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mulligan Sean J, 2006, Sci STKE, V2006, ppe42; NEAL MJ, 1979, BRAIN RES, V167, P337, DOI 10.1016/0006-8993(79)90827-8; O'Brien KB, 2006, ELECTROPHORESIS, V27, P1949, DOI 10.1002/elps.200500770; Oliet SHR, 2009, NEUROSCIENCE, V158, P275, DOI 10.1016/j.neuroscience.2008.01.071; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Price P.J., 2001, PROTOCOLS NEURAL CEL, P255, DOI 10.1385/1-59259-207-4:255; Puyal J, 2006, J COMP NEUROL, V497, P610, DOI 10.1002/cne.21016; Ribeiro CS, 2002, BRAIN RES, V929, P202, DOI 10.1016/S0006-8993(01)03390-X; Rutter AR, 2007, EUR J NEUROSCI, V25, P1757, DOI 10.1111/j.1460-9568.2007.05446.x; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Yasuda E, 2001, NEUROSCI LETT, V299, P162, DOI 10.1016/S0304-3940(01)01502-6; Yoshikawa M, 2007, ARCH HISTOL CYTOL, V70, P127, DOI 10.1679/aohc.70.127	46	94	96	3	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2951	2961		10.1096/fj.09-147967	http://dx.doi.org/10.1096/fj.09-147967			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371631	Green Published			2022-12-25	WOS:000285005400034
J	Rowling, PJE; Cook, R; Itzhaki, LS				Rowling, Pamela J. E.; Cook, Rebecca; Itzhaki, Laura S.			Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER SUSCEPTIBILITY; PHOSPHOPEPTIDE BINDING; FUNCTIONAL-ANALYSIS; PROTEIN-STRUCTURE; STRUCTURAL BASIS; MUTATIONS; STABILITY; SEQUENCE; DOMAINS; DISEASE	Carriers of germ line mutations in breast cancer susceptibility gene BRCA1 have an increased risk of developing breast and ovarian cancers; missense mutations have, however, been difficult to assess for disease association. Here we have used a biophysical approach to classify these variants. We established an assay for measuring the thermodynamic stability of the BRCA1 BRCT domains and investigated the effects of 36 missense mutations. The mutations show a range of effects. Some do not change the stability, whereas others destabilize the protein by as much as 6 kcal mol(-1); one-third of the mutants could not be expressed in soluble form in Escherichia coli, and we conclude that these destabilize the protein by an even greater amount. We tested several computer algorithms for their ability to predict the mutant effects and found that by grouping them into two classes (destabilizing by less than or more than 2.2 kcal mol(-1)), the algorithms could predict the stability changes. Importantly, with the exception of the few mutants located in the binding site, none showed a significant reduction in affinity for phosphorylated substrate. These results indicate that despite very large losses in stability, the integrity of the structure is not compromised by the mutations. Thus, the majority of mutations cause loss of function by reducing the proportion of BRCA1 molecules that are in the folded state and increasing the proportion of molecules that are unfolded. Consequently, small molecule stabilization of the structure could be a generally applicable preventative therapeutic strategy for rescuing many BRCA1 mutations.	[Rowling, Pamela J. E.; Cook, Rebecca; Itzhaki, Laura S.] MRC, Canc Cell Unit, Hutchison MRC Res Ctr, Cambridge CB2 0XZ, England		Itzhaki, LS (corresponding author), MRC, Canc Cell Unit, Hutchison MRC Res Ctr, Hills Rd, Cambridge CB2 0XZ, England.	lsi@hutchison-mrc.cam.ac.uk		Cook, Rebecca/0000-0003-3359-9745	Medical Research Council [MC_U105370180] Funding Source: Medline; MRC [MC_U105370180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Coyne RS, 2004, CANCER BIOL THER, V3, P453, DOI 10.4161/cbt.3.5.809; Dalby PA, 1998, J MOL BIOL, V276, P625, DOI 10.1006/jmbi.1997.1546; Deffenbaugh AM, 2002, GENET TEST, V6, P119, DOI 10.1089/10906570260199375; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Gaiser OJ, 2004, BIOCHEMISTRY-US, V43, P15983, DOI 10.1021/bi049550q; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glover JNM, 2006, FAM CANCER, V5, P89, DOI 10.1007/s10689-005-2579-z; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hayes F, 2000, CANCER RES, V60, P2411; Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Rodriguez MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5905, DOI 10.2741/3125; Starita LM, 2006, CANCER BIOL THER, V5, P137, DOI 10.4161/cbt.5.2.2479; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Worth Catherine L, 2007, J Bioinform Comput Biol, V5, P1297, DOI 10.1142/S0219720007003120; Wu WW, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-1; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhou HY, 2002, PROTEINS, V49, P483, DOI 10.1002/prot.10241	37	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20080	20087		10.1074/jbc.M109.088922	http://dx.doi.org/10.1074/jbc.M109.088922			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20378548	Green Published, hybrid			2022-12-25	WOS:000279012000042
J	Blomster, HA; Imanishi, SY; Siimes, J; Kastu, J; Morrice, NA; Eriksson, JE; Sistonen, L				Blomster, Henri A.; Imanishi, Susumu Y.; Siimes, Jenny; Kastu, Juha; Morrice, Nick A.; Eriksson, John E.; Sistonen, Lea			In Vivo Identification of Sumoylation Sites by a Signature Tag and Cysteine-targeted Affinity Purification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GO EXTRACTION TIPS; MASS-SPECTROMETRY; TRANSCRIPTIONAL ACTIVITY; PHOSPHORYLATED PEPTIDES; SUMO MODIFICATION; HEAT-SHOCK; PROTEOMICS; UBIQUITIN; ENRICHMENT; STRATEGY	Small ubiquitin-like modifier ( SUMO) is conjugated to its substrates via an enzymatic cascade consisting of three enzymes, E1, E2, and E3. The active site of the E2 enzyme, Ubc9, recognizes the substrate through binding to a consensus tetrapeptide Psi KXE. However, recent proteomics studies suggested that a considerable part of sumoylation occurs on non-consensus sites. Current unbiased sumoylation site identification techniques typically require high stoichiometry in vitro sumoylation, mass spectrometry, and complex data analysis. To facilitate in vivo analysis, we have designed a mass spectrometric method based on an engineered human SUMO-1 construct that creates a signature tag on SUMO substrates. This construct enables affinity purification by covalent binding to cysteine residues in LysC/trypsin-cleaved peptides and site identification by diglycyl lysine tagging of sumoylation sites. As a proof of concept, site-specific and substrate-unbiased in vivo sumoylation analysis of HeLa cells was performed. We identified 14 sumoylation sites, including well known sites, such as Lys(524) of RanGAP1, and novel non-consensus sites. Only 3 of the 14 sites matched consensus sites, supporting the emerging view that non-consensus sumoylation is a common event in live cells. Six of the non-consensus sites had a nearby SUMO interaction motif (SIM), which emphasizes the role of SIM in non-consensus sumoylation. Nevertheless, the lack of near by SIM residues among the remaining non-consensus sites indicates that there are also other specificity determinants of non-consensus sumoylation. The method we have developed proved to be a useful tool for sumoylation studies and will facilitate identification of novel SUMO substrates containing both consensus and non-consensus sites.	[Eriksson, John E.; Sistonen, Lea] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland; [Blomster, Henri A.; Imanishi, Susumu Y.; Siimes, Jenny; Kastu, Juha; Eriksson, John E.; Sistonen, Lea] Abo Akad Univ, Turku Ctr Biotechnol, FI-20521 Turku, Finland; [Blomster, Henri A.; Imanishi, Susumu Y.; Siimes, Jenny; Kastu, Juha; Eriksson, John E.; Sistonen, Lea] Univ Turku, FI-20521 Turku, Finland; [Morrice, Nick A.] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Abo Akademi University; Abo Akademi University; University of Turku; University of Turku; University of Dundee	Eriksson, JE (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6, FIN-20520 Turku, Finland.	john.eriksson@abo.fi; lea.sistonen@btk.fi	Imanishi, Susumu/B-8697-2014	Imanishi, Susumu/0000-0002-3641-4390; Sistonen, Lea/0000-0003-1341-2867; Joutsen, Jenny/0000-0002-7868-556X	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Organizations; Abo Akademi University; Turku Graduate School of Biomedical Sciences; Magnus Ehrnrooth Foundation; Stiftelsens for Abo Akademi forskningsinstitut	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Abo Akademi University; Turku Graduate School of Biomedical Sciences; Magnus Ehrnrooth Foundation; Stiftelsens for Abo Akademi forskningsinstitut	This work was supported by grants from the Academy of Finland (to J.E.E., L. S., and S.Y.I.), the Sigrid Juselius Foundation, the Finnish Cancer Organizations and the Abo Akademi University (to J.E.E. and L. S.), the Turku Graduate School of Biomedical Sciences, the Magnus Ehrnrooth Foundation, and the Stiftelsens for Abo Akademi forskningsinstitut (to H. A. B.).	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Boja ES, 2001, ANAL CHEM, V73, P3576, DOI 10.1021/ac0103423; Cooper HJ, 2005, ANAL CHEM, V77, P6310, DOI 10.1021/ac058019d; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Imanishi SY, 2007, MOL CELL PROTEOMICS, V6, P1380, DOI 10.1074/mcp.M600480-MCP200; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Jeram SM, 2009, PROTEOMICS, V9, P922, DOI 10.1002/pmic.200800666; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Messner S, 2009, FASEB J, V23, P3978, DOI 10.1096/fj.09-137695; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	27	58	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19324	19329		10.1074/jbc.M110.106955	http://dx.doi.org/10.1074/jbc.M110.106955			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388717	Green Published, hybrid			2022-12-25	WOS:000278727800042
J	Wathen, B; Jia, ZC				Wathen, Brent; Jia, Zongchao			Protein beta-Sheet Nucleation Is Driven by Local Modular Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN INTERACTIONS; HAIRPIN FORMATION; SECONDARY STRUCTURE; CONFORMATIONAL-ANALYSIS; PAIR CORRELATIONS; RESIDUE PAIRS; ANTIPARALLEL; STABILITY; MECHANISM; PEPTIDES	Despite its central role in the protein folding process, the specific mechanism(s) behind beta-sheet formation has yet to be determined. For example, whether the nucleation of beta-sheets, often containing strands separated in sequence by many residues, is local or not remains hotly debated. Here, we investigate the initial nucleation step of beta-sheet formation by performing an analysis of the smallest beta-sheets in a non-redundant dataset on the grounds that the smallest sheets, having undergone little growth after nucleation, will be enriched for nucleating characteristics. We find that the residue propensities are similar for small and large beta-sheets as are their interstrand pairing preferences, suggesting that nucleation is not primarily driven by specific residues or interacting pairs. Instead, an examination of the structural environments of the two-stranded sheets shows that virtually all of them are contained in single, compact structural modules, or when multiple modules are present, one or both of the chain termini are involved. We, therefore, find that beta-nucleation is a local phenomenon resulting either from sequential or topological proximity. We propose that beta-nucleation is a result of two opposite factors; that is, the relative rigidity of an associated folding module that holds two stretches of coil close together in topology coupled with sufficient chain flexibility that enables the stretches of coil to bring their backbones in close proximity. Our findings lend support to the hydrophobic zipper model of protein folding (Dill, K. A., Fiebig, K. M., and Chan, H. S. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 1942-1946). Implications for protein folding are discussed.	[Wathen, Brent; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca			Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research.; Recipient of Natural Science and Engineering Research Council of Canada graduate studentship.	Blanco F, 1998, CURR OPIN STRUC BIOL, V8, P107, DOI 10.1016/S0959-440X(98)80017-1; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; COLLOCH N, 1991, J MOL BIOL, V221, P603, DOI 10.1016/0022-2836(91)80075-6; Colombo G, 2003, PROTEIN SCI, V12, P538, DOI 10.1110/ps.0227203; Cootes AP, 1998, PROTEINS, V32, P175, DOI 10.1002/(SICI)1097-0134(19980801)32:2<175::AID-PROT4>3.3.CO;2-P; Deechongkit S, 2006, CURR OPIN STRUC BIOL, V16, P94, DOI 10.1016/j.sbi.2006.01.014; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; Dinner AR, 1999, P NATL ACAD SCI USA, V96, P9068, DOI 10.1073/pnas.96.16.9068; Dyer RB, 2004, BIOCHEMISTRY-US, V43, P11560, DOI 10.1021/bi049177m; Espinosa JF, 2002, PROTEIN SCI, V11, P1492, DOI 10.1110/ps.4140102; Fooks HM, 2006, J MOL BIOL, V356, P32, DOI 10.1016/j.jmb.2005.11.008; Ho BK, 2002, J MOL BIOL, V317, P291, DOI 10.1006/jmbi.2001.5385; Hughes RM, 2006, CURR OPIN STRUC BIOL, V16, P514, DOI 10.1016/j.sbi.2006.06.008; Hutchinson EG, 1998, PROTEIN SCI, V7, P2287, DOI 10.1002/pro.5560071106; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuo NNW, 2005, J AM CHEM SOC, V127, P16945, DOI 10.1021/ja0543191; Lacroix E, 1999, CURR OPIN STRUC BIOL, V9, P487, DOI 10.1016/S0959-440X(99)80069-4; LIFSON S, 1979, NATURE, V282, P109, DOI 10.1038/282109a0; Mandel-Gutfreund Y, 2001, J MOL BIOL, V305, P1145, DOI 10.1006/jmbi.2000.4364; Munoz V, 1998, P NATL ACAD SCI USA, V95, P5872, DOI 10.1073/pnas.95.11.5872; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Noguchi T, 2001, NUCLEIC ACIDS RES, V29, P219, DOI 10.1093/nar/29.1.219; Pal D, 2000, ACTA CRYSTALLOGR D, V56, P589, DOI 10.1107/S090744490000367X; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; RamirezAlvarado M, 1997, PROTEIN SCI, V6, P162; Santiveri CM, 2004, J PEPT SCI, V10, P546, DOI 10.1002/psc.564; Santiveri CM, 2004, PROTEIN SCI, V13, P1134, DOI 10.1110/ps.03520704; Sung SS, 1999, BIOPHYS J, V76, P164, DOI 10.1016/S0006-3495(99)77186-9; Syud FA, 2001, J AM CHEM SOC, V123, P8667, DOI 10.1021/ja0109803; Viguera AR, 1996, J MOL BIOL, V255, P507, DOI 10.1006/jmbi.1996.0042; Wathen B, 2009, INT J MOL SCI, V10, P1567, DOI 10.3390/ijms10041567; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205; Zhang C, 2000, J MOL BIOL, V299, P1075, DOI 10.1006/jmbi.2000.3678; Zhu HY, 1999, PROTEIN SCI, V8, P326	40	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18376	18384		10.1074/jbc.M110.120824	http://dx.doi.org/10.1074/jbc.M110.120824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382979	Green Published, hybrid			2022-12-25	WOS:000278453900031
J	Jensen, PJ; Gunter, LB; Carayannopoulos, MO				Jensen, Penny J.; Gunter, Laura B.; Carayannopoulos, Mary O.			Akt2 Modulates Glucose Availability and Downstream Apoptotic Pathways during Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL HYPOGLYCEMIA; CELL-DEATH; GROWTH; GLUT1; INSULIN; INHIBITION; ZEBRAFISH; SURVIVAL; BAX; PHOSPHORYLATION	Glucose is the primary energy substrate for eukaryotic cells and the predominant substrate for the brain. Studies suggest that glucose serves an additional role in the regulation of cellular functions, including viability. Zebrafish is a tractable system for defining the cellular and molecular mechanisms perturbed by impaired glucose transport and metabolism. Previously, we demonstrated a critical role for the facilitative glucose transporter, Glut1, in the regulation of embryonic brain development. In this study, we aim to identify mediators in this Glut1-sensitive process by investigating the role of the antiapoptotic kinase, Akt2. Results show that abrogating expression of akt2 causes a phenotype strikingly similar to that observed when glut1 expression is inhibited. akt2-deficient embryos exhibit increased neuronal apoptosis, impaired glucose uptake, and death by 72 h postfertilization. Similar to what was observed in the glut1 morphants, inhibiting the expression of the proapoptotic protein, bad, in the context of impaired akt2 expression results in the inhibition of apoptosis and rescue of the morphant embryos. Intriguingly, overexpression of glut1 in the akt2 morphants was also able to rescue these embryos. Quantitative reverse transcription-PCR analysis revealed decreased glut1 transcript expression in akt2 morphant embryos. Taken together, these data suggest that Akt2 modulates glucose availability by regulating Glut1 expression at the transcript level. These data support a role for akt2 in an integrative pathway directly linking glucose, Glut1 expression, and activation of apoptosis and demonstrate the dependence of akt2 on glucose availability for the maintenance of cellular viability, particularly in the central nervous system.	[Jensen, Penny J.; Gunter, Laura B.; Carayannopoulos, Mary O.] Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Carayannopoulos, MO (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, 125 Paterson St,MEB 212, New Brunswick, NJ 08901 USA.	carayamo@umdnj.edu			National Institutes of Health (NIH) [NS057105, HD01459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Neuroscience Blueprint Core Grant NS057105 (to Washington University and the Bakewell Family Foundation) and NIH Grant HD01459 (to M. O. C.).	Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Boluyt N, 2006, PEDIATRICS, V117, P2231, DOI 10.1542/peds.2005-1919; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Lonlay Pascale, 2004, Semin Neonatol, V9, P49, DOI 10.1016/j.siny.2003.08.002; Dekelbab Bassem H, 2006, Adv Pediatr, V53, P5, DOI 10.1016/j.yapd.2006.04.004; DEL PL, 1997, SCIENCE, V278, P687; DEVIVO DC, 2002, J CHILD NEUROL S3, V17; Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; HEYWORTH CM, 1992, BLOOD, V80, P2230; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Jensen PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; KAN O, 1994, J EXP MED, V180, P917, DOI 10.1084/jem.180.3.917; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; MENON RK, 1988, SEMIN PERINATOL, V12, P157; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; MOLEY K, 1999, DIABETES PREIMPLANTA; Moley KH, 1998, AM J PHYSIOL-ENDOC M, V275, pE38, DOI 10.1152/ajpendo.1998.275.1.E38; Moley KH, 1998, NAT MED, V4, P1421, DOI 10.1038/4013; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rozance PJ, 2006, BIOL NEONATE, V90, P74, DOI 10.1159/000091948; Rozen S, 2000, Methods Mol Biol, V132, P365; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; Sperling MA, 2004, PEDIATR CLIN N AM, V51, P703, DOI 10.1016/j.pcl.2004.01.014; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Wang D, 2003, J BIOL CHEM, V278, P49015, DOI 10.1074/jbc.M308765200; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Wirrell E, 2005, CAN J NEUROL SCI, V32, P409, DOI 10.1017/S0317167100004388; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Yager JY, 2002, CLIN PERINATOL, V29, P651, DOI 10.1016/S0095-5108(02)00054-4; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5	52	23	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17673	17680		10.1074/jbc.M109.079343	http://dx.doi.org/10.1074/jbc.M109.079343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356836	hybrid, Green Published			2022-12-25	WOS:000278133400045
J	Sohl, CD; Guengerich, FP				Sohl, Christal D.; Guengerich, F. Peter			Kinetic Analysis of the Three-step Steroid Aromatase Reaction of Human Cytochrome P450 19A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLACENTAL AROMATASE; ESTROGEN SYNTHETASE AROMATASE; ESCHERICHIA-COLI; SPECTRAL CHARACTERIZATION; SUCCESSIVE REACTIONS; LIGAND-BINDING; BREAST-CANCER; PURIFICATION; EXPRESSION; MICROSOMES	Cytochrome P450 19A1 (P450 19A1), the aromatase, catalyzes the conversion of androgens to estrogens through a sequential three-step reaction, generating 19-hydroxy and 19-aldehyde intermediates en route to the product estrogen. A procedure for the heterologous expression and purification of P450 19A1 in Escherichia coli was developed (k(cat) of 0.06 s(-1) for the conversion of androstenedione to estrone). Binding of the substrate and intermediates show low micromolar dissociation constants and are at least two-step processes. Rates of reduction of the iron were fast in the presence of substrate, either intermediate, or product. P450 19A1 is a distributive rather than a processive enzyme, with the sequential reaction allowing free dissociation of the intermediates as revealed by pulse-chase experiments. Conversion of androstenedione to estrone (under single turnover conditions) generated a progress curve showing changes in the concentrations of the substrate, intermediates, and product. A minimal kinetic model containing the individual rate constants for the steps in P450 19A1 catalysis was developed to globally fit the time course of the overall reaction, the dissociation constants, the two-step ligand binding, the distributive character, the iron-reduction rates, and the steady-state conversion of the 19-hydroxy androstenedione and 19-aldehyde androstenedione intermediates to estrone.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R37 CA090426, P30 ES000267, T32 ES007028]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426, P30 ES000267, and T32 ES007028 (to F. P. G.).	AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Altundag K, 2006, ONCOLOGIST, V11, P553, DOI 10.1634/theoncologist.11-6-553; AMARNEH B, 1995, MOL CELL ENDOCRINOL, V109, pR1, DOI 10.1016/0303-7207(95)03524-B; BEDNARSKI PJ, 1989, J STEROID BIOCHEM, V32, P309, DOI 10.1016/0022-4731(89)90269-0; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; BRASELTON WE, 1974, EUR J BIOCHEM, V48, P35, DOI 10.1111/j.1432-1033.1974.tb03740.x; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; COLE PA, 1991, J AM CHEM SOC, V113, P8130, DOI 10.1021/ja00021a044; DEMONTELLANO PRO, 2005, CYTOCHROME P450S STR; FALK JE, 1964, PORPHYRINS METALLOPO, P213; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FISHMAN J, 1967, BIOCHEMISTRY-US, V6, P1683, DOI 10.1021/bi00858a016; FISHMAN J, 1981, J BIOL CHEM, V256, P4466; Gartner CA, 2001, PROTEIN EXPRES PURIF, V22, P443, DOI 10.1006/prep.2001.1464; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; GUO ZY, 1994, ARCH BIOCHEM BIOPHYS, V312, P436, DOI 10.1006/abbi.1994.1330; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; HAGERMAN DD, 1987, J BIOL CHEM, V262, P2398; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106, DOI 10.1093/oxfordjournals.jbchem.a122213; HOLLANDER N, 1962, ENDOCRINOLOGY, V71, P723, DOI 10.1210/endo-71-5-723; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Johnson KA, 1998, CURR OPIN BIOTECH, V9, P87, DOI 10.1016/S0958-1669(98)80089-X; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Kagawa N, 2004, STEROIDS, V69, P235, DOI 10.1016/j.steroids.2004.01.002; KELLIS JT, 1984, SCIENCE, V225, P1032, DOI 10.1126/science.6474163; KELLIS JT, 1987, J BIOL CHEM, V262, P4413; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Nakayama K, 2001, J BIOL CHEM, V276, P31459, DOI 10.1074/jbc.M103943200; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; RYAN KJ, 1959, J BIOL CHEM, V234, P268; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SHIMIZU Y, 1993, J STEROID BIOCHEM, V44, P651, DOI 10.1016/0960-0760(93)90274-Z; SIGLE RO, 1994, BIOCHEM BIOPH RES CO, V201, P694, DOI 10.1006/bbrc.1994.1756; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; TAN L, 1986, EUR J BIOCHEM, V156, P243, DOI 10.1111/j.1432-1033.1986.tb09574.x; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; Tomaszewski M, 2009, ATHEROSCLEROSIS, V203, P257, DOI 10.1016/j.atherosclerosis.2008.06.002; VICKERY L E, 1987, Steroids, V50, P29, DOI 10.1016/0039-128X(83)90059-4; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004; Yun CH, 2000, BIOCHEMISTRY-US, V39, P11319, DOI 10.1021/bi000869u; Zhang FM, 2002, BIOCHEM PHARMACOL, V64, P1317, DOI 10.1016/S0006-2952(02)01361-8; ZHOU D, 1992, J BIOL CHEM, V267, P762	58	64	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17734	17743		10.1074/jbc.M110.123711	http://dx.doi.org/10.1074/jbc.M110.123711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385561	Green Published, hybrid			2022-12-25	WOS:000278133400051
J	Richard, C; Lanner, C; Naryzhny, SN; Sherman, L; Lee, H; Lambert, PF; Zehbe, I				Richard, C.; Lanner, C.; Naryzhny, S. N.; Sherman, L.; Lee, H.; Lambert, P. F.; Zehbe, I.			The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer	ONCOGENE			English	Article						human papillomavirus; human primary foreskin keratinocytes; immortalization; transformation; cervical cancer	MAMMARY EPITHELIAL-CELLS; TYPE-16 E6; HUMAN-PAPILLOMAVIRUS-16 E6; INTRAEPITHELIAL NEOPLASIA; TELOMERASE ACTIVATION; HUMAN KERATINOCYTES; NATURAL VARIANTS; P53 DEGRADATION; E7 ONCOGENES; IN-VIVO	Persistent infection with high-risk human papillomaviruses (HPVs), especially type 16 has been undeniably linked to cervical cancer. The Asian-American (AA) variant of HPV16 is more common in the Americas than the prototype in cervical cancer. The different prevalence is based on three amino acid changes within the E6 protein denoted Q14H/H78Y/L83V. To investigate the mechanism(s) behind this observation, both E6 proteins, in the presence of E7, were evaluated for their ability to extend the life span of and transform primary human foreskin keratinocytes (PHFKs). Longterm cell culture studies resulted in death at passage 9 of vector-transduced PHFKs (negative control), but survival of both E6 PHFKs to passage 65 (and beyond). Compared with E6/E7 PHFKs, AA/E7 PHFKs were significantly faster dividing, developed larger cells in monolayer cultures, showed double the epithelial thickness and expressed cytokeratin 10 when grown as organotypic raft cultures. Telomerase activation and p53 inactivation, two hallmarks of immortalization, were not significantly different between the two populations. Both were resistant to anoikis at later passages, but only AA/E7 PHFKs acquired the capacity for in vitro transformation. Proteomic analysis revealed markedly different protein patterns between E6/E7 and AA/E7, particularly with respect to key cellular metabolic enzymes. Our results provide new insights into the reasons underlying the greater prevalence of the AA variant in cervical cancer as evidenced by characteristics associated with higher oncogenic potential. Oncogene (2010) 29, 3435-3445; doi:10.1038/onc.2010.93; published online 12 April 2010	[Zehbe, I.] Thunder Bay Reg Res Inst, Thunder Bay, ON P7B 6V4, Canada; [Richard, C.] Thunder Bay Reg Hlth Sci Ctr, Res Lab, Thunder Bay, ON, Canada; [Lanner, C.; Lee, H.] Laurentian Univ, No Ontario Sch Med, Sudbury, ON P3E 2C6, Canada; [Naryzhny, S. N.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada; [Naryzhny, S. N.; Lee, H.] Sudbury Reg Hosp, NE Ontario Reg Canc Program, Sudbury, ON, Canada; [Sherman, L.] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Lambert, P. F.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	Northern Ontario School of Medicine; Northern Ontario School of Medicine; Laurentian University; Northern Ontario School of Medicine; Laurentian University; Health Sciences North; Tel Aviv University; Sackler Faculty of Medicine; University of Wisconsin System; University of Wisconsin Madison	Zehbe, I (corresponding author), Thunder Bay Reg Res Inst, 980 Oliver Rd, Thunder Bay, ON P7B 6V4, Canada.	zehbei@tbh.net	Lambert, Paul F/F-3747-2012; Naryzhny, Stanislav/D-1683-2012	Naryzhny, Stanislav/0000-0002-4102-3423	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We are grateful to the staff from the Central Laboratory of the Thunder Bay Regional Health Sciences Centre for technical assistance and Bruce Weaver from the Northern School of Medicine, West-Campus, Thunder Bay for help with statistical analysis. This work was funded by a Discovery Grant to IZ from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; ANDROPHY EJ, 1985, SCIENCE, V230, P442, DOI 10.1126/science.2996134; Asadurian Y, 2007, J MED VIROL, V79, P1751, DOI 10.1002/jmv.20978; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Bernard HU, 2005, J CLIN VIROL, V32, pS1, DOI 10.1016/j.jcv.2004.10.021; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Dalal S, 1996, J VIROL, V70, P683, DOI 10.1128/JVI.70.2.683-688.1996; Souza PSD, 2009, FUTURE ONCOL, V5, P359, DOI [10.2217/fon.09.8, 10.2217/FON.09.8]; DeCarlo CA, 2008, ANAL BIOCHEM, V381, P59, DOI 10.1016/j.ab.2008.06.009; Fu BJ, 2003, CANCER RES, V63, P7815; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; James MA, 2006, INT J CANCER, V119, P1878, DOI 10.1002/ijc.22064; Ji Q, 2004, CANCER RES, V64, P7610, DOI 10.1158/0008-5472.CAN-04-1608; Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024; KAUR P, 1989, VIROLOGY, V173, P302, DOI 10.1016/0042-6822(89)90247-X; Kirkpatrick Katharine L, 2004, J Carcinog, V3, P1, DOI 10.1186/1477-3163-3-1; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kyo S, 1999, INT J CANCER, V80, P60, DOI 10.1002/(SICI)1097-0215(19990105)80:1<60::AID-IJC12>3.3.CO;2-5; Lee K, 2008, VIRUS RES, V131, P106, DOI 10.1016/j.virusres.2007.08.003; Lichtig H, 2006, VIROLOGY, V350, P216, DOI 10.1016/j.virol.2006.01.038; Maddox P, 1999, J CLIN PATHOL, V52, P41, DOI 10.1136/jcp.52.1.41; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Mazurek S, 2001, BIOCHEM J, V356, P247, DOI 10.1042/0264-6021:3560247; McMurray HR, 2004, J VIROL, V78, P5698, DOI 10.1128/JVI.78.11.5698-5706.2004; Naryzhny SN, 2007, FEBS LETT, V581, P4917, DOI 10.1016/j.febslet.2007.09.022; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Penning TM, 2009, ANN NY ACAD SCI, V1155, P33, DOI 10.1111/j.1749-6632.2009.03700.x; Pollard PJ, 2009, SCIENCE, V324, P192, DOI 10.1126/science.1173362; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHONK DM, 1989, HUM GENET, V83, P297, DOI 10.1007/BF00285178; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Sekaric P, 2008, J VIROL, V82, P71, DOI 10.1128/JVI.01776-07; Shamanin VA, 2008, J VIROL, V82, P3912, DOI 10.1128/JVI.02466-07; Shen ZY, 2004, ONCOL REP, V11, P647; SMEDTS F, 1992, AM J PATHOL, V141, P497; SMEDTS F, 1993, OBSTET GYNECOL, V82, P465; Song SY, 1998, P NATL ACAD SCI USA, V95, P2290, DOI 10.1073/pnas.95.5.2290; Sprague DL, 2002, VIROLOGY, V301, P247, DOI 10.1006/viro.2002.1542; Stoppler MC, 1996, J VIROL, V70, P6987; Sumida T, 1999, INT J CANCER, V80, P1, DOI 10.1002/(SICI)1097-0215(19990105)80:1<1::AID-IJC1>3.0.CO;2-U; TIDY JA, 1989, LANCET, V1, P1225; WOODWORTH CD, 1988, CANCER RES, V48, P4620; Xi LF, 1998, CANCER RES, V58, P3839; Xi LF, 1997, JNCI-J NATL CANCER I, V89, P796, DOI 10.1093/jnci/89.11.796; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Zehbe I, 1999, ONCOGENE, V18, P2201, DOI 10.1038/sj.onc.1202549; Zehbe I, 2003, HUM IMMUNOL, V64, P538, DOI 10.1016/S0198-8859(03)00033-8; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520; Zehbe I, 1998, CANCER RES, V58, P829; Zehbe I, 2009, VIROLOGY, V383, P69, DOI 10.1016/j.virol.2008.09.036; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zwerschke W, 2000, J BIOL CHEM, V275, P9534, DOI 10.1074/jbc.275.13.9534	65	54	54	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3435	3445		10.1038/onc.2010.93	http://dx.doi.org/10.1038/onc.2010.93			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20383192				2022-12-25	WOS:000278622700011
J	Yin, Y; Yang, SQ; Yu, L; Yu, CA				Yin, Ying; Yang, Shaoqing; Yu, Linda; Yu, Chang-An			Reaction Mechanism of Superoxide Generation during Ubiquinol Oxidation by the Cytochrome bc(1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; Q-CYCLE; HEART-MITOCHONDRIA; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; QUINOL OXIDATION; Q(O) SITE; RHODOBACTER-SPHAEROIDES; BOUND UBISEMIQUINONE; C REDUCTASE	In addition to its main functions of electron transfer and proton translocation, the cytochrome bc(1) complex (bc(1)) also catalyzes superoxide anion (O-2(center dot-)) generation upon oxidation of ubiquinol in the presence of molecular oxygen. The reaction mechanism of superoxide generation by bc(1) remains elusive. The maximum O(2)radical anion. generation activity is observed when the complex is inhibited by antimycin A or inactivated by heat treatment or proteinase K digestion. The fact that the cytochrome bc(1) complex with less structural integrity has higher O-2(center dot-)-generating activity encouraged us to speculate that O-2(center dot-) is generated inside the complex, perhaps in the hydrophobic environment of the Q(P) pocket through bifurcated oxidation of ubiquinol by transferring its two electrons to a high potential electron acceptor, iron-sulfur cluster, and a low potential heme b(L) or molecular oxygen. If this speculation is correct, then one should see more O-2(center dot-) generation upon oxidation of ubiquinol by a high potential oxidant, such as cytochrome c or ferricyanide, in the presence of phospholipid vesicles or detergent micelles than in the hydrophilic conditions, and this is indeed the case. The protein subunits, at least those surrounding the Q(P) pocket, may play a role either in preventing the release of O-2(center dot-) from its production site to aqueous environments or in preventing O-2(center dot-) from getting access to the hydrophobic Q(P) pocket and might not directly participate in superoxide production.	[Yin, Ying; Yang, Shaoqing; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	cayuq@okstate.edu	yang, shaoqing/C-9761-2012		National Institutes of Health [GM30721]; Oklahoma State University [1819, 2372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030721, R37GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30721 (to C.-A.Y.). This work was also supported by Oklahoma Agricultural Experiment Station Projects 1819 and 2372 from the Oklahoma State University.	AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Gong X, 2005, J BIOL CHEM, V280, P9251, DOI 10.1074/jbc.M409994200; Helenius A, 1979, Methods Enzymol, V56, P734; Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LOSCHEN G, 1973, FEBS LETT, V33, P84, DOI 10.1016/0014-5793(73)80165-6; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; NAKANO M, 1990, METHOD ENZYMOL, V186, P585; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Trumpower BL, 2002, BBA-BIOENERGETICS, V1555, P166, DOI 10.1016/S0005-2728(02)00273-6; Tso SC, 2006, BBA-BIOENERGETICS, V1757, P1561, DOI 10.1016/j.bbabio.2006.06.010; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Yang SQ, 2008, J BIOL CHEM, V283, P28767, DOI 10.1074/jbc.M803013200; YU C, 1980, BIOCHIM BIOPHYS ACTA, V591, P409, DOI 10.1016/0005-2728(80)90172-3; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; Yu LD, 2009, METHOD ENZYMOL, V456, P459, DOI 10.1016/S0076-6879(08)04425-X; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	42	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17038	17045		10.1074/jbc.M110.104364	http://dx.doi.org/10.1074/jbc.M110.104364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371599	Green Published, hybrid			2022-12-25	WOS:000277982600067
J	Ingold, B; Simon, E; Ungethum, U; Kuban, RJ; Muller, BM; Lupp, A; Neumann, U; Ebert, MPA; Denkert, C; Weichert, W; Schulz, S; Rocken, C				Ingold, Barbara; Simon, Eva; Ungethuem, Ute; Kuban, Ralf-Juergen; Mueller, Berit M.; Lupp, Amelie; Neumann, Ulf; Ebert, Matthias P. A.; Denkert, Carsten; Weichert, Wilko; Schulz, Stefan; Roecken, Christoph			Vascular CXCR4 Expression - a Novel Antiangiogenic Target in Gastric Cancer?	PLOS ONE			English	Article							HORMONE-RELEASING HORMONE; CHEMOKINE RECEPTORS; PROSTATE-CANCER; TUMOR-GROWTH; DUFFY ANTIGEN/RECEPTOR; COLORECTAL-CANCER; BREAST-CANCER; ANGIOGENESIS; METASTASIS; LYMPHOPOIESIS	Background: G-protein-coupled receptors (GPCRs) are prime candidates for novel cancer prevention and treatment strategies. We searched for differentially expressed GPCRs in node positive gastric carcinomas. Methodology/Principal Findings: Differential expression of GPCRs in three node positive vs. three node negative intestinal type gastric carcinomas was analyzed by gene array technology. The candidate genes CXCL12 and its receptor CXCR4 were validated by real-time reverse-transcription polymerase chain reaction in an independent set of 37 gastric carcinomas. Translation was studied by immunohistochemistry in 347 gastric carcinomas using tissue microarrays as well as in 61 matching lymph node metastases. Protein expression was correlated with clinicopathological patient characteristics and survival. 52 GPCRs and GPCR-related genes were up-or down-regulated in node positive gastric cancer, including CXCL12. Differential expression of CXCL12 was confirmed by RT-PCR and correlated with local tumour growth. CXCL12 immunopositivity was negatively associated with distant metastases and tumour grade. Only 17% of gastric carcinomas showed CXCR4 immunopositive tumour cells, which was associated with higher local tumour extent. 29% of gastric carcinomas showed CXCR4 positive tumour microvessels. Vascular CXCR4 expression was significantly associated with higher local tumour extent as well as higher UICC-stages. When expressing both, CXCL12 in tumour cells and CXCR4 in tumour microvessels, these tumours also were highly significantly associated with higher T-and UICC-stages. Three lymph node metastases revealed vascular CXCR4 expression while tumour cells completely lacked CXCR4 in all cases. The expression of CXCL12 and CXCR4 had no impact on patient survival. Conclusions/Significance: Our results substantiate the significance of GPCRs on the biology of gastric carcinomas and provide evidence that the CXCL12-CXCR4 pathway might be a novel promising antiangiogenic target for the treatment of gastric carcinomas.	[Ingold, Barbara; Simon, Eva; Mueller, Berit M.; Denkert, Carsten; Weichert, Wilko; Roecken, Christoph] Charite, Inst Pathol Campus Mitte, Berlin, Germany; [Ungethuem, Ute; Kuban, Ralf-Juergen] Charite, Lab Funct Genom, Berlin, Germany; [Lupp, Amelie; Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, D-6900 Jena, Germany; [Neumann, Ulf] Charite, Dept Gen Visceral & Transplantat Surg, Berlin, Germany; [Ebert, Matthias P. A.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Ingold, B (corresponding author), Charite, Inst Pathol Campus Mitte, Berlin, Germany.	christoph.roecken@uk-sh.de	Schulz, Stefan/A-6928-2017; Röcken, Christoph/A-9239-2010; Denkert, Carsten/AHE-2675-2022	Schulz, Stefan/0000-0002-5997-8885; Röcken, Christoph/0000-0002-6989-8002; Denkert, Carsten/0000-0002-2249-0982	Berliner Krebshilfe	Berliner Krebshilfe	This study was supported by grants of the Berliner Krebshilfe (Berlin Canceraid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Dicken BJ, 2004, ANN SURG ONCOL, V11, P629, DOI 10.1245/ASO.2004.09.002; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Horak CE, 2007, CANCER RES, V67, P11751, DOI 10.1158/0008-5472.CAN-07-3175; INGOLD B, ROLE VASCUL IN PRESS; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee HJ, 2009, INT J ONCOL, V34, P473, DOI 10.3892/ijo_00000172; Lentsch AB, 2002, FASEB J, V16, P1093, DOI 10.1096/fj.02-0066hyp; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagy A, 2005, CURR PHARM DESIGN, V11, P1167, DOI 10.2174/1381612053507594; Nagy A, 2000, P NATL ACAD SCI USA, V97, P829, DOI 10.1073/pnas.97.2.829; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Richard DE, 2001, ONCOGENE, V20, P1556, DOI 10.1038/sj.onc.1204193; Rocken C, 2007, CANCER EPIDEM BIOMAR, V16, P1206, DOI 10.1158/1055-9965.EPI-05-0934; SAIGUSA S, ANN SURG ONCOL; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Schimanski CC, 2005, CLIN CANCER RES, V11, P1743, DOI 10.1158/1078-0432.CCR-04-1195; Scotton CJ, 2002, CANCER RES, V62, P5930; Shen H, 2006, FASEB J, V20, P59, DOI 10.1096/fj.05-4764com; Smith CJ, 2005, NUCL MED BIOL, V32, P733, DOI 10.1016/j.nucmedbio.2005.05.005; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Taichman RS, 2002, CANCER RES, V62, P1832; Thomas L, 2005, LANCET ONCOL, V6, P266, DOI 10.1016/S1470-2045(05)70156-X; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	39	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10087	10.1371/journal.pone.0010087	http://dx.doi.org/10.1371/journal.pone.0010087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386750	Green Published, gold			2022-12-25	WOS:000276482000016
J	Bates, LA; Handford, R; Lee, PC; Njiraini, N; Poole, JH; Sayialel, K; Sayialel, S; Moss, CJ; Byrne, RW				Bates, Lucy A.; Handford, Rosie; Lee, Phyllis C.; Njiraini, Norah; Poole, Joyce H.; Sayialel, Katito; Sayialel, Soila; Moss, Cynthia J.; Byrne, Richard W.			Why Do African Elephants (Loxodonta africana) Simulate Oestrus? An Analysis of Longitudinal Data	PLOS ONE			English	Article							FEMALE CHOICE; BEHAVIOR; SIGNALS; MUSTH	Female African elephants signal oestrus via chemicals in their urine, but they also exhibit characteristic changes to their posture, gait and behaviour when sexually receptive. Free-ranging females visually signal receptivity by holding their heads and tails high, walking with an exaggerated gait, and displaying increased tactile behaviour towards males. Parous females occasionally exhibit these visual signals at times when they are thought not to be cycling and without attracting interest from musth males. Using demographic and behavioural records spanning a continuous 28-year period, we investigated the occurrence of this "simulated" oestrus behaviour. We show that parous females in the Amboseli elephant population do simulate receptive oestrus behaviours, and this false oestrus occurs disproportionately in the presence of naive female kin who are observed coming into oestrus for the first time. We compare several alternative hypotheses for the occurrence of this simulation: 1) false oestrus has no functional purpose (e. g., it merely results from abnormal hormonal changes); 2) false oestrus increases the reproductive success of the simulating female, by inducing sexual receptivity; and 3) false oestrus increases the inclusive fitness of the simulating female, either by increasing the access of related females to suitable males, or by encouraging appropriate oestrus behaviours from female relatives who are not responding correctly to males. Although the observed data do not fully conform to the predictions of any of these hypotheses, we rule out the first two, and tentatively suggest that parous females most likely exhibit false oestrus behaviours in order to demonstrate to naive relatives at whom to direct their behaviour.	[Bates, Lucy A.; Handford, Rosie; Byrne, Richard W.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Lee, Phyllis C.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Lee, Phyllis C.; Njiraini, Norah; Poole, Joyce H.; Sayialel, Katito; Sayialel, Soila; Moss, Cynthia J.] Amboseli Trust Elephants, Nairobi, Kenya	University of St Andrews; University of Stirling	Bates, LA (corresponding author), Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland.	rwb@st-andrews.ac.uk	Bates, Lucy A/N-6371-2017	Bates, Lucy A/0000-0003-4746-3312; Lee, Phyllis/0000-0002-4296-3513; Byrne, Richard/0000-0001-9862-9373	Leverhulme Trust [F/00268/W]	Leverhulme Trust(Leverhulme Trust)	This analysis was supported by a project grant from The Leverhulme Trust (F/00268/W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley KR, 2006, ANIM BEHAV, V71, P1439, DOI 10.1016/j.anbehav.2006.01.003; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Elder JH, 1936, ANAT RECORD, V67, P119, DOI 10.1002/ar.1090670112; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Ganswindt A, 2005, HORM BEHAV, V47, P83, DOI 10.1016/j.yhbeh.2004.09.002; Heistermann M, 2001, P ROY SOC B-BIOL SCI, V268, P2445, DOI 10.1098/rspb.2001.1833; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Leadbeater E, 2006, CURR BIOL, V16, pR323, DOI 10.1016/j.cub.2006.03.078; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; MCCOMB K, 1987, NATURE, V330, P648, DOI 10.1038/330648a0; MOSS CJ, 1983, BEHAVIOUR, V86, P167, DOI 10.1163/156853983X00354; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Ortolani A, 2005, ZOO BIOL, V24, P311, DOI 10.1002/zoo.20053; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; POOLE JH, AMBOSELI EL IN PRESS; POOLE JH, 2008, ELEPHANTS ETHICS MOR; Raihani NJ, 2008, ANIM BEHAV, V75, P3, DOI 10.1016/j.anbehav.2007.07.024; Rapaport LG, 2008, EVOL ANTHROPOL, V17, P189, DOI 10.1002/evan.20180; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; Rasmussen LEL, 2002, NATURE, V415, P975, DOI 10.1038/415975a; Schulte BA, 2007, APPL ANIM BEHAV SCI, V102, P344, DOI 10.1016/j.applanim.2006.05.035; SCHULTZ ADOLPH H., 1938, JOUR MAMMAL, V19, P363, DOI 10.2307/1374577; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Thornton A, 2008, ANIM BEHAV, V75, P1823, DOI [10.1016/j.anbehav.2007.12.014, 10.1111/j.1558-5646.2011.01370.x]; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a	31	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10052	10.1371/journal.pone.0010052	http://dx.doi.org/10.1371/journal.pone.0010052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383331	Green Published, gold, Green Accepted			2022-12-25	WOS:000276454000012
J	Shimshek, DR; Mueller, M; Wiessner, C; Schweizer, T; van der Putten, PH				Shimshek, Derya R.; Mueller, Matthias; Wiessner, Christoph; Schweizer, Tatjana; van der Putten, P. Herman			The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of alpha-synucleinopathy	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; PROTEIN; AGGREGATION; TOXICITY; MUTATION; MICE; DEGENERATION	Background: Aggregation and misfolded alpha-synuclein is thought to be central in the pathogenesis of Parkinson's disease (PD). Heat-shock proteins (HSPs) that are involved in refolding and degradation processes could lower the aggregate load of alpha-synuclein and thus be beneficial in alpha-synucleinopathies. Methodology/Principal Findings: We co-overexpressed human A53T point-mutated alpha-synuclein and human HSP70 in mice, both under the control of Thy1 regulatory sequences. Behavior read-outs showed no beneficial effect of HSP70 expression in mice. In contrast, motor coordination, grip strength and weight were even worse in the alpha-synucleinopathy model in the presence of HSP70 overexpression. Biochemical analyses revealed no differences in alpha-synuclein oligomers/aggregates, truncations and phosphorylation levels and alpha-synuclein localization was unchanged in immunostainings. Conclusion/Significance: Overexpressing HSP70 in a mouse model of alpha-synucleinopathy did not lower the toxic load of alpha-synuclein species and had no beneficial effect on alpha-synuclein-related motor deficits.	[Shimshek, Derya R.; Mueller, Matthias] Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways Model Dis Ctr, Basel, Switzerland	Novartis	Shimshek, DR (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways Model Dis Ctr, Basel, Switzerland.	derya.shimshek@novartis.com		Shimshek, Derya/0000-0001-8602-7850	Novartis Pharma AG	Novartis Pharma AG	The work was funded by the Novartis Pharma AG (www.novartis.com). The company had a role in this study due to employment of one or more authors of this study.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Dedeoglu A, 2002, EXP NEUROL, V176, P262, DOI 10.1006/exnr.2002.7933; Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007; Douglas Michael R, 2007, Expert Rev Neurother, V7, P657, DOI 10.1586/14737175.7.6.657; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Muchowski PJ, 2008, J BIOL CHEM, V283, P6330, DOI 10.1074/jbc.M709678200; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	24	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10014	10.1371/journal.pone.0010014	http://dx.doi.org/10.1371/journal.pone.0010014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368804	gold, Green Published, Green Submitted			2022-12-25	WOS:000276419900014
J	Harding, MJ; Lepus, CM; Gibson, TF; Shepherd, BR; Gerber, SA; Graham, M; Paturzo, FX; Rahner, C; Madri, JA; Bothwell, ALM; Lindenbach, BD; Pober, JS				Harding, Martha J.; Lepus, Christin M.; Gibson, Thomas F.; Shepherd, Benjamin R.; Gerber, Scott A.; Graham, Morven; Paturzo, Frank X.; Rahner, Christoph; Madri, Joseph A.; Bothwell, Alfred L. M.; Lindenbach, Brett D.; Pober, Jordan S.			An Implantable Vascularized Protein Gel Construct That Supports Human Fetal Hepatoblast Survival and Infection by Hepatitis C Virus in Mice	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; HUMAN ENDOTHELIAL-CELLS; LIVER EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; MOUSE-LIVER; STEM-CELLS; RAT-LIVER; ANGIOGENESIS; REPLICATION	Background: Widely accessible small animal models suitable for the study of hepatitis C virus (HCV) in vivo are lacking, primarily because rodent hepatocytes cannot be productively infected and because human hepatocytes are not easily engrafted in immunodeficient mice. Methodology/Principal Findings: We report here on a novel approach for human hepatocyte engraftment that involves subcutaneous implantation of primary human fetal hepatoblasts (HFH) within a vascularized rat collagen type I/human fibronectin (rCI/hFN) gel containing Bcl-2-transduced human umbilical vein endothelial cells (Bcl-2-HUVEC) in severe combined immunodeficient X beige (SCID/bg) mice. Maturing hepatic epithelial cells in HFH/Bcl-2-HUVEC co-implants displayed endocytotic activity at the basolateral surface, canalicular microvilli and apical tight junctions between adjacent cells assessed by transmission electron microscopy. Some primary HFH, but not Huh-7.5 hepatoma cells, appeared to differentiate towards a cholangiocyte lineage within the gels, based on histological appearance and cytokeratin 7 (CK7) mRNA and protein expression. Levels of human albumin and hepatic nuclear factor 4 alpha (HNF4 alpha) mRNA expression in gel implants and plasma human albumin levels in mice engrafted with HFH and Bcl-2-HUVEC were somewhat enhanced by including murine liver-like basement membrane (mLBM) components and/or hepatocyte growth factor (HGF)-HUVEC within the gel matrix. Following ex vivo viral adsorption, both HFH/Bcl-2-HUVEC and Huh-7.5/Bcl-2-HUVEC co-implants sustained HCV Jc1 infection for at least 2 weeks in vivo, based on qRT-PCR and immunoelectron microscopic (IEM) analyses of gel tissue. Conclusion/Significance: The system described here thus provides the basis for a simple and robust small animal model of HFH engraftment that is applicable to the study of HCV infections in vivo.	[Harding, Martha J.; Lepus, Christin M.; Paturzo, Frank X.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Gibson, Thomas F.; Shepherd, Benjamin R.; Gerber, Scott A.; Bothwell, Alfred L. M.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Graham, Morven; Rahner, Christoph] Yale Univ, Sch Med, Ctr Cellular & Mol Imaging, New Haven, CT 06510 USA; [Madri, Joseph A.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Lindenbach, Brett D.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA; [Pober, Jordan S.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Harding, MJ (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA.	martha.harding@yale.edu			American Gastroenterology Association; Section of Comparative Medicine; NIH [NIH-R01HL085416, NIH-T32AR07107, NIH-RO1HL-088258, NIH-KO1CA107092, NIH-RO1HL62188]; NATIONAL CANCER INSTITUTE [K01CA107092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085416, R01HL062188, R01HL088258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007107] Funding Source: NIH RePORTER	American Gastroenterology Association; Section of Comparative Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the American Gastroenterology Association (Research Scholar Award to M.J.H.), Section of Comparative Medicine (M.J.H., C.M.L.), NIH-R01HL085416 (B.R.S.), NIH-T32AR07107 (S.A.G.), NIH-RO1HL-088258 (A.L. M.B.), NIH-KO1CA107092 (B.D.L.) and NIH-RO1HL62188 (J.S.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bouhadir KH, 2001, J DRUG TARGET, V9, P397, DOI 10.3109/10611860108998775; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHEN FMC, 1976, CHING SHIH WEN TI, V3, P1; Chen Y, 2005, TRANSPLANTATION, V79, P1378, DOI 10.1097/01.TP.0000160813.37515.97; Dabeva MD, 2000, AM J PATHOL, V156, P2017, DOI 10.1016/S0002-9440(10)65074-2; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X; DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; FUJIWARA K, 1993, HEPATOLOGY, V18, P1443, DOI 10.1016/0270-9139(93)90237-H; Gerber SA, 2003, BRIT J CANCER, V88, P1453, DOI 10.1038/sj.bjc.6600907; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; GM A, 1976, PROG HEMOST THROMB, V3, P1; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Iacovacci S, 1997, HEPATOLOGY, V26, P1328; IACOVACCI S, 1993, RES VIROLOGY, V144, P275, DOI 10.1016/S0923-2516(06)80040-3; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Kedem A, 2005, TISSUE ENG, V11, P715, DOI 10.1089/ten.2005.11.715; Kelm JM, 2005, J BIOTECHNOL, V118, P213, DOI 10.1016/j.jbiotec.2005.03.016; Kirkiles-Smith NC, 2009, TRANSPLANTATION, V87, P189, DOI 10.1097/TP.0b013e318192e05d; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Lazaro CA, 2007, AM J PATHOL, V170, P478, DOI 10.2353/ajpath.2007.060789; LEPUS CM, 2009, HUM IMMUNOL; LINDENBACH BD, 2005, SCIENCE; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Liu YH, 1998, BIOCHEM BIOPH RES CO, V246, P821, DOI 10.1006/bbrc.1998.8676; MAHER JJ, 1988, GASTROENTEROLOGY, V94, P1053, DOI 10.1016/0016-5085(88)90566-5; Mahieu-Caputo D, 2004, HUM GENE THER, V15, P1219, DOI 10.1089/hum.2004.15.1219; Malhi H, 2002, J CELL SCI, V115, P2679; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Matsumoto S, 1999, LIVER, V19, P32, DOI 10.1111/j.1478-3231.1999.tb00006.x; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C; NAGAKI M, 1995, BIOCHEM BIOPH RES CO, V210, P38, DOI 10.1006/bbrc.1995.1624; Neubauer K, 2001, CAN J GASTROENTEROL, V15, P187, DOI 10.1155/2001/870205; Nguyen TH, 2005, J HEPATOL, V43, P1031, DOI 10.1016/j.jhep.2005.05.036; Nierhoff D, 2005, HEPATOLOGY, V42, P130, DOI 10.1002/hep.20735; Nowak G, 2005, GUT, V54, P972, DOI 10.1136/gut.2005.064477; Ogawa K, 2004, TRANSPLANTATION, V77, P1783, DOI 10.1097/01.tp.0000131153.78169.24; Ohashi K, 2005, HEPATOLOGY, V41, P132, DOI 10.1002/hep.20484; Ohashi K, 2000, NAT MED, V6, P327; Petersen J, 1998, P NATL ACAD SCI USA, V95, P310, DOI 10.1073/pnas.95.1.310; Phan T, 2009, J VIROL; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; ROOS F, 1995, AM J PHYSIOL-GASTR L, V268, pG380, DOI 10.1152/ajpgi.1995.268.2.G380; Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SHIMA N, 1994, BIOCHEM BIOPH RES CO, V200, P808, DOI 10.1006/bbrc.1994.1523; Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709; STOKER M, 1985, J CELL SCI, V77, P209; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Tsukada Y, 2009, BIOCHEM BIOPH RES CO, V381, P733, DOI 10.1016/j.bbrc.2009.02.158; Turrini P, 2006, TRANSPL P, V38, P1181, DOI 10.1016/j.transproceed.2006.02.149; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Xiong AM, 2008, TISSUE ENG PT A, V14, P995, DOI 10.1089/tea.2007.0087; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Yao C, 2004, CELLS TISSUES ORGANS, V178, P189, DOI 10.1159/000083730; Yokoyama T, 2006, AM J TRANSPLANT, V6, P50, DOI 10.1111/j.1600-6143.2005.01155.x; Zeisberg M, 2006, MOL CELL BIOCHEM, V283, P181, DOI 10.1007/s11010-006-2677-8; Zheng L, 2000, J IMMUNOL, V164, P4665, DOI 10.4049/jimmunol.164.9.4665; ZHONG J, 2005, P NATL ACAD SCI US; Zhou YJ, 2006, BIOCHEM BIOPH RES CO, V344, P658, DOI 10.1016/j.bbrc.2006.03.167; Zhu Q, 2006, ANTIMICROB AGENTS CH, V50, P3260, DOI 10.1128/AAC.00413-06	77	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9987	10.1371/journal.pone.0009987	http://dx.doi.org/10.1371/journal.pone.0009987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376322	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200057
J	Kong, EC; Woo, K; Li, HY; Lebestky, T; Mayer, N; Sniffen, MR; Heberlein, U; Bainton, RJ; Hirsh, J; Wolf, FW				Kong, Eric C.; Woo, Katherine; Li, Haiyan; Lebestky, Tim; Mayer, Nasima; Sniffen, Melissa R.; Heberlein, Ulrike; Bainton, Roland J.; Hirsh, Jay; Wolf, Fred W.			A Pair of Dopamine Neurons Target the D1-Like Dopamine Receptor DopR in the Central Complex to Promote Ethanol-Stimulated Locomotion in Drosophila	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; MUSHROOM BODIES; SYNAPTIC-TRANSMISSION; DIFFERENT FORMS; ELLIPSOID BODY; MOTOR-ACTIVITY; TERM-MEMORY; COCAINE; LOCALIZATION	Dopamine is a mediator of the stimulant properties of drugs of abuse, including ethanol, in mammals and in the fruit fly Drosophila. The neural substrates for the stimulant actions of ethanol in flies are not known. We show that a subset of dopamine neurons and their targets, through the action of the D1-like dopamine receptor DopR, promote locomotor activation in response to acute ethanol exposure. A bilateral pair of dopaminergic neurons in the fly brain mediates the enhanced locomotor activity induced by ethanol exposure, and promotes locomotion when directly activated. These neurons project to the central complex ellipsoid body, a structure implicated in regulating motor behaviors. Ellipsoid body neurons are required for ethanol-induced locomotor activity and they express DopR. Elimination of DopR blunts the locomotor activating effects of ethanol, and this behavior can be restored by selective expression of DopR in the ellipsoid body. These data tie the activity of defined dopamine neurons to D1-like DopR-expressing neurons to form a neural circuit that governs acute responding to ethanol.	[Kong, Eric C.; Heberlein, Ulrike; Wolf, Fred W.] Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Woo, Katherine; Sniffen, Melissa R.; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Li, Haiyan; Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Lebestky, Tim] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mayer, Nasima; Bainton, Roland J.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Virginia; California Institute of Technology; University of California System; University of California San Francisco	Kong, EC (corresponding author), Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	frederick.wolf@ucsf.edu			United States National Institutes of Health [AA014594-04, GM27318, DA19573, GM081863-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081863, R01GM027318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019573] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this research was provided by United States National Institutes of Health grant AA014594-04 (FWW), GM27318 (JH), DA19573 (UH), and GM081863-03 (RJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Berger KH, 2004, ALCOHOL CLIN EXP RES, V28, P1469, DOI 10.1097/01.ALC.0000141817.15993.98; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; BOOKER R, 1981, P NATL ACAD SCI-BIOL, V78, P3940, DOI 10.1073/pnas.78.6.3940; Borue X, 2010, J NEUROCHEM, V113, P188, DOI 10.1111/j.1471-4159.2010.06588.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; DICHIARA G, 1986, ANN NY ACAD SCI, V473, P367; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Feng GP, 1996, J NEUROSCI, V16, P3925; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Gotzes F, 1996, BIOCHEM BIOPH RES CO, V222, P121, DOI 10.1006/bbrc.1996.0708; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ilius M, 2007, J NEUROGENET, V21, P321, DOI 10.1080/01677060701693503; Ito K, 1998, LEARN MEMORY, V5, P52; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; KONG EC, 2009, ALCOHOL CLIN EXP RES; Konopka RJ, 1996, J NEUROGENET, V11, P117, DOI 10.3109/01677069609107066; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Martin JR, 1998, LEARN MEMORY, V5, P179; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Meyer PJ, 2009, GENES BRAIN BEHAV, V8, P346, DOI 10.1111/j.1601-183X.2009.00481.x; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; MORGAN BA, 1986, EMBO J, V5, P3335, DOI 10.1002/j.1460-2075.1986.tb04648.x; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Neckameyer W, 2001, J NEUROBIOL, V47, P280, DOI 10.1002/neu.1035; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; RISINGER FO, 1994, PSYCHOPHARMACOLOGY, V116, P207, DOI 10.1007/BF02245064; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rodan AR, 2002, J NEUROSCI, V22, P9490; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Szumlinski KK, 2008, BIOCHEM PHARMACOL, V75, P112, DOI 10.1016/j.bcp.2007.07.031; Thimgan MS, 2006, J EXP BIOL, V209, P3383, DOI 10.1242/jeb.02328; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Urizar NL, 2007, J NEUROSCI, V27, P4541, DOI 10.1523/JNEUROSCI.0305-07.2007; WALLER MB, 1986, PHARMACOL BIOCHEM BE, V24, P617, DOI 10.1016/0091-3057(86)90567-8; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wolf FW, 2002, J NEUROSCI, V22, P11035; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	78	130	131	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9954	10.1371/journal.pone.0009954	http://dx.doi.org/10.1371/journal.pone.0009954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376353	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000276418200030
J	Singh, IR; Gorzynski, JE; Drobysheva, D; Bassit, L; Schinazi, RF				Singh, Ila R.; Gorzynski, John E.; Drobysheva, Daria; Bassit, Leda; Schinazi, Raymond F.			Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; CONTROLLED TRIAL; PREVALENCE; RETROVIRUS; RESISTANT; THERAPY; BLIND	Background: Xenotropic murine leukemia-related retrovirus (XMRV) is a recently discovered retrovirus that has been linked to human prostate cancer and chronic fatigue syndrome (CFS). Both diseases affect a large fraction of the world population, with prostate cancer affecting one in six men, and CFS affecting an estimated 0.4 to 1% of the population. Principal Findings: Forty-five compounds, including twenty-eight drugs approved for use in humans, were evaluated against XMRV replication in vitro. We found that the retroviral integrase inhibitor, raltegravir, was potent and selective against XMRV at submicromolar concentrations, in MCF-7 and LNCaP cells, a breast cancer and prostate cancer cell line, respectively. Another integrase inhibitor, L-000870812, and two nucleoside reverse transcriptase inhibitors, zidovudine (ZDV), and tenofovir disoproxil fumarate (TDF) also inhibited XMRV replication. When combined, these drugs displayed mostly synergistic effects against this virus, suggesting that combination therapy may delay or prevent the selection of resistant viruses. Conclusions: If XMRV proves to be a causal factor in prostate cancer or CFS, these discoveries may allow for rational design of clinical trials.	[Singh, Ila R.; Gorzynski, John E.; Drobysheva, Daria] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Bassit, Leda; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Decatur, GA 30033 USA; [Bassit, Leda; Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Utah System of Higher Education; University of Utah; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Singh, IR (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	ila.singh@path.utah.edu	Schinazi, Raymond F/B-6777-2017	Gorzynski, John/0000-0002-9034-9016	NIH [2P30-AI-50409]; Department of Veterans Affairs (RFS); NATIONAL CANCER INSTITUTE [R01CA149719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (RFS)(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by NIH grant 2P30-AI-50409 (CFAR to RFS), and by the Department of Veterans Affairs (RFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; Bassit Leda, 2008, Antiviral Chemistry & Chemotherapy, V19, P25; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; Coffin JM, 2009, SCIENCE, V326, P530, DOI 10.1126/science.1181349; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Ernst E, 2004, J PSYCHOSOM RES, V57, P503, DOI 10.1016/j.jpsychores.2004.08.005; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FLOYD RA, 1998, USPTO PATENT FULL TE; Gregg VH, 1997, J ROY SOC MED, V90, P682, DOI 10.1177/014107689709001213; GROOM HCT, 2010, RETROVIROLOGY, V7, DOI DOI 10.1186/1742-4690-1187-1110; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; HO W, 1995, J MED CHEM, V38, P794, DOI 10.1021/jm00005a006; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; LAND S, 1992, J INFECT DIS, V166, P1139, DOI 10.1093/infdis/166.5.1139; LLOYD A, 1990, AM J MED, V89, P561, DOI 10.1016/0002-9343(90)90173-B; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Mears Tim, 2005, Acupunct Med, V23, P141; Naarding MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-6; PETERSON PK, 1990, AM J MED, V89, P554, DOI 10.1016/0002-9343(90)90172-A; Reid S, 2000, BMJ-BRIT MED J, V320, P292, DOI 10.1136/bmj.320.7230.292; RUPRECHT RM, 1986, NATURE, V323, P467, DOI 10.1038/323467a0; Sackner MA, 2004, MED HYPOTHESES, V63, P118, DOI 10.1016/j.mehy.2004.01.025; SAKUMA R, 2009, VIROLOGY; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; SCHINAZI RF, 1990, BIOL ROLE DEHYDROEPI, P157; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Telesnitsky A, 1995, METHOD ENZYMOL, V262, P347; Tharakan B, 2006, PHYTOTHER RES, V20, P91, DOI 10.1002/ptr.1794; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; VOLBERDING PA, 1994, JAMA-J AM MED ASSOC, V272, P437, DOI 10.1001/jama.272.6.437; VollmerConna U, 1997, AM J MED, V103, P38, DOI 10.1016/S0002-9343(97)90045-0; Weatherley-Jones E, 2004, J PSYCHOSOM RES, V56, P189, DOI 10.1016/S0022-3999(03)00377-5; Yamada Akihiro, 2009, Nihon Shokakibyo Gakkai Zasshi, V106, P1758; Zachrisson O, 2002, EUR J PAIN-LONDON, V6, P455, DOI 10.1016/S1090-3801(02)00044-7	42	43	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9948	10.1371/journal.pone.0009948	http://dx.doi.org/10.1371/journal.pone.0009948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376347	gold, Green Published, Green Submitted			2022-12-25	WOS:000276418200024
J	Mulle, JG; Patel, VC; Warren, ST; Hegde, MR; Cutler, DJ; Zwick, ME				Mulle, Jennifer G.; Patel, Viren C.; Warren, Stephen T.; Hegde, Madhuri R.; Cutler, David J.; Zwick, Michael E.			Empirical Evaluation of Oligonucleotide Probe Selection for DNA Microarrays	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; COPY NUMBER; GENOME; DESIGN; IDENTIFICATION; MAP	DNA-based microarrays are increasingly central to biomedical research. Selecting oligonucleotide sequences that will behave consistently across experiments is essential to the design, production and performance of DNA microarrays. Here our aim was to improve on probe design parameters by empirically and systematically evaluating probe performance in a multivariate context. We used experimental data from 19 array CGH hybridizations to assess the probe performance of 385,474 probes tiled in the Duchenne muscular dystrophy (DMD) region of the X chromosome. Our results demonstrate that probe melting temperature, single nucleotide polymorphisms (SNPs), and homocytosine motifs all have a strong effect on probe behavior. These findings, when incorporated into future microarray probe selection algorithms, may improve microarray performance for a wide variety of applications.	[Mulle, Jennifer G.; Patel, Viren C.; Warren, Stephen T.; Hegde, Madhuri R.; Cutler, David J.; Zwick, Michael E.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Mulle, JG (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	jmulle@emory.edu	Warren, Stephen T/A-2498-2012		Kirschstein National Research Service Award (NRSA); NARSAD Young Investigator	Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator(NARSAD)	G. M. was supported by a Kirschstein National Research Service Award (NRSA) fellowship and a NARSAD Young Investigator award (http://www.narsad.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1992, No To Hattatsu, V24, P127; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; BERTHET N, 2008, MICROBIAL BIOTECHNOL; Bertone P, 2006, GENOME RES, V16, P271, DOI 10.1101/gr.4455906; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Flibotte S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-497; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Graf S, 2007, BIOINFORMATICS, V23, pI195, DOI 10.1093/bioinformatics/btm200; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HARTMANN A, 2008, HUM MUTAT; Hegde MR, 2008, HUM MUTAT, V29, P1091, DOI 10.1002/humu.20831; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; MAITRA A, 2004, HUMAN MITOCHIP HIGH; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; *NIMBLEGEN SYST IN, 2007, ROCH NIMBLEGEN PROB, P1; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Patil Nila, 2001, SCIENCE; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rouleau E, 2007, CLIN GENET, V72, P199, DOI 10.1111/j.1399-0004.2007.00849.x; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sharp AJ, 2007, HUM MOL GENET, V16, P2770, DOI 10.1093/hmg/ddm234; Vainrub A, 2004, BIOPOLYMERS, V73, P614, DOI 10.1002/bip.20008; ZWICK KMP, 2008, PLOS ONE; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	31	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9921	10.1371/journal.pone.0009921	http://dx.doi.org/10.1371/journal.pone.0009921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360966	Green Submitted, gold, Green Published			2022-12-25	WOS:000276163100014
J	Turner, H; Lieshout, N; Van Ginkel, WE; Menken, SBJ				Turner, Hubert; Lieshout, Niek; Van Ginkel, Wil E.; Menken, Steph B. J.			Molecular Phylogeny of the Small Ermine Moth Genus Yponomeuta (Lepidoptera, Yponomeutidae) in the Palaearctic	PLOS ONE			English	Article							LENGTH DIFFERENCE TEST; MULTIPLE SEQUENCE ALIGNMENT; CYTOCHROME-OXIDASE-I; MITOCHONDRIAL-DNA; NUCLEOTIDE-SEQUENCE; PLANT RELATIONSHIPS; MIXED MODELS; CLUSTAL-X; INSECT; INCONGRUENCE	Background: The small ermine moth genus Yponomeuta (Lepidoptera, Yponomeutidae) contains 76 species that are specialist feeders on hosts from Celastraceae, Rosaceae, Salicaceae, and several other plant families. The genus is a model for studies in the evolution of phytophagous insects and their host-plant associations. Here, we reconstruct the phylogeny to provide a solid framework for these studies, and to obtain insight into the history of host-plant use and the biogeography of the genus. Methodology/Principal Findings: DNA sequences from an internal transcribed spacer region (ITS-1) and from the 16S rDNA (16S) and cytochrome oxidase (COII) mitochondrial genes were collected from 20-23 (depending on gene) species and two outgroup taxa to reconstruct the phylogeny of the Palaearctic members of this genus. Sequences were analysed using three different phylogenetic methods (parsimony, likelihood, and Bayesian inference). Conclusions/Significance: Roughly the same patterns are retrieved irrespective of the method used, and they are similar among the three genes. Monophyly is well supported for a clade consisting of the Japanese (but not the Dutch) population of Yponomeuta sedellus and Y. yanagawanus, a Y. kanaiellus-polystictus clade, and a Rosaceae-feeding, western Palaearctic clade (Y. cagnagellus-irrorellus clade). Within these clades, relationships are less well supported, and the patterns between the different gene trees are not so similar. The position of the remaining taxa is also variable among the gene trees and rather weakly supported. The phylogenetic information was used to elucidate patterns of biogeography and resource use. In the Palaearctic, the genus most likely originated in the Far East, feeding on Celastraceae, dispersing to the West concomitant with a shift to Rosaceae and further to Salicaceae. The association of Y. cagnagellus with Euonymus europaeus (Celastraceae), however, is a reversal. The only oligophagous species, Y. padellus, belongs to the derived western Palaearctic clade, evidence that specialisation is reversible.	[Turner, Hubert; Lieshout, Niek; Van Ginkel, Wil E.; Menken, Steph B. J.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Turner, Hubert] Netherlands Ctr Biodivers Nat, Sect Natl Herbarium Nederland, Leiden, Netherlands	University of Amsterdam; Naturalis Biodiversity Center	Turner, H (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	turner@nhn.leidenuniv.nl	Turner, Hubert/A-7360-2010	Turner, Hubert/0000-0001-8052-8988	Netherlands Organization for Scientific Research [441.041]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Niek Lieshout was supported by the Netherlands Organization for Scientific Research (NWO; SLW grant 441.041) http://www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AC, 2008, ENTOMOL EXP APPL, V128, P240, DOI 10.1111/j.1570-7458.2008.00684.x; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; BROWN JM, 1994, MOL BIOL EVOL, V11, P128; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Cossentine JE, 2000, CAN ENTOMOL, V132, P685, DOI 10.4039/Ent132685-5; CROZIER RH, 1989, MOL BIOL EVOL, V6, P399; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Dowton M, 2002, SYST BIOL, V51, P19, DOI 10.1080/106351502753475853; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; *GEN COMP GROUP, 1991, PROGR MAN GCG PACK V; Gershenson Z.S., 1998, YPONOMEUTIDAE LEPIDO; HARRISON RG, 1987, MOL BIOL EVOL, V4, P144; Herrebout W.M., 1976, Symposia Biologica Hungarica, V16, P91; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; JERMY T, 1993, ENTOMOL EXP APPL, V66, P3, DOI 10.1007/BF02381541; Kelley ST, 1998, EVOLUTION, V52, P1731, DOI [10.2307/2411346, 10.1111/j.1558-5646.1998.tb02253.x]; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kolsch G, 2008, MOL PHYLOGENET EVOL, V48, P936, DOI 10.1016/j.ympev.2008.05.035; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; McKenna DD, 2009, P NATL ACAD SCI USA, V106, P7083, DOI 10.1073/pnas.0810618106; Menken SBJ, 1996, ENTOMOL EXP APPL, V80, P297, DOI 10.1007/BF00194779; MENKEN SBJ, 1992, ANNU REV ENTOMOL, V37, P41, DOI 10.1146/annurev.en.37.010192.000353; Menken SBJ, 1998, ENDLESS FORMS, P145; MENKEN SBJ, 1982, Z ZOOL SYST EVOL, V20, P131; MENKEN SBJ, 1987, EVOLUTION, V41, P630, DOI 10.1111/j.1558-5646.1987.tb05834.x; Moriuti S, 1977, FAUNA JAPONICA YPONO; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pellmyr O, 1999, P NATL ACAD SCI USA, V96, P9178, DOI 10.1073/pnas.96.16.9178; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; POVEL GDE, 1987, P K NED AKAD C BIOL, V90, P367; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Roessingh P, 2000, CHEMOECOLOGY, V10, P41, DOI 10.1007/s000490050006; ROESSINGH P, 1989, ENTOMOL EXP APPL, V51, P49, DOI 10.1007/BF00343443; Roessingh P, 2007, J COMP PHYSIOL A, V193, P635, DOI 10.1007/s00359-007-0218-x; Rokas A, 2001, HEREDITY, V87, P294, DOI 10.1046/j.1365-2540.2001.00872.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Southwood TRE, 1996, ENTOMOL EXP APPL, V80, P320, DOI 10.1007/BF00194783; SPERLING FAH, 1995, ANN ENTOMOL SOC AM, V88, P155, DOI 10.1093/aesa/88.2.155; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2002, PAUP PHYL AN US PARS; Teasdale BW, 2009, EUR J PHYCOL, V44, P171, DOI 10.1080/09670260802590877; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ulenberg Sandrine A., 2009, Tijdschrift voor Entomologie, V152, P187; WHEELER WC, 1988, MOL BIOL EVOL, V5, P90; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WILGENBUSCH JC, AWTY SYST GRAPH EXPL; XIONG B, 1990, GENOME, V34, P3006; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801	62	12	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9933	10.1371/journal.pone.0009933	http://dx.doi.org/10.1371/journal.pone.0009933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360968	Green Submitted, gold, Green Published			2022-12-25	WOS:000276163100022
J	Bhan, U; Ballinger, MN; Zeng, XY; Newstead, MJ; Cornicelli, MD; Standiford, TJ				Bhan, Urvashi; Ballinger, Megan N.; Zeng, Xianying; Newstead, Michael J.; Cornicelli, Matthew D.; Standiford, Theodore J.			Cooperative Interactions between TLR4 and TLR9 Regulate Interleukin 23 and 17 Production in a Murine Model of Gram Negative Bacterial Pneumonia	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; PROTECTIVE INNATE IMMUNITY; CONTAINING ADAPTER PROTEIN; KLEBSIELLA-PNEUMONIAE; HOST-DEFENSE; PSEUDOMONAS-AERUGINOSA; MACROPHAGE ACTIVATION; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; DENDRITIC CELLS	Toll like receptors play an important role in lung host defense against bacterial pathogens. In this study, we investigated independent and cooperative functions of TLR4 and TLR9 in microbial clearance and systemic dissemination during Gram-negative bacterial pneumonia. To access these responses, wildtype Balb/c mice, mice with defective TLR4 signaling (TLR4 lps-d), mice deficient in TLR9 (TLR9(-/-)) and TLR4/9 double mutant mice (TLR4(lps-d)/TLR9(-/-)) were challenged with K. pneumoniae, then time-dependent lung bacterial clearance and systemic dissemination determined. We found impaired lung bacterial clearance in TLR4 and TLR9 single mutant mice, whereas the greatest impairment in clearance was observed in TLR4(lps-d)/TLR9(-/-) double mutant mice. Early lung expression of TNF-alpha, IL-12, and chemokines was TLR4 dependent, while IFN-gamma production and the later expression of TNF-alpha and IL-12 was dependent on TLR9. Classical activation of lung macrophages and maximal induction of IL-23 and IL-17 required both TLR4 and TLR9. Finally, the i.t. instillation of IL-17 partially restored anti-bacterial immunity in TLR4(lps-d)/TLR9(-/-) double mutant mice. In conclusion, our studies indicate that TLR4 and TLR9 have both non-redundant and cooperative roles in lung innate responses during Gram-negative bacterial pneumonia and are both critical for IL-17 driven antibacterial host response.	[Bhan, Urvashi; Ballinger, Megan N.; Zeng, Xianying; Newstead, Michael J.; Cornicelli, Matthew D.; Standiford, Theodore J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bhan, U (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	ubhan@med.umich.edu		Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [K08HL094762, P50 HL074024, HL25243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094762, R01HL057243, P50HL074024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health Grants: K08HL094762 (UB), P50 HL074024 and HL25243 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Deng JC, 2004, J IMMUNOL, V173, P5148, DOI 10.4049/jimmunol.173.8.5148; Elkins KL, 2009, MICROBES INFECT, V11, P49, DOI 10.1016/j.micinf.2008.10.005; Gikas A, 1998, INFECTION, V26, P155, DOI 10.1007/BF02771841; Gordon DJ, 2003, BIOCHEMISTRY-US, V42, P475, DOI 10.1021/bi0259857; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Heiman AS, 2005, J INTERF CYTOK RES, V25, P82, DOI 10.1089/jir.2005.25.82; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Jeyaseelan S, 2005, J IMMUNOL, V175, P7484, DOI 10.4049/jimmunol.175.11.7484; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Sjolinder H, 2008, INFECT IMMUN, V76, P5421, DOI 10.1128/IAI.00615-08; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Suzuki K, 2005, AM J RESP CRIT CARE, V171, P707, DOI 10.1164/rccm.200408-1078OC; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Yinnon AM, 1996, QJM-MON J ASSOC PHYS, V89, P933; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhou XP, 2008, CURR NANOSCI, V4, P88, DOI 10.2174/157341308783591870	35	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9896	10.1371/journal.pone.0009896	http://dx.doi.org/10.1371/journal.pone.0009896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360853	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600006
J	Antony, R; Lukiw, WJ; Bazan, NG				Antony, Rajee; Lukiw, Walter J.; Bazan, Nicolas G.			Neuroprotectin D1 Induces Dephosphorylation of Bcl-x(L) in a PP2A-dependent Manner during Oxidative Stress and Promotes Retinal Pigment Epithelial Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; BCL-X-L; DOCOSAHEXAENOIC ACID; MACULAR DEGENERATION; PROAPOPTOTIC FUNCTION; PHOSPHORYLATION SITE; CARDIAC MYOCYTES; FAMILY PROTEINS; LEUKEMIA-CELLS; APOPTOSIS	Retinal pigment epithelial (RPE) cell integrity is critical for the survival of photoreceptor cells. Bcl-x(L) is a major anti-apoptotic Bcl-2 protein required for RPE cell survival, and phosphorylation of Bcl-x(L) at residue Ser-62 renders this protein pro-apoptotic. In this study, we identify serine/threonine protein phosphatase 2A (PP2A) as a key regulator of Bcl-x(L) phosphorylation at residue Ser-62 in ARPE-19 cells, a spontaneously arising RPE cell line in which Bcl-x(L) is highly expressed. We found that either PP2A inhibitor okadaic acid or depletion of catalytic subunit alpha of PP2A (PP2A/C alpha) by small interfering RNA enhanced Bcl-x(L) phosphorylation when activated with hydrogen peroxide and tumor necrosis factor alpha-induced oxidative stress. Disruption of PP2A/C alpha exacerbated oxidative stress-induced apoptosis. PP2A/C alpha colocalized and interacted with S62Bcl-x(L) in cells stressed with H2O2/tumor necrosis factor alpha. By contrast, the omega-3 fatty acid docosahexaenoic acid derivative, neuroprotectin D1 (NPD1), a potent activator of survival signaling, down-regulated oxidative stress-induced phosphorylation of Bcl-x(L) by increasing protein phosphatase activity. NPD1 also attenuated the oxidative stress-induced apoptosis by knockdown of PP2A/C alpha and increased the association of PP2A/C alpha with S62Bcl-x(L) as well as total Bcl-x(L). NPD1 also enhanced the heterodimerization of Bcl-x(L) with its counterpart, pro-apoptotic protein Bax. Thus, NPD1 modulates the activation of this Bcl-2 family protein by dephosphorylating in a PP2A-dependent manner, suggesting a coordinated, NPD1-mediated regulation of cell survival in response to oxidative stress.	[Antony, Rajee; Lukiw, Walter J.; Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, NG (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health through the NEI [R01 EY005121]; United States Public Health Service; NATIONAL EYE INSTITUTE [R01EY005121] Funding Source: NIH RePORTER	National Institutes of Health through the NEI; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY005121 through the NEI, United States Public Health Service.	Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Basu A, 2008, INT J ONCOL, V33, P657, DOI 10.3892/ijo_00000051; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Benito A, 1997, LEUKEMIA, V11, P940, DOI 10.1038/sj.leu.2400699; Bok D, 2007, ARCH OPHTHALMOL-CHIC, V125, P160, DOI 10.1001/archopht.125.2.160; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Cittelly DM, 2007, J NEUROSCI RES, V85, P1894, DOI 10.1002/jnr.21313; Cook SA, 1999, CIRC RES, V85, P940; Covacci V, 2001, CHEM RES TOXICOL, V14, P1492, DOI 10.1021/tx010021m; Deng XM, 2009, BLOOD, V113, P422, DOI 10.1182/blood-2008-06-165134; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kovacech B, 2007, FEBS LETT, V581, P617, DOI 10.1016/j.febslet.2007.01.015; LAW B, 1995, J BIOL CHEM, V270, P12808, DOI 10.1074/jbc.270.21.12808; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Lotery A, 2007, HUM GENET, V122, P219, DOI 10.1007/s00439-007-0406-3; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marcheselli VL, 2010, PROSTAG LEUKOTR ESS, V82, P27, DOI 10.1016/j.plefa.2009.10.010; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Parsons Ramon, 1998, Current Opinion in Oncology, V10, P88, DOI 10.1097/00001622-199801000-00014; Reed JC, 1996, ADV EXP MED BIOL, V406, P99; Rothstein EC, 2002, AM J PHYSIOL-HEART C, V283, pH598, DOI 10.1152/ajpheart.00198.2002; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Schmierer K, 2007, J MAGN RESON IMAGING, V26, P41, DOI 10.1002/jmri.20984; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Sheets KG, 2010, MOL VIS, V16, P320; Simizu S, 2004, CANCER SCI, V95, P266, DOI 10.1111/j.1349-7006.2004.tb02214.x; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tamura Y, 2004, FEBS LETT, V569, P249, DOI 10.1016/j.febslet.2004.06.003; Thuduppathy GR, 2006, J MOL BIOL, V359, P1045, DOI 10.1016/j.jmb.2006.03.052; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Valks DM, 2003, J BIOL CHEM, V278, P25542, DOI 10.1074/jbc.M303760200; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhou H, 2005, EXP CELL RES, V309, P316, DOI 10.1016/j.yexcr.2005.06.014	56	55	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18301	18308		10.1074/jbc.M109.095232	http://dx.doi.org/10.1074/jbc.M109.095232			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363734	hybrid, Green Published			2022-12-25	WOS:000278453900023
J	Blue, R; Li, JH; Steinberger, J; Murcia, M; Filizola, M; Coller, BS				Blue, Robert; Li, Jihong; Steinberger, Jonathan; Murcia, Marta; Filizola, Marta; Coller, Barry S.			Effects of Limiting Extension at the alpha IIb Genu on Ligand Binding to Integrin alpha IIb beta 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MONOCLONAL-ANTIBODY; I-LIKE DOMAIN; GLYCOPROTEIN-IIB; CRYSTAL-STRUCTURE; IMMOBILIZED FIBRINOGEN; CONFORMATIONAL-CHANGES; EXTRACELLULAR SEGMENT; CYTOPLASMIC DOMAIN; PLATELET-ADHESION; IIIA COMPLEX	Structural data of integrin alpha IIb beta 3 have been interpreted as supporting a model in which: 1) the receptor exists primarily in a "bent," low affinity conformation on unactivated platelets and 2) activation induces an extended, high affinity conformation prior to, or following, ligand binding. Previous studies found that "clasping" the alpha IIb head domain to the beta 3 tail decreased fibrinogen binding. To study the role of alpha IIb extension about the genu, we introduced a disulfide "clamp" between the alpha IIb thigh and calf-1 domains. Clamped alpha IIb beta 3 had markedly reduced ability to bind the large soluble ligands fibrinogen and PAC-1 when activated with monoclonal antibody (mAb) PT25-2 but not when activated by Mn2+ or by coexpressing the clamped alpha IIb with a beta 3 subunit containing the activating mutation N339S. The clamp had little effect on the binding of the snake venom kistrin (M-r 7,500) or alpha IIb beta 3-mediated adhesion to immobilized fibrinogen, but it did diminish the enhanced binding of mAbAP5 in the presence of kistrin. Collectively, our studies support a role for alpha IIb extension about the genu in the binding of ligands of 340,000 and 900,000 M-r with mAb-induced activation but indicate that it is not an absolute requirement. Our data are consistent with alpha IIb extension resulting in increased access to the ligand-binding site and/or facilitating the conformational change(s) in beta 3 that affect the intrinsic affinity of the binding pocket for ligand.	[Blue, Robert; Li, Jihong; Steinberger, Jonathan; Coller, Barry S.] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA; [Murcia, Marta; Filizola, Marta] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10065 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Coller, BS (corresponding author), 1230 York Ave,Box 309, New York, NY 10065 USA.	collerb@rockefeller.edu		Blue, Robert/0000-0002-0872-0358; Filizola, Marta/0000-0002-4382-8276	National Institutes of Health [19278]; National Center for Research Resources at the National Institutes of Health [UL1-RR024143]; Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 19278. This work was also supported by Clinical and Translational Science Award UL1-RR024143 from the National Center for Research Resources at the National Institutes of Health and by funds from Stony Brook University.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; BEER JH, 1992, BLOOD, V79, P117; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; COLLER BS, 1986, J CELL BIOL, V103, P451, DOI 10.1083/jcb.103.2.451; COLLER BS, 1980, BLOOD, V55, P169; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; DU XP, 1993, J BIOL CHEM, V268, P23087; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; Law DA, 1999, BLOOD, V93, P2645, DOI 10.1182/blood.V93.8.2645.408k13_2645_2652; LINDON JN, 1986, BLOOD, V68, P355; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Moskowitz KA, 1998, THROMB HAEMOSTASIS, V79, P824, DOI 10.1055/s-0037-1615072; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Rocco M, 2008, STRUCTURE, V16, P954, DOI 10.1016/j.str.2008.02.019; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; SHADLE PJ, 1984, J CELL BIOL, V99, P2056, DOI 10.1083/jcb.99.6.2056; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307; Shi ML, 2005, J BIOL CHEM, V280, P30586, DOI 10.1074/jbc.M502525200; STANFORD MF, 1983, ANN NY ACAD SCI, V416, P504, DOI 10.1111/j.1749-6632.1983.tb35208.x; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318; ZUCKER MB, 1984, THROMB HAEMOSTASIS, V51, P119	47	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17604	17613		10.1074/jbc.M110.107763	http://dx.doi.org/10.1074/jbc.M110.107763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363746	Green Published, hybrid			2022-12-25	WOS:000278133400039
J	Rajagopal, S; Ji, YX; Xu, K; Li, YHA; Wicks, K; Liu, JW; Wong, KW; Herman, IM; Isberg, RR; Buchsbaum, RJ				Rajagopal, Soumitra; Ji, Yuxin; Xu, Kun; Li, Yuhuan; Wicks, Kathleen; Liu, Jiewei; Wong, Ka-Wing; Herman, Ira M.; Isberg, Ralph R.; Buchsbaum, Rachel J.			Scaffold Proteins IRSp53 and Spinophilin Regulate Localized Rac Activation by T-lymphocyte Invasion and Metastasis Protein 1 (TIAM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; COMPLEX-FORMATION; PLASMA-MEMBRANE; ACTIN ISOFORMS; LIVING CELLS; KINASE; RHO; GTP; MIGRATION; BINDING	The Rac exchange factor Tiam1 is involved in diverse cell functions and signaling pathways through multiple protein interactions, raising the question of how signaling and functional specificity are achieved. We have shown that Tiam1 interactions with different scaffold proteins activate different Rac-dependent pathways by recruiting specific Rac effector proteins, and reasoned that there must be regulatory mechanisms governing each interaction. Fibroblasts express at least two Tiam1-interacting proteins, insulin receptor substrate protein 53 kDa (IRSp53) and spinophilin. We used fluorescent resonance energy transfer (FRET) to measure localized Rac activation associated with IRSp53 and spinophilin complexes in individual fibroblasts to test this hypothesis. Pervanadate or platelet-derived growth factor induced localized Rac activation dependent on Tiam1 and IRSp53. Forskolin or epinephrine induced localized Rac activation dependent on Tiam1 and spinophilin. In spinophilin-deficient cells, Tiam1 co-localized with IRSp53 in response to pervanadate or platelet-derived growth factor. In IRSp53-deficient cells, Tiam1 co-localized with spinophilin in response to forskolin or epinephrine. Total cellular levels of activated Rac were affected only in cells with exogenous Tiam1, and were primarily increased in the membrane fraction. Downstream effects of Rac activation were also stimulus and scaffold-specific. Cell ruffling, spreading, and cell adhesion were dependent on IRSp53, but not spinophilin. Epinephrine decreased IRSp53-dependent adhesion and increased cell migration in a Rac and spinophilin-dependent fashion. These results support the idea that Tiam1 interactions with different scaf-fold proteins couple distinct upstream signals to localized Rac activation and specific downstream pathways, and suggest that manipulating Tiam1-scaffold interactions can modulate Rac-dependent cellular behaviors.	[Rajagopal, Soumitra; Ji, Yuxin; Xu, Kun; Liu, Jiewei] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Buchsbaum, Rachel J.] Tufts Univ, Dept Med, Sch Med, Boston, MA 02111 USA; [Wong, Ka-Wing; Isberg, Ralph R.] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Herman, Ira M.] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Cellular & Mol Physiol, Boston, MA 02111 USA; [Li, Yuhuan] Providence Portland Med Ctr, Portland, OR 97213 USA; [Wicks, Kathleen] Boston Univ, Sch Med, Boston, MA 02118 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; Providence Portland Medical Center; Boston University	Buchsbaum, RJ (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 75 Kneeland St,12th Floor, Boston, MA 02111 USA.	rachel.buchsbaum@tufts.edu			National Institutes of Health [CA95559]; NCI; NIAID [R37AI023538]; NEI [EY15125, EY19533]; Howard Hughes Medical Institute; Tufts Medical Center GRASP Digestive Disease Center [P30DK34928]; Center for Neuroscience Research Core facility [P30NS047243]; NATIONAL CANCER INSTITUTE [R01CA095559] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015125, K08EY019533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Tufts Medical Center GRASP Digestive Disease Center; Center for Neuroscience Research Core facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA95559 (to R. J. B.) from the NCI, R37AI023538 (to R. R. I.) from the NIAID, and EY15125 and EY19533 (to I. M. H.) from the NEI, grants from the Howard Hughes Medical Institute (to K. W. and R. R. I.), Tufts Medical Center GRASP Digestive Disease Center Grant P30DK34928 (to R. J. B.), and Center for Neuroscience Research Core facility Grant P30NS047243.	Allen PG, 1996, BIOCHEMISTRY-US, V35, P14062, DOI 10.1021/bi961326g; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bourguignon LYW, 2000, J CELL BIOL, V150, P177, DOI 10.1083/jcb.150.1.177; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Buchsbaum R, 1996, MOL CELL BIOL, V16, P4888; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DENOFRIO D, 1989, J CELL BIOL, V109, P191, DOI 10.1083/jcb.109.1.191; Downes CP, 2005, BIOCHEM SOC T, V33, P1303, DOI 10.1042/BST0331303; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Mertens AEE, 2006, TRENDS CELL BIOL, V16, P308, DOI 10.1016/j.tcb.2006.04.001; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wong KW, 2008, J BIOL CHEM, V283, P35954, DOI 10.1074/jbc.M804717200; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	43	22	24	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18060	18071		10.1074/jbc.M109.051490	http://dx.doi.org/10.1074/jbc.M109.051490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360004	hybrid, Green Published			2022-12-25	WOS:000278133400081
J	Lombardi, A; Busiello, RA; Napolitano, L; Cioffi, F; Moreno, M; de Lange, P; Silvestri, E; Lanni, A; Goglia, F				Lombardi, Assunta; Busiello, Rosa Anna; Napolitano, Laura; Cioffi, Federica; Moreno, Maria; de Lange, Pieter; Silvestri, Elena; Lanni, Antonia; Goglia, Fernando			UCP3 Translocates Lipid Hydroperoxide and Mediates Lipid Hydroperoxide-dependent Mitochondrial Uncoupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; PROTON CONDUCTANCE; FATTY-ACIDS; PROTEIN-3; SUPEROXIDE; METABOLISM; ACTIVATION; TRANSITION; MECHANISM; MATRIX	Although the literature contains many studies on the function of UCP3, its role is still being debated. It has been hypothesized that UCP3 may mediate lipid hydroperoxide (LOOH) translocation across the mitochondrial inner membrane (MIM), thus protecting the mitochondrial matrix from this very aggressive molecule. However, no experiments on mitochondria have provided evidence in support of this hypothesis. Here, using mitochondria isolated from UCP3-null mice and their wild-type littermates, we demonstrate the following. (i) In the absence of free fatty acids, proton conductance did not differ between wild-type and UCP3-null mitochondria. Addition of arachidonic acid (AA) to such mitochondria induced an increase in proton conductance, with wild-type mitochondria showing greater enhancement. In wild-type mitochondria, the uncoupling effect of AA was significantly reduced both when the release of O-2(+) in the matrix was inhibited and when the formation of LOOH was inhibited. In UCP3-null mitochondria, however, the uncoupling effect of AA was independent of the above mechanisms. (ii) In the presence of AA, wild-type mitochondria released significantly more LOOH compared with UCP3-null mitochondria. This difference was abolished both when UCP3 was inhibited by GDP and under a condition in which there was reduced LOOH formation on the matrix side of the MIM. These data demonstrate that UCP3 is involved both in mediating the translocation of LOOH across the MIM and in LOOH-dependent mitochondrial uncoupling.	Univ Naples Federico II, Dipartimento Sci Biol, I-80134 Naples, Italy; [Cioffi, Federica; de Lange, Pieter; Lanni, Antonia] Univ Naples 2, Dipartimento Sci Vita, I-81100 Caserta, Italy; [Moreno, Maria; Silvestri, Elena; Goglia, Fernando] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Sannio		assunta.lombardi@unina.it; goglia@unisannio.it	cioffi, federica/AAB-8161-2019; de Lange, Pieter/GXA-3052-2022	cioffi, federica/0000-0002-1530-8556; MORENO, Maria/0000-0002-6218-5501; GOGLIA, Fernando/0000-0003-0468-9645; Silvestri, Elena/0000-0002-0592-9033	Ministero dell'Istruzione, dell'Universitae della Ricerca [COFIN-MIUR 2008]	Ministero dell'Istruzione, dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione, dell'Universitae della Ricerca COFIN-MIUR 2008.	Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jaburek M, 2004, J BIOL CHEM, V279, P53097, DOI 10.1074/jbc.M405339200; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lanni A, 1999, FEBS LETT, V444, P250, DOI 10.1016/S0014-5793(99)00061-7; Lombardi A, 2008, BBA-BIOENERGETICS, V1777, P826, DOI 10.1016/j.bbabio.2008.04.019; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286; Parker N, 2008, BIOSCIENCE REP, V28, P83, DOI 10.1042/BSR20080002; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Talbot DA, 2005, BBA-BIOENERGETICS, V1709, P150, DOI 10.1016/j.bbabio.2005.07.001; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199	34	44	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16599	16605		10.1074/jbc.M110.102699	http://dx.doi.org/10.1074/jbc.M110.102699			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363757	Green Published, hybrid			2022-12-25	WOS:000277982600023
J	Polidoro, BA; Carpenter, KE; Collins, L; Duke, NC; Ellison, AM; Ellison, JC; Farnsworth, EJ; Fernando, ES; Kathiresan, K; Koedam, NE; Livingstone, SR; Miyagi, T; Moore, GE; Vien, NN; Ong, JE; Primavera, JH; Salmo, SG; Sanciangco, JC; Sukardjo, S; Wang, YM; Yong, JWH				Polidoro, Beth A.; Carpenter, Kent E.; Collins, Lorna; Duke, Norman C.; Ellison, Aaron M.; Ellison, Joanna C.; Farnsworth, Elizabeth J.; Fernando, Edwino S.; Kathiresan, Kandasamy; Koedam, Nico E.; Livingstone, Suzanne R.; Miyagi, Toyohiko; Moore, Gregg E.; Vien Ngoc Nam; Ong, Jin Eong; Primavera, Jurgenne H.; Salmo, Severino G., III; Sanciangco, Jonnell C.; Sukardjo, Sukristijono; Wang, Yamin; Yong, Jean Wan Hong			The Loss of Species: Mangrove Extinction Risk and Geographic Areas of Global Concern	PLOS ONE			English	Article							RED LIST INDEXES; CONSERVATION; BIODIVERSITY; ECOSYSTEM; FORESTS; MANAGEMENT; DYNAMICS; TRENDS; FISH; SUSTAINABILITY	Mangrove species are uniquely adapted to tropical and subtropical coasts, and although relatively low in number of species, mangrove forests provide at least US $1.6 billion each year in ecosystem services and support coastal livelihoods worldwide. Globally, mangrove areas are declining rapidly as they are cleared for coastal development and aquaculture and logged for timber and fuel production. Little is known about the effects of mangrove area loss on individual mangrove species and local or regional populations. To address this gap, species-specific information on global distribution, population status, life history traits, and major threats were compiled for each of the 70 known species of mangroves. Each species' probability of extinction was assessed under the Categories and Criteria of the IUCN Red List of Threatened Species. Eleven of the 70 mangrove species (16%) are at elevated threat of extinction. Particular areas of geographical concern include the Atlantic and Pacific coasts of Central America, where as many as 40% of mangroves species present are threatened with extinction. Across the globe, mangrove species found primarily in the high intertidal and upstream estuarine zones, which often have specific freshwater requirements and patchy distributions, are the most threatened because they are often the first cleared for development of aquaculture and agriculture. The loss of mangrove species will have devastating economic and environmental consequences for coastal communities, especially in those areas with low mangrove diversity and high mangrove area or species loss. Several species at high risk of extinction may disappear well before the next decade if existing protective measures are not enforced.	[Polidoro, Beth A.; Carpenter, Kent E.; Livingstone, Suzanne R.; Sanciangco, Jonnell C.] Old Dominion Univ, IUCN Species Programme, SSC, Norfolk, VA 23529 USA; [Collins, Lorna] Nature Conservancy, Ctr Global Trends, Arlington, VA USA; [Collins, Lorna] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Duke, Norman C.; Salmo, Severino G., III] Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia; [Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Ellison, Joanna C.] Univ Tasmania, Sch Geog & Environm Studies, Launceston, Tas 7250, Australia; [Farnsworth, Elizabeth J.] New England Wild Flower Soc, Framingham, MA USA; [Fernando, Edwino S.] Univ Philippines, Los Banos Coll, Dept Forest Biol Sci, Laguna, Philippines; [Kathiresan, Kandasamy] Annamalai Univ, Ctr Adv Study Marine Biol, Parangipettai, India; [Koedam, Nico E.] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Brussels, Belgium; [Miyagi, Toyohiko] Tohoku Gakuin Univ, Fac Liberal Art, Dept Reg Management, Sendai, Miyagi 980, Japan; [Moore, Gregg E.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Moore, Gregg E.] Univ New Hampshire, Jackson Estuarine Lab, Durham, NH 03824 USA; [Vien Ngoc Nam] Nong Lam Univ, Fac Forestry, Ho Chi Minh City, Vietnam; [Ong, Jin Eong] Univ Sains Malaysia, Ctr Marine & Coastal Studies, George Town, Malaysia; [Primavera, Jurgenne H.] SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo, Philippines; [Salmo, Severino G., III] Cent Luzon State Univ, Coll Agr, Sci City Of Munoz, Nueva Ecija, Philippines; [Sukardjo, Sukristijono] Indonesian Inst Sci, Ctr Oceanol Res & Dev, Jakarta, Indonesia; [Wang, Yamin] Shandong Univ, Coll Ocean, Weihai, Peoples R China; [Yong, Jean Wan Hong] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ Acad Grp, Singapore, Singapore	Old Dominion University; Nature Conservancy; University of Plymouth; University of Queensland; Harvard University; University of Tasmania; University of the Philippines System; University of the Philippines Los Banos; Annamalai University; Vrije Universiteit Brussel; Tohoku Gakuin University; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Nong Lam University; Universiti Sains Malaysia; Southeast Asian Fisheries Development Center; Central Luzon State University; Indonesian Institute of Sciences; Shandong University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Polidoro, BA (corresponding author), Old Dominion Univ, IUCN Species Programme, SSC, Norfolk, VA 23529 USA.	bpolidor@odu.edu	Salmo, Severino G./T-4794-2018; Yong, Jean/B-9976-2019; Ellison, Joanna C/C-2372-2014; Yong, Jean W. H./H-4671-2012; Kandasamy, Kathiresan/X-7933-2019; Duke, Norman C/K-5729-2013; Yong, Jean WH/G-4839-2012	Salmo, Severino G./0000-0001-6807-4397; Yong, Jean/0000-0003-3325-8254; Ellison, Joanna C/0000-0003-0692-8347; Yong, Jean W. H./0000-0003-3325-8254; Kandasamy, Kathiresan/0000-0003-1203-0023; Duke, Norman C/0000-0003-2081-9120; Sanciangco, Jonnell Cueto/0000-0001-8268-3180; Ellison, Aaron/0000-0003-4151-6081; Fernando, Edwino/0000-0001-9422-5451	Tom Haas; New Hampshire Charitable Foundation	Tom Haas; New Hampshire Charitable Foundation	This research was generously supported by core funding from Tom Haas and the New Hampshire Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 1986, CONSERVATION BIOL SC; [Anonymous], WORLD ATLAS MANGROVE; Armitage D, 2002, GLOBAL ENVIRON CHANG, V12, P203, DOI 10.1016/S0959-3780(02)00023-7; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CLARKE PJ, 1995, HYDROBIOLOGIA, V295, P83, DOI 10.1007/BF00029114; Cohen JE, 1997, SCIENCE, V278, P1211; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahdouh-Guebas F, 2008, AQUAT BOT, V89, P80, DOI 10.1016/j.aquabot.2008.03.012; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; Dahdouh-Guebas F., 2004, Systematics and Biodiversity, V2, P113; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; Dittmar T, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002570; Dodd Richard S., 2008, P172, DOI 10.1017/CBO9780511751790.017; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Duarte Carlos M., 1999, Mangroves and Salt Marshes, V3, P251, DOI 10.1023/A:1009967401337; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Duke N.C., 1992, TROPICAL MANGROVE EC, V41, P63, DOI [10.1029/ce041p0063, DOI 10.1029/CE041P0063]; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; DUKE NC, 1992, BIOTROPICA, V24, P173, DOI 10.2307/2388671; Duke NC, 1997, BIOTROPICA, V29, P2, DOI 10.1111/j.1744-7429.1997.tb00001.x; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Ellison AM, 2000, J ECOL, V88, P813, DOI 10.1046/j.1365-2745.2000.00500.x; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; Ellison J, 2005, PALAEOGEOGR PALAEOCL, V220, P291, DOI 10.1016/j.palaeo.2005.01.008; Ellison JC, 2009, WETL ECOL MANAG, V17, P169, DOI 10.1007/s11273-008-9097-3; EMERTON L, 2002, 4 IUCN SRI LANK COUN; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; FAO, 2007, 153 FAO FOR RES DIV; Farnsworth EJ, 1997, AMBIO, V26, P328; Field CB, 1998, GLOBAL ECOL BIOGEOGR, V7, P3, DOI 10.2307/2997693; Fosberg FR, 1971, BIOL CONSERV, V4, P38; Glaser M, 2003, WETL ECOL MANAG, V11, P265, DOI 10.1023/A:1025015600125; Green EP, 1998, INT J REMOTE SENS, V19, P935, DOI 10.1080/014311698215801; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; Jayatissa LP, 2002, BOT J LINN SOC, V138, P29, DOI 10.1046/j.1095-8339.2002.00002.x; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; KOEDAM N, 2008, SCIENCE, V319, P321; Kovacs JM, 2005, ESTUAR COAST SHELF S, V62, P377, DOI 10.1016/j.ecss.2004.09.027; Kress W. John, 2003, Contributions from the United States National Herbarium, V45, P1; LAMPARELLI CC, 1997, MANGROVE ECOSYSTEM S, P191; Leuteritz T., 2008, IUCN RED LIST THREAT; Lopez-Hoffman L, 2006, ECOL SOC, V11; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Lugo A.E., 2002, MADERA BOSQUES, V8, P5, DOI DOI 10.21829/MYB.2002.801289; Luther DA, 2009, BIOSCIENCE, V59, P602, DOI 10.1525/bio.2009.59.7.11; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Miththapala S., 2008, COASTAL ECOSYSTEMS S, V2; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Neukermans G, 2008, J SPAT SCI, V53, P75, DOI 10.1080/14498596.2008.9635137; Ong J. E., 2003, FOLIA MALAYSIANA, V4, P1; ONG JE, 1995, HYDROBIOLOGIA, V295, P343; ONG JE, 1993, CHEMOSPHERE, V27, P1097; PAGLIOSA PA, 2004, IMPACT URBANIZATION; Primavera J., 2004, HDB MANGROVES PHILIP; Primavera JH, 2000, ECOL ECON, V35, P91, DOI 10.1016/S0921-8009(00)00170-1; Primavera JH, 1998, ESTUAR COAST SHELF S, V46, P457, DOI 10.1006/ecss.1997.0275; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; Rodrigues ASL, 2002, CONSERV BIOL, V16, P674, DOI 10.1046/j.1523-1739.2002.00455.x; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Ronnback P, 1999, ECOL ECON, V29, P235, DOI 10.1016/S0921-8009(99)00016-6; Saenger P, 2013, MANGROVE ECOLOGY SIL; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SHEUE CR, 2009, BLUMEA IN PRESS, V54; SIMBERLOFF D, 1988, ANNU REV ECOL SYST, V19, P473, DOI 10.1146/annurev.ecolsys.19.1.473; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sullivan C, 2005, IMPORTANCE MANGROVES; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tovilla-Hernandez C, 2001, REV BIOL TROP, V49, P571; Upadhyay VP, 2002, CURR SCI INDIA, V83, P1328; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Verheyden A, 2004, ANN BOT-LONDON, V94, P59, DOI 10.1093/aob/mch115; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Wang L, 2004, REMOTE SENS ENVIRON, V91, P432, DOI 10.1016/j.rse.2004.04.005; WILKIE ML, 2003, 63 FAO FOR RES DIV; Xue XZ, 2004, J ENVIRON MANAGE, V71, P271, DOI 10.1016/j.jenvman.2004.03.006	86	647	680	11	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10095	10.1371/journal.pone.0010095	http://dx.doi.org/10.1371/journal.pone.0010095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386710	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000276482000021
J	Gujral, TS; MacBeath, G				Gujral, Taranjit S.; MacBeath, Gavin			A System-Wide Investigation of the Dynamics of Wnt Signaling Reveals Novel Phases of Transcriptional Regulation	PLOS ONE			English	Article							BETA-CATENIN; CANCER; ACTIVATION; CELLS; COLON; ASSOCIATION; MECHANISMS; APOPTOSIS; PATHWAYS; PROTEINS	Aberrant Wnt signaling has been implicated in a wide variety of cancers and many components of the Wnt signaling network have now been identified. Much less is known, however, about how these proteins are coordinately regulated. Here, a broad, quantitative, and dynamic study of Wnt3a-mediated stimulation of HEK 293 cells revealed two phases of transcriptional regulation: an early phase in which signaling antagonists were downregulated, providing positive feedback, and a later phase in which many of these same antagonists were upregulated, attenuating signaling. The dynamic expression profiles of several response genes, including MYC and CTBP1, correlated significantly with proliferation and migration (P<0.05). Additionally, their levels tracked with the tumorigenicity of colon cancer cell lines and they were significantly overexpressed in colorectal adenocarcinomas (P<0.05). Our data highlight CtBP1 as a transcription factor that contributes to positive feedback during the early phases of Wnt signaling and serves as a novel marker for colorectal cancer progression.	[Gujral, Taranjit S.; MacBeath, Gavin] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Gujral, TS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	gavin_macbeath@harvard.edu		Gujral, Taran/0000-0002-4453-3031; MacBeath, Gavin/0000-0003-2585-6772	WM Keck Foundation; Camille and Henry Dreyfus Foundation; National Institutes of Health [R33 CA128726, R21 CA126720, P50 GM068762]; NATIONAL CANCER INSTITUTE [R33CA128726, R21CA126720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); Camille and Henry Dreyfus Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by awards from the WM Keck Foundation and the Camille and Henry Dreyfus Foundation, and by grants from the National Institutes of Health (R33 CA128726, R21 CA126720, and P50 GM068762). TSG is a Human Frontier Science Program Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Oyama T, 2008, CARCINOGENESIS, V29, P666, DOI 10.1093/carcin/bgn001; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Shi SR, 1999, APPL IMMUNOHISTO M M, V7, P201, DOI 10.1097/00022744-199909000-00005; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	37	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10024	10.1371/journal.pone.0010024	http://dx.doi.org/10.1371/journal.pone.0010024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383323	Green Submitted, Green Published, gold			2022-12-25	WOS:000276454000005
J	Paccalet, T; Coulombe, Z; Tremblay, JP				Paccalet, Thomas; Coulombe, Zoe; Tremblay, Jacques P.			Ganglioside GM3 Levels Are Altered in a Mouse Model of HIBM: GM3 as a Cellular Marker of the Disease	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE GNE; SIALIC-ACID BIOSYNTHESIS; DISTAL MYOPATHY; SKELETAL-MUSCLE; NEUTRAL GLYCOSPHINGOLIPIDS; ALPHA-DYSTROGLYCAN; RIMMED VACUOLES; KEY ENZYME; HEREDITARY	Objective: HIBM (Hereditary Inclusion Body Myopathy) is a recessive hereditary disease characterized by adult-onset, slowly progressive muscle weakness sparing the quadriceps. It is caused by a single missense mutation of each allele of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene, a bifunctional enzyme catalyzing the first two steps of sialic acid synthesis in mammals. However, the mechanisms and cellular pathways affected by the GNE mutation and causing the muscle weakness could not be identified so far. Based on recent evidence in literature, we investigated a new hypothesis, i.e. the involvement in the disease of the GM3 ganglioside, a specific glycolipid implicated in muscle cell proliferation and differentiation. Methods: qRT-PCR analysis of St3gal5 (GM3 synthase) gene expression and HPLC quantification of GM3 ganglioside were conducted on muscle tissue from a mouse model of HIBM harboring the M712T mutation of GNE (Gne(M712T/M712T) mouse) vs control mice (Gne(+/+) mouse). Results: St3gal5 mRNA levels were significantly lower in Gne(M712T/M712T) mouse muscles vs Gne(+/+) mouse muscles (64.41% +/- 610% of Gne(+/+) levels). GM3 ganglioside levels showed also a significant decrease in Gne(M712T/M712T) mouse muscle compared to Gne(+/+) mouse muscle (18.09% +/- 65.33% of Gne(+/+) levels). Although these Gne(M712T/M712T) mice were described to suffer severe glomerular proteinuria, no GM3 alterations were noted in kidneys, highlighting a tissue specific alteration of gangliosides. Conclusion: The M712T mutation of GNE hampers the muscle ability to synthesize normal levels of GM3. This is the first time that a mutation of GNE can be related to the molecular pathological mechanism of HIBM.	[Paccalet, Thomas; Coulombe, Zoe; Tremblay, Jacques P.] Univ Laval, CHU Quebec, Unite Genet Humaine, Ctr Rech, Quebec City, PQ, Canada	Laval University	Paccalet, T (corresponding author), Univ Laval, CHU Quebec, Unite Genet Humaine, Ctr Rech, Quebec City, PQ, Canada.	Jacques-P.Tremblay@crchul.ulaval.ca	; Paccalet, Thomas/F-9137-2014	Tremblay, Jacques P./0000-0001-9404-9195; Paccalet, Thomas/0000-0003-4955-2140	Ministere du Developpement economique, de l'Innovation et de l'Exportation; Neuromuscular Disease Foundation	Ministere du Developpement economique, de l'Innovation et de l'Exportation; Neuromuscular Disease Foundation	This study is supported partly by the "Ministere du Developpement economique, de l'Innovation et de l'Exportation" and the Neuromuscular Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RS, 2008, SKELETAL RADIOL, V37, P43, DOI 10.1007/s00256-007-0367-6; Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; AMSILI S, 2007, CELL DEATH DIFFER; Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Broccolini A, 2005, NEUROMUSCULAR DISORD, V15, P177, DOI 10.1016/j.nmd.2004.10.001; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; CACIC M, 1995, GLYCOCONJUGATE J, V12, P721, DOI 10.1007/BF00731270; CACIC M, 1994, GLYCOCONJUGATE J, V11, P477, DOI 10.1007/BF00731284; CAMBRON LD, 1994, MOL CELL BIOCHEM, V130, P173, DOI 10.1007/BF01457398; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Hollister J, 2003, GLYCOBIOLOGY, V13, P487, DOI 10.1093/glycob/cwg053; Holthofer H, 1996, AM J PATHOL, V149, P1009; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010; Krause S, 2007, NEUROLOGY, V69, P655, DOI 10.1212/01.wnl.0000267426.97138.fd; Kumamoto T, 1998, ACTA NEUROPATHOL, V95, P571, DOI 10.1007/s004010050842; Kumamoto T, 2000, MUSCLE NERVE, V23, P1686, DOI 10.1002/1097-4598(200011)23:11<1686::AID-MUS3>3.0.CO;2-F; Kwak DH, 2003, LIFE SCI, V72, P1997, DOI 10.1016/S0024-3205(03)00090-0; LADISCH S, 1985, ANAL BIOCHEM, V146, P220, DOI 10.1016/0003-2697(85)90419-1; Langeveld M, 2008, J CLIN ENDOCR METAB, V93, P845, DOI 10.1210/jc.2007-1702; LESKAWA KC, 1988, MOL CELL BIOCHEM, V83, P47; LESKAWA KC, 1990, MOL CELL BIOCHEM, V96, P163, DOI 10.1007/BF00420908; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; Malik KA, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/03/004; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; MitraniRosenbaum S, 1996, HUM MOL GENET, V5, P159, DOI 10.1093/hmg/5.1.159; MOHOS SC, 1969, SCIENCE, V164, P1519, DOI 10.1126/science.164.3887.1519; Muthing J, 1997, GLYCOCONJUGATE J, V14, P19, DOI 10.1023/A:1018552729572; MUTHING J, 1994, J BIOCHEM, V115, P248; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Nonaka I, 1998, NEUROMUSCULAR DISORD, V8, P333, DOI 10.1016/S0960-8966(98)00027-3; Nonaka I, 1999, CURR OPIN NEUROL, V12, P493, DOI 10.1097/00019052-199910000-00002; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Penner J, 2006, BIOCHEMISTRY-US, V45, P2968, DOI 10.1021/bi0522504; Pilkington GJ, 2005, CELL PROLIFERAT, V38, P423, DOI 10.1111/j.1365-2184.2005.00358.x; Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f; SADEH M, 1993, BRAIN, V116, P217, DOI 10.1093/brain/116.1.217; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; SHAYMAN JA, 1991, AM J PHYSIOL, V260, pF291, DOI 10.1152/ajprenal.1991.260.3.F291; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Sparks SE, 2005, GLYCOBIOLOGY, V15, P1102, DOI 10.1093/glycob/cwi100; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; Tsuruta Y, 2001, ACTA NEUROPATHOL, V101, P579; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100	63	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10055	10.1371/journal.pone.0010055	http://dx.doi.org/10.1371/journal.pone.0010055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383336	Green Published, gold, Green Submitted			2022-12-25	WOS:000276454000015
J	Liu, JY; Morgan, M; Hutchison, K; Calhoun, VD				Liu, Jingyu; Morgan, Marilee; Hutchison, Kent; Calhoun, Vince D.			A Study of the Influence of Sex on Genome Wide Methylation	PLOS ONE			English	Article							DNA METHYLATION; ALCOHOL DEPENDENCE; SYNOVIAL SARCOMA; GENDER; EXPRESSION; TLE1; GENE; PROMOTER; COMPLEX; CDKN2B	Sex differences in methylation status have been observed in specific gene-disease studies and healthy methylation variation studies, but little work has been done to study the impact of sex on methylation at the genome wide locus-to-locus level or to determine methods for accounting for sex in genomic association studies. In this study we investigate the genomic sex effect on saliva DNA methylation of 197 subjects (54 females) using 20,493 CpG sites. Three methods, two-sample T-test, principle component analysis and independent component analysis, all successfully identify sex influences. The results show that sex not only influences the methylation of genes in the X chromosome but also in autosomes. 580 autosomal sites show strong differences between males and females. They are found to be highly involved in eight functional groups, including DNA transcription, RNA splicing, membrane, etc. Equally important is that we identify some methylation sites associated with not only sex, but also other phenotypes (age, smoking and drinking level, and cancer). Verification was done through an independent blood cell DNA methylation data (1298 CpG sites from a cancer panel array). The same genomic site-specific influence pattern and potential confounding effects with cancer were observed. The overlapping rate of identified sex affected genes between saliva and blood cell is 81% for X chromosome, and 8% for autosomes. Therefore, correction for sex is necessary. We propose a simple correction method based on independent component analysis, which is a data driven method and accommodates sample differences. Comparison before and after the correction suggests that the method is able to effectively remove the potentially confounding effects of sex, and leave other phenotypes untouched. As such, our method is able to disentangle the sex influence on a genome wide level, and paves the way to achieve more accurate association analyses in genome wide methylation studies.	[Liu, Jingyu; Morgan, Marilee; Hutchison, Kent; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Liu, Jingyu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Hutchison, Kent] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico	Liu, JY (corresponding author), Mind Res Network, Albuquerque, NM USA.	jliu@mrn.org	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747; Liu, Jingyu/0000-0002-1724-7523	National Institutes of Health [NIH R01EB005846, NIH R01AA012238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the National Institutes of Health (NIH R01EB005846 to V. Calhoun and NIH R01AA012238 to K. Hutchison). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Au WY, 2005, BRIT J HAEMATOL, V131, P632, DOI 10.1111/j.1365-2141.2005.05818.x; Babor TF, 2006, AUDIT ALCOHOL USE DI; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Cardoso JF, 1997, IEEE SIGNAL PROC LET, V4, P112, DOI 10.1109/97.566704; Chim CS, 2006, LEUKEMIA, V20, P149, DOI 10.1038/sj.leu.2404052; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jackson JE, 1991, USERS GUIDE PRINCIPA; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Kosemehmetoglu K, 2009, MODERN PATHOL, V22, P872, DOI 10.1038/modpathol.2009.47; Liu JY, 2009, HUM BRAIN MAPP, V30, P241, DOI 10.1002/hbm.20508; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Okabe H, 2003, CANCER RES, V63, P3043; Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778; Raj K, 2007, LEUKEMIA, V21, P1937, DOI 10.1038/sj.leu.2404796; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Terry J, 2007, AM J SURG PATHOL, V31, P240, DOI 10.1097/01.pas.0000213330.71745.39; Tost J, 2008, DNA METHYLATION METH, P3; Wiencke JK, 1999, CANCER EPIDEM BIOMAR, V8, P501; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Xiao YM, 2008, CELL BIOL TOXICOL, V24, P265, DOI 10.1007/s10565-007-9035-9	32	169	170	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10028	10.1371/journal.pone.0010028	http://dx.doi.org/10.1371/journal.pone.0010028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386599	gold, Green Published, Green Submitted			2022-12-25	WOS:000276420400006
J	Donadoni, C; Bisighini, C; Scotti, L; Diomede, L; Ngyen, M; Nouhin, J; DeSantis, L; Zambon, A; Ferrari, D; Gallotta, G; Corrao, G; Pancino, G; Lopalco, L				Donadoni, Carla; Bisighini, Cinzia; Scotti, Lorenza; Diomede, Lorenzo; Ngyen, Marie; Nouhin, Janin; DeSantis, Lucia; Zambon, Antonella; Ferrari, Davide; Gallotta, Giulia; Corrao, Giovanni; Pancino, Gianfranco; Lopalco, Lucia			Setting of Methods for Analysis of Mucosal Antibodies in Seminal and Vaginal Fluids of HIV Seropositive Subjects from Cambodian and Italian Cohorts	PLOS ONE			English	Article							EXPOSED SERONEGATIVE INDIVIDUALS; NEUTRALIZING ANTIBODIES; 1-INFECTED INDIVIDUALS; HUMORAL IMMUNITY; MENSTRUAL-CYCLE; GENITAL-TRACT; SECRETIONS; IGA; INFECTION; WOMEN	Background: Genital mucosae play a key role in protection from STD and HIV infection, due to their involvement in both horizontal and vertical disease transmission. High variability of published observations concerning IgA isolation and quantification underlies the strong requirement of specific methods able to maximize investigation on HIV-specific IgA. Methodology: Genital fluids from 109 subjects, including male and female cohorts from Italy and Cambodia, were collected, aliquoted and processed with different techniques, to assess optimal conditions maximizing mucosal antibody recovery. Three sampling techniques, up to sixteen preservation conditions, six ELISA methods and four purifications protocols were compared. Principal Findings: The optimal method here described took advantage of Weck-Cel sampling of female mucosal fluids. Immediate processing of genital fluids, with the addition of antibiotics and EDTA, improved recovery of vaginal IgA, while the triple addition of EDTA, antibiotics and protease inhibitors provided the highest amount of seminal IgA. Due to low amount of IgA in mucosal fluids, a high sensitive sandwich ELISA assay was set; sensitivity was enhanced by milk-based overcoating buffer and by a two-step biotin-streptavidin signal amplification. Indeed, commercial antisera to detect human immunoglobulins showed weak cross-reactivity to different antibody types. Three-step affinity purification provided reproducible immunoglobulin recovery from genital specimens, while conventional immuno-affinity IgA purification was found poorly manageable. Affinity columns were suitable to isolate mucosal IgA, which are ten-fold less concentrated than IgG in genital specimens, and provided effective separation of IgA monomers, dimers, and J-chains. Jacalin-bound resin successfully separated IgA1 from IgA2 subfraction. Conclusions/Significance: Specific, effective and reliable methods to study local immunity are key items in understanding host mucosal response. The sequence of methods here described is effective and reliable in analysing humoral local responses, and may provide a solid advance to identify and measure the effective mucosal responses to HIV.	[Donadoni, Carla; Bisighini, Cinzia; Diomede, Lorenzo; Lopalco, Lucia] Ist Sci San Raffaele, Div Immunol Infect Dis & Trasplantat, I-20132 Milan, Italy; [Scotti, Lorenza; Zambon, Antonella; Corrao, Giovanni] Univ Milanobicocca, Dept Stat, Milan, Italy; [Ngyen, Marie; Nouhin, Janin] Inst Pasteur Cambodge, HIV Hepatitis Lab, Phnom Penh, Cambodia; [DeSantis, Lucia] Univ Vita Salute, San Raffaele Sci Inst, Dept Obstet & Gynaecol, Milan, Italy; [Ferrari, Davide] Ist Sci San Raffaele, Dept Obstet & Gynaecol, I-20132 Milan, Italy; [Gallotta, Giulia] Ist Sci San Raffaele, Dept Infect Dis, I-20132 Milan, Italy; [Pancino, Gianfranco] Inst Pasteur, Regulat Retroviral Infect Unit, Paris, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Donadoni, C (corresponding author), Univ Milanobicocca, Dept Clin Med & Prevent, Milan, Italy.	lopalco.lucia@hsr.it	Nouhin, Janin/AAM-2322-2021; Nouhin, Janin/AAS-6946-2020; De Santis, Lucia/ABI-2166-2020; , Lopalco/AAN-2429-2020; Scotti, Lorenza/AAB-9544-2019; Pancino, Gianfranco/A-5519-2010	Nouhin, Janin/0000-0003-4985-8377; Nouhin, Janin/0000-0003-4985-8377; Scotti, Lorenza/0000-0002-3861-9058; Lopalco, Lucia/0000-0003-3812-1759; Zambon, Antonella/0000-0001-6443-3858	European Commission [201433]; National Institutes of Health (NIH) [1 U19 AI062150]; Bill and Melinda Gates Foundation [53030, PP1008144]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062150] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by Grant no 201433 from European Commission/Seventh Framework Programme (URL:www.ngin.eu), Grant no 1 U19 AI062150 from National Institutes of Health (NIH) and Grant GCE no 53030 and PP1008144 from the Bill and Melinda Gates Foundation; the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R, 2007, CURR HIV RES, V5, P588, DOI 10.2174/157016207782418452; Barassi C, 2004, BLOOD, V104, P2205, DOI 10.1182/blood-2004-06-2134; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; GREGORY RL, 1987, J IMMUNOL METHODS, V99, P101, DOI 10.1016/0022-1759(87)90037-8; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Hocini H, 2000, J IMMUNOL METHODS, V235, P53, DOI 10.1016/S0022-1759(99)00214-8; Jackson S, 2000, AIDS RES HUM RETROV, V16, P595, DOI 10.1089/088922200309016; JEA M, 1999, MANUAL COLLECTION PR; KAETZEL CM, 2005, IMMUNOGLOBULIN TRANS, P211; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; LEHNER T, 1992, SCIENCE, V258, P1365, DOI 10.1126/science.1360702; Lehner T, 2003, VACCINE, V21, pS68, DOI 10.1016/S0264-410X(03)00204-4; Lopalco L, 2004, CURR HIV RES, V2, P127, DOI 10.2174/1570162043484951; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mestecky H, 2007, J REPROD IMMUNOL, V73, P85, DOI 10.1016/j.jri.2007.01.005; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Moldoveanu Z, 2005, J IMMUNOL, V175, P4127, DOI 10.4049/jimmunol.175.6.4127; PACK TD, 2001, CURR PROTOC IMMUNOL, P1; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Ruprecht RM, 2001, TRANSFUS CLIN BIOL, V8, P350, DOI 10.1016/S1246-7820(01)00187-2; RUSSELL M, 2005, BIOL ACTIVITIES, P267; TJOKRONEGORO A, 1974, J REPROD FERTIL, V38, P221; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Veazey RS, 2001, TRENDS IMMUNOL, V22, P626, DOI 10.1016/S1471-4906(01)02039-7; Westfall PH, 1997, J AM STAT ASSOC, V92, P299, DOI 10.2307/2291474; WILK MB, 1968, BIOMETRIKA, V55, P1; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334	32	11	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9920	10.1371/journal.pone.0009920	http://dx.doi.org/10.1371/journal.pone.0009920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360961	Green Published, gold			2022-12-25	WOS:000276163100013
J	Rahman, FZ; Smith, AM; Hayee, B; Marks, DJB; Bloom, SL; Segal, AW				Rahman, Farooq Z.; Smith, Andrew M.; Hayee, Bu'Hussain; Marks, Daniel J. B.; Bloom, Stuart L.; Segal, Anthony W.			Delayed Resolution of Acute Inflammation in Ulcerative Colitis Is Associated with Elevated Cytokine Release Downstream of TLR4	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CD4(+) T-CELLS; CROHNS-DISEASE; BOWEL-DISEASE; TRIF; PATHOGENESIS; LOCI; MICE; INTERFERON-BETA-1A; INHIBITION	Background: Ulcerative colitis (UC) is widely viewed as a leukocyte-mediated disorder. Although strong evidence implicates an exuberant response to microbial components in its pathogenesis, no intrinsic immune defect has been identified and the underlying pathogenic mechanisms remain obscure. Methodology/Principal Findings: The acute immune response to bacterial injection was determined in UC patients with quiescent disease and directly compared to healthy control subjects. Monocyte-derived macrophages were used to investigate bacterial recognition mechanisms in vitro. An exuberant and protracted acute inflammatory response to bacteria was evident in patients with UC, which coincides with increased systemic levels of CXCL10. Macrophages stimulated with bacteria and Toll-like receptor (TLR) ligands revealed a specific defect in the TLR4 response in UC. The defect resulted in the over-expression of a number of pro-inflammatory molecules under transcriptional control of the adaptor TIR-domain containing adaptor inducing interferon-b (TRIF). Conclusion: These findings highlight a dysregulated innate immune response with over-expression of molecules associated with leukocyte recruitment and activation that may eventuate in the hallmark chronic immune-mediated inflammation of UC.	[Rahman, Farooq Z.; Smith, Andrew M.; Hayee, Bu'Hussain; Marks, Daniel J. B.; Segal, Anthony W.] UCL, Dept Med, London, England; [Bloom, Stuart L.] Univ Coll London Hosp, Dept Gastroenterol, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Rahman, FZ (corresponding author), UCL, Dept Med, London, England.	andrew.m.smith@ucl.ac.uk		Segal, Anthony/0000-0001-7602-9043; Hayee, Bu'Hussain/0000-0003-1670-8815; Smith, Andrew/0000-0002-4691-5973	Wellcome Trust; Broad Medical Research Program	Wellcome Trust(Wellcome TrustEuropean Commission); Broad Medical Research Program	This work was supported by The Wellcome Trust (GHACB) (www.wellcome.ac.uk) and The Broad Medical Research Program (GHADY) (www.broadmedical.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari N, 2006, J CLIN PATHOL, V59, P1066, DOI 10.1136/jcp.2005.034983; Brain O, 2008, CURR OPIN GASTROEN, V24, P469, DOI 10.1097/MOG.0b013e3282ff0dd5; CEKIC C, 2009, J BIOL CHEM; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Eri R, 2008, INFLAMM BOWEL DIS, V14, P458, DOI 10.1002/ibd.20344; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Mavrogiannis C, 2001, J HEPATOL, V34, P964, DOI 10.1016/S0168-8278(01)00022-8; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Noguchi A, 2007, J GASTROENTEROL, V42, P947, DOI 10.1007/s00535-007-2118-9; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pena-Rossi C, 2008, ALIMENT PHARM THER, V28, P758, DOI 10.1111/j.1365-2036.2008.03778.x; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Scarpa M, 2004, DIGEST DIS SCI, V49, P1738, DOI 10.1007/s10620-004-9562-7; Schott E, 2007, WORLD J GASTROENTERO, V13, P3638, DOI 10.3748/wjg.v13.i26.3638; Seow CH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006790.pub2; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Singh UP, 2008, J INTERF CYTOK RES, V28, P31, DOI 10.1089/jir.2007.0059; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Tursi A, 2007, INFLAMM BOWEL DIS, V13, P1189, DOI 10.1002/ibd.20152; Uguccioni M, 1999, AM J PATHOL, V155, P331, DOI 10.1016/S0002-9440(10)65128-0; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Youn HS, 2005, J IMMUNOL, V175, P3339, DOI 10.4049/jimmunol.175.5.3339	37	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9891	10.1371/journal.pone.0009891	http://dx.doi.org/10.1371/journal.pone.0009891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360984	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600005
J	Tsuchiya, K; Hayashi, F				Tsuchiya, Kaori; Hayashi, Fumio			Factors Affecting Sperm Quality Before and After Mating of Calopterygid Damselflies	PLOS ONE			English	Article							PRUINOSA SELYS ODONATA; COPULATION DURATION; WING PIGMENTATION; SUCCESS; VIABILITY; REMOVAL; FEMALES; TACTICS; CHOICE; AGE	Damselflies (Odonata: Zygoptera) have a more complex sperm transfer system than other internally ejaculating insects. Males translocate sperm from the internal reproductive organs to the specific sperm vesicles, a small cavity on the body surface, and then transfer them into the female. To examine how the additional steps of sperm transfer contribute to decreases in sperm quality, we assessed sperm viability (the proportion of live sperm) at each stage of mating and after different storage times in male and female reproductive organs in two damselfly species, Mnais pruinosa and Calopteryx cornelia. Viability of stored sperm in females was lower than that of male stores even just after copulation. Male sperm vesicles were not equipped to maintain sperm quality for longer periods than the internal reproductive organs. However, the sperm vesicles were only used for short-term storage; therefore, this process appeared unlikely to reduce sperm viability when transferred to the female. Males remove rival sperm prior to transfer of their own ejaculate using a peculiar-shaped aedeagus, but sperm removal by males is not always complete. Thus, dilution occurs between newly received sperm and aged sperm already stored in the female, causing lower viability of sperm inside the female than that of sperm transferred by males. If females do not remate, sperm viability gradually decreases with the duration of storage. Frequent mating of females may therefore contribute to the maintenance of high sperm quality.	[Tsuchiya, Kaori; Hayashi, Fumio] Tokyo Metropolitan Univ, Dept Biol, Tokyo 158, Japan	Tokyo Metropolitan University	Tsuchiya, K (corresponding author), Tokyo Metropolitan Univ, Dept Biol, Setagaya Ku, Tokyo 158, Japan.	fhayashi@tmu.ac.jp			Japan Society for the Promotion of Science [13640632, 15570019]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by Grant-in-Aid for Scientific Research ( C) from the Japan Society for the Promotion of Science (13640632 and 15570019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman R.F., 2012, INSECTS STRUCTURE FU; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordoba-Aguilar A, 2005, J EVOLUTION BIOL, V18, P132, DOI 10.1111/j.1420-9101.2004.00796.x; Cordoba-Aguilar A, 2002, ANIM BEHAV, V63, P759, DOI 10.1006/anbe.2001.1974; Damiens D, 2002, PHYSIOL ENTOMOL, V27, P97, DOI 10.1046/j.1365-3032.2002.00274.x; den Boer SPA, 2009, P ROY SOC B-BIOL SCI, V276, P3945, DOI 10.1098/rspb.2009.1184; Fedina TY, 2004, P ROY SOC B-BIOL SCI, V271, P1393, DOI 10.1098/rspb.2004.2731; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Hayashi F, 2005, ENTOMOL SCI, V8, P245, DOI 10.1111/j.1479-8298.2005.00123.x; HIGASHI K, 1982, Odonatologica, V11, P129; HIGASHI K, 1987, DRAGONFLY MATING SYS; Holman L, 2009, BEHAV ECOL SOCIOBIOL, V63, P1679, DOI 10.1007/s00265-009-0816-4; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Lodesani M, 2004, J APICULT RES, V43, P27, DOI 10.1080/00218839.2004.11101105; NOMAKUCHI S, 1988, Ecological Research, V3, P75, DOI 10.1007/BF02346931; NOMAKUCHI S, 1985, Odonatologica, V14, P301; Plaistow SJ, 2000, P ROY SOC B-BIOL SCI, V267, P969, DOI 10.1098/rspb.2000.1098; Reinhardt K, 2007, Q REV BIOL, V82, P375, DOI 10.1086/522811; Reinhardt K, 2010, GENETICA, V138, P119, DOI 10.1007/s10709-009-9360-4; Simmons L. W., 2001, MG BEH ECOL; Siva-Jothy MT, 1999, BEHAVIOUR, V136, P1365, DOI 10.1163/156853999500776; SIVAJOTHY MT, 1989, BEHAV ECOL SOCIOBIOL, V25, P261, DOI 10.1007/BF00300052; SIVAJOTHY MT, 1989, BEHAV ECOL SOCIOBIOL, V24, P39, DOI 10.1007/BF00300116; SIVAJOTHY MT, 1995, P ROY SOC B-BIOL SCI, V259, P313, DOI 10.1098/rspb.1995.0046; SIVAJOTHY MT, 1995, BEHAV ECOL SOCIOBIOL, V37, P39, DOI 10.1007/s002650050171; Sugimura M, 1999, DRAGONFLIES JAPANESE; SUZUKI K, 1981, J COLL LIB ARTS TOYA, V14, P25; TSUCHIYA K, 2005, THESIS TOKYO METROPO; Tsuchiya K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1417, DOI 10.1007/s00265-008-0571-y; WAAGE JK, 1979, SCIENCE, V203, P916, DOI 10.1126/science.203.4383.916; WAAGE JK, 1987, BEHAV ECOL SOCIOBIOL, V20, P439, DOI 10.1007/BF00302987; WATANABE M, 1990, J ETHOL, V8, P129, DOI 10.1007/BF02350283; Zar JH, 1999, BIOSTATISTICAL ANAL	34	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9904	10.1371/journal.pone.0009904	http://dx.doi.org/10.1371/journal.pone.0009904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361037	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600010
J	Thalmann, J; Janik, K; May, M; Sommer, K; Ebeling, J; Hofmann, F; Genth, H; Klos, A				Thalmann, Jessica; Janik, Katrin; May, Martin; Sommer, Kirsten; Ebeling, Jenny; Hofmann, Fred; Genth, Harald; Klos, Andreas			Actin Re-Organization Induced by Chlamydia trachomatis Serovar D - Evidence for a Critical Role of the Effector Protein CT166 Targeting Rac	PLOS ONE			English	Article							DIFFICILE TOXIN-B; CLOSTRIDIUM-DIFFICILE; RHO-GTPASES; HELA-CELLS; ENTRY; GLYCOSYLTRANSFERASES; ACTIVATION; INVASION; CNF1; CYTOSKELETON	The intracellular bacterium Chlamydia trachomatis causes infections of urogenital tract, eyes or lungs. Alignment reveals homology of CT166, a putative effector protein of urogenital C. trachomatis serovars, with the N-terminal glucosyltransferase domain of clostridial glucosylating toxins (CGTs). CGTs contain an essential DXD-motif and mono-glucosylate GTP-binding proteins of the Rho/Ras families, the master regulators of the actin cytoskeleton. CT166 is preformed in elementary bodies of C. trachomatis D and is detected in the host-cell shortly after infection. Infection with high MOI of C. trachomatis serovar D containing the CT166 ORF induces actin re-organization resulting in cell rounding and a decreased cell diameter. A comparable phenotype was observed in HeLa cells treated with the Rho-GTPase-glucosylating Toxin B from Clostridium difficile (TcdB) or HeLa cells ectopically expressing CT166. CT166 with a mutated DXD-motif (CT166-mut) exhibited almost unchanged actin dynamics, suggesting that CT166-induced actin re-organization depends on the glucosyltransferase motif of CT166. The cytotoxic necrotizing factor 1 (CNF1) from E. coli deamidates and thereby activates Rho-GTPases and transiently protects them against TcdB-induced glucosylation. CNF1-treated cells were found to be protected from TcdB- and CT166-induced actin re-organization. CNF1 treatment as well as ectopic expression of non-glucosylable Rac1-G12V, but not RhoA-G14A, reverted CT166-induced actin re-organization, suggesting that CT166-induced actin re-organization depends on the glucosylation of Rac1. In accordance, over-expression of CT166-mut diminished TcdB induced cell rounding, suggesting shared substrates. Cell rounding induced by high MOI infection with C. trachomatis D was reduced in cells expressing CT166-mut or Rac1-G12V, and in CNF1 treated cells. These observations indicate that the cytopathic effect of C. trachomatis D is mediated by CT166-induced Rac1 glucosylation. Finally, chlamydial uptake was impaired in CT166 over-expressing cells. Our data strongly suggest CT166's participation as an effector protein during host-cell entry, ensuring a balanced uptake into host-cells by interfering with Rac-dependent cytoskeletal changes.	[Thalmann, Jessica] Hannover Med Sch, Dept Nephrol, Inst Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany; [May, Martin; Hofmann, Fred; Genth, Harald] Hannover Med Sch, Inst Toxicol, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School	Thalmann, J (corresponding author), Hannover Med Sch, Dept Nephrol, Inst Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany.	klos.andreas@mh-hannover.de	Genth, Harald/HHS-0118-2022; Janik, Katrin/U-2525-2019	Janik, Katrin/0000-0003-0878-7402; May, Martin/0000-0002-8335-6699	German Research Foundation [SFB587/A16]; International Research Training Group [1273]; Center of Infection Biology (ZIB)	German Research Foundation(German Research Foundation (DFG)); International Research Training Group; Center of Infection Biology (ZIB)	This project was partially supported by a grant of the German Research Foundation (DFG)-SFB587/A16 and partially also by the International Research Training Group 1273 funded by the DFG and the Center of Infection Biology (ZIB) at the Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Ando Y, 2007, MOL BIOL CELL, V18, P3752, DOI 10.1091/mbc.E07-03-0281; Barth H, 1999, J BIOL CHEM, V274, P27407, DOI 10.1074/jbc.274.39.27407; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; Busch C, 2000, J BIOL CHEM, V275, P13228, DOI 10.1074/jbc.275.18.13228; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Dreger SC, 2009, BIOCHEMISTRY-US, V48, P1785, DOI 10.1021/bi800708b; Fiorentini C, 1997, J BIOL CHEM, V272, P19532, DOI 10.1074/jbc.272.31.19532; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Halabi-Cabezon I, 2008, FEBS LETT, V582, P3751, DOI 10.1016/j.febslet.2008.10.003; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Herrmann C, 1998, J BIOL CHEM, V273, P16134, DOI 10.1074/jbc.273.26.16134; Hoffmann C, 2005, REV PHYSIOL BIOCH P, V152, P49, DOI 10.1007/s10254-004-0026-4; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Huelsenbeck SC, 2009, CELL MOTIL CYTOSKEL, V66, P967, DOI 10.1002/cm.20390; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; MAJEED M, 1991, INFECT IMMUN, V59, P4465, DOI 10.1128/IAI.59.12.4465-4472.1991; Page K, 1999, J BIOL CHEM, V274, P22065, DOI 10.1074/jbc.274.31.22065; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stoll T, 2009, TOXICON, V54, P745, DOI 10.1016/j.toxicon.2009.05.038; Subtil A, 2004, J CELL SCI, V117, P3923, DOI 10.1242/jcs.01247; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	36	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9887	10.1371/journal.pone.0009887	http://dx.doi.org/10.1371/journal.pone.0009887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360858	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969500014
J	D'Aiuto, L; Marzulli, M; Mohan, KN; Borowczyk, E; Saporiti, F; VanDemark, A; Chaillet, JR				D'Aiuto, Leonardo; Marzulli, Marco; Mohan, K. Naga; Borowczyk, Ewa; Saporiti, Federica; VanDemark, Andrew; Chaillet, J. Richard			Dissection of Structure and Function of the N-Terminal Domain of Mouse DNMT1 Using Regional Frame-Shift Mutagenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MAMMALIAN DNA METHYLTRANSFERASE; METHYLATED DNA; EPIGENETIC INHERITANCE; REGULATORY DOMAIN; REPLICATION FOCI; GENE; BINDING; RECOGNITION; MAINTENANCE	Deletion analysis of mouse DNMT1, the primary maintenance methyltransferase in mammals, showed that most of the N-terminal regulatory domain (amino acid residues 412-1112) is required for its enzymatic activity. Although analysis of deletion mutants helps to identify regions of a protein sequence required for a particular activity, amino acid deletions can have drastic effects on protein structure and/or stability. Alternative approaches represented by rational design and directed evolution are resource demanding, and require high-throughput selection or screening systems. We developed Regional Frame-shift Mutagenesis (RFM) as a new approach to identify portions required for the methyltransferase activity of DNMT1 within the N-terminal 89-905 amino acids. In this method, a short stretch of amino acids in the wild-type protein is converted to a different amino acid sequence. The resultant mutant protein retains the same amino acid length as the wild type, thereby reducing physical constrains on normal folding of the mutant protein. Using RFM, we identified three small regions in the amino-terminal one-third of the protein that are essential for DNMT1 function. Two of these regions (amino acids 124-160 and 341-368) border a large disordered region that regulates maintenance methylation activity. This organization of DNMT1's amino terminus suggests that the borders define the position of the disordered region within the DNMT1 protein, which in turn allows for its proper function.	[D'Aiuto, Leonardo; Marzulli, Marco; Mohan, K. Naga; Borowczyk, Ewa; Chaillet, J. Richard] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [VanDemark, Andrew] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Saporiti, Federica] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	D'Aiuto, L (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	Chaillet@pitt.edu	Mohan, Kommu Naga/HIK-1746-2022	SAPORITI, FEDERICA/0000-0003-2647-3212; D'Aiuto, Leonardo/0000-0002-7102-2093; VanDemark, Andrew/0000-0003-3424-4831	National Institutes of Health USA [R01HD044133]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044133] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by Grant R01HD044133 from the National Institutes of Health USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antikainen NM, 2005, BIOORGAN MED CHEM, V13, P2701, DOI 10.1016/j.bmc.2005.01.059; Araujo FD, 2001, J BIOL CHEM, V276, P6930, DOI 10.1074/jbc.M009037200; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Borowczyk E, 2009, P NATL ACAD SCI USA, V106, P20806, DOI 10.1073/pnas.0905668106; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chan MF, 2001, MOL CELL BIOL, V21, P7587, DOI 10.1128/MCB.21.22.7587-7600.2001; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; D'Aiuto L, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-52; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Flores-Ramirez Gabriela, 2007, BMC Chemical Biology, V7, P1, DOI 10.1186/1472-6769-7-1; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu YL, 1998, NUCLEIC ACIDS RES, V26, P1038, DOI 10.1093/nar/26.4.1038; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Margot JB, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-7; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pradhan S, 2000, EMBO J, V19, P2103, DOI 10.1093/emboj/19.9.2103; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sajedi E, 2008, BBA-MOL CELL RES, V1783, P131, DOI 10.1016/j.bbamcr.2007.08.010; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suetake I, 2006, J BIOCHEM, V140, P763, DOI 10.1093/jb/mvj210; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Warnecke PM, 1999, MOL CELL BIOL, V19, P164; Zhao HM, 2007, BIOTECHNOL BIOENG, V98, P313, DOI 10.1002/bit.21455	34	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9831	10.1371/journal.pone.0009831	http://dx.doi.org/10.1371/journal.pone.0009831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352123	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000275894400030
J	Dorsten, JN; Varughese, BE; Karmo, S; Seeger, MA; VanBerkum, MFA				Dorsten, Joy N.; Varughese, Bridget E.; Karmo, Stephanie; Seeger, Mark A.; VanBerkum, Mark F. A.			In the Absence of Frazzled Over-Expression of Abelson Tyrosine Kinase Disrupts Commissure Formation and Causes Axons to Leave the Embryonic CNS	PLOS ONE			English	Article							GROWTH CONE GUIDANCE; LONG-RANGE GUIDANCE; RHO FAMILY GTPASES; NETRIN-RECEPTOR; ROBO RECEPTORS; DROSOPHILA CNS; GENETIC-ANALYSIS; COLORECTAL-CANCER; CELL-ADHESION; ABL-FAMILY	Background: In the Drosophila embryonic nerve cord, the formation of commissures require both the chemoattractive Netrin receptor Frazzled (Fra) and the Abelson (Abl) cytoplasmic tyrosine kinase. Abl binds to the cytoplasmic domain of Fra and loss-of-function mutations in abl enhance fra-dependent commissural defects. To further test Abl's role in attractive signaling, we over-expressed Abl in Fra mutants anticipating rescue of commissures. Methodology/Principal Findings: The Gal4-UAS system was used to pan-neurally over-express Abl in homozygous fra embryos. Surprisingly, this led to a significant decrease in both posterior and anterior commissure formation and induced some commissural and longitudinal axons to project beyond the CNS/PNS border. Re-expressing wild-type Fra, or Fra mutants with a P-motif deleted, revert both commissural and exiting phenotypes, indicating that Fra is required but not a specific P-motif. This is supported by S2 cell experiments demonstrating that Abl binds to Fra independent of any specific P-motif and that Fra continues to be phosphorylated when individual P-motifs are removed. Decreasing midline repulsion by reducing Robo signaling had no effect on the Abl phenotype and the phenotypes still occur in a Netrin mutant. Pan-neural over-expression of activated Rac or Cdc42 in a fra mutant also induced a significant loss in commissures, but axons did not exit the CNS. Conclusion/Significance: Taken together, these data suggest that Fra activity is required to correctly regulate Abl-dependent cytoskeletal dynamics underlying commissure formation. In the absence of Fra, increased Abl activity appears to be incorrectly utilized downstream of other guidance receptors resulting in a loss of commissures and the abnormal projections of some axons beyond the CNS/PNS border.	[Dorsten, Joy N.; Varughese, Bridget E.; Karmo, Stephanie; VanBerkum, Mark F. A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Seeger, Mark A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Seeger, Mark A.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Wayne State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Dorsten, JN (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mvanberk@biology.biosci.wayne.edu			National Science Foundation [0416472]; Wayne State University; William Turner Memorial Foundation Scholarship	National Science Foundation(National Science Foundation (NSF)); Wayne State University; William Turner Memorial Foundation Scholarship	This work was funded by the National Science Foundation (# 0416472) to M. VanBerkum. J. D. was partially supported by a Rumble Graduate Fellowship from Wayne State University and was a recipient of the William Turner Memorial Foundation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-31; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 2001, J CELL BIOL, V155, P1117, DOI 10.1083/jcb.200110077; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dorsten JN, 2008, INT J DEV NEUROSCI, V26, P753, DOI 10.1016/j.ijdevneu.2008.07.004; Dorsten JN, 2007, DEV BIOL, V308, P120, DOI 10.1016/j.ydbio.2007.05.012; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fogerty FJ, 1999, ONCOGENE, V18, P219, DOI 10.1038/sj.onc.1202239; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Garbe DS, 2007, DEVELOPMENT, V134, P4325, DOI 10.1242/dev.012872; Garbe DS, 2007, J NEUROSCI, V27, P3584, DOI 10.1523/JNEUROSCI.0301-07.2007; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Georgiou M, 2003, MECH DEVELOP, V120, P1009, DOI 10.1016/S0925-4773(03)00179-5; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Gilestro GF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003798; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hiramoto M, 2006, NAT NEUROSCI, V9, P58, DOI 10.1038/nn1612; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Hu S, 1998, J NEUROBIOL, V35, P77, DOI 10.1002/(SICI)1097-4695(199804)35:1<77::AID-NEU7>3.0.CO;2-8; Huang CH, 2007, J BIOL CHEM, V282, P32442, DOI 10.1074/jbc.M702583200; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jeon M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-3; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kidd T, 2009, SCIENCE, V324, P893, DOI 10.1126/science.1174216; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Ku HY, 2009, MOL CELL BIOL, V29, P3623, DOI 10.1128/MCB.00229-09; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Li WQ, 2006, J CELL SCI, V119, P47, DOI 10.1242/jcs.02697; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liebl EC, 2003, DEVELOPMENT, V130, P3217, DOI 10.1242/dev.00545; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; McGovern VL, 2003, DEV GENES EVOL, V213, P500, DOI 10.1007/s00427-003-0349-1; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Ren XR, 2008, NEUROSIGNALS, V16, P235, DOI 10.1159/000111566; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Schindelholz B, 2001, DEVELOPMENT, V128, P4371; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Song JK, 2008, MECH DEVELOP, V125, P247, DOI 10.1016/j.mod.2007.11.005; Stevens TL, 2008, MOL BIOL CELL, V19, P378, DOI 10.1091/mbc.E07-01-0008; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104	95	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9822	10.1371/journal.pone.0009822	http://dx.doi.org/10.1371/journal.pone.0009822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352105	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894400022
J	Matos, PM; Castanho, MARB; Santos, NC				Matos, Pedro M.; Castanho, Miguel A. R. B.; Santos, Nuno C.			HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes	PLOS ONE			English	Article							MULTIFUNCTIONAL DOMAINS; GP41; CELLS; ENTRY; BIOMEMBRANES; MECHANISMS; FLUIDITY; RECEPTOR; BINDING; AIDS	Enfuvirtide and T-1249 are two HIV-1 fusion inhibitor peptides that bind to gp41 and prevent its fusogenic conformation, inhibiting viral entry into host cells. Previous studies established the relative preferences of these peptides for membrane model systems of defined lipid compositions. We aimed to understand the interaction of these peptides with the membranes of erythrocytes and peripheral blood mononuclear cells. The peptide behavior toward cell membranes was followed by di-8-ANEPPS fluorescence, a lipophilic probe sensitive to the changes in membrane dipole potential. We observed a fusion inhibitor concentration-dependent decrease on the membrane dipole potential. Quantitative analysis showed that T-1249 has an approximately eight-fold higher affinity towards cells, when compared with enfuvirtide. We also compared the binding towards di-8-ANEPPS labeled lipid vesicles that model cell membranes and obtained concordant results. We demonstrated the distinct enfuvirtide and T-1249 membranotropism for circulating blood cells, which can be translated to a feasible in vivo scenario. The enhanced interaction of T-1249 with cell membranes correlates with its higher efficacy, as it can increase and accelerate the drug binding to gp41 in its pre-fusion state.	[Matos, Pedro M.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal	Universidade de Lisboa	Matos, PM (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal.	nsantos@fm.ul.pt	Santos, Nuno/N-7248-2013; Matos, Pedro/B-4718-2010	Santos, Nuno/0000-0002-0580-0475; Matos, Pedro/0000-0002-8386-6613; Castanho, Miguel/0000-0001-7891-7562; FCCN, Bogus/0000-0001-6282-8004; FCCN, Bogus/0000-0003-1034-3552	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science, Technology and Higher Education (MCTES) [PTDC/QUI-BIQ/104787/2008, SFRH/BD/42205/2007]	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science, Technology and Higher Education (MCTES)(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT, http://www.fct.mctes.pt) of the Portuguese Ministry of Science, Technology and Higher Education (MCTES), including project PTDC/QUI-BIQ/104787/2008. P. M. M. was funded by the FCT-MCTES PhD grant SFRH/BD/42205/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; Banki Z, 2006, J IMMUNOL, V177, P3469, DOI 10.4049/jimmunol.177.5.3469; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Castanho MARB, 2006, EUR BIOPHYS J BIOPHY, V35, P92, DOI 10.1007/s00249-005-0007-9; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Clarke RJ, 1997, BBA-BIOMEMBRANES, V1323, P223, DOI 10.1016/S0005-2736(96)00188-5; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Greene WC, 2007, EUR J IMMUNOL, V37, pS94, DOI 10.1002/eji.200737441; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Martin-Carbonero L, 2004, AIDS REV, V6, P61; Matos PM, 2008, J PEPT SCI, V14, P407, DOI 10.1002/psc.1005; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Peisajovich SG, 2003, J BIOL CHEM, V278, P21012, DOI 10.1074/jbc.M212773200; Qi Z, 2008, J BIOL CHEM, V283, P30376, DOI 10.1074/jbc.M804672200; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Veiga AS, 2004, J AM CHEM SOC, V126, P14758, DOI 10.1021/ja0459882; Veiga S, 2004, BIOCHEM J, V377, P107, DOI 10.1042/BJ20031350; Vitha MF, 2007, BBA-BIOMEMBRANES, V1768, P107, DOI 10.1016/j.bbamem.2006.06.022; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Zhang HY, 2008, ORG PROCESS RES DEV, V12, P101, DOI 10.1021/op7002198	38	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9830	10.1371/journal.pone.0009830	http://dx.doi.org/10.1371/journal.pone.0009830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352107	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894400029
J	Ingermann, AR; Yang, YF; Han, JF; Mikami, A; Garza, AE; Mohanraj, L; Fan, LB; Idowu, M; Ware, JL; Kim, HS; Lee, DY; Oh, Y				Ingermann, Angela R.; Yang, Yong-Feng; Han, Jinfeng; Mikami, Aki; Garza, Amanda E.; Mohanraj, Lathika; Fan, Lingbo; Idowu, Michael; Ware, Joy L.; Kim, Ho-Seong; Lee, Dae-Yeol; Oh, Youngman			Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-3; FACTOR (IGF)-INDEPENDENT ACTION; LUNG EPITHELIAL-CELLS; GROWTH-INHIBITION; INDUCED APOPTOSIS; IGFBP-3 BINDING; LEUCINE-ZIPPER; INDUCTION; ACTIVATION; EXPRESSION	Insulin-like growth factor-binding protein-3 (IGFBP-3), a major regulator of endocrine actions of IGFs, is a p53-regulated potent apoptotic factor and is significantly suppressed in a variety of cancers. Recent epidemiologic studies suggest that IGFBP-3 contributes to cancer risk protection in a variety of cancers, and a polymorphic variation of IGFBP-3 influences cancer risk, although other studies vary in their conclusions. Some antiproliferative actions of IGFBP-3 have been reported to be independent of IGFs, but the precise biochemical/molecular mechanisms of IGF-independent, antiproliferative actions of IGFBP-3 are largely unknown. Here we report a new cell death receptor, IGFBP-3R, that is a singlespan membrane protein and binds specifically to IGFBP-3 but not other IGFBP species. Expression analysis of IGFBP-3 and IGFBP-3R indicates that the IGFBP-3/IGFBP-3R axis is impaired in breast and prostate cancer. We also provide evidence for anti-tumor effect of IGFBP-3R in vivo using prostate and breast cancer xenografts in athymic nude mice. Further in vitro studies demonstrate that IGFBP-3R mediates IGFBP-3-induced caspase-8-dependent apoptosis in various cancer cells. Knockdown of IGFBP-3R attenuated IGFBP-3-induced caspase activities and apoptosis, whereas overexpression of IGFBP-3R enhanced IGFBP-3 biological effects. IGFBP-3R physically interacts and activates caspase-8, and knockdown of caspase-8 expression or activity inhibited IGFBP-3/IGFBP- 3R-induced apoptosis. Here, we propose that IGFBP-3R represents a novel cell death receptor and is essential for the IGFBP-3- induced apoptosis and tumor suppression. Thus, the IGFBP-3/IGFBP-3R axis may provide therapeutic and prognostic value for the treatment of cancer.	[Ingermann, Angela R.; Yang, Yong-Feng; Kim, Ho-Seong; Oh, Youngman] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Kim, Ho-Seong] Yonsei Univ, Dept Pediat, Yongdong Severance Hosp, Seoul 135720, South Korea; [Lee, Dae-Yeol] Chonbuk Natl Univ Hosp, Dept Pediat, Jeonju 560182, Jeonbuk, South Korea; [Han, Jinfeng; Mikami, Aki; Garza, Amanda E.; Mohanraj, Lathika; Fan, Lingbo; Idowu, Michael; Ware, Joy L.; Oh, Youngman] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23298 USA	Oregon Health & Science University; Yonsei University; Jeonbuk National University; Jeonbuk National University Hospital; Virginia Commonwealth University	Oh, Y (corresponding author), 1101 E Marshall St,POB 980662, Richmond, VA 23298 USA.	yoh@mcvh-vcu.edu		Kim, Ho-Seong/0000-0003-1135-099X; Mohanraj, Lathika/0000-0002-5504-1518	NINDS, National Institutes of Health [5P30NS047463]; United States Department of Defense [DAMD17-97-17204, DAMD17-02-1-0533, PC040971, PC061151]; Korea Science and Engineering Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States Department of Defense(United States Department of Defense); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant Center Core Grant 5P30NS047463 (NINDS). This work was also supported by United States Department of Defense Grants DAMD17-97-17204, DAMD17-02-1-0533, PC040971, and PC061151 (to Y.O.) and by the Korea Science and Engineering Foundation Grant (to D.-Y.L.).	Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chen XY, 2006, GROWTH HORM IGF RES, V16, P41, DOI 10.1016/j.ghir.2005.09.003; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Fu P, 2007, J BIOL CHEM, V282, P22298, DOI 10.1074/jbc.M703066200; Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Kiepe D, 2008, ENDOCRINOLOGY, V149, P4901, DOI 10.1210/en.2007-1395; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Mishra S, 2004, MOL CELL BIOCHEM, V267, P83, DOI 10.1023/B:MCBI.0000049368.40558.0a; Mishra S, 2004, CANCER RES, V64, P2516, DOI 10.1158/0008-5472.CAN-03-2877; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; OH Y, 1993, J BIOL CHEM, V268, P26045; OH YM, 1993, J BIOL CHEM, V268, P14964; Oufattole M, 2006, ENDOCRINOLOGY, V147, P2138, DOI 10.1210/en.2005-1269; Perks CM, 1999, J MOL ENDOCRINOL, V22, P141, DOI 10.1677/jme.0.0220141; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Schedlich LJ, 2004, BIOCHEM BIOPH RES CO, V314, P83, DOI 10.1016/j.bbrc.2003.12.049; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Takaoka M, 2004, CANCER RES, V64, P7711, DOI 10.1158/0008-5472.CAN-04-0715; Walker G.E., 2004, INSULIN LIKE GROWTH, P1; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; Wu HB, 2000, J CELL BIOCHEM, V77, P288, DOI 10.1002/(SICI)1097-4644(20000501)77:2<288::AID-JCB11>3.0.CO;2-J; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; Zappala G, 2008, ENDOCRINOLOGY, V149, P1802, DOI 10.1210/en.2007-1315; Zhao HB, 2005, MOL ENDOCRINOL, V19, P771, DOI 10.1210/me.2004-0161; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	43	89	97	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30233	30246		10.1074/jbc.M110.122226	http://dx.doi.org/10.1074/jbc.M110.122226			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20353938	Green Published, hybrid			2022-12-25	WOS:000281984300060
J	Tarry-Adkins, JL; Chen, JH; Jones, RH; Smith, NH; Ozanne, SE				Tarry-Adkins, Jane L.; Chen, Jian-Hua; Jones, Richard H.; Smith, Noel H.; Ozanne, Susan E.			Poor maternal nutrition leads to alterations in oxidative stress, antioxidant defense capacity, and markers of fibrosis in rat islets: potential underlying mechanisms for development of the diabetic phenotype in later life	FASEB JOURNAL			English	Article						hyperglycemia; fibrosis; type 2 diabetes	LOW-PROTEIN-DIET; LOW-BIRTH-WEIGHT; PANCREATIC-ISLETS; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; HEME OXYGENASE-1; PROTECTIVE ROLE; NADPH OXIDASES; FREE-RADICALS	Low birth weight is associated with glucose intolerance, insulin resistance, and type 2 diabetes (T2D) in later life. Good evidence indicates that the environment plays an important role in this relationship. However, the mechanisms underlying these relationships are defined poorly. Islets are particularly susceptible to oxidative stress, and this condition combined with fibrosis is thought to be instrumental in T2D pathogenesis. Here we use our maternal low-protein (LP) rat model to determine the effect of early diet on oxidative stress and fibrosis in pancreatic islets of male offspring at 3 and 15 mo of age. Islet xanthine oxidase (XO) expression was increased in 15-mo LP offspring, which suggests increased oxidative-stress. Manganese superoxide-dismutase (MnSOD), copper-zinc superoxide dismutase (CuZnSOD), and heme oxygenase-1 (HO-1) (antioxidant enzymes) were reduced significantly in LP offspring, which indicated impairment of oxidative defense. Expression of fibrosis markers collagen I and collagen III also increased in 15-mo LP offspring. Angiotensin II receptor type I (AT(II)R(I)), induced by hyperglycemia and oxidative-stress, was significantly up-regulated in 15-mo LP offspring. Lipid peroxidation was also increased in 15-mo LP animals. We conclude that maternal protein restriction causes age-associated increased oxidative stress, impairment of oxidative defense, and fibrosis. These findings provide mechanisms by which suboptimal early nutrition can lead to T2D development later in life.-TarryAdkins, J. L., Chen, J.-H., Jones, R. H., Smith, N. H., Ozanne, S. E. Poor maternal nutrition leads to alterations in oxidative stress, antioxidant defense capacity, and markers of fibrosis in rat islets: potential underlying mechanisms for development of the diabetic phenotype in later life. FASEB J. 24, 2762-2771 (2010). www.fasebj.org	[Tarry-Adkins, Jane L.; Chen, Jian-Hua; Jones, Richard H.; Smith, Noel H.; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Tarry-Adkins, JL (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England.	janeadkins@googlemail.com		Tarry-Adkins, Jane/0000-0001-9569-6132; Ozanne, Susan/0000-0001-8753-5144	British Heart Foundation; Biotechnology and Biological Sciences Research Council; Medical Research Council Centre for Obesity and Related Metabolic Diseases; Parthenon Trust; BBSRC [BB/D007909/1, BB/E002161/1, BB/F015364/1, BB/E00797X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D007909/1, BB/E00797X/1, BB/E002161/1, BB/F015364/1] Funding Source: researchfish; British Heart Foundation [PG/09/037/27387, FS/09/029/27902] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Centre for Obesity and Related Metabolic Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parthenon Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	The authors thank A. Wayman and D. Hawkes for their technical expertise. This work was supported by the British Heart Foundation, the Biotechnology and Biological Sciences Research Council, the Medical Research Council Centre for Obesity and Related Metabolic Diseases, and the Parthenon Trust.	Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Azevedo-Martins AK, 2003, DIABETES, V52, P93, DOI 10.2337/diabetes.52.1.93; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bo S, 2000, DIABETIC MED, V17, P365, DOI 10.1046/j.1464-5491.2000.00288.x; Bonnefont-Rousselot D, 2000, DIABETES METAB, V26, P163; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chu KY, 2006, DIABETES, V55, P367, DOI 10.2337/diabetes.55.02.06.db05-1022; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Garofano A, 1999, DIABETOLOGIA, V42, P711, DOI 10.1007/s001250051219; GRANKVIST K, 1981, BIOCHEM J, V173, P83; Grunnet L, 2007, J INTERN MED, V262, P96, DOI 10.1111/j.1365-2796.2007.01793.x; Guichard C, 2008, BIOCHEM SOC T, V36, P920, DOI 10.1042/BST0360920; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Hong OK, 2007, J CELL BIOCHEM, V101, P665, DOI 10.1002/jcb.21222; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; KARAWICZBINISKA A, 2008, MED SCI MONITOR, V8, pCR211; Karger A, 2008, CELL SIGNAL, V20, P1865, DOI 10.1016/j.cellsig.2008.06.016; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Leung KK, 2008, J PANCREAS, V9, P290; Li YX, 2006, CHINESE MED J-PEKING, V119, P1639, DOI 10.1097/00029330-200610010-00008; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Lodovici M, 2009, TOXICOL IND HEALTH, V25, P337, DOI 10.1177/0748233709106464; Manea A, 2005, BIOL CELL, V97, P723, DOI 10.1042/BC20040107; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; MCMILLEN C, 2005, AM PHYSL J, V85, P571; Memisogullari R, 2003, CELL BIOCHEM FUNCT, V21, P291, DOI 10.1002/cbf.1025; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; Nagashio Y, 2004, AM J PHYSIOL-GASTR L, V287, pG170, DOI 10.1152/ajpgi.00005.2004; Nakayama M, 2005, BIOCHEM BIOPH RES CO, V332, P927, DOI 10.1016/j.bbrc.2005.05.065; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; NEWSHOLME P, 2007, J PHYSL, V581, P9; Ong KK, 2004, DIABETOLOGIA, V47, P1064, DOI 10.1007/s00125-004-1405-8; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Petry CJ, 2000, HORM METAB RES, V32, P233, DOI 10.1055/s-2007-978627; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Poulsen P, 1997, DIABETOLOGIA, V40, P439, DOI 10.1007/s001250050698; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Shao JQ, 2007, ACTA PHARMACOL SIN, V28, P246, DOI 10.1111/j.1745-7254.2007.00492.x; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Shimizu K, 2008, J RHEUMATOL, V35, P2214, DOI 10.3899/jrheum.080191; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Tanioka H, 2006, J GASTROEN HEPATOL, V21, P537, DOI 10.1111/j.1440-1746.2005.03999.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Won KC, 2006, J KOREAN MED SCI, V21, P418, DOI 10.3346/jkms.2006.21.3.418; Ye J, 1998, ENDOCRINOLOGY, V139, P4155, DOI 10.1210/en.139.10.4155	55	63	65	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2762	2771		10.1096/fj.10-156075	http://dx.doi.org/10.1096/fj.10-156075			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20388698				2022-12-25	WOS:000285005400017
J	Zheng, B; Ohkawa, S; Li, HY; Roberts-Wilson, TK; Price, SR				Zheng, Bin; Ohkawa, Sakae; Li, Haiyan; Roberts-Wilson, Tiffany K.; Price, S. Russ			FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy	FASEB JOURNAL			English	Article						diabetes; transcription	INSULIN-RECEPTOR SUBSTRATE-1; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; GROWTH-FACTOR-I; PROTEIN-DEGRADATION; PROTEASOME; ACTIVATION; PATHWAY; RAT; TRANSCRIPTION; BINDING	Muscle atrophy is a consequence of chronic diseases (e.g., diabetes) and glucocorticoid-induced insulin resistance that results from enhanced activity of the ubiquitin-proteasome pathway. The PI3K/Akt pathway inhibits the FOXO-mediated transcription of the muscle-specific E3 ligase atrogin-1/MAFbx (AT-1), whereas the MEK/ERK pathway increases Sp1 activity and ubiquitin (UbC) expression. The observations raise a question about how the transcription of these atrogenes is synchronized in atrophic muscle. We tested a signaling model in which FOXO3a mediates crosstalk between the PI3K/Akt and MEK/ERK pathways to coordinate AT-1 and UbC expression. In rat L6 myotubes, dexamethasone (>= 24 h) reduced insulin receptor substrate (IRS)-1 protein and PI3K/Akt signaling and increased AT-1 mRNA. IRS-2 protein, MEK/ERK signaling, Sp1 phosphorylation, and UbC transcription were simultaneously increased. Knockdown of IRS-1 using small interfering RNA or adenovirus-mediated expression of constitutively activated FOXO3a increased IRS-2 protein, MEK/ERK signaling, and UbC expression. Changes in PI3K/Akt and MEK/ERK signaling were recapitulated in rat muscles undergoing atrophy due to streptozotocin-induced insulin deficiency and concurrently elevated glucocorticoid production. IRS-1 and Akt phosphorylation were decreased, whereas MEK/ERK signaling and expression of IRS-2, UbC and AT-1 were increased. We conclude that FOXO3a mediates a reciprocal communication between the IRS-1/PI3K/Akt and IRS-2/MEK/ERK pathways that coordinates AT-1 and ubiquitin expression during muscle atrophy.-Zheng, B., Ohkawa, S., Li, H., Roberts-Wilson, T.-K., Price, S. R. FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy. FASEB J. 24, 2660-2669 (2010). www.fasebj.org	[Zheng, Bin; Ohkawa, Sakae; Li, Haiyan; Price, S. Russ] Emory Univ, Div Renal, Sch Med, Atlanta, GA 30322 USA; [Roberts-Wilson, Tiffany K.] Emory Univ, Grad Div Biol & Biomed Sci, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Price, SR (corresponding author), Emory Univ, Div Renal, Sch Med, Rm 3319A,Woodruff Mem Res Bldg,1639 Pierce Dr, Atlanta, GA 30322 USA.	russ.price@emory.edu		Roberts, Tiffany/0000-0003-0770-9568	U.S. National Institutes of Health [DK-50740, DK-61521, DK-73476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050740, P01DK061521, R01DK073476] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. C. Ronald Kahn (Harvard University, Boston, MA, USA) for providing the p85 alpha adenovirus. The authors also thank Dr. H.A. Franch and Sara Zoromsky for performing experiments for the revised manuscript. Financial support was from U.S. National Institutes of Health grants DK-50740 (to S.R.P.), DK-61521 (to S.R.P.), and DK-73476 (to H.F.).	Alroy I, 1999, MOL CELL BIOL, V19, P1961; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Auclair D, 1997, AM J PHYSIOL-CELL PH, V272, pC1007; Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chrysis D, 1999, ENDOCRINOLOGY, V140, P5635, DOI 10.1210/en.140.12.5635; Combaret L, 2004, BIOCHEM J, V378, P239, DOI 10.1042/BJ20031660; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; FOJAS DB, 2001, EMBO J, V20, P5737; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Franch HA, 2004, AM J PHYSIOL-RENAL, V287, pF700, DOI 10.1152/ajprenal.00440.2003; Gao YM, 2008, J APPL PHYSIOL, V105, P1772, DOI 10.1152/japplphysiol.90636.2008; Garcia A, 2000, J BIOL CHEM, V275, P9385, DOI 10.1074/jbc.275.13.9385; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Giorgino F, 1997, J BIOL CHEM, V272, P7455, DOI 10.1074/jbc.272.11.7455; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; GULVE EA, 1989, BIOCHEM J, V260, P377, DOI 10.1042/bj2600377; Guo SD, 2006, MOL ENDOCRINOL, V20, P3389, DOI 10.1210/me.2006-0092; HAAS AL, 1987, J BIOL CHEM, V262, P345; HAAS AL, 1995, J BIOL CHEM, V270, P9407, DOI 10.1074/jbc.270.16.9407; HALLANGERAS M, 1991, SURGERY, V109, P468; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; HAYASHI T, 1994, BBA-GENE STRUCT EXPR, V1218, P232, DOI 10.1016/0167-4781(94)90020-5; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Ibrahim NM, 2000, BIOTECHNIQUES, V29, P782, DOI 10.2144/00294st04; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Isozaki Y, 1996, P NATL ACAD SCI USA, V93, P1967, DOI 10.1073/pnas.93.5.1967; JURKOVITZ CT, 1992, KIDNEY INT, V42, P595, DOI 10.1038/ki.1992.323; KONAGAYA M, 1986, ENDOCRINOLOGY, V119, P375, DOI 10.1210/endo-119-1-375; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Leis H, 2004, MOL ENDOCRINOL, V18, P303, DOI 10.1210/me.2003-0350; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; Marinovic AC, 2000, BIOCHEM BIOPH RES CO, V274, P537, DOI 10.1006/bbrc.2000.3171; Marinovic AC, 2007, AM J PHYSIOL-RENAL, V292, pF660, DOI 10.1152/ajprenal.00178.2006; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Plum L, 2005, PHYSIOLOGY, V20, P152, DOI 10.1152/physiol.00049.2004; PRICE SR, 1994, AM J PHYSIOL-CELL PH, V267, pC955, DOI 10.1152/ajpcell.1994.267.4.C955; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Shirakami A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740309; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun XY, 2002, AM J PHYSIOL-REG I, V282, pR509, DOI 10.1152/ajpregu.00509.2001; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Workeneh BT, 2006, J AM SOC NEPHROL, V17, P3233, DOI 10.1681/ASN.2006020131; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	59	92	98	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2660	2669		10.1096/fj.09-151480	http://dx.doi.org/10.1096/fj.09-151480			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371624	Green Published			2022-12-25	WOS:000285005400008
J	Fritz, RD; Varga, Z; Radziwill, G				Fritz, R. D.; Varga, Z.; Radziwill, G.			CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis	ONCOGENE			English	Article						CNK1; Akt; FoxO; proliferation; oncogenic signalling; breast cancer	RICTOR-MTOR COMPLEX; PROTEIN-KINASE B; NF-KAPPA-B; SCAFFOLD PROTEIN; RAF ACTIVATION; CANCER; DOWNSTREAM; DROSOPHILA; PATHWAY; TARGET	The scaffold proteins connector enhancer of KSR (CNK) participate in Raf-, Rho-and NF-kappa B-dependent signalling and promote cell differentiation and invasion. In this study, we demonstrate that CNK1 downregulation inhibits, whereas CNK1 overexpression stimulates the proliferation of breast cancer cells and human embryonic kidney cells, respectively. This stimulatory effect depends on a functional phosphatidylinositol-3 kinase (PI3K) pathway because treatment of cells with the PI3K inhibitor, LY294002, abrogates CNK1-induced proliferation. CNK1 interacts with the PI3K effector Akt and knockdown of CNK1 decreases Akt activity in breast cancer cells. CNK1 controls Akt-dependent phosphorylation and transcriptional activity of FoxO, which is a negative regulator of proliferation. Consistent with this, CNK1-induced cell proliferation is blocked by FoxO overexpression. Moreover, CNK1 regulates anchorage-independent proliferation and focus formation of breast cancer cells. CNK1 is predominantly localized at the plasma membrane of breast cancer cells, whereas in non-transformed mammary epithelial cells, CNK1 is cytoplasmatic. Accordingly, CNK1 is found preferentially at the plasma membrane in carcinoma in situ and invasive breast cancer tumours compared with normal breast tissue sections. Analysis of multiple breast cancer samples reveals that CNK1-negative tumours show less Akt activity. Thus, CNK1 promotes oncogenic signalling through Akt in breast cancer cell lines and tumours. Oncogene (2010) 29, 3575-3582; doi:10.1038/onc.2010.104; published online 12 April 2010	[Fritz, R. D.; Radziwill, G.] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Varga, Z.] Univ Zurich Hosp, Inst Clin Pathol, CH-8091 Zurich, Switzerland; [Radziwill, G.] Univ Freiburg, Fac Biol, Freiburg, Germany	University of Zurich; University of Zurich; University Zurich Hospital; University of Freiburg	Radziwill, G (corresponding author), Univ Freiburg, Fac Biol Biochem, Schaenzlestr 1, D-79104 Freiburg, Germany.	gerald.radziwill@biologie.uni-freiburg.de			Cancer League of Zurich; Centre of Biological Signaling Studies (bioss)	Cancer League of Zurich; Centre of Biological Signaling Studies (bioss)	We thank Dr Thorsten Fritzius for providing the FoxO1 and Akt1 m/p expression constructs and Julia Fritz for help with fractionation experiments and critical reading of the paper. We are grateful to Dr Alexandra Trkola for providing the infrastructure. This work was supported by the Cancer League of Zurich and the Centre of Biological Signaling Studies (bioss).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bumeister R, 2004, CURR BIOL, V14, P439, DOI 10.1016/j.cub.2004.02.037; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Fritz RD, 2010, MOL CANCER RES, V8, P395, DOI 10.1158/1541-7786.MCR-09-0296; Fritz RD, 2005, BIOCHEM BIOPH RES CO, V338, P1906, DOI 10.1016/j.bbrc.2005.10.168; Fritzius T, 2008, EMBO J, V27, P1399, DOI 10.1038/emboj.2008.67; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kasper G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-12; Laberge G, 2005, EMBO J, V24, P487, DOI 10.1038/sj.emboj.7600558; Lanigan TM, 2003, FASEB J, V17, P2048, DOI 10.1096/fj.02-1096com; Lopez-Ilasaca MA, 2005, FEBS LETT, V579, P648, DOI 10.1016/j.febslet.2004.12.039; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Rocheleau CE, 2005, P NATL ACAD SCI USA, V102, P11757, DOI 10.1073/pnas.0500937102; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Therrien M, 1998, CELL, V95, P343, DOI 10.1016/S0092-8674(00)81766-3; Theurillat JP, 2007, CANCER IMMUNOL IMMUN, V56, P1723, DOI 10.1007/s00262-007-0316-1; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Ziogas A, 2005, J BIOL CHEM, V280, P24205, DOI 10.1074/jbc.M413327200	33	24	25	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3575	3582		10.1038/onc.2010.104	http://dx.doi.org/10.1038/onc.2010.104			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20383191	Bronze			2022-12-25	WOS:000278835400012
J	Vigneron, S; Brioudes, E; Burgess, A; Labbe, JC; Lorca, T; Castro, A				Vigneron, S.; Brioudes, E.; Burgess, A.; Labbe, J-C; Lorca, T.; Castro, A.			RSK2 is a kinetochore-associated protein that participates in the spindle assembly checkpoint	ONCOGENE			English	Article						Rsk2; SAC; kinetochore; Mad2; CENP-E	CELL-CYCLE EXTRACTS; CENP-E; MITOTIC CHECKPOINT; MAP KINASE; ERK; ATTACHMENT; EGGS; LOCALIZATION; ACTIVATION; PATHWAY	The spindle assembly checkpoint (SAC) prevents anaphase onset until all the chromosomes have successfully attached to the spindle microtubules. The MAP kinase (MAPK) is an important player in this pathway, however its exact role is not fully understood. One major target of MAPK is the p90 ribosomal protein S6 kinase (RSKs) family. In this study, we analyse whether Rsk2 could participate in the activation of the SAC. Our data indicate that this protein is localized at the kinetochores under checkpoint conditions. Moreover, it is essential for the SAC activity in Xenopus egg extracts as its depletion prevents metaphase arrest as well as the kinetochore localization of the other SAC components. We also show that this kinase might also participate in the maintenance of the SAC in mammalian cells as Rsk2 knockdown in these cells prevents the kinetochore localization of Mad1, Mad2 and CENP-E under checkpoint conditions. Oncogene (2010) 29, 3566-3574; doi:10.1038/onc.2010.105; published online 12 April 2010	[Castro, A.] Univ Montpellier 2, Ctr Rech Biochim Macromol, CNRS, UMR 5237,IFR 122, F-34293 Montpellier 5, France; [Castro, A.] Univ Montpellier 1, Ctr Rech Biochim Macromol, CNRS, UMR 5237,IFR 122, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Castro, A (corresponding author), Univ Montpellier 2, Ctr Rech Biochim Macromol, CNRS, UMR 5237,IFR 122, 1919 Route Mende, F-34293 Montpellier 5, France.	thierry.lorca@crbm.cnrs.fr; anna.castro@crbm.cnrs.fr	CASTRO, ANNA/F-4350-2010; labbe, jean-claude/B-2277-2009; Burgess, Andrew/C-7952-2009; Burgess, Andrew/H-3339-2019	CASTRO, ANNA/0000-0002-3655-1352; Burgess, Andrew/0000-0003-4536-9226; Burgess, Andrew/0000-0003-4536-9226; Lorca, Thierry/0000-0003-2007-8924	Ligue Nationale Contre le Cancer (Equipe Labellisee)	Ligue Nationale Contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer)	We thank Dr JE Ferrell for the generous gift of the pFast-Rsk2 WT and the pFast-Rsk2 KD constructs. We thank Julian Cau from the Montpellier RIO Imaging facility (CRBM). This work was supported by the Ligue Nationale Contre le Cancer (Equipe Labellisee). AB and EB are fellows from the Fondation pour la Recherche Medicale and the Ligue Nationale Contre le Cancer, respectively.	Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bhatt RR, 2000, J BIOL CHEM, V275, P32983, DOI 10.1074/jbc.M006386200; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nam HJ, 2008, CELL SIGNAL, V20, P1349, DOI 10.1016/j.cellsig.2008.03.008; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	24	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3566	3574		10.1038/onc.2010.105	http://dx.doi.org/10.1038/onc.2010.105			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20383198	Green Published			2022-12-25	WOS:000278835400011
J	Lau, C; Dolle, C; Gossmann, TI; Agledal, L; Niere, M; Ziegler, M				Lau, Corinna; Dolle, Christian; Gossmann, Toni I.; Agledal, Line; Niere, Marc; Ziegler, Mathias			Isoform-specific Targeting and Interaction Domains in Human Nicotinamide Mononucleotide Adenylyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; MULTIPLE SEQUENCE ALIGNMENT; NMN/NAMN ADENYLYLTRANSFERASE; ADENINE-DINUCLEOTIDE; AXONAL DEGENERATION; NAD BIOSYNTHESIS; ADP-RIBOSYLATION; MATRIX PROTEINS; GOLGI PROTEINS; NUCLEAR ENZYME	Several important signaling pathways require NAD as substrate, thereby leading to significant consumption of the molecule. Because NAD is also an essential redox carrier, its continuous resynthesis is vital. In higher eukaryotes, maintenance of compartmentalized NAD pools is critical, but so far rather little is known about the regulation and subcellular distribution of NAD biosynthetic enzymes. The key step in NAD biosynthesis is the formation of the dinucleotide by nicotinamide/nicotinic acid mononucleotide adenylyltransferases (NMNATs). The three human isoforms were localized to the nucleus, the Golgi complex, and mitochondria. Here, we show that their genes contain unique exons that encode isoform-specific domains to mediate subcellular targeting and post-translational modifications. These domains are dispensable for catalytic activity, consistent with their absence from NMNATs of lower organisms. We further demonstrate that the Golgi-associated NMNAT is palmitoylated at two adjacent cysteine residues of its isoform-specific domain and thereby anchored at the cytoplasmic surface, a potential mechanism to regulate the cytosolic NAD pool. Insertion of unique domains thus provides a yet unrecognized enzyme targeting mode, which has also been adapted to modulate subcellular NAD supply.	[Lau, Corinna; Dolle, Christian; Agledal, Line; Niere, Marc; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5008 Bergen, Norway; [Gossmann, Toni I.] Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England	University of Bergen; University of Sussex	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	mathias.ziegler@mbi.uib.no	Gossmann, Toni/H-6579-2013	Gossmann, Toni/0000-0001-6609-4116; Ziegler, Mathias/0000-0001-6961-2396; Lau, Corinna/0000-0003-1750-8065	National Research Council of Norway; University of Bergen	National Research Council of Norway(Research Council of Norway); University of Bergen	This work was supported by the National Research Council of Norway and the University of Bergen.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Couture JF, 2004, J MOL BIOL, V339, P89, DOI 10.1016/j.jmb.2004.03.035; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denu JM, 2005, TRENDS BIOCHEM SCI, V30, P479, DOI 10.1016/j.tibs.2005.07.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang J, 2009, CELL ADHES MIGR, V3, P77, DOI 10.4161/cam.3.1.7483; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yang W, 1998, MOL BIOL CELL, V9, P191, DOI 10.1091/mbc.9.1.191; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	65	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18868	18876		10.1074/jbc.M110.107631	http://dx.doi.org/10.1074/jbc.M110.107631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388704	Green Published, hybrid			2022-12-25	WOS:000278453900077
J	Soto, AG; Trejo, J				Soto, Antonio G.; Trejo, JoAnn			N-Linked Glycosylation of Protease-activated Receptor-1 Second Extracellular Loop A CRITICAL DETERMINANT FOR LIGAND-INDUCED RECEPTOR ACTIVATION AND INTERNALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELL INVASION; THROMBIN RECEPTOR; COUPLED RECEPTORS; ENDOPLASMIC-RETICULUM; PHOSPHOLIPASE-C; DOWN-REGULATION; BINDING; OLIGOSACCHARIDES; EXPRESSION; CLEAVAGE	Protease-activated receptor-1 (PAR1) contains five N-linked glycosylation consensus sites as follows: three residing in the N terminus and two localized on the surface of the second extracellular loop (ECL2). To study the effect of N-linked glycosylation in the regulation of PAR1 signaling and trafficking, we generated mutants in which the critical asparagines of the consensus sites were mutated. Here, we report that both the PAR1 N terminus and ECL2 serve as sites for N-linked glycosylation but have different functions in the regulation of receptor signaling and trafficking. N-Linked glycosylation of the PAR1 N terminus is important for transport to the cell surface, whereas the PAR1 mutant lacking glycosylation at ECL2 (NA ECL2) trafficked to the cell surface like the wild-type receptor. However, activated PAR1 NA ECL2 mutant internalization was impaired compared with wild-type receptor, whereas constitutive internalization of unactivated receptor remained intact. Remarkably, thrombin-activated PAR1 NA ECL2 mutant displayed an enhanced maximal signaling response compared with wild-type receptor. The increased PAR1 NA ECL2 mutant signaling was not due to defects in the ability of thrombin to cleave the receptor or signal termination mechanisms. Rather, the PAR1 NA ECL2 mutant displayed a greater efficacy in thrombin-stimulated G protein signaling. Thus, N-linked glycosylation of the PAR1 extracellular surface likely influences ligand docking interactions and the stability of the active receptor conformation. Together, these studies strongly suggest that N-linked glycosylation of PAR1 at the N terminus versus the surface of ECL2 serves distinct functions critical for proper regulation of receptor trafficking and the fidelity of thrombin signaling.	[Soto, Antonio G.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Soto, Antonio G.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3044A, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [HL073328]; American Heart Association; National Institutes of Health, NIGMS [T32]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073328 (to J. T.). This work was also supported by an American Heart Association established investigator award (to J. T.).; Supported by National Institutes of Health Training Grant T32 from NIGMS (pharmacological sciences training grant).	Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; BAFFY G, 1994, J BIOL CHEM, V269, P8483; BENKA ML, 1995, FEBS LETT, V363, P49, DOI 10.1016/0014-5793(95)00278-H; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; BRASS LF, 1994, J BIOL CHEM, V269, P2943; Compton SJ, 2003, DRUG DEVELOP RES, V59, P350, DOI 10.1002/ddr.10303; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Datta A, 2003, PROTEIN SCI, V12, P2482, DOI 10.1110/ps.03254303; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; HOE MH, 1992, J BIOL CHEM, V267, P4916; ISHII K, 1993, J BIOL CHEM, V268, P9780; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; LIU XB, 1993, J BIOL CHEM, V268, P1513; Luga V, 2009, BIOCHEM J, V421, P119, DOI 10.1042/BJ20081131; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TORDAI A, 1995, BIOCHEM BIOPH RES CO, V206, P857, DOI 10.1006/bbrc.1995.1122; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	50	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18781	18793		10.1074/jbc.M110.111088	http://dx.doi.org/10.1074/jbc.M110.111088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20368337	hybrid, Green Published			2022-12-25	WOS:000278453900069
J	Brown, SAN; Ghosh, A; Winkles, JA				Brown, Sharron A. N.; Ghosh, Arundhati; Winkles, Jeffrey A.			Full-length, Membrane-anchored TWEAK Can Function as a Juxtacrine Signaling Molecule and Activate the NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HYPOHIDROTIC ECTODERMAL DYSPLASIA; HUMAN FAS LIGAND; FACTOR-ALPHA; PROPROTEIN CONVERTASES; TNF SUPERFAMILY; FACTOR FAMILY; WEAK INDUCER; RECEPTOR ACTIVATOR; CEREBRAL-ISCHEMIA	Tumor necrosis factor (TNF) family members are initially synthesized as type II transmembrane proteins, but some of these proteins are substrates for proteolytic enzymes that generate soluble cytokines with biological activity. TWEAK (TNF-like weak inducer of apoptosis), a member of the TNF family, is a multifunctional cytokine that acts via binding to a cell surface receptor named Fn14 (fibroblast growth factor-inducible 14). Studies conducted to date indicate that TWEAK-producing cells can co-express both membrane-anchored and soluble TWEAK isoforms, but there is little information on TWEAK proteolytic processing. Also, it is presently unclear whether membrane-anchored TWEAK, like soluble TWEAK, is biologically active. Here we show that full-length human TWEAK is processed intracellularly by the serine protease furin and identify TWEAK amino acid residues 90-93 as the predominant furin recognition site. In addition, we report that full-length, membrane-anchored TWEAK can bind the Fn14 receptor on neighboring cells and activate the NF-kappa B signaling pathway. Thus, TWEAKcan act in a juxtacrine manner to initiate cellular responses, and this property may be important for TWEAK function during physiological wound repair and disease pathogenesis.	Univ Maryland, Sch Med, Dept Surg, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Winkles, JA (corresponding author), 800 W Baltimore St,Rm 320, Baltimore, MD 21201 USA.	jwinkles@som.umaryland.edu			National Institutes of Health [NS55126, CA130967]; Susan G. Komen for the Cure [KG081095]; NATIONAL CANCER INSTITUTE [P30CA134274, R01CA130967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS55126 and CA130967. This work was also supported by Susan G. Komen for the Cure Grant KG081095 (to J. A. W.).	Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Contin C, 2003, J BIOL CHEM, V278, P32801, DOI 10.1074/jbc.M209993200; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; DECOSTER E, 1995, J BIOL CHEM, V270, P18473, DOI 10.1074/jbc.270.31.18473; Desplat-Jego S, 2009, J LEUKOCYTE BIOL, V85, P132, DOI 10.1189/jlb.0608347; Diwan A, 2004, CIRCULATION, V109, P262, DOI 10.1161/01.CIR.0000109642.27985.FA; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Glenney GW, 2007, J IMMUNOL, V178, P7955, DOI 10.4049/jimmunol.178.12.7955; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kawakita T, 2005, INT J ONCOL, V26, P87; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kolfschoten GA, 2003, BIOCHEM PHARMACOL, V66, P1427, DOI 10.1016/S0006-2952(03)00493-3; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Pradet-Balade B, 2002, EMBO J, V21, P5711, DOI 10.1093/emboj/cdf565; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; RobacheGallea S, 1997, EUR J IMMUNOL, V27, P1275, DOI 10.1002/eji.1830270532; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Shui Y, 2008, VET IMMUNOL IMMUNOP, V126, P396, DOI 10.1016/j.vetimm.2008.08.005; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vaisanen T, 2006, J BIOL CHEM, V281, P33352, DOI 10.1074/jbc.M605896200; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yepes M, 2005, AM J PATHOL, V166, P511, DOI 10.1016/S0002-9440(10)62273-0; Zhang XH, 2007, J CEREBR BLOOD F MET, V27, P534, DOI 10.1038/sj.jcbfm.9600368; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	77	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17432	17441		10.1074/jbc.M110.131979	http://dx.doi.org/10.1074/jbc.M110.131979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385556	hybrid, Green Published			2022-12-25	WOS:000278133400021
J	Chia, DJ; Varco-Merth, B; Rotwein, P				Chia, Dennis J.; Varco-Merth, Ben; Rotwein, Peter			Dispersed Chromosomal Stat5b-binding Elements Mediate Growth Hormone-activated Insulin-like Growth Factor-I Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-I; BINDING-SITES; SIGNAL TRANSDUCER; HUMAN GENOME; CHROMATIN IMMUNOPRECIPITATION; TYROSINE PHOSPHORYLATION; TARGET GENES; IDENTIFICATION; EXPRESSION; STAT5B	The growth hormone (GH)-insulin-like growth factor-I (IGF-I) axis regulates somatic growth during childhood and orchestrates tissue repair throughout the life span. Recently described inactivating mutations in Stat5b in humans with impaired growth have focused attention on this transcription factor as a key agent linking GH-stimulated signals to IGF-I gene expression, and several putative Stat5b sites have been identified in the IGF-I gene. Here, we define and characterize potential GH- and Stat5b-activated chromosomal enhancers that can regulate IGF-I gene transcription. Of 89 recognizable Stat5 sequences in 200 kb centering on the rat IGF-I gene, 22 resided within conserved regions and/or were identical among different species. Only 15 of these sites, organized into 7 distinct domains, were found to bind Stat5b by quantitative chromatin immunoprecipitation assays in liver chromatin of rats, but only after acute GH treatment. These sites could bind Stat5b in vitro, and individual domains could mediate GH- and Stat5b-stimulated IGF-I promoter activity in cultured cells. Further analyses revealed that four Stat5b domains possessed chromatin signatures of enhancers, including binding of co-activators p300 and Med1, and RNA polymerase II. These modifications preceded GH-stimulated recruitment of Stat5b, as did lysine 4 monomethylation of histone H3, which was enriched in 6/7 Stat5b-binding elements. In contrast, histone acetylation was induced by GH but was limited to Stat5b binding domains found within the IGF-I transcription unit. We conclude that GH stimulates recruitment of Stat5b to multiple dispersed regions within the igf1 locus, including several with properties consistent with long range transcriptional enhancers that collectively regulate GH-activated IGF-I gene transcription.	[Varco-Merth, Ben; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chia, Dennis J.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd,Mail Code L224, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [K08 DK077897, K12 HD057588, T32 DK007674-16, R01 DK069703]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK077897, R01DK069703, T32DK007680, T32DK007674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK077897 and K12 HD057588 (to D. J. C.), T32 DK007674-16 (to B. V.-M.), and R01 DK069703 (to P. R.).	ADAMO ML, 1991, MOL ENDOCRINOL, V5, P1677, DOI 10.1210/mend-5-11-1677; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chia DJ, 2010, MOL ENDOCRINOL, V24, P779, DOI 10.1210/me.2009-0430; Chia DJ, 2006, J BIOL CHEM, V281, P3190, DOI 10.1074/jbc.M510204200; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eleswarapu S, 2008, ENDOCRINOLOGY, V149, P2230, DOI 10.1210/en.2007-1344; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Gronowski AM, 1996, ENDOCRINOLOGY, V137, P55, DOI 10.1210/en.137.1.55; HALL LJ, 1992, DNA CELL BIOL, V11, P301, DOI 10.1089/dna.1992.11.301; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; HOYT EC, 1988, MOL ENDOCRINOL, V2, P1077, DOI 10.1210/mend-2-11-1077; Hwa V, 2005, J CLIN ENDOCR METAB, V90, P4260, DOI 10.1210/jc.2005-0515; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Laz EV, 2009, MOL ENDOCRINOL, V23, P1242, DOI 10.1210/me.2008-0449; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; Nelson EA, 2006, J BIOL CHEM, V281, P26216, DOI 10.1074/jbc.M605001200; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenfeld RG, 2009, HORM RES, V71, P36, DOI 10.1159/000192434; Rotwein P, 2010, PEDIATR NEPHROL, V25, P651, DOI 10.1007/s00467-009-1258-y; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang Y, 2005, J BIOL CHEM, V280, P10955, DOI 10.1074/jbc.M412808200; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Woelfle J, 2005, PEDIATR NEPHROL, V20, P295, DOI 10.1007/s00467-004-1602-1; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; WOOD TJJ, 1995, J BIOL CHEM, V270, P9448, DOI 10.1074/jbc.270.16.9448; Ye P, 1997, ENDOCRINOLOGY, V138, P5466, DOI 10.1210/en.138.12.5466; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	56	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17636	17647		10.1074/jbc.M110.117697	http://dx.doi.org/10.1074/jbc.M110.117697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378540	Green Published, hybrid			2022-12-25	WOS:000278133400042
J	Ghosh, S; Hamdan, SM; Richardson, CC				Ghosh, Sharmistha; Hamdan, Samir M.; Richardson, Charles C.			Two Modes of Interaction of the Single-stranded DNA-binding Protein of Bacteriophage T7 with the DNA Polymerase-Thioredoxin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 2.5 PROTEIN; ESCHERICHIA-COLI THIOREDOXIN; HELICASE-PRIMASE; CONFERS PROCESSIVITY; CRYSTAL-STRUCTURE; REPLICATION FORK; DOMAIN; TERMINUS; RESIDUES; MOLECULE	The DNA polymerase encoded by bacteriophage T7 has low processivity. Escherichia coli thioredoxin binds to a segment of 76 residues in the thumb subdomain of the polymerase and increases the processivity. The binding of thioredoxin leads to the formation of two basic loops, loops A and B, located within the thioredoxin-binding domain (TBD). Both loops interact with the acidic C terminus of the T7 helicase. A relatively weak electrostatic mode involves the C-terminal tail of the helicase and the TBD, whereas a high affinity interaction that does not involve the C-terminal tail occurs when the polymerase is in a polymerization mode. T7 gene 2.5 single-stranded DNA-binding protein (gp2.5) also has an acidic C-terminal tail. gp2.5 also has two modes of interaction with the polymerase, but both involve the C-terminal tail of gp2.5. An electrostatic interaction requires the basic residues in loops A and B, and gp2.5 binds to both loops with similar affinity as measured by surface plasmon resonance. When the polymerase is in a polymerization mode, the C terminus of gene 2.5 protein interacts with the polymerase in regions outside the TBD. gp2.5 increases the processivity of the polymerase-helicase complex during leading strand synthesis. When loop B of the TBD is altered, abortive DNA products are observed during leading strand synthesis. Loop B appears to play an important role in communication with the helicase and gp2.5, whereas loop A plays a stabilizing role in these interactions.	[Ghosh, Sharmistha; Hamdan, Samir M.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM054937, R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54937.	Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Ghosh S, 2008, J BIOL CHEM, V283, P32077, DOI 10.1074/jbc.M805062200; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15032; KIM YT, 1992, J BIOL CHEM, V267, P15022; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; Marintcheva B, 2009, MOL MICROBIOL, V72, P869, DOI 10.1111/j.1365-2958.2009.06682.x; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; TABOR S, 1987, J BIOL CHEM, V262, P16212; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang XM, 1996, J BIOL CHEM, V271, P24207, DOI 10.1074/jbc.271.39.24207	25	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18103	18112		10.1074/jbc.M110.107656	http://dx.doi.org/10.1074/jbc.M110.107656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375019	Green Published, hybrid			2022-12-25	WOS:000278133400085
J	Severin, IC; Gaudry, JP; Johnson, Z; Kungl, A; Jansma, A; Gesslbauer, B; Mulloy, B; Power, C; Proudfoot, AEI; Handel, T				Severin, India C.; Gaudry, Jean-Philippe; Johnson, Zoe; Kungl, Andreas; Jansma, Ariane; Gesslbauer, Bernd; Mulloy, Barbara; Power, Christine; Proudfoot, Amanda E. I.; Handel, Tracy			Characterization of the Chemokine CXCL11-Heparin Interaction Suggests Two Different Affinities for Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; HUMAN-PLATELET FACTOR-4; HEPARIN-BINDING SITES; I-TAC; RECEPTOR-BINDING; CC-CHEMOKINE; MCP-1 RECEPTOR; CXC CHEMOKINE; T-CELLS; IDENTIFICATION	Chemokines orchestrate the migration of leukocytes in the context of homeostasis and inflammation. In addition to interactions of chemokines with receptors on migrating cells, these processes require interactions of chemokines with glycosaminoglycans (GAGs) for cell surface localization. Most chemokines are basic proteins with Arg/Lys/His residue clusters functioning as recognition epitopes for GAGs. In this study we characterized the GAG-binding epitopes of the chemokine I-TAC/CXCL11. Four separate clusters of basic residues were mutated to alanine and tested for their ability to bind to GAGs in vitro and to activate the receptor, CXCR3. Mutation of a set of basic residues in the C-terminal helix (the 50s cluster, (57)KSKQAR(62)) along with Lys(17), significantly impaired heparin binding in vitro, identifying these residues as components of the dominant epitope. However, this GAG mutant retained nearly wild type receptor binding affinity, and its ability to induce cell migration in vitro was only mildly perturbed. Nevertheless, the mutant was unable to induce cell migration in vivo, establishing a requirement of CXCL11 for GAG binding for in vivo function. These studies also led to some interesting findings. First, CXCL11 exhibits conformational heterogeneity, as evidenced by the doubling of peaks in its HSQC spectra. Second, it exhibits more than one affinity state for both heparin and CXCR3, which may be related to its structural plasticity. Finally, although the binding affinities of chemokines for GAGs are typically weaker than interactions with receptors, the high affinity GAG binding state of CXCL11 is comparable with typical receptor binding affinities, suggesting some unique properties of this chemokine.	[Severin, India C.; Gaudry, Jean-Philippe; Johnson, Zoe; Power, Christine; Proudfoot, Amanda E. I.] Merck Serono Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Kungl, Andreas; Gesslbauer, Bernd] ProtAffin Biotechnol AG, A-8020 Graz, Austria; [Mulloy, Barbara] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Jansma, Ariane; Handel, Tracy] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Merck KGaA; EMD Serono Inc.; National Institute for Biological Standards & Control; University of California System; University of California San Diego	Proudfoot, AEI (corresponding author), Merck Serono Geneva Res Ctr, 9 Chemin Mines, CH-1202 Geneva, Switzerland.	amanda.proudfoot@merckserono.net	Severin, India/J-1558-2017; Gesslbauer, Bernd/U-4033-2018; Sawant, Kirti V/H-3778-2013	Gesslbauer, Bernd/0000-0003-4910-8322; Kungl, Andreas/0000-0003-3362-797X; Johnson, Zoe/0000-0002-4120-2579	National Institutes of Health [RO1-AI37113]; Lymphoma Research Foundation; United States Department of Defense [USAMRAA W81XWH0710446]; European Union [LSHB-CT-2005-518167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; United States Department of Defense(United States Department of Defense); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AI37113 (T. M. H.). This work was also supported by the Lymphoma Research Foundation, United States Department of Defense Grant USAMRAA W81XWH0710446, and European Union FP6 INNOCHEM Award LSHB-CT-2005-518167 (to A. E. I. P.).	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Ali S, 2007, MOL IMMUNOL, V44, P1477, DOI 10.1016/j.molimm.2006.08.011; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Dehner A, 2005, CHEMBIOCHEM, V6, P1550, DOI 10.1002/cbic.200500093; Falsone SF, 2007, PROTEOMICS, V7, P2375, DOI 10.1002/pmic.200600996; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hoogewerf AJ, 2000, METH MOL B, V138, P173; Jabeen T, 2008, ACTA CRYSTALLOGR D, V64, P611, DOI 10.1107/S0907444908007026; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Langenkamp A, 2003, EUR J IMMUNOL, V33, P474, DOI 10.1002/immu.200310023; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Loetscher P, 2001, J LEUKOCYTE BIOL, V69, P881; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; MAYO KH, 1989, BIOCHEMISTRY-US, V28, P9469, DOI 10.1021/bi00450a034; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Sauty A, 1999, J IMMUNOL, V162, P3549; Shahrara S, 2008, J IMMUNOL, V180, P3447, DOI 10.4049/jimmunol.180.5.3447; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Wijtmans M, 2008, CHEMMEDCHEM, V3, P861, DOI 10.1002/cmdc.200700365; ZHANG XH, 1994, BIOCHEMISTRY-US, V33, P8361, DOI 10.1021/bi00193a025	61	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17713	17724		10.1074/jbc.M109.082552	http://dx.doi.org/10.1074/jbc.M109.082552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363748	hybrid, Green Published			2022-12-25	WOS:000278133400049
J	Singh, NK; Van Quyen, D; Kundumani-Sridharan, V; Brooks, PC; Rao, GN				Singh, Nikhlesh K.; Van Quyen, Dong; Kundumani-Sridharan, Venkatesh; Brooks, Peter C.; Rao, Gadiparthi N.			AP-1 (Fra-1/c-Jun)-mediated Induction of Expression of Matrix Metalloproteinase-2 Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; RHO-GTPASES; MUSCLE; ACTIVATION; 15-HETE; GROWTH; HYPOXIA; KINASE; MMP-2; 12/15-LIPOXYGENASE	To understand the involvement of matrix metalloproteinases (MMPs) in 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE)-induced angiogenesis, we have studied the role of MMP-2. 15(S)-HETE induced MMP-2 expression and activity in a time-dependent manner in human dermal microvascular endothelial cells (HDMVECs). Inhibition of MMP-2 activity or depletion of its levels attenuated 15(S)-HETE-induced HDMVEC migration, tube formation, and Matrigel plug angiogenesis. 15(S)-HETE also induced Fra-1 and c-Jun expression in a Rac1-MEK1-JNK1-dependent manner. In addition, 15(S)-HETE-induced MMP-2 expression and activity were mediated by Rac1-MEK1-JNK1 dependent activation of AP-1 (Fra-1/c-Jun). Cloning and site-directed mutagenesis of MMP-2 promoter revealed that AP-1 site proximal to the transcriptional start site is required for 15(S)-HETE-induced MMP-2 expression, and Fra-1 and c-Jun are the essential components of AP-1 that bind to MMP-2 promoter in response to 15(S)-HETE. Hind limb ischemia led to an increase in MEK1 and JNK1 activation and Fra-1, c-Jun, and MMP-2 expression resulting in enhanced neovascularization and recovery of blood perfusion in wild-type mice as compared with 12/15-Lox(-/-) mice. Together, these results provide the first direct evidence for a role of 12/15-Lox-12/15(S)-HETE axis in the regulation of ischemia-induced angiogenesis.	[Singh, Nikhlesh K.; Van Quyen, Dong; Kundumani-Sridharan, Venkatesh; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Brooks, Peter C.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	University of Tennessee System; University of Tennessee Health Science Center; Maine Medical Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023; Quyen, Dong Van/0000-0003-1002-7517	NHLBI [HL074860]; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074860] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL074860 from NHLBI.	Alexander SM, 1997, DEV DYNAM, V209, P261, DOI 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Coker ML, 1999, AM J PHYSIOL-HEART C, V277, pH777, DOI 10.1152/ajpheart.1999.277.2.H777; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fatar M, 2005, CEREBROVASC DIS, V20, P141, DOI 10.1159/000087197; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Freedman SB, 2001, J MOL CELL CARDIOL, V33, P379, DOI 10.1006/jmcc.2000.1329; Gagne PJ, 2005, AM J PATHOL, V167, P1349, DOI 10.1016/S0002-9440(10)61222-9; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gonzalez AL, 2004, HUM PATHOL, V35, P840, DOI 10.1016/j.humpath.2004.04.001; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Gu JL, 2001, CIRCULATION, V103, P1446, DOI 10.1161/01.CIR.103.10.1446; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Kelavkar UP, 2004, NEOPLASIA, V6, P821, DOI 10.1593/neo.04286; Khurana R, 2004, CIRCULATION, V110, P2436, DOI 10.1161/01.CIR.0000145138.25577.F1; Koutouzis M, 2007, ATHEROSCLEROSIS, V192, P457, DOI 10.1016/j.atherosclerosis.2007.01.035; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Levi E, 1996, P NATL ACAD SCI USA, V93, P7069, DOI 10.1073/pnas.93.14.7069; Li YM, 2009, APOPTOSIS, V14, P42, DOI 10.1007/s10495-008-0286-6; Linask KK, 2005, MICROSC MICROANAL, V11, P200, DOI 10.1017/S1431927605050440; Linask KK, 2005, DEV DYNAM, V233, P739, DOI 10.1002/dvdy.20377; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mohammed FF, 2003, ANN RHEUM DIS, V62, P43; Poeckel D, 2009, J BIOL CHEM, V284, P21077, DOI 10.1074/jbc.M109.000901; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Preston IR, 2006, AM J PHYSIOL-LUNG C, V290, pL367, DOI 10.1152/ajplung.00114.2005; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Viita H, 2008, CIRC RES, V102, P177, DOI 10.1161/CIRCRESAHA.107.155556; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zahradka P, 2004, AM J PHYSIOL-HEART C, V287, pH2861, DOI 10.1152/ajpheart.00230.2004; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhao TQ, 2009, J LIPID RES, V50, P521, DOI 10.1194/jlr.M800388-JLR200; Zhu DL, 2003, CIRC RES, V92, P992, DOI 10.1161/01.RES.0000070881.65194.8F; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	65	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16830	16843		10.1074/jbc.M110.106187	http://dx.doi.org/10.1074/jbc.M110.106187			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353950	hybrid, Green Published			2022-12-25	WOS:000277982600047
J	Gartmann, M; Blau, M; Armache, JP; Mielke, T; Topf, M; Beckmann, R				Gartmann, Marco; Blau, Michael; Armache, Jean-Paul; Mielke, Thorsten; Topf, Maya; Beckmann, Roland			Mechanism of eIF6-mediated Inhibition of Ribosomal Subunit Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE HOMOLOG; EUKARYOTIC INITIATION FACTOR-6; ELECTRON-MICROSCOPY; 80S RIBOSOME; PROTEIN; TRANSLATION; YEAST; VISUALIZATION; TRANSLOCATION; REFINEMENT	During the process of ribosomal assembly, the essential eukaryotic translation initiation factor 6 (eIF6) is known to act as a ribosomal anti-association factor. However, a molecular understanding of the anti-association activity of eIF6 is still missing. Here we present the cryo-electron microscopy reconstruction of a complex of the large ribosomal subunit with eukaryotic eIF6 from Saccharomyces cerevisiae. The structure reveals that the eIF6 binding site involves mainly rpL23 (L14p in Escherichia coli). Based on our structural data, we propose that the mechanism of the anti-association activity of eIF6 is based on steric hindrance of intersubunit bridge formation around the dynamic bridge B6.	[Gartmann, Marco; Armache, Jean-Paul; Beckmann, Roland] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Gartmann, Marco; Armache, Jean-Paul; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10098 Berlin, Germany; [Blau, Michael] Humboldt Univ, Inst Biochem Charite, D-10117 Berlin, Germany; [Topf, Maya] Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, London WC1E 7HX, England	University of Munich; University of Munich; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Birkbeck University London	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Armache, Jean-Paul/U-3113-2019	Armache, Jean-Paul/0000-0001-9195-2282; Topf, Maya/0000-0002-8185-1215	Deutsche Forschungsgemeinschaft (DFG) [SFB594, SFB646, SFB740]; Center for Integrated Protein Science Munich; European Union; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (Anwenderzentrum); MRC [G0600084] Funding Source: UKRI; Medical Research Council [G0600084] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; European Union(European Commission); Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (Anwenderzentrum); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (Grants SFB594 and SFB646) and the Center for Integrated Protein Science Munich (to R. B.), by a grant from the Deutsche Forschungsgemeinschaft SFB740 (to T. M.), and by grants from the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (Anwenderzentrum).	Basu U, 2003, MOL CELL BIOL, V23, P6187, DOI 10.1128/MCB.23.17.6187-6199.2003; Benelli D, 2009, NUCLEIC ACIDS RES, V37, P256, DOI 10.1093/nar/gkn959; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Graindorge JS, 2005, J MOL BIOL, V352, P355, DOI 10.1016/j.jmb.2005.07.037; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Miluzio A, 2009, EMBO REP, V10, P459, DOI 10.1038/embor.2009.70; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Si K, 1999, MOL CELL BIOL, V19, P1416; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Topf M, 2006, J MOL BIOL, V357, P1655, DOI 10.1016/j.jmb.2006.01.062; Topf M, 2005, J STRUCT BIOL, V149, P191, DOI 10.1016/j.jsb.2004.11.004; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712	26	84	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14848	14851		10.1074/jbc.C109.096057	http://dx.doi.org/10.1074/jbc.C109.096057			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20356839	Green Published, hybrid			2022-12-25	WOS:000277399000002
J	Carvalho, FM; Tinoco, EMB; Deeley, K; Duarte, PM; Faveri, M; Marques, MR; Mendonca, AC; Wang, XJ; Cuenco, K; Menezes, R; Garlet, GP; Vieira, AR				Carvalho, Flavia M.; Tinoco, Eduardo M. B.; Deeley, Kathleen; Duarte, Poliana M.; Faveri, Marcelo; Marques, Marcelo R.; Mendonca, Adriana C.; Wang, Xiaojing; Cuenco, Karen; Menezes, Renato; Garlet, Gustavo P.; Vieira, Alexandre R.			FAM5C Contributes to Aggressive Periodontitis	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; JUVENILE PERIODONTITIS; ASSOCIATION; LINKAGE; SUSCEPTIBILITY; CELLS; DISEASE; LESIONS	Aggressive periodontitis is characterized by a rapid and severe periodontal destruction in young systemically healthy subjects. A greater prevalence is reported in Africans and African descendent groups than in Caucasians and Hispanics. We first fine mapped the interval 1q24.2 to 1q31.3 suggested as containing an aggressive periodontitis locus. Three hundred and eighty-nine subjects from 55 pedigrees were studied. Saliva samples were collected from all subjects, and DNA was extracted. Twenty-one single nucleotide polymorphisms were selected and analyzed by standard polymerase chain reaction using TaqMan chemistry. Non-parametric linkage and transmission distortion analyses were performed. Although linkage results were negative, statistically significant association between two markers, rs1935881 and rs1342913, in the FAM5C gene and aggressive periodontitis (p = 0.03) was found. Haplotype analysis showed an association between aggressive periodontitis and the haplotype A-G (rs1935881-rs1342913; p = 0.009). Sequence analysis of FAM5C coding regions did not disclose any mutations, but two variants in conserved intronic regions of FAM5C, rs57694932 and rs10494634, were found. However, these two variants are not associated with aggressive periodontitis. Secondly, we investigated the pattern of FAM5C expression in aggressive periodontitis lesions and its possible correlations with inflammatory/immunological factors and pathogens commonly associated with periodontal diseases. FAM5C mRNA expression was significantly higher in diseased versus healthy sites, and was found to be correlated to the IL-1 beta, IL-17A, IL-4 and RANKL mRNA levels. No correlations were found between FAM5C levels and the presence and load of red complex periodontopathogens or Aggregatibacter actinomycetemcomitans. This study provides evidence that FAM5C contributes to aggressive periodontitis.	[Carvalho, Flavia M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil; [Tinoco, Eduardo M. B.] Univ Estado Rio De Janeiro, Sch Dent, Dept Periodontol, Rio De Janeiro, Brazil; [Tinoco, Eduardo M. B.] UNIGRANRIO, Sch Hlth Sci, Postgrad Program Dent, Rio De Janeiro, Brazil; [Deeley, Kathleen; Wang, Xiaojing; Cuenco, Karen; Menezes, Renato; Vieira, Alexandre R.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA USA; [Vieira, Alexandre R.] Univ Pittsburgh, Dept Pediat Dent, Pittsburgh, PA USA; [Deeley, Kathleen; Wang, Xiaojing; Cuenco, Karen; Menezes, Renato; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Cuenco, Karen; Vieira, Alexandre R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Vieira, Alexandre R.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15261 USA; [Duarte, Poliana M.; Faveri, Marcelo; Mendonca, Adriana C.] Univ Guarulhos, Dent Res Div, Dept Periodont, Sao Paulo, Brazil; [Marques, Marcelo R.] Univ Estadual Campinas, Dept Morphol, Div Histol, Sch Dent Piracicaba, Sao Paulo, Brazil; [Garlet, Gustavo P.] Univ Sao Paulo, Dept Biol Sci, FOB USP, Sch Dent Bauru, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Grande Rio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade Guarulhos; Universidade Estadual de Campinas; Universidade de Sao Paulo	Carvalho, FM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.	arv11@pitt.edu	de Carvalho, Flavia/AAF-3922-2019; Tinoco, Eduardo/B-5571-2014; Faveri, Marcelo MF/A-8915-2010; Tinoco, Eduardo/H-8000-2012; Marques, Marcelo Rocha/F-5318-2014; DE CARVALHO, FLAVIA MARTINEZ/H-6932-2012; Faveri, Marcelo/C-4738-2012; Garlet, Gustavo Pompermaier/E-6762-2012	Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Tinoco, Eduardo/0000-0003-4798-7175; Marques, Marcelo/0000-0001-9771-9844; Faveri, Marcelo/0000-0002-9830-1391	Coordenacao de Aperfeiacoamento de Pessoal de Nivel Superior [CAPES/BEX 094308-8]; National Institutes of Health [K99-DE018413]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE018413] Funding Source: NIH RePORTER	Coordenacao de Aperfeiacoamento de Pessoal de Nivel Superior; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Coordenacao de Aperfeiacoamento de Pessoal de Nivel Superior [CAPES/BEX 094308-8 to F. M. C.; http://www.capes.gov.br/]; and the National Institutes of Health [K99-DE018413 to R. M.; http://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Albandar JM, 1997, J PERIODONTOL, V68, P545, DOI 10.1902/jop.1997.68.6.545; Albandar JM, 2002, PERIODONTOL 2000, V29, P153, DOI 10.1034/j.1600-0757.2002.290108.x; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOUGHMAN JA, 1986, J CRAN GENET DEV BIO, V6, P341; Brett PM, 2005, J DENT RES, V84, P1149, DOI 10.1177/154405910508401211; Cardoso CR, 2009, ORAL MICROBIOL IMMUN, V24, P1, DOI 10.1111/j.1399-302X.2008.00463.x; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Conner Anthony J., 2008, New Zealand Natural Sciences, V33, P47; Covani U, 2008, J PERIODONTOL, V79, P1974, DOI [10.1902/jop.2008.080062, 10.1902/jop.2008.080062 ]; de Carvalho FM, 2009, J CLIN PERIODONTOL, V36, P468, DOI 10.1111/j.1600-051X.2009.01410.x; EASTCOTT JW, 1994, ORAL MICROBIOL IMMUN, V9, P284, DOI 10.1111/j.1399-302X.1994.tb00072.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garlet GP, 2004, J CLIN PERIODONTOL, V31, P671, DOI 10.1111/j.1600-051X.2004.00545.x; Gemmell E, 2002, CRIT REV ORAL BIOL M, V13, P17, DOI 10.1177/154411130201300104; Gonzales JR, 2010, MOL IMMUNOL, V47, P701, DOI 10.1016/j.molimm.2009.10.025; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Greenberg DA, 1996, GENET EPIDEMIOL, V13, P243; HART TC, 1993, HUM GENET, V91, P416; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2008, SINT IND SOC 2008; Jin QM, 2007, J PERIODONTOL, V78, P1300, DOI 10.1902/jop.2007.070073; Kawano H, 2004, MOL BRAIN RES, V125, P60, DOI 10.1016/j.molbrainres.2004.04.001; Kinane DF, 2005, PERIODONTOL 2000, V39, P91, DOI 10.1111/j.1600-0757.2005.00118.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li YF, 2004, HUM GENET, V114, P291, DOI 10.1007/s00439-003-1065-7; LOE H, 1991, J PERIODONTOL, V62, P608, DOI 10.1902/jop.1991.62.10.608; MARAZITA ML, 1994, J PERIODONTOL, V65, P623, DOI 10.1902/jop.1994.65.6.623; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meng HX, 2007, PERIODONTOL 2000, V43, P133, DOI 10.1111/j.1600-0757.2006.00204.x; Novak M J, 1996, Curr Opin Periodontol, V3, P45; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranade K, 2001, GENOME RES, V11, P1262; Repeke CE, 2009, J CLIN PERIODONTOL, V36, P726, DOI 10.1111/j.1600-051X.2009.01447.x; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Schaefer AS, 2010, HUM MOL GENET, V19, P553, DOI 10.1093/hmg/ddp508; Shorts-Cary L, 2007, ENDOCRINOLOGY, V148, P967, DOI 10.1210/en.2006-0905; Tinoco EMB, 1998, J CLIN PERIODONTOL, V25, P99, DOI 10.1111/j.1600-051X.1998.tb02415.x; Tinoco EMB, 1997, EUR J ORAL SCI, V105, P9, DOI 10.1111/j.1600-0722.1997.tb00174.x; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; VANDERVELDEN U, 1993, J CLIN PERIODONTOL, V20, P683; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Yu MJ, 2009, J BIOL CHEM, V284, P32968, DOI 10.1074/jbc.M109.001016	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10053	10.1371/journal.pone.0010053	http://dx.doi.org/10.1371/journal.pone.0010053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383335	Green Accepted, Green Published, gold			2022-12-25	WOS:000276454000013
J	Dietrich, MF; van der Weyden, L; Prosser, HM; Bradley, A; Herz, J; Adams, DJ				Dietrich, Martin F.; van der Weyden, Louise; Prosser, Haydn M.; Bradley, Allan; Herz, Joachim; Adams, David J.			Ectodomains of the LDL Receptor-Related Proteins LRP1b and LRP4 Have Anchorage Independent Functions In Vivo	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TYROSINE PHOSPHORYLATION; GROWTH; CANCER; GENE; MICE; EXPRESSION; REGIONS; DOMAIN; PDGF	Background: The low-density lipoprotein (LDL) receptor gene family is a highly conserved group of membrane receptors with diverse functions in developmental processes, lipoprotein trafficking, and cell signaling. The low-density lipoprotein (LDL) receptor-related protein 1b (LRP1B) was reported to be deleted in several types of human malignancies, including non-small cell lung cancer. Our group has previously reported that a distal extracellular truncation of murine Lrp1b that is predicted to secrete the entire intact extracellular domain (ECD) is fully viable with no apparent phenotype. Methods and Principal Findings: Here, we have used a gene targeting approach to create two mouse lines carrying internally rearranged exons of Lrp1b that are predicted to truncate the protein closer to the N-terminus and to prevent normal trafficking through the secretary pathway. Both mutations result in early embryonic lethality, but, as expected from the restricted expression pattern of LRP1b in vivo, loss of Lrp1b does not cause cellular lethality as homozygous Lrp1b-deficient blastocysts can be propagated normally in culture. This is similar to findings for another LDL receptor family member, Lrp4. We provide in vitro evidence that Lrp4 undergoes regulated intramembraneous processing through metalloproteases and gamma-secretase cleavage. We further demonstrate negative regulation of the Wnt signaling pathway by the soluble extracellular domain. Conclusions and Significance: Our results underline a crucial role for Lrp1b in development. The expression in mice of truncated alleles of Lrp1b and Lrp4 with deletions of the transmembrane and intracellular domains leads to release of the extracellular domain into the extracellular space, which is sufficient to confer viability. In contrast, null mutations are embryonically (Lrp1b) or perinatally (Lrp4) lethal. These findings suggest that the extracellular domains of both proteins may function as a scavenger for signaling ligands or signal modulators in the extracellular space, thereby preserving signaling thresholds that are critical for embryonic development, as well as for the clear, but poorly understood role of LRP1b in cancer.	[Dietrich, Martin F.; Herz, Joachim] UT Southwestern, Dept Mol Genet, Dallas, TX USA; [van der Weyden, Louise; Prosser, Haydn M.; Bradley, Allan; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; Wellcome Trust Sanger Institute	Dietrich, MF (corresponding author), UT Southwestern, Dept Mol Genet, Dallas, TX USA.	joachim.herz@utsouthwestern.edu; da1@sanger.ac.uk	van der Weyden, Louise/AAV-5711-2021	van der Weyden, Louise/0000-0002-0645-1879; Adams, David/0000-0001-9490-0306; Bradley, Allan/0000-0002-2349-8839	Kay Kendall Leukaemia Foundation; Cancer Research UK; Wellcome Trust; Boehringer Ingelheim; National Institutes of Health; Perot Family Foundation; American Health Assistance Foundation; Humboldt Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	Kay Kendall Leukaemia Foundation; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Boehringer Ingelheim(Boehringer Ingelheim); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; American Health Assistance Foundation; Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LvdW is supported by a fellowship from the Kay Kendall Leukaemia Foundation, and DJA is supported by Cancer Research UK and the Wellcome Trust. MFD is supported by a Boehringer Ingelheim Fellowship, and JH is supported by the National Institutes of Health, the Perot Family Foundation, the American Health Assistance Foundation and the Humboldt Foundation. HP and AB are supported by the Wellcome Trust. The funders have or had no influence on data collection and sharing, experimental planning, data interpretation, decision to publish or time of publication.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Cengiz B, 2007, ORAL ONCOL, V43, P241, DOI 10.1016/j.oraloncology.2006.03.004; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Croy JE, 2003, BIOCHEMISTRY-US, V42, P13049, DOI 10.1021/bi034752s; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Langbein S, 2002, LAB INVEST, V82, P639, DOI 10.1038/labinvest.3780458; Liu CX, 2007, J BIOL CHEM, V282, P7504, DOI 10.1074/jbc.M608088200; Liu CX, 2000, CANCER RES, V60, P1961; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Nakagawa T, 2006, CANCER SCI, V97, P1070, DOI 10.1111/j.1349-7006.2006.00283.x; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Pastrana DV, 2005, BBA-MOL BASIS DIS, V1741, P234, DOI 10.1016/j.bbadis.2005.06.007; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Tanaga K, 2004, ARTERIOSCL THROM VAS, V24, P1422, DOI 10.1161/01.ATV.0000133607.80554.09; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	27	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e9960	10.1371/journal.pone.0009960	http://dx.doi.org/10.1371/journal.pone.0009960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383322	Green Submitted, Green Published, gold			2022-12-25	WOS:000276454000002
J	Gal, R; Libersat, F				Gal, Ram; Libersat, Frederic			A Wasp Manipulates Neuronal Activity in the Sub-Esophageal Ganglion to Decrease the Drive for Walking in Its Cockroach Prey	PLOS ONE			English	Article							OCTOPAMINE-LIKE IMMUNOREACTIVITY; DROSOPHILA-MELANOGASTER; AMPULEX-COMPRESSA; LOCOMOTOR-ACTIVITY; CENTRAL COMPLEX; FRUIT-FLY; SUBESOPHAGEAL GANGLION; PERIPLANETA-AMERICANA; TRANSIENT PARALYSIS; MOTIVATED BEHAVIORS	Background: The parasitoid Jewel Wasp hunts cockroaches to serve as a live food supply for its offspring. The wasp stings the cockroach in the head and delivers a cocktail of neurotoxins directly inside the prey's cerebral ganglia. Although not paralyzed, the stung cockroach becomes a living yet docile 'zombie', incapable of self-initiating spontaneous or evoked walking. We show here that such neuro-chemical manipulation can be attributed to decreased neuronal activity in a small region of the cockroach cerebral nervous system, the sub-esophageal ganglion (SEG). A decrease in descending permissive inputs from this ganglion to thoracic central pattern generators decreases the propensity for walking-related behaviors. Methodology and Principal Findings: We have used behavioral, neuro-pharmacological and electrophysiological methods to show that: (1) Surgically removing the cockroach SEG prior to wasp stinging prolongs the duration of the sting 5-fold, suggesting that the wasp actively targets the SEG during the stinging sequence; (2) injecting a sodium channel blocker, procaine, into the SEG of non-stung cockroaches reversibly decreases spontaneous and evoked walking, suggesting that the SEG plays an important role in the up-regulation of locomotion; (3) artificial focal injection of crude milked venom into the SEG of non-stung cockroaches decreases spontaneous and evoked walking, as seen with naturally-stung cockroaches; and (4) spontaneous and evoked neuronal spiking activity in the SEG, recorded with an extracellular bipolar microelectrode, is markedly decreased in stung cockroaches versus non-stung controls. Conclusions and Significance: We have identified the neuronal substrate responsible for the venom-induced manipulation of the cockroach's drive for walking. Our data strongly support previous findings suggesting a critical and permissive role for the SEG in the regulation of locomotion in insects. By injecting a venom cocktail directly into the SEG, the parasitoid Jewel Wasp selectively manipulates the cockroach's motivation to initiate walking without interfering with other non-related behaviors.	[Gal, Ram; Libersat, Frederic] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Libersat, Frederic] Univ Aix Marseille 2, Inst Neurobiol Mediterranee, INSERM, U901, Marseille, France	Ben Gurion University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Gal, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	galra@bgu.ac.il; libersat@bgu.ac.il	LIBERSAT, FREDERIC/AAL-1437-2020	libersat, frederic/0000-0002-2379-6078	Israeli Science Foundation [848/07]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israeli Science Foundation (848/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER U, 1986, J COMP PHYSIOL A, V158, P345, DOI 10.1007/BF00603618; BLAGBURN JM, 1987, J COMP PHYSIOL A, V161, P215, DOI 10.1007/BF00615242; Braunig P, 2004, J COMP NEUROL, V478, P164, DOI 10.1002/cne.20287; BRAUNIG P, 1991, PHILOS T ROY SOC B, V332, P221, DOI 10.1098/rstb.1991.0051; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Cholewa J, 2009, ZOOLOGY, V112, P251, DOI 10.1016/j.zool.2008.10.004; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Crisp KM, 2006, J EXP BIOL, V209, P1746, DOI 10.1242/jeb.02204; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Delcomyn F, 1999, AUTON ROBOT, V7, P259, DOI 10.1023/A:1008928605612; Devaud JM, 2007, EUR J NEUROSCI, V26, P3193, DOI 10.1111/j.1460-9568.2007.05904.x; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Duch C, 1999, J COMP NEUROL, V403, P119, DOI 10.1002/(SICI)1096-9861(19990105)403:1<119::AID-CNE9>3.0.CO;2-F; ECKERT M, 1992, J COMP NEUROL, V322, P1, DOI 10.1002/cne.903220102; FOUAD K, 1994, ZOOL-ANAL COMPLEX SY, V98, P23; Fouad K, 1996, J COMP PHYSIOL A, V178, P91, DOI 10.1007/BF00189593; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gal R, 2005, ARCH INSECT BIOCHEM, V60, P198, DOI 10.1002/arch.20092; Gal R, 2008, CURR BIOL, V18, P877, DOI 10.1016/j.cub.2008.04.076; Gal R, 2006, J COMP PHYSIOL A, V192, P1003, DOI 10.1007/s00359-006-0135-4; GRAHAM D, 1979, BIOL CYBERN, V32, P147, DOI 10.1007/BF00337391; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Haspel G, 2005, J COMP PHYSIOL A, V191, P529, DOI 10.1007/s00359-005-0620-1; Haspel G, 2003, J NEUROBIOL, V56, P287, DOI 10.1002/neu.10238; Haspel G, 2003, J NEUROBIOL, V54, P628, DOI 10.1002/neu.10195; HUBER F, 1960, Z VERGL PHYSIOL, V44, P60, DOI 10.1007/BF00297863; Huber R, 2005, J COMP PHYSIOL A, V191, P231, DOI 10.1007/s00359-004-0585-5; Keasar T, 2006, ETHOLOGY, V112, P699, DOI 10.1111/j.1439-0310.2006.01214.x; KIEN J, 1992, COMP BIOCHEM PHYS A, V103, P15, DOI 10.1016/0300-9629(92)90236-J; Kien J., 1992, PERGAMON STUDIES NEU, V4, P147; Libersat F, 2003, J COMP PHYSIOL A, V189, P497, DOI 10.1007/s00359-003-0432-0; LIBERSAT F, 1994, J EXP BIOL, V197, P405; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Martin JR, 1998, LEARN MEMORY, V5, P179; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Moore EL, 2006, J NEUROBIOL, V66, P811, DOI 10.1002/neu.20254; Muller D, 2003, BRAIN RES, V977, P124, DOI 10.1016/S0006-8993(03)02760-4; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; PEARSON KG, 1973, J EXP BIOL, V58, P725; Pielage J, 2002, DEV BIOL, V249, P283, DOI 10.1006/dbio.2002.0770; Ridgel AL, 2005, J COMP PHYSIOL A, V191, P559, DOI 10.1007/s00359-005-0621-0; Ridgel AL, 2007, J COMP PHYSIOL A, V193, P385, DOI 10.1007/s00359-006-0193-7; Ritzmann RE, 2005, J COMP PHYSIOL A, V191, P253, DOI 10.1007/s00359-004-0537-0; Roeder KD, 1937, J EXP ZOOL, V76, P353, DOI 10.1002/jez.1400760302; Rosenberg LA, 2007, J EXP BIOL, V210, P4411, DOI 10.1242/jeb.010488; Schaefer PL, 2001, J NEUROBIOL, V49, P9, DOI 10.1002/neu.1062; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; WATSON JT, 1994, ANIM BEHAV, V48, P476, DOI 10.1006/anbe.1994.1263; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001	60	30	30	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10019	10.1371/journal.pone.0010019	http://dx.doi.org/10.1371/journal.pone.0010019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383324	Green Published, gold			2022-12-25	WOS:000276454000004
J	Chiliveru, S; Birkelund, S; Paludan, SR				Chiliveru, Srikanth; Birkelund, Svend; Paludan, Soren R.			Induction of Interferon-Stimulated Genes by Chlamydia pneumoniae in Fibroblasts Is Mediated by Intracellular Nucleotide-Sensing Receptors	PLOS ONE			English	Article							DENDRITIC CELLS; I IFNS; TRACHOMATIS SEROVAR-L2; RIG-I; INFECTION; RECOGNITION; ACTIVATION; PATHOGEN; PATHWAY; SUSCEPTIBILITY	Background: Recognition of microorganisms by the innate immune system is mediated by pattern recognition receptors, including Toll-like receptors and cytoplasmic RIG-I-like receptors. Chlamydia, which include several human pathogenic species, are obligate intracellular gram-negative bacteria that replicate in cytoplasmic vacuoles. The infection triggers a host response contributing to both bacterial clearance and tissue damage. For instance, type I interferons (IFN)s have been demonstrated to exacerbate the course of Chlamydial lung infections in mice. Methods/Principal Findings: Here we show that Chlamydia pneumoniae induces expression of IFN-stimulated genes (ISG)s dependent on recognition by nucleotide-sensing Toll-like receptors and RIG-I-like receptors, localized in endosomes and the cytoplasm, respectively. The ISG response was induced with a delayed kinetics, compared to virus infections, and was dependent on bacterial replication and the bacterial type III secretion system (T3SS). Conclusions/Significance: Activation of the IFN response during C. pneumoniae infection is mediated by intracellular nucleotide-sensing PRRs, which operate through a mechanism dependent on the bacterial T3SS. Strategies to inhibit the chlamydial T3SS may be used to limit the detrimental effects of the type I IFN system in the host response to Chlamydia infection.	[Chiliveru, Srikanth; Birkelund, Svend; Paludan, Soren R.] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark	Aarhus University	Chiliveru, S (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	srp@microbiology.au.dk		Birkelund, Svend/0000-0001-6171-5606	Danish Medical Research Council [271-05-0488, 09-072636]; Lundbeck Foundation [R17-A1526, R19-A2023]; Kathrine og Vigo Skovgards Fond; Aase and Ejnar Danielsens Fond; Aarhus University Research Foundation; Lundbeck Foundation [R17-2007-1526] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Kathrine og Vigo Skovgards Fond; Aase and Ejnar Danielsens Fond; Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Danish Medical Research Council Grant nos. 271-05-0488 and 09-072636, the Lundbeck Foundation (Grants no. R17-A1526 and R19-A2023), the Kathrine og Vigo Skovgards Fond, the Aase and Ejnar Danielsens Fond, and The Aarhus University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; BIRKELUND S, 1992, J BACTERIOL, V174, P2742, DOI 10.1128/JB.174.9.2742-2747.1992; BIRKELUND S, 1989, INFECT IMMUN, V57, P2683, DOI 10.1128/IAI.57.9.2683-2690.1989; BIRKELUND S, 1989, INFECT IMMUN, V57, P3250, DOI 10.1128/IAI.57.10.3250-3253.1989; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Derbigny WA, 2007, INFECT IMMUN, V75, P1280, DOI 10.1128/IAI.01525-06; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hvid M, 2007, CELL MICROBIOL, V9, P2795, DOI 10.1111/j.1462-5822.2007.00996.x; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Prantner D, 2009, INFECT IMMUN, V77, P76, DOI 10.1128/IAI.00963-08; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Slepenkin A, 2003, INFECT IMMUN, V71, P2555, DOI 10.1128/IAI.71.5.2555-2562.2003; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	37	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10005	10.1371/journal.pone.0010005	http://dx.doi.org/10.1371/journal.pone.0010005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386592	Green Published, gold, Green Submitted			2022-12-25	WOS:000276420400004
J	Gil, O; Diaz, I; Vilaplana, C; Tapia, G; Diaz, J; Fort, M; Caceres, N; Pinto, S; Cayla, J; Corner, L; Domingo, M; Cardona, PJ				Gil, Olga; Diaz, Ivan; Vilaplana, Cristina; Tapia, Gustavo; Diaz, Jorge; Fort, Maria; Caceres, Neus; Pinto, Sergio; Cayla, Joan; Corner, Leigh; Domingo, Mariano; Cardona, Pere-Joan			Granuloma Encapsulation Is a Key Factor for Containing Tuberculosis Infection in Minipigs	PLOS ONE			English	Article							MOUSE PERITONEAL-MACROPHAGES; MYCOBACTERIUM-TUBERCULOSIS; TUBERCLE-BACILLI; GUINEA-PIGS; MICE; AEROSOL; MODEL; LUNG; CELL; MYOFIBROBLAST	A transthoracic infection involving a low dose of Mycobacterium tuberculosis has been used to establish a new model of infection in minipigs. The 20-week monitoring period showed a marked Th1 response and poor humoral response for the whole infection. A detailed histopathological analysis was performed after slicing the formalin-fixed whole lungs of each animal. All lesions were recorded and classified according to their microscopic aspect, their relationship with the intralobular connective network and their degree of maturity in order to obtain a dissemination ratio (DR) between recent and old lesions. CFU counts and evolution of the DR with time showed that the proposed model correlated with a contained infection, decreasing from week 9 onwards. These findings suggest that the infection induces an initial Th1 response, which is followed by local fibrosis and encapsulation of the granulomas, thereby decreasing the onset of new lesions. Two therapeutic strategies were applied in order to understand how they could influence the model. Thus, chemotherapy with isoniazid alone helped to decrease the total number of lesions, despite the increase in DR after week 9, with similar kinetics to those of the control group, whereas addition of a therapeutic M. tuberculosis fragment-based vaccine after chemotherapy increased the Th1 and humoral responses, as well as the number of lesions, but decreased the DR. By providing a local pulmonary structure similar to that in humans, the mini-pig model highlights new aspects that could be key to a better understanding tuberculosis infection control in humans.	[Gil, Olga; Vilaplana, Cristina; Diaz, Jorge; Caceres, Neus; Pinto, Sergio; Cardona, Pere-Joan] Univ Autonoma Barcelona, UTE, Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Catalonia, Spain; [Gil, Olga; Vilaplana, Cristina; Diaz, Jorge; Caceres, Neus; Pinto, Sergio; Cardona, Pere-Joan] Inst Carlos III, CIBER Enfermedades Resp, Palma de Mallorca, Spain; [Diaz, Ivan; Fort, Maria; Domingo, Mariano] UAB IRTA, CReSA, Bellaterra, Catalonia, Spain; [Tapia, Gustavo] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Badalona, Catalonia, Spain; [Cayla, Joan] Agencia Salut Publ, Serv Epidemiol, TB Invest Unit Barcelona, Barcelona, Catalonia, Spain; [Corner, Leigh] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; IRTA; Hospital Germans Trias i Pujol; Public Health Agency of Barcelona; University College Dublin	Gil, O (corresponding author), Univ Autonoma Barcelona, UTE, Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Catalonia, Spain.	pjcardona.igtp.germanstrias@gencat.cat	Domingo, Mariano/A-1015-2009; Tapia, Gustavo/M-9938-2017; Vilaplana, Cristina/K-7216-2012; Cardona, Pere-Joan/A-5258-2011; luque, ivan diaz/I-2654-2015; diaz, ivan/C-7043-2008	Domingo, Mariano/0000-0002-9623-4826; Vilaplana, Cristina/0000-0002-2808-7270; Cardona, Pere-Joan/0000-0001-5623-7873; luque, ivan diaz/0000-0002-8090-1073; diaz, ivan/0000-0002-8090-1073; Cayla, Joan A./0000-0003-3891-111X; Tapia Melendo, Gustavo/0000-0003-1882-0368	Spanish Ministry of Health [FIS PI080785, CM06/00123]; Spanish Ministry of Science and Innovation [BIO2005-07949-C02-02]; Bill and Melinda Gates Foundation [GC12]; European Community [FP7/2007-2013, 200999]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Community(European Commission)	Archivel Farma S.L. supported the study by providing the vaccine RUTI (R). The Spanish Ministry of Health (FIS PI080785; National Plan I+D+I FIS CM06/00123); the Spanish Ministry of Science and Innovation (BIO2005-07949-C02-02; CIBER Enfermedades Respiratorias, programa CRP-TB); the Bill and Melinda Gates Foundation (Grand Challenges GC12) and the European Community's 7th Framework Programme (FP7/2007-2013: STOPLATENT-TB project under grant agreement 200999) collaborated in funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2006, INFECT IMMUN, V74, P5397, DOI 10.1128/IAI.00332-06; Bezuidenhout J., 2009, TUBERCULOSIS COMPREH, P117; Bolin CA, 1997, J INFECT DIS, V176, P1559, DOI 10.1086/514155; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Buddle BM, 2005, TUBERCULOSIS, V85, P19, DOI 10.1016/j.tube.2004.09.003; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Canetti G., 1955, TUBERCLE BACILLUS PU; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2000, SCAND J IMMUNOL, V52, P156, DOI 10.1046/j.1365-3083.2000.00763.x; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Cardona PJ, 2002, SCAND J IMMUNOL, V55, P639, DOI 10.1046/j.1365-3083.2002.01088.x; Corner LAL, 2007, RES VET SCI, V83, P53, DOI 10.1016/j.rvsc.2006.10.016; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Diaz I, 2005, VET IMMUNOL IMMUNOP, V106, P107, DOI 10.1016/j.vetimm.2005.01.005; Domingo M, 2009, SCAND J IMMUNOL, V69, P500, DOI 10.1111/j.1365-3083.2009.02251.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fraser R. S., 2005, PHYSL BASIS RESP DIS; Fujita J, 2002, MICROBIOL IMMUNOL, V46, P67, DOI 10.1111/j.1348-0421.2002.tb02660.x; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guirado E, 2008, CLIN VACCINE IMMUNOL, V15, P1229, DOI 10.1128/CVI.00094-08; Guirado E, 2006, MICROBES INFECT, V8, P1252, DOI 10.1016/j.micinf.2005.12.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsu HHT, 2004, BBA-MOL BASIS DIS, V1690, P118, DOI 10.1016/j.bbadis.2004.06.001; Huitema LFA, 2007, FRONT BIOSCI-LANDMRK, V12, P2631, DOI 10.2741/2260; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; KIERNAN JA, 2008, HISTOLOGICAL HISTOCH, V16; Krasnow I, 1966, Tech Bull Regist Med Technol, V36, P34; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lenzi HL, 1999, BRAZ J MED BIOL RES, V32, P639, DOI 10.1590/S0100-879X1999000500018; LURIE MB, 1952, J EXP MED, V95, P119, DOI 10.1084/jem.95.2.119; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Mullarky IK, 2006, INFECT IMMUN, V74, P1181, DOI 10.1128/IAI.74.2.1181-1188.2006; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; NISHIKAWA K, 1993, BIOCHIM BIOPHYS ACTA, V1169, P257; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Orme IM, 2005, TUBERCULOSIS, V85, P13, DOI 10.1016/j.tube.2004.08.001; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; PLOPPER CG, 2005, LAB PRIMATE, V30, P503; POTTENGER FM, 1934, TUBERCULOSIS CHILD A; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; Thoen C., 1995, MYCOBACTERIUM BOVIS; Thoen Charles O., 1994, P157; Torday JS, 2007, AM J PHYSIOL-LUNG C, V292, pL608, DOI 10.1152/ajplung.00379.2006; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; WALLACE JG, 1961, AM REV RESPIR DIS, V83, P866; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; World Health Organization, 2009, GLOB TUB CONTR EP ST; WRIGHT AE, 1906, P ROY SOC LOND B BIO, P194	62	70	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10030	10.1371/journal.pone.0010030	http://dx.doi.org/10.1371/journal.pone.0010030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386605	Green Published, Green Submitted, gold			2022-12-25	WOS:000276420400008
J	Schmidberger, JW; Bate, MA; Reboul, CF; Androulakis, SG; Phan, JMN; Whisstock, JC; Goscinski, WJ; Abramson, D; Buckle, AM				Schmidberger, Jason W.; Bate, Mark A.; Reboul, Cyril F.; Androulakis, Steve G.; Phan, Jennifer M. N.; Whisstock, James C.; Goscinski, Wojtek J.; Abramson, David; Buckle, Ashley M.			MrGrid: A Portable Grid Based Molecular Replacement Pipeline	PLOS ONE			English	Article							PROTEIN; DATABASE	Background: The crystallographic determination of protein structures can be computationally demanding and for difficult cases can benefit from user-friendly interfaces to high-performance computing resources. Molecular replacement (MR) is a popular protein crystallographic technique that exploits the structural similarity between proteins that share some sequence similarity. But the need to trial permutations of search models, space group symmetries and other parameters makes MR time-and labour-intensive. However, MR calculations are embarrassingly parallel and thus ideally suited to distributed computing. In order to address this problem we have developed MrGrid, web-based software that allows multiple MR calculations to be executed across a grid of networked computers, allowing high-throughput MR. Methodology/Principal Findings: MrGrid is a portable web based application written in Java/JSP and Ruby, and taking advantage of Apple Xgrid technology. Designed to interface with a user defined Xgrid resource the package manages the distribution of multiple MR runs to the available nodes on the Xgrid. We evaluated MrGrid using 10 different protein test cases on a network of 13 computers, and achieved an average speed up factor of 5.69. Conclusions: MrGrid enables the user to retrieve and manage the results of tens to hundreds of MR calculations quickly and via a single web interface, as well as broadening the range of strategies that can be attempted. This high-throughput approach allows parameter sweeps to be performed in parallel, improving the chances of MR success.	[Schmidberger, Jason W.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Bate, Mark A.; Reboul, Cyril F.; Androulakis, Steve G.; Phan, Jennifer M. N.; Whisstock, James C.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Reboul, Cyril F.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Androulakis, Steve G.; Goscinski, Wojtek J.; Abramson, David] Monash Univ, Monash eRes Ctr, Clayton, Vic 3800, Australia; [Abramson, David] Monash Univ, Clayton Sch Informat Technol, Clayton, Vic 3800, Australia	Karolinska Institutet; Monash University; Monash University; Monash University; Monash University	Schmidberger, JW (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	ashley.buckle@med.monash.edu.au	Schmidberger, Jason/D-5978-2015; Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Whisstock, James/0000-0003-4200-5611; Reboul, Cyril/0000-0002-6258-2697; Goscinski, Wojtek James/0000-0001-6587-1016; Abramson, David/0000-0003-0441-4596	National Health & Medical Research Council; Australian Research Council; Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; state government of Victoria (Australia)	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; state government of Victoria (Australia)	The authors thank the National Health & Medical Research Council, Australian Research Council, Victorian Partnership for Advanced Computing, the Victorian Bioinformatics Consortium, Monash eResearch Centre, and the state government of Victoria (Australia) for funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Ito K, 2006, PROTEIN SCI, V15, P1187, DOI 10.1110/ps.062148506; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159	9	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10049	10.1371/journal.pone.0010049	http://dx.doi.org/10.1371/journal.pone.0010049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386612	gold, Green Submitted, Green Published			2022-12-25	WOS:000276420400018
J	Chou, KC; Shen, HB				Chou, Kuo-Chen; Shen, Hong-Bin			A New Method for Predicting the Subcellular Localization of Eukaryotic Proteins with Both Single and Multiple Sites: Euk-mPLoc 2.0	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; LOCATION PREDICTION; APOPTOSIS PROTEINS; GENE ONTOLOGY; DOMAIN; DATABASE; BIOINFORMATICS; CLASSIFICATION; DISCRIMINANT	Information of subcellular locations of proteins is important for in-depth studies of cell biology. It is very useful for proteomics, system biology and drug development as well. However, most existing methods for predicting protein subcellular location can only cover 5 to 12 location sites. Also, they are limited to deal with single-location proteins and hence failed to work for multiplex proteins, which can simultaneously exist at, or move between, two or more location sites. Actually, multiplex proteins of this kind usually posses some important biological functions worthy of our special notice. A new predictor called "Euk-mPLoc 2.0'' is developed by hybridizing the gene ontology information, functional domain information, and sequential evolutionary information through three different modes of pseudo amino acid composition. It can be used to identify eukaryotic proteins among the following 22 locations: (1) acrosome, (2) cell wall, (3) centriole, (4) chloroplast, (5) cyanelle, (6) cytoplasm, (7) cytoskeleton, (8) endoplasmic reticulum, (9) endosome, (10) extracell, (11) Golgi apparatus, (12) hydrogenosome, (13) lysosome, (14) melanosome, (15) microsome (16) mitochondria, (17) nucleus, (18) peroxisome, (19) plasma membrane, (20) plastid, (21) spindle pole body, and (22) vacuole. Compared with the existing methods for predicting eukaryotic protein subcellular localization, the new predictor is much more powerful and flexible, particularly in dealing with proteins with multiple locations and proteins without available accession numbers. For a newly-constructed stringent benchmark dataset which contains both single- and multiple-location proteins and in which none of proteins has >= 25% pairwise sequence identity to any other in a same location, the overall jackknife success rate achieved by Euk-mPLoc 2.0 is more than 24% higher than those by any of the existing predictors. As a user-friendly web-server, Euk-mPLoc 2.0 is freely accessible at http://www.csbio.sjtu.edu.cn/bioinf/euk-multi-2/. For a query protein sequence of 400 amino acids, it will take about 15 seconds for the web-server to yield the predicted result; the longer the sequence is, the more time it may usually need. It is anticipated that the novel approach and the powerful predictor as presented in this paper will have a significant impact to Molecular Cell Biology, System Biology, Proteomics, Bioinformatics, and Drug Development.	[Chou, Kuo-Chen; Shen, Hong-Bin] Gordon Life Sci Inst, San Diego, CA USA; [Chou, Kuo-Chen; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chou, KC (corresponding author), Gordon Life Sci Inst, San Diego, CA USA.	kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60704047]; Science and Technology Commission of Shanghai Municipality [08ZR1410600, 08JC1410600]; Shanghai Municipal Education Commission [10ZZ17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the National Natural Science Foundation of China (Grant No. 60704047), Science and Technology Commission of Shanghai Municipality (Grant No. 08ZR1410600, 08JC1410600), sponsored by Shanghai Pujiang Program and Innovation Program of Shanghai Municipal Education Commission (10ZZ17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gerstein M, 2003, CURR OPIN STRUC BIOL, V13, P341, DOI 10.1016/S0959-440X(03)00080-0; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771; Gonzalez-Diaz H, 2009, CURR PROTEOMICS, V6, P214, DOI 10.2174/157016409789973789; Gonzalez-Diaz H, 2008, CURR TOP MED CHEM, V8, P1676, DOI 10.2174/156802608786786543; Jahandideh S, 2007, J THEOR BIOL, V249, P785, DOI 10.1016/j.jtbi.2007.09.002; Jahandideh S, 2007, BIOPHYS CHEM, V128, P87, DOI 10.1016/j.bpc.2007.03.006; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; JIANG Y, 2008, J COMPUT CHEM; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Murvai J, 2001, NUCLEIC ACIDS RES, V29, P58, DOI 10.1093/nar/29.1.58; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Nanni L, 2009, PROTEIN PEPTIDE LETT, V16, P163, DOI 10.2174/092986609787316199; Perez-Montoto LG, 2009, CURR PROTEOMICS, V6, P246, DOI 10.2174/157016409789973761; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SMITH C, 2008, SUBCELLULAR TARGETIN; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vilar S, 2009, J THEOR BIOL, V261, P449, DOI 10.1016/j.jtbi.2009.07.031; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	68	300	310	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9931	10.1371/journal.pone.0009931	http://dx.doi.org/10.1371/journal.pone.0009931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368981	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200009
J	Pachulec, E; van der Does, C				Pachulec, Emilia; van der Does, Chris			Conjugative Plasmids of Neisseria gonorrhoeae	PLOS ONE			English	Article							TETRACYCLINE-RESISTANCE PLASMID; BETA-LACTAMASE PLASMID; TOXIN-ANTITOXIN SYSTEM; MOLECULAR EPIDEMIOLOGY; DEOXYRIBONUCLEIC-ACID; GENETIC ORGANIZATION; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; RHODOCOCCUS-EQUI; TETM GENES	Many clinical isolates of the human pathogen Neisseria gonorrhoeae contain conjugative plasmids. The host range of these plasmids is limited to Neisseria species, but presence of a tetracycline (tetM) determinant inserted in several of these plasmids is an important cause of the rapid spread of tetracycline resistance. Previously plasmids with different backbones (Dutch and American type backbones) and with and without different tetM determinants (Dutch and American type tetM determinants) have been identified. Within the isolates tested, all plasmids with American or Dutch type tetM determinants contained a Dutch type plasmid backbone. This demonstrated that tetM determinants should not be used to differentiate between conjugal plasmid backbones. The nucleotide sequences of conjugative plasmids with Dutch type plasmid backbones either not containing the tetM determinant (pEP5233) or containing Dutch (pEP5289) or American (pEP5050) type tetM determinants were determined. Analysis of the backbone sequences showed that they belong to a novel IncP1 subfamily divergent from the IncP1 alpha, beta, gamma, delta and epsilon subfamilies. The tetM determinants were inserted in a genetic load region found in all these plasmids. Insertion was accompanied by the insertion of a gene with an unknown function, and rearrangement of a toxin/antitoxin gene cluster. The genetic load region contains two toxin/antitoxins of the Zeta/Epsilon toxin/antitoxin family previously only found in Gram positive organisms and the virulence associated protein D of the VapD/VapX toxin/antitoxin family. Remarkably, presence of VapX of pJD1, a small cryptic neisserial plasmid, in the acceptor strain strongly increased the conjugation efficiency, suggesting that it functions as an antitoxin for the conjugative plasmid. The presence of the toxin and antitoxin on different plasmids might explain why the host range of this IncP1 plasmid is limited to Neisseria species. The isolated plasmids conjugated efficiently between N. gonorrhoeae strains, but did not enhance transfer of a genetic marker.	[Pachulec, Emilia; van der Does, Chris] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands; [Pachulec, Emilia; van der Does, Chris] Univ Groningen, Zernike Inst Adv Mat, Haren, Netherlands; [van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	University of Groningen; University of Groningen; Max Planck Society	Pachulec, E (corresponding author), Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Kerklaan 30, NL-9751 NN Haren, Netherlands.	does@mpi-marburg.mpg.de	Institute, Zernike/W-7033-2019					ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Benoit S, 2001, RES MICROBIOL, V152, P439, DOI 10.1016/S0923-2508(01)01217-7; BURDETT V, 1982, J BACTERIOL, V149, P995, DOI 10.1128/JB.149.3.995-1004.1982; Catani CF, 2004, PROTEIN EXPRES PURIF, V37, P320, DOI 10.1016/j.pep.2004.07.002; Chalkley LJ, 1997, J ANTIMICROB CHEMOTH, V40, P817, DOI 10.1093/jac/40.6.817; Daines DA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-30; EISENSTEIN BI, 1977, SCIENCE, V195, P998, DOI 10.1126/science.402693; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FLETCHER HM, 1989, J GEN MICROBIOL, V135, P3067; FLETT F, 1981, J GEN MICROBIOL, V125, P123; GALLI DM, 1994, PLASMID, V31, P148, DOI 10.1006/plas.1994.1016; GASCOYNE DM, 1990, J ANTIMICROB CHEMOTH, V25, P39, DOI 10.1093/jac/25.1.39; GASCOYNE DM, 1991, J ANTIMICROB CHEMOTH, V28, P173, DOI 10.1093/jac/28.2.173; GASCOYNEBINZI DM, 1993, J ANTIMICROB CHEMOTH, V32, P667, DOI 10.1093/jac/32.5.667; GASCOYNEBINZI DM, 1994, J ANTIMICROB CHEMOTH, V33, P1011, DOI 10.1093/jac/33.5.1011; GENCO CA, 1984, J INFECT DIS, V150, P397, DOI 10.1093/infdis/150.3.397; Gharizadeh B, 2005, INT J ANTIMICROB AG, V26, P486, DOI 10.1016/j.ijantimicag.2005.08.017; Giebelhaus LA, 1996, J BACTERIOL, V178, P6378, DOI 10.1128/jb.178.21.6378-6381.1996; GUINEY DG, 1983, P NATL ACAD SCI-BIOL, V80, P3595, DOI 10.1073/pnas.80.12.3595; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; ISON CA, 1993, SEX TRANSM DIS, V20, P329, DOI 10.1097/00007435-199320060-00005; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P369, DOI 10.1128/CVI.00448-06; JOHNSON SR, 1991, J ANTIMICROB CHEMOTH, V27, P864, DOI 10.1093/jac/27.6.864; KATZ ME, 1994, J BACTERIOL, V176, P2663, DOI 10.1128/JB.176.9.2663-2669.1994; KATZ ME, 1992, INFECT IMMUN, V60, P4586, DOI 10.1128/IAI.60.11.4586-4592.1992; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; KNAPP JS, 1987, J INFECT DIS, V155, P819, DOI 10.1093/infdis/155.4.819; KNAPP JS, 1988, ANTIMICROB AGENTS CH, V32, P765, DOI 10.1128/AAC.32.5.765; Kolader ME, 2006, J CLIN MICROBIOL, V44, P2689, DOI 10.1128/JCM.02311-05; KORCH C, 1985, J BACTERIOL, V163, P430, DOI 10.1128/JB.163.2.430-438.1985; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Marques MV, 2001, PLASMID, V45, P184, DOI 10.1006/plas.2000.1514; Marquez C, 1999, SEX TRANSM DIS, V26, P157, DOI 10.1097/00007435-199903000-00006; MAYER LW, 1974, INFECT IMMUN, V10, P712, DOI 10.1128/IAI.10.4.712-717.1974; MCGEE ZA, 1981, J INFECT DIS, V143, P413, DOI 10.1093/infdis/143.3.413; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; MORSE SA, 1986, ANTIMICROB AGENTS CH, V30, P664, DOI 10.1128/AAC.30.5.664; ROBERTS M, 1979, J GEN MICROBIOL, V114, P491, DOI 10.1099/00221287-114-2-491; ROBERTS MC, 1986, ANTIMICROB AGENTS CH, V30, P810, DOI 10.1128/AAC.30.5.810; ROBERTS MC, 1986, PEDIATR INFECT DIS J, V5, pS338, DOI 10.1097/00006454-198611010-00032; ROBERTS MC, 1985, ANTIMICROB AGENTS CH, V28, P141, DOI 10.1128/AAC.28.1.141; ROBERTS MC, 1988, ANTIMICROB AGENTS CH, V32, P488, DOI 10.1128/AAC.32.4.488; Rodriguez-Bonano NM, 2004, PLASMID, V52, P89, DOI 10.1016/j.plasmid.2004.05.002; Scharbaai-Vazquez R, 2007, PLASMID, V57, P156, DOI 10.1016/j.plasmid.2006.07.006; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STIFFLER PW, 1975, J BACTERIOL, V122, P1293, DOI 10.1128/JB.122.3.1293-1300.1975; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; SWARTLEY JS, 1993, MOL MICROBIOL, V10, P299, DOI 10.1111/j.1365-2958.1993.tb01956.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner A, 1999, SEX TRANSM INFECT, V75, P60, DOI 10.1136/sti.75.1.60; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Weng SC, 1999, FEMS MICROBIOL LETT, V179, P11, DOI 10.1111/j.1574-6968.1999.tb08701.x; XIA MS, 1995, MOL CELL PROBE, V9, P327, DOI 10.1016/S0890-8508(95)91620-2; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	63	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9962	10.1371/journal.pone.0009962	http://dx.doi.org/10.1371/journal.pone.0009962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376355	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200036
J	Buron, N; Porceddu, M; Brabant, M; Desgue, D; Racoeur, C; Lassalle, M; Pechoux, C; Rustin, P; Jacotot, E; Borgne-Sanchez, A				Buron, Nelly; Porceddu, Mathieu; Brabant, Magali; Desgue, Diana; Racoeur, Cindy; Lassalle, Myriam; Pechoux, Christine; Rustin, Pierre; Jacotot, Etienne; Borgne-Sanchez, Annie			Use of Human Cancer Cell Lines Mitochondria to Explore the Mechanisms of BH3 Peptides and ABT-737-Induced Mitochondrial Membrane Permeabilization	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY PROTEINS; MIMETIC ABT-737; OUTER-MEMBRANE; CASPASE ACTIVATION; BAX; APOPTOSIS; DEATH; INHIBITORS; DOMAINS	Current limitations of chemotherapy include toxicity on healthy tissues and multidrug resistance of malignant cells. A number of recent anti-cancer strategies aim at targeting the mitochondrial apoptotic machinery to induce tumor cell death. In this study, we set up protocols to purify functional mitochondria from various human cell lines to analyze the effect of peptidic and xenobiotic compounds described to harbour either Bcl-2 inhibition properties or toxic effects related to mitochondria. Mitochondrial inner and outer membrane permeabilization were systematically investigated in cancer cell mitochondria versus non-cancerous mitochondria. The truncated (t-) Bid protein, synthetic BH3 peptides from Bim and Bak, and the small molecule ABT-737 induced a tumor-specific and OMP-restricted mitochondrio-toxicity, while compounds like HA-14.1, YC-137, Chelerythrine, Gossypol, TW-37 or EM20-25 did not. We found that ABT-737 can induce the Bax-dependent release of apoptotic proteins (cytochrome c, Smac/Diablo and Omi/HtrA2 but not AIF) from various but not all cancer cell mitochondria. Furthermore, ABT-737 addition to isolated cancer cell mitochondria induced oligomerization of Bax and/or Bak monomers already inserted in the mitochondrial membrane. Finally immunoprecipatations indicated that ABT-737 induces Bax, Bak and Bim desequestration from Bcl-2 and Bcl-xL but not from Mcl-1L. This study investigates for the first time the mechanism of action of ABT-737 as a single agent on isolated cancer cell mitochondria. Hence, this method based on MOMP (mitochondrial outer membrane permeabilization) is an interesting screening tool, tailored for identifying Bcl-2 antagonists with selective toxicity profile against cancer cell mitochondria but devoid of toxicity against healthy mitochondria.	[Buron, Nelly; Porceddu, Mathieu; Brabant, Magali; Desgue, Diana; Racoeur, Cindy; Lassalle, Myriam; Jacotot, Etienne; Borgne-Sanchez, Annie] THERAPTOSIS SA, Dept Oncol, Romainville, France; [Buron, Nelly; Porceddu, Mathieu; Borgne-Sanchez, Annie] MITOLOGICS SAS, Mitol Res Lab, Hop Robert Debre, Paris, France; [Pechoux, Christine] INRA, Plateau Microscopie Elect MIMA2, UR Genom & Physiol Lactat 1196, Jouy En Josas, France; [Rustin, Pierre] Hop Robert Debre, Inserm U676, F-75019 Paris, France; [Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, Paris, France; [Jacotot, Etienne] Univ London Imperial Coll Sci Technol & Med, Canc Div, Dept Reprod Biol, Hammersmith Hosp, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Imperial College London	Buron, N (corresponding author), THERAPTOSIS SA, Dept Oncol, Biocitech Technol Pk, Romainville, France.	aborgne.sanchez@mitologics.com		/0000-0002-5301-1569	Agence Nationale pour la Valorisation de la Recherche; Theraptosis SA; Mitologics SAS	Agence Nationale pour la Valorisation de la Recherche; Theraptosis SA; Mitologics SAS	This study was supported by Agence Nationale pour la Valorisation de la Recherche (http://www.agence-nationale-recherche.fr) to Theraptosis SA (http://www.theraptosis.com), by Theraptosis SA and Mitologics SAS (http://www.mitologics.com). The Agence Nationale pour la Valorisation de la Recherche had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; AOUACHERIA A, 2007, GENE SEQUENCES, V1, P43; Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bombrun A, 2003, J MED CHEM, V46, P4365, DOI 10.1021/jm034107j; BRENNER D, 2009, CURR OPIN CELL BIOL; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cartron PF, 2008, FEBS LETT, V582, P3045, DOI 10.1016/j.febslet.2008.07.047; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; CHEN S, 2009, MOL CELL BIOL; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Fu GF, 2005, CANCER BIOL THER, V4, P822, DOI 10.4161/cbt.4.8.1889; GALLUZZI L, 2009, MOL ASPECTS MED; Goldsmith KC, 2006, ONCOGENE, V25, P4525, DOI 10.1038/sj.onc.1209489; GOLDSMITH KC, 2009, CELL DEATH DIFFER; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hermanson D, 2009, MOL PHARMACOL, V76, P667, DOI 10.1124/mol.109.055830; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Kim H, 2002, BIOCHEM J, V365, P765, DOI 10.1042/BJ20011848; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lecoeur H, 2004, EXP CELL RES, V294, P106, DOI 10.1016/j.yexcr.2003.10.030; Letai A, 2005, J CLIN INVEST, V115, P2648, DOI 10.1172/JCI26250; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai A, 2006, CANCER CELL, V10, P343, DOI 10.1016/j.ccr.2006.10.014; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; Polster BM, 2003, J NEUROSCI, V23, P2735; Polster BM, 2001, J BIOL CHEM, V276, P37887; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willison HJ, 2005, NAT CLIN PRACT NEURO, V1, P2, DOI 10.1038/ncpneuro0001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	49	40	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9924	10.1371/journal.pone.0009924	http://dx.doi.org/10.1371/journal.pone.0009924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360986	Green Published, gold			2022-12-25	WOS:000276163200006
J	Oleksiak, A; Manko, M; Postma, A; van der Ham, IJM; van den Berg, AV; van Wezel, RJA				Oleksiak, Anna; Manko, Miroslawa; Postma, Albert; van der Ham, Ineke J. M.; van den Berg, Albert V.; van Wezel, Richard J. A.			Distance Estimation Is Influenced by Encoding Conditions	PLOS ONE			English	Article							RECEPTIVE-FIELD SIZE; VISUAL-SPATIAL INFORMATION; PSYCHOPHYSICS TOOLBOX; STRIATE CORTEX; SERIAL MEMORY; EYE-MOVEMENTS; FOVEAL BIAS; REPULSION; POSITION; ECCENTRICITY	Background: It is well established that foveating a behaviorally relevant part of the visual field improves localization performance as compared to the situation where the gaze is directed elsewhere. Reduced localization performance in the peripheral encoding conditions has been attributed to an eccentricity-dependent increase in positional uncertainty. It is not known, however, whether and how the foveal and peripheral encoding conditions can influence spatial interval estimation. In this study we compare observers' estimates of a distance between two co-planar dots in the condition where they foveate the two sample dots and where they fixate a central dot while viewing the sample dots peripherally. Methodology/Principal Findings: Observers were required to reproduce, after a short delay, a distance between two sample dots based on a stationary reference dot and a movable mouse pointer. When both sample dots are foveated, we find that the distance estimation error is small but consistently increases with the dots-separation size. In comparison, distance judgment in peripheral encoding condition is significantly overestimated for smaller separations and becomes similar to the performance in foveal trials for distances from 10 to 16 degrees. Conclusions/Significance: Although we find improved accuracy of distance estimation in the foveal condition, the fact that the difference is related to the reduction of the estimation bias present in the peripheral conditon, challenges the simple account of reducing the eccentricity-dependent positional uncertainty. Contrary to this, we present evidence for an explanation in terms of neuronal populations activated by the two sample dots and their inhibitory interactions under different visual encoding conditions. We support our claims with simulations that take into account receptive fields size differences between the two encoding conditions.	[Oleksiak, Anna; Manko, Miroslawa; van Wezel, Richard J. A.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Oleksiak, Anna; van den Berg, Albert V.; van Wezel, Richard J. A.] Univ Utrecht, Funct Neurobiol & Helmholtz Inst, Utrecht, Netherlands; [Postma, Albert; van der Ham, Ineke J. M.] Univ Utrecht, Expt Psychol & Helmholtz Inst, Utrecht, Netherlands; [van Wezel, Richard J. A.] Univ Twente, Biomed Signals & Syst Grp, NL-7500 AE Enschede, Netherlands	Utrecht University; Utrecht University; Utrecht University; University of Twente	Oleksiak, A (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	a.oleksiak@uu.nl	van den Berg, Albert/G-3108-2012; van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069; van den Berg, Albert Victor/0000-0002-1543-5408; van der Ham, Ineke/0000-0003-2520-7422	Netherlands Organisation for Scientific Research	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant of the Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl/NWOHome.nsf/pages/NWOP_5T8EXB) (Evolution and Behaviour: 051-14-027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; ANDREWS DP, 1978, VISION RES, V18, P615, DOI 10.1016/0042-6989(78)90140-2; BLAKEMOR.C, 1970, NATURE, V228, P37, DOI 10.1038/228037a0; BOUMA H, 1970, VISION RES, V10, P333, DOI 10.1016/0042-6989(70)90104-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURBECK CA, 1987, VISION RES, V27, P417, DOI 10.1016/0042-6989(87)90090-3; Carandini M, 1997, VISION RES, V37, P3061, DOI 10.1016/S0042-6989(97)00100-4; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; DOW BM, 1981, EXP BRAIN RES, V44, P213; FISCHER B, 1970, EXP BRAIN RES, V11, P448; FISCHER B, 1973, VISION RES, V13, P2113, DOI 10.1016/0042-6989(73)90188-0; HESS RF, 1994, VISION RES, V34, P625, DOI 10.1016/0042-6989(94)90018-3; Hiris E, 1996, VISUAL NEUROSCI, V13, P187, DOI 10.1017/S0952523800007227; INUI T, 1981, J OPT SOC AM, V71, P151, DOI 10.1364/JOSA.71.000151; ISRAEL I, 1992, EXP BRAIN RES, V90, P221; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kerzel D, 2002, VISION RES, V42, P159, DOI 10.1016/S0042-6989(01)00274-7; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; KINGSTONE A, 1993, J EXP PSYCHOL HUMAN, V19, P1251, DOI 10.1037/0096-1523.19.6.1251; LEVI DM, 1990, VISION RES, V30, P557, DOI 10.1016/0042-6989(90)90068-V; LEVI DM, 1988, VISION RES, V28, P597, DOI 10.1016/0042-6989(88)90109-5; MARSHAK W, 1979, SCIENCE, V205, P1399, DOI 10.1126/science.472756; MATEEFF S, 1983, BIOL CYBERN, V49, P111, DOI 10.1007/BF00320391; Mikaelian S, 2000, VISION RES, V40, P2999, DOI 10.1016/S0042-6989(00)00143-7; OEHLER R, 1985, EXP BRAIN RES, V59, P217; OTOOLE B, 1977, VISION RES, V17, P367, DOI 10.1016/0042-6989(77)90025-6; OYAMA T, 1978, PSYCHOL RES-PSYCH FO, V40, P101, DOI 10.1007/BF00308406; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poirier FJAM, 2005, VISION RES, V45, P2436, DOI 10.1016/j.visres.2005.03.007; Polimeni JR, 2006, VISION RES, V46, P3336, DOI 10.1016/j.visres.2006.03.006; Rauber HJ, 1999, VISION RES, V39, P3187, DOI 10.1016/S0042-6989(99)00025-5; Rauber HJ, 1998, PERCEPTION, V27, P393, DOI 10.1068/p270393; Rijpkema M, 2008, BRAIN RES, V1189, P90, DOI 10.1016/j.brainres.2007.10.100; Saint-Aubin J, 2007, EXP PSYCHOL, V54, P264, DOI 10.1027/1618-3169.54.4.264; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; STEVENSON SB, 1991, VISION RES, V31, P805, DOI 10.1016/0042-6989(91)90148-X; TAM WJ, 1994, PERCEPT PSYCHOPHYS, V56, P251, DOI 10.3758/BF03209759; Terao Y, 2002, J NEUROPHYSIOL, V88, P1716, DOI 10.1152/jn.2002.88.4.1716; TOET A, 1988, VISION RES, V28, P535, DOI 10.1016/0042-6989(88)90175-7; Tremblay S, 2006, PSYCHON B REV, V13, P452, DOI 10.3758/BF03193869; TRUJILLIORTIZ A, 2004, RMAOV2 2 WAY REPEATE; Uddin MK, 2005, VISION RES, V45, P3301, DOI 10.1016/j.visres.2005.03.006; WESTHEIMER G, 1977, VISION RES, V17, P941, DOI 10.1016/0042-6989(77)90069-4; Westheimer G, 1998, VISION RES, V38, P487, DOI 10.1016/S0042-6989(97)00192-2; WHITE JM, 1992, VISION RES, V32, P513, DOI 10.1016/0042-6989(92)90243-C; WILSON ME, 1970, J PHYSIOL-LONDON, V207, P611, DOI 10.1113/jphysiol.1970.sp009083; YAP YL, 1989, VISION RES, V29, P789, DOI 10.1016/0042-6989(89)90091-6; Yazdanbakhsh A, 2008, NEUROSCI LETT, V438, P246, DOI 10.1016/j.neulet.2008.04.040	53	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9918	10.1371/journal.pone.0009918	http://dx.doi.org/10.1371/journal.pone.0009918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360953	Green Published, gold			2022-12-25	WOS:000276163100011
J	Weimerskirch, H; Bertrand, S; Silva, J; Marques, JC; Goya, E				Weimerskirch, Henri; Bertrand, Sophie; Silva, Jaime; Carlos Marques, Jose; Goya, Elisa			Use of Social Information in Seabirds: Compass Rafts Indicate the Heading of Food Patches	PLOS ONE			English	Article							PUBLIC INFORMATION; COLONIES; BEHAVIOR; CENTERS; BIRD; PERU	Ward and Zahavi suggested in 1973 that colonies could serve as information centres, through a transfer of information on the location of food resources between unrelated individuals (Information Centre Hypothesis). Using GPS tracking and observations on group movements, we studied the search strategy and information transfer in two of the most colonial seabirds, Guanay cormorants (Phalacrocorax bougainvillii) and Peruvian boobies (Sula variegata). Both species breed together and feed on the same prey. They do return to the same feeding zone from one trip to the next indicating high unpredictability in the location of food resources. We found that the Guanay cormorants use social information to select their bearing when departing the colony. They form a raft at the sea surface whose position is continuously adjusted to the bearing of the largest returning columns of cormorants. As such, the raft serves as a compass signal that gives an indication on the location of the food patches. Conversely, Peruvian boobies rely mainly on personal information based on memory to take heading at departure. They search for food patches solitarily or in small groups through network foraging by detecting the white plumage of congeners visible at long distance. Our results show that information transfer does occur and we propose a new mechanism of information transfer based on the use of rafts off colonies. The use of rafts for information transfer may be common in central place foraging colonial seabirds that exploit short lasting and/or unpredictably distributed food patches. Over the past decades Guanay cormorants have declined ten times whereas Peruvian boobies have remained relatively stable. We suggest that the decline of the cormorants could be related to reduced social information opportunities and that social behaviour and search strategies have the potential to play an important role in the population dynamics of colonial animals.	[Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Bertrand, Sophie] Ctr Rech Halieuth, Inst Rech Dev, Sete, France; [Bertrand, Sophie; Silva, Jaime; Carlos Marques, Jose; Goya, Elisa] Inst Mar Peru, Direcc Recursos Pelag, Callao, Peru	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	henriw@cebc.cnrs.fr	Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; bertrand, sophie/F-4161-2012	Weimerskirch, Henri/0000-0002-0457-586X; bertrand, sophie/0000-0003-1976-3799	CNRS-INEE (Centre National de la Recherche Scientifique - Institut National Ecologie et Environnement); IRD (Institut de Recherche pour le Developpement) and IMARPE (Institut del Mar del Peru)	CNRS-INEE (Centre National de la Recherche Scientifique - Institut National Ecologie et Environnement); IRD (Institut de Recherche pour le Developpement) and IMARPE (Institut del Mar del Peru)	This study was funded by CNRS-INEE (Centre National de la Recherche Scientifique - Institut National Ecologie et Environnement), IRD (Institut de Recherche pour le Developpement) and IMARPE (Institut del Mar del Peru). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barta Z, 2001, BEHAV ECOL, V12, P121, DOI 10.1093/beheco/12.2.121; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; BRETAGNOLLE V, 1993, AM NAT, V142, P141, DOI 10.1086/285532; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Burger AE, 1997, COLON WATERBIRD, V20, P55, DOI 10.2307/1521764; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; DUFFY DC, 1983, AUK, V100, P800, DOI 10.1093/auk/100.4.800; EVANS RM, 1982, AUK, V99, P24, DOI 10.2307/4086018; GASTON A.J., 1981, WILDLIFE MONOGRAPH, V6; Giraldeau L.A., 2000, MG BEH ECOL; Goya E., 2000, B I MAR PERU, V19, P125; GREENE E, 1987, NATURE, V329, P239, DOI 10.1038/329239a0; Gutierrez D, 2009, BIOGEOSCIENCES, V6, P835, DOI 10.5194/bg-6-835-2009; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jahncke J., 1998, B I MAR PERU, V17, P15; JORDAN R, 1967, REP CALIF COOP OCEAN, V11, P105; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Lack D., 1968, pvii; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; MILINSKI M, 1994, ECOLOGY, V75, P1150, DOI 10.2307/1939438; MOCK DW, 1988, ORNIS SCAND, V19, P231, DOI 10.2307/3676564; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; NEVITT G, 1999, BIRDLIFE S AFRICA, P2072; Orians G.H., 1979, P155; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; TOVAR H, 1987, ICLARM REV STUDIES; VALONE T, 1989, GROUP FORAGING PUBLI, P357; WAGNER R, 2009, OIKOS, P9999; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wittenberger J.F., 1985, Avian Biology, V8, P1; Zavalaga CB, 1999, S AFR J MARINE SCI, V21, P251	40	94	94	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9928	10.1371/journal.pone.0009928	http://dx.doi.org/10.1371/journal.pone.0009928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360959	gold, Green Published, Green Submitted			2022-12-25	WOS:000276163100020
J	Ding, ZY; Liang, JY; Li, J; Lu, YL; Ariyaratna, V; Lu, ZM; Davies, MA; Westwick, JK; Mills, GB				Ding, Zhiyong; Liang, Jiyong; Li, Jin; Lu, Yiling; Ariyaratna, Vathsala; Lu, Zhimin; Davies, Michael A.; Westwick, John K.; Mills, Gordon B.			Physical Association of PDK1 with AKT1 Is Sufficient for Pathway Activation Independent of Membrane Localization and Phosphatidylinositol 3 Kinase	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; RICTOR-MTOR COMPLEX; FLUORESCENT PROTEIN; PH DOMAIN; PHOSPHORYLATION; AKT/PKB; IDENTIFICATION; TRANSLOCATION; INHIBITION; MECHANISM	Frequent activation of the AKT serine-threonine kinase in cancer confers resistance to therapy. AKT is activated by a multistep process involving phosphatidylinositide (PtdIns) phosphate-mediated recruitment of AKT and its upstream kinases, including 3-Phosphoinositide-dependent kinase 1 (PDK1), to the inner surface of the cell membrane. PDK1 in the appropriate context phosphorylates AKT at threonine 308 (T308) to activate AKT. Whether PtdIns(3,4,5) Ps (PtdInsP3) binding and AKT membrane translocation mediate functions other than formation of a functional PDK1:: AKT complex have not been fully elucidated. We fused complementary fragments of intensely fluorescent protein (IFP) to AKT1 and PDK1 to induce a stable complex to study the prerequisites of AKT1 phosphorylation and function. In the stabilized PDK1-IFPC::IFPN-AKT1 complex, AKT1 T308 phosphorylation was independent of PtdIns, as demonstrated by treatment with Phosphatidylinositol 3 Kinase (PI3K) inhibitors. Further when interaction with PtdIns and the cell membrane was prevented by creating PH-domain mutants of AKT1 (R25A) and PDK1 (R474A), AKT1 phosphorylation on T308 was maintained in the PDK1-IFPC::IFPN-AKT1 complex. The PDK1-IFPC::IFPN-AKT1 complex was sufficient for phosphorylation of known AKT substrates, and conferred resistance to inhibitors of PI3K (LY294002, PI103, GDC0941 and TGX286) but not inhibitors of the downstream TORC1 complex (rapamycin). Thus the locus of action of targeted therapeutics can be elucidated by the constitutively active AKT1 complex. Our data indicate that PtdIns and membrane localization are not required for AKT phosphorylation and activation, but rather serve to induce a functional physical interaction between PDK1 and AKT. The PDK1-IFPC::IFPN-AKT1 complex provides a cell-based platform to examine specificity of drugs targeting PI3K pathway components.	[Ding, Zhiyong; Liang, Jiyong; Li, Jin; Lu, Yiling; Ariyaratna, Vathsala; Davies, Michael A.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Westwick, John K.] Odyssey Thera Inc, San Ramon, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ding, ZY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	zding@mdanderson.org	Davies, Michael/GWV-2527-2022		National Institutes of Health (NIH) [5R21CA126700]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, R21CA126700] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) Innovative Molecular Analysis Technologies (IMAT) grant 5R21CA126700 to Z.D. http://innovation.cancer.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson E.W., 1998, J SERV RES-US, V1, P5, DOI DOI 10.1177/109467059800100102; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Howe CJ, 2002, J BIOL CHEM, V277, P30469, DOI 10.1074/jbc.M205036200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; KERPPOLA TK, 2006, NAT REV MOL CELL BIO; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; LaHair MM, 2006, ANTIOXID REDOX SIGN, V8, P1749, DOI 10.1089/ars.2006.8.1749; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; MACDONALD ML, 2006, NAT CHEM BIOL; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Saji M, 2005, BIOCHEM BIOPH RES CO, V332, P167, DOI 10.1016/j.bbrc.2005.04.109; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	32	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9910	10.1371/journal.pone.0009910	http://dx.doi.org/10.1371/journal.pone.0009910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361045	Green Submitted, Green Published, gold			2022-12-25	WOS:000275969600016
J	Evans-Roberts, KM; Breuer, C; Wall, MK; Sugimoto-Shirasu, K; Maxwell, A				Evans-Roberts, Katherine M.; Breuer, Christian; Wall, Melisa K.; Sugimoto-Shirasu, Keiko; Maxwell, Anthony			Arabidopsis thaliana GYRB3 Does Not Encode a DNA Gyrase Subunit	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING DOMAIN; ARABIDOPSIS; TOPOISOMERASES; SEQUENCES; ALIGNMENT; COMPLEX; ENERGY; SERVER	Background: DNA topoisomerases are enzymes that control the topology of DNA in all cells. DNA gyrase is unique among the topoisomerases in that it is the only enzyme that can actively supercoil DNA using the free energy of ATP hydrolysis. Until recently gyrase was thought to be unique to bacteria, but has now been discovered in plants. The genome of the model plant, Arabidopsis thaliana, is predicted to encode four gyrase subunits: AtGyrA, AtGyrB1, AtGyrB2 and AtGyrB3. Methodology/Principal Findings: We found, contrary to previous data, that AtGyrB3 is not essential to the survival of A. thaliana. Bioinformatic analysis suggests AtGyrB3 is considerably shorter than other gyrase B subunits, lacking part of the ATPase domain and other key motifs found in all type II topoisomerases; but it does contain a putative DNA-binding domain. Partially purified AtGyrB3 cannot bind E. coli GyrA or support supercoiling. AtGyrB3 cannot complement an E. coli gyrB temperature-sensitive strain, whereas AtGyrB2 can. Yeast two-hybrid analysis suggests that AtGyrB3 cannot bind to AtGyrA or form a dimer. Conclusions/Significance: These data strongly suggest that AtGyrB3 is not a gyrase subunit but has another unknown function. One possibility is that it is a nuclear protein with a role in meiosis in pollen.	[Evans-Roberts, Katherine M.; Breuer, Christian; Wall, Melisa K.; Maxwell, Anthony] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Breuer, Christian; Sugimoto-Shirasu, Keiko] RIKEN, Plant Sci Ctr, Kanagawa, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; RIKEN	Evans-Roberts, KM (corresponding author), Papworth Hosp, Hlth Enterprise E Ltd, Papworth Everard, Everard, England.	tony.maxwell@bbsrc.ac.uk	Sugimoto, Keiko/B-3368-2010; Breuer, Christian/A-8977-2011	Sugimoto, Keiko/0000-0002-9209-8230; Maxwell, Anthony/0000-0002-5756-6430	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC); KMER was funded jointly by a studentship from BBSRC and Syngenta (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Bates A. D., 2005, DNA TOPOLOGY; Bates AD, 2007, BIOCHEMISTRY-US, V46, P7929, DOI 10.1021/bi700789g; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Caron P R, 1994, Adv Pharmacol, V29B, P271; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Costenaro L, 2007, STRUCTURE, V15, P329, DOI 10.1016/j.str.2007.01.013; Depiereux E, 1997, COMPUT APPL BIOSCI, V13, P249; DONG KC, 2008, PROTEIN NUCL ACID IN; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim OK, 2001, EXPERT OPIN INV DRUG, V10, P199, DOI 10.1517/13543784.10.2.199; Maxwell A, 1999, METH MOL B, V94, P135; Maxwell A, 1999, BIOCHEM SOC T, V27, P48, DOI 10.1042/bst0270048; Maxwell A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gk1054; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Morgante CV, 2009, MOL GENET GENOMICS, V281, P525, DOI 10.1007/s00438-009-0429-7; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smith CV, 1998, BIOCHEMISTRY-US, V37, P9658, DOI 10.1021/bi9801309; Wall MK, 2004, P NATL ACAD SCI USA, V101, P7821, DOI 10.1073/pnas.0400836101; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; YAMAGISHI J, 1986, MOL GEN GENET, V204, P367, DOI 10.1007/BF00331012; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	35	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9899	10.1371/journal.pone.0009899	http://dx.doi.org/10.1371/journal.pone.0009899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360860	Green Submitted, Green Published, gold			2022-12-25	WOS:000275969600007
J	Boal, F; Stephens, DJ				Boal, Frederic; Stephens, David J.			Specific Functions of BIG1 and BIG2 in Endomembrane Organization	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; ADP-RIBOSYLATION FACTORS; TRANS-GOLGI NETWORK; PROTEIN-KINASE-A; BREFELDIN-A; MEMBRANE-TRAFFICKING; ENDOPLASMIC-RETICULUM; RECYCLING ENDOSOMES; DISTINCT FUNCTIONS; MAMMALIAN-CELLS	Background: Transport of molecules from one subcellular compartment to another involves the recruitment of cytosolic coat protein complexes to a donor membrane to concentrate cargo, deform the membrane and ultimately to form an independent carrier. Small-GTP-binding proteins of the Arf family are central to many membrane trafficking events. Arfs are activated by guanine nucleotide exchange factors (GEFs) which results in their recruitment to membranes and subsequent engagement with Arf-effectors, many of which are coat proteins. Among the human BFA-sensitive large Arf-GEFs, the function of the two closely related BIG1 and BIG2 is still not clear, and recent studies have raised the question of functional redundancy between the two proteins. Methodology/Principal Findings: Here we have used small-interfering RNA on human cells and a combination of fixed and live-cell imaging to investigate the differential functions of BIG1 and BIG2 in endomembrane organization and function. Importantly, in this direct comparative study, we show discrete functions for BIG1 and BIG2. Our results show that depletion of BIG2 but not of BIG1 induces a tubulation of the recycling endosomal compartment, consistent with a specific role for BIG2 here. In contrast, suppression of BIG1 induces the formation of Golgi mini-stacks still polarized and functional in terms of cargo export. Conclusions: A key finding from our work is that suppression of BIG1 expression results in a fragmentation of the Golgi apparatus. Our data indicate that the human BFA-sensitive large Arf-GEFs have non-redundant functions in cell organization and membrane trafficking. BIG1 is required to maintain the normal morphology of the Golgi; BIG2 is important for endosomal compartment integrity and cannot replace the function of BIG1 in Golgi organization.	[Boal, Frederic; Stephens, David J.] Univ Bristol, Sch Med Sci, Cell Biol Labs, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Boal, F (corresponding author), Univ Bristol, Sch Med Sci, Cell Biol Labs, Dept Biochem, Bristol BS8 1TD, Avon, England.	fred.boal@bristol.ac.uk	Boal, Frédéric/O-6306-2018	Boal, Frédéric/0000-0001-7607-4573; Stephens, David/0000-0001-5297-3240	Biotechnology and Biological Sciences Research Council [E012450]; Biotechnology and Biological Sciences Research Council [BB/E012450/1] Funding Source: researchfish; Medical Research Council [G117/554] Funding Source: researchfish; BBSRC [BB/E012450/1] Funding Source: UKRI; MRC [G117/554] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is funded by a research grant from the Biotechnology and Biological Sciences Research Council [E012450]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Bejarano E, 2006, J CELL SCI, V119, P3764, DOI 10.1242/jcs.03146; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Citterio C, 2006, P NATL ACAD SCI USA, V103, P2683, DOI 10.1073/pnas.0510571103; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Kuroda F, 2007, P NATL ACAD SCI USA, V104, P3201, DOI 10.1073/pnas.0611696104; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Padilla PI, 2004, P NATL ACAD SCI USA, V101, P2752, DOI 10.1073/pnas.0307345101; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; REAVES B, 1992, J CELL BIOL, V116, P85, DOI 10.1083/jcb.116.1.85; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saeki N, 2005, J BIOL CHEM, V280, P10128, DOI 10.1074/jbc.M413415200; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Shen XY, 2006, P NATL ACAD SCI USA, V103, P2635, DOI 10.1073/pnas.0510599103; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Wang YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001647; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	57	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9898	10.1371/journal.pone.0009898	http://dx.doi.org/10.1371/journal.pone.0009898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360857	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969500018
J	Dawood, FS; Hope, KG; Durrheim, DN; Givney, R; Fry, AM; Dalton, CB				Dawood, Fatimah S.; Hope, Kirsty G.; Durrheim, David N.; Givney, Rodney; Fry, Alicia M.; Dalton, Craig B.			Estimating the Disease Burden of Pandemic (H1N1) 2009 Virus Infection in Hunter New England, Northern New South Wales, Australia, 2009	PLOS ONE			English	Article							INFLUENZA; HOSPITALIZATIONS	Introduction: On May 26, 2009, the first confirmed case of Pandemic (H1N1) 2009 virus (pH1N1) infection in Hunter New England (HNE), New South Wales (NSW), Australia (population 866,000) was identified. We used local surveillance data to estimate pH1N1-associated disease burden during the first wave of pH1N1 circulation in HNE. Methods: Surveillance was established during June 1-August 30, 2009, for: 1) laboratory detection of pH1N1 at HNE and NSW laboratories, 2) pH1N1 community influenza-like illness (ILI) using an internet survey of HNE residents, and 3) pH1N1-associated hospitalizations and deaths using respiratory illness International Classification of Diseases 10 codes at 35 HNE hospitals and mandatory reporting of confirmed pH1N1-associated hospitalizations and deaths to the public health service. The proportion of pH1N1 positive specimens was applied to estimates of ILI, hospitalizations, and deaths to estimate disease burden. Results: Of 34,177 specimens tested at NSW laboratories, 4,094 (12%) were pH1N1 positive. Of 1,881 specimens from patients evaluated in emergency departments and/or hospitalized, 524 (26%) were pH1N1 positive. The estimated number of persons with pH1N1-associated ILI in the HNE region was 53,383 (range 37,828-70,597) suggesting a 6.2% attack rate (range 4.4-8.2%). An estimated 509 pH1N1-associated hospitalizations (range 388-630) occurred (reported: 184), and up to 10 pH1N1-associated deaths (range 8-13) occurred (reported: 5). The estimated case hospitalization ratio was 1% and case fatality ratio was 0.02%. Discussion: The first wave of pH1N1 activity in HNE resulted in symptomatic infection in a small proportion of the population, and the number of HNE pH1N1-associated hospitalizations and deaths is likely higher than officially reported.	[Dawood, Fatimah S.; Fry, Alicia M.] Ctr Dis Control & Prevent CDC, Influenza Div, Atlanta, GA 30333 USA; [Hope, Kirsty G.] Univ Newcastle, Hunter New England Populat Hlth & Newcastle Inst, Wallsend, Tyne & Wear, England; [Durrheim, David N.; Dalton, Craig B.] Hunter New England Populat Hlth & Hunter Med Res, Wallsend, Tyne & Wear, England; [Givney, Rodney] John Hunter Hosp, Hunter Area Pathol Serv, Newcastle, NSW, Australia	Centers for Disease Control & Prevention - USA; Newcastle University - UK; John Hunter Hospital	Dawood, FS (corresponding author), Ctr Dis Control & Prevent CDC, Influenza Div, Atlanta, GA 30333 USA.	fdawood@cdc.gov						[Anonymous], 2009, PREVALENCE FLU LIKE; *AUSTR INFL, 2009, 11 AUSTR INFL; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mathews JD, 2009, INFLUENZA OTHER RESP, V3, P143, DOI 10.1111/j.1750-2659.2009.00089.x; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; *NSW, WEEKL INFL EP REP; PARRELLA A, 2009, AUSTR FAMILY PHYS, V39; REED C, 2009, EMERG INFECT DIS APR; Wilson N, 2009, EUROSURVEILLANCE, V14; 2009 VICTORIAN INFLU; 2009, ECDC INTERIM RISK AS; PANDEMIC INFLUENZA P, P1; ASSESSMENT 2009 INFL	15	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9880	10.1371/journal.pone.0009880	http://dx.doi.org/10.1371/journal.pone.0009880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360868	Green Submitted, Green Published, gold			2022-12-25	WOS:000275969500012
J	Liang, B; Ferguson, K; Kadyk, L; Watts, JL				Liang, Bin; Ferguson, Kim; Kadyk, Lisa; Watts, Jennifer L.			The Role of Nuclear Receptor NHR-64 in Fat Storage Regulation in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; HORMONE-RECEPTOR; BETA-OXIDATION; ACID; SREBP; DROSOPHILA; PATHWAY; DOMAIN; IDENTIFICATION; DESATURASE	Nuclear hormone receptors (NHRs) play vital roles in the regulation of metabolism, reproduction, and development. We found that inactivation of a C. elegans HNF4 homologue nhr-64 by RNA interference (RNAi) suppresses low fat stores in stearoyl-CoA desaturase-deficient fat-6; fat-7 double mutants and sterol regulatory element binding protein (SREBP) sbp-1 mutants. Furthermore, inactivation of nhr-64 improves the growth rate of the fat-6; fat-7and sbp-1 strains. While nhr-64RNAi subtly affects fatty acid composition and fat storage in wild-type C. elegans, its effects on lipid metabolism are most apparent in the background of stearoyl-CoA desaturase or SREBP deficiency. NHR-64 displays transcriptional activating activity when expressed in yeast, and inactivation of nhr-64 affects the expression of at least 14 metabolic genes. Wild-type worms treated with nhr-64 RNAi display increased expression of acetyl-CoA carboxylase as well as increased abundance of de novo synthesized monomethyl branched chain fatty acids, suggesting an increase in fat synthesis. However, reduced expression of the acetyl-CoA synthetase gene acs-2 and an acyl-CoA oxidase gene indicates that a key role of NHR-64 may be to promote fatty acid oxidation in mitochondria and peroxisomes. These studies reveal that NHR-64 is an important regulator of fat storage in C. elegans.	[Liang, Bin; Watts, Jennifer L.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Ferguson, Kim; Kadyk, Lisa] Exelixis Inc, San Francisco, CA USA	Washington State University; Exelixis, Inc.	Liang, B (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jwatts@wsu.edu	Watts, Jennifer/AAC-7425-2020; Kadyk, Lisa/W-5243-2019	Watts, Jennifer/0000-0003-4349-0639	National Institutes of Health (NIH) [R01DK74114]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by National Institutes of Health (NIH) (R01DK74114). Exelixis provided support in terms of employment of Lisa Kadyk and Kim Ferguson, who generated the sbp-1(ep79) mutant strain and did the analysis that is shown in supplemental Figure S1A. Other than that, the funders had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of the C. elegans strains used in this work were obtained from the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Antebi A, 2000, GENE DEV, V14, P1512; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Magner DB, 2008, TRENDS ENDOCRIN MET, V19, P153, DOI 10.1016/j.tem.2008.02.005; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	43	43	48	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9869	10.1371/journal.pone.0009869	http://dx.doi.org/10.1371/journal.pone.0009869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360843	gold, Green Published, Green Submitted			2022-12-25	WOS:000275969500008
J	Drake, KR; Kang, M; Kenworthy, AK				Drake, Kimberly R.; Kang, Minchul; Kenworthy, Anne K.			Nucleocytoplasmic Distribution and Dynamics of the Autophagosome Marker EGFP-LC3	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-1; LASER-SCANNING MICROSCOPES; NUCLEAR EXPORT SIGNAL; SMOOTH-MUSCLE-CELLS; LIGHT-CHAIN 3; FLUORESCENCE RECOVERY; MONITORING AUTOPHAGY; MAMMALIAN-CELLS; LIVING CELLS; IN-VIVO	The process of autophagy involves the formation of autophagosomes, double-membrane structures that encapsulate cytosol. Microtubule-associated protein light chain 3 (LC3) was the first protein shown to specifically label autophagosomal membranes in mammalian cells, and subsequently EGFP-LC3 has become one of the most widely utilized reporters of autophagy. Although LC3 is currently thought to function primarily in the cytosol, the site of autophagosome formation, EGFP-LC3 often appears to be enriched in the nucleoplasm relative to the cytoplasm in published fluorescence images. However, the nuclear pool of EGFP-LC3 has not been specifically studied in previous reports, and mechanisms by which LC3 shuttles between the cytoplasm and nucleoplasm are currently unknown. In this study, we therefore investigated the regulation of the nucleo-cytoplasmic distribution of EGFP-LC3 in living cells. By quantitative fluorescence microscopy analysis, we demonstrate that soluble EGFP-LC3 is indeed enriched in the nucleus relative to the cytoplasm in two commonly studied cell lines, COS-7 and HeLa. Although LC3 contains a putative nuclear export signal (NES), inhibition of active nuclear export or mutation of the NES had no effect on the nucleo-cytoplasmic distribution of EGFP-LC3. Furthermore, FRAP analysis indicates that EGFP-LC3 undergoes limited passive nucleo-cytoplasmic transport under steady state conditions, and that the diffusional mobility of EGFP-LC3 was substantially slower in the nucleus and cytoplasm than predicted for a freely diffusing monomer. Induction of autophagy led to a visible decrease in levels of soluble EGFP-LC3 relative to autophagosome-bound protein, but had only modest effects on the nucleo-cytoplasmic ratio or diffusional mobility of the remaining soluble pools of EGFP-LC3. We conclude that the enrichment of soluble EGFP-LC3 in the nucleus is maintained independently of active nuclear export or induction of autophagy. Instead, incorporation of soluble EGFP-LC3 into large macromolecular complexes within both the cytoplasm and nucleus may prevent its rapid equilibrium between the two compartments.	[Drake, Kimberly R.; Kang, Minchul; Kenworthy, Anne K.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37203 USA; [Kenworthy, Anne K.] Vanderbilt Univ Sch Med, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Drake, KR (corresponding author), Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37203 USA.	Anne.kenworthy@vanderbilt.edu		Kenworthy, Anne/0000-0001-6567-9059	NIH [R01 GM073846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM073846 (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Cieehomska IA, 2007, AUTOPHAGY, V3, P586, DOI 10.4161/auto.4843; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Furuta S, 2002, ONCOGENE, V21, P7060, DOI 10.1038/sj.onc.1205790; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Houtsmuller AB, 2005, ADV BIOCHEM ENG BIOT, V95, P177, DOI 10.1007/b102214; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Liang XH, 2001, CANCER RES, V61, P3443; LIPPINCOTTSCHWA.J, 2001, MOL CELL BIOL, V2, P444; MANN SS, 1994, J BIOL CHEM, V269, P11492; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Meyer T, 2007, FEBS J, V274, P815, DOI 10.1111/j.1742-4658.2006.05626.x; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Seldenbecher CI, 2004, J MOL BIOL, V336, P957, DOI 10.1016/j.jmb.2003.12.054; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stavreva DA, 2004, METHOD ENZYMOL, V375, P443; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Wachsmuth M, 2003, BIOPHYS J, V84, P3353, DOI 10.1016/S0006-3495(03)70059-9; Wei XB, 2003, BIOPHYS J, V84, P1317, DOI 10.1016/S0006-3495(03)74947-9; Zhou B, 1997, J CLIN INVEST, V100, P3070, DOI 10.1172/JCI119862; Zhou B, 1998, CIRC RES, V83, P481, DOI 10.1161/01.RES.83.5.481	61	71	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9806	10.1371/journal.pone.0009806	http://dx.doi.org/10.1371/journal.pone.0009806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352102	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400012
J	Stuelten, CH; Busch, JI; Tang, BW; Flanders, KC; Oshima, A; Sutton, E; Karpova, TS; Roberts, AB; Wakefield, LM; Niederhuber, JE				Stuelten, Christina H.; Busch, Johanna I.; Tang, Binwu; Flanders, Kathleen C.; Oshima, Akira; Sutton, Emily; Karpova, Tatiana S.; Roberts, Anita B.; Wakefield, Lalage M.; Niederhuber, John E.			Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-beta Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ENHANCES TUMORIGENESIS; MAMMARY ADENOCARCINOMA; SUPPRESSES METASTASIS; STROMAL FIBROBLASTS; INVASION; HOMEOSTASIS; EXPRESSION; PROSTATE; PROMOTE	Carcinoma are complex societies of mutually interacting cells in which there is a progressive failure of normal homeostatic mechanisms, causing the parenchymal component to expand inappropriately and ultimately to disseminate to distant sites. When a cancer cell metastasizes, it first will be exposed to cancer associated fibroblasts in the immediate tumor microenvironment and then to normal fibroblasts as it traverses the underlying connective tissue towards the bloodstream. The interaction of tumor cells with stromal fibroblasts influences tumor biology by mechanisms that are not yet fully understood. Here, we report a role for normal stroma fibroblasts in the progression of invasive tumors to metastatic tumors. Using a coculture system of human metastatic breast cancer cells (MCF10CA1a) and normal murine dermal fibroblasts, we found that medium conditioned by cocultures of the two cell types (CoCM) increased migration and scattering of MCF10CA1a cells in vitro, whereas medium conditioned by homotypic cultures had little effect. Transient treatment of MCF10CA1a cells with CoCM in vitro accelerated tumor growth at orthotopic sites in vivo, and resulted in an expanded pattern of metastatic engraftment. The effects of CoCM on MCF10CA1a cells were dependent on small amounts of active TGF-beta 1 secreted by fibroblasts under the influence of the tumor cells, and required intact ALK5-, p38-, and JNK signaling in the tumor cells. In conclusion, these results demonstrate that transient interactions between tumor cells and normal fibroblasts can modify the acellular component of the local microenvironment such that it induces long-lasting increases in tumorigenicity and alters the metastatic pattern of the cancer cells in vivo. TGF-beta appears to be a key player in this process, providing further rationale for the development of anti-cancer therapeutics that target the TGF-beta pathway.	[Stuelten, Christina H.; Busch, Johanna I.; Sutton, Emily; Niederhuber, John E.] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Tang, Binwu; Flanders, Kathleen C.; Oshima, Akira; Roberts, Anita B.; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Karpova, Tatiana S.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stuelten, CH (corresponding author), NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA.	chrisstu@mail.nih.gov	Wakefield, Lalage M/M-1963-2017	Wakefield, Lalage M/0000-0003-4124-5250; Stuelten, Christina/0000-0002-2850-5399; Karpova, Tatiana/0000-0001-6025-2128	National Cancer Institute, NIH, Bethesda, USA; NATIONAL CANCER INSTITUTE [ZIABC010929, ZIABC010796, ZIABC010797, ZIABC005785] Funding Source: NIH RePORTER	National Cancer Institute, NIH, Bethesda, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute, NIH, Bethesda, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHENG N, 2005, ONCOGENE; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Javelaud D, 2005, ONCOGENE, V24, P7624, DOI 10.1038/sj.onc.1208900; Jechlinger M, 2002, J MAMMARY GLAND BIOL, V7, P415, DOI 10.1023/A:1024090116451; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kawai N, 2002, GASTROENTEROLOGY, V122, P331, DOI 10.1053/gast.2002.31023; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lewis MP, 2004, BRIT J CANCER, V90, P822, DOI 10.1038/sj.bjc.6601611; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Proia DA, 2005, CELL CYCLE, V4, P1022, DOI 10.4161/cc.4.8.1903; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rosen E M, 1993, EXS, V65, P301; Seoane J, 2008, CLIN TRANSL ONCOL, V10, P14, DOI 10.1007/s12094-008-0148-2; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Stuelten CH, 2005, J CELL SCI, V118, P2143, DOI 10.1242/jcs.02334; Stuelten CH, 2008, CANCER RES, V68, P7278, DOI 10.1158/0008-5472.CAN-08-1842; Stuelten CH, 2007, BIOTECHNIQUES, V43, P289, DOI 10.2144/000112549; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Thomas GJ, 2002, BRIT J CANCER, V87, P859, DOI 10.1038/sj.bjc.6600545; Tian F, 2004, CANCER RES, V64, P4523, DOI 10.1158/0008-5472.CAN-04-0030; Tian F, 2003, CANCER RES, V63, P8284; TIMME TL, 1994, ENDOCRINOLOGY, V134, P1039, DOI 10.1210/en.134.3.1039; VanWaarde MAWH, 1997, ANAL BIOCHEM, V247, P45, DOI 10.1006/abio.1997.2026; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	48	67	71	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9832	10.1371/journal.pone.0009832	http://dx.doi.org/10.1371/journal.pone.0009832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352126	gold, Green Published, Green Submitted			2022-12-25	WOS:000275894400031
J	Boyer, A; Lapointe, E; Zheng, XF; Cowan, RG; Li, HG; Quirk, SM; DeMayo, FJ; Richards, JS; Boerboom, D				Boyer, Alexandre; Lapointe, Evelyne; Zheng, Xiaofeng; Cowan, Robert G.; Li, Huaiguang; Quirk, Susan M.; DeMayo, Francesco J.; Richards, JoAnne S.; Boerboom, Derek			WNT4 is required for normal ovarian follicle development and female fertility	FASEB JOURNAL			English	Article						granulosa cell; conditional gene targeting; CTNNB1; microarray	GRANULOSA-CELL TUMOR; ENDOTHELIAL GROWTH-FACTOR; MULLERIAN-DUCT REGRESSION; STRESS-INDUCIBLE GENE; SIGNALING PATHWAY; INTESTINAL POLYPOSIS; REGULATED EXPRESSION; MESSENGER-RNA; BETA; PROTEIN	To study the role of WNT4 in the postnatal ovary, a mouse strain bearing a floxed Wnt4 allele was created and mated to the Amhr2(tm3(cre)Bhr) strain to target deletion of Wnt4 to granulosa cells. Wnt4(flox/-); Amhr2(tm3(cre)Bhr/+) mice had reduced ovary weights and produced smaller litters (P<0.05). Serial follicle counting demonstrated that Wnt4(flox/-); Amhr2(tm3(cre)Bhr/+) mice were born with a normal ovarian reserve and maintained normal numbers of small follicles until puberty but had only 25.2% of the normal number of healthy antral follicles. Some Wnt4(flox/-); Amhr2(tm3(cre)Bhr/+) mice had no antral follicles or corpora lutea and underwent premature follicle depletion. RT-PCR analyses of Wnt4(flox/-); Amhr2(tm3(cre)Bhr/+) granulosa cells and cultured granulosa cells that overexpress WNT4 demonstrated that WNT4 regulates the expression of Star, Cyp11a1, and Cyp19, steroidogenic genes previously identified as downstream targets of the WNT signaling effector CTNNB1. Decreased serum progesterone levels were found in immature, gonadotropin-treated Wnt4(flox/-); Amhr2(tm3(cre)Bhr/+) mice (P<0.05). WNT4-and CTNNB1-overexpressing cultured granulosa cells were analyzed by microarray for alterations in gene expression, which showed that WNT4 regulates additional genes involved in late follicle development via the WNT/CTNNB1 signaling pathway. Together, these data indicate that WNT4 is required for normal antral follicle development and may act by regulating granulosa cell functions including steroidogenesis.-Boyer, A., Lapointe, E., Zheng, X., Cowan, R. G., Li, H., Quirk, S. M., DeMayo, F. J., Richards, J. S., Boerboom, D. WNT4 is required for normal ovarian follicle development and female fertility. FASEB J. 24, 3010-3025 (2010). www.fasebj.org	[Boyer, Alexandre; Lapointe, Evelyne; Zheng, Xiaofeng; Boerboom, Derek] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada; [Boyer, Alexandre; Li, Huaiguang; DeMayo, Francesco J.; Richards, JoAnne S.; Boerboom, Derek] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cowan, Robert G.; Quirk, Susan M.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA	Universite de Montreal; Baylor College of Medicine; Cornell University	Boerboom, D (corresponding author), Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, CP 5000, St Hyacinthe, PQ J2S 7C6, Canada.	derek.boerboom@umontreal.ca	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336	Canadian Institutes of Health Research; Canada Research Chair in Ovarian Molecular Biology and Functional Genomics; U.S. National Institutes of Health [HD16272, HD07495]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016272, P30HD007495] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Ovarian Molecular Biology and Functional Genomics(Canada Research Chairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Lisa White, Dr. John Lydon, Dr. Marilene Paquet, Dr. Bruce D. Murphy, Dr. Alan K. Goff, Celine Forget, Mayra Tsoi, Janet DeMayo, Mira Dobias-Goff, and Aron Cory for expertise and technical assistance with microarray analyses, targeting vector design, embryonic stem cell procedures, histopathological analyses, mouse colony management, steroid hormone radioimmunoassays, statistical analyses, dissections, and follicle counting. Amhr2<SUP>tm3(cre)Bhr</SUP> and Ctnnb1<SUP>tm1Mmt</SUP> mice were kindly provided by Dr. Richard R. Behringer (University of Texas, Houston, TX, USA) and Dr. Makoto M. Taketo (Kyoto University, Kyoto, Japan), respectively. The R1 embryonic stem cell line was provided by Dr. Andras Nagy, Reka Nagy, Dr. Janet Rossant, and Dr. Wanda Abramow-Newerly (University of Toronto, Toronto, ON, Canada). This work was supported by a Canadian Institutes of Health Research operating grant and the Canada Research Chair in Ovarian Molecular Biology and Functional Genomics (D.B.) and U.S. National Institutes of Health grants HD16272 and HD07495 (J.S.R.).	Abramovich D, 2010, FERTIL STERIL, V93, P1369, DOI 10.1016/j.fertnstert.2009.01.127; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Boyer A, 2009, CARCINOGENESIS, V30, P869, DOI 10.1093/carcin/bgp051; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; BYSKOV AGS, 1974, J REPROD FERTIL, V37, P277, DOI 10.1530/jrf.0.0370277; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chen M, 2006, HORM METAB RES, V38, P549, DOI 10.1055/s-2006-950500; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Coveney D, 2008, GENE EXPR PATTERNS, V8, P529, DOI 10.1016/j.gep.2008.05.006; Das S, 2008, CELL CYCLE, V7, P154, DOI 10.4161/cc.7.2.5236; Devine PJ, 2000, BIOL REPROD, V63, P1245, DOI 10.1095/biolreprod63.5.1245; Douglas DA, 1998, BIOL REPROD, V58, P1163, DOI 10.1095/biolreprod58.5.1163; FISCHER B, 1992, EUR J OBSTET GYN R B, V43, P39, DOI 10.1016/0028-2243(92)90241-P; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Gevry NYH, 2004, MOL ENDOCRINOL, V18, P1778, DOI 10.1210/me.2003-0323; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Greenaway J, 2005, BIOL REPROD, V72, P1071, DOI 10.1095/biolreprod.104.031120; Greenaway J, 2004, ENDOCRINOLOGY, V145, P2896, DOI 10.1210/en.2003-1620; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2003, ENDOCRINOLOGY, V144, P4597, DOI 10.1210/en.2003-0048; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jamnongjit M, 2006, CELL CYCLE, V5, P1178, DOI 10.4161/cc.5.11.2803; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jirawatnotai S, 2003, J BIOL CHEM, V278, P17021, DOI 10.1074/jbc.M301206200; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Joyce IM, 2001, ENDOCRINOLOGY, V142, P3187, DOI 10.1210/en.142.7.3187; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; LI Z, 2004, CURRENT PROTOCOLS S, V58; Liu Y, 2006, CELL STRESS CHAPERON, V11, P379, DOI 10.1379/CSC-210.1; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Natesampillai S, 2008, AM J PHYSIOL-ENDOC M, V294, pE385, DOI 10.1152/ajpendo.00480.2007; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; PELUSO JJ, 1980, CELL TISSUE RES, V211, P105; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; PUTOWSKI LT, 1995, J SOC GYNECOL INVEST, V2, P735, DOI 10.1016/1071-5576(95)00028-D; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Ronen-Fuhrmann T, 1998, ENDOCRINOLOGY, V139, P303, DOI 10.1210/en.139.1.303; Roy L, 2009, ENDOCRINOLOGY, V150, P5036, DOI 10.1210/en.2009-0771; Sambook J, 1989, MOL CLONING LAB MANU; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Segi E, 2003, BIOL REPROD, V68, P804, DOI 10.1095/biolreprod.102.003590; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Terada Y, 2003, J AM SOC NEPHROL, V14, P1223, DOI 10.1097/01.ASN.0000060577.94532.06; Tevosian SG, 2008, DEV DYNAM, V237, P3672, DOI 10.1002/dvdy.21784; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wahlberg P, 2008, ENDOCRINOLOGY, V149, P5070, DOI 10.1210/en.2007-1736; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; ZELEZNIK AJ, 1974, ENDOCRINOLOGY, V95, P818, DOI 10.1210/endo-95-3-818	67	108	114	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					3010	3025		10.1096/fj.09-145789	http://dx.doi.org/10.1096/fj.09-145789			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371632	Green Published, Bronze			2022-12-25	WOS:000285005400039
J	Costa, B; Dettori, D; Lorenzato, A; Bardella, C; Coltella, N; Martino, C; Cammarata, C; Carmeliet, P; Olivero, M; Di Renzo, MF				Costa, Barbara; Dettori, Daniela; Lorenzato, Annalisa; Bardella, Chiara; Coltella, Nadia; Martino, Cosimo; Cammarata, Cristina; Carmeliet, Peter; Olivero, Martina; Di Renzo, Maria Flavia			Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis	FASEB JOURNAL			English	Article						hypoxia inducible factor; mitochondrial tumor suppressors; tyrosine kinase oncogenes	RENAL-CELL CARCINOMA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SMALL-MOLECULE INHIBITOR; C-MET; HEREDITARY LEIOMYOMATOSIS; ACTIVATOR INHIBITOR; SOMATIC MUTATIONS; INVASIVE GROWTH; SCATTER-FACTOR; CANCER CELLS	Loss of the fumarate hydratase (FH) tumor suppressor gene results in the development of benign tumors that rarely, but regrettably, progress to very aggressive cancers. Using mouse embryo fibroblasts (MEFs) to model transformation, we found that fh knockdown results in increased expression of the met oncogene-encoded tyrosine kinase receptor through hypoxia-inducible factor (hif) stabilization. MET-increased expression was alone able to stabilize hif, thus establishing a feed forward loop that might enforce tumor progression. The fh-defective MEFs showed increased motility and protection from apoptosis. Motility, but not survival, relied on hif-1 alpha and was greatly enhanced by MET ligand hepatocyte growth factor. Met cooperated with a weakly oncogenic ras in making MEFs transformed and tumorigenic, as shown by in vitro and in vivo assays. Loss of fh was not equally effective by itself but enhanced the transformed and tumorigenic phenotype induced by ras and MET. Consistently, the rescue of fumarase expression abrogated the motogenic and transformed phenotype of fh-defective MEFs. In conclusion, the data suggest that the progression of tumors where FH is lost might be boosted by activation of the MET oncogene, which is able to drive cell-autonomous tumor progression and is a strong candidate for targeted therapy.-Costa, B., Dettori, D., Lorenzato, A., Bardella, C., Coltella, N., Martino, C., Cammarata, C., Carmeliet, P., Olivero, M., Di Renzo, M. F. Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis. FASEB J. 24, 2680-2688 (2010). www.fasebj.org	[Di Renzo, Maria Flavia] Univ Turin, Inst Canc Res & Treatment, IRCC, Sch Med,Dept Oncol Sci, I-10060 Turin, Italy; [Cammarata, Cristina] Inst Canc Res & Treatment, Lab Med Oncol, Candiolo, Italy; [Costa, Barbara; Dettori, Daniela; Lorenzato, Annalisa; Bardella, Chiara; Coltella, Nadia; Martino, Cosimo; Olivero, Martina; Di Renzo, Maria Flavia] Inst Canc Res & Treatment, Canc Genet Lab, Candiolo, Italy; [Dettori, Daniela; Carmeliet, Peter] Vesalius Res Ctr VIB, Louvain, Belgium; [Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, Leuven, Belgium	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia; Flanders Institute for Biotechnology (VIB); KU Leuven	Di Renzo, MF (corresponding author), Univ Turin, Inst Canc Res & Treatment, IRCC, Sch Med,Dept Oncol Sci, SP142 Km 3-95, I-10060 Turin, Italy.	mariaflavia.direnzo@unito.it	Carmeliet, Peter/AAQ-5140-2020; Coltella, Nadia/AAO-3671-2020; DI RENZO, Maria Flavia/B-6091-2012; olivero, martina/J-4811-2018; bardella, chiara/AAG-6272-2021	Carmeliet, Peter/0000-0001-7961-1821; DI RENZO, Maria Flavia/0000-0002-5093-3373; olivero, martina/0000-0002-6815-3498; Lorenzato, Annalisa/0000-0002-9324-2337; Costa, Barbara/0000-0001-5958-5099; Martino, Cosimo/0000-0002-7286-9755; Bardella, Chiara/0000-0002-7780-2541	Italian Association for Cancer Research; Regione Piemonte	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte(Regione Piemonte)	The authors thank Enzo De Sio and Raffaella Albano for technical help. This work was supported by grants from the Italian Association for Cancer Research and from Regione Piemonte (to M.F.D). The authors declare no financial conflicts of interest.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bardos JI, 2004, BIOESSAYS, V26, P262, DOI 10.1002/bies.20002; Baysal BE, 2003, TRENDS ENDOCRIN MET, V14, P453, DOI 10.1016/j.tem.2003.08.004; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bertotti A, 2003, TRENDS BIOCHEM SCI, V28, P527, DOI 10.1016/j.tibs.2003.09.001; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blum R, 2005, CANCER RES, V65, P999; Bramwell VHC, 2005, CANCER BIOL THER, V4, P1336, DOI 10.4161/cbt.4.12.2166; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Christensen JG, 2003, CANCER RES, V63, P7345; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; GHERARDI E, 1990, NATURE, V346, P228, DOI 10.1038/346228b0; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; Inoue K, 1998, VIRCHOWS ARCH, V433, P511, DOI 10.1007/s004280050282; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kataoka H, 2003, CANCER METAST REV, V22, P223, DOI 10.1023/A:1023051500010; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; KOSKI TA, 2009, GENE CHROMOSOME CANC, V16, P16; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Long IS, 2003, MOL CANCER RES, V1, P393; Lorenzato A, 2002, CANCER RES, V62, P7025; Lorenzato A, 2008, INT J CANCER, V122, P947, DOI 10.1002/ijc.23209; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pollard P, 2005, J PATHOL, V205, P41, DOI 10.1002/path.1686; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; RONG S, 1995, CANCER RES, V55, P1963; Ryan HE, 2000, CANCER RES, V60, P4010; Scarpino S, 2004, J PATHOL, V202, P352, DOI 10.1002/path.1522; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Scotlandi K, 1996, AM J PATHOL, V149, P1209; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SUDARSHAN S, 2009, MOL CELL BIOL, V26, P26; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Yamauchi M, 2004, J UROLOGY, V171, P890, DOI 10.1097/01.ju.0000092861.21122.d2; Yang Y, 2008, MOL CANCER THER, V7, P952, DOI 10.1158/1535-7163.MCT-07-2045	52	10	10	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2680	2688		10.1096/fj.09-146928	http://dx.doi.org/10.1096/fj.09-146928			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354140				2022-12-25	WOS:000285005400010
J	Stokes, L; Fuller, SJ; Sluyter, R; Skarratt, KK; Gu, BJ; Wiley, JS				Stokes, Leanne; Fuller, Stephen J.; Sluyter, Ronald; Skarratt, Kristen K.; Gu, Ben J.; Wiley, James S.			Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1 beta secretion	FASEB JOURNAL			English	Article						purinergic receptor; inflammation	IL-1-BETA SECRETION; POTENT ANTAGONIST; ALA POLYMORPHISM; P2X7 RECEPTOR; ION-CHANNEL; ATP; RELEASE; GENE; ACTIVATION; SUSCEPTIBILITY	The P2X(7) receptor is an ATP-gated cation channel expressed in immune cells and plays a role in proinflammatory cytokine release from monocytes and macrophages. This study investigated the coinheritance of 12 functionally relevant single nucleotide polymorphisms (SNPs) in the human P2X(7) gene (P2RX7), and the functional effect of each singly and in combination was assessed by measurements of ATP-induced currents and ethidium(+) uptake. Genotyping of 3430 Caucasian subjects identified 4 common haplotypes in addition to the common (wild-type) P2X(7)-1. Two haplotypes (denoted P2X(7)-2 and P2X(7)-4) contained various combinations of gain-of-function SNPs. P2X(7)-4 was identified uniquely by the Gln-460 to Arg polymorphism (rs2230912). When expressed in HEK-293 cells, recombinant P2X(7)-2, and P2X(7)-4 haplotypes displayed a 3-fold and 5-fold increase, respectively, in receptor function compared to the wildtype P2X(7)-1. Both P2X(7) haplotypes contained the Ala-348>Thr polymorphism (rs1718119), and this mutation was critical for the gain-of-function effect. Peripheral blood monocytes and erythrocytes from subjects homozygous for gain-of-function P2X(7) haplotypes exhibited increased ATP-induced ethidium(+) uptake and Rb-86(+) efflux, respectively, and this correlated with increased IL-1 beta secretion from LPS-primed monocytes. Inheritance of these P2X(7) haplotypes predisposing to increased proinflammatory cytokine secretion may be important in genetic association studies of inflammatory, infectious, and psychiatric disorders.-Stokes, L., Fuller, S. J., Sluyter, R., Skarratt, K. K., Gu, B. J., Wiley, J. S. Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1 beta secretion. FASEB J. 24, 2916-2927 (2010). www.fasebj.org	[Gu, Ben J.; Wiley, James S.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Stokes, Leanne; Fuller, Stephen J.; Sluyter, Ronald; Skarratt, Kristen K.; Gu, Ben J.; Wiley, James S.] Univ Sydney, Nepean Clin Sch, Nepean Hosp, Dept Med, Penrith, NSW, Australia; [Sluyter, Ronald] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Nepean Hospital; University of Sydney; University of Wollongong	Wiley, JS (corresponding author), Univ Melbourne, Florey Neurosci Inst, Level 3 Alan Gilbert Bldg, Melbourne, Vic 3010, Australia.	james.wiley@florey.edu.au	Sluyter, Ronald/B-5798-2009; Skarratt, Kristy/AAN-1479-2020; Stokes, Leanne/B-9580-2008; Fuller, Stephen/W-6646-2019	Sluyter, Ronald/0000-0003-4909-686X; Fuller, Stephen/0000-0003-4637-7391; Gu, Ben/0000-0001-5500-4453; Wiley, James/0000-0001-9421-4154; Skarratt, Kristy/0000-0003-4971-2773; Stokes, Leanne/0000-0003-4013-6781	National Health and Medical Research Council of Australia; Leukemia Research Foundation (Australia); Cure Cancer Australia; University of Sydney Faculty of Medicine; Nepean Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia Research Foundation (Australia); Cure Cancer Australia; University of Sydney Faculty of Medicine(University of Sydney); Nepean Medical Research Foundation	L.S. conducted the majority of experiments and analyzed data; L.S., B.J.G., and J.S.W. designed experiments; S.J.F. conducted haplotype analysis; K.K.S. performed genotyping; R.S. contributed data for Fig. 6; L.S. and J.S.W. wrote the manuscript; and S.J.F., K.K.S, R.S., and B.J.G. contributed to the writing of the manuscript. The authors are grateful to Leah McKinnon for collection of blood for experiments on native cells. This work is funded by the National Health and Medical Research Council of Australia, Leukemia Research Foundation (Australia), and Cure Cancer Australia. The authors acknowledge equipment grants awarded by the University of Sydney Faculty of Medicine and Nepean Medical Research Foundation to L.S. and J.S.W. for the purchase of electrophysiology equipment.	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; ELMOATASSIM C, 1992, J BIOL CHEM, V267, P23664; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Fernando SL, 2005, J INFECT DIS, V192, P149, DOI 10.1086/430622; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; Grigoroiu-Serbanescu M, 2009, AM J MED GENET B, V150B, P1017, DOI 10.1002/ajmg.b.30952; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Jursik C, 2007, J IMMUNOL METHODS, V325, P67, DOI 10.1016/j.jim.2007.06.002; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lester S, 2008, ARTHRITIS RHEUM, V58, pS792; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; ROGER S, 2009, PSYCHIAT RES, DOI DOI 10.1016/J.JPSYCHIRES.2009.10.005; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Skarratt KK, 2005, FEBS LETT, V579, P2675, DOI 10.1016/j.febslet.2005.03.091; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200	59	127	132	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2916	2927		10.1096/fj.09-150862	http://dx.doi.org/10.1096/fj.09-150862			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20360457	Bronze			2022-12-25	WOS:000285005400031
J	Gupte, RS; Rawat, DK; Chettimada, S; Cioffi, DL; Wolin, MS; Gerthoffer, WT; McMurtry, IF; Gupte, SA				Gupte, Rakhee S.; Rawat, Dhawjbahadur K.; Chettimada, Sukrutha; Cioffi, Donna L.; Wolin, Michael S.; Gerthoffer, William T.; McMurtry, Ivan F.; Gupte, Sachin A.			Activation of Glucose-6-phosphate Dehydrogenase Promotes Acute Hypoxic Pulmonary Artery Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; SUPEROXIDE GENERATION; MYOSIN PHOSPHATASE; CORONARY-ARTERY; BOVINE CORONARY; RHO-KINASE; HYPERTENSION; VASOCONSTRICTION; CELLS; PATHWAY	Hypoxic pulmonary vasoconstriction (HPV) is a physiological response to a decrease in airway O-2 tension, but the underlying mechanism is incompletely understood. We studied the contribution of glucose-6-phosphate dehydrogenase (Glc-6-PD), an important regulator of NADPH redox and production of reactive oxygen species, to the development of HPV. We found that hypoxia (95% N-2, 5% CO2) increased contraction of bovine pulmonary artery (PA) precontracted with KCl or serotonin. Depletion of extracellular glucose reducedNADPH, NADH, and HPV, substantiating the idea that glucose metabolism and Glc-6-PD play roles in the response of PA to hypoxia. Our data also show that inhibition of glycolysis and mitochondrial respiration (indicated by an increase in NAD(+) and decrease in the ATP-toADP ratio) by hypoxia, or by inhibitors of pyruvate dehydrogenase or electron transport chain complexes I or III, increased generation of reactive oxygen species, which in turn activated Glc6-PD. Inhibition of Glc-6-PD decreased Ca2+ sensitivity to the myofilaments and diminished Ca2+ -independent and -dependent myosin light chain phosphorylation otherwise increased by hypoxia. Silencing Glc-6-PD expression in PA using a targeted small interfering RNA abolished HPV and decreased extracellular Ca2+-dependent PA contraction increased by hypoxia. Similarly, Glc-6-PD expression and activity were significantly reduced in lungs from Glc-6-PDmut(-/-) mice, and there was a corresponding reduction in HPV. Finally, regression analysis relating Glc-6-PD activity and the NADPH-to-NADP(+) ratio to the HPV response clearly indicated a positive linear relationship between Glc-6-PD activity and HPV. Based on these findings, we propose that Glc-6-PD and NADPH redox are crucially involved in the mechanism of HPV and, in turn, may play a key role in increasing pulmonary arterial pressure, which is involved in the development of pulmonary hypertension.	[Gupte, Rakhee S.; Rawat, Dhawjbahadur K.; Chettimada, Sukrutha; Cioffi, Donna L.; Gerthoffer, William T.; Gupte, Sachin A.] Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, Mobile, AL 36688 USA; [McMurtry, Ivan F.] Univ S Alabama, Dept Pharmacol, Coll Med, Mobile, AL 36688 USA; [Wolin, Michael S.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of South Alabama; University of South Alabama; New York Medical College	Gupte, SA (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, MSB Rm 2312,307 N Univ Blvd, Mobile, AL 36688 USA.	sagupte@usouthal.edu		Chettimada, Sukrutha/0000-0002-2224-9988; Gerthoffer, William/0000-0001-5154-4962	National Institutes of Health [HL085352, HL31069, HL43023, HL66331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031069, R01HL077726, R01HL085352, P01HL043023, R01HL066331, R21HL097220, R01HL132574, R23HL031069, R37HL031069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085352, HL31069, HL43023, and HL66331.	Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; BARRON JT, 1986, ATHEROSCLEROSIS, V59, P57, DOI 10.1016/0021-9150(86)90033-X; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bonnet S, 2003, P NATL ACAD SCI USA, V100, P9488, DOI 10.1073/pnas.1633724100; Eddahibi S, 2002, EUR RESPIR J, V20, P1559, DOI 10.1183/09031936.02.00081302; EGGLESTON LV, 1974, BIOCHEM J, V138, P425, DOI 10.1042/bj1380425; Esteve JM, 2007, CELL BIOCHEM BIOPHYS, V47, P33, DOI 10.1385/CBB:47:1:33; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Gao Q, 2008, AM J PHYSIOL-HEART C, V295, pH978, DOI 10.1152/ajpheart.00316.2008; Gupte SA, 2006, PULM PHARMACOL THER, V19, P303, DOI 10.1016/j.pupt.2005.08.002; Gupte SA, 2005, AM J PHYSIOL-HEART C, V288, pH13, DOI 10.1152/ajpheart.00629.2004; Gupte SA, 2003, AM J PHYSIOL-HEART C, V285, pH2316, DOI 10.1152/ajpheart.00229.2003; Gupte SA, 2002, J PHARMACOL EXP THER, V301, P299, DOI 10.1124/jpet.301.1.299; Gupte SA, 2008, ANTIOXID REDOX SIGN, V10, P1137, DOI 10.1089/ars.2007.1995; Homma N, 2008, AM J PHYSIOL-LUNG C, V295, pL71, DOI 10.1152/ajplung.90251.2008; KAUFFMAN FC, 1969, J BIOL CHEM, V244, P3647; LAMANNA JC, 1980, CIRC RES, V46, P755, DOI 10.1161/01.RES.46.6.755; Leach RM, 2002, RESP PHYSIOL NEUROBI, V132, P55, DOI 10.1016/S1569-9048(02)00049-6; Leach RM, 2001, J PHYSIOL-LONDON, V536, P211, DOI 10.1111/j.1469-7793.2001.00211.x; LEE S, 1994, PFLUG ARCH EUR J PHY, V427, P378, DOI 10.1007/BF00374548; LYNCH RM, 1983, SCIENCE, V222, P1344, DOI 10.1126/science.6658455; MARTIN GR, 1994, PHARMACOL THERAPEUT, V62, P283, DOI 10.1016/0163-7258(94)90048-5; McMurtry I F, 1982, Adv Shock Res, V8, P21; Mohazzab-H KM, 1999, AM J PHYSIOL-HEART C, V276, pH235; Oka M, 2008, BRIT J PHARMACOL, V155, P444, DOI 10.1038/bjp.2008.239; Oka M, 2007, CARDIOVASC RES, V74, P377, DOI 10.1016/j.cardiores.2007.01.021; OZAKI H, 1991, J PHYSIOL-LONDON, V440, P207, DOI 10.1113/jphysiol.1991.sp018704; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Park MK, 1997, PFLUG ARCH EUR J PHY, V434, P764, DOI 10.1007/s004240050463; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Perez JF, 2005, J GEN PHYSIOL, V125, P555, DOI 10.1085/jgp.200409217; Peri R, 2001, J BIOL CHEM, V276, P738, DOI 10.1074/jbc.M008445200; POST JM, 1992, AM J PHYSIOL, V262, P882; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; SATO K, 1994, J PHYSIOL-LONDON, V481, P677, DOI 10.1113/jphysiol.1994.sp020473; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sommer N, 2008, EUR RESPIR J, V32, P1639, DOI 10.1183/09031936.00013908; STANBROOK HS, 1983, J APPL PHYSIOL, V55, P1467, DOI 10.1152/jappl.1983.55.5.1467; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Tipparaju SM, 2008, BIOCHEMISTRY-US, V47, P8840, DOI 10.1021/bi800301b; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Ward JPT, 2009, CURR OPIN PHARMACOL, V9, P287, DOI 10.1016/j.coph.2009.02.006; Ward JPT, 2004, CELL CALCIUM, V36, P209, DOI 10.1016/j.ceca.2004.02.017; Wardle RL, 2006, J PHYSIOL-LONDON, V572, P259, DOI 10.1113/jphysiol.2005.104083; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Waypa GB, 2006, CIRC RES, V99, P970, DOI 10.1161/01.RES.0000247068.75808.3f; WIENER CM, 1991, J APPL PHYSIOL, V70, P439, DOI 10.1152/jappl.1991.70.1.439; Zhao Y, 1996, EXP LUNG RES, V22, P51, DOI 10.3109/01902149609074017; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013	51	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19561	19571		10.1074/jbc.M109.092916	http://dx.doi.org/10.1074/jbc.M109.092916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20363753	Green Published, hybrid			2022-12-25	WOS:000278727800066
J	Katz, A; Lifshitz, Y; Bab-Dinitz, E; Kapri-Pardes, E; Goldshleger, R; Tal, DM; Karlish, SJD				Katz, Adriana; Lifshitz, Yael; Bab-Dinitz, Elizabeta; Kapri-Pardes, Einat; Goldshleger, Rivka; Tal, Daniel M.; Karlish, Steven J. D.			Selectivity of Digitalis Glycosides for Isoforms of Human Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; NA+-K+-ATPASE; CARDIAC-GLYCOSIDES; PICHIA-PASTORIS; CARDIOTONIC STEROIDS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; BINDING-SITE; OUABAIN; SUGAR	There are four isoforms of the alpha subunit (alpha 1-4) and three isoforms of the beta subunit (beta 1-3) of Na,K-ATPase, with distinct tissue-specific distribution and physiological functions. alpha 2 is thought to play a key role in cardiac and smooth muscle contraction and be an important target of cardiac glycosides. An alpha 2-selective cardiac glycoside could provide important insights into physiological and pharmacological properties of alpha 2. The isoform selectivity of a large number of cardiac glycosides has been assessed utilizing alpha 1 beta 1, alpha 2 beta 1, and alpha 3 beta 1 isoforms of human Na, K-ATPase expressed in Pichia pastoris and the purified detergent-soluble isoform proteins. Binding affinities of the digitalis glycosides, digoxin, beta-methyl digoxin, and digitoxin show moderate but highly significant selectivity (up to 4-fold) for alpha 2/beta 3 over alpha 1 (K-D alpha 1 > alpha 2 = alpha 3). By contrast, ouabain shows moderate selectivity (approximate to 2.5-fold) for alpha 1 over alpha 2 (K-D alpha 1 <= alpha 3 < alpha 2). Binding affinities for the three isoforms of digoxigenin, digitoxigenin, and all other aglycones tested are indistinguishable (K-D alpha 1 = alpha 3 = alpha 2), showing that the sugar determines isoform selectivity. Selectivity patterns for inhibition of Na, K-ATPase activity of the purified isoform proteins are consistent with binding selectivities, modified somewhat by different affinities of K+ ions for antagonizing cardiac glycoside binding on the three isoforms. The mechanistic insight on the role of the sugars is strongly supported by a recent structure of Na, K-ATPase with bound ouabain, which implies that aglycones of cardiac glycosides cannot discriminate between isoforms. In conclusion, several digitalis glycosides, but not ouabain, are moderately alpha 2-selective. This supports a major role of alpha 2 in cardiac contraction and cardiotonic effects of digitalis glycosides.	[Katz, Adriana; Lifshitz, Yael; Bab-Dinitz, Elizabeta; Kapri-Pardes, Einat; Goldshleger, Rivka; Tal, Daniel M.; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	steven.karlish@weizmann.ac.il						Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; AHMED K, 1983, J BIOL CHEM, V258, P8092; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; DESPA S, 2010, BIOPHYS J, V98; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Dostanic-Larson I, 2006, AM J PHYSIOL-REG I, V290, pR524, DOI 10.1152/ajpregu.00838.2005; Dvela Moran, 2007, Pathophysiology, V14, P159, DOI 10.1016/j.pathophys.2007.09.011; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; FROM AHL, 1990, MOL CELL BIOCHEM, V94, P157, DOI 10.1007/BF00214122; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; HASHIMOTO T, 1986, J MED CHEM, V29, P997, DOI 10.1021/jm00156a017; Hauck C, 2009, EUR J PHARMACOL, V622, P7, DOI 10.1016/j.ejphar.2009.08.039; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; MANUNTA P, 1994, J HYPERTENS, V12, P549; Manunta P, 2001, HYPERTENSION, V37, P472, DOI 10.1161/01.HYP.37.2.472; Mijatovic T, 2008, EXPERT OPIN THER TAR, V12, P1403, DOI [10.1517/14728222.12.11.1403, 10.1517/14728222.12.11.1403 ]; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; Muller-Ehmsen J, 2001, CELL MOL BIOL, V47, P373; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Perry G, 1997, NEW ENGL J MED, V336, P525; RATHORE H, 1986, J MED CHEM, V29, P1945, DOI 10.1021/jm00160a025; SATOH D, 1970, Chemical and Pharmaceutical Bulletin (Tokyo), V18, P94; SCHON R, 1995, N-S ARCH PHARMACOL, V351, P282; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; SCHONFELD W, 1985, N-S ARCH PHARMACOL, V329, P414, DOI 10.1007/BF00496377; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Wang JN, 2001, AM J PHYSIOL-CELL PH, V281, pC1336, DOI 10.1152/ajpcell.2001.281.4.C1336; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; YODA A, 1973, MOL PHARMACOL, V9, P51; Zhang J, 2005, J PHYSIOL-LONDON, V569, P243, DOI 10.1113/jphysiol.2005.091801	46	115	124	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19582	19592		10.1074/jbc.M110.119248	http://dx.doi.org/10.1074/jbc.M110.119248			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388710	hybrid, Green Published			2022-12-25	WOS:000278727800068
J	Nygaard, R; Valentin-Hansen, L; Mokrosinski, J; Frimurer, TM; Schwartz, TW				Nygaard, Rie; Valentin-Hansen, Louise; Mokrosinski, Jacek; Frimurer, Thomas M.; Schwartz, Thue W.			Conserved Water-mediated Hydrogen Bond Network between TM-I, -II, -VI, and -VII in 7TM Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; PROTONATION STATES; METARHODOPSIN-II; RHODOPSIN FAMILY; BOVINE RHODOPSIN; LIGAND-BINDING; SWITCH; GPCR	Five highly conserved polar residues connected by a number of structural water molecules together with two rotamer microswitches, TrpVI:13 and TyrVII:20, constitute an extended hydrogen bond network between the intracellular segments of TM-I, -II, -VI, and -VII of 7TM receptors. Molecular dynamics simulations showed that, although the fewer water molecules in rhodopsin were relatively movable, the hydrogen bond network of the beta 2-adrenergic receptor was fully loaded with water molecules that were surprisingly immobilized between the two rotamer switches, both apparently being in their closed conformation. Manipulations of the rotamer state of TyrVII:20 and TrpVI:13 demonstrated that these residues served as gates for the water molecules at the intracellular and extracellular ends of the hydrogen bond network, respectively. TrpVI:13 at the bottom of the main ligand-binding pocket was shown to apparently function as a catching trap for water molecules. Mutational analysis of the beta 2-adrenergic receptor demonstrated that the highly conserved polar residues of the hydrogen bond network were all important for receptor signaling but served different functions, some dampening constitutive activity (AsnI:18, AspII:10, and AsnVII:13), whereas others (AsnVII:12 and AsnVII:16) located one helical turn apart and sharing a water molecule were shown to be essential for agonist-induced signaling. It is concluded that the conserved water hydrogen bond network of 7TM receptors constitutes an extended allosteric interface between the transmembrane segments being of crucial importance for receptor signaling and that part of the function of the rotamer micro-switches, TyrVII:20 and TrpVI:13, is to gate or trap the water molecules.	[Nygaard, Rie; Valentin-Hansen, Louise; Mokrosinski, Jacek; Schwartz, Thue W.] Univ Copenhagen, Mol Pharmacol Lab, Inst Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn, Prot Res Ctr, DK-2200 Copenhagen, Denmark; [Nygaard, Rie; Frimurer, Thomas M.] 7TM Pharma, DK-2970 Horsholm, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	tws@sund.ku.dk	Nygaard, Rie/B-7351-2013; Mokrosinski, Jacek/J-9506-2012; Mokrosinski, Jacek/M-1963-2019	Mokrosinski, Jacek/0000-0003-1710-1679; Mokrosinski, Jacek/0000-0001-5008-0457; Schwartz, Thue W./0000-0002-0261-6904; Frimruer, Thomas/0000-0002-9682-8245	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; European Union [223057-GIPIO]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); European Union(European Commission)	The work was supported by grants from The Danish Medical Research Council, The Novo Nordisk Foundation, The Lundbeck Foundation, and European Union's Seventh Framework Programme (Grant Agreement 223057-GIPIO).	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Crozier PS, 2007, PROTEINS, V66, P559, DOI 10.1002/prot.21175; Crozier PS, 2003, J MOL BIOL, V333, P493, DOI 10.1016/j.jmb.2003.08.045; Donnelly D, 1999, BIOCHEM J, V339, P55, DOI 10.1042/0264-6021:3390055; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Huber T, 2004, BIOPHYS J, V86, P2078, DOI 10.1016/S0006-3495(04)74268-X; Huber T, 2008, BIOCHEMISTRY-US, V47, P11013, DOI 10.1021/bi800891r; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Khelashvili G, 2009, PROTEINS, V76, P403, DOI 10.1002/prot.22355; Kholmurodov Kh T, 2007, Neurosci Behav Physiol, V37, P161, DOI 10.1007/s11055-007-0164-7; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schlegel B, 2005, J MOL MODEL, V12, P49, DOI 10.1007/s00894-005-0004-z; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Spooner PJR, 2004, J MOL BIOL, V343, P719, DOI 10.1016/j.jmb.2004.08.049; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; ZHOU W, 1994, MOL PHARMACOL, V45, P165	56	41	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19625	19636		10.1074/jbc.M110.106021	http://dx.doi.org/10.1074/jbc.M110.106021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395291	Green Published, hybrid			2022-12-25	WOS:000278727800072
J	Cavigiolio, G; Geier, EG; Shao, BH; Heinecke, JW; Oda, MN				Cavigiolio, Giorgio; Geier, Ethan G.; Shao, Baohai; Heinecke, Jay W.; Oda, Michael N.			Exchange of Apolipoprotein A-I between Lipid-associated and Lipid-free States A POTENTIAL TARGET FOR OXIDATIVE GENERATION OF DYSFUNCTIONAL HIGH DENSITY LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABCA1-DEPENDENT CHOLESTEROL EFFLUX; FLUORESCENCE ENERGY-TRANSFER; ESTER TRANSFER PROTEIN; N-TERMINAL DOMAIN; PRE-BETA-HDL; APOA-I; METHIONINE OXIDATION; MOLECULAR REGULATION; SCAVENGER RECEPTOR; MYELOPEROXIDASE	An important event in cholesterol metabolism is the efflux of cellular cholesterol by apolipoprotein A-I (apoA-I), the major protein of high density lipoproteins (HDL). Lipid-free apoA-I is the preferred substrate for ATP-binding cassette A1, which promotes cholesterol efflux from macrophage foam cells in the arterial wall. However, the vast majority of apoA-I in plasma is associated with HDL, and the mechanisms for the generation of lipid-free apoA-I remain poorly understood. In the current study, we used fluorescently labeled apoA-I that exhibits a distinct fluorescence emission spectrum when in different states of lipid association to establish the kinetics of apoA-I transition between the lipid-associated and lipid-free states. This approach characterized the spontaneous and rapid exchange of apoA-I between the lipid-associated and lipid-free states. In contrast, the kinetics of apoA-I exchange were significantly reduced when apoA-I on HDL was cross-linked with a bi-functional reagent or oxidized by myeloperoxidase. Our observations support the hypothesis that oxidative damage to apoA-I by myeloperoxidase limits the ability of apoA-I to be liberated in a lipid-free form from HDL. This impairment of apoA-I exchange reaction may be a trait of dysfunctional HDL contributing to reduced ATP-binding cassette A1-mediated cholesterol efflux and atherosclerosis.	[Cavigiolio, Giorgio; Geier, Ethan G.; Oda, Michael N.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Shao, Baohai; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Washington; University of Washington Seattle	Oda, MN (corresponding author), 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	moda@chori.org		Cavigiolio, Giorgio/0000-0002-1622-0628; Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [HL077268, HL086708, HL030086]; Tobacco-related Disease Research Program of California [16FT-0163, 16FT-0054, 18KT-0021]; National Institutes of Health, NHLBI [K99/R00, K99HL091055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091055, R01HL086798, P01HL030086, R00HL091055, R01HL077268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program of California(University of California System); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077268, HL086708, and HL030086. This work was also supported by Tobacco-related Disease Research Program of California Grant 16FT-0163.; Supported by Postdoctoral Fellowship 16FT-0054 and New Investigator Award 18KT-0021 from the Tobacco-related Disease Research Program of California.; Supported by K99/R00 Award K99HL091055 from the National Institutes of Health, NHLBI.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Artola RL, 1997, BIOCHEM BIOPH RES CO, V239, P570, DOI 10.1006/bbrc.1997.7496; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bernhard D, 2005, FASEB J, V19, P1096, DOI 10.1096/fj.04-3192com; BIELICKI JK, 1995, J LIPID RES, V36, P322; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DALLINGATHIE GM, 1986, J LIPID RES, V27, P1035; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DEPAUW M, 1995, BIOCHEMISTRY-US, V34, P10953, DOI 10.1021/bi00034a030; Duong PT, 2008, J LIPID RES, V49, P1006, DOI 10.1194/jlr.M700506-JLR200; Fisher CA, 1999, J LIPID RES, V40, P93; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Forster T., 1965, MODERN QUANTUM CHEM; Forte TM, 1996, J LIPID RES, V37, P1076; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; Heinecke JW, 2003, AM J CARDIOL, V91, p12A; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kawashiri MA, 2002, ATHEROSCLEROSIS, V165, P15, DOI 10.1016/S0021-9150(02)00103-X; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, P367; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; Liang HQ, 1996, J LIPID RES, V37, P1962; Lillo MP, 1997, BIOCHEMISTRY-US, V36, P11273, DOI 10.1021/bi970789z; Lund-Katz S, 2010, J LIPID RES, V51, P606, DOI 10.1194/jlr.M002055; Lusa S, 1996, BIOCHEM J, V313, P275, DOI 10.1042/bj3130275; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Malle E, 2006, ARCH BIOCHEM BIOPHYS, V445, P245, DOI 10.1016/j.abb.2005.08.008; MALMENDIER CL, 1983, CLIN CHIM ACTA, V131, P201, DOI 10.1016/0009-8981(83)90089-X; Marcel YL, 2008, CURR OPIN LIPIDOL, V19, P455, DOI 10.1097/MOL.0b013e32830f4a1d; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MASSEY JB, 1981, BIOCHEM BIOPH RES CO, V99, P466, DOI 10.1016/0006-291X(81)91768-X; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Miyazaki M, 2009, BIOCHEMISTRY-US, V48, P7756, DOI 10.1021/bi900785x; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Navab Mohamad, 2007, Curr Atheroscler Rep, V9, P244, DOI 10.1007/s11883-007-0026-3; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Okuhira K, 2004, J LIPID RES, V45, P645, DOI 10.1194/jlr.M300257-JLR200; PASZTY C, 1994, J CLIN INVEST, V94, P899, DOI 10.1172/JCI117412; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pennathur Subramaniam, 2007, Curr Diab Rep, V7, P257, DOI 10.1007/s11892-007-0041-3; Petersen M, 2005, CLIN CHEM, V51, P1457, DOI 10.1373/clinchem.2004.046748; Phu MJ, 2005, J NEUROSCI RES, V80, P877, DOI 10.1002/jnr.20503; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Pownall HJ, 2007, BIOCHEMISTRY-US, V46, P7449, DOI 10.1021/bi700496w; Pownall HJ, 2005, BIOCHEMISTRY-US, V44, P9714, DOI 10.1021/bi050729q; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; REIJNGOUD DJ, 1982, BIOCHEMISTRY-US, V21, P2969, DOI 10.1021/bi00541a026; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; RYAN RO, 1992, BIOCHEMISTRY-US, V31, P4509, DOI 10.1021/bi00133a018; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 1997, J BIOL CHEM, V272, P3953, DOI 10.1074/jbc.272.7.3953; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Schobel U, 1999, BIOCONJUGATE CHEM, V10, P1107, DOI 10.1021/bc990073b; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Yamamoto T, 2006, J LIPID RES, V47, P1091, DOI 10.1194/jlr.D600001-JLR200; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	94	72	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18847	18857		10.1074/jbc.M109.098434	http://dx.doi.org/10.1074/jbc.M109.098434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385548	Green Published, hybrid			2022-12-25	WOS:000278453900075
J	Serra-Perez, A; Planas, AM; Nunez-O'Mara, A; Berra, E; Garcia-Villoria, J; Ribes, A; Santalucia, T				Serra-Perez, Anna; Planas, Anna M.; Nunez-O'Mara, Analia; Berra, Edurne; Garcia-Villoria, Judit; Ribes, Antonia; Santalucia, Tomas			Extended Ischemia Prevents HIF1 alpha Degradation at Reoxygenation by Impairing Prolyl-hydroxylation ROLE OF KREBS CYCLE METABOLITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; LINDAU TUMOR-SUPPRESSOR; MAMMALIAN TARGET; CELL-METABOLISM; GLUCOSE DEPRIVATION; CEREBRAL-ISCHEMIA; MOUSE MODEL; HIF-ALPHA; HIF-1-ALPHA; OXYGEN	Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that activates the cellular response to hypoxia. The HIF1 alpha subunit is constantly synthesized and degraded under normoxia, but degradation is rapidly inhibited when oxygen levels drop. Oxygen-dependent hydroxylation by prolyl-4-hydroxylases (PHD) mediates HIF1 alpha proteasome degradation. Brain ischemia limits the availability not only of oxygen but also of glucose. We hypothesized that this circumstance could have a modulating effect on HIF. We assessed the separate involvement of oxygen and glucose in HIF1 alpha regulation in differentiated neuroblastoma cells subjected to ischemia. We report higher transcriptional activity and HIF1 alpha expression under oxygen deprivation in the presence of glucose (OD), than in its absence (oxygen and glucose deprivation, OGD). Unexpectedly, HIF1 alpha was not degraded at reoxygenation after an episode of OGD. This was not due to impairment of proteasome function, but was associated with lower HIF1 alpha hydroxylation. Krebs cycle metabolites fumarate and succinate are known inhibitors of PHD, while zeta-ketoglutarate is a co-substrate of the reaction. Lack of HIF1 alpha degradation in the presence of oxygen was accompanied by a very low alpha-ketoglutarate/fumarate ratio. Furthermore, treatment with a fumarate analogue prevented HIF1 alpha degradation under normoxia. In all, our data suggest that postischemic metabolic alterations in Krebs cycle metabolites impair HIF1 alpha degradation in the presence of oxygen by decreasing its hydroxylation, and highlight the involvement of metabolic pathways in HIF1 alpha regulation besides the well known effects of oxygen.	[Serra-Perez, Anna; Planas, Anna M.; Santalucia, Tomas] IIBB CSIC IDIBAPS, Dept Brain Ischemia & Neurodegenerat, E-08036 Barcelona, Spain; [Nunez-O'Mara, Analia; Berra, Edurne] Cooperat Res Ctr Biosci, Cell Biol & Stem Cells Unit, Derio 48160, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] IDIBAPS, Dept Biochem & Mol Genet, Barcelona 08028, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] IDIBAPS, CIBERER, Barcelona 08028, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Santalucia, T (corresponding author), IIBB CSIC IDIBAPS, Dept Brain Ischemia & Neurodegenerat, Rossello 161,6th Floor, E-08036 Barcelona, Spain.	tomas.santalucia@iibb.csic.es	Berra, Edurne/F-9692-2011; cancer, biogune/H-7276-2012; Garcia, Judit/AAN-1753-2021; Planas, Anna M/J-5991-2014; Santalucia, Tomas/I-7411-2012; Santalucia, Tomas/B-6140-2012	Berra, Edurne/0000-0002-3820-5744; Planas, Anna M/0000-0002-6147-1880; Santalucia, Tomas/0000-0003-4604-9195; Santalucia, Tomas/0000-0003-4604-9195; Ribes Rubio, Antonia/0000-0002-2249-246X	MICINN [SAF2005-05793-C02-02, SAF2008-04515-C02-02]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was funded by projects from MICINN (Projects SAF2005-05793-C02-02 and SAF2008-04515-C02-02).	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Banasiak KJ, 1998, BRAIN RES, V797, P295, DOI 10.1016/S0006-8993(98)00286-8; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Boulahbel H, 2009, BIOCHEM SOC T, V37, P291, DOI 10.1042/BST0370291; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Guo SH, 2009, J NEUROCHEM, V108, P1309, DOI 10.1111/j.1471-4159.2009.05877.x; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lee MN, 2009, MOL CELL BIOL, V29, P3991, DOI 10.1128/MCB.00165-09; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Mole DR, 2001, IUBMB LIFE, V52, P43; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; RIBES A, 1992, J INHERIT METAB DIS, V15, P367, DOI 10.1007/BF02435978; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Serra-Perez A, 2008, J NEUROCHEM, V106, P1237, DOI 10.1111/j.1471-4159.2008.05467.x; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; TANAKA K, 1980, CLIN CHEM, V26, P1847; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Vordermark D, 2005, CANCER LETT, V230, P122, DOI 10.1016/j.canlet.2004.12.040; YAGER JY, 1991, AM J PHYSIOL, V261, pH1102, DOI 10.1152/ajpheart.1991.261.4.H1102; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou Jing, 2008, Kobe J Med Sci, V53, P283	40	35	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18217	18224		10.1074/jbc.M110.101048	http://dx.doi.org/10.1074/jbc.M110.101048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20368331	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000278453900013
J	Staples, GO; Shi, XF; Zaia, J				Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph			Extended N-Sulfated Domains Reside at the Nonreducing End of Heparan Sulfate Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HEPARIN/HEPARAN SULFATE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CELL-SURFACE; FACTOR FGF; K5 LYASE; RECEPTOR; BINDING; SPECIFICITY	Heparan sulfate (HS) serves as a cell-surface co-receptor for growth factors, morphogens, and chemokines. These HS and protein binding events depend on the fine structure and distribution of domains along an HS chain. A given domain can vary in terms of uronic acid epimer, N- and O-sulfate, and N-acetate content. The most highly sulfated regions of HS chains, N-sulfated (NS) domains, play prominent roles in HS and protein binding. We have analyzed HS oligosaccharides from various mammalian sources and provide evidence that NS domains residing at the nonreducing end (NRE) are, on average, longer than those residing in the internal regions of the chain. Additionally, they are more highly sulfated than their internal counterparts. These features are independent of the sulfation pattern of the bulk HS chains. From disaccharide analysis, it is clear that NS domains do not always occupy HS NREs. However, when they do, they tend to terminate in a subset of N-sulfated disaccharides. Our observations are consistent with a significant role of NRE NS domains in HS-growth factor interactions.	[Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA	Boston University	Zaia, J (corresponding author), 670 Albany St,Rm 509, Boston, MA 02118 USA.	jzaia@bu.edu	Shi, Xiaofeng/B-8700-2011; Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701	National Institutes of Health [P41RR10888]; Agilent Technologies Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agilent Technologies Foundation(Principality of Asturias); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P41RR10888. This work was also supported by the Agilent Technologies Foundation through a Research Project Gift.	Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Hitchcock AM, 2006, BIOCHEMISTRY-US, V45, P2350, DOI 10.1021/bi052100t; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; LYON M, 1994, J BIOL CHEM, V269, P11216; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MIDURA RJ, 1995, J BIOL CHEM, V270, P8009, DOI 10.1074/jbc.270.14.8009; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Oesterholm C, 2009, J BIOL CHEM, V284, P34935, DOI 10.1074/jbc.M109.005264; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; STAPLES G, 2009, P 57 ASMS C MASS SPE; STAPLES GO, 2010, ANAL CHEM IN PRESS; Staples GO, 2009, PROTEOMICS, V9, P686, DOI 10.1002/pmic.200701008; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xu XL, 2007, J BIOL CHEM, V282, P2363, DOI 10.1074/jbc.M604218200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200	47	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18336	18343		10.1074/jbc.M110.101592	http://dx.doi.org/10.1074/jbc.M110.101592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363743	Green Published, hybrid			2022-12-25	WOS:000278453900027
J	Vilardo, E; Barbato, C; Ciotti, M; Cogoni, C; Ruberti, F				Vilardo, Elisa; Barbato, Christian; Ciotti, MariaTeresa; Cogoni, Carlo; Ruberti, Francesca			MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; ALZHEIMERS-DISEASE; SECRETASE ACTIVITY; PROSTAGLANDIN E-2; CELL-LINES; BRAIN; IDENTIFICATION; INTERLEUKIN-1; GENE; REGION	The amyloid precursor protein (APP) and its proteolytic product amyloid beta (A beta) are associated with both familial and sporadic forms of Alzheimer disease (AD). Aberrant expression and function of microRNAs has been observed in AD. Here, we show that in rat hippocampal neurons cultured in vitro, the down-regulation of Argonaute-2, a key component of the RNA-induced silencing complex, produced an increase in APP levels. Using site-directed mutagenesis, a microRNA responsive element (RE) for miR-101 was identified in the 3'-untranslated region (UTR) of APP. The inhibition of endogenous miR-101 increased APP levels, whereas lentiviral-mediated miR-101 overexpression significantly reduced APP and A beta load in hippocampal neurons. In addition, miR-101 contributed to the regulation of APP in response to the proinflammatory cytokine interleukin-1 beta (IL-1 beta). Thus, miR-101 is a negative regulator of APP expression and affects the accumulation of A beta, suggesting a possible role for miR-101 in neuropathological conditions.	[Vilardo, Elisa; Barbato, Christian; Ciotti, MariaTeresa; Ruberti, Francesca] CNR, INMM, I-00143 Rome, Italy; [Barbato, Christian; Cogoni, Carlo] Fdn EBRI Rita Levi Montalcini, EBRI, I-00143 Rome, Italy; [Cogoni, Carlo] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, I-00161 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Ruberti, F (corresponding author), CNR, INMM, Via Fosso Fiorano 64-65, I-00143 Rome, Italy.	francesca.ruberti@inmm.cnr.it	Vilardo, Elisa/F-3656-2010; Barbato, Christian/B-8080-2015	Vilardo, Elisa/0000-0003-2733-6009; Barbato, Christian/0000-0003-1737-9064; Ruberti, Francesca/0000-0001-5880-9564	National Research Council (CNR) [DG.RSTL.059.012]; Compagnia di San Paolo-Programma Neuroscienze; REGIONE LAZIO	National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Compagnia di San Paolo-Programma Neuroscienze(Compagnia di San Paolo); REGIONE LAZIO(Regione Lazio)	This work was supported by National Research Council (CNR) Grant DG.RSTL.059.012 (to F. R.) and partially supported by Compagnia di San Paolo-Programma Neuroscienze (to C. B.) and REGIONE LAZIO grant (to C. C.).	Amara FM, 1999, MOL BRAIN RES, V71, P42, DOI 10.1016/S0169-328X(99)00158-8; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Barbato C, 2010, J NEUROCHEM, V113, P591, DOI 10.1111/j.1471-4159.2009.06560.x; Barbato C, 2008, MAMM GENOME, V19, P541, DOI 10.1007/s00335-008-9129-6; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Broytman O, 2009, NEUROBIOL AGING, V30, P1962, DOI 10.1016/j.neurobiolaging.2008.02.011; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; DEL BR, 1995, NEUROSCI LETT, V188, P70; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Ge YW, 2004, J NEUROCHEM, V90, P1432, DOI 10.1111/j.1471-4159.2004.02608.x; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GONZALEZGONZALE.E, 2008, BIOCH BIOPHYS ACTA G, V1179, P306; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hong X, 2009, P NATL ACAD SCI USA, V106, P15085, DOI 10.1073/pnas.0908149106; Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee RKK, 1999, J NEUROSCI, V19, P940; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Romano A, 2003, BEHAV BRAIN RES, V147, P73, DOI 10.1016/S0166-4328(03)00118-9; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007	49	157	174	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18344	18351		10.1074/jbc.M110.112664	http://dx.doi.org/10.1074/jbc.M110.112664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395292	Green Published, hybrid			2022-12-25	WOS:000278453900028
J	Haq, SR; Jurgens, MC; Chi, CN; Koh, CS; Elfstrom, L; Selmer, M; Gianni, S; Jemth, P				Haq, S. Raza; Jurgens, Maike C.; Chi, Celestine N.; Koh, Cha-San; Elfstrom, Lisa; Selmer, Maria; Gianni, Stefano; Jemth, Per			The Plastic Energy Landscape of Protein Folding A TRIANGULAR FOLDING MECHANISM WITH AN EQUILIBRIUM INTERMEDIATE FOR A SMALL PROTEIN DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON-PATHWAY INTERMEDIATE; PDZ DOMAIN; TRANSITION-STATES; KINETIC-ANALYSIS; 3-STATE MODEL; IM7; REFINEMENT	Protein domains usually fold without or with only transiently populated intermediates, possibly to avoid misfolding, which could result in amyloidogenic disease. Whether observed intermediates are productive and obligatory species on the folding reaction pathway or dispensable by-products is a matter of debate. Here, we solved the crystal structure of a small protein domain, SAP97 PDZ2 I342W C378A, and determined its folding pathway. The presence of a folding intermediate was demonstrated both by single and double-mixing kinetic experiments using urea-induced (un) folding as well as ligand-induced folding. This protein domain was found to fold via a triangular scheme, where the folding intermediate could be either on-or off-pathway, depending on the experimental conditions. Furthermore, we found that the intermediate was present at equilibrium, which is rarely seen in folding reactions of small protein domains. The folding mechanism observed here illustrates the roughness and plasticity of the protein folding energy landscape, where several routes may be employed to reach the native state. The results also reconcile the folding mechanisms of topological variants within the PDZ domain family.	[Jurgens, Maike C.; Koh, Cha-San; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Gianni, Stefano] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gianni, Stefano] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy	Uppsala University; Uppsala University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden.	Maria.Selmer@icm.uu.se; Stefano.Gianni@uniroma1.it; Per.Jemth@imbim.uu.se	gianni, stefano/C-8536-2009	Gianni, Stefano/0000-0003-1653-1925	Swedish Research Council; Edla Johansson's Foundation; Carl Trygger's Foundation; Jeansson's Foundation; Clas Groschinskys Minnesfond; Swedish Foundation for Strategic Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Edla Johansson's Foundation; Carl Trygger's Foundation; Jeansson's Foundation; Clas Groschinskys Minnesfond; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Research Council (to P. J. and M. S.), O. E. and Edla Johansson's Foundation, Carl Trygger's Foundation, Jeansson's Foundation, Clas Groschinskys Minnesfond (to P. J.), and the Swedish Foundation for Strategic Research (to M. S.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P14121, DOI 10.1073/pnas.260502597; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2005, PROTEIN ENG DES SEL, V18, P389, DOI 10.1093/protein/gzi047; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gianni S, 2003, J MOL BIOL, V330, P1145, DOI 10.1016/S0022-2836(03)00689-2; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Ivarsson Y, 2008, PROTEIN ENG DES SEL, V21, P155, DOI 10.1093/protein/gzm077; Ivarsson Y, 2007, J BIOL CHEM, V282, P8568, DOI 10.1074/jbc.M611026200; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; KIELHABER T, 1995, P NATL ACAD SCI USA, V92, P9029; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Liu Y, 2007, BIOCHEMISTRY-US, V46, P10864, DOI 10.1021/bi700879k; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Sauder JM, 1996, BIOCHEMISTRY-US, V35, P16852, DOI 10.1021/bi961976k; Spence GR, 2004, J MOL BIOL, V341, P215, DOI 10.1016/j.jmb.2004.05.049; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Travaglini-Allocatelli C, 2003, J BIOL CHEM, V278, P41136, DOI 10.1074/jbc.M303990200; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06	47	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18051	18059		10.1074/jbc.M110.110833	http://dx.doi.org/10.1074/jbc.M110.110833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356847	Green Published, hybrid			2022-12-25	WOS:000278133400080
J	Schott, A; Ravaud, S; Keller, S; Radzimanowski, J; Viotti, C; Hillmer, S; Sinning, I; Strahl, S				Schott, Andrea; Ravaud, Stephanie; Keller, Sabrina; Radzimanowski, Jens; Viotti, Corrado; Hillmer, Stefan; Sinning, Irmgard; Strahl, Sabine			Arabidopsis Stromal-derived Factor2 (SDF2) Is a Crucial Target of the Unfolded Protein Response in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREVACUOLAR COMPARTMENT; QUALITY-CONTROL; STRESS; GENE; SEQUENCE; INSIGHTS; PATTERN; COMPLEX; YEAST	Stresses increasing the load of unfolded proteins that enter the endoplasmic reticulum (ER) trigger a protective response termed the unfolded protein response (UPR). Stromal cell-derived factor2 (SDF2)-type proteins are highly conserved throughout the plant and animal kingdoms. In this study we have characterized AtSDF2 as crucial component of the UPR in Arabidopsis thaliana. Using a combination of biochemical and cell biological methods, we demonstrate that SDF2 is induced in response to ER stress conditions causing the accumulation of unfolded proteins. Transgenic reporter plants confirmed induction of SDF2 during ER stress. Under normal growth conditions SDF2 is highly expressed in fast growing, differentiating cells and meristematic tissues. The increased production of SDF2 due to ER stress and in tissues that require enhanced protein biosynthesis and secretion, and its association with the ER membrane qualifies SDF2 as a downstream target of the UPR. Determination of the SDF2 three-dimensional crystal structure at 1.95 angstrom resolution revealed the typical beta-trefoil fold with potential carbohydrate binding sites. Hence, SDF2 might be involved in the quality control of glycoproteins. Arabidopsis sdf2 mutants display strong defects and morphological phenotypes during seedling development specifically under ER stress conditions, thus establishing that SDF2-type proteins play a key role in the UPR.	[Ravaud, Stephanie; Radzimanowski, Jens; Sinning, Irmgard] Heidelberg Univ, Heidelberg Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Schott, Andrea; Keller, Sabrina; Strahl, Sabine] Heidelberg Univ, Dept Cell Chem, Inst Plant Sci, D-69120 Heidelberg, Germany; [Viotti, Corrado; Hillmer, Stefan] Heidelberg Univ, Dept Cell Biol, Inst Plant Sci, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Heidelberg Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de; sstrahl@HIP.uni-heidelberg.de	Hillmer, Stefan/E-1910-2014; Ravaud, Stephanie/I-4059-2015	Ravaud, Stephanie/0000-0001-5867-0785; Hillmer, Stefan/0000-0002-2739-5044; Viotti, Corrado/0000-0002-0135-7533	Deutsche Forschungs Gemeinschaft [SFB638]	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungs Gemeinschaft (SFB638).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bubeck J, 2008, TRAFFIC, V9, P1629, DOI 10.1111/j.1600-0854.2008.00803.x; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Christensen A, 2008, PLANT CELL PHYSIOL, V49, P912, DOI 10.1093/pcp/pcn065; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; daSilva LLP, 2005, PLANT CELL, V17, P132, DOI 10.1105/tpc.104.026351; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X; Holm L, 1996, METHOD ENZYMOL, V266, P653; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; MCLACHLAN AD, 1979, J MOL BIOL, V133, P557, DOI 10.1016/0022-2836(79)90408-X; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; PRYME IF, 1986, MOL CELL BIOCHEM, V71, P3; Radzimanowski J, 2010, ACTA CRYSTALLOGR F, V66, P12, DOI 10.1107/S1744309109042018; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Weigel D., 2002, ARABIDOPSIS LAB MANU; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yamamoto M, 2008, PLANT CELL PHYSIOL, V49, P1547, DOI 10.1093/pcp/pcn119	46	38	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18113	18121		10.1074/jbc.M110.117176	http://dx.doi.org/10.1074/jbc.M110.117176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378538	Green Published, hybrid			2022-12-25	WOS:000278133400086
J	Zhang, Z; Zhu, WJ; Lapolla, SM; Miao, YW; Shao, YL; Falcone, M; Boreham, D; McFarlane, N; Ding, JZ; Johnson, AE; Zhang, XJC; Andrews, DW; Lin, JL				Zhang, Zhi; Zhu, Weijia; Lapolla, Suzanne M.; Miao, Yiwei; Shao, Yuanlong; Falcone, Mina; Boreham, Doug; McFarlane, Nicole; Ding, Jingzhen; Johnson, Arthur E.; Zhang, Xuejun C.; Andrews, David W.; Lin, Jialing			Bax Forms an Oligomer via Separate, Yet Interdependent, Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL APOPTOSIS; MEMBRANE PERMEABILIZATION; CONFORMATIONAL-CHANGE; BH3-ONLY PROTEINS; PEPTIDE COMPLEX; ACTIVATED BAX; BCL-2 FAMILY; BH3 DOMAIN; CELL-DEATH	Interactions of Bcl-2 family proteins regulate permeability of the mitochondrial outer membrane and apoptosis. In particular, Bax forms an oligomer that permeabilizes the membrane. To map the interface of the Bax oligomer we used Triton X-100 as a membrane surrogate and performed site-specific photocross-linking. Bax-specific adducts were formed through photo-reactive probes at multiple sites that can be grouped into two surfaces. The first surface overlaps with the BH1-3 groove formed by Bcl-2 Homology motif 1, 2, and 3; the second surface is a rear pocket located on the opposite side of the protein from the BH1-3 groove. Further cross-linking experiments using Bax BH3 peptides and mutants demonstrated that the two surfaces interact with their counterparts in neighboring proteins to form two separated interfaces and that interaction at the BH1-3 groove primes the rear pocket for further interaction. Therefore, Bax oligomerization proceeds through a series of interactions that occur at separate, yet allosterically, coupled interfaces.	[Zhang, Zhi; Lapolla, Suzanne M.; Ding, Jingzhen; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Zhu, Weijia; Falcone, Mina; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Boreham, Doug; McFarlane, Nicole] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8N 3Z5, Canada; [Johnson, Arthur E.] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Miao, Yiwei; Shao, Yuanlong; Johnson, Arthur E.] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Chem, College Stn, TX 77843 USA; [Zhang, Xuejun C.] Oklahoma Med Res Fdn, Crystallog Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; McMaster University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Oklahoma Medical Research Foundation	Lin, JL (corresponding author), 940 Stanton L Young Blvd,Biomed Sci Bldg 935,POB, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu	Johnson, Arthur E/G-3457-2012; ding, Jingzhen/B-5427-2015	Andrews, David/0000-0002-9266-7157	National Institutes of Health [GM062964]; Canadian Institutes of Health Research [FRN 12517]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494, R01GM062964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062964 (to J. L.). This work was also supported by Canadian Institutes of Health Research Grant FRN 12517 (to D. W. A. and Brian Leber).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; BHAIRI SM, 2001, DETERGENTS GUIDE PRO, P37; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; HJELMELAND LM, 1990, METHOD ENZYMOL, V182, P277; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Makin GWJ, 2001, EMBO J, V20, P6306, DOI 10.1093/emboj/20.22.6306; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; OLTVAI ZN, 1993, CELL, V74, P619; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Peyerl FW, 2007, CELL DEATH DIFFER, V14, P447, DOI 10.1038/sj.cdd.4402025; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200	54	65	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17614	17627		10.1074/jbc.M110.113456	http://dx.doi.org/10.1074/jbc.M110.113456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382739	Green Published, hybrid			2022-12-25	WOS:000278133400040
J	Lau, NC; Mulder, KW; Brenkman, AB; Mohammed, S; van den Broek, NJF; Heck, AJR; Timmers, HTM				Lau, Nga-Chi; Mulder, Klaas W.; Brenkman, Arjan B.; Mohammed, Shabaz; van den Broek, Niels J. F.; Heck, Albert J. R.; Timmers, H. Th. Marc			Phosphorylation of Not4p Functions Parallel to BUR2 to Regulate Resistance to Cellular Stresses in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA METABOLISM; CYCLIN-DEPENDENT KINASE; TRANSCRIPTION IN-VIVO; CCR4-NOT COMPLEX; HISTONE METHYLATION; GENE-EXPRESSION; PROTEIN-KINASE; POLYMERASE-II; SET1 COMPLEX; YEAST	Background: The evolutionarily conserved Ccr4-Not and Bur1/2 kinase complexes are functionally related in Saccharomyces cerevisiae. In this study, we further explore the relationship between the subunits Not4p and Bur2p. Methodology/Principal Findings: First, we investigated the presence of post-translational modifications on the Ccr4-Not complex. Using mass spectrometry analyses we identified several SP/TP phosphorylation sites on its Not4p, Not1p and Caf1p subunits. Secondly, the influence of Not4p phosphorylation on global H3K4 tri-methylation status was examined by immunoblotting. This histone mark is severely diminished in the absence of Not4p or of Bur2p, but did not require the five identified Not4p phosphorylation sites. Thirdly, we found that Not4p phosphorylation is not affected by the kinase-defective bur1-23 mutant. Finally, phenotypic analyses of the Not4p phosphomutant (not4S/T5A) and bur2D strains showed overlapping sensitivities to drugs that abolish cellular stress responses. The double-mutant not4S/T5A and bur2D strain even revealed enhanced phenotypes, indicating that phosphorylation of Not4p and BUR2 are active in parallel pathways for drug tolerance. Conclusions: Not4p is a phospho-protein with five identified phosphorylation sites that are likely targets of a cyclin-dependent kinase(s) other than the Bur1/2p complex. Not4p phosphorylation on the five Not4 S/T sites is not required for global H3K4 tri-methylation. In contrast, Not4p phosphorylation is involved in tolerance to cellular stresses and acts in pathways parallel to BUR2 to affect stress responses in Saccharomyces cerevisiae.	[Lau, Nga-Chi; Mulder, Klaas W.; Brenkman, Arjan B.; van den Broek, Niels J. F.; Timmers, H. Th. Marc] Univ Med Ctr Utrecht, Dept Physiol Chem, Utrecht, Netherlands; [Lau, Nga-Chi; Mohammed, Shabaz; Heck, Albert J. R.; Timmers, H. Th. Marc] Netherlands Prote Ctr, Utrecht, Netherlands; [Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Lau, NC (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Utrecht, Netherlands.	h.t.m.timmers@umcutrecht.nl	Mulder, Klaas/A-1882-2013; Mohammed, Shabaz/AAY-6313-2020; Heck, Albert/D-7098-2011; Mohammed, Shabaz/D-1042-2010	Mulder, Klaas/0000-0001-8516-4458; Mohammed, Shabaz/0000-0003-2640-9560; Heck, Albert/0000-0002-2405-4404; Mohammed, Shabaz/0000-0003-2640-9560	Netherlands Organization for Scientific Research [NWO-CW 700-50-034]; European Union [RTN2-2001-00026, LSHG-CT-2004-502950]; EMBO [ASTF 184.00-02]; Netherlands Proteomics Centre [NPC4.5, NPC4.7]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Netherlands Proteomics Centre	This work was supported by the Netherlands Organization for Scientific Research (NWO-CW #700-50-034), European Union (Improving Human Potential RTN2-2001-00026 and STREP LSHG-CT-2004-502950), EMBO (ASTF 184.00-02) and the Netherlands Proteomics Centre (NPC4.5 and NPC4.7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Chuang SM, 2005, GENETICS, V171, P1477, DOI 10.1534/genetics.105.046888; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Mulder KW, 2005, NUCLEIC ACIDS RES, V33, P6384, DOI 10.1093/nar/gki938; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; PRELICH G, 1993, GENETICS, V135, P665; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	28	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9864	10.1371/journal.pone.0009864	http://dx.doi.org/10.1371/journal.pone.0009864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386698	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482000001
J	Konagurthu, AS; Reboul, CF; Schmidberger, JW; Irving, JA; Lesk, AM; Stuckey, PJ; Whisstock, JC; Buckle, AM				Konagurthu, Arun S.; Reboul, Cyril F.; Schmidberger, Jason W.; Irving, James A.; Lesk, Arthur M.; Stuckey, Peter J.; Whisstock, James C.; Buckle, Ashley M.			MUSTANG-MR Structural Sieving Server: Applications in Protein Structural Analysis and Crystallography	PLOS ONE			English	Article							ALIGNMENT; DATABASE	Background: A central tenet of structural biology is that related proteins of common function share structural similarity. This has key practical consequences for the derivation and analysis of protein structures, and is exploited by the process of "molecular sieving" whereby a common core is progressively distilled from a comparison of two or more protein structures. This paper reports a novel web server for "sieving" of protein structures, based on the multiple structural alignment program MUSTANG. Methodology/Principal Findings: "Sieved" models are generated from MUSTANG-generated multiple alignment and superpositions by iteratively filtering out noisy residue-residue correspondences, until the resultant correspondences in the models are optimally "superposable" under a threshold of RMSD. This residue-level sieving is also accompanied by iterative elimination of the poorly fitting structures from the input ensemble. Therefore, by varying the thresholds of RMSD and the cardinality of the ensemble, multiple sieved models are generated for a given multiple alignment and superposition from MUSTANG. To aid the identification of structurally conserved regions of functional importance in an ensemble of protein structures, Lesk-Hubbard graphs are generated, plotting the number of residue correspondences in a superposition as a function of its corresponding RMSD. The conserved "core" (or typically active site) shows a linear trend, which becomes exponential as divergent parts of the structure are included into the superposition. Conclusions: The application addresses two fundamental problems in structural biology: First, the identification of common substructures among structurally related proteins-an important problem in characterization and prediction of function; second, generation of sieved models with demonstrated uses in protein crystallographic structure determination using the technique of Molecular Replacement.	[Konagurthu, Arun S.; Stuckey, Peter J.] Univ Melbourne, NICTA Victoria Res Lab, Melbourne, Vic, Australia; [Konagurthu, Arun S.; Stuckey, Peter J.] Univ Melbourne, Dept Comp Sci & Software Engn, Melbourne, Vic, Australia; [Reboul, Cyril F.; Schmidberger, Jason W.; Irving, James A.; Whisstock, James C.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Reboul, Cyril F.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Lesk, Arthur M.] Penn State Univ, Dept Biochem & Mol Biol, Huck Inst Genom Prote & Bioinformat, University Pk, PA 16802 USA	University of Melbourne; University of Melbourne; Monash University; Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Konagurthu, AS (corresponding author), Univ Melbourne, NICTA Victoria Res Lab, Melbourne, Vic, Australia.	ashley.buckle@med.monash.edu.au	Irving, James A/I-8467-2015; Buckle, Ashley/P-8366-2016; Irving, James/P-3860-2019; Schmidberger, Jason/D-5978-2015	Buckle, Ashley/0000-0003-2943-9044; Irving, James/0000-0003-3204-6356; Konagurthu, Arun/0000-0002-1610-8329; Whisstock, James/0000-0003-4200-5611; Stuckey, Peter/0000-0003-2186-0459; Lesk, Arthur/0000-0002-2596-0601; Reboul, Cyril/0000-0002-6258-2697	Australian Research Council; National Health and Medical Research Council; Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; State Government of Victoria (Australia); Australian Government's Department of Communications, Information Technology and the Arts; ICT Centre of Excellence program	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; State Government of Victoria (Australia); Australian Government's Department of Communications, Information Technology and the Arts(Australian Government); ICT Centre of Excellence program	Australian Research Council, National Health and Medical Research Council, Victorian Partnership for Advanced Computing, the Victorian Bioinformatics Consortium, Monash eResearch Centre, the State Government of Victoria (Australia), National ICT Australia (NICTA) is funded by: the Australian Government's Department of Communications, Information Technology and the Arts; the Australian Research Council through Backing Australia's Ability and ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Irving JA, 2001, PROTEINS, V42, P378, DOI 10.1002/1097-0134(20010215)42:3<378::AID-PROT70>3.0.CO;2-3; Ito K, 2006, PROTEIN SCI, V15, P1187, DOI 10.1110/ps.062148506; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622	16	40	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10048	10.1371/journal.pone.0010048	http://dx.doi.org/10.1371/journal.pone.0010048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386610	Green Published, gold, Green Submitted			2022-12-25	WOS:000276420400017
J	Robert, D; Nguyen, TH; Gallet, F; Wilhelm, C				Robert, Damien; Nguyen, Thi-Hanh; Gallet, Francois; Wilhelm, Claire			In Vivo Determination of Fluctuating Forces during Endosome Trafficking Using a Combination of Active and Passive Microrheology	PLOS ONE			English	Article							MOTOR PROTEINS; LIVING CELLS; MECHANICS; KINESIN; MOVE; VISCOELASTICITY; CYTOPLASM; DIFFUSION; DYNAMICS; TRACKING	Background: Regulation of intracellular trafficking is a central issue in cell biology. The forces acting on intracellular vesicles (endosomes) can be assessed in living cells by using a combination of active and passive microrheology. Methodology/Principal Findings: This dual approach is based on endosome labeling with magnetic nanoparticles. The resulting magnetic endosomes act both as probes that can be manipulated with external magnetic fields to infer the viscoelastic modulus of their surrounding microenvironment, and as biological vehicles that are trafficked along the microtubule network by means of forces generated by molecular motors. The intracellular viscoelastic modulus exhibits power law dependence with frequency, which is microtubule and actin-dependent. The mean square displacements of endosomes do not follow the predictions of the fluctuation-dissipation theorem, which offers evidence for active force generation. Microtubule disruption brings the intracellular medium closer to thermal equilibrium: active forces acting on the endosomes depend on microtubule-associated motors. The power spectra of these active forces, deduced through the use of a generalized Langevin equation, show a power law decrease with frequency and reveal an actin-dependent persistence of the force with time. Experimental spectra have been reproduced by a simple model consisting in a series of force steps power-law distributed in time. This model enlightens the role of the cytoskeleton dependent force exerted on endosomes to perform intracellular trafficking. Conclusions/Significance: In this work, the influence of cytoskeleton components and molecular motors on intracellular viscoelasticity and transport is addressed. The use of an original probe, the magnetic endosome, allows retrieving the power spectrum of active forces on these organelles thanks to interrelated active and passive measures. Finally a computational model gives estimates of the force itself and hence of the number of the motors pulling on endosomes.	[Robert, Damien] CNRS, UMR 7057, Lab Matiere & Syst Complexes, Paris, France; Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Robert, D (corresponding author), CNRS, UMR 7057, Lab Matiere & Syst Complexes, Paris, France.	claire.wilhelm@univ-paris-diderot.fr	Gallet, Francois/B-9862-2008	Wilhelm, Claire/0000-0001-7024-9627	ANR Physique et Chimie du Vivant	ANR Physique et Chimie du Vivant(French National Research Agency (ANR))	This work was supported by ANR Physique et Chimie du Vivant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcizet D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248103; Balland M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021911; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; Caspi A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011916; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Feneberg W, 2001, EUR BIOPHYS J BIOPHY, V30, P284, DOI 10.1007/s002490100135; Gallet F, 2009, SOFT MATTER, V5, P2947, DOI 10.1039/b901311c; Girard KD, 2006, P NATL ACAD SCI USA, V103, P2103, DOI 10.1073/pnas.0508819103; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Heidemann SR, 2004, TRENDS CELL BIOL, V14, P160, DOI 10.1016/j.tcb.2004.02.003; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Levine AJ, 2009, J PHYS CHEM B, V113, P3820, DOI 10.1021/jp808192w; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Marion S, 2004, J CELL SCI, V117, P3271, DOI 10.1242/jcs.01178; Masson JB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048103; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Nan XL, 2008, CHEMPHYSCHEM, V9, P707, DOI 10.1002/cphc.200700839; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Pottier N, 2005, PHYSICA A, V345, P472, DOI 10.1016/j.physa.2004.07.019; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Taunton J, 2001, CURR OPIN CELL BIOL, V13, P85, DOI 10.1016/S0955-0674(00)00178-2; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Trepat X, 2008, SOFT MATTER, V4, P1750, DOI 10.1039/b804866e; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Wilhelm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.011504; Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Yanai M, 2004, AM J PHYSIOL-CELL PH, V287, pC603, DOI 10.1152/ajpcell.00347.2003; Zeldovich KB, 2005, EUR PHYS J E, V17, P155, DOI 10.1140/epje/i2004-10137-6	41	100	100	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10046	10.1371/journal.pone.0010046	http://dx.doi.org/10.1371/journal.pone.0010046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386607	Green Published, gold, Green Submitted			2022-12-25	WOS:000276420400016
J	Marshall, AK; Barrett, OPT; Cullingford, TE; Shanmugasundram, A; Sugden, PH; Clerk, A				Marshall, Andrew K.; Barrett, Oliver P. T.; Cullingford, Timothy E.; Shanmugasundram, Achchuthan; Sugden, Peter H.; Clerk, Angela			ERK1/2 Signaling Dominates Over RhoA Signaling in Regulating Early Changes in RNA Expression Induced by Endothelin-1 in Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; VENTRICULAR MYOCYTES; GENE-EXPRESSION; GROWTH; STIMULATION; HYPERTROPHY; INHIBITION; ACTIVATE; RECEPTOR; HEART	Background: Cardiomyocyte hypertrophy is associated with changes in gene expression. Extracellular signal-regulated kinases 1/2 (ERK1/2) and RhoA [activated by hypertrophic agonists (e. g. endothelin-1)] regulate gene expression and are implicated in the response, but their relative significance in regulating the cardiomyocyte transcriptome is unknown. Our aim was to establish the significance of ERK1/2 and/or RhoA in the early cardiomyocyte transcriptomic response to endothelin-1. Methods/Principal Findings: Cardiomyocytes were exposed to endothelin-1 (1 h) with/without PD184352 (to inhibit ERK1/2) or C3 transferase (C3T, to inhibit RhoA). RNA expression was analyzed using microarrays and qPCR. ERK1/2 signaling positively regulated similar to 65% of the early gene expression response to ET-1 with a small (similar to 2%) negative effect, whereas RhoA signaling positively regulated similar to 10% of the early gene expression response to ET-1 with a greater (similar to 14%) negative contribution. Of RNAs non-responsive to endothelin-1, 66 or 448 were regulated by PD184352 or C3T, respectively, indicating that RhoA had a more significant effect on baseline RNA expression. mRNAs upregulated by endothelin-1 encoded a number of receptor ligands (e. g. Ereg, Areg, Hbegf) and transcription factors (e. g. Abra/Srf) that potentially propagate the response. Conclusions/Significance: ERK1/2 dominates over RhoA in the early transcriptomic response to endothelin-1. RhoA plays a major role in maintaining baseline RNA expression but, with upregulation of Abra/Srf by endothelin-1, RhoA may regulate changes in RNA expression over longer times. Our data identify ERK1/2 as a more significant node than RhoA in regulating the early stages of cardiomyocyte hypertrophy.	[Marshall, Andrew K.; Barrett, Oliver P. T.; Cullingford, Timothy E.; Shanmugasundram, Achchuthan; Sugden, Peter H.; Clerk, Angela] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England	Imperial College London	Marshall, AK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England.	a.clerk@imperial.ac.uk		Clerk, Angela/0000-0002-5658-0708	British Heart Foundation [FS/07/005, PG/07/074/23445, PG/07/018/22411]; Fondation Leducq	British Heart Foundation(British Heart Foundation); Fondation Leducq(Leducq Foundation)	A. K. M., O. P. T. B and T. E. C. were supported by grants from the British Heart Foundation (FS/07/005, PG/07/074/23445, PG/07/018/22411). The work was also supported by the Fondation Leducq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710; Bromann PA, 2005, J BIOL CHEM, V280, P10253, DOI 10.1074/jbc.M413806200; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Clerk A, 1996, BIOCHEM J, V317, P109, DOI 10.1042/bj3170109; Clerk A, 2001, MOL CELL BIOL, V21, P1173, DOI 10.1128/MCB.21.4.1173-1184.2001; Clerk A, 1998, J CELL BIOL, V142, P523, DOI 10.1083/jcb.142.2.523; Clerk A, 2007, J CELL PHYSIOL, V212, P311, DOI 10.1002/jcp.21094; Cullingford TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r32; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Fischer P, 2008, BRIT J PHARMACOL, V153, pS414, DOI 10.1038/bjp.2008.1; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Kennedy RA, 2006, J MOL CELL CARDIOL, V41, P236, DOI 10.1016/j.yjmcc.2006.04.011; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266	28	31	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10027	10.1371/journal.pone.0010027	http://dx.doi.org/10.1371/journal.pone.0010027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368814	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000276419900021
J	Caccia, S; Hernandez-Rodriguez, CS; Mahon, RJ; Downes, S; James, W; Bautsoens, N; Van Rie, J; Ferre, J				Caccia, Silvia; Sara Hernandez-Rodriguez, Carmen; Mahon, Rod J.; Downes, Sharon; James, William; Bautsoens, Nadine; Van Rie, Jeroen; Ferre, Juan			Binding Site Alteration Is Responsible for Field-Isolated Resistance to Bacillus thuringiensis Cry2A Insecticidal Proteins in Two Helicoverpa Species	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; ARMIGERA LEPIDOPTERA; PLUTELLA-XYLOSTELLA; DIAMONDBACK MOTH; DELTA-ENDOTOXIN; BT CROPS; AUSTRALIAN POPULATIONS; EVOLVED RESISTANCE; CROSS-RESISTANCE; TOXINS CRY1AC	Background: Evolution of resistance by target pests is the main threat to the long-term efficacy of crops expressing Bacillus thuringiensis (Bt) insecticidal proteins. Cry2 proteins play a pivotal role in current Bt spray formulations and transgenic crops and they complement Cry1A proteins because of their different mode of action. Their presence is critical in the control of those lepidopteran species, such as Helicoverpa spp., which are not highly susceptible to Cry1A proteins. In Australia, a transgenic variety of cotton expressing Cry1Ac and Cry2Ab (Bollgard II) comprises at least 80% of the total cotton area. Prior to the widespread adoption of Bollgard II, the frequency of alleles conferring resistance to Cry2Ab in field populations of Helicoverpa armigera and Helicoverpa punctigera was significantly higher than anticipated. Colonies established from survivors of F-2 screens against Cry2Ab are highly resistant to this toxin, but susceptible to Cry1Ac. Methodology/Principal Findings: Bioassays performed with surface-treated artificial diet on neonates of H. armigera and H. punctigera showed that Cry2Ab resistant insects were cross-resistant to Cry2Ae while susceptible to Cry1Ab. Binding analyses with I-125-labeled Cry2Ab were performed with brush border membrane vesicles from midguts of Cry2Ab susceptible and resistant insects. The results of the binding analyses correlated with bioassay data and demonstrated that resistant insects exhibited greatly reduced binding of Cry2Ab toxin to midgut receptors, whereas no change in I-125-labeled-Cry1Ac binding was detected. As previously demonstrated for H. armigera, Cry2Ab binding sites in H. punctigera were shown to be shared by Cry2Ae, which explains why an alteration of the shared binding site would lead to cross-resistance between the two Cry2A toxins. Conclusion/Significance: This is the first time that a mechanism of resistance to the Cry2 class of insecticidal proteins has been reported. Because we found the same mechanism of resistance in multiple strains representing several field populations, we conclude that target site alteration is the most likely means that field populations evolve resistance to Cry2 proteins in Helicoverpa spp. Our work also confirms the presence in the insect midgut of specific binding sites for this class of proteins. Characterizing the Cry2 receptors and their mutations that enable resistance could lead to the development of molecular tools to monitor resistance in the field.	[Caccia, Silvia; Sara Hernandez-Rodriguez, Carmen; Ferre, Juan] Univ Valencia, Dept Genet, E-46100 Burjassot, Spain; [Mahon, Rod J.; James, William] CSIRO Entomol, Canberra, ACT, Australia; [Downes, Sharon] CSIRO Entomol, Narrabri, Australia; [Bautsoens, Nadine; Van Rie, Jeroen] Bayer BioSci, Ghent, Belgium	University of Valencia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Bayer AG	Caccia, S (corresponding author), Univ Valencia, Dept Genet, E-46100 Burjassot, Spain.	juan.ferre@uv.es	James, Bill J/C-8908-2012; Hernandez Rodriguez, C Sara Hernández-Rodríguez/J-6739-2012; Ferré, Juan/L-9426-2014; Downes, Sharon Joy/C-1770-2008; Hernandez-Rodriguez, Carmen Sara/D-5648-2012	Hernandez Rodriguez, C Sara Hernández-Rodríguez/0000-0002-1234-1190; Ferré, Juan/0000-0001-5535-0612; Downes, Sharon Joy/0000-0002-3729-1732; CACCIA, Silvia/0000-0003-1954-7180	The Cotton Research and Development Corporation in Australia CSIRO; Spanish Ministry of Science and Innovation [AGL2006-11914]; European FEDER; Bayer BioScience; EU [PIEF-GA-2008-219993]	The Cotton Research and Development Corporation in Australia CSIRO(Cotton R&D Corp); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European FEDER(European Commission); Bayer BioScience; EU(European Commission)	The Cotton Research and Development Corporation in Australia CSIRO, the Spanish Ministry of Science and Innovation (project AGL2006-11914), European FEDER funds, and Bayer BioScience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript except for JVR and NB, employed by Bayer BioScience. SC was supported by a Marie Curie fellowship No. PIEF-GA-2008-219993 from the EU.	Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Baxter SW, 2008, INSECT BIOCHEM MOLEC, V38, P125, DOI 10.1016/j.ibmb.2007.09.014; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bird LJ, 2007, BIOL CONTROL, V40, P196, DOI 10.1016/j.biocontrol.2006.11.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CONVENTS D, 1990, J BIOL CHEM, V265, P1369; CRICKMORE N, 1992, MOL MICROBIOL, V6, P1533, DOI 10.1111/j.1365-2958.1992.tb00874.x; DOWNES S, 2009, J ECON ENTOMOL, V100, P1844; DOWNES S, 2009, J EC ENTOMO IN PRESS; ENGLISH L, 1994, INSECT BIOCHEM MOLEC, V24, P1025, DOI 10.1016/0965-1748(94)90140-6; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; Ferre Juan, 2008, V5, P41; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gao YL, 2009, J ECON ENTOMOL, V102, P1217, DOI 10.1603/029.102.0347; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; GOULD F, 1992, P NATL ACAD SCI USA, V89, P7986, DOI 10.1073/pnas.89.17.7986; Granero F, 1996, BIOCHEM BIOPH RES CO, V224, P779, DOI 10.1006/bbrc.1996.1099; Hernandez CS, 2004, J INVERTEBR PATHOL, V85, P182, DOI 10.1016/j.jip.2004.03.002; Herrero S, 2001, APPL ENVIRON MICROB, V67, P1085, DOI 10.1128/AEM.67.3.1085-1089.2001; Jurat-Fuentes JL, 2003, APPL ENVIRON MICROB, V69, P5898, DOI 10.1128/AEM.69.10.5898-5906.2003; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; LEE MK, 1995, APPL ENVIRON MICROB, V61, P3836, DOI 10.1128/AEM.61.11.3836-3842.1995; *LEORA SOFTW, 2008, POLO PC; Luo SD, 2007, J ECON ENTOMOL, V100, P909, DOI 10.1603/0022-0493(2007)100[909:CSOCSO]2.0.CO;2; Mahon RJ, 2008, J ECON ENTOMOL, V101, P909, DOI 10.1603/0022-0493(2008)101[909:IOCRIA]2.0.CO;2; Mahon RJ, 2007, J ECON ENTOMOL, V100, P1844, DOI 10.1603/0022-0493(2007)100[1844:FOACRT]2.0.CO;2; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2; Matten Sharlene R., 2008, V5, P27, DOI 10.1007/978-1-4020-8373-0_2; Moar W, 2008, NAT BIOTECHNOL, V26, P1072, DOI 10.1038/nbt1008-1072; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nester E., 2002, 100 YEARS BACILLUS T; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Sayyed AH, 2000, APPL ENVIRON MICROB, V66, P1509, DOI 10.1128/AEM.66.4.1509-1516.2000; Sayyed AH, 2005, APPL ENVIRON MICROB, V71, P6863, DOI 10.1128/AEM.71.11.6863-6869.2005; SAYYED AH, 2004, APPL ENVIRON MICROB, V70, P1710; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P1074, DOI 10.1038/nbt1008-1074; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; VANRIE J, 1990, APPL ENVIRON MICROB, V56, P1378, DOI 10.1128/AEM.56.5.1378-1385.1990; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wright DJ, 1997, APPL ENVIRON MICROB, V63, P1814, DOI 10.1128/AEM.63.5.1814-1819.1997; Yang YJ, 2006, INSECT BIOCHEM MOLEC, V36, P735, DOI 10.1016/j.ibmb.2006.06.003	55	68	75	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9975	10.1371/journal.pone.0009975	http://dx.doi.org/10.1371/journal.pone.0009975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376312	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200048
J	Garcia-Jimenez, B; Juan, D; Ezkurdia, I; Andres-Leon, E; Valencia, A				Garcia-Jimenez, Beatriz; Juan, David; Ezkurdia, Iakes; Andres-Leon, Eduardo; Valencia, Alfonso			Inference of Functional Relations in Predicted Protein Networks with a Machine Learning Approach	PLOS ONE			English	Article							IDENTIFICATION; ALIGNMENT	Background: Molecular biology is currently facing the challenging task of functionally characterizing the proteome. The large number of possible protein-protein interactions and complexes, the variety of environmental conditions and cellular states in which these interactions can be reorganized, and the multiple ways in which a protein can influence the function of others, requires the development of experimental and computational approaches to analyze and predict functional associations between proteins as part of their activity in the interactome. Methodology/Principal Findings: We have studied the possibility of constructing a classifier in order to combine the output of the several protein interaction prediction methods. The AODE (Averaged One-Dependence Estimators) machine learning algorithm is a suitable choice in this case and it provides better results than the individual prediction methods, and it has better performances than other tested alternative methods in this experimental set up. To illustrate the potential use of this new AODE-based Predictor of Protein InterActions (APPIA), when analyzing high-throughput experimental data, we show how it helps to filter the results of published High-Throughput proteomic studies, ranking in a significant way functionally related pairs. Availability: All the predictions of the individual methods and of the combined APPIA predictor, together with the used datasets of functional associations are available at http://ecid.bioinfo.cnio.es/. Conclusions: We propose a strategy that integrates the main current computational techniques used to predict functional associations into a unified classifier system, specifically focusing on the evaluation of poorly characterized protein pairs. We selected the AODE classifier as the appropriate tool to perform this task. AODE is particularly useful to extract valuable information from large unbalanced and heterogeneous data sets. The combination of the information provided by five prediction interaction prediction methods with some simple sequence features in APPIA is useful in establishing reliability values and helpful to prioritize functional interactions that can be further experimentally characterized.	[Garcia-Jimenez, Beatriz] Univ Carlos III Madrid, Dept Comp Sci, Madrid, Spain; [Juan, David; Ezkurdia, Iakes; Andres-Leon, Eduardo; Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain	Universidad Carlos III de Madrid; Centro Nacional de Investigaciones Oncologicas (CNIO)	Garcia-Jimenez, B (corresponding author), Univ Carlos III Madrid, Dept Comp Sci, Madrid, Spain.	valencia@cnio.es	García-Jiménez, Beatriz/ABH-2355-2020; Andrés-León., Eduardo/K-8944-2014; Juan, David/AAA-2614-2020; Valencia, Alfonso/I-3127-2015	García-Jiménez, Beatriz/0000-0002-8129-6506; Andrés-León., Eduardo/0000-0002-0621-9914; Juan, David/0000-0003-1912-9667; Valencia, Alfonso/0000-0002-8937-6789	BioSapiens [LSHG-CT-2003-503265]; Experimental Network for Functional Integration (ENFIN) Networks of Excellence [LSHG-CT-2005-518254]; Consolider BSC [CSD2007-00050]; Spanish Ministry of Education and Science [BIO2007-66855]	BioSapiens; Experimental Network for Functional Integration (ENFIN) Networks of Excellence; Consolider BSC; Spanish Ministry of Education and Science(Spanish Government)	This work was funded by the BioSapiens (grant number LSHG-CT-2003-503265) and the Experimental Network for Functional Integration (ENFIN) Networks of Excellence (contract number LSHG-CT-2005-518254), by Consolider BSC (grant number CSD2007-00050) and by the project "Functions for gene sets" from the Spanish Ministry of Education and Science (BIO2007-66855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Leon E, 2009, NUCLEIC ACIDS RES, V37, pD629, DOI 10.1093/nar/gkn853; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Bishop C. M., 1995, NEURAL NETWORKS PATT; Bouckaert R., BAYESIAN NETWORK CLA; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cleary JG, 1995, ED INN EC BUS ADM, P108; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Drummond C, 2006, MACH LEARN, V65, P95, DOI 10.1007/s10994-006-8199-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FRANK E, 1998, P 15 INT C MACH LEAR, P144; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Rumelhart D.E., 1985, LEARNING INTERNAL RE, DOI 10.1016/b978-1-4832-1446-7.50035-2; Sahami M., 1996, P 2 INT C KNOWL DISC, P335; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Webb GI, 2005, MACH LEARN, V58, P5, DOI 10.1007/s10994-005-4258-6; WITTEN IH, 2005, DATA MINING PRACTICA; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9969	10.1371/journal.pone.0009969	http://dx.doi.org/10.1371/journal.pone.0009969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376314	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200042
J	Markusic, DM; de Waart, DR; Seppen, J				Markusic, David M.; de Waart, Dirk R.; Seppen, Jurgen			Separating Lentiviral Vector Injection and Induction of Gene Expression in Time, Does Not Prevent an Immune Response to rtTA in Rats	PLOS ONE			English	Article							IN-VIVO; TRANSGENE EXPRESSION; ADENOASSOCIATED VIRUS; MAMMALIAN-CELLS; TETRACYCLINE; THERAPY; SYSTEM; TRANSACTIVATOR; DANGER; MUSCLE	Background: Lentiviral gene transfer can provide long-term expression of therapeutic genes such as erythropoietin. Because overexpression of erythropoietin can be toxic, regulated expression is needed. Doxycycline inducible vectors can regulate expression of therapeutic transgenes efficiently. However, because they express an immunogenic transactivator (rtTA), their utility for gene therapy is limited. In addition to immunogenic proteins that are expressed from inducible vectors, injection of the vector itself is likely to elicit an immune response because viral capsid proteins will induce "danger signals" that trigger an innate response and recruit inflammatory cells. Methodology and Principal Findings: We have developed an autoregulatory lentiviral vector in which basal expression of rtTA is very low. This enabled us to temporally separate the injection of virus and the expression of the therapeutic gene and rtTA. Wistar rats were injected with an autoregulatory rat erythropoietin expression vector. Two or six weeks after injection, erythropoietin expression was induced by doxycycline. This resulted in an increase of the hematocrit, irrespective of the timing of the induction. However, most rats only responded once to doxycycline administration. Antibodies against rtTA were detected in the early and late induction groups. Conclusions: Our results suggest that, even when viral vector capsid proteins have disappeared, expression of foreign proteins in muscle will lead to an immune response.	[Markusic, David M.; de Waart, Dirk R.; Seppen, Jurgen] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Markusic, DM (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.seppen@amc.uva.nl		Seppen, Jurgen/0000-0001-9689-9919; Markusic, David/0000-0002-3774-0825	NWO [016.026.012]	NWO(Netherlands Organization for Scientific Research (NWO))	This research was partially funded by NWO (http://www.zonmw.nl/), 016.026.012, to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha-Mohammadi S, 2000, J CLIN INVEST, V105, P1177, DOI 10.1172/JCI10027; Ailles LE, 2002, CURR TOP MICROBIOL, V261, P31; Brown BD, 2002, BLOOD, V100, P1133, DOI 10.1182/blood-2001-11-0067; Centlivre M, 2010, GENE THER, V17, P14, DOI 10.1038/gt.2009.109; Clackson T, 2000, GENE THER, V7, P120, DOI 10.1038/sj.gt.3301120; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; DERELANKO MJ, 1987, FUND APPL TOXICOL, V9, P271, DOI 10.1016/0272-0590(87)90049-2; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Favre D, 2002, J VIROL, V76, P11605, DOI 10.1128/JVI.76.22.11605-11611.2002; Galimi F, 2002, CURR TOP MICROBIOL, V261, P245; Ginhoux F, 2004, MOL THER, V10, P279, DOI 10.1016/j.ymthe.2004.05.012; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Hartigan-O'Connor D, 2001, MOL THER, V4, P525, DOI 10.1006/mthe.2001.0496; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Lena AM, 2005, J GENE MED, V7, P1086, DOI 10.1002/jgm.758; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; May T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002372; Scherr M, 2002, GENE THER, V9, P1708, DOI 10.1038/sj.gt.3301848; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Seppen J, 2001, BLOOD, V98, P594, DOI 10.1182/blood.V98.3.594; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9974	10.1371/journal.pone.0009974	http://dx.doi.org/10.1371/journal.pone.0009974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376311	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200047
J	Hayles, B; Yellaboina, S; Wang, DG				Hayles, Brewster; Yellaboina, Sailu; Wang, Degeng			Comparing Transcription Rate and mRNA Abundance as Parameters for Biochemical Pathway and Network Analysis	PLOS ONE			English	Article							PHYLOGENETIC PROFILES; ESCHERICHIA-COLI; GENE-EXPRESSION; GENOME; GENERATION; PREDICTION; SEQUENCE; DATABASE; OPERONS; BIOLOGY	The cells adapt to extra- and intra-cellular signals by dynamic orchestration of activities of pathways in the biochemical networks. Dynamic control of the gene expression process represents a major mechanism for pathway activity regulation. Gene expression has thus been routinely measured, most frequently at steady-state mRNA abundance level using microarray technology. The results are widely used in statistical inference of the structures of underlying biochemical networks, with the assumption that functionally related genes exhibit similar dynamic profiles. Steady-state mRNA abundance, however, is a composite of two factors: transcription rate and mRNA degradation rate. The question being asked here is therefore whether steady-state mRNA abundance or any of two factors is a more informative measurement target for studying network dynamics. The yeast S. cerevisiae was used as model organism and transcription rate was chosen out of the two factors in this study, because genome-wide determination of transcription rates has been reported for several physiological processes in this species. Our strategy is to test which one is a better measurement of functional relatedness between genes. The analysis was performed on those S. cerevisiae genes that have bacterial orthologs as identified by reciprocal BLAST analysis, so that functional relatedness of a gene pair can be measured by the frequency at which their bacterial orthologs co-occur in the same operon in the collection of bacterial genomes. It is found that transcription rate data is generally a better parameter for functional relatedness than steady state mRNA abundance, suggesting transcription rate data is more informative to use in deciphering the logics used by the cells in dynamic regulation of biochemical network behaviors. The significance of this finding for network and systems biology, as well as biomedical research in general, is discussed.	[Hayles, Brewster; Yellaboina, Sailu; Wang, Degeng] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Hayles, B (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA.	dwang1@cas.usf.edu			University of South Florida (USF) Foundation	University of South Florida (USF) Foundation	This work was supported by the University of South Florida (USF) Foundation and a USF New Researcher Grant to D. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Karimpour-Fard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-393; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marchionni Luigi, 2007, Evid Rep Technol Assess (Full Rep), P1; McGuire AM, 2000, NUCLEIC ACIDS RES, V28, P4523, DOI 10.1093/nar/28.22.4523; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Moreno-Hagelsieb G, 2008, PROTEINS, V70, P344, DOI 10.1002/prot.21564; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Teng XK, 2009, SCI CHINA SER C, V52, P7, DOI 10.1007/s11427-009-0012-9; Tissot B, 2009, FEBS LETT, V583, P1728, DOI 10.1016/j.febslet.2009.03.049; Wu Hongwei, 2005, Genome Inform, V16, P247; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Yuan Y, 2007, PLOS COMPUT BIOL, V3, P2391, DOI 10.1371/journal.pcbi.0030243	30	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9908	10.1371/journal.pone.0009908	http://dx.doi.org/10.1371/journal.pone.0009908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361042	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600014
J	Pemberton, AD; Brown, JK				Pemberton, Alan D.; Brown, Jeremy K.			In Vitro Interactions of Extracellular Histones with LDL Suggest a Potential Pro-Atherogenic Role	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PLASMA-PROTEOME; HEPARAN-SULFATE; RETENTION; BINDING; ATHEROSCLEROSIS; PROLIFERATION; COMPLEXES; PERLECAN; PROTEINS	Background: Nuclear histones have previously been shown to aggregate LDL in vitro, suggestive of a possible proatherogenic role. Recent studies indicate that histones are released during acute inflammation, and therefore might interact with circulating lipoproteins in vivo. In view of the associative link between inflammation and cardiovascular disease, the behaviour of histones was investigated using in vitro models of LDL retention and foam cell formation. Methodology/Principal Findings: Heparin agarose beads were used as a model of a matrix rich in sulphated glycosaminoglycans, to which histones bind strongly. Histone-modified beads were observed to pull down more LDL from solution than untreated beads, indicating that histones can function as bridging molecules, enhancing LDL retention. Furthermore, addition of heparin inhibited histone-induced aggregation of LDL. To model foam cell formation, murine RAW 264.7 macrophages were incubated for 24 h in the presence of LDL, histones, LDL plus histones or vehicle control. Cells incubated with LDL in the presence of histones accumulated significantly more intracellular lipid than with LDL or histone alone. Conclusions/Significance: These results are consistent with a potential pro-atherogenic role for extracellular histones, which should be investigated further.	[Pemberton, Alan D.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Pemberton, AD (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	alan.pemberton@ed.ac.uk			University of Edinburgh Development Fund; Biotechnology and Biological Sciences Research Council [BBE01867X1]	University of Edinburgh Development Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the University of Edinburgh Development Fund. JKB was funded by the Biotechnology and Biological Sciences Research Council (Grant no. BBE01867X1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILOZUR ME, 1990, J BIOL CHEM, V265, P19697; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; COURVALIN JC, 1982, J BIOL CHEM, V257, P456; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; GONIAS SL, 1985, THROMB RES, V39, P97, DOI 10.1016/0049-3848(85)90125-2; Gustafsson M, 2007, CIRC RES, V101, P777, DOI 10.1161/CIRCRESAHA.107.149666; Henriquez JP, 2002, J CELL SCI, V115, P2041; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; PEMBERTON AD, 2010, PROTEOMICS IN PRESS; PEREIRA LF, 1994, CLIN EXP IMMUNOL, V97, P175; SKRZYDLEWSKI Z, 1976, ACTA BIOL ACAD SCI H, V27, P291; SKRZYDLEWSKI Z, 1977, B ACAD POL SCI BIOL, V25, P71; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; WEISGRABER KH, 1987, J BIOL CHEM, V262, P11097; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Wilson PWF, 2008, AM J MED, V121, P15, DOI 10.1016/j.amjmed.2008.06.012; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zheng XY, 2009, J CHROMATOGR A, V1216, P3538, DOI 10.1016/j.chroma.2009.01.063	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9884	10.1371/journal.pone.0009884	http://dx.doi.org/10.1371/journal.pone.0009884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360839	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969500013
J	Cepeda-Cornejo, V; Dirzo, R				Cepeda-Cornejo, Veronica; Dirzo, Rodolfo			Sex-Related Differences in Reproductive Allocation, Growth, Defense and Herbivory in Three Dioecious Neotropical Palms	PLOS ONE			English	Article							RAIN-FOREST; RESOURCE-ALLOCATION; BIOMASS ALLOCATION; ILEX-AQUIFOLIUM; PLANT TOLERANCE; TREE; PATTERNS; COSTS; SHRUB; CHAMAEDOREA	Background: Frequently, in dioecious plants, female plants allocate more resources to reproduction than male plants. Therefore it is expected that asymmetrical allocation to reproduction may lead to a reproduction-growth tradeoff, whereby female plants grow less than male plants, but invest more in defenses and thus experience lower herbivory than male plants. Methodology/Principal Findings: We tested these expectations by comparing resource allocation to reproduction, growth and defense and its consequences on herbivory in three sympatric dioecious Chamaedorea palms (C. alternans, C. pinnatifrons and C. ernesti-augusti) using a pair-wise design (replicated male/female neighboring plants) in a Mexican tropical rain forest. Our findings support the predictions. Biomass allocation to reproduction in C. pinnatifrons was 3-times higher in female than male plants, consistent with what is known in C. alternans and C. ernesti-augusti. Growth (height and leaf production rate and biomass production) was higher in male plants of all three species. Female plants of the three species had traits that suggest greater investment in defense, as they had 4-16% tougher leaves, and 8-18% higher total phenolic compounds concentration. Accordingly, female plants sustained 53-78% lower standing herbivory and 49-87% lower herbivory rates than male plants. Conclusions/Significance: Our results suggests that resource allocation to reproduction in the studied palms is more costly to female plants and this leads to predictable intersexual differences in growth, defense and herbivory. We conclude that resource allocation to reproduction in plants can have important consequences that influence their interaction with herbivores. Since herbivory is recognized as an important selective force in plants, these results are of significance to our understanding of plant defense evolution.	[Cepeda-Cornejo, Veronica; Dirzo, Rodolfo] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Universidad Nacional Autonoma de Mexico; Stanford University	Cepeda-Cornejo, V (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	vcepeda@ecologia.unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN229002]; National Council of Science and Technology of Mexico (CONACYT); Posgrado en Ciencias Biologicas; Universidad Nacional Autonoma de Mexico (UNAM); Instituto de Ecologia (UNAM); Direccion general de Estudios de Posgrado (DGEP-UNAM)	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); National Council of Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Posgrado en Ciencias Biologicas; Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Instituto de Ecologia (UNAM)(Universidad Nacional Autonoma de Mexico); Direccion general de Estudios de Posgrado (DGEP-UNAM)(Universidad Nacional Autonoma de Mexico)	This study was supported by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) IN229002 (http://www.unam.mx). The National Council of Science and Technology of Mexico (CONACYT), the Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico (UNAM), the Instituto de Ecologia (UNAM) and the Direccion general de Estudios de Posgrado (DGEP-UNAM), provided financial support for graduate studies to V. C. C. Field work of R. D was supported by a CONACYT grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agren J., 1999, GENDER SEXUAL DIMORP, P217, DOI DOI 10.1007/978-3-662-03908-3_8; Antos JA, 1999, J ECOL, V87, P77, DOI 10.1046/j.1365-2745.1999.00331.x; Araújo Ana Paula A., 2003, Rev. Bras. entomol., V47, P483, DOI 10.1590/S0085-56262003000400001; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BULLOCK SH, 1984, OECOLOGIA, V63, P426, DOI 10.1007/BF00390677; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; DELPH LF, 1990, ECOLOGY, V71, P1342, DOI 10.2307/1938271; DELPH LF, 1993, AM J BOT, V80, P607, DOI 10.2307/2445429; Delph LF, 1999, GENDER SEXUAL DIMORP, P149, DOI DOI 10.1007/978-3-662-03908-3_6; Dudley LS, 2006, AM J BOT, V93, P1775, DOI 10.3732/ajb.93.12.1775; ELMQVIST T, 1991, OIKOS, V61, P65, DOI 10.2307/3545407; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; FEENY P, 1976, COEVOLUTION ANIMALS, P3; FEENY PP, 1976, ANAL PHENOLIC PLANT; Fincher RM, 2008, J CHEM ECOL, V34, P558, DOI 10.1007/s10886-008-9432-4; Fordyce JA, 2001, J ANIM ECOL, V70, P997, DOI 10.1046/j.0021-8790.2001.00568.x; GONZALEZSORIANO E, HISTORIA NATURAL TUX; GOVAERTS R, 2006, WORLD CHECKLIST AREC; GROSS KL, 1981, AM J BOT, V68, P801, DOI 10.2307/2443186; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HJALTEN J, 1992, OECOLOGIA, V89, P253, DOI 10.1007/BF00317225; HUNT R, 1982, CONCEPTS PLANT GROWT, P14; IBARRAMANRIQUEZ G, 1992, AM J BOT, V79, P383, DOI 10.2307/2445150; JING SW, 1990, OIKOS, V58, P369, DOI 10.2307/3545228; Karlsson P. Staffan, 2005, P1, DOI 10.1016/B978-012088386-8/50001-6; KRISCHIK VA, 1990, OECOLOGIA, V83, P182, DOI 10.1007/BF00317750; LEVINS RICHARD, 1968; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; Montesinos D, 2006, ANN BOT-LONDON, V98, P885, DOI 10.1093/aob/mcl172; Obeso JR, 1997, J ECOL, V85, P159, DOI 10.2307/2960648; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Obeso JR, 2002, REV CHIL HIST NAT, V75, P67; Otero-Arnaiz A, 2001, J TROP ECOL, V17, P745, DOI 10.1017/S0266467401001559; OYAMA K, 1991, Principes, V35, P86; OYAMA K, 1988, Plant Species Biology, V3, P27, DOI 10.1111/j.1442-1984.1988.tb00168.x; OYAMA K, 1990, J ECOL, V78, P648, DOI 10.2307/2260890; OYAMA K, 1992, TROPICS, V2, P23; POPP JW, 1988, AM J BOT, V75, P1732, DOI 10.2307/2444688; Quero H.J., 1994, FLORA VERACRUZ; Ramos A, 2008, HORTIC BRAS, V26, P138, DOI 10.1590/S0102-05362008000200002; REEKIE EG, 1987, AM NAT, V129, P876, DOI 10.1086/284681; Rocheleau AF, 2001, AM J BOT, V88, P659, DOI 10.2307/2657066; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; SAGERS CL, 1995, ECOLOGY, V76, P1835, DOI 10.2307/1940715; Soto M., 1997, HIST NATURAL TUXTLAS, P7; Stearns SC, 1992, TRADE OFFS EVOLUTION, P72; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Suzuki AA, 2005, AM J BOT, V92, P2003, DOI 10.3732/ajb.92.12.2003; Thomas MM, 2006, MOL PHYLOGENET EVOL, V38, P398, DOI 10.1016/j.ympev.2005.08.019; Torimaru T, 2006, CAN J BOT, V84, P1860, DOI 10.1139/B06-129; Turcotte J, 2001, ECOSCIENCE, V8, P506, DOI 10.1080/11956860.2001.11682682; Ueno N, 2006, CAN J BOT, V84, P1852, DOI 10.1139/B06-142	55	57	62	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9824	10.1371/journal.pone.0009824	http://dx.doi.org/10.1371/journal.pone.0009824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352113	gold, Green Submitted, Green Published			2022-12-25	WOS:000275894400024
J	Zhao, SX; Pan, CM; Cao, HM; Han, B; Shi, JY; Liang, J; Gao, GQ; Peng, YD; Su, Q; Chen, JL; Zhao, JJ; Song, HD				Zhao, Shuang-Xia; Pan, Chun-Ming; Cao, Huang-Ming; Han, Bing; Shi, Jing-Yi; Liang, Jun; Gao, Guan-Qi; Peng, Yong-De; Su, Qing; Chen, Jia-Lun; Zhao, Jia-Jun; Song, Huai-Dong			Association of the CTLA4 Gene with Graves' Disease in the Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AUTOIMMUNE THYROID-DISEASE; SUSCEPTIBILITY; POLYMORPHISM; SNPS; REGION; ANTIBODIES; VARIANTS; PROMOTER; RECEPTOR	To determine whether genetic heterogeneity exists in patients with Graves' disease (GD), the cytotoxic T-lymphocyte associated 4 (CTLA-4) gene, which is implicated a susceptibility gene for GD by considerable genetic and immunological evidence, was used for association analysis in a Chinese Han cohort recruited from various geographic regions. Our association study for the SNPs in the CTLA4 gene in 2640 GD patients and 2204 control subjects confirmed that CTLA4 is the susceptibility gene for GD in the Chinese Han population. Moreover, the logistic regression analysis in the combined Chinese Han cohort revealed that SNP rs231779 (allele frequencies p = 2.81 x 10(-9), OR = 1.35, and genotype distributions p = 2.75 x 10(-9), OR = 1.42) is likely the susceptibility variant for GD. Interestingly, the logistic regression analysis revealed that SNP rs35219727 may be the susceptibility variant to GD in the Shandong population; however, SNP, rs231779 in the CTLA4 gene probably independently confers GD susceptibility in the Xuzhou and southern China populations. These data suggest that the susceptibility variants of the CTLA4 gene varied between the different geographic populations with GD.	[Zhao, Shuang-Xia; Pan, Chun-Ming; Cao, Huang-Ming; Han, Bing; Shi, Jing-Yi; Chen, Jia-Lun; Song, Huai-Dong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Shanghai Inst Endocrinol, State Key Lab Med Genom,Mol Med Ctr, Shanghai 200030, Peoples R China; [Liang, Jun] Fourth Hosp Xuzhou, Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China; [Gao, Guan-Qi] Peoples Hosp Linyi, Dept Endocrinol, Linyi, Shandong, Peoples R China; [Peng, Yong-De] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Endocrinol, Shanghai 200030, Peoples R China; [Su, Qing] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Endocrinol, Shanghai 200030, Peoples R China; [Zhao, Jia-Jun] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhao, SX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Shanghai Inst Endocrinol, State Key Lab Med Genom,Mol Med Ctr, Shanghai 200030, Peoples R China.	jjzhao@medmail.com.cn; huaidong_s1966@163.com	Song, Huai-Dong/G-8961-2011; Zhao, Jiajun/W-2963-2018	Zhao, Jiajun/0000-0003-3267-9292; Song, Huai-Dong/0000-0002-9609-5803	National Natural Science Foundation of China [30971595, 30771017, 30971383]; Chinese High Tech Program (863) [2006AA02Z175]; Commission for Science and Technology of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese High Tech Program (863)(National High Technology Research and Development Program of China); Commission for Science and Technology of Shanghai	This work was supported in part by the National Natural Science Foundation of China (30971595, 30771017 and 30971383), Chinese High Tech Program (863)(2006AA02Z175), and Commission for Science and Technology of Shanghai. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; BRIX TH, 2001, EVIDENCE MAJOR ROLE, P930; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chen X., 2000, CHIN J ENDOCRINOL ME, V18, P342; Chistyakov DA, 2000, MOL GENET METAB, V70, P214, DOI 10.1006/mgme.2000.3007; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; GU LQ, 2009, CLIN ENDOCR IN PRESS; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; KOCHI Y, 2005, FUNCTIONAL VARIANT F, P478; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; ONODERA T, 1990, IMMUNOLOGY, V71, P581; Petrone A, 2005, THYROID, V15, P232, DOI 10.1089/thy.2005.15.232; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song HD, 2009, HUM MOL GENET, V18, P1156, DOI 10.1093/hmg/ddn442; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Tomer Y, 2007, J AUTOIMMUN, V29, P69, DOI 10.1016/j.jaut.2007.05.006; Tsai ST, 2008, J PEDIATR ENDOCR MET, V21, P665; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang PW, 2007, J CLIN ENDOCR METAB, V92, P2513, DOI 10.1210/jc.2006-2761; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yanagawa T, 1997, THYROID, V7, P843, DOI 10.1089/thy.1997.7.843; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41	34	34	43	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9821	10.1371/journal.pone.0009821	http://dx.doi.org/10.1371/journal.pone.0009821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352109	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894400021
J	Gluenz, E; Hoog, JL; Smith, AE; Dawe, HR; Shaw, MK; Gull, K				Gluenz, Eva; Hoeoeg, Johanna L.; Smith, Amy E.; Dawe, Helen R.; Shaw, Michael K.; Gull, Keith			Beyond 9+0: noncanonical axoneme structures characterize sensory cilia from protists to humans	FASEB JOURNAL			English	Article						signaling; host-pathogen interaction; primary cilium; electron microscopy	CLASS-II MOLECULES; INTRAFLAGELLAR TRANSPORT; LEISHMANIA-AMAZONENSIS; FINE-STRUCTURE; ULTRASTRUCTURE; AMASTIGOTES; FLAGELLUM; NEURONS; RAT	The intracellular amastigote stages of parasites such as Leishmania are often referred to as aflagellate. They do, however, possess a short axoneme of cryptic function. Here, our examination of the structure of this axoneme leads to a testable hypothesis of its role in the cell biology of pathogenicity. We show a striking similarity between the microtubule axoneme structure of the Leishmania mexicana parasite infecting a macrophage and vertebrate primary cilia. In both, the 9-fold microtubule doublet symmetry is broken by the incursion of one or more microtubule doublets into the axoneme core, giving rise to an architecture that we term here the 9v (variable) axoneme. Three-dimensional reconstructions revealed that no particular doublet initiated the symmetry break, and moreover it often involved 2 doublets. The tip of the L. mexicana flagellum was frequently intimately associated with the macrophage vacuole membrane. We propose that the main function of the amastigote flagellum is to act as a sensory organelle with important functions in host-parasite interactions and signaling in the intracellular stage of the L. mexicana life cycle.-Gluenz, E., Hoog, J. L., Smith, A. E., Dawe, H. R., Shaw, M. K., Gull, K. Beyond 9 + 0: noncanonical axoneme structures characterize sensory cilia from protists to humans. FASEB J. 24, 3117-3121 (2010). www.fasebj.org	[Gluenz, Eva; Hoeoeg, Johanna L.; Smith, Amy E.; Dawe, Helen R.; Shaw, Michael K.; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Hoeoeg, Johanna L.] Univ Colorado, Boulder Lab Electron Microscopy Cells 3D, Dept MCD Biol, Boulder, CO 80309 USA	University of Oxford; University of Colorado System; University of Colorado Boulder	Gull, K (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	keith.gull@path.ox.ac.uk		Hoog, Johanna/0000-0003-2162-3816; Gluenz, Eva/0000-0003-4346-8896	Wellcome Trust; Beit Memorial Fellowships for Medical Research; Jackson Scholarship Fund; EMBO long-term fellowship; E. P. Abraham Trust; National Institutes of Health, (University of Colorado, Boulder, CO, USA) [RR00592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Beit Memorial Fellowships for Medical Research; Jackson Scholarship Fund; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); E. P. Abraham Trust; National Institutes of Health, (University of Colorado, Boulder, CO, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dick McIntosh for comments on the manuscript and David Vaux (University of Oxford, Oxford, UK) for the gift of J774 macrophages. This work was funded by the Wellcome Trust, the Beit Memorial Fellowships for Medical Research, the Jackson Scholarship Fund (Merton College Oxford, to A. E. S.), an EMBO long-term fellowship (to J.L.H.), and the E. P. Abraham Trust. K. G. held a Wellcome Trust Principal Research Fellowship, H. R. D. is a Beit Memorial Fellow, and J.L.H. is a Sir Henry Wellcome Fellow. The Boulder Laboratory for 3D Electron Microscopy of Cells is supported by National Institutes of Health Biotechnology grant RR00592 to A. Hoenger (University of Colorado, Boulder, CO, USA).	ALEXANDER J, 1978, T ROY SOC TROP MED H, V72, P345, DOI 10.1016/0035-9203(78)90124-4; ALLEN RA, 1965, J ULTRA MOL STRUCT R, V12, P730, DOI 10.1016/S0022-5320(65)80058-2; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; BRETONGORIUS J, 1967, NOUV REV FR HEMATOL, V7, P79; Castro R, 2006, J PARASITOL, V92, P1162, DOI 10.1645/GE-841R.1; CHANG KP, 1980, SCIENCE, V209, P1240, DOI 10.1126/science.7403880; DAHL HA, 1963, Z ZELLFORSCH MIK ANA, V60, P369, DOI 10.1007/BF00336612; Dawe HR, 2005, J CELL SCI, V118, P5421, DOI 10.1242/jcs.02659; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Gadelha C, 2006, J CELL SCI, V119, P2405, DOI 10.1242/jcs.02969; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gull K, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P453; HENTZER B, 1977, ACTA PATH MICRO IM B, V85, P153; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LANG T, 1994, J CELL SCI, V107, P69; LEAO SD, 1995, J CELL SCI, V108, P3219; MORAN DT, 1982, J NEUROCYTOL, V11, P721, DOI 10.1007/BF01153516; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; SIMPSON CF, 1982, AM J VET RES, V43, P1684; SOLTER KM, 1977, NATURE, V265, P444, DOI 10.1038/265444a0	23	69	71	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3117	3121		10.1096/fj.09-151381	http://dx.doi.org/10.1096/fj.09-151381			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20371625	Green Published			2022-12-25	WOS:000281446400002
J	Goswami, AV; Chittoor, B; D'Silva, P				Goswami, Arvind Vittal; Chittoor, Balasubramanyam; D'Silva, Patrick			Understanding the Functional Interplay between Mammalian Mitochondrial Hsp70 Chaperone Machine Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT MOTOR; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; CO-CHAPERONE; DNAK; HOMOLOG; IDENTIFICATION; MECHANISM; SYSTEM; PURIFICATION	Mitochondria biogenesis requires the import of several precursor proteins that are synthesized in the cytosol. The mitochondrial heat shock protein 70 (mtHsp70) machinery components are highly conserved among eukaryotes, including humans. However, the functional properties of human mtHsp70 machinery components have not been characterized among all eukaryotic families. To study the functional interactions, we have reconstituted the components of the mtHsp70 chaperone machine (Hsp70/J-protein/GrpE/Hep) and systematically analyzed in vitro conditions for biochemical functions. We observed that the sequence-specific interaction of human mtHsp70 toward mitochondrial client proteins differs significantly from its yeast counterpart Ssc1. Interestingly, the helical lid of human mtHsp70 was found dispensable to the binding of P5 peptide as compared with the other Hsp70s. We observed that the two human mitochondrial matrix J-protein splice variants differentially regulate the mtHsp70 chaperone cycle. Strikingly, our results demonstrated that human Hsp70 escort protein (Hep) possesses a unique ability to stimulate the ATPase activity of mtHsp70 as well as to prevent the aggregation of unfolded client proteins similar to J-proteins. We observed that Hep binds with the C terminus of mtHsp70 in a full-length context and this interaction is distinctly different from unfolded client-specific or J-protein binding. In addition, we found that the interaction of Hep at theCterminus of mtHsp70 is regulated by the helical lid region. However, the interaction of Hep at the ATPase domain of the human mtHsp70 is mutually exclusive with J-proteins, thus promoting a similar conformational change that leads to ATPase stimulation. Additionally, we highlight the biochemical defects of the mtHsp70 mutant (G489E) associated with a myelodysplastic syndrome.	[Goswami, Arvind Vittal; Chittoor, Balasubramanyam; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), CV Raman Ave, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	D'Silva, Patrick/L-6653-2019		Wellcome Trust [WT081643MA]; Council of Scientific and Industrial Research Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Council of Scientific and Industrial Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Wellcome Trust International Senior Research Fellowship in Biomedical Science WT081643MA (to P. D.) and a Council of Scientific and Industrial Research Fellowship (to A. V. G.).	Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Choglay AA, 2001, GENE, V267, P125, DOI 10.1016/S0378-1119(01)00396-1; Chou CC, 2003, J BIOL CHEM, V278, P30311, DOI 10.1074/jbc.M304563200; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; Kaul SC, 2000, DNA RES, V7, P229, DOI 10.1093/dnares/7.3.229; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Lopez-Buesa P, 1998, P NATL ACAD SCI USA, V95, P15253, DOI 10.1073/pnas.95.26.15253; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; Ohno M, 2004, FEBS LETT, V576, P381, DOI 10.1016/j.febslet.2004.09.044; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rajan VBV, 2009, FUNCT INTEGR GENOMIC, V9, P433, DOI 10.1007/s10142-009-0132-0; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200	45	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19472	19482		10.1074/jbc.M110.105957	http://dx.doi.org/10.1074/jbc.M110.105957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392697	hybrid, Green Published			2022-12-25	WOS:000278727800057
J	Liu, L; Luo, GZ; Yang, W; Zhao, XY; Zheng, QY; Lv, Z; Li, W; Wu, HJ; Wang, L; Wang, XJ; Zhou, Q				Liu, Lei; Luo, Guan-Zheng; Yang, Wei; Zhao, Xiaoyang; Zheng, Qinyuan; Lv, Zhuo; Li, Wei; Wu, Hua-Jun; Wang, Liu; Wang, Xiu-Jie; Zhou, Qi			Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; FIBROBLASTS; MICE	Low reprogramming efficiency and reduced pluripotency have been the two major obstacles in induced pluripotent stem (iPS) cell research. An effective and quick method to assess the pluripotency levels of iPS cells at early stages would significantly increase the successrate of iPS cell generation and promote its applications. We have identified a conserved imprinted region of the mouse genome, the Dlk1-Dio3 region, which was activated in fully pluripotent mouse stem cells but repressed in partially pluripotent cells. The degree of activation of this region was positively correlated with the pluripotency levels of stem cells. A mammalian conserved cluster of microRNAs encoded by this region exhibited significant expression differences between full and partial pluripotent stem cells. Several microRNAs from this cluster potentially target components of the polycomb repressive complex 2 (PRC2) and may form a feedback regulatory loop resulting in the expression of all genes and non-coding RNAs encoded by this region in full pluripotent stem cells. No other genomic regions were found to exhibit such clear expression changes between cell lines with different pluripotency levels; therefore, the Dlk1-Dio3 region may serve as a marker to identify fully pluripotent iPS or embryonic stem cells from partial pluripotent cells. These findings also provide a step forward toward understanding the operating mechanisms during reprogramming to produce iPS cells and can potentially promote the application of iPS cells in regenerative medicine and cancer therapy.	[Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Luo, Guan-Zheng; Yang, Wei; Wu, Hua-Jun; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Luo, Guan-Zheng; Yang, Wei; Zhao, Xiaoyang; Zheng, Qinyuan; Lv, Zhuo; Li, Wei; Wu, Hua-Jun] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XJ (corresponding author), 1 Beichen W Rd, Beijing 100101, Peoples R China.	xjwang@genetics.ac.cn; qzhou@ioz.ac.cn	Wang, Xiu-Jie/L-1312-2019; Lu, Zhuo/D-4517-2014	ZHAO, Xiao-Yang/0000-0003-2544-8293	National High Technology Research and Development Program of China [2006AA02A101]; Ministry of Science and Technology of China [2006CB701501, 2007CB946901]; National Natural Science Foundation of China [90919060, 30725014]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was in part supported by the National High Technology Research and Development Program of China Grant 2006AA02A101 (to Q.Z.), the Ministry of Science and Technology of China Grants 2006CB701501 (to Q.Z.) and 2007CB946901 to (X.-J.W.), and the National Natural Science Foundation of China Grants 90919060 (to Q.Z.) and 30725014 (to X.-J.W.).	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	23	206	228	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19483	19490		10.1074/jbc.M110.131995	http://dx.doi.org/10.1074/jbc.M110.131995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382743	Green Published, hybrid			2022-12-25	WOS:000278727800058
J	Watanabe, TM; Tokuo, H; Gonda, K; Higuchi, H; Ikebe, M				Watanabe, Tomonobu M.; Tokuo, Hiroshi; Gonda, Kohsuke; Higuchi, Hideo; Ikebe, Mitsuo			Myosin-X Induces Filopodia by Multiple Elongation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE FLOW; MOLECULAR MOTOR; ACTIN; PROTEINS; LAMELLIPODIA; KERATOCYTES; DOWNSTREAM; EXTENSION; DOMAIN; CELLS	Filopodia are actin-rich finger-like cytoplasmic projections extending from the leading edge of cells. Unconventional myosin- X is involved in the protrusion of filopodia. However, the underlying mechanism of myosin-X-induced filopodia formation is obscure. Here, we studied the movements of myosin-X during filopodia protrusion using a total internal reflection microscope to clarify the mechanism of myosin-X-induced filopodia formation. Myosin-X was recruited to the discrete site at the leading edge where it assembles with exponential kinetics before the filopodia extension. The myosin-X-induced filopodia showed repeated extension-retraction cycles with each extension of 2.4 mu m, which was critical to produce long filopodia. Myosin-X, lacking the FERM domain, could move to the tip as does the wild type. However, it was transported toward the cell body during filopodia retraction, did not undergo multiple extension-retraction cycles, and failed to produce long filopodia. During the filopodia protrusion, the single molecules of full-length myosin-X moved within filopodia. The majority of the fluorescence spots showed two-step photobleaching, suggesting that the moving myosin-X is a dimer. Deletion of the FERM domain did not change the movement at the single molecule level with the same velocity of similar to 600 nm/s as wild-type, suggesting that the myosin-X in filopodia moves without interaction with the attached membrane via the FERM domain. Based upon these results, we have proposed a model of myosin-X-induced filopodia protrusion.	[Watanabe, Tomonobu M.; Tokuo, Hiroshi; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; [Watanabe, Tomonobu M.] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr Initiat, Suita, Osaka 5650871, Japan; [Watanabe, Tomonobu M.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Gonda, Kohsuke] Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Higuchi, Hideo] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyou Ku, Tokyo 1138654, Japan	University of Massachusetts System; University of Massachusetts Worcester; Osaka University; Japan Science & Technology Agency (JST); Tohoku University; University of Tokyo	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.	Mitsuo.Ikebe@umassmed.edu	Watanabe, Tomonobu/J-4812-2013	Watanabe, Tomonobu/0000-0002-2420-4230; Tokuo, Hiroshi/0000-0002-7614-7805	NHLBI NIH HHS [R01 HL073050] Funding Source: Medline; NIAMS NIH HHS [R01 AR048526, R01 AR048898, AR048898, AR048526] Funding Source: Medline; NIDCD NIH HHS [DC006103, R01 DC006103] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048526, R01AR048898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Sako Y, 2003, NAT CELL BIOL, pSS1, DOI 10.1038/nrm1193; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; WARD WW, 1980, PHOTOCHEM PHOTOBIOL, V31, P611, DOI 10.1111/j.1751-1097.1980.tb03755.x; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	33	58	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19605	19614		10.1074/jbc.M109.093864	http://dx.doi.org/10.1074/jbc.M109.093864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392702	hybrid, Green Published			2022-12-25	WOS:000278727800070
J	Baur, R; Kaur, KH; Sigel, E				Baur, Roland; Kaur, Kuldeep H.; Sigel, Erwin			Diversity of Structure and Function of alpha(1)alpha(6)beta(3)delta GABA(A) Receptors COMPARISON WITH alpha(1)beta(3)delta AND alpha(6)beta(3)delta RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; CEREBELLAR GRANULE CELLS; DELTA-SUBUNIT; A RECEPTORS; RAT-BRAIN; QUANTITATIVE IMPORTANCE; ALPHA(6) SUBUNITS; ETHANOL; SENSITIVITY; CHANNELS	delta subunit-containing gamma-aminobutyric acid, type A (GABA(A))-receptors are expressed extrasynaptically and mediate tonic inhibition. In cerebellar granule cells, they often form receptors together with alpha(1) and/ or alpha(6) subunits. We were interested in determining the architecture of receptors containing both subunits. We predefined the subunit arrangement of several different GABAA receptor pentamers by concatenation. These receptors composed of alpha(1), alpha(6), beta(3), and delta subunits were expressed in Xenopus oocytes. Currents elicited in response to GABA were determined in the presence and absence of 3 alpha,21-dihydroxy-5 alpha-pregnan-20-one (THDOC) or ethanol, or currents were elicited by 4,5,6,7-tetrahydroisoxazolo[5,4-c]-pyridin-3-ol (THIP). Several subunit configurations formed active channels. We therefore conclude that delta can assume multiple positions in a receptor pentamer made up of alpha(1), alpha(6), beta(3), and delta subunits. The different receptors differ in their functional properties. Functional expression of one receptor type was only evident in the combined presence of the neurosteroid THDOC with the channel agonist GABA. Most, but not all, receptors active with GABA/THDOC responded to THIP. None of the receptors was modulated by ethanol concentrations up to 30 mM. Several observations point to a preferred position of delta subunits between two alpha subunits in alpha(1)alpha(6)beta(3)delta receptors. This property is shared by alpha(1)beta(3)delta and alpha(6)beta(3)delta receptors, but there are differences in the additionally expressed isoforms.	[Baur, Roland; Kaur, Kuldeep H.; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sigel@mci.unibe.ch	Sigel, Erwin/F-7736-2015		Swiss National Science Foundation [3100A0-105272/2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 3100A0-105272/2.	Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Barnard EA, 1998, PHARMACOL REV, V50, P291; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Jechlinger M, 1998, J NEUROSCI, V18, P2449; Jones A, 1997, J NEUROSCI, V17, P1350; KAUR KH, 2009, BIOL CHEM, V284, P7889; Khan ZU, 1996, J NEUROCHEM, V66, P685; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, J NEUROSCI, V16, P103; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Saxena NC, 1996, MOL PHARMACOL, V49, P567; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; Sigel E, 2000, J NEUROCHEM, V74, P2590, DOI 10.1046/j.1471-4159.2000.0742590.x; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Zheleznova N, 2008, BRIT J PHARMACOL, V153, P1062, DOI 10.1038/sj.bjp.0707665	40	26	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17398	17405		10.1074/jbc.M110.108670	http://dx.doi.org/10.1074/jbc.M110.108670			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382738	Green Published, hybrid			2022-12-25	WOS:000278133400017
J	Fitzkee, NC; Masse, JE; Shen, Y; Davies, DR; Bax, A				Fitzkee, Nicholas C.; Masse, James E.; Shen, Yang; Davies, David R.; Bax, Ad			Solution Conformation and Dynamics of the HIV-1 Integrase Core Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEAR-MAGNETIC-RESONANCE; REFINED SOLUTION STRUCTURE; MODEL-FREE APPROACH; DNA-BINDING DOMAIN; PARAMAGNETIC RELAXATION ENHANCEMENT; PROTEIN SECONDARY STRUCTURE; RIBONUCLEASE-H DOMAIN; TERMINAL HHCC DOMAIN; NMR CHEMICAL-SHIFTS	The human immunodeficiency virus type 1 (HIV-1) integrase (IN) is a critical enzyme involved in infection. It catalyzes two reactions to integrate the viral cDNA into the host genome, 3' processing and strand transfer, but the dynamic behavior of the active site during catalysis of these two processes remains poorly characterized. NMR spectroscopy can reveal important structural details about enzyme mechanisms, but to date the IN catalytic core domain has proven resistant to such an analysis. Here, we present the first NMR studies of a soluble variant of the catalytic core domain. The NMR chemical shifts are found to corroborate structures observed in crystals, and confirm prior studies suggesting that the alpha 4 helix extends toward the active site. We also observe a dramatic improvement in NMR spectra with increasing MgCl2 concentration. This improvement suggests a structural transition not only near the active site residues but also throughout the entire molecule as IN binds Mg2+. In particular, the stability of the core domain is linked to the conformation of its C-terminal helix, which has implications for relative domain orientation in the full-length enzyme. N-15 relaxation experiments further show that, although conformationally flexible, the catalytic loop of IN is not fully disordered in the absence of DNA. Indeed, automated chemical shift-based modeling of the active site loop reveals several stable clusters that show striking similarity to a recent crystal structure of prototype foamy virus IN bound to DNA.	NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Davies, David R.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bax, A (corresponding author), 5 Mem Dr, Bethesda, MD 20892 USA.	bax@nih.gov	Shen, Yang/C-3064-2008; Shen, Yang/ABH-8248-2022; Shen, Yang/AAH-2403-2022	Shen, Yang/0000-0003-1408-8034; 	NIDDK; Office of the Director, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075024, ZIADK034002, ZIADK029048] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDDK and the Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH.	Andrake MD, 1996, J BIOL CHEM, V271, P19633, DOI 10.1074/jbc.271.33.19633; Asante-Appiah E, 1998, J BIOL CHEM, V273, P35078, DOI 10.1074/jbc.273.52.35078; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Baldanti F, 2010, J MED VIROL, V82, P116, DOI 10.1002/jmv.21651; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; Bujacz G, 1996, FEBS LETT, V398, P175, DOI 10.1016/S0014-5793(96)01236-7; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUSHMAN FD, 1990, SCIENCE, V249, P1555, DOI 10.1126/science.2171144; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chill JH, 2006, J BIOMOL NMR, V36, P123, DOI 10.1007/s10858-006-9071-4; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eaton WA, 1998, ACCOUNTS CHEM RES, V31, P745, DOI 10.1021/ar9700825; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; Eijkelenboom APAM, 2000, J BIOMOL NMR, V18, P119, DOI 10.1023/A:1008342312269; Eijkelenboom APAM, 1999, PROTEINS, V36, P556, DOI 10.1002/(SICI)1097-0134(19990901)36:4<556::AID-PROT18>3.0.CO;2-6; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ENGELMAN A, 1995, J VIROL, V69, P5908, DOI 10.1128/JVI.69.9.5908-5911.1995; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; GEEN H, 1991, J MAGN RESON, V93, P93, DOI 10.1016/0022-2364(91)90034-Q; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; IKURA M, 1990, FEBS LETT, V266, P155, DOI 10.1016/0014-5793(90)81528-V; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jones JA, 1996, J MAGN RESON SER B, V113, P25, DOI 10.1006/jmrb.1996.0151; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh E, 2003, PROTEIN SCI, V12, P1376, DOI 10.1110/ps.0300703; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; KATZMAN M, 1989, J VIROL, V63, P5319, DOI 10.1128/JVI.63.12.5319-5327.1989; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R. L. J., 2004, THESIS EIDGENOSSISCH, P1; Kontaxis G, 2005, METHOD ENZYMOL, V394, P42, DOI 10.1016/S0076-6879(05)94003-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; LAFEMINA RL, 1992, J VIROL, V66, P7414, DOI 10.1128/JVI.66.12.7414-7419.1992; Lee MC, 2005, BIOPHYS J, V88, P3133, DOI 10.1529/biophysj.104.058446; Lins RD, 1999, BIOPHYS J, V76, P2999, DOI 10.1016/S0006-3495(99)77453-9; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Newman JL, 2004, PROTEIN SCI, V13, P2101, DOI 10.1110/ps.04614804; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; POWERS R, 1992, BIOCHEMISTRY-US, V31, P9150, DOI 10.1021/bi00153a006; R Development Core Team, 2009, R FDN STAT COMP; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Semenova EA, 2008, ADV PHARMACOL, V56, P199, DOI 10.1016/S1054-3589(07)56007-2; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tong KI, 2008, J BIOMOL NMR, V42, P59, DOI 10.1007/s10858-008-9264-0; TORCHIA DA, 1989, BIOCHEMISTRY-US, V28, P5509, DOI 10.1021/bi00439a028; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; WAGNER G, 1990, PROG NUCL MAG RES SP, V22, P101, DOI 10.1016/0079-6565(90)80003-Z; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang Y, 2009, BIOCHEMISTRY-US, V48, P4548, DOI 10.1021/bi9002887; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yi JZ, 1999, BIOCHEMISTRY-US, V38, P8458, DOI 10.1021/bi982870n; Ying JF, 2007, J BIOMOL NMR, V37, P195, DOI 10.1007/s10858-006-9120-z; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000	107	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18072	18084		10.1074/jbc.M110.113407	http://dx.doi.org/10.1074/jbc.M110.113407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363759	Green Published, hybrid			2022-12-25	WOS:000278133400082
J	Ojha, AK; Trivelli, X; Guerardel, Y; Kremer, L; Hatfull, GF				Ojha, Anil K.; Trivelli, Xavier; Guerardel, Yann; Kremer, Laurent; Hatfull, Graham F.			Enzymatic Hydrolysis of Trehalose Dimycolate Releases Free Mycolic Acids during Mycobacterial Growth in Biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL BIOFILMS; CORD FACTOR; TUBERCULOSIS; COMPLEX; ANTIGEN; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE; MORPHOLOGY; CHAPERONE	Mycobacterial species, like other microbes, spontaneously form multicellular drug-tolerant biofilms when grown in vitro in detergent-free liquid media. The structure of Mycobacterium tuberculosis biofilms is formed through genetically programmed pathways and is built upon a large abundance of novel extracellular free mycolic acids (FM), although the mechanism of FM synthesis remained unclear. Here we show that the FM in Mycobacterium smegmatis biofilms is produced through the enzymatic release from constitutively present mycolyl derivatives. One of the precursors for FM is newly synthesized trehalose dimycolate (TDM), which is cleaved by a novel TDM-specific serine esterase, Msmeg_1529. Disruption of Msmeg_1529 leads to undetectable hydrolytic activity, reduced levels of FM in the mutant, and retarded biofilm growth. Furthermore, enzymatic hydrolysis of TDM remains conserved in M. tuberculosis, suggesting the presence of a TDM-specific esterase in this pathogen. Overall, this study provides the first evidence for an enzymatic release of free mycolic acids from cell envelope mycolates during mycobacterial growth.	Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hatfull, Graham F.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15261 USA; [Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Trivelli, Xavier; Guerardel, Yann] Univ Lille 1, CNRS, UGSF UMR 8576, F-59650 Villeneuve Dascq, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Ojha, AK (corresponding author), 130 DeSoto St, Pittsburgh, PA 15261 USA.	ano7@pitt.edu	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Trivelli, Xavier/0000-0001-6775-9650; Guerardel, Yann/0000-0003-4967-9512	National Institutes of Health [AI079288, AI064494]; American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064494, R21AI079288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI079288 (to A. K. O.) and AI064494 (to G. F. H.). This work was also supported by an award from the American Lung Association (to A. K. O.).	Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; COSTERTON JW, 1981, CRC CR REV MICROBIOL, V8, P303, DOI 10.3109/10408418109085082; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; LAM J, 1980, INFECT IMMUN, V28, P546; Lewis JA, 2000, MOL MICROBIOL, V35, P350, DOI 10.1046/j.1365-2958.2000.01695.x; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; McNeill K, 2003, FEMS MICROBIOL LETT, V221, P25, DOI 10.1016/S0378-1097(03)00164-2; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; NOLL H, 1956, BIOCHIM BIOPHYS ACTA, V20, P299, DOI 10.1016/0006-3002(56)90289-X; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; SCHU M, 2010, FASEB J IN PRESS; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Teng R, 2003, FEMS MICROBIOL LETT, V227, P171, DOI 10.1016/S0378-1097(03)00584-6; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; *WHO, 2009, WHO REP 2009 GLOB TU	54	88	91	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17380	17389		10.1074/jbc.M110.112813	http://dx.doi.org/10.1074/jbc.M110.112813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375425	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000278133400015
J	John, K; Fitzpatrick, J; French, N; Kazwala, R; Kambarage, D; Mfinanga, GS; MacMillan, A; Cleaveland, S				John, Kunda; Fitzpatrick, Julie; French, Nigel; Kazwala, Rudovick; Kambarage, Dominic; Mfinanga, Godfrey S.; MacMillan, Alastair; Cleaveland, Sarah			Quantifying Risk Factors for Human Brucellosis in Rural Northern Tanzania	PLOS ONE			English	Article							UNITED-STATES	Background: Brucellosis is a zoonosis of veterinary, public health and economic significance in most developing countries. Human brucellosis is a severely debilitating disease that requires prolonged treatment with a combination of antibiotics. The disease can result in permanent and disabling sequel, and results in considerable medical expenses in addition to loss of income due to loss of working hours. A study was conducted in Northern Tanzania to determine the risk factors for transmission of brucellosis to humans in Tanzania. Methods: This was a matched case-control study. Any patient with a positive result by a competitive ELISA (c-ELISA) test for brucellosis, and presenting to selected hospitals with at least two clinical features suggestive of brucellosis such as headache, recurrent or continuous fever, sweating, joint pain, joint swelling, general body malaise or backache, was defined as a case. For every case in a district, a corresponding control was traced and matched by sex using multistage cluster sampling. Other criteria for inclusion as a control included a negative c-ELISA test result and that the matched individual would present to hospital if falls sick. Results: Multivariable analysis showed that brucellosis was associated with assisted parturition during abortion in cattle, sheep or goat. It was shown that individuals living in close proximity to other households had a higher risk of brucellosis. People who were of Christian religion were found to have a higher risk of brucellosis compared to other religions. The study concludes that assisting an aborting animal, proximity to neighborhoods, and Christianity were associated with brucellosis infection. There was no association between human brucellosis and Human Immunodeficiency Virus (HIV) serostatus. Protecting humans against contact with fluids and tissues during assisted parturition of livestock may be an important means of reducing the risk of transferring brucellosis from livestock to humans. These can be achieved through health education to the communities where brucellosis is common.	[John, Kunda; Mfinanga, Godfrey S.] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [John, Kunda; Cleaveland, Sarah] Univ Glasgow, Div Ecol & Evolutionary Biol, Glasgow, Lanark, Scotland; [Fitzpatrick, Julie] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [French, Nigel] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Kambarage, Dominic] Sokoine Univ Agr, Morogoro, Tanzania; [MacMillan, Alastair] Dept Environm Food & Rural Affairs, Vet Res Directorate, London, England	National Institute of Medical Research; University of Glasgow; Moredun Research Institute; Massey University; Sokoine University of Agriculture	John, K (corresponding author), Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania.	jkundas@yahoo.com	French, Nigel/F-5725-2011; Stephen, Kunda/ABE-9681-2020	French, Nigel/0000-0002-6334-0657; Cleaveland, Sarah/0000-0002-0456-0959	Department for International Development of the UK	Department for International Development of the UK	The study was funded by the Department for International Development of the UK through the Animal Health Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M M, 2001, Cent Eur J Public Health, V9, P158; Bikas C, 2003, EUR J EPIDEMIOL, V18, P267, DOI 10.1023/A:1023368420840; Bouza E, 2005, J HOSP INFECT, V61, P80, DOI 10.1016/j.jhin.2005.02.018; BUCHANAN TM, 1974, MEDICINE, V53, P415, DOI 10.1097/00005792-197411000-00002; BUSCH LA, 1972, J INFECT DIS, V125, P289, DOI 10.1093/infdis/125.3.289; COOPER CW, 1992, T ROY SOC TROP MED H, V86, P206, DOI 10.1016/0035-9203(92)90575-W; COX PSV, 1966, E AFR MED J, P43; DAVIES G, 1971, VET REC, V88, P447, DOI 10.1136/vr.88.17.447; KOZUKEEV TB, 2006, MORBIDITY MORTALI S1, P31; KUNDA J, 2007, THESIS U EDINBURGH; LAROCHE R, 1987, MED TROPICALE REV CO, V1, P35; LIM HS, 2005, J PREVENTIVE MED PUB, V4, P482; MANTHEI CA, 1950, AM J VET RES, V173, P180; MARTIN SW, 1986, CAN J VET RES, V50, P15; Mfinanga S G M, 2004, East Afr Med J, V81, P171; Mfinanga SG, 2003, INT J TUBERC LUNG D, V7, P933; *MIN AGR COOP, 1995, EMERG INFECT DIS, V2, P213; MOHD MG, 1989, J TROP MED HYG, V2, P86; Moreno S, 1998, EUR J CLIN MICROBIOL, V17, P319, DOI 10.1007/BF01709454; PAUL J, 1995, T ROY SOC TROP MED H, V89, P228, DOI 10.1016/0035-9203(95)90508-1; Perret L., 2001, GUIDE EIA TECHNIQUES; PERRY BD, 2001, PREVENTIVE VET MED H, P228; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Shirima GM, 2005, THESIS U GLASGOW; Smits HL, 2004, AFRICAN J BIOTECHNOL, V12, P631; Solera J, 1997, DRUGS, V53, P245, DOI 10.2165/00003495-199753020-00005; STARK C, 1973, B EPIZOOTIC DIS AFRI, V67; WHO, 2006, CONTR NEGL ZOON DIS; *WHO, 1997, N173 WHO; YOUNG EJ, 1983, REV INFECT DIS, V5, P821	30	71	76	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9968	10.1371/journal.pone.0009968	http://dx.doi.org/10.1371/journal.pone.0009968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376363	Green Published, gold			2022-12-25	WOS:000276418200041
J	Null, SE; Viers, JH; Mount, JF				Null, Sarah E.; Viers, Joshua H.; Mount, Jeffrey F.			Hydrologic Response and Watershed Sensitivity to Climate Warming in California's Sierra Nevada	PLOS ONE			English	Article							JOAQUIN RIVER-BASIN; POTENTIAL IMPACTS; UNCERTAINTY; MEADOWS; MODEL	This study focuses on the differential hydrologic response of individual watersheds to climate warming within the Sierra Nevada mountain region of California. We describe climate warming models for 15 west-slope Sierra Nevada watersheds in California under unimpaired conditions using WEAP21, a weekly one-dimensional rainfall-runoff model. Incremental climate warming alternatives increase air temperature uniformly by 2 degrees, 4 degrees, and 6 degrees C, but leave other climatic variables unchanged from observed values. Results are analyzed for changes in mean annual flow, peak runoff timing, and duration of low flow conditions to highlight which watersheds are most resilient to climate warming within a region, and how individual watersheds may be affected by changes to runoff quantity and timing. Results are compared with current water resources development and ecosystem services in each watershed to gain insight into how regional climate warming may affect water supply, hydropower generation, and montane ecosystems. Overall, watersheds in the northern Sierra Nevada are most vulnerable to decreased mean annual flow, southern-central watersheds are most susceptible to runoff timing changes, and the central portion of the range is most affected by longer periods with low flow conditions. Modeling results suggest the American and Mokelumne Rivers are most vulnerable to all three metrics, and the Kern River is the most resilient, in part from the high elevations of the watershed. Our research seeks to bridge information gaps between climate change modeling and regional management planning, helping to incorporate climate change into the development of regional adaptation strategies for Sierra Nevada watersheds.	[Null, Sarah E.; Viers, Joshua H.; Mount, Jeffrey F.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Null, SE (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.	senull@ucdavis.edu	Kostin, Yurii/H-6755-2018; Orlov, Mykhailo/D-2417-2019; Reheilo, Iryna/B-6365-2016; Vorobev, Alexander/C-1918-2016; Bazeliuk, Oleksandr/B-2657-2016; Mykheliev, Ihor/A-5709-2019; Steksova, Tatiana I/J-5397-2016; Savychuk, Natali O/X-9305-2018; Kavura, Victor/M-9646-2018; Null, Sarah/E-4422-2011; Orlova, Nelya/N-1393-2018; Doroshenko, Alexander/N-7175-2015; Viers, Joshua/ABC-1851-2020	Kostin, Yurii/0000-0002-1823-5110; Orlov, Mykhailo/0000-0002-3705-8631; Reheilo, Iryna/0000-0003-0512-2456; Vorobev, Alexander/0000-0002-7324-428X; Bazeliuk, Oleksandr/0000-0002-3206-2287; Mykheliev, Ihor/0000-0001-9579-6547; Steksova, Tatiana I/0000-0003-4275-7450; Savychuk, Natali O/0000-0001-9532-665X; Kavura, Victor/0000-0003-0876-8332; Null, Sarah/0000-0001-7451-7908; Orlova, Nelya/0000-0002-0518-3593; Doroshenko, Alexander/0000-0003-3693-3876; Viers, Joshua/0000-0001-7957-7942	Resources Legacy Fund Foundation (RLFF) [2008-0201]	Resources Legacy Fund Foundation (RLFF)	This study was funded by Resources Legacy Fund Foundation (RLFF) under the Delta Solutions Grant (#2008-0201). Funder's website: http://www.resourceslegacyfund.org/rlff.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ASP ENV M CUB, 2005, POT CHANG HYDR PROD; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Berlow EL, 2002, ECOL APPL, V12, P1103, DOI 10.1890/1051-0761(2002)012[1103:SEIMMT]2.0.CO;2; Brekke LD, 2004, J AM WATER RESOUR AS, V40, P149, DOI 10.1111/j.1752-1688.2004.tb01016.x; *CWR, 2009, B CDWR; *CWR, 1988, B CDWR, V1788; Daly C., 2008, INT J CLIMATOLOGY; DETTINGER MD, 2009, CEC5002009050D CALEP; DETTINGER MD, 2005, SAN FRANCISCO ESTUAR, V3; Fu G, 2007, J HYDROL ENG, V12, P452, DOI 10.1061/(ASCE)1084-0699(2007)12:5(452); GLEICK PH, 1987, WATER RESOUR RES, V23, P1049, DOI 10.1029/WR023i006p01049; Hammersmark CT, 2008, RIVER RES APPL, V24, P735, DOI 10.1002/rra.1077; Hanak E., 2008, ADAPTING CALIFORNIAS; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Jefferson A, 2008, HYDROL PROCESS, V22, P4371, DOI 10.1002/hyp.7041; Jeton A. E., 1996, 954260 US GEOL SURV; KAPNICK S, 2009, CEC5002009016D CALEP; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; LETTENMAIER DP, 1990, WATER RESOUR RES, V26, P69, DOI 10.1029/WR026i001p00069; MADANI K, 2007, HYDROLOGICAL SCI TEC, V23, P137; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; Medellin-Azuara J, 2008, CLIMATIC CHANGE, V87, pS75, DOI 10.1007/s10584-007-9355-z; MEDELLINAZUARA J, 2009, CEC5002009049D CALEP; Micheli ER, 2002, EARTH SURF PROC LAND, V27, P687, DOI 10.1002/esp.340; Miller NL, 2003, J AM WATER RESOUR AS, V39, P771, DOI 10.1111/j.1752-1688.2003.tb04404.x; PATTON DR, 1970, J RANGE MANAGE, V23, P272, DOI 10.2307/3896220; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Stonefelt MD, 2000, J AM WATER RESOUR AS, V36, P321, DOI 10.1111/j.1752-1688.2000.tb04271.x; Vicuna S, 2008, CLIMATIC CHANGE, V87, pS123, DOI 10.1007/s10584-007-9365-x; Vrba J, INT CONTRIBUTIONS HY, V16; Xu CY, 1999, AGR FOREST METEOROL, V98-9, P295, DOI 10.1016/S0168-1923(99)00106-9; Yates D, 2005, WATER INT, V30, P487, DOI 10.1080/02508060508691893; YOUNG CA, 2009, J AM WATER RESOURCES	33	96	96	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9932	10.1371/journal.pone.0009932	http://dx.doi.org/10.1371/journal.pone.0009932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368984	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200010
J	Poppe, J; Sutcliffe, P; Hooper, JNA; Worheide, G; Erpenbeck, D				Poeppe, Judith; Sutcliffe, Patricia; Hooper, John N. A.; Woerheide, Gert; Erpenbeck, Dirk			CO I Barcoding Reveals New Clades and Radiation Patterns of Indo-Pacific Sponges of the Family Irciniidae (Demospongiae: Dictyoceratida)	PLOS ONE			English	Article							MARINE SPONGE; SEQUENCE EVOLUTION; PHYLUM PORIFERA; MITOCHONDRIAL; GENUS; ALIGNMENT; SPECIATION; PHYLOGENY; GENES	Background: DNA barcoding is a promising tool to facilitate a rapid and unambiguous identification of sponge species. Demosponges of the order Dictyoceratida are particularly challenging to identify, but are of ecological as well as biochemical importance. Methodology/Principal Findings: Here we apply DNA barcoding with the standard CO1-barcoding marker on selected Indo-Pacific specimens of two genera, Ircinia and Psammocinia of the family Irciniidae. We show that the CO1 marker identifies several species new to science, reveals separate radiation patterns of deep-sea Ircinia sponges and indicates dispersal patterns of Psammocinia species. However, some species cannot be unambiguously barcoded by solely this marker due to low evolutionary rates. Conclusions/Significance: We support previous suggestions for a combination of the standard CO1 fragment with an additional fragment for sponge DNA barcoding.	[Poeppe, Judith] Humboldt Univ, Museum Nat Kunde, Dept Malacozool, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany; [Sutcliffe, Patricia; Hooper, John N. A.] Queensland Museum, Biodivers Program, Brisbane, Australia; [Woerheide, Gert; Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Woerheide, Gert; Erpenbeck, Dirk] Univ Munich, GeoBioCtr, Munich, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Queensland Museum; University of Munich; University of Munich	Poppe, J (corresponding author), Humboldt Univ, Museum Nat Kunde, Dept Malacozool, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany.	erpenbeck@lmu.de	Wörheide, Gert/C-1080-2008	Wörheide, Gert/0000-0002-6380-7421; Hooper, John/0000-0003-1722-5954	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This study benefited from funding by the German Research Foundation (DFG, www.dfg.de) to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bergquist P. R., 2002, SYSTEMA PORIFERA GUI; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; BIFULCO G, 1995, J NAT PRODUCTS, V58, P1444, DOI 10.1021/np50123a017; Blanquer A, 2007, MOL PHYLOGENET EVOL, V45, P392, DOI 10.1016/j.ympev.2007.03.004; Blunt J., 2003, MARINLIT DATABASE LI; Chombard C, 1997, BIOL BULL, V193, P359, DOI 10.2307/1542938; Cook SDC, 1998, NEW ZEAL J MAR FRESH, V32, P399; COOK SDC, 2002, SYSTEMA PORIFERA GUI; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Fromont J.P., 1990, P273; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEIM I, 2007, J MAR BIOL ASSOC UK, V87, P14; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; LOPEZLEGENTIL S, 2008, CORAL REEFS, P9; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mikkelsen PM, 2001, B MAR SCI, V69, P525; Nichols SA, 2005, J EXP MAR BIOL ECOL, V323, P1, DOI 10.1016/j.jembe.2005.02.012; Palumbi SR, 1997, EVOLUTION, V51, P1506, DOI 10.1111/j.1558-5646.1997.tb01474.x; Park MH, 2007, MOL CELLS, V23, P220; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raleigh J, 2007, J MAR BIOL ASSOC UK, V87, P1577, DOI 10.1017/S0025315407058341; Schlacher-Hoenlinger MA, 2005, ZOOSYSTEMA, V27, P649; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Sole-Cava Antonio M., 1999, Memoirs of the Queensland Museum, V44, P591; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; VANSOEST RWM, 2008, WORLD PORIFERA DATAB; VETHAAK AD, 1982, BIJDR DIERKD, V52, P82, DOI 10.1163/26660644-05202002; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1629, DOI 10.1017/S0025315407058274; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Worheide G, 2008, PORIFERA RES BIODIVE, P123; Worheide Gert, 1999, Memoirs of the Queensland Museum, V43, P859	45	35	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9950	10.1371/journal.pone.0009950	http://dx.doi.org/10.1371/journal.pone.0009950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376349	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200026
J	Wang, B; Liu, P; Tang, YY; Pan, HH; Xu, XR; Tang, RK				Wang, Ben; Liu, Peng; Tang, Yanyan; Pan, Haihua; Xu, Xurong; Tang, Ruikang			Guarding Embryo Development of Zebrafish by Shell Engineering: A Strategy to Shield Life from Ozone Depletion	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; UV-B; MORTALITY; REPAIR; LARVAE; EGGS	Background: The reduced concentration of stratospheric ozone results in an increased flux of biologically damaging midultraviolet radiation (UVB, 280 to 320 nm) reaching earth surfaces. Environmentally relevant levels of UVB negatively impact various natural populations of marine organisms, which is ascribed to suppressed embryonic development by increased radiation. Methodology/Principal Findings: Inspired by strategies in the living systems generated by evolution, we induce an extra UVB-adsorbed coat on the chorion (eggshell surrounding embryo) of zebrafish, during the blastula period. Short and long UV exposure experiments show that the artificial mineral-shell reduces the UV radiation effectively and the enclosed embryos become more robust. In contrast, the uncoated embryos cannot survive under the enhanced UVB condition. Conclusions: We suggest that an engineered shell of functional materials onto biological units can be developed as a strategy to shield lives to counteract negative changes of global environment, or to provide extra protection for the living units in biological research.	[Wang, Ben; Liu, Peng; Tang, Yanyan; Pan, Haihua; Xu, Xurong; Tang, Ruikang] Zhejiang Univ, Ctr Biomat & Biopathways, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Ben] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Tang, Ruikang] Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Harvard University; Zhejiang University	Wang, B (corresponding author), Zhejiang Univ, Ctr Biomat & Biopathways, Hangzhou 310003, Zhejiang, Peoples R China.	rtang@zju.edu.cn	xu, xurong/AAA-7823-2020; Pan, Haihua/O-7512-2018; Wang, Ben/B-6488-2011; Wang, Ben/P-4732-2017; Wang, Ben/AAE-7987-2021	xu, xurong/0000-0002-0626-0597; Pan, Haihua/0000-0003-0327-7622; Wang, Ben/0000-0002-4134-1835; Wang, Ben/0000-0002-4134-1835; 	National Natural Science Foundation of China [20871102]; National Basic Research Program of China [2007CB516806]; Cheung Kong Scholars Program; Chinese Universities Scientific Fund [2008632016]; Zhejiang Provincial Natural Science Foundation [R407087]; Daming Biomineralization Fundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Cheung Kong Scholars Program; Chinese Universities Scientific Fund; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Daming Biomineralization Fundation	This work was supported by the National Natural Science Foundation of China (20871102)(http://www.nsfc.gov.cn/Portal0/default106.htm), the National Basic Research Program of China (2007CB516806)(http://www.973.gov.cn/English/Index.aspx), Cheung Kong Scholars Program (RT)(http://www.lksf.org/eng/project/education/ckh_award/main01.shtml), Chinese Universities Scientific Fund (2008632016), Zhejiang Provincial Natural Science Foundation (R407087) and Daming Biomineralization Fundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; BLAUSTEIN AR, 1994, P NATL ACAD SCI USA, V91, P1791, DOI 10.1073/pnas.91.5.1791; Blaustein AR, 1997, P NATL ACAD SCI USA, V94, P13735, DOI 10.1073/pnas.94.25.13735; Bonsignorio D, 1996, ZYGOTE, V4, P101, DOI 10.1017/S0967199400002975; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; Dethlefsen V, 2001, HELGOLAND MAR RES, V55, P45, DOI 10.1007/s101520000062; DIFFEY BL, 1991, PHYS MED BIOL, V36, P299, DOI 10.1088/0031-9155/36/3/001; Feldmann C, 2003, ADV FUNCT MATER, V13, P511, DOI 10.1002/adfm.200301005; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; FREDERICK JE, 1988, SCIENCE, V241, P438, DOI 10.1126/science.241.4864.438; HALEY TJ, 1965, J PHARM SCI-US, V54, P663, DOI 10.1002/jps.2600540502; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; HUNTER JR, 1979, PHOTOCHEM PHOTOBIOL, V29, P325, DOI 10.1111/j.1751-1097.1979.tb07055.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; PRATHER MJ, 1984, NATURE, V312, P227, DOI 10.1038/312227a0; Quintero-Torres R, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.032901; SMITH RC, 1989, PHOTOCHEM PHOTOBIOL, V50, P459, DOI 10.1111/j.1751-1097.1989.tb05550.x; SOLOMON S, 1990, NATURE, V347, P347, DOI 10.1038/347347a0; Staehelin J, 2001, REV GEOPHYS, V39, P231, DOI 10.1029/1999RG000059; Tang RK, 2005, ANGEW CHEM INT EDIT, V44, P3698, DOI 10.1002/anie.200500153; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wang B, 2008, ANGEW CHEM INT EDIT, V47, P3560, DOI 10.1002/anie.200704718; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wubben DL, 2000, J PLANKTON RES, V22, P2095, DOI 10.1093/plankt/22.11.2095	28	28	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9963	10.1371/journal.pone.0009963	http://dx.doi.org/10.1371/journal.pone.0009963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376356	gold, Green Published, Green Submitted			2022-12-25	WOS:000276418200037
J	Pacini, S; Carnicelli, V; Trombi, L; Montali, M; Fazzi, R; Lazzarini, E; Giannotti, S; Petrini, M				Pacini, Simone; Carnicelli, Vittoria; Trombi, Luisa; Montali, Marina; Fazzi, Rita; Lazzarini, Edoardo; Giannotti, Stefano; Petrini, Mario			Constitutive Expression of Pluripotency-Associated Genes in Mesodermal Progenitor Cells (MPCs)	PLOS ONE			English	Article							NEURAL STEM-CELLS; GENERATION; OCT-4; SOX2	Background: We recently characterized a progenitor of mesodermal lineage (MPCs) from the human bone marrow of adults or umbilical cord blood. These cells are progenitors able to differentiate toward mesenchymal, endothelial and cardiomyogenic lineages. Here we present an extensive molecular characterization of MPCs, from bone marrow samples, including 39 genes involved in stem cell machinery, differentiation and cell cycle regulation. Methodology/Principal Findings: MPCs are cytofluorimetrically characterized and quantitative RT-PCR was performed to evaluate the gene expression profile, comparing it with MSCs and hESCs lines. Immunofluorescence and dot-blot analysis confirm qRT-PCR data. MPCs exhibit an increased expression of OCT4, NANOG, SALL4, FBX15, SPP1 and to a lesser extent c-MYC and KLF4, but lack LIN28 and SOX2. MPCs highly express SOX15. Conclusions/Significance: MPCs express many pluripotency-associated genes and show a peculiar Oct-4 molecular circuit. Understanding this unique molecular mechanism could lead to identifying MPCs as feasible, long telomeres, target cells for reprogramming with no up-regulation of the p53 pathway. Furthermore MPCs are easily and inexpensively harvested from human bone marrow.	[Pacini, Simone; Trombi, Luisa; Montali, Marina; Fazzi, Rita; Lazzarini, Edoardo; Petrini, Mario] Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy; [Carnicelli, Vittoria] Univ Pisa, Dipartimento Sci Uomo & Ambiente, Pisa, Italy; [Giannotti, Stefano] Univ Pisa, Dipartimento Endocrinol & Metab Ortopedia & Traum, Pisa, Italy	University of Pisa; University of Pisa; University of Pisa	Pacini, S (corresponding author), Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy.	s.pacini@med.unipi.it	Pacini, Simone/H-3318-2019; Lazzarini, Edoardo/J-8459-2018	Pacini, Simone/0000-0003-1701-6001; Lazzarini, Edoardo/0000-0001-6369-5442; Montali, Marina/0000-0001-8804-4320	Department of Oncology; Transplants and New Advances in Medicine; University of Pisa	Department of Oncology; Transplants and New Advances in Medicine; University of Pisa	The work was exclusively supported by institutional funds of the Department of Oncology, Transplants and New Advances in Medicine, University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Beltrami AP, 2009, PHARMACOL THERAPEUT, V124, P23, DOI 10.1016/j.pharmthera.2009.06.003; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Petrini M, 2009, STEM CELLS DEV, V18, P857, DOI 10.1089/scd.2008.0291; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2008, CELL STEM CELL, V2, P295, DOI 10.1016/j.stem.2008.03.015; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Trombi L, 2009, STEM CELLS DEV, V18, P1227, DOI 10.1089/scd.2009.0054; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	33	33	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9861	10.1371/journal.pone.0009861	http://dx.doi.org/10.1371/journal.pone.0009861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360837	Green Published, gold, Green Submitted			2022-12-25	WOS:000275969500007
J	Souslova, V; Townsend, PA; Mann, J; van der Loos, CM; Motterle, A; D'Acquisto, F; Mann, DA; Ye, S				Souslova, Veronika; Townsend, Paul A.; Mann, Jelena; van der Loos, Chris M.; Motterle, Anna; D'Acquisto, Fulvio; Mann, Derek A.; Ye, Shu			Allele-Specific Regulation of Matrix Metalloproteinase-3 Gene by Transcription Factor NF kappa B	PLOS ONE			English	Article							STROMELYSIN-1 MMP3 GENE; CORONARY ATHEROSCLEROSIS; 5A/6A POLYMORPHISM; PROMOTER; EXPRESSION; RISK; INTERLEUKIN-6; DETERMINANTS; MACROPHAGES; ACTIVATION	Background: Matrix metalloproteinase-3 (MMP3) is implicated in the pathogenesis and progression of atherosclerotic lesions. Previous studies suggested that MMP3 expression is influenced by a polymorphism (known as the 5A/6A polymorphism) in the promoter of the MMP3 gene and that this polymorphism is located within a cis-element that interacts with the transcription factor NF kappa B. In the present study, we sought to investigate whether MMP3 and NF kappa B were co-localized in atherosclerotic lesions and whether NF kappa B had differential effects on the two alleles of the MMP3 5A/6A polymorphism. Methodology/Principal Findings: Immunohistochemical examination showed that MMP3 and both the NF kappa B p50 and p65 subunits were expressed abundantly in macrophages in atherosclerotic lesions and that MMP3 expression was co-localized with p50 and p65. Chromatin immunoprecipitation experiments showed interaction of p50 and p65 with the MMP3 promoter in macrophages, with greater binding to the 5A allele than to the 6A allele. Reporter gene assays in transiently transfected macrophages showed that the 5A allele had greater transcriptional activity than the 6A allele, and that this allele-specific effect was augmented when the cells were treated with the NF kappa B activator lipopolysaccharides or co-transfected with p50 and/or p65 expressing plasmids, but was reduced when the cells were treated with the NF kappa B inhibitor 6-Amino-4-(4-phenoxyphenylethylamino)-quinazoline or transfected with a dominant negative mutant of IkB kinase-beta. Conclusion: These results corroborate an effect of the 5A/6A polymorphism on MMP3 transcription and indicate that NF kappa B has differential effects on the 5A and 6A alleles.	[Souslova, Veronika; Motterle, Anna; D'Acquisto, Fulvio; Ye, Shu] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Townsend, Paul A.] Univ Southampton, Sch Med, Div Human Genet, Southampton, Hants, England; [Mann, Jelena; Mann, Derek A.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [van der Loos, Chris M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of London; Queen Mary University London; University of Southampton; Newcastle University - UK; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Souslova, V (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.	s.ye@qmul.ac.uk	Townsend, Paul/AAF-8234-2020; Ye, Shu/C-4067-2009; D'Acquisto, Fulvio/E-7204-2018; Ye, Shu/R-6384-2017	D'Acquisto, Fulvio/0000-0002-4513-1608; Ye, Shu/0000-0002-4126-4278; Mann, Derek/0000-0003-0950-243X; Townsend, Paul/0000-0001-8956-9508	British Heart Foundation [PG/08/051/25141, FS/07/021]; National Institute of Health Research	British Heart Foundation(British Heart Foundation); National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation (PG/08/051/25141, FS/07/021) www.bhf.org.uk. It forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2006, J MED GENET, V43, P897, DOI 10.1136/jmg.2006.040808; Beyzade S, 2003, J AM COLL CARDIOL, V41, P2130, DOI 10.1016/S0735-1097(03)00482-0; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bond M, 1999, BIOCHEM BIOPH RES CO, V264, P561, DOI 10.1006/bbrc.1999.1551; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Bondeson J, 2007, J RHEUMATOL, V34, P523; Borghaei RC, 2004, BIOCHEM BIOPH RES CO, V316, P182, DOI 10.1016/j.bbrc.2004.02.030; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gnasso A, 2000, ARTERIOSCL THROM VAS, V20, P1600, DOI 10.1161/01.ATV.20.6.1600; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hoppmann P, 2004, EUR HEART J, V25, P335, DOI 10.1016/j.ehj.2003.12.004; Humphries S, 2002, EUR HEART J, V23, P721, DOI 10.1053/euhj.2001.2895; Humphries SE, 2002, ANN HUM GENET, V66, P343, DOI 10.1017/S0003480002001264; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Lamblin N, 2002, J AM COLL CARDIOL, V40, P43, DOI 10.1016/S0735-1097(02)01909-5; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lichtinghagen R, 2003, CLIN SCI, V105, P373, DOI 10.1042/CS20030098; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Medley TL, 2003, CIRC RES, V92, P1254, DOI 10.1161/01.RES.0000076891.24317.CA; Mizon-Gerard F, 2004, EUR HEART J, V25, P688, DOI 10.1016/j.ehj.2004.01.015; Nagase H, 1998, BIOL EXTRAC, P43; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Rauramaa R, 2000, ARTERIOSCL THROM VAS, V20, P2657, DOI 10.1161/01.ATV.20.12.2657; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Silence J, 2001, ARTERIOSCL THROM VAS, V21, P1440, DOI 10.1161/hq0901.097004; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Terashima M, 1999, CIRCULATION, V99, P2717, DOI 10.1161/01.CIR.99.21.2717; van der Loos CM, 2008, J HISTOTECHNOL, V31, P119, DOI 10.1179/his.2008.31.3.119; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Ye S, 2006, CARDIOVASC RES, V69, P636, DOI 10.1016/j.cardiores.2005.07.015; Zhu CY, 2006, BIOCHEM BIOPH RES CO, V348, P1150, DOI 10.1016/j.bbrc.2006.07.174	45	33	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9902	10.1371/journal.pone.0009902	http://dx.doi.org/10.1371/journal.pone.0009902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360864	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000275969500020
J	Nakamura, KJ; Gach, JS; Jones, L; Semrau, K; Walter, J; Bibollet-Ruche, F; Decker, JM; Heath, L; Decker, WD; Sinkala, M; Kankasa, C; Thea, D; Mullins, J; Kuhn, L; Zwick, MB; Aldrovandi, GM				Nakamura, Kyle J.; Gach, Johannes S.; Jones, Laura; Semrau, Katherine; Walter, Jan; Bibollet-Ruche, Frederic; Decker, Julie M.; Heath, Laura; Decker, William D.; Sinkala, Moses; Kankasa, Chipepo; Thea, Donald; Mullins, James; Kuhn, Louise; Zwick, Michael B.; Aldrovandi, Grace M.			4E10-Resistant HIV-1 Isolated from Four Subjects with Rare Membrane-Proximal External Region Polymorphisms	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; FUSION INHIBITOR T-20; NEUTRALIZING ANTIBODY; ENVELOPE GLYCOPROTEIN; PASSIVE-IMMUNIZATION; GP41 ECTODOMAIN; CRAC SEGMENT; VACCINE; EPITOPE	Human antibody 4E10 targets the highly conserved membrane-proximal external region (MPER) of the HIV-1 transmembrane glycoprotein, gp41, and has extraordinarily broad neutralizing activity. It is considered by many to be a prototype for vaccine development. In this study, we describe four subjects infected with viruses carrying rare MPER polymorphisms associated with resistance to 4E10 neutralization. In one case resistant virus carrying a W680G substitution was transmitted from mother to infant. We used site-directed mutagenesis to demonstrate that the W680G substitution is necessary for conferring the 4E10-resistant phenotype, but that it is not sufficient to transfer the phenotype to a 4E10-sensitive Env. Our third subject carried Envs with a W680R substitution causing variable resistance to 4E10, indicating that residues outside the MPER are required to confer the phenotype. A fourth subject possessed a F673L substitution previously associated with 4E10 resistance. For all three subjects with W680 polymorphisms, we observed additional residues in the MPER that co-varied with position 680 and preserved charged distributions across this region. Our data provide important caveats for vaccine development targeting the MPER. Naturally occurring Env variants described in our study also represent unique tools for probing the structure-function of HIV-1 envelope.	[Nakamura, Kyle J.; Jones, Laura; Walter, Jan; Decker, William D.; Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Nakamura, Kyle J.] Univ So Calif, Keck Sch Med, Syst Biol & Dis Program, Los Angeles, CA 90033 USA; [Gach, Johannes S.; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA; [Semrau, Katherine; Thea, Donald] Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA USA; [Bibollet-Ruche, Frederic; Decker, Julie M.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Heath, Laura; Mullins, James] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Sinkala, Moses] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Kankasa, Chipepo] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia; [Mullins, James] Univ Washington, Dept Med, Seattle, WA USA; [Kuhn, Louise] Columbia Univ, Dept Epidemiol, New York, NY USA	Children's Hospital Los Angeles; University of Southern California; Scripps Research Institute; Boston University; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Zambia; University of Washington; University of Washington Seattle; Columbia University	Nakamura, KJ (corresponding author), Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA.	galdrovandi@chla.usc.edu		Gach, Johannes/0000-0002-5043-5710; Semrau, Katherine/0000-0002-8360-1391; Thea, Donald/0000-0002-6933-1030; Walter, Jan/0000-0003-2247-5560	National Institutes of Health Cellular, Biochemical and Molecular Sciences Training Program [T 32 067587]; National Institute of Child Health and Human Development [HD 57161, HD 39611, HD 40777]; National Institute of Allergy and Immunology [AI69993]; International Maternal Pediatric Adolescent AIDS Trials Group [U01 AI068632]; Austrian Science Fund [J2845-B13]; NIH AIDS Research and Reference Reagent; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040777, R01HD039611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069993, P30AI027757, U01AI068632] Funding Source: NIH RePORTER	National Institutes of Health Cellular, Biochemical and Molecular Sciences Training Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Immunology; International Maternal Pediatric Adolescent AIDS Trials Group; Austrian Science Fund(Austrian Science Fund (FWF)); NIH AIDS Research and Reference Reagent; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program Grant (T 32 067587), National Institute of Child Health and Human Development (HD 57161, HD 39611, and HD 40777), National Institute of Allergy and Immunology (AI69993), International Maternal Pediatric Adolescent AIDS Trials Group U01 AI068632 and Austrian Science Fund Grant J2845-B13. GMA is an Elizabeth Glaser Pediatric AIDS Foundation Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Hessell and D. Burton (TSRI) for IgG DEN3 and S. Ingale and P. Dawson (TSRI) for MPER peptide 179-4. We also thank the NIH AIDS Research and Reference Reagent program and Drs. M. Sharp and D. Finzi for their support of this project.	Armbruster C, 2004, J ANTIMICROB CHEMOTH, V54, P915, DOI 10.1093/jac/dkh428; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burke B, 2007, CURR HIV RES, V5, P625, DOI 10.2174/157016207782418533; Burton DR, 2006, NATURE, V441, P817, DOI 10.1038/441817a; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dimitrov AS, 2003, BIOCHEMISTRY-US, V42, P14150, DOI 10.1021/bi035154g; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2008, J VIROL, V82, P2367, DOI 10.1128/JVI.02161-07; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HESSELL AJ, J VIROL, V84, P1302; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001; Levine AJ, 2008, J VIROL, V82, P11998, DOI 10.1128/JVI.01953-08; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; LU M, 2009, BIOCHEMISTRY; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Montefiori DC, 2005, NAT MED, V11, P593, DOI 10.1038/nm0605-593; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Nakowitsch S, 2005, AIDS, V19, P1957, DOI 10.1097/01.aids.0000189856.13817.76; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Perez LG, 2009, J VIROL, V83, P7397, DOI 10.1128/JVI.00656-09; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Safrit JT, 2004, JAIDS-J ACQ IMM DEF, V35, P169, DOI 10.1097/00126334-200402010-00012; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P11869, DOI 10.1021/bi8014828; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Xu WD, 2002, VACCINE, V20, P1956, DOI 10.1016/S0264-410X(02)00077-4; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	61	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9786	10.1371/journal.pone.0009786	http://dx.doi.org/10.1371/journal.pone.0009786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352106	gold, Green Published, Green Submitted			2022-12-25	WOS:000275894400010
J	Theodoropoulou, S; Kolovou, PE; Morizane, Y; Kayama, M; Nicolaou, F; Miller, JW; Gragoudas, E; Ksander, BR; Vavvas, DG				Theodoropoulou, Sofia; Kolovou, Paraskevi E.; Morizane, Yuki; Kayama, Maki; Nicolaou, Fotini; Miller, Joan W.; Gragoudas, Evangelos; Ksander, Bruce R.; Vavvas, Demetrios G.			Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase	FASEB JOURNAL			English	Article						cancer; energy; metabolism; eye; intraocular tumors	RIBOSIDE INDUCES APOPTOSIS; PROTEIN-KINASE; BILATERAL RETINOBLASTOMA; ENERGY STATUS; KEY SENSOR; CANCER; GROWTH; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE-1-BETA-D-RIBOFURANOSIDE; CHEMOREDUCTION; CHEMOTHERAPY	5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR), an analog of AMP, is widely used as an activator of AMP-kinase (AMPK), a protein that regulates the responses of the cell to energy change. We studied the effects of AICAR on the growth of retinoblastoma cell lines (Y79, WERI, and RB143). AICAR inhibited Rb cell growth, induced apoptosis and S-phase cell cycle arrest, and led to activation of AMPK. These effects were abolished by treatment with dypiridamole, an inhibitor that blocks entrance of AICAR into cells. Treatment with the adenosine kinase inhibitor 5-iodotubericidin to inhibit the conversion of AICAR to ZMP (the direct activator of AMPK) reversed most of the growth-inhibiting effects of AICAR, indicating that some of the antiproliferative effects of AICAR are mediated through AMPK activation. In addition, AICAR treatment was associated with inhibition of the mammalian target of rapamycin pathway, decreased phosphorylation of ribosomal protein-S6 and 4E-BP1, down-regulation of cyclins A and E, and decreased expression of p21. Our results indicate that AICAR-induced activation of AMPK inhibits retinoblastoma cell growth. This is one of the first descriptions of a nonchemotherapeutic drug with low toxicity that may be effective in treating Rb patients.-Theodoropoulou, S., Kolovou, P. E., Morizane, Y., Kayama, M., Nicolaou, F., Miller, J. W., Gragoudas, E., Ksander, B. R., Vavvas, D. G. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. FASEB J. 24, 2620-2630 (2010). www.fasebj.org	[Theodoropoulou, Sofia; Morizane, Yuki; Kayama, Maki; Miller, Joan W.; Gragoudas, Evangelos; Vavvas, Demetrios G.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Retina Serv,Dept Ophthalmol, Boston, MA 02114 USA; [Kolovou, Paraskevi E.; Ksander, Bruce R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Nicolaou, Fotini] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pediat Surg Labs, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts General Hospital; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Vavvas, DG (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Retina Serv,Dept Ophthalmol, Boston, MA 02114 USA.	demetrios_vavvas@meei.harvard.edu		Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478; Theodoropoulou, Sofia/0000-0003-3038-5354	Onassis Foundation; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness; U.S. National Institutes of Health [NIH EY009294]; NATIONAL EYE INSTITUTE [R01EY009294] Funding Source: NIH RePORTER	Onassis Foundation; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	D.G.V. was supported by an Onassis Foundation Scholars grant, the Massachusetts Lions Eye Research Fund, and Research to Prevent Blindness. B.R.K. was supported by U.S. National Institutes of Health grant NIH EY009294.	Baumann P, 2007, EXP CELL RES, V313, P3592, DOI 10.1016/j.yexcr.2007.06.020; Benz MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P577; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; GURNEY J, 2003, CANC INFANTS; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; MacPherson D, 2007, EMBO J, V26, P784, DOI 10.1038/sj.emboj.7601515; Nakanishi C, 2004, ONCOLOGY-BASEL, V67, P476, DOI 10.1159/000082933; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nishimura S, 2001, J CLIN ONCOL, V19, P4182, DOI 10.1200/JCO.2001.19.21.4182; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; ROARTY JD, 1988, OPHTHALMOLOGY, V95, P1583; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Rodriguez-Galindo C, 2003, OPHTHALMOLOGY, V110, P1237, DOI 10.1016/S0161-6420(03)00258-6; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schefler AC, 2007, OPHTHALMOLOGY, V114, P162, DOI 10.1016/j.ophtha.2006.06.042; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shields Carol L, 2008, Semin Ophthalmol, V23, P324, DOI 10.1080/08820530802506029; Shields CL, 2009, OPHTHALMOLOGY, V116, P544, DOI 10.1016/j.ophtha.2008.10.014; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P282, DOI 10.1001/archophthalmol.2008.626; Shields CL, 2003, ARCH OPHTHALMOL-CHIC, V121, P1571, DOI 10.1001/archopht.121.11.1571; Shields CL, 2002, ARCH OPHTHALMOL-CHIC, V120, P460; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Sussman DA, 2003, ARCH OPHTHALMOL-CHIC, V121, P979, DOI 10.1001/archopht.121.7.979; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; YOUNG J, 2003, RETINOBLASTOMA; Zang Y, 2009, J BIOL CHEM, V284, P6175, DOI 10.1074/jbc.M806887200; Zhang JK, 2004, CELL CYCLE, V3, P952	44	30	32	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2620	2630		10.1096/fj.09-152546	http://dx.doi.org/10.1096/fj.09-152546			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371623	Green Published			2022-12-25	WOS:000285005400004
J	Torri, F; Akelai, A; Lupoli, S; Sironi, M; Amann-Zalcenstein, D; Fumagalli, M; Dal Fiume, C; Ben-Asher, E; Kanyas, K; Cagliani, R; Cozzi, P; Trombetti, G; Lievers, LS; Salvi, E; Orro, A; Beckmann, JS; Lancet, D; Kohn, Y; Milanesi, L; Ebstein, RB; Lerer, B; Macciardi, F				Torri, Federica; Akelai, Anna; Lupoli, Sara; Sironi, Manuela; Amann-Zalcenstein, Daniela; Fumagalli, Matteo; Dal Fiume, Chiara; Ben-Asher, Edna; Kanyas, Kyra; Cagliani, Rachele; Cozzi, Paolo; Trombetti, Gabriele; Lievers, Luisa Strik; Salvi, Erika; Orro, Alessandro; Beckmann, Jacques S.; Lancet, Doron; Kohn, Yoav; Milanesi, Luciano; Ebstein, Richard B.; Lerer, Bernard; Macciardi, Fabio			Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence	FASEB JOURNAL			English	Article						AHI1 association studies; positive selection	GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; NEUROTROPHIC FACTOR; JOUBERT-SYNDROME; DIAGNOSTIC CRITERIA; NATIONAL-INSTITUTE; LINKAGE ANALYSIS; CHROMOSOME 6Q23; BRAIN; LOCUS	In previous studies, we identified a locus for schizophrenia on 6q23.3 and proposed the Abelson helper integration site 1 (AHI1) as the candidate gene. AHI1 is expressed in the brain and plays a key role in neurodevelopment, is involved in Joubert syndrome, and has been recently associated with autism. The neurodevelopmental role of AHI1 fits with etiological hypotheses of schizophrenia. To definitively confirm our hypothesis, we searched for associations using a dense map of the region. Our strongest findings lay within the AHI1 gene: single-nucleotide polymorphisms rs11154801 and rs7759971 showed significant associations (P=6.23E-06; P=0.84E-06) and haplotypes gave P values in the 10E-8 to 10E-10 range. The second highest significant region maps close to AHI1 and includes the intergenic region between BC040979 and PDE7B (rs2038549 at P=9.70E-06 and rs1475069 at P=6.97E-06), and PDE7B and MAP7. Using a sample of Palestinian Arab families to confirm these findings, we found isolated signals. While these results did not retain their significance after correction for multiple testing, the joint analysis across the 2 samples supports the role of AHI1, despite the presence of heterogeneity. Given the hypothesis of positive selection of schizophrenia genes, we resequenced a 11 kb region within AHI1 in ethnically defined populations and found evidence for a selective sweep. Network analysis indicates 2 haplotype clades, with schizophrenia-susceptibility haplotypes clustering within the major clade. In conclusion, our data support the role of AHI1 as a susceptibility gene for schizophrenia and confirm it has been subjected to positive selection, also shedding light on new possible candidate genes, MAP7 and PDE7B.-Torri, F., Akelai, A., Lupoli, S., Sironi, M., Amann-Zalcenstein, D., Fumagalli, M., Dal Fiume, C., BenAsher, E., Kanyas, K., Cagliani, R., Cozzi, P., Trombetti, G., Lievers, L. S., Salvi, E., Orro, A., Beckmann, J. S., Lancet, D., Kohn, Y., Milanesi, L., Ebstein, R. B., Lerer, B., Macciardi, F. Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence. FASEB J. 24, 3066 -3082 (2010). www.fasebj.org	[Macciardi, Fabio] Univ Milan, Sch Med, Dept Sci & Biomed Technol, Fondaz Filarete,Genom & Bioinformat Unit, I-20090 Milan, Italy; [Torri, Federica; Lievers, Luisa Strik; Salvi, Erika] Univ Milan, Dept Med Surg & Dent, San Paolo Hosp, I-20090 Milan, Italy; [Lupoli, Sara] Ist Sci San Raffaele, INSPE, I-20132 Milan, Italy; [Sironi, Manuela; Fumagalli, Matteo; Cagliani, Rachele] Ist Ricovero & Cura Carattere Sci E Medea, Inst Sci, Parini, Italy; [Fumagalli, Matteo] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy; [Orro, Alessandro] CILEA Consortium, Milan, Italy; [Cozzi, Paolo; Trombetti, Gabriele; Orro, Alessandro; Milanesi, Luciano] CNR, Inst Biomed Technol, I-20133 Milan, Italy; [Akelai, Anna; Kanyas, Kyra; Kohn, Yoav; Lerer, Bernard] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel; [Ben-Asher, Edna; Beckmann, Jacques S.] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Ben-Asher, Edna; Beckmann, Jacques S.] Univ Lausanne, Lausanne, Switzerland; [Amann-Zalcenstein, Daniela; Lancet, Doron] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Ebstein, Richard B.] Herzog Hosp, Jerusalem, Israel; [Macciardi, Fabio] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Eugenio Medea; Polytechnic University of Milan; CINECA, Italy; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Hebrew University of Jerusalem; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Weizmann Institute of Science; Hebrew University of Jerusalem; Herzog Medical Center; University of California System; University of California Irvine	Macciardi, F (corresponding author), Univ Milan, Sch Med, Dept Sci & Biomed Technol, Fondaz Filarete,Genom & Bioinformat Unit, Via F Lli Cervi 93, I-20090 Milan, Italy.	fabio.macciardi@unimi.it	Orro, Alessandro/ABA-3542-2020; Cagliani, Rachele/K-4545-2016; Beckmann, Jacques S/A-9772-2008; Salvi, Erika/C-1033-2015; Macciardi, Fabio/N-3768-2014; Sironi, manuela/K-5633-2016; Salvi, Erika/AAA-1415-2019; Fumagalli, Matteo/H-6448-2019; Cozzi, Paolo/AFM-1008-2022; Milanesi, Luciano/AAE-7230-2019	Cagliani, Rachele/0000-0003-2670-3532; Beckmann, Jacques S/0000-0002-9741-1900; Salvi, Erika/0000-0002-2724-2291; Macciardi, Fabio/0000-0003-0537-4266; Sironi, manuela/0000-0002-2267-5266; Salvi, Erika/0000-0002-2724-2291; Fumagalli, Matteo/0000-0002-4084-2953; Milanesi, Luciano/0000-0002-1201-3939; Ebstein, Richard/0000-0002-3626-541X; Cozzi, Paolo/0000-0003-0388-6874; Trombetti, Gabriele/0000-0001-7604-9351	FIRB Italia-Israele [RBIN04SWHR]; Doctorate School of Molecular Medicine, University of Milan, POCEMON [FP7-ICT-2007-216088]; Hypergenes [Health-F4-2007-201550]; InGenious HyperCare [LSHM-CT-2006-037093]; Israel Science Foundation (Israel Academy of Sciences) [348/09]	FIRB Italia-Israele; Doctorate School of Molecular Medicine, University of Milan, POCEMON; Hypergenes; InGenious HyperCare(European Commission); Israel Science Foundation (Israel Academy of Sciences)(Israel Science Foundation)	The study was conceived and designed by F.M., B.L., and D.A. The DNA samples were prepared by D.A. and A.A. and genotyped by F.T. and C.D.F. Analyses were performed by F.T., S.L., M.S., M.F., and A.A. C.B. supervised the genotyping and F.M. the analysis. The manuscript was written by F.T. with contributions from F.M., M.S., L.S.L., J.S.B., and B.L. All authors read and approved the manuscript. The authors thank Dr. Adnan Hamdan for assistance in recruitment and Alexandra Slonimsky for assistance with preparation of DNA samples. This work was supported by FIRB Italia-Israele (RBIN04SWHR), a fellowship of the Doctorate School of Molecular Medicine, University of Milan, POCEMON (FP7-ICT-2007-216088), Hypergenes (Health-F4-2007-201550), InGenious HyperCare (LSHM-CT-2006-037093), and the Israel Science Foundation (Israel Academy of Sciences, grant 348/09).	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bailer U, 2002, BIOL PSYCHIAT, V52, P40, DOI 10.1016/S0006-3223(02)01320-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARON M, 1994, PSYCHIATR GENET, V4, P43, DOI 10.1097/00041444-199421000-00007; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleuler E., 1911, HDB PSYCHIAT; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Carrera N, 2009, AM J MED GENET B, V150B, P369, DOI 10.1002/ajmg.b.30823; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; Crow TJ, 2008, SCHIZOPHR RES, V102, P31, DOI 10.1016/j.schres.2008.03.010; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824; Duan JB, 2004, AM J HUM GENET, V75, P624, DOI 10.1086/424887; Durany N, 2001, SCHIZOPHR RES, V52, P79, DOI 10.1016/S0920-9964(00)00084-0; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fay JC, 2000, GENETICS, V155, P1405; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; First MB, 1996, PSYCHIAT CLIN N AM, V19, P29, DOI 10.1016/S0193-953X(05)70271-9; Frantseva MV, 2008, CEREB CORTEX, V18, P990, DOI 10.1093/cercor/bhm151; FU YX, 1993, GENETICS, V133, P693; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gorski JA, 2003, J NEUROSCI, V23, P6856; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; GRIFFITHS RC, 1995, MATH BIOSCI, V127, P77, DOI 10.1016/0025-5564(94)00044-Z; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Hirayasu Y, 2007, NEUROPATHOLOGY, V27, P601, DOI 10.1111/j.1440-1789.2007.00827.x; Horrobin DF, 1998, MED HYPOTHESES, V50, P269, DOI 10.1016/S0306-9877(98)90000-7; HUDSON RR, 1987, GENETICS, V116, P153; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Jaber L, 2000, CLIN GENET, V58, P106, DOI 10.1034/j.1399-0004.2000.580203.x; JABER L, 1994, ARCH PEDIAT ADOL MED, V148, P412, DOI 10.1001/archpedi.1994.02170040078013; Jensen JD, 2008, MOL BIOL EVOL, V25, P438, DOI 10.1093/molbev/msm273; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Khaitovich P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r124; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Kohn Y, 2005, MOL PSYCHIATR, V10, P1062, DOI 10.1038/sj.mp.4001738; Kohn Y, 2002, ISR J PSYCHIATR REL, V39, P240; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Levi A, 2005, EUR J HUM GENET, V13, P763, DOI 10.1038/sj.ejhg.5201406; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtermann D, 2000, EUR ARCH PSY CLIN N, V250, P304, DOI 10.1007/s004060070005; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez M, 1999, AM J MED GENET, V88, P337, DOI 10.1002/(SICI)1096-8628(19990820)88:4<337::AID-AJMG9>3.3.CO;2-1; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; MCGUE M, 1989, ARCH GEN PSYCHIAT, V46, P478; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Muglia P, 2003, MOL PSYCHIATR, V8, P146, DOI 10.1038/sj.mp.4001221; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; OCKLEFORD CD, 1987, J CELL SCI, V87, P27; Owen MJ, 2002, PSYCHIAT GENETICS GE, P247; Ozonoff S, 1999, J CHILD NEUROL, V14, P636, DOI 10.1177/088307389901401003; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Perez-Torres S, 2003, EXP NEUROL, V182, P322, DOI 10.1016/S0014-4886(03)00042-6; Potkin SG, 2009, MOL PSYCHIATR, V14, P416, DOI 10.1038/mp.2008.127; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Riley BP, 2000, AM J MED GENET, V97, P23, DOI 10.1002/(SICI)1096-8628(200021)97:1<23::AID-AJMG5>3.0.CO;2-K; Sasaki T, 2000, BIOCHEM BIOPH RES CO, V271, P575, DOI 10.1006/bbrc.2000.2661; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; SHINODA K, 1993, J COMP NEUROL, V329, P1, DOI 10.1002/cne.903290102; Spampinato MV, 2008, AM J MED GENET A, V146A, P1389, DOI 10.1002/ajmg.a.32282; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; STEEN KV, 2005, HUM GENOMICS, V2, P67; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weir BS., 1996, GENETIC DATA ANAL; White T, 2008, SCHIZOPHRENIA BULL, V34, P18, DOI 10.1093/schbul/sbm110; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Williams NM, 2003, AM J HUM GENET, V73, P1355, DOI 10.1086/380206; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yu FL, 2009, HUM MOL GENET, V18, P4853, DOI 10.1093/hmg/ddp457; Zeng K, 2007, MOL BIOL EVOL, V24, P1562, DOI 10.1093/molbev/msm078; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231	124	30	30	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					3066	3082		10.1096/fj.09-152611	http://dx.doi.org/10.1096/fj.09-152611			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371615	Green Submitted			2022-12-25	WOS:000285005400043
J	Larsen, KS; Ostergaard, H; Olsen, OH; Bjelke, JR; Ruf, W; Petersen, LC				Larsen, Katrine S.; Ostergaard, Henrik; Olsen, Ole H.; Bjelke, Jais R.; Ruf, Wolfram; Petersen, Lars C.			Engineering of Substrate Selectivity for Tissue Factor.Factor VIIa Complex Signaling through Protease-activated Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR CYTOPLASMIC DOMAIN; BLOOD-COAGULATION FACTOR; INHIBITOR SPECIFICITIES; FACTOR-X; SURFACE RESIDUES; MDA-MB-231 CELLS; THROMBIN; BINDING; PAR1; PROTEASE-ACTIVATED-RECEPTOR-2	The complex of factor VIIa (FVIIa) with tissue factor (TF) triggers coagulation by recognizing its macromolecular substrate factors IX (FIX) and X (FX) predominantly through extended exosite interactions. In addition, TF mediates unique cell-signaling properties in cancer, angiogenesis, and inflammation that involve proteolytic cleavage of protease-activated receptor 2 (PAR2). PAR2 is cleaved by FVIIa in the binary TF.FVIIa complex and by FXa in the ternary TF.FVIIa.FXa complex, but physiological roles of these signaling complexes are incompletely understood. In a screen of FVIIa protease domain mutants, three variants (Q40A, Q143N, and T151S) activated macromolecular coagulation substrates and supported signaling of the ternary TF.FVIIa.Xa complex normally but were severely impaired in binary TF.FVIIa.PAR2 signaling. The residues identified were located in the model-predicted S2' pocket of FVIIa, and complementary PAR2 P2' Leu-38 replacements demonstrated that the P2' side chain was indeed crucial for PAR2 cleavage by TF.FVIIa. In addition, PAR2 was activated more efficiently by FVIIa T99Y, consistent with further contributions from the S2 subsite. The P2 residue preference of FVIIa and FXa predicted additional PAR2 mutants that were efficiently activated by TF.FVIIa but resistant to cleavage by the alternative PAR2 activator FXa. Thus, contrary to the paradigm of exosite-assisted cleavage of PAR1 by thrombin, the cofactor-associated protease FVIIa recognizes PAR2 predominantly by catalytic cleft interactions. Furthermore, the delineated molecular details of this substrate interaction enabled protein engineering of protease-selective PAR2 receptors that will aid further studies to dissect the roles of TF signaling complexes in vivo.	[Petersen, Lars C.] Novo Nordisk AS, Dept Vitro Haemostasis Biol, DK-2760 Malov, Denmark; [Bjelke, Jais R.] Novo Nordisk AS, Dept Prot Purificat, DK-2760 Malov, Denmark; [Larsen, Katrine S.; Ostergaard, Henrik; Olsen, Ole H.] Novo Nordisk AS, Dept Haemostasis Biochem, DK-2760 Malov, Denmark; [Larsen, Katrine S.; Ostergaard, Henrik; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Novo Nordisk; Novo Nordisk; Novo Nordisk; Scripps Research Institute	Petersen, LC (corresponding author), Novo Nordisk AS, Dept Vitro Haemostasis Biol, Novo Nordisk Pk, DK-2760 Malov, Denmark.	lcp@novonordisk.com			National Institutes of Health [P01-HL31950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL31950 (to W.R.).	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Albrektsen T, 2007, J THROMB HAEMOST, V5, P1588, DOI 10.1111/j.1538-7836.2007.02603.x; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Bjelke JR, 2008, J BIOL CHEM, V283, P25863, DOI 10.1074/jbc.M800841200; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Chang YJ, 1999, BIOCHEMISTRY-US, V38, P10940, DOI 10.1021/bi990055h; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Dickinson CD, 1996, CIRCULATION, V94, P1272; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; ISHII K, 1993, J BIOL CHEM, V268, P9780; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Larsen KS, 2007, BIOCHEM J, V405, P429, DOI 10.1042/BJ20061901; LIU LW, 1991, J BIOL CHEM, V266, P16977; Myles T, 2001, EUR J BIOCHEM, V268, P70, DOI 10.1046/j.1432-1327.2001.01844.x; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P8701, DOI 10.1021/bi00027a020; Norledge BV, 2003, PROTEINS, V53, P640, DOI 10.1002/prot.10445; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Shobe J, 1999, J BIOL CHEM, V274, P24171, DOI 10.1074/jbc.274.34.24171; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452; Zhong DG, 2002, J BIOL CHEM, V277, P3622, DOI 10.1074/jbc.M111202200	43	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19959	19966		10.1074/jbc.M110.101030	http://dx.doi.org/10.1074/jbc.M110.101030			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20388709	Green Published, hybrid			2022-12-25	WOS:000279012000029
J	Wu, L; Nam, YJ; Kung, G; Crow, MT; Kitsis, RN				Wu, Lily; Nam, Young-Jae; Kung, Gloria; Crow, Michael T.; Kitsis, Richard N.			Induction of the Apoptosis Inhibitor ARC by Ras in Human Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; CASPASE RECRUITMENT DOMAIN; ETS TRANSCRIPTION FACTORS; CELL-DEATH; PROTEIN ARC; ACTIVATION; PATHWAY; KINASE; GROWTH; GENE	Inhibition of apoptosis is critical for carcinogenesis. ARC (apoptosis repressor with caspase recruitment domain) is an endogenous inhibitor of apoptosis that antagonizes both intrinsic and extrinsic apoptosis pathways. Although normally expressed in striated myocytes and neurons, ARC is markedly induced in a variety of primary human epithelial cancers and renders cancer cells resistant to killing. The mechanisms that mediate the induction of ARC in cancer are unknown. Herein we demonstrate that increases in ARC abundance are stimulated by Ras through effects on transcription and protein stability. Overexpression of activated N-Ras or H-Ras in normal cells is sufficient to increase ARC mRNA and protein levels. Similarly, transgenic expression of activated H-Ras induces ARC in both the normal mammary epithelium and resulting tumors of intact mice. Conversely, knockdown of endogenous N-Ras in breast and colon cancer cells significantly reduces ARC mRNA and protein levels. The promoter of the Nol3 locus, encoding ARC, is activated by N-Ras and H-Ras in a MEK/ERK-dependent manner. Ras also stabilizes ARC protein by suppressing its polyubiquitination and subsequent proteasomal degradation. In addition to the effects of Ras on ARC abundance, ARC mediates Ras-induced cell survival and cell cycle progression. Thus, Ras induces ARC in epithelial cancers, and ARC plays a role in the oncogenic actions of Ras.	[Wu, Lily; Nam, Young-Jae; Kung, Gloria; Kitsis, Richard N.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Wu, Lily; Nam, Young-Jae; Kung, Gloria; Kitsis, Richard N.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Crow, Michael T.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Kitsis, RN (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.kitsis@einstein.yu.edu			National Institutes of Health [HL60665, HL61550, HL80607, CA013330]; Wilf Family; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060665, R01HL061550, R01HL080607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilf Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL60665, HL61550, and HL80607 (to R.N.K.) and institutional National Institutes of Health P30 Cancer Center Grant CA013330. This work was also supported by the Wilf Family.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chen LH, 2008, CANCER RES, V68, P834, DOI 10.1158/0008-5472.CAN-07-5056; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cosenza MA, 2002, NEUROPATH APPL NEURO, V28, P480, DOI 10.1046/j.1365-2990.2002.00420.x; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gartel AL, 2000, ONCOGENE, V19, P961, DOI 10.1038/sj.onc.1203411; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; GIARETTI W, 1994, METHOD CELL BIOL, V41, P389; GRAHAM KA, 1985, CANCER RES, V45, P2201; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARRINGTON EA, 1994, CURR OPIN GENET DEV, V4, P120, DOI 10.1016/0959-437X(94)90100-7; IGLEHART JD, 1990, CANCER RES, V50, P6701; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; LACROIX H, 1989, ONCOGENE, V4, P145; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mercier I, 2005, CELL DEATH DIFFER, V12, P682, DOI 10.1038/sj.cdd.4401631; Mercier I, 2008, CELL CYCLE, V7, P1640, DOI 10.4161/cc.7.11.5979; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nam YJ, 2007, J BIOL CHEM, V282, P5522, DOI 10.1074/jbc.M609186200; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; PEAR W, 1997, METHODS MOL MED GENE; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; Stoss O, 1999, J BIOL CHEM, V274, P10951, DOI 10.1074/jbc.274.16.10951; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Turner DP, 2007, J CELL BIOCHEM, V102, P549, DOI 10.1002/jcb.21494; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Zhang L, 1999, NUCLEIC ACIDS RES, V27, P2947, DOI 10.1093/nar/27.14.2947	48	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19235	19245		10.1074/jbc.M110.114892	http://dx.doi.org/10.1074/jbc.M110.114892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392691	Green Published, hybrid			2022-12-25	WOS:000278727800033
J	Kim, G; Cole, NB; Lim, JC; Zhao, H; Levine, RL				Kim, Geumsoo; Cole, Nelson B.; Lim, Jung Chae; Zhao, Hang; Levine, Rodney L.			Dual Sites of Protein Initiation Control the Localization and Myristoylation of Methionine Sulfoxide Reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; N-MYRISTOYLATION; OXIDATIVE DAMAGE; GENE ENCODES; SUBCELLULAR-LOCALIZATION; CYTOSOLIC ISOFORMS; MESSENGER-RNAS; A MSRA; MITOCHONDRIAL	Methionine sulfoxide reductase A is an essential enzyme in the antioxidant system, which scavenges reactive oxygen species through cyclic oxidation and reduction of methionine and methionine sulfoxide. In mammals, one gene encodes two forms of the reductase, one targeted to the cytosol and the other to mitochondria. The cytosolic form displays faster mobility than the mitochondrial form, suggesting a lower molecular weight for the former. The apparent size difference and targeting to two cellular compartments had been proposed to result from differential splicing of mRNA. We now show that differential targeting is effected by use of two initiation sites, one of which includes a mitochondrial targeting sequence, whereas the other does not. We also demonstrate that the mass of the cytosolic form is not less than that of the mitochondrial form; the faster mobility of cytosolic form is due to its myristoylation. Lipidation of methionine sulfoxide reductase A occurs in the mouse, in transfected tissue culture cells, and even in a cell-free protein synthesis system. The physiologic role of myristoylation of MsrA remains to be elucidated.	[Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Cole, Nelson B.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 50,Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov	Levine, Rodney L/D-9885-2011; Zhao, Hang/A-2558-2012		National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole by the National Institutes of Health, NHLBI, Intramural Research Program.	BELTZER JP, 1988, J BIOL CHEM, V263, P368; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabreiro F, 2007, BIOCHIMIE, V89, P1388, DOI 10.1016/j.biochi.2007.05.005; Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Chabregas SM, 2003, J CELL SCI, V116, P285, DOI 10.1242/jcs.00228; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Gangal M, 1999, P NATL ACAD SCI USA, V96, P12394, DOI 10.1073/pnas.96.22.12394; GODDARD C, 1988, BIOCHEM J, V253, P839, DOI 10.1042/bj2530839; Hansel A, 2002, FASEB J, V16, P911, DOI 10.1096/fj.01-0737fje; Kim G, 2000, ARCH BIOCHEM BIOPHYS, V377, P334, DOI 10.1006/abbi.2000.1793; Kim HY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-11; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Stadtman ER, 2006, REDOX PROTEOMICS PRO, P123; Taggart C, 2000, J BIOL CHEM, V275, P27258; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Ueda M, 1998, BBA-GENE STRUCT EXPR, V1397, P213, DOI 10.1016/S0167-4781(98)00009-8; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Willer M, 1999, CURR BIOL, V9, P1085, DOI 10.1016/S0960-9822(99)80477-1; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	49	41	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18085	18094		10.1074/jbc.M110.119701	http://dx.doi.org/10.1074/jbc.M110.119701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368336	hybrid, Green Published			2022-12-25	WOS:000278133400083
J	Tate, JJ; Georis, I; Dubois, E; Cooper, TG				Tate, Jennifer J.; Georis, Isabelle; Dubois, Evelyne; Cooper, Terrance G.			Distinct Phosphatase Requirements and GATA Factor Responses to Nitrogen Catabolite Repression and Rapamycin Treatment in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE GENE-EXPRESSION; TOR SIGNALING PATHWAY; METHIONINE SULFOXIMINE TREATMENT; DNA-BINDING DOMAIN; NUCLEAR-LOCALIZATION; GLN3 PHOSPHORYLATION; INTRACELLULAR-LOCALIZATION; TRANSCRIPTION FACTORS; CARBON STARVATION; 2A PHOSPHATASES	In yeast, rapamycin (Rap)-inhibited TorC1, and the phosphatases it regulates (Sit4 and PP2A) are components of a conserved pathway regulating the response of eukaryotic cells to nutrient availability. TorC1 and intracellular nitrogen levels regulate the localization of Gln3 and Gat1, the activators of nitrogen catabolite repression (NCR)-sensitive genes whose products are required to utilize poor nitrogen sources. In nitrogen excess, Gln3 and Gat1 are cytoplasmic, and NCR-sensitive transcription is repressed. During nitrogen limitation or Rap treatment, Gln3 and Gat1 are nuclear, and transcription is derepressed. We previously demonstrated that the Sit4 and Pph21/22-Tpd3-Cdc55/Rts1 requirements for nuclear Gln3 localization differ. We now show that Sit4 and Pph21/22-Tpd3-Cdc55/Rts1 requirements for NCR-sensitive and Rap-induced nuclear Gat1 localization markedly differ from those of Gln3. Our data suggest that Gln3 and Gat1 localizations are controlled by two different regulatory pathways. Gln3 localization predominantly responds to intracellular nitrogen levels, as reflected by its stronger NCR-sensitivity, weaker response to Rap treatment, and strong response to methionine sulfoximine (Msx, a glutamine synthetase inhibitor). In contrast, Gat1 localization predominantly responds to TorC1 regulation as reflected by its weaker NCR sensitivity, stronger response to Rap, and immunity to the effects of Msx. Nuclear Gln3 localization in proline-grown (nitrogen limited) cells exhibits no requirement for Pph21/22-Tpd3/Cdc55, whereas nuclear Gat1 localization under these conditions is absolutely dependent on Pph21/22- Tpd3/Cdc55. Furthermore, the extent to which Pph21/22-Tpd3-Cdc55 is required for the TorC1 pathway (Rap) to induce nuclear Gat1 localization is regulated in parallel with Pph21/22-Tpd3-Cdc55-dependent Gln3 dephosphorylation and NCRsensitive transcription, being highest in limiting nitrogen and lowest when nitrogen is in excess.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Georis, Isabelle; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 (to T. G. C. and J .J. T.). This work was also supported by Commission Communautaire Francaise (to E. D. and I. G.).	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Chen JCY, 2006, CURR GENET, V49, P281, DOI 10.1007/s00294-005-0055-9; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 1996, J BACTERIOL, V178, P3470, DOI 10.1128/jb.178.12.3470-3479.1996; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2009, GENETICS, V182, P927, DOI 10.1534/genetics.109.105031; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MAREK ET, 1987, J BACTERIOL, V169, P2440, DOI 10.1128/jb.169.6.2440-2448.1987; MINEHART PL, 1991, MOL CELL BIOL, V11, P6216, DOI 10.1128/MCB.11.12.6216; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Starich MR, 1998, J MOL BIOL, V277, P605, DOI 10.1006/jmbi.1998.1625; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Tate JJ, 2008, FEMS YEAST RES, V8, P1223, DOI 10.1111/j.1567-1364.2008.00441.x; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463; 2009, NAT CELL BIOL, V11, P667	58	45	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17880	17895		10.1074/jbc.M109.085712	http://dx.doi.org/10.1074/jbc.M109.085712			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378536	Green Published, hybrid			2022-12-25	WOS:000278133400065
J	Min, BS; Collins, K				Min, Bosun; Collins, Kathleen			Multiple Mechanisms for Elongation Processivity within the Reconstituted Tetrahymena Telomerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE; IN-VITRO; G-QUADRUPLEXES; DNA; RNA; EXTENSION; TEMPLATE; RPA; MAINTENANCE; PROTEINS	To maintain telomeres, telomerase evolved a unique biochemical activity: the use of a single-stranded RNA template for the synthesis of single-stranded DNA repeats. High repeat addition processivity (RAP) of the Tetrahymena telomerase holoenzyme requires association of the catalytic core with the telomere adaptor subcomplex (TASC) and an RPA1-related subunit (p82 or Teb1). Here, we used DNA binding and holoenzyme reconstitution assays to investigate the mechanism by which Teb1 and TASC confer high RAP. We show that TASC association with the recombinant telomerase catalytic core increases enzyme activity. Subsequent association of the Teb1 C-terminal domain with TASC confers the capacity for high RAP even though the Teb1 C-terminal domain does not provide a high-affinity DNA interaction site. Efficient RAP also requires suppression of nascent product folding mediated by the central Teb1 DNA-binding domains (DBDs). These sequence-specific high-affinity DBDs of Teb1 can be functionally substituted by the analogous DBDsof Tetrahymena Rpa1 to suppress nascent product folding but only if the Rpa1 high-affinity DBDs are physically tethered into holoenzyme context though the Teb1 C-terminal domain. Overall, our findings reveal multiple mechanisms and multiple surfaces of protein-DNA and protein-protein interaction that give rise to elongation processivity in the synthesis of a single-stranded nucleic acid product.	[Min, Bosun; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [GM54198]; University of California Berkeley Cancer Research Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Berkeley Cancer Research Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GM54198. This work was also supported by a University of California Berkeley Cancer Research Laboratory training grant.	Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Cohen S, 2004, BBA-GENE STRUCT EXPR, V1679, P129, DOI 10.1016/j.bbaexp.2004.06.002; Collins Kathleen, 2009, V13, P285, DOI 10.1007/978-3-540-70840-7_14; Fan JH, 2009, BIOCHEMISTRY-US, V48, P1099, DOI 10.1021/bi801538h; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Greene EC, 1998, GENE DEV, V12, P2921, DOI 10.1101/gad.12.18.2921; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; Hardy CD, 2001, J BIOL CHEM, V276, P4863, DOI 10.1074/jbc.M005158200; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Jarstfer MB, 2002, BIOCHEMISTRY-US, V41, P151, DOI 10.1021/bi011649z; Karamysheva Z, 2003, CELL, V113, P565, DOI 10.1016/S0092-8674(03)00363-5; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Lue NF, 2004, BIOESSAYS, V26, P955, DOI 10.1002/bies.20093; Maine IP, 1999, BIOCHEMISTRY-US, V38, P15325, DOI 10.1021/bi991596+; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Oganesian L, 2009, J CELL SCI, V122, P4013, DOI 10.1242/jcs.050567; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Prathapam R, 2005, NAT STRUCT MOL BIOL, V12, P252, DOI 10.1038/nsmb900; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Rubtsova MP, 2009, BIOCHEMISTRY-MOSCOW+, V74, P92, DOI 10.1134/S0006297909010143; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Sekaran VG, 2010, BBA-PROTEINS PROTEOM, V1804, P1190, DOI 10.1016/j.bbapap.2009.07.019; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wellinger RJ, 2009, MOL CELL, V36, P168, DOI 10.1016/j.molcel.2009.10.001; Witkin KL, 2007, MOL CELL BIOL, V27, P2074, DOI 10.1128/MCB.02105-06; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Xie MY, 2010, NUCLEIC ACIDS RES, V38, P1982, DOI 10.1093/nar/gkp1198; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	36	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16434	16443		10.1074/jbc.M110.119172	http://dx.doi.org/10.1074/jbc.M110.119172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363756	Green Published, hybrid			2022-12-25	WOS:000277982600005
J	Peralta, ER; Martin, BC; Edinger, AL				Peralta, Eigen R.; Martin, Brent C.; Edinger, Aimee L.			Differential Effects of TBC1D15 and Mammalian Vps39 on Rab7 Activation State, Lysosomal Morphology, and Growth Factor Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST VACUOLE FUSION; SMALL GTPASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE PREFERENCE; LATE ENDOSOME; PROTEIN RILP; AUTOPHAGY; DOCKING; COMPLEX; TRANSPORT	The small GTPase Rab7 promotes fusion events between late endosomes and lysosomes. Rab7 activity is regulated by extrinsic signals, most likely via effects on its guanine nucleotide exchange factor (GEF) or GTPase-activating protein (GAP). Based on their homology to the yeast proteins that regulate the Ypt7 GTP binding state, TBC1D15, and mammalian Vps39 (mVps39) have been suggested to function as the Rab7 GAP and GEF, respectively. We developed an effector pull-down assay to test this model. TBC1D15 functioned as a Rab7 GAP in cells, reducing Rab7 binding to its effector protein RILP, fragmenting the lysosome, and conferring resistance to growth factor with-drawal-induced cell death. In a cellular context, TBC1D15 GAP activity was selective for Rab7. TBC1D15 overexpression did not inhibit transferrin internalization or recycling, Rab7-independent processes that require Rab4, Rab5, and Rab11 activation. TBC1D15 was thus renamed Rab7-GAP. Contrary to expectations for a Rab7 GEF, mVps39 induced lysosomal clustering without increasing Rab7 GTP binding. Moreover, a dominant-negative mVps39 mutant fragmented the lysosome and promoted growth factor independence without decreasing Rab7-GTP levels. These findings suggest that a protein other than mVps39 serves as the Rab7 GEF. In summary, although only TBC1D15/Rab7-GAP altered Rab7-GTP levels, both Rab7-GAP and mVps39 regulate lysosomal morphology and play a role in maintaining growth factor dependence.	[Peralta, Eigen R.; Martin, Brent C.; Edinger, Aimee L.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Edinger, AL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 2128 Nat Sci 1, Irvine, CA 92697 USA.	aedinger@uci.edu			NCI, National Institutes of Health [K08 CA100526]; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE [K08CA100526] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Public Health Service Grant K08 CA100526 from the NCI, National Institutes of Health and by a Medical Research Award from the Gabrielle's Angel Foundation (to A. L. E.).	Bertram EM, 2002, INT IMMUNOL, V14, P309, DOI 10.1093/intimm/14.3.309; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Colombo MI, 2007, IUBMB LIFE, V59, P238, DOI 10.1080/15216540701230503; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Karnauskas R, 2003, ONCOGENE, V22, P688, DOI 10.1038/sj.onc.1206159; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Marsman M, 2004, MOL BIOL CELL, V15, P2954, DOI 10.1091/mbc.E03-08-0614; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; Meijerink JPP, 2005, INT J CANCER, V114, P917, DOI 10.1002/ijc.20822; Nakamura N, 1997, J BIOL CHEM, V272, P11344; NUNEZ G, 1990, J IMMUNOL, V144, P3602; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pfeffer S, 2005, NAT CELL BIOL, V7, P856, DOI 10.1038/ncb0905-856; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rosales KR, 2009, MOL BIOL CELL, V20, P2831, DOI 10.1091/mbc.E08-09-0911; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCHIMMOLLER F, 1993, J CELL SCI, V106, P823; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Vollmer P, 1999, EUR J BIOCHEM, V260, P284, DOI 10.1046/j.1432-1327.1999.00192.x; WADA Y, 1992, J BIOL CHEM, V267, P18665; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070	77	80	85	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16814	16821		10.1074/jbc.M110.111633	http://dx.doi.org/10.1074/jbc.M110.111633			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363736	Green Published, hybrid			2022-12-25	WOS:000277982600045
J	Asai, T; Sugimori, E; Tanno, Y				Asai, Tomohisa; Sugimori, Eriko; Tanno, Yoshihiko			Two Agents in the Brain: Motor Control of Unimanual and Bimanual Reaching Movements	PLOS ONE			English	Article							INTERHEMISPHERIC-TRANSFER; HEMISPHERIC-ASYMMETRY; MANUAL ASYMMETRIES; CONSTANT ERROR; LEFT-HANDERS; PERSPECTIVES; HANDEDNESS; MODELS; ATTENTION; DYNAMICS	Previous studies have suggested that the left and right hands have different specialties for motor control that can be represented as two agents in the brain. This study examined how coordinated movements are performed during bimanual reaching tasks to highlight differences in the characteristics of the hands. We examined motor movement accuracy, reaction time, and movement time in right-handed subjects performing a three-dimensional motor control task (visually guided reaching). In the no-visual-feedback condition, right-hand movement had lower accuracy and a shorter reaction time than did left-hand movement, whereas bimanual movement had the longest reaction time, but the best accuracy. This suggests that the two hands have different internal models and specialties: closed-loop control for the right hand and open-loop control for the left hand. Consequently, during bimanual movements, both models might be used, creating better control and planning (or prediction), but requiring more computation time compared to the use of one hand only.	[Asai, Tomohisa; Sugimori, Eriko; Tanno, Yoshihiko] Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo	Asai, T (corresponding author), Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Arts & Sci, Tokyo, Japan.	as@beck.c.u-tokyo.ac.jp			JSPS [198987]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for JSPS Fellowship (198987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2008, CONSCIOUS COGN, V17, P1131, DOI 10.1016/j.concog.2008.04.004; Baldauf D, 2008, VISION RES, V48, P549, DOI 10.1016/j.visres.2007.11.023; Barthelemy S, 2001, NEUROSCI LETT, V315, P41, DOI 10.1016/S0304-3940(01)02313-8; Boulinguez P, 2001, CORTEX, V37, P123, DOI 10.1016/S0010-9452(08)70562-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; ELLIOTT D, 1994, ACTA PSYCHOL, V85, P1, DOI 10.1016/0001-6918(94)90016-7; Elliott D, 1999, HUM MOVEMENT SCI, V18, P121, DOI 10.1016/S0167-9457(99)00004-4; Elliott D, 2000, BRAIN COGNITION, V42, P153, DOI 10.1006/brcg.1999.1188; Elliott Digby, 1996, P143; FLOWERS K, 1975, BRIT J PSYCHOL, V66, P39, DOI 10.1111/j.2044-8295.1975.tb01438.x; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; GUIARD Y, 1983, NEUROPSYCHOLOGIA, V21, P111, DOI 10.1016/0028-3932(83)90106-9; Haaland KY, 1996, CURR OPIN NEUROBIOL, V6, P796, DOI 10.1016/S0959-4388(96)80030-4; Hatta T., 1975, PAPERS CELEBRATING 6, P224; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Lenhard A, 2007, LATERALITY, V12, P227, DOI 10.1080/13576500701203891; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mieschke PE, 2001, BRAIN COGNITION, V45, P129, DOI 10.1006/brcg.2000.1262; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; ROY EA, 1989, Q J EXP PSYCHOL-A, V41, P501, DOI 10.1080/14640748908402379; ROY EA, 1978, CORTEX, V14, P250, DOI 10.1016/S0010-9452(78)80051-3; RUDEL RG, 1977, NEUROLOGY, V27, P160, DOI 10.1212/WNL.27.2.160; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; TODOR JI, 1985, J MOTOR BEHAV, V17, P355, DOI 10.1080/00222895.1985.10735354; Velay JL, 2001, CORTEX, V37, P75, DOI 10.1016/S0010-9452(08)70559-8; Velay JL, 1999, NEUROPSYCHOLOGIA, V37, P895, DOI 10.1016/S0028-3932(98)00149-3; WITELSON S F, 1974, Cortex, V10, P3; Witney AG, 2004, HUM MOVEMENT SCI, V23, P747, DOI 10.1016/j.humov.2004.10.009; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3; Yamauchi M, 2004, PERCEPT MOTOR SKILL, V98, P1199, DOI 10.2466/PMS.98.3.1199-1209	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10086	10.1371/journal.pone.0010086	http://dx.doi.org/10.1371/journal.pone.0010086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580WT	20386749	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482000015
J	Doshi, N; Mitragotri, S				Doshi, Nishit; Mitragotri, Samir			Macrophages Recognize Size and Shape of Their Targets	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; POLYMERIC NANOPARTICLES; DRUG-DELIVERY; PARTICLE-SIZE; PHAGOCYTOSIS; INNATE; BIODISTRIBUTION; INTERNALIZATION; CLEARANCE; SYSTEM	Recognition by macrophages is a key process in generating immune response against invading pathogens. Previous studies have focused on recognition of pathogens through surface receptors present on the macrophage's surface. Here, using polymeric particles of different geometries that represent the size and shape range of a variety of bacteria, the importance of target geometry in recognition was investigated. The studies reported here reveal that attachment of particles of different geometries to macrophages exhibits a strong dependence on size and shape. For all sizes and shapes studied, particles possessing the longest dimension in the range of 2-3 mu m exhibited highest attachment. This also happens to be the size range of most commonly found bacteria in nature. The surface features of macrophages, in particular the membrane ruffles, might play an important role in this geometry-based target recognition by macrophages. These findings have significant implications in understanding the pathogenicity of bacteria and in designing drug delivery carriers.	[Doshi, Nishit; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Doshi, N (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	samir@engineering.ucsb.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Institutes of Health [1UO1 HL080718]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (1UO1 HL080718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Beningo KA, 2002, J CELL SCI, V115, P849; *CDCP, 2006, 5776 CDCP; *CDCP PHIL, 2006, MYC TUB; *CDCS PUBL HLTH IM, 2006, AC BAUM; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Champion JA, 2009, PHARM RES-DORDR, V26, P244, DOI 10.1007/s11095-008-9626-z; COLI E, 2006, MOUNTAIN LAB; Doshi N, 2009, ADV FUNCT MATER, V19, P3843, DOI 10.1002/adfm.200901538; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; JOEL D, 2006, PHAGOCYTOSIS BACTERI; JULIANO RL, 1975, BIOCHEM BIOPH RES CO, V63, P651, DOI 10.1016/S0006-291X(75)80433-5; KAMMER GM, 1970, J BACTERIOL, V104, P499, DOI 10.1128/JB.104.1.499-502.1970; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thomas P, 2004, BACTERIA VIRUSES; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; *WHO, 2010, N331 WHO; 2005, PLOS BIOL, V3, pE166, DOI DOI 10.1371/JOURNAL.PBIO.0030166; 2006, VIBRIO CHOLERAE	35	221	225	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10051	10.1371/journal.pone.0010051	http://dx.doi.org/10.1371/journal.pone.0010051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386614	Green Published, Green Submitted, gold			2022-12-25	WOS:000276420400019
J	Rosa-Rosa, JM; Gracia-Aznarez, FJ; Hodges, E; Pita, G; Rooks, M; Xuan, ZY; Bhattacharjee, A; Brizuela, L; Silva, JM; Hannon, GJ; Benitez, J				Manuel Rosa-Rosa, Juan; Javier Gracia-Aznarez, Francisco; Hodges, Emily; Pita, Guillermo; Rooks, Michelle; Xuan, Zhenyu; Bhattacharjee, Arindam; Brizuela, Leonardo; Silva, Jose M.; Hannon, Gregory J.; Benitez, Javier			Deep Sequencing of Target Linkage Assay-Identified Regions in Familial Breast Cancer: Methods, Analysis Pipeline and Troubleshooting	PLOS ONE			English	Article							GENOME; MUTATIONS; CAPTURE; GENES	Background: The classical candidate-gene approach has failed to identify novel breast cancer susceptibility genes. Nowadays, massive parallel sequencing technology allows the development of studies unaffordable a few years ago. However, analysis protocols are not yet sufficiently developed to extract all information from the huge amount of data obtained. Methodology/Principal Findings: In this study, we performed high throughput sequencing in two regions located on chromosomes 3 and 6, recently identified by linkage studies by our group as candidate regions for harbouring breast cancer susceptibility genes. In order to enrich for the coding regions of all described genes located in both candidate regions, a hybrid-selection method on tiling microarrays was performed. Conclusions/Significance: We developed an analysis pipeline based on SOAP aligner to identify candidate variants with a high real positive confirmation rate (0.89), with which we identified eight variants considered candidates for functional studies. The results suggest that the present strategy might be a valid second step for identifying high penetrance genes.	[Manuel Rosa-Rosa, Juan; Javier Gracia-Aznarez, Francisco; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain; [Hodges, Emily; Rooks, Michelle; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Pita, Guillermo; Benitez, Javier] Spanish Natl Canc Res Ctr, Genotyping Unit CEGEN, Madrid, Spain; [Xuan, Zhenyu] Univ Texas Richardson, Dept Mol & Cell Biol, Richardson, TX USA; [Bhattacharjee, Arindam; Brizuela, Leonardo] Agilent Technol, Santa Clara, CA USA; [Silva, Jose M.] Irving Canc Res Ctr, New York, NY USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; University of Texas Dallas; Agilent Technologies	Rosa-Rosa, JM (corresponding author), Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain.	jbenitez@cnio.es	Hannon, Gregory/AAB-3568-2019; Gracia Aznarez, Francisco Javier/AFV-2344-2022	Xuan, Zhenyu/0000-0001-9344-8493; Hodges, Emily/0000-0001-6513-610X	Spanish Association Against Cancer (AECC); Agilent, Inc.; Ministerio de Eduacion y Cultura; Universidad Autonoma de Madrid; European Association for Cancer Research	Spanish Association Against Cancer (AECC); Agilent, Inc.; Ministerio de Eduacion y Cultura; Universidad Autonoma de Madrid; European Association for Cancer Research	This project was funded by the Spanish Association Against Cancer (AECC) with no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; and Agilent, Inc. supplying the arrays that can be used for the hybrid selection procedures described in this manuscript. JMRR's short stay at CSHL was supported by funding from the Ministerio de Eduacion y Cultura, the Universidad Autonoma de Madrid, and the European Association for Cancer Research, with no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bergman A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-108; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Rosa-Rosa JM, 2009, BREAST CANCER RES TR, V118, P151, DOI 10.1007/s10549-009-0317-1; Rosa-Rosa JM, 2009, AM J HUM GENET, V84, P115, DOI 10.1016/j.ajhg.2008.12.013; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Oldenburg RA, 2008, GENE CHROMOSOME CANC, V47, P947, DOI 10.1002/gcc.20597; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PUSHKAREV D, 2009, NAT BIOTECHNOL; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	21	6	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e9976	10.1371/journal.pone.0009976	http://dx.doi.org/10.1371/journal.pone.0009976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368986	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000276419900001
J	Peron, J; Le Jeune, F; Haegelen, C; Dondaine, T; Drapier, D; Sauleau, P; Reymann, JM; Drapier, S; Rouaud, T; Millet, B; Verin, M				Peron, Julie; Le Jeune, Florence; Haegelen, Claire; Dondaine, Thibaut; Drapier, Dominique; Sauleau, Paul; Reymann, Jean-Michel; Drapier, Sophie; Rouaud, Tiphaine; Millet, Bruno; Verin, Marc			Subthalamic Nucleus Stimulation Affects Theory of Mind Network: A PET Study in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VARIANT FRONTOTEMPORAL DEMENTIA; FRONTAL VARIANT; BASAL GANGLIA; FDG-PET; EXPRESSION RECOGNITION; EMOTION RECOGNITION; ALZHEIMERS-DISEASE; SOCIAL COGNITION; SCHIZOPHRENIA	Background: There appears to be an overlap between the limbic system, which is modulated by subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD), and the brain network that mediates theory of mind (ToM). Accordingly, the aim of the present study was to investigate the effects of STN DBS on ToM of PD patients and to correlate ToM modifications with changes in glucose metabolism. Methodology/Principal Findings: To this end, we conducted (18)FDG-PET scans in 13 PD patients in pre- and post-STN DBS conditions and correlated changes in their glucose metabolism with modified performances on the Eyes test, a visual ToM task requiring them to describe thoughts or feelings conveyed by photographs of the eye region. Postoperative PD performances on this emotion recognition task were significantly worse than either preoperative PD performances or those of healthy controls (HC), whereas there was no significant difference between preoperative PD and HC. Conversely, PD patients in the postoperative condition performed within the normal range on the gender attribution task included in the Eyes test. As far as the metabolic results are concerned, there were correlations between decreased cerebral glucose metabolism and impaired ToM in several cortical areas: the bilateral cingulate gyrus (BA 31), right middle frontal gyrus (BA 8, 9 and 10), left middle frontal gyrus (BA 6), temporal lobe (fusiform gyrus, BA 20), bilateral parietal lobe (right BA 3 and right and left BA 7) and bilateral occipital lobe (BA 19). There were also correlations between increased cerebral glucose metabolism and impaired ToM in the left superior temporal gyrus (BA 22), left inferior frontal gyrus (BA 13 and BA 47) and right inferior frontal gyrus (BA 47). All these structures overlap with the brain network that mediates ToM. Conclusion/Significance: These results seem to confirm that STN DBS hinders the ability to infer the mental states of others and modulates a distributed network known to subtend ToM.	[Peron, Julie; Dondaine, Thibaut; Drapier, Sophie; Rouaud, Tiphaine; Verin, Marc] CHU Rennes, Hop Pontchaillou, Neurol Clin, Rennes, France; [Peron, Julie; Le Jeune, Florence; Haegelen, Claire; Dondaine, Thibaut; Drapier, Dominique; Sauleau, Paul; Reymann, Jean-Michel; Drapier, Sophie; Rouaud, Tiphaine; Millet, Bruno; Verin, Marc] Univ Rennes 1, Hop Pontchaillou, CHU Rennes, Unite Rech Univ EM Behav & Basal Ganglia 425, Rennes, France; [Le Jeune, Florence] Ctr Anticanc Eugene Marquis Rennes, Nucl Med Serv, Rennes, France; [Haegelen, Claire] CHU Rennes, Hop Pontchaillou, Serv Neurochirurg, Rennes, France; [Dondaine, Thibaut; Drapier, Dominique; Millet, Bruno] Ctr Hosp Guillaume Regnier Rennes, Serv Hosp Univ Psychiat Adulte, Rennes, France; [Sauleau, Paul] CHU Rennes, Hop Pontchaillou, Serv Explorat Fonct, Rennes, France; [Reymann, Jean-Michel] CHU Rennes, Hop Pontchaillou, Ctr Invest Clin, Rennes, France	CHU Rennes; CHU Rennes; Universite de Rennes; UNICANCER; Centre Eugene Marquis; CHU Rennes; CHU Rennes; CHU Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Peron, J (corresponding author), CHU Rennes, Hop Pontchaillou, Neurol Clin, Rennes, France.	marc.verin@chu-rennes.fr	Haegelen, Claire CH/J-5332-2016; Le Jeune, Florence/ABC-6983-2020; Sauleau, Paul/ABC-4459-2020; Péron, Julie/C-5658-2013; Verin, Marc/ABC-6924-2020	Péron, Julie/0000-0002-6579-4011; Dondaine, Thibaut/0000-0002-8778-5079	Neurology Unit of Pontchaillou University Hospital in Rennes, France	Neurology Unit of Pontchaillou University Hospital in Rennes, France	This study was funded by the Neurology Unit of Pontchaillou University Hospital in Rennes, France (Prof. G. Edan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Benabid AL, 2000, NEUROLOGY, V55, pS40; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Biseul I, 2005, NEUROPSYCHOLOGIA, V43, P1054, DOI 10.1016/j.neuropsychologia.2004.10.006; Bora E, 2007, EUR ARCH PSY CLIN N, V257, P104, DOI 10.1007/s00406-006-0681-3; Bora E, 2006, PSYCHIAT RES, V145, P95, DOI 10.1016/j.psychres.2005.11.003; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; COHEN R, 2006, FRENCH ADAPATION 3 T; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Drapier D, 2008, NEUROPSYCHOLOGIA, V46, P2796, DOI 10.1016/j.neuropsychologia.2008.05.006; Dujardin K, 2004, J NEUROL NEUROSUR PS, V75, P202; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Farrant A, 2005, EPILEPSY BEHAV, V7, P506, DOI 10.1016/j.yebeh.2005.07.018; Finton MJ, 1998, J CLIN EXP NEUROPSYC, V20, P186, DOI 10.1076/jcen.20.2.186.1167; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geday J, 2006, NEUROIMAGE, V33, P706, DOI 10.1016/j.neuroimage.2006.06.056; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hilker R, 2004, J CEREBR BLOOD F MET, V24, P7, DOI 10.1097/01.WCB.0000092831.44769.09; Hirao K, 2008, SCHIZOPHR RES, V105, P165, DOI 10.1016/j.schres.2008.07.021; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Howard K, 1992, PYRAMIDS PALM TREES; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Irani F, 2006, SCHIZOPHR RES, V88, P151, DOI 10.1016/j.schres.2006.07.016; Joel D, 1997, BRAIN RES REV, V23, P62, DOI 10.1016/S0165-0173(96)00018-5; Kalbe E, 2009, NEUROLOGY, V72, P42, DOI 10.1212/01.wnl.0000338536.31388.f0; Kelemen O, 2005, NEUROPSYCHOLOGY, V19, P494, DOI 10.1037/0894-4105.19.4.494; Kington JM, 2000, J PSYCHIAT RES, V34, P341, DOI 10.1016/S0022-3956(00)00029-7; Kleiner-Fisman G, 2004, MOVEMENT DISORD, V19, P1209, DOI 10.1002/mds.20151; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Le Jeune F, 2008, BRAIN, V131, P1599, DOI 10.1093/brain/awn084; Le Jeune F, 2009, NEUROLOGY, V73, P1746, DOI 10.1212/WNL.0b013e3181c34b34; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; LOZANO AM, 1995, LANCET, V346, P1383, DOI 10.1016/S0140-6736(95)92404-3; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; MANDAL MK, 1991, CORTEX, V27, P247, DOI 10.1016/S0010-9452(13)80129-3; Mattis S, 1988, DEMENTIA RATING SCAL; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Peron J, 2010, NEUROPSYCHOLOGIA, V48, P1053, DOI 10.1016/j.neuropsychologia.2009.12.003; Peron J, 2010, NEUROPSYCHOLOGY, V24, P1, DOI 10.1037/a0017433; Peron J, 2009, NEUROPSYCHOLOGIA, V47, P406, DOI 10.1016/j.neuropsychologia.2008.09.008; Pourfar M, 2009, J NEUROSURG, V110, P1278, DOI 10.3171/2008.12.JNS08991; PREMACK D, 1978, SCIENCE, V202, P532, DOI 10.1126/science.705342; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Schroeder U, 2004, J NEUROL NEUROSUR PS, V75, P648, DOI 10.1136/jnnp.2003.019794; Schroeder U, 2003, ANN NEUROL, V54, P445, DOI 10.1002/ana.10683; Schroeder U, 2002, BRAIN, V125, P1995, DOI 10.1093/brain/awf199; Schwab R.S., 1969, 3 S PARK DIS, P152; Spielberger C. D., 1993, MANUEL INVENTAIRE AN; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TALAIRACH J, 1988, COPLANAR STERETOXIC; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Thobois S, 2007, J CEREBR BLOOD F MET, V27, P1173, DOI 10.1038/sj.jcbfm.9600425; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Welter ML, 2002, BRAIN, V125, P575, DOI 10.1093/brain/awf050; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104	68	43	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9919	10.1371/journal.pone.0009919	http://dx.doi.org/10.1371/journal.pone.0009919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360963	Green Submitted, Green Published, gold			2022-12-25	WOS:000276163100012
J	Amitay, S; Halliday, L; Taylor, J; Sohoglu, E; Moore, DR				Amitay, Sygal; Halliday, Lorna; Taylor, Jenny; Sohoglu, Ediz; Moore, David R.			Motivation and Intelligence Drive Auditory Perceptual Learning	PLOS ONE			English	Article							VERNIER DISCRIMINATION TASK; FREQUENCY DISCRIMINATION; IDENTICAL STIMULI; FEEDBACK; ORIENTATION; IMPROVEMENT; PLASTICITY; CHILDREN; BRAIN; SPECIFICITY	Background: Although feedback on performance is generally thought to promote perceptual learning, the role and necessity of feedback remain unclear. We investigated the effect of providing varying amounts of positive feedback while listeners attempted to discriminate between three identical tones on learning frequency discrimination. Methodology/Principal Findings: Using this novel procedure, the feedback was meaningless and random in relation to the listeners' responses, but the amount of feedback provided (or lack thereof) affected learning. We found that a group of listeners who received positive feedback on 10% of the trials improved their performance on the task (learned), while other groups provided either with excess (90%) or with no feedback did not learn. Superimposed on these group data, however, individual listeners showed other systematic changes of performance. In particular, those with lower non-verbal IQ who trained in the no feedback condition performed more poorly after training. Conclusions/Significance: This pattern of results cannot be accounted for by learning models that ascribe an external teacher role to feedback. We suggest, instead, that feedback is used to monitor performance on the task in relation to its perceived difficulty, and that listeners who learn without the benefit of feedback are adept at self-monitoring of performance, a trait that also supports better performance on non-verbal IQ tests. These results show that ` perceptual' learning is strongly influenced by top-down processes of motivation and intelligence.	[Amitay, Sygal; Halliday, Lorna; Taylor, Jenny; Sohoglu, Ediz; Moore, David R.] Inst Hearing Res, MRC, Nottingham, England		Amitay, S (corresponding author), Inst Hearing Res, MRC, Nottingham, England.	sygal@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012; Sohoglu, Ediz/B-7682-2013	Amitay, Sygal/0000-0001-9482-3435; Halliday, Lorna/0000-0003-1883-7741; Sohoglu, Ediz/0000-0002-0755-6445	Medical Research Council (MRC), United Kingdom; MRC [MC_U135097130] Funding Source: UKRI; Medical Research Council [MC_U135097130] Funding Source: researchfish	Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council (MRC), United Kingdom. All authors were MRC employees at the time the research was conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Calero MD, 2007, LEARN INDIVID DIFFER, V17, P328, DOI 10.1016/j.lindif.2007.03.012; CAMPBELL RA, 1963, J ACOUST SOC AM, V35, P1511, DOI 10.1121/1.1918738; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; DEARY IJ, 1994, INTELLIGENCE, V18, P189, DOI 10.1016/0160-2896(94)90027-2; DEARY IJ, 1995, DEV PSYCHOL, V31, P237, DOI 10.1037/0012-1649.31.2.237; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; Ferdinand NK, 2008, J COGNITIVE NEUROSCI, V20, P629, DOI 10.1162/jocn.2008.20046; Green DM, 1966, SIGNAL DETECTION THE; Hebb Donald O., 1949, ORG BEHAV; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Herzog MH, 1998, BIOL CYBERN, V78, P107, DOI 10.1007/s004220050418; Herzog MH, 1999, VISION RES, V39, P4232, DOI 10.1016/S0042-6989(99)00138-8; Hinton G. E., 1999, UNSUPERVISED LEARNIN; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KNUDSEN EI, 1994, J NEUROSCI, V14, P3985; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LUKASZEWSKI JS, 1962, J ACOUST SOC AM, V34, P223, DOI 10.1121/1.1909173; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; Micheyl C, 2009, ATTEN PERCEPT PSYCHO, V71, P5, DOI 10.3758/APP.71.1.5; Petrov AA, 2006, VISION RES, V46, P3177, DOI 10.1016/j.visres.2006.03.022; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Psychological Corp, 1999, WASI WECHSL ABBR SCA; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2006, J VISION, V6, P966, DOI 10.1167/6.9.9; Shibata K, 2009, VISION RES, V49, P2574, DOI 10.1016/j.visres.2009.06.009; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Swets JA, 1964, SIGNAL DETECTION REC; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; ZWISLOCKI J, 1958, J ACOUST SOC AM, V30, P254, DOI 10.1121/1.1909559	44	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9816	10.1371/journal.pone.0009816	http://dx.doi.org/10.1371/journal.pone.0009816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FS	20352121	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000275894400018
J	Voelckel, C; Borevitz, JO; Kramer, EM; Hodges, SA				Voelckel, Claudia; Borevitz, Justin O.; Kramer, Elena M.; Hodges, Scott A.			Within and between Whorls: Comparative Transcriptional Profiling of Aquilegia and Arabidopsis	PLOS ONE			English	Article							MADS-BOX GENES; HETEROTOPIC EXPRESSION; FLOWER DEVELOPMENT; ABC MODEL; EVOLUTION; DEFENSE; ANGIOSPERMS; RADIATION; SUPPORTS; ECOLOGY	Background: The genus Aquilegia is an emerging model system in plant evolutionary biology predominantly because of its wide variation in floral traits and associated floral ecology. The anatomy of the Aquilegia flower is also very distinct. There are two whorls of petaloid organs, the outer whorl of sepals and the second whorl of petals that form nectar spurs, as well as a recently evolved fifth whorl of staminodia inserted between stamens and carpels. Methodology/Principal Findings: We designed an oligonucleotide microarray based on EST sequences from a mixed tissue, normalized cDNA library of an A. formosa x A. pubescens F2 population representing 17,246 unigenes. We then used this array to analyze floral gene expression in late pre-anthesis stage floral organs from a natural A. formosa population. In particular, we tested for gene expression patterns specific to each floral whorl and to combinations of whorls that correspond to traditional and modified ABC model groupings. Similar analyses were performed on gene expression data of Arabidopsis thaliana whorls previously obtained using the Ath1 gene chips (data available through The Arabidopsis Information Resource). Conclusions/Significance: Our comparative gene expression analyses suggest that 1) petaloid sepals and petals of A. formosa share gene expression patterns more than either have organ-specific patterns, 2) petals of A. formosa and A. thaliana may be independently derived, 3) staminodia express B and C genes similar to stamens but the staminodium genetic program has also converged on aspects of the carpel program and 4) staminodia have unique up-regulation of regulatory genes and genes that have been implicated with defense against microbial infection and herbivory. Our study also highlights the value of comparative gene expression profiling and the Aquilegia microarray in particular for the study of floral evolution and ecology.	[Voelckel, Claudia] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand; [Borevitz, Justin O.] Univ Chicago, Chicago, IL 60637 USA; [Kramer, Elena M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hodges, Scott A.] Univ Calif Santa Barbara, Dept Ecol & Evolut, Santa Barbara, CA 93106 USA	Massey University; University of Chicago; Harvard University; University of California System; University of California Santa Barbara	Voelckel, C (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	c.voelckel@massey.ac.nz	Borevitz, Justin/B-5423-2012; Voelckel, Claudia/F-2693-2011	Borevitz, Justin/0000-0001-8408-3699; Hodges, Scott/0000-0002-0401-6072	National Science Foundation [0412727]; Alexander von Humboldt Foundation	National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was funded under a National Science Foundation grant to SA Hodges (http://www.nsf.gov/awardsearch/showAward. do? Award Number = 0412727). C Voelckel acknowledges funding from the Alexander von Humboldt Foundation through a Feodor Lynen Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XZ, 2004, PLANT CELL, V16, P1478, DOI 10.1105/tpc.021147; Baum DA, 1998, CURR OPIN PLANT BIOL, V1, P79, DOI 10.1016/S1369-5266(98)80132-5; Bhuiyan NH, 2009, J EXP BOT, V60, P509, DOI 10.1093/jxb/ern290; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bowman JL, 1997, J BIOSCIENCE, V22, P515, DOI 10.1007/BF02703197; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Chanderbali AS, 2009, P NATL ACAD SCI USA, V106, P8929, DOI 10.1073/pnas.0811476106; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cooper EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008655; De Craene LPR, 2007, ANN BOT-LONDON, V100, P621, DOI 10.1093/aob/mcm076; Erbar C, 1999, FLORA, V194, P317; Gould B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-6; Hodges SA, 2009, P NATL ACAD SCI USA, V106, P9947, DOI 10.1073/pnas.0901594106; Irish VF, 2009, J EXP BOT, V60, P2517, DOI 10.1093/jxb/erp159; Kalivas A, 2007, DNA SEQUENCE, V18, P120, DOI 10.1080/10425170601060582; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kramer EM, 2007, PLANT CELL, V19, P750, DOI 10.1105/tpc.107.050385; Kramer EM, 2010, PHILOS T R SOC B, V365, P477, DOI 10.1098/rstb.2009.0230; Kramer EM, 2009, ANNU REV PLANT BIOL, V60, P261, DOI 10.1146/annurev.arplant.043008.092051; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Kramer EM, 2005, J EXP ZOOL PART B, V304B, P526, DOI 10.1002/jez.b.21046; Laitinen RAE, 2005, GENOME RES, V15, P475, DOI 10.1101/gr.3043705; Laitinen RAE, 2007, PLANTA, V226, P347, DOI 10.1007/s00425-007-0486-2; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Peiffer JA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-43; Ralph SG, 2006, PLANT CELL ENVIRON, V29, P1545, DOI 10.1111/j.1365-3040.2006.01532.x; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Soltis DE, 2007, ANN BOT-LONDON, V100, P155, DOI 10.1093/aob/mcm117; TAKHTAJAN, 1991, EVOLUTIONARY TRENDS; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Tucker SC, 2005, INT J PLANT SCI, V166, P557, DOI 10.1086/429848; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang W, 2007, TAXON, V56, P811, DOI 10.2307/25065864; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Whittall JB, 2006, MOL ECOL, V15, P4645, DOI 10.1111/j.1365-294X.2006.03114.x; Yu LF, 2009, PLANTA, V229, P693, DOI 10.1007/s00425-008-0867-1; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032	49	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9735	10.1371/journal.pone.0009735	http://dx.doi.org/10.1371/journal.pone.0009735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352114	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400008
J	Eiseler, T; Hausser, A; De Kimpe, L; Van Lint, J; Pfizenmaier, K				Eiseler, Tim; Hausser, Angelika; De Kimpe, Line; Van Lint, Johan; Pfizenmaier, Klaus			Protein Kinase D Controls Actin Polymerization and Cell Motility through Phosphorylation of Cortactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFILIN-PHOSPHATASE SLINGSHOT; ARP2/3 COMPLEX; CARCINOMA-CELLS; F-ACTIN; LEADING-EDGE; N-WASP; C-MU; SITES; MIGRATION; LAMELLIPODIA	We here identify protein kinase D (PKD) as an upstream regulator of the F-actin-binding protein cortactin and the Arp actin polymerization machinery. PKD phosphorylates cortactin in vitro and in vivo at serine 298 thereby generating a 14-3-3 binding motif. In vitro, a phosphorylation-deficient cortactin-S298A protein accelerated VCA-Arp-cortactin-mediated synergistic actin polymerization and showed reduced F-actin binding, indicative of enhanced turnover of nucleation complexes. In vivo, cortactin co-localized with the nucleation promoting factor WAVE2, essential for lamellipodia extension, in the actin polymerization zone in Heregulin-treated MCF-7 cells. Using a 3-dye FRET-based approach we further demonstrate that WAVE2-Arp and cortactin prominently interact at these structures. Accordingly, cortactin-S298A significantly enhanced lamellipodia extension and directed cell migration. Our data thus unravel a previously unrecognized mechanism by which PKD controls cancer cell motility.	[Eiseler, Tim; Hausser, Angelika; Pfizenmaier, Klaus] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [De Kimpe, Line; Van Lint, Johan] Katholieke Univ Leuven, Fac Med, Dept Mol Cell Biol, B-3000 Louvain, Belgium	University of Stuttgart; KU Leuven	Pfizenmaier, K (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	klaus.pfizenmaier@izi.uni-stuttgart.de	Van Lint, Johan/P-9073-2019; Hausser, Angelika/AAC-4531-2021	Van Lint, Johan/0000-0002-0275-571X	Baden-Wurttemberg State Ministry for Science and Arts for the Center Systems Biology Stuttgart [A1]; BMBF; Heidelberger Akademie der Wissenschaften (WIN-Kolleg); FWO-Vlaanderen (Research Foundation-Flanders) [G.0612.07]; FWO-Vlaanderen; Interuniversity Attraction Poles Programme [IAP 6/18]	Baden-Wurttemberg State Ministry for Science and Arts for the Center Systems Biology Stuttgart; BMBF(Federal Ministry of Education & Research (BMBF)); Heidelberger Akademie der Wissenschaften (WIN-Kolleg); FWO-Vlaanderen (Research Foundation-Flanders)(FWO); FWO-Vlaanderen(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	This work was supported by grants from the Baden-Wurttemberg State Ministry for Science and Arts for the Center Systems Biology Stuttgart (project A1) (to K. P. and A. H.), the BMBF Systec-Program (to K. P.), and the Heidelberger Akademie der Wissenschaften (WIN-Kolleg) (to A. H.). This work was also supported by Grant G.0612.07 from FWO-Vlaanderen (Research Foundation-Flanders) (to J.V.L.), an Aspirtant Fellowship of the FWO-Vlaanderen (to L. D. K.), and Grant IAP 6/18 from the Interuniversity Attraction Poles Programme, initiated by the Belgian State Science Policy Office.	Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; De Kimpe L, 2009, CELL SIGNAL, V21, P253, DOI 10.1016/j.cellsig.2008.10.015; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Storz P, 2009, CELL CYCLE, V8, P1975; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2005, NOVART FDN SYMP, V269, P30; Takenawa T, 2005, NOVART FDN SYMP, V269, P10; Takenawa Tadaomi, 2005, Novartis Found Symp, V269, P3; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	39	81	81	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18672	18683		10.1074/jbc.M109.093880	http://dx.doi.org/10.1074/jbc.M109.093880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363754	Green Published, hybrid			2022-12-25	WOS:000278453900060
J	Faoro, L; Singleton, PA; Cervantes, GM; Lennon, FE; Choong, NW; Kanteti, R; Ferguson, BD; Husain, AN; Tretiakova, MS; Ramnath, N; Vokes, EE; Salgia, R				Faoro, Leonardo; Singleton, Patrick A.; Cervantes, Gustavo M.; Lennon, Frances E.; Choong, Nicholas W.; Kanteti, Rajani; Ferguson, Benjamin D.; Husain, Aliya N.; Tretiakova, Maria S.; Ramnath, Nithya; Vokes, Everett E.; Salgia, Ravi			EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; PROTEIN EXPRESSION; COLORECTAL-CANCER; OVARIAN-CANCER; GROWTH; OVEREXPRESSION; SUPPRESSES; P130(CAS); THERAPY; GENE	Non-small cell lung cancer (NSCLC) has a poor prognosis and improved therapies are needed. Expression of EphA2 is increased in NSCLC metastases. In this study, we investigated EphA2 mutations in NSCLC and examined molecular pathways involved in NSCLC. Tumor and cell line DNA was sequenced. One EphA2 mutation was modeled by expression in BEAS2B cells, and functional and biochemical studies were conducted. A G391R mutation was detected in H2170 and 2/28 squamous cell carcinoma patient samples. EphA2 G391R caused constitutive activation of EphA2 with increased phosphorylation of Src, cortactin, and p130Cas. Wild-type (WT) and G391R cells had 20 and 40% increased invasiveness; this was attenuated with knockdown of Src, cortactin, or p130Cas. WT and G391R cells demonstrated a 70% increase in focal adhesion area. Mammalian target of rapamycin (mTOR) phosphorylation was increased in G391R cells with increased survival (55%) compared with WT (30%) and had increased sensitivity to rapamycin. A recurrent EphA2 mutation is present in lung squamous cell carcinoma and increases tumor invasion and survival through activation of focal adhesions and actin cytoskeletal regulatory proteins as well as mTOR. Further study of EphA2 as a therapeutic target is warranted.	[Faoro, Leonardo; Cervantes, Gustavo M.; Choong, Nicholas W.; Kanteti, Rajani; Ferguson, Benjamin D.; Vokes, Everett E.; Salgia, Ravi] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60637 USA; [Singleton, Patrick A.; Lennon, Frances E.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; [Husain, Aliya N.; Tretiakova, Maria S.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Ferguson, Benjamin D.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Ramnath, Nithya] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Michigan System; University of Michigan	Salgia, R (corresponding author), Univ Chicago, Med Ctr, Hematol Oncol Sect, 5841 S Maryland Ave,MC2115, Chicago, IL 60637 USA.	rsalgia@medicine.bsd.uchicago.edu	Tretiakova, Maria/U-3320-2019; Vokes, Everett/Q-2146-2019; Ferguson, Benjamin/O-3214-2013	Ferguson, Benjamin/0000-0001-8358-3368	V-Foundation (Guy Geleerd Memorial Foundation); Kate McMullen Foundation; Respiratory Health Association of Chicago; ASCO Translational Award;  [5P01HL058064-140009];  [5R01CA100750-07];  [3R01CA100750-06S1];  [5R01CA125541-04];  [5R01CA129501-02];  [5R21CA140003-02]; NATIONAL CANCER INSTITUTE [R21CA140003, R01CA100750, R01CA125541, R01CA129501] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064] Funding Source: NIH RePORTER	V-Foundation (Guy Geleerd Memorial Foundation); Kate McMullen Foundation; Respiratory Health Association of Chicago; ASCO Translational Award; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the following research grants and awards: 5P01HL058064-140009, 5R01CA100750-07, 3R01CA100750-06S1, 5R01CA125541-04, 5R01CA129501-02, 5R21CA140003-02, V-Foundation (Guy Geleerd Memorial Foundation), Kate McMullen Foundation, Respiratory Health Association of Chicago (to R.S.), and ASCO Translational Award (to E.E.V.).	Astier A, 1997, J BIOL CHEM, V272, P228; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brannan JM, 2009, CLIN CANCER RES, V15, P4423, DOI 10.1158/1078-0432.CCR-09-0473; Carayol N, 2008, J BIOL CHEM, V283, P8601, DOI 10.1074/jbc.M707934200; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Faoroa L, 2008, ANTI-CANCER DRUG, V19, P841, DOI 10.1097/CAD.0b013e32830ce506; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kataoka H, 2004, CANCER SCI, V95, P136, DOI 10.1111/j.1349-7006.2004.tb03194.x; Kinch MS, 2003, CLIN CANCER RES, V9, P613; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; Landen CN, 2006, CANCER BIOL THER, V5, P1708, DOI 10.4161/cbt.5.12.3468; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Leung ELH, 2009, MOL CANCER RES, V7, P923, DOI 10.1158/1541-7786.MCR-09-0003; Lin YG, 2007, CANCER, V109, P332, DOI 10.1002/cncr.22415; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Mudali SV, 2006, CLIN EXP METASTAS, V23, P357, DOI 10.1007/s10585-006-9045-7; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Nasreen N, 2006, CANCER-AM CANCER SOC, V107, P2425, DOI 10.1002/cncr.22254; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Saito T, 2004, ONCOL REP, V11, P605; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; van Rens MTM, 2000, CHEST, V117, P374, DOI 10.1378/chest.117.2.374; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Zelinski DP, 2001, CANCER RES, V61, P2301; Zeng GY, 2003, AM J PATHOL, V163, P2271, DOI 10.1016/S0002-9440(10)63584-5	41	85	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18575	18585		10.1074/jbc.M109.075085	http://dx.doi.org/10.1074/jbc.M109.075085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20360610	Green Published, hybrid			2022-12-25	WOS:000278453900051
J	Bicknell, AA; Tourtellotte, J; Niwa, M				Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho			Late Phase of the Endoplasmic Reticulum Stress Response Pathway Is Regulated by Hog1 MAP Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-WALL STRESS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; TYROSINE PHOSPHATASES; TRANSMEMBRANE PROTEIN; MONITORING AUTOPHAGY; SIGNALING PATHWAYS; YEAST; GENE	When unfolded proteins accumulate in the endoplasmic reticulum (ER) causing ER stress, the unfolded protein response (UPR) responds rapidly to induce a transcriptional program that functions to alleviate the stress. However, under extreme conditions, when UPR activation is not sufficient to alleviate ER stress, the stress may persist long term. Very little is known about how the cell responds to persistent ER stress that is not resolved by the immediate activation of the UPR. We show that Hog1 MAP kinase becomes phosphorylated during the late stage of ER stress and helps the ER regain homeostasis. Although Hog1 is well known to function in osmotic stress and cell wall integrity pathways, we show that the activation mechanism for Hog1 during ER stress is distinct from both of these pathways. During late stage ER stress, upon phosphorylation, Hog1 translocates into the nucleus and regulates gene expression. Subsequently, Hog1 returns to the cytoplasm, where its phosphorylation levels remain high. From its cytoplasmic location, Hog1 contributes to the activation of autophagy by enhancing the stability of Atg8, a critical autophagy protein. Thus, Hog1 coordinates a multifaceted response to persistent ER stress.	[Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Niwa, M (corresponding author), 9500 Gilman Dr,MC0377, La Jolla, CA 92093 USA.	niwa@ucsd.edu			American Cancer Society [ACS RSG-05-01 GMC]; Searle [03-G107]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087415] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Searle; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society (Grant ACS RSG-05-01 GMC) and Searle (Grant 03-G107) (to M. N.).; Supported in part by a National Science Foundation predoctoral fellowship.	Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Arroyo J, 2009, CLIN MICROBIOL INFEC, V15, P44, DOI 10.1111/j.1469-0691.2008.02676.x; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky Daniel J., 2007, V390, P363; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marquez JA, 1998, EMBO J, V17, P2543, DOI 10.1093/emboj/17.9.2543; Mattison CP, 2000, GENE DEV, V14, P1229; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; MORI K, 1993, CELL, V74, P743; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Prick T, 2006, BIOCHEM J, V394, P153, DOI 10.1042/BJ20051243; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 1999, MOL CELL BIOL, V19, P5474; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Schmid D, 2006, J MOL MED-JMM, V84, P194, DOI 10.1007/s00109-005-0014-4; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; VARELA JCS, 1995, MOL CELL BIOL, V15, P6232; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	73	46	47	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17545	17555		10.1074/jbc.M109.084681	http://dx.doi.org/10.1074/jbc.M109.084681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382742	Green Published, hybrid			2022-12-25	WOS:000278133400033
J	Marmolino, D; Manto, M; Acquaviva, F; Vergara, P; Ravella, A; Monticelli, A; Pandolfo, M				Marmolino, Daniele; Manto, Mario; Acquaviva, Fabio; Vergara, Paola; Ravella, Ajay; Monticelli, Antonella; Pandolfo, Massimo			PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia	PLOS ONE			English	Article							PROMOTES MITOCHONDRIAL BIOGENESIS; OXIDATIVE STRESS; TRANSCRIPTIONAL COACTIVATOR; IRON ACCUMULATION; GENE-EXPRESSION; YEAST FRATAXIN; TRIPLET REPEAT; MOUSE MODELS; PGC-1-ALPHA; PROTEIN	Background: Cells from individuals with Friedreich's ataxia (FRDA) show reduced activities of antioxidant enzymes and cannot up-regulate their expression when exposed to oxidative stress. This blunted antioxidant response may play a central role in the pathogenesis. We previously reported that Peroxisome Proliferator Activated Receptor Gamma (PPAR gamma) Coactivator 1-alpha (PGC-1 alpha), a transcriptional master regulator of mitochondrial biogenesis and antioxidant responses, is down-regulated in most cell types from FRDA patients and animal models. Methodology/Principal Findings: We used primary fibroblasts from FRDA patients and the knock in-knock out animal model for the disease (KIKO mouse) to determine basal superoxide dismutase 2 (SOD2) levels and the response to oxidative stress induced by the addition of hydrogen peroxide. We measured the same parameters after pharmacological stimulation of PGC-1 alpha. Compared to control cells, PGC-1 alpha and SOD2 levels were decreased in FRDA cells and did not change after addition of hydrogen peroxide. PGC-1 alpha direct silencing with siRNA in control fibroblasts led to a similar loss of SOD2 response to oxidative stress as observed in FRDA fibroblasts. PGC-1 alpha activation with the PPAR gamma agonist (Pioglitazone) or with a cAMP-dependent protein kinase (AMPK) agonist (AICAR) restored normal SOD2 induction. Treatment of the KIKO mice with Pioglitazone significantly up-regulates SOD2 in cerebellum and spinal cord. Conclusions/Significance: PGC-1 alpha down-regulation is likely to contribute to the blunted antioxidant response observed in cells from FRDA patients. This response can be restored by AMPK and PPAR gamma agonists, suggesting a potential therapeutic approach for FRDA.	[Marmolino, Daniele; Manto, Mario; Ravella, Ajay; Pandolfo, Massimo] Univ Libre Bruxelles, Lab Neurol Expt, Brussels, Belgium; [Manto, Mario] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Acquaviva, Fabio; Vergara, Paola] Univ Naples Federico II, Dept Cellular & Mol Biol, Naples, Italy; [Monticelli, Antonella] CNR, IEOS, I-80125 Naples, Italy	Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Marmolino, D (corresponding author), Univ Libre Bruxelles, Lab Neurol Expt, Brussels, Belgium.	massimo.pandolfo@ulb.ac.be	Vergara, Paola/K-9145-2013; Acquaviva, Fabio/N-6402-2016; Manto, Mario/ABF-6008-2021	Acquaviva, Fabio/0000-0001-9192-1232; 	GOFAR Association; Fonds Erasme; Belgian Fonds National de la Recherche Scientifique [3.4572.08]	GOFAR Association; Fonds Erasme; Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the GOFAR Association (grant to M. P.), the Fonds Erasme (grant Jean Van Damme for Orphan Diseases to M. P.), the Belgian Fonds National de la Recherche Scientifique (grant n. 3.4572.08 to M. P.). M. M. is supported by FNRS-Belgium. Takeda pharmaceuticals provided the compound pioglitazone-AD4833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bird AJ, 2008, ADV MICROB PHYSIOL, V53, P231, DOI 10.1016/SO065-2911(07)53004-3; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Clark J, 2009, ANTIOXID REDOX SIGN, V11, P509, DOI 10.1089/ARS.2008.2241; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Delatycki MB, 2000, J MED GENET, V37, P1, DOI 10.1136/jmg.37.1.1; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Filla A, 2000, MOVEMENT DISORD, V15, P1255, DOI 10.1002/1531-8257(200011)15:6<1255::AID-MDS1031>3.0.CO;2-C; FILLA A, 1990, J NEUROL, V237, P345, DOI 10.1007/BF00315657; FINOCCHIARO G, 1988, NEUROLOGY, V38, P1292, DOI 10.1212/WNL.38.8.1292; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Fujisawa K, 2009, BIOCHEM BIOPH RES CO, V379, P43, DOI 10.1016/j.bbrc.2008.11.141; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Jiralerspong S, 2001, FEBS LETT, V509, P101, DOI 10.1016/S0014-5793(01)03140-4; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lodi R, 2006, ANTIOXID REDOX SIGN, V8, P438, DOI 10.1089/ars.2006.8.438; LOTTE L, 2010, EXP GERONTOL    0118; Marmolino D, 2009, CEREBELLUM, V8, P245, DOI 10.1007/s12311-008-0084-2; Marmolino D, 2009, CEREBELLUM, V8, P98, DOI 10.1007/s12311-008-0087-z; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; PANDOLFO M, 2006, GENETIC INSTABILITIE, V2, P277; PANDOLFO M, 2003, NEUROL          0910, P163; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; PI J, 2009, TOXICOL APPL PHARM; Pianese L, 2002, HUM MOL GENET, V11, P2989, DOI 10.1093/hmg/11.23.2989; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Santos MM, 2001, HUM MOL GENET, V10, P1935, DOI 10.1093/hmg/10.18.1935; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; SHAPCOTT D, 1976, Canadian Journal of Neurological Sciences, V3, P361; Spiegelman Bruce M, 2007, Novartis Found Symp, V286, P3; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tabrizi SJ, 1999, BIOCHEM SOC SYMP, V66, P99, DOI 10.1042/bss0660099; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vina J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006; WENZ T, 2009, CURR OPIN LIPIDOL, V20, P98; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wu ZD, 1999, CURR OPIN CELL BIOL, V11, P689, DOI 10.1016/S0955-0674(99)00037-X; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200	80	103	104	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10025	10.1371/journal.pone.0010025	http://dx.doi.org/10.1371/journal.pone.0010025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383327	Green Submitted, gold, Green Published			2022-12-25	WOS:000276454000006
J	Boeke, J; Regnard, C; Cai, WL; Johansen, J; Johansen, KM; Becker, PB; Imhof, A				Boeke, Joern; Regnard, Catherine; Cai, Weili; Johansen, Jorgen; Johansen, Kristen M.; Becker, Peter B.; Imhof, Axel			Phosphorylation of SU(VAR)3-9 by the Chromosomal Kinase JIL-1	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; CHROMATIN-STRUCTURE; HETEROCHROMATIN PROTEIN-1; METHYLTRANSFERASE SUV39H1; DROSOPHILA SU(VAR)3-9; HISTONE; BINDING; HP1; METHYLATION; HP1-ALPHA	The histone methyltransferase SU(VAR)3-9 plays an important role in the formation of heterochromatin within the eukaryotic nucleus. Several studies have shown that the formation of condensed chromatin is highly regulated during development, suggesting that SU(VAR)3-9's activity is regulated as well. However, no mechanism by which this may be achieved has been reported so far. As we and others had shown previously that the N-terminus of SU(VAR)3-9 plays an important role for its activity, we purified interaction partners from Drosophila embryo nuclear extract using as bait a GST fusion protein containing the SU(VAR)3-9 N-terminus. Among several other proteins known to bind Su(VAR)3-9 we isolated the chromosomal kinase JIL-1 as a strong interactor. We show that SU(VAR)3-9 is a substrate for JIL-1 in vitro as well as in vivo and map the site of phosphorylation. These findings may provide a molecular explanation for the observed genetic interaction between SU(VAR)3-9 and JIL-1.	[Boeke, Joern; Regnard, Catherine; Becker, Peter B.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Boeke, Joern; Regnard, Catherine; Becker, Peter B.; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci CIPS, Munich, Germany; [Cai, Weili; Johansen, Jorgen; Johansen, Kristen M.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of Munich; University of Munich; Iowa State University	Boeke, J (corresponding author), Univ Munich, Adolf Butenandt Inst, Munich, Germany.	Imhof@lmu.de	Imhof, Axel/AAU-5313-2021; Cai, Weili/B-7691-2013	Imhof, Axel/0000-0003-2993-8249; Regnard, Catherine/0000-0001-9915-7494; Cai, Weili/0000-0002-6781-5322; Becker, Peter/0000-0001-7186-0372	Deutsche Forschungsgemeinschaft [IM 23/4-3, SFB-TR5]; National Institutes of Health [GM62916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Imhof and Becker labs is supported by grants from the Deutsche Forschungsgemeinschaft [IM 23/4-3 and SFB-TR5 accordingly]. Work in the Johansen laboratory is supported by a grant from the National Institutes of Health [GM62916]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Aagaard L, 2000, J CELL SCI, V113, P817; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Cattaneo F, 2008, J CELL BIOCHEM, V105, P344, DOI 10.1002/jcb.21869; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Deng H, 2007, GENETICS, V177, P79, DOI 10.1534/genetics.107.075143; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; EISSENBERG JC, 1994, J BIOL CHEM, V269, P21315; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fan JY, 2007, METHODS, V41, P286, DOI 10.1016/j.ymeth.2006.11.001; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; JOHANSEN KM, 2009, NETHODS, V48, P387; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lerach S, 2006, GENETICS, V173, P2403, DOI 10.1534/genetics.106.059253; LeRoy G, 2009, MOL CELL PROTEOMICS, pS11; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Ogawa M, 2003, IMMUNOL LETT, V86, P57, DOI 10.1016/S0165-2478(02)00293-6; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rudenko A, 2003, EMBO REP, V4, P59, DOI 10.1038/sj.embor.embor712; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Spensberger D, 2008, FEBS LETT, V582, P2761, DOI 10.1016/j.febslet.2008.06.056; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhao T, 1999, J BIOL CHEM, V274, P15095, DOI 10.1074/jbc.274.21.15095; Zhou J, 2008, RNA, V14, P1773, DOI 10.1261/rna.1036308	52	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10042	10.1371/journal.pone.0010042	http://dx.doi.org/10.1371/journal.pone.0010042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386606	gold, Green Published, Green Submitted			2022-12-25	WOS:000276420400013
J	Lundin, S; Stranneheim, H; Pettersson, E; Klevebring, D; Lundeberg, J				Lundin, Sverker; Stranneheim, Henrik; Pettersson, Erik; Klevebring, Daniel; Lundeberg, Joakim			Increased Throughput by Parallelization of Library Preparation for Massive Sequencing	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; DNA; PRECIPITATION	Background: Massively parallel sequencing systems continue to improve on data output, while leaving labor-intensive library preparations a potential bottleneck. Efforts are currently under way to relieve the crucial and time-consuming work to prepare DNA for high-throughput sequencing. Methodology/Principal Findings: In this study, we demonstrate an automated parallel library preparation protocol using generic carboxylic acid-coated superparamagnetic beads and polyethylene glycol precipitation as a reproducible and flexible method for DNA fragment length separation. With this approach the library preparation for DNA sequencing can easily be adjusted to a desired fragment length. The automated protocol, here demonstrated using the GS FLX Titanium instrument, was compared to the standard manual library preparation, showing higher yield, throughput and great reproducibility. In addition, 12 libraries were prepared and uniquely tagged in parallel, and the distribution of sequence reads between these indexed samples could be improved using quantitative PCR-assisted pooling. Conclusions/Significance: We present a novel automated procedure that makes it possible to prepare 36 indexed libraries per person and day, which can be increased to up to 96 libraries processed simultaneously. The yield, speed and robust performance of the protocol constitute a substantial improvement to present manual methods, without the need of extensive equipment investments. The described procedure enables a considerable efficiency increase for small to midsize sequencing centers.	[Lundin, Sverker; Stranneheim, Henrik; Pettersson, Erik; Klevebring, Daniel; Lundeberg, Joakim] Royal Inst Technol KTH, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden	Royal Institute of Technology	Lundin, S (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden.	joalun@kth.se		Klevebring, Daniel/0000-0002-9810-3838	Swedish Scientific Council; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation	Swedish Scientific Council; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Scientific Council, the Swedish Foundation for Strategic Research and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Klevebring D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/396808; Lis J T, 1980, Methods Enzymol, V65, P347; LIS JT, 1975, NUCLEIC ACIDS RES, V2, P383, DOI 10.1093/nar/2.3.383; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maricic T, 2009, BIOTECHNIQUES, V46, P51, DOI 10.2144/000113042; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; NYREN P, 1993, ANAL BIOCHEM, V208, P171, DOI 10.1006/abio.1993.1024; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Sandberg J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp188; Sauer ML, 2008, ANAL BIOCHEM, V380, P310, DOI 10.1016/j.ab.2008.05.044; Schmitz A, 2006, ANAL BIOCHEM, V354, P311, DOI 10.1016/j.ab.2006.03.014; Wiley G., 2009, CURR PROTOC HUM GENE	18	86	95	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10029	10.1371/journal.pone.0010029	http://dx.doi.org/10.1371/journal.pone.0010029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386591	Green Published, Green Submitted, gold			2022-12-25	WOS:000276420400007
J	Cermeno, P; de Vargas, C; Abrantes, F; Falkowski, PG				Cermeno, Pedro; de Vargas, Colomban; Abrantes, Fatima; Falkowski, Paul G.			Phytoplankton Biogeography and Community Stability in the Ocean	PLOS ONE			English	Article							MARINE-PHYTOPLANKTON; MASS-SPECTROMETRY; ATLANTIC; DIVERSITY; ASSEMBLAGES; VARIABILITY; MICROBES; TIME	Background: Despite enormous environmental variability linked to glacial/interglacial climates of the Pleistocene, we have recently shown that marine diatom communities evolved slowly through gradual changes over the past 1.5 million years. Identifying the causes of this ecological stability is key for understanding the mechanisms that control the tempo and mode of community evolution. Methodology/Principal Findings: If community assembly were controlled by local environmental selection rather than dispersal, environmental perturbations would change community composition, yet, this could revert once environmental conditions returned to previous-like states. We analyzed phytoplankton community composition across >10(4) km latitudinal transects in the Atlantic Ocean and show that local environmental selection of broadly dispersed species primarily controls community structure. Consistent with these results, three independent fossil records of marine diatoms over the past 250,000 years show cycles of community departure and recovery tightly synchronized with the temporal variations in Earth's climate. Conclusions/Significance: Changes in habitat conditions dramatically alter community structure, yet, we conclude that the high dispersal of marine planktonic microbes erases the legacy of past environmental conditions, thereby decreasing the tempo of community evolution.	[Cermeno, Pedro; Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08903 USA; [de Vargas, Colomban] CNRS, Biol Stn, Roscoff, France; [de Vargas, Colomban] UPMC, Roscoff, France; [Abrantes, Fatima] LNEG, Marine Geol Dept, Alfragide, Portugal; [Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Laboratorio Nacional de Energia e Geologia IP (LNEG); Rutgers State University New Brunswick	Cermeno, P (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	pedro@uvigo.es	Abrantes, Fatima F G/B-5985-2013; Abrantes, Fatima/N-7253-2019	Abrantes, Fatima F G/0000-0002-9110-0212; Abrantes, Fatima/0000-0002-9110-0212; de Vargas, Colomban/0000-0002-6476-6019; Cermeno, Pedro/0000-0002-3902-3475	European Union; UK Natural Environmental Research Council [NER/O/S/2001/00680]; Natural Environment Research Council [NER/O/S/2001/00680] Funding Source: researchfish	European Union(European Commission); UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was funded by the European Union through a Marie Curie project within 6th European Community framework Program. http://cordis.europa.eu/mariecurie-actions/.Atlantic Meridional Transect data collection was supported by the UK Natural Environmental Research Council through the Atlantic Meridional Transect consortium (NER/O/S/2001/00680). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This is AMT contribution number 189.	ABRANTES F, 1988, MAR MICROPALEONTOL, V13, P79, DOI 10.1016/0377-8398(88)90013-8; Abrantes F, 2000, EARTH PLANET SC LETT, V176, P7, DOI 10.1016/S0012-821X(99)00312-X; ABRANTES F, 1994, CARBON CYCLING GLACI, P425; Abrantes FF, 1991, PALEOCEANOGRAPHY, V6, P431, DOI 10.1029/91PA00049; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BATTARBE.RW, 1973, LIMNOL OCEANOGR, V18, P647, DOI 10.4319/lo.1973.18.4.0647; Bennett, 1997, EVOLUTION ECOLOGY PA; Bown P, 2009, MAR MICROPALEONTOL, V71, P60, DOI 10.1016/j.marmicro.2009.01.005; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Cermeno P, 2008, LIMNOL OCEANOGR, V53, P312, DOI 10.4319/lo.2008.53.1.0312; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; De Vargas C, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P271; DiMichele WA, 2004, ANNU REV ECOL EVOL S, V35, P285, DOI 10.1146/annurev.ecolsys.35.120202.110110; Dolan JR, 2005, AQUAT MICROB ECOL, V41, P39, DOI 10.3354/ame041039; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Falkowski PG, 2002, SCI AM, V287, P54, DOI 10.1038/scientificamerican0802-54; Fenchel T, 2006, PHILOS T R SOC B, V361, P1965, DOI 10.1098/rstb.2006.1924; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hayward BW, 2001, GEOLOGY, V29, P599, DOI 10.1130/0091-7613(2001)029<0599:GDSEDT>2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; HUGHESMARTINY JB, 2006, NATURE REV MICROBIOL, V4, P101, DOI DOI 10.1038/NRMICRO1341; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; JACKSON JBC, 1999, TRENDS ECOLOGY EVOLU, V14; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Koroleff F., 1976, METHODS SEAWATER ANA, P117; Legendre L., 1983, DEV ENV MODELLING; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; MAC ARTHUR ROBERT H., 1967; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; MARTENS R., 1987, SPORT PSYCHOL, V1, P29, DOI [10.1123/tsp.1.1.29, DOI 10.1123/TSP.1.1.29]; MCINTYRE A, 1967, SCIENCE, V158, P1314, DOI 10.1126/science.158.3806.1314; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pichevin L, 2005, MAR GEOL, V218, P81, DOI 10.1016/j.margeo.2005.04.003; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Robinson C, 2006, DEEP-SEA RES PT II, V53, P1483, DOI 10.1016/j.dsr2.2006.06.002; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; Roy Kaustuv, 2005, P160; SCHULMAN NM, 1992, J POP FILM TV, V20, P2; Sluijs A, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P323; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; Sokal RR, 1995, BIOMETRY; Stanley S. M., 1979, MACROEVOLUTION; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WEI KY, 1988, PALEOBIOLOGY, V14, P345, DOI 10.1017/S0094837300012094; Weinbauer Markus G., 2007, Endangered Species Research, V3, P205, DOI 10.3354/esr003205; West S, 2004, MAR MICROPALEONTOL, V51, P321, DOI 10.1016/j.marmicro.2004.01.004; WESTERHAUSEN L, 1993, DEEP-SEA RES PT I, V40, P1087, DOI 10.1016/0967-0637(93)90091-G	51	38	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10037	10.1371/journal.pone.0010037	http://dx.doi.org/10.1371/journal.pone.0010037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368810	Green Published, gold			2022-12-25	WOS:000276419900023
J	Anand, B; Surana, P; Prakash, B				Anand, Baskaran; Surana, Parag; Prakash, Balaji			Deciphering the Catalytic Machinery in 30S Ribosome Assembly GTPase YqeH	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSITION-STATE ANALOG; BACILLUS-SUBTILIS; HYDROLYSIS; PROTEIN; SUBUNIT; BINDING; COMPLEX; MUTAGENESIS; BIOGENESIS	Background: YqeH, a circularly permuted GTPase (cpGTPase), which is conserved across bacteria and eukaryotes including humans is important for the maturation of small (30S) ribosomal subunit in Bacillus subtilis. Recently, we have shown that it binds 30S in a GTP/GDP dependent fashion. However, the catalytic machinery employed to hydrolyze GTP is not recognized for any of the cpGTPases, including YqeH. This is because they possess a hydrophobic substitution in place of a catalytic glutamine (present in Ras-like GTPases). Such GTPases were categorized as HAS-GTPases and were proposed to follow a catalytic mechanism, different from the Ras-like proteins. Methodology/Principal Findings: MnmE, another HAS-GTPase, but not circularly permuted, utilizes a potassium ion and water mediated interactions to drive GTP hydrolysis. Though the G-domain of MnmE and YqeH share only similar to 25% sequence identity, the conservation of characteristic sequence motifs between them prompted us to probe GTP hydrolysis machinery in YqeH, by employing homology modeling in conjunction with biochemical experiments. Here, we show that YqeH too, uses a potassium ion to drive GTP hydrolysis and stabilize the transition state. However, unlike MnmE, it does not dimerize in the transition state, suggesting alternative ways to stabilize switches I and II. Furthermore, we identify a potential catalytic residue in Asp-57, whose recognition, in the absence of structural information, was non-trivial due to the circular permutation in YqeH. Interestingly, when compared with MnmE, helix alpha 2 that presents Asp-57 is relocated towards the N-terminus in YqeH. An analysis of the YqeH homology model, suggests that despite such relocation, Asp-57 may facilitate water mediated catalysis, similarly as the catalytic Glu-282 of MnmE. Indeed, an abolished catalysis by D571 mutant supports this inference. Conclusions/Significance: An uncommon means to achieve GTP hydrolysis utilizing a K(+) ion has so far been demonstrated only for MnmE. Here, we show that YqeH also utilizes a similar mechanism. While the catalytic machinery is similar in both, mechanistic differences may arise based on the way they are deployed. It appears that K(+) driven mechanism emerges as an alternative theme to stabilize the transition state and hydrolyze GTP in a subset of GTPases, such as the HAS-GTPases.	[Anand, Baskaran; Surana, Parag; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Anand, B (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	bprakash@iitk.ac.in		, Anand/0000-0002-7125-4011	Wellcome Trust, United Kingdom [073616]; Department of Biotechnology, India [BT/PR7897/Med/14/1178/2006]; All India Council for Technical Education (AICTE)	Wellcome Trust, United Kingdom(Wellcome Trust); Department of Biotechnology, India(Department of Biotechnology (DBT) India); All India Council for Technical Education (AICTE)	This work was supported by funding from Wellcome Trust (Grant No: 073616), United Kingdom (http://www. wellcome. ac. uk/) and Department of Biotechnology (Grant No: BT/PR7897/Med/14/1178/2006), India (http://dbtindia.nic.in/index.asp). B. P. is a Wellcome Trust International Senior Research Fellow. B. A. acknowledges the All India Council for Technical Education (AICTE) for the National Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Anand B, 2009, BIOCHEM BIOPH RES CO, V386, P602, DOI 10.1016/j.bbrc.2009.06.078; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Campbell TL, 2008, J BACTERIOL, V190, P2537, DOI 10.1128/JB.01744-07; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Martinez-Vicente M, 2005, J BIOL CHEM, V280, P30660, DOI 10.1074/jbc.M503223200; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008	38	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9944	10.1371/journal.pone.0009944	http://dx.doi.org/10.1371/journal.pone.0009944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376346	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200020
J	Yue, P; Chen, ZJ; Nassir, F; Bernal-Mizrachi, C; Finck, B; Azhar, S; Abumrad, NA				Yue, Pin; Chen, Zhouji; Nassir, Fatiha; Bernal-Mizrachi, Carlos; Finck, Brian; Azhar, Salman; Abumrad, Nada A.			Enhanced Hepatic apoA-I Secretion and Peripheral Efflux of Cholesterol and Phospholipid in CD36 Null Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR BI; APOLIPOPROTEIN-A-I; LIPID DROPLETS; SR-BI; SELECTIVE UPTAKE; CELLULAR UPTAKE; OXIDIZED LDL; FATTY-ACID; CLEARANCE	CD36 facilitates oxidized low density lipoprotein uptake and is implicated in development of atherosclerotic lesions. CD36 also binds unmodified high and very low density lipoproteins (HDL, VLDL) but its role in the metabolism of these particles is unclear. Several polymorphisms in the CD36 gene were recently shown to associate with serum HDL cholesterol. To gain insight into potential mechanisms for these associations we examined HDL metabolism in CD36 null (CD36(-/-)) mice. Feeding CD36(-/-) mice a high cholesterol diet significantly increased serum HDL, cholesterol and phospholipids, as compared to wild type mice. HDL apolipoproteins apoA-I and apoA-IV were increased and shifted to higher density HDL fractions suggesting altered particle maturation. Clearance of dual-labeled HDL was unchanged in CD36(-/-) mice and cholesterol uptake from HDL or LDL by isolated CD36(-/-) hepatocytes was unaltered. However, CD36(-/-) hepatocytes had higher cholesterol and phospholipid efflux rates. In addition, expression and secretion of apoA-I and apoA-IV were increased reflecting enhanced PXR. Similar to hepatocytes, cholesterol and phospholipid efflux were enhanced in CD36(-/-) macrophages without changes in protein levels of ABCA1, ABCG1 or SR-B1. However, biotinylation assays showed increased surface ABCA1 localization in CD36(-/-) cells. In conclusion, CD36 influences reverse cholesterol transport and hepatic ApoA-I production. Both pathways are enhanced in CD36 deficiency, increasing HDL concentrations, which suggests the potential benefit of CD36 inhibition.	[Yue, Pin; Chen, Zhouji; Nassir, Fatiha; Finck, Brian; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Sch Med, Dept Med, Div Endocrinol, St Louis, MO 63110 USA; [Azhar, Salman] Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Dept Vet Affairs, Palo Alto, CA USA; [Azhar, Salman] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Washington University (WUSTL); Washington University (WUSTL); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Yue, P (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA.	pyue@DOM.wustl.edu		Finck, Brian/0000-0001-5411-3674; Nassir, Fatiha/0000-0002-3653-3621; Bernal-Mizrachi, Carlos/0000-0002-8991-7522	National Institutes of Health [R01 DK33301, R01 DK60022, R01 HL092271]; Nutrition Obesity Research Center [P30DK056341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881, R01HL092473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060022, P30DK056341, R01DK033301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institutes of Health grants R01 DK33301, R01 DK60022 and R01 HL092271 and by the Nutrition Obesity Research Center grant P30DK056341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Arai T, 1999, P NATL ACAD SCI USA, V96, P12050, DOI 10.1073/pnas.96.21.12050; AZHAR S, 1990, BIOCHIM BIOPHYS ACTA, V1047, P148, DOI 10.1016/0005-2760(90)90041-U; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; BUERS I, 2009, ARTERIOSCLER THROMB; Calvo D, 1998, J LIPID RES, V39, P777; Chahil TJ, 2006, ENDOCRIN METAB CLIN, V35, P491, DOI 10.1016/j.ecl.2006.06.002; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chroni A, 2005, BIOCHEMISTRY-US, V44, P13132, DOI 10.1021/bi051029o; Collot-Teixeira S, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/813236; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; de Villiers WJS, 2001, J LIPID RES, V42, P1231; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Johnson LA, 2008, ARTERIOSCL THROM VAS, V28, P1745, DOI 10.1161/ATVBAHA.108.169680; Jones C, 2007, J CLIN INVEST, V117, P165, DOI 10.1172/JCI29415; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Linder MD, 2009, ARTERIOSCL THROM VAS, V29, P883, DOI 10.1161/ATVBAHA.108.179481; Liu PS, 2008, METHOD ENZYMOL, V439, P327, DOI 10.1016/S0076-6879(07)00424-7; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Luangrath V, 2008, ARTERIOSCL THROM VAS, V28, P1290, DOI 10.1161/ATVBAHA.107.161653; Malik S, 2003, FRONT BIOSCI, V8, pD360, DOI 10.2741/1005; MEHRDAD H, 1995, ATHEROSCLEROSIS, V117, P199; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Nicholson AC, 2000, ANN NY ACAD SCI, V902, P128; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Srivastava RAK, 2000, MOL CELL BIOCHEM, V209, P125, DOI 10.1023/A:1007107712725; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Sviridov D, 2009, J LIPID RES, V50, P1257, DOI 10.1194/jlr.E900003-JLR200; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Waddington EI, 2005, METHODS, V36, P196, DOI 10.1016/j.ymeth.2004.12.002; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	57	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9906	10.1371/journal.pone.0009906	http://dx.doi.org/10.1371/journal.pone.0009906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360851	Green Published, gold			2022-12-25	WOS:000275969600012
J	Cook, TR; Kato, A; Tanaka, H; Ropert-Coudert, Y; Bost, CA				Cook, Timothee R.; Kato, Akiko; Tanaka, Hideji; Ropert-Coudert, Yan; Bost, Charles-Andre			Buoyancy under Control: Underwater Locomotor Performance in a Deep Diving Seabird Suggests Respiratory Strategies for Reducing Foraging Effort	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; GREAT CORMORANTS; ENERGETIC COSTS; METABOLIC-RATE; DEPTH; BIRDS; PENGUINS; STROKE; PATTERNS; MAMMALS	Background: Because they have air stored in many body compartments, diving seabirds are expected to exhibit efficient behavioural strategies for reducing costs related to buoyancy control. We study the underwater locomotor activity of a deep-diving species from the Cormorant family (Kerguelen shag) and report locomotor adjustments to the change of buoyancy with depth. Methodology/Principal Findings: Using accelerometers, we show that during both the descent and ascent phases of dives, shags modelled their acceleration and stroking activity on the natural variation of buoyancy with depth. For example, during the descent phase, birds increased swim speed with depth. But in parallel, and with a decay constant similar to the one in the equation explaining the decrease of buoyancy with depth, they decreased foot-stroke frequency exponentially, a behaviour that enables birds to reduce oxygen consumption. During ascent, birds also reduced locomotor cost by ascending passively. We considered the depth at which they started gliding as a proxy to their depth of neutral buoyancy. This depth increased with maximum dive depth. As an explanation for this, we propose that shags adjust their buoyancy to depth by varying the amount of respiratory air they dive with. Conclusions/Significance: Calculations based on known values of stored body oxygen volumes and on deep-diving metabolic rates in avian divers suggest that the variations of volume of respiratory oxygen associated with a respiration mediated buoyancy control only influence aerobic dive duration moderately. Therefore, we propose that an advantage in cormorants - as in other families of diving seabirds - of respiratory air volume adjustment upon diving could be related less to increasing time of submergence, through an increased volume of body oxygen stores, than to reducing the locomotor costs of buoyancy control.	[Cook, Timothee R.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Ctr Excellence, DST,NRF, ZA-7925 Cape Town, South Africa; [Cook, Timothee R.; Bost, Charles-Andre] CNRS, CEBC, UPR 1934, Villiers En Bois, France; [Kato, Akiko] Natl Inst Polar Res, Tokyo, Japan; [Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, CNRS, IPHC, DEPE, Strasbourg, France; [Tanaka, Hideji] Hokkaido Univ, Grad Sch Fisheries Sci, COE Neosci Nat Hist, Hakodate, Hokkaido, Japan	National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hokkaido University	Cook, TR (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Ctr Excellence, DST,NRF, ZA-7925 Cape Town, South Africa.	timothee.cook@gmail.com	Kato, Akiko/W-2447-2019	Cook, Timothee/0000-0003-2354-824X; Kato, Akiko/0000-0002-8947-3634	French Polar Institute [394]	French Polar Institute	This research was funded by program no. 394 of the French Polar Institute (Institut Paul Emile Victor - IPEV, URL: http://www.institut-polaire.fr/), with the logistical help of the Terres Australes et Antarctiques Francaises (TAAF, URL: http://www.taaf.fr/spip/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNASCH R, 1994, J EXP BIOL, V194, P83; Boyd IL, 1997, TRENDS ECOL EVOL, V12, P213, DOI 10.1016/S0169-5347(97)01054-9; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; Butler PJ, 2001, NEWS PHYSIOL SCI, V16, P222; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Cook TR, 2008, MAR BIOL, V154, P383, DOI 10.1007/s00227-008-0939-6; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; COOK TR, 2008, THESIS LA ROCHELLE U; Davis RW, 2001, COMP BIOCHEM PHYS A, V129, P759, DOI 10.1016/S1095-6433(01)00345-2; Duncker H.-R., 1985, Biona Report, V3, P361; ECKERT R, 1999, ANIMAL PHYSL MECH AD, P727; Enstipp MR, 2005, J EXP BIOL, V208, P3451, DOI 10.1242/jeb.01791; Green JA, 2005, PHYSIOL BIOCHEM ZOOL, V78, P766, DOI 10.1086/432423; Gremillet D, 2005, J AVIAN BIOL, V36, P57, DOI 10.1111/j.0908-8857.2005.03331.x; Hansen ES, 2004, AM NAT, V163, P358, DOI 10.1086/381943; Hays GC, 2007, MAR BIOL, V150, P1003, DOI 10.1007/s00227-006-0412-3; Hooker SK, 2005, P ROY SOC B-BIOL SCI, V272, P355, DOI 10.1098/rspb.2004.2964; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Insley S. J., 2008, Endangered Species Research, V4, P147, DOI 10.3354/esr00050; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P15; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Laich Agustina Gomez, 2010, Endangered Species Research, V10, P29, DOI 10.3354/esr00091; Lovvorn JR, 2004, J EXP BIOL, V207, P4679, DOI 10.1242/jeb.01331; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Ribak G, 2005, J EXP BIOL, V208, P3835, DOI 10.1242/jeb.01856; Ribak G, 2005, J AVIAN BIOL, V36, P89, DOI 10.1111/j.0908-8857.2005.03499.x; Ribak G, 2004, J EXP BIOL, V207, P2101, DOI 10.1242/jeb.00997; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Ropert-Coudert Y, 2006, MAR BIOL, V149, P415, DOI 10.1007/s00227-005-0242-8; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2002, J EXP BIOL, V205, P1189; SCHMID D, 1995, MAR BIOL, V123, P875, DOI 10.1007/BF00349133; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Watanuki Y, 2005, J EXP BIOL, V208, P2207, DOI 10.1242/jeb.01639; Watanuki Y, 2003, P ROY SOC B-BIOL SCI, V270, P483, DOI 10.1098/rspb.2002.2252; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson Rory P., 1992, Marine Ornithology, V20, P7; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; Wilson RP, 2004, MAR ECOL PROG SER, V278, P303, DOI 10.3354/meps278303; Wilson RP, 2003, MAR BIOL, V142, P537, DOI 10.1007/s00227-002-0964-9; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305	44	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9839	10.1371/journal.pone.0009839	http://dx.doi.org/10.1371/journal.pone.0009839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352122	Green Submitted, gold, Green Published			2022-12-25	WOS:000275894400033
J	Li, C; Pazgier, M; Li, J; Li, CQ; Liu, M; Zou, GZ; Li, ZY; Chen, JD; Tarasov, SG; Lu, WY; Lu, WY				Li, Chong; Pazgier, Marzena; Li, Jing; Li, Changqing; Liu, Min; Zou, Guozhang; Li, Zhenyu; Chen, Jiandong; Tarasov, Sergey G.; Lu, Wei-Yue; Lu, Wuyuan			Limitations of Peptide Retro-inverso Isomerization in Molecular Mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HIV-1 CAPSID PROTEIN; IMAGE PHAGE DISPLAY; SH3 DOMAINS; P53 PATHWAY; TRANSACTIVATION DOMAIN; DIMERIZATION DOMAIN; CHEMICAL LIGATION; STRUCTURAL BASIS; DRUG DISCOVERY	A retro-inverso peptide is made up of D-amino acids in a reversed sequence and, when extended, assumes a side chain topology similar to that of its parent molecule but with inverted amide peptide bonds. Despite their limited success as antigenic mimicry, retro-inverso isomers generally fail to emulate the protein-binding activities of their parent peptides of an alpha-helical nature. In studying the interaction between the tumor suppressor protein p53 and its negative regulator MDM2, Sakurai et al. (Sakurai, K., Chung, H. S., and Kahne, D. (2004) J. Am. Chem. Soc. 126, 16288-16289) made a surprising finding that the retro-inverso isomer of p53(15-29) retained the same binding activity as the wild type peptide as determined by inhibition enzyme-linked immunosorbent assay. The authors attributed the unusual outcome to the ability of the D-peptide to adopt a right-handed helical conformation upon MDM2 binding. Using a battery of biochemical and biophysical tools, we found that retro-inverso isomerization diminished p53 (15-29) binding to MDM2 or MDMX by 3.2-3.3 kcal/mol. Similar results were replicated with the C-terminal domain of HIV-1 capsid protein (3.0 kcal/mol) and the Src homology 3 domain of Abl tyrosine kinase (3.4 kcal/mol). CD and NMR spectroscopic as well as x-ray crystallographic studies showed that D-peptide ligands ofMDM2invariably adopted left-handed helical conformations in both free and bound states. Our findings reinforce that the retro-inverso strategy works poorly in molecular mimicry of biologically active helical peptides, due to inherent differences at the secondary and tertiary structure levels between an L-peptide and its retro-inverso isomer despite their similar side chain topologies at the primary structure level.	[Li, Chong; Pazgier, Marzena; Li, Jing; Li, Changqing; Liu, Min; Zou, Guozhang; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Li, Chong; Pazgier, Marzena; Li, Jing; Li, Changqing; Liu, Min; Zou, Guozhang; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Li, Chong; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Li, Zhenyu; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Tarasov, Sergey G.] NCI Frederick, Struct Biophys Lab, NIH, Frederick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fudan University; H Lee Moffitt Cancer Center & Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Lu, WY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	wlu@ihv.umaryland.edu	Lu, Weiyue/E-7938-2010; Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017; Pazgier, Marzena/B-7295-2012; Li, Chong/H-2515-2011	Lu, Wuyuan/0000-0003-1318-9968; Liu, Min/0000-0002-5059-3743; LIU, MIN/0000-0003-2420-2769	NATIONAL CANCER INSTITUTE [ZICBC010965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R01AI072732, R21AI087423] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI072732, R01 AI061482, R21 AI087423, AI061482, AI072732] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; GOODMAN M, 1979, ACCOUNTS CHEM RES, V12, P1, DOI 10.1021/ar50133a001; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Keller R., 2004, COMPUTER AIDED RESON, V1; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lai ZH, 2000, ARCH BIOCHEM BIOPHYS, V381, P278, DOI 10.1006/abbi.2000.1998; LANE DP, 1992, NATURE, V358, P16; LI C, 2010, ANGEW CHEM IN PRESS; Li C, 2008, J AM CHEM SOC, V130, P13546, DOI 10.1021/ja8042036; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li CH, 2009, INORG CHEM, V48, P2010, DOI 10.1021/ic801846h; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mayer BJ, 2001, J CELL SCI, V114, P1253; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair DT, 2003, J IMMUNOL, V170, P1362, DOI 10.4049/jimmunol.170.3.1362; Nanda V, 2006, J AM CHEM SOC, V128, P809, DOI 10.1021/ja054452t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pal-Bhowmick I, 2007, BIOCHEM BIOPH RES CO, V364, P608, DOI 10.1016/j.bbrc.2007.10.056; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Rai J, 2007, CHEM BIOL DRUG DES, V70, P552, DOI 10.1111/j.1747-0285.2007.00595.x; RICHARDS FM, 1963, ANNU REV BIOCHEM, V32, P269, DOI 10.1146/annurev.bi.32.070163.001413; Sakurai K, 2004, J AM CHEM SOC, V126, P16288, DOI 10.1021/ja044883w; Santamaria F, 2003, J MOL RECOGNIT, V16, P131, DOI 10.1002/jmr.620; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Sia SK, 2001, BIOCHEMISTRY-US, V40, P8981, DOI 10.1021/bi010725v; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Welch BD, 2007, P NATL ACAD SCI USA, V104, P16828, DOI 10.1073/pnas.0708109104; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	73	57	62	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19572	19581		10.1074/jbc.M110.116814	http://dx.doi.org/10.1074/jbc.M110.116814			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382735	hybrid, Green Published			2022-12-25	WOS:000278727800067
J	Kolachala, VL; Wang, LX; Obertone, TS; Prasad, M; Yan, YT; Dalmasso, G; Gewirtz, AT; Merlin, D; Sitaraman, SV				Kolachala, Vasantha L.; Wang, Lixin; Obertone, Tracy S.; Prasad, Meena; Yan, Yutao; Dalmasso, Guillaume; Gewirtz, Andrew T.; Merlin, Didier; Sitaraman, Shanthi V.			Adenosine 2B Receptor Expression Is Post-transcriptionally Regulated by MicroRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL LINE; INTESTINAL EPITHELIA; APICAL MEMBRANE; A2B RECEPTOR; SECRETION; RNAS; INHIBITION	We have reported that epithelial adenosine 2B receptor (A(2B)AR) mRNA and protein are up-regulated in colitis, which we demonstrated to be regulated by tumor necrosis factor alpha (TNF-alpha). Here, we examined the mechanism that governs A(2B)AR expression during colitis. A 1.4-kb sequence of the A(2B)AR promoter was cloned into the pFRL7 luciferase vector. Anti-microRNA (miRNA) was custom-synthesized based on specific miRNA binding sites. The binding of miRNA to the 3'-untranslated region (UTR) of A(2B)AR mRNA was examined by cloning this 3'-UTR downstream of the luciferase gene in pMIR-REPORT. In T84 cells, TNF-alpha induced a 35-fold increase in A(2B)AR mRNA but did not increase promoter activity in luciferase assays. By nuclear run-on assay, no increase in A(2B)AR mRNA following TNF-alpha treatment was observed. Four putative miRNA target sites (miR27a, miR27b, miR128a, miR128b) in the 3'-UTR of the A(2B)AR mRNA were identified in T84 cells and mouse colon. Pretreatment of cells with TNF-alpha reduced the levels of miR27b and miR128a by 60%. Over expression of premiR27b and pre-miR128a reduced A(2B)AR levels by >60%. Blockade of miR27b increased A(2B)AR mRNA levels by 6-fold in vitro. miR27b levels declined significantly in colitis-affected tissue in mice in the presence of increased A(2B)AR mRNA. Collectively, these data demonstrate that TNF-alpha -induced A(2B)AR expression in colonic epithelial cells is post-transcriptionally regulated by miR27b and miR128a and show that miR27b influences A2BAR expression in murine colitis.	[Kolachala, Vasantha L.; Wang, Lixin; Obertone, Tracy S.; Prasad, Meena; Yan, Yutao; Dalmasso, Guillaume; Merlin, Didier; Sitaraman, Shanthi V.] Emory Univ, Div Digest Dis, Sch Med, Atlanta, GA 30322 USA; [Gewirtz, Andrew T.] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Kolachala, VL (corresponding author), Emory Univ, Div Digest Dis, Sch Med, Rm 265,615 Michael St,Whitehead Res Bldg, Atlanta, GA 30322 USA.	vkolach@emory.edu	Dalmasso, Guillaume/N-2443-2018	Dalmasso, Guillaume/0000-0002-3433-870X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064711] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK064711] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRETT KE, 1989, AM J PHYSIOL, V256, pC197; BARRETT KE, 1990, AM J PHYSIOL, V258, pC902, DOI 10.1152/ajpcell.1990.258.5.C902; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; D'Haens G, 2003, CURR PHARM DESIGN, V9, P289, DOI 10.2174/1381612033391982; Hecht G, 1999, J CLIN INVEST, V104, P253, DOI 10.1172/JCI6373; Hilaire CS, 2008, J CELL BIOCHEM, V103, P1962, DOI 10.1002/jcb.21586; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Jobin C, 1998, GUT, V42, P779, DOI 10.1136/gut.42.6.779; Kolachala V, 2005, CELL MOL LIFE SCI, V62, P2647, DOI 10.1007/s00018-005-5328-4; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Kolachala VL, 2008, GASTROENTEROLOGY, V135, P861, DOI 10.1053/j.gastro.2008.05.049; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Malo MS, 2006, ANAL BIOCHEM, V350, P307, DOI 10.1016/j.ab.2005.12.018; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Merlin D, 1998, AM J PHYSIOL-CELL PH, V275, pC484, DOI 10.1152/ajpcell.1998.275.2.C484; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Walia B, 2004, BIOCHEM J, V382, P589, DOI 10.1042/BJ20040021; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005049; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002	32	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18184	18190		10.1074/jbc.M109.066555	http://dx.doi.org/10.1074/jbc.M109.066555			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388705	hybrid, Green Published			2022-12-25	WOS:000278453900009
J	Wilson, JD; Barlowe, C				Wilson, Joshua D.; Barlowe, Charles			Yet1p and Yet3p, the Yeast Homologs of BAP29 and BAP31, Interact with the Endoplasmic Reticulum Translocation Apparatus and Are Required for Inositol Prototrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; CLASS-I MOLECULES; SACCHAROMYCES-CEREVISIAE; SECRETORY PROTEIN; QUALITY-CONTROL; TRANSPORT VESICLES; MEMBRANE-PROTEINS; SHUTTLE VECTORS; SEC PROTEINS	The mammalian B-cell receptor-associated proteins of 29 and 31 kDa (BAP29 and BAP31) are conserved integral membrane proteins that have reported roles in endoplasmic reticulum (ER) quality control, ER export of secretory cargo, and programmed cell death. In this study we investigated the yeast homologs of BAP29 and BAP31, known as Yet1p and Yet3p, to gain insight on cellular function. We found that Yet1p forms a complex with Yet3p (Yet complex) and that complex assembly was important for subunit stability and proper ER localization. The Yet complex was not efficiently packaged into ER-derived COPII vesicles and therefore does not appear to act as an ER export receptor. Instead, a fraction of the Yet complex was detected in association with the ER translocation apparatus (Sec complex). Specific mutations in the Sec complex or Yet complex influenced these interactions. Moreover, associations between the Yet complex and Sec complex were increased by ER stress and diminished when protein translocation substrates were depleted. Surprisingly, yet1 Delta and yet3 Delta mutant strains displayed inositol starvation-related growth defects. In accord with the biochemical data, these growth defects were exacerbated by a combination of certain mutations in the Sec complex with yet1 Delta or yet3 Delta mutations. We propose a model for the Yet-Sec complex interaction that places Yet1p and Yet3p at the translocation pore to manage biogenesis of specific transmembrane secretory proteins.	[Wilson, Joshua D.; Barlowe, Charles] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	barlowe@dartmouth.edu			National Institutes of Health [GM052549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052549, R01GM052549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM052549.	Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; ESNAULT Y, 1994, J BIOL CHEM, V269, P27478; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Ladasky JJ, 2006, J IMMUNOL, V177, P6172, DOI 10.4049/jimmunol.177.9.6172; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; NIKAWA J, 1994, GENE, V149, P367, DOI 10.1016/0378-1119(94)90178-3; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Scheper W, 2003, J BIOL CHEM, V278, P37998, DOI 10.1074/jbc.M300176200; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Szczesna-Skorupa E, 2006, J BIOL CHEM, V281, P4142, DOI 10.1074/jbc.M509522200; TOIKKANEN JH, 2006, J BIOL SCI, V6, P446; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; WOLF DH, 1975, J BACTERIOL, V123, P1150, DOI 10.1128/JB.123.3.1150-1156.1975; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zhang Yimao, 2002, Methods Mol Med, V70, P257	64	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18252	18261		10.1074/jbc.M109.080382	http://dx.doi.org/10.1074/jbc.M109.080382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378542	hybrid, Green Published			2022-12-25	WOS:000278453900017
J	Boucher, J; Tseng, YH; Kahn, CR				Boucher, Jeremie; Tseng, Yu-Hua; Kahn, C. Ronald			Insulin and Insulin-like Growth Factor-1 Receptors Act as Ligand-specific Amplitude Modulators of a Common Pathway Regulating Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-I; MICROARRAY ANALYSIS; CYTOPLASMIC DOMAINS; SIGNAL-TRANSDUCTION; GLUCOSE-METABOLISM; BROWN ADIPOCYTES; CELL-CULTURES; MUSCLE-CELLS; MICE; EXPRESSION	Insulin and insulin-like growth factor-1 (IGF-1) act on highly homologous receptors, yet in vivo elicit distinct effects on metabolism and growth. To investigate how the insulin and IGF-1 receptors exert specificity in their biological responses, we assessed their role in the regulation of gene expression using three experimental paradigms: 1) preadipocytes before and after differentiation into adipocytes that express both receptors, but at different ratios; 2) insulin receptor (IR) or IGF1R knock-out preadipocytes that only express the complimentary receptor; and 3) IR/IGF1R double knock-out (DKO) cells reconstituted with the IR, IGF1R, or both. In wild-type preadipocytes, which express predominantly IGF1R, microarray analysis revealed similar to 500 IGF-1 regulated genes (p < 0.05). The largest of these were confirmed by quantitative PCR, which also revealed that insulin produced a similar effect, but with a smaller magnitude of response. After differentiation, when IR levels increase and IGF1R decrease, insulin became the dominant regulator of each of these genes. Measurement of the 50 most highly regulated genes by quantitative PCR did not reveal a single gene regulated uniquely via the IR or IGF1R using cells expressing exclusively IGF-1 or insulin receptors. Insulin and IGF-1 dose responses from 1 to 100 nM in WT, IRKO, IGFRKO, and DKO cells re-expressing IR, IGF1R, or both showed that insulin and IGF-1 produced effects in proportion to the concentration of ligand and the specific receptor on which they act. Thus, IR and IGF1R act as identical portals to the regulation of gene expression, with differences between insulin and IGF-1 effects due to a modulation of the amplitude of the signal created by the specific ligand-receptor interaction.	Joslin Diabet Ctr, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Boucher, Jeremie/G-6602-2015; Tseng, Yu-Hua/AAE-6471-2021	Kahn, Ronald/0000-0002-7583-9228; Tseng, Yu-Hua/0000-0003-2053-9559	National Institutes of Health [DK31036, DK33201, DK077097]; Diabetes Genome Anatomy Project [DK60837]; Harvard Catalyst/The Harvard Clinical and Translational Science Center [UL1 RR 025758-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031036, P30DK036836, R01DK077097, R01DK033201, R01DK060837, R01DK031036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Genome Anatomy Project; Harvard Catalyst/The Harvard Clinical and Translational Science Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK31036, DK33201, and DK077097, Diabetes Genome Anatomy Project Grant DK60837, and Harvard Catalyst/The Harvard Clinical and Translational Science Center Grant UL1 RR 025758-01.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Back K, 2009, GROWTH HORM IGF RES, V19, P101, DOI 10.1016/j.ghir.2008.06.004; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P5551, DOI 10.1210/jc.2005-1007; Clemmons DR, 2006, CURR OPIN PHARMACOL, V6, P620, DOI 10.1016/j.coph.2006.08.006; Clemmons DR, 2005, GROWTH HORM IGF RES, V15, P265, DOI 10.1016/j.ghir.2005.05.002; DiCola G, 1997, J CLIN INVEST, V99, P2538, DOI 10.1172/JCI119438; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Entingh AJ, 2003, J BIOL CHEM, V278, P33377, DOI 10.1074/jbc.M303056200; Entingh-Pearsall A, 2004, J BIOL CHEM, V279, P38016, DOI 10.1074/jbc.M313201200; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; KallooHosein HE, 1997, J BIOL CHEM, V272, P24325, DOI 10.1074/jbc.272.39.24325; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; LAMMERS R, 1989, EMBO J, V8, P1369, DOI 10.1002/j.1460-2075.1989.tb03517.x; Lamothe B, 1998, FEBS LETT, V426, P381, DOI 10.1016/S0014-5793(98)00377-9; Laron Zvi, 2008, Archives of Physiology and Biochemistry, V114, P11, DOI 10.1080/13813450801928356 ; Le Roith D, 2002, CURR OPIN CLIN NUTR, V5, P371, DOI 10.1097/00075197-200207000-00004; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; Mulligan C, 2002, J BIOL CHEM, V277, P42480, DOI 10.1074/jbc.M206206200; Mur C, 2002, DIABETES, V51, P743, DOI 10.2337/diabetes.51.3.743; Palsgaard J, 2009, GROWTH HORM IGF RES, V19, P168, DOI 10.1016/j.ghir.2008.09.004; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; Simpson HL, 1998, GROWTH HORM IGF RES, V8, P83, DOI 10.1016/S1096-6374(98)80098-1; Simpson HL, 2004, J CLIN ENDOCR METAB, V89, P425, DOI 10.1210/jc.2003-031274; TARTARE S, 1994, J BIOL CHEM, V269, P11449; Urso B, 1999, J BIOL CHEM, V274, P30864, DOI 10.1074/jbc.274.43.30864; Verleysdonk S, 2004, NEUROCHEM RES, V29, P127, DOI 10.1023/B:NERE.0000010441.08234.ca; WILSON CM, 1995, FEBS LETT, V368, P19, DOI 10.1016/0014-5793(95)00589-2	40	98	100	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17235	17245		10.1074/jbc.M110.118620	http://dx.doi.org/10.1074/jbc.M110.118620			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360006	Green Published, hybrid			2022-12-25	WOS:000277982600085
J	Collins, RM; Afzal, M; Ward, DA; Prescott, MC; Sait, SM; Rees, HH; Tomsett, AB				Collins, Richard M.; Afzal, Muhammed; Ward, Deborah A.; Prescott, Mark C.; Sait, Steven M.; Rees, Huw H.; Tomsett, A. Brian			Differential Proteomic Analysis of Arabidopsis thaliana Genotypes Exhibiting Resistance or Susceptibility to the Insect Herbivore, Plutella xylostella	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GERMIN-LIKE PROTEINS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; IN-VIVO; OXALATE OXIDASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; POLYACRYLAMIDE GELS; CARBONIC-ANHYDRASE; DIAMONDBACK MOTH	A proteomic study was conducted to investigate physiological factors affecting feeding behaviour by larvae of the insect, Plutella xylostella, on herbivore-susceptible and herbivore-resistant Arabidopsis thaliana. The leaves of 162 recombinant inbred lines (Rils) were screened to detect genotypes upon which Plutella larvae fed least (P. xylostella-resistant) or most (P. xylostella-susceptible). 2D-PAGE revealed significant differences in the proteomes between the identified resistant and susceptible Rils. The proteomic results, together with detection of increased production of hydrogen peroxide in resistant Rils, suggest a correlation between P. xylostella resistance and the production of increased levels of reactive oxygen species (ROS), in particular H2O2, and that this was expressed prior to herbivory. Many of the proteins that were more abundant in the Plutella-resistant Rils are known in other biological systems to be involved in limiting ROS damage. Such proteins included carbonic anhydrases, malate dehydrogenases, glutathione S-transferases, isocitrate dehydrogenase-like protein (R1), and lipoamide dehydrogenase. In addition, patterns of germin-like protein 3 isoforms could also be indicative of higher levels of reactive oxygen species in the resistant Rils. Consistent with the occurrence of greater oxidative stress in the resistant Rils is the observation of greater abundance in susceptible Rils of polypeptides of the photosynthetic oxygen-evolving complex, which are known to be damaged under oxidative stress. The combined results suggest that enhanced production of ROS may be a major pre-existing mechanism of Plutella resistance in Arabidopsis, but definitive corroboration of this requires much further work.	[Collins, Richard M.; Afzal, Muhammed; Ward, Deborah A.; Prescott, Mark C.; Rees, Huw H.; Tomsett, A. Brian] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Sait, Steven M.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Liverpool; University of Leeds	Collins, RM (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	R.M.Collins@leeds.ac.uk			NERC (Natural Environment Research Council); BBSRC (Biotechnology and Biological Sciences Research Council)	NERC (Natural Environment Research Council)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was enabled by a postgraduate studentship from NERC (Natural Environment Research Council). BBSRC (Biotechnology and Biological Sciences Research Council) provided proteomic facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2005, PLANT PHYSIOL BIOCH, V43, P213, DOI 10.1016/j.plaphy.2005.01.007; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; ANGELINI R, 1990, PLANTA, V182, P89, DOI 10.1007/BF00239989; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; Berna A, 1999, PLANT MOL BIOL, V39, P539, DOI 10.1023/A:1006123432157; BI JL, 1995, J CHEM ECOL, V21, P1511, DOI 10.1007/BF02035149; Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Cesaratto L, 2005, FREE RADICAL RES, V39, P255, DOI 10.1080/10715760400029603; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Chivasa S, 2002, ELECTROPHORESIS, V23, P1754, DOI 10.1002/1522-2683(200206)23:11&lt;1754::AID-ELPS1754&gt;3.0.CO;2-E; Clauss MJ, 2006, J CHEM ECOL, V32, P2351, DOI 10.1007/s10886-006-9150-8; DUMAS B, 1995, PLANT PHYSIOL, V107, P1091, DOI 10.1104/pp.107.4.1091; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; FELTON GW, 1994, J CHEM ECOL, V20, P639, DOI 10.1007/BF02059604; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Giavalisco P, 2003, ELECTROPHORESIS, V24, P207, DOI 10.1002/elps.200390016; Gong HB, 2005, PLANT MOL BIOL, V57, P53, DOI 10.1007/s11103-004-4516-1; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Hoh J, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-14; Huang HS, 1998, INSECT BIOCHEM MOLEC, V28, P651, DOI 10.1016/S0965-1748(98)00049-6; Hurkman WJ, 1996, PLANT PHYSIOL, V111, P735, DOI 10.1104/pp.111.3.735; Ivanov S, 2005, J PLANT PHYSIOL, V162, P275, DOI 10.1016/j.jplph.2004.07.010; Kil IS, 2004, REDOX REP, V9, P271, DOI 10.1179/135100004225006056; Kim JH, 2005, PLANT SCI, V168, P1115, DOI 10.1016/j.plantsci.2004.12.012; Kim JH, 2003, J NEUROCHEM, V85, P1228, DOI 10.1046/j.1471-4159.2003.01755.x; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kliebenstein D, 2002, GENETICS, V161, P325; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Le Deunff E, 2004, PLANT J, V38, P421, DOI 10.1111/j.1365-313X.2004.02056.x; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Liu K, 2004, PHOTOSYNTH RES, V81, P41, DOI 10.1023/B:PRES.0000028340.44043.6c; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Mohan M, 2001, CROP PROT, V20, P311, DOI 10.1016/S0261-2194(00)00157-5; Mooney BP, 2006, PHYSIOL PLANTARUM, V128, P237, DOI 10.1111/j.1399-3054.2006.00746.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Oh TJ, 2002, ENVIRON TOXICOL PHAR, V11, P9, DOI 10.1016/S1382-6689(01)00093-X; OLSON PD, 1993, PLANT J, V4, P887, DOI 10.1046/j.1365-313X.1993.04050887.x; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Pfalz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000578; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Preisser EL, 2007, ACTA OECOL, V31, P210, DOI 10.1016/j.actao.2006.09.004; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Ramputh AI, 2002, PLANT SCI, V162, P431, DOI 10.1016/S0168-9452(01)00584-2; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Rodriguez CE, 2005, CHEM-BIOL INTERACT, V155, P97, DOI 10.1016/j.cbi.2005.05.002; Schlesier B, 2004, PHYTOCHEMISTRY, V65, P1565, DOI 10.1016/j.phytochem.2004.04.027; Singh R, 2005, EXTREMOPHILES, V9, P367, DOI 10.1007/s00792-005-0450-7; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; Subramanian B, 2005, J AGR FOOD CHEM, V53, P313, DOI 10.1021/jf048922z; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Underwood N, 2002, OECOLOGIA, V131, P211, DOI 10.1007/s00442-002-0867-y; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zhang PJ, 2009, ENTOMOL EXP APPL, V131, P58, DOI 10.1111/j.1570-7458.2009.00829.x; ZHANG ZG, 1995, PLANT J, V8, P139, DOI 10.1046/j.1365-313X.1995.08010139.x	72	42	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10103	10.1371/journal.pone.0010103	http://dx.doi.org/10.1371/journal.pone.0010103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386709	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482000022
J	Utani, K; Kohno, Y; Okamoto, A; Shimizu, N				Utani, Koh-ichi; Kohno, Yuka; Okamoto, Atsushi; Shimizu, Noriaki			Emergence of Micronuclei and Their Effects on the Fate of Cells under Replication Stress	PLOS ONE			English	Article							EXTRACHROMOSOMALLY AMPLIFIED DNA; CANCER-CELLS; CHROMOSOME SEGREGATION; SELECTIVE ELIMINATION; DOUBLE MINUTES; S PHASE; INDUCTION; CHROMATIN; ASSAY; MYC	The presence of micronuclei in mammalian cells is related to several mutagenetic stresses. In order to understand how micronuclei emerge, behave in cells, and affect cell fate, we performed extensive time-lapse microscopy of HeLa H2B-GFP cells in the presence of hydroxyurea at low concentration. Micronuclei formed after mitosis from lagging chromatids or chromatin bridges between anaphase chromosomes and were stably maintained in the cells for up to one cell cycle. Nuclear buds also formed from chromatin bridges or during interphase. If the micronuclei-bearing cells entered mitosis, they either produced daughter cells without micronuclei or, more frequently, produced cells with additional micronuclei. Low concentrations of hydroxyurea efficiently induced multipolar mitosis, which generated lagging chromatids or chromatin bridges, and also generated multinuclear cells that were tightly linked to apoptosis. We found that the presence of micronuclei is related to apoptosis but not to multipolar mitosis. Furthermore, the structural heterogeneity among micronuclei, with respect to chromatin condensation or the presence of lamin B, derived from the mechanism of micronuclei formation. Our study reinforces the notion that micronucleation has important implications in the genomic plasticity of tumor cells.	[Utani, Koh-ichi; Kohno, Yuka; Okamoto, Atsushi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Hiroshima University	Utani, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp		Utani, Koichi/0000-0002-8065-3161	Japan Society for the Promotion of Science [17370002]; Ministry of Education, Science, Sports and Culture of Japan [19038016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) [grant number 17370002] from the Japan Society for the Promotion of Science to N.S. and a Grant-in-Aid for Scientific Research on Priority Areas Nuclear Dynamics [grant number 19038016] from the Ministry of Education, Science, Sports and Culture of Japan to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Cimini D, 2002, J CELL SCI, V115, P507; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; El-Zein RA, 2006, CANCER RES, V66, P6449, DOI 10.1158/0008-5472.CAN-06-0326; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2009, MUTAT RES-REV MUTAT, V681, P111, DOI 10.1016/j.mrrev.2008.11.003; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; Mateuca R, 2006, BIOCHIMIE, V88, P1515, DOI 10.1016/j.biochi.2006.07.004; Offer T, 2004, FASEB J, V18, P485, DOI 10.1096/fj.04-2729fje; PaulinLevasseur M, 1996, CHROMOSOMA, V104, P367, DOI 10.1007/s004120050128; Rao XT, 2008, MUTAT RES-FUND MOL M, V646, P41, DOI 10.1016/j.mrfmmm.2008.09.004; RUDDLE FH, 1962, J NATL CANCER I, V28, P1247; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; SCHULTZ N, 1994, MUTAGENESIS, V9, P117, DOI 10.1093/mutage/9.2.117; Serrano-Garcia L, 2001, ENVIRON MOL MUTAGEN, V38, P38, DOI 10.1002/em.1048; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2000, MUTAT RES-FUND MOL M, V448, P81, DOI 10.1016/S0027-5107(00)00003-8; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Tanaka T, 2000, J CELL SCI, V113, P697; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651; Zaharopoulos P, 1998, ACTA CYTOL, V42, P317, DOI 10.1159/000331610	27	104	110	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10089	10.1371/journal.pone.0010089	http://dx.doi.org/10.1371/journal.pone.0010089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386692	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482000017
J	Qin, QY; Liao, GH; Baudry, M; Bi, XN				Qin, Qingyu; Liao, Guanghong; Baudry, Michel; Bi, Xiaoning			Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation	PLOS ONE			English	Article							DISEASE TYPE-C; RHO-KINASE; LOCAL TRANSLATION; GROWTH CONES; MOUSE-BRAIN; PATHWAY; NEURONS; NPC1; NEURODEGENERATION; UBIQUITINATION	Perturbation of lipid metabolism, especially of cholesterol homeostasis, can be catastrophic to mammalian brain, as it has the highest level of cholesterol in the body. This notion is best illustrated by the severe progressive neurodegeneration in Niemann-Pick Type C (NPC) disease, one of the lysosomal storage diseases, caused by mutations in the NPC1 or NPC2 gene. In this study, we found that growth cone collapse induced by genetic or pharmacological disruption of cholesterol egress from late endosomes/lysosomes was directly related to a decrease in axonal and growth cone levels of the phosphorylated form of the tumor suppressor factor p53. Cholesterol perturbation-induced growth cone collapse and decrease in phosphorylated p53 were reduced by inhibition of p38 mitogen-activated protein kinase (MAPK) and murine double minute (Mdm2) E3 ligase. Growth cone collapse induced by genetic (npc1-/-) or pharmacological modification of cholesterol metabolism was Rho kinase (ROCK)-dependent and associated with increased RhoA protein synthesis; both processes were significantly reduced by P38 MAPK or Mdm2 inhibition. Finally, in vivo ROCK inhibition significantly increased phosphorylated p53 levels and neurofilaments in axons, and axonal bundle size in npc1-/- mice. These results indicate that NPC-related and cholesterol perturbation-induced axonal pathology is associated with an abnormal signaling pathway consisting in p38 MAPK activation leading to Mdm2-mediated p53 degradation, followed by ROCK activation. These results also suggest new targets for pharmacological treatment of NPC disease and other diseases associated with disruption of cholesterol metabolism.	[Qin, Qingyu; Liao, Guanghong; Bi, Xiaoning] Western Univ Hlth Sci, COMP, Dept Basic Med Sci, Pomona, CA USA; [Baudry, Michel] Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA	Western University of Health Sciences; University of Southern California	Qin, QY (corresponding author), Western Univ Hlth Sci, COMP, Dept Basic Med Sci, Pomona, CA USA.	xbi@westernu.edu	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022		National Institute of Neurological Disorders and Stroke [NS048423, NS45260]; Daljit and Elaine Sarkaria Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045260, R01NS048423] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Daljit and Elaine Sarkaria Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NS048423 (Xiaoning Bi) and NS45260 (Christine M. Gall) from the National Institute of Neurological Disorders and Stroke. Xiaoning Bi was also supported by funds from the Daljit and Elaine Sarkaria Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Bi XN, 2005, AM J PATHOL, V167, P1081, DOI 10.1016/S0002-9440(10)61197-2; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Distl R, 2003, J PATHOL, V200, P104, DOI 10.1002/path.1320; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fu XH, 1998, FEBS LETT, V440, P183, DOI 10.1016/S0014-5793(98)01455-0; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hackeng CM, 1999, THROMB HAEMOSTASIS, V82, P1749, DOI 10.1055/s-0037-1614909; Haupt S, 2003, J CELL BIOCHEM, V88, P76, DOI 10.1002/jcb.10311; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Ishibashi S, 2009, J CLIN NEUROSCI, V16, P954, DOI 10.1016/j.jocn.2008.09.020; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; March PA, 1997, ACTA NEUROPATHOL, V94, P164, DOI 10.1007/s004010050689; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ong WY, 2001, EXP BRAIN RES, V141, P218, DOI 10.1007/s002210100870; Qin QY, 2009, J NEUROSCI, V29, P5183, DOI 10.1523/JNEUROSCI.0420-09.2009; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; Satoh S, 2007, BRAIN RES, V1128, P175, DOI 10.1016/j.brainres.2006.10.027; Shirao S, 2002, CIRC RES, V91, P112, DOI 10.1161/01.RES.0000026057.13161.42; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; Tashiro Y, 2004, EUR J NEUROSCI, V20, P2015, DOI 10.1111/j.1460-9568.2004.03677.x; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Wood NT, 2009, FEBS LETT, V583, P615, DOI 10.1016/j.febslet.2009.01.003; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yang SR, 2006, STEM CELLS, V24, P292, DOI 10.1634/stemcells.2005-0221; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	46	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e9999	10.1371/journal.pone.0009999	http://dx.doi.org/10.1371/journal.pone.0009999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386595	Green Submitted, Green Published, gold			2022-12-25	WOS:000276420400003
J	Vijay, S; Kumar, P; Chauhan, LS; Vollepore, BH; Kizhakkethil, UP; Rao, SG				Vijay, Sophia; Kumar, Prahlad; Chauhan, Lakbir Singh; Vollepore, Balasangameshwara Hanumanthappa; Kizhakkethil, Unnikrishnan Pallikkara; Rao, Sumathi Govinda			Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; NONCOMPLIANCE; ADHERENCE; BARRIERS; DISTRICT	Background: Poor treatment adherence leading to risk of drug resistance, treatment failure, relapse, death and persistent infectiousness remains an impediment to the tuberculosis control programmes. The objective of the study was to identify predictors of default among new smear positive TB patients registered for treatment to suggest possible interventions to set right the problems to sustain and enhance the programme performance. Methodology & Principal Findings: Twenty districts selected from six states were assigned to six strata formed, considering the geographic, socio-cultural and demographic setup of the area. New smear positive patients registered for treatment in two consecutive quarters during III quarter 2004 to III quarter 2005 formed the retrospective study cohort. Case control analysis was done including defaulted patients as "cases" and equal number of age and sex matched patients completing treatment as "controls". The presence and degree of association between default and determinant factors was computed through univariate and multivariate logistic regression analysis. Data collection was through patient interviews using pretested semi structured questionnaire and review of treatment related records. Information on a wide range of socio demographic and patient related factors was obtained. Among the 687 defaulted and equal numbers of patients in completed group, 389 and 540 patients respectively were satisfactorily interviewed. In the logistic regression analysis, factors independently associated with default were alcoholism [AOR-1.72 (1.23-2.44)], illiteracy [AOR-1.40 (1.03-1.92)], having other commitments during treatment [AOR-3.22 (1.1-9.09)], inadequate knowledge of TB [AOR-1.88(1.35-2.63)], poor patient provider interaction [AOR-1.72(1.23-2.44)], lack of support from health staff [AOR-1.93(1.41-2.64)], having instances of missed doses [AOR-2.56(1.82-3.57)], side effects to anti TB drugs [AOR-2.55 (1.87-3.47)] and dissatisfaction with services provided [AOR-1.73 (1.14-2.6)]. Conclusion: Majority of risk factors for default were treatment and provider oriented and rectifiable with appropriate interventions, which would help in sustaining the good programme performance.	[Vijay, Sophia; Kumar, Prahlad; Rao, Sumathi Govinda] Natl TB Inst, Bangalore, Karnataka, India; [Chauhan, Lakbir Singh] Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Vollepore, Balasangameshwara Hanumanthappa] TB Lab Support, Bangalore, Karnataka, India; [Kizhakkethil, Unnikrishnan Pallikkara] Zonal Off, NSSO FOD, Bangalore, Karnataka, India		Vijay, S (corresponding author), Natl TB Inst, Bangalore, Karnataka, India.	nti@ntiindia.org.in			Ministry of Health and Family Welfare, government of India [47]	Ministry of Health and Family Welfare, government of India	This study was funded by Ministry of Health and Family Welfare, government of India under NTCP (plan) Demand No. 47 major head -2210 medical and public health-06101 - prevention and control of diseases (minor head - 30 NTCP - 3002 TB Cell at HQ (EAC) 300220 Other Administrative expenses (plan) for the year 2004-2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; Burman WJ, 1997, CHEST, V111, P1168, DOI 10.1378/chest.111.5.1168; *CENTR TB DIV, MAN REV TUB CONTR PR, P97; *CENTR TB DIV, 2003, RNTCP PERF REP IND 2; *CENTR TB DIV, 2006, RNTCP PERF REP IND 3; *CENTR TB DIV, 2004, TB IND 2004 RNTCP ST; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Comolet TM, 1998, INT J TUBERC LUNG D, V2, P891; CORCORAN R, 1986, IRISH MED J, V79, P87; Dandona R, 2004, NATL MED J INDIA, V17, P292; DEMISSIE M, 1994, ETHIOPIAN MED J, V32, P97; ESTIFANOS B, 2007, PLOS MED, V4, P280; FERRER X, 1991, Boletin de la Oficina Sanitaria Panamericana, V111, P423; Gopi P G, 2007, Indian J Tuberc, V54, P66; Hane F, 2007, INT J TUBERC LUNG D, V11, P539; *ISTC, 2006, TUB COAL TECHN ASS; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; JANANIPINIDIYAP, 2008, SE ASIAN J TROP MED, V39, P1076; Kangangi JK, 2003, INT J TUBERC LUNG D, V7, pS5; Kruyt ML, 1999, B WORLD HEALTH ORGAN, V77, P386; LAGARDA LP, 2008, KEKKAKU, V83, P765; Liam CK, 1998, INT J TUBERC LUNG D, V2, P818; NYUREBDA TE, 2003, INT J TUBERC LUNG S, pS21; Office of the Registrar General & Census Commissioner Ministry of Home Affairs Government of India, 2001, CENS IND; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Shargie EB, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-62; Snider, 1982, B INT UNION TUBERC, V57, P247; SOPHIAVIJAY, 2003, IND J TUB, V50, P185; SOPHIAVIJAY, 2005, IND J TUB, V3, P163; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; *WHO, WHOHTMTB2006362	35	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10043	10.1371/journal.pone.0010043	http://dx.doi.org/10.1371/journal.pone.0010043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386611	Green Published, Green Submitted, gold			2022-12-25	WOS:000276420400014
J	Wang, F; Zhang, RX; Wu, XM; Hankinson, O				Wang, Feng; Zhang, Ruixue; Wu, Xiaomeng; Hankinson, Oliver			Roles of Coactivators in Hypoxic Induction of the Erythropoietin Gene	PLOS ONE			English	Article							STEROID-RECEPTOR COACTIVATOR-1; ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTIONAL ACTIVATION; HISTONE ACETYLTRANSFERASE; ENHANCER ELEMENT; TRANSGENIC MICE; BINDING-PROTEIN; CBP; COMPLEX; SRC-1	Background Hypoxia-inducible expression of the erythropoietin (EPO) gene is mediated principally by hypoxia-inducible factor 2a (HIF-2a) in Hep3B cells under physiologic conditions. How/whether p300/CBP and the members of p160 coactivator family potentiate hypoxic induction of endogenous EPO and other HIF-2a and hypoxia-inducible factor 1a (HIF-1a) target genes remains unclear. Methodology/Principal Findings We demonstrate, using chromatin immunoprecipitation (ChIP) analysis, that the histone acetyl transferase (HAT) coactivators p300, SRC-1 and SRC-3 are recruited to the 3' enhancer of the EPO gene upon hypoxic stimulation, and that each associates with the enhancer in a periodic fashion. Hypoxia induced acetylation of the EPO gene 5' promoter at histone 4 and lysine 23 of histone 3. Knocking down SRC-3, but not SRC-1 or SRC-2, using short interfering RNAs (siRNAs), reduced EPO transcriptional activity. Knocking down p300 resulted in dramatic down-regulation of hypoxic stimulation of EPO gene transcription, negated recruitment of RNA polymerase II to the gene's promoter, and eliminated hypoxia-stimulated acetylation at the promoter and recruitments of SRC-1 and SRC-3 to the enhancer. The inhibitory effects of knocking down p300 and the chromatin remodeling coactivator, Brm/Brg-1, on EPO transcription were additive, suggesting that p300 and Brm/Brg-1 act independently. p300 was also required for hypoxia induced transcription of the HIF-1a target gene, VEGF, but was dispensable for induction of two other HIF-1a target genes, PGK and LDHA. Knocking down CBP, a homolog of p300, augmented hypoxic induction of VEGF, LDHA and PGK. Different HIF target genes also exhibited different requirements for members of the p160 coactivator family. Conclusions/Significance p300 plays a central coactivator role in hypoxic induction of EPO. The coactivators exhibit different specificities for different HIF target genes and each can behave differently in transcriptional regulation of different target genes mediated by the same transcription factor.	[Wang, Feng; Zhang, Ruixue; Wu, Xiaomeng; Hankinson, Oliver] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Wang, Feng; Zhang, Ruixue; Wu, Xiaomeng; Hankinson, Oliver] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hankinson, O (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA.	ohank@mednet.ucla.edu			NIH [R01 CA28868]; NATIONAL CANCER INSTITUTE [R01CA028868] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 CA28868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; BECK I, 1991, J BIOL CHEM, V266, P15563; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; PROBST MR, 1993, MOL PHARMACOL, V44, P511; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Ruas JL, 2005, J CELL SCI, V118, P301, DOI 10.1242/jcs.01617; Sanchez-Elsner T, 2004, J MOL BIOL, V336, P9, DOI 10.1016/j.jmb.2003.12.023; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P8725, DOI 10.1073/pnas.88.19.8725; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922	39	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10002	10.1371/journal.pone.0010002	http://dx.doi.org/10.1371/journal.pone.0010002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368990	gold, Green Published, Green Submitted			2022-12-25	WOS:000276419900006
J	Erhardt, M; Wegrzyn, RD; Deuerling, E				Erhardt, Marc; Wegrzyn, Renee D.; Deuerling, Elke			Extra N-Terminal Residues Have a Profound Effect on the Aggregation Properties of the Potential Yeast Prion Protein Mca1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; URE2 PROTEIN; PROPAGATION; INHERITANCE; HSP104; PSI; CHAPERONE; FEATURES; ELEMENT; SYSTEM	The metacaspase Mca1 from Saccharomyces cerevisiae displays a Q/N-rich region at its N-terminus reminiscent of yeast prion proteins. In this study, we show that the ability of Mca1 to form insoluble aggregates is modulated by a peptide stretch preceding its putative prion-forming domain. Based on its genomic locus, three potential translational start sites of Mca1 can give rise to two slightly different long Mca1 proteins or a short version, Mca1(451/453) and Mca1(432), respectively, although under normal physiological conditions Mca1(432) is the predominant form expressed. All Mca1 variants exhibit the Q/N-rich regions, while only the long variants Mca1(451/453) share an extra stretch of 19 amino acids at their N-terminal end. Strikingly, only long versions of Mca1 but not Mca1(432) revealed pronounced aggregation in vivo and displayed prion-like properties when fused to the C-terminal domain of Sup35 suggesting that the N-terminal peptide element promotes the conformational switch of Mca1 protein into an insoluble state. Transfer of the 19 N-terminal amino acid stretch of Mca1(451) to the N-terminus of firefly luciferase resulted in increased aggregation of luciferase, suggesting a protein destabilizing function of the peptide element. We conclude that the aggregation propensity of the potential yeast prion protein Mca1 in vivo is strongly accelerated by a short peptide segment preceding its Q/N-rich region and we speculate that such a conformational switch might occur in vivo via the usage of alternative translational start sites.	[Erhardt, Marc; Deuerling, Elke] Univ Konstanz, Fachbereich Biol, Constance, Germany; [Wegrzyn, Renee D.] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany	University of Konstanz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Erhardt, M (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	elke.deuerling@uni-konstanz.de		Erhardt, Marc/0000-0001-6292-619X	HFSP (Human Frontier Science Program); DFG (German Science Foundation) [DE-783/3-1]	HFSP (Human Frontier Science Program)(Human Frontier Science Program); DFG (German Science Foundation)(German Research Foundation (DFG))	M. E. gratefully acknowledges scholarship support of the Boehringer Ingelheim Fonds. This work was supported by an Alexander von Humboldt Postdoctoral Fellowship for R. D. W. and grants of the HFSP (Human Frontier Science Program) and of the DFG (German Science Foundation, DE-783/3-1) to E. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Allen KD, 2007, J BIOL CHEM, V282, P3004, DOI 10.1074/jbc.M609597200; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 1996, GENETICS, V144, P1375; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Fernandez-Bellot E, 1999, BIOCHEM J, V338, P403, DOI 10.1042/0264-6021:3380403; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Komar AA, 2003, EMBO J, V22, P1199, DOI 10.1093/emboj/cdg103; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	32	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9929	10.1371/journal.pone.0009929	http://dx.doi.org/10.1371/journal.pone.0009929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360952	Green Published, Green Submitted, gold			2022-12-25	WOS:000276163100021
J	Herberich, E; Sikorski, J; Hothorn, T				Herberich, Esther; Sikorski, Johannes; Hothorn, Torsten			A Robust Procedure for Comparing Multiple Means under Heteroscedasticity in Unbalanced Designs	PLOS ONE			English	Article							BACILLUS-SIMPLEX; EVOLUTION CANYON; ANOVA; ADAPTATION	Investigating differences between means of more than two groups or experimental conditions is a routine research question addressed in biology. In order to assess differences statistically, multiple comparison procedures are applied. The most prominent procedures of this type, the Dunnett and Tukey-Kramer test, control the probability of reporting at least one false positive result when the data are normally distributed and when the sample sizes and variances do not differ between groups. All three assumptions are non-realistic in biological research and any violation leads to an increased number of reported false positive results. Based on a general statistical framework for simultaneous inference and robust covariance estimators we propose a new statistical multiple comparison procedure for assessing multiple means. In contrast to the Dunnett or Tukey-Kramer tests, no assumptions regarding the distribution, sample sizes or variance homogeneity are necessary. The performance of the new procedure is assessed by means of its familywise error rate and power under different distributions. The practical merits are demonstrated by a reanalysis of fatty acid phenotypes of the bacterium Bacillus simplex from the "Evolution Canyons" I and II in Israel. The simulation results show that even under severely varying variances, the procedure controls the number of false positive findings very well. Thus, the here presented procedure works well under biologically realistic scenarios of unbalanced group sizes, non-normality and heteroscedasticity.	[Herberich, Esther; Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Sikorski, Johannes] Deutsch Sammlung Mikroorganismen & Zellkulturen G, Braunschweig, Germany	University of Munich; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Herberich, E (corresponding author), Univ Munich, Inst Stat, Munich, Germany.	torsten.hothorn@stat.uni-muenchen.de	Hothorn, Torsten/A-3639-2010; Sikorski, Johannes/AAD-9775-2019; Sikorski, Johannes/AAX-1960-2020	Hothorn, Torsten/0000-0001-8301-0471; Sikorski, Johannes/0000-0002-1890-5540	Deutsche Forschungsgemeinschaft [SI 1352/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	J.S. received funding from Deutsche Forschungsgemeinschaft, grant number SI 1352/1-2 (http://www.dfg.de). E. H. and T. H. were supported by the Ludwig-Maximilians-Universitat Munchen LMUinnovative project "BioMed-S" (http://www.biomed-s.uni-muenchen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathke AC, 2009, AM STAT, V63, P239, DOI 10.1198/tast.2009.08187; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Boyd WA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001259; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; Hollander M, 1973, NONPARAMETRIC STAT M; Hothorn T., 2009, MULTCOMP SIMULTANEOU; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lee S, 2003, COMMUN STAT-SIMUL C, V32, P987, DOI 10.1081/SAC-120023874; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; MACKINNON JG, 1985, J ECONOMETRICS, V29, P305, DOI 10.1016/0304-4076(85)90158-7; R Development Core Team, 2009, R FDN STAT COMP; Sarantseva S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008191; Sikorski J, 2005, P NATL ACAD SCI USA, V102, P15924, DOI 10.1073/pnas.0507944102; Sikorski J, 2008, FEMS MICROBIOL ECOL, V66, P38, DOI 10.1111/j.1574-6941.2008.00574.x; Sikorski J, 2008, MICROBIOL-SGM, V154, P2416, DOI 10.1099/mic.0.2007/016105-0; TUKEY J. W, 1953, PROBLEM MULTIPLE COM; WEERAHANDI S, 1995, BIOMETRICS, V51, P589, DOI 10.2307/2532947; XU J, 2008, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000294; Xu LW, 2008, COMMUN STAT-THEOR M, V37, P1002, DOI 10.1080/03610920701713252; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	23	205	208	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9788	10.1371/journal.pone.0009788	http://dx.doi.org/10.1371/journal.pone.0009788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360960	Green Published, Green Submitted, gold			2022-12-25	WOS:000276163100001
J	MacLean, D; Elina, N; Havecker, ER; Heimstaedt, SB; Studholme, DJ; Baulcombe, DC				MacLean, Daniel; Elina, Nataliya; Havecker, Ericka R.; Heimstaedt, Susanne B.; Studholme, David J.; Baulcombe, David C.			Evidence for Large Complex Networks of Plant Short Silencing RNAs	PLOS ONE			English	Article							SIRNA BIOGENESIS; EXPANSION; PATHWAY; FAMILY; SET	Background: In plants and animals there are many classes of short RNAs that carry out a wide range of functions within the cell; short silencing RNAs (ssRNAs) of 21-25 nucleotides in length are produced from double-stranded RNA precursors by the protein Dicer and guide nucleases and other proteins to their RNA targets through base pairing interactions. The consequence of this process is degradation of the targeted RNA, suppression of its translation or initiation of secondary ssRNA production. The secondary ssRNAs in turn could then initiate further layers of ssRNA production to form extensive cascades and networks of interacting RNA [1]. Previous empirical analysis in plants established the existence of small secondary ssRNA cascade [2], in which a single instance of this event occurred but it was not known whether there are other more extensive networks of secondary sRNA production. Methodology/Principal Findings: We generated a network by predicting targets of ssRNA populations obtained from high-throughput sequencing experiments. The topology of the network shows it to have power law connectivity distribution, to be dissortative, highly clustered and composed of multiple components. We also identify protein families, PPR and ULP1, that act as hubs within the network. Comparison of the repetition of genomic sub-sequences of ssRNA length between Arabidopsis and E. coli suggest that the network structure is made possible by the underlying repetitiveness in the genome sequence. Conclusions/Significance: Together our results provide good evidence for the existence of a large, robust ssRNA interaction network with distinct regulatory function. Such a network could have a massive effect on the regulation of gene expression via mediation of transcript levels.	[MacLean, Daniel; Heimstaedt, Susanne B.; Studholme, David J.] John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Elina, Nataliya] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London, England; [Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Imperial College London; University of Cambridge	MacLean, D (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	dan.maclean@sainsbury-laboratory.ac.uk	Studholme, David/H-6790-2019; MacLean, Dan/C-7046-2013	Studholme, David/0000-0002-3010-6637; MacLean, Dan/0000-0003-1032-0887; Baulcombe, David/0000-0003-0780-6878; Yelina (Elina), Natasha (Nataliya)/0000-0001-9863-1414	Gatsby Charitable Foundation [MEST-CT2004-404273]	Gatsby Charitable Foundation	The work was funded by the Gatsby Charitable Foundation (www.gatsby.org); S. H. was supported by a studentship from Gatsby Charitable Foundation and a Marie Curie Fellowship (MEST-CT2004-404273)(http://mcfa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alon U, 2007, INTRO SYSTEMS BIOL D; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baulcombe DC, 2006, COLD SPRING HARB SYM, V71, P13, DOI 10.1101/sqb.2006.71.052; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Hoen DR, 2006, MOL BIOL EVOL, V23, P1254, DOI 10.1093/molbev/msk015; Hofacker Ivo L, 2009, Curr Protoc Bioinformatics, VChapter 12, DOI [10.1002/0471250953.bi1202s04, 10.1002/0471250953.bi1202s26]; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Luscombe NM, 2002, GENOME BIOL, V3; MILO R, 2002, SCIENCE, V5594, P763; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; R Development Core Team, 2007, R LANG ENV STAT COMP; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Redner S, 2008, NATURE, V453, P47, DOI 10.1038/453047a; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	31	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9901	10.1371/journal.pone.0009901	http://dx.doi.org/10.1371/journal.pone.0009901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360863	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600008
J	Billen, B; Vassilevski, A; Nikolsky, A; Debaveye, S; Tytgat, J; Grishin, E				Billen, Bert; Vassilevski, Alexander; Nikolsky, Anton; Debaveye, Sarah; Tytgat, Jan; Grishin, Eugene			Unique Bell-shaped Voltage-dependent Modulation of Na+ Channel Gating by Novel Insect-selective Toxins from the Spider Agelena orientalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; FUNNEL-WEB SPIDER; SCORPION BETA-TOXINS; PEPTIDE TOXINS; FUNCTIONAL EXPRESSION; SELENOCOSMIA-HAINANA; MOLECULAR-MECHANISMS; MEMBRANE-PROTEIN; HOLOLENA-CURTA; ION CHANNELS	Spider venoms provide a highly valuable source of peptide toxins that act on a wide diversity of membrane-bound receptors and ion channels. In this work, we report isolation, biochemical analysis, and pharmacological characterization of a novel family of spider peptide toxins, designated beta/delta-agatoxins. These toxins consist of 36-38 amino acid residues and originate from the venom of the agelenid funnel-web spider Agelena orientalis. The presented toxins show considerable amino acid sequence similarity to other known toxins such as mu-agatoxins, curtatoxins, and delta-palutoxins-IT from the related spiders Agelenopsis aperta, Hololena curta, and Paracoelotes luctuosus. beta/delta-Agatoxins modulate the insect Na-V channel (DmNa(V)1/tipE) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non-inactivating persistent Na+ current is induced (site 3-likeaction). Interestingly, both effects take place in a voltage-dependent manner, producing a bell-shaped curve between -80 and 0 mV, and they are absent in mammalian Na-V channels. To the best of our knowledge, this is the first detailed report of peptide toxins with such a peculiar pharmacological behavior, clearly indicating that traditional classification of toxins according to their binding sites may not be as exclusive as previously assumed.	[Billen, Bert; Debaveye, Sarah; Tytgat, Jan] Univ Leuven, Toxicol Lab, KU Leuven, B-3000 Louvain, Belgium; [Vassilevski, Alexander; Nikolsky, Anton; Grishin, Eugene] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia	KU Leuven; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Tytgat, J (corresponding author), Univ Leuven, Toxicol Lab, KU Leuven, Campus Gasthuisberg O&N2,Herestr 49,POB 922, B-3000 Louvain, Belgium.	jan.tytgat@pharm.kuleuven.be; grev@ibch.ru	Vassilevski, Alexander/S-3824-2016; Tytgat, Jan/F-1560-2010	Vassilevski, Alexander/0000-0002-1359-0076; Tytgat, Jan/0000-0003-1778-6022	Federal Agency for Education of the Russian Federation [P1388]; Program of Cell and Molecular Biology of the Russian Academy of Sciences; Russian Foundation for Basic Research [05-04-50828, BIL05/50]; F.W.O. Vlaanderen) [G.0257.08, G.0330.06]; K.U. Leuven [OT-05-64]; Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy [UA P6/31]	Federal Agency for Education of the Russian Federation; Program of Cell and Molecular Biology of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); F.W.O. Vlaanderen)(FWO); K.U. Leuven(KU Leuven); Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Federal Agency for Education of the Russian Federation (State Contract P1388), the Program of Cell and Molecular Biology of the Russian Academy of Sciences, the Russian Foundation for Basic Research (Grant 05-04-50828), Grant BIL05/50 (bilateral collaboration between Flanders and the Russian Federation), Grants G.0257.08 and G.0330.06 (F.W.O. Vlaanderen), Grant OT-05-64 (K.U. Leuven), and Grant UA P6/31 (Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy).	ADAMS ME, 1989, J COMP PHYSIOL A, V164, P333, DOI 10.1007/BF00612993; Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Billen B, 2008, TOXICON, V52, P309, DOI 10.1016/j.toxicon.2008.05.018; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Bosmans F, 2007, TOXICON, V49, P550, DOI 10.1016/j.toxicon.2006.11.029; Bosmans F, 2007, TOXICOL APPL PHARM, V218, P45, DOI 10.1016/j.taap.2006.10.009; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; COHEN CJ, 1993, BIOPHYS J, V64, pA4; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Corzo G, 2000, EUR J BIOCHEM, V267, P5783, DOI 10.1046/j.1432-1327.2000.01653.x; Corzo G, 2005, BIOCHEMISTRY-US, V44, P1542, DOI 10.1021/bi048434k; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; De Lima ME, 2007, COMP BIOCHEM PHYS C, V146, P264, DOI 10.1016/j.cbpc.2006.10.010; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Ekberg J, 2008, INT J BIOCHEM CELL B, V40, P2363, DOI 10.1016/j.biocel.2007.08.017; Elinder F, 2007, PHYSIOL BEHAV, V92, P1, DOI 10.1016/j.physbeh.2007.05.058; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; FAINZILBER M, 1994, J BIOL CHEM, V269, P2574; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Ferrat G, 2005, PROTEINS, V59, P368, DOI 10.1002/prot.20424; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Grishin E, 1999, EUR J BIOCHEM, V264, P276, DOI 10.1046/j.1432-1327.1999.00622.x; HONDEGHEM LM, 1984, ANNU REV PHARMACOL, V24, P387, DOI 10.1146/annurev.pa.24.040184.002131; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; NICHOLSON GM, 1994, PFLUG ARCH EUR J PHY, V428, P400, DOI 10.1007/BF00724524; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; Nikolsky AS, 2009, BIOCHEM MOSC SUPPL S, V3, P245, DOI 10.1134/S1990747809030027; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Norris T. M., 1995, Society for Neuroscience Abstracts, V21, P1820; Omecinsky DO, 1996, BIOCHEMISTRY-US, V35, P2836, DOI 10.1021/bi952605r; Petrinos, 2009, PROTEIN BIOSYNTHESIS, P225; QUISTAD GB, 1991, TOXICON, V29, P329, DOI 10.1016/0041-0101(91)90286-Z; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; SHLYAPNIKOV YM, 2010, BIOORG KHIM, V36, P81; SKINNER WS, 1989, J BIOL CHEM, V264, P2150; STAPLETON A, 1990, J BIOL CHEM, V265, P2054; Tan JG, 2002, J NEUROSCI, V22, P5300; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2003, TOXICON, V41, P643, DOI 10.1016/S0041-0101(02)00280-5; Yamaji N, 2007, FEBS LETT, V581, P3789, DOI 10.1016/j.febslet.2007.06.077; Yamaji N, 2009, J BIOL CHEM, V284, P24568, DOI 10.1074/jbc.M109.030841; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	60	27	35	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18545	18554		10.1074/jbc.M110.125211	http://dx.doi.org/10.1074/jbc.M110.125211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385552	hybrid, Green Published			2022-12-25	WOS:000278453900048
J	Ding, X; Deng, H; Wang, DM; Zhou, JJ; Huang, YJ; Zhao, XN; Yu, X; Wang, M; Wang, FS; Ward, T; Aikhionbare, F; Yao, XB				Ding, Xia; Deng, Hui; Wang, Dongmei; Zhou, Jiajia; Huang, Yuejia; Zhao, Xuannv; Yu, Xue; Wang, Ming; Wang, Fengsong; Ward, Tarsha; Aikhionbare, Felix; Yao, Xuebiao			Phospho-regulated ACAP4-Ezrin Interaction Is Essential for Histamine-stimulated Parietal Cell Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-ACID-SECRETION; APICAL MEMBRANE; HCL SECRETION; RECYCLING HYPOTHESIS; OXYNTIC CELLS; GLAND MODEL; EZRIN; PROTEIN; PHOSPHORYLATION; LOCALIZATION	The ezrin-radixin-moesin proteins provide a regulated linkage between membrane proteins and the cortical cytoskeleton and also participate in signal transduction pathways. Ezrin is localized to the apical membrane of parietal cells and couples the protein kinase A activation cascade to the regulated HCl secretion. Our recent proteomic study revealed a protein complex of ezrin-ACAP4-ARF6 essential for volatile membrane remodeling (Fang, Z., Miao, Y., Ding, X., Deng, H., Liu, S., Wang, F., Zhou, R., Watson, C., Fu, C., Hu, Q., Lillard, J. W., Jr., Powell, M., Chen, Y., Forte, J. G., and Yao, X. (2006) Mol. Cell Proteomics 5, 1437-1449). However, knowledge of whether ACAP4 physically interacts with ezrin and how their interaction is integrated into membrane-cytoskeletal remodeling has remained elusive. Here we provide the first evidence that ezrin interacts with ACAP4 in a protein kinase A-mediated phosphorylation-dependent manner through the N-terminal 400 amino acids of ACAP4. ACAP4 locates in the cytoplasmic membrane in resting parietal cells but translocates to the apical plasma membrane upon histamine stimulation. ACAP4 was precipitated with ezrin from secreting but not resting parietal cell lysates, suggesting a phospho-regulated interaction. Indeed, this interaction is abolished by phosphatase treatment and validated by an in vitro reconstitution assay using phospho-mimicking ezrin(S66D). Importantly, ezrin specifies the apical distribution of ACAP4 in secreting parietal cells because either suppression of ezrin or overexpression of non-phosphorylatable ezrin prevents the apical localization of ACAP4. In addition, overexpressing GTPase-activating protein-deficient ACAP4 results in an inhibition of apical membrane-cytoskeletal remodeling and gastric acid secretion. Taken together, these results define a novel molecular mechanism linking ACAP4-ezrin interaction to polarized epithelial secretion.	[Ding, Xia; Deng, Hui; Wang, Dongmei; Zhou, Jiajia; Huang, Yuejia; Zhao, Xuannv; Yu, Xue; Wang, Ming; Wang, Fengsong; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Ding, Xia] Beijing Univ Chinese Med, Dept Internal Med, Beijing 100029, Peoples R China; [Deng, Hui; Huang, Yuejia; Wang, Fengsong; Ward, Tarsha; Aikhionbare, Felix] Morehouse Sch Med, Dept Physiol & Med, Atlanta, GA 30310 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine; Morehouse School of Medicine	Yao, XB (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014	Wang, Ming/0000-0002-7000-1063	National Institutes of Health (NIH) [DK-56292, CA132389]; NIH, National Center for Research Resources (NCRR) [UL1 RR025008, G12RR03034]; Chinese Natural Science Foundation [30500183, 30870990, 30900497, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R195]; Chinese 973 Project [2006CB943603, 2007CB914503, 2010CB912103]; International Collaboration Grant [2009DFA31010]; Technology grant [2006BAI08B01-07]; China National Key Projects for Infectious Disease Grant [2008ZX10002-021]; Georgia Cancer Coalition breast cancer research grant; Atlanta Clinical and Translational Science Award Chemical Biology Grant [P20RR011104]; Anhui Province Key Project Grant [08040102005]; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011104, UL1RR025008, G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); International Collaboration Grant; Technology grant; China National Key Projects for Infectious Disease Grant; Georgia Cancer Coalition breast cancer research grant; Atlanta Clinical and Translational Science Award Chemical Biology Grant; Anhui Province Key Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants DK-56292 and CA132389 and NIH, National Center for Research Resources (NCRR), Grant UL1 RR025008 from the Clinical and Translational Science Award program. This work was also supported by Chinese Natural Science Foundation Grants 30500183 and 30870990 (to X. D.), 30900497 (to F. W.), and 90508002 and 90913016 (to X. Y.); Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R195; Chinese 973 Project Grants 2006CB943603, 2007CB914503, and 2010CB912103; International Collaboration Grant 2009DFA31010 (to X. D.); and Technology grant 2006BAI08B01-07 (to X. D.); China National Key Projects for Infectious Disease Grant 2008ZX10002-021; a Georgia Cancer Coalition breast cancer research grant; Atlanta Clinical and Translational Science Award Chemical Biology Grant P20RR011104; and Anhui Province Key Project Grant 08040102005. The facilities used were supported in part by NCRR, NIH, Grant G12RR03034.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; BERRYMAN M, 1993, J CELL SCI, V105, P1025; BLACK JA, 1982, GASTROENTEROLOGY, V83, P595; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Ding Xia, 2008, V440, P217, DOI 10.1007/978-1-59745-178-9_16; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Forte JG, 1996, TRENDS CELL BIOL, V6, P45, DOI 10.1016/0962-8924(96)81009-9; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; GOLDENRING JR, 1994, AM J PHYSIOL, V267, P187; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Matsukawa J, 2003, J BIOL CHEM, V278, P36470, DOI 10.1074/jbc.M305444200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; URUSHIDANI T, 1987, AM J PHYSIOL, V252, pG458, DOI 10.1152/ajpgi.1987.252.4.G458; URUSHIDANI T, 1987, BIOCHIM BIOPHYS ACTA, V930, P209, DOI 10.1016/0167-4889(87)90033-4; URUSHIDANI T, 1989, AM J PHYSIOL, V256, pG1070, DOI 10.1152/ajpgi.1989.256.6.G1070; Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200; YAO X, 1993, AM J PHYSIOL, V265, P36; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yao XB, 1996, AM J PHYSIOL-CELL PH, V271, pC61, DOI 10.1152/ajpcell.1996.271.1.C61; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Yeaman C, 1999, CURR BIOL, V9, pR515, DOI 10.1016/S0960-9822(99)80324-8; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200; Zhu LX, 2009, AM J PHYSIOL-GASTR L, V296, pG185, DOI 10.1152/ajpgi.90597.2008	31	24	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18769	18780		10.1074/jbc.M110.129007	http://dx.doi.org/10.1074/jbc.M110.129007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20360010	hybrid, Green Published			2022-12-25	WOS:000278453900068
J	Yao, JY; Zhang, L; Zhang, X; He, ZY; Ma, Y; Hui, LJ; Wang, X; Hu, YP				Yao, Jia-Yi; Zhang, Lei; Zhang, Xin; He, Zhi-Ying; Ma, Yue; Hui, Li-Jian; Wang, Xin; Hu, Yi-Ping			H3K27 Trimethylation Is an Early Epigenetic Event of p16(INK4a) Silencing for Regaining Tumorigenesis in Fusion Reprogrammed Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TUMOR-SUPPRESSOR GENES; SOMATIC-CELLS; HEPATOCELLULAR-CARCINOMA; HYBRID-CELLS; PLURIPOTENT CELLS; EPITHELIAL-CELLS; DNA METHYLATION; IN-VITRO; CANCER	Stable epigenetic silencing of p16(INK4a) is a common event in hepatocellular carcinoma (HCC) cells, which is associated with abnormal cell proliferation and liberation from cell cycle arrest. Understanding the early epigenetic events in silencing p16(INK4a) expression may illuminate a prognostic strategy to block HCC development. Toward this end, we created a reprogram cell model by the fusion mouse HCC cells with mouse embryonic stem cells, in which the ES-Hepa hybrids forfeited HCC cell characteristics along with reactivation of the silenced p16(INK4a). HCC characteristics, in terms of gene expression pattern and tumorigenic potential, was restored upon induced differentiation of these reprogrammed ES-Hepa hybrids. The histone methylation pattern relative to p16(INK4a) silencing during differentiation of the ES-Hepa hybrids was analyzed. H3K27 trimethylation at the p16(INK4a) promoter region, occurring in the early onset of p16(INK4a) silencing, was followed by H3K9 dimethylation at later stages. During the induced differentiation of the ES-Hepa hybrids, H3K4 di- and trimethylations were maintained at high levels during the silencing of p16(INK4a), strongly suggesting that H3K4 methylation events did not cause the silencing of p16(INK4a). Our results suggested that the enrichment of H3K27 trimethylation, independent of H3K9 dimethylation, trimethylation, and DNA methylation, was an early event in the silencing of p16(INK4a) during the tumor development. This unique chromatin pattern may be a heritable marker of epigenetic regulation for p16(INK4a) silencing during the developmental process of hepatocellular carcinogenesis.	[Yao, Jia-Yi; Zhang, Lei; Zhang, Xin; Hui, Li-Jian; Wang, Xin] Chinese Acad Sci, Key Lab Mol & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Yao, Jia-Yi; Zhang, Xin; He, Zhi-Ying; Hu, Yi-Ping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Ma, Yue] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Xin] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Minnesota System; University of Minnesota Twin Cities	Wang, X (corresponding author), Chinese Acad Sci, Key Lab Mol & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	wangx@sibs.ac.cn; yphu@smmu.edu.cn	Ma, Yue/D-4343-2011	Ma, Yue/0000-0002-3922-594X; Zhang, Lei/0000-0002-0222-4417; Yao, Jiayi/0000-0001-9235-2406	National Institutes of Health [DK074561, AI065565]; National Natural Science Foundation of China [30671044, 30623003, 30801115, 30901449]; National Key Basic Research and Development Program of China [2005CB522701, 2006CB943901, 2007CB947903, 2007CB947102, 2009CB941100, 2010CB945602]; Chinese National 863 Plan Project [2006AA02Z474]; Chinese Academy of Sciences [KSCX2-YW-R-49]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese National 863 Plan Project(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK074561 and AI065565. This work was also supported by the National Natural Science Foundation of China (Grants 30671044, 30623003, 30801115, and 30901449), the National Key Basic Research and Development Program of China (Grants 2005CB522701, 2006CB943901, 2007CB947903, 2007CB947102, 2009CB941100, and 2010CB945602), the Chinese National 863 Plan Project (Grant 2006AA02Z474), and the Chinese Academy of Sciences (Grant KSCX2-YW-R-49).	Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Bonilla F, 1998, INT J ONCOL, V12, P583; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Do JT, 2006, STEM CELL REV, V2, P257, DOI 10.1007/BF02698052; Do JT, 2007, STEM CELLS, V25, P1013, DOI 10.1634/stemcells.2006-0691; Do JT, 2005, REPROD FERT DEVELOP, V17, P143, DOI 10.1071/RD04120; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Holst CR, 2003, CANCER RES, V63, P1596; Hui AM, 1996, HEPATOLOGY, V24, P575, DOI 10.1002/hep.510240319; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kita R, 1996, INT J CANCER, V67, P176, DOI 10.1002/(SICI)1097-0215(19960717)67:2<176::AID-IJC4>3.0.CO;2-Q; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Li L, 2003, CANCER RES, V63, P2733; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Matveeva NM, 1998, MOL REPROD DEV, V50, P128, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;128::AID-MRD2&gt;3.0.CO;2-M; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; MILLER SC, 1988, GENE DEV, V2, P330, DOI 10.1101/gad.2.3.330; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sherr CJ, 2000, CANCER RES, V60, P3689; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TOLLEFSBOL TO, 2009, CANC EPIGENETICS, P446; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Wong DJ, 1999, MOL CELL BIOL, V19, P5642	40	26	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18828	18837		10.1074/jbc.M109.077974	http://dx.doi.org/10.1074/jbc.M109.077974			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382980	Green Published, hybrid			2022-12-25	WOS:000278453900073
J	Wu, BX; Rajagopalan, V; Roddy, PL; Clarke, CJ; Hannun, YA				Wu, Bill X.; Rajagopalan, Vinodh; Roddy, Patrick L.; Clarke, Christopher J.; Hannun, Yusuf A.			Identification and Characterization of Murine Mitochondria-associated Neutral Sphingomyelinase (MA-nSMase), the Mammalian Sphingomyelin Phosphodiesterase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; LUNG EPITHELIAL-CELLS; SPHINGOLIPID METABOLISM; BIOACTIVE SPHINGOLIPIDS; CERAMIDE CHANNELS; APOPTOSIS; GENE; CHROMATOGRAPHY; TRAFFICKING	Sphingolipids play important roles in regulating cellular responses. Although mitochondria contain sphingolipids, direct regulation of their levels in mitochondria or mitochondria-associated membranes is mostly unclear. Neutral SMase (N-SMase) isoforms, which catalyze hydrolysis of sphingomyelin (SM) to ceramide and phosphocholine, have been found in the mitochondria of yeast and zebrafish, yet their existence in mammalian mitochondria remains unknown. Here, we have identified and cloned a cDNA based on nSMase homologous sequences. This cDNA encodes a novel protein of 483 amino acids that displays significant homology to nSMase2 and possesses the same catalytic core residues as members of the extended N-SMase family. A transiently expressed V5-tagged protein co-localized with both mitochondria and endoplasmic reticulum markers in MCF-7 and HEK293 cells; accordingly, the enzyme is referred to as mitochondria-associated nSMase (MA-nSMase). MA-nSMase was highly expressed in testis, pancreas, epididymis, and brain. MA-nSMase had an absolute requirement for cations such as Mg2+ and Mn2+ and activation by the anionic phospholipids, especially phosphatidylserine and the mitochondrial cardiolipin. Importantly, overexpression of MA-nSMase in HEK293 cells significantly increased in vitro N-SMase activity and also modulated the levels of SM and ceramide, indicating that the identified cDNA encodes a functional SMase. Thus, these studies identify and characterize, for the first time, a mammalian MA-nSMase. The characterization of MA-nSMase described here will contribute to our understanding of pathways regulated by sphingolipid metabolites, particularly with reference to the mitochondria and associated organelles.	[Wu, Bill X.; Rajagopalan, Vinodh; Roddy, Patrick L.; Clarke, Christopher J.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu	Rajagopalan, Vinodh/AAG-4769-2020		National Institutes of Health [GM 43825, P20 RR0176677, P01-CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 43825 to (Y. A. H.).; We thank Drs. Cungui Mao and Ashley Snider for expert advice and assistance. We also thank the Lipidomics Core at the Medical University of South Carolina for mass spectrometry analysis of lipids. The core facility is supported by National Institutes of Health Grants P20 RR0176677 and P01-CA97132.	Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Butler A, 2002, AM J PATHOL, V161, P1061, DOI 10.1016/S0002-9440(10)64267-8; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Corcoran CA, 2008, MOL CANCER RES, V6, P795, DOI 10.1158/1541-7786.MCR-07-2097; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Garcia-Ruiz C, 2002, J BIOL CHEM, V277, P36443, DOI 10.1074/jbc.M206021200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Modrak DE, 2006, MOL CANCER THER, V5, P200, DOI 10.1158/1535-7163.MCT-05-0420; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; Otala M, 2005, BIOL REPROD, V72, P86, DOI 10.1095/biolreprod.104.031278; Raimann PE, 1999, MOL CELL BIOCHEM, V201, P125, DOI 10.1023/A:1007046024246; Sawai H, 1999, J BIOL CHEM, V274, P38131, DOI 10.1074/jbc.274.53.38131; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; SPENCE MW, 1979, BRAIN RES, V168, P543, DOI 10.1016/0006-8993(79)90308-1; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580	46	82	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17993	18002		10.1074/jbc.M110.102988	http://dx.doi.org/10.1074/jbc.M110.102988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378533	Green Published, hybrid			2022-12-25	WOS:000278133400075
J	Wang, SE; Yu, Y; Criswell, TL; DeBusk, LM; Lin, PC; Zent, R; Johnson, DH; Ren, X; Arteaga, CL				Wang, S. E.; Yu, Y.; Criswell, T. L.; DeBusk, L. M.; Lin, P. C.; Zent, R.; Johnson, D. H.; Ren, X.; Arteaga, C. L.			Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators	ONCOGENE			English	Article						HER2/ErbB2; Ras; TGF-beta; VEGF; EGFR ligands; tumor microenvironment	TYROSINE KINASE INHIBITOR; FACTOR-BETA; BREAST-CANCER; TRANSFORMING GROWTH-FACTOR-BETA-1; SOMATIC MUTATIONS; CELL-MIGRATION; IN-VITRO; H-RAS; RECEPTOR; ERBB2	Activating mutations in the tyrosine kinase domain of HER2 (ErbB2) have been identified in human cancers. Compared with wild-type HER2, mutant HER2 shows constitutively activate kinase activity and increased oncogenicity. Cells transformed by mutant HER2 are resistant to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and exhibit an attenuated response to the HER2 antibody trastuzumab. We investigated herein pathways through which mutant HER2 alters the extracellular environment, potentially leading to drug resistance and the effect of simultaneously targeting HER2 and the tumor cell microenvironment with a therapeutic intent. Expression of mutant HER2 in mammary epithelial cells activated autocrine transforming growth factor (TGF) beta 1 signaling through a mechanism involving Rac1 and c-Jun N-terminal kinase-activating protein 1-dependent transcription. Cells transformed by an activating mutant of H-Ras (G12V) also expressed higher TGF-beta 1 level through Rac1 activation. In addition, mutant HER2 induced the EGFR ligands TGF-alpha and amphiregulin at the mRNA and protein levels. Vascular endothelial growth factor, a target of the TGF-beta-Smad transcriptional regulation, was also induced as a result of expression of mutant HER2. Inhibition of TGF-beta signaling with the Alk5 small molecule inhibitor LY2109761 reduced growth and invasiveness of cells expressing mutant HER2. Combined inhibition of intracellular and paracrine effects of mutant HER2 by trastuzumab and the EGFR antibody cetuximab were more efficient than single-agent therapies. These data suggest that mutations in oncogenes such as HER2 and Ras not only alter intracellular signaling but also influence on other components of the tumor microenvironment by inducing several pro-invasive growth factors. In turn, these serve as extracellular targets of novel therapeutic strategies directed at both cancer-driving oncogenes and the modified tumor microenvironment. Oncogene (2010) 29, 3335-3348; doi:10.1038/onc.2010.112; published online 12 April 2010	[Wang, S. E.] Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA 91010 USA; [Yu, Y.; Ren, X.] Tianjin Med Univ, Tianjin Canc Inst & Hosp, Dept Immunol & Biotherapy, Tianjin, PR, Peoples R China; [Criswell, T. L.; DeBusk, L. M.; Lin, P. C.; Zent, R.; Arteaga, C. L.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA; [DeBusk, L. M.; Lin, P. C.] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA; [Zent, R.; Johnson, D. H.; Arteaga, C. L.] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA; [Arteaga, C. L.] Vanderbilt Univ, Sch Med, Breast Canc Res Program, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA	City of Hope; Beckman Research Institute of City of Hope; Tianjin Medical University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wang, SE (corresponding author), Beckman Res Inst City Hope, Div Tumor Cell Biol, 1500 E Duarte Rd,KCRB Room 2007, Duarte, CA 91010 USA.	ewang@coh.org; carlos.arteaga@vanderbilt.edu			NCI [K99/R00 CA125892, NCI R01 CA62212, R01 CA80195]; ACS [CRP-07-234]; Breast Cancer Specialized Program of Research Excellence (SPORE) [P50 CA98131]; Vanderbilt-Ingram Comprehensive Cancer Center [P30 CA68485]; NATIONAL CANCER INSTITUTE [K99CA125892, ZIABC011390, P30CA068485, R01CA080195, R00CA125892, T32CA009592, R01CA062212, P50CA098131] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); Breast Cancer Specialized Program of Research Excellence (SPORE); Vanderbilt-Ingram Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI K99/R00 CA125892 (SEW), NCI R01 CA62212 (CLA), R01 CA80195 (CLA), ACS Clinical Research Professorship Grant CRP-07-234 (CLA), Breast Cancer Specialized Program of Research Excellence (SPORE) P50 CA98131, and Vanderbilt-Ingram Comprehensive Cancer Center Support Grant P30 CA68485.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bakin AV, 2002, J CELL SCI, V115, P3193; BARNARD JA, 1994, J BIOL CHEM, V269, P22817; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Erdogan M, 2007, J BIOL CHEM, V282, P27713, DOI 10.1074/jbc.M703037200; Fahey MS, 1996, BRIT J CANCER, V74, P1074, DOI 10.1038/bjc.1996.492; Fong TAT, 1999, CANCER RES, V59, P99; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Heasley LE, 2006, MOL CELLS, V21, P167; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Josko J, 2004, MED SCI MONITOR, V10, pRA89; Kim ES, 2005, CYTOKINE, V29, P84, DOI 10.1016/j.cyto.2004.10.001; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Maity A, 2000, CANCER RES, V60, P5879; MALIPIERO U, 1990, BIOCHEM BIOPH RES CO, V171, P1145, DOI 10.1016/0006-291X(90)90804-V; Moulder SL, 2001, CANCER RES, V61, P8887; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; Normanno N, 2001, FRONT BIOSCI-LANDMRK, V6, pD685, DOI 10.2741/Normano; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Sawyer JS, 2004, BIOORG MED CHEM LETT, V14, P3581, DOI 10.1016/j.bmcl.2004.04.007; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang LM, 1998, P NATL ACAD SCI USA, V95, P6809, DOI 10.1073/pnas.95.12.6809; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Weigert C, 2000, J AM SOC NEPHROL, V11, P2007, DOI 10.1681/ASN.V11112007; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye DW, 1999, ONCOGENE, V18, P731, DOI 10.1038/sj.onc.1202319	55	35	36	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3335	3348		10.1038/onc.2010.112	http://dx.doi.org/10.1038/onc.2010.112			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20383197	Green Accepted			2022-12-25	WOS:000278622700003
J	Schmidt, A; Kimmel, DB; Bai, C; Scafonas, A; Rutledge, S; Vogel, RL; McElwee-Witmer, S; Chen, F; Nantermet, PV; Kasparcova, V; Leu, CT; Zhang, HZ; Duggan, ME; Gentile, MA; Hodor, P; Pennypacker, B; Masarachia, P; Opas, EE; Adamski, SA; Cusick, TE; Wang, JB; Mitchell, HJ; Kim, Y; Prueksaritanont, T; Perkins, JJ; Meissner, RS; Hartman, GD; Freedman, LP; Harada, S; Ray, WJ				Schmidt, Azriel; Kimmel, Donald B.; Bai, Chang; Scafonas, Angela; Rutledge, SuJane; Vogel, Robert L.; McElwee-Witmer, Sheila; Chen, Fang; Nantermet, Pascale V.; Kasparcova, Viera; Leu, Chih-tai; Zhang, Hai-Zhuan; Duggan, Mark E.; Gentile, Michael A.; Hodor, Paul; Pennypacker, Brenda; Masarachia, Patricia; Opas, Evan E.; Adamski, Sharon A.; Cusick, Tara E.; Wang, Jiabing; Mitchell, Helen J.; Kim, Yuntae; Prueksaritanont, Thomayant; Perkins, James J.; Meissner, Robert S.; Hartman, George D.; Freedman, Leonard P.; Harada, Shun-ichi; Ray, William J.			Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic Anabolism Versus Reproductive Physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAN BODY-MASS; POSTMENOPAUSAL WOMEN; GENETIC PATHWAYS; MALE RATS; TESTOSTERONE; PROSTATE; BONE; INSENSITIVITY; EXPRESSION; MUTATIONS	Selective androgen receptor modulators (SARMs) are androgen receptor (AR) ligands that induce anabolism while having reduced effects in reproductive tissues. In various experimental contexts SARMs fully activate, partially activate, or even antagonize the AR, but how these complex activities translate into tissue selectivity is not known. Here, we probed receptor function using >1000 synthetic AR ligands. These compounds produced a spectrum of activities in each assay ranging from 0 to 100% of maximal response. By testing different classes of compounds in ovariectomized rats, we established that ligands that transactivated a model promoter 40-80% of an agonist, recruited the coactivator GRIP-1 <15%, and stabilized the N-/C-terminal interdomain interaction <7% induced bone formation with reduced effects in the uterus and in sebaceous glands. Using these criteria, multiple SARMs were synthesized including MK-0773, a 4-aza-steroid that exhibited tissue selectivity in humans. Thus, AR activated to moderate levels due to reduced cofactor recruitment, and N-/C-terminal interactions produce a fully anabolic response, whereas more complete receptor activation is required for reproductive effects. This bimodal activation provides a molecular basis for the development of SARMs.	[Schmidt, Azriel; Kimmel, Donald B.; Bai, Chang; Scafonas, Angela; Rutledge, SuJane; Vogel, Robert L.; McElwee-Witmer, Sheila; Chen, Fang; Nantermet, Pascale V.; Kasparcova, Viera; Leu, Chih-tai; Zhang, Hai-Zhuan; Gentile, Michael A.; Pennypacker, Brenda; Masarachia, Patricia; Opas, Evan E.; Adamski, Sharon A.; Cusick, Tara E.; Harada, Shun-ichi; Ray, William J.] Merck Res Labs, Dept Mol Endocrinol, West Point, PA 19486 USA; [Duggan, Mark E.; Wang, Jiabing; Mitchell, Helen J.; Kim, Yuntae; Perkins, James J.; Meissner, Robert S.; Hartman, George D.; Freedman, Leonard P.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA; [Prueksaritanont, Thomayant] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA; [Hodor, Paul] Merck Res Labs, Dept Mol Profiling, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Schmidt, A (corresponding author), 54 Haymarket Lane, Bryn Mawr, PA 19010 USA.	azriel.schmidt@gmail.com; james_ray@merck.com	Ray, William J/E-9834-2016	Ray, William/0000-0002-4491-167X	Merck Co., Inc	Merck Co., Inc(Merck & Company)	This work was supported by the research and development budget of Merck & Co., Inc.	Allan G, 2008, J STEROID BIOCHEM, V110, P207, DOI 10.1016/j.jsbmb.2007.10.012; Allan GF, 2007, ENDOCRINE, V32, P41, DOI 10.1007/s12020-007-9005-2; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Bettoun DJ, 2005, J BIOL CHEM, V280, P38898, DOI 10.1074/jbc.C500324200; Bhasin S, 2003, J ENDOCRINOL INVEST, V26, P814, DOI 10.1007/BF03345230; Bhasin S, 2003, J GERONTOL A-BIOL, V58, P1002; Bhasin S, 2009, CURR OPIN CLIN NUTR, V12, P232, DOI 10.1097/MCO.0b013e32832a3d79; Bohl CE, 2004, J MED CHEM, V47, P3765, DOI 10.1021/jm0499007; Braunstein GD, 2007, FERTIL STERIL, V88, P1, DOI 10.1016/j.fertnstert.2007.01.118; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chang CY, 2002, MOL ENDOCRINOL, V16, P647, DOI 10.1210/me.16.4.647; Chen F, 2004, J STEROID BIOCHEM, V91, P247, DOI 10.1016/j.jsbmb.2004.04.009; Draper MW, 1996, J BONE MINER RES, V11, P835; Fuse H, 1997, J BONE MINER RES, V12, P590, DOI 10.1359/jbmr.1997.12.4.590; Gao WQ, 2005, ENDOCRINOLOGY, V146, P4887, DOI 10.1210/en.2005-0572; Gao WQ, 2004, ENDOCRINOLOGY, V145, P5420, DOI 10.1210/en.2004-0627; HALL RE, 1994, EUR J CANCER, V30A, P484, DOI 10.1016/0959-8049(94)90424-3; Hanada K, 2003, BIOL PHARM BULL, V26, P1563, DOI 10.1248/bpb.26.1563; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Holterhus PM, 2005, EXP CLIN ENDOCR DIAB, V113, P457, DOI 10.1055/s-2005-865770; Isidori A M, 2005, J Endocrinol Invest, V28, P73; KALLIO PJ, 1995, MOL ENDOCRINOL, V9, P1017, DOI 10.1210/me.9.8.1017; Kaufman J M, 2003, Aging Male, V6, P166, DOI 10.1080/713604787; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Li J, 2009, MATURITAS, V63, P142, DOI 10.1016/j.maturitas.2009.03.008; Manfredi MC, 2007, BIOORG MED CHEM LETT, V17, P4487, DOI 10.1016/j.bmcl.2007.06.007; MEISSNER RS, 2009, 237 ACS NAT M SALT L; Miner JN, 2007, ENDOCRINOLOGY, V148, P363, DOI 10.1210/en.2006-0793; Mohler ML, 2009, J MED CHEM, V52, P3597, DOI 10.1021/jm900280m; Nantermet P, 2008, ENDOCRINOLOGY, V149, P1551, DOI 10.1210/en.2007-1151; Nantermet PV, 2005, ENDOCRINOLOGY, V146, P564, DOI 10.1210/en.2004-1132; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Narayanan Ramesh, 2008, Nucl Recept Signal, V6, pe010, DOI 10.1621/nrs.06010; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; Riedmaier I, 2009, J STEROID BIOCHEM, V114, P167, DOI 10.1016/j.jsbmb.2009.01.019; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Schmidt A, 2009, J BIOL CHEM, V284, P36367, DOI 10.1074/jbc.M109.049734; Segal S, 2006, EXPERT OPIN INV DRUG, V15, P377, DOI 10.1517/13543784.15.4.377; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Stanworth RD, 2009, FRONT HORM RES, V37, P74, DOI 10.1159/000176046; STOCH SA, 2008, 90 ANN M END SOC SAN; STOCH SA, 2009, 91 ANN M END SOC WAS; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998; Ye XC, 2005, P NATL ACAD SCI USA, V102, P9487, DOI 10.1073/pnas.0503577102; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	49	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17054	17064		10.1074/jbc.M109.099002	http://dx.doi.org/10.1074/jbc.M109.099002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356837	Green Published, hybrid			2022-12-25	WOS:000277982600069
J	Khatri, S; Yepiskoposyan, H; Gallo, CA; Tandon, P; Plas, DR				Khatri, Shikha; Yepiskoposyan, Hasmik; Gallo, Catherine A.; Tandon, Preeti; Plas, David R.			FOXO3a Regulates Glycolysis via Transcriptional Control of Tumor Suppressor TSC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS-SCLEROSIS; GENE-EXPRESSION; CELL-SURVIVAL; CANCER-CELLS; AKT; HOMEOSTASIS; APOPTOSIS; LIVER; PHOSPHORYLATION; DEPRIVATION	Akt signal transduction induces coordinated increases in glycolysis and apoptosis resistance in a broad spectrum of cancers. Downstream of Akt, the FoxO transcription factors regulate apoptosis via Bim, but the contributions of FoxOs in regulating Akt-induced glycolysis are not well described. We find that FoxO3a knockdown is sufficient to induce apoptosis resistance in conjunction with elevated glycolysis. Glycolysis in FoxO3a-deficient cells was associated with increased S6K1 phosphorylation and was sensitive to rapamycin, an inhibitor of the mTORC1 pathway that has been linked to glycolysis regulation. We show that mTORC1-dependent glycolysis is increased in FoxO3a knockdown cells due to decreased expression of the TSC1 tumor suppressor that opposes mTORC1 activation. FoxO3a binds to and transactivates the TSC1 promoter, indicating a key role for FoxO3a in regulating TSC1 expression. Together, these data demonstrate that FoxO3a regulates glycolysis downstream of Akt through transcriptional control of Tsc1.	[Khatri, Shikha; Yepiskoposyan, Hasmik; Gallo, Catherine A.; Tandon, Preeti; Plas, David R.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Plas, DR (corresponding author), 3125 Eden Ave, Cincinnati, OH 45267 USA.	plasd@uc.edu		Yepiskoposyan, Hasmik/0000-0002-3687-1372	National Institutes of Health through the NCI [K01 CA98743, R01 CA133164]; American Cancer Society [RSG-08-293-01-CCG]; NATIONAL CANCER INSTITUTE [T32CA059268, R01CA133164, K01CA098743] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 CA98743 and R01 CA133164 through the NCI (to D. R. P.). This work was also supported by American Cancer Society Grant RSG-08-293-01-CCG.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; ATADJA P, 2004, NOVART FDN SYMP, V259, P266; ATADJA P, 2004, NOVART FDN SYMP, V259, P285; Atadja Peter, 2004, Novartis Found Symp, V259, P249; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAY O, 1992, CANCER RES, V52, P5794; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; KAPLAN O, 1990, CANCER RES, V50, P544; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park S, 2009, J BIOL CHEM, V284, P2187, DOI 10.1074/jbc.M806131200; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Pymar LS, 2008, HUM MOL GENET, V17, P2006, DOI 10.1093/hmg/ddn098; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	39	66	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15960	15965		10.1074/jbc.M110.121871	http://dx.doi.org/10.1074/jbc.M110.121871			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20371605	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000277715900033
J	Moussaid, M; Perozo, N; Garnier, S; Helbing, D; Theraulaz, G				Moussaid, Mehdi; Perozo, Niriaska; Garnier, Simon; Helbing, Dirk; Theraulaz, Guy			The Walking Behaviour of Pedestrian Social Groups and Its Impact on Crowd Dynamics	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; SELF-ORGANIZATION; PARTICIPATION; DISTANCE; FLIGHT; MODEL; SIZE	Human crowd motion is mainly driven by self-organized processes based on local interactions among pedestrians. While most studies of crowd behaviour consider only interactions among isolated individuals, it turns out that up to 70% of people in a crowd are actually moving in groups, such as friends, couples, or families walking together. These groups constitute medium-scale aggregated structures and their impact on crowd dynamics is still largely unknown. In this work, we analyze the motion of approximately 1500 pedestrian groups under natural condition, and show that social interactions among group members generate typical group walking patterns that influence crowd dynamics. At low density, group members tend to walk side by side, forming a line perpendicular to the walking direction. As the density increases, however, the linear walking formation is bent forward, turning it into a V-like pattern. These spatial patterns can be well described by a model based on social communication between group members. We show that the V-like walking pattern facilitates social interactions within the group, but reduces the flow because of its "non-aerodynamic" shape. Therefore, when crowd density increases, the group organization results from a trade-off between walking faster and facilitating social exchange. These insights demonstrate that crowd dynamics is not only determined by physical constraints induced by other pedestrians and the environment, but also significantly by communicative, social interactions among individuals.	[Moussaid, Mehdi; Perozo, Niriaska; Garnier, Simon; Theraulaz, Guy] Univ Toulouse 3, Ctr Rech Cognit Anim, F-31062 Toulouse, France; [Moussaid, Mehdi; Helbing, Dirk] ETH, Swiss Fed Inst Technol, Chair Sociol, Zurich, Switzerland; [Moussaid, Mehdi; Theraulaz, Guy] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Perozo, Niriaska] Univ Centroccidental Lisandro Alvarado, Unidad Invest Inteligencia Artificial, Barquisimeto, Venezuela; [Helbing, Dirk] Santa Fe Inst, Santa Fe, NM 87501 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; The Santa Fe Institute	Moussaid, M (corresponding author), Univ Toulouse 3, Ctr Rech Cognit Anim, F-31062 Toulouse, France.	moussaid@cict.fr	Garnier, Simon/N-3814-2019; Theraulaz, Guy/H-8464-2016; Moussaïd, Mehdi/G-2366-2010; Garnier, Simon/A-3998-2010	Theraulaz, Guy/0000-0002-3062-4215; Garnier, Simon/0000-0002-3886-3974	ETH Zurich; CNRS;  [ANR-08-SYSC-015]	ETH Zurich(ETH Zurich); CNRS(Centre National de la Recherche Scientifique (CNRS)); 	This work was supported by the ANR-08-SYSC-015. Mehdi Moussaid is supported by a jointly financed doctoral-engineer fellowship from ETH Zurich and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini G, 2006, TRANSPORT RES B-METH, V40, P667, DOI 10.1016/j.trb.2005.09.006; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; AVENI AF, 1977, SOCIOMETRY, V40, P96, DOI 10.2307/3033551; Ball P., 2004, CRITICAL MASS ONE TH; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; COLEMAN JS, 1961, SOCIOMETRY, V24, P36, DOI 10.2307/2785927; COLLINS RD, 1995, J NEUROSCI METH, V60, P95, DOI 10.1016/0165-0270(94)00224-5; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; DAAMEN W, 2002, J TRANSPORT INFRASTR, V3, P39; Hare AP, 1962, HDB SMALL GROUP RES; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2001, ENVIRON PLANN B, V28, P361, DOI 10.1068/b2697; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; HEPPNER FH, 1974, BIRD BANDING, V45, P160, DOI 10.2307/4512025; Hoogendoorn SP, 2005, TRANSPORT SCI, V39, P147, DOI 10.1287/trsc.1040.0102; HORVATH WJ, 1965, BEHAV SCI, V10, P164, DOI 10.1002/bs.3830100206; James J, 1953, AM SOCIOL REV, V18, P569, DOI 10.2307/2087444; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10001; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10014; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; MORI M, 1987, TRANSPORT RES A-POL, V21, P223, DOI 10.1016/0191-2607(87)90016-1; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Seyfried A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10002; Singh H, 2009, APPL MATH MODEL, V33, P4408, DOI 10.1016/j.apm.2009.03.020; Stephan FF, 1952, AM SOCIOL REV, V17, P598, DOI 10.2307/2088227; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; WEIDMANN U, 1993, 90 SCHRIFTENREIHEIVT; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105	31	544	572	8	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10047	10.1371/journal.pone.0010047	http://dx.doi.org/10.1371/journal.pone.0010047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580MX	20383280	Green Published, Green Submitted, gold			2022-12-25	WOS:000276454000011
J	Dutta, K; Ghosh, D; Nazmi, A; Kumawat, KL; Basu, A				Dutta, Kallol; Ghosh, Debapriya; Nazmi, Arshed; Kumawat, Kanhaiya Lal; Basu, Anirban			A Common Carcinogen Benzo[a]pyrene Causes Neuronal Death in Mouse via Microglial Activation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BENZO(A)PYRENE; EXPOSURE; BENZO<A>PYRENE; NEUROTOXICITY; METABOLISM; EXPRESSION; CANCER; FOOD; RAT	Background: Benzo[a]pyrene (B[a]P) belongs to a class of polycyclic aromatic hydrocarbons that serve as micropollutants in the environment. B[a]P has been reported as a probable carcinogen in humans. Exposure to B[a]P can take place by ingestion of contaminated (especially grilled, roasted or smoked) food or water, or inhalation of polluted air. There are reports available that also suggests neurotoxicity as a result of B[a]P exposure, but the exact mechanism of action is unknown. Methodology/Principal Findings: Using neuroblastoma cell line and primary cortical neuron culture, we demonstrated that B[a]P has no direct neurotoxic effect. We utilized both in vivo and in vitro systems to demonstrate that B[a]P causes microglial activation. Using microglial cell line and primary microglial culture, we showed for the first time that B[a]P administration results in elevation of reactive oxygen species within the microglia thereby causing depression of antioxidant protein levels; enhanced expression of inducible nitric oxide synthase, that results in increased production of NO from the cells. Synthesis and secretion of proinflammatory cytokines were also elevated within the microglia, possibly via the p38MAP kinase pathway. All these factors contributed to bystander death of neurons, in vitro. When administered to animals, B[a]P was found to cause microglial activation and astrogliosis in the brain with subsequent increase in proinflammatory cytokine levels. Conclusions/Significance: Contrary to earlier published reports we found that B[a]P has no direct neurotoxic activity. However, it kills neurons in a bystander mechanism by activating the immune cells of the brain viz the microglia. For the first time, we have provided conclusive evidence regarding the mechanism by which the micropollutant B[a]P may actually cause damage to the central nervous system. In today's perspective, where rising pollution levels globally are a matter of grave concern, our study throws light on other health hazards that such pollutants may exert.	[Dutta, Kallol; Ghosh, Debapriya; Nazmi, Arshed; Kumawat, Kanhaiya Lal; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dutta, K (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in	Nazmi, Arshed/I-2645-2015; Dutta, Kallol/J-5827-2019	Dutta, Kallol/0000-0001-6402-1300; Ghosh, Debapriya/0000-0002-8251-6945; Basu, Anirban/0000-0002-5200-2054; Nazmi, Arshed/0000-0002-5073-2061	National Brain Research Centre; Department of Biotechnology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	National Brain Research Centre; Department of Biotechnology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by the core grants of National Brain Research Centre to A. B. and also supported by an extramural grant from Department of Biotechnology to A. B. K. D. is a recipient of Research Associateship in Biotechnology and Life Sciences from the Department of Biotechnology, Government of India; A. N. is a recipient of Junior Research Fellowship from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JD, 1987, CARCINOGENESIS, V8, P729, DOI 10.1093/carcin/8.5.729; Agarwal T, 2009, J HAZARD MATER, V171, P894, DOI 10.1016/j.jhazmat.2009.06.081; ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Aygun SF, 2005, INT J FOOD SCI NUTR, V56, P581, DOI 10.1080/09637480500465436; Basu A, 2002, GLIA, V40, P109, DOI 10.1002/glia.10118; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; CHAO CC, 1992, J IMMUNOL, V149, P2736; Conroy SM, 2004, J NEUROIMMUNOL, V155, P43, DOI 10.1016/j.jneuroim.2004.06.014; Courter LA, 2007, MUTAT RES-FUND MOL M, V625, P72, DOI 10.1016/j.mrfmmm.2007.05.005; Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X; DANHEISER SL, 1989, MUTAT RES, V210, P143, DOI 10.1016/0027-5107(89)90053-5; DARBY FW, 1986, ANN OCCUP HYG, V30, P445, DOI 10.1093/annhyg/30.4.445; DAS M, 1985, B ENVIRON CONTAM TOX, V35, P500, DOI 10.1007/BF01636545; DAVIES GM, 1986, ANN OCCUP HYG, V30, P51, DOI 10.1093/annhyg/30.1.51; DENNIS MJ, 1983, FOOD CHEM TOXICOL, V21, P569, DOI 10.1016/0278-6915(83)90142-4; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; FROEHNER S, 2009, ENV MONIT ASSESS; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Ghosh D, 2009, J NEUROCHEM, V110, P1070, DOI 10.1111/j.1471-4159.2009.06203.x; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; HAMMOND EC, 1976, ANN NY ACAD SCI, V271, P116, DOI 10.1111/j.1749-6632.1976.tb23100.x; HATTEMERFREY HA, 1991, TOXICOL IND HEALTH, V7, P141, DOI 10.1177/074823379100700303; HECHT SS, 1979, FOOD COSMET TOXICOL, V17, P223, DOI 10.1016/0015-6264(79)90284-0; HOPIA A, 1986, J AM OIL CHEM SOC, V63, P889, DOI 10.1007/BF02540921; KAISERMAN MJ, 1992, AM J PUBLIC HEALTH, V82, P1023, DOI 10.2105/AJPH.82.7.1023; Karle IL, 2004, P NATL ACAD SCI USA, V101, P1433, DOI 10.1073/pnas.0307305101; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; LARSSON BK, 1983, J AGR FOOD CHEM, V31, P867, DOI 10.1021/jf00118a049; Lee BM, 2007, J TOXICOL ENV HEAL A, V70, P1391, DOI 10.1080/15287390701434182; Leonoudakis D, 2004, NEURON GLIA BIOL, V1, P263, DOI 10.1017/S1740925X05000608; Lin HW, 2009, J NEUROCHEM, V111, P808, DOI 10.1111/j.1471-4159.2009.06366.x; LIOY PL, 1988, ARCH ENVIRON HEALTH, V43, P304, DOI 10.1080/00039896.1988.10545954; Lloyd J W, 1971, J Occup Med, V13, P53, DOI 10.1097/00043764-197102000-00001; McCarthy JF, 2003, ARCH ENVIRON CON TOX, V45, P364, DOI 10.1007/s00244-003-2148-0; Moret S, 2000, J CHROMATOGR A, V882, P245, DOI 10.1016/S0021-9673(00)00079-0; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Nwaneshiudu OC, 2007, J ENVIRON SCI HEAL B, V42, P201, DOI 10.1080/03601230601125321; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Redondo PC, 2005, BIOCHEM BIOPH RES CO, V333, P794, DOI 10.1016/j.bbrc.2005.05.178; Ross JS, 2001, ANN NY ACAD SCI, V947, P271; ROUET P, 1981, CARCINOGENESIS, V2, P919, DOI 10.1093/carcin/2.9.919; Saunders CR, 2006, J APPL TOXICOL, V26, P427, DOI 10.1002/jat.1157; Saunders CR, 2001, NEUROTOX RES, V3, DOI 10.1007/BF03033211; Schwab JM, 2004, CELL DEATH DIFFER, V11, P1245, DOI 10.1038/sj.cdd.4401487; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Tang Y, 2003, J TOXICOL ENV HEAL A, V66, P919, DOI 10.1080/15287390306455; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Tu Baijie, 2004, Wei Sheng Yan Jiu, V33, P15; Tu Baijie, 2004, Wei Sheng Yan Jiu, V33, P660; Waldman J M, 1991, J Expo Anal Environ Epidemiol, V1, P193; Wei TT, 2000, BBA-MOL CELL RES, V1498, P72, DOI 10.1016/S0167-4889(00)00078-1; Weng MW, 2004, TOXICOL LETT, V151, P345, DOI 10.1016/j.toxlet.2004.03.007; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; ZHONG Z, 1994, DRUG METAB DISPOS, V22, P680	56	66	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9984	10.1371/journal.pone.0009984	http://dx.doi.org/10.1371/journal.pone.0009984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376308	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200054
J	Gottstein, B; Wittwer, M; Schild, M; Merli, M; Leib, SL; Muller, N; Muller, J; Jaggi, R				Gottstein, Bruno; Wittwer, Matthias; Schild, Marc; Merli, Michael; Leib, Stephen L.; Mueller, Norbert; Mueller, Joachim; Jaggi, Rolf			Hepatic Gene Expression Profile in Mice Perorally Infected with Echinococcus multilocularis Eggs	PLOS ONE			English	Article							EOSINOPHIL-DERIVED NEUROTOXIN; GUANYLATE-BINDING PROTEIN-1; IN-VIVO TREATMENT; IMMUNE-RESPONSE; T-CELLS; ALVEOLAR ECHINOCOCCOSIS; INFLAMMATORY RESPONSES; INTERFERON-GAMMA; PROTECTS MICE; LIVER	Background: Alveolar echinococcosis (AE) is a severe chronic hepatic parasitic disease currently emerging in central and eastern Europe. Untreated AE presents a high mortality (>90%) due to a severe hepatic destruction as a result of parasitic metacestode proliferation which behaves like a malignant tumor. Despite this severe course and outcome of disease, the genetic program that regulates the host response leading to organ damage as a consequence of hepatic alveolar echinococcosis is largely unknown. Methodology/Principal Findings: We used a mouse model of AE to assess gene expression profiles in the liver after establishment of a chronic disease status as a result of a primary peroral infection with eggs of the fox tapeworm Echinococcus multilocularis. Among 38 genes differentially regulated (false discovery rate adjusted p <= 0.05), 35 genes were assigned to the functional gene ontology group < immune response >, while 3 associated with the functional group < intermediary metabolism >. Upregulated genes associated with, immune response. could be clustered into functional subgroups including < macrophages >, < APCs >, < lymphocytes, chemokines and regulation >, < B-cells > and < eosinophils >. Two downregulated genes related to < lymphocytes, chemokines and regulation > and < intermediary metabolism >, respectively. The < immune response > genes either associated with an < immunosupression > or an < immunostimulation > pathway. From the overexpressed genes, 18 genes were subsequently processed with a Custom Array microfluidic card system in order to assess respective expression status at the mRNA level relative to 5 reference genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37) selected upon a constitutive and stable expression level. The results generated by the two independent tools used for the assessment of gene expression, i.e., microarray and microfluidic card system, exhibited a high level of congruency (Spearman correlation rho = 0.81, p = 7.87e-5) and thus validated the applied methods. Conclusions/Significance: Based on this set of biomarkers, new diagnostic targets have been made available to predict disease status and progression. These biomarkers may also offer new targets for immuno-therapeutic intervention.	[Gottstein, Bruno; Schild, Marc; Mueller, Norbert; Mueller, Joachim] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Wittwer, Matthias; Leib, Stephen L.] Univ Bern, Fac Med, Inst Infect Dis, Bern, Switzerland; [Merli, Michael] Univ Hohenheim, Dept Parasitol, D-7000 Stuttgart, Germany; [Jaggi, Rolf] Univ Bern, Dept Clin Res, Fac Med, Bern, Switzerland	University of Bern; University of Bern; University of Geneva; University Hohenheim; University of Bern; University of Geneva	Gottstein, B (corresponding author), Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland.	bruno.gottstein@ipa.unibe.ch	Leib, Stephen/M-3786-2019; Kummer, Juerg/B-3322-2011; Leib, Stephen L/A-7866-2011; Wittwer, Matthias/K-4512-2014	Leib, Stephen/0000-0002-1106-6123; Leib, Stephen L/0000-0002-1106-6123; Wittwer, Matthias/0000-0003-4713-8392; Muller, Joachim/0000-0001-8189-9270				Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; Amiot F, 1999, PARASITE IMMUNOL, V21, P475, DOI 10.1046/j.1365-3024.1999.00245.x; Asefa B, 2006, FEBS LETT, V580, P1205, DOI 10.1016/j.febslet.2006.01.032; Bandyopadhyay SK, 2008, AM J PATHOL, V173, P1361, DOI 10.2353/ajpath.2008.080444; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; BARON RW, 1976, INT J PARASITOL, V6, P37, DOI 10.1016/0020-7519(76)90008-4; Bauder B, 1999, PARASITE IMMUNOL, V21, P409, DOI 10.1046/j.1365-3024.1999.00241.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernthaler P, 2009, INFECT IMMUN, V77, P5564, DOI 10.1128/IAI.00653-09; Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378; BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x; Dai WJ, 2003, IMMUNOLOGY, V108, P238, DOI 10.1046/j.1365-2567.2003.01567.x; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; DEVOUGE M, 1983, TROPENMED PARASITOL, V34, P15; Emery I, 1998, PARASITE IMMUNOL, V20, P81, DOI 10.1046/j.1365-3024.1998.00131.x; Emery I, 1996, PARASITE IMMUNOL, V18, P463, DOI 10.1111/j.1365-3024.1996.tb01030.x; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Fujii C, 2005, INT J CANCER, V114, P209, DOI 10.1002/ijc.20719; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gauci C, 2002, INFECT IMMUN, V70, P3969, DOI 10.1128/IAI.70.7.3969-3972.2002; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godot V, 2003, GASTROENTEROLOGY, V124, P1441, DOI 10.1016/S0016-5085(03)00273-7; Gottstein B, 2008, PARASITE, V15, P291, DOI 10.1051/parasite/2008153291; GOTTSTEIN B, 2009, MANSONS TROPICAL DIS, P1549; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Jenne L, 1998, CLIN INFECT DIS, V26, P492, DOI 10.1086/516316; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; KIZAKI T, 1993, IMMUNOLOGY, V79, P412; Koniaris LG, 2001, J IMMUNOL, V167, P399, DOI 10.4049/jimmunol.167.1.399; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Liance M, 1998, PARASITE, V5, P231, DOI 10.1051/parasite/1998053231; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Liu N, 2004, FEBS LETT, V569, P49, DOI 10.1016/j.febslet.2004.05.061; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Manicone AM, 2008, EXP LUNG RES, V34, P391, DOI 10.1080/01902140802221987; McManus DP, 2009, PARASITOLOGY, V136, P1643, DOI 10.1017/S0031182009005666; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mejri N, 2006, PARASITE IMMUNOL, V28, P373, DOI 10.1111/j.1365-3024.2006.00836.x; MEJRI N, 2009, PARASITOL RES   0702; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Nakajima M, 2001, INT ARCH ALLERGY IMM, V125, P241, DOI 10.1159/000053822; Nakamichi K, 2004, J VIROL, V78, P9376, DOI 10.1128/JVI.78.17.9376-9388.2004; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; PATER C, 1998, INTESTINAL SYSTEMIC; Pennock JL, 2006, CHEM IMMUNOL ALLERGY, V90, P128, DOI 10.1159/000088885; PLAYFORD MC, 1992, JPN J VET RES, V40, P113; PLAYFORD MC, 1992, INT J PARASITOL, V22, P975, DOI 10.1016/0020-7519(92)90056-Q; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Sailer M, 1997, J PEDIATR-US, V130, P320, DOI 10.1016/S0022-3476(97)70364-0; Santiago HD, 2004, INFECT IMMUN, V72, P4918, DOI 10.1128/IAI.72.8.4918-4923.2004; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; Shalev I, 2009, HEPATOLOGY, V49, P387, DOI 10.1002/hep.22684; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Siles-Lucas M, 2003, VACCINE, V21, P431, DOI 10.1016/S0264-410X(02)00517-0; SILESLUCAS M, 2003, PARASITE IMMUNOL, V20, P623; STANLEY AC, 2008, PLOS PATHOG, V19; Stanley AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000158; Vuitton DA, 2006, PARASITOL INT, V55, pS51, DOI 10.1016/j.parint.2005.11.007; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Xiao H, 2002, J BIOL CHEM, V277, P8091, DOI 10.1074/jbc.M106650200; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340; Yang D, 2003, BLOOD, V102, P3396, DOI 10.1182/blood-2003-01-0151; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Zhai YA, 2008, HEPATOLOGY, V47, P207, DOI 10.1002/hep.21986; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190; Zingg W, 2004, INFECTION, V32, P299, DOI 10.1007/s15010-004-3134-9	74	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9779	10.1371/journal.pone.0009779	http://dx.doi.org/10.1371/journal.pone.0009779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368974	gold, Green Submitted, Green Published			2022-12-25	WOS:000276418200003
J	Singh, AK; Battu, A; Mohareer, K; Hasnain, SE; Ehtesham, NZ				Singh, Anil K.; Battu, Aruna; Mohareer, Krishnaveni; Hasnain, Seyed E.; Ehtesham, Nasreen Z.			Transcription of Human Resistin Gene Involves an Interaction of Sp1 with Peroxisome Proliferator-Activating Receptor Gamma (PPAR gamma)	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; 30-KDA PROTEIN-BINDING; SMOOTH-MUSCLE CELLS; IN-VITRO; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; DIABETIC SUBJECTS; CONTROL ELEMENT; EXPRESSION; PROMOTER	Background: Resistin is a cysteine rich protein, mainly expressed and secreted by circulating human mononuclear cells. While several factors responsible for transcription of mouse resistin gene have been identified, not much is known about the factors responsible for the differential expression of human resistin. Methodology/Principal Finding: We show that the minimal promoter of human resistin lies within similar to 80 bp sequence upstream of the transcriptional start site (-240) whereas binding sites for cRel, CCAAT enhancer binding protein alpha (C/EBP-alpha), activating transcription factor 2 (ATF-2) and activator protein 1 (AP-1) transcription factors, important for induced expression, are present within sequences up to -619. Specificity Protein 1(Sp1) binding site (-276 to -295) is also present and an interaction of Sp1 with peroxisome proliferator activating receptor gamma (PPAR gamma) is necessary for constitutive expression in U937 cells. Indeed co-immunoprecipitation assay demonstrated a direct physical interaction of Sp1 with PPAR gamma in whole cell extracts of U937 cells. Phorbol myristate acetate (PMA) upregulated the expression of resistin mRNA in U937 cells by increasing the recruitment of Sp1, ATF-2 and PPAR gamma on the resistin gene promoter. Furthermore, PMA stimulation of U937 cells resulted in the disruption of Sp1 and PPAR gamma interaction. Chromatin immunoprecipitation (ChIP) assay confirmed the recruitment of transcription factors phospho ATF-2, Sp1, Sp3, PPAR gamma, chromatin modifier histone deacetylase 1 (HDAC1) and the acetylated form of histone H3 but not cRel, C/EBP-alpha and phospho c-Jun during resistin gene transcription. Conclusion: Our findings suggest a complex interplay of Sp1 and PPAR gamma along with other transcription factors that drives the expression of resistin in human monocytic U937 cells.	[Singh, Anil K.; Hasnain, Seyed E.; Ehtesham, Nasreen Z.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Battu, Aruna; Ehtesham, Nasreen Z.] Indian Council Med Res, Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Hasnain, Seyed E.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	University of Hyderabad; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Singh, AK (corresponding author), Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India.	nasreen_e1@hotmail.com	EHTESHAM, NASREEN ZAFAR/AAI-3169-2020; Singh, Anil K/H-6225-2019	Singh, Anil K/0000-0002-4102-2420; Battu, Aruna/0000-0001-7878-8983; Hasnain, Seyed/0000-0002-2967-0791	Indian Council of Medical Research and Council of Scientific and Industrial Research	Indian Council of Medical Research and Council of Scientific and Industrial Research	This work was supported by the Indian Council of Medical Research and Council of Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun H, 1998, J BIOL CHEM, V273, P9821, DOI 10.1074/jbc.273.16.9821; BURMA S, 1994, J BIOL CHEM, V269, P2750; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Conn KJ, 1996, J BIOL CHEM, V271, P28853, DOI 10.1074/jbc.271.46.28853; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ehtesham NZ, 2002, CURR SCI INDIA, V83, P1190; Ehtesham NZ, 2001, CURR SCI INDIA, V80, P1369; Ghosh S, 2003, GENE, V305, P27, DOI 10.1016/S0378-1119(02)01213-1; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Hata Y, 1998, J BIOL CHEM, V273, P19294, DOI 10.1074/jbc.273.30.19294; Heilbronn LK, 2004, J CLIN ENDOCR METAB, V89, P1844, DOI 10.1210/jc.2003-031410; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hoppe KL, 1998, J LIPID RES, V39, P969; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jonke J, 2002, OBES RES, V10, P1; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; Lee YW, 2001, J MOL CELL CARDIOL, V33, P83, DOI 10.1006/jmcc.2000.1278; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; LI BY, 1994, J BIOL CHEM, V269, P7756; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; MUKHERJEE B, 1995, J BIOL CHEM, V270, P4405, DOI 10.1074/jbc.270.9.4405; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Nielsen SJ, 1998, BIOCHEM J, V333, P511, DOI 10.1042/bj3330511; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Rajakumar RA, 1998, J BIOL CHEM, V273, P27474, DOI 10.1074/jbc.273.42.27474; Ramachandran A, 2001, J BIOL CHEM, V276, P23440, DOI 10.1074/jbc.M101537200; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; Song HY, 2002, BIOCHEM BIOPH RES CO, V299, P291, DOI 10.1016/S0006-291X(02)02551-2; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Tanaka T, 2000, ARTERIOSCL THROM VAS, V20, P392, DOI 10.1161/01.ATV.20.2.392; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Vines CR, 2000, ENDOCRINOLOGY, V141, P938, DOI 10.1210/en.141.3.938; Yajima S, 1998, DNA CELL BIOL, V17, P471, DOI 10.1089/dna.1998.17.471; Zhou L, 2006, DOMEST ANIM ENDOCRIN, V30, P98, DOI 10.1016/j.domaniend.2005.06.004; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	68	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9912	10.1371/journal.pone.0009912	http://dx.doi.org/10.1371/journal.pone.0009912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360975	Green Published, gold			2022-12-25	WOS:000276163100007
J	Hadorn, M; Hotz, PE				Hadorn, Maik; Hotz, Peter Eggenberger			DNA-Mediated Self-Assembly of Artificial Vesicles	PLOS ONE			English	Article							LIPID VESICLES; BIOTIN INTERACTIONS; BILAYER VESICLES; LATERAL MOBILITY; LIPOSOMES; ADHESION; BINDING; AGGREGATION; RECOGNITION; FUSION	Background: Although multicompartment systems made of single unilamellar vesicles offer the potential to outperform single compartment systems widely used in analytic, synthetic, and medical applications, their use has remained marginal to date. On the one hand, this can be attributed to the binary character of the majority of the current tethering protocols that impedes the implementation of real multicomponent or multifunctional systems. On the other hand, the few tethering protocols theoretically providing multicompartment systems composed of several distinct vesicle populations suffer from the readjustment of the vesicle formation procedure as well as from the loss of specificity of the linking mechanism over time. Methodology/Principal Findings: In previous studies, we presented implementations of multicompartment systems and resolved the readjustment of the vesicle formation procedure as well as the loss of specificity by using linkers consisting of biotinylated DNA single strands that were anchored to phospholipid-grafted biotinylated PEG tethers via streptavidin as a connector. The systematic analysis presented herein provides evidences for the incorporation of phospholipid-grafted biotinylated PEG tethers to the vesicle membrane during vesicle formation, providing specific anchoring sites for the streptavidin loading of the vesicle membrane. Furthermore, DNA-mediated vesicle-vesicle self-assembly was found to be sequence-dependent and to depend on the presence of monovalent salts. Conclusions/Significance: This study provides a solid basis for the implementation of multi-vesicle assemblies that may affect at least three distinct domains. (i) Analysis. Starting with a minimal system, the complexity of a bottom-up system is increased gradually facilitating the understanding of the components and their interaction. (ii) Synthesis. Consecutive reactions may be implemented in networks of vesicles that outperform current single compartment bioreactors in versatility and productivity. (iii) Personalized medicine. Transport and targeting of long-lived, pharmacologically inert prodrugs and their conversion to short-lived, active drug molecules directly at the site of action may be accomplished if multi-vesicle assemblies of predefined architecture are used.	[Hadorn, Maik] Univ Zurich, Dept Informat, Artificial Intelligence Lab, Zurich, Switzerland; [Hotz, Peter Eggenberger] Univ So Denmark, Maersk Mc Kinney Moller Inst, Odense, Denmark	University of Zurich; University of Southern Denmark	Hadorn, M (corresponding author), Univ Zurich, Dept Informat, Artificial Intelligence Lab, Zurich, Switzerland.	hadorn@ifi.uzh.ch	Hadorn, Maik/I-8909-2012	Hadorn, Maik/0000-0003-4530-9346	Swiss National Foundation [200020-118127]; European Community [FP7/2007-2013, 249032]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Community(European Commission)	Maik Hadorn was partly funded by the Swiss National Foundation Project 200020-118127: 'Embryogenic Evolution: From Simulations to Robotic Applications' (http://www. projectdb.snf.ch/WebForms/Frameset.aspx). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 249032 (http://cordis.europa.eu/fetch?CALLER= PROJ_ICT&ACTION=D&CAT=PROJ&RCN= 92864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Beales PA, 2007, J PHYS CHEM A, V111, P12372, DOI 10.1021/jp075792z; Benkoski JJ, 2005, J PHYS CHEM B, V109, P9773, DOI 10.1021/jp044947p; Berti D, 1998, J PHYS CHEM B, V102, P303, DOI 10.1021/jp972954q; Biancaniello PL, 2007, LANGMUIR, V23, P2688, DOI 10.1021/la062885j; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Bolinger PY, 2008, ANGEW CHEM INT EDIT, V47, P5544, DOI 10.1002/anie.200801606; Bonacucina G, 2009, J PHARM SCI-US, V98, P1, DOI 10.1002/jps.21423; Boyer C, 2007, ACS NANO, V1, P176, DOI 10.1021/nn7002025; Burridge KA, 2004, LANGMUIR, V20, P10252, DOI 10.1021/la0489099; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; CHIRUVOLU S, 1994, SCIENCE, V264, P1753, DOI 10.1126/science.8209255; Chiu DT, 1999, SCIENCE, V283, P1892, DOI 10.1126/science.283.5409.1892; Cobbe S, 2003, J PHYS CHEM B, V107, P470, DOI 10.1021/jp021503p; Constable EC, 1999, CHEM COMMUN, P1483, DOI 10.1039/a904665h; Coussaert T, 2001, BIOPHYS J, V80, P2004, DOI 10.1016/S0006-3495(01)76170-X; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Farbman-Yogev I, 1998, J PHYS CHEM A, V102, P9586, DOI 10.1021/jp9823300; Gomez-Hens A, 2005, TRAC-TREND ANAL CHEM, V24, P9, DOI 10.1016/j.trac.2004.07.017; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HADORN M, 2010, 3 INT JOINT IN PRESS; Hadorn M, 2009, LECT NOTES ARTIF INT, V5865, P126, DOI 10.1007/978-3-642-10427-5_13; Hadorn M, 2009, LECT NOTES ARTIF INT, V5865, P169, DOI 10.1007/978-3-642-10427-5_17; HAN HK, 2002, AAPS J, V2, P48; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747; Kisak ET, 2004, CURR MED CHEM, V11, P199, DOI 10.2174/0929867043456197; Kisak ET, 2000, LANGMUIR, V16, P2825, DOI 10.1021/la990787a; Lasic DD., 1993, LIPOSOMES PHYS APPL; Li WM, 2001, BBA-BIOMEMBRANES, V1513, P193, DOI 10.1016/S0005-2736(01)00351-0; Licata NA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041406; Lynch NJ, 1996, BIOTECHNOL BIOENG, V50, P151; Marchi-Artzner V, 2001, CHEMPHYSCHEM, V2, P367, DOI 10.1002/1439-7641(20010618)2:6<367::AID-CPHC367>3.0.CO;2-#; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; Menger FM, 2002, ANGEW CHEM INT EDIT, V41, P1350, DOI 10.1002/1521-3773(20020415)41:8<1350::AID-ANIE1350>3.0.CO;2-#; Michel M, 2004, LANGMUIR, V20, P6127, DOI 10.1021/la049862u; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; NopplSimson DA, 1996, BIOPHYS J, V70, P1391, DOI 10.1016/S0006-3495(96)79697-2; Owen RL, 2005, ELECTROPHORESIS, V26, P735, DOI 10.1002/elps.200410288; Paleos CM, 1996, J PHYS CHEM-US, V100, P13898, DOI 10.1021/jp961424b; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Pfeiffer I, 2006, ANAL CHEM, V78, P7493, DOI 10.1021/ac061280p; Ratanabanangkoon P, 2003, LANGMUIR, V19, P1054, DOI 10.1021/la026251y; Ratanabanangkoon P, 2002, LANGMUIR, V18, P4270, DOI 10.1021/la025568v; RECORD MT, 1967, BIOPOLYMERS, V5, P975, DOI 10.1002/bip.1967.360051010; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Sideratou Z, 2002, LANGMUIR, V18, P5036, DOI 10.1021/la020150i; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stadler B, 2004, LANGMUIR, V20, P11348, DOI 10.1021/la0482305; Stengel G, 2007, J AM CHEM SOC, V129, P9584, DOI 10.1021/ja073200k; Svedhem S, 2003, CHEMBIOCHEM, V4, P339, DOI 10.1002/cbic.200390055; Tomac S, 1996, J AM CHEM SOC, V118, P5544, DOI 10.1021/ja960495l; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; Vermette P, 2002, LANGMUIR, V18, P505, DOI 10.1021/la0109967; Walker SA, 1997, NATURE, V387, P61, DOI 10.1038/387061a0; Wang CZ, 2003, LANGMUIR, V19, P7676, DOI 10.1021/la0345946; Weikl TR, 2002, EUROPHYS LETT, V59, P916, DOI 10.1209/epl/i2002-00130-3; Wiedmer SK, 2004, TRAC-TREND ANAL CHEM, V23, P562, DOI 10.1016/j.trac.2004.03.001; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yoshina-Ishii C, 2003, J AM CHEM SOC, V125, P3696, DOI 10.1021/ja029783+	65	50	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9886	10.1371/journal.pone.0009886	http://dx.doi.org/10.1371/journal.pone.0009886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360854	Green Published, gold, Green Submitted			2022-12-25	WOS:000275969600004
J	Lindsey, R; Ha, Y; Momany, M				Lindsey, Rebecca; Ha, Youngsil; Momany, Michelle			A Septin from the Filamentous Fungus A. nidulans Induces Atypical Pseudohyphae in the Budding Yeast S. cerevisiae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; GENE FAMILY; BUD NECK; GROWTH; ROLES; LOCALIZATION; ORGANIZATION; CYTOKINESIS; EMERGENCE	Background: Septins, novel cytoskeletal proteins, form rings at the bases of emerging round buds in yeasts and at the bases of emerging elongated hyphal initials in filamentous fungi. Methodology/Principal Findings: When introduced into the yeast Saccharomyces cerevisiae, the septin AspC from the filamentous fungus Aspergillus nidulans induced highly elongated atypical pseudohyphae and spore-producing structures similar to those of hyphal fungi. AspC induced atypical pseudohyphae when S. cerevisiae pseudohyphal or haploid invasive genes were deleted, but not when the CDC10 septin gene was deleted. AspC also induced atypical pseudohyphae when S. cerevisiae genes encoding Cdc12-interacting proteins Bem4, Cla4, Gic1 and Gic2 were deleted, but not when BNI1, a Cdc12-interacting formin gene, was deleted. AspC localized to bud and pseudohypha necks, while its S. cerevisiae ortholog, Cdc12, localized only to bud necks. Conclusions/Significance: Our results suggest that AspC competes with Cdc12 for incorporation into the yeast septin scaffold and once there alters cell shape by altering interactions with the formin Bni1. That introduction of the A. nidulans septin AspC into S. cerevisiae induces a shift from formation of buds to formation of atypical pseudohyphae suggests that septins play an important role in the morphological plasticity of fungi.	[Lindsey, Rebecca; Ha, Youngsil; Momany, Michelle] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Lindsey, R (corresponding author), USDA, ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, Richard B Russell Agr Res Ctr, Athens, GA USA.	momany@plantbio.uga.edu	Momany, Michelle/L-2327-2016	Lindsey, Rebecca/0000-0002-2149-7971; Momany, Michelle/0000-0001-7110-063X	NSF [MCB0211787]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant MCB0211787 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Burke D., 2000, METHODS YEAST GENETI; Cid VJ, 2002, MICROBIOL-SGM, V148, P2647, DOI 10.1099/00221287-148-9-2647; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; DeVirgilio C, 1996, MICROBIOL-SGM, V142, P2897, DOI 10.1099/13500872-142-10-2897; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fares H, 1996, J CELL BIOL, V132, P399, DOI 10.1083/jcb.132.3.399; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Liu HP, 1996, GENETICS, V144, P967; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Momany M, 2001, GENETICS, V157, P969; OZSARAC N, 1995, GENE, V164, P157, DOI 10.1016/0378-1119(95)00438-C; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; RUOHONEN L, 1995, J BIOTECHNOL, V39, P193, DOI 10.1016/0168-1656(95)00024-K; RUOHONEN L, 1991, YEAST, V7, P337, DOI 10.1002/yea.320070404; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; SIKORSKI RS, 1989, GENETICS, V122, P19; VERSELE M, 2004, MOL BIOL CELL; Westfall PJ, 2002, MOL BIOL CELL, V13, P110, DOI 10.1091/mbc.01-06-0312; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	33	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9858	10.1371/journal.pone.0009858	http://dx.doi.org/10.1371/journal.pone.0009858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360845	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969500005
J	Devillard, R; Galvani, S; Thiers, JC; Guenet, JL; Hannun, Y; Bielawski, J; Negre-Salvayre, A; Salvayre, R; Auge, N				Devillard, Raphael; Galvani, Sylvain; Thiers, Jean-Claude; Guenet, Jean-Louis; Hannun, Yusuf; Bielawski, Jacek; Negre-Salvayre, Anne; Salvayre, Robert; Auge, Nathalie			Stress-Induced Sphingolipid Signaling: Role of Type-2 Neutral Sphingomyelinase in Murine Cell Apoptosis and Proliferation (Publication with Expression of Concern. See vol. 13, 2018)	PLOS ONE			English	Article; Publication with Expression of Concern							TUMOR-NECROSIS-FACTOR; LOW-DENSITY LIPOPROTEINS; FACTOR-ALPHA; INDUCED ACTIVATION; CERAMIDE PATHWAY; DEATH; SMPD3; PATHOPHYSIOLOGY; RECEPTORS; GROWTH	Background: Sphingomyelin hydrolysis in response to stress-inducing agents, and subsequent ceramide generation, are implicated in various cellular responses, including apoptosis, inflammation and proliferation, depending on the nature of the different acidic or neutral sphingomyelinases. This study was carried out to investigate whether the neutral Mg2+-dependent neutral sphingomyelinase-2 (nSMase2) plays a role in the cellular signaling evoked by TNFalpha and oxidized LDLs, two stress-inducing agents, which are mitogenic at low concentrations and proapoptotic at higher concentrations. Methodology and Principal Findings: For this purpose, we used nSMase2-deficient cells from homozygous fro/fro (fragilitas ossium) mice and nSMase2-deficient cells reconstituted with a V5-tagged nSMase2. We report that the genetic defect of nSMase2 (in fibroblasts from fro/fro mice) does not alter the TNFalpha and oxidized LDLs-mediated apoptotic response. Likewise, the hepatic toxicity of TNFalpha is similar in wild type and fro mice, thus is independent of nSMase2 activation. In contrast, the mitogenic response elicited by low concentrations of TNFalpha and oxidized LDLs (but not fetal calf serum) requires nSMase2 activation. Conclusion and Significance: nSMase2 activation is not involved in apoptosis mediated by TNFalpha and oxidized LDLs in murine fibroblasts, and in the hepatotoxicity of TNFalpha in mice, but is required for the mitogenic response to stress-inducing agents.	[Devillard, Raphael; Galvani, Sylvain; Thiers, Jean-Claude; Negre-Salvayre, Anne; Salvayre, Robert; Auge, Nathalie] CHU Rangueil, INSERM, U858, F-31054 Toulouse, France; [Galvani, Sylvain; Thiers, Jean-Claude; Negre-Salvayre, Anne; Salvayre, Robert; Auge, Nathalie] Univ Toulouse 3, Fac Med, F-31062 Toulouse, France; [Devillard, Raphael] Univ Bordeaux 2, UFR Odontol, F-33076 Bordeaux, France; [Guenet, Jean-Louis] Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; [Hannun, Yusuf; Bielawski, Jacek] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Medical University of South Carolina	Devillard, R (corresponding author), CHU Rangueil, INSERM, U858, F-31054 Toulouse, France.	nathalie.auge@inserm.fr	Devillard, Raphael/K-9279-2019	Devillard, Raphael/0000-0002-2962-2044; Negre-Salvayre, Anne/0000-0003-2136-5706; Auge, Nathalie/0000-0003-2088-7211	INSERM; Universite Toulouse-3; Institut Francais pour la Recherche Odontologique (IFRO); Fondation pour la Recherche Medicale; Fondation Coeur et Arteres; NIH [GM 43825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Toulouse-3; Institut Francais pour la Recherche Odontologique (IFRO); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Coeur et Arteres; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	INSERM, Universite Toulouse-3, Institut Francais pour la Recherche Odontologique (IFRO), Fondation pour la Recherche Medicale, Fondation Coeur et Arteres, and NIH-GM 43825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Auge N, 2004, CIRCULATION, V110, P571, DOI 10.1161/01.CIR.0000136995.83451.1D; Auge N, 2000, PROG LIPID RES, V39, P207, DOI 10.1016/S0163-7827(00)00007-2; Auge N, 2002, ARTERIOSCL THROM VAS, V22, P1990, DOI 10.1161/01.ATV.0000043453.21629.3B; AUGE N, 1995, BIOCHEM J, V309, P1015, DOI 10.1042/bj3091015; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BROUCKAERT P, 1993, IMMUNOBIOLOGY, V187, P317, DOI 10.1016/S0171-2985(11)80347-5; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Coatrieux C, 2007, FREE RADICAL BIO MED, V43, P80, DOI 10.1016/j.freeradbiomed.2007.03.036; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Escargueil-Blanc I, 1998, J BIOL CHEM, V273, P27389, DOI 10.1074/jbc.273.42.27389; ESCARGUEILBLANC I, 1994, FASEB J, V8, P1075, DOI 10.1096/fasebj.8.13.7926374; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; KITTRELL FS, 1992, CANCER RES, V52, P1924; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Porn-Ares MI, 2003, BIOCHEM J, V374, P403, DOI 10.1042/BJ20021955; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Vieira O, 2000, FASEB J, V14, P532, DOI 10.1096/fasebj.14.3.532; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002	44	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9826	10.1371/journal.pone.0009826	http://dx.doi.org/10.1371/journal.pone.0009826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352118	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400026
J	Fernandes, F; Ansari, IUH; Striker, R				Fernandes, Fiona; Ansari, Israr-ul H.; Striker, Rob			Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO; RNA-POLYMERASE; CELL-CULTURE; REPLICATION; PROTEIN; GENOME; BINDING; STRAIN; DOMAIN	Background: Hepatitis C Virus (HCV) infection is a leading indication for liver transplantation. HCV infection reoccurs almost universally post transplant, decreasing both graft longevity and patient survival. The immunosuppressant, cyclosporine A (CsA) has potent anti-HCV activity towards both HCV replicons and the genotype 2a cell culture infectious virus. Previously, we isolated mutations in the 1bN replicon with less sensitivity to CsA that mapped to both NS5A and NS5B regions of the virus. Mutations in NS5A alone conferred decreased CsA susceptibility regardless of NS5B mutations. Methodology/Principal Findings: We examined the mechanisms by which NS5A mutations contribute to CsA resistance and if they are strain dependent. Using in vitro mutagenesis, the amino acid position 321 mutation of NS5A was restored to the wild-type tyrosine residue conferring partial CsA susceptibility on the mutant replicon. The 321 mutation also alters CsA susceptibility of the JFH cell culture virus. Additionally, we demonstrated a novel CsA-sensitive interaction between NS5A and both cyclophilin A and B. Both the mutant NS5A and wild type NS5A bind cyclophilin in vitro. The NS5A: cyclophilin interaction requires both the NS5A region identified by the resistance mutants and cyclophilin catalytic residues. In cell culture, NS5A from CsA resistant mutant has an enhanced interaction with cyclophilin B. Additionally; NS5B facilitates a stronger binding of mutant NS5A to endogenous cyclophilin B than wild-type in cell culture. Conclusions/Significance: Collectively, this data suggests direct interactions between cyclophilins and NS5A are critical to understand for optimal use of cyclophilin inhibitors in anti-HCV therapy.	[Fernandes, Fiona; Ansari, Israr-ul H.; Striker, Rob] Univ Wisconsin, Dept Med, Madison, WI USA; [Striker, Rob] Univ Wisconsin Hosp & Clin, William S Middleton Mem Vet Adm Hosp, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Fernandes, F (corresponding author), SUNY Stony Brook, Dept Microbiol & Mol Genet, Stony Brook, NY 11794 USA.	tstriker@wisc.edu		Striker, Rob/0000-0002-0454-895X; ANSARI, Israrul/0000-0003-0326-0329	American Cancer Society Research Scholar [07-077-01]; Office of Research and Development; Biomedical Laboratory R&D Service, Department of Veterans Affairs; University of Wisconsin Institute for Clinical and Translational Research; NIH Clinical and Translational Science [1UL1RR025011]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	American Cancer Society Research Scholar(American Cancer Society); Office of Research and Development; Biomedical Laboratory R&D Service, Department of Veterans Affairs(US Department of Veterans Affairs); University of Wisconsin Institute for Clinical and Translational Research; NIH Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the American Cancer Society Research Scholar Grant (07-077-01) to R. S., by the Office of Research and Development, Biomedical Laboratory R&D Service, Department of Veterans Affairs, and by the University of Wisconsin Institute for Clinical and Translational Research, funded through an NIH Clinical and Translational Science Award, grant number 1UL1RR025011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari IH, 2004, J VIROL, V78, P9612, DOI 10.1128/JVI.78.18.9612-9623.2004; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Castro APV, 2003, J VIROL, V77, P9052, DOI 10.1128/JVI.77.16.9052-9068.2003; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Dietrich L, 2001, J VIROL, V75, P4721, DOI 10.1128/JVI.75.10.4721-4733.2001; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; GAITHER LA, VIROLOGY, V397, P43; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; HECK JA, 2009, BIOCH PHARM; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu TW, 2009, ACTA MATH APPL SIN-E, V25, P33, DOI 10.1007/s10255-004-4100-0; LIU X, 2009, CELL MICROBIOL; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; SAMBROOK J, 2001, MOLECULAR CLONING LA; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652	38	74	76	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9815	10.1371/journal.pone.0009815	http://dx.doi.org/10.1371/journal.pone.0009815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352119	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894400017
J	Huster, M; Frei, E; Hofmann, F; Wegener, JW				Huster, Maria; Frei, Eva; Hofmann, Franz; Wegener, Joerg W.			A complex of Ca(V)1.2/PKC is involved in muscarinic signaling in smooth muscle	FASEB JOURNAL			English	Article						micturition; contraction; urinary bladder; phospholipase D	PROTEIN-KINASE-C; RAT URINARY-BLADDER; CARBACHOL-INDUCED CONTRACTION; CALCIUM-CHANNELS; GUINEA-PIG; CA2+ CHANNELS; TRANSDUCTION PATHWAYS; MYOSIN PHOSPHATASE; DETRUSOR MUSCLE; XENOPUS OOCYTES	Here we present functional and biochemical evidence for a Ca2+ channel (Ca(V)1.2)/protein kinase C (PKC) signaling complex being a key player in muscarinic regulation of urinary bladder smooth muscle. Muscarinic stimulation induced Ca2+ signals and concomitant contractions in detrusor muscle from mice that were dependent on functional Ca2+ channels. These signals were still present in muscles being depolarized by 85 mM extracellular K+. Muscarinic-induced contractions were reduced by a PKC inhibitor [bisindolylmaleimide I (BIM-I)] and a phospholipase D (PLD) inhibitor (1-butanol). A phorbol ester (PDBu) enlarged muscarinic-induced Ca2+ signals and contractions. The effects of BIM-I and PDBu were inhibited by isradipine and/or absent in muscles from Ca(V)1.2-deficient mice. Both carbachol and PDBu increased Ca(V)1.2 channel currents in isolated bladder myocytes. Blue native-PAGE electrophoresis revealed that Ca(V)1.2, PKC, and PLD are closely associated in muscles being previously stimulated by carbachol. Immunoprecipitation using anti-Ca(V)1.2 followed by Western blotting demonstrated that Ca(V)1.2 and PKC are coupled in stimulated muscles from wild-type mice. Autoradiography on immunoprecipitates showed that Ca(V)1.2 is a substrate for PKC-mediated phosphorylation. These findings suggest that a signaling complex consisting of Ca(V)1.2, PKC, and, probably, PLD controls muscarinic-mediated phasic contraction of urinary bladder smooth muscle.-Huster, M., Frei, E., Hofmann, F., Wegener, J.W. A complex of Ca(V)1.2/PKC is involved in muscarinic signaling in smooth muscle. FASEB J. 24, 2651-2659 (2010). www.fasebj.org	[Huster, Maria; Frei, Eva; Hofmann, Franz; Wegener, Joerg W.] Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Technical University of Munich	Wegener, JW (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Biedersteiner Str 29, D-80802 Munich, Germany.	wegener@ipt.med.tu-muenchen.de		Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft. The authors thank Lucia Koblitz for excellent technical assistance.	Albert AP, 2005, J PHYSIOL-LONDON, V566, P769, DOI 10.1113/jphysiol.2005.090852; An JY, 2002, BRIT J PHARMACOL, V137, P1001, DOI 10.1038/sj.bjp.0704954; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; BO X, 1990, BRIT J PHARMACOL, V101, P494, DOI 10.1111/j.1476-5381.1990.tb12736.x; Callaghan B, 2004, CIRC RES, V94, P626, DOI 10.1161/01.RES.0000118248.17466.B7; Chang S, 2009, LAB INVEST, V89, P823, DOI 10.1038/labinvest.2009.38; CREED KE, 1983, J PHYSIOL-LONDON, V338, P149, DOI 10.1113/jphysiol.1983.sp014666; Durlu-Kandilci NT, 2006, BRIT J PHARMACOL, V148, P376, DOI 10.1038/sj.bjp.0706723; Ekman M, 2009, BJU INT, V104, P690, DOI 10.1111/j.1464-410X.2009.08576.x; Ekman M, 2009, BJU INT, V103, P90, DOI 10.1111/j.1464-410X.2008.07935.x; FISH RD, 1988, CIRC RES, V62, P1049, DOI 10.1161/01.RES.62.5.1049; Fleichman M, 2004, J PHARMACOL EXP THER, V308, P54, DOI 10.1124/jpet.103.058255; FOVAEUS M, 1987, J UROLOGY, V137, P798, DOI 10.1016/S0022-5347(17)44214-5; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Frazier EP, 2007, J PHARMACOL EXP THER, V322, P998, DOI 10.1124/jpet.107.125393; Frei E, 2009, EUR J PHARMACOL, V610, P106, DOI 10.1016/j.ejphar.2009.03.036; FUJII K, 1988, J PHYSIOL-LONDON, V404, P39, DOI 10.1113/jphysiol.1988.sp017277; Gerthoffer WT, 2005, AM J PHYSIOL-GASTR L, V288, pG849, DOI 10.1152/ajpgi.00530.2004; IACOVOU JW, 1990, J UROLOGY, V144, P775, DOI 10.1016/S0022-5347(17)39590-3; Kajioka S, 2002, EUR J PHARMACOL, V443, P19, DOI 10.1016/S0014-2999(02)01593-5; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Keef KD, 2001, AM J PHYSIOL-CELL PH, V281, pC1743; Koller A, 2003, BIOCHEM BIOPH RES CO, V300, P155, DOI 10.1016/S0006-291X(02)02799-7; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Lai HH, 2004, NEUROCHEM INT, V45, P1185, DOI 10.1016/j.neuint.2004.06.016; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lin MJ, 1998, N-S ARCH PHARMACOL, V357, P553, DOI 10.1007/PL00005207; Liu XR, 2001, GASTROENTEROLOGY, V120, P480, DOI 10.1053/gast.2001.21167; Ludwig A, 1997, J NEUROSCI, V17, P1339; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; MUNRO DD, 1994, CELL CALCIUM, V15, P369, DOI 10.1016/0143-4160(94)90012-4; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; NAKAYAMA S, 1993, BRIT J PHARMACOL, V110, P317, DOI 10.1111/j.1476-5381.1993.tb13811.x; NELSON MT, 1988, NATURE, V336, P382, DOI 10.1038/336382a0; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; Ratz PH, 2002, BRIT J PHARMACOL, V137, P983, DOI 10.1038/sj.bjp.0704952; Rivera L, 2006, BJU INT, V98, P868, DOI 10.1111/j.1464-410X.2006.06431.x; Rumenapp U, 2001, J BIOL CHEM, V276, P2474, DOI 10.1074/jbc.M004957200; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Schneider T, 2004, J PHARMACOL EXP THER, V309, P1148, DOI 10.1124/jpet.103.063735; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; SINGERLAHAT D, 1992, FEBS LETT, V306, P113, DOI 10.1016/0014-5793(92)80980-U; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Weiss S, 2004, J BIOL CHEM, V279, P12503, DOI 10.1074/jbc.M310196200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Wuest M, 2007, EUR J PHARMACOL, V565, P180, DOI 10.1016/j.ejphar.2007.02.046; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; Yang L, 2009, BIOCHEMISTRY-US, V48, P6674, DOI 10.1021/bi900322a; YOSHINO M, 1995, EXP PHYSIOL, V80, P575, DOI 10.1113/expphysiol.1995.sp003868	52	19	19	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2010	24	8					2651	2659		10.1096/fj.09-149856	http://dx.doi.org/10.1096/fj.09-149856			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371628				2022-12-25	WOS:000285005400007
J	Lui, JC; Forcinito, P; Chang, M; Chen, WP; Barnes, KM; Baron, J				Lui, Julian C.; Forcinito, Patricia; Chang, Maria; Chen, Weiping; Barnes, Kevin M.; Baron, Jeffrey			Coordinated postnatal down-regulation of multiple growth-promoting genes: evidence for a genetic program limiting organ growth	FASEB JOURNAL			English	Article						organ size; microarray; histone modification; proliferation	HUMAN GENOME; CELLULAR MEMORY; SOMATIC GROWTH; GROUP PROTEINS; FETAL-RAT; LIVER; SIZE; POLYCOMB; DIFFERENTIATION; TRANSPLANTS	Children grow, but adults do not. The cessation of growth in multiple organs is the end result of a progressive decline in cell proliferation beginning in early life. The mechanisms responsible for this growth deceleration are largely unknown. Using expression microarray and real-time PCR, we identified a common program of gene expression in lung, kidney, and liver during growth deceleration in juvenile rats. Gene ontology analyses and siRNA-mediated knockdown in vitro indicated that many of the down-regulated genes are growth promoting. Down-regulated genes in the program showed declining histone H3K4 trimethylation with age, implicating underlying epigenetic mechanisms. To investigate the physiological processes driving the genetic program, a tryptophan-deficient diet was used to temporarily inhibit juvenile growth in newborn rats for 4 wk. Afterward, microarray analysis showed that the genetic program had been delayed, implying that it is driven by body growth itself rather than age. Taken together, the findings suggest that growth in early life induces progressive down-regulation of a large set of proliferation-stimulating genes, causing organ growth to slow and eventually cease.-Lui, J. C., Forcinito, P., Chang, M., Chen, W., Barnes, K. M., Baron, J. Coordinated postnatal down-regulation of multiple growth-promoting genes: evidence for a genetic program limiting organ growth. FASEB J. 24, 3083-3092 (2010). www.fasebj.org	[Lui, Julian C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Dev Endocrinol Branch, Program Dev Endocrinol & Genet, NIH,CRC, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDKD, Microarray Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Lui, JC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Dev Endocrinol Branch, Program Dev Endocrinol & Genet, NIH,CRC, Room 1-3330,10 Ctr Dr,MSC-1103, Bethesda, MD 20892 USA.	luichunk@mail.nih.gov	Lui, Julian/E-2253-2012; Chen, Wei/GZK-7348-2022	Lui, Julian/0000-0002-0611-4901; Forcinito, Patricia/0000-0001-9754-9881	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	Bantignies F, 2006, CURR OPIN CELL BIOL, V18, P275, DOI 10.1016/j.ceb.2006.04.003; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BRENNER WE, 1976, AM J OBSTET GYNECOL, V126, P555, DOI 10.1016/0002-9378(76)90748-1; Chang M, 2008, PEDIATR RES, V64, P240, DOI 10.1203/PDR.0b013e318180e47a; COOKE PS, 1986, BIOL NEONATE, V49, P211; El Khattabi I, 2003, AM J PHYSIOL-ENDOC M, V285, pE991, DOI 10.1152/ajpendo.00037.2003; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Kennedy D, 2005, SCIENCE, V309, P75, DOI 10.1126/science.309.5731.75; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Orozco-Suarez S, 2003, INT J DEV NEUROSCI, V21, P13, DOI 10.1016/S0736-5748(02)00124-7; Pape L, 2006, NEPHROL DIAL TRANSPL, V21, P2596, DOI 10.1093/ndt/gfl119; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; ROSE SR, 1991, J CLIN ENDOCR METAB, V73, P428, DOI 10.1210/jcem-73-2-428; Sakai Y, 2002, CELL TRANSPLANT, V11, P435; Schafer R, 2006, ARTIF ORGANS, V30, P130, DOI 10.1111/j.1525-1594.2006.00199.x; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SEGALL PE, 1976, MECH AGEING DEV, V5, P109, DOI 10.1016/0047-6374(76)90012-9; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Watanabe N, 2007, HEPATOLOGY, V45, P1240, DOI 10.1002/hep.21539; WINICK M, 1965, DEV BIOL, V12, P451, DOI 10.1016/0012-1606(65)90009-6; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yao M, 2007, ENDOCRINOLOGY, V148, P2518, DOI 10.1210/en.2006-1413; ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379	36	40	41	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2010	24	8					3083	3092		10.1096/fj.09-152835	http://dx.doi.org/10.1096/fj.09-152835			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371622	Green Published			2022-12-25	WOS:000285005400044
J	Allewell, NM				Allewell, Norma M.			Thematic Minireview Series: Single-molecule Measurements in Biochemistry and Molecular Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Maryland, Coll Chem & Life Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Allewell, NM (corresponding author), Univ Maryland, Coll Chem & Life Sci, College Pk, MD 20742 USA.	nallewell@asbmb.org							0	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18959	18960		10.1074/jbc.R110.132449	http://dx.doi.org/10.1074/jbc.R110.132449			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382736	Green Published, hybrid			2022-12-25	WOS:000278727800001
J	Mestdagh, P; Fredlund, E; Pattyn, F; Rihani, A; Van Maerken, T; Vermeulen, J; Kumps, C; Menten, B; De Preter, K; Schramm, A; Schulte, J; Noguera, R; Schleiermacher, G; Janoueix-Lerosey, I; Laureys, G; Powel, R; Nittner, D; Marine, JC; Ringner, M; Speleman, F; Vandesompele, J				Mestdagh, P.; Fredlund, E.; Pattyn, F.; Rihani, A.; Van Maerken, T.; Vermeulen, J.; Kumps, C.; Menten, B.; De Preter, K.; Schramm, A.; Schulte, J.; Noguera, R.; Schleiermacher, G.; Janoueix-Lerosey, I.; Laureys, G.; Powel, R.; Nittner, D.; Marine, J-C; Ringner, M.; Speleman, F.; Vandesompele, J.			An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours	ONCOGENE			English	Article						neuroblastoma; T-UCR; non-coding RNA	NONCODING RNAS; MICRORNAS; PCR; ANTAGONISTS; ASSOCIATE; PATHWAY; MAPS	Different classes of non-coding RNAs, including microRNAs, have recently been implicated in the process of tumourigenesis. In this study, we examined the expression and putative functions of a novel class of non-coding RNAs known as transcribed ultraconserved regions (T-UCRs) in neuroblastoma. Genome-wide expression pro. ling revealed correlations between specific T-UCR expression levels and important clinicogenetic parameters such as MYCN amplification status. A functional genomics approach based on the integration of multi-level transcriptome data was adapted to gain insights into T-UCR functions. Assignments of T-UCRs to cellular processes such as TP53 response, differentiation and proliferation were verified using various cellular model systems. For the first time, our results de. ne a T-UCR expression landscape in neuroblastoma and suggest widespread T-UCR involvement in diverse cellular processes that are deregulated in the process of tumourigenesis. Oncogene (2010) 29, 3583-3592; doi:10.1038/onc.2010.106; published online 12 April 2010	[Vandesompele, J.] Ghent Univ Hosp, Ctr Med Genet, MRB, B-9000 Ghent, East Flanders, Belgium; [Fredlund, E.; Ringner, M.] Lund Univ, Dept Oncol, Lund, Sweden; [Fredlund, E.; Ringner, M.] Lund Univ, Strateg Ctr Translat Canc Res, CREATE Hlth, Lund, Sweden; [Schramm, A.; Schulte, J.] Univ Hosp Essen, Essen, Germany; [Noguera, R.] Med Sch Valencia, Valencia, Spain; [Schleiermacher, G.] Inst Curie, Dept Paediat Oncol, Paris, France; [Schleiermacher, G.; Janoueix-Lerosey, I.] Inst Curie, INSERM, U830, Paris, France; [Laureys, G.] Ghent Univ Hosp, Dept Pediat Oncol, B-9000 Ghent, Belgium; [Powel, R.] PrimerDesign, Southampton, Hants, England; [Nittner, D.; Marine, J-C] VIB UGent, Lab Mol Canc Biol, Ghent, Belgium	Ghent University; Ghent University Hospital; Lund University; Lund University; University of Duisburg Essen; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University	Vandesompele, J (corresponding author), Ghent Univ Hosp, Ctr Med Genet, MRB, Pintelaan 185, B-9000 Ghent, East Flanders, Belgium.	Joke.Vandesompele@UGent.be	Janoueix-Lerosey, Isabelle/G-1758-2018; De Preter, Katleen/I-7135-2013; Marine, Jean Christophe/J-2237-2015; speleman, frank/AAR-5184-2020; Schleiermacher, Gudrun/AAN-4711-2021; Pattyn, Filip/A-4164-2015; Rihani, Ali/R-6608-2019; Schramm, Alexander/G-5688-2010; laureys, genevieve/AAG-2390-2021; Schulte, Johannes H/G-3981-2010; Marine, Jean-Christophe/K-3292-2016; Menten, Björn/B-3072-2013; Ringnér, Markus/G-3641-2011; Vandesompele, Jo/W-3411-2018	Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; De Preter, Katleen/0000-0002-7726-5096; speleman, frank/0000-0002-6628-8559; Schleiermacher, Gudrun/0000-0002-0133-5879; Pattyn, Filip/0000-0003-0858-6651; Rihani, Ali/0000-0002-6176-0519; Schramm, Alexander/0000-0001-7670-7529; Marine, Jean-Christophe/0000-0003-2433-9837; Ringnér, Markus/0000-0001-5469-8940; Vandesompele, Jo/0000-0001-6274-0184; Schulte, Johannes Hubertus/0000-0003-0671-1201; Nittner, David/0000-0002-2939-2453; Mestdagh, Pieter/0000-0001-7821-9684	Gent University [BOF 01D31406, BOF 01F07207, BOF 01Z09407]; Belgian Kid's Fund; Fondation pour la recherche Nuovo-Soldati; RTICC/ISCIII [RD06/0020/0102]; American Cancer Association; Swedish Cancer Society; Fund for Scientific Research [G.0198.08, 31511809]; Belgian Foundation Against Cancer [SCIE2006-25]; Fund for Scientific Research-Flanders; Institute for the Promotion of Innovation by Science and Technology in Flanders [IWT - 081373]; European Community [037260, 201102]	Gent University; Belgian Kid's Fund; Fondation pour la recherche Nuovo-Soldati(Fondation pour la Recherche Medicale); RTICC/ISCIII(Instituto de Salud Carlos III); American Cancer Association; Swedish Cancer Society(Swedish Cancer Society); Fund for Scientific Research; Belgian Foundation Against Cancer; Fund for Scientific Research-Flanders(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Community(European Commission)	We are indebted to all the members of the SIOPEN and the GPOH for providing tumour samples or the clinical history of patients. This research was funded by the Gent University Research Fund (BOF 01D31406 to PM, BOF 01F07207 to FP, BOF 01Z09407 to J Vandesompele), the Belgian Kid's Fund and the Fondation pour la recherche Nuovo-Soldati (J Vermeulen), RD06/0020/0102 from RTICC/ISCIII to RN, the American Cancer Association to EF, the Swedish Cancer Society to MR, the Fund for Scientific Research (grant number: G.0198.08 and 31511809) and the Belgian Foundation Against Cancer, found of public interest (project SCIE2006-25). KDP is a postdoctoral researcher with the Fund for Scientific Research-Flanders. CK is supported by a doctoral grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT - 081373). We acknowledge the support of the European Community under the FP6 (project: STREP: EET-pipeline, number: 037260) and FP7 (ONCOMIRS, grant agreement number 201102). This publication reflects only authors' views; the commission is not liable for any use that may be made of the information herein. This article presents research results of the Belgian programme of Interuniversity Poles of Attraction, initiated by the Belgian State, Prime Minister's Office, Science Policy Programming.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lazcoz P, 2007, CANCER GENET CYTOGEN, V174, P1, DOI 10.1016/j.cancergencyto.2006.08.014; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rozen S, 2000, Methods Mol Biol, V132, P365; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	32	109	118	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2010	29	24					3583	3592		10.1038/onc.2010.106	http://dx.doi.org/10.1038/onc.2010.106			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20383195				2022-12-25	WOS:000278835400013
J	Boitz, JM; Ullman, B				Boitz, Jan M.; Ullman, Buddy			Amplification of Adenine Phosphoribosyltransferase Suppresses the Conditionally Lethal Growth and Virulence Phenotype of Leishmania donovani Mutants Lacking Both Hypoxanthine-guanine and Xanthine Phosphoribosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-ANALYSIS; PURINE METABOLISM; VISCERAL LEISHMANIASIS; NUCLEOSIDE HYDROLASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; ADENOSINE KINASE; IN-VITRO; PROMASTIGOTES; EXPRESSION	Leishmania donovani cannot synthesize purines de novo and obligatorily scavenge purines from the host. Previously, we described a conditional lethal Delta hgprt/Delta xprt mutant of L. donovani (Boitz, J. M., and Ullman, B. (2006) J. Biol. Chem. 281, 16084-16089) that establishes that L. donovani salvages purines primarily through hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and xanthine phosphoribosyltransferase (XPRT). Unlike wild type L. donovani, the Delta hgprt/Delta xprt knockout cannot grow on 6-oxypurines and displays an absolute requirement for adenine or adenosine and 2'-deoxycoformycin, an inhibitor of parasite adenine aminohydrolase activity. Here, we demonstrate that the ability of Delta hgprt/Delta xprt parasites to infect mice was profoundly compromised. Surprisingly, mutant parasites that survived the initial passage through mice partially regained their virulence properties, exhibiting a >10-fold increase in parasite burden in a subsequent mouse infection. To dissect the mechanism by which Delta hgprt/Delta xprt parasites persisted in vivo, suppressor strains that had regained their capacity to grow under restrictive conditions were cloned from cultured Delta hgprt/Delta xprt parasites. The ability of these suppressor clones to grow in and metabolize 6-oxypurines could be ascribed to a marked amplification and overexpression of the adenine phosphoribosyltransferase (APRT) gene. Moreover, transfection of Delta hgprt/Delta xprt cells with an APRT episome recapitulated the suppressor phenotype in vitro and enabled growth on 6-oxypurines. Biochemical studies further showed that hypoxanthine, unexpectedly, was an inefficient substrate for APRT, evidence that could account for the ability of the suppressors to metabolize hypoxanthine. Subsequent analysis implied that APRT amplification was also a potential contributory mechanism by which Delta hgprt/Delta xprt parasites displayed persistence and increased virulence in mice.	[Boitz, Jan M.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Ullman, B (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ullmanb@ohsu.edu			National Institutes of Health [AI023682]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682.	Allen T, 1995, MOL BIOCHEM PARASIT, V74, P99, DOI 10.1016/0166-6851(95)02475-1; ALLEN T, 1989, MOL BIOCHEM PARASIT, V33, P273, DOI 10.1016/0166-6851(89)90089-3; ALLEN TE, 1995, MOL BIOCHEM PARASIT, V73, P133, DOI 10.1016/0166-6851(94)00105-V; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; Cui LW, 2001, GENE, V280, P153, DOI 10.1016/S0378-1119(01)00768-5; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15094; Galazka J, 2006, MOL BIOCHEM PARASIT, V149, P223, DOI 10.1016/j.molbiopara.2006.06.001; Garg R, 2006, INDIAN J MED RES, V123, P439; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HANSON S, 1992, MOL CELL BIOL, V12, P5499, DOI 10.1128/MCB.12.12.5499; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Jardim A, 1999, J BIOL CHEM, V274, P34403, DOI 10.1074/jbc.274.48.34403; KIDDER GW, 1979, P NATL ACAD SCI USA, V76, P3670, DOI 10.1073/pnas.76.8.3670; KIDDER GW, 1977, ARCH BIOCHEM BIOPHYS, V183, P7, DOI 10.1016/0003-9861(77)90412-X; KOSZALKA GW, 1979, J BIOL CHEM, V254, P8185; Krenitsky T A, 1979, Adv Exp Med Biol, V122B, P51; LOOKER DL, 1983, MOL BIOCHEM PARASIT, V9, P15, DOI 10.1016/0166-6851(83)90053-1; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Mullen AB, 1998, ANTIMICROB AGENTS CH, V42, P2722, DOI 10.1128/AAC.42.10.2722; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; Phillips CL, 1999, EMBO J, V18, P3533, DOI 10.1093/emboj/18.13.3533; Phillips CL, 1996, PROTEINS, V25, P510, DOI 10.1002/(SICI)1097-0134(199608)25:4<510::AID-PROT11>3.0.CO;2-K; ROBINSON N, 1984, J BIOL CHEM, V259, P7637; Sambrook J., 2002, MOL CLONING LAB MANU; Shi WX, 2002, J BIOL CHEM, V277, P39981, DOI 10.1074/jbc.M205596200; Shi WX, 2001, BIOCHEMISTRY-US, V40, P10800, DOI 10.1021/bi010465h; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Sillero MAG, 2001, EUR J BIOCHEM, V268, P3605, DOI 10.1046/j.1432-1327.2001.02271.x; Silva M, 2004, BBA-PROTEINS PROTEOM, V1696, P31, DOI 10.1016/j.bbapap.2003.09.003; SOBRAL BWS, 1989, NUCLEIC ACIDS RES, V17, P7359, DOI 10.1093/nar/17.18.7359; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; WILSON K, 1991, J BIOL CHEM, V266, P1665; WILSON K, 1992, MOL BIOCHEM PARASIT, V55, P197, DOI 10.1016/0166-6851(92)90140-F; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016	50	12	13	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18555	18564		10.1074/jbc.M110.125393	http://dx.doi.org/10.1074/jbc.M110.125393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363738	Green Published, hybrid			2022-12-25	WOS:000278453900049
J	Veiga-da-Cunha, M; Tyteca, D; Stroobant, V; Courtoy, PJ; Opperdoes, FR; Van Schaftingen, E				Veiga-da-Cunha, Maria; Tyteca, Donatienne; Stroobant, Vincent; Courtoy, Pierre J.; Opperdoes, Fred R.; Van Schaftingen, Emile			Molecular Identification of NAT8 as the Enzyme That Acetylates Cysteine S-Conjugates to Mercapturic Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL N-ACETYLTRANSFERASE; INTERMEDIATE COMPARTMENT; ENDOPLASMIC-RETICULUM; RAT-LIVER; METABOLISM; KIDNEY; LEUKOTRIENES; PROTEIN; GENES; SPECIFICITY	Our goal was to identify the reaction catalyzed by NAT8 (N-acetyltransferase 8), a putative N-acetyltransferase homologous to the enzyme (NAT8L) that produces N-acetylaspartate in brain. The almost exclusive expression of NAT8 in kidney and liver and its predicted association with the endoplasmic reticulum suggested that it was cysteinyl-S-conjugate N-acetyltransferase, the microsomal enzyme that catalyzes the last step of mercapturic acid formation. In agreement, HEK293T extracts of cells overexpressing NAT8 catalyzed the N-acetylation of S-benzyl-L-cysteine and leukotriene E-4, two cysteine conjugates, but were inactive on other physiological amines or amino acids. Confocal microscopy indicated that NAT8 was associated with the endoplasmic reticulum. Neither of the two frequent single nucleotide polymorphisms found in NAT8, E104K nor F143S, changed the enzymatic activity or the expression of the protein by >= 2-fold, whereas a mutation (R149K) replacing an extremely conserved arginine suppressed the activity. Sequencing of genomic DNA and EST clones corresponding to the NAT8B gene, which resulted from duplication of the NAT8 gene in the primate lineage, disclosed the systematic presence of a premature stop codon at codon 16. Furthermore, truncated NAT8B and NAT8 proteins starting from the following methionine (Met-25) showed no cysteinyl-S-conjugate N-acetyltransferase activity when transfected in HEK293T cells. Taken together, these findings indicate that NAT8 is involved in mercapturic acid formation and confirm that NAT8B is an inactive gene in humans. NAT8 homologues are found in all vertebrate genomes, where they are often encoded by multiple, tandemly repeated genes as many other genes encoding xenobiotic metabolism enzymes.	[Veiga-da-Cunha, Maria; Van Schaftingen, Emile] de Duve Inst, Physiol Chem Lab, B-1200 Brussels, Belgium; [Tyteca, Donatienne; Courtoy, Pierre J.] de Duve Inst, CELL Unit, B-1200 Brussels, Belgium; [Stroobant, Vincent] de Duve Inst, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Opperdoes, Fred R.] de Duve Inst, Trop Dis Res Unit, B-1200 Brussels, Belgium; [Opperdoes, Fred R.] Catholic Univ Louvain, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain	Van Schaftingen, E (corresponding author), de Duve Inst, Physiol Chem Lab, 75 Av Hippocrate, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020; Opperdoes, Fred/N-9922-2019; Opperdoes, Frederik R/C-8897-2018	Opperdoes, Fred/0000-0003-1984-3764; Opperdoes, Frederik R/0000-0003-1984-3764; Van Schaftingen, Emile/0000-0002-6199-7647	Belgian "Fonds National de la Recherche Scientifique,"; Interuniversity Attraction Poles Programme-Belgian Science Policy [P6/05, P6/28]; Region Wallonne; Asco Industries	Belgian "Fonds National de la Recherche Scientifique,"(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office); Region Wallonne; Asco Industries	This work was supported by grants from the Belgian "Fonds National de la Recherche Scientifique," the Interuniversity Attraction Poles Programme-Belgian Science Policy (Networks P6/05 and P6/28), the DIANE Center of Excellence Programme of the Region Wallonne and by Asco Industries.	Aigner A, 1996, BIOCHEM J, V317, P213, DOI 10.1042/bj3170213; Altuntas TG, 2001, TOXICOL APPL PHARM, V177, P85, DOI 10.1006/taap.2001.9302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; Cooper AJL, 2006, AMINO ACIDS, V30, P1, DOI 10.1007/s00726-005-0243-4; Cooper AJL, 2008, ARCH BIOCHEM BIOPHYS, V474, P72, DOI 10.1016/j.abb.2008.02.038; Dekant W, 2001, TOXICOL LETT, V124, P21, DOI 10.1016/S0378-4274(00)00285-X; DENZLINGER C, 1985, SCIENCE, V230, P330, DOI 10.1126/science.4048937; GREEN RM, 1975, BIOCHEM J, V147, P283, DOI 10.1042/bj1470283; HUBER M, 1990, EUR J BIOCHEM, V194, P309, DOI 10.1111/j.1432-1033.1990.tb19458.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Josch C, 1998, BIOCHEM PHARMACOL, V56, P763, DOI 10.1016/S0006-2952(98)00065-3; Juhanson P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-25; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; Keppler D, 2005, METHOD ENZYMOL, V400, P531, DOI 10.1016/S0076-6879(05)00029-7; Keppler D, 1997, BIOL CHEM, V378, P787; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Lespinet O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-436; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; MURPHY RC, 1988, ANN NY ACAD SCI, V524, P35; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; OKAJIMA K, 1984, EUR J BIOCHEM, V142, P281, DOI 10.1111/j.1432-1033.1984.tb08282.x; ORNING L, 1986, J BIOL CHEM, V261, P766; Ozaki K, 1998, J HUM GENET, V43, P255, DOI 10.1007/s100380050084; Popsueva AE, 2001, DEV BIOL, V234, P483, DOI 10.1006/dbio.2001.0261; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; SALA A, 1990, J BIOL CHEM, V265, P21771; STENE DO, 1988, J BIOL CHEM, V263, P2773; STIJNTJES GJ, 1993, TOXICOLOGY, V79, P67, DOI 10.1016/0300-483X(93)90206-8; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VILLA A, 1991, J CELL BIOL, V113, P779, DOI 10.1083/jcb.113.4.779; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006	39	44	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18888	18898		10.1074/jbc.M110.110924	http://dx.doi.org/10.1074/jbc.M110.110924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392701	Green Published, hybrid			2022-12-25	WOS:000278453900079
J	Wong, JK; Campbell, GR; Spector, SA				Wong, Justine K.; Campbell, Grant R.; Spector, Stephen A.			Differential Induction of Interleukin-10 in Monocytes by HIV-1 Clade B and Clade C Tat Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 SUBTYPE-C; PERIPHERAL-BLOOD MONOCYTES; DISEASE PROGRESSION; T-CELLS; ANTIRETROVIRAL THERAPY; KINASE INHIBITORS; IL-10; EXPRESSION; REPLICATION	The clade B human immunodeficiency virus, type 1 (HIV-1) Tat (trans-acting regulatory protein) induces interleukin-10 (IL-10) production in monocytes. IL-10, an anti-inflammatory cytokine, down-regulates proinflammatory cytokines and suppresses the immune response, leading to a rapid progression from HIV-1 infection to AIDS. Nine clades of HIV-1 are responsible for the majority of infections worldwide. Recent studies demonstrate that different HIV-1 clades have biological differences in relation to transmission, replication, and disease progression. In this study, we show that the cysteine to serine mutation at position 31, found in >90% of HIV-1 clade C Tat proteins, results in a marked decrease in IL-10 production in monocytes compared with clade B Tat. Additionally, the C31S mutation found in C Tat is responsible for the inability of these Tat proteins to produce high IL-10 levels in monocytes due to its inability to induce intracellular calcium flux through L-type calcium channels. Moreover, we show that p38 alpha/p38 beta and phosphoinositide 3-kinase are crucial to Tat-induced IL-10 production. These findings provide further evidence that HIV-1 clades differ in their biological properties that may impact HIV-1 pathogenesis and disease progression.	[Wong, Justine K.; Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Wong, Justine K.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	NIAID/National Institutes of Health [AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068632, U01AI068632] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID/National Institutes of Health Grant AI068632 to the IMPAACT Network.	AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Albini A, 1998, J BIOL CHEM, V273, P15895, DOI 10.1074/jbc.273.26.15895; ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022; AMEGLIO E, 1994, J BIOL REG HOMEOS AG, V8, P48; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Ancuta P, 2001, J IMMUNOL, V166, P4244, DOI 10.4049/jimmunol.166.6.4244; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; Bennasser Yamina, 2001, Journal de la Societe de Biologie, V195, P319; BENNETT WE, 1966, J EXP MED, V123, P145, DOI 10.1084/jem.123.1.145; Bhoopat L, 2006, MODERN PATHOL, V19, P255, DOI 10.1038/modpathol.3800527; Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; Campbell GR, 2010, J BIOL CHEM, V285, P1681, DOI 10.1074/jbc.M109.049957; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Conant K, 1996, J VIROL, V70, P1384, DOI 10.1128/JVI.70.3.1384-1389.1996; Contreras X, 2005, VIROLOGY, V332, P316, DOI 10.1016/j.virol.2004.11.032; Cota-Gomez A, 2002, J BIOL CHEM, V277, P14390, DOI 10.1074/jbc.M108591200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Goodchild A, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-40; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JOHNSON WD, 1977, J EXP MED, V146, P1613, DOI 10.1084/jem.146.6.1613; Kaleebu P, 2001, AIDS, V15, P293, DOI 10.1097/00002030-200102160-00001; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; KOOTSTRA NA, 1994, J VIROL, V68, P6967, DOI 10.1128/JVI.68.11.6967-6975.1994; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; Li JCB, 2007, IMMUNOLOGY, V121, P337, DOI 10.1111/j.1365-2567.2007.02580.x; Li JCB, 2005, FEBS LETT, V579, P3055, DOI 10.1016/j.febslet.2005.04.060; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MASOOD R, 1994, BIOCHEM BIOPH RES CO, V202, P374, DOI 10.1006/bbrc.1994.1938; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Naif HM, 1996, AIDS RES HUM RETROV, V12, P1237, DOI 10.1089/aid.1996.12.1237; Novitsky VA, 1999, J VIROL, V73, P4427, DOI 10.1128/JVI.73.5.4427-4432.1999; Opi S, 2004, VACCINE, V22, P3105, DOI 10.1016/j.vaccine.2004.01.057; Orsilles MA, 2006, APMIS, V114, P55, DOI 10.1111/j.1600-0463.2006.apm_108.x; Ott M, 1998, J IMMUNOL, V160, P2872; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RAUTONEN J, 1994, AIDS RES HUM RETROV, V10, P781, DOI 10.1089/aid.1994.10.781; Saruta M, 2009, EUR J IMMUNOL, V39, P2195, DOI 10.1002/eji.200939216; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Ta TA, 2006, MOL PHARMACOL, V69, P532, DOI 10.1124/mol.105.019125; Tebit DM, 2007, AIDS REV, V9, P75; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Wang JH, 1998, J VIROL, V72, P7642, DOI 10.1128/JVI.72.9.7642-7647.1998; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466	56	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18319	18325		10.1074/jbc.M110.120840	http://dx.doi.org/10.1074/jbc.M110.120840			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378550	Green Published, hybrid			2022-12-25	WOS:000278453900025
J	Yamashita, Y; Yamashita, M				Yamashita, Yumiko; Yamashita, Michiaki			Identification of a Novel Selenium-containing Compound, Selenoneine, as the Predominant Chemical Form of Organic Selenium in the Blood of Bluefin Tuna	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; DEATH	A novel selenium-containing compound having a selenium atom in the imidazole ring, 2-selenyl-N-alpha,N-alpha,N-alpha-trimethyl-L-histidine, 3-(2-hydroseleno-1H-imidazol-5-yl)-2-(trimethylammonio)propanoate, was identified from the blood and other tissues of the bluefin tuna, Thunnus orientalis. The seleniumcontaining compound was purified from the tuna blood in several chromatographic steps. High resolution mass spectrometry and nuclear magnetic resonance spectroscopy showed that the exact mass of the [M + H](+) ion of the compound was 533.0562 and the molecular formula was C18H29N6O4Se2. Its gross structure was assigned as the oxidized dimeric form of an ergothioneine selenium analog in which the sulfur of ergothioneine is replaced by selenium. Therefore, we named this novel seleniumcontaining compound "selenoneine." By speciation analysis of organic selenium compounds using liquid chromatography inductively coupled plasma mass spectrometry, selenoneine was found widely distributed in various tissues of the tuna, with the highest concentration in blood; mackerel blood contained similar levels. Selenoneine was measurable at 2-4 orders of magnitude lower concentration in a limited set of tissues from squid, tilapia, pig, and chicken. Quantitatively, selenoneine is the predominant form of organic selenium in tuna tissues.	[Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 236, Japan	Japan Fisheries Research & Education Agency (FRA)	Yamashita, M (corresponding author), Natl Res Inst Fisheries Sci, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 236, Japan.	mic@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [BM-D2300]; Fisheries Research Agency	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Fisheries Research Agency	This work was supported in part by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Rural Biomass Research Project, BM-D2300) and the Fisheries Research Agency.	ARTHUR JR, 1993, AM J CLIN NUTR, V57, P236; Benedict SR, 1926, J BIOL CHEM, V67, P267; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Combs G.F., 1986, ROLE SELENIUM NUTR, P1; CUVINARALAR MLA, 1991, ECOTOX ENVIRON SAFE, V21, P348, DOI 10.1016/0147-6513(91)90074-Y; El-Bayoumy K, 2001, MUTAT RES-FUND MOL M, V475, P123, DOI 10.1016/S0027-5107(01)00075-6; ELGUERO J, 1976, ADV HETEROCYCLIC C S, V1; Ge HH, 1996, ANAL COMMUN, V33, P279, DOI 10.1039/ac9963300279; Ghose A, 2001, BIOFACTORS, V14, P127, DOI 10.1002/biof.5520140117; HATFIELD DL, 2006, SELENIUM ITS MOL BIO, P1; Himeno S, 2000, J HEALTH SCI, V46, P393; IMURA N, 1991, ROCH S ENV, P275; Kiremidjian-Schumacher L, 2001, BIOFACTORS, V14, P161, DOI 10.1002/biof.5520140121; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Oki T, 2003, BREEDING SCI, V53, P101, DOI 10.1270/jsbbs.53.101; Raymond LJ, 2020, NEUROTOXICOLOGY, V81, P294, DOI 10.1016/j.neuro.2020.09.020; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; SALONEN JT, 1982, LANCET, V2, P175; Sasakura C, 1998, J INORG BIOCHEM, V71, P159, DOI 10.1016/S0162-0134(98)10048-X; SAYATO Y, 1993, JPN J TOX ENV HEALTH, V39, P289; TANRET C, 1909, J PHARM CHIM PARIS, V30, P145; WATKINSON JH, 1966, ANAL CHEM, V38, P92; WHO, 1987, ENV HLTH CRIT; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; XU JZ, 1995, J ORG CHEM, V60, P6296, DOI 10.1021/jo00125a014	26	132	137	5	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18134	18138		10.1074/jbc.C110.106377	http://dx.doi.org/10.1074/jbc.C110.106377			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388714	Green Published			2022-12-25	WOS:000278453900003
J	Janbandhu, VC; Singh, AK; Mukherji, A; Kumar, V				Janbandhu, Vaibhao C.; Singh, Anup K.; Mukherji, Atish; Kumar, Vijay			p65 Negatively Regulates Transcription of the Cyclin E Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BIPARTITE REPRESSOR ELEMENT; CELL-CYCLE; RETINOBLASTOMA PROTEIN; DEPENDENT KINASES; HISTONE DEACETYLATION; DOWN-REGULATION; PHO5 PROMOTER; E EXPRESSION; TUMOR-CELLS	NF-kappa B family members play a pivotal role in many cellular and organismal functions, including the cell cycle. As an activator of cyclin D1 and p21(Waf1) genes, NF-kappa B has been regarded as a critical modulator of cell cycle. To study the involvement of NF-kappa B in G(1)/S phase regulation, the levels of selected transcriptional regulators were monitored following overexpression of NF-kappa B or its physiological induction by tumor necrosis factor-alpha. Cyclin E gene was identified as a major transcriptional target of NF-kappa B. Recruitment of NF-kappa B to the cyclin E promoter was correlated with the transrepression of cyclin E gene. Ligation-mediated PCR and micrococcal nuclease-Southern assays suggested the nucleosomal nature of this region while chromatin immunoprecipitation analysis confirmed the exchange of cofactors following tumor necrosis factor-alpha treatment or release from serum starvation. There was a progressive reduction in cyclin E transcription along with the accumulation of catalytically inactive cyclin E-cdk2 complexes and arrest of cells in G(1)/S-phase. Thus, our study clearly establishes NF-kappa B as a negative regulator of cell cycle through transcriptional repression of cyclin E.	[Janbandhu, Vaibhao C.; Singh, Anup K.; Mukherji, Atish; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, POB 10504,Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in		Janbandhu, Vaibhao/0000-0002-3837-1865	International Centre for Genetic Engineering and Biotechnology, New Delhi	International Centre for Genetic Engineering and Biotechnology, New Delhi	This project was supported by a core grant of the International Centre for Genetic Engineering and Biotechnology, New Delhi.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ahn JH, 2001, J BIOL CHEM, V276, P47100, DOI 10.1074/jbc.M107385200; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Bash J, 1997, MOL CELL BIOL, V17, P6526, DOI 10.1128/MCB.17.11.6526; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BOCQUEL MT, 1989, NUCLEIC ACIDS RES, V17, P2581, DOI 10.1093/nar/17.7.2581; Botz J, 1996, MOL CELL BIOL, V16, P3401; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Bresnahan WA, 1996, CELL GROWTH DIFFER, V7, P1283; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chen EY, 1998, BIOCHEM BIOPH RES CO, V249, P728, DOI 10.1006/bbrc.1998.9224; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chou MM, 2003, J BIOL CHEM, V278, P35241, DOI 10.1074/jbc.M305246200; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Donepudi M, 2001, J IMMUNOL, V166, P6491, DOI 10.4049/jimmunol.166.11.6491; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; Geng Y, 1996, ONCOGENE, V12, P1173; Gudas JM, 1999, MOL CELL BIOL, V19, P612; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Henzinger T, 1998, J BIOL CHEM, V273, P14958, DOI 10.1074/jbc.273.24.14958; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Hulleman E, 1999, EXP CELL RES, V253, P422, DOI 10.1006/excr.1999.4677; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KUPRASH DV, 1995, ONCOGENE, V11, P97; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Loeb DM, 2002, J BIOL CHEM, V277, P19627, DOI 10.1074/jbc.M201336200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; Morrison AJ, 2002, MOL CELL BIOL, V22, P856, DOI 10.1128/MCB.22.3.856-865.2002; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Mullany LK, 2007, J BIOL CHEM, V282, P21244, DOI 10.1074/jbc.M702110200; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Polanowska J, 2001, ONCOGENE, V20, P4115, DOI 10.1038/sj.onc.1204514; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sambrook J, 2001, MOL CLONING LAB MANU; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sheehy AM, 1999, J BIOL CHEM, V274, P8708, DOI 10.1074/jbc.274.13.8708; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shih SC, 1996, CANCER RES, V56, P1591; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Steger David J., 1996, Bioessays, V18, P875, DOI 10.1002/bies.950181106; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	86	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17453	17464		10.1074/jbc.M109.058974	http://dx.doi.org/10.1074/jbc.M109.058974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385564	Green Published, hybrid			2022-12-25	WOS:000278133400023
J	Copple, IM; Lister, A; Obeng, AD; Kitteringham, NR; Jenkins, RE; Layfield, R; Foster, BJ; Goldring, CE; Park, BK				Copple, Ian M.; Lister, Adam; Obeng, Akua D.; Kitteringham, Neil R.; Jenkins, Rosalind E.; Layfield, Robert; Foster, Brian J.; Goldring, Christopher E.; Park, B. Kevin			Physical and Functional Interaction of Sequestosome 1 with Keap1 Regulates the Keap1-Nrf2 Cell Defense Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; UBIQUITIN LIGASE COMPLEX; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; PROTEIN; SUBSTRATE; AUTOPHAGY; GENES; ADAPTER; ACETAMINOPHEN	Nrf2 regulates the expression of numerous cytoprotective genes in mammalian cells. The activity of Nrf2 is regulated by the Cul3 adaptor Keap1, yet little is known regarding mechanisms of regulation of Keap1 itself. Here, we have used immunopurification of Keap1 and mass spectrometry, in addition to immunoblotting, to identify sequestosome 1 (SQSTM1) as a cellular binding partner of Keap1. SQSTM1 serves as a scaffold in various signaling pathways and shuttles polyubiquitinated proteins to the proteasomal and lysosomal degradation machineries. Ectopic expression of SQSTM1 led to a decrease in the basal protein level of Keap1 in a panel of cells. Furthermore, RNA interference (RNAi) depletion of SQSTM1 resulted in an increase in the protein level of Keap1 and a concomitant decrease in the protein level of Nrf2 in the absence of changes in Keap1 or Nrf2 mRNA levels. The increased protein level of Keap1 in cells depleted of SQSTM1 by RNAi was linked to a decrease in its rate of degradation; the half-life of Keap1 was almost doubled by RNAi depletion of SQSTM1. The decreased level of Nrf2 in cells depleted of SQSTM1 by RNAi was associated with decreases in the mRNA levels, protein levels, and function of several Nrf2-regulated cell defense genes. SQSTM1 was dispensable for the induction of the Keap1-Nrf2 pathway, as Nrf2 activation by tert-butylhydroquinone or iodoacetamide was not affected by RNAi depletion of SQSTM1. These findings demonstrate a physical and functional interaction between Keap1 and SQSTM1 and reveal an additional layer of regulation in the Keap1-Nrf2 pathway.	[Foster, Brian J.; Goldring, Christopher E.; Park, B. Kevin] Univ Liverpool, MRC, Ctr Drug Safety Sci, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England; [Layfield, Robert] Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2UH, England	University of Liverpool; University of Nottingham	Goldring, CE (corresponding author), Univ Liverpool, MRC, Ctr Drug Safety Sci, Dept Pharmacol & Therapeut, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	c.e.p.goldring@liv.ac.uk		Copple, Ian/0000-0003-4101-1913; Layfield, Robert/0000-0003-0702-3259	Medical Research Council (UK); Wellcome Trust; University of Liverpool; Medical Research Council [G0700654] Funding Source: researchfish; MRC [G0700654] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Liverpool; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (UK), the Wellcome Trust, and the University of Liverpool.	Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Copple IM, 2008, HEPATOLOGY, V48, P1292, DOI 10.1002/hep.22472; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Layfield R, 2008, BIOCHEM SOC T, V36, P469, DOI 10.1042/BST0360469; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Najat D, 2009, J BONE MINER RES, V24, P632, DOI 10.1359/JBMR.081204; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	29	182	193	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16782	16788		10.1074/jbc.M109.096545	http://dx.doi.org/10.1074/jbc.M109.096545			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20378532	Green Published, hybrid			2022-12-25	WOS:000277982600041
J	Wunderlich, K; Juozapaitis, M; Manz, B; Maye, D; Gotz, V; Zohner, A; Wolff, T; Schwemmle, M; Martin, A				Wunderlich, Kerstin; Juozapaitis, Mindaugas; Maenz, Benjamin; Maye, Daniel; Goetz, Veronika; Zoehner, Andrea; Wolff, Thorsten; Schwemmle, Martin; Martin, Arnold			Limited Compatibility of Polymerase Subunit Interactions in Influenza A and B Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; PA SUBUNIT; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; VIRAL-PROTEINS; BINDING; PB1; INTERFERENCE; COMPLEX; MODEL	Despite their close phylogenetic relationship, natural intertypic reassortants between influenza A (FluA) and B (FluB) viruses have not been described. Inefficient polymerase assembly of the three polymerase subunits may contribute to this incompatibility, especially because the known protein-protein interaction domains, including the PA-binding domain of PB1, are highly conserved for each virus type. Here we show that substitution of the FluA PA-binding domain (PB1-A(1-25)) with that of FluB (PB1-B1-25) is accompanied by reduced polymerase activity and viral growth of FluA. Consistent with these findings, surface plasmon resonance spectroscopy measurements revealed that PA of FluA exhibits impaired affinity to biotinylated PB1-B1-25 peptides. PA of FluB showed no detectable affinity to biotinylated PB1-A(1-25) peptides. Consequently, FluB PB1 harboring the PA-binding domain of FluA (PB1-AB) failed to assemble with PA and PB2 into an active polymerase complex. To regain functionality, we used a single amino acid substitution (T6Y) known to confer binding to PA of both virus types, which restored polymerase complex formation but surprisingly not polymerase activity for FluB. Taken together, our results demonstrate that the conserved virus type-specific PA-binding domains differ in their affinity to PA and thus might contribute to intertypic exclusion of reassortants between FluA and FluB viruses.	[Wunderlich, Kerstin; Schwemmle, Martin; Martin, Arnold] Univ Freiburg, Dept Virol, D-70104 Freiburg, Germany; [Wunderlich, Kerstin] Univ Freiburg, Spemann Grad Sch Biol & Med, D-70104 Freiburg, Germany; [Wunderlich, Kerstin] Univ Freiburg, Fac Biol, D-70104 Freiburg, Germany; [Juozapaitis, Mindaugas] Inst Biotechnol, LT-02241 Vilnius, Lithuania; [Zoehner, Andrea; Wolff, Thorsten] Robert Koch Inst, D-13353 Berlin, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Vilnius University; Robert Koch Institute	Schwemmle, M (corresponding author), Hermann Herder Str 11, D-70104 Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de		Juozapaitis, Mindaugas/0000-0002-5112-5562	Deutsche Forschungsgemeinschaft; European Commission; FluResearchNet; German Research Foundation [GSC-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); FluResearchNet; German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the European Commission's Seventh Framework, and FluResearchNet.; Supported by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School).	BAINE WB, 1980, AM J MED, V68, P181, DOI 10.1016/0002-9343(80)90352-6; Biswas SK, 1996, J VIROL, V70, P6716, DOI 10.1128/JVI.70.10.6716-6722.1996; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Crescenzo-Chaigne B, 1999, VIROLOGY, V265, P342, DOI 10.1006/viro.1999.0059; Dauber B, 2004, J VIROL, V78, P1865, DOI 10.1128/JVI.78.4.1865-1872.2004; Dauber B, 2006, J VIROL, V80, P11667, DOI 10.1128/JVI.01142-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, J GEN VIROL, V89, P939, DOI 10.1099/vir.0.83449-0; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Horimoto T, 2003, J VIROL, V77, P8031, DOI 10.1128/JVI.77.14.8031-8038.2003; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Iwatsuki-Horimoto K, 2008, VIRUS RES, V135, P161, DOI 10.1016/j.virusres.2008.03.010; Jambrina E, 1997, VIROLOGY, V235, P209, DOI 10.1006/viro.1997.8682; KAVERIN NV, 1983, J GEN VIROL, V64, P2139, DOI 10.1099/0022-1317-64-10-2139; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; MIKHEEVA A, 1982, ARCH VIROL, V73, P287, DOI 10.1007/BF01318082; MUSTER T, 1991, P NATL ACAD SCI USA, V88, P5177, DOI 10.1073/pnas.88.12.5177; NOLAN TF, 1980, J INFECT DIS, V142, P360, DOI 10.1093/infdis/142.3.360; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; PEREZ DR, 1995, J VIROL, V69, P6932; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; SASNAUSKAS K, 1992, GENE, V116, P105, DOI 10.1016/0378-1119(92)90636-4; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; TOBITA K, 1983, ARCH VIROL, V75, P17, DOI 10.1007/BF01314124; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Wunderlich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007517; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	36	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16704	16712		10.1074/jbc.M110.102533	http://dx.doi.org/10.1074/jbc.M110.102533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363752	Green Published, hybrid			2022-12-25	WOS:000277982600034
J	Yamada, C; Ozaki, T; Ando, K; Suenaga, Y; Inoue, K; Ito, Y; Okoshi, R; Kageyama, H; Kimura, H; Miyazaki, M; Nakagawara, A				Yamada, Chizu; Ozaki, Toshinori; Ando, Kiyohiro; Suenaga, Yusuke; Inoue, Ken-ichi; Ito, Yoshiaki; Okoshi, Rintaro; Kageyama, Hajime; Kimura, Hideki; Miyazaki, Masaru; Nakagawara, Akira			RUNX3 Modulates DNA Damage-mediated Phosphorylation of Tumor Suppressor p53 at Ser-15 and Acts as a Co-activator for p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-LINES; PROMOTER HYPERMETHYLATION; INDUCED APOPTOSIS; GENE-EXPRESSION; GASTRIC-CANCER; PROTEIN MISLOCALIZATION; INDUCE APOPTOSIS; FAMILY GENES; GROWTH; P21(WAF1/CIP1)	Although it has been shown that the gastric tumor suppressor RUNX3 has a growth inhibitory activity, the precise molecular mechanisms behind RUNX3-mediated tumor suppression remained unclear. In this study, we found that RUNX3 is closely involved in DNA damage-dependent phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53. The small interference RNA-mediated knockdown of RUNX3 inhibited adriamycin (ADR)-dependent apoptosis in p53-proficient cells but not in p53-deficient cells in association with a significant reduction of p53-target gene expression as well as phosphorylation of p53 at Ser-15. In response to ADR, RUNX3 was induced to accumulate in the cell nucleus and co-localized with p53. Immunoprecipitation experiments demonstrated that RUNX3 forms a complex with p53 in cells. In vitro pulldown assays revealed that the COOH-terminal portion of p53 is required for the interaction with RUNX3. Forced expression of RUNX3 enhanced p53-mediated transcriptional activation. Additionally, RUNX3 had an ability to induce the phosphorylation of p53 at Ser-15, thereby promoting p53-dependent apoptosis. Intriguingly, RUNX3 interacted with phosphorylated forms of ataxia telangiectasia-mutated in response to ADR; however, it did not affect the extent of DNA damage. From the clinical point of view, coordinated p53 mutation and decreased expression of RUNX3 in 105 human lung adenocarcinomas were significantly associated with the poor outcome of patients (p = 0.0203). Thus, our present results strongly suggest that RUNX3 acts as a novel co-activator for p53 through regulating its DNA damage-induced phosphorylation at Ser-15 and also provide a clue to understanding the molecular mechanisms underlying RUNX3-mediated tumor suppression.	[Yamada, Chizu; Ando, Kiyohiro; Suenaga, Yusuke; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh Ku, Chiba 2608717, Japan; [Yamada, Chizu; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuoh Ku, Chiba 2600856, Japan; [Ozaki, Toshinori; Okoshi, Rintaro] Chiba Canc Ctr Res Inst, Lab Antitumor Res, Chuoh Ku, Chiba 2608717, Japan; [Inoue, Ken-ichi; Ito, Yoshiaki] Proteos, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Inoue, Ken-ichi; Ito, Yoshiaki] Natl Univ Singapore, Yong Loo Lin Sch Med, Oncol Res Inst, Singapore 117456, Singapore; [Kageyama, Hajime] Chiba Canc Ctr Res Inst, Div Chemotherapy & Canc Diag, Chuoh Ku, Chiba 2608717, Japan; [Kimura, Hideki] Chiba Canc Ctr Hosp, Div Resp Surg, Chuoh Ku, Chiba 2608717, Japan	Chiba Cancer Center; Chiba University; Chiba Cancer Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Chiba Cancer Center; Chiba Cancer Center	Nakagawara, A (corresponding author), Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp		Suenaga, Yusuke/0000-0001-6902-5386	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from the Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer, a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a grant-in-aid for scientific research from Japan Society for the Promotion of Science.	Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FRIEND S, 1994, SCIENCE, V265, P334, DOI 10.1126/science.8023155; Furuya K, 2007, J BIOL CHEM, V282, P18365, DOI 10.1074/jbc.M610522200; Goel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ikawa S, 1999, CELL DEATH DIFFER, V6, P1154, DOI 10.1038/sj.cdd.4400631; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; LEVINE AJ, 1994, J LAB CLIN MED, V123, P817; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wada M, 2004, ONCOGENE, V23, P2401, DOI 10.1038/sj.onc.1207395; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoshida K, 2008, ONCOGENE, V27, P1183, DOI 10.1038/sj.onc.1210722; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	43	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16693	16703		10.1074/jbc.M109.055525	http://dx.doi.org/10.1074/jbc.M109.055525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353948	Green Published, hybrid			2022-12-25	WOS:000277982600033
J	Oglesby-Sherrouse, AG; Vasil, ML				Oglesby-Sherrouse, Amanda G.; Vasil, Michael L.			Characterization of a Heme-Regulated Non-Coding RNA Encoded by the prrF Locus of Pseudomonas aeruginosa	PLOS ONE			English	Article							VIRULENCE FACTOR PRODUCTION; FERRIC UPTAKE REGULATOR; BINDING PROTEIN PHUS; SERRATIA-MARCESCENS; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; SIGNAL-TRANSDUCTION; IRON TRANSPORT; GENE; SIDEROPHORE	Pseudomonas aeruginosa, an opportunistic pathogen, requires iron for virulence and can obtain this nutrient via the acquisition of heme, an abundant source of iron in the human body. A surplus of either iron or heme can lead to oxidative stress; thus, the Fur (ferric uptake regulator) protein blocks expression of genes required for iron and heme uptake in iron-replete environments. Fur also represses expression of two nearly identical genes encoding the 116- and 114-nucleotide (nt) long PrrF1 and PrrF2 RNAs, respectively. While other Pseudomonads encode for the two PrrF RNAs at separate genomic loci, PrrF1 and PrrF2 are encoded in tandem in all sequenced strains of P. aeruginosa. In this report we characterize a third longer transcript encoded by the prrF locus, PrrH, which is repressed by heme as well as iron. We mapped the PrrH RNA in PA01 using 5' rapid amplification of cDNA ends (RACE) and northern analysis, demonstrating the PrrH RNA is 325 nt in length. Accordingly, transcription of PrrH initiates at the 5' end of prrF1, proceeds through the prrF1 terminator and prrF1-prrF2 intergenic sequence (95 nt), and terminates at the 3' end of the prrF2 gene. We also present evidence that repression of PrrH by heme causes increased expression of previously identified PrrF-regulated genes, as well as newly identified iron-and heme-activated genes. Thus, the PrrH RNA appears to impart a novel heme regulatory mechanism to P. aeruginosa.	[Oglesby-Sherrouse, Amanda G.; Vasil, Michael L.] Univ Colorado, Dept Microbiol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Oglesby-Sherrouse, AG (corresponding author), Univ Colorado, Dept Microbiol, Anschutz Med Campus, Aurora, CO USA.	Amanda.Oglesby@ucdenver.edu		Oglesby, Mandy/0000-0003-4440-3840	Cystic Fibrosis Foundation [OGLESB08F0]; National Institutes of Health [R37-NIH AI15940]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015940] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Cystic Fibrosis Foundation (http://cff.org/) Grant OGLESB08F0 (to A.G.O.) and National Institutes of Health (http://nih.gov/) Grant R37-NIH AI15940 (to M. L. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Alontaga AY, 2009, BIOCHEMISTRY-US, V48, P96, DOI 10.1021/bi801860g; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bibb LA, 2007, INFECT IMMUN, V75, P2421, DOI 10.1128/IAI.01821-06; Brickman TJ, 2006, INFECT IMMUN, V74, P1741, DOI 10.1128/IAI.74.3.1741-1744.2006; COX CD, 1982, INFECT IMMUN, V36, P17, DOI 10.1128/IAI.36.1.17-23.1982; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; GUDAT JC, 1973, BIOCHIM BIOPHYS ACTA, V292, P376, DOI 10.1016/0005-2728(73)90044-3; Hagan EC, 2009, MOL MICROBIOL, V71, P79, DOI 10.1111/j.1365-2958.2008.06509.x; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jung YS, 2008, CURR MICROBIOL, V57, P593, DOI 10.1007/s00284-008-9248-z; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 1996, MOL MICROBIOL, V21, P1019, DOI 10.1046/j.1365-2958.1996.481425.x; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; PRINCE RW, 1991, MOL MICROBIOL, V5, P2823, DOI 10.1111/j.1365-2958.1991.tb01991.x; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Sambrook J, 2001, MOL CLONING LAB MANU; Sapriel G, 2003, J BACTERIOL, V185, P80, DOI 10.1128/JB.185.1.80-88.2003; Stauff DL, 2007, J BIOL CHEM, V282, P26111, DOI 10.1074/jbc.M703797200; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Takase H, 2000, INFECT IMMUN, V68, P4498, DOI 10.1128/IAI.68.8.4498-4504.2000; TAYLOR RK, 1989, J BACTERIOL, V171, P1870, DOI 10.1128/jb.171.4.1870-1878.1989; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vanderpool CK, 2003, J BACTERIOL, V185, P909, DOI 10.1128/JB.185.3.909-917.2003; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001; Wilson MJ, 2000, BIOCHEM BIOPH RES CO, V273, P578, DOI 10.1006/bbrc.2000.2996; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	53	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9930	10.1371/journal.pone.0009930	http://dx.doi.org/10.1371/journal.pone.0009930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386693	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482000002
J	Schildkraut, JM; Iversen, ES; Wilson, MA; Clyde, MA; Moorman, PG; Palmieri, RT; Whitaker, R; Bentley, RC; Marks, JR; Berchuck, A				Schildkraut, Joellen M.; Iversen, Edwin S.; Wilson, Melanie A.; Clyde, Merlise A.; Moorman, Patricia G.; Palmieri, Rachel T.; Whitaker, Regina; Bentley, Rex C.; Marks, Jeffrey R.; Berchuck, Andrew			Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; OVEREXPRESSION; P53; SUSCEPTIBILITY; OVULATION; MUTATION; BENIGN	Background: We analyzed the association between 53 genes related to DNA repair and p53-mediated damage response and serous ovarian cancer risk using case-control data from the North Carolina Ovarian Cancer Study (NCOCS), a population-based, case-control study. Methods/Principal Findings: The analysis was restricted to 364 invasive serous ovarian cancer cases and 761 controls of white, non-Hispanic race. Statistical analysis was two staged: a screen using marginal Bayes factors (BFs) for 484 SNPs and a modeling stage in which we calculated multivariate adjusted posterior probabilities of association for 77 SNPs that passed the screen. These probabilities were conditional on subject age at diagnosis/interview, batch, a DNA quality metric and genotypes of other SNPs and allowed for uncertainty in the genetic parameterizations of the SNPs and number of associated SNPs. Six SNPs had Bayes factors greater than 10 in favor of an association with invasive serous ovarian cancer. These included rs5762746 (median OR(odds ratio)(per allele) = 0.66; 95% credible interval (CI) = 0.44-1.00) and rs6005835 (median ORper (allele) = 0.69; 95% CI = 0.53-0.91) in CHEK2, rs2078486 (median ORper allele = 1.65; 95% CI = 1.21-2.25) and rs12951053 (median ORper allele = 1.65; 95% CI = 1.20-2.26) in TP53, rs411697 (median ORrare homozygote = 0.53; 95% CI = 0.35-0.79) in BACH1 and rs10131 (median ORrare homozygote = not estimable) in LIG4. The six most highly associated SNPs are either predicted to be functionally significant or are in LD with such a variant. The variants in TP53 were confirmed to be associated in a large follow-up study. Conclusions/Significance: Based on our findings, further follow-up of the DNA repair and response pathways in a larger dataset is warranted to confirm these results.	[Schildkraut, Joellen M.; Moorman, Patricia G.] Duke Univ, Med Ctr, Dept Community, Durham, NC 27706 USA; [Schildkraut, Joellen M.; Moorman, Patricia G.] Duke Univ, Med Ctr, Dept Family Med, Durham, NC USA; [Schildkraut, Joellen M.; Iversen, Edwin S.; Moorman, Patricia G.; Marks, Jeffrey R.; Berchuck, Andrew] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Iversen, Edwin S.; Wilson, Melanie A.; Clyde, Merlise A.] Duke Univ, Med Ctr, Dept Stat Sci, Durham, NC USA; [Palmieri, Rachel T.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Whitaker, Regina; Berchuck, Andrew] Duke Univ, Med Ctr, Obstet & Gynecol Div Gynecol Oncol, Durham, NC USA; [Bentley, Rex C.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Marks, Jeffrey R.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Marks, Jeffrey R.; Berchuck, Andrew] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University	Schildkraut, JM (corresponding author), Duke Univ, Med Ctr, Dept Community, Durham, NC 27706 USA.	schil001@mc.duke.edu	Clyde, Merlise/ABG-3538-2020	Clyde, Merlise/0000-0002-3595-1872; Weber, Rachel/0000-0001-7119-7734	National Institutes of Health [1-R01-CA76016, 1-R01-HL090559]; NATIONAL CANCER INSTITUTE [R01CA076016, U01CA084955] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript was supported by grants from the National Institutes of Health 1-R01-CA76016 and 1-R01-HL090559. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscipt.	American Cancer Society, 2009, CANC FACTS FIG 2009; AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; Auranen A, 2005, INT J CANCER, V117, P611, DOI 10.1002/ijc.21047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beesley J, 2007, CANCER EPIDEM BIOMAR, V16, P2557, DOI 10.1158/1055-9965.EPI-07-0542; BERCHUCK A, 1994, GYNECOL ONCOL, V52, P232, DOI 10.1006/gyno.1994.1037; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Clyde M, 2004, STAT SCI, V19, P81, DOI 10.1214/088342304000000035; EMIGH TH, 1980, COMP TESTS HARDY WEI, P627; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Havrilesky L, 2003, J CLIN ONCOL, V21, P3814, DOI 10.1200/JCO.2003.11.052; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hoeting JA, 2000, STAT SCI, V15, P193, DOI 10.1214/ss/1009212814; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Modugno F, 2004, AM J OBSTET GYNECOL, V191, P733, DOI 10.1016/j.ajog.2004.03.035; Moorman PG, 2008, AM J EPIDEMIOL, V167, P1059, DOI 10.1093/aje/kwn006; Moorman PG, 2002, CANCER CAUSE CONTROL, V13, P807, DOI 10.1023/A:1020678100977; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Murdoch WJ, 2001, BIOL REPROD, V65, P1417, DOI 10.1095/biolreprod65.5.1417; Ness RB, 2002, AM J EPIDEMIOL, V155, P217, DOI 10.1093/aje/155.3.217; Pearce CL, 2009, BRIT J CANCER, V100, P412, DOI 10.1038/sj.bjc.6604820; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; Schildkraut JM, 2008, CANCER EPIDEM BIOMAR, V17, P585, DOI 10.1158/1055-9965.EPI-07-0596; Schildkraut JM, 2007, CANCER EPIDEM BIOMAR, V16, P473, DOI 10.1158/1055-9965.EPI-06-0868; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; Song HL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000268; Song HL, 2006, CARCINOGENESIS, V27, P2235, DOI 10.1093/carcin/bgl089; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; WILSON MA, 2009, ANN APPL ST IN PRESS; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	38	55	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10061	10.1371/journal.pone.0010061	http://dx.doi.org/10.1371/journal.pone.0010061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386703	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482000007
J	Drenos, F; Kirkwood, TBL				Drenos, Fotios; Kirkwood, Thomas B. L.			Selection on Alleles Affecting Human Longevity and Late-Life Disease: The Example of Apolipoprotein E	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; E POLYMORPHISM; E GENOTYPE; E GENE; RELATIVE RISK; BLOOD-PRESSURE; APOE; ASSOCIATION; EVOLUTION	It is often claimed that genes affecting health in old age, such as cardiovascular and Alzheimer diseases, are beyond the reach of natural selection. We show in a simulation study based on known genetic (apolipoprotein E) and non-genetic risk factors (gender, diet, smoking, alcohol, exercise) that, because there is a statistical distribution of ages at which these genes exert their influence on morbidity and mortality, the effects of selection are in fact non-negligible. A gradual increase with each generation of the epsilon 2 and epsilon 3 alleles of the gene at the expense of the epsilon 4 allele was predicted from the model. The epsilon 2 allele frequency was found to increase slightly more rapidly than that for epsilon 3, although there was no statistically significant difference between the two. Our result may explain the recent evolutionary history of the epsilon 2, 3 and 4 alleles of the apolipoprotein E gene and has wider relevance for genes affecting human longevity.	[Drenos, Fotios; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Drenos, F (corresponding author), UCL, Dept Med, Div Cardiovasc Genet, London, England.	F.Drenos@ucl.ac.uk	; Stefanadis, Christodoulos/ABH-2232-2020	Drenos, Fotios/0000-0003-2469-5516; Stefanadis, Christodoulos/0000-0001-5974-6454	Dr Hadwen Trust; Biotechnology and Biological Sciences Research Council [BB/C008200/1] Funding Source: researchfish; Medical Research Council [G0700718B] Funding Source: researchfish	Dr Hadwen Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the Dr Hadwen Trust for financial support (http://www.drhadwentrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bernstein MS, 2002, ARTERIOSCL THROM VAS, V22, P133, DOI 10.1161/hq0102.101819; Blanche H, 2001, CR ACAD SCI III-VIE, V324, P129, DOI 10.1016/S0764-4469(00)01274-9; Charlesworth B, 1996, CURR BIOL, V6, P20, DOI 10.1016/S0960-9822(02)00411-6; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; CORBO RM, 1995, ANN HUM GENET, V59, P197, DOI 10.1111/j.1469-1809.1995.tb00741.x; Corbo RM, 2004, MOL HUM REPROD, V10, P617, DOI 10.1093/molehr/gah082; Corbo RM, 2004, FERTIL STERIL, V81, P104, DOI 10.1016/j.fertnstert.2003.05.029; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Corella D, 2001, AM J CLIN NUTR, V73, P736; Cournil A, 2000, P ROY SOC B-BIOL SCI, V267, P1021, DOI 10.1098/rspb.2000.1105; DeCarli C, 2001, ARCH NEUROL-CHICAGO, V58, P643, DOI 10.1001/archneur.58.4.643; DONG LM, 1994, J BIOL CHEM, V269, P22358; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Ewbank DC, 2004, J GERONTOL A-BIOL, V59, P16; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Frisoni GB, 2001, J GERONTOL A-BIOL, V56, pM75, DOI 10.1093/gerona/56.2.M75; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Gerdes LU, 1996, HUM GENET, V98, P239, DOI 10.1007/s004390050200; Gerdes LU, 1996, HUM GENET, V98, P546, DOI 10.1007/s004390050257; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; HAWKES K, 2002, GRANDMOTHERS EVOLUTI, P380; Henneman P, 2009, EUR J HUM GENET, V17, P620, DOI 10.1038/ejhg.2008.202; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; Kauma H, 1998, AM J HYPERTENS, V11, P1334, DOI 10.1016/S0895-7061(98)00163-0; Kennedy GE, 2003, J ROY ANTHROPOL INST, V9, P549, DOI 10.1111/1467-9655.00163; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kolovou G, 2002, CURR MED RES OPIN, V18, P118, DOI 10.1185/030079902125000444; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; Lewis SJ, 2004, INT J EPIDEMIOL, V33, P962, DOI 10.1093/ije/dyh214; Ljungquist B, 1998, J GERONTOL A-BIOL, V53, pM441, DOI 10.1093/gerona/53A.6.M441; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, NEUROBIOL AGING, V20, P429, DOI 10.1016/S0197-4580(99)00081-0; Martin GM, 1999, NEUROBIOL AGING, V20, P441, DOI 10.1016/S0197-4580(99)00078-0; Marz W, 1998, J LIPID RES, V39, P658; Masson LF, 2003, AM J CLIN NUTR, V77, P1098, DOI 10.1093/ajcn/77.5.1098; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Medawar P., 1952, UNSOLVED PROBLEM BIO; Millen BE, 2002, PREV MED, V35, P540, DOI 10.1006/pmed.2002.1116; Millen BE, 2001, J AM DIET ASSOC, V101, P187, DOI 10.1016/S0002-8223(01)00051-7; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; MILTON K, CRITICAL ROLE PLAYED, pS3886; Ordovas JM, 1999, P NUTR SOC, V58, P171, DOI 10.1079/PNS19990023; Ordovas JM, 1995, ATHEROSCLEROSIS, V118, pS11; Panagiotakos DB, 2002, PREV MED, V35, P548, DOI 10.1006/pmed.2002.1108; Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9; PETERSEN S, 2002, CORONARY HEART STAT; PRENTICE AM, INSIGHTS DEV WORLD T, P153; Puddey IB, 1999, AM J HYPERTENS, V12, P946; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; RALL SC, 1982, J BIOL CHEM, V257, P4171; Rea IM, 2001, MECH AGEING DEV, V122, P1367, DOI 10.1016/S0047-6374(01)00278-0; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; Roses AD, 1997, NEUROBIOL DIS, V4, P170, DOI 10.1006/nbdi.1997.0161; Sapolsky RM, 2000, ANN NY ACAD SCI, V924, P99; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Smith JD, 2002, AGEING RES REV, V1, P345, DOI 10.1016/S1568-1637(02)00005-3; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stengard JH, 1996, HUM GENET, V97, P677; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Twisk JWR, 2001, ANN EPIDEMIOL, V11, P157, DOI 10.1016/S1047-2797(00)00202-7; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; van der Meer IM, 2002, J HYPERTENS, V20, P2327, DOI 10.1097/00004872-200212000-00003; VANBOCKXMEER FM, 1994, NAT GENET, V6, P4, DOI 10.1038/ng0194-4; WERNETTEHAMMOND ME, 1989, J BIOL CHEM, V264, P9094; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	85	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10022	10.1371/journal.pone.0010022	http://dx.doi.org/10.1371/journal.pone.0010022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368805	Green Submitted, gold, Green Published			2022-12-25	WOS:000276419900019
J	Said-Sadier, N; Padilla, E; Langsley, G; Ojcius, DM				Said-Sadier, Najwane; Padilla, Eduardo; Langsley, Gordon; Ojcius, David M.			Aspergillus fumigatus Stimulates the NLRP3 Inflammasome through a Pathway Requiring ROS Production and the Syk Tyrosine Kinase	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; INVASIVE ASPERGILLOSIS; HOST-DEFENSE; CASPASE-1 ACTIVATION; FUNGAL-INFECTIONS; CANDIDA-ALBICANS; RECEPTORS; DECTIN-1; PROTEIN; CELLS	Invasive aspergillosis (IA) is a life-threatening disease that occurs in immunodepressed patients when infected with Aspergillus fumigatus. This fungus is the second most-common causative agent of fungal disease after Candida albicans. Nevertheless, much remains to be learned about the mechanisms by which A. fulmigatus activates the innate immune system. We investigated the inflammatory response to conidia and hyphae of A. fumigatus and specifically, their capacity to trigger activation of an inflammasome. Our results show that in contrast to conidia, hyphal fragments induce NLRP3 inflammasome assembly, caspase-1 activation and IL-1 beta release from a human monocyte cell line. The ability of Aspergillus hyphae to activate the NLRP3 inflammasome in the monocytes requires K+ efflux and ROS production. In addition, our data show that NLRP3 inflammasome activation as well as pro-IL-1 beta expression relies on the Syk tyrosine kinase, which is downstream from the pathogen recognition receptor Dectin-1, reinforcing the importance of Dectin-1 in the innate immune response against fungal infection. Furthermore, we show that treatment of monocytes with corticosteroids inhibits transcription of the gene encoding IL-1 beta. Thus, our data demonstrate that the innate immune response against A. fumigatus infection involves a two step activation process, with a first signal promoting expression and synthesis of pro-IL-1 beta; and a second signal, involving Syk-induced activation of the NLRP3 inflammasome and caspase-1, allowing processing and secretion of the mature cytokine.	[Said-Sadier, Najwane; Padilla, Eduardo; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Said-Sadier, Najwane; Padilla, Eduardo; Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Said-Sadier, Najwane; Langsley, Gordon] Univ Paris Diderot, Grad Grp Biochim Biotherapies Biol Mol & Infectio, Paris, France; [Langsley, Gordon] Univ Paris 05, CNRS, UMR 8104, Inst Cochin,INSERM,U1016, Paris, France	University of California System; University of California Merced; University of California System; University of California Merced; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Said-Sadier, N (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA.	david.ojcius@gmail.com	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495	University of California	University of California(University of California System)	Experiments for this study were funded by the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, DRUG TODAY, V45, P105; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Almyroudis NG, 2005, MED MYCOL, V43, pS247, DOI 10.1080/13693780400025203; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Carneiro LAM, 2004, MICROBES INFECT, V6, P609, DOI 10.1016/j.micinf.2004.01.012; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Herbrecht R, 2005, MED MYCOL, V43, pS239, DOI 10.1080/13693780400025161; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ito JI, 2006, INFECT IMMUN, V74, P5075, DOI 10.1128/IAI.00815-06; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MEDOFF G, 1991, HOSP PRACT, V26, P41; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Silveira F, 2005, CURR OPIN PULM MED, V11, P242, DOI 10.1097/01.mcp.0000159832.20648.70; Simitsopoulou M, 2007, ANTIMICROB AGENTS CH, V51, P1048, DOI 10.1128/AAC.01095-06; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wiederhold NP, 2003, PHARMACOTHERAPY, V23, P1592, DOI 10.1592/phco.23.15.1592.31965; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	45	216	229	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10008	10.1371/journal.pone.0010008	http://dx.doi.org/10.1371/journal.pone.0010008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368800	Green Submitted, Green Published, gold			2022-12-25	WOS:000276419900011
J	Lee, TY; Folkman, J; Javaherian, K				Lee, Tong-Young; Folkman, Judah; Javaherian, Kashi			HSPG-Binding Peptide Corresponding to the Exon 6a-Encoded Domain of VEGF Inhibits Tumor Growth by Blocking Angiogenesis in Murine Model	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; IDENTIFICATION; DROSOPHILA; RECEPTOR; MIGRATION; VARIANTS; HEDGEHOG; ISOFORM	Vascular endothelial growth factor VEGF165 is a critical element for development of the vascular system in physiological and pathological angiogenesis. VEGF isoforms have different affinities for heparan sulphate proteoglycan (HSPG) as well as for VEGF receptors; HSPGs are important regulators in vascular development. Therefore, inhibition of interactions between VEGF and HSPGs may prevent angiogenesis. Here, we demonstrate that an HSPG-binding synthetic peptide, corresponding to exon 6a-encoded domain of VEGF gene, has anti-angiogenic property. This 20 amino acids synthetic peptide prevents VEGF165 binding to several different cell types, mouse embryonic sections and inhibits endothelial cell migration, despite its absence in VEGF165 sequence. Our in vivo anti-tumor studies show that the peptide inhibits tumor growth in both mouse Lewis-Lung Carcinoma and human Liposarcoma tumor-bearing animal models. This is the first evidence that a synthetic VEGF fragment corresponding to exon 6a has functional antagonism both in vitro and in vivo. We conclude that the above HPSG binding peptide (6a-P) is a potent inhibitor of angiogenesis-dependent diseases.	[Lee, Tong-Young; Folkman, Judah; Javaherian, Kashi] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Lee, Tong-Young; Folkman, Judah; Javaherian, Kashi] Harvard Univ, Sch Med, Boston, MA USA; [Javaherian, Kashi] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Dept Med,Ctr Canc Syst Biol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; St. Elizabeth's Medical Center; Tufts University	Lee, TY (corresponding author), Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA.	tongyounglee@gmail.com; kashi.javaherian@caritaschristi.org			National Institutes of Health (NIH) [R01-CA064481, P01-CA45548]; The Breast Cancer Research Foundation [DOE (DE-SC0002606)]; NATIONAL CANCER INSTITUTE [R01CA064481, P01CA045548] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants R01-CA064481 (J.F.), NIH P01-CA45548 (J.F.), Department of Defense Grant W81XWH-05-1-0115 (J.F.), a grant from The Breast Cancer Research Foundation (J.F.), and a grant from DOE (DE-SC0002606) (K.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brekken RA, 1998, CANCER RES, V58, P1952; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Herve MA, 2005, EXP CELL RES, V309, P24, DOI 10.1016/j.yexcr.2005.05.022; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Neufeld G, 1996, CANCER METAST REV, V15, P153, DOI 10.1007/BF00437467; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; OLANDER JV, 1991, BIOCHEM BIOPH RES CO, V175, P68, DOI 10.1016/S0006-291X(05)81201-X; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Robinson CJ, 2001, J CELL SCI, V114, P853; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Stringer SE, 1997, INT J BIOCHEM CELL B, V29, P709, DOI 10.1016/S1357-2725(96)00170-7; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tournaire R, 2004, EMBO REP, V5, P262, DOI 10.1038/sj.embor.7400100; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988	33	36	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9945	10.1371/journal.pone.0009945	http://dx.doi.org/10.1371/journal.pone.0009945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376344	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200021
J	Pinter, R; Hindges, R				Pinter, Rita; Hindges, Robert			Perturbations of MicroRNA Function in Mouse Dicer Mutants Produce Retinal Defects and Lead to Aberrant Axon Pathfinding at the Optic Chiasm	PLOS ONE			English	Article							BRAIN MORPHOGENESIS; BINOCULAR VISION; DISTINCT ASPECTS; GENE-EXPRESSION; HOMEOBOX GENE; SMALL RNAS; GUIDANCE; MIDLINE; IDENTIFICATION; GROWTH	Background: During development axons encounter a variety of choice points where they have to make appropriate pathfinding decisions. The optic chiasm is a major decision point for retinal ganglion cell (RGC) axons en route to their target in order to ensure the correct wiring of the visual system. MicroRNAs (miRNAs) belong to the class of small non-coding RNA molecules and have been identified as important regulators of a variety of processes during embryonic development. However, their involvement in axon guidance decisions is less clear. Methodology/Principal Findings: We report here that the early loss of Dicer, an essential protein for the maturation of miRNAs, in all cells of the forming retina and optic chiasm leads to severe phenotypes of RGC axon pathfinding at the midline. Using a conditional deletion approach in mice, we find in homozygous Dicer mutants a marked increase of ipsilateral projections, RGC axons extending outside the optic chiasm, the formation of a secondary optic tract and a substantial number of RGC axons projecting aberrantly into the contralateral eye. In addition, the mutant mice display a microphthalmia phenotype. Conclusions: Our work demonstrates an important role of Dicer controlling the extension of RGC axons to the brain proper. It indicates that miRNAs are essential regulatory elements for mechanisms that ensure correct axon guidance decisions at the midline and thus have a central function in the establishment of circuitry during the development of the nervous system.	[Pinter, Rita; Hindges, Robert] Kings Coll London, MRC, Ctr Dev Neurobiol, London, England	University of London; King's College London	Pinter, R (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Guys Campus, London, England.	robert.hindges@kcl.ac.uk	Hindges, Robert/C-5344-2009	Hindges, Robert/0000-0003-0095-7913	MRC [G0601182]; Wellcome Trust [087883/Z/08/Z]; Medical Research Council [G0601182, G0901899] Funding Source: researchfish; MRC [G0901899] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC Grant G0601182 (www.mrc.ac.uk) and Wellcome Trust Grant 087883/Z/08/Z (www.wellcome.ac.uk) to RH. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Brown LY, 2003, GENE EXPR PATTERNS, V3, P361, DOI 10.1016/S1567-133X(03)00043-7; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Decembrini S, 2008, INT J DEV BIOL, V52, P1099, DOI 10.1387/ijdb.082646sd; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Erskine L, 2000, J NEUROSCI, V20, P4975; Fabre PJ, 2010, J NEUROSCI, V30, P266, DOI 10.1523/JNEUROSCI.3778-09.2010; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Garcia-Frigola C, 2008, DEVELOPMENT, V135, P1833, DOI 10.1242/dev.020693; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jin ZB, 2009, MOL VIS, V15, P523; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Makarev E, 2006, MOL VIS, V12, P1386; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marcus RC, 1999, J COMP NEUROL, V403, P346; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Mui SH, 2002, DEVELOPMENT, V129, P797; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Petros TJ, 2009, J NEUROSCI, V29, P3463, DOI 10.1523/JNEUROSCI.5655-08.2009; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Pratt T, 2004, DEVELOPMENT, V131, P3773, DOI 10.1242/dev.01246; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; Thompson H, 2009, DEV BIOL, V335, P418, DOI 10.1016/j.ydbio.2009.09.034; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Torres MA, 1996, DEVELOPMENT, V122, P3381; Trousse F, 2001, DEVELOPMENT, V128, P3927; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhang L, 2000, GENESIS, V28, P135, DOI 10.1002/1526-968X(200011/12)28:3/4<135::AID-GENE70>3.0.CO;2-P	76	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e10021	10.1371/journal.pone.0010021	http://dx.doi.org/10.1371/journal.pone.0010021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20386732	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200066
J	Zhang, NY; Gur, A; Gibon, Y; Sulpice, R; Flint-Garcia, S; McMullen, MD; Stitt, M; Buckler, ES				Zhang, Nengyi; Gur, Amit; Gibon, Yves; Sulpice, Ronan; Flint-Garcia, Sherry; McMullen, Michael D.; Stitt, Mark; Buckler, Edward S.			Genetic Analysis of Central Carbon Metabolism Unveils an Amino Acid Substitution That Alters Maize NAD-Dependent Isocitrate Dehydrogenase Activity	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; LINKAGE DISEQUILIBRIUM; ENZYME-ACTIVITIES; DROSOPHILA-MELANOGASTER; ALCOHOL-DEHYDROGENASE; CANDIDATE GENES; HIGHER-PLANTS; ASSOCIATION; ARABIDOPSIS; EXPRESSION	Background: Central carbon metabolism (CCM) is a fundamental component of life. The participating genes and enzymes are thought to be structurally and functionally conserved across and within species. Association mapping utilizes a rich history of mutation and recombination to achieve high resolution mapping. Therefore, applying association mapping in maize (Zea mays ssp. mays), the most diverse model crop species, to study the genetics of CCM is a particularly attractive system. Methodology/Principal Findings: We used a maize diversity panel to test the CCM functional conservation. We found heritable variation in enzyme activity for every enzyme tested. One of these enzymes was the NAD-dependent isocitrate dehydrogenase (IDH, E.C. 1.1.1.41), in which we identified a novel amino-acid substitution in a phylogenetically conserved site. Using candidate gene association mapping, we identified that this non-synonymous polymorphism was associated with IDH activity variation. The proposed mechanism for the IDH activity variation includes additional components regulating protein level. With the comparison of sequences from maize and teosinte (Zea mays ssp. Parviglumis), the maize wild ancestor, we found that some CCM genes had also been targeted for selection during maize domestication. Conclusions/Significance: Our results demonstrate the efficacy of association mapping for dissecting natural variation in primary metabolic pathways. The considerable genetic diversity observed in maize CCM genes underlies heritable phenotypic variation in enzyme activities and can be useful to identify putative functional sites.	[Zhang, Nengyi; Gur, Amit; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Gibon, Yves; Sulpice, Ronan; Stitt, Mark] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Flint-Garcia, Sherry; McMullen, Michael D.] Univ Missouri, USDA ARS, Columbia, MO 65211 USA; [Flint-Garcia, Sherry; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Buckler, Edward S.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA	Cornell University; Max Planck Society; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Zhang, NY (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY USA.	nz45@cornell.edu	Buckler, Edward/GPS-4932-2022; Gibon, Yves/B-9919-2011; Gur, Amit/AFT-6744-2022; Buckler, Edward/L-7651-2019; Sulpice, Ronan/I-2738-2013; Stitt, Mark/GVT-1242-2022	Buckler, Edward/0000-0002-3100-371X; Sulpice, Ronan/0000-0002-6113-9570; Stitt, Mark/0000-0002-4900-1763; Flint-Garcia, Sherry/0000-0003-4156-5318; Gibon, Yves/0000-0001-8161-1089	National Science Foundation [DBI-0501700, DBI-0321467, DBI-0820619]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS); Vaadia-BARD Postdoctoral Fellowship, BARD [FI-360-2004]; United States - Israel Binational Agricultural Research and Development Fund; Max Planck Society	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Vaadia-BARD Postdoctoral Fellowship, BARD; United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by National Science Foundation DBI-0501700, DBI-0321467 and DBI-0820619, United States Department of Agriculture-Agricultural Research Service (USDA-ARS), Vaadia-BARD Postdoctoral Fellowship Award (FI-360-2004) from BARD, the United States - Israel Binational Agricultural Research and Development Fund, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY A, 1993, GENETICS, V134, P869; Bradbury P.J., 2007, BIOINFORMATICS; Busch W, 2007, CURR OPIN PLANT BIOL, V10, P136, DOI 10.1016/j.pbi.2007.01.002; Carrari F, 2003, PLANT PHYSIOL, V133, P1322, DOI 10.1104/pp.103.026716; CAUSSE M, 1995, MOL BREEDING, V1, P259, DOI 10.1007/BF02277426; CLARK AG, 1993, GENES ECOLOGY, P193; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gallais A, 2004, J EXP BOT, V55, P295, DOI 10.1093/jxb/erh006; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; Huege J, 2007, PHYTOCHEMISTRY, V68, P2258, DOI 10.1016/j.phytochem.2007.03.026; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Keurentjes JJB, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r129; Limami AM, 2002, PLANT PHYSIOL, V130, P1860, DOI 10.1104/pp.009647; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Manjunath S, 1998, PLANT PHYSIOL, V117, P997, DOI 10.1104/pp.117.3.997; McIntosh CA, 1997, PLANT SCI, V129, P9, DOI 10.1016/S0168-9452(97)00162-3; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Mitchell-Olds T, 1998, GENETICS, V149, P739; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; POWERS DA, 1991, ANNU REV GENET, V25, P629; Prioul JL, 1999, J EXP BOT, V50, P1281, DOI 10.1093/jexbot/50.337.1281; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Szalma SJ, 2005, THEOR APPL GENET, V110, P1324, DOI 10.1007/s00122-005-1973-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Tracy WF, 2006, CROP SCI, V46, pS49, DOI 10.2135/cropsci2006-03-0149tpg; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Weber AL, 2008, GENETICS, V180, P1221, DOI 10.1534/genetics.108.090134; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Whitt Sr, 2003, METH MOL B, V236, P123; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	45	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9991	10.1371/journal.pone.0009991	http://dx.doi.org/10.1371/journal.pone.0009991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376324	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200060
J	Gordon, RL; Schon, D; Magne, C; Astesano, C; Besson, M				Gordon, Reyna L.; Schoen, Daniele; Magne, Cyrille; Astesano, Corine; Besson, Mireille			Words and Melody Are Intertwined in Perception of Sung Words: EEG and Behavioral Evidence	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; SCALP DISTRIBUTIONS; MUSIC; LANGUAGE; MEMORY; ERP; INTEGRATION; TEXT; EXPECTANCY	Language and music, two of the most unique human cognitive abilities, are combined in song, rendering it an ecological model for comparing speech and music cognition. The present study was designed to determine whether words and melodies in song are processed interactively or independently, and to examine the influence of attention on the processing of words and melodies in song. Event-Related brain Potentials (ERPs) and behavioral data were recorded while non-musicians listened to pairs of sung words (prime and target) presented in four experimental conditions: same word, same melody; same word, different melody; different word, same melody; different word, different melody. Participants were asked to attend to either the words or the melody, and to perform a same/different task. In both attentional tasks, different word targets elicited an N400 component, as predicted based on previous results. Most interestingly, different melodies (sung with the same word) elicited an N400 component followed by a late positive component. Finally, ERP and behavioral data converged in showing interactions between the linguistic and melodic dimensions of sung words. The finding that the N400 effect, a well-established marker of semantic processing, was modulated by musical melody in song suggests that variations in musical features affect word processing in sung language. Implications of the interactions between words and melody are discussed in light of evidence for shared neural processing resources between the phonological/semantic aspects of language and the melodic/harmonic aspects of music.	[Gordon, Reyna L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Gordon, Reyna L.; Schoen, Daniele; Astesano, Corine; Besson, Mireille] CNRS, Inst Neurosci Cognit Mediterranee, Marseille, France; [Gordon, Reyna L.; Schoen, Daniele; Astesano, Corine; Besson, Mireille] Univ Mediterranee, Marseille, France; [Magne, Cyrille] Middle Tennessee State Univ, Dept Psychol, Murfreesboro, TN 37132 USA; [Astesano, Corine] Univ Toulouse 2, Toulouse, France	State University System of Florida; Florida Atlantic University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Middle Tennessee State University; Universite de Toulouse; Universite de Toulouse - Jean Jaures	Gordon, RL (corresponding author), Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	reyna.gordon@alumni.usc.edu	Schön, Daniele/B-2484-2013; Besson, Mireille/H-5110-2015	Schön, Daniele/0000-0003-4472-4150; Besson, Mireille/0000-0002-9549-5274; Gordon, Reyna/0000-0003-1643-6979	Human Frontier Science Program (HFSP) [RGP0053]; French Ministry of Research; American Academy of University Women	Human Frontier Science Program (HFSP)(Human Frontier Science Program); French Ministry of Research(Ministry of Research, FranceEuropean Commission); American Academy of University Women	This research was supported by a grant from the Human Frontier Science Program "An interdisciplinary approach to the problem of language and music specificity" (HFSP#RGP0053) to M. Besson and was conducted at the Institut de Neurosciences Cognitives de la Mediterranee, while R. L. Gordon was a graduate student. D. Schon and C. Astesano were supported by the HFSP grant; C. Magne benefitted from a "Cognitive Science" Fellowship from the French Ministry of Research; and R. L. Gordon benefited from a Fellowship from the American Academy of University Women. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S. O., 2006, PSYCHOL MUSIC, V34, P511, DOI DOI 10.1177/0305735606067168; ARAMAKI M, J COGNITIVE IN PRESS; Astesano C, 2004, COGNITIVE BRAIN RES, V18, P172, DOI 10.1016/j.cogbrainres.2003.10.002; Astesano C., 2001, RYTHME ACCENTUATION; BARTHOLOMEUS B, 1974, Cortex, V10, P215; BENTIN S, 1993, PSYCHOPHYSIOLOGY, V30, P161, DOI 10.1111/j.1469-8986.1993.tb01729.x; Bergeson TR, 1999, INFANT BEHAV DEV, V22, P51, DOI 10.1016/S0163-6383(99)80005-8; BESSON M, 1992, J COGNITIVE NEUROSCI, V4, P132, DOI 10.1162/jocn.1992.4.2.132; Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; BESSON M, 1987, PSYCHOPHYSIOLOGY, V24, P14, DOI 10.1111/j.1469-8986.1987.tb01853.x; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Brown S, 2000, ORIGINS OF MUSIC, P271; Carrion RE, 2008, PSYCHOPHYSIOLOGY, V45, P759, DOI 10.1111/j.1469-8986.2008.00687.x; Cunningham WA, 2005, NEUROIMAGE, V28, P827, DOI 10.1016/j.neuroimage.2005.04.044; Daltrozzo J, 2009, BRAIN RES, V1270, P88, DOI 10.1016/j.brainres.2009.03.019; de l'Etoile SK, 2006, INFANT BEHAV DEV, V29, P456, DOI 10.1016/j.infbeh.2006.03.002; Digeser FM, 2009, EAR HEARING, V30, P704, DOI 10.1097/AUD.0b013e3181b1d42d; Dissanayake E., 2008, MUSIC SCI, V12, P169, DOI [DOI 10.1177/1029864908012001081, 10.1177/1029864908012001081]; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Fedorenko E, 2009, MEM COGNITION, V37, P1, DOI 10.3758/MC.37.1.1; FREY A, 2009, TEMPORAL SEMIOTIC UN, P247; GARNER WR, 1970, COGNITIVE PSYCHOL, V1, P225, DOI 10.1016/0010-0285(70)90016-2; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; GOODGLASS H, 1977, NEUROPSYCHOLOGIA, V15, P397, DOI 10.1016/0028-3932(77)90091-4; GORDON RL, 2006, MUSIC MOTOR CONTROL; Gregg MK, 2009, ATTEN PERCEPT PSYCHO, V71, P607, DOI 10.3758/APP.71.3.607; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Hebert S, 2001, BRAIN COGNITION, V46, P169, DOI 10.1016/S0278-2626(01)80058-0; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hohlfeld A, 2005, COGNITIVE BRAIN RES, V24, P500, DOI 10.1016/j.cogbrainres.2005.03.001; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Ibanez A, 2006, BRAIN LANG, V98, P264, DOI 10.1016/j.bandl.2006.05.005; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; JOHNSON R, 1978, ELECTROEN CLIN NEURO, V44, P424, DOI 10.1016/0013-4694(78)90027-5; Kilgour AR, 2000, MEM COGNITION, V28, P700, DOI 10.3758/BF03198404; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Koelsch S, 2003, ANN NY ACAD SCI, V999, P15, DOI 10.1196/annals.1284.002; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; Levy DA, 2003, PSYCHOPHYSIOLOGY, V40, P291, DOI 10.1111/1469-8986.00031; Lidji P, 2009, ANN NY ACAD SCI, V1169, P481, DOI 10.1111/j.1749-6632.2009.04770.x; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Magne C, 2007, CEREB CORTEX, V17, P2659, DOI 10.1093/cercor/bhl174; MCCALLUM WC, 1984, ELECTROEN CLIN NEURO, V59, P477, DOI 10.1016/0168-5597(84)90006-6; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Mietz A, 2008, BRAIN LANG, V104, P159, DOI 10.1016/j.bandl.2007.03.005; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Mithen S., 2005, SINGING NEANDERTHALS; Nakata T, 2004, INFANT BEHAV DEV, V27, P455, DOI 10.1016/j.infbeh.2004.03.002; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Nguyen N., 2005, PHONOLOGIE PHONETIQU, P425; Nguyen N, 2008, J PHONETICS, V36, P1, DOI 10.1016/j.wocn.2007.07.001; NI V. J., 1984, ADV PSYCHOL, V19, P71, DOI [10.1016/S0166-4115(08)62346-8, DOI 10.1016/S0166-4115(08)62346-8]; Norton A, 2009, ANN NY ACAD SCI, V1169, P431, DOI 10.1111/j.1749-6632.2009.04859.x; PACHELLA RG, 1976, PERCEPT PSYCHOPHYS, V19, P29; PALLER KA, 1992, PSYCHOPHYSIOLOGY, V29, P202, DOI 10.1111/j.1469-8986.1992.tb01686.x; Pastor MC, 2008, BRAIN RES, V1189, P145, DOI 10.1016/j.brainres.2007.10.072; Patel A. D., 1997, PERCEPTION COGNITION, P191; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Peretz I, 2004, MEM COGNITION, V32, P142, DOI 10.3758/BF03195827; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; Perrin F, 2003, COGNITIVE BRAIN RES, V17, P36, DOI 10.1016/S0926-6410(03)00078-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; Racette A, 2006, BRAIN, V129, P2571, DOI 10.1093/brain/awl250; Rainey DW, 2002, MUSIC PERCEPT, V20, P173, DOI 10.1525/mp.2002.20.2.173; Relander K, 2009, J COGNITIVE NEUROSCI, V21, P1511, DOI 10.1162/jocn.2009.21127; Russo, 2004, POLSKIE FORUM PSYCHO, V9, P51; Schmidt-Kassow M, 2009, J COGNITIVE NEUROSCI, V21, P1693, DOI 10.1162/jocn.2008.21153; Schmithorst VJ, 2005, NEUROIMAGE, V25, P444, DOI 10.1016/j.neuroimage.2004.12.006; SCHON D, NEUROIMAGE IN PRESS; SCHON D, J COGNITIVE IN PRESS; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; SERAFINE ML, 1986, J MEM LANG, V25, P123, DOI 10.1016/0749-596X(86)90025-2; SERAFINE ML, 1984, COGNITION, V16, P285, DOI 10.1016/0010-0277(84)90031-3; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; Spreckelmeyer KN, 2006, BRAIN RES, V1070, P160, DOI 10.1016/j.brainres.2005.11.075; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Stratton V.N., 1994, EMPIR STUD ARTS, V12, P173, DOI DOI 10.2190/35T0-U4DT-N09Q-LQHW; Thiessen ED, 2009, ANN NY ACAD SCI, V1169, P225, DOI 10.1111/j.1749-6632.2009.04547.x; Thomas RD, 2006, J MATH PSYCHOL, V50, P441, DOI 10.1016/j.jmp.2006.05.006; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; van Besouw Rachel M, 2005, Logoped Phoniatr Vocol, V30, P129, DOI 10.1080/14015430500262160; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; VERLEGER R, 1990, INT J NEUROSCI, V55, P171, DOI 10.3109/00207459008985972; WALLACE WT, 1994, J EXP PSYCHOL LEARN, V20, P1471, DOI 10.1037/0278-7393.20.6.1471	103	37	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9889	10.1371/journal.pone.0009889	http://dx.doi.org/10.1371/journal.pone.0009889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360991	Green Submitted, Green Published, gold			2022-12-25	WOS:000276163200005
J	Clement, CC; Cannizzo, ES; Nastke, MD; Sahu, R; Olszewski, W; Miller, NE; Stern, LJ; Santambrogio, L				Clement, Cristina C.; Cannizzo, Elvira S.; Nastke, Maria-Dorothea; Sahu, Ranjit; Olszewski, Waldemar; Miller, Norman E.; Stern, Lawrence J.; Santambrogio, Laura			An Expanded Self-Antigen Peptidome Is Carried by the Human Lymph As Compared to the Plasma	PLOS ONE			English	Article							DENDRITIC CELLS; EXTRACELLULAR-MATRIX; STEM-CELLS; T-CELLS; RHEUMATOID-ARTHRITIS; II PRESENTATION; AFFERENT LYMPH; LEG LYMPH; IMMUNOTHERAPY; NODE	Background: The pre-nodal afferent lymph is the fluid which directly derives from the extracellular milieu from every parenchymal organ and, as it continues to circulate between the cells, it collects products deriving from the organ metabolism/catabolism. A comprehensive qualitative and quantitative investigation of the self-antigenic repertoire transported by the human lymph is still missing. Methodology/Principal Findings: A major difference between lymph and plasma could be visualized by FPLC and 2D gel in the amount of low molecular weight products corresponding to peptide fragments. Naturally processed peptides in normal pre-nodal human lymph were then fractionated by HPLC and characterized by multidimensional mass spectrometry. Analysis of more then 300 sequences identified self-peptides derived from both intracellular and extracellular proteins revealing the variety of catabolic products transported by human lymph. Quantitative analysis established that at least some of these peptides are present in the circulating lymph in nanomolar concentration. Conclusions/Significance: The peptidome, generated by physiological tissue catabolism and transported by the pre-nodal lymph, is in addition to the self-peptidome generated in endosomal compartment. Unlike self antigen processed by local or nodal APC, which mostly produce epitopes constrained by the endosomal processing activity, self antigens present in the lymph could derived from a wider variety of processing pathways; including caspases, involved in cellular apoptosis, and ADAM and other metalloproteinases involved in surface receptor editing, cytokines processing and matrix remodeling. Altogether, expanding the tissue-specific self-repertoire available for the maintenance of immunological tolerance.	[Clement, Cristina C.; Cannizzo, Elvira S.; Sahu, Ranjit; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Nastke, Maria-Dorothea; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Olszewski, Waldemar] Polish Acad Sci, Dept Surg Res & Transplantol, Warsaw, Poland; [Miller, Norman E.] Univ Oxford Magdalen Coll, Oxford OX1 4AU, England; [Santambrogio, Laura] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Yeshiva University; University of Massachusetts System; University of Massachusetts Worcester; Polish Academy of Sciences; University of Oxford; Yeshiva University	Clement, CC (corresponding author), Albert Einstein Coll Med, Dept Pathol, New York, NY USA.	laura.santambrogio@einstein.yu.edu	Miller, Norman E/P-6032-2017; Clement, Cristina/ABG-4525-2021	Miller, Norman E/0000-0001-7087-3390; Clement, Cristina/0000-0003-1464-407X; Cannizzo, Elvira stefania/0000-0001-9623-3041	National Institutes of Health [AI48832, AI-48833]; Irene Diamond Professorships in Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048833, R01AI048832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Professorships in Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI48832 to LS and grant AI-48833 to LJS) and Irene Diamond Professorships in Immunology (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FR, 2005, EXPERT REV VACCINES, V4, P881, DOI 10.1586/14760584.4.6.881; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; BAXTER AG, 1994, LANCET, V343, P1169; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Burke ZD, 2007, BIOCHEM J, V404, P169, DOI 10.1042/BJ20070167; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dustin ML, 2001, CURR OPIN IMMUNOL, V13, P286, DOI 10.1016/S0952-7915(00)00217-X; Fugger L, 1996, EUR J IMMUNOL, V26, P928, DOI 10.1002/eji.1830260431; Gretz JE, 1996, J IMMUNOL, V157, P495; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hochweller K, 2006, CURR MOL MED, V6, P631, DOI 10.2174/156652406778194982; Hunger RE, 2001, ARCH DERMATOL RES, V293, P420, DOI 10.1007/s004030100253; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Interewicz B, 2004, LYMPHOLOGY, V37, P65; Jackson L, 2007, J POSTGRAD MED, V53, P121; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Kavanaugh A, 2003, J RHEUMATOL, V30, P449; KIRSCHMANN DA, 1995, J IMMUNOL, V155, P5655; Kogawa K, 2002, IMMUNOL LETT, V80, P195, DOI 10.1016/S0165-2478(01)00314-5; Korbling M, 2003, BONE MARROW TRANSPL, V32, pS23, DOI 10.1038/sj.bmt.1703939; Korpos E, 2009, CURR PHARM DESIGN, V15, P1349, DOI 10.2174/138161209787846685; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Leak LV, 2004, PROTEOMICS, V4, P753, DOI 10.1002/pmic.200300573; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Nanjee MN, 2000, J LIPID RES, V41, P1317; Oehrl W, 2008, CONNECT TISSUE RES, V49, P145, DOI 10.1080/03008200802148629; Olszewski WL, 2001, LYMPHOLOGY, V34, P179; Pabst O, 2007, J LEUKOCYTE BIOL, V82, P795, DOI 10.1189/jlb.0307144; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; REED RK, 1994, INT J MICROCIRC, V14, P56, DOI 10.1159/000178207; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Satpute SR, 2008, SEMIN ARTHRITIS RHEU, V38, P195, DOI 10.1016/j.semarthrit.2007.10.002; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sohn RL, 2007, EXPERT REV CARDIOVAS, V5, P507, DOI 10.1586/14779072.5.3.507; Tanabe S, 2007, CURR PROTEIN PEPT SC, V8, P109, DOI 10.2174/138920307779941569; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Virtanen T, 2006, CURR OPIN ALLERGY CL, V6, P461, DOI 10.1097/01.all.0000246615.40085.2f; Zheng XC, 2004, EUR J IMMUNOL, V34, P3126, DOI 10.1002/eji.200425177	50	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9863	10.1371/journal.pone.0009863	http://dx.doi.org/10.1371/journal.pone.0009863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360855	Green Published, gold, Green Submitted			2022-12-25	WOS:000275969600002
J	Arking, DE; Reinier, K; Post, W; Jui, J; Hilton, G; O'Connor, A; Prineas, RJ; Boerwinkle, E; Psaty, BM; Tomaselli, GF; Rea, T; Sotoodehnia, N; Siscovick, DS; Burke, GL; Marban, E; Spooner, PM; Chakravarti, A; Chugh, SS				Arking, Dan E.; Reinier, Kyndaron; Post, Wendy; Jui, Jonathan; Hilton, Gina; O'Connor, Ashley; Prineas, Ronald J.; Boerwinkle, Eric; Psaty, Bruce M.; Tomaselli, Gordon F.; Rea, Thomas; Sotoodehnia, Nona; Siscovick, David S.; Burke, Gregory L.; Marban, Eduardo; Spooner, Peter M.; Chakravarti, Aravinda; Chugh, Sumeet S.			Genome-Wide Association Study Identifies GPC5 as a Novel Genetic Locus Protective against Sudden Cardiac Arrest	PLOS ONE			English	Article							GOLABI-BEHMEL-SYNDROME; QT INTERVAL; ATHEROSCLEROSIS RISK; UNEXPECTED DEATH; HEPARAN-SULFATE; POPULATION; EPIDEMIOLOGY; COMMUNITIES; REGULATOR; GLYPICAN	Background: Existing studies indicate a significant genetic component for sudden cardiac arrest (SCA) and genome-wide association studies (GWAS) provide an unbiased approach for identification of novel genes. We performed a GWAS to identify genetic determinants of SCA. Methodology/Principal Findings: We used a case-control design within the ongoing Oregon Sudden Unexpected Death Study (Oregon-SUDS). Cases (n = 424) were SCAs with coronary artery disease (CAD) among residents of Portland, OR (2002-07, population similar to 1,000,000) and controls (n = 226) were residents with CAD, but no history of SCA. All subjects were of White-European ancestry and GWAS was performed using Affymetrix 500K/5.0 and 6.0 arrays. High signal markers were genotyped in SCA cases (n = 521) identified from the Atherosclerosis Risk in Communities Study (ARIC) and the Cardiovascular Health Study (CHS) (combined n = 19,611). No SNPs reached genome-wide significance (p < 5x10(-8)). SNPs at 6 loci were prioritized for follow-up primarily based on significance of p < 10(-4) and proximity to a known gene (CSMD2, GPR37L1, LIN9, B4GALNT3, GPC5, and ZNF592). The minor allele of GPC5 (GLYPICAN 5, rs3864180) was associated with a lower risk of SCA in Oregon-SUDS, an effect that was also observed in ARIC/CHS whites (p < 0.05) and blacks (p < 0.04). In a combined Cox proportional hazards model analysis that adjusted for race, the minor allele exhibited a hazard ratio of 0.85 (95% CI 0.74 to 0.98; p < 0.01). Conclusions/Significance: A novel genetic locus for SCA, GPC5, was identified from Oregon-SUDS and successfully validated in the ARIC and CHS cohorts. Three other members of the Glypican family have been previously implicated in human disease, including cardiac conditions. The mechanism of this specific association requires further study.	[Reinier, Kyndaron; Marban, Eduardo; Chugh, Sumeet S.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Arking, Dan E.; Hilton, Gina; O'Connor, Ashley; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Post, Wendy; Tomaselli, Gordon F.; Spooner, Peter M.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Jui, Jonathan] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Prineas, Ronald J.; Burke, Gregory L.] Wake Forest Univ, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA; [Psaty, Bruce M.; Rea, Thomas; Sotoodehnia, Nona; Siscovick, David S.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA	Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins University; Oregon Health & Science University; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Washington; University of Washington Seattle	Arking, DE (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	aravinda@jhmi.edu; sumeet.chugh@cshs.org	Marban, Eduardo/GWC-8514-2022	Ballantyne, Christie/0000-0002-6432-1730	Donald W. Reynolds Cardiovascular Clinical Research Center; National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI [R01 HL088416, R01 HL088456]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, N01-HC-85086, N01 HC-15103, N01 HC-55222, U01 HL080295]; National Human Genome Research Institute [U01HG004402]; NIH [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; National Center for Research Resources (NCRR) [1UL1RR025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC045133, N01HC055016, N01HC015103, N01HC085079, N01HC085086, N01HC075150, N01HC055222, N01HC055015, N01HC055020, N01HC035129, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R42HL055018, R01HL059367, R01HL088456, R01HL087641, R41HL055019, R01HL088416, U01HL080295, R41HL055018] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	Donald W. Reynolds Cardiovascular Clinical Research Center; National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Donald W. Reynolds Cardiovascular Clinical Research Center at the Johns Hopkins University School of Medicine; and National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) grant R01 HL088416 (to S. S. C) and R01 HL088456 (to N.S.). S.S.C. is the Pauline and Harold Price Professor at Cedars-Sinai Medical Center, Los Angeles, California. The Atherosclerosis Risk in Communities Study (ARIC) is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and NIH contract HHSN268200625226C. Infrastructure was partly supported by grant number UL1RR025005, a component of the NIH and NIH Roadmap for Medical Research. The Cardiovascular Heart Study is supported by contracts N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through N01-HC-85086, N01 HC-15103, N01 HC-55222, and U01 HL080295 from the NHLBI, with additional contribution from the National Institute of Neurological Disorders and Stroke. This publication was made possible by grant number 1UL1RR025005 from the National Center for Research Resources (NCRR), a component of the NIH, and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2006, BRLMM IMPR GEN CALL; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Chugh SS, 2009, CIRCULATION, V119, P663, DOI 10.1161/CIRCULATIONAHA.108.797035; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1985, J AM COLL CARDIOL S6, V0005; KANNEL WB, 1990, CAN J CARDIOL, V6, P439; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; KONIG R, 1991, AM J MED GENET, V38, P244, DOI 10.1002/ajmg.1320380215; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kuller L, 2002, ARTERIOSCL THROM VAS, V22, P1175, DOI 10.1161/01.ATV.0000022015.97341.3A; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Stecker EC, 2006, J AM COLL CARDIOL, V47, P1161, DOI 10.1016/j.jacc.2005.11.045; Veugelers M, 1998, GENOMICS, V53, P1, DOI 10.1006/geno.1998.5465; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	31	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9879	10.1371/journal.pone.0009879	http://dx.doi.org/10.1371/journal.pone.0009879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360844	gold, Green Published, Green Submitted			2022-12-25	WOS:000275969500011
J	Martin, CD; Thierry, G; Demonet, JF				Martin, Clara D.; Thierry, Guillaume; Demonet, Jean-Francois			ERP Characterization of Sustained Attention Effects in Visual Lexical Categorization	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; EVENT-RELATED POTENTIALS; WORD RECOGNITION; PREFRONTAL CORTEX; WORKING-MEMORY; READING ALOUD; SLOW WAVES; TASK; BRAIN; BLINK	As our understanding of the basic processes underlying reading is growing, the key role played by attention in this process becomes evident. Two research topics are of particular interest in this domain: (1) it is still undetermined whether sustained attention affects lexical decision tasks; (2) the influence of attention on early visual processing (i.e., before orthographic or lexico-semantic processing stages) remains largely under-specified. Here we investigated early perceptual modulations by sustained attention using an ERP paradigm adapted from Thierry et al. [1]. Participants had to decide whether visual stimuli presented in pairs pertained to a pre-specified category (lexical categorization focus on word or pseudoword pairs). Depending on the lexical category of the first item of a pair, participants either needed to fully process the second item (hold condition) or could release their attention and make a decision without full processing of the second item (release condition). The P1 peak was unaffected by sustained attention. The N1 was delayed and reduced after the second item of a pair when participants released their attention. Release of sustained attention also reduced a P3 wave elicited by the first item of a pair and abolished the P3 wave elicited by the second. Our results are consistent with differential effects of sustained attention on early processing stages and working memory. Sustained attention modulated early processing stages during a lexical decision task without inhibiting the process of stimulus integration. On the contrary, working memory involvement/updating was highly dependent upon the allocation of sustained attention. Moreover, the influence of sustained attention on both early and late cognitive processes was independent of lexical categorization focus.	[Martin, Clara D.] Univ Pompeu Fabra, Dept Technol, Barcelona, Spain; [Martin, Clara D.; Demonet, Jean-Francois] Hop Purpan, INSERM, U825, Toulouse, France; [Martin, Clara D.; Thierry, Guillaume] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Thierry, Guillaume] Bangor Univ, Ctr Res Bilingualism Theory & Practice, Econ & Social Res Council, Bangor, Wales	Pompeu Fabra University; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Bangor University; Bangor University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC)	Martin, CD (corresponding author), Univ Pompeu Fabra, Dept Technol, Barcelona, Spain.	Claramartin3@gmail.com	Demonet, Jean-Francois/E-6725-2010; Thierry, Guillaume/C-2688-2008; Martin, Clara/B-4563-2012	Thierry, Guillaume/0000-0003-1325-2656; Martin, Clara/0000-0003-2701-5045; Demonet, Jean-Francois/0000-0003-0100-6175	Spanish government [2008-01191/PSIC, CE-CSD2007-00121]; Economic and Social Research Council [ES/E024556/1]; European Research Council [ERC-SG-209704]; ESRC [ES/E024556/1] Funding Source: UKRI	Spanish government(Spanish GovernmentEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	M. was funded by the Spanish government (PSI 2008-01191/PSIC and Consolider Ingenio 2010 CE-CSD2007-00121). G. T. is supported by the Economic and Social Research Council (ES/E024556/1) and the European Research Council (ERC-SG-209704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1987, ELECTROEN CLIN NEURO, V68, P458, DOI 10.1016/0168-5597(87)90057-8; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Croft RJ, 2003, PSYCHOPHYSIOLOGY, V40, P322, DOI 10.1111/1469-8986.00036; CURRY SH, 1984, ANN NY ACAD SCI, V425, P171, DOI 10.1111/j.1749-6632.1984.tb23529.x; Doallo S, 2004, CLIN NEUROPHYSIOL, V115, P199, DOI 10.1016/S1388-2457(03)00317-1; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DOUROS C, 1987, BIOFEEDBACK SELF-REG, V12, P39, DOI 10.1007/BF01000077; EASON RG, 1969, PHYSIOL BEHAV, V4, P283, DOI 10.1016/0031-9384(69)90176-0; Filipovic SR, 2001, CLIN NEUROPHYSIOL, V112, P1307, DOI 10.1016/S1388-2457(01)00558-2; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guillaume T, 2003, COGNITIVE BRAIN RES, V17, P535, DOI 10.1016/S0926-6410(03)00168-X; Hillyard S.A., 1987, HDB PHYSL 1, V5, P519; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Johnson Jr. R., 1988, ADV PSYCHOPHYSIOLOGY, V3, P69; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Lien MC, 2006, PSYCHOL AGING, V21, P431, DOI 10.1037/0882-7974.21.3.431; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Martin CD, 2006, BRAIN RES, V1098, P153, DOI 10.1016/j.brainres.2006.04.097; McCann RS, 2000, J EXP PSYCHOL HUMAN, V26, P1352, DOI 10.1037//0096-1523.26.4.1352; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; NAATANEN R, 1992, NEUROREPORT, V3, P493; Naatanen R., 1987, KNOWLEDGE AIDED INFO, P241; NAZIR TA, 1991, PERCEPT PSYCHOPHYS, V49, P373, DOI 10.3758/BF03205995; O'Malley S, 2008, J EXP PSYCHOL LEARN, V34, P422, DOI 10.1037/0278-7393.34.2.422; OREGAN JK, 1984, J EXP PSYCHOL HUMAN, V10, P250, DOI 10.1037/0096-1523.10.2.250; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; Rabovsky M, 2008, BRAIN RES, V1222, P156, DOI 10.1016/j.brainres.2008.05.066; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; Rosazza C, 2009, BRAIN RES, V1272, P32, DOI 10.1016/j.brainres.2009.03.033; RUCHKIN DS, 1988, PSYCHOPHYSIOLOGY, V25, P339, DOI 10.1111/j.1469-8986.1988.tb01253.x; RUGG MD, 1984, BRAIN LANG, V23, P225, DOI 10.1016/0093-934X(84)90065-8; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TECCE JJ, 1993, ELECTROENCEPHALOGRAP, P887; Telford CW, 1931, J EXP PSYCHOL, V14, P1, DOI 10.1037/h0073262; Thierry G, 1998, NEUROIMAGE, V8, P391, DOI 10.1006/nimg.1998.0371; Thierry G, 2003, HUM BRAIN MAPP, V19, P37, DOI 10.1002/hbm.10101; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Weisz N, 2002, INT J PSYCHOPHYSIOL, V45, P253, DOI 10.1016/S0167-8760(02)00032-6	54	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9892	10.1371/journal.pone.0009892	http://dx.doi.org/10.1371/journal.pone.0009892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574DS	20361039	Green Submitted, gold, Green Published			2022-12-25	WOS:000275969500016
J	Takeuchi, K; Abe, M; Hiasa, M; Oda, A; Amou, H; Kido, S; Harada, T; Tanaka, O; Miki, H; Nakamura, S; Nakano, A; Kagawa, K; Yata, K; Ozaki, S; Matsumoto, T				Takeuchi, Kyoko; Abe, Masahiro; Hiasa, Masahiro; Oda, Asuka; Amou, Hiroe; Kido, Shinsuke; Harada, Takeshi; Tanaka, Osamu; Miki, Hirokazu; Nakamura, Shingen; Nakano, Ayako; Kagawa, Kumiko; Yata, Kenichiro; Ozaki, Shuji; Matsumoto, Toshio			TGF-beta Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth	PLOS ONE			English	Article							INFLAMMATORY PROTEIN (MIP)-1-ALPHA; BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; I RECEPTOR KINASE; RESISTANCE CAM-DR; OSTEOLYTIC LESIONS; VICIOUS CYCLE; ACTIVATION; ADHESION; CANCER	Background: Multiple myeloma (MM) expands almost exclusively in the bone marrow and generates devastating bone lesions, in which bone formation is impaired and osteoclastic bone resorption is enhanced. TGF-beta, a potent inhibitor of terminal osteoblast (OB) differentiation, is abundantly deposited in the bone matrix, and released and activated by the enhanced bone resorption in MM. The present study was therefore undertaken to clarify the role of TGF-beta and its inhibition in bone formation and tumor growth in MM. Methodology/Principal Findings: TGF-beta suppressed OB differentiation from bone marrow stromal cells and MC3T3-E1 preosteoblastic cells, and also inhibited adipogenesis from C3H10T1/2 immature mesenchymal cells, suggesting differentiation arrest by TGF-beta. Inhibitors for a TGF-beta type I receptor kinase, SB431542 and Ki26894, potently enhanced OB differentiation from bone marrow stromal cells as well as MC3T3-E1 cells. The TGF-beta inhibition was able to restore OB differentiation suppressed by MM cell conditioned medium as well as bone marrow plasma from MM patients. Interestingly, TGF-beta inhibition expedited OB differentiation in parallel with suppression of MM cell growth. The anti-MM activity was elaborated exclusively by terminally differentiated OBs, which potentiated the cytotoxic effects of melphalan and dexamethasone on MM cells. Furthermore, TGF-beta inhibition was able to suppress MM cell growth within the bone marrow while preventing bone destruction in MM-bearing animal models. Conclusions/Significance: The present study demonstrates that TGF-beta inhibition releases stromal cells from their differentiation arrest by MM and facilitates the formation of terminally differentiated OBs, and that terminally differentiated OBs inhibit MM cell growth and survival and enhance the susceptibility of MM cells to anti-MM agents to overcome the drug resistance mediated by stromal cells. Therefore, TGF-beta appears to be an important therapeutic target in MM bone lesions.	[Takeuchi, Kyoko; Abe, Masahiro; Oda, Asuka; Amou, Hiroe; Kido, Shinsuke; Harada, Takeshi; Tanaka, Osamu; Miki, Hirokazu; Nakamura, Shingen; Nakano, Ayako; Kagawa, Kumiko; Yata, Kenichiro; Matsumoto, Toshio] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Hiasa, Masahiro] Univ Tokushima, Grad Sch Oral Sci, Dept Biomat & Bioengn, Tokushima 770, Japan; [Ozaki, Shuji] Tokushima Univ Hosp, Div Transfus Med, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University	Takeuchi, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan.	masabe@clin.med.tokushima-u.ac.jp	日浅, 雅博/S-1537-2019; HIASA, MASAHIRO/ABB-3885-2021; Tanaka, Osamu/AAS-9252-2020	HIASA, MASAHIRO/0000-0002-4830-6274; 	Ministry of Education, Culture, Science and Sports of Japan; Ministry of Health, Labor and Welfare of Japan [17-16]	Ministry of Education, Culture, Science and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-aid for Scientific Research (A) to T. M. and (C) to M. A., and for the 21st Century Center of Excellence Program from the Ministry of Education, Culture, Science and Sports of Japan, and a Grant-in-aid for Cancer Research (17-16) to M. A. from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Abe M, 2009, J BONE MINER METAB, V27, P16, DOI 10.1007/s00774-008-0012-z; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Choi SJ, 2001, J CLIN INVEST, V108, P1833, DOI 10.1172/JCI13116; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Date T, 2004, J ORTHOP SCI, V9, P503, DOI 10.1007/s00776-004-0815-2; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Giuliani N, 2007, CANCER RES, V67, P7665, DOI 10.1158/0008-5472.CAN-06-4666; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hashimoto T, 2004, BRIT J HAEMATOL, V125, P38, DOI 10.1111/j.1365-2141.2004.04864.x; Hazlehurst LA, 2000, ONCOGENE, V19, P4319, DOI 10.1038/sj.onc.1203782; Hiraga T, 2001, CANCER RES, V61, P4418; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; Landowski TH, 2003, ONCOGENE, V22, P2417, DOI 10.1038/sj.onc.1206315; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Matsumoto T, 2006, ANN NY ACAD SCI, V1068, P319, DOI 10.1196/annals.1346.035; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; Oyajobi B. O., 2004, J BONE MINER RES, V19, P1011; Ozaki S, 2007, INT J HEMATOL, V86, P180, DOI 10.1532/IJH97.07030; Pennisi A, 2006, BLOOD, V108, p154A; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109; Qiang YW, 2008, BLOOD; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Suzawa M, 1999, ENDOCRINOLOGY, V140, P2125, DOI 10.1210/en.140.5.2125; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tassone P, 2005, BLOOD, V106, P713, DOI 10.1182/blood-2005-01-0373; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Yaccoby S, 2004, CANCER RES, V64, P2016, DOI 10.1158/0008-5472.CAN-03-1131; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zangari M, 2005, BRIT J HAEMATOL, V131, P71, DOI 10.1111/j.1365-2141.2005.05733.x; Zangari M, 2006, CLIN LYMPHOMA MYELOM, V7, P109, DOI 10.3816/CLM.2006.n.047	49	99	101	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9870	10.1371/journal.pone.0009870	http://dx.doi.org/10.1371/journal.pone.0009870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360846	Green Published, gold, Green Submitted			2022-12-25	WOS:000275969500009
J	Zakharova, E; Grandhi, J; Wewers, MD; Gavrilin, MA				Zakharova, Ekaterina; Grandhi, Jaykumar; Wewers, Mark D.; Gavrilin, Mikhail A.			Mycoplasma Suppression of THP-1 Cell TLR Responses Is Corrected with Antibiotics	PLOS ONE			English	Article							INDUCED SIGNAL-TRANSDUCTION; CHRONIC-FATIGUE-SYNDROME; GENE-EXPRESSION; HUMAN MONOCYTES; MESSENGER-RNA; KAPPA-B; LIPOPOLYSACCHARIDE; MACROPHAGES; FERMENTANS; FRANCISELLA	Mycoplasma contamination of cultured cell lines is a serious problem in research, altering cellular response to different stimuli thus compromising experimental results. We found that chronic mycoplasma contamination of THP-1 cells suppresses responses of THP-1 cells to TLR stimuli. For example, E. coli LPS induced IL-1 beta was suppressed by 6 fold and IL-8 by 10 fold in mycoplasma positive THP-1 cells. Responses to live F. novicida challenge were suppressed by 50-fold and 40-fold respectively for IL-1 beta and IL-8. Basal TLR4 expression level in THP-1 cells was decreased by mycoplasma by 2.4-fold (p = 0.0003). Importantly, cell responses to pathogen associated molecular patterns are completely restored by mycoplasma clearance with Plasmocin. Thus, routine screening of cell lines for mycoplasma is important for the maintenance of reliable experimental data and contaminated cell lines can be restored to their baseline function with antibiotic clearance of mycoplasma.	[Zakharova, Ekaterina; Grandhi, Jaykumar; Wewers, Mark D.; Gavrilin, Mikhail A.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Zakharova, E (corresponding author), Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	wewers.2@osu.edu; gavrilin.1@osu.edu	Wewers, Mark/AAB-6202-2021	Gavrilin, Mikhail/0000-0003-2003-768X	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID); NIH [5-U54-AI-057153, R01-HL089440, HL076278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076278, R01HL089440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V Great Lakes RCE (NIH award 5-U54-AI-057153). This work was also supported by NIH grants R01-HL089440 and HL076278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Choppa PC, 1998, MOL CELL PROBE, V12, P301, DOI 10.1006/mcpr.1998.0186; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; DEMCZUK S, 1988, J BIOL CHEM, V263, P13039; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Kaufmann A, 2000, EUR J IMMUNOL, V30, P1562, DOI 10.1002/1521-4141(200006)30:6<1562::AID-IMMU1562>3.0.CO;2-Q; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Seya T, 2002, INT J BIOCHEM CELL B, V34, P901, DOI 10.1016/S1357-2725(01)00164-9; Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x; VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994; Vojdani A, 1998, FEMS IMMUNOL MED MIC, V22, P355; Wewers MD, 1997, J IMMUNOL, V159, P5964	21	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9900	10.1371/journal.pone.0009900	http://dx.doi.org/10.1371/journal.pone.0009900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360862	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969500019
J	Ofek, P; Fischer, W; Calderon, M; Haag, R; Satchi-Fainaro, R				Ofek, Paula; Fischer, Wiebke; Calderon, Marcelo; Haag, Rainer; Satchi-Fainaro, Ronit			In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers	FASEB JOURNAL			English	Article						angiogenesis; polymer therapeutics; dendrimers; luciferase; glioblastoma; noninvasive intravital imaging	MACROMOLECULAR THERAPEUTICS; DIVALENT PEPTIDE; CATIONIC LIPIDS; GENE; CONJUGATE; ACCUMULATION; EXPRESSION; LIPOSOMES; CHLORIDE; CELLS	New targets for RNA interference (RNAi)based cancer therapy are constantly emerging from the increasing knowledge on key molecular pathways that are paramount for carcinogenesis. Nevertheless, in vivo delivery of small interfering RNA (siRNA) remains a crucial challenge for therapeutic success. siRNAs on their own are not taken up by most mammalian cells in a way that preserves their activity. Moreover, when applied in vivo, siRNA-based approaches are all limited by poor penetration into the target tissue and low silencing efficiency. To circumvent these limitations, we have developed novel polymerized polyglycerol-based dendrimer core shell structures to deliver siRNA to tumors in vivo. These cationic dendrimers can strongly improve the stability of the siRNA, its intracellular trafficking, its silencing efficacy, and its accumulation in the tumor environment owing to the enhanced permeability and retention effect. Here, we show that our dendritic nanocarriers exhibited low cytotoxicity and high efficacy in delivering active siRNA into cells. With use of human glioblastoma and murine mammary adenocarcinoma cell lines as model systems, these siRNA-dendrimer polyplexes silenced the luciferase gene, ectopically overexpressed in these cells. Importantly, significant gene silencing was accomplished in vivo within 24 h of treatment with our luciferase siRNA-nanocarrier polyplexes, as measured by noninvasive intravital bioluminescence imaging. Moreover, our siRNA-nanocarriers show very low levels of toxicity as no significant weight loss was observed after intravenous administration of the polyplexes. We show a proof of concept for siRNA delivery in vivo using a luciferase-based model. We predict that in vivo silencing of important cell growth and angiogenesis regulator genes in a selective manner will justify this approach as a successful anticancer therapy.-Ofek, P., Fischer, W., Calderon, M., Haag, R., Satchi-Fainaro, R. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. FASEB J. 24, 3122-3134 (2010). www.fasebj.org	[Ofek, Paula; Satchi-Fainaro, Ronit] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Fischer, Wiebke; Calderon, Marcelo; Haag, Rainer] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany	Tel Aviv University; Sackler Faculty of Medicine; Free University of Berlin	Satchi-Fainaro, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	ronitsf@post.tau.ac.il	Satchi-Fainaro, Ronit/F-9137-2011; Calderon, Marcelo/A-3594-2013	Satchi-Fainaro, Ronit/0000-0002-7360-7837; Calderon, Marcelo/0000-0002-2734-9742; Ofek, Paula/0000-0002-8516-1107; Calderon, Marcelo/0000-0002-3108-3852	Israel Science Foundation [1300/06]; Marguerite Stolz Research Fellowship; Adams Super Center for Brain Studies; German Ministry of Science	Israel Science Foundation(Israel Science Foundation); Marguerite Stolz Research Fellowship; Adams Super Center for Brain Studies; German Ministry of Science	The authors thank Leonid Mitelman (Interdepartmental Core Facility at the Sackler School of Medicine) for his excellent assistance with the confocal laser scanning microscope. The authors thank Professor Ronit Sagi-Eisenberg for insightful discussion on endocytosis and Andrea Schulz for AFM measurements. The authors also thank Merkel Technologies Ltd. and David Merkel Golan for his kind assistance using the ImageStream multispectral imaging flow cytometer. This research was supported by the Israel Science Foundation (grant 1300/06), the Marguerite Stolz Research Fellowship Fund for Outstanding Junior Faculty, and the Adams Super Center for Brain Studies. R. H. is grateful to the German Ministry of Science for a NanoFuture award.	Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; CAIN BF, 1978, J MED CHEM, V21, P658, DOI 10.1021/jm00205a013; Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144; CARRASCO L, 1994, FEBS LETT, V350, P151, DOI 10.1016/0014-5793(94)00780-2; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; DIJKSTRA J, 1984, BIOCHIM BIOPHYS ACTA, V804, P58, DOI 10.1016/0167-4889(84)90099-5; DUNCAN R, 1994, J DRUG TARGET, V2, P341, DOI 10.3109/10611869409015915; FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Firon M, 2000, ONCOGENE, V19, P2386, DOI 10.1038/sj.onc.1203557; FU YX, 1990, CANCER RES, V50, P227; Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021; Geall AJ, 2000, J PHARMACEUT BIOMED, V22, P849, DOI 10.1016/S0731-7085(00)00250-8; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Guillot-Nieckowski M, 2007, LANGMUIR, V23, P737, DOI 10.1021/la0624891; Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113; HAAG R, 2004, Patent No. 10211664; HARD T, 1988, EUR BIOPHYS J BIOPHY, V16, P231, DOI 10.1007/BF00261265; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Karmali PP, 2007, MED RES REV, V27, P696, DOI 10.1002/med.20090; Kramer M, 2005, MACROMOLECULES, V38, P8308, DOI 10.1021/ma0510791; Kramer M, 2004, CHEMBIOCHEM, V5, P1081, DOI 10.1002/cbic.200300905; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Melnikov S, 2009, CELL SIGNAL, V21, P1607, DOI 10.1016/j.cellsig.2009.06.007; Miller K, 2009, ANGEW CHEM INT EDIT, V48, P2949, DOI 10.1002/anie.200805133; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Oh YK, 2009, ADV DRUG DELIVER REV, V61, P850, DOI 10.1016/j.addr.2009.04.018; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Roller S, 2005, MOL DIVERS, V9, P305, DOI 10.1007/s11030-005-8117-y; Ryppa C, 2008, BIOCONJUGATE CHEM, V19, P1414, DOI 10.1021/bc800117r; Ryppa C, 2009, INT J PHARMACEUT, V368, P89, DOI 10.1016/j.ijpharm.2008.09.055; Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140; Segal E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005233; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w; Sunder A, 2000, MACROMOLECULES, V33, P253, DOI 10.1021/ma9915881; Takakura Y, 2002, J DRUG TARGET, V10, P99, DOI 10.1080/10611860290016694; Welsh DJ, 2009, ANGEW CHEM INT EDIT, V48, P4047, DOI 10.1002/anie.200900401	48	103	108	1	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3122	3134		10.1096/fj.09-149641	http://dx.doi.org/10.1096/fj.09-149641			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20385622				2022-12-25	WOS:000281446400003
J	Gambaryan, S; Kobsar, A; Rukoyatkina, N; Herterich, S; Geiger, J; Smolenski, A; Lohmann, SM; Walter, U				Gambaryan, Stepan; Kobsar, Anna; Rukoyatkina, Natalia; Herterich, Sabine; Geiger, Joerg; Smolenski, Albert; Lohmann, Suzanne M.; Walter, Ulrich			Thrombin and Collagen Induce a Feedback Inhibitory Signaling Pathway in Platelets Involving Dissociation of the Catalytic Subunit of Protein Kinase A from an NF kappa B-I kappa B Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED-PHOSPHOPROTEIN; GTPASE-ACTIVATING PROTEIN; TRANSCRIPTIONAL ACTIVITY; CYCLIC-NUCLEOTIDES; ADHESION MECHANISMS; BONE-MARROW; PPAR-GAMMA; C-SRC; CAMP; CGMP	Protein kinase A (PKA) activation by cAMP phosphorylates multiple target proteins in numerous platelet inhibitory pathways that have a very important role in maintaining circulating platelets in a resting state. Here we show that in thrombin-and collagen-stimulated platelets, PKA is activated by cAMP-independent mechanisms involving dissociation of the catalytic subunit of PKA (PKAc) from an NF kappa B-I kappa B alpha-PKAc complex. We demonstrate mRNA and protein expression for most of the NF kappa B family members in platelets. From resting platelets, PKAc was co-immunoprecipitated with I kappa B alpha, and conversely, I kappa B alpha was also co-immunoprecipitated with PKAc. This interaction was significantly reduced in thrombin-and collagen-stimulated platelets. Stimulation of platelets with thrombin-or collagen-activated IKK, at least partly by PI3 kinase-dependent pathways, leading to phosphorylation of I kappa B alpha, disruption of an I kappa B alpha-PKAc complex, and release of free, active PKAc, which phosphorylated VASP and other PKA substrates. IKK inhibitor inhibited thrombin-stimulated IkB alpha phosphorylation, PKA-IkB alpha dissociation, and VASP phosphorylation, and potentiated integrin alpha IIb beta 3 activation and the early phase of platelet aggregation. We conclude that thrombin and collagen not only cause platelet activation but also appear to fine-tune this response by initiating downstream NF kappa B-dependent PKAc activation, as a novel feedback inhibitory signaling mechanism for preventing undesired platelet activation.	[Gambaryan, Stepan; Kobsar, Anna; Rukoyatkina, Natalia; Herterich, Sabine; Geiger, Joerg; Lohmann, Suzanne M.; Walter, Ulrich] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; [Gambaryan, Stepan; Rukoyatkina, Natalia] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; [Smolenski, Albert] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	University of Wurzburg; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; University College Dublin	Gambaryan, S (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Grombuhlstr 12, D-97080 Wurzburg, Germany.	gambaryan@klin-biochem.uni-wuerzburg.de	Rukoyatkina, Natalia/AAN-2227-2020; Walter, ulrich/W-2478-2017; Geiger, Joerg/I-6661-2013; Gambaryan, Stepan/I-3940-2016	Walter, ulrich/0000-0001-6784-2307; Geiger, Joerg/0000-0002-7689-531X; Gambaryan, Stepan/0000-0002-1470-0791; Rukoyatkina, Natalia/0000-0002-3920-206X; Smolenski, Albert/0000-0001-9210-9406	DFG [SFB 688 TP A2, GA 1561/1-1]; Science Foundation Ireland	DFG(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the DFG (Grants SFB 688 TP A2 and GA 1561/1-1, to S. G. and U. W.) and by a grant from the Science Foundation Ireland (to A. S.).	Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Ali FY, 2006, FASEB J, V20, P326, DOI 10.1096/fj.05-4395fje; Beaulieu LM, 2009, J THROMB HAEMOST, V7, P1329, DOI 10.1111/j.1538-7836.2009.03505.x; Bijli KM, 2007, AM J PHYSIOL-LUNG C, V292, pL396, DOI 10.1152/ajplung.00163.2006; Boulaftali Y, 2010, BLOOD, V115, P97, DOI 10.1182/blood-2009-04-217240; Chang H, 2010, THROMB RES, V125, P159, DOI 10.1016/j.thromres.2009.11.006; Chitaley K, 2004, FEBS LETT, V556, P211, DOI 10.1016/S0014-5793(03)01435-2; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dittrich M, 2006, THROMB HAEMOSTASIS, V95, P643, DOI 10.1160/TH05-11-0764; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Gambaryan S, 2004, BLOOD, V103, P2593, DOI 10.1182/blood-2003-09-3349; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Italiano JE, 2007, J THROMB HAEMOST, V5, P18, DOI 10.1111/j.1538-7836.2007.02487.x; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kim KW, 2001, J BIOL CHEM, V276, P13186, DOI 10.1074/jbc.M008092200; Lee HS, 2010, EUR J PHARMACOL, V627, P85, DOI 10.1016/j.ejphar.2009.11.005; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Liu FQ, 2002, THROMB RES, V106, P199, DOI 10.1016/S0049-3848(02)00130-5; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Majka M, 2000, BLOOD, V96, P4142, DOI 10.1182/blood.V96.13.4142.h8004142_4142_4151; Malaver E, 2009, J THROMB HAEMOST, V7, P1333, DOI 10.1111/j.1538-7836.2009.03492.x; Moraes LA, 2010, J THROMB HAEMOST, V8, P577, DOI 10.1111/j.1538-7836.2009.03732.x; Moraes LA, 2007, BLOOD, V109, P3741, DOI 10.1182/blood-2006-05-022566; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Naseem KM, 2008, J THROMB HAEMOST, V6, P10; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Profirovic J, 2005, J BIOL CHEM, V280, P32866, DOI 10.1074/jbc.M501361200; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1031, DOI 10.1152/ajpendo.00204.2006; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Spinelli SL, 2010, ARTERIOSCL THROM VAS, V30, P591, DOI 10.1161/ATVBAHA.109.197343; Steele BM, 2009, P NATL ACAD SCI USA, V106, P19836, DOI 10.1073/pnas.0906268106; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; WALTER U, 1993, ADV EXP MED BIOL, V344, P237; Walter Ulrich, 2009, V191, P533, DOI 10.1007/978-3-540-68964-5_23; Wentworth JKI, 2006, BIOCHEM J, V393, P555, DOI 10.1042/BJ20050796; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	56	109	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18352	18363		10.1074/jbc.M109.077602	http://dx.doi.org/10.1074/jbc.M109.077602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20356841	Green Published, hybrid			2022-12-25	WOS:000278453900029
J	Suzuki, Y; Yanagisawa, M; Yagi, H; Nakatani, Y; Yu, RK				Suzuki, Yusuke; Yanagisawa, Makoto; Yagi, Hirokazu; Nakatani, Yoshihiko; Yu, Robert K.			Involvement of beta 1-Integrin Up-regulation in Basic Fibroblast Growth Factor- and Epidermal Growth Factor-induced Proliferation of Mouse Neuroepithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; PRECURSOR CELLS; SIGNALING PATHWAY; FACTOR RECEPTOR; MEMBRANE DOMAINS; N-GLYCOSYLATION; MAPK PATHWAY; INTEGRIN; DIFFERENTIATION	In neural stem cells, basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) promote cell proliferation and self-renewal. In the bFGF-and EGF-responsive neural stem cells, beta 1-integrin also plays important roles in crucial cellular processes, including proliferation, migration, and apoptosis. The cross-talk of the signaling pathways mediated by these growth factors and beta 1-integrin, however, has not been fully elucidated. Here we report a novel molecular mechanism through which bFGF or EGF promotes the proliferation of mouse neuroepithelial cells (NECs). In the NECs, total beta 1-integrin expression levels and proliferation were dose-dependently increased by bFGF but not by EGF. EGF rather than bFGF strongly induced the increase of beta 1-integrin localization on the NEC surface. bFGF-and EGF-induced beta 1-integrin up-regulation and proliferation were inhibited after treatment with a mitogen-activated protein kinase kinase inhibitor, U0126, which indicates the dependence on the mitogen-activated protein kinase pathway. Involvement of beta 1-integrin in bFGF-and EGF-induced proliferation was confirmed by the finding that NEC proliferation and adhesion to fibronectin-coated dishes were inhibited by knockdown of beta 1-integrin using small interfering RNA. On the other hand, apoptosis was induced in NECs treated with RGD peptide, a small beta 1-integrin inhibitor peptide with the Arg-Gly-Asp motif, but it was independent of beta 1-integrin expression levels. Those results suggest that regulation of beta 1-integrin expression/localization is involved in cellular processes, such as proliferation, induced by bFGF and EGF in NECs. The mechanism underlying the proliferation through beta 1-integrin would not be expected to be completely identical, however, for bFGF and EGF.	[Suzuki, Yusuke; Yanagisawa, Makoto; Yagi, Hirokazu; Nakatani, Yoshihiko; Yu, Robert K.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Suzuki, Yusuke; Yanagisawa, Makoto; Yagi, Hirokazu; Nakatani, Yoshihiko; Yu, Robert K.] Med Coll Georgia, Inst Neurosci, Augusta, GA 30912 USA; [Yagi, Hirokazu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Nagoya City University	Yu, RK (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, 1120 15th St, Augusta, GA 30912 USA.	ryu@mcg.edu	Yagi, Hirokazu/ABH-6151-2020	Yagi, Hirokazu/0000-0001-9296-0225	National Institutes of Health [NS11853, NS26994]; Children's Medical Research Foundation (Chicago, IL); Medical College of Georgia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853, R01NS026994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Research Foundation (Chicago, IL); Medical College of Georgia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS11853 and NS26994. This work was also supported by a grant from the Children's Medical Research Foundation (Chicago, IL) (to R.K.Y.) and a start-up fund from the Medical College of Georgia (to M.Y.).	Andressen C, 2005, EUR J CELL BIOL, V84, P973, DOI 10.1016/j.ejcb.2005.09.017; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Dasgupta S, 2009, J NEUROSCI RES, V87, P3591, DOI 10.1002/jnr.22153; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Faraldo MM, 2001, EMBO REP, V2, P431, DOI 10.1093/embo-reports/kve086; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Fukuda Shinji, 2005, Anatomical Science International, V80, P12; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kalyani AJ, 1999, J NEUROBIOL, V38, P207, DOI 10.1002/(SICI)1097-4695(19990205)38:2<207::AID-NEU4>3.0.CO;2-G; Kazui A, 2000, BIOCHEM BIOPH RES CO, V273, P159, DOI 10.1006/bbrc.2000.2903; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Learish RD, 2000, DEV BRAIN RES, V122, P97; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Murozuka Y, 2007, GLYCOCONJUGATE J, V24, P551, DOI 10.1007/s10719-007-9051-2; Nagato M, 2005, J NEUROSCI RES, V80, P456, DOI 10.1002/jnr.20442; Nakashima K, 1999, J NEUROSCI, V19, P5429; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Singh RD, 2010, TRAFFIC, V11, P348, DOI 10.1111/j.1600-0854.2009.01022.x; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Suri SS, 2009, BIOMATERIALS, V30, P3084, DOI 10.1016/j.biomaterials.2009.02.014; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Watson PMD, 2007, MOL CELL NEUROSCI, V34, P147, DOI 10.1016/j.mcn.2006.10.007; Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yanagisawa M, 2009, BIOCHEM BIOPH RES CO, V386, P101, DOI 10.1016/j.bbrc.2009.05.132; Yates AJ, 1998, ANN NY ACAD SCI, V845, P57, DOI 10.1111/j.1749-6632.1998.tb09662.x; Yu RK, 2007, J NEUROCHEM, V103, P39, DOI 10.1111/j.1471-4159.2007.04710.x; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zhao M, 2008, MOL BIOTECHNOL, V40, P19, DOI 10.1007/s12033-008-9043-x; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	68	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18443	18451		10.1074/jbc.M110.114645	http://dx.doi.org/10.1074/jbc.M110.114645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20371608	Green Published, hybrid			2022-12-25	WOS:000278453900038
J	Eyre, DR; Weis, MA; Wu, JJ				Eyre, David R.; Weis, Mary Ann; Wu, Jiann-Jiu			Maturation of Collagen Ketoimine Cross-links by an Alternative Mechanism to Pyridinoline Formation in Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ARTICULAR-CARTILAGE; II COLLAGEN; IDENTIFICATION; GLYCATION; SITES; CHEMISTRY; RELEVANCE; TURNOVER; RESIDUES; LOCATION	The tensile strength of fibrillar collagens depends on stable intermolecular cross-links formed through the lysyl oxidase mechanism. Such cross-links based on hydroxylysine aldehydes are particularly important in cartilage, bone, and other skeletal tissues. In adult cartilages, the mature cross-linking structures are trivalent pyridinolines, which form spontaneously from the initial divalent ketoimines. We examined whether this was the complete story or whether other ketoimine maturation products also form, as the latter are known to disappear almost completely from mature tissues. Denatured, insoluble, bovine articular cartilage collagen was digested with trypsin, and cross-linked peptides were isolated by copper chelation chromatography, which selects for their histidine-containing sequence motifs. The results showed that in addition to the naturally fluorescent pyridinoline peptides, a second set of crosslinked peptides was recoverable at a high yield from mature articular cartilage. Sequencing and mass spectral analysis identified their origin from the same molecular sites as the initial ketoimine cross-links, but the latter peptides did not fluoresce and were nonreducible with NaBH4. On the basis of their mass spectra, they were identical to their precursor ketoimine crosslinked peptides, but the cross-linking residue had an M+ 188 adduct. Considering the properties of an analogous adduct of identical added mass on a glycated lysine-containing peptide from type II collagen, we predicted that similar dihydroxyimidazolidine structures would form from their ketoimine groups by spontaneous oxidation and free arginine addition. We proposed the trivial name arginoline for the ketoimine cross-link derivative. Mature bovine articular cartilage contains about equimolar amounts of arginoline and hydroxylysyl pyridinoline based on peptide yields.	[Eyre, David R.; Weis, Mary Ann; Wu, Jiann-Jiu] Univ Washington, Orthoped Res Labs, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), 1959 NE Pacific St,HSB BB1052,Box 356500, Seattle, WA 98195 USA.	deyre@u.washington.edu			National Institutes of Health [AR37318, AR36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794, R37AR036794, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37318 and AR36794 (to D. R. E.).	Ahsan T, 2005, OSTEOARTHR CARTILAGE, V13, P709, DOI 10.1016/j.joca.2005.03.005; Avery NC, 2005, SCAND J MED SCI SPOR, V15, P231, DOI 10.1111/j.1600-0838.2005.00464.x; BAILEY AJ, 1977, BIOCHEM BIOPH RES CO, V78, P1403, DOI 10.1016/0006-291X(77)91448-6; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BAILEY AJ, 1971, BIOCHEM J, V121, P257, DOI 10.1042/bj1210257; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Biemel KM, 2001, J BIOL CHEM, V276, P23405, DOI 10.1074/jbc.M102035200; Brock JWC, 2007, J MASS SPECTROM, V42, P89, DOI 10.1002/jms.1144; DAVIS NR, 1975, BIOCHEMISTRY-US, V14, P2031, DOI 10.1021/bi00680a034; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Eyre DR, 2004, CLIN ORTHOP RELAT R, pS118, DOI 10.1097/01.blo.0000144855.48640.b9; EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290; EYRE DR, 1973, BIOCHEM J, V135, P393, DOI 10.1042/bj1350393; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; EYRE DR, 1981, SEMIN ARTHRITIS RHEU, V11, P46, DOI 10.1016/0049-0172(81)90034-2; EYRE DR, 1975, BIOCHEM J, V151, P595, DOI 10.1042/bj1510595; EYRE DR, 1981, DEV BIOCHEM, V22, P51; Harding JJ, 2006, BBA-PROTEINS PROTEOM, V1764, P1436, DOI 10.1016/j.bbapap.2006.08.001; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Miyazaki K, 2002, J BIOCHEM, V132, P543, DOI 10.1093/oxfordjournals.jbchem.a003255; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Muir H, 1970, J Bone Joint Surg Br, V52, P554; ROBINS SP, 1983, BIOCHEM J, V215, P175, DOI 10.1042/bj2150175; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Weis MA, 1998, J BIOL CHEM, V273, P4761, DOI 10.1074/jbc.273.8.4761; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041; WU JJ, 1992, J BIOL CHEM, V267, P23007; WU JJ, 1985, ANN NY ACAD SCI, V460, P520, DOI 10.1111/j.1749-6632.1985.tb51228.x	33	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16675	16682		10.1074/jbc.M110.111534	http://dx.doi.org/10.1074/jbc.M110.111534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363745	Green Published, hybrid			2022-12-25	WOS:000277982600031
J	Pradhan, A; Lambert, QT; Griner, LN; Reuther, GW				Pradhan, Anuradha; Lambert, Que T.; Griner, Lori N.; Reuther, Gary W.			Activation of JAK2-V617F by Components of Heterodimeric Cytokine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TYROSINE KINASE JAK2; COMMON BETA-SUBUNIT; HUMAN GM-CSF; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; CONSTITUTIVE ACTIVATION; HEMATOPOIETIC-CELLS; SIGNAL-TRANSDUCTION; V617F MUTATION	The JAK2-V617F mutation is an important etiologic factor for the development of myeloproliferative neoplasms. The mechanism by which this mutated tyrosine kinase initiates deregulated signals in cells is not completely understood. It is believed that JAK2-V617F requires interactions with homodimeric cytokine receptors to elicit its transforming signal. In this study, we demonstrate that components of heterodimeric cytokine receptors can also activate JAK2-V617F. Expression of IL27Ra, a heterodimeric receptor component, enhanced the activation of JAK2-V617F and subsequent downstream signaling to activation of STAT5 and ERK. In addition, expression of components of the interleukin-3 receptor, IL3Ra and the common beta chain, activated JAK2-V617F as well as STAT5 and ERK. Importantly, expression of IL27Ra functionally replaced the requirement of a homodimeric cytokine receptor to promote the activation and transforming activity of JAK2-V617F in BaF3 cells. Tyrosine phosphorylation of IL27Ra was not required to induce activation of JAK2-V617F or STAT5, or to enhance the transforming activity of JAK2-V617F. Expression of IL3Ra or the common beta chain in BaF3 cells also enhanced the ability of JAK2-V617F to transform these hematopoietic cells. However, the heterodimeric receptor component IL12RB1 did not enhance the activation or transforming signals of JAK2-V617F in BaF3 cells. IL27Ra also activated the K539L and R683G JAK2 mutants. Together our data demonstrate that in addition to homodimeric receptors, some heterodimeric receptor components can support the activation and transforming signals of JAK2-V617F and other JAK2 mutants. Therefore, heterodimeric receptors may play unappreciated roles in JAK2 activation in the development of hematopoietic diseases including myeloproliferative neoplasms.	H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Griner, Lori N.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Reuther, GW (corresponding author), MRC3E,12902 Magnolia Dr, Tampa, FL 33612 USA.	gary.reuther@moffitt.org	Reuther, Gary/AFR-2892-2022		National Institutes of Health [R01CA127250]; Molecular Biology Core Facility of the Moffitt Cancer Center; American Cancer Society [RSG-07-197-01-LIB]; Lauri Strauss Leukemia Foundation; Children's Leukemia Research Association; NATIONAL CANCER INSTITUTE [R01CA127250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biology Core Facility of the Moffitt Cancer Center; American Cancer Society(American Cancer Society); Lauri Strauss Leukemia Foundation; Children's Leukemia Research Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA127250 and the Molecular Biology Core Facility of the Moffitt Cancer Center, American Cancer Society Research Scholar Grant RSG-07-197-01-LIB, the Lauri Strauss Leukemia Foundation, and the Children's Leukemia Research Association (all to G. W. R.).	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chatti K, 2004, BIOCHEMISTRY-US, V43, P4272, DOI 10.1021/bi036109b; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fisher GM, 1999, CYTOKINE, V11, P111, DOI 10.1006/cyto.1998.0403; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Geijsen N, 2001, CYTOKINE GROWTH F R, V12, P19, DOI 10.1016/S1359-6101(00)00019-8; Grohmann U, 2001, J IMMUNOL, V167, P221, DOI 10.4049/jimmunol.167.1.221; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hornakova T, 2009, J BIOL CHEM, V284, P6773, DOI 10.1074/jbc.M807531200; Huang HM, 2005, J CELL BIOCHEM, V96, P361, DOI 10.1002/jcb.20513; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lee TS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-58; Lee TS, 2009, CANCER-AM CANCER SOC, V115, P1692, DOI 10.1002/cncr.24183; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Muto A, 1996, J EXP MED, V183, P1911, DOI 10.1084/jem.183.4.1911; Okuda K, 1997, BLOOD, V90, P4759, DOI 10.1182/blood.V90.12.4759.4759_4759_4766; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Reuther GW, 2008, CELL CYCLE, V7, P714, DOI 10.4161/cc.7.6.5567; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; YODA A, 2007, P NATL ACAD SCI USA, V252, P257; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	66	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16651	16663		10.1074/jbc.M109.071191	http://dx.doi.org/10.1074/jbc.M109.071191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363735	Green Published, hybrid			2022-12-25	WOS:000277982600029
J	Das, BC; McCartin, K; Liu, TC; Peterson, RT; Evans, T				Das, Bhaskar C.; McCartin, Kellie; Liu, Ting-Chun; Peterson, Randall T.; Evans, Todd			A Forward Chemical Screen in Zebrafish Identifies a Retinoic Acid Derivative with Receptor Specificity	PLOS ONE			English	Article							GENETICS	Background: Retinoids regulate key developmental pathways throughout life, and have potential uses for differentiation therapy. It should be possible to identify novel retinoids by coupling new chemical reactions with screens using the zebrafish embryonic model. Principal Findings: We synthesized novel retinoid analogues and derivatives by amide coupling, obtaining 80-92% yields. A small library of these compounds was screened for bioactivity in living zebrafish embryos. We found that several structurally related compounds significantly affect development. Distinct phenotypes are generated depending on time of exposure, and we characterize one compound (BT10) that produces specific cardiovascular defects when added 1 day post fertilization. When compared to retinoic acid (ATRA), BT10 shows similar but not identical changes in the expression pattern of embryonic genes that are known targets of the retinoid pathway. Reporter assays determined that BT10 interacts with all three RAR receptor sub-types, but has no activity for RXR receptors, at all concentrations tested. Conclusions: Our screen has identified a novel retinoid with specificity for retinoid receptors. This lead compound may be useful for manipulating components of retinoid signaling networks, and may be further derivatized for enhanced activity.	[Das, Bhaskar C.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Das, Bhaskar C.] Albert Einstein Coll Med, Dept Nucl Med, New York, NY USA; [McCartin, Kellie; Liu, Ting-Chun; Evans, Todd] Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10021 USA; [Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA	Yeshiva University; Yeshiva University; Cornell University; Harvard University; Massachusetts General Hospital	Das, BC (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA.	bhaskar.das@einstein.yu.edu; tre2003@med.cornell.edu		Peterson, Randall/0000-0003-0727-3469	Albert Einstein College of Medicine; National Science Foundation (NSF) [DBI9601607, DBI0331934]; National Institutes of Health (NIH) [RR017998, HL056182, HL064282]; Howard Hughes Medical Institute (HHMI) Research Resources for Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017998] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064282, R37HL056182, R01HL056182] Funding Source: NIH RePORTER	Albert Einstein College of Medicine; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI) Research Resources for Biomedical Sciences(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	B. C. D. is thankful to the Albert Einstein College of Medicine for start up funding. The instrumentation in the Structural Nuclear Magnetic Resonance Resource is supported by the Albert Einstein College of Medicine and in part by Grants from the National Science Foundation (NSF) (DBI9601607 and DBI0331934), the National Institutes of Health (NIH) (RR017998) and the Howard Hughes Medical Institute (HHMI) Research Resources for Biomedical Sciences. T. E. is supported by the NIH (HL056182, HL064282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Das BC, 2009, CHEM COMMUN, P2133, DOI 10.1039/b823063c; Garattini E, 2007, CURR PHARM DESIGN, V13, P1375, DOI 10.2174/138161207780618786; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lokey RS, 2003, CURR OPIN CHEM BIOL, V7, P91, DOI 10.1016/S1367-5931(02)00002-9; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; Malvasi A, 2009, EUR REV MED PHARMACO, V13, P393; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Skromne I, 2008, DEV DYNAM, V237, P861, DOI 10.1002/dvdy.21484; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; STAINIER DYR, 1992, DEV BIOL, V153, P91, DOI 10.1016/0012-1606(92)90094-W; Tan DS, 2002, NAT BIOTECHNOL, V20, P561, DOI 10.1038/nbt0602-561; Waxman JS, 2009, DEV DYNAM, V238, P1207, DOI 10.1002/dvdy.21951; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705	24	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10004	10.1371/journal.pone.0010004	http://dx.doi.org/10.1371/journal.pone.0010004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368991	Green Published, gold, Green Submitted			2022-12-25	WOS:000276419900008
J	Cui, CY; Kunisada, M; Piao, Y; Childress, V; Ko, MSH; Schlessinger, D				Cui, Chang-Yi; Kunisada, Makoto; Piao, Yulan; Childress, Victoria; Ko, Minoru S. H.; Schlessinger, David			Dkk4 and Eda Regulate Distinctive Developmental Mechanisms for Subtypes of Mouse Hair	PLOS ONE			English	Article							SWEAT GLAND DEVELOPMENT; FOLLICLE MORPHOGENESIS; ECTODERMAL DYSPLASIA; SONIC-HEDGEHOG; BETA-CATENIN; GENE-EXPRESSION; WNT; SKIN; DIFFERENTIATION; ECTODYSPLASIN	The mouse hair coat comprises protective "primary'' and thermo-regulatory "secondary'' hairs. Primary hair formation is ectodysplasin (Eda) dependent, but it has been puzzling that Tabby (Eda(-/y)) mice still make secondary hair. We report that Dickkopf 4 (Dkk4), a Wnt antagonist, affects an auxiliary pathway for Eda-independent development of secondary hair. A Dkk4 transgene in wild-type mice had no effect on primary hair, but secondary hairs were severely malformed. Dkk4 action on secondary hair was further demonstrated when the transgene was introduced into Tabby mice: the usual secondary follicle induction was completely blocked. The Dkk4-regulated secondary hair pathway, like the Eda-dependent primary hair pathway, is further mediated by selective activation of Shh. The results thus reveal two complex molecular pathways that distinctly regulate subtype-based morphogenesis of hair follicles, and provide a resolution for the longstanding puzzle of hair formation in Tabby mice lacking Eda.	[Cui, Chang-Yi; Kunisada, Makoto; Piao, Yulan; Childress, Victoria; Ko, Minoru S. H.; Schlessinger, David] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cui, CY (corresponding author), NIA, Genet Lab, NIH, Baltimore, MD 21224 USA.	SchlessingerD@grc.nia.nih.gov	Cui, Chang-Yi/AAO-8984-2021; Ko, Minoru/B-7969-2009	KUNISADA, Makoto/0000-0003-2210-6108; Cui, Chang-Yi/0000-0002-9856-9427; Ko, Minoru/0000-0002-3530-3015	NIH/National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000643, ZIAAG000702, ZIAAG000662] Funding Source: NIH RePORTER	NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the IRP of the NIH/National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2009, J CLIN GASTROENTEROL, V43, P327, DOI 10.1097/MCG.0b013e31816256ff; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Cui CY, 2007, HUM MOL GENET, V16, P2583, DOI 10.1093/hmg/ddm210; Cui CY, 2006, P NATL ACAD SCI USA, V103, P9142, DOI 10.1073/pnas.0509678103; Cui CY, 2009, J INVEST DERMATOL, V129, P984, DOI 10.1038/jid.2008.318; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Durmowicz MC, 2002, GENE, V285, P203, DOI 10.1016/S0378-1119(02)00407-9; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Kunisada M, 2009, HUM MOL GENET, V18, P1769, DOI 10.1093/hmg/ddp089; Laurikkala J, 2002, DEVELOPMENT, V129, P2541; Millar SE, 2003, J INVEST DERMATOL, V120, P7, DOI 10.1046/j.1523-1747.2003.00001.x; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Schlake T, 2005, MECH DEVELOP, V122, P988, DOI 10.1016/j.mod.2005.04.012; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Sharov AA, 2006, P NATL ACAD SCI USA, V103, P18166, DOI 10.1073/pnas.0608899103; Shindo M, 2004, BIOCHEM BIOPH RES CO, V315, P73, DOI 10.1016/j.bbrc.2004.01.025; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vielkind U, 1996, ACTA ANAT, V157, P183; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Yamago G, 2001, ARCH DERMATOL RES, V293, P435, DOI 10.1007/s004030100252; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Zhang N, 2009, J GLOB INF MANAG, V17, P49, DOI 10.4018/jgim.2009010103	47	27	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e10009	10.1371/journal.pone.0010009	http://dx.doi.org/10.1371/journal.pone.0010009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20386733	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200064
J	Das, ND; Jung, KH; Chai, YG				Das, Nando Dulal; Jung, Kyoung Hwa; Chai, Young Gyu			The Role of NF-kappa B and H3K27me3 Demethylase, Jmjd3, on the Anthrax Lethal Toxin Tolerance of RAW 264.7 Cells	PLOS ONE			English	Article							HISTONE H3; MURINE MACROPHAGES; SIGNALING PATHWAY; UP-REGULATION; DIFFERENTIATION; SUSCEPTIBILITY; RESPONSES; RECEPTOR	Background: In Bacillus anthracis, lethal toxin (LeTx) is a critical virulence factor that causes immune suppression and toxic shock in the infected host. NF-kappa B is a key mediator of the inflammatory response and is crucial for the plasticity of first level immune cells such as macrophages, monocytes and neutrophils. In macrophages, this inflammatory response, mediated by NF-kappa B, can regulate host defense against invading pathogens. A Jumonji C family histone 3 lysine-27 (H3K27) demethylase, Jmjd3, plays a crucial role in macrophage plasticity and inflammation. Here we report that NF-kappa B and Jmjd3 can modulate the LeTx intoxication resistance of RAW 264.7 cells. Principal Findings: This study showed that a 2 h exposure of macrophages to LeTx caused substantial cell death with a survival rate of around 40%. The expression of the Jmjd3 gene was induced 8-fold in intoxication-resistant cells generated by treatment with lipopolysaccharides of RAW 264.7 cells. These intoxication-resistant cell lines (PLx intox and PLxL intox) were maintained for 8 passages and had a survival rate of around 100% on secondary exposure to LeTx and lipopolysaccharides. Analysis of NF-kappa B gene expression showed that the expression of p100, p50 and p65 was induced around 20, 7 and 4 fold, respectively, in both of the intoxication-resistant cell lines following a 2 h treatment with PLxL (0.1+0.1+1 mu g/ml). In contrast, these NF-kappa B genes were not induced following treatment with PLx treatment at the same concentrations. Conclusions: Although LeTx influences macrophage physiology and causes defects of some key signaling pathways such as GSK3b which contributes to cytotoxicity, these results indicate that modulation of NF-kappa B by p50, p100 and Jmjd3 could be vital for the recovery of murine macrophages from exposure to the anthrax lethal toxin.	[Das, Nando Dulal; Jung, Kyoung Hwa; Chai, Young Gyu] Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea	Hanyang University	Das, ND (corresponding author), Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea.	ygchai@hanyang.ac.kr		Das, Nando/0000-0001-7537-4021	Ministry of Education, Science and Technology, Republic of Korea [2009-0077023]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This project was performed under the Basic Science Research Program (2009-0077023) of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Baik SY, 2005, NEUROSCI LETT, V374, P53, DOI 10.1016/j.neulet.2004.10.047; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Comer JE, 2005, INFECT IMMUN, V73, P1879, DOI 10.1128/IAI.73.3.1879-1885.2005; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Ha SD, 2007, J BIOL CHEM, V282, P36230, DOI 10.1074/jbc.M707622200; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jung KH, 2008, BBA-PROTEINS PROTEOM, V1784, P1501, DOI 10.1016/j.bbapap.2008.06.016; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popov SG, 2002, FEBS LETT, V527, P211, DOI 10.1016/S0014-5793(02)03228-3; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rmali KA, 2004, INT J MOL MED, V14, P75; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Volmat V, 2001, J CELL SCI, V114, P3433; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Ziegler-Heitbrock L, 2001, J ENDOTOXIN RES, V7, P219, DOI 10.1177/09680519010070030401	34	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9913	10.1371/journal.pone.0009913	http://dx.doi.org/10.1371/journal.pone.0009913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360974	Green Published, Green Submitted, gold			2022-12-25	WOS:000276163100008
J	Talens, RP; Boomsma, DI; Tobi, EW; Kremer, D; Jukema, JW; Willemsen, G; Putter, H; Slagboom, PE; Heijmans, BT				Talens, Rudolf P.; Boomsma, Dorret I.; Tobi, Elmar W.; Kremer, Dennis; Jukema, J. Wouter; Willemsen, Gonneke; Putter, Hein; Slagboom, P. Eline; Heijmans, Bastiaan T.			Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology	FASEB JOURNAL			English	Article						epigenome; biobank; human studies; complex disease	MASS-SPECTROMETRY; COLORECTAL-CANCER; GENE-EXPRESSION; EPIGENOME; LOCUS; TWINS; ASSOCIATION; UPSTREAM; IMPRINTS; FAMILIES	The prospect of finding epigenetic risk factors for complex diseases would be greatly enhanced if DNA from existing biobanks, which is generally extracted from whole blood, could be used to perform epigenetic association studies. We characterized features of DNA methylation at 16 candidate loci, 8 of which were imprinted, in DNA samples from the Netherlands Twin Register biobank. Except for un-methylated or fully methylated sites, CpG methylation varied considerably in a sample of 30 unrelated individuals. This variation remained after accounting for the cellular heterogeneity of blood. Methylation of CpG sites was correlated within loci and, for 4 imprinted loci, across chromosomes. In 34 additional individuals, we investigated the DNA methylation of 8 representative loci in 2 longitudinal blood and 2 longitudinal buccal cell samples (follow-up 11-20 and 2-8 yr, respectively). Five of 8 loci were stable over time (rho > 0.75) in both tissues, indicating that prospective epigenetic studies may be possible. For 4 loci, the DNA methylation in blood (mesoderm) correlated with that in the buccal cells (ectoderm) (rho > 0.75). Our data suggest that epigenetic studies on complex diseases may be feasible for a proportion of genomic loci provided that they are carefully designed.-Talens, R. P., Boomsma, D. I., Tobi, E. W., Kremer, D., Jukema, J. W., Willemsen, G., Putter, H., Slagboom, P. E., Heijmans, B. T. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 24, 3135-3144 (2010). www.fasebj.org	[Talens, Rudolf P.; Tobi, Elmar W.; Kremer, Dennis; Slagboom, P. Eline; Heijmans, Bastiaan T.] Leiden Univ, Med Ctr, Dept Mol Epidemiol, NL-2300 RC Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Putter, Hein] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands; [Boomsma, Dorret I.; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Slagboom, P. Eline; Heijmans, Bastiaan T.] Netherlands Consortium Healthy Ageing, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Heijmans, BT (corresponding author), Leiden Univ, Med Ctr, Dept Mol Epidemiol, Postal Zone S-05-P,POB 9600, NL-2300 RC Leiden, Netherlands.	b.t.heijmans@lumc.nl	Tobi, Elmar W/C-1834-2014; Jukema, J. Wouter/ABD-6503-2021; Slagboom, P. Eline/R-4790-2016; Boomsma, Dorret I/AAX-4470-2020; Putter, Hein/C-2244-2018	Tobi, Elmar W/0000-0002-1378-3687; Jukema, J. Wouter/0000-0002-3246-8359; Slagboom, P. Eline/0000-0002-2875-4723; Putter, Hein/0000-0001-5395-1422; Willemsen, Gonneke/0000-0003-3755-0236	Netherlands Heart Foundation [NHS2006B083]; Netherlands Organization for Scientific Research (NWO); Twin-family database for behavior genomics studies [480-04-004, 911-03-016]; Spinozapremie [SPI 56-464-14192]; Centre for Medical Systems Biology (CMSB); Centre for Neurogenomics and Cognitive Research (CNCR-VU); Genome-wide analyses of European twin and population cohorts [EU/QLRT-2001-01254]; European Union [FP6 036894]; NGI/NWO [050 60 810]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Twin-family database for behavior genomics studies; Spinozapremie; Centre for Medical Systems Biology (CMSB); Centre for Neurogenomics and Cognitive Research (CNCR-VU); Genome-wide analyses of European twin and population cohorts; European Union(European Commission); NGI/NWO(Netherlands Organization for Scientific Research (NWO))	The authors thank Dr. L. H. Lumey (Mailman School of Public Health, Columbia University, New York, NY, USA), for access to the Dutch Hunger Winter Family Study samples used in our analysis. This work was supported by grants from the Netherlands Heart Foundation (NHS2006B083); the Netherlands Organization for Scientific Research (NWO); the twin-family database for behavior genomics studies (480-04-004, 911-03-016); Spinozapremie (SPI 56-464-14192); the Centre for Medical Systems Biology (CMSB) in the framework of the Netherlands Genomics Initiative (NGI) and the Centre for Neurogenomics and Cognitive Research (CNCR-VU); genome-wide analyses of European twin and population cohorts (EU/QLRT-2001-01254); the European Union-funded Network of Excellence LifeSpan (FP6 036894); and the NGI/NWO-funded Netherlands Consortium for Healthy Ageing (050 60 810).	Adkins RM, 2007, PEDIATR RES, V62, P451, DOI 10.1203/PDR.0b013e3181425841; Ally MS, 2009, CANCER EPIDEM BIOMAR, V18, P922, DOI 10.1158/1055-9965.EPI-08-0703; Altman D.G., 1991, PRACTICAL STATISTIC; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dong J, 2007, J IMMUNOL, V179, P2389, DOI 10.4049/jimmunol.179.4.2389; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Foley DL, 2009, AM J EPIDEMIOL, V169, P389, DOI 10.1093/aje/kwn380; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kouzarides T, 2007, CELL, V128, P802, DOI 10.1016/j.cell.2007.02.018; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Probst MCO, 2004, ATHEROSCLEROSIS, V175, P269, DOI 10.1016/j.atherosclerosis.2004.02.019; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Rosa AL, 2005, CHROMOSOME RES, V13, P809, DOI 10.1007/s10577-005-1015-4; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; Shen LL, 2007, CURR OPIN CLIN NUTR, V10, P576, DOI 10.1097/MCO.0b013e3282bf6f43; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Stanssens P, 2004, GENOME RES, V14, P126; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; West B. T., 2006, LINEAR MIXED MODELS, P180	62	235	238	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3135	3144		10.1096/fj.09-150490	http://dx.doi.org/10.1096/fj.09-150490			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20385621				2022-12-25	WOS:000281446400004
J	Job, V; Mattei, PJ; Lemaire, D; Attree, I; Dessen, A				Job, Viviana; Mattei, Pierre-Jean; Lemaire, David; Attree, Ina; Dessen, Andrea			Structural Basis of Chaperone Recognition of Type III Secretion System Minor Translocator Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; NEEDLE COMPLEX; TETRATRICOPEPTIDE REPEATS; SHIGELLA-FLEXNERI; PORE FORMATION; V-ANTIGEN; INJECTISOME; BINDING; TIP; FORMS	The type III secretion system (T3SS) is a complex nanomachine employed by many Gram-negative pathogens, including the nosocomial agent Pseudomonas aeruginosa, to inject toxins directly into the cytoplasm of eukaryotic cells. A key component of all T3SS is the translocon, a proteinaceous channel that is inserted into the target membrane, which allows passage of toxins into target cells. In most bacterial species, two distinct membrane proteins (the "translocators") are involved in translocon formation, whereas in the bacterial cytoplasm, however, they remain associated to a common chaperone. To date, the strategy employed by a single chaperone to recognize two distinct translocators is unknown. Here, we report the crystal structure of a complex between the Pseudomonas translocator chaperone PcrH and a short region from the minor translocator PopD. PcrH displays a 7-helical tetratricopeptide repeat fold that harbors the PopD peptide within its concave region, originally believed to be involved in recognition of the major translocator, PopB. Point mutations introduced into the PcrH-interacting region of PopD impede translocator-chaperone recognition in vitro and lead to impairment of bacterial cytotoxicity toward macrophages in vivo. These results indicate that T3SS translocator chaperones form binary complexes with their partner molecules, and the stability of their interaction regions must be strictly maintained to guarantee bacterial infectivity. The PcrH-PopD complex displays homologs among a number of pathogenic strains and could represent a novel, potential target for antibiotic development.	Univ Grenoble 1, Commissariat Energie Atom, Bacterial Pathogenesis Grp, Inst Biol Struct,CNRS,UMR 5075, F-38027 Grenoble, France; [Lemaire, David] Univ Aix Marseille, Commisariat Energie Atom, Lab Interact Prot Met, CNRS,IBEB,UMR 6191, F-13108 St Paul Les Durance, France; [Attree, Ina] Univ Grenoble 1, Commissariat Energie Atom, iRTSV, LBBSI,CNRS,UMR5092, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)		andrea.dessen@ibs.fr		Lemaire, David/0000-0001-6874-3685; Attree, Ina/0000-0002-2580-764X; Dessen, Andrea/0000-0001-6487-4020; Job, Viviana/0000-0001-8421-5292	Commissariat a l'Energie Atomique "Transport de Proteines Membranaires" program	Commissariat a l'Energie Atomique "Transport de Proteines Membranaires" program	This work was supported in part by a grant from the Commissariat a l'Energie Atomique "Transport de Proteines Membranaires" program (to A. D. and I. A.).	Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Broms JE, 2006, FEMS MICROBIOL LETT, V256, P57, DOI 10.1111/j.1574-6968.2005.00099.x; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Creasey EA, 2003, MOL MICROBIOL, V47, P209, DOI 10.1046/j.1365-2958.2003.03290.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005	37	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23222	23230		10.1074/jbc.M110.111278	http://dx.doi.org/10.1074/jbc.M110.111278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20385547	Green Published, hybrid			2022-12-25	WOS:000279999900056
J	Harrison, CF; Lawson, VA; Coleman, BM; Kim, YS; Masters, CL; Cappai, R; Barnham, KJ; Hill, AF				Harrison, Christopher F.; Lawson, Victoria A.; Coleman, Bradley M.; Kim, Yong-Sun; Masters, Colin L.; Cappai, Roberto; Barnham, Kevin J.; Hill, Andrew F.			Conservation of a Glycine-rich Region in the Prion Protein Is Required for Uptake of Prion Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; CRYSTAL-STRUCTURE; SCRAPIE ISOFORM; CELL-SURFACE; GXXXG MOTIF; AMINO-ACIDS; RESISTANT; PRP; EXOSOMES; PROPAGATION	Prion diseases are associated with the misfolding of the endogenously expressed prion protein (designated PrPC) into an abnormal isoform (PrPSc) that has infectious properties. The hydrophobic domain of PrPC is highly conserved and contains a series of glycine residues that show perfect conservation among all species, strongly suggesting it has functional and evolutionary significance. These glycine residues appear to form repeats of the GXXXG protein-protein interaction motif (two glycines separated by any three residues); the retention of these residues is significant and presumably relates to the functionality of PrPC. Mutagenesis studies demonstrate that minor alterations to this highly conserved region of PrPC drastically affect the ability of cells to uptake and replicate prion infection in both cell and animal bioassay. The localization and processing of mutant PrPC are not affected, although in vitro and in vivo studies demonstrate that this region is not essential for interaction with PrPSc, suggesting these residues provide conformational flexibility. These data suggest that this region of PrPC is critical in the misfolding process and could serve as a novel, species-independent target for prion disease therapeutics.	[Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Harrison, Christopher F.; Lawson, Victoria A.; Coleman, Bradley M.; Cappai, Roberto; Barnham, Kevin J.; Hill, Andrew F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Lawson, Victoria A.; Masters, Colin L.; Barnham, Kevin J.; Hill, Andrew F.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, Kyounggi Do, South Korea	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Hallym University	Hill, AF (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	a.hill@unimelb.edu.au	Hill, Andrew F./AAH-2854-2020; Hill, Andrew F./GZL-4124-2022; Lawson, Victoria/AAJ-7392-2021; Hill, Andrew F/B-4527-2009; Cappai, Roberto/B-3347-2010	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Lawson, Victoria/0000-0002-7362-7176; Cappai, Roberto/0000-0002-9505-8496	Australian Research Council [DP0987227]; National Health and Medical Research Council [400202]; Australian postgraduate award; University of Melbourne	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); University of Melbourne(University of Melbourne)	This work was supported in part by Australian Research Council Discovery Project Grant DP0987227 and National Health and Medical Research Council Program Grant 400202.; Recipient of an Australian postgraduate award scholarship.; Recipient of a University of Melbourne CR Roper fellowship.; Recipient of a University of Melbourne research scholarship.; Recipient of a National Health and Medical Research Council senior research fellowship.; Recipient of National Health and Medical Research Council career development award (Level 2). A shareholder in and consultant to D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, therapeutics, and decontamination. D-Gen markets the ICSM18 antibody used in this study.	Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; Americo TA, 2007, BIOCHEM BIOPH RES CO, V358, P620, DOI 10.1016/j.bbrc.2007.04.202; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Choi JK, 2006, HYBRIDOMA, V25, P271, DOI 10.1089/hyb.2006.25.271; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Collins SJ, 2005, NEUROBIOL DIS, V20, P336, DOI 10.1016/j.nbd.2005.03.014; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Guilbert C, 2000, BIOPOLYMERS, V54, P406, DOI 10.1002/1097-0282(200011)54:6<406::AID-BIP50>3.0.CO;2-6; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Harrison CF, 2007, J NEUROCHEM, V103, P1709, DOI 10.1111/j.1471-4159.2007.04936.x; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2009, NEUROPATH APPL NEURO, V35, P111, DOI 10.1111/j.1365-2990.2008.00964.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kovacs GG, 2001, NEUROBIOL DIS, V8, P881, DOI 10.1006/nbdi.2001.0418; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Mallucci GR, 1999, BRAIN, V122, P1823, DOI 10.1093/brain/122.10.1823; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2009, NEW ENGL J MED, V361, P2056, DOI 10.1056/NEJMoa0809716; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Panegyres PK, 2001, ARCH NEUROL-CHICAGO, V58, P1899, DOI 10.1001/archneur.58.11.1899; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Polymenidou M, 2008, VACCINE, V26, P2601, DOI 10.1016/j.vaccine.2008.03.035; Priola SA, 2001, EMBO J, V20, P6692, DOI 10.1093/emboj/20.23.6692; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Rodriguez MM, 2005, NEUROLOGY, V64, P1455, DOI 10.1212/01.WNL.0000158618.39527.93; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Stockel J, 2001, J MOL BIOL, V313, P861, DOI 10.1006/jmbi.2001.5085; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vorberg I, 2001, J VIROL, V75, P10024, DOI 10.1128/JVI.75.21.10024-10032.2001; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	66	23	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20213	20223		10.1074/jbc.M109.093310	http://dx.doi.org/10.1074/jbc.M109.093310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20356832	hybrid, Green Published			2022-12-25	WOS:000279012000056
J	Rothe, R; Liguori, L; Villegas-Mendez, A; Marques, B; Grunwald, D; Drouet, E; Lenormand, JL				Rothe, Romy; Liguori, Lavinia; Villegas-Mendez, Ana; Marques, Bruno; Grunwald, Didier; Drouet, Emmanuel; Lenormand, Jean-Luc			Characterization of the Cell-penetrating Properties of the Epstein-Barr Virus ZEBRA trans-Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAT-FUSION PROTEINS; DEPENDENT KINASE INHIBITORS; HIV-1 TAT; TRANSDUCTION DOMAIN; HEPARAN-SULFATE; GROWTH ARREST; HUMAN GAMMAHERPESVIRUSES; MEDIATED DELIVERY; CATIONIC PEPTIDES; ENDOSOMAL ESCAPE	The Epstein-Barr virus basic leucine zipper transcriptional activator ZEBRA was shown recently to cross the outer membrane of live cells and to accumulate in the nucleus of lymphocytes. We investigated the potential application of the EpsteinBarr virus trans-activator ZEBRA as a transporter protein to facilitate transduction of cargo proteins. Analysis of different truncated forms of ZEBRA revealed that the minimal domain (MD) required for internalization spans residues 170-220. MD efficiently transported reporter proteins such as enhanced green fluorescent protein (EGFP) and beta-galactosidase in several normal and tumor cell lines. Functionality of internalized cargo proteins was confirmed by beta-galactosidase activity in transduced cells, and no MD-associated cell toxicity was detected. Translocation of MD through the cell membrane required binding to cell surface-associated heparan sulfate proteoglycans as shown by strong inhibition of protein uptake in the presence of heparin. We found that internalization was blocked at 4 degrees C, whereas no ATP was required as shown by an only 25% decreased uptake efficiency in energy-depleted cells. Common endocytotic inhibitors such as nystatin, chlorpromazine, and wortmannin had no significant impact on MD-EGFP uptake. Only methyl-beta-cyclodextrin inhibited MD-EGFP uptake by 40%, implicating the lipid raft-mediated endocytotic pathway. These data suggest that MD-reporter protein transduction occurs mostly via direct translocation through the lipid bilayer and not by endocytosis. This mechanism of MD-mediated internalization is suitable for the efficient delivery of biologically active proteins and renders ZEBRA-MD a promising candidate for therapeutic protein delivery applications.	[Lenormand, Jean-Luc] Univ Grenoble 1, CNRS, UFR Med, UMR5525,TIMC IMAG Lab, F-38700 La Tronche, France; [Liguori, Lavinia] Univ Grenoble 1, Fdn RTRA Nanosci, TIMC GMCAO, F-38706 La Tronche, France; [Grunwald, Didier] Commissariat Energie Atom Grenoble, INSERM, U873, iRTSV TS, F-38054 Grenoble 9, France; [Drouet, Emmanuel] Univ Grenoble 1, CNRS, EMBL, Unit Virus Host Cell Interact,UMR5233, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lenormand, JL (corresponding author), Univ Grenoble 1, CNRS, UFR Med, UMR5525,TIMC IMAG Lab, F-38700 La Tronche, France.	jllenormand@chu-grenoble.fr	Lenormand, Jean-Luc/ABF-3850-2021; Lenormand, Jean-Luc/M-6644-2014	villegas-mendez, ana/0000-0002-8363-680X; Lenormand, Jean-Luc/0000-0002-2766-9180	Marie Curie Excellence Grant [014320]	Marie Curie Excellence Grant(European Commission)	This work was supported by Marie Curie Excellence Grant 014320.	Abes S, 2007, NUCLEIC ACIDS RES, V35, P4495, DOI 10.1093/nar/gkm418; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Cayrol C, 1996, J BIOL CHEM, V271, P31799, DOI 10.1074/jbc.271.50.31799; Cayrol C, 1996, EMBO J, V15, P2748, DOI 10.1002/j.1460-2075.1996.tb00635.x; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Endoh T, 2008, BIOCONJUGATE CHEM, V19, P1017, DOI 10.1021/bc800020n; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Fuchs SM, 2006, CELL MOL LIFE SCI, V63, P1819, DOI 10.1007/s00018-006-6170-z; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Harada H, 2002, CANCER RES, V62, P2013; Ho A, 2001, CANCER RES, V61, P474; Joliot A, 2008, ADV DRUG DELIVER REV, V60, P608, DOI 10.1016/j.addr.2007.09.004; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kramer SD, 2003, BBA-BIOMEMBRANES, V1609, P161, DOI 10.1016/S0005-2736(02)00683-1; Langel U, 2007, HDB CELL PENETRATING; Liguori L, 2008, J CONTROL RELEASE, V126, P217, DOI 10.1016/j.jconrel.2007.12.004; Lindgren M, 2000, BIOCONJUGATE CHEM, V11, P619, DOI 10.1021/bc990156s; Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630; Mahot S, 2005, VIRUS RES, V110, P187, DOI 10.1016/j.virusres.2005.01.014; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Mukai Y, 2006, BIOL PHARM BULL, V29, P1570, DOI 10.1248/bpb.29.1570; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; Nishi K, 2007, J BIOL CHEM, V282, P27503, DOI 10.1074/jbc.M703810200; Oliveira S, 2008, CURR PHARM DESIGN, V14, P3686, DOI 10.2174/138161208786898789; Oliveira S, 2007, INT J PHARM, V331, P211, DOI 10.1016/j.ijpharm.2006.11.050; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Rodriguez A, 1999, J VIROL, V73, P9029, DOI 10.1128/JVI.73.11.9029-9038.1999; Rodriguez A, 2001, VIROLOGY, V284, P159, DOI 10.1006/viro.2001.0923; Rothe R, 2008, CURR PROTOC PROTEIN; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Shiraishi T, 2006, NAT PROTOC, V1, P633, DOI 10.1038/nprot.2006.92; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; Sinclair AJ, 2006, TRENDS MICROBIOL, V14, P289, DOI 10.1016/j.tim.2006.05.003; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Watson P, 2005, ADV DRUG DELIVER REV, V57, P43, DOI 10.1016/j.addr.2004.05.003; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	49	21	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20224	20233		10.1074/jbc.M110.101550	http://dx.doi.org/10.1074/jbc.M110.101550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20385549	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000279012000057
J	Guignard, TJP; Jin, MH; Pequignot, MO; Li, SH; Chassigneux, Y; Chekroud, K; Guillou, L; Richard, E; Hamel, CP; Brabet, P				Guignard, Thomas J. P.; Jin, Minghao; Pequignot, Marie O.; Li, Songhua; Chassigneux, Yolaine; Chekroud, Karim; Guillou, Laurent; Richard, Eric; Hamel, Christian P.; Brabet, Philippe			FATP1 Inhibits 11-cis Retinol Formation via Interaction with the Visual Cycle Retinoid Isomerase RPE65 and Lecithin:Retinol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID TRANSPORT PROTEIN-1; ACYL-COA SYNTHETASE; LEBERS CONGENITAL AMAUROSIS; PIGMENT EPITHELIAL-CELLS; ISOMEROHYDROLASE ACTIVITY; RHODOPSIN REGENERATION; EXPRESSION; MUTATIONS; LOCALIZATION; LIGHT	The isomerization of all-trans retinol (vitamin A) to 11-cis retinol in the retinal pigment epithelium (RPE) is a key step in the visual process for the regeneration of the visual pigment chromophore, 11-cis retinal. LRAT and RPE65 are recognized as the minimal isomerase catalytic components. However, regulators of this rate-limiting step are not fully identified and could account for the phenotypic variability associated with inherited retinal degeneration (RD) caused by mutations in the RPE65 gene. To identify new RPE65 partners, we screened a porcine RPE mRNA library using a yeast two-hybrid assay with full-length human RPE65. One identified clone (here named FATP1c), containing the cytosolic C-terminal sequence from the fatty acid transport protein 1 (FATP1 or SLC27A1, solute carrier family 27 member 1), was demonstrated to interact dose-dependently with the native RPE65 and with LRAT. Furthermore, these interacting proteins colocalize in the RPE. Cellular reconstitution of human interacting proteins shows that FATP1 markedly inhibits 11-cis retinol production by acting on the production of all-trans retinyl esters and the isomerase activity of RPE65. The identification of this new visual cycle inhibitory component in RPE may contribute to further understanding of retinal pathogenesis.	[Guignard, Thomas J. P.; Pequignot, Marie O.; Chassigneux, Yolaine; Chekroud, Karim; Guillou, Laurent; Hamel, Christian P.; Brabet, Philippe] INSERM, U583, Inst Neurosci Montpellier, F-34091 Montpellier, France; [Brabet, Philippe] Univ Montpellier 1, F-34967 Montpellier, France; [Brabet, Philippe] Univ Montpellier 2, F-34095 Montpellier, France; [Jin, Minghao; Li, Songhua] Louisiana State Univ, Sch Med, Dept Ophthalmol, Ctr Neurosci, New Orleans, LA 70112 USA; [Richard, Eric] INSERM, UMR 554, CNRS, Ctr Biochim Struct,UMR 5048,UM1, F-34090 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Louisiana State University System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Brabet, P (corresponding author), INSERM, U583, Inst Neurosci Montpellier, F-34091 Montpellier, France.	philippe.brabet@inserm.fr	Pequignot, Marie O/P-1994-2017; Brabet, Philippe/AAO-8522-2020	Brabet, Philippe/0000-0003-2739-1622; Richard, Eric/0000-0003-0277-4141; Pequignot, Marie/0000-0002-8866-3778	private foundations (Fe de ration des Aveugles et Handicapes Visuels de France, IRRP, Retina France, SOS Retinite); Region Languedoc Roussillon; French Ministry for National Education; Inserm	private foundations (Fe de ration des Aveugles et Handicapes Visuels de France, IRRP, Retina France, SOS Retinite); Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France); French Ministry for National Education; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported in part by private foundations (Fe de ration des Aveugles et Handicapes Visuels de France, IRRP, Retina France, SOS Retinite), Region Languedoc Roussillon, French Ministry for National Education, and Inserm.	Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen Y, 2006, FEBS LETT, V580, P4200, DOI 10.1016/j.febslet.2006.06.078; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; FISHER S, 1982, DEACYLATION ACYLATIO; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Martin G, 2000, GENOMICS, V66, P296, DOI 10.1006/geno.2000.6191; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Mondal MS, 2001, FEBS LETT, V489, P14, DOI 10.1016/S0014-5793(00)02428-5; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Saari J, 1994, RETINOIDS PHOTOSENSI; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schmuth M, 2005, J INVEST DERMATOL, V125, P1174, DOI 10.1111/j.0022-202X.2005.23934.x; Silva Eduardo, 2004, Ophthalmic Genet, V25, P205, DOI 10.1080/13816810490513451; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; STECHER H, 2000, MULTIENZYME ANAL VIS; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Xue LL, 2006, BIOCHEMISTRY-US, V45, P10710, DOI 10.1021/bi060897y	40	11	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18759	18768		10.1074/jbc.M109.064329	http://dx.doi.org/10.1074/jbc.M109.064329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20356843	Green Published, hybrid			2022-12-25	WOS:000278453900067
J	Lou, HY; Montoya, SE; Alerte, TNM; Wang, J; Wu, JJ; Peng, XM; Hong, CS; Friedrich, EE; Mader, SA; Pedersen, CJ; Marcus, BS; McCormack, AL; Di Monte, DA; Daubner, SC; Perez, RG				Lou, Haiyan; Montoya, Susana E.; Alerte, Tshianda N. M.; Wang, Jian; Wu, Jianjun; Peng, Xiangmin; Hong, Chang-Sook; Friedrich, Emily E.; Mader, Samantha A.; Pedersen, Courtney J.; Marcus, Brian S.; McCormack, Alison L.; Di Monte, Donato A.; Daubner, S. Colette; Perez, Ruth G.			Serine 129 Phosphorylation Reduces the Ability of alpha-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2A in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ADRENAL CHROMAFFIN CELLS; INCLUSION-BODY FORMATION; CHAPERONE-LIKE ACTIVITY; PARKINSONS-DISEASE; KINASE-II; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; GENE-EXPRESSION; MEDIATED PHOSPHORYLATION	alpha-Synuclein (a-Syn), a protein implicated in Parkinson disease, contributes significantly to dopamine metabolism. a-Syn binding inhibits the activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. Phosphorylation of TH stimulates its activity, an effect that is reversed by protein phosphatase 2A (PP2A). In cells, a-Syn overexpression activates PP2A. Here we demonstrate that a-Syn significantly inhibited TH activity in vitro and in vivo and that phosphorylation of a-Syn serine 129 (Ser-129) modulated this effect. In MN9D cells, a-Syn overexpression reduced TH serine 19 phosphorylation (Ser(P)-19). In dopaminergic tissues from mice overexpressing human a-Syn in catecholamine neurons only, TH-Ser-19 and TH-Ser-40 phosphorylation and activity were also reduced, whereas PP2A was more active. Cerebellum, which lacks excess a-Syn, had PP2A activity identical to controls. Conversely, a-Syn knock-out mice had elevated TH-Ser-19 phosphorylation and activity and less active PP2A in dopaminergic tissues. Using an a-Syn Ser-129 dephosphorylation mimic, with serine mutated to alanine, TH was more inhibited, whereas PP2A was more active in vitro and in vivo. Phosphorylation of a-Syn Ser-129 by Polo-like-kinase 2 in vitro reduced the ability of a-Syn to inhibit TH or activate PP2A, identifying a novel regulatory role for Ser-129 on a-Syn. These findings extend our understanding of normal a-Syn biology and have implications for the dopamine dysfunction of Parkinson disease.	[Lou, Haiyan; Montoya, Susana E.; Alerte, Tshianda N. M.; Wang, Jian; Wu, Jianjun; Peng, Xiangmin; Hong, Chang-Sook; Friedrich, Emily E.; Mader, Samantha A.; Pedersen, Courtney J.; Marcus, Brian S.; Perez, Ruth G.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15261 USA; [Lou, Haiyan] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250012, Shandong, Peoples R China; [McCormack, Alison L.; Di Monte, Donato A.] Parkinsons Inst, Sunnyvale, CA 94085 USA; [Daubner, S. Colette] St Marys Univ, Dept Biol Sci, San Antonio, TX 78229 USA; [Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shandong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Perez, RG (corresponding author), 3501 5th Ave,BST3 7021, Pittsburgh, PA 15260 USA.	perezrg@pitt.edu	/AAO-5184-2020; Perez, Ruth G./AAK-9844-2020; Marcus, Brian/AGZ-1385-2022; Friedrich, Emily/R-3925-2017; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	/0000-0003-1869-7558; Marcus, Brian/0000-0001-5775-4143; Friedrich, Emily/0000-0003-1869-7558; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Di Monte, Donato/0000-0002-8296-836X; Pedersen, Courtney/0000-0002-5917-2742	National Institutes of Health [NS42094, GM47291]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS42094 (to R. G. P. with a supplement provided for S. E. M. (NINDS)) and GM47291 (to S. C. D.). This work was also supported by the China Scholarship Council (to H. L.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Baptista MJ, 2003, J NEUROCHEM, V85, P957, DOI 10.1046/j.1471-4159.2003.01742.x; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BERRESHEIM U, 1994, BRAIN RES, V637, P273, DOI 10.1016/0006-8993(94)91244-0; Bevilaqua LRM, 2003, J NEUROCHEM, V85, P1368, DOI 10.1046/j.1471-4159.2003.01792.x; Bobrovskaya L, 2004, J NEUROCHEM, V90, P857, DOI 10.1111/j.1471-4159.2004.02550.x; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; COLBRAN RJ, 1992, NEUROCHEM INT, V21, P469, DOI 10.1016/0197-0186(92)90080-B; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; DAUBNER SC, 1993, PROTEIN SCI, V2, P1452, DOI 10.1002/pro.5560020909; DAUBNER SC, 1992, J BIOL CHEM, V267, P12639; DAUBNER SC, 1993, ADV EXP MED BIOL, V338, P87; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fujita M, 2006, NEUROPATHOLOGY, V26, P383, DOI 10.1111/j.1440-1789.2006.00732.x; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; HAAVIK J, 1990, FEBS LETT, V262, P363, DOI 10.1016/0014-5793(90)80230-G; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; Haendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Haycock JW, 1998, J NEUROCHEM, V71, P1670; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; HAYCOCK JW, 1992, J NEUROCHEM, V58, P57, DOI 10.1111/j.1471-4159.1992.tb09276.x; Hirai Y, 2004, FEBS LETT, V572, P227, DOI 10.1016/j.febslet.2004.07.046; Hsu LJ, 1998, J NEUROCHEM, V71, P338; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; Jakowec MW, 2001, DEV NEUROSCI-BASEL, V23, P91, DOI 10.1159/000048700; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kumer SC, 1996, J NEUROCHEM, V67, P443; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Leal RB, 2002, NEUROCHEM RES, V27, P207, DOI 10.1023/A:1014880403970; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Liberini P, 2000, J NEUROL, V247, P88, DOI 10.1007/PL00007803; Liu DM, 2008, NEUROCHEM RES, V33, P1401, DOI 10.1007/s11064-008-9599-7; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; McCormack AL, 2004, J COMP NEUROL, V471, P387, DOI 10.1002/cne.20036; McCormack AL, 2008, J NEUROPATH EXP NEUR, V67, P793, DOI 10.1097/NEN.0b013e318180f0bd; McCormack AL, 2009, CURR PROTEIN PEPT SC, V10, P476, DOI 10.2174/138920309789351912; Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078; MILLER DW, 2006, SOC NEUR ABSTR; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; Ramsey AJ, 1998, BIOCHEMISTRY-US, V37, P8980, DOI 10.1021/bi980582l; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Royo M, 2005, PROTEINS, V58, P14, DOI 10.1002/prot.20293; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schweikl H, 2008, BIOMATERIALS, V29, P1377, DOI 10.1016/j.biomaterials.2007.11.049; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Sutoo D, 2002, BRAIN RES, V933, P1, DOI 10.1016/S0006-8993(02)02271-0; TANJI M, 1994, J NEUROCHEM, V63, P1908; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Toska K, 2002, ANN NY ACAD SCI, V971, P66, DOI 10.1111/j.1749-6632.2002.tb04435.x; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang J, 2009, J BIOL CHEM, V284, P14011, DOI 10.1074/jbc.M901310200; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; WU B, 2010, ACTA HISTOC IN PRESS; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	106	94	96	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17648	17661		10.1074/jbc.M110.100867	http://dx.doi.org/10.1074/jbc.M110.100867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356833	Green Published, hybrid			2022-12-25	WOS:000278133400043
J	Mata-Greenwood, E; Liao, WX; Wang, W; Zheng, J; Chen, DB				Mata-Greenwood, Eugenia; Liao, Wu-xiang; Wang, Wen; Zheng, Jing; Chen, Dong-bao			Activation of AP-1 Transcription Factors Differentiates FGF2 and Vascular Endothelial Growth Factor Regulation of Endothelial Nitric-oxide Synthase Expression in Placental Artery Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SIGNALING PATHWAYS; PROTEIN-KINASE CASCADE; UTERINE ARTERY; RESPONSIVE ELEMENT; GENE-EXPRESSION; UP-REGULATION; NO SYNTHASE; ENOS GENE; DUAL ROLE; IN-VITRO	FGF2 (fibroblast growth factor 2), but not vascular endothelial growth factor (VEGF), stimulates sustained activation of ERK2/1 for endothelial NOS3 (nitric-oxide synthase 3) protein expression in ovine fetoplacental artery endothelial cells (oFPAEC). We deciphered herein the downstream signaling of ERK2/1 responsible for NOS3 expression by FGF2 in oFPAEC. FGF2, but not VEGF, increased NOS3 mRNA levels without altering its degradation. FGF2, but not VEGF, trans-activated sheep NOS3 promoter, and this was dependent on ERK2/1 activation. FGF2 did not trans-activate NOS3 promoters with deletions upstream of the consensus AP-1 site(TGAGTCA, -678 to -685). Trans-activation of wild-type NOS3 promoter by FGF2 was significantly inhibited when either the AP-1 or the cAMP-response element (CRE)-like sequence (TGCGTCA, -752 to -758) was mutated and was completely blocked when both were mutated. EMSA analyses showed that FGF2, but not VEGF, stimulated AP-1 and CRE DNA-protein complexes primarily composed of JunB and Fra1. Chromatin immunoprecipitation assays confirmed JunB/Fra1 binding to NOS3 promoter AP-1 and CRE elements in intact cells. FGF2, but not VEGF, stimulated JunB and Fra1 expressions; all preceded NOS3 up-regulation and were inhibited by PD98059. Down-regulation of JunB or Fra-1, but not c-Jun, blocked FGF2 stimulation of NOS3 expression and NO production. AP-1 inhibition suppressed FGF2 stimulation of NOS3 expression in human umbilical vein EC and uterine artery endothelial cells. Thus, FGF2 induction of NOS3 expression is mainly mediated by AP-1-dependent transcription involving JunB and Fra1 up-regulation via sustained ERK2/1 activation in endothelial cells.	[Liao, Wu-xiang; Wang, Wen; Chen, Dong-bao] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92697 USA; [Mata-Greenwood, Eugenia; Liao, Wu-xiang; Chen, Dong-bao] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Zheng, Jing] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53715 USA	University of California System; University of California Irvine; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Chen, DB (corresponding author), Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92697 USA.	dongbaoc@uci.edu	Marta-Greenwood, Eugenia/AAR-9190-2020	Mata-Greenwood, Eugenia/0000-0002-6647-9048	National Institutes of Health [RO1 HL64703, RO1 HL74947, HL70562]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070562, R01HL074947, R01HL064703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL64703 (to J. Z.) and RO1 HL74947 and HL70562 (to D.-b. C.).	Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; BIELINSKA A, 1990, SCIENCE, V250, P997, DOI 10.1126/science.2237444; Borowicz PP, 2007, BIOL REPROD, V76, P259, DOI 10.1095/biolreprod.106.054684; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Ducsay CA, 2006, AM J PHYSIOL-REG I, V291, pR1406, DOI 10.1152/ajpregu.00077.2006; Fish JE, 2006, CELL MOL LIFE SCI, V63, P144, DOI 10.1007/s00018-005-5421-8; Fisslthaler B, 2003, NITRIC OXIDE-BIOL CH, V8, P253, DOI 10.1016/S1089-8603(03)00042-9; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; HSU JC, 1993, CANCER RES, V53, P3789; Hurd TW, 2002, BIOCHEM J, V368, P573, DOI 10.1042/BJ20020579; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Li Y, 2004, BIOL REPROD, V70, P785, DOI 10.1095/biolreprod.103.022293; Liao WX, 2009, MOL ENDOCRINOL, V23, P1428, DOI 10.1210/me.2008-0475; Liao WX, 2005, BIOL REPROD, V72, P530, DOI 10.1095/biolreprod.104.035949; Mata-Greenwood E, 2008, PLACENTA, V29, P708, DOI 10.1016/j.placenta.2008.05.005; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Min J, 2006, HYPERTENSION, V47, P1189, DOI 10.1161/01.HYP.0000222892.37375.4d; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Nelson SH, 2000, CIRC RES, V87, P406; Niwano K, 2003, CIRC RES, V93, P523, DOI 10.1161/01.RES.0000091336.55487.F7; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Qian XX, 2007, MOL CELL ENDOCRINOL, V279, P39, DOI 10.1016/j.mce.2007.08.017; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reynolds LP, 2006, J PHYSIOL-LONDON, V572, P51, DOI 10.1113/jphysiol.2005.104430; Rui T, 2005, CARDIOVASC RES, V65, P719, DOI 10.1016/j.cardiores.2004.11.019; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Varghese S, 2000, ENDOCRINOLOGY, V141, P2185, DOI 10.1210/en.141.6.2185; Wedgwood S, 2003, AM J PHYSIOL-LUNG C, V284, pL650, DOI 10.1152/ajplung.00252.2002; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; Young MR, 2002, MOL CELL BIOL, V22, P587, DOI 10.1128/MCB.22.2.587-598.2002; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320; Zheng J, 2005, BIOL REPROD, V72, P1421, DOI 10.1095/biolreprod.104.039172; Zheng J, 2005, J PHYSIOL-LONDON, V565, P59, DOI 10.1113/jphysiol.2004.082420; Zheng J, 1999, ENDOCRINOLOGY, V140, P1399, DOI 10.1210/en.140.3.1399; Zheng J, 2008, BIOL REPROD, V78, P143, DOI 10.1095/biolreprod.107.064477	43	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17348	17358		10.1074/jbc.M109.092791	http://dx.doi.org/10.1074/jbc.M109.092791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371606	hybrid, Green Published			2022-12-25	WOS:000278133400012
J	Wang, K; Li, PF				Wang, Kun; Li, Pei-Feng			Foxo3a Regulates Apoptosis by Negatively Targeting miR-21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA-21; P53; EXPRESSION; CANCER; TRANSCRIPTION; GENE; CONTRIBUTES; BINDING; PDCD4; INVASION	MicroRNAs are a class of small non-coding RNAs and participate in the regulation of apoptotic program. Although miR-21 is able to inhibit apoptosis, its expression regulation and downstream targets remain to be fully elucidated. Here we report that the transcriptional factor Foxo3a initiates apoptosis by transcriptionally repressing miR-21 expression. Our results showed that doxorubicin could simultaneously induce the translocation of Foxo3a to the cell nuclei and a reduction in miR-21 expression. Knockdown of Foxo3a resulted in an elevation in miR-21 levels, whereas enforced expression of Foxo3a led to a decrease in miR-21 expression. In exploring the molecular mechanism by which Foxo3a regulates miR-21, we observed that Foxo3a bound to the promoter region of miR-21 and suppressed its promoter activity. These results indicate that Foxo3a can transcriptionally repress miR-21 expression. In searching for the downstream targets of miR-21 in apoptosis, we found that miR-21 suppressed the translation of Fas ligand (FasL), a pro-apoptotic factor. Furthermore, Foxo3a was able to up-regulate FasL expression through down-regulating miR-21. Our data suggest that Foxo3a negatively regulates miR-21 in initiating apoptosis.	[Wang, Kun; Li, Pei-Feng] Chinese Acad Sci, Canc Res Grp, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Canc Res Grp, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Li, Peifeng/ABD-5663-2021; Li, Peifeng/AHE-6906-2022	Li, Peifeng/0000-0002-0969-9407	National Natural Science Foundation of China [30730045, 30871243]; National Basic Research Program of China (973 Program) [2007CB512000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730045 and 30871243 and by the National Basic Research Program of China (973 Program, Grant 2007CB512000).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Li PF, 1999, FEBS LETT, V448, P206, DOI 10.1016/S0014-5793(99)00370-1; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	49	85	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16958	16966		10.1074/jbc.M109.093005	http://dx.doi.org/10.1074/jbc.M109.093005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371612	hybrid, Green Published			2022-12-25	WOS:000277982600059
J	Maniscalco, JM; Springer, AM; Parker, P				Maniscalco, John M.; Springer, Alan M.; Parker, Pamela			High Natality Rates of Endangered Steller Sea Lions in Kenai Fjords, Alaska and Perceptions of Population Status in the Gulf of Alaska	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; SEQUENTIAL MEGAFAUNAL COLLAPSE; MATERNAL ATTENDANCE PATTERNS; PUPS EUMETOPIAS-JUBATUS; NORTH PACIFIC-OCEAN; REPRODUCTIVE-PERFORMANCE; DECLINING POPULATION; WEDDELL SEALS; FEMALE; COSTS	Steller sea lions experienced a dramatic population collapse of more than 80% in the late 1970s through the 1990s across their western range in Alaska. One of several competing hypotheses about the cause holds that reduced female reproductive rates (natality) substantively contributed to the decline and continue to limit recovery in the Gulf of Alaska despite the fact that there have been very few attempts to directly measure natality in this species. We conducted a longitudinal study of natality among individual Steller sea lions (n = 151) at a rookery and nearby haulouts in Kenai Fjords, Gulf of Alaska during 2003-2009. Multi-state models were built and tested in Program MARK to estimate survival, resighting, and state transition probabilities dependent on whether or not a female gave birth in the previous year. The models that most closely fit the data suggested that females which gave birth had a higher probability of surviving and giving birth in the following year compared to females that did not give birth, indicating some females are more fit than others. Natality, estimated at 69%, was similar to natality for Steller sea lions in the Gulf of Alaska prior to their decline (67%) and much greater than the published estimate for the 2000s (43%) which was hypothesized from an inferential population dynamic model. Reasons for the disparity are discussed, and could be resolved by additional longitudinal estimates of natality at this and other rookeries over changing ocean climate regimes. Such estimates would provide an appropriate assessment of a key parameter of population dynamics in this endangered species which has heretofore been lacking. Without support for depressed natality as the explanation for a lack of recovery of Steller sea lions in the Gulf of Alaska, alternative hypotheses must be more seriously considered.	[Maniscalco, John M.; Springer, Alan M.; Parker, Pamela] Alaska SeaLife Ctr, Dept Sci, Seward, AK USA; [Springer, Alan M.] Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks	Maniscalco, JM (corresponding author), Alaska SeaLife Ctr, Dept Sci, Seward, AK USA.	john_maniscalco@alaskasealife.org			National Marine Fisheries Service [NA16FX2846, NA07NMF4390312, NA09NMF4390169, NA05NMF4391148]	National Marine Fisheries Service	Funding for this study was provided by grants (Nos. NA16FX2846, NA07NMF4390312, NA09NMF4390169, NA05NMF4391148) to the Alaska SeaLife Center from the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Atkinson S, 2008, MAR MAMMAL SCI, V24, P276, DOI 10.1111/j.1748-7692.2008.00188.x; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Berman MD, 2008, MAR POLICY, V32, P580, DOI 10.1016/j.marpol.2007.10.007; Boyd IL, 1999, BEHAV ECOL, V10, P198, DOI 10.1093/beheco/10.2.198; BOYD IL, 1995, J ANIM ECOL, V64, P505, DOI 10.2307/5653; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burek KA, 2005, J WILDLIFE DIS, V41, P512, DOI 10.7589/0090-3558-41.3.512; Calkins DG, 1998, MAR MAMMAL SCI, V14, P232, DOI 10.1111/j.1748-7692.1998.tb00713.x; Choquet R., 2005, U CARE 2 2 USERS MAN; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Dabin W, 2004, CAN J ZOOL, V82, P1043, DOI 10.1139/Z04-079; Dalton R, 2005, NATURE, V436, P14, DOI 10.1038/436014a; DEMASTER D, 2002, AKSG0202 U AL SEA GR; Donnelly CP, 2003, BRIT J NUTR, V89, P71, DOI 10.1079/BJN2002750; Doroff AM, 2003, J MAMMAL, V84, P55, DOI 10.1644/1545-1542(2003)084<0055:SOPDIT>2.0.CO;2; Eberhardt LL, 2005, MAR MAMMAL SCI, V21, P728, DOI 10.1111/j.1748-7692.2005.tb01262.x; Fowler SL, 2007, FUNCT ECOL, V21, P922, DOI 10.1111/j.1365-2435.2007.01295.x; Fowler SL, 2006, J ANIM ECOL, V75, P358, DOI 10.1111/j.1365-2656.2006.01055.x; Fritz L, 2005, NMFSAFSC183 NOAA US; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; FRITZ LW, 2008, SURV AD JUV STELL SE; Hadley GL, 2007, J ANIM ECOL, V76, P448, DOI 10.1111/j.1365-2656.2007.01219.x; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Hood WR, 1997, CAN J ZOOL, V75, P1241, DOI 10.1139/z97-146; Horning Markus, 2010, Endangered Species Research, V10, P135, DOI 10.3354/esr00220; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Kaplan CC, 2008, MAR MAMMAL SCI, V24, P443, DOI 10.1111/j.1748-7692.2008.00203.x; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco John M., 2008, Aquatic Mammals, V34, P277, DOI 10.1578/AM.34.3.2008.277; Mashburn KL, 2007, GEN COMP ENDOCR, V150, P246, DOI 10.1016/j.ygcen.2006.08.009; MATHISEN OA, 1963, US FISH WILDLIFE SER, V424, P20; McKenzie J, 2005, J MAMMAL, V86, P1237, DOI 10.1644/05-MAMM-A-085R.1; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; Myers MJ, 2008, SCI TOTAL ENVIRON, V396, P60, DOI 10.1016/j.scitotenv.2008.02.008; National Research Council, 2003, DECL STELL SEA LION; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; PITCHER KW, 1990, MAR MAMMAL SCI, V6, P121, DOI 10.1111/j.1748-7692.1990.tb00234.x; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Rea LD, 1998, COMP BIOCHEM PHYS A, V120, P617, DOI 10.1016/S1095-6433(98)10074-0; Rosen DAS, 2000, P 3 COMP NUTR SOC S, P182; SEASE JL, 2001, NMFSAFSC122 NOAA US; Springer AM, 2008, MAR MAMMAL SCI, V24, P414, DOI 10.1111/j.1748-7692.2008.00185.x; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; TESTA JW, 1987, CAN J ZOOL, V65, P1091, DOI 10.1139/z87-173; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	57	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10076	10.1371/journal.pone.0010076	http://dx.doi.org/10.1371/journal.pone.0010076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386691	gold, Green Published, Green Submitted			2022-12-25	WOS:000276482000012
J	Romanuk, TN; Levings, CD				Romanuk, Tamara N.; Levings, Colin D.			Reciprocal Subsidies and Food Web Pathways Leading to Chum Salmon Fry in a Temperate Marine-Terrestrial Ecotone	PLOS ONE			English	Article							SANDY BEACH; BRITISH-COLUMBIA; TROPHIC POSITION; STABLE ISOTOPES; CARBON ISOTOPES; HOWE-SOUND; MACROFAUNA; NITROGEN; WRACK; COMMUNITIES	Stable isotope analysis was used to determine the relative proportions of terrestrial and marine subsidies of carbon to invertebrates along a tidal gradient (low-intertidal, mid-intertidal, high-intertidal, supralittoral) and to determine the relative importance of terrestrial carbon in food web pathways leading to chum salmon fry Oncorhynchus keta (Walbaum) in Howe Sound, British Columbia. We found a clear gradient in the proportion of terrestrially derived carbon along the tidal gradient ranging from 68% across all invertebrate taxa in the supralittoral to 25% in the high-intertidal, 20% in the mid-intertidal, and 12% in the low-intertidal. Stable isotope values of chum salmon fry indicated carbon contributions from both terrestrial and marine sources, with terrestrially derived carbon ranging from 12.8 to 61.5% in the muscle tissue of chum salmon fry (mean 30%). Our results provide evidence for reciprocal subsidies of marine and terrestrially derived carbon on beaches in the estuary and suggest that the vegetated supralittoral is an important trophic link in supplying terrestrial carbon to nearshore food webs.	[Romanuk, Tamara N.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Levings, Colin D.] Ctr Aquaculture & Environm Res, Dept Fisheries & Oceans, W Vancouver, BC, Canada	Dalhousie University; Fisheries & Oceans Canada	Romanuk, TN (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tromanuk@gmail.com	Romanuk, t N/C-6493-2008		NSERC PDF; Department of Fisheries and Oceans (Canada)	NSERC PDF(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Fisheries and Oceans (Canada)	NSERC PDF and Discovery Grant to TNR. Department of Fisheries and Oceans (Canada) provided funding for the data collection, stable isotope analysis, and gut content analysis. The funders had no role in the analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 1998, OIKOS, V81, P75, DOI 10.2307/3546469; Barnes RSF, 1988, INTRO MARINE ECOLOGY; Colombini I, 2000, MAR BIOL, V136, P531, DOI 10.1007/s002270050713; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; FARQUHAR GD, 1989, PHILOS T ROY SOC B, V323, P357, DOI 10.1098/rstb.1989.0016; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Hasler A. D., 1975, COUPLING LAND WATER; Healey M., 1982, ESTUARINE COMP, P315; Healey MC, 1980, SALMONID ECOSYSTEMS, P203; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Hocking MD, 2009, OIKOS, V118, P1307, DOI 10.1111/j.1600-0706.2009.17302.x; Hunt R.L., 1975, COUPLING LAND WATER, P137; INGLIS G, 1989, J EXP MAR BIOL ECOL, V125, P203, DOI 10.1016/0022-0981(89)90097-X; Jedrzejczak MF, 2002, OCEANOLOGIA, V44, P367; Levings CD, 2004, HYDROBIOLOGIA, V525, P185, DOI 10.1023/B:HYDR.0000038866.20304.3d; Levings Colin, 2004, Canadian Manuscript Report of Fisheries and Aquatic Sciences, V2680, P3; Lewis TL, 2007, ESTUAR COAST, V30, P451, DOI 10.1007/BF02819391; Maier GO, 2009, ESTUAR COAST, V32, P984, DOI 10.1007/s12237-009-9197-1; Mann K.H., 1991, DYNAMICS MARINE ECOS, DOI 10.1002/9781118687901; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Olabarria C, 2007, MAR ENVIRON RES, V63, P19, DOI 10.1016/j.marenvres.2006.06.001; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; RAU GH, 1980, CAN J FISH AQUAT SCI, V37, P742, DOI 10.1139/f80-098; Romanuk TN, 2005, FISHERIES MANAG ECOL, V12, P113, DOI 10.1111/j.1365-2400.2004.00432.x; Romanuk TN, 2003, ENVIRON ENTOMOL, V32, P1343, DOI 10.1603/0046-225X-32.6.1343; ROUNICK JS, 1986, BIOSCIENCE, V36, P171, DOI 10.2307/1310304; Sobocinski K.L., 2003, THESIS U WASHINGTON; SYVITSKI JPM, 1982, CAN J EARTH SCI, V19, P1025, DOI 10.1139/e82-085; Toft JD, 2007, N AM J FISH MANAGE, V27, P465, DOI 10.1577/M05-158.1; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Wipfli MS, 1997, CAN J FISH AQUAT SCI, V54, P1259, DOI 10.1139/cjfas-54-6-1259	36	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10073	10.1371/journal.pone.0010073	http://dx.doi.org/10.1371/journal.pone.0010073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386705	Green Published, gold			2022-12-25	WOS:000276482000011
J	Poole, AC; Thomas, RE; Yu, S; Vincow, ES; Pallanck, L				Poole, Angela C.; Thomas, Ruth E.; Yu, Selina; Vincow, Evelyn S.; Pallanck, Leo			The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway	PLOS ONE			English	Article							DROSOPHILA-PARKIN MUTANTS; SUBSTANTIA-NIGRA NEURONS; OXIDATIVE STRESS; DNA DELETIONS; DISEASE; PINK1; EXPRESSION; DYSFUNCTION; PATHOLOGY; FISSION	Loss-of-function mutations in the PINK1 or parkin genes result in recessive heritable forms of parkinsonism. Genetic studies of Drosophila orthologs of PINK1 and parkin indicate that PINK1, a mitochondrially targeted serine/threonine kinase, acts upstream of Parkin, a cytosolic ubiquitin-protein ligase, to promote mitochondrial fragmentation, although the molecular mechanisms by which the PINK1/Parkin pathway promotes mitochondrial fragmentation are unknown. We tested the hypothesis that PINK1 and Parkin promote mitochondrial fragmentation by targeting core components of the mitochondrial morphogenesis machinery for ubiquitination. We report that the steady-state abundance of the mitochondrial fusion-promoting factor Mitofusin (dMfn) is inversely correlated with the activity of PINK1 and Parkin in Drosophila. We further report that dMfn is ubiquitinated in a PINK1- and Parkin-dependent fashion and that dMfn co-immunoprecipitates with Parkin. By contrast, perturbations of PINK1 or Parkin did not influence the steady-state abundance of the mitochondrial fission-promoting factor Drp1 or the mitochondrial fusion-promoting factor Opa1, or the subcellular distribution of Drp1. Our findings suggest that dMfn is a direct substrate of the PINK1/Parkin pathway and that the mitochondrial morphological alterations and tissue degeneration phenotypes that derive from mutations in PINK1 and parkin result at least in part from reduced ubiquitin-mediated turnover of dMfn.	[Poole, Angela C.; Thomas, Ruth E.; Yu, Selina; Vincow, Evelyn S.; Pallanck, Leo] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Vincow, Evelyn S.] Univ Washington, Neurobiol & Behav Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Poole, AC (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	pallanck@u.washington.edu		Poole, Angela/0000-0003-0278-7655	Genetic Approaches to Aging [5T32AG000057-32]; National Institutes of Health [1R01GM086394-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	Genetic Approaches to Aging; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Genetic Approaches to Aging Training Grant (5T32AG000057-32) to A. C. P. and a National Institutes of Health Grant (1R01GM086394-01) to L. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Hwa JJ, 2002, MECH DEVELOP, V116, P213, DOI 10.1016/S0925-4773(02)00141-7; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160; Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004; Thomas KJ, 2009, INT J BIOCHEM CELL B, V41, P2025, DOI 10.1016/j.biocel.2009.02.018; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VIVESBAUZA C, 2009, P NATL ACAD SCI US; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; YANG Y, 2008, P NATL ACAD SCI US; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; ZIVIANI E, 2010, P NATL ACAD SCI US	39	346	348	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10054	10.1371/journal.pone.0010054	http://dx.doi.org/10.1371/journal.pone.0010054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383334	Green Submitted, Green Published, gold			2022-12-25	WOS:000276454000014
J	Adams, BR; Golding, SE; Rao, RR; Valerie, K				Adams, Bret R.; Golding, Sarah E.; Rao, Raj R.; Valerie, Kristoffer			Dynamic Dependence on ATR and ATM for Double-Strand Break Repair in Human Embryonic Stem Cells and Neural Descendants	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION REPAIR; HISTONE H2AX; DNA-REPAIR; SELF-RENEWAL; DIFFERENTIATION; PROLIFERATION; APOPTOSIS; PATHWAYS; CLEAVAGE; ARREST	The DNA double-strand break (DSB) is the most toxic form of DNA damage. Studies aimed at characterizing DNA repair during development suggest that homologous recombination repair (HRR) is more critical in pluripotent cells compared to differentiated somatic cells in which nonhomologous end joining (NHEJ) is dominant. We have characterized the DNA damage response (DDR) and quality of DNA double-strand break (DSB) repair in human embryonic stem cells (hESCs), and in vitro-derived neural cells. Resolution of ionizing radiation-induced foci (IRIF) was used as a surrogate for DSB repair. The resolution of gamma-H2AX foci occurred at a slower rate in hESCs compared to neural progenitors (NPs) and astrocytes perhaps reflective of more complex DSB repair in hESCs. In addition, the resolution of RAD51 foci, indicative of active homologous recombination repair (HRR), showed that hESCs as well as NPs have high capacity for HRR, whereas astrocytes do not. Importantly, the ATM kinase was shown to be critical for foci formation in astrocytes, but not in hESCs, suggesting that the DDR is different in these cells. Blocking the ATM kinase in astrocytes not only prevented the formation but also completely disassembled preformed repair foci. The ability of hESCs to form IRIF was abrogated with caffeine and siRNAs targeted against ATR, implicating that hESCs rely on ATR, rather than ATM for regulating DSB repair. This relationship dynamically changed as cells differentiated. Interestingly, while the inhibition of the DNA-PKcs kinase (and presumably non-homologous endjoining [NHEJ]) in astrocytes slowed IRIF resolution it did not in hESCs, suggesting that repair in hESCs does not utilize DNA-PKcs. Altogether, our results show that hESCs have efficient DSB repair that is largely ATR-dependent HRR, whereas astrocytes critically depend on ATM for NHEJ, which, in part, is DNA-PKcs-independent.	[Adams, Bret R.; Golding, Sarah E.; Valerie, Kristoffer] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA; [Adams, Bret R.; Valerie, Kristoffer] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Rao, Raj R.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA USA; [Valerie, Kristoffer] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Adams, BR (corresponding author), Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA.	KVALERIE@VCU.EDU	Valerie, Kristoffer/AAL-8299-2021; Rao, Raj/AAW-4308-2021		NIH [P01CA72955, R01NS064593, R21ES016636, T32CA085159, P30CA16059]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [T32CA085159, P30CA016059, P01CA072955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES016636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by NIH P01CA72955, R01NS064593, and R21ES016636 (K. V.), NIH T32CA085159 (S. E. G.), and the American Brain Tumor Association (S. E. G.). The Massey Cancer Center Flow Cytometry and Imaging Facility is supported in part by NIH grant P30CA16059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Biton S, 2007, DNA REPAIR, V6, P128, DOI 10.1016/j.dnarep.2006.10.019; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Dhara SK, 2009, TISSUE ENG PT A, V15, P3621, DOI 10.1089/ten.tea.2009.0155; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Flygare J, 1998, FEBS LETT, V427, P247, DOI 10.1016/S0014-5793(98)00433-5; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; Hardcastle IR, 2005, J MED CHEM, V48, P7829, DOI 10.1021/jm050444b; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; POVIRK LF, 2007, NUCL ACIDS RES; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Short SC, 2007, NEURO-ONCOLOGY, V9, P404, DOI 10.1215/15228517-2007-030; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Suzuki K, 2006, RADIAT RES, V165, P499, DOI 10.1667/RR3542.1; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wilczynska KM, 2009, STEM CELLS, V27, P1173, DOI 10.1002/stem.35; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385	45	89	90	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10001	10.1371/journal.pone.0010001	http://dx.doi.org/10.1371/journal.pone.0010001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368801	Green Published, gold, Green Submitted			2022-12-25	WOS:000276419900005
J	Kovanen, L; Saarikoski, ST; Aromaa, A; Lonnqvist, J; Partonen, T				Kovanen, Leena; Saarikoski, Sirkku T.; Aromaa, Arpo; Lonnqvist, Jouko; Partonen, Timo			ARNTL (BMAL1) and NPAS2 Gene Variants Contribute to Fertility and Seasonality	PLOS ONE			English	Article							TO-HIP RATIO; CLOCK GENE; AFFECTIVE-DISORDER; CIRCADIAN-RHYTHMS; PROTEIN BMAL1; CDNA CLONING; POLYMORPHISM; ASSOCIATION; SLEEP; TESTOSTERONE	Background: Circadian clocks guide the metabolic, cell-division, sleep-wake, circadian and seasonal cycles. Abnormalities in these clocks may be a health hazard. Circadian clock gene polymorphisms have been linked to sleep, mood and metabolic disorders. Our study aimed to examine polymorphisms in four key circadian clock genes in relation to seasonal variation, reproduction and well-being in a sample that was representative of the general population, aged 30 and over, living in Finland. Methodology/Principal Findings: Single-nucleotide polymorphisms in the ARNTL, ARNTL2, CLOCK and NPAS2 genes were genotyped in 511 individuals. 19 variants were analyzed in relation to 31 phenotypes that were assessed in a health interview and examination study. With respect to reproduction, women with ARNTL rs2278749 TT genotype had more miscarriages and pregnancies, while NPAS2 rs11673746 T carriers had fewer miscarriages. NPAS2 rs2305160 A allele carriers had lower Global Seasonality Scores, a sum score of six items i.e. seasonal variation of sleep length, social activity, mood, weight, appetite and energy level. Furthermore, carriers of A allele at NPAS2 rs6725296 had greater loadings on the metabolic factor (weight and appetite) of the global seasonality score, whereas individuals with ARNTL rs6290035 TT genotype experienced less seasonal variation of energy level. Conclusions/Significance: ARNTL and NPAS2 gene variants were associated with reproduction and with seasonal variation. Earlier findings have linked ARNTL to infertility in mice, but this is the first time when any polymorphism of these genes is linked to fertility in humans.	[Kovanen, Leena; Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Kovanen, Leena; Saarikoski, Sirkku T.] Natl Inst Hlth & Welf, Dept Alcohol Drugs & Addict, Helsinki, Finland; [Aromaa, Arpo] Natl Inst Hlth & Welf, Div Welf & Hlth Policies, Helsinki, Finland; [Lonnqvist, Jouko] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki	Kovanen, L (corresponding author), Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland.	timo.partonen@thl.fi	Partonen, Timo/G-1105-2012	Partonen, Timo/0000-0003-1951-2455; Kovanen, Leena/0000-0002-3552-124X	Academy of Finland [210262]; Yrjo Jahnsson Foundation [6113]	Academy of Finland(Academy of Finland); Yrjo Jahnsson Foundation	Funding for this study was provided in part by the grant # 210262 from the Academy of Finland (http://www.aka.fi/en-gb/A/) to Dr Partonen, and the grant # 6113 from Yrjo Jahnsson Foundation (http://www.yjs.fi/) to Ms Kovanen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Bailer U, 2005, EUR NEUROPSYCHOPHARM, V15, P51, DOI 10.1016/j.euroneuro.2004.05.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benedetti F, 2008, GENES BRAIN BEHAV, V7, P20, DOI 10.1111/j.1601-183X.2007.00312.x; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Boden MJ., 2004, REPROD FERT DEVELOP, V16, P280; Boden MJ., 2005, REPROD FERT DEVELOP, V17, P126, DOI [10.1071/SRB05Abs297, DOI 10.1071/SRB05ABS297]; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Chu LW, 2008, CANCER EPIDEM BIOMAR, V17, P3268, DOI 10.1158/1055-9965.EPI-08-0073; Desan PH, 2000, AM J MED GENET, V96, P418, DOI 10.1002/1096-8628(20000612)96:3<418::AID-AJMG34>3.0.CO;2-S; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; Grimaldi S, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/165013; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Iwase T, 2002, PSYCHIAT RES, V109, P121, DOI 10.1016/S0165-1781(02)00006-9; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Kishi T, 2009, EUR ARCH PSY CLIN N, V259, P293, DOI 10.1007/s00406-009-0869-4; Kishi T, 2009, NEUROMOL MED, V11, P53, DOI 10.1007/s12017-009-8060-7; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lavebratt C, 2010, AM J MED GENET B, V153B, P570, DOI 10.1002/ajmg.b.31021; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Magnusson A, 2005, CNS SPECTRUMS, V10, P625, DOI 10.1017/S1092852900019593; Mishima K, 2005, AM J MED GENET B, V133B, P101, DOI 10.1002/ajmg.b.30110; Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Pedrazzoli M, 2007, CHRONOBIOL INT, V24, P1, DOI 10.1080/07420520601139789; Perry HM, 2000, METABOLISM, V49, P1085, DOI 10.1053/meta.2000.7710; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Robilliard DL, 2002, J SLEEP RES, V11, P305, DOI 10.1046/j.1365-2869.2002.00320.x; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Ruhayel Y, 2007, CLIN ENDOCRINOL, V67, P85, DOI 10.1111/j.1365-2265.2007.02843.x; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sasaki M, 2009, J BIOL CHEM, V284, P25149, DOI 10.1074/jbc.M109.040758; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Svartberg J, 2003, J CLIN ENDOCR METAB, V88, P3099, DOI 10.1210/jc.2002-021878; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; van Anders SM, 2006, PSYCHONEUROENDOCRINO, V31, P895, DOI 10.1016/j.psyneuen.2006.03.002; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wehr T., 1984, SEASONAL PATTERN ASS; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zitzmann M, 2006, AGING MALE, V9, P195, DOI 10.1080/13685530601040679	58	68	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10007	10.1371/journal.pone.0010007	http://dx.doi.org/10.1371/journal.pone.0010007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368993	Green Submitted, Green Published, gold			2022-12-25	WOS:000276419900010
J	Singer, G; Besemer, K; Schmitt-Kopplin, P; Hodl, I; Battin, TJ				Singer, Gabriel; Besemer, Katharina; Schmitt-Kopplin, Philippe; Hoedl, Iris; Battin, Tom J.			Physical Heterogeneity Increases Biofilm Resource Use and Its Molecular Diversity in Stream Mesocosms	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; ENVIRONMENTAL HETEROGENEITY; BIOPHYSICAL CONTROLS; ECOSYSTEM PROCESSES; SPECIES RICHNESS; BIODIVERSITY; CARBON; COMPLEMENTARITY; ASSEMBLAGES; DYNAMICS	Background: Evidence increasingly shows that stream ecosystems greatly contribute to global carbon fluxes. This involves a tight coupling between biofilms, the dominant form of microbial life in streams, and dissolved organic carbon (DOC), a very significant pool of organic carbon on Earth. Yet, the interactions between microbial biodiversity and the molecular diversity of resource use are poorly understood. Methodology/Principal Findings: Using six 40-m-long streamside flumes, we created a gradient of streambed landscapes with increasing spatial flow heterogeneity to assess how physical heterogeneity, inherent to streams, affects biofilm diversity and DOC use. We determined bacterial biodiversity in all six landscapes using 16S-rRNA fingerprinting and measured carbon uptake from glucose and DOC experimentally injected to all six flumes. The diversity of DOC molecules removed from the water was determined from ultrahigh-resolution Fourier Transform Ion Cyclotron Resonance mass spectrometry (FTICR-MS). Bacterial beta diversity, glucose and DOC uptake, and the molecular diversity of DOC use all increased with increasing flow heterogeneity. Causal modeling and path analyses of the experimental data revealed that the uptake of glucose was largely driven by physical processes related to flow heterogeneity, whereas biodiversity effects, such as complementarity, most likely contributed to the enhanced uptake of putatively recalcitrant DOC compounds in the streambeds with higher flow heterogeneity. Conclusions/Significance: Our results suggest biophysical mechanisms, including hydrodynamics and microbial complementarity effects, through which physical heterogeneity induces changes of resource use and carbon fluxes in streams. These findings highlight the importance of fine-scale streambed heterogeneity for microbial biodiversity and ecosystem functioning in streams, where homogenization and loss of habitats increasingly reduce biodiversity.	[Singer, Gabriel; Besemer, Katharina; Hoedl, Iris; Battin, Tom J.] Univ Vienna, Dept Freshwater Ecol, Vienna, Austria; [Singer, Gabriel; Besemer, Katharina; Hoedl, Iris; Battin, Tom J.] WasserKluster Lunz GmbH, Lunz Am See, Austria; [Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Inst Ecol Chem, Helmholtz Zentrum Munchen, Neuherberg, Germany	University of Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Battin, TJ (corresponding author), Univ Vienna, Dept Freshwater Ecol, Vienna, Austria.	tom.battin@univie.ac.at	Schmitt-Kopplin, Philippe/H-6271-2011; BAttin, Tom/H-7971-2012; Singer, Gabriel/C-6285-2012	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Singer, Gabriel/0000-0002-7389-9788	Austrian Science Foundation (FWF); European Science Foundation (EuroDIVERSITY, COMIX); Land Niederoesterreich, Austria	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); European Science Foundation (EuroDIVERSITY, COMIX)(European Science Foundation (ESF)); Land Niederoesterreich, Austria	This research was supported by the Austrian Science Foundation (FWF), the European Science Foundation (EuroDIVERSITY, COMIX) and the Land Niederoesterreich, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Homoud A, 2008, APPL MICROBIOL BIOT, V79, P643, DOI 10.1007/s00253-008-1446-x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Battin TJ, 2003, FRESHWATER BIOL, V48, P995, DOI 10.1046/j.1365-2427.2003.01062.x; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Besemer K, 2009, APPL ENVIRON MICROB, V75, P7189, DOI 10.1128/AEM.01284-09; Besemer K, 2009, ISME J, V3, P1318, DOI 10.1038/ismej.2009.73; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Bottacin-Busolin A, 2009, ENVIRON SCI TECHNOL, V43, P7337, DOI 10.1021/es900852w; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Buzas Martin A., 1996, Biodiversity Letters, V3, P40, DOI 10.2307/2999767; Cardenas MB, 2007, ADV WATER RESOUR, V30, P301, DOI 10.1016/j.advwatres.2006.06.009; Cardinale BJ, 2002, ECOLOGY, V83, P412, DOI 10.1890/0012-9658(2002)083[0412:TIOSHO]2.0.CO;2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chesson P., 2001, FUNCTIONAL CONSEQUEN, P213; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Dittmar T, 2007, MAR CHEM, V107, P378, DOI 10.1016/j.marchem.2007.04.006; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Einsiedl F, 2007, GEOCHIM COSMOCHIM AC, V71, P5474, DOI 10.1016/j.gca.2007.09.024; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; GANTZER CJ, 1988, WATER RES, V22, P709, DOI 10.1016/0043-1354(88)90182-0; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Gordon ND, 2004, STREAM HYDROLOGY INT; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4; Hertkorn N, 2008, ANAL CHEM, V80, P8908, DOI 10.1021/ac800464g; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; HOOPER DU, 2005, ECOL MONOGR, V75, P12844; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kim S, 2006, LIMNOL OCEANOGR, V51, P1054, DOI 10.4319/lo.2006.51.2.1054; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Orr CH, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000825; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Qualls RG, 2005, ENVIRON SCI TECHNOL, V39, P1616, DOI 10.1021/es049090o; R Development Core Team, 2005, R LANG ENV STAT COMP; Raffaelli D, 2004, SCIENCE, V306, P1141, DOI 10.1126/science.1106365; Seitzinger SP, 2005, LIMNOL OCEANOGR, V50, P1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; THURMAN EM, 1981, ENVIRON SCI TECHNOL, V15, P463, DOI 10.1021/es00086a012; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Vallino JJ, 1996, LIMNOL OCEANOGR, V41, P1591, DOI 10.4319/lo.1996.41.8.1591; Wacker L, 2008, BASIC APPL ECOL, V9, P467, DOI 10.1016/j.baae.2007.08.003; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; Wickland KP, 2007, ECOSYSTEMS, V10, P1323, DOI 10.1007/s10021-007-9101-4; WOLFAARDT GM, 1994, CAN J MICROBIOL, V40, P331, DOI 10.1139/m94-055	68	75	76	8	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9988	10.1371/journal.pone.0009988	http://dx.doi.org/10.1371/journal.pone.0009988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376323	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200058
J	Lin, HB; Fan, H; Zhang, F; Huang, XQ; Lin, KQ; Shi, L; Hu, SN; Chu, JY; Wang, DM				Lin, Hongbin; Fan, Hao; Zhang, Feng; Huang, Xiaoqin; Lin, Keqin; Shi, Lei; Hu, Songnian; Chu, Jiayou; Wang, Duen-Mei			Genetic Relationships of Ethnic Minorities in Southwest China Revealed by Microsatellite Markers	PLOS ONE			English	Article							Y-CHROMOSOME EVIDENCE; POPULATION-STRUCTURE; EAST-ASIA; PHYLOGENETIC TREES; BREEDS; DIVERSITY; HISTORY; DNA; RECONSTRUCTION; DISTANCES	Population migrations in Southwest and South China have played an important role in the formation of East Asian populations and led to a high degree of cultural diversity among ethnic minorities living in these areas. To explore the genetic relationships of these ethnic minorities, we systematically surveyed the variation of 10 autosomal STR markers of 1,538 individuals from 30 populations of 25 ethnic minorities, of which the majority were chosen from Southwest China, especially Yunnan Province. With genotyped data of the markers, we constructed phylogenies of these populations with both D-A and D-C measures and performed a principal component analysis, as well as a clustering analysis by structure. Results showed that we successfully recovered the genetic structure of analyzed populations formed by historical migrations. Aggregation patterns of these populations accord well with their linguistic affiliations, suggesting that deciphering of genetic relationships does in fact offer clues for study of ethnic differentiation.	[Fan, Hao; Huang, Xiaoqin; Lin, Keqin; Shi, Lei; Chu, Jiayou] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Lin, Hongbin; Zhang, Feng; Hu, Songnian; Wang, Duen-Mei] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Lin, Hongbin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Fan, Hao] Kunming Med Coll, Dept Biochem, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University	Chu, JY (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.	chujy@imbcams.com.cn; wangdm@big.ac.cn	Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Science Foundation of China [30470946]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Science Foundation of China grants 30470946 (Dr. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; Benedict Paul King, 1972, SINO TIBETAN CONSPEC; Benedict Paul King, 1975, AUSTRO THAI LANGUAGE; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 1998, P NATL ACAD SCI USA, V95, P11501, DOI 10.1073/pnas.95.20.11501; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Chu J.-Y., 2008, INT J GENETICS, V31, P241; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; DAI Q, 1998, 20 CENTURY RES MINOR; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Guldin Gregory E., 1994, SAGA ANTHR CHINA MAL; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harrell S, 2001, WAYS BEING ETHNIC SW; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jin L., 2001, GENETIC LINGUISTIC A; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kim TH, 2005, J ANIM SCI, V83, P2255; Koskinen MT, 2004, HEREDITAS, V141, P61, DOI 10.1111/j.1601-5223.2004.01804.x; Li, 1977, HDB COMP TAI; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; MANTEL N, 1967, CANCER RES, V27, P209; Minch E, 1998, MICROSAT COMPUTER PR; Moazami-Goudarzi K, 2002, GENETICS, V162, P473; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; Nei M., 2000, MOL EVOLUTION PHYLOG; Ota T, 1993, DISPAN GENETIC DISTA; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rosenberg NA, 2001, GENETICS, V159, P699; RUIZOLINARES A, 1999, MICROSATELLITES RECO; SAGART L, 2005, PEOPLING E ASIA PUTT, P177; Sahoo S, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-4; Sanchez-Mazas A, 2005, PEOPLING E ASIA PUTT, P273; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Starosta Stanley, 2005, PEOPLING E ASIA PUTT, P182, DOI DOI 10.4324/9780203343685_CHAPTER_11; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Takezaki N, 1996, GENETICS, V144, P389; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Yang S.M., 2003, ETHNOGRAPHY CHINA; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	55	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9895	10.1371/journal.pone.0009895	http://dx.doi.org/10.1371/journal.pone.0009895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360948	Green Submitted, gold, Green Published			2022-12-25	WOS:000276163100005
J	Matynia, A; Ng, CH; Dansithong, W; Chiang, A; Silva, AJ; Reddy, S				Matynia, Anna; Ng, Carina Hoi; Dansithong, Warunee; Chiang, Andy; Silva, Alcino J.; Reddy, Sita			Muscleblind1, but Not Dmpk or Six5, Contributes to a Complex Phenotype of Muscular and Motivational Deficits in Mouse Models of Myotonic Dystrophy	PLOS ONE			English	Article							CTG REPEAT; REDUCES EXPRESSION; MICE LACKING; PROTEIN; EXPANSION; DISRUPTION; PROFILE; MEMORY; GENE	Assessment of molecular defects that underlie cognitive deficits observed in mendelian disorders provides a unique opportunity to identify key regulators of human cognition. Congenital Myotonic Dystrophy 1 (cDM1), a multi-system disorder is characterized by both cognitive deficits and a spectrum of behavioral abnormalities, which include visuo-spatial memory deficits, anxiety and apathy. Decreased levels of DMPK (Dystrophia Myotonica-protein kinase), SIX5, a transcription factor or MBNL1 (Muscleblind-like 1), an RNA splice regulator have been demonstrated to contribute to distinct features of cDM1. Mouse strains in which either Dmpk, Six5 or Mbnl1 are inactivated were therefore studied to determine the relative contribution of each gene to these cognitive functions. The open field and elevated plus maze tasks were used to examine anxiety, sucrose consumption was used to assess motivation, whereas the water maze and context fear conditioning were used to examine spatial learning and memory. Cognitive and behavioral abnormalities were observed only in Mbnl1 deficient mice, which demonstrate behavior consistent with motivational deficits in the Morris water maze, a complex visuo-spatial task and in the sucrose consumption test for anhedonia. All three models of cDM1 exhibit normal spatial learning and memory. These data identify MBNL1 as a potential regulator of emotional state with decreased MBNL1 levels underlying the motivational deficits observed in cDM1.	[Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Gonda Neurosci & Genet Ctr, Los Angeles, CA 90095 USA; [Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Ng, Carina Hoi; Dansithong, Warunee; Chiang, Andy; Reddy, Sita] Univ So Calif, Inst Med Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Matynia, A (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Gonda Neurosci & Genet Ctr, Los Angeles, CA 90095 USA.	sitaredd@usc.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558	Muscular Dystrophy Association; NIH [RO1 NS 050861]; NIMH [P50-MH0779720]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050861] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Muscular Dystrophy Association and the NIH (RO1 NS 050861) to SR, and from the NIMH (P50-MH0779720) to AJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Antonini G, 2006, J REHABIL MED, V38, P181, DOI 10.1080/16501970500477967; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; COLOMBO G, 1992, ITAL J NEUROL SCI, V13, P53, DOI 10.1007/BF02222889; COLOMBO G, 1992, ANN NY ACAD SCI, V654, P421, DOI 10.1111/j.1749-6632.1992.tb25986.x; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; EKSTROM AB, 2008, AM J MED GENET B; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; Goossens E, 2000, GENET COUNSEL, V11, P317; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Logigian EL, 2005, MUSCLE NERVE, V32, P35, DOI 10.1002/mus.20339; Lueck JD, 2007, J GEN PHYSIOL, V129, P79, DOI 10.1085/jgp.200609635; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Matynia A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002121; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Rubinsztein JS, 1998, J NEUROL NEUROSUR PS, V64, P510, DOI 10.1136/jnnp.64.4.510; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; TURNPENNY P, 1994, J MED GENET, V31, P300, DOI 10.1136/jmg.31.4.300; Wakimoto H, 2002, J INTERV CARD ELECTR, V7, P127, DOI 10.1023/A:1020881520353; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118	34	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9857	10.1371/journal.pone.0009857	http://dx.doi.org/10.1371/journal.pone.0009857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360842	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969500004
J	Shi, H; Boadu, E; Mercan, F; Le, AM; Flach, RJR; Zhang, L; Tyner, KJ; Olwin, BB; Bennett, AM				Shi, Hao; Boadu, Emmanuel; Mercan, Fatih; Le, Annie M.; Flach, Rachel J. Roth; Zhang, Lei; Tyner, Kristina J.; Olwin, Bradley B.; Bennett, Anton M.			MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy	FASEB JOURNAL			English	Article						myogenesis; muscle damage; MAPK; protein tyrosine phosphatase; muscle stem cells	INNATE IMMUNE-RESPONSES; DISTINCT SIGNALING PATHWAYS; FIBROBLAST-GROWTH-FACTOR; SATELLITE CELLS; MYOBLAST PROLIFERATION; DIFFERENTIATION; MYOGENESIS; MICE; P38; MKP-1	In skeletal muscle, the mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) is a critical negative regulator of the MAPKs. Since the MAPKs have been reported to be both positive and negative for myogenesis, the physiological role of MKP-1 in skeletal muscle repair and regeneration has remained unclear. Here, we show that MKP-1 plays an essential role in adult regenerative myogenesis. In a cardiotoxin-induced muscle injury model, lack of MKP-1 impaired muscle regeneration. In mdx mice, MKP-1 deficiency reduced body weight, muscle mass, and muscle fiber cross-sectional area. In addition, MKP-1-deficient muscles exhibit exacerbated myopathy accompanied by increased inflammation. Lack of MKP-1 compromised myoblast proliferation and induced precocious differentiation, phenotypes that were rescued by pharmacological inhibition of p38 alpha/beta MAPK. MKP-1 coordinates both myoblast proliferation and differentiation. Mechanistically, MyoD bound to the MKP-1 promoter and activated MKP-1 expression in proliferating myoblasts. Later, during myogenesis, MyoD uncoupled from the MKP-1 promoter leading to the down-regulation of MKP-1 and facilitation of promyogenic p38 alpha/beta MAPK signaling. Hence, MKP-1 plays a critical role in muscle stem cells and in the immune response to coordinate muscle repair and regeneration.-Shi, H., Boadu, E., Mercan, F., Le, A. M., Roth Flach, R. J., Zhang, L., Tyner, K. J., Olwin, B. B., Bennett, A. M. MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy. FASEB J. 24, 2985-2997 (2010). www.fasebj.org	[Shi, Hao; Boadu, Emmanuel; Mercan, Fatih; Le, Annie M.; Flach, Rachel J. Roth; Zhang, Lei; Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Tyner, Kristina J.; Olwin, Bradley B.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Yale University; University of Colorado System; University of Colorado Boulder	Bennett, AM (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B226D,333 Cedar St, New Haven, CT 06520 USA.	anton.bennett@yale.edu	Olwin, Bradley B/A-1333-2014	Bennett, Anton/0000-0001-5187-7599	National Institutes of Health [AR46504, AR039467]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR039467, R01AR046504, R01AR039467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AR46504 to A.M.B. and AR039467 to B.B.O.	Amalfitano A, 1996, MUSCLE NERVE, V19, P1549, DOI 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chi H, 2007, J ORGAN DYSFUNCT, V3, P72; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; CLARKE MSF, 1993, J CELL SCI, V106, P121; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Gallo R, 1999, MOL BIOL CELL, V10, P3137, DOI 10.1091/mbc.10.10.3137; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Khurana A, 2004, J MUSCLE RES CELL M, V25, P645, DOI 10.1007/s10974-004-7099-1; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; KWAK SP, 1994, J BIOL CHEM, V269, P3569; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Meriane M, 2002, BIOL CELL, V94, P535, DOI 10.1016/S0248-4900(02)00023-0; Milasincic DJ, 1996, MOL CELL BIOL, V16, P5964; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Roth RJ, 2009, J CLIN INVEST, V119, P3817, DOI 10.1172/JCI39054; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; Shi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1040, DOI 10.1152/ajpcell.00475.2008; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Weyman CM, 1997, ONCOGENE, V14, P697, DOI 10.1038/sj.onc.1200874; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	41	38	39	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2985	2997		10.1096/fj.09-150045	http://dx.doi.org/10.1096/fj.09-150045			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371627	Green Published			2022-12-25	WOS:000285005400037
J	Ramakrishnan, L; Muller-Steffner, H; Bosc, C; Vacquier, VD; Schuber, F; Moutin, MJ; Dale, L; Patel, S				Ramakrishnan, Latha; Muller-Steffner, Helene; Bosc, Christophe; Vacquier, Victor D.; Schuber, Francis; Moutin, Marie-Jo; Dale, Leslie; Patel, Sandip			A Single Residue in a Novel ADP-ribosyl Cyclase Controls Production of the Calcium-mobilizing Messengers Cyclic ADP-ribose and Nicotinic Acid Adenine Dinucleotide Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-SPECIFIC NADASE; ACTIVE-SITE; SEA-URCHIN; MOLECULAR CHARACTERIZATION; INOSITOL TRISPHOSPHATE; NAD(+) GLYCOHYDROLASE; 2ND-MESSENGER ENZYME; SCHISTOSOMA-MANSONI; XENOPUS DEVELOPMENT; CD38	Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate are ubiquitous calcium-mobilizing messengers produced by the same family of multifunctional enzymes, the ADP-ribosyl cyclases. Not all ADP-ribosyl cyclases have been identified, and how production of different messengers is achieved is incompletely understood. Here, we report the cloning and characterization of a novel ADP-ribosyl cyclase (SpARC4) from the sea urchin, a key model organism for the study of calcium-signaling pathways. Like several other members of the ADP-ribosyl cyclase superfamily, SpARC4 is a glycoprotein targeted to the plasma membrane via a glycosylphosphatidylinositol anchor. However, unlike most other members, SpARC4 shows a remarkable preference for producing cyclic ADP-ribose over nicotinic acid adenine dinucleotide phosphate. Mutation of a single residue (tyrosine 142) within a noncanonical active site reversed this striking preference. Our data highlight further diversification of this unusual enzyme family, provide mechanistic insight into multifunctionality, and suggest that different ADP-ribosyl cyclases are fine-tuned to produce specific calcium-mobilizing messengers.	[Ramakrishnan, Latha; Dale, Leslie; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Muller-Steffner, Helene; Schuber, Francis] Univ Strasbourg, Fac Pharm, F-67400 Illkirch Graffenstaden, France; [Bosc, Christophe; Moutin, Marie-Jo] Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci,CEA iRTSV GPC, F-38042 Grenoble, France; [Vacquier, Victor D.] Univ Calif San Diego, Div Marine Biol Res, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of London; University College London; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of California System; University of California San Diego; Scripps Institution of Oceanography	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Bosc, Christophe/P-3401-2017; Bosc, Christophe/Q-8877-2019; Moutin, Marie-Jo/P-7518-2017; Patel, Sandip/O-9591-2015	Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; Moutin, Marie-Jo/0000-0003-2681-9818; Patel, Sandip/0000-0001-7247-2013	Biotechnology and Biological Sciences Research Council [BB/D018110/1, BB/G013721/1]; Medical Research Council; BBSRC [BB/G013721/1, BB/D018110/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Grants BB/D018110/1 and BB/G013721/1 from the Biotechnology and Biological Sciences Research Council (to S.P.).; Recipient of a Ph.D. studentship from the Medical Research Council.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Billington RA, 2006, FERTIL STERIL, V86, P891, DOI 10.1016/j.fertnstert.2006.03.030; Birsoy B, 2005, DEVELOPMENT, V132, P591, DOI 10.1242/dev.01599; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Ceni C, 2003, J BIOL CHEM, V278, P40670, DOI 10.1074/jbc.M301196200; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GLICK DL, 1991, CELL REGUL, V2, P211, DOI 10.1091/mbc.2.3.211; Goodrich SP, 2005, BIOCHEMISTRY-US, V44, P11082, DOI 10.1021/bi050704r; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HELLMICH MR, 1991, CELL REGUL, V2, P193, DOI 10.1091/mbc.2.3.193; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kim SY, 2010, J BIOL CHEM, V285, P576, DOI 10.1074/jbc.M109.076216; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 1999, MOL CELL BIOCHEM, V193, P89; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Matsumura N, 1998, BIOCHEM BIOPH RES CO, V253, P246, DOI 10.1006/bbrc.1998.9752; Meszaros LG, 1997, BIOCHEM BIOPH RES CO, V234, P252, DOI 10.1006/bbrc.1997.6620; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Nelsen S, 2005, DEV DYNAM, V233, P1038, DOI 10.1002/dvdy.20378; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Patel S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.295pe69; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Sternfeld L, 2003, J BIOL CHEM, V278, P33629, DOI 10.1074/jbc.M301043200; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Wilson HL, 2001, J BIOL CHEM, V276, P11180, DOI 10.1074/jbc.M004849200; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zhang B, 2007, BIOCHEMISTRY-US, V46, P4100, DOI 10.1021/bi061933w; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	66	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19900	19909		10.1074/jbc.M110.105312	http://dx.doi.org/10.1074/jbc.M110.105312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20385553	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-25	WOS:000279012000023
J	Hassani, BK; Astier, C; Nitschke, W; Ouchane, S				Hassani, Bahia Khalfaoui; Astier, Chantal; Nitschke, Wolfgang; Ouchane, Soufian			CtpA, a Copper-translocating P-type ATPase Involved in the Biogenesis of Multiple Copper-requiring Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CBB(3) OXIDASES; BACTERIA; REDUCTASE; PHOTOSYNTHESIS; HOMEOSTASIS; MECHANISMS; COMPLEXES; PATHWAY; SYSTEM	The ctpA (ccoI) gene product, a putative inner membrane copper-translocating P1B-type ATPase present in many bacteria, has been shown to be involved only in the cbb(3) assembly in Rhodobacter capsulatus and Bradyrhizobium japonicum. ctpA was disrupted in Rubrivivax gelatinosus, and the mutants showed a drastic decrease in both cbb(3) and caa(3) oxidase activities. Inactivation of ctpA results also in a decrease in the amount of the nitrous oxide reductase, NosZ. This pleiotropic phenotype could be partially rescued by excess copper in the medium, indicating that CtpA is likely a copper transporter that supplies copper-requiring proteins in the membrane with this metal. Although CtpA shares significant sequence homologies with the homeostasis copper efflux P1B-type ATPases including the bacterial CopA and the human ATP7A and ATP7B, disruption of ctpA did not result in any sensitivity to excess copper. This indicates that the CtpA is not crucial for copper tolerance but is involved in the assembly of membrane and periplasmic copper enzymes in this bacterium. The potential roles of CtpA in bacteria in comparison with CopA are discussed.	CNRS, Ctr Genet Mol, FRE 3144, F-91198 Gif Sur Yvette, France; Univ Paris 11, F-91405 Orsay, France; [Nitschke, Wolfgang] CNRS, Lab Bioenerget & Ingn Prot UPR 9036, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite		souchane@cgm.cnrs-gif.fr	Nitschke, Wolfgang/C-4812-2012; Ouchane, Soufian/ABE-2609-2020; OUCHANE, Soufian/HHM-5430-2022; Johnson, Michael D. L./B-4352-2012	Ouchane, Soufian/0000-0002-8161-3866; Nitschke, Wolfgang/0000-0003-2084-3032	Agence Nationale de la Recherche [ANR BLAN06-2_147814]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ANR BLAN06-2_147814).	Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bayle D, 1998, J BACTERIOL, V180, P317, DOI 10.1128/JB.180.2.317-329.1998; Cox DW, 2002, J BIOENERG BIOMEMBR, V34, P333, DOI 10.1023/A:1021293818125; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hassani BK, 2010, J BIOL CHEM, V285, P19891, DOI 10.1074/jbc.M109.086066; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; LEE HS, 1991, J BACTERIOL, V173, P5406, DOI 10.1128/jb.173.17.5406-5413.1991; Lemaire Claire, 2008, V432, P65, DOI 10.1007/978-1-59745-028-7_5; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; MARRS B, 1973, J BACTERIOL, V114, P1045, DOI 10.1128/JB.114.3.1045-1051.1973; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Ostermeier C, 1996, CURR OPIN STRUC BIOL, V6, P460, DOI 10.1016/S0959-440X(96)80110-2; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Ouchane S, 2007, J BIOL CHEM, V282, P7690, DOI 10.1074/jbc.M605985200; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rasmussen T, 2000, BIOCHEMISTRY-US, V39, P12753, DOI 10.1021/bi001811i; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Sambrook J, 2010, MOL CLONING LAB MANU; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Swem DL, 2005, J BACTERIOL, V187, P8081, DOI 10.1128/JB.187.23.8081-8087.2005; TASHIRO H, 1995, J BIOCHEM-TOKYO, V117, P521, DOI 10.1093/oxfordjournals.jbchem.a124739; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Wunsch P, 2003, J BACTERIOL, V185, P887, DOI 10.1128/JB.185.3.887-896.2003; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X	33	49	50	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19330	19337		10.1074/jbc.M110.116020	http://dx.doi.org/10.1074/jbc.M110.116020			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20363758	Green Published, hybrid			2022-12-25	WOS:000278727800043
J	Eshraghi, A; Maldonado-Arocho, FJ; Gargi, A; Cardwell, MM; Prouty, MG; Blanke, SR; Bradley, KA				Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Gargi, Amandeep; Cardwell, Marissa M.; Prouty, Michael G.; Blanke, Steven R.; Bradley, Kenneth A.			Cytolethal Distending Toxin Family Members Are Differentially Affected by Alterations in Host Glycans and Membrane Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HAEMOPHILUS-DUCREYI; CAMPYLOBACTER-JEJUNI; N-ACETYLGLUCOSAMINYLTRANSFERASE; GLYCOSYLATION MUTANTS; POINT MUTATIONS; G(2) ARREST; HELA-CELLS	Cytolethal distending toxins (CDTs) are tripartite protein exotoxins produced by a diverse group of pathogenic Gram-negative bacteria. Based on their ability to induce DNA damage, cell cycle arrest, and apoptosis of cultured cells, CDTs are proposed to enhance virulence by blocking cellular division and/or directly killing epithelial and immune cells. Despite the widespread distribution of CDTs among several important human pathogens, our understanding of how these toxins interact with host cells is limited. Here we demonstrate that CDTs from Haemophilus ducreyi, Aggregatibacter actinomycetemcomitans, Escherichia coli, and Campylobacter jejuni differ in their abilities to intoxicate host cells with defined defects in host factors previously implicated in CDT binding, including glycoproteins, and glycosphingolipids. The absence of cell surface sialic acid sensitized cells to intoxication by three of the four CDTs tested. Surprisingly, fucosylated N-linked glycans and glycolipids, previously implicated in CDT-host interactions, were not required for intoxication by any of the CDTs tested. Finally, altering host-cellular cholesterol, also previously implicated in CDT binding, affected intoxication by only a subset of CDTs tested. The findings presented here provide insight into the molecular and cellular basis of CDT-host interactions.	[Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Cardwell, Marissa M.; Bradley, Kenneth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Gargi, Amandeep; Prouty, Michael G.; Blanke, Steven R.] Univ Illinois, Dept Microbiol, Inst Genom Biol, Urbana, IL 61801 USA	University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Urbana-Champaign	Bradley, KA (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 609 Charles E Young Dr E, Los Angeles, CA 90095 USA.	kbradley@microbio.ucla.edu			National Institutes of Health [T32DE007296, F31AI061837, AI59095]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI061837, R21AI059095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants T32DE007296 (to A. E.), F31AI061837 (to F.J.M.-A.), and AI59095 (to S.R.B.).	Akifusa S, 2005, MICROBIOL-SGM, V151, P1395, DOI 10.1099/mic.0.27671-0; Akifusa S, 2001, INFECT IMMUN, V69, P5925, DOI 10.1128/IAI.69.9.5925-5930.2001; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Boesze-Battaglia Kathleen, 2006, V332, P169; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Cao L, 2005, MOL MICROBIOL, V58, P1303, DOI 10.1111/j.1365-2958.2005.04905.x; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Deng KP, 2003, INFECT IMMUN, V71, P6633, DOI 10.1128/IAI.71.11.6633-6640.2003; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hong Y, 2004, J BIOL CHEM, V279, P49894, DOI 10.1074/jbc.M410121200; Hu X, 2006, PROTEINS, V62, P421, DOI 10.1002/prot.20767; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; Lofling J, 2008, GLYCOBIOLOGY, V18, P494, DOI 10.1093/glycob/cwn030; Mathieu S, 2004, AM J PATHOL, V164, P371, DOI 10.1016/S0002-9440(10)63127-6; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; Pickett CL, 1996, INFECT IMMUN, V64, P2070, DOI 10.1128/IAI.64.6.2070-2078.1996; Purdy D, 2000, J MED MICROBIOL, V49, P473, DOI 10.1099/0022-1317-49-5-473; Rabin SDP, 2009, INFECT IMMUN, V77, P3161, DOI 10.1128/IAI.01227-08; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; VOLPE JJ, 1983, J BIOL CHEM, V258, P9220; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	54	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18199	18207		10.1074/jbc.M110.112912	http://dx.doi.org/10.1074/jbc.M110.112912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385557	Green Published, hybrid			2022-12-25	WOS:000278453900011
J	Shao, BH; Pennathur, S; Pagani, I; Oda, MN; Witztum, JL; Oram, JF; Heinecke, JW				Shao, Baohai; Pennathur, Subramaniam; Pagani, Ioanna; Oda, Michael N.; Witztum, Joseph L.; Oram, John F.; Heinecke, Jay W.			Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; HUMAN ATHEROSCLEROTIC LESIONS; SITE-SPECIFIC MODIFICATION; TANDEM MASS-SPECTROMETRY; CASSETTE TRANSPORTER A1; GLYCATION END-PRODUCTS; HUMAN-SERUM-ALBUMIN; C-TERMINAL DOMAIN; AMINO-ACIDS; DIABETIC COMPLICATIONS	Dysfunctional high density lipoprotein (HDL) is implicated in the pathogenesis of cardiovascular disease, but the underlying pathways remain poorly understood. One potential mechanism involves covalent modification by reactive carbonyls of apolipoprotein A-I (apoA-I), the major HDL protein. We therefore determined whether carbonyls resulting from lipid peroxidation (malondialdehyde (MDA) and hydroxynonenal) or carbohydrate oxidation (glycolaldehyde, glyoxal, and methylglyoxal) covalently modify lipid-free apoA-I and inhibit its ability to promote cellular cholesterol efflux by the ABCA1 pathway. MDA markedly impaired the ABCA1 activity of apoA-I. In striking contrast, none of the other four carbonyls were effective. Liquid chromatographyelectrospray ionization-tandem mass spectrometry of MDA-modified apoA-I revealed that Lys residues at specific sites had been modified. The chief adducts were MDA-Lys and a Lys-MDA-Lys cross-link. Lys residues in the C terminus of apoA-I were targeted for cross-linking in high yield, and this process may hinder the interaction of apoA-I with lipids and ABCA1, two key steps in reverse cholesterol transport. Moreover, levels of MDA-protein adducts were elevated in HDL isolated from human atherosclerotic lesions, suggesting that lipid peroxidation might render HDL dysfunctional in vivo. Taken together, our observations indicate that MDA damages apoA-I by a pathway that generates lysine adducts at specific sites on the protein. Such damage may facilitate the formation of macrophage foam cells by impairing cholesterol efflux by the ABCA1 pathway.	[Shao, Baohai; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pagani, Ioanna; Oda, Michael N.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Diego	Shao, BH (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Box 358055,815 Mercer St, Seattle, WA 98109 USA.	bhshao@u.washington.edu	Pagani, Ioanna/E-7390-2012	Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [HL086798, HL77268, P30ES07083, HL086559, P01HL088093, HL092237, P01HL030086, K99HL091055]; Diabetes Education and Research Center, University of Washington [P30DK017047]; Doris Duke Foundation; Tobacco-related Disease Research Program of California [16FT-0054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077268, P01HL088093, R01HL086559, R21HL092237, K99HL091055, P01HL030086, R01HL086798, R00HL091055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Education and Research Center, University of Washington(University of Washington); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Tobacco-related Disease Research Program of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL086798, HL77268, P30ES07083, HL086559, P01HL088093, HL092237, and P01HL030086. This work was also supported by Grant P30DK017047 from the Diabetes Education and Research Center, University of Washington.; 1Supported by National Institutes of Health K99/R00 Award K99HL091055 from the NHLBI. To whom correspondence should be addressed: Box 358055, Division of Metabolism, Endocrinology, and Nutrition, Dept. of Medicine, 815 Mercer St., University of Washington, South Lake Union, Seattle, WA 98109. E-mail: bhshao@u.washington.edu.; 2 Supported by a clinical scientist development award from The Doris Duke Foundation.; 3 Supported by Grant 16FT-0054 from the Tobacco-related Disease Research Program of California.	ACHARYA AS, 1983, P NATL ACAD SCI-BIOL, V80, P3590, DOI 10.1073/pnas.80.12.3590; Anderson MM, 2003, DIABETES, V52, P2137, DOI 10.2337/diabetes.52.8.2137; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Burgess JW, 1999, BIOCHEMISTRY-US, V38, P14524, DOI 10.1021/bi990930z; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; HABERLAND ME, 1982, P NATL ACAD SCI-BIOL, V79, P1712, DOI 10.1073/pnas.79.6.1712; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; Heinecke JW, 1999, METHOD ENZYMOL, V300, P124; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; Ishii T, 2006, CHEM RES TOXICOL, V19, P122, DOI 10.1021/tx050231p; Ishii T, 2008, BIOCHEM BIOPH RES CO, V371, P28, DOI 10.1016/j.bbrc.2008.03.140; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Nobecourt E, 2007, DIABETOLOGIA, V50, P643, DOI 10.1007/s00125-006-0574-z; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Szapacs ME, 2008, J PROTEOME RES, V7, P4237, DOI 10.1021/pr8001222; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	66	105	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18473	18484		10.1074/jbc.M110.118182	http://dx.doi.org/10.1074/jbc.M110.118182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378541	hybrid, Green Published			2022-12-25	WOS:000278453900041
J	Wilson, A; Kinney, JN; Zwart, PH; Punginelli, C; D'Haene, S; Perreau, F; Klein, MG; Kirilovsky, D; Kerfeld, CA				Wilson, Adjele; Kinney, James N.; Zwart, Petrus H.; Punginelli, Claire; D'Haene, Sandrine; Perreau, Francois; Klein, Michael G.; Kirilovsky, Diana; Kerfeld, Cheryl A.			Structural Determinants Underlying Photoprotection in the Photoactive Orange Carotenoid Protein of Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-BINDING PROTEIN; SHORT HYDROGEN-BONDS; BLUE-LIGHT; ENERGY-DISSIPATION; PHYCOBILISOME FLUORESCENCE; CRYSTAL-STRUCTURES; PHOTOTROPIN 1; MECHANISM; DOMAIN; FAMILY	The photoprotective processes of photosynthetic organisms involve the dissipation of excess absorbed light energy as heat. Photoprotection in cyanobacteria is mechanistically distinct from that in plants; it involves the orange carotenoid protein (OCP), a water-soluble protein containing a single carotenoid. The OCP is a new member of the family of blue light-photoactive proteins; blue-green light triggers the OCP-mediated photoprotective response. Here we report structural and functional characterization of the wild type and two mutant forms of the OCP, from the model organism Synechocystis PCC6803. The structural analysis provides high resolution detail of the carotenoid-protein interactions that underlie the optical properties of the OCP, unique among carotenoid-proteins in binding a single pigment per polypeptide chain. Collectively, these data implicate several key amino acids in the function of the OCP and reveal that the photoconversion and photoprotective responses of the OCP to blue-green light can be decoupled.	[Kinney, James N.; Zwart, Petrus H.; Klein, Michael G.; Kerfeld, Cheryl A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wilson, Adjele; Punginelli, Claire; D'Haene, Sandrine; Kirilovsky, Diana] CEA, Inst Biol & Technol Saclay, Gif Sur Yvette, France; [Wilson, Adjele; Punginelli, Claire; D'Haene, Sandrine; Kirilovsky, Diana] CENS, Lab Leon Brillouin, CNRS, URA 2906, F-91191 Gif Sur Yvette, France; [Perreau, Francois] INRA Versailles Grignon, INRA AgroParisTech, UMR 1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Berkeley	Kerfeld, CA (corresponding author), 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	ckerfeld@berkeley.edu	Punginelli, Claire/M-1759-2014; Zwart, Peter/F-7123-2013; Kirilovsky, Diana/I-2359-2014	Kirilovsky, Diana/0000-0003-2146-3103; Wilson, Adjele Flore/0000-0003-2622-3600; Perreau, Francois/0000-0001-7873-9866	CNRS; Commissariat a l'Energie Atomique (Saclay, France); United States Department of Energy's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; National Science Foundation [MCB-085170]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique (Saclay, France)(French Atomic Energy Commission); United States Department of Energy's Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	The work of these authors was supported by grants from l'Agence Nationale de la Recherche (Program CAROPROTECT) from CNRS and the Commissariat a l'Energie Atomique (Saclay, France).; The work of these authors was performed under the auspices of the United States Department of Energy's Office of Science, Biological and Environmental Research Program, and the University of California, Lawrence Berkeley National Laboratory under Contract DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344, and National Science Foundation Grant MCB-085170.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alexandre MTA, 2009, BIOPHYS J, V97, P238, DOI 10.1016/j.bpj.2009.03.047; Anderson S, 2004, ACTA CRYSTALLOGR D, V60, P1008, DOI 10.1107/S090744490400616X; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Boulay C, 2008, BBA-BIOENERGETICS, V1777, P1344, DOI 10.1016/j.bbabio.2008.07.002; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cleland WW, 2000, ARCH BIOCHEM BIOPHYS, V382, P1, DOI 10.1006/abbi.2000.2011; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; El Bissati K, 2000, BBA-BIOENERGETICS, V1457, P229, DOI 10.1016/S0005-2728(00)00104-3; El Bissati K, 2001, PLANT PHYSIOL, V125, P1988; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; GILMORE AM, 1993, PHOTOSYNTH RES, V35, P67, DOI 10.1007/BF02185412; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; Hellingwerf KJ, 2003, J PHYS CHEM A, V107, P1082, DOI 10.1021/jp027005y; HERDMAN M, 1973, J GEN MICROBIOL, V79, P233, DOI 10.1099/00221287-79-2-233; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Kerfeld CA, 2010, CAROTENOIDS: PHYSICAL, CHEMICAL, AND BIOLOGICAL FUNCTIONS AND PROPERTIES, P3; Kirilovsky D, 2007, PHOTOSYNTH RES, V93, P7, DOI 10.1007/s11120-007-9168-y; Koyama T, 2009, BIOCHEMISTRY-US, V48, P7621, DOI 10.1021/bi9009192; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2008, P NATL ACAD SCI USA, V105, P7, DOI 10.1073/pnas.0710523105; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Mao LS, 2003, J PHYS CHEM B, V107, P3963, DOI 10.1021/jp0276496; Metz S, 2009, J BACTERIOL, V191, P4473, DOI 10.1128/JB.00262-09; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakasone Y, 2006, BIOPHYS J, V91, P645, DOI 10.1529/biophysj.106.084772; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Polivka T, 2005, BIOCHEMISTRY-US, V44, P3994, DOI 10.1021/bi047473t; Ponstingl H, 2000, PROTEINS, V41, P47; Punginelli C, 2009, BBA-BIOENERGETICS, V1787, P280, DOI 10.1016/j.bbabio.2009.01.011; Rajagopal S, 2005, FEBS J, V272, P1819, DOI 10.1111/j.1742-4658.2005.04604.x; Rakhimberdieva MG, 2007, FEBS LETT, V581, P2429, DOI 10.1016/j.febslet.2007.04.056; Rakhimberdieva MG, 2004, FEBS LETT, V574, P85, DOI 10.1016/j.febslet.2004.07.087; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Roszak AW, 2004, STRUCTURE, V12, P765, DOI 10.1016/j.str.2004.02.037; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; Scott M, 2006, BIOCHEMISTRY-US, V45, P8952, DOI 10.1021/bi060767p; Singh AK, 2008, PLANT PHYSIOL, V148, P467, DOI 10.1104/pp.108.123489; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yamamoto A, 2009, BIOPHYS J, V96, P2771, DOI 10.1016/j.bpj.2008.12.3924; YAMAMOTO HY, 1979, PURE APPL CHEM, V51, P639, DOI 10.1351/pac197951030639; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n	81	120	122	1	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18364	18375		10.1074/jbc.M110.115709	http://dx.doi.org/10.1074/jbc.M110.115709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20368334	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000278453900030
J	Ek-Ramos, MJ; Avila, J; Cheng, C; Martin, GB; Devarenne, TP				Ek-Ramos, Mara J.; Avila, Julian; Cheng, Cheng; Martin, Gregory B.; Devarenne, Timothy P.			The T-loop Extension of the Tomato Protein Kinase AvrPto-dependent Pto-interacting Protein 3 (Adi3) Directs Nuclear Localization for Suppression of Plant Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT HAIR-GROWTH; DISEASE RESISTANCE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; AGC KINASES; HYPERSENSITIVE RESPONSE; POSITIVE REGULATOR; MOLECULAR-CLONING; ACTIVATION; APOPTOSIS	In tomato (Solanum lycopersicum), resistance to Pseudomonas syringae pv. tomato is elicited by the interaction of the host Pto kinase with the pathogen effector protein AvrPto, which leads to various immune responses including localized cell death termed the hypersensitive response. The AGC kinase Adi3 functions to suppress host cell death and interacts with Pto only in the presence of AvrPto. The cell death suppression (CDS) activity of Adi3 requires phosphorylation by 3-phospho-inositide-dependent protein kinase 1 (Pdk1) and loss of Adi3 function is associated with the hypersensitive response cell death initiated by the Pto/AvrPto interaction. Here we studied the relationship between Adi3 cellular localization and its CDS activity. Adi3 is a nuclear-localized protein, and this localization is dictated by a nuclear localization signal found in the Adi3 T-loop extension, an similar to 80 amino acid insertion into the T-loop, or activation loop, which is phosphorylated for kinase activation. Nuclear localization of Adi3 is required for its CDS activity and loss of nuclear localization causes elimination of Adi3 CDS activity and induction of cell death. This nuclear localization of Adi3 is dependent on Ser-539 phosphorylation by Pdk1 and nonnuclear Adi3 is found in punctate structures throughout the cell. Our data support a model in which Pdk1 phosphorylation of Adi3 directs nuclear localization for CDS and that disruption of Adi3 nuclear localization may be a mechanism for induction of cell death such as that during the Pto/AvrPto interaction.	[Ek-Ramos, Mara J.; Avila, Julian; Cheng, Cheng; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Martin, Gregory B.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Martin, Gregory B.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA	Texas A&M University System; Texas A&M University College Station; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Devarenne, TP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tpd8@tamu.edu	Martin, Gregory B/F-6262-2011; Ramos, Maria Julissa Ek/W-1017-2018	Martin, Gregory B/0000-0003-0044-6830; Ramos, Maria Julissa Ek/0000-0002-1556-0823; Devarenne, Timothy/0000-0001-6032-8049; Avila, Julian/0000-0001-9388-3946	USDA-CSREES [2007-35319-17832]; USDA-AFRI [2010-65108-20526]; Texas A&M University Dept. of Biochemistry and Biophysics	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-AFRI(United States Department of Agriculture (USDA)); Texas A&M University Dept. of Biochemistry and Biophysics	This work was supported by USDA-CSREES Grant 2007-35319-17832 (to G. B. M. and T. P. D.), USDA-AFRI Grant 2010-65108-20526 (to T. P. D.), and by Texas A&M University Dept. of Biochemistry and Biophysics start-up funds (to T. P. D.).	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Anthony RG, 2006, J BIOL CHEM, V281, P37536, DOI 10.1074/jbc.M607341200; Arico S, 2002, J BIOL CHEM, V277, P27613, DOI 10.1074/jbc.M201119200; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Bogdanove AJ, 2000, P NATL ACAD SCI USA, V97, P8836, DOI 10.1073/pnas.97.16.8836; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Doukhanina EV, 2006, J BIOL CHEM, V281, P18793, DOI 10.1074/jbc.M511794200; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; Hergovich A, 2008, BBA-PROTEINS PROTEOM, V1784, P3, DOI 10.1016/j.bbapap.2007.07.017; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lam E, 2008, CRIT REV PLANT SCI, V27, P413, DOI 10.1080/07352680802467744; LARN E, 2004, NAT REV MOL CELL BIO, V5, P305; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee C, 2006, VIROLOGY, V346, P238, DOI 10.1016/j.virol.2005.11.005; Lee SB, 2008, P NATL ACAD SCI USA, V105, P16584, DOI 10.1073/pnas.0807668105; Li ST, 2007, PLANT PHYSIOL, V145, P236, DOI 10.1104/pp.107.101741; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; MILLWARD T, 1995, P NATL ACAD SCI USA, V92, P5022, DOI 10.1073/pnas.92.11.5022; Miyamoto S, 2009, CARDIOVASC RES, V82, P272, DOI 10.1093/cvr/cvp087; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nguyen TLX, 2006, BIOCHEM BIOPH RES CO, V349, P789, DOI 10.1016/j.bbrc.2006.08.120; Oyama T, 2002, PLANT J, V30, P289, DOI 10.1046/j.1365-313X.2002.01290.x; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; RIZHSKY L, 2004, MEASURING PROGRAMMED, P179; Robert HS, 2008, CURR OPIN PLANT BIOL, V11, P495, DOI 10.1016/j.pbi.2008.06.004; Rodin S A, 2001, Dokl Biochem Biophys, V379, P235, DOI 10.1023/A:1011639531452; SALMERON JM, 1994, PLANT CELL, V6, P511, DOI 10.1105/tpc.6.4.511; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; SOBKO A, 2006, SCI STKE, pRE9; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Zegzouti H, 2006, P NATL ACAD SCI USA, V103, P6404, DOI 10.1073/pnas.0510283103; Zegzouti H, 2006, J BIOL CHEM, V281, P35520, DOI 10.1074/jbc.M605167200; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	73	26	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17584	17594		10.1074/jbc.M110.117416	http://dx.doi.org/10.1074/jbc.M110.117416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371603	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000278133400037
J	Gao, YJ; Balut, CM; Bailey, MA; Patino-Lopez, G; Shaw, S; Devor, DC				Gao, Yajuan; Balut, Corina M.; Bailey, Mark A.; Patino-Lopez, Genaro; Shaw, Stephen; Devor, Daniel C.			Recycling of the Ca2+-activated K+ Channel, KCa2.3, Is Dependent upon RME-1, Rab35/EPI64C, and an N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-CONDUCTANCE; INTERMEDIATE-CONDUCTANCE; HYPERPOLARIZING FACTOR; POTASSIUM CHANNEL; EDHF RESPONSES; SMOOTH-MUSCLE; CL-SECRETION; TRAFFICKING; RECEPTOR; RAB35	Regulation of the number of Ca2+-activated K+ channels at the endothelial cell surface contributes to control of the endothelium-derived hyperpolarizing factor response, although this process is poorly understood. To address the fate of plasma membrane-localized KCa2.3, we utilized an extracellular epitope-tagged channel in combination with fluorescence and biotinylation techniques in both human embryonic kidney cells and the human microvascular endothelial cell line, HMEC-1. KCa2.3 was internalized from the plasma membrane and degraded with a time constant of 18 h. Cell surface biotinylation demonstrated that KCa2.3 was rapidly endocytosed and recycled back to the plasma membrane. Consistent with recycling, expression of a dominant negative (DN) RME-1 or Rab35 as well as wild type EPI64C, the Rab35 GTPase-activating protein, resulted in accumulation of KCa2.3 in an intracellular compartment. Expression of DN RME-1, DN Rab35, or wild type EPI64C resulted in a decrease in steady-state plasma membrane expression. Knockdown of EPI64C increased cell surface expression of KCa2.3. Furthermore, the effect of EPI64C was dependent upon its GTPase-activating proteins activity. Co-immunoprecipitation studies confirmed an association between KCa2.3 and both Rab35 and RME-1. In contrast to KCa2.3, KCa3.1 was rapidly endocytosed and degraded in an RME-1 and Rab35-independent manner. A series of N-terminal deletions identified a 12-amino acid region, Gly(206)-Pro(217), as being required for the rapid recycling of KCa2.3. Deletion of Gly(206)-Pro(217) had no effect on the association of KCa2.3 with Rab35 but significantly decreased the association with RME-1. These represent the first studies elucidating the mechanisms by which KCa2.3 is maintained at the plasma membrane.	[Devor, Daniel C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Patino-Lopez, Genaro; Shaw, Stephen] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Devor, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S331 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	dd2@pitt.edu	Patiño López, Genaro/GQI-4414-2022; Patino-Lopez, Genaro/O-3484-2018	Patino-Lopez, Genaro/0000-0002-8716-722X	National Institutes of Health [HL083060, HL092157]; American Heart Fellowship [0825542D]; NATIONAL CANCER INSTITUTE [ZIABC009257] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092157, R01HL083060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083060 and HL092157 (to D. C. D.). This work was also supported by American Heart Fellowship 0825542D (to C. M. B.).	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Balut CM, 2009, BIOPHYS J, V96, p472A, DOI 10.1016/j.bpj.2008.12.2445; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Crane GJ, 2003, J PHYSIOL-LONDON, V553, P183, DOI 10.1113/jphysiol.2003.051896; Devor DC, 1997, AM J PHYSIOL-CELL PH, V273, pC531, DOI 10.1152/ajpcell.1997.273.2.C531; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Griffith TM, 2004, BRIT J PHARMACOL, V141, P881, DOI 10.1038/sj.bjp.0705698; Hinton JM, 2003, BRIT J PHARMACOL, V138, P1031, DOI 10.1038/sj.bjp.0705171; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Lewarchik CM, 2008, J BIOL CHEM, V283, P28401, DOI 10.1074/jbc.M800516200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Parkington HC, 2002, J PHYSIOL-LONDON, V542, P929, DOI 10.1113/jphysiol.2002.021030; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Roncarati R, 2005, MOL CELL NEUROSCI, V28, P314, DOI 10.1016/j.mcn.2004.09.015; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060	47	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17938	17953		10.1074/jbc.M109.086553	http://dx.doi.org/10.1074/jbc.M109.086553			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360009	Green Published, hybrid			2022-12-25	WOS:000278133400070
J	Matilla, I; Alfonso, C; Rivas, G; Bolt, EL; de la Cruz, F; Cabezon, E				Matilla, Inmaculada; Alfonso, Carlos; Rivas, German; Bolt, Edward L.; de la Cruz, Fernando; Cabezon, Elena			The Conjugative DNA Translocase TrwB Is a Structure-specific DNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; BACTERIAL CONJUGATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; HELICASE; MECHANISM; GENE; FTSK; SUBSTRATE; TRANSPORT	TrwB is a DNA-dependent ATPase involved in DNA transport during bacterial conjugation. The protein presents structural similarity to hexameric molecular motors such as F1-ATPase, FtsK, or ring helicases, suggesting that TrwB also operates as a motor, using energy released from ATP hydrolysis to pump single-stranded DNA through its central channel. In this work, we have carried out an extensive analysis with various DNA substrates to determine the preferred substrate for TrwB. Oligonucleotides with G-rich sequences forming G4 DNA structures were the optimal substrates for TrwB ATPase activity. The protein bound with 100-fold higher affinity to G4 DNA than to single-stranded DNA of the same sequence. Moreover, TrwB formed oligomeric protein complexes only with oligonucleotides presenting such a G-quadruplex DNA structure, consistent with stoichiometry of six TrwB monomers to G4 DNA, as demonstrated by gel filtration chromatography and analytical ultracentrifugation experiments. A protein-DNA complex was also formed with unstructured oligonucleotides, but the molecular mass corresponded to one monomer protein bound to one oligonucleotide molecule. Sequences capable of forming G-quadruplex structures are widespread through genomes and are thought to play a biological function in transcriptional regulation. They form stable structures that can obstruct DNA replication, requiring the action of specific helicases to resolve them. Nevertheless, TrwB displayed no G4 DNA unwinding activity. These observations are discussed in terms of a possible role for TrwB in recognizing G-quadruplex structures as loading sites on the DNA.	[Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena] Univ Cantabria, Dept Mol Biol, Santander 39011, Spain; [Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena] CSIC UC IDICAN, IBBTEC, Santander 39011, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, Dept Ciencia Prot, E-28040 Madrid, Spain; [Bolt, Edward L.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Nottingham	Cabezon, E (corresponding author), Univ Cantabria, Dept Mol Biol, Santander 39011, Spain.	cabezone@unican.es	Cabezon, Elena/K-5874-2014; Alfonso, Carlos/K-1316-2014; Rivas, German/AAG-7458-2022; de la Cruz, Fernando/L-2812-2014; Rivas, German/AFL-7528-2022	Alfonso, Carlos/0000-0001-7165-4800; Rivas, German/0000-0003-3450-7478; de la Cruz, Fernando/0000-0003-4758-6857; Rivas, German/0000-0003-3450-7478; Cabezon, Elena/0000-0002-6177-5016; Bolt, Edward/0000-0002-5656-7706	Ministerio de Ciencia e Innovacion (MCINN, Spain) [BFU2008-00806, BFU2008-00995/BMC]; Instituto de Salud Carlos III [RD06/0008/1012]; European VI Framework Program [LSHM-CT-2005_019023]; Biomedical Sciences (Nottingham) Research Fund; University of Cantabria	Ministerio de Ciencia e Innovacion (MCINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European VI Framework Program; Biomedical Sciences (Nottingham) Research Fund; University of Cantabria	This work was supported by Ministerio de Ciencia e Innovacion (MCINN, Spain) Grant BFU2008-00806 (to E. C.), Grants BFU2008-00995/BMC from MCINN, RD06/0008/1012 from Instituto de Salud Carlos III, and LSHM-CT-2005_019023 from the European VI Framework Program (to F.d.I.C.), and a grant from The Biomedical Sciences (Nottingham) Research Fund (to E. L. B.).; Supported by a fellowship from the University of Cantabria.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Baran N, 1997, NUCLEIC ACIDS RES, V25, P297, DOI 10.1093/nar/25.2.297; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Briggs GS, 2005, J BIOL CHEM, V280, P13921, DOI 10.1074/jbc.M412054200; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; COHEN A, 1968, P NATL ACAD SCI USA, V61, P61, DOI 10.1073/pnas.61.1.61; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Cole JL, 2004, METHOD ENZYMOL, V384, P212; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; El Karoui M, 1999, RES MICROBIOL, V150, P579, DOI 10.1016/S0923-2508(99)00132-1; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; Howlett GJ, 2000, METHOD ENZYMOL, V323, P231; IRINO N, 1986, MOL GEN GENET, V205, P298, DOI 10.1007/BF00430442; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; OHKI M, 1968, COLD SPRING HARB SYM, V33, P651, DOI 10.1101/SQB.1968.033.01.074; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X	42	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17537	17544		10.1074/jbc.M109.084137	http://dx.doi.org/10.1074/jbc.M109.084137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375020	Green Published, hybrid			2022-12-25	WOS:000278133400032
J	Tao, Z; Rosental, N; Kanner, BI; Gameiro, A; Mwaura, J; Grewer, C				Tao, Zhen; Rosental, Noa; Kanner, Baruch I.; Gameiro, Armanda; Mwaura, Juddy; Grewer, Christof			Mechanism of Cation Binding to the Glutamate Transporter EAAC1 Probed with Mutation of the Conserved Amino Acid Residue Thr(101)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ASPARTATE TRANSPORTER; RAT-BRAIN; FUNCTIONAL-CHARACTERIZATION; PYROCOCCUS-HORIKOSHII; EXTRACELLULAR GATE; MEMBRANE-VESICLES; CHLORIDE CHANNEL; NA+ BINDING; SUBSTRATE; TRANSLOCATION	The glutamate transporter excitatory amino acid carrier 1 (EAAC1) catalyzes the co-transport of three Na+ ions, one H+ ion, and one glutamate molecule into the cell, in exchange for one K+ ion. Na+ binding to the glutamate-free form of the transporter generates a high affinity binding site for glutamate and is thus required for transport. Moreover, sodium binding to the transporters induces a basal anion conductance, which is further activated by glutamate. Here, we used the [Na+] dependence of this conductance as a read-out of Na+ binding to the substrate-free transporter to study the impact of a highly conserved amino acid residue, Thr(101), in transmembrane domain 3. The apparent affinity of substrate-free EAAC1 for Na+ was dramatically decreased by the T101A but not by the T101S mutation. Interestingly, in further contrast to EAAC1(WT), in the T101A mutant this [Na+] dependence was biphasic. This behavior can be explained by assuming that the binding of two Na+ ions prior to glutamate binding is required to generate a high affinity substrate binding site. In contrast to the dramatic effect of the T101A mutation on Na+ binding, other properties of the transporter, such as its ability to transport glutamate, were impaired but not eliminated. Our results are consistent with the existence of a cation binding site deeply buried in the membrane and involving interactions with the side chain oxygens of Thr(101) and Asp(367). A theoretical valence screening approach confirms that the predicted site of cation interaction has the potential to be a novel, so far undetected sodium binding site.	[Tao, Zhen; Gameiro, Armanda; Mwaura, Juddy; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Med, Dept Biochem, IL-91120 Jerusalem, Israel	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Hebrew University of Jerusalem; Hadassah University Medical Center	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu	Albers, Thomas/A-9082-2012		National Institutes of Health [2R01NS049335-06A1, NS 16708]; Binational Science Foundation [2007051]; American Heart Association [0525485B]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335, R56NS049335, R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01NS049335-06A1 (to C. G.) and NS 16708 (to B. I. K.). This work was also supported by Binational Science Foundation Grant 2007051 (to C. G. and B. I. K.) and American Heart Association Grant 0525485B (to Z. T.).	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Grewer C, 2001, BIOCHEMISTRY-US, V40, P232, DOI 10.1021/bi0015919; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; HUANG Z, 2010, 54 ANN M BIOPHYS SOC; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1978, FEBS LETT, V94, P245, DOI 10.1016/0014-5793(78)80947-8; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2008, BIOCHEMISTRY-US, V47, P12923, DOI 10.1021/bi8017174; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	49	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17725	17733		10.1074/jbc.M110.121798	http://dx.doi.org/10.1074/jbc.M110.121798			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378543	hybrid, Green Published			2022-12-25	WOS:000278133400050
J	Kitko, RD; Wilks, JC; Garduque, GM; Slonczewski, JL				Kitko, Ryan D.; Wilks, Jessica C.; Garduque, Gian M.; Slonczewski, Joan L.			Osmolytes Contribute to pH Homeostasis of Escherichia coli	PLOS ONE			English	Article							POTASSIUM-TRANSPORT; INTRACELLULAR PH; ACID RESISTANCE; BACTERIA; K+; CATABOLISM; GRADIENT; CELLS; K-12; ACCUMULATION	Background: Cytoplasmic pH homeostasis in Escherichia coli includes numerous mechanisms involving pH-dependent catabolism and ion fluxes. An important contributor is transmembrane K(+) flux, but the actual basis of K(+) compensation for pH stress remains unclear. Osmoprotection could mediate the pH protection afforded by K(+) and other osmolytes. Methods and Principal Findings: The cytoplasmic pH of E. coli K-12 strains was measured by GFPmut3 fluorimetry. The wild-type strain Frag1 was exposed to rapid external acidification by HCl addition. Recovery of cytoplasmic pH was enhanced equally by supplementation with NaCl, KCl, proline, or sucrose. A triple mutant strain TK2420 defective for the Kdp, Trk and Kup K(+) uptake systems requires exogenous K(+) for steady-state pH homeostasis and for recovery from sudden acid shift. The K(+) requirement however was partly compensated by supplementation with NaCl, choline chloride, proline, or sucrose. Thus, the K(+) requirement was mediated in part by osmolarity, possibly by relieving osmotic stress which interacts with pH stress. The rapid addition of KCl to strain TK2420 suspended at external pH 5.6 caused a transient decrease in cytoplasmic pH, followed by slow recovery to an elevated steady-state pH. In the presence of 150 mM KCl, however, rapid addition of another 150 mM KCl caused a transient increase in cytoplasmic pH. These transient effects may arise from secondary K(+) fluxes occurring through other transport processes in the TK2420 strain. Conclusions: Diverse osmolytes including NaCl, KCl, proline, or sucrose contribute to cytoplasmic pH homeostasis in E. coli, and increase the recovery from rapid acid shift. Osmolytes other than K(+) restore partial pH homeostasis in a strain deleted for K(+) transport.	[Kitko, Ryan D.; Wilks, Jessica C.; Garduque, Gian M.; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA	Kenyon College	Kitko, RD (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu			National Science Foundation [MCB-0644167]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant MCB-0644167 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; Booth IR, 1999, NOVART FDN SYMP, V221, P19; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Buurman ET, 2004, J BACTERIOL, V186, P4238, DOI 10.1128/JB.186.13.4238-4245.2004; Casey PG, 2002, INT J FOOD MICROBIOL, V76, P199, DOI 10.1016/S0168-1605(02)00018-1; Chapman B, 2006, APPL ENVIRON MICROB, V72, P5165, DOI 10.1128/AEM.02522-05; Chapman B, 2009, APPL ENVIRON MICROB, V75, P3605, DOI 10.1128/AEM.02462-08; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Kitko RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008255; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; KROLL RG, 1981, BIOCHEM J, V198, P691, DOI 10.1042/bj1980691; Krulwich TA, 2009, MOL MICROBIOL, V74, P257, DOI 10.1111/j.1365-2958.2009.06842.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Miller J.H., 1972, EXPT MOL GENETICS; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1976, EUR J BIOCHEM, V63, P533, DOI 10.1111/j.1432-1033.1976.tb10257.x; Richard H, 2007, MICROBIOL-SGM, V153, P3154, DOI 10.1099/mic.0.2007/007575-0; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; STEWART LMD, 1985, J GEN MICROBIOL, V131, P77; Trchounian A, 1997, ANAEROBE, V3, P355, DOI 10.1006/anae.1997.0122; Trchounian A, 2000, BIOSCIENCE REP, V20, P277, DOI 10.1023/A:1026493024066; WHITE S, 1992, J BACTERIOL, V174, P1537, DOI 10.1128/jb.174.5.1537-1543.1992; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zakharyan E, 2001, FEMS MICROBIOL LETT, V204, P61, DOI 10.1111/j.1574-6968.2001.tb10863.x; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	36	35	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10078	10.1371/journal.pone.0010078	http://dx.doi.org/10.1371/journal.pone.0010078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386696	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482000013
J	Pelletier, J; Hughes, DT; Luetje, CW; Leal, WS				Pelletier, Julien; Hughes, David T.; Luetje, Charles W.; Leal, Walter S.			An Odorant Receptor from the Southern House Mosquito Culex pipiens quinquefasciatus Sensitive to Oviposition Attractants	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; PHEROMONE; PROTEINS; IDENTIFICATION; EXPRESSION; RESPONSES; DIPTERA; PALPS	Background: Insect odorant receptors (ORs) are heteromers comprised of highly variable odorant-binding subunits associated with one conserved co-receptor. They are potential molecular targets for the development of novel mosquito attractants and repellents. ORs have been identified in the malaria mosquito, Anopheles gambiae, and in the yellow fever mosquito, Aedes aegypti. However, they are still unknown in the Southern house mosquito, Culex quinquefasciatus, which transmits pathogens that cause human diseases throughout the world, including West Nile Virus in the United States. Methodology: We have employed a combination of bioinformatics, molecular cloning and electrophysiology approaches to identify and characterize the response profile of an OR in Cx. quinquefasciatus. First, we have unveiled a large multigenic family of one-hundred-fifty-eight putative ORs in this species, including a subgroup of conserved ORs in three mosquito species. Using the Xenopus oocytes expression system, we have determined the response profile of CquiOR2, an antennae-specific OR, which shares high identity with putative orthologs in Anopheles gambiae (AgamOR2) and Aedes aegypti (AaegOR2). Conclusion: We show that CquiOR2 is highly sensitive to indole, an oviposition attractant for Cx. quinquefasciatus. The response profile of CquiOR2 expressed in Xenopus oocytes resembles that of an olfactory receptor neuron housed in the antennal short blunt-tipped sensilla (A2) of Cx. quinquefasciatus, which are natural detectors for oviposition attractants. This first Culex OR de-orphanized is, therefore, a potential molecular target for screening oviposition attractants.	[Pelletier, Julien; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hughes, David T.; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of California System; University of California Davis; University of Miami	Pelletier, J (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	National Science Foundation [0918177]; National Institutes of Health [DC008119]; Cooperative Agreement with Bedoukian Research, Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008119, R01DC011091] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative Agreement with Bedoukian Research, Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Science Foundation (0918177 to W. S. L), National Institutes of Health (DC008119 to C. W. L.), and a Cooperative Agreement with Bedoukian Research, Inc., but the funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Carey AF, 2010, NATURE; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Du YJ, 1999, J MED ENTOMOL, V36, P158, DOI 10.1093/jmedent/36.2.158; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2010, NATURE, V464, P37, DOI 10.1038/464037a; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MCIVER S, 1970, CAN J ZOOLOG, V48, P293, DOI 10.1139/z70-048; MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11; MORDUE AJ, 1992, EXPERIENTIA, V48, P1109, DOI 10.1007/BF01947999; Olagbemiro TO, 2004, J CHEM ECOL, V30, P965, DOI 10.1023/B:JOEC.0000028461.86243.19; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WANG G, 2010, P NATL ACAD IN PRESS; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	35	87	91	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10090	10.1371/journal.pone.0010090	http://dx.doi.org/10.1371/journal.pone.0010090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386699	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482000018
J	Prahalad, P; Dakshanamurthy, S; Ressom, H; Byers, SW				Prahalad, Priya; Dakshanamurthy, Sivanesan; Ressom, Habtom; Byers, Stephen W.			Retinoic Acid Mediates Regulation of Network Formation by COUP-TFII and VE-Cadherin Expression by TGF beta Receptor Kinase in Breast Cancer Cells	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; VASCULOGENIC MIMICRY; TYROSINE KINASE; DOWN-REGULATION; TIE2 RECEPTOR; IN-VITRO; GROWTH; ANGIOGENESIS; ACTIVATION; PLASTICITY	Tumor development, growth, and metastasis depend on the provision of an adequate vascular supply. This can be due to regulated angiogenesis, recruitment of circulating endothelial progenitors, and/or vascular transdifferentiation. Our previous studies showed that retinoic acid (RA) treatment converts a subset of breast cancer cells into cells with significant endothelial genotypic and phenotypic elements including marked induction of VE-cadherin, which was responsible for some but not all morphological changes. The present study demonstrates that of the endothelial-related genes induced by RA treatment, only a few were affected by knockdown of VE-cadherin, ruling it out as a regulator of the RA-induced endothelial genotypic switch. In contrast, knockdown of the RA-induced gene COUP-TFII prevented the formation of networks in Matrigel but had no effect on VE-cadherin induction or cell fusion. Two pan-kinase inhibitors markedly blocked RA-induced VE-cadherin expression and cell fusion. However, RA treatment resulted in a marked and broad reduction in tyrosine kinase activity. Several genes in the TGF beta signaling pathway were induced by RA, and specific inhibition of the TGF beta type I receptor blocked both RA-induced VE-cadherin expression and cell fusion. Together these data indicate a role for the TGF beta pathway and COUP-TFII in mediating the endothelial transdifferentiating properties of RA.	[Prahalad, Priya; Dakshanamurthy, Sivanesan; Ressom, Habtom; Byers, Stephen W.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University	Prahalad, P (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA.	byerss@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121	NIH [1R01CA129813, R01 DK58196]; DOD [W81XWH-08-1-0103]; Lombardi Comprehensive Cancer Center [NIH P30 CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA129813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Lombardi Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: NIH 1R01CA129813, NIH R01 DK58196 (S. W. B.) and DOD W81XWH-08-1-0103 (P. P.). The authors acknowledge the support of the following Shared Resources supported by the Lombardi Comprehensive Cancer Center grant NIH P30 CA51008: Microscopy and Imaging, Genomics and Epigenomics, Tissue Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombeli T, 1997, THROMB HAEMOSTASIS, V77, P408; Camacho M, 2008, J LIPID RES, V49, P1707, DOI 10.1194/jlr.M700559-JLR200; Cong RH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-124; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Endo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002714; Esser S, 1998, J CELL SCI, V111, P1853; Faloon P, 2000, DEVELOPMENT, V127, P1931; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FLAMME I, 1992, DEVELOPMENT, V116, P435; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fujimoto A, 2006, ANTICANCER RES, V26, P59; Gifford SM, 2004, J ENDOCRINOL, V182, P485, DOI 10.1677/joe.0.1820485; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hansen LA, 2000, CARCINOGENESIS, V21, P1271, DOI 10.1093/carcin/21.7.1271; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hendrix MJC, 2000, BREAST CANCER RES, V2, P417, DOI 10.1186/bcr88; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Nagasaki S, 2009, CANCER SCI, V100, P639, DOI 10.1111/j.1349-7006.2008.01078.x; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Piao M, 2006, ENDOTHELIUM-J ENDOTH, V13, P249, DOI 10.1080/10623320600903940; Seftor EA, 2002, CRIT REV ONCOL HEMAT, V44, P17, DOI 10.1016/S1040-8428(01)00199-8; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sharma N, 2002, PROSTATE, V50, P189, DOI 10.1002/pros.10048; Shirakawa K, 2002, BRIT J CANCER, V87, P1454, DOI 10.1038/sj.bjc.6600610; Shirakawa K, 2002, CANCER RES, V62, P560; Sood AK, 2004, AM J OBSTET GYNECOL, V190, P899, DOI 10.1016/j.ajog.2004.02.011; Sun BC, 2006, ONCOL REP, V16, P693; Sun BC, 2004, INT J ONCOL, V25, P1609; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Yang QF, 2002, BREAST CANCER RES TR, V76, P167, DOI 10.1023/A:1020576606004; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zanetta L, 2005, THROMB HAEMOSTASIS, V93, P1041, DOI 10.1160/TH04-10-0680	47	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10023	10.1371/journal.pone.0010023	http://dx.doi.org/10.1371/journal.pone.0010023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386594	Green Submitted, Green Published, gold			2022-12-25	WOS:000276420400005
J	Jensen, CJ; Stankovich, J; Van der Walt, A; Bahlo, M; Taylor, BV; van der Mei, IAF; Foote, SJ; Kilpatrick, TJ; Johnson, LJ; Wilkins, E; Field, J; Danoy, P; Brown, MA; Rubio, JP; Butzkueven, H				Jensen, Cathy J.; Stankovich, Jim; Van der Walt, Anneke; Bahlo, Melanie; Taylor, Bruce V.; van der Mei, Ingrid A. F.; Foote, Simon J.; Kilpatrick, Trevor J.; Johnson, Laura J.; Wilkins, Ella; Field, Judith; Danoy, Patrick; Brown, Matthew A.; Rubio, Justin P.; Butzkueven, Helmut		Australian & New Zealand Multiple	Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENES; HLA; AGE; INTERLEUKIN-4; POLYMORPHISMS; DISABILITY; DIAGNOSIS; VARIANTS; HLA-DRB1	Recent association studies in multiple sclerosis (MS) have identified and replicated several single nucleotide polymorphism (SNP) susceptibility loci including CLEC16A, IL2RA, IL7R, RPL5, CD58, CD40 and chromosome 12q13-14 in addition to the well established allele HLA-DR15. There is potential that these genetic susceptibility factors could also modulate MS disease severity, as demonstrated previously for the MS risk allele HLA-DR15. We investigated this hypothesis in a cohort of 1006 well characterised MS patients from South-Eastern Australia. We tested the MS-associated SNPs for association with five measures of disease severity incorporating disability, age of onset, cognition and brain atrophy. We observed trends towards association between the RPL5 risk SNP and time between first demyelinating event and relapse, and between the CD40 risk SNP and symbol digit test score. No associations were significant after correction for multiple testing. We found no evidence for the hypothesis that these new MS disease risk-associated SNPs influence disease severity.	[Jensen, Cathy J.; Johnson, Laura J.; Wilkins, Ella; Field, Judith; Rubio, Justin P.; Butzkueven, Helmut] Howard Florey Inst Expt Physiol & Med, Melbourne, Vic, Australia; [Jensen, Cathy J.] Monash Univ, Dept Physiol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3168, Australia; [Stankovich, Jim; Taylor, Bruce V.; van der Mei, Ingrid A. F.; Foote, Simon J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Van der Walt, Anneke; Butzkueven, Helmut] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Van der Walt, Anneke; Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Van der Walt, Anneke; Butzkueven, Helmut] Box Hill Hosp, Box Hill, Vic, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Brown, Matthew A.] Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Oxford, England	Florey Institute of Neuroscience & Mental Health; Monash University; University of Tasmania; Menzies Institute for Medical Research; Royal Melbourne Hospital; University of Melbourne; Box Hill Hospital; Walter & Eliza Hall Institute; University of Queensland; University of Oxford	Jensen, CJ (corresponding author), Howard Florey Inst Expt Physiol & Med, Melbourne, Vic, Australia.	helmut.butzkueven@florey.edu.au	Foote, Simon J/F-2802-2013; van der Mei, Ingrid/AAI-2566-2020; MOSCATO, PABLO ALBERTO/G-7668-2013; Kermode, Allan/G-3568-2019; Brown, Matthew A/E-5749-2010; Browning, Brian L/A-1178-2010; van der Mei, Ingrid/J-7457-2014; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	van der Mei, Ingrid/0000-0001-9009-7472; Kermode, Allan/0000-0002-4476-4016; Brown, Matthew A/0000-0003-0538-8211; Browning, Brian L/0000-0001-6454-6633; van der Mei, Ingrid/0000-0001-9009-7472; Scott, Rodney/0000-0001-7724-3404; Moscato, Pablo/0000-0003-2570-5966; Foote, Simon/0000-0002-9142-2107; Butzkueven, Helmut/0000-0003-3940-8727; Slee, Mark/0000-0003-4323-2453; Griffiths, Lyn/0000-0002-6774-5475; Stankovich, Jim/0000-0001-9344-7749; RUBIO, JUSTIN/0000-0003-3750-917X; Field, Judith/0000-0002-7089-0999; Lechner-Scott, Jeannette/0000-0002-3850-447X; Bahlo, Melanie/0000-0001-5132-0774; Kilpatrick, Trevor/0000-0003-3999-085X	Peter Doherty Post-doctoral Fellowship (NHMRC); NHMRC Biomedical Career Development Awards; NHMRC Australian Research Training Fellowship; NHMRC Principal Research Fellowship; Multiple Sclerosis Research Australia Fellowship; Monash Departmental Scholarship; Multiple Sclerosis Research Australia; Australia Research Council [LP0776744]	Peter Doherty Post-doctoral Fellowship (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Biomedical Career Development Awards(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australian Research Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia Fellowship; Monash Departmental Scholarship; Multiple Sclerosis Research Australia; Australia Research Council(Australian Research Council)	HB is supported by a Peter Doherty Post-doctoral Fellowship (NHMRC). JPR and MB are supported by NHMRC Biomedical Career Development Awards, IvdM by a NHMRC Australian Research Training Fellowship (Part-Time) and MAB by an NHMRC Principal Research Fellowship. JF is supported by a Multiple Sclerosis Research Australia Fellowship and CJJ is supported by a Monash Departmental Scholarship. This study was supported by Multiple Sclerosis Research Australia (http://www.msaustralia.org.au/msra) and an Australia Research Council (http://www.arc.gov.au/) Linkage Grant (LP0776744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barcellos LF, 2002, BRAIN, V125, P150; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; Butzkueven H, 2008, J CLIN NEUROSCI, V15, P130, DOI 10.1016/j.jocn.2007.02.089; Celius EG, 2000, J NEUROL SCI, V178, P132, DOI 10.1016/S0022-510X(00)00389-0; Fiotti N, 2004, J NEUROIMMUNOL, V152, P147, DOI 10.1016/j.jneuroim.2004.03.009; Hackstein H, 2001, J NEUROIMMUNOL, V113, P240, DOI 10.1016/S0165-5728(00)00455-0; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; HAUSER SL, 2000, NEUROLOGY, V54; Hensiek AE, 2002, J NEUROL NEUROSUR PS, V72, P184, DOI 10.1136/jnnp.72.2.184; Kantarci OH, 2000, J NEUROIMMUNOL, V106, P220, DOI 10.1016/S0165-5728(00)00202-2; Kantarci OH, 2003, J NEUROIMMUNOL, V137, P134, DOI 10.1016/S0165-5728(03)00046-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Mirel DB, 2004, GENES IMMUN, V5, P138, DOI 10.1038/sj.gene.6364048; MIROWSKAGUZEL D, J NEUROIMMU IN PRESS; Nelissen I, 2000, J NEUROIMMUNOL, V105, P58, DOI 10.1016/S0165-5728(00)00189-2; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; PERERA D, 2009, J NEUROIMMUNOL; Ramagopalan SV, 2008, J NEUROL, V255, P1215, DOI 10.1007/s00415-008-0878-7; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; RUBIO JP, 2008, GENES IMMUN; RUNMARKER B, 1994, J NEUROL, V241, P385, DOI 10.1007/BF02033356; Smestad C, 2007, EUR J NEUROL, V14, P835, DOI 10.1111/j.1468-1331.2007.01825.x; STANKOVICH J, 2009, TISSUE ANTIGENS; Suppiah V, 2005, INT J IMMUNOGENET, V32, P383, DOI 10.1111/j.1744-313X.2005.00542.x; THORPE JW, 1994, J NEUROL NEUROSUR PS, V57, P491, DOI 10.1136/jnnp.57.4.491; van der Walt A, 2009, NEUROLOGY, V73, P1018, DOI 10.1212/WNL.0b013e3181b9c85e; VANDERWALT A, 2009, MULT SCLER, V15, pS151; Weatherby SJM, 2001, J NEUROL, V248, P304, DOI 10.1007/s004150170205; Wechsler D., 1981, WECHSLER ADULT INTEL; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171; Zivadinov R, 2003, J NEUROL, V250, P1099, DOI 10.1007/s00415-003-0164-7	36	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10003	10.1371/journal.pone.0010003	http://dx.doi.org/10.1371/journal.pone.0010003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368992	Green Published, gold, Green Submitted			2022-12-25	WOS:000276419900007
J	Apri, M; Molenaar, J; de Gee, M; van Voorn, G				Apri, Mochamad; Molenaar, Jaap; de Gee, Maarten; van Voorn, George			Efficient Estimation of the Robustness Region of Biological Models with Oscillatory Behavior	PLOS ONE			English	Article							NETWORK; CELLS	Robustness is an essential feature of biological systems, and any mathematical model that describes such a system should reflect this feature. Especially, persistence of oscillatory behavior is an important issue. A benchmark model for this phenomenon is the Laub-Loomis model, a nonlinear model for cAMP oscillations in Dictyostelium discoideum. This model captures the most important features of biomolecular networks oscillating at constant frequencies. Nevertheless, the robustness of its oscillatory behavior is not yet fully understood. Given a system that exhibits oscillating behavior for some set of parameters, the central question of robustness is how far the parameters may be changed, such that the qualitative behavior does not change. The determination of such a "robustness region'' in parameter space is an intricate task. If the number of parameters is high, it may be also time consuming. In the literature, several methods are proposed that partially tackle this problem. For example, some methods only detect particular bifurcations, or only find a relatively small boxshaped estimate for an irregularly shaped robustness region. Here, we present an approach that is much more general, and is especially designed to be efficient for systems with a large number of parameters. As an illustration, we apply the method first to a well understood low-dimensional system, the Rosenzweig-MacArthur model. This is a predator-prey model featuring satiation of the predator. It has only two parameters and its bifurcation diagram is available in the literature. We find a good agreement with the existing knowledge about this model. When we apply the new method to the high dimensional Laub-Loomis model, we obtain a much larger robustness region than reported earlier in the literature. This clearly demonstrates the power of our method. From the results, we conclude that the biological system underlying is much more robust than was realized until now.	[Apri, Mochamad; Molenaar, Jaap; de Gee, Maarten; van Voorn, George] Wageningen Univ, Dept Math & Stat Methods, Wageningen, Netherlands; [Apri, Mochamad; Molenaar, Jaap] Netherlands Consortium Syst Biol, Amsterdam, Netherlands	Wageningen University & Research	Apri, M (corresponding author), Wageningen Univ, Dept Math & Stat Methods, Wageningen, Netherlands.	mochamad.apri@wur.nl		Apri, Mochamad/0000-0001-7057-4323				Alon U., 2006, INTRO SYSTEMS BIOL D; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Boer MP, 2001, MATH BIOSCI, V169, P109, DOI 10.1016/S0025-5564(00)00058-4; Doedel E., 2007, CONTINUATION BIFURCA; Ghaemi R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-95; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kim J, 2006, IEE P SYST BIOL, V153, P96, DOI 10.1049/ip-syb:20050024; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KLEBANOFF A, 1994, J MATH BIOL, V32, P427, DOI 10.1007/BF00160167; Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, IMPLEMENTATION AND APPLICATION, P1, DOI 10.1002/3527603603; Kuznetsov YA, 1996, MATH BIOSCI, V134, P1, DOI 10.1016/0025-5564(95)00104-2; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Ma L, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-38; Mattheij R, 2002, ORDINARY DIFFERENTIA; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nayfeh A.H., 2004, APPL NONLINEAR DYNAM; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Torrini G, 1998, CHAOS SOLITON FRACT, V9, P121, DOI 10.1016/S0960-0779(97)00055-6; Verhulst F. F., 1996, NONLINEAR DIFFERENTI, DOI 10.1007978-3-642-61453-8; Zhou K., 1996, ROBUST OPTIMAL CONTR	21	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9865	10.1371/journal.pone.0009865	http://dx.doi.org/10.1371/journal.pone.0009865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368983	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200005
J	Ozaki, Y; Uda, S; Saito, TH; Chung, J; Kubota, H; Kuroda, S				Ozaki, Yu-ichi; Uda, Shinsuke; Saito, Takeshi H.; Chung, Jaehoon; Kubota, Hiroyuki; Kuroda, Shinya			A Quantitative Image Cytometry Technique for Time Series or Population Analyses of Signaling Networks	PLOS ONE			English	Article							NUCLEAR TRANSLOCATION; GROWTH-FACTOR; ERK; DIFFERENTIATION; ACTIVATION; DYNAMICS; KINASES; CASCADE	Background: Modeling of cellular functions on the basis of experimental observation is increasingly common in the field of cellular signaling. However, such modeling requires a large amount of quantitative data of signaling events with high spatio-temporal resolution. A novel technique which allows us to obtain such data is needed for systems biology of cellular signaling. Methodology/Principal Findings: We developed a fully automatable assay technique, termed quantitative image cytometry (QIC), which integrates a quantitative immunostaining technique and a high precision image-processing algorithm for cell identification. With the aid of an automated sample preparation system, this device can quantify protein expression, phosphorylation and localization with subcellular resolution at one-minute intervals. The signaling activities quantified by the assay system showed good correlation with, as well as comparable reproducibility to, western blot analysis. Taking advantage of the high spatio-temporal resolution, we investigated the signaling dynamics of the ERK pathway in PC12 cells. Conclusions/Significance: The QIC technique appears as a highly quantitative and versatile technique, which can be a convenient replacement for the most conventional techniques including western blot, flow cytometry and live cell imaging. Thus, the QIC technique can be a powerful tool for investigating the systems biology of cellular signaling.	[Ozaki, Yu-ichi; Uda, Shinsuke; Saito, Takeshi H.; Chung, Jaehoon; Kubota, Hiroyuki; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Kuroda, Shinya] Univ Tokyo, CREST, Japan Sci & Technol Agcy, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Ozaki, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	oza@bi.s.u-tokyo.ac.jp; skuroda@bi.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [17017005]; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by a grant in-aid for scientific research on priority areas "Systems Genomics" (17017005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and by a grant in-aid from Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SANO M, 1995, BRAIN RES, V688, P213, DOI 10.1016/0006-8993(95)00558-8; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Volmat V, 2001, J CELL SCI, V114, P3433; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	26	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9955	10.1371/journal.pone.0009955	http://dx.doi.org/10.1371/journal.pone.0009955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376360	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200031
J	Neuman, RJ; Wasson, J; Atzmon, G; Wainstein, J; Yerushalmi, Y; Cohen, J; Barzilai, N; Blech, I; Glaser, B; Permutt, MA				Neuman, Rosalind J.; Wasson, Jon; Atzmon, Gil; Wainstein, Julio; Yerushalmi, Yair; Cohen, Joseph; Barzilai, Nir; Blech, Ilana; Glaser, Benjamin; Permutt, M. Alan			Gene-Gene Interactions Lead to Higher Risk for Development of Type 2 Diabetes in an Ashkenazi Jewish Population	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTIONS; EXCEPTIONAL LONGEVITY; COMMON VARIANTS; HUMAN-DISEASES; WFS1 GENE; EPISTASIS; KCNJ11; POLYMORPHISM	Background: Evidence has accumulated that multiple genetic and environmental factors play important roles in determining susceptibility to type 2 diabetes (T2D). Although variants from candidate genes have become prime targets for genetic analysis, few studies have considered their interplay. Our goal was to evaluate interactions among SNPs within genes frequently identified as associated with T2D. Methods/Principal Findings: Logistic regression was used to study interactions among 4 SNPs, one each from HNF4A[rs1884613], TCF7L2[rs12255372], WFS1[rs10010131], and KCNJ11[rs5219] in a case-control Ashkenazi sample of 974 diabetic subjects and 896 controls. Nonparametric multifactor dimensionality reduction (MDR) and generalized MDR (GMDR) were used to confirm findings from the logistic regression analysis. HNF4A and WFS1 SNPs were associated with T2D in logistic regression analyses [P<0.0001, P<0.0002, respectively]. Interaction between these SNPs were also strong using parametric or nonparametric methods: the unadjusted odds of being affected with T2D was 3 times greater in subjects with the HNF4A and WFS1 risk alleles than those without either (95% CI = [1.7-5.3]; P <= 0.0001). Although the univariate association between the TCF7L2 SNP and T2D was relatively modest [P = 0.02], when paired with the HNF4A SNP, the OR for subjects with risk alleles in both SNPs was 2.4 [95% CI = 1.7-3.4; P <= 0.0001]. The KCNJ11 variant reached significance only when paired with either the HNF4A or WFSI SNPs: unadjusted ORs were 2.0 [95% CI = 1.4-2.8; P <= 0.0001] and 2.3 [95% CI = 1.2-4.4; P <= 0.0001], respectively. MDR and GMDR results were consistent with the parametric findings. Conclusions: These results provide evidence of strong independent associations between T2D and SNPs in HNF4A and WFS1 and their interaction in our Ashkenazi sample. We also observed an interaction in the nonparametric analysis between the HNF4A and KCNJ11 SNPs (P <= 0.001), demonstrating that an independently non-significant variant may interact with another variant resulting in an increased disease risk.	[Neuman, Rosalind J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Neuman, Rosalind J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wasson, Jon; Permutt, M. Alan] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Dept Med & Genet, Inst Aging, New York, NY USA; [Blech, Ilana; Glaser, Benjamin] Hadassah Hebrew Univ, Endocrinol & Metab Serv, Med Ctr, Jerusalem, Israel; [Wainstein, Julio] E Wolfson Med Ctr, Diabet Unit, Holon, Israel; [Yerushalmi, Yair] Clalit Hlth Org, Endocrinol Unit, Tel Aviv, Israel; [Cohen, Joseph] Macabbi Hlth Serv, Diabet Clin, Tel Aviv, Israel	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Yeshiva University; Hebrew University of Jerusalem; Hadassah University Medical Center; Clalit Health Services	Neuman, RJ (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	rneuman@wustl.edu	Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000	Israel Ministry of Health; Russell Berrie Foundation; Paul Beeson Physician Faculty Scholar in Aging Award; Ellison Medical Foundation Senior Scholar; National Institutes of Health [2R01DK49583-10A1, RO1s 18728-01A1 AG024391, AG7992, PO1 AG027734, M01-RR12248]; Diabetes Research and Training Cente [DK 20541]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR012248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK049583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024391, P01AG027734, R01AG007992] Funding Source: NIH RePORTER	Israel Ministry of Health; Russell Berrie Foundation; Paul Beeson Physician Faculty Scholar in Aging Award; Ellison Medical Foundation Senior Scholar; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Training Cente; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the chief scientist of the Israel Ministry of Health [B. G.], the Russell Berrie Foundation and D-Cure, Diabetes Care in Israel [B. G.], the Paul Beeson Physician Faculty Scholar in Aging Award, the Ellison Medical Foundation Senior Scholar Award, National Institutes of Health (NIH) 2R01DK49583-10A1 [M. A. P.], NIH RO1s 18728-01A1 AG024391, and AG7992, PO1 AG027734, Paul Beeson Physician Faculty Scholar in Aging Award, the Ellison Medical Foundation Senior Scholar Award, Glenn Award for Research in Biological Mechanisms of Aging, General Clinical Research Center [NIH M01-RR12248] and Diabetes Research and Training Center (DK 20541) [N. B.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmadi O, 2008, DIABETES-METAB RES, V24, P137, DOI 10.1002/dmrr.777; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Florez JC, 2008, DIABETOLOGIA, V51, P451, DOI 10.1007/s00125-007-0891-x; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Franks PW, 2008, DIABETOLOGIA, V51, P458, DOI 10.1007/s00125-007-0887-6; Frayling TM, 2003, DIABETES, V52, P1857, DOI 10.2337/diabetes.52.7.1857; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant RW, 2009, DIABETES CARE, V32, P1107, DOI 10.2337/dc08-2171; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hanlon P, 2006, PHYSIOL GENOMICS, V26, P46, DOI 10.1152/physiolgenomics.00247.2005; Hansen SK, 2005, J CLIN ENDOCR METAB, V90, P3629, DOI 10.1210/jc.2004-1942; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jarvis JP, 2009, J EVOLUTION BIOL, V22, P1658, DOI 10.1111/j.1420-9101.2009.01776.x; JORDE LB, 1992, GENETIC DIVERSITY AMONG JEWS, P305; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Love-Gregory L, 2003, DIABETOLOGIA, V46, P136, DOI 10.1007/s00125-002-0947-x; Mensink Marco, 2005, Metabolic Syndrome and Related Disorders, V3, P26, DOI 10.1089/met.2005.3.26; Minton JAL, 2002, DIABETES, V51, P1287, DOI 10.2337/diabetes.51.4.1287; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Pearson ER, 2007, PLOS MED, V4, P760, DOI 10.1371/journal.pmed.0040118; Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681; Qi L, 2007, DIABETIC MED, V24, P1187, DOI 10.1111/j.1464-5491.2007.02255.x; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Sparso T, 2009, DIABETOLOGIA, V52, P1308, DOI 10.1007/s00125-009-1362-3; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Wasson J, 2008, DIABETOLOGIA, V51, P391, DOI 10.1007/s00125-007-0920-9; Wasson J, 2002, BIOTECHNIQUES, V32, P1144, DOI 10.2144/02325dd04; Weedon MN, 2007, DIABETIC MED, V24, P1062, DOI 10.1111/j.1464-5491.2007.02258.x; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202	46	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9903	10.1371/journal.pone.0009903	http://dx.doi.org/10.1371/journal.pone.0009903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361036	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600009
J	Caito, S; Rajendrasozhan, S; Cook, S; Chung, S; Yao, HW; Friedman, AE; Brookes, PS; Rahman, I				Caito, Samuel; Rajendrasozhan, Saravanan; Cook, Suzanne; Chung, Sangwoon; Yao, Hongwei; Friedman, Alan E.; Brookes, Paul S.; Rahman, Irfan			SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress	FASEB JOURNAL			English	Article						sirtuins; aldehydes; epithelium; cigarette smoke inflammation	NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR EPITHELIAL-CELLS; INDUCED OXIDATIVE STRESS; FREE-RADICAL CHEMISTRY; PROTEIN-KINASE CK2; CIGARETTE-SMOKE; INFLAMMATORY RESPONSES; CYTOKINE RELEASE; GENE-EXPRESSION	Sirtuin1 (SIRT1) deacetylase levels are decreased in chronic inflammatory conditions and aging where oxidative stress occurs. We determined the mechanism of SIRT1 redox post-translational modifications leading to its degradation. Human lung epithelial cells exposed to hydrogen peroxide (150-250 mu M), aldehyde-acrolein (10-30 mu M), and cigarette smoke extract (CSE; 0.1-1.5%) in the presence of intracellular glutathione-modulating agents at 1-24 h, and oxidative post-translational modifications were assayed in cells, as well as in lungs of mice lacking and overexpressing glutaredoxin-1 (Glrx1), and wild-type (WT) mice in response to cigarette smoke (CS). CSE and aldehydes dose and time dependently decreased SIRT1 protein levels, with EC50 of 1% for CSE and 30 mu M for acrolein at 6 h, and > 80% inhibition at 24 h with CSE, which was regulated by modulation of intracellular thiol status of the cells. CS decreased the lung levels of SIRT1 in WT mice, which was enhanced by deficiency of Glrx1 and prevented by overexpression of Glrx1. Oxidants, aldehydes, and CS induced carbonyl modifications on SIRT1 on cysteine residues concomitant with decreased SIRT1 activity. Proteomics studies revealed alkylation of cysteine residue on SIRT1. Our data suggest that oxidants/aldehydes covalently modify SIRT1, decreasing enzymatic activity and marking the protein for proteasomal degradation, which has implications in inflammatory conditions.-Caito, S., Rajendrasozhan, S., Cook, S., Chung, S., Yao, H., Friedman, A. E., Brookes, P. S., Rahman, I. SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 24, 3145-3159 (2010). www.fasebj.org	[Caito, Samuel; Rajendrasozhan, Saravanan; Cook, Suzanne; Chung, Sangwoon; Yao, Hongwei; Friedman, Alan E.; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Friedman, Alan/Q-4858-2018; Yao, Hongwei/G-6444-2010; Rajendrasozhan, Saravanan/ABC-5213-2020	Friedman, Alan/0000-0002-4764-8168; Rajendrasozhan, Saravanan/0000-0002-4234-9417; Brookes, Paul/0000-0002-8639-8413	U.S. National Institutes of Health [1R01-HL092842, R01-HL085613, 1R01HL097751-01]; National Institute of Environmental Health Sciences Center [ES01247]; Toxicology Training Program [T32-ES07026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613, R01HL092842, R01HL097751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, T32ES007026] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Toxicology Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institutes of Health grants 1R01-HL092842, R01-HL085613, and 1R01HL097751-01; National Institute of Environmental Health Sciences Center grant ES01247; and Toxicology Training Program grant T32-ES07026. The authors thank Dr. Se-Ran Yang for her technical assistance. The authors also thank Dr. Ye-Shih Ho (Institute of Environmental Health Sciences and Department of Biochemistry and Molecular Biology, Wayne State University, Detroit, MI, USA) for providing Glrx1-KO and Glrx1-Tg mice. None of the authors have any ethical conflicts of interest for publication of this manuscript.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Carbone DL, 2004, FREE RADICAL BIO MED, V37, P1430, DOI 10.1016/j.freeradbiomed.2004.07.016; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; EISERICH JP, 1995, AM J CLIN NUTR, V62, P1490, DOI 10.1093/ajcn/62.6.1490S; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Fujioka K, 2006, ENVIRON TOXICOL, V21, P47, DOI 10.1002/tox.20153; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2003, PROTEOMICS, V3, P1145, DOI 10.1002/pmic.200300435; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Karrasch S, 2008, RESP MED, V102, P1215, DOI 10.1016/j.rmed.2008.04.013; Kodama M, 1997, ANTICANCER RES, V17, P433; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mulier B, 1998, EUR RESPIR J, V11, P384, DOI 10.1183/09031936.98.11020384; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V174, P997, DOI 10.1164/rccm.200605-721OC; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; Salminen A, 2008, CELL MOL LIFE SCI, V65, P1049, DOI 10.1007/s00018-008-7461-3; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P637, DOI 10.1016/S0278-6915(00)00051-X; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Tuder RM, 2006, AM J RESP CRIT CARE, V174, P490, DOI 10.1164/rccm.200607-924ED; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vogelmeier C, 2007, AM J RESP CRIT CARE, V175, P1217, DOI 10.1164/rccm.200703-513ED; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Whitekus MJ, 2002, J IMMUNOL, V168, P2560, DOI 10.4049/jimmunol.168.5.2560; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	77	224	235	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3145	3159		10.1096/fj.09-151308	http://dx.doi.org/10.1096/fj.09-151308			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20385619	Green Published			2022-12-25	WOS:000281446400005
J	Langelier, MF; Ruhl, DD; Planck, JL; Kraus, WL; Pascal, JM				Langelier, Marie-France; Ruhl, Donald D.; Planck, Jamie L.; Kraus, W. Lee; Pascal, John M.			The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME ACTIVATION; ZINC-FINGERS; BINDING; REPAIR; TRANSCRIPTION; BREAKS; RECOGNITION; INHIBITION; MODULATION; INSULATION	PARP-1 is involved in multiple cellular processes, including transcription, DNA repair, and apoptosis. PARP-1 attaches ADP-ribose units to target proteins, including itself as a post-translational modification that can change the biochemical properties of target proteins and mediate recruitment of proteins to sites of poly(ADP-ribose) synthesis. Independent of its catalytic activity, PARP-1 binds to chromatin and promotes compaction affecting RNA polymerase II transcription. PARP-1 has a modular structure composed of six independent domains. Two homologous zinc fingers, Zn1 and Zn2, form the DNA-binding module. Zn1-Zn2 binding to DNA breaks triggers catalytic activity. Recently, we have identified a third zinc binding domain in PARP-1, the Zn3 domain, which is essential for DNA-dependent PARP-1 activity. The crystal structure of the Zn3 domain revealed a novel zinc-ribbon fold and a homodimeric Zn3 structure that formed in the crystal lattice. Structure-guided mutagenesis was used here to investigate the roles of these two features of the Zn3 domain. Our results indicate that the zinc-ribbon fold of the Zn3 domain mediates an interdomain contact crucial to assembly of the DNA-activated conformation of PARP-1. In contrast, residues located at the Zn3 dimer interface are not required for DNA-dependent activation but rather make important contributions to the chromatin compaction activity of PARP-1. Thus, the Zn3 domain has dual roles in regulating the functions of PARP-1.	[Langelier, Marie-France; Planck, Jamie L.; Pascal, John M.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Ruhl, Donald D.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Jefferson University; Cornell University	Pascal, JM (corresponding author), 233 S 10th St,BLSB 804, Philadelphia, PA 19107 USA.	john.pascal@mail.jci.tju.edu			NIDDK, National Institutes of Health [DK069710]; American Cancer Society [IRG0806001, RSG0918301DMC]; Emerald Foundation, Inc.; Susan G. Komen Breast Cancer Foundation; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069710, R01DK069710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087282] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); Emerald Foundation, Inc.; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069710 from NIDDK (to W. L. K). This work was also supported by American Cancer Society Grants IRG0806001 and RSG0918301DMC, The Emerald Foundation, Inc. (to J.M.P.), and The Susan G. Komen Breast Cancer Foundation (to D. D. R.).; Recipient of postdoctoral fellowships from the Canadian Institutes of Health Research.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gamble MJ, 2007, CELL, V128, P433, DOI 10.1016/j.cell.2007.01.017; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Mendoza-Alvarez H, 1999, BIOCHEMISTRY-US, V38, P3948, DOI 10.1021/bi982148p; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Trucco C, 1996, FEBS LETT, V399, P313, DOI 10.1016/S0014-5793(96)01347-6; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhang J, 1997, METHOD ENZYMOL, V280, P255	39	119	124	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18877	18887		10.1074/jbc.M110.105668	http://dx.doi.org/10.1074/jbc.M110.105668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388712	Green Published, hybrid			2022-12-25	WOS:000278453900078
J	Coultrap, SJ; Buard, I; Kulbe, JR; Dell'Acqua, ML; Bayer, KU				Coultrap, Steven J.; Buard, Isabelle; Kulbe, Jaqueline R.; Dell'Acqua, Mark L.; Bayer, K. Ulrich			CaMKII Autonomy Is Substrate-dependent and Further Stimulated by Ca2+/Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; CALMODULIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; ACTIVATION; DOMAIN; AUTOREGULATION; ASSOCIATION; CONDUCTANCE	A hallmark feature of Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) regulation is the generation of Ca2+-independent autonomous activity by Thr-286 autophosphorylation. CaMKII autonomy has been regarded a form of molecular memory and is indeed important in neuronal plasticity and learning/memory. Thr-286-phosphorylated CaMKII is thought to be essentially fully active (similar to 70-100%), implicating that it is no longer regulated and that its dramatically increased Ca2+/CaM affinity is of minor functional importance. However, this study shows that autonomy greater than 15-25% was the exception, not the rule, and required a special mechanism (T-site binding; by the T-substrates AC2 or NR2B). Autonomous activity toward regular R-substrates (including tyrosine hydroxylase and GluR1) was significantly further stimulated by Ca2+/CaM, both in vitro and within cells. Altered K-m and V-max made autonomy also substrate- (and ATP) concentration-dependent, but only over a narrow range, with remarkable stability at physiological concentrations. Such regulation still allows molecular memory of previous Ca2+ signals, but prevents complete uncoupling from subsequent cellular stimulation.	[Coultrap, Steven J.; Buard, Isabelle; Kulbe, Jaqueline R.; Dell'Acqua, Mark L.; Bayer, K. Ulrich] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bayer, KU (corresponding author), Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu		Kulbe, Jacqueline/0000-0002-7070-9264; Dell'Acqua, Mark/0000-0003-3798-3461	National Institutes of Health [P30NS048154, R01NS040701, R01NS052644]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701, R01NS052644, P30NS048154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30NS048154 (UCD Center Grant), R01NS040701 (to M. L. D.), and R01NS052644 (to K. U. B.).	Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bobrovskaya L, 2004, J NEUROCHEM, V90, P857, DOI 10.1111/j.1471-4159.2004.02550.x; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; DE KP, 1998, SCIENCE, V279, P227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	38	72	73	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17930	17937		10.1074/jbc.M109.069351	http://dx.doi.org/10.1074/jbc.M109.069351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353941	Green Published, hybrid			2022-12-25	WOS:000278133400069
J	Dweck, D; Reynaldo, DP; Pinto, JR; Potter, JD				Dweck, David; Reynaldo, Daniel P.; Pinto, Jose R.; Potter, James D.			A Dilated Cardiomyopathy Troponin C Mutation Lowers Contractile Force by Reducing Strong Myosin-Actin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN; CALCIUM REGULATION; G159D MUTATION; CROSS-BRIDGES; T MUTATIONS; CA2+; SUBFRAGMENT-1; AFFINITY; SITES	In this study we explore the mechanisms by which a double mutation (E59D/D75Y) in cardiac troponin C (CTnC) associated with dilated cardiomyopathy reduces the Ca2+-activated maximal tension of cardiac muscle. Studying the single mutants (i.e. E59D or D75Y) indicates that D75Y, but not E59D, causes a reduction in the calcium affinity of CTnC in troponin complex, regulated thin filaments (RTF), and the Ca2+ sensitivity of contraction and ATPase in cardiac muscle preparations. However, both D75Y and E59D are required to reduce the actomyosin ATPase activity and maximal force in muscle fibers, indicating that E59D enhances the effects of D75Y. Part of the reduction in force/ATPase may be due to a defect in the interactions between CTnC and cardiac troponin T, which are known to be necessary for ATPase activation. An additional mechanism for the reduction in force/ATPase comes from measurements of the binding stoichiometry of myosin subfragment-1 (S-1) to the RTF. Using wild type RTFs, 4.8 mol S-1 was bound per mol filament (seven actins), whereas with E59D/D75Y RTFs, the number of binding sites was reduced by similar to 23% to 3.7. Altogether, these results suggest that the reduction in force and ATPase activation is possibly due to a thin filament conformation that promotes fewer accessible S-1-binding sites. In the absence of any family segregation data, the functional results presented here support the concept that this is likely a dilated cardiomyopathy-causing mutation.	[Dweck, David; Reynaldo, Daniel P.; Pinto, Jose R.; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave R-189, Miami, FL 33136 USA.	jdpotter@miami.edu	Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976; Pereira Reynaldo, Daniel/0000-0003-2531-2097	National Institutes of Health [HL042325]; American Heart Association [AHA 0315164B, AHA 0825368E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL042325 (to J. D. P.).; Supported by American Heart Association Grant AHA 0315164B.; Supported by American Heart Association Grant AHA 0825368E.	Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; BOREJDO J, 1980, BIOCHEMISTRY-US, V19, P4913, DOI 10.1021/bi00562a033; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; GUTH K, 1987, J BIOL CHEM, V262, P13627; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; INGRAHAM RH, 1984, J BIOL CHEM, V259, P9544; Jain M, 1998, CIRCULATION, V98, P179; Kaski JP, 2007, CARDIOL YOUNG, V17, P675, DOI 10.1017/S1047951107001291; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Margossian SS, 1999, MOL CELL BIOCHEM, V194, P301, DOI 10.1023/A:1006980405359; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Wang Y, 2002, J APPL PHYSIOL, V92, P2409, DOI 10.1152/japplphysiol.00376.2001; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	30	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17371	17379		10.1074/jbc.M109.064105	http://dx.doi.org/10.1074/jbc.M109.064105			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371872	Green Published, hybrid			2022-12-25	WOS:000278133400014
J	Hassinen, A; Rivinoja, A; Kauppila, A; Kellokumpu, S				Hassinen, Antti; Rivinoja, Antti; Kauppila, Annika; Kellokumpu, Sakari			Golgi N-Glycosyltransferases Form Both Homo- and Heterodimeric Enzyme Complexes in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PATHWAY; KIN RECOGNITION; MEDIAL-GOLGI; GLYCOSYLATION; LOCALIZATION; ORGANIZATION; APPARATUS; PH; GALACTOSYLTRANSFERASE; MISLOCALIZATION	Glycans (i.e. oligosaccharide chains attached to cellular proteins and lipids) are crucial for nearly all aspects of life, including the development of multicellular organisms. They come in multiple forms, and much of this diversity between molecules, cells, and tissues is generated by Golgi-resident glycosidases and glycosyltransferases. However, their exact mode of functioning in glycan processing is currently unclear. Here we investigate the supramolecular organization of the N-glycosylation pathway in live cells by utilizing the bimolecular fluorescence complementation approach. We show that all four N-glycosylation enzymes tested (beta-1,2-N-acetylglucosaminyltransferase I, beta-1,2-N-acetylglucosaminyltransferase II, 1,4-galactosyltransferaseI,and alpha-2,6-sialyltransferaseI)form Golgi-localizedhomodimers. Intriguingly, the same enzymes also formed two distinct and functionally relevant heterodimers between the medial Golgi enzymes beta-1,2-N-acetylglucosaminyltransferase I and beta-1,2-N-acetylglucosaminyltransferase II and the trans-Golgi enzymes 1,4-galactosyltransferase I and alpha-2,6-sialyltransferase I. Given their strict Golgi localization and sequential order of function, the two heterodimeric complexes are probably responsible for the processing and maturation of N-glycans in live cells.	[Kellokumpu, Sakari] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; Glycosci Grad Sch Finland, FIN-90014 Oulu, Finland	Finland National Institute for Health & Welfare; University of Oulu	Kellokumpu, S (corresponding author), Univ Oulu, Dept Biochem, POB 3000,Door J,Rm MN 212-1, FIN-90014 Oulu, Finland.	sakari.kellokumpu@oulu.fi		Hassinen, Antti/0000-0001-9491-2868	Academy of Finland; University of Oulu; Finnish Glycoscience Graduate School	Academy of Finland(Academy of Finland); University of Oulu; Finnish Glycoscience Graduate School	This work was supported by grants from the Academy of Finland, the University of Oulu, and the Finnish Glycoscience Graduate School.	Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Chen C, 2000, J BIOL CHEM, V275, P13819, DOI 10.1074/jbc.275.18.13819; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; DUNPHY WG, 1981, P NATL ACAD SCI-BIOL, V78, P7453, DOI 10.1073/pnas.78.12.7453; FARQUHAR MG, 1981, J CELL BIOL, V91, pS77, DOI 10.1083/jcb.91.3.77s; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Freeze HH, 2001, GLYCOBIOLOGY, V11, p37G; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gleeson PA, 1998, HISTOCHEM CELL BIOL, V109, P517, DOI 10.1007/s004180050252; Glick BS, 2000, CURR OPIN CELL BIOL, V12, P450, DOI 10.1016/S0955-0674(00)00116-2; Grunewald S, 2002, PEDIATR RES, V52, P618, DOI 10.1203/01.PDR.0000031921.02259.35; Holappa K, 2001, J HISTOCHEM CYTOCHEM, V49, P259, DOI 10.1177/002215540104900213; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; Noffz C, 2009, GLYCOBIOLOGY, V19, P472, DOI 10.1093/glycob/cwp001; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; TEASDALE RD, 1994, GLYCOBIOLOGY, V4, P917, DOI 10.1093/glycob/4.6.917; Ungar D, 2009, SEMIN CELL DEV BIOL, V20, P762, DOI 10.1016/j.semcdb.2009.03.004; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; Yang W, 1997, CELL BIOL INT, V21, P223, DOI 10.1006/cbir.1997.0138; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5	50	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17771	17777		10.1074/jbc.M110.103184	http://dx.doi.org/10.1074/jbc.M110.103184			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378551	hybrid, Green Published			2022-12-25	WOS:000278133400055
J	Palaima, E; Leymarie, N; Stroud, D; Mizanur, RM; Hodgkin, J; Gravato-Nobre, MJ; Costello, CE; Cipollo, JF				Palaima, Elizabeth; Leymarie, Nancy; Stroud, Dave; Mizanur, Rahman M.; Hodgkin, Jonathan; Gravato-Nobre, Maria J.; Costello, Catherine E.; Cipollo, John F.			The Caenorhabditis elegans bus-2 Mutant Reveals a New Class of O-Glycans Affecting Bacterial Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN; TOXIN; ATTACHMENT; DIVERSITY; INFECTION; ANTIGENS; FEATURES; BINDING; GENES	Microbacterium nematophilum causes a deleterious infection of the C. elegans hindgut initiated by adhesion to rectal and anal cuticle. C. elegans bus-2 mutants, which are resistant to M. nematophilum and also to the formation of surface biofilms by Yersinia sp., carry genetic lesions in a putative glycosyltransferase containing conserved domains of core-1 beta 1,3-galactosyltransferases. bus-2 is predicted to act in the synthesis of core-1 type O-glycans. This observation implies that the infection requires the presence of host core-1 O-glycoconjugates and is therefore carbohydrate-dependent. Chemical analysis reported here reveals that bus-2 is indeed deficient in core-1 O-glycans. These mutants also exhibit a new subclass of O-glycans whose structures were determined by high performance tandem mass spectrometry; these are highly fucosylated and have a novel core that contains internally linked GlcA. Lectin studies showed that core-1 glycans and this novel class of O-glycans are both expressed in the tissue that is infected in the wild type worms. In worms having the bus-2 genetic background, core-1 glycans are decreased, whereas the novel fucosyl O-glycans are increased in abundance in this region. Expression analysis using a red fluorescent protein marker showed that bus-2 is expressed in the posterior gut, cuticle seam cells, and spermatheca, the first two of which are likely to be involved in secreting the carbohydrate-rich surface coat of the cuticle. Therefore, in the bus-2 background of reduced core-1 O-glycans, the novel fucosyl glycans likely replace or mask remaining core-1 ligands, leading to the resistance phenotype. There are more than 35 Microbacterium species, some of which are pathogenic in man. This study is the first to analyze the biochemistry of adhesion to a host tissue by a Microbacterium species.	[Mizanur, Rahman M.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Palaima, Elizabeth; Leymarie, Nancy; Costello, Catherine E.; Cipollo, John F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Palaima, Elizabeth; Leymarie, Nancy; Costello, Catherine E.; Cipollo, John F.] Boston Univ, Sch Med, Dept Mol Med, Boston, MA 02118 USA; [Stroud, Dave; Hodgkin, Jonathan; Gravato-Nobre, Maria J.] Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	US Food & Drug Administration (FDA); Boston University; Boston University; University of Oxford	Cipollo, JF (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bldg 29,Rm 126,8800 Rockville Pike, Bethesda, MD 20892 USA.	john.cipollo@fda.hhs.gov		Gravato-Nobre, Maria Joao/0000-0002-8032-2565; Costello, Catherine/0000-0003-1594-5122	National Institutes of Health [P41RR010888, S10RR015942, S10RR020946]; Medical Research Council (United Kingdom) [G0600238]; Medical Research Council [G0600238] Funding Source: researchfish; MRC [G0600238] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020946, P41RR010888, S10RR015942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR010888 and S10RR015942 (to C. E. C.) and S10RR020946 (to J. Zaia). This work was also supported by Medical Research Council (United Kingdom) Grant G0600238 (to J. H.).	Barrows BD, 2007, J BIOL CHEM, V282, P3302, DOI 10.1074/jbc.M606621200; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BORGONIE G, 1994, HISTOCHEMISTRY, V101, P379, DOI 10.1007/BF00269000; BRENNER S, 1974, GENETICS, V77, P71; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; CHUNGJATUPORNCHAI W, 1988, EUR J BIOCHEM, V173, P9, DOI 10.1111/j.1432-1033.1988.tb13960.x; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; Costello CE, 2007, J AM SOC MASS SPECTR, V18, P1799, DOI 10.1016/j.jasms.2007.07.016; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Gneiding K, 2008, J CLIN MICROBIOL, V46, P3646, DOI 10.1128/JCM.01202-08; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; KAMERLING JP, 1975, BIOCHEM J, V151, P491, DOI 10.1042/bj1510491; Ko FC, 2000, DEV GROWTH DIFFER, V42, P69, DOI 10.1046/j.1440-169x.2000.00487.x; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; LINK CD, 1992, GENETICS, V131, P867; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Rajamohan F, 1998, PROG NUCLEIC ACID RE, V60, P1, DOI 10.1016/S0079-6603(08)60887-9; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087	37	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17662	17672		10.1074/jbc.M109.065433	http://dx.doi.org/10.1074/jbc.M109.065433			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385555	hybrid, Green Published			2022-12-25	WOS:000278133400044
J	Bal, NC; Sharon, A; Gupta, SC; Jena, N; Shaikh, S; Gyorke, S; Periasamy, M				Bal, Naresh C.; Sharon, Ashoke; Gupta, Subash C.; Jena, Nivedita; Shaikh, Sana; Gyorke, Sandor; Periasamy, Muthu			The Catecholaminergic Polymorphic Ventricular Tachycardia Mutation R33Q Disrupts the N-terminal Structural Motif That Regulates Reversible Calsequestrin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC CALSEQUESTRIN; CALCIUM-RELEASE CHANNEL; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; RYANODINE RECEPTOR; CA2+ REGULATION; LUMINAL CA2+; PROTEIN; MECHANISM; ARRHYTHMIAS	Calsequestrin undergoes dynamic polymerization with increasing calcium concentration by front-to-front dimerization and back-to-back packing, forming wire-shaped structures. A recent finding that point mutation R33Q leads to lethal catecholaminergic polymorphic ventricular tachycardia (CPVT) implies a crucial role for the N terminus. In this study, we demonstrate that this mutation resides in a highly conserved alternately charged residue cluster (DGKDR; cluster 1) in the N-terminal end of calsequestrin. We further show that this cluster configures itself as a ring system and that the dipolar arrangement within the cluster brings about a critical conformational flip of Lys(31)-Asp(32) essential for dimer stabilization by formation of a H-bond network. We additionally show that Ca2+-induced calsequestrin aggregation is nonlinear and reversible and can regain the native conformation by Ca2+ chelation with EGTA. This study suggests that cluster 1 works as a molecular switch and governs the bidirectional transition between the CASQ2 monomer and dimer. We further demonstrate that mutations disrupting the alternating charge pattern of the cluster, including R33Q, impair Ca2+-CASQ2 interaction, leading to altered polymerization-depolymerization dynamics. This study provides new mechanistic insight into the functional effects of the R33Q mutation and its potential role in CPVT.	[Bal, Naresh C.; Gupta, Subash C.; Jena, Nivedita; Shaikh, Sana; Gyorke, Sandor; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bal, Naresh C.; Gupta, Subash C.; Jena, Nivedita; Shaikh, Sana; Gyorke, Sandor; Periasamy, Muthu] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Sharon, Ashoke] Birla Inst Technol, Dept Appl Chem, Ranchi 835215, Jharkhand, India; [Sharon, Ashoke] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi 835215, Jharkhand, India	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Birla Institute of Technology Mesra; Birla Institute of Technology Mesra	Periasamy, M (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Gupta, Subash/AAF-2563-2019; Jena, Nivedita/F-4945-2012; Sharon, Ashoke/GYU-7600-2022; Sharon, Ashoke/C-3916-2009	Gupta, Subash/0000-0002-0418-1940; Sharon, Ashoke/0000-0001-5738-1607; Sharon, Ashoke/0000-0001-5738-1607; Periasamy, Muthu/0000-0001-8834-5975	National Institutes of Health [R01 HL64014]; Department of Science and Technology, Government of India	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL64014 (to M. P.). This work was also supported by a Fund for Improvement of Science and Technology Infrastructure grant from the Department of Science and Technology, Government of India (to A. S.).	Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Bers DM, 1997, BASIC RES CARDIOL, V92, P1, DOI 10.1007/BF00794062; Blayney LM, 2009, PHARMACOL THERAPEUT, V123, P151, DOI 10.1016/j.pharmthera.2009.03.006; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Franzini-Armstrong C, 2009, APPL PHYSIOL NUTR ME, V34, P323, DOI 10.1139/H09-017; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Kalyanasundaram A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.053892; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Liu N, 2008, CARDIOVASC RES, V77, P293, DOI 10.1093/cvr/cvm004; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; MacLennan D., 1983, CALCIUM CELL FUNCT, V4, P151; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MAURER A, 1985, P NATL ACAD SCI USA, V82, P4036, DOI 10.1073/pnas.82.12.4036; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Pape PC, 2007, J PHYSIOL-LONDON, V581, P319, DOI 10.1113/jphysiol.2006.126474; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Qin J, 2008, J GEN PHYSIOL, V131, P325, DOI 10.1085/jgp.200709907; Renken C, 2009, J STRUCT BIOL, V165, P53, DOI 10.1016/j.jsb.2008.09.011; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; Rizzi N, 2008, CIRC RES, V103, P298, DOI 10.1161/CIRCRESAHA.108.171660; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Scheinman MM, 2006, ANNU REV MED, V57, P473, DOI 10.1146/annurev.med.57.081704.090151; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; SLUPSKY JR, 1987, BIOCHEMISTRY-US, V26, P6539, DOI 10.1021/bi00394a038; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; Valle G, 2008, BIOCHEM J, V413, P291, DOI 10.1042/BJ20080163; Wagenknecht T, 2002, BIOPHYS J, V83, P2491, DOI 10.1016/S0006-3495(02)75260-0; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; WILLIAMS RW, 1986, J BIOL CHEM, V261, P2408	42	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17188	17196		10.1074/jbc.M109.096354	http://dx.doi.org/10.1074/jbc.M109.096354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353949	hybrid, Green Published			2022-12-25	WOS:000277982600081
J	Barry, C; Key, T; Haddad, R; Duncan, R				Barry, Christopher; Key, Tim; Haddad, Rami; Duncan, Roy			Features of a Spatially Constrained Cystine Loop in the p10 FAST Protein Ectodomain Define a New Class of Viral Fusion Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOMATITIS-VIRUS GLYCOPROTEIN; SMALL TRANSMEMBRANE PROTEIN; CELL-CELL FUSION; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL-CHANGE; DISULFIDE-ISOMERASE; SYNCYTIUM FORMATION; MUTATIONAL ANALYSIS	The reovirus fusion-associated small transmembrane (FAST) proteins are the smallest known viral membrane fusion proteins. With ectodomains of only similar to 20-40 residues, it is unclear how such diminutive fusion proteins can mediate cell-cell fusion and syncytium formation. Contained within the 40-residue ectodomain of the p10 FAST protein resides an 11-residue sequence of moderately apolar residues, termed the hydrophobic patch (HP). Previous studies indicate the p10 HP shares operational features with the fusion peptide motifs found within the enveloped virus membrane fusion proteins. Using biotinylation assays, we now report that two highly conserved cysteine residues flanking the p10 HP form an essential intramolecular disulfide bond to create a cystine loop. Mutagenic analyses revealed that both formation of the cystine loop and p10 membrane fusion activity are highly sensitive to changes in the size and spatial arrangement of amino acids within the loop. The p10 cystine loop may therefore function as a cystine noose, where fusion peptide activity is dependent on structural constraints within the noose that force solvent exposure of key hydrophobic residues. Moreover, inhibitors of cell surface thioreductase activity indicate that disruption of the disulfide bridge is important for p10-mediated membrane fusion. This is the first example of a viral fusion peptide composed of a small, spatially constrained cystine loop whose function is dependent on altered loop formation, and it suggests the p10 cystine loop represents a new class of viral fusion peptides.	[Barry, Christopher; Key, Tim; Haddad, Rami; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 1X5, Canada	Dalhousie University; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,Tupper Med Bldg,Rm 7S-1, Halifax, NS B3H 1X5, Canada.	roy.duncan@dal.ca	Barry, Christopher/G-5843-2015	Barry, Christopher/0000-0002-5413-5918; Duncan, Roy/0000-0002-5162-5081	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported in part by a grant from the Canadian Institutes of Health Research (to R.D.).	Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Balliet JW, 2000, J VIROL, V74, P3731, DOI 10.1128/JVI.74.8.3731-3739.2000; Barry C, 2009, J VIROL, V83, P12185, DOI 10.1128/JVI.01667-09; Cheng LTT, 2005, J VIROL, V79, P1853, DOI 10.1128/JVI.79.3.1853-1860.2005; Cheng SF, 2004, EUR J BIOCHEM, V271, P4725, DOI 10.1111/j.1432-1033.2004.04436.x; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Clancy EK, 2010, VIROLOGY, V397, P119, DOI 10.1016/j.virol.2009.10.039; Clancy EK, 2009, J VIROL, V83, P2941, DOI 10.1128/JVI.01869-08; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2005, J VIROL, V79, P6216, DOI 10.1128/JVI.79.10.6216-6226.2005; Delos SE, 2000, J VIROL, V74, P9738, DOI 10.1128/JVI.74.20.9738-9741.2000; Delos SE, 2000, J VIROL, V74, P1686, DOI 10.1128/JVI.74.4.1686-1693.2000; Dowling W, 2000, J VIROL, V74, P6368, DOI 10.1128/JVI.74.14.6368-6376.2000; Duncan R, 2004, VIROLOGY, V319, P131, DOI 10.1016/j.virol.2003.10.025; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; FALCONER MM, 1995, J VIROL, V69, P5582, DOI 10.1128/JVI.69.9.5582-5591.1995; FEENER EP, 1990, J BIOL CHEM, V265, P18780; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GOLDENBERG DP, 1993, BIOCHEMISTRY-US, V32, P2835, DOI 10.1021/bi00062a015; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; JANES RW, 1994, NAT STRUCT BIOL, V1, P311, DOI 10.1038/nsb0594-311; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; LAPTHORN AJ, 1995, NAT STRUCT BIOL, V2, P266, DOI 10.1038/nsb0495-266; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Martin FL, 2008, REV CARDIOVASC MED, V9, P39; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mou YL, 1998, J IMMUNOL, V161, P6323; Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466; Putz MM, 2003, EUR J BIOCHEM, V270, P1515, DOI 10.1046/j.1432-1033.2003.03517.x; Racine T, 2007, J BIOL CHEM, V282, P25613, DOI 10.1074/jbc.M703708200; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Reichert J, 2007, EUR BIOPHYS J BIOPHY, V36, P405, DOI 10.1007/s00249-006-0106-2; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000016; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Shmulevitz M, 2004, J VIROL, V78, P5996, DOI 10.1128/JVI.78.11.5996-6004.2004; Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004; Shmulevitz M, 2003, J VIROL, V77, P9769, DOI 10.1128/JVI.77.18.9769-9779.2003; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0; Sugawara M, 2002, J PEPT RES, V60, P271, DOI 10.1034/j.1399-3011.2002.21027.x; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Top D, 2005, EMBO J, V24, P2980, DOI 10.1038/sj.emboj.7600767; Top D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000331; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]	64	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16424	16433		10.1074/jbc.M110.118232	http://dx.doi.org/10.1074/jbc.M110.118232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363742	hybrid, Green Published			2022-12-25	WOS:000277982600004
J	Barton, ER				Barton, Elisabeth R.			Restoration of gamma-Sarcoglycan Localization and Mechanical Signal Transduction Are Independent in Murine Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; PROTEIN REFERENCE DATABASE; MEDIATED GENE-TRANSFER; MUSCULAR-DYSTROPHY; DEFICIENT MICE; EXPRESSION; IDENTIFICATION; RESCUE; SYSTEM	Limb girdle muscular dystrophy 2C is caused by mutations in the gamma-sarcoglycan gene (gsg) that results in loss of this protein, and disruption of the sarcoglycan (SG) complex. Signal transduction after mechanical perturbation is mediated, in part, through the SG complex and leads to phosphorylation of tyrosines on the intracellular portions of the sarcoglycans. This study tested if the Tyr(6) in the intracellular region of gamma-sarcoglycan protein (gamma-SG) was necessary for proper localization of the protein in skeletal muscle membranes or for the normal pattern of ERK1/2 phosphorylation after eccentric contractions. Viral mediated gene transfer of wild type gsg (WTgsg) and mutant gsg lacking Tyr(6) (Y6Agsg) was performed into the muscles of gsg(-/-) mice. Muscles were examined for production and stability of the gamma-SG, as well as the level of ERK1/2 phosphorylation before and after eccentric contraction. Sarcolemmal localization of gamma-SG was achieved regardless of which construct was expressed. However, only expression of WTgsg corrected the aberrant ERK1/2 phosphorylation associated with the absence of gamma-SG, whereas Y6Agsg failed to have any effect. This study shows that localization of gamma-SG does not require Tyr(6), but localization alone is insufficient for restoration of normal signal transduction patterns after mechanical perturbation.	[Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Barton, ER (corresponding author), 240 S 40th St,441A Levy Bldg, Philadelphia, PA 19104 USA.	erbarton@dental.upenn.edu			American Heart Association [0235157N]; Paul Wellstone Muscular Dystrophy Cooperative Research Center [U54 AR052646]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Paul Wellstone Muscular Dystrophy Cooperative Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by American Heart Association Grant 0235157N and the Paul Wellstone Muscular Dystrophy Cooperative Research Center (U54 AR052646).	Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234; Anastasi G, 2003, CELLS TISSUES ORGANS, V175, P151, DOI 10.1159/000074631; Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Aronson D, 1997, J CLIN INVEST, V99, P1251, DOI 10.1172/JCI119282; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Bonnemann Carsten G, 2002, Semin Pediatr Neurol, V9, P81, DOI 10.1053/spen.2002.33795; Carlson CJ, 2001, J APPL PHYSIOL, V91, P2079, DOI 10.1152/jappl.2001.91.5.2079; Chamberlain JS, 2002, HUM MOL GENET, V11, P2355, DOI 10.1093/hmg/11.20.2355; Cordier L, 2000, MOL THER, V1, P119, DOI 10.1006/mthe.1999.0019; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hack AA, 1999, P NATL ACAD SCI USA, V96, P10723, DOI 10.1073/pnas.96.19.10723; Hayashi T, 1999, AM J PHYSIOL-CELL PH, V277, pC701, DOI 10.1152/ajpcell.1999.277.4.C701; Herzog Roland W, 2004, Methods Mol Biol, V246, P179; Heydemann A, 2005, NEUROMUSCULAR DISORD, V15, P601, DOI 10.1016/j.nmd.2005.05.004; Holt KH, 1998, J BIOL CHEM, V273, P34667, DOI 10.1074/jbc.273.52.34667; Holt KH, 1998, MOL CELL, V1, P841, DOI 10.1016/S1097-2765(00)80083-0; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Kefi M, 2003, NEUROMUSCULAR DISORD, V13, P779, DOI 10.1016/S0960-8966(03)00136-6; KESHAVA, 2009, NUCLEIC ACIDS RES, V37, pD767; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; LI Z, 1993, DEVELOPMENT, V117, P947; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Wagner KR, 2002, NEUROL CLIN, V20, P645, DOI 10.1016/S0733-8619(02)00002-6; Wang P, 2002, BIOCHEMISTRY-US, V41, P6202, DOI 10.1021/bi025591f; Yoshida T, 1998, J BIOL CHEM, V273, P1583, DOI 10.1074/jbc.273.3.1583; Zhu XL, 2001, J BIOL CHEM, V276, P21785, DOI 10.1074/jbc.M101877200	34	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17263	17270		10.1074/jbc.M109.063990	http://dx.doi.org/10.1074/jbc.M109.063990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371873	Green Published, hybrid			2022-12-25	WOS:000277982600088
J	Athanasiadou, R; de Sousa, D; Myant, K; Merusi, C; Stancheva, I; Bird, A				Athanasiadou, Rodoniki; de Sousa, Dina; Myant, Kevin; Merusi, Cara; Stancheva, Irina; Bird, Adrian			Targeting of De Novo DNA Methylation Throughout the Oct-4 Gene Regulatory Region in Differentiating Embryonic Stem Cells	PLOS ONE			English	Article							METHYLTRANSFERASES DNMT3A; CPG ISLAND; MAINTENANCE; EXPRESSION; PROMOTER; BINDING; TRANSCRIPTION; LYSINE-9; SITES; LSH	Differentiation of embryonic stem (ES) cells is accompanied by silencing of the Oct-4 gene and de novo DNA methylation of its regulatory region. Previous studies have focused on the requirements for promoter region methylation. We therefore undertook to analyse the progression of DNA methylation of the similar to 2000 base pair regulatory region of Oct-4 in ES cells that are wildtype or deficient for key proteins. We find that de novo methylation is initially seeded at two discrete sites, the proximal enhancer and distal promoter, spreading later to neighboring regions, including the remainder of the promoter. De novo methyltransferases Dnmt3a and Dnmt3b cooperate in the initial targeted stage of de novo methylation. Efficient completion of the pattern requires Dnmt3a and Dnmt1, but not Dnmt3b. Methylation of the Oct-4 promoter depends on the histone H3 lysine 9 methyltransferase G9a, as shown previously, but CpG methylation throughout most of the regulatory region accumulates even in the absence of G9a. Analysis of the Oct-4 regulatory domain as a whole has allowed us to detect targeted de novo methylation and to refine our understanding the roles of key protein components in this process.	[Athanasiadou, Rodoniki; de Sousa, Dina; Myant, Kevin; Merusi, Cara; Stancheva, Irina; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Athanasiadou, R (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Mol Genet, New York, NY 10033 USA.	A.Bird@ed.ac.uk	Stancheva, Irina/B-4461-2014	Stancheva, Irina/0000-0002-5127-5245; myant, kevin/0000-0001-8017-1093; Bird, Adrian/0000-0002-8600-0372	The Wellcome Trust [077224]; Darwin Trust Scholarship [C7215/A8983, C7215/A4399]; Cancer Research UK [8983] Funding Source: researchfish	The Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust Scholarship; Cancer Research UK(Cancer Research UK)	This work was supported by The Wellcome Trust (http://www.wellcome.ac.uk,grant number: 077224) and Cancer Research-UK (http://www.cancerresearchuk.org, grant numbers: C7215/A8983 and C7215/A4399). R. A. was supported by a Darwin Trust Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; GALLAIS R, 2007, MOL ENDOCRINOLOGY ME, P2006; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Sakamoto H, 2007, GENES CELLS, V12, P1123, DOI 10.1111/j.1365-2443.2007.01120.x; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Xi SC, 2009, STEM CELLS, V27, P2691, DOI 10.1002/stem.183; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	51	48	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9937	10.1371/journal.pone.0009937	http://dx.doi.org/10.1371/journal.pone.0009937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376339	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200014
J	Ding, SZ; Fischer, W; Kaparakis-Liaskos, M; Liechti, G; Merrell, DS; Grant, PA; Ferrero, RL; Crowe, SE; Haas, R; Hatakeyama, M; Goldberg, JB				Ding, Song-Ze; Fischer, Wolfgang; Kaparakis-Liaskos, Maria; Liechti, George; Merrell, D. Scott; Grant, Patrick A.; Ferrero, Richard L.; Crowe, Sheila E.; Haas, Rainer; Hatakeyama, Masanori; Goldberg, Joanna B.			Helicobacter pylori-Induced Histone Modification, Associated Gene Expression in Gastric Epithelial Cells, and Its Implication in Pathogenesis	PLOS ONE			English	Article							CAG PATHOGENICITY ISLAND; NF-KAPPA-B; VACUOLATING CYTOTOXIN; BETA-CATENIN; HOST-CELL; C-MET; PHOSPHORYLATION; ACTIVATION; RECEPTOR; INDUCTION	Histone modifications are critical in regulating gene expression, cell cycle, cell proliferation, and development. Relatively few studies have investigated whether Helicobacter pylori, the major cause of human gastric diseases, affects histone modification. We therefore investigated the effects of H. pylori infection on histone modifications in a global and promoter-specific manner in gastric epithelial cells. Infection of gastric epithelial cells by wild-type H. pylori induced time- and dose-dependent dephosphorylation of histone H3 at serine 10 (H3 Ser10) and decreased acetylation of H3 lysine 23, but had no effects on seven other specific modifications. Different cag pathogenicity island (PAI)-containing-clinical isolates showed similar abilities to induce H3 Ser10 dephosphorylation. Mutation of cagA, vacA, nonphosphorylateable CagA mutant cagA(EPISA), or disruption of the flagella showed no effects, while deletion of the entire cagPAI restored the H3 Ser10 phosphorylation to control levels. Analysis of 27 cagPAI mutants indicated that the genes that caused H3 Ser10 dephosphorylation were similar to those that were previously found to induce interleukin-8, irrespective of CagA translocation. This effect was independent of ERK or p38 pathways and type I interferon signaling. Additionally, c-Jun and hsp70 gene expression was associated with this histone modification. These results demonstrate that H. pylori alters histone modification and host response via a cagA-, vacA-independent, but cagPAI-dependent mechanisms, which contribute to its persistent infection and pathogenesis.	[Ding, Song-Ze; Liechti, George; Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22903 USA; [Fischer, Wolfgang; Haas, Rainer] Max Von Pettenkofer Inst, D-8000 Munich, Germany; [Fischer, Wolfgang; Haas, Rainer] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Kaparakis-Liaskos, Maria; Ferrero, Richard L.] Monash Inst Med Res, Ctr Innate Immunity & Infect Dis, Clayton, Vic, Australia; [Merrell, D. Scott] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Grant, Patrick A.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Crowe, Sheila E.] Univ Virginia Hlth Syst, Dept Med, Div Gastroenterol & Hepatol, Charlottesville, VA USA; [Ding, Song-Ze; Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido, Japan	University of Virginia; University of Munich; University of Munich; Monash University; Uniformed Services University of the Health Sciences - USA; University of Virginia; University of Virginia; Hokkaido University	Ding, SZ (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22903 USA.	jbg2b@virginia.edu	Kaparakis-Liaskos, Maria/I-6511-2013; Liechti, George/C-3129-2015; Kaparakis-Liaskos, Maria/R-9321-2019; Ferrero, Richard/U-1332-2017	Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Liechti, George/0000-0003-3028-8474; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Ferrero, Richard/0000-0001-6817-6211	NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051291, R01AI065529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK061769] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009109, 5T32 CA 009109] Funding Source: Medline; NIAID NIH HHS [R01 AI065529-05, R01-AI51291, R01 AI065529, R01-AI65529, R01 AI051291] Funding Source: Medline; NIDDK NIH HHS [P30 DK067629, R01 DK061769, R01-DK61769] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed A, 2000, MICROBES INFECT, V2, P1159, DOI 10.1016/S1286-4579(00)01270-3; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Churin Y, 2001, MOL MICROBIOL, V40, P815, DOI 10.1046/j.1365-2958.2001.02443.x; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; COVER TL, 1994, J BIOL CHEM, V269, P10566; Ding SZ, 2008, FEMS IMMUNOL MED MIC, V53, P385, DOI 10.1111/j.1574-695X.2008.00439.x; Ding SZ, 2008, J GASTROEN HEPATOL, V23, pE67, DOI 10.1111/j.1440-1746.2007.04912.x; Ding SZ, 2005, HELICOBACTER, V10, P193, DOI 10.1111/j.1523-5378.2005.00311.x; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; Fehri LF, 2009, EPIGENETICS-US, V4, P577, DOI 10.4161/epi.4.8.10217; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huang W, 2006, MOL CELL BIOL, V26, P1307, DOI 10.1128/MCB.26.4.1307-1317.2006; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lu H, 2005, CURR OPIN GASTROEN, V21, P653, DOI 10.1097/01.mog.0000181711.04529.d5; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mizzen CA, 2000, SCIENCE, V289, P2290, DOI 10.1126/science.289.5488.2290; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Pierzchalski P, 2006, HELICOBACTER, V11, P96, DOI 10.1111/j.1523-5378.2006.00383.x; Rokutan K, 2000, J GASTROEN HEPATOL, V15, pD12, DOI 10.1046/j.1440-1746.2000.02144.x; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Schmeck B, 2005, J IMMUNOL, V175, P2843, DOI 10.4049/jimmunol.175.5.2843; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Xia GQ, 2008, BIOCHEM BIOPH RES CO, V369, P526, DOI 10.1016/j.bbrc.2008.02.073; Yeo M, 2004, PROTEOMICS, V4, P3335, DOI 10.1002/pmic.200400951	48	94	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9875	10.1371/journal.pone.0009875	http://dx.doi.org/10.1371/journal.pone.0009875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368982	Green Submitted, gold, Green Published			2022-12-25	WOS:000276418200006
J	O'Connell, J; Lynch, L; Cawood, TJ; Kwasnik, A; Nolan, N; Geoghegan, J; McCormick, A; O'Farrelly, C; O'Shea, D				O'Connell, Jean; Lynch, Lydia; Cawood, Tom J.; Kwasnik, Anna; Nolan, Niamh; Geoghegan, Justin; McCormick, Aiden; O'Farrelly, Cliona; O'Shea, Donal			The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; ENDOCRINE ORGAN; CELL SIZE; EXPRESSION; WOMEN; RISK; INFLAMMATION	Objective: Several studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity. Subjects: Thirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71). Results: There was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9 +/- 10.9 mu m) when compared with metabolically unhealthy patients (100.0 +/- 7.6 mu m, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1 +/- 8.5 mu m versus 107.9 +/- 7.1 mu m). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis. Conclusion: Metabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.	[O'Connell, Jean; Lynch, Lydia; Kwasnik, Anna; O'Shea, Donal] St Vincents Univ Hosp, Obes Res Grp, Educ & Res Ctr, Dublin 4, Ireland; [Cawood, Tom J.] Christchurch Hosp, Dept Endocrinol, Christchurch, New Zealand; [Nolan, Niamh] St Vincents Univ Hosp, Dept Pathol, Dublin 4, Ireland; [Nolan, Niamh; Geoghegan, Justin; O'Shea, Donal] St Columcilles Hosp, Dublin, Ireland; [Geoghegan, Justin] St Vincents Univ Hosp, Dept Surg, Dublin 4, Ireland; [McCormick, Aiden] St Vincents Univ Hosp, Liver Transplant Unit, Dublin 4, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [O'Shea, Donal] St Vincents Univ Hosp, Dept Endocrinol, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital; Christchurch Hospital New Zealand; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin; University College Dublin; Saint Vincent's University Hospital	O'Connell, J (corresponding author), St Vincents Univ Hosp, Obes Res Grp, Educ & Res Ctr, Dublin 4, Ireland.	jeanoco@gmail.com	Lynch, Lydia/ABD-5598-2021	Lynch, Lydia/0000-0002-4273-4681; O'Shea, Donal/0000-0002-1408-5274; O'Farrelly, Cliona/0000-0002-0616-2874; O'Connell, Jean/0000-0001-7241-8025	Irish Health Research Board; Medical Research Charities Group and Diabetes Federation of Ireland	Irish Health Research Board; Medical Research Charities Group and Diabetes Federation of Ireland	This work was supported by a clinical fellowship from the Irish Health Research Board and an award from the Medical Research Charities Group and Diabetes Federation of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES R, 1980, INT J OBESITY, V4, P381; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; ARNER E, DIABETES, V59, P105; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Drolet R, 2009, OBESITY, V17, P424, DOI 10.1038/oby.2008.555; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Imbeault P, 1999, METABOLISM, V48, P355, DOI 10.1016/S0026-0495(99)90085-9; JACOBSSON B, 1972, J LIPID RES, V13, P651; Jensen MD, 1996, METABOLISM, V45, P662, DOI 10.1016/S0026-0495(96)90040-2; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; LONN M, 2009, FASEB J; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Palekar NA, 2006, LIVER INT, V26, P151, DOI 10.1111/j.1478-3231.2005.01209.x; Rasmussen MS, 2006, OBESITY, V14, P28, DOI 10.1038/oby.2006.5; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shen W, 2003, OBES RES, V11, P5, DOI 10.1038/oby.2003.3; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Tchoukalova YD, 2008, AM J CLIN NUTR, V87, P56, DOI 10.1093/ajcn/87.1.56; Tordjman J, 2009, J HEPATOL, V51, P354, DOI 10.1016/j.jhep.2009.02.031; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Votruba SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1823, DOI 10.1152/ajpendo.00601.2006; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Yang X, 2007, DIABETOLOGIA, V50, P1127, DOI 10.1007/s00125-007-0640-1; Yang YK, 2008, CELL PHYSIOL BIOCHEM, V22, P531, DOI 10.1159/000185527; Youssef WI, 2002, BEST PRACT RES CL GA, V16, P733, DOI 10.1053/bega.2002.0334	46	145	146	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9997	10.1371/journal.pone.0009997	http://dx.doi.org/10.1371/journal.pone.0009997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376319	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200062
J	Joos, C; Marrama, L; Polson, HEJ; Corre, S; Diatta, AM; Diouf, B; Trape, JF; Tall, A; Longacre, S; Perraut, R				Joos, Charlotte; Marrama, Laurence; Polson, Hannah E. J.; Corre, Sandra; Diatta, Antoine-Marie; Diouf, Babacar; Trape, Jean-Francois; Tall, Adama; Longacre, Shirley; Perraut, Ronald			Clinical Protection from Falciparum Malaria Correlates with Neutrophil Respiratory Bursts Induced by Merozoites Opsonized with Human Serum Antibodies	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SURFACE PROTEIN-1; HOLOENDEMIC AREA; PHAGOCYTOSIS; MECHANISMS; BLOOD; VACCINE; IMMUNITY; GROWTH; STIMULATION	Background: Effective vaccines to combat malaria are urgently needed, but have proved elusive in the absence of validated correlates of natural immunity. Repeated blood stage infections induce antibodies considered to be the main arbiters of protection from pathology, but their essential functions have remained speculative. Methodology/Principal Findings: This study evaluated antibody dependent respiratory burst (ADRB) activity in polymorphonuclear neutrophils (PMN) induced by Plasmodium falciparum merozoites and antibodies in the sera of two different African endemic populations, and investigated its association with naturally acquired clinical protection. Respiratory bursts by freshly isolated PMN were quantified by chemiluminescence readout in the presence of isoluminol, which preferentially detects extra-cellular reactive oxygen species (ROS). Using a standardized, high throughput protocol, 230 sera were analyzed from individuals of all age groups living in meso-(Ndiop) or holo-endemic (Dielmo) Senegalese villages, and enrolled in a cross-sectional prospective study with intensive follow-up. Statistical significance was determined using non-parametric tests and Poisson regression models. The most important finding was that PMN ADRB activity was correlated with acquired clinical protection from malaria in both high and low transmission areas (P = 0.006 and 0.036 respectively). Strikingly, individuals in Dielmo with dichotomized high ADRB indexes were seventeen fold less susceptible to malaria attacks (P = 0.006). Complementary results showed that ADRB activity was (i) dependent on intact merozoites and IgG opsonins, but not parasitized erythrocytes, or complement, (ii) correlated with merozoite specific cytophilic IgG1 and IgG3 antibody titers (P < 0.001 for both), and (iii) stronger in antisera from a holo-endemic compared to a meso-endemic site (P = 0.002), and reduced in asymptomatic carriers (P < 0.001). Conclusions/Significance: This work presents the first clearly demonstrated functional antibody immune correlate of clinical protection from Plasmodium falciparum malaria, and begs the question regarding the importance of ADRB by PMN for immune protection against malaria in vivo.	[Joos, Charlotte; Corre, Sandra; Diatta, Antoine-Marie; Diouf, Babacar; Perraut, Ronald] Inst Pasteur, Unite Immunol, Dakar, Senegal; [Joos, Charlotte; Polson, Hannah E. J.; Longacre, Shirley] CNRS, Inst Pasteur, Lab Vaccinol Parasitaire, URA 1961, Paris, France; [Marrama, Laurence; Tall, Adama] Inst Pasteur, Unite Epidemiol, Dakar, Senegal; [Trape, Jean-Francois] IRD, Lab Paludol Zool Med, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD)	Joos, C (corresponding author), Inst Pasteur, Unite Immunol, Dakar, Senegal.	longacre@pasteur.fr			Pasteur Institute Foundation; French Ministry of Research and Technology (VIHPAL Program); Pharmaciens Sans Frontieres Comite International; Agence Universitaire de la Francophonie; Sanofi Aventis/French Ministry of Higher Education and Research (Combating Parasitic Diseases program)	Pasteur Institute Foundation; French Ministry of Research and Technology (VIHPAL Program); Pharmaciens Sans Frontieres Comite International; Agence Universitaire de la Francophonie; Sanofi Aventis/French Ministry of Higher Education and Research (Combating Parasitic Diseases program)(Sanofi-Aventis)	This work was funded by the Pasteur Institute Foundation, the French Ministry of Research and Technology (VIHPAL Program), Pharmaciens Sans Frontieres Comite International, the Agence Universitaire de la Francophonie, Sanofi Aventis/French Ministry of Higher Education and Research (Combating Parasitic Diseases program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFSSAPS, 2006, FRENCH POST DRUGS DR; ALLISON AC, 1983, ANNU REV IMMUNOL, V1, P361, DOI 10.1146/annurev.iy.01.040183.002045; Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; BROWN J, 1981, CLIN EXP IMMUNOL, V46, P106; Carvalho LJM, 2002, SCAND J IMMUNOL, V56, P327, DOI 10.1046/j.1365-3083.2002.01160.x; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; CELADA A, 1983, J PARASITOL, V69, P49, DOI 10.2307/3281273; CLARK IA, 1983, INFECT IMMUN, V39, P1; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Diouf B, 2002, Dakar Med, V47, P5; Giersing BK, 2006, VACCINE, V24, P4264, DOI 10.1016/j.vaccine.2006.01.005; Greve B, 1999, J INFECT DIS, V179, P1584, DOI 10.1086/314780; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; KHUSMITH S, 1982, INFECT IMMUN, V35, P874, DOI 10.1128/IAI.35.3.874-879.1982; Kremsner PG, 2000, LANCET, V355, P40, DOI 10.1016/S0140-6736(99)04761-3; KUMARATILAKE LM, 1990, INFECT IMMUN, V58, P788, DOI 10.1128/IAI.58.3.788-793.1990; KUMARATILAKE LM, 1992, INFECT IMMUN, V60, P3731, DOI 10.1128/IAI.60.9.3731-3738.1992; Kumaratilake LM, 2000, CLIN DIAGN LAB IMMUN, V7, P9, DOI 10.1128/CDLI.7.1.9-13.2000; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Lensen AHW, 1997, INFECT IMMUN, V65, P3834, DOI 10.1128/IAI.65.9.3834-3837.1997; LUNEL F, 1989, INFECT IMMUN, V57, P2043, DOI 10.1128/IAI.57.7.2043-2049.1989; LUNEL F, 1990, ACTA TROP, V47, P61, DOI 10.1016/0001-706X(90)90068-B; MAGRISSO MJ, 1995, J BIOLUM CHEMILUM, V10, P77, DOI 10.1002/bio.1170100203; MALHOTRA K, 1988, CR SOC BIOL, V182, P270; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Miller LH, 1997, PARASITOL TODAY, V13, P46, DOI 10.1016/S0169-4758(96)20063-8; NNALUE NA, 1988, PARASITE IMMUNOL, V10, P47, DOI 10.1111/j.1365-3024.1988.tb00202.x; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Perraut R., 2005, Update in tropical immunology, P157; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Perraut R, 2003, J INFECT DIS, V188, P1940, DOI 10.1086/379838; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 2003, REV EPIDEMIOL SANTE, V51, P175; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; SALMON D, 1986, INFECT IMMUN, V51, P801, DOI 10.1128/IAI.51.3.801-806.1986; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; SUN T, 1985, ANN CLIN LAB SCI, V15, P465; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; *WHO, WHO INF SHEETS PRESC; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067	50	108	108	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9871	10.1371/journal.pone.0009871	http://dx.doi.org/10.1371/journal.pone.0009871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360847	gold, Green Published, Green Submitted			2022-12-25	WOS:000275969500010
J	Kiyota, T; Okuyama, S; Swan, RJ; Jacobsen, MT; Gendelman, HE; Ikezu, T				Kiyota, Tomomi; Okuyama, Satoshi; Swan, Russell J.; Jacobsen, Michael T.; Gendelman, Howard E.; Ikezu, Tsuneya			CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice	FASEB JOURNAL			English	Article						IL-4; AAV therapy; memory formation; neurogenesis; NMDA receptor	AMYLOID-PRECURSOR-PROTEIN; PASSIVE IMMUNOTHERAPY; SYNAPTIC PLASTICITY; MEMORY DEFICITS; IN-VITRO; A-BETA; IL-4; ACTIVATION; CELLS; PATHOLOGY	Cytokines play an emerging role as neurotransmitters, neuromodulators, and neurohormones in the brain. This paradigm shift in cytokine function offers a new framework to understand their roles in ameliorating neurodegenerative disorders, such as Alzheimer's disease (AD). Molecular adjuvant therapy of AD animal models with glatiramer acetate induces antiinflammatory responses and therapeutic effects. Although these effects are potentially mediated through antiinflammatory cytokine signaling, the exact molecular identities and pathways are poorly understood. Here, we show that virus-mediated expression of the mouse interleukin (IL)-4 gene in beta-amyloid precursor protein + presenilin-1 (APP + PS1) bigenic mice attenuates AD pathogenesis. Introduction of an adeno-associated viral (AAV) vector encoding IL-4 into the hippocampus resulted in sustained expression of IL-4, reduced astro/microgliosis, amyloid-beta peptide (A beta) oligomerization and deposition, and enhanced neurogenesis. Moreover, increased levels of IL-4 improved spatial learning, promoted phosphorylation of N-methyl-D-aspartate receptor subunit 2B at Tyr 1472, and enhanced its cell surface retention both in vivo and in vitro. Our data suggest that neuronal anti-inflammatory cytokine signaling may be a potential alternative target for non-A beta-mediated treatment of AD.-Kiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., Ikezu, T. CNS expression of anti-inflammatory cytokine interleukin- 4 attenuates Alzheimer's disease-like pathogenesis in APP + PS1 bigenic mice. FASEB J. FASEB J. 24, 3093-3102 (2010). www.fasebj.org	[Kiyota, Tomomi; Okuyama, Satoshi; Swan, Russell J.; Jacobsen, Michael T.; Gendelman, Howard E.; Ikezu, Tsuneya] Univ Nebraska Med Ctr, Ctr Neurodegenerat Disorders, Omaha, NE USA; [Kiyota, Tomomi; Swan, Russell J.; Jacobsen, Michael T.; Gendelman, Howard E.; Ikezu, Tsuneya] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Okuyama, Satoshi; Ikezu, Tsuneya] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Ikezu, T (corresponding author), 985930 Nebraska Med Ctr, Omaha, NE 68198 USA.	tikezu@unmc.edu		Ikezu, Tsuneya/0000-0002-3979-8596	Vada Kinman Oldfield Alzheimer's Research Fund; UNMC; NIH [P01 NS043985, R01 MH083523, R21 AG032600]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032600] Funding Source: NIH RePORTER	Vada Kinman Oldfield Alzheimer's Research Fund; UNMC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Karen Hsiao-Ashe (University of Minnesota, Minneapolis, MN, USA) for providing Tg2576 mice; Dr. Karen Duff (Columbia University, New York, NY, USA) for providing M146L PS1 mice; Dr. Dave Morgan (University of South Florida, Tampa, FL, USA) for RAWM test training and consultation; Dr. Ronald Klein (Louisiana State University, Shreveport, LA, USA) for pGFP plasmid; the University of Pennsylvania Gene Therapy Program for recombinant AAV1 vectors; Dr. Sylvain Lesne (University of Minnesota, Minneapolis, MN, USA) for the A beta oligomer immunoblotting protocol; and Tim Smith, Scott Andrews, and Meg Marquardt for editing of the manuscript. This work is supported by the Vada Kinman Oldfield Alzheimer's Research Fund (T.K., T.I.); UNMC Brain Bank Core Fund (T.I.); and NIH grants P01 NS043985 (H.E.G., T.I.), R01 MH083523 (T.I.), and R21 AG032600 (T.I.).	Adao-Novaes J, 2009, J NEUROSCI RES, V87, P2167, DOI 10.1002/jnr.22026; Aharoni R, 2002, J NEUROIMMUNOL, V126, P58, DOI 10.1016/S0165-5728(02)00053-X; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Birmingham K, 2002, NAT MED, V8, P199, DOI 10.1038/nm0302-199b; Braithwaite SP, 2006, TRENDS NEUROSCI, V29, P452, DOI 10.1016/j.tins.2006.06.007; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DaSilva KA, 2006, NEUROBIOL DIS, V23, P433, DOI 10.1016/j.nbd.2006.03.013; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Frenkel D, 2005, CLIN IMMUNOL, V115, pS24; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; HOWARD M, 1992, J CLIN IMMUNOL, V12, P239, DOI 10.1007/BF00918147; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; Kiyota T, 2009, MOL THER, V17, P803, DOI 10.1038/mt.2009.44; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Koeberle PD, 2004, NEUROSCIENCE, V125, P903, DOI 10.1016/S0306-4522(03)00398-1; Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin SJ, 2007, APOPTOSIS, V12, P1659, DOI 10.1007/s10495-007-0085-5; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Lyons A, 2007, J NEUROCHEM, V101, P771, DOI 10.1111/j.1471-4159.2006.04370.x; Maher FO, 2005, NEUROBIOL AGING, V26, P717, DOI 10.1016/j.neurobiolaging.2004.07.002; Marques CP, 2004, GLIA, V47, P358, DOI 10.1002/glia.20045; Molina-Holgado E, 2002, J NEUROCHEM, V81, P1242, DOI 10.1046/j.1471-4159.2002.00925.x; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murata T, 1996, J IMMUNOL, V156, P2972; Opal SM, 1998, CLIN INFECT DIS, V27, P1497, DOI 10.1086/515032; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Sayeski PP, 1999, J BIOL CHEM, V274, P33131, DOI 10.1074/jbc.274.46.33131; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimizu E, 2008, J IMMUNOL, V181, P6503, DOI 10.4049/jimmunol.181.9.6503; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stern JNH, 2008, P NATL ACAD SCI USA, V105, P5172, DOI 10.1073/pnas.0712131105; Szczepanik AM, 2001, J NEUROIMMUNOL, V113, P49, DOI 10.1016/S0165-5728(00)00404-5; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Vincent AM, 2004, NEUROBIOL DIS, V16, P407, DOI 10.1016/j.nbd.2004.03.001; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378	60	148	154	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					3093	3102		10.1096/fj.10-155317	http://dx.doi.org/10.1096/fj.10-155317			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371618	Green Published			2022-12-25	WOS:000285005400045
J	Koga, H; Kaushik, S; Cuervo, AM				Koga, Hiroshi; Kaushik, Susmita; Cuervo, Ana Maria			Altered lipid content inhibits autophagic vesicular fusion	FASEB JOURNAL			English	Article						lysosomes; membrane fusion; proteolysis	RAT-LIVER LYSOSOMES; SELECTIVE UPTAKE; IN-VITRO; DEGRADATION; PROTEINS; CARDIOMYOPATHY; RECONSTITUTION; MACROAUTOPHAGY; MATURATION; DEPENDENCE	The autophagic/lysosomal system includes a variety of vesicular compartments that undergo dynamic fusion events. However, the characteristics and factors modulating these interactions remain, for the most part, unknown. To gain insights on the properties that govern lysosomal fusion events, we have established an in vitro fusion assay using different lysosomal/autophagic compartments isolated from mouse liver. We have found that autophagosome/lysosome fusion is a temperaturedependent process (fusion increment of 0.2 +/- 0.01%/degrees C), which requires ATP (1-3 mM), GTP (1-2 mM), Ca2+ (0.2-2 mM), and an acidic lysosomal pH (pH 5.2). Furthermore, changes in membrane lipid composition, induced either in vitro, by treatment with 25 mM methyl-beta-cyclodextrin, or in vivo, by subjecting animals to a high-fat-diet challenge (60% kcal in fat) reduce autophagosome/lysosome fusion up to 70% of that observed in untreated fractions or from animals under a normal regular diet. These findings reveal a novel role for lipids in autophagic fusion and provide a mechanism for the reduced macroautophagic rates observed during exposure to a chronic lipid challenge. Changes in the intracellular lipid content (i.e., metabolic disorders) may thus have pronounced effects on the fusion step of macroautophagy and affect the overall activity of this intracellular proteolytic pathway.-Koga, H., Kaushik, S., Cuervo, A. M. Altered lipid content inhibits autophagic vesicular fusion. FASEB J. 24, 3052-3065 (2010). www.fasebj.org	[Koga, Hiroshi; Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Chanin Bldg Rm 504,1300 Morris Pk Ave, Bronx, NY 10461 USA.	ana-maria.cuervo@einstein.yu.edu	Kaushik, Susmita/GVS-3186-2022	Kaushik, Susmita/0000-0002-6096-5387; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [AG031782, AG021904, DK041918]; NIN/NIA [T32AG023475]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475, P01AG031782, R01AG021904, R37AG021904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIN/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Samantha J. Orenstein and Dr. Fernando Macian for their insights and critical revision of this manuscript, and to Drs. Mark J. Czaja, Allan W. Wolkoff, and John W. Murray (Albert Einstein College of Medicine, Bronx, NY, USA) for providing us with valuable reagents. This work was supported by National Institutes of Health grants AG031782, AG021904, and DK041918. S.K. is supported by NIN/NIA T32AG023475.	AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; BAKER L, 1990, DIABETOLOGIA, V33, P593, DOI 10.1007/BF00400202; Bananis E, 2003, J CELL SCI, V116, P2749, DOI 10.1242/jcs.00478; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; Deretic V, 2008, FUTURE MICROBIOL, V3, P517, DOI 10.2217/17460913.3.5.517; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; Morvan J, 2009, AUTOPHAGY, V5, P676, DOI 10.4161/auto.5.5.8378; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Murray John W, 2007, Methods Mol Biol, V392, P143; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Overbye A, 2007, AUTOPHAGY, V3, P300, DOI 10.4161/auto.3910; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Wang YJ, 2004, J BIOL CHEM, V279, P31089, DOI 10.1074/jbc.M404170200; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; WILSCHUT J, 1985, BIOCHEMISTRY-US, V24, P8, DOI 10.1021/bi00322a002; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	47	315	324	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					3052	3065		10.1096/fj.09-144519	http://dx.doi.org/10.1096/fj.09-144519			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20375270	Green Published			2022-12-25	WOS:000285005400042
J	Adrover, M; Pauwels, K; Prigent, S; de Chiara, C; Xu, Z; Chapuis, C; Pastore, A; Rezaei, H				Adrover, Miquel; Pauwels, Kris; Prigent, Stephanie; de Chiara, Cesira; Xu, Zhou; Chapuis, Celine; Pastore, Annalisa; Rezaei, Human			Prion Fibrillization Is Mediated by a Native Structural Element That Comprises Helices H2 and H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAUSSLER-SCHEINKER-DISEASE; CREUTZFELDT-JAKOB-DISEASE; PROTEIN NMR STRUCTURES; IN-VITRO; HYDROGEN/DEUTERIUM EXCHANGE; AMYLOID FIBRILS; ALPHA-HELIX; CONVERSION; STABILITY; GENE	Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of lethal neurodegenerative diseases affecting humans and other animals. Although the structures of PrP from several species have been solved, still little is known about the mechanisms that lead to the misfolded species. Here, we show that the region of PrP comprising the hairpin formed by the helices H2 and H3 is a stable independently folded unit able to retain its secondary and tertiary structure also in the absence of the rest of the sequence. We also prove that the isolated H2H3 is highly fibrillogenic and forms amyloid fibers morphologically similar to those obtained for the full-length protein. Fibrillization of H2H3 but not of full-length PrP is concomitant with formation of aggregates. These observations suggest a "banana-peeling" mechanism for misfolding of PrP in which H2H3 is the aggregation seed that needs to be first exposed to promote conversion from a helical to a beta-rich structure.	[Adrover, Miquel; Pauwels, Kris; de Chiara, Cesira; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Adrover, Miquel] Univ Illes Balears, Dept Quim, E-07122 Palma de Mallorca, Spain; [Prigent, Stephanie; Xu, Zhou; Chapuis, Celine; Pastore, Annalisa; Rezaei, Human] INRA, F-78352 Jouy En Josas, France; [Xu, Zhou] Commissariat Energie Atom, F-92265 Fontenay Aux Roses, France	MRC National Institute for Medical Research; Universitat de les Illes Balears; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pastore, A (corresponding author), Natl Inst Med Res, MRC, Ridgeway, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk; human.rezaei@jouy.inra.fr	Xu, Zhou/F-8513-2011	Xu, Zhou/0000-0001-9468-1406; de Chiara, Cesira/0000-0002-9766-2515; Adrover, Miquel/0000-0002-4211-9013; Pauwels, Kris/0000-0002-7341-0890	MRC [U117584256]; Spanish Ministerio de Ciencia e Innovacion for a Jose Castillejo [JC2009-00284]; EMBO; Institut National de la Recherche Agronomique; Medical Research Council [MC_U117533887, MC_U117584256] Funding Source: researchfish; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministerio de Ciencia e Innovacion for a Jose Castillejo(Ministry of Science and Innovation, Spain (MICINN)); EMBO(European Molecular Biology Organization (EMBO)); Institut National de la Recherche Agronomique; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC Grant U117584256.; Supported by the Spanish Ministerio de Ciencia e Innovacion for a Jose Castillejo fellowship (Grant JC2009-00284).; Supported by an EMBO long term postdoctoral fellowship.; Recipients of a package grant from Institut National de la Recherche Agronomique.	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Barducci A, 2006, J AM CHEM SOC, V128, P2705, DOI 10.1021/ja057076l; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; CHAPMAN J, 1994, NEUROLOGY, V44, P1683, DOI 10.1212/WNL.44.9.1683; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeMarco ML, 2007, BIOCHEMISTRY-US, V46, P3045, DOI 10.1021/bi0619066; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Eghiaian F, 2004, P NATL ACAD SCI USA, V101, P10254, DOI 10.1073/pnas.0400014101; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Heller J, 1996, PROTEIN SCI, V5, P1655, DOI 10.1002/pro.5560050819; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; HSIAO K, 1992, NAT GENET, V1, P68, DOI 10.1038/ng0492-68; Julien O, 2009, PROTEIN SCI, V18, P2172, DOI 10.1002/pro.231; KAMTEKAR S, 1995, FASEB J, V9, P1013, DOI 10.1096/fasebj.9.11.7649401; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Mastrianni JA, 1996, NEUROLOGY, V47, P1305, DOI 10.1212/WNL.47.5.1305; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Nazabal A, 2009, J MASS SPECTROM, V44, P965, DOI 10.1002/jms.1572; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pastore A, 2007, PRION, V1, P185, DOI 10.4161/pri.1.3.5281; Peoc'h K, 2000, HUM MUTAT, V15; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; POCCHIARI M, 1993, ANN NEUROL, V34, P802, DOI 10.1002/ana.410340608; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Thomas D, 2005, ACTA CRYSTALLOGR D, V61, P112, DOI 10.1107/S0907444904027684; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Xian WJ, 2006, PROTEIN SCI, V15, P2062, DOI 10.1110/ps.062297006	61	67	69	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21004	21012		10.1074/jbc.M110.111815	http://dx.doi.org/10.1074/jbc.M110.111815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20375014	Green Published, hybrid			2022-12-25	WOS:000279228600064
J	Bacik, JP; Walker, JR; Ali, M; Schimmer, AD; Dhe-Paganon, S				Bacik, John-Paul; Walker, John R.; Ali, Mohsin; Schimmer, Aaron D.; Dhe-Paganon, Sirano			Crystal Structure of the Human Ubiquitin-activating Enzyme 5 (UBA5) Bound to ATP MECHANISTIC INSIGHTS INTO A MINIMALISTIC E1 ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYMES; PROTEIN-ACTIVATION; CYSTEINE RESIDUES; SYSTEM; E1; INSIGHTS; PATHWAYS; AFFINITY; COMPLEX; CASCADE	E1 ubiquitin-activating enzymes (UBAs) are large multidomain proteins that catalyze formation of a thioester bond between the terminal carboxylate of a ubiquitin or ubiquitin-like modifier (UBL) and a conserved cysteine in an E2 protein, producing reactive ubiquityl units for subsequent ligation to substrate lysines. Two important E1 reaction intermediates have been identified: a ubiquityl-adenylate phosphoester and a ubiquityl-enzyme thioester. However, the mechanism of thioester bond formation and its subsequent transfer to an E2 enzyme remains poorly understood. We have determined the crystal structure of the human UFM1 (ubiquitin-fold modifier 1) E1-activating enzyme UBA5, bound to ATP, revealing a structure that shares similarities with both large canonical E1 enzymes and smaller ancestral E1-like enzymes. In contrast to other E1 active site cysteines, which are in a variably sized domain that is separate and flexible relative to the adenylation domain, the catalytic cysteine of UBA5 (Cys(250)) is part of the adenylation domain in an alpha-helical motif. The novel position of the UBA5 catalytic cysteine and conformational changes associated with ATP binding provides insight into the possible mechanisms through which the ubiquityl-enzyme thioester is formed. These studies reveal structural features that further our understanding of the UBA5 enzyme reaction mechanism and provide insight into the evolution of ubiquitin activation.	[Bacik, John-Paul; Walker, John R.; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Bacik, John-Paul; Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Ali, Mohsin; Schimmer, Aaron D.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Dhe-Paganon, S (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	sirano.dhepaganon@utoronto.ca	Ali, Mohsin/GRY-0476-2022	Bacik, John-Paul/0000-0001-9315-5332; /0000-0002-5255-895X; Schimmer, Aaron/0000-0003-4023-3899	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The Structural Genomics Consortium is a registered charity (1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; A Leukemia and Lymphoma Society Scholar in Clinical Research.; We thank Yanjun Li, Lianet Lopez, Patrick J. Finerty, Jr., and Taras Makhnevych for technical assistance. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dou TH, 2005, MOL BIOL REP, V32, P265, DOI 10.1007/s11033-005-4822-y; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miranda JJL, 2003, PROTEIN SCI, V12, P73, DOI 10.1110/ps.0224203; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Senisterra GA, 2009, MOL BIOSYST, V5, P217, DOI 10.1039/b814377c; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; Tang ZS, 2008, FEBS J, V275, P3003, DOI 10.1111/j.1742-4658.2008.06459.x; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791	35	44	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20273	20280		10.1074/jbc.M110.102921	http://dx.doi.org/10.1074/jbc.M110.102921			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20368332	Green Published, hybrid			2022-12-25	WOS:000279012000062
J	Galloux, M; Libersou, S; Alves, ID; Marquant, R; Salgado, GF; Rezaei, H; Lepault, J; Delmas, B; Bouaziz, S; Morellet, N				Galloux, Marie; Libersou, Sonia; Alves, Isabel D.; Marquant, Rodrigue; Salgado, Gilmar F.; Rezaei, Human; Lepault, Jean; Delmas, Bernard; Bouaziz, Serge; Morellet, Nelly			NMR Structure of a Viral Peptide Inserted in Artificial Membranes A VIEW ON THE EARLY STEPS OF THE BIRNAVIRUS ENTRY PROCESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANTIMICROBIAL PEPTIDE; BURSAL DISEASE VIRUS; DIFFERENTIAL SCANNING CALORIMETRY; GUIDE RESONANCE SPECTROSCOPY; ICOSAHEDRAL ANIMAL VIRUS; LIPID-BILAYER MEMBRANES; FLOCK HOUSE VIRUS; NONENVELOPED VIRUS; PORE FORMATION; DODECYLPHOSPHOCHOLINE MICELLES	Nonenveloped virus must penetrate the cellular membrane to access the cytoplasm without the benefit of membrane fusion. For birnavirus, one of the peptides present in the virus capsid, pep46 for infectious bursal disease virus, is able to induce pores into membranes as an intermediate step of the birnavirus-penetration pathway. Using osmotic protection experiments, we demonstrate here that pep46 and its pore-forming N-terminal moiety (pep22) form pores of different diameters, 5-8 and 2-4 nm, respectively, showing that both pep46 moieties participate to pore formation. The solution structures of pep46, pep22, and pep24 (the pep46 C-terminal moiety) in different hydrophobic environments and micelles determined by H-1 NMR studies provide structural insights of the pep46 domain interaction. In CDCl3/CD3OH mixture and in dodecylphosphocholine micelles, the N-terminal domain of pep46 is structured in a long kinked helix, although the C terminus is structured in one or two helices depending upon the solvents used. We also show that the folding and the proline isomerization status of pep46 depend on the type of hydrophobic environment. NMR spectroscopy with labeled phospholipid micelles, differential scanning calorimetry, and plasmon waveguide resonance studies show the peptides lie parallel to the lipid-water interface, perturbing the fatty acid chain packing. All these data lead to a model in which the two domains of pep46 interact with the membrane to form pores.	[Galloux, Marie; Marquant, Rodrigue; Bouaziz, Serge; Morellet, Nelly] Univ Paris 05, CNRS, Unite Pharmacol Chim & Genet, Fac Sci Pharmaceut & Biol,UMR 8151, F-75270 Paris 06, France; [Galloux, Marie; Rezaei, Human; Delmas, Bernard] INRA, UR892, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France; [Alves, Isabel D.; Salgado, Gilmar F.] Univ Paris 06, CNRS, UMR 7203, Lab BioMol,FR 2769, F-75252 Paris 05, France; [Libersou, Sonia; Lepault, Jean] CNRS, UMR 2472, INRA 1157, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Morellet, N (corresponding author), Univ Paris 05, CNRS, Unite Pharmacol Chim & Genet, Fac Sci Pharmaceut & Biol,UMR 8151, 4 Ave Observ, F-75270 Paris 06, France.	nelly.morellet@icsn.cnrs-gif.fr	Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Salgado, Gilmar/M-1081-2016; Salgado, Gilmar/M-5476-2019; Alves, Isabel D/R-9613-2016; Lepault, Jean/AAN-8859-2020; SALGADO, Gilmar/AAQ-8734-2020	Bouaziz, Serge/0000-0001-7792-8307; Salgado, Gilmar/0000-0002-0296-5979; Alves, Isabel D/0000-0003-3193-2436; morellet, nelly/0000-0001-5076-8884	French Ministere de la Recherche et Technologie (MRT); Agence Nationale de la Recherche	French Ministere de la Recherche et Technologie (MRT); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant of the Action Concertee Incitative (ACI) "Microbiologie" from the French Ministere de la Recherche et Technologie (MRT) and the Agence Nationale de la Recherche "Projets blancs" programs.	Agosto MA, 2006, P NATL ACAD SCI USA, V103, P16496, DOI 10.1073/pnas.0605835103; ALTENBACH C, 1988, PROTEINS, V3, P230, DOI 10.1002/prot.340030404; Andrushchenko VV, 2008, BBA-BIOMEMBRANES, V1778, P1004, DOI 10.1016/j.bbamem.2007.12.022; Arias CF, 1996, J VIROL, V70, P5832, DOI 10.1128/JVI.70.9.5832-5839.1996; ARNOLD E, 1987, P NATL ACAD SCI USA, V84, P21, DOI 10.1073/pnas.84.1.21; Banerjee M, 2009, J VIROL, V83, P6929, DOI 10.1128/JVI.02299-08; Basanez G, 2002, FEBS LETT, V532, P115, DOI 10.1016/S0014-5793(02)03651-7; BAZZO R, 1988, EUR J BIOCHEM, V173, P139, DOI 10.1111/j.1432-1033.1988.tb13977.x; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; Beswick V, 1998, BIOCHIMIE, V80, P451, DOI 10.1016/S0300-9084(00)80012-7; Beswick V, 1998, EUR BIOPHYS J BIOPHY, V28, P48, DOI 10.1007/s002490050182; Biggin PC, 1999, BIOPHYS CHEM, V76, P161, DOI 10.1016/S0301-4622(98)00233-6; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bong DT, 1999, CHEM BIOL, V6, P473, DOI 10.1016/S1074-5521(99)80065-9; Bong DT, 2000, BIOPHYS J, V78, P839, DOI 10.1016/S0006-3495(00)76641-0; BROWN LR, 1981, BIOCHIM BIOPHYS ACTA, V642, P296, DOI 10.1016/0005-2736(81)90447-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Burkhart BM, 1999, BIOPOLYMERS, V51, P129, DOI 10.1002/(SICI)1097-0282(1999)51:2<129::AID-BIP3>3.0.CO;2-Y; Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; CHENG RH, 1994, STRUCTURE, V2, P271; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Chia BCS, 2000, EUR J BIOCHEM, V267, P1894, DOI 10.1046/j.1432-1327.2000.01089.x; COHEN J, 1975, BIOCHEM BIOPH RES CO, V62, P689, DOI 10.1016/0006-291X(75)90454-4; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; Epand RM, 2007, BIOPHYS CHEM, V126, P197, DOI 10.1016/j.bpc.2006.05.008; ESTES MK, 1981, J VIROL, V39, P879, DOI 10.1128/JVI.39.3.879-888.1981; FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0; FREEDMAN JC, 1979, J GEN PHYSIOL, V74, P157, DOI 10.1085/jgp.74.2.157; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gesell J, 1997, J BIOMOL NMR, V9, P127, DOI 10.1023/A:1018698002314; Glaser RW, 2004, J MAGN RESON, V168, P153, DOI 10.1016/j.jmr.2004.02.008; Greber UF, 1996, EMBO J, V15, P1766, DOI 10.1002/j.1460-2075.1996.tb00525.x; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Joanne P, 2009, BBA-BIOMEMBRANES, V1788, P1772, DOI 10.1016/j.bbamem.2009.05.001; Latal A, 1997, EUR J BIOCHEM, V248, P938, DOI 10.1111/j.1432-1033.1997.00938.x; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Lee MT, 2004, BIOCHEMISTRY-US, V43, P3590, DOI 10.1021/bi036153r; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; LUDTKE SJ, 1994, BBA-BIOMEMBRANES, V1190, P181, DOI 10.1016/0005-2736(94)90050-7; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Maia LF, 2006, J BIOL CHEM, V281, P29278, DOI 10.1074/jbc.M604689200; Malev VV, 2002, BIOPHYS J, V82, P1985, DOI 10.1016/S0006-3495(02)75547-1; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y; MATSUZAKI K, 1991, BIOCHIM BIOPHYS ACTA, V1063, P162, DOI 10.1016/0005-2736(91)90366-G; MUELLER P, 1968, NATURE, V217, P713, DOI 10.1038/217713a0; Naito A, 2000, BIOPHYS J, V78, P2405, DOI 10.1016/S0006-3495(00)76784-1; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Orekhov VY, 2000, J BIOMOL NMR, V17, P257, DOI 10.1023/A:1008346414720; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park SH, 2002, BIOCHEM J, V368, P171, DOI 10.1042/BJ20020385; Pashkov VS, 1999, FEBS LETT, V457, P117, DOI 10.1016/S0014-5793(99)01023-6; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Plesniak LA, 2004, PROTEIN SCI, V13, P1988, DOI 10.1110/ps.04853204; Poranen MM, 2002, ANNU REV MICROBIOL, V56, P521, DOI 10.1146/annurev.micro.56.012302.160643; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Prenner EJ, 1999, BBA-BIOMEMBRANES, V1417, P211, DOI 10.1016/S0005-2736(99)00004-8; Quijano JC, 2008, BBA-BIOMEMBRANES, V1778, P2775, DOI 10.1016/j.bbamem.2008.07.009; Reid C, 1997, BIOPHYS J, V73, P1692, DOI 10.1016/S0006-3495(97)78201-8; Ruiz MC, 2000, CELL CALCIUM, V28, P137, DOI 10.1054/ceca.2000.0142; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; Salamon Z, 2004, BIOPHYS J, V86, P2508, DOI 10.1016/S0006-3495(04)74306-4; Salamon Z, 1998, BIOPHYS J, V75, P1874, DOI 10.1016/S0006-3495(98)77628-3; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; SPIES U, 1987, VIRUS RES, V8, P127, DOI 10.1016/0168-1702(87)90024-4; Takei J, 1998, BIOCHEMISTRY-US, V37, P5699, DOI 10.1021/bi9729007; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; Vinogradova O, 1998, J BIOMOL NMR, V11, P381, DOI 10.1023/A:1008289624496; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; ZLOTNICK A, 1994, J BIOL CHEM, V269, P13680	90	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19409	19421		10.1074/jbc.M109.076083	http://dx.doi.org/10.1074/jbc.M109.076083			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20385550	Green Published, hybrid			2022-12-25	WOS:000278727800052
J	Bialkowska, K; Ma, YQ; Bledzka, K; Sossey-Alaoui, K; Izem, L; Zhang, XX; Malinin, N; Qin, J; Byzova, T; Plow, EF				Bialkowska, Katarzyna; Ma, Yan-Qing; Bledzka, Kamila; Sossey-Alaoui, Khalid; Izem, Lahoucine; Zhang, Xiaoxia; Malinin, Nikolay; Qin, Jun; Byzova, Tatiana; Plow, Edward F.			The Integrin Co-activator Kindlin-3 Is Expressed and Functional in a Non-hematopoietic Cell, the Endothelial Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION; MATRIX ADHESION; ACTIVATION; BINDING; MIG-2; TALIN; ALPHA(IIB)BETA(3); IDENTIFICATION; LOCALIZATION; MUTATIONS	Integrin activation is crucial for numerous cellular responses, including cell adhesion, migration, and survival. Recent studies in mice have specifically emphasized the vital role of kindlin-3 in integrin activation. Kindlin-3 deficiency in humans also has now been documented and includes symptoms of bleeding, frequent infections, and osteopetrosis, which are consequences of an inability to activate beta 1, beta 2, and beta 3 integrins. To date, kindlin-3 was thought to be restricted to hematopoietic cells. In this article, we demonstrate that kindlin-3 is present in human endothelial cells derived from various anatomical origins. The mRNA and protein for KINDLIN-3 was detected in endothelial cells by reverse transcription-PCR and Western blots. When subjected to sequencing by mass spectrometry, the protein was identified as authentic kindlin-3 and unequivocally distinguished from KINDLIN-1 and KINDLIN-2 or any other known protein. By quantitative real time PCR, the level of kindlin-3 in endothelial cells was 20-50% of that of kindlin-2. Using knockdown approaches, we show that kindlin-3 plays a role in integrin-mediated adhesion of endothelial cells. This function depends upon the integrin and substrate and is distinct from that of kindlin-2. Formation of tube-like structures in Matrigel also was impaired by kindlin-3 knockdown. Mechanistically, the distinct functions of the kindlins can be traced to differences in their subcellular localization in integrin-containing adhesion structures. Thus, the prevailing view that individual kindlins exert their functions in a cell type-specific manner must now be modified to consider distinct functions of the different family members within the same cell type.	[Bialkowska, Katarzyna; Ma, Yan-Qing; Bledzka, Kamila; Sossey-Alaoui, Khalid; Zhang, Xiaoxia; Malinin, Nikolay; Qin, Jun; Byzova, Tatiana; Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [Izem, Lahoucine] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Plow, EF (corresponding author), Dept Mol Cardiol NB5 50, 9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org	Malinin, Nikolay/J-4271-2012; Malinin, Nikolay/Z-5308-2019	Malinin, Nikolay/0000-0002-2654-1783; Qin, Jun/0000-0002-2647-9270; Byzova, Tatiana/0000-0002-2615-875X	National Institutes of Health, NHLBI [P01HL073311, R01 HL096062-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL096062] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL073311 and R01 HL096062-01 from the NHLBI.	Alon R, 2003, TRENDS IMMUNOL, V24, P561, DOI 10.1016/j.it.2003.08.001; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Ehlers R, 2003, J EXP MED, V198, P1077, DOI 10.1084/jem.20022181; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kato K, 2004, HUM PATHOL, V35, P55, DOI 10.1016/j.humpath.2003.08.019; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; McDowall A, 2003, J CLIN INVEST, V111, P51, DOI 10.1172/JCI200314076; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mori D, 2007, J ATHEROSCLER THROMB, V14, P213, DOI 10.5551/jat.E492; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Postea O, 2006, ARTERIOSCL THROM VAS, V26, P508, DOI 10.1161/01.ATV.0000201039.21705.dc; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6	34	78	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18640	18649		10.1074/jbc.M109.085746	http://dx.doi.org/10.1074/jbc.M109.085746			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378539	hybrid, Green Published			2022-12-25	WOS:000278453900057
J	Li, HX; Han, M; Bernier, M; Zheng, B; Sun, SG; Su, M; Zhang, R; Fu, JR; Wen, JK				Li, Hui-xuan; Han, Mei; Bernier, Michel; Zheng, Bin; Sun, Shao-guang; Su, Ming; Zhang, Rui; Fu, Jian-ran; Wen, Jin-kun			Kruppel-like Factor 4 Promotes Differentiation by Transforming Growth Factor-beta Receptor-mediated Smad and p38 MAPK Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; DOWN-REGULATION; MARKER GENES; ACTIVATION; INHIBITION; EXPRESSION; PROLIFERATION; PROTEIN; KRUPPEL-LIKE-FACTOR-4; MECHANISM	KLF4 (Kruppel-like factor 4) has been implicated in vascular smooth muscle cell (VSMC) differentiation induced by transforming growth factor beta (TGF-beta). However, the role of KLF4 and mechanism of KLF4 actions in regulating TGF-beta signaling in VSMCs remain unclear. In this study, we showed that TGF-beta 1 inhibited cell cycle progression and induced differentiation in cultured rat VSMCs. This activity of TGF-beta 1 was accompanied by up-regulation of KLF4, with concomitant increase in T beta RI (TGF-beta type I receptor) expression. KLF4 was found to transduce TGF-beta 1 signals via phosphorylation-mediated activation of Smad2, Smad3, and p38 MAPK. The activation of both pathways, in turn, increased the phosphorylation of KLF4, which enabled the formation of KLF4-Smad2 complex in response to TGF-beta 1. Chromatin immunoprecipitation studies and oligonucleotide pull-down assays showed the direct binding of KLF4 to the KLF4-binding sites 2 and 3 of the T beta RI promoter and the recruitment of Smad2 to the Smad-responsive region. Formation of a stable KLF4-Smad2 complex in the promoter's Smad-responsive region mediated cooperative T beta RI promoter transcription in response to TGF-beta 1. These results suggest that KLF4-dependent regulation of Smad and p38 MAPK signaling via T beta RI requires prior phosphorylation of KLF4 through Smad and p38 MAPK pathways. This study demonstrates a novel mechanism by which TGF-beta 1 regulates VSMC differentiation.	[Li, Hui-xuan; Han, Mei; Zheng, Bin; Sun, Shao-guang; Su, Ming; Zhang, Rui; Fu, Jian-ran; Wen, Jin-kun] Hebei Med Univ, China Minist Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Li, Hui-xuan] Hebei Univ Econ & Business, Coll Biol Sci & Engn, Shijiazhuang 050061, Peoples R China; [Bernier, Michel] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA	Hebei Medical University; Hebei University of Economics & Business; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wen, JK (corresponding author), Hebei Med Univ, China Minist Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, 361 Zhongshan E Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Bernier, Michel/AAO-3983-2021; Han, Mei/GXH-8347-2022; Cheng, Yunhui/A-5668-2010; Bernier, Michel/Y-7139-2019	Bernier, Michel/0000-0002-5948-368X; Sun, Shao-Guang/0000-0002-2827-0948; Wen, Jinkun/0000-0002-8453-4549	National Institutes of Health, NIA; National Natural Science Foundation of China [30971457, 90919035]; Ministry of Science and Technology of China [2008CB517402]; Natural Science Foundation of Hebei Province [C2008001049]	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported, in whole or in part, by the National Institutes of Health, NIA, Intramural Research Program. This work is also supported by National Natural Science Foundation of China Grants 30971457 and 90919035, Special Fund for Preliminary Research of Key Basic Research Project of the Ministry of Science and Technology of China Grant 2008CB517402, and Natural Science Foundation of Hebei Province Grant C2008001049.	Autieri MV, 2008, CIRC RES, V102, P1455, DOI 10.1161/CIRCRESAHA.108.178954; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Boon RA, 2007, ARTERIOSCL THROM VAS, V27, P532, DOI 10.1161/01.ATV.0000256466.65450.ce; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Giordano A, 2008, CARDIOVASC RES, V79, P519, DOI 10.1093/cvr/cvn079; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Han M, 2009, FEBS J, V276, P1720, DOI 10.1111/j.1742-4658.2009.06902.x; He M, 2009, J BIOCHEM, V146, P683, DOI 10.1093/jb/mvp115; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; Kamiya K, 2007, MOL CELL BIOL, V27, P3489, DOI 10.1128/MCB.00665-06; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; King-Briggs KE, 2000, DIFFERENTIATION, V66, P43, DOI 10.1046/j.1432-0436.2000.066001043.x; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meng F, 2009, BIOCHEM BIOPH RES CO, V387, P13, DOI 10.1016/j.bbrc.2009.05.112; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Weber DS, 2008, CIRC RES, V102, P1448, DOI 10.1161/CIRCRESAHA.108.179044; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang HB, 2008, AM J PHYSIOL-GASTR L, V295, pG170, DOI 10.1152/ajpgi.00492.2007; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zheng B, 2008, BIOCHEMISTRY-MOSCOW+, V73, P353, DOI 10.1134/S0006297908030188; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	50	73	82	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17846	17856		10.1074/jbc.M109.076992	http://dx.doi.org/10.1074/jbc.M109.076992			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375011	Green Published, hybrid			2022-12-25	WOS:000278133400062
J	Vranka, JA; Pokidysheva, E; Hayashi, L; Zientek, K; Mizuno, K; Ishikawa, Y; Maddox, K; Tufa, S; Keene, DR; Klein, R; Bachinger, HP				Vranka, Janice A.; Pokidysheva, Elena; Hayashi, Lauren; Zientek, Keith; Mizuno, Kazunori; Ishikawa, Yoshihiro; Maddox, Kerry; Tufa, Sara; Keene, Douglas R.; Klein, Robert; Baechinger, Hans Peter			Prolyl 3-Hydroxylase 1 Null Mice Display Abnormalities in Fibrillar Collagen-rich Tissues Such as Tendons, Skin, and Bones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; AMINO-ACID SEQUENCE; COVALENT STRUCTURE; DEFICIENCY; PEPTIDES; MUTATIONS; MODEL; CRTAP; MASS	Osteogenesis imperfecta (OI) is a skeletal disorder primarily caused by mutations in the type I collagen genes. However, recent investigations have revealed that mutations in the genes encoding for cartilage-associated protein (CRTAP) or prolyl 3-hydroxylase 1 (P3H1) can cause a severe, recessive form of OI. These reports show minimal 3-hydroxylation of key proline residues in type I collagen as a result of CRTAP or P3H1 deficiency and demonstrate the importance of P3H1 and CRTAP to bone structure and development. P3H1 and CRTAP have previously been shown to form a stable complex with cyclophilin B, and P3H1 was shown to catalyze the 3-hydroxylation of specific proline residues in procollagen I in vitro. Here we describe a mouse model in which the P3H1 gene has been inactivated. Our data demonstrate abnormalities in collagen fibril ultrastructure in tendons from P3H1 null mice by electron microscopy. Differences are also seen in skin architecture, as well as in developing limbs by histology. Additionally bone mass and strength were significantly lower in the P3H1 mice as compared with wild-type littermates. Altogether these investigations demonstrate disturbances of collagen fiber architecture in tissues rich in fibrillar collagen, including bone, tendon, and skin. This model system presents a good opportunity to study the underlying mechanisms of recessive OI and to better understand its effects in humans.	[Vranka, Janice A.; Pokidysheva, Elena; Hayashi, Lauren; Zientek, Keith; Mizuno, Kazunori; Ishikawa, Yoshihiro; Maddox, Kerry; Tufa, Sara; Keene, Douglas R.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Pokidysheva, Elena; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Klein, Robert] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SWSam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Tufa, Sara/0000-0002-6447-8041; Ishikawa, Yoshihiro/0000-0003-2013-0518	Osteogenesis Imperfecta Foundation; Shriners Hospitals for Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030498, R01GM032335] Funding Source: NIH RePORTER	Osteogenesis Imperfecta Foundation; Shriners Hospitals for Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Osteogenesis Imperfecta Foundation (to J. A. V.) and by grants from the Shriners Hospitals for Children (to H. P. B. and D. R. K.).	Aoyama C, 2004, BIOMED CHROMATOGR, V18, P630, DOI 10.1002/bmc.365; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2007, HUM MUTAT, V28, P396, DOI 10.1002/humu.20456; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; FIETZEK PP, 1973, EUR J BIOCHEM, V38, P396, DOI 10.1111/j.1432-1033.1973.tb03072.x; FIETZEK PP, 1972, FEBS LETT, V26, P74, DOI 10.1016/0014-5793(72)80545-3; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; KEFALIDE.NA, 1972, BIOCHEM BIOPH RES CO, V47, P1151, DOI 10.1016/0006-291X(72)90955-2; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; REXRODT FW, 1975, EUR J BIOCHEM, V59, P105, DOI 10.1111/j.1432-1033.1975.tb02430.x; RHODES RK, 1978, BIOCHEMISTRY-US, V17, P3442, DOI 10.1021/bi00610a003; ROYCE PM, 2002, CONNECTIVE TISSUE IT, P385; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SILLENCE DO, 1987, AM J MED GENET, V27, P75, DOI 10.1002/ajmg.1320270109; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Yadav VK, 2009, AGING-US, V1, P954, DOI 10.18632/aging.100100; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	27	68	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17253	17262		10.1074/jbc.M110.102228	http://dx.doi.org/10.1074/jbc.M110.102228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363744	Green Published, hybrid			2022-12-25	WOS:000277982600087
J	Lee, CC; Jan, HJ; Lai, JH; Ma, HI; Hueng, DY; Lee, YCG; Cheng, YY; Liu, LW; Wei, HW; Lee, HM				Lee, C-C; Jan, H-J; Lai, J-H; Ma, H-I; Hueng, D-Y; Lee, Y-C Gladys; Cheng, Y-Y; Liu, L-W; Wei, H-W; Lee, H-M			Nodal promotes growth and invasion in human gliomas	ONCOGENE			English	Article						glioma; invasion; MMP-2; Nodal	EMBRYONIC STEM-CELLS; HUMAN GLIOBLASTOMA; GENE-EXPRESSION; FACTOR-BETA; CANCER-CELLS; TUMOR-GROWTH; BRAIN-TUMOR; IN-VITRO; DIFFERENTIATION; PROLIFERATION	Uncontrolled growth and diffused invasion are major causes of mortality in patients with malignant gliomas. Nodal has been shown to have a central role in the tumorigenic signaling pathways of malignant melanoma. In this study, we show that grade IV human glioma cell lines expressed different levels of Nodal, paralleled to the potential for cell invasiveness. Treatment of glioma cell lines with recombinant Nodal (rNodal) increased matrix metalloproteinase 2 (MMP-2) secretion and cell invasiveness. The ectopic expression of Nodal in GBM glioma cells that expressed Nodal at low level resulted in increased MMP-2 secretion, enhanced cell invasiveness, raised cell proliferation rates in vitro, increased tumor growth in vivo, and was associated with poor survival in a mice xenograft model. In contrast, the knockdown of Nodal expression in U87MG glioma cells with high Nodal expression level had reduced MMP-2 secretion, less cell invasiveness, lower tumor growth in vivo and longer lifespan in mice with U87MG/shNodal cell xenografts. In addition, Nodal knockdown promoted the reversion of malignant glioma cells toward a differentiated astrocytic phenotype. Furthermore, our data support the notion that Nodal may regulate glioma progression through the induction of the leukemia inhibitory factor (LIF) and Cripto-1 through activated Smad. Oncogene (2010) 29, 3110-3123; doi: 10.1038/onc.2010.55; published online 12 April 2010	[Jan, H-J; Lai, J-H; Cheng, Y-Y; Liu, L-W; Lee, H-M] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Lee, C-C] Shin Kong Mem Hosp, Dept Pathol, Taipei, Taiwan; [Lee, C-C] Taipei Med Univ, Dept Pathol, Taipei 110, Taiwan; [Lee, C-C] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Ma, H-I; Hueng, D-Y] Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan; [Lee, Y-C Gladys] Taipei Med Univ, Grad Inst Biomed Informat, Taipei 110, Taiwan; [Wei, H-W] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Lee, H-M] Cent Taiwan Univ Sci & Technol, Inst Pharmaceut Sci & Technol, Taichung, Taiwan; [Lee, H-M] Taipei Med Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Taipei 110, Taiwan	Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Fu Jen Catholic University; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; National Taiwan University; Central Taiwan University Science & Technology; Taipei Medical University	Lee, HM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Hsing St, Taipei 110, Taiwan.	leehorng@tmu.edu.tw	Hueng, Dueng-Yuan/AAM-7807-2021	Hueng, Dueng-Yuan/0000-0001-7868-3161; WEI, HEN-WEI/0000-0001-9096-1013				Bennett JT, 2007, NATURE, V450, pE1, DOI 10.1038/nature06314; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chakravarti Arnab, 2008, P173; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Koul D, 2001, ONCOGENE, V20, P6669, DOI 10.1038/sj.onc.1204799; Ma HI, 2002, CANCER RES, V62, P756; Ma HI, 2002, GENE THER, V9, P2, DOI 10.1038/sj.gt.3301616; Mancino M, 2008, J CELL PHYSIOL, V215, P192, DOI 10.1002/jcp.21301; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Postovit LM, 2008, PIGM CELL MELANOMA R, V21, P348, DOI 10.1111/j.1755-148X.2008.00463.x; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Rooprai HK, 2000, BRIT J CANCER, V82, P52, DOI 10.1054/bjoc.1999.0876; Rutka JT, 1997, J NEUROSURG, V87, P420, DOI 10.3171/jns.1997.87.3.0420; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Strizzi Luigi, 2008, Breast Dis, V29, P91; Strizzi L, 2009, CANCER RES, V69, P7131, DOI 10.1158/0008-5472.CAN-09-1199; Strojnik T, 2006, ANTICANCER RES, V26, P2887; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Svechnikova I, 2008, INT J ONCOL, V32, P821; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; Zhou RX, 2000, EXP CELL RES, V254, P269, DOI 10.1006/excr.1999.4762	35	87	95	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2010	29	21					3110	3123		10.1038/onc.2010.55	http://dx.doi.org/10.1038/onc.2010.55			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20383200	Green Submitted			2022-12-25	WOS:000278133100008
J	Smith-McCune, KK; Shiboski, S; Chirenje, MZ; Magure, T; Tuveson, J; Ma, YF; Da Costa, M; Moscicki, AB; Palefsky, JM; Makunike-Mutasa, R; Chipato, T; van der Straten, A; Sawaya, GF				Smith-McCune, Karen K.; Shiboski, Stephen; Chirenje, Mike Z.; Magure, Tsitsi; Tuveson, Jennifer; Ma, Yifei; Da Costa, Maria; Moscicki, Anna-Barbara; Palefsky, Joel M.; Makunike-Mutasa, Rudo; Chipato, Tsungai; van der Straten, Ariane; Sawaya, George F.			Type-Specific Cervico-Vaginal Human Papillomavirus Infection Increases Risk of HIV Acquisition Independent of Other Sexually Transmitted Infections	PLOS ONE			English	Article							LUBRICANT GEL; WOMEN; CLASSIFICATION; DIAPHRAGM; VACCINE; SYSTEM; HERPES; CELLS	Background: Sexually transmitted infections (STIs) such as herpes simplex virus (HSV)-2 are associated with an increased risk of HIV infection. Human papillomavirus (HPV) is a common STI, but little is know about its role in HIV transmission. The objective of this study was to determine whether cervico-vaginal HPV infection increases the risk of HIV acquisition in women independent of other common STIs. Methods and Findings: This prospective cohort study followed 2040 HIV-negative Zimbabwean women (average age 27 years, range 18-49 years) for a median of 21 months. Participants were tested quarterly for 29 HPV types (with L1 PCR primers) and HIV (antibody testing on blood samples with DNA or RNA PCR confirmation). HIV incidence was 2.7 per 100 woman-years. Baseline HPV prevalence was 24.5%, and the most prevalent HPV types were 58 (5.0%), 16 (4.7%), 70 (2.4%), and 18 (2.3%). In separate regression models adjusting for baseline variables (including age, high risk partner, positive test for STIs, positive HSV-2 serology and condom use), HIV acquisition was associated with having baseline prevalent infection with HPV 58 (aHR 2.13; 95% CI 1.09-4.15) or HPV 70 (aHR 2.68; 95% CI 1.08-6.66). In separate regression models adjusting for both baseline variables and time-dependent variables (including HSV-2 status, incident STIs, new sexual partner and condom use), HIV acquisition was associated with concurrent infection with any non-oncogenic HPV type (aHR 1.70; 95% CI 1.02-2.85), any oncogenic HPV type (aHR 1.96; 95% CI 1.16-3.30), HPV 31 (aHR 4.25; 95% CI 1.81-9.97) or HPV 70 (aHR 3.30; 95% CI 1.50-7.20). Detection of any oncogenic HPV type within the previous 6 months was an independent predictor of HIV acquisition, regardless of whether HPV status at the HIV acquisition visit was included (aHR 1.95; 95% CI 1.19-3.21) or excluded (aHR 1.96; 95% CI 1.02-2.85) from the analysis. Conclusions/Significance: Cervico-vaginal HPV infection was associated with an increased risk of HIV acquisition in women, and specific HPV types were implicated in this association. The observational nature of our study precludes establishment of causation between HPV infection and HIV acquisition. However, given the high prevalence of HPV infection in women, further investigation of the role of HPV in HIV transmission is warranted.	[Smith-McCune, Karen K.; Tuveson, Jennifer; Sawaya, George F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Smith-McCune, Karen K.; Moscicki, Anna-Barbara; Palefsky, Joel M.; Sawaya, George F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Shiboski, Stephen; Sawaya, George F.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Ma, Yifei; Moscicki, Anna-Barbara] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Da Costa, Maria; Palefsky, Joel M.; van der Straten, Ariane] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Chirenje, Mike Z.; Magure, Tsitsi; Makunike-Mutasa, Rudo; Chipato, Tsungai] Univ Zimbabwe, Dept Obstet & Gynecol, Harare, Zimbabwe; [van der Straten, Ariane] RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Zimbabwe; Research Triangle Institute	Smith-McCune, KK (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	kmccune@cc.ucsf.edu	Moscicki, Anna-Barbara/AAP-3806-2021	van der Straten, Ariane/0000-0001-8536-648X	Bill and Melinda Gates Foundation [21082]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding was obtained from the Bill and Melinda Gates Foundation (number 21082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Bjorge T, 2002, BRIT J CANCER, V87, P61, DOI 10.1038/sj.bjc.6600350; Cao YC, 2008, J IMMUNOL, V180, P7681, DOI 10.4049/jimmunol.180.11.7681; Castellsague X, 2007, HPV CERVICAL CANC WO; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; EDWARDS RP, 1995, CANCER-AM CANCER SOC, V76, P1411, DOI 10.1002/1097-0142(19951015)76:8<1411::AID-CNCR2820760817>3.0.CO;2-V; Frazer IH, 2009, VIROLOGY, V384, P410, DOI 10.1016/j.virol.2008.10.004; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Fukuchi E, 2009, SEX TRANSM DIS, V36, P305, DOI 10.1097/OLQ.0b013e318194eb76; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; RAMJEE G, 2008, PLOS ONE, P3; Sawaya GF, 2008, OBSTET GYNECOL, V112, P990, DOI 10.1097/AOG.0b013e318189a8a4; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231	23	77	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10094	10.1371/journal.pone.0010094	http://dx.doi.org/10.1371/journal.pone.0010094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386706	Green Submitted, gold, Green Published			2022-12-25	WOS:000276482000020
J	Csibi, A; Communi, D; Muller, N; Bottari, SP				Csibi, Alfredo; Communi, David; Mueller, Nathalie; Bottari, Serge P.			Angiotensin II Inhibits Insulin-Stimulated GLUT4 Translocation and Akt Activation through Tyrosine Nitration-Dependent Mechanisms	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS; SKELETAL-MUSCLE; METABOLIC SYNDROME; PROTEIN-KINASES; HIGH-RISK; SENSITIVITY; RECEPTOR; PEROXYNITRITE	Angiotensin II (Ang II) plays a major role in the pathogenesis of insulin resistance and diabetes by inhibiting insulin's metabolic and potentiating its trophic effects. Whereas the precise mechanisms involved remain ill-defined, they appear to be associated with and dependent upon increased oxidative stress. We found Ang II to block insulin-dependent GLUT4 translocation in L6 myotubes in an NO- and O-2(center dot-)-dependent fashion suggesting the involvement of peroxynitrite. This hypothesis was confirmed by the ability of Ang II to induce tyrosine nitration of the MAP kinases ERK1/2 and of protein kinase B/Akt (Akt). Tyrosine nitration of ERK1/2 was required for their phosphorylation on Thr and Tyr and their subsequent activation, whereas it completely inhibited Akt phosphorylation on Ser(473) and Thr(308) as well as its activity. The inhibitory effect of nitration on Akt activity was confirmed by the ability of SIN-1 to completely block GSK3 alpha phosphorylation in vitro. Inhibition of nitric oxide synthase and NAD(P)Hoxidase and scavenging of free radicals with myricetin restored insulin-stimulated Akt phosphorylation and GLUT4 translocation in the presence of Ang II. Similar restoration was obtained by inhibiting the ERK activating kinase MEK, indicating that these kinases regulate Akt activation. We found a conserved nitration site of ERK1/2 to be located in their kinase domain on Tyr(156/139), close to their active site Asp(166/149), in agreement with a permissive function of nitration for their activation. Taken together, our data show that Ang II inhibits insulin-mediated GLUT4 translocation in this skeletal muscle model through at least two pathways: first through the transient activation of ERK1/2 which inhibit IRS-1/2 and second through a direct inhibitory nitration of Akt. These observations indicate that not only oxidative but also nitrative stress play a key role in the pathogenesis of insulin resistance. They underline the role of protein nitration as a major mechanism in the regulation of Ang II and insulin signaling pathways and more particularly as a key regulator of protein kinase activity.	[Csibi, Alfredo; Mueller, Nathalie; Bottari, Serge P.] Grenoble Univ, INSERM, Lab Bioenerget Fondamentale & Appliquee, U884, Grenoble, France; [Communi, David] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Bottari, Serge P.] CHU Grenoble, F-38043 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Libre de Bruxelles; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Csibi, A (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Serge.Bottari@ujf-grenoble.fr	Bottari, Serge/ABF-3990-2021	Bottari, Serge P./0000-0002-4172-2400	AGIR	AGIR	This work was partly supported by AGIR a dom, grant: "Nitration and insulin resistance" (www.agiradom.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Barnett AH, 2005, ACTA DIABETOL, V42, pS42, DOI 10.1007/s00592-005-0180-4; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Blendea MC, 2005, AM J PHYSIOL-ENDOC M, V288, pE353, DOI 10.1152/ajpendo.00402.2004; BROVKOVYCH V, 2009, J CELL MOL MED; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Ceriello A, 2004, DIABETOLOGIA, V47, P1535, DOI 10.1007/s00125-004-1487-3; Ceriello A, 2002, DIABETES CARE, V25, P1439, DOI 10.2337/diacare.25.8.1439; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453; Coyle JD, 2004, ANN PHARMACOTHER, V38, P1731, DOI 10.1345/aph.1E182; Daiber A, 2009, FREE RADICAL BIO MED, V47, P458, DOI 10.1016/j.freeradbiomed.2009.05.019; Dorenkamp M, 2005, EUR J PHARMACOL, V520, P179, DOI 10.1016/j.ejphar.2005.07.020; Duplain H, 2008, J PHYSIOL-LONDON, V586, P4011, DOI 10.1113/jphysiol.2008.154302; El Bekay R, 2007, J MOL ENDOCRINOL, V39, P351, DOI 10.1677/JME-07-0074; Fan QL, 2004, NEPHROL DIAL TRANSPL, V19, P3012, DOI 10.1093/ndt/gfh499; Frank GD, 2000, ENDOCRINOLOGY, V141, P3120, DOI 10.1210/en.141.9.3120; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Guo W, 2003, AM J PHYSIOL-HEART C, V285, pH1396, DOI 10.1152/ajpheart.00096.2003; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Ischiropoulos H, 2005, TOXICOLOGY, V208, P299, DOI 10.1016/j.tox.2004.11.018; Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kintscher U, 2008, EXPERT OPIN THER TAR, V12, P1257, DOI [10.1517/14728222.12.10.1257, 10.1517/14728222.12.10.1257 ]; Kintscher U, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-12; Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b; Klotz LO, 2000, BIOCHEM J, V352, P219, DOI 10.1042/0264-6021:3520219; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Leiter LA, 2005, AM J HYPERTENS, V18, P121, DOI 10.1016/j.amjhyper.2004.07.001; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; NAVARROCID J, 1995, HYPERTENSION, V26, P1074, DOI 10.1161/01.HYP.26.6.1074; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pacher P, 2006, CURR OPIN PHARMACOL, V6, P136, DOI 10.1016/j.coph.2006.01.001; Perkins JM, 2008, CURR OPIN ENDOCRINOL, V15, P147, DOI 10.1097/MED.0b013e3282f7026f; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pinzar E, 2005, FEBS LETT, V579, P5100, DOI 10.1016/j.febslet.2005.08.019; Pueyo ME, 1998, AM J PHYSIOL-CELL PH, V274, pC214, DOI 10.1152/ajpcell.1998.274.1.C214; Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38; Redon J, 2008, J HYPERTENS, V26, P1891, DOI 10.1097/HJH.0b013e328302ca38; Richey JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE920, DOI 10.1152/ajpendo.1999.277.5.E920; Scheen AJ, 2004, DIABETES METAB, V30, P498, DOI 10.1016/S1262-3636(07)70147-7; Shiuchi T, 2004, HYPERTENSION, V43, P1003, DOI 10.1161/01.HYP.0000125142.41703.64; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Sloniger JA, 2005, METABOLISM, V54, P1659, DOI 10.1016/j.metabol.2005.06.016; Sowers JR, 2004, AM J PHYSIOL-HEART C, V286, pH1597, DOI 10.1152/ajpheart.00026.2004; Sowers JR, 2002, NEW ENGL J MED, V346, P1999, DOI 10.1056/NEJMe020054; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Ullrich V, 2006, J INORG BIOCHEM, V100, P2079, DOI 10.1016/j.jinorgbio.2006.09.019; Wattanapitayakul SK, 2000, FASEB J, V14, P271, DOI 10.1096/fasebj.14.2.271; Wayenberg JL, 2009, FREE RADICAL BIO MED, V47, P975, DOI 10.1016/j.freeradbiomed.2009.07.003; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Whaley-Connell A, 2005, ENDOCRIN METAB CLIN, V34, P63, DOI 10.1016/j.ecl.2004.11.007; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yonemitsu S, 2001, DIABETES, V50, P1093, DOI 10.2337/diabetes.50.5.1093; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	69	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10070	10.1371/journal.pone.0010070	http://dx.doi.org/10.1371/journal.pone.0010070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383279	gold, Green Submitted, Green Published			2022-12-25	WOS:000276454000020
J	Groves, CP; Fernando, P; Robovsky, J				Groves, Colin P.; Fernando, Prithiviraj; Robovsky, Jan			The Sixth Rhino: A Taxonomic Re-Assessment of the Critically Endangered Northern White Rhinoceros	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM-COTTONI; PHYLOGEOGRAPHY; AFRICAN	Background: The two forms of white rhinoceros; northern and southern, have had contrasting conservation histories. The Northern form, once fairly numerous is now critically endangered, while the southern form has recovered from a few individuals to a population of a few thousand. Since their last taxonomic assessment over three decades ago, new material and analytical techniques have become available, necessitating a review of available information and re-assessment of the taxonomy. Results: Dental morphology and cranial anatomy clearly diagnosed the southern and northern forms. The differentiation was well supported by dental metrics, cranial growth and craniometry, and corresponded with differences in post-cranial skeleton, external measurements and external features. No distinctive differences were found in the limited descriptions of their behavior and ecology. Fossil history indicated the antiquity of the genus, dating back at least to early Pliocene and evolution into a number of diagnosable forms. The fossil skulls examined fell outside the two extant forms in the craniometric analysis. Genetic divergence between the two forms was consistent across both nuclear and mitochondrial genomes, and indicated a separation of over a million years. Conclusions: On re-assessing the taxonomy of the two forms we find them to be morphologically and genetically distinct, warranting the recognition of the taxa formerly designated as subspecies; Ceratotherium simum simum the southern form and Ceratotherium simum cottoni the northern form, as two distinct species Ceratotherium simum and Ceratotherium cottoni respectively. The recognition of the northern form as a distinct species has profound implications for its conservation.	[Groves, Colin P.] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Fernando, Prithiviraj] Ctr Conservat & Res, Rajagiriya, Sri Lanka; [Robovsky, Jan] Univ S Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic	Australian National University; University of South Bohemia Ceske Budejovice	Groves, CP (corresponding author), Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia.	Colin.Groves@anu.edu.au	Robovsky, Jan/AAL-3362-2020; Fernando, Prithiviraj/I-8238-2012	Robovsky, Jan/0000-0001-8720-9314; Fernando, Prithiviraj/0000-0001-6968-4189	Czech MSMT 6007665801	Czech MSMT 6007665801	JR was partly supported by Czech grant No. MSMT 6007665801; neither of the other authors were financially supported for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A., 1965, Lammergeyer, V3, P1; Arambourg C., 1970, Annls Mus. natn. Hist, nat. Paris (Ser. 7), V10, P1; Backhaus D., 1964, Zoologische Garten Leipzig, V29, P93; CAVE A. J. E., 1959, PROC ZOOL SOC LONDON, V132, P99; CINKOVA I, 2006, THESIS PALACKY U OLO; Fernando P, 2000, HEREDITY, V84, P362, DOI 10.1046/j.1365-2540.2000.00674.x; Fernando P, 2006, CONSERV GENET, V7, P439, DOI 10.1007/s10592-006-9139-4; Garcia-Rodriguez AI, 1998, MOL ECOL, V7, P1137, DOI 10.1046/j.1365-294x.1998.00430.x; GEORGE M, 1993, RHINOCEROS BIOLOGY AND CONSERVATION, P105; GEORGE M, 1983, INT STUDBOOK AFRICAN, V2, P60; Geraads D, 2005, J VERTEBR PALEONTOL, V25, P451, DOI 10.1671/0272-4634(2005)025[0451:PRMFHA]2.0.CO;2; GROVES C P, 1975, Saeugetierkundliche Mitteilungen, V23, P200; GROVES C P, 1972, Mammalian Species, V8, P1; Guerin C., 1987, P320; Guerin C., 1979, Bulletin de la Societe Geologique de France, V21, P283; GUERIN C, 1985, FAUNES PLIO PLEISTOC, P69; GUERIN C, 1980, DOCUM LAB GEOL LYON, V79; HARRIS JM, 1983, FOSSIL UNGULATES PRO, P130; Hayssen V., 1993, ASDELLS PATTERNS MAM; Heller E., 1913, SMITHSONIAN MISCELLA, V61, P1; HILLMANSMITH AKK, 1986, J ZOOL, V210, P355; HILLMANSMITH K, 1997, NASHORNER BEGEGNUNG, P173; HOLECKOVA D, 2000, DRUR KRALOVE ZOO, P1; Hooijer D.A., 1978, P371; HOOIJER DA, 1969, FOSSIL VERTEBRATES A, V1, P71; HOUCK ML, 1994, J HERED, V85, P30; Jentink F. A., 1892, MUSEUM HIST NATURELL, VXI; Kingston JD, 2007, PALAEOGEOGR PALAEOCL, V243, P272, DOI 10.1016/j.palaeo.2006.08.002; Kirby F. V., 1920, ANN DURBAN MUS, V2, P223; Kunes Martin, 2002, Acta Universitatis Palackianae Olomucensis Facultas Rerum Naturalium Biologica, V39-40, P81; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN EB, 1982, RUN RHINO RUN; MERENLENDER AM, 1989, J HERED, V80, P377, DOI 10.1093/oxfordjournals.jhered.a110878; Mikulica V., 1991, Zoologische Garten, V61, P365; MOLLOY PG, 1954, GRAND LIVRE FAUNE AF, P50; MORALES JC, 1994, MOL PHYLOGENET EVOL, V3, P128, DOI 10.1006/mpev.1994.1015; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Penny M, 1987, RHINOS ENDANGERED SP; PITMAN CRS, 1954, GRAND LIVRE FAUNE AF, P35; Player I. C., 1960, Lammergeyer, V1, P3; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Rachlow JL, 1998, J MAMMAL, V79, P1317, DOI 10.2307/1383023; ROOKMAAKER K, 1982, ZOONOOZ, V55, P4; Schomber H. W., 1966, Saugetierkundliche Mitteilungen, V14, P214; SILINSKI S, 2003, THESIS LUDWIG MAXIMI; SPASSOV N, 1991, ONGULES UNGULATES, V91, P467; STRATIL A, 1990, COMP BIOCHEM PHYS B, V95, P803, DOI 10.1016/0305-0491(90)90320-S; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Vahala Jiri, 1993, International Zoo Yearbook, V32, P16; VANGYSEGHEM R, 1984, Z SAUGETIERKD, V49, P348; 1987, PACHYDERM, V9, P6	52	55	57	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e9703	10.1371/journal.pone.0009703	http://dx.doi.org/10.1371/journal.pone.0009703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383328	Green Published, gold			2022-12-25	WOS:000276454000001
J	Burian, M; Wolz, C; Goerke, C				Burian, Marc; Wolz, Christiane; Goerke, Christiane			Regulatory Adaptation of Staphylococcus aureus during Nasal Colonization of Humans	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; DEVICE-RELATED INFECTION; CLUMPING FACTOR-B; IN-VITRO; SIGNAL-TRANSDUCTION; BIOFILM FORMATION; IMMUNE EVASION; TEICHOIC-ACIDS; PROTEIN; TRANSCRIPTION	The nasopharynx is the main ecological niche of the human pathogen Staphylococcus aureus. Although colonization of the nares is asymptomatic, nasal carriage is a known risk factor for endogenous staphylococcal infection. We quantified S. aureus mRNA levels in nose swabs of persistent carriers to gain insight into the regulatory adaptation of the bacterium to the nasal environment. We could elucidate a general response of the pathogen to the surrounding milieu independent of the strain background or the human host. Colonizing bacteria preferentially express molecules necessary for tissue adherence or immune-evasion whereas toxins are down regulated. From the analysis of regulatory loci we found evidence for a predominate role of the essential two-component system WalKR of S. aureus. The results suggest that during persistent colonization the bacteria are metabolically active with a high cell surface turnover. The increased understanding of bacterial factors that maintain the colonization state can open new therapeutic options to control nasal carriage and subsequent infections.	[Burian, Marc; Wolz, Christiane; Goerke, Christiane] Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Tubingen, Germany	Eberhard Karls University of Tubingen	Burian, M (corresponding author), Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Tubingen, Germany.	christiane.goerke@med.uni-tuebingen.de		Wolz, Christiane/0000-0003-3909-5281	Deutsche Forschungsgemeinschaft [TR34, SFB766]; IZKF, Universitat Tubingen [1596-0-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF, Universitat Tubingen	This work was supported by grants from the Deutsche Forschungsgemeinschaft (TR34 and SFB766) and from the IZKF, Universitat Tubingen (1596-0-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito Y, 2000, RNA, V6, P668, DOI 10.1017/S1355838200992550; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; BURIAN M, 2010, J INFECT DI IN PRESS, V201; Casado B, 2005, PROTEOMICS, V5, P2949, DOI 10.1002/pmic.200401172; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Cole AM, 2002, J IMMUNOL, V169, P6985, DOI 10.4049/jimmunol.169.12.6985; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dubrac S, 2008, ADV EXP MED BIOL, V631, P214, DOI 10.1007/978-0-387-78885-2_15; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Goerke C, 2000, J INFECT DIS, V181, P984, DOI 10.1086/315331; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Qian ZL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-74; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wolz C, 2002, INFECT IMMUN, V70, P2758, DOI 10.1128/IAI.70.6.2758-2762.2002	51	83	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10040	10.1371/journal.pone.0010040	http://dx.doi.org/10.1371/journal.pone.0010040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386721	Green Submitted, Green Published, gold			2022-12-25	WOS:000276420400011
J	Konstantinopoulos, PA; Fountzilas, E; Goldsmith, JD; Bhasin, M; Pillay, K; Francoeur, N; Libermann, TA; Gebhardt, MC; Spentzos, D				Konstantinopoulos, Panagiotis A.; Fountzilas, Elena; Goldsmith, Jeffrey D.; Bhasin, Manoj; Pillay, Kamana; Francoeur, Nancy; Libermann, Towia A.; Gebhardt, Mark C.; Spentzos, Dimitrios			Analysis of Multiple Sarcoma Expression Datasets: Implications for Classification, Oncogenic Pathway Activation and Chemotherapy Resistance	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; GENE-EXPRESSION; GROWTH-FACTOR; IMATINIB MESYLATE; TUMORS; SIGNATURES; CANCER; RECEPTOR; GUIDE; RNA	Background: Diagnosis of soft tissue sarcomas (STS) is challenging. Many remain unclassified (not-otherwise-specified, NOS) or grouped in controversial categories such as malignant fibrous histiocytoma (MFH), with unclear therapeutic value. We analyzed several independent microarray datasets, to identify a predictor, use it to classify unclassifiable sarcomas, and assess oncogenic pathway activation and chemotherapy response. Methodology/Principal Findings: We analyzed 5 independent datasets (325 tumor arrays). We developed and validated a predictor, which was used to reclassify MFH and NOS sarcomas. The molecular "match'' between MFH and their predicted subtypes was assessed using genome-wide hierarchical clustering and Subclass-Mapping. Findings were validated in 15 paraffin samples profiled on the DASL platform. Bayesian models of oncogenic pathway activation and chemotherapy response were applied to individual STS samples. A 170-gene predictor was developed and independently validated (80-85% accuracy in all datasets). Most MFH and NOS tumors were reclassified as leiomyosarcomas, liposarcomas and fibrosarcomas. "Molecular match'' between MFH and their predicted STS subtypes was confirmed both within and across datasets. This classification revealed previously unrecognized tissue differentiation lines (adipocyte, fibroblastic, smooth-muscle) and was reproduced in paraffin specimens. Different sarcoma subtypes demonstrated distinct oncogenic pathway activation patterns, and reclassified MFH tumors shared oncogenic pathway activation patterns with their predicted subtypes. These patterns were associated with predicted resistance to chemotherapeutic agents commonly used in sarcomas. Conclusions/Significance: STS profiling can aid in diagnosis through a predictor tracking distinct tissue differentiation in unclassified tumors, and in therapeutic management via oncogenic pathway activation and chemotherapy response assessment.	[Konstantinopoulos, Panagiotis A.; Fountzilas, Elena; Pillay, Kamana; Francoeur, Nancy; Spentzos, Dimitrios] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Konstantinopoulos, Panagiotis A.; Fountzilas, Elena; Goldsmith, Jeffrey D.; Bhasin, Manoj; Pillay, Kamana; Francoeur, Nancy; Libermann, Towia A.; Gebhardt, Mark C.; Spentzos, Dimitrios] Harvard Univ, Sch Med, Boston, MA USA; [Goldsmith, Jeffrey D.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia A.; Spentzos, Dimitrios] Beth Israel Deaconess Med Ctr, Dept Med, Genom Ctr, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia A.; Spentzos, Dimitrios] Beth Israel Deaconess Med Ctr, Dept Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Gebhardt, Mark C.] Beth Israel Deaconess Med Ctr, Dept Orthoped Surg, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Konstantinopoulos, PA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA.	dspentzo@bidmc.harvard.edu		Bhasin, Manoj/0000-0001-5172-420X; Libermann, Towia/0000-0002-4006-8179	Children's Hospital Molecular Genetics Core facility	Children's Hospital Molecular Genetics Core facility	We wish to thank Hal Schneider, PhD, Laboratory Supervisor, and the personnel of the Children's Hospital Molecular Genetics Core facility, for service and support provided in running the DASL microarray experiments.	Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Blay Jean-Yves, 2004, Cancer Treat Res, V120, P151; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Brenton JD, 2001, BREAST CANCER RES, V3, P77, DOI 10.1186/bcr274; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Dabney AR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001002; Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681; Dagher R, 2002, CLIN CANCER RES, V8, P3034; Daugaard S, 2004, EUR J CANCER, V40, P543, DOI 10.1016/j.ejca.2003.11.009; de Alava E, 2007, CLIN TRANSL ONCOL, V9, P130, DOI 10.1007/s12094-007-0027-2; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fletcher C D, 1997, Verh Dtsch Ges Pathol, V81, P318; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; FLETCHER CDM, 1992, AM J SURG PATHOL, V16, P213, DOI 10.1097/00000478-199203000-00001; Goldberg BR, 2007, ORTHOP NURS, V26, P4; Hegde U, 2001, Curr Oncol Rep, V3, P243, DOI 10.1007/s11912-001-0057-9; Henderson SR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r76; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; LAWRENCE W, 1987, ANN SURG, V205, P349, DOI 10.1097/00000658-198704000-00003; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nascimento AF, 2008, J SURG ONCOL, V97, P330, DOI 10.1002/jso.20972; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 	42	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9747	10.1371/journal.pone.0009747	http://dx.doi.org/10.1371/journal.pone.0009747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368975	gold, Green Published, Green Submitted			2022-12-25	WOS:000276418200002
J	Liou, LY; Walsh, KB; Vartanian, AR; de Bernabe, DBV; Welch, M; Campbell, KP; Oldstone, MBA; Kunz, S				Liou, Li-Ying; Walsh, Kevin B.; Vartanian, Arineh R.; de Bernabe, Daniel Beltran-Valero; Welch, Megan; Campbell, Kevin P.; Oldstone, Michael B. A.; Kunz, Stefan			Functional Glycosylation of Dystroglycan Is Crucial for Thymocyte Development in the Mouse	PLOS ONE			English	Article							T-CELL DEVELOPMENT; IMMUNOLOGICAL SYNAPSE; ALPHA-DYSTROGLYCAN; SURVIVAL; CD8(+); VIRUS; LYMPHOCYTES; ACTIVATION; DELETION; RECEPTOR	Background: Alpha-dystroglycan (alpha-DG) is a cell surface receptor providing a molecular link between the extracellular matrix (ECM) and the actin-based cytoskeleton. During its biosynthesis, alpha-DG undergoes specific and unusual O-glycosylation crucial for its function as a high-affinity cellular receptor for ECM proteins. Methodology/Principal Findings: We report that expression of functionally glycosylated alpha-DG during thymic development is tightly regulated in developing T cells and largely confined to CD4(-) CD8(-) double negative (DN) thymocytes. Ablation of DG in T cells had no effect on proliferation, migration or effector function but did reduce the size of the thymus due to a significant loss in absolute numbers of thymocytes. While numbers of DN thymocytes appeared normal, a marked reduction in CD4(+) CD8(+) double positive (DP) thymocytes occurred. In the periphery mature naive T cells deficient in DG showed both normal proliferation in response to allogeneic cells and normal migration, effector and memory T cell function when tested in acute infection of mice with either lymphocytic choriomeningitis virus (LCMV) or influenza virus. Conclusions/Significance: Our study demonstrates that DG function is modulated by glycosylation during T cell development in vivo and that DG is essential for normal development and differentiation of T cells.	[Liou, Li-Ying; Walsh, Kevin B.; Vartanian, Arineh R.; Welch, Megan; Oldstone, Michael B. A.; Kunz, Stefan] Scripps Res Inst, Dept Immunol & Microbial Sci, Viral Immunobiol Lab, La Jolla, CA 92037 USA; [de Bernabe, Daniel Beltran-Valero; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys,Dept Neurol, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys,Dept Internal Med, Iowa City, IA 52242 USA; [Oldstone, Michael B. A.] Scripps Florida, Dept Infectol, Jupiter, FL USA; [Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Kunz, Stefan] Univ Lausanne, Lausanne, Switzerland	Scripps Research Institute; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; State University System of Florida; University of Florida; University of Lausanne	Liou, LY (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, Viral Immunobiol Lab, La Jolla, CA 92037 USA.	mbaobo@scripps.edu; stefan.kunz@chuv.ch	; Kunz, Stefan/K-5840-2017	Campbell, Kevin/0000-0003-2066-5889; Kunz, Stefan/0000-0001-6030-9550	US Public Health Service [AI009484, AI045927, AI055540, AI074564, NS041219]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [NS053672]; National Science Foundation [3100A0-120250/1]; Marie Curie International Reintegration [224780]; European Community; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055540, R01AI045927, R01AI009484, R01AI055540, U01AI074564, R37AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672, T32NS041219] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center(Ohio State University); National Science Foundation(National Science Foundation (NSF)); Marie Curie International Reintegration(European Commission); European Community(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US Public Health Service grants AI009484, AI045927, AI055540, AI074564 and training grant NS041219 to L-Y.L. and K. B. W. This work was also supported in part by the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant NS053672. K. P. C. is an Investigator of the Howard Hughes Medical Institute. S. K. was supported by a Medical Research Position Award of the Foundation Prof. Dr. Max Cloetta (Switzerland), by Swiss National Science Foundation grant Nr. 3100A0-120250/1, and the Marie Curie International Reintegration Grant Nr. 224780 of the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Berger DP, 2000, VIROLOGY, V266, P257, DOI 10.1006/viro.1999.0074; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; BORROW P, 1991, J EXP MED, V174, P203, DOI 10.1084/jem.174.1.203; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Cohn RD, 2005, NEUROMUSCULAR DISORD, V15, P207, DOI 10.1016/j.nmd.2004.11.005; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Gong YP, 2008, FASEB J, V22, P1426, DOI 10.1096/fj.07-9264com; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 2001, J CELL SCI, V114, P1137; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Iwao M, 2000, IMMUNOLOGY, V99, P481, DOI 10.1046/j.1365-2567.2000.00990.x; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Kutlesa S, 2002, IMMUNOLOGY, V105, P407, DOI 10.1046/j.1365-2567.2002.01384.x; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miller NE, 2005, J VIROL, V79, P9419, DOI 10.1128/JVI.79.15.9419-9429.2005; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Zhang JP, 2006, FASEB J, V20, P50, DOI 10.1096/fj.04-3303com	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9915	10.1371/journal.pone.0009915	http://dx.doi.org/10.1371/journal.pone.0009915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369005	Green Published, Green Submitted, gold			2022-12-25	WOS:000276163100009
J	Velten, J; Cakir, C; Cazzonelli, CI				Velten, Jeff; Cakir, Cahid; Cazzonelli, Christopher I.			A Spontaneous Dominant-Negative Mutation within a 35S::AtMYB90 Transgene Inhibits Flower Pigment Production in Tobacco	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; R2R3-MYB GENE FAMILY; ANTHOCYANIN BIOSYNTHESIS; ZEA-MAYS; EXPRESSION ANALYSIS; MOLECULAR ANALYSIS; ACTIVATION DOMAIN; REGULATORY GENE; C1-I ALLELE; ARABIDOPSIS	Background: In part due to the ease of visual detection of phenotypic changes, anthocyanin pigment production has long been the target of genetic and molecular research in plants. Specific members of the large family of plant myb transcription factors have been found to play critical roles in regulating expression of anthocyanin biosynthetic genes and these genes continue to serve as important tools in dissecting the molecular mechanisms of plant gene regulation. Findings: A spontaneous mutation within the coding region of an Arabidopsis 35S::AtMYB90 transgene converted the activator of plant-wide anthocyanin production to a dominant-negative allele (PG-1) that inhibits normal pigment production within tobacco petals. Sequence analysis identified a single base change that created a premature nonsense codon, truncating the encoded myb protein. The resulting mutant protein lacks 78 amino acids from the wild type C-terminus and was confirmed as the source of the white-flower phenotype. A putative tobacco homolog of AtMYB90 (NtAN2) was isolated and found to be expressed in flower petals but not leaves of all tobacco plants tested. Using transgenic tobacco constitutively expressing the NtAN2 gene confirmed the NtAN2 protein as the likely target of PG-1-based inhibition of tobacco pigment production. Conclusions: Messenger RNA and anthocyanin analysis of PG-1Sh transgenic lines (and PG-1Sh x purple 35S:: NtAN2 seedlings) support a model in which the mutant myb transgene product acts as a competitive inhibitor of the native tobacco NtAN2 protein. This finding is important to researchers in the field of plant transcription factor analysis, representing a potential outcome for experiments analyzing in vivo protein function in test transgenic systems that over-express or mutate plant transcription factors.	[Velten, Jeff; Cakir, Cahid] USDA ARS, Plant Stress & Water Conservat Lab, Lubbock, TX USA; [Cazzonelli, Christopher I.] Australian Natl Univ, Res Sch Biol, Ctr Excellence Plant Energy Biol, Australian Res Council, Canberra, ACT, Australia	United States Department of Agriculture (USDA); Australian National University	Velten, J (corresponding author), USDA ARS, Plant Stress & Water Conservat Lab, Lubbock, TX USA.	VeltenLab@gmail.com	Cazzonelli, Christopher I/A-5347-2010	Cazzonelli, Christopher I/0000-0003-3096-3193	United States Department of Agriculture, Agricultural Research Service [6208-21000-016-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture, Agricultural Research Service (CRIS project number 6208-21000-016-00D), <http://www.ars.usda.gov/main/main.htm>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; Cazzonelli CI, 2004, PLANT MOL BIOL REP, V22, P347, DOI 10.1007/BF02772678; Chen BJ, 2004, MOL BIOTECHNOL, V26, P187, DOI 10.1385/MB:26:3:187; COE EH, 1962, GENETICS, V47, P779; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; D.P.S, PLANT MOL BIOL MANUA, P1, DOI 10.1007/978-94-009-0951-9; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; FRANKEN P, 1994, PLANT J, V6, P21, DOI 10.1046/j.1365-313X.1994.6010021.x; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; LLOYD AM, 1992, SCIENCE, V258, P1773, DOI 10.1126/science.1465611; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Maiti IB, 1998, BIOCHEM BIOPH RES CO, V244, P440, DOI 10.1006/bbrc.1998.8287; MALIGA P, 1975, NATURE, V255, P401, DOI 10.1038/255401a0; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Matousek J, 2006, J AGR FOOD CHEM, V54, P7606, DOI 10.1021/jf061785g; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Orzaez D, 2009, PLANT PHYSIOL, V150, P1122, DOI 10.1104/pp.109.139006; Park JS, 2008, PLANT CELL REP, V27, P985, DOI 10.1007/s00299-008-0521-1; Pattanaik S, 2008, PLANTA, V227, P707, DOI 10.1007/s00425-007-0676-y; PAZARES J, 1990, EMBO J, V9, P315, DOI 10.1002/j.1460-2075.1990.tb08113.x; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rushton PJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-53; SABLOWSKI RWM, 1994, EMBO J, V13, P128, DOI 10.1002/j.1460-2075.1994.tb06242.x; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Sambrook J., 2001, MOL CLONING LAB MANU; Shen LY, 2006, MOL BREEDING, V18, P57, DOI 10.1007/s11032-006-9018-1; Singer T, 1998, GENET RES, V71, P127, DOI 10.1017/S0016672398003218; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; STADLER LJ, 1946, GENETICS, V31, P377; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Svab Zora, 1995, P55; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Urao T, 1996, PLANT J, V10, P1145, DOI 10.1046/j.1365-313X.1996.10061145.x; VELTEN J, 1985, NUCLEIC ACIDS RES, V13, P6981, DOI 10.1093/nar/13.19.6981; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1235, DOI 10.1002/biot.200700184; Walker Clive H., 1994, P1; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x; Zuluaga DL, 2008, FUNCT PLANT BIOL, V35, P606, DOI 10.1071/FP08021	72	11	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9917	10.1371/journal.pone.0009917	http://dx.doi.org/10.1371/journal.pone.0009917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360951	Green Submitted, Green Published, gold			2022-12-25	WOS:000276163100010
J	Carroll, P; Schreuder, LJ; Muwanguzi-Karugaba, J; Wiles, S; Robertson, BD; Ripoll, J; Ward, TH; Bancroft, GJ; Schaible, UE; Parish, T				Carroll, Paul; Schreuder, Lise J.; Muwanguzi-Karugaba, Julian; Wiles, Siouxsie; Robertson, Brian D.; Ripoll, Jorge; Ward, Theresa H.; Bancroft, Gregory J.; Schaible, Ulrich E.; Parish, Tanya			Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red Reporters	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; BACTERIAL-INFECTIONS; REAL-TIME; TUBERCULOSIS; PROMOTER; DYNAMICS; MARKER; INSTABILITY; PROGRESSION	Fluorescent reporter proteins have proven useful for imaging techniques in many organisms. We constructed optimized expression systems for several fluorescent proteins from the far-red region of the spectrum and analyzed their utility in several mycobacterial species. Plasmids expressing variants of the Discosoma Red fluorescent protein (DsRed) from the Mycobacterium bovis hsp60 promoter were unstable; in contrast expression from the Mycobacterium smegmatis rpsA promoter was stable. In Mycobacterium tuberculosis expression of several of the far-red reporters was readily visualised by eye and three reporters (mCherry, tdTomato, and Turbo-635) fluoresced at a high intensity. Strains expressing mCherry showed no fitness defects in vitro or in macrophages. Treatment of cells with antibiotics demonstrated that mCherry could also be used as a reporter for cell death, since fluorescence decreased in the presence of a bactericidal compound, but remained stable in the presence of a bacteriostatic compound. mCherry was functional under hypoxic conditions; using mCherry we demonstrated that the PmtbB is expressed early in hypoxia and progressively down-regulated. mCherry and other far-red fluorescent proteins will have multiple uses in investigating the biology of mycobacteria, particularly under non-replicating, or low cell density conditions, as well as providing a novel means of detecting cell death rapidly.	[Carroll, Paul; Schreuder, Lise J.; Muwanguzi-Karugaba, Julian; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Wiles, Siouxsie; Robertson, Brian D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Wiles, Siouxsie] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Ripoll, Jorge] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Greece; [Ward, Theresa H.; Bancroft, Gregory J.; Schaible, Ulrich E.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England; [Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Res, Borstel, Germany; [Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA	University of London; Queen Mary University London; Imperial College London; University of Auckland; Foundation for Research & Technology - Hellas (FORTH); University of London; London School of Hygiene & Tropical Medicine; Forschungszentrum Borstel	Carroll, P (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	t.parish@qmul.ac.uk	Schaible, Ulrich/C-7837-2011; Ripoll, Jorge/J-8134-2012; Wiles, Siouxsie/E-1690-2011; Ripoll, Jorge/AAW-2245-2020; Ward, Theresa H./E-9650-2013	Schaible, Ulrich/0000-0002-6638-7282; Ripoll, Jorge/0000-0001-8856-7738; Wiles, Siouxsie/0000-0002-0467-0015; Ripoll, Jorge/0000-0001-8856-7738; Ward, Theresa H./0000-0002-9881-8649; Robertson, Brian D./0000-0001-5785-5307	Bill and Melinda Gates Foundation TB Drug Accelerator Programme; BBSRC [BB/E52708X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish	Bill and Melinda Gates Foundation TB Drug Accelerator Programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Bill and Melinda Gates Foundation TB Drug Accelerator Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarouni M, 2002, TUBERCULOSIS, V82, P283, DOI 10.1054/tube.2002.0374; Anilkumar G, 1998, GENE, V214, P7, DOI 10.1016/S0378-1119(98)00248-0; Barker LP, 1998, MOL MICROBIOL, V29, P1167, DOI 10.1046/j.1365-2958.1998.00996.x; Bourn WR, 2007, TUBERCULOSIS, V87, P481, DOI 10.1016/j.tube.2007.08.003; Brown AC, 2006, PLASMID, V55, P81, DOI 10.1016/j.plasmid.2005.06.005; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Coons AH, 1942, J IMMUNOL, V45, P159; Cosma CL, 2008, J INFECT DIS, V198, P1851, DOI 10.1086/593175; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; De Smet KAL, 1999, MICROBIOL-UK, V145, P3177, DOI 10.1099/00221287-145-11-3177; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Dunn KW, 2002, AM J PHYSIOL-CELL PH, V283, pC905, DOI 10.1152/ajpcell.00159.2002; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Gall K, 2006, FEMS MICROBIOL LETT, V255, P301, DOI 10.1111/j.1574-6968.2005.00078.x; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; KATZ MH, 2003, J SURG RES, P113; KREMER L, 1995, MOL MICROBIOL, V17, P913, DOI 10.1111/j.1365-2958.1995.mmi_17050913.x; LIM CR, 1995, J BIOCHEM-TOKYO, V118, P13, DOI 10.1093/oxfordjournals.jbchem.a124868; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Lukey P T, 2001, Methods Mol Med, V54, P271, DOI 10.1385/1-59259-147-7:271; Mansson LE, 2007, CELL MICROBIOL, V9, P2334, DOI 10.1111/j.1462-5822.2007.01019.x; Mansson LE, 2007, CELL MICROBIOL, V9, P413, DOI 10.1111/j.1462-5822.2006.00799.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Muller-Taubenberger A, 2007, APPL MICROBIOL BIOT, V77, P1, DOI 10.1007/s00253-007-1131-5; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; RALPH P, 1975, J IMMUNOL, V114, P898; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; SCHERBO D, 2009, BIOCHEM J, V418, P567; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Srivastava R, 1997, BIOCHEM BIOPH RES CO, V235, P602, DOI 10.1006/bbrc.1997.6837; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yamamoto N, 2004, CANCER RES, V64, P4251, DOI 10.1158/0008-5472.CAN-04-0643; Yamamoto N, 2003, CANCER RES, V63, P7785; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Zinselmeyer BH, 2008, INFLAMM RES, V57, P93, DOI 10.1007/s00011-007-7195-y	57	111	113	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9823	10.1371/journal.pone.0009823	http://dx.doi.org/10.1371/journal.pone.0009823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352111	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000275894400023
J	Han, JM; Kwon, NH; Lee, JY; Jeong, SJ; Jung, HJ; Kim, HR; Li, ZH; Kim, S				Han, Jung Min; Kwon, Nam Hoon; Lee, Jin Young; Jeong, Seung Jae; Jung, Hee Jung; Kim, Hyeong Rae; Li, Zihai; Kim, Sunghoon			Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CELL-SURFACE EXPRESSION; DENDRITIC CELLS; GOLGI-COMPLEX; KDEL RECEPTOR; LUPUS; HSP90; OLIGOMERIZATION; LOCALIZATION; INHIBITION	Heat shock proteins have been implicated as endogenous activators for dendritic cells (DCs). Chronic expression of heat shock protein gp96 on cell surfaces induces significant DC activations and systemic lupus erythematosus (SLE)-like phenotypes in mice. However, its potential as a therapeutic target against SLE remains to be evaluated. In this work, we conducted chemical approach to determine whether SLE-like phenotypes can be compromised by controlling surface translocation of gp96. From screening of chemical library, we identified a compound that binds and suppresses surface presentation of gp96 by facilitating its oligomerization and retrograde transport to endoplasmic reticulum. In vivo administration of this compound reduced maturation of DCs, populations of antigen presenting cells, and activated B and T cells. The chemical treatment also alleviated the SLE-associated symptoms such as glomerulonephritis, proteinuria, and accumulation of anti-nuclear and -DNA antibodies in the SLE model mice resulting from chronic surface exposure of gp96. These results suggest that surface translocation of gp96 can be chemically controlled and gp96 as a potential therapeutic target to treat autoimmune disease like SLE.	[Han, Jung Min; Kwon, Nam Hoon; Lee, Jin Young; Jeong, Seung Jae; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Seoul, South Korea; [Kim, Sunghoon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Suwon, South Korea; [Han, Jung Min] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Jung, Hee Jung; Kim, Hyeong Rae] Korea Res Inst Chem Technol, Bioorgan Sci Div, Canc & Infect Dis Res Ctr, Taejon 305606, South Korea; [Li, Zihai] Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Chemical Technology (KRICT); University of Connecticut	Han, JM (corresponding author), Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Seoul, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Han, Jung Min/0000-0003-3372-7575; kim, sunghoon/0000-0002-1570-3230	Korean Government [NRF-2008-359-C00024]; Korean Ministry of Science and Technology [FPR08B1- 250]; Ministry of Education, Science, and Technology [R31-2008-000-10103-0]; Korea Science and Engineering Foundation	Korean Government(Korean Government); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2008-359-C00024), by FPR08B1- 250 of 21C Frontier Functional Proteomics Project from Korean Ministry of Science and Technology, by R31-2008-000-10103-0 from the WCU project of the Ministry of Education, Science, and Technology and the Korea Science and Engineering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Banerjee PP, 2002, J IMMUNOL, V169, P3507, DOI 10.4049/jimmunol.169.7.3507; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BERDEN JHM, 1983, J IMMUNOL, V130, P1699; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Han JM, 2007, AM J PATHOL, V170, P2042, DOI 10.2353/ajpath.2007.061266; Hilf N, 2002, BLOOD, V99, P3676, DOI 10.1182/blood.V99.10.3676; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Lee SW, 2008, EXPERT OPIN DRUG DIS, V3, P945, DOI 10.1517/17460441.3.8.945; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Li ZH, 2002, FRONT BIOSCI-LANDMRK, V7, pD731; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Monrad S, 2007, IMMUNOL RES, V37, P135, DOI 10.1007/BF02685895; Nagy G, 2005, CRIT REV IMMUNOL, V25, P123, DOI 10.1615/CritRevImmunol.v25.i2.30; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Neve EPA, 2005, J MOL BIOL, V354, P556, DOI 10.1016/j.jmb.2005.09.077; PELHAM H R B, 1991, Current Opinion in Cell Biology, V3, P585, DOI 10.1016/0955-0674(91)90027-V; Robert J, 1999, J IMMUNOL, V163, P4133; Schur PH, 1995, LUPUS, V4, P425, DOI 10.1177/096120339500400603; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; SINGER GG, 1994, CURR OPIN IMMUNOL, V6, P913, DOI 10.1016/0952-7915(94)90013-2; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; VABULAS RM, 2002, J BIOL CHEM; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5	42	35	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9792	10.1371/journal.pone.0009792	http://dx.doi.org/10.1371/journal.pone.0009792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352117	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400011
J	von Kampen, O; Lipinski, S; Till, A; Martin, SJ; Nietfeld, W; Lehrach, H; Schreiber, S; Rosenstiel, P				von Kampen, Oliver; Lipinski, Simone; Till, Andreas; Martin, Seamus J.; Nietfeld, Wilfried; Lehrach, Hans; Schreiber, Stefan; Rosenstiel, Philip			Caspase Recruitment Domain-containing Protein 8 (CARD8) Negatively Regulates NOD2-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; KAPPA-B ACTIVATION; INFLAMMATORY CASPASES; CROHNS-DISEASE; IMMUNE-SYSTEM; FAMILY MEMBER; NOD2 GENE; MUTATION; ASSOCIATION; EXPRESSION	Caspase activating and recruitment domain 8 (CARD8) has been implicated as a co-regulator of several pro-inflammatory and apoptotic signaling pathways. In the present study, we demonstrate a specific modulation of NOD2-induced signaling by CARD8 in intestinal epithelial cells. We show that CARD8 physically interacts with NOD2 and inhibits nodosome assembly and subsequent signaling upon muramyl-dipeptide stimulation. Furthermore, CARD8 inhibits the direct bactericidal effect of NOD2 against intracellular infection by Listeria monocytogenes. Thus, CARD8 represents a novel molecular switch involved in the endogenous regulation of NOD2-dependent inflammatory processes in epithelial cells.	[von Kampen, Oliver; Lipinski, Simone; Till, Andreas; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Martin, Seamus J.] Univ Dublin Trinity Coll, Smurfit Inst, Mol Cell Biol Lab, Dept Genet, Dublin 2, Ireland; [Nietfeld, Wilfried; Lehrach, Hans] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Kiel; Trinity College Dublin; Max Planck Society	Rosenstiel, P (corresponding author), Univ Kiel, Inst Clin Mol Biol, Schittenhelmstr 12, D-24105 Kiel, Germany.	p.rosenstiel@mucosa.de	Rosenstiel, Philip/A-5137-2009; Lipinski, Simone/L-9818-2017; Till, Andreas/AAO-6375-2021; Till, Andreas/E-9661-2013	Rosenstiel, Philip/0000-0002-9692-8828; Lipinski, Simone/0000-0002-9322-7372; Martin, Seamus/0000-0002-8539-3143; Till, Andreas/0000-0002-0139-9143	DFG (Deutsche Forschungsgemeinschaft) [SCHR512/11-1]; Clusters of Excellence Inflammation at Interfaces and The Future Ocean; German Federal Ministry of Education and Research BMBF through the NGFN plus Network on Environment-related diseases	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Clusters of Excellence Inflammation at Interfaces and The Future Ocean; German Federal Ministry of Education and Research BMBF through the NGFN plus Network on Environment-related diseases(Federal Ministry of Education & Research (BMBF))	This work was supported by the DFG (Deutsche Forschungsgemeinschaft) SCHR512/11-1, the Clusters of Excellence Inflammation at Interfaces and The Future Ocean and by the German Federal Ministry of Education and Research BMBF through the NGFN plus Network on Environment-related diseases.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Checinska A, 2006, ANTICANCER RES, V26, P3819; Dinarello CA, 2004, IMMUNITY, V20, P243, DOI 10.1016/S1074-7613(04)00055-X; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Gattin Z, 2008, CHEMBIOCHEM, V9, P923, DOI 10.1002/cbic.200700434; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; ROSENSTIEL P, 2006, P NATL ACAD SCI USA; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Verma UN, 2004, J BIOL CHEM, V279, P3509, DOI 10.1074/jbc.M309300200	36	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19921	19926		10.1074/jbc.M110.127480	http://dx.doi.org/10.1074/jbc.M110.127480			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20385562	Green Published			2022-12-25	WOS:000279012000025
J	Zhang, LP; Tran, DT; Ten Hagen, KG				Zhang, Liping; Tran, Duy T.; Ten Hagen, Kelly G.			An O-Glycosyltransferase Promotes Cell Adhesion during Development by Influencing Secretion of an Extracellular Matrix Integrin Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; HYPEROSTOSIS-HYPERPHOSPHATEMIA SYNDROME; DROSOPHILA-MELANOGASTER; UDP-GALNAC; MEDIATED ADHESION; GENETIC-ANALYSIS; PS INTEGRINS; GLYCOSYLATION; PROTEIN; EXPRESSION	Protein secretion and localization are crucial during eukaryotic development, establishing local cell environments as well as mediating cell interactions, signaling, and adhesion. In this study, we demonstrate that the glycosyltransferase, pgant3, specifically modulates integrin-mediated cell adhesion by influencing the secretion and localization of the integrin ligand, Tiggrin. We demonstrate that Tiggrin is normally O-glycosylated and localized to the basal matrix where the dorsal and ventral cell layers adhere in wild type Drosophila wings. In pgant3 mutants, Tiggrin is no longer O-glycosylated and fails to be properly secreted to this basal cell layer interface, resulting in disruption of integrin-mediated cell adhesion in the wing. pgant3-mediated effects are dependent on enzymatic activity, as mutations that form a stable protein yet abrogate O-glycosyltransferase activity result in Tiggrin accumulation within the dorsal and ventral cells comprising the wing. Our results provide the first in vivo evidence for the role of O-glycosylation in the secretion of specific extracellular matrix proteins, thus altering the composition of the cellular "microenvironment" and thereby modulating developmentally regulated cell adhesion events. As alterations in cell adhesion are a hallmark of cancer progression, this work provides insight into the long-standing association between aberrant O-glycosylation and tumorigenesis.	[Zhang, Liping; Tran, Duy T.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	kelly.tenhagen@nih.gov			National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIDCR.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Araujo H, 2003, DEVELOPMENT, V130, P3851, DOI 10.1242/dev.00613; Avichezer D, 1997, INT J CANCER, V72, P119, DOI 10.1002/(SICI)1097-0215(19970703)72:1<119::AID-IJC17>3.3.CO;2-5; Bloor JW, 1998, GENETICS, V148, P1127; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; BROWER DL, 1995, DEVELOPMENT, V121, P1311; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bunch TA, 1998, DEVELOPMENT, V125, P1679; Chanana B, 2007, MECH DEVELOP, V124, P463, DOI 10.1016/j.mod.2007.03.005; Delannoy P, 1996, GLYCOCONJUGATE J, V13, P717, DOI 10.1007/BF00702335; Devenport D, 2007, DEV BIOL, V308, P294, DOI 10.1016/j.ydbio.2007.02.046; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Frishberg Y, 2007, J BONE MINER RES, V22, P235, DOI 10.1359/JBMR.061105; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Funes M, 2006, J BIOL CHEM, V281, P19310, DOI 10.1074/jbc.M603225200; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gouyer V, 2001, J CELL SCI, V114, P1455; Graner MW, 1998, J BIOL CHEM, V273, P18235, DOI 10.1074/jbc.273.29.18235; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Narasimha M, 2004, CURR BIOL, V14, P381, DOI 10.1016/j.cub.2004.02.033; O'Keefe DD, 2007, DEV BIOL, V311, P25, DOI 10.1016/j.ydbio.2007.08.003; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Prout M, 1997, GENETICS, V146, P275; Schock F, 2003, GENE DEV, V17, P597, DOI 10.1101/gad.1068403; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Subramanian A, 2007, DEVELOPMENT, V134, P1269, DOI 10.1242/dev.000406; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Walsh EP, 1998, GENETICS, V150, P791; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	60	39	42	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19491	19501		10.1074/jbc.M109.098145	http://dx.doi.org/10.1074/jbc.M109.098145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20371600	Green Published, hybrid			2022-12-25	WOS:000278727800059
J	Okamura-Ikeda, K; Hosaka, H; Maita, N; Fujiwara, K; Yoshizawa, AC; Nakagawa, A; Taniguchi, H				Okamura-Ikeda, Kazuko; Hosaka, Harumi; Maita, Nobuo; Fujiwara, Kazuko; Yoshizawa, Akiyasu C.; Nakagawa, Atsushi; Taniguchi, Hisaaki			Crystal Structure of Aminomethyltransferase in Complex with Dihydrolipoyl-H-Protein of the Glycine Cleavage System IMPLICATIONS FOR RECOGNITION OF LIPOYL PROTEIN SUBSTRATE, DISEASE-RELATED MUTATIONS, AND REACTION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI T-PROTEIN; UNDERSTANDING NONKETOTIC HYPERGLYCINEMIA; LIPOAMIDE DEHYDROGENASE; TERMINAL REGION; RESOLUTION; BINDING; IDENTIFICATION; INTERMEDIATE; COMPONENT	Aminomethyltransferase, a component of the glycine cleavage system termed T-protein, reversibly catalyzes the degradation of the aminomethyl moiety of glycine attached to the lipoate cofactor of H-protein, resulting in the production of ammonia, 5,10-methylenetetrahydrofolate, and dihydrolipoate-bearing H-protein in the presence of tetrahydrofolate. Several mutations in the human T-protein gene are known to cause nonketotic hyperglycinemia. Here, we report the crystal structure of Escherichia coli T-protein in complex with dihydrolipoate-bearing H-protein and 5-methyltetrahydrofolate, a complex mimicking the ternary complex in the reverse reaction. The structure of the complex shows a highly interacting intermolecular interface limited to a small area and the protein-bound dihydrolipoyllysine arm inserted into the active site cavity of the T-protein. Invariant Arg(292) of the T-protein is essential for complex assembly. The structure also provides novel insights in understanding the disease-causing mutations, in addition to the disease-related impairment in the cofactor-enzyme interactions reported previously. Furthermore, structural and mutational analyses suggest that the reversible transfer of the methylene group between the lipoate and tetrahydrofolate should proceed through the electron relay-assisted iminium intermediate formation.	[Okamura-Ikeda, Kazuko; Maita, Nobuo; Fujiwara, Kazuko; Yoshizawa, Akiyasu C.; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; [Hosaka, Harumi; Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Tokushima University; Osaka University	Okamura-Ikeda, K (corresponding author), Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan.	ikeda@ier.tokushima-u.ac.jp	Maita, Nobuo/J-1443-2012; Nakagawa, Atsushi/D-4329-2009; Taniguchi, Hisaaki/I-9171-2012; Nakagawa, Atsushi/M-5731-2019	Maita, Nobuo/0000-0003-2260-5783; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (to H. T.) and by the National Project on Protein Structural and Functional Analyses from Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; COHENADDAD C, 1995, NAT STRUCT BIOL, V2, P63, DOI 10.1038/nsb0195-63; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIWARA K, 1984, J BIOL CHEM, V259, P664; Guilhaudis L, 2000, BIOCHEMISTRY-US, V39, P4259, DOI 10.1021/bi992674w; KALLEN RG, 1966, J BIOL CHEM, V241, P5851; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee HH, 2004, J BIOL CHEM, V279, P50514, DOI 10.1074/jbc.M409672200; Lokanath NK, 2005, PROTEINS, V58, P769, DOI 10.1002/prot.20345; MATTEVI A, 1991, J MOL BIOL, V220, P975, DOI 10.1016/0022-2836(91)90367-F; MOTOKAWA Y, 1995, BIOTHIOLS HLTH DIS, P389; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; NANAO K, 1994, HUM GENET, V93, P655; Okamura-Ikeda K, 1999, EUR J BIOCHEM, V264, P446, DOI 10.1046/j.1432-1327.1999.00637.x; Okamura-Ikeda K, 2005, J MOL BIOL, V351, P1146, DOI 10.1016/j.jmb.2005.06.056; Okamura-Ikeda K, 2003, J BIOL CHEM, V278, P10067, DOI 10.1074/jbc.M210853200; Okamura-Ikeda K, 1999, J BIOL CHEM, V274, P17471, DOI 10.1074/jbc.274.25.17471; OKAMURAIKEDA K, 1987, J BIOL CHEM, V262, P6746; OKAMURAIKEDA K, 1982, J BIOL CHEM, V257, P135; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; Rizzi M, 1998, STRUCTURE, V6, P1129, DOI 10.1016/S0969-2126(98)00114-2; TADA K, 1987, EUR J PEDIATR, V146, P221, DOI 10.1007/BF00716464; Toyoda T, 1998, J BIOCHEM-TOKYO, V123, P668; Watanabe K, 2007, NATURE, V449, P867, DOI 10.1038/nature06167	26	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18684	18692		10.1074/jbc.M110.110718	http://dx.doi.org/10.1074/jbc.M110.110718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375021	hybrid, Green Published			2022-12-25	WOS:000278453900061
J	Li, H; Liu, JW				Li, Hai; Liu, Jingwen			Identification of Heterogeneous Nuclear Ribonucleoprotein K as a Transactivator for Human Low Density Lipoprotein Receptor Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT REGULATORY ELEMENT; SINGLE-STRANDED-DNA; HNRNP-K; MESSENGER-RNA; POLY(C)-BINDING PROTEINS; LDL RECEPTOR; PROMOTER; BINDING; CHOLESTEROL; COMPLEX	hnRNP K, a member of the family of heterogeneous ribonucleoproteins, is known to exert various functional roles in the nucleus, cytoplasm, and mitochondria to affect different cellular processes including chromatin remodeling, transcription, splicing, and translation. Here we report, for the first time, that hnRNP K is specifically involved in human LDL receptor (LDLR) gene transcription in HepG2 cells. We show that depletion of hnRNP K by siRNA transfection reduces the expression of LDLR mRNA and protein by more than 50% as measured by quantitative real-time PCR and Western blot analysis. Importantly, we show that the decay rate of LDLR mRNA is not affected by hnRNP K siRNA transfection, whereas the LDLR promoter activity is significantly decreased. Furthermore, overexpression of hnRNP K increased the LDLR promoter activity by the luciferase reporter assay. By utilizing a series of mutational and deletional constructs of LDLR promoter luciferase reporters, we mapped the K-responsive element to the repeat 3 (R3) sequence of the LDLR promoter. Electrophoretic mobility shift assays show that the K protein binds to a single-stranded DNA probe containing the CT-rich element of R3, which is in contrast to the requirement of double-stranded DNA for Sp1 to bind to R3. Finally, chromatin immunoprecipitation assays reveal a direct interaction of hnRNP K with the LDLR promoter in intact HepG2 cells. These new findings provide strong evidence demonstrating that hnRNP K is an important transactivator for human LDLR gene transcription. This work sheds new light on our current understanding of how LDLR gene expression is controlled at the transcriptional level.	[Li, Hai; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, JW (corresponding author), VA Palo Alto Hlth Care Syst 154P, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	jingwen.liu@va.gov			National Institutes of Health, NCCAM [1R01 AT002543-01A1, 1R21AT003195-01A2]; Dept. of Veterans Affairs (Office of Research and Development, Medical Research Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543, R21AT003195] Funding Source: NIH RePORTER	National Institutes of Health, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Dept. of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health (Grants 1R01 AT002543-01A1 and 1R21AT003195-01A2, to J. L.) from NCCAM. This study was also supported by the Dept. of Veterans Affairs (Office of Research and Development, Medical Research Service, to J. L.).	Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; Davidson MH, 2009, CURR ATHEROSCLER REP, V11, P67, DOI 10.1007/s11883-009-0011-0; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Li Hai, 2009, Recent Pat DNA Gene Seq, V3, P201; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; Liu JW, 2000, J BIOL CHEM, V275, P5214, DOI 10.1074/jbc.275.7.5214; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Miau LH, 1998, J BIOL CHEM, V273, P10784, DOI 10.1074/jbc.273.17.10784; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostrowski J, 2002, J BIOL CHEM, V277, P6303, DOI 10.1074/jbc.M110267200; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Zhang F, 2002, J LIPID RES, V43, P1477, DOI 10.1194/jlr.M200126-JLR200	42	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17789	17797		10.1074/jbc.M109.082057	http://dx.doi.org/10.1074/jbc.M109.082057			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371611	Green Published, hybrid			2022-12-25	WOS:000278133400057
J	Martinez, K; Kennedy, A; West, T; Milatovic, D; Aschner, M; McIntosh, M				Martinez, Kristina; Kennedy, Arion; West, Tiffany; Milatovic, Dejan; Aschner, Michael; McIntosh, Michael			trans-10,cis-12-Conjugated Linoleic Acid Instigates Inflammation in Human Adipocytes Compared with Preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE ADIPOSE-TISSUE; TYPE-2 DIABETES-MELLITUS; LEAN BODY-MASS; INSULIN-RESISTANCE; POSTMENOPAUSAL WOMEN; 3T3-L1 PREADIPOCYTES; ENERGY-EXPENDITURE; PRIMARY CULTURES; GENE-EXPRESSION; OBESE HUMANS	We showed previously in cultures of primary human adipocytes and preadipocytes that lipopolysaccharide and trans-10, cis-12-conjugated linoleic acid (10,12-CLA) activate the inflammatory signaling that promotes insulin resistance. Because our published data demonstrated that preadipocytes are the primary instigators of inflammatory signaling in lipopolysaccharide-treated cultures, we hypothesized that they played the same role in 10,12-CLA-mediated inflammation. To test this hypothesis, we employed four distinct models. In model 1, a differentiation model, CLA activation of MAPK and induction of interleukin-8 (IL-8), IL-6, IL-1 beta, and cyclo-oxygenase-2 COX-2) were greatest in differentiated compared with undifferentiated cultures. In model 2, a cell separation model, the mRNA levels of these inflammatory proteins were increased by 10,12-CLA compared with bovine serum albumin vehicle in the adipocyte fraction and the preadipocyte fraction. In model 3, a co-culture insert model, inserts containing similar to 50% adipocytes AD50) or similar to 100% preadipocytes (AD0) were suspended over wells containing AD50 or AD0 cultures. 10,12-CLA-induced IL-8, IL-6, IL-1 beta, and COX-2 mRNA levels were highest in AD50 cultures when co-cultured with AD0 inserts. In model 4, a conditioned medium (CM) model, CM collected from CLA-treated AD50 but not AD0 cultures induced IL-8 and IL-6 mRNA levels and activated phosphorylation of MAPK in naive AD0 and AD50 cultures. Consistent with these data, 10,12-CLA-mediated secretions of IL-8 and IL-6 from AD50 cultures were higher than from AD0 cultures. Notably, blocking adipocytokine secretion prevented the inflammatory capacity of CM from 10,12-CLA-treated cultures. These data suggest that CLA instigates the release of inflammatory signals from adipocytes that subsequently activate adjacent preadipocytes.	[Martinez, Kristina; West, Tiffany; McIntosh, Michael] Univ N Carolina, Dept Nutr, Greensboro, NC 27402 USA; [Kennedy, Arion] Vanderbilt Univ, Med Ctr, Dept Mol Physiol, Nashville, TN 37232 USA; [Milatovic, Dejan; Aschner, Michael] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	University of North Carolina; University of North Carolina Greensboro; Vanderbilt University; Vanderbilt University	McIntosh, M (corresponding author), Univ N Carolina, Dept Nutr, 318 Stone Bldg,POB 26170, Greensboro, NC 27402 USA.	mkmcinto@uncg.edu		Kennedy, Arion/0000-0002-8443-3131; Martinez, Kristina/0000-0002-9676-0009	National Institutes of Health [5R01 DK063070-07, F31DK084812-01]; North Carolina Agricultural Research Service [NCARS 06771]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063070, F31DK084812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Agricultural Research Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01 DK063070-07 (to M. M.) and F31DK084812-01 (to K. M.). This work was also supported by North Carolina Agricultural Research Service Grant NCARS 06771 (to M. M.).	AWAS JA, 1996, TRANSPLANTATION, V61, P1624; Azain MJ, 2000, J NUTR, V130, P1548; Banu J, 2008, J BONE MINER METAB, V26, P436, DOI 10.1007/s00774-008-0863-3; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Brodie AE, 1999, J NUTR, V129, P602; Brown JM, 2004, J BIOL CHEM, V279, P26735, DOI 10.1074/jbc.M401766200; Brown JM, 2003, J LIPID RES, V44, P1287, DOI 10.1194/jlr.M300001-JLR200; Brown JM, 2001, J NUTR, V131, P2316, DOI 10.1093/jn/131.9.2316; Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Chung SY, 2005, J LIPID RES, V46, P885, DOI 10.1194/jlr.M400476-JLR200; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Close RN, 2007, AM J CLIN NUTR, V86, P797, DOI 10.1093/ajcn/86.3.797; Evans M, 2000, LIPIDS, V35, P899, DOI 10.1007/S11745-000-0599-6; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Gaullier JM, 2007, BRIT J NUTR, V97, P550, DOI 10.1017/S0007114507381324; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gil A, 2007, BRIT J NUTR, V98, pS121, DOI 10.1017/S0007114507838050; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; House RL, 2005, PHYSIOL GENOMICS, V21, P351, DOI 10.1152/physiolgenomics.00244.2004; Houseknecht KL, 1998, BIOCHEM BIOPH RES CO, V244, P678, DOI 10.1006/bbrc.1998.8303; Kang KW, 2004, BIOCHEM BIOPH RES CO, V315, P532, DOI 10.1016/j.bbrc.2004.01.087; Kennedy A, 2008, J NUTR, V138, P455, DOI 10.1093/jn/138.3.455; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Kennedy A, 2009, J LIPID RES, V50, P225, DOI 10.1194/jlr.M800258-JLR200; Khan Laura Kettel, 2009, Morbidity and Mortality Weekly Report, V58, P1; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Milatovic D, 2007, TOXICOL SCI, V98, P198, DOI 10.1093/toxsci/kfm095; Miner JL, 2001, OBES RES, V9, P129, DOI 10.1038/oby.2001.16; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Nagao K, 2003, NUTRITION, V19, P652, DOI 10.1016/S0899-9007(03)00060-1; Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Raff M, 2009, J NUTR, V139, P1347, DOI 10.3945/jn.109.104471; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Riserus U, 2002, CIRCULATION, V106, P1925, DOI 10.1161/01.CIR.0000033589.15413.48; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; So MHH, 2009, J NUTR, V139, P145, DOI 10.3945/jn.108.093849; Steck SE, 2007, J NUTR, V137, P1188, DOI 10.1093/jn/137.5.1188; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Tholstrup T, 2008, J NUTR, V138, P1445, DOI 10.1093/jn/138.8.1445; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Wendel AA, 2008, J LIPID RES, V49, P98, DOI 10.1194/jlr.M700195-JLR200; West DB, 2000, J NUTR, V130, P2471, DOI 10.1093/jn/130.10.2471	50	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17701	17712		10.1074/jbc.M109.043976	http://dx.doi.org/10.1074/jbc.M109.043976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353947	Green Published, hybrid			2022-12-25	WOS:000278133400048
J	Tokunaga, A; Tsukimoto, M; Harada, H; Moriyama, Y; Kojima, S				Tokunaga, Akihiro; Tsukimoto, Mitsutoshi; Harada, Hitoshi; Moriyama, Yoshinori; Kojima, Shuji			Involvement of SLC17A9-dependent Vesicular Exocytosis in the Mechanism of ATP Release during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE TRANSPORTER; P2X(7) RECEPTORS; ASTROCYTES; PATHWAY; DIFFERENTIATION; IDENTIFICATION; HEMICHANNELS; LYMPHOCYTES; CHANNEL; P2Y(6)	Recent reports have shown that T cell receptor (TCR)-dependent ATP release from T cells is involved in production of interleukin-2 (IL-2) through activation of P2 receptors. Stimulation of TCR induces ATP release from T cells through gap junction hemichannels and maxianion channels, at least in part. However, the mechanisms of ATP release from activated T cells are not fully understood. Here, we studied the mechanisms of ATP release during TCR-dependent T cell activation by investigating the effects of various inhibitors on TCR-dependent ATP release from murine T cells. We found that not only anion channel and gap junction hemichannel inhibitors, but also exocytosis inhibitors suppressed the ATP release. These results suggest that ATP release from murine T cells is regulated by various mechanisms, including exocytosis. An inhibitor of exocytosis, bafilomycin A, significantly blocked TCR signaling, such as Ca2+ elevation and IL-2 production. Furthermore, bafilomycin A, ectonucleotidase, and P2Y(6) receptor antagonist significantly inhibited production of pro-inflammatory cytokines from external antigen-restimulated splenocytes, indicating that vesicular exocytosis-mediated purinergic signaling has a significant role in TCR-dependent cytokine production. We also detected vesicular ATP in murine T cells and human T lymphoma Jurkat cells, both of which also expressed mRNA of SLC17A9, a vesicular nucleotide transporter. Knockdown of SLC17A9 in Jurkat cells markedly reduced ATP release and cytosolic Ca2+ elevation after TCR stimulation, suggesting involvement of SLC17A9-dependent vesicular exocytosis in ATP release and T cell activation. In conclusion, vesicular exocytosis of ATP appears to play a role in T cell activation and immune responses.	Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Radiat Biosci, Noda, Chiba 278, Japan; [Harada, Hitoshi] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan	Tokyo University of Science; Okayama University	Tokunaga, A (corresponding author), 2641 Yamazaki, Noda, Chiba 2788510, Japan.	tsukim@rs.noda.tus.ac.jp						Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bal-Price A, 2002, GLIA, V40, P312, DOI 10.1002/glia.10124; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Iwatsuki K, 2009, BIOCHEM BIOPH RES CO, V388, P1, DOI 10.1016/j.bbrc.2009.07.069; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Oh-hora M, 2009, IMMUNOL REV, V231, P210, DOI 10.1111/j.1600-065X.2009.00819.x; Ohshima Y, 2010, BBA-GEN SUBJECTS, V1800, P40, DOI 10.1016/j.bbagen.2009.10.008; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tsukimoto M, 2005, J BIOL CHEM, V280, P2653, DOI 10.1074/jbc.M411072200; Tsukimoto M., 2007, DRUG DISCOV TODAY TH, V1, P33; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Tsukimoto M, 2009, BIOCHEM BIOPH RES CO, V384, P512, DOI 10.1016/j.bbrc.2009.05.011; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	35	71	73	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17406	17416		10.1074/jbc.M110.112417	http://dx.doi.org/10.1074/jbc.M110.112417			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382737	hybrid, Green Published			2022-12-25	WOS:000278133400018
J	Papale, LA; Paul, KN; Sawyer, NT; Manns, JR; Tufik, S; Escayg, A				Papale, Ligia A.; Paul, Ketema N.; Sawyer, Nikki T.; Manns, Joseph R.; Tufik, Sergio; Escayg, Andrew			Dysfunction of the Scn8a Voltage-gated Sodium Channel Alters Sleep Architecture, Reduces Diurnal Corticosterone Levels, and Enhances Spatial Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE MYOCLONIC EPILEPSY; CENTRAL NUCLEUS; MOUSE MODEL; MUTATION; SCN1A; MICE; GENE; SEIZURES; NA(V)1.6; ATAXIA	Voltage-gated sodium channels (VGSCs) are responsible for the initiation and propagation of transient depolarizing currents and play a critical role in the electrical signaling between neurons. A null mutation in the VGSC gene SCN8A, which encodes the transmembrane protein Na(v)1.6, was identified previously in a human family. Heterozygous mutation carriers displayed a range of phenotypes, including ataxia, cognitive deficits, and emotional instability. A possible role for SCN8A was also proposed in studies examining the genetic basis of attempted suicide and bipolar disorder. In addition, mice with a Scn8a loss-of-function mutation (Scn8a(med-Tg/+)) show altered anxiety and depression-like phenotypes. Because psychiatric abnormalities are often associated with altered sleep and hormonal patterns, we evaluated heterozygous Scn8a(med-jo/+) mutants for alterations in sleep-wake architecture, diurnal corticosterone levels, and behavior. Compared with their wild-type littermates, Scn8a(med-jo/+) mutants experience more non-rapid eye movement (non-REM) sleep, a chronic impairment of REM sleep generation and quantity, and a lowered and flattened diurnal rhythm of corticosterone levels. No robust differences were observed between mutants and wild-type littermates in locomotor activity or in behavioral paradigms that evaluate anxiety or depression-like phenotypes; however, Scn8a(med-jo/+) mutants did show enhanced spatial memory. This study extends the spectrum of phenotypes associated with mutations in Scn8a and suggests a novel role for altered sodium channel function in human sleep disorders.	[Papale, Ligia A.; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psychobiol, BR-04024002 Sao Paulo, Brazil; [Papale, Ligia A.; Sawyer, Nikki T.; Escayg, Andrew] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Manns, Joseph R.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Paul, Ketema N.] Morehouse Sch Med, Dept Anat & Neurobiol, Atlanta, GA 30310 USA	Universidade Federal de Sao Paulo (UNIFESP); Emory University; Emory University; Morehouse School of Medicine	Escayg, A (corresponding author), Whitehead Bldg,Suite 301, Atlanta, GA 30322 USA.	aescayg@emory.edu	Tufik, Sergio/D-7606-2012	Sawyer, Nikki/0000-0002-8601-6497	National Institutes of Health [NS046484, NS065187, NS060659]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065187, U54NS060659, R01NS046484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS046484 and NS065187 (to A.E.) and NS060659 (to K.N.P.).	Andersen ML, 2005, J SLEEP RES, V14, P83, DOI 10.1111/j.1365-2869.2004.00428.x; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Blumenfeld H, 2009, EPILEPSIA, V50, P44, DOI 10.1111/j.1528-1167.2008.01710.x; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Bourgeois JA, 2009, J CLIN PSYCHIAT, V70, P852, DOI 10.4088/JCP.08m04476; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Douglas CL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-42; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; FEHM HL, 1993, EXP CLIN ENDOCRINOL, V101, P267, DOI 10.1055/s-0029-1211243; Friess E, 2008, J PSYCHIATR RES, V42, P1154, DOI 10.1016/j.jpsychires.2008.01.005; Goder R, 2004, J PSYCHIATR RES, V38, P591, DOI 10.1016/j.jpsychires.2004.04.005; Herlenius E, 2007, EPILEPSIA, V48, P1138, DOI 10.1111/j.1528-1167.2007.01049.x; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Holland KD, 2008, NEUROSCI LETT, V433, P65, DOI 10.1016/j.neulet.2007.12.064; Kimura M, 2010, MOL PSYCHIATR, V15, P154, DOI 10.1038/mp.2009.46; Kohrman DC, 1996, J NEUROSCI, V16, P5993; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Martin MS, 2010, J BIOL CHEM, V285, P9823, DOI 10.1074/jbc.M109.078568; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P629, DOI 10.1111/j.1601-183X.2008.00399.x; Meisler MH, 2001, NEUROSCIENTIST, V7, P136, DOI 10.1177/107385840100700208; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Papale LA, 2009, HUM MOL GENET, V18, P1633, DOI 10.1093/hmg/ddp081; Paul KN, 2004, EUR J NEUROSCI, V19, P2808, DOI 10.1111/j.0953-816X.2004.03387.x; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Sanford LD, 2006, BRAIN RES, V1084, P80, DOI 10.1016/j.brainres.2006.02.020; Smith MR, 1999, NEUROREPORT, V10, P3027, DOI 10.1097/00001756-199909290-00028; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Striano P, 2006, EPILEPSIA, V47, P218, DOI 10.1111/j.1528-1167.2006.00392.x; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tang XD, 2005, SLEEP, V28, P923, DOI 10.1093/sleep/28.8.923; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6; Walker E, 2008, ANNU REV CLIN PSYCHO, V4, P189, DOI 10.1146/annurev.clinpsy.4.022007.141248; Wang Y, 2008, PROG NEURO-PSYCHOPH, V32, P1902, DOI 10.1016/j.pnpbp.2008.09.003; Wasserman D, 2005, AM J MED GENET B, V133B, P116, DOI 10.1002/ajmg.b.30128; Young AH, 2004, STRESS, V7, P205, DOI 10.1080/10253890500069189; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	48	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16553	16561		10.1074/jbc.M109.090084	http://dx.doi.org/10.1074/jbc.M109.090084			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353942	hybrid, Green Published			2022-12-25	WOS:000277982600018
J	Reyes, ED; Patidar, PL; Uranga, LA; Bortoletto, AS; Lusetti, SL				Reyes, Emigdio D.; Patidar, Praveen L.; Uranga, Lee A.; Bortoletto, Angelina S.; Lusetti, Shelley L.			RecN Is a Cohesin-like Protein That Stimulates Intermolecular DNA Interactions in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; BACTERIUM DEINOCOCCUS-RADIODURANS; BACILLUS-SUBTILIS RECN; ESCHERICHIA-COLI; SMC PROTEINS; REPLICATION FORKS; CHROMOSOME CONDENSATION; REPAIR; COMPLEX; DAMAGE	The bacterial RecN protein is involved in the recombinational repair of DNA double-stranded breaks, and recN mutants are sensitive to DNA-damaging agents. Little is known about the biochemical function of RecN. Protein sequence analysis suggests that RecN is related to the SMC(structural maintenance of chromosomes) family of proteins, predicting globular N- and C-terminal domains connected by an extensive coil-coiled domain. The N- and C-domains contain the nucleotide-binding sequences Walker A and Walker B, respectively. We have purified the RecN protein from Deinococcus radiodurans and characterized its DNA-dependent and DNA-independent ATPase activity. The RecN protein hydrolyzes ATP with a k(cat) of 24 min(-1), and this rate is stimulated 4-fold by duplex DNA but not by single-stranded DNA. This DNA-dependent ATP turnover rate exhibits a dependence on the concentration of RecN protein, suggesting that RecN-RecN interactions are required for efficient ATP hydrolysis, and those interactions are stabilized only by duplex DNA. Finally, we show that RecN stimulates the intermolecular ligation of linear DNA molecules in the presence of DNA ligase. This DNA bridging activity is strikingly similar to that of the cohesin complex, an SMC family member, to which RecN is related.	[Reyes, Emigdio D.; Patidar, Praveen L.; Uranga, Lee A.; Bortoletto, Angelina S.; Lusetti, Shelley L.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Lusetti, SL (corresponding author), POB 30001,MSC 3C, Las Cruces, NM 88003 USA.	slusetti@nmsu.edu		Bortoletto, Angelina/0000-0001-7033-4274	National Institutes of Health [SC2 GM083697, P20 RR016480, R25 GM06122, F31 GM090483, P20 RR016464]; Howard Hughes Medical Institute [52005881]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464, P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM083697, F31GM090483, R25GM061222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants SC2 GM083697 and P20 RR016480 (to S.L.L.), R25 GM06122 (to E.D.R. and L.A.U.), and F31 GM090483 (to E.D.R.). This work was also supported by Howard Hughes Medical Institute Undergraduate Science Education Grant 52005881 (to A.S.B.). Research support was also provided by the proteomics facility of the Nevada-INBRE Program, National Institutes of Health Grant P20 RR016464.	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Cortes-Ledesma F, 2007, CELL CYCLE, V6, P914, DOI 10.4161/cc.6.8.4107; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; FINCH PW, 1985, J BACTERIOL, V164, P653, DOI 10.1128/JB.164.2.653-658.1985; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; GARGER SJ, 1983, BIOCHEM BIOPH RES CO, V117, P835, DOI 10.1016/0006-291X(83)91672-8; Grove JI, 2009, DNA REPAIR, V8, P1434, DOI 10.1016/j.dnarep.2009.09.015; Hiraga S, 2000, ANNU REV GENET, V34, P21, DOI 10.1146/annurev.genet.34.1.21; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; LLOYD RG, 1983, MOL GEN GENET, V190, P162, DOI 10.1007/BF00330340; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Mascarenhas J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-20; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200; PICKSLEY SM, 1984, MOL GEN GENET, V195, P267, DOI 10.1007/BF00332758; PUGH BF, 1989, J MOL BIOL, V205, P487, DOI 10.1016/0022-2836(89)90219-2; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROSTAS K, 1987, NUCLEIC ACIDS RES, V15, P5041, DOI 10.1093/nar/15.13.5041; Sanchez H, 2005, NUCLEIC ACIDS RES, V33, P2343, DOI 10.1093/nar/gki533; Sanchez H, 2006, J BACTERIOL, V188, P353, DOI 10.1128/JB.188.2.353-360.2006; SARGENTINI NJ, 1986, RADIAT RES, V107, P58, DOI 10.2307/3576850; SARGENTINI NJ, 1983, RADIAT RES, V93, P461, DOI 10.2307/3576026; SARGENTINI NJ, 1988, J BACTERIOL, V170, P2392, DOI 10.1128/jb.170.5.2392-2394.1988; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; van der Linden E, 2009, NUCLEIC ACIDS RES, V37, P1580, DOI 10.1093/nar/gkn1072; Wang G, 2008, INFECT IMMUN, V76, P153, DOI 10.1128/IAI.00791-07; Watrin E, 2006, EXP CELL RES, V312, P2687, DOI 10.1016/j.yexcr.2006.06.024; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069	54	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16521	16529		10.1074/jbc.M110.119164	http://dx.doi.org/10.1074/jbc.M110.119164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360008	Green Published, hybrid			2022-12-25	WOS:000277982600014
J	Shimahara, A; Yamakawa, N; Nishikata, I; Morishita, K				Shimahara, Akiko; Yamakawa, Norio; Nishikata, Ichiro; Morishita, Kazuhiro			Acetylation of Lysine 564 Adjacent to the C-terminal Binding Protein-binding Motif in EVI1 Is Crucial for Transcriptional Activation of GATA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; ACUTE MYELOID-LEUKEMIA; KRUPPEL-LIKE FACTOR; CELL-LINE; REVERSIBLE ACETYLATION; DNA-BINDING; GENE; EXPRESSION; SEQUENCE; CTBP	Ecotropic viral integration site 1 (EVI1) is an important transcription factor for leukemogenesis. EVI1 is a member of a group of transcription factors with C-terminal binding protein (CtBP)-binding motifs that act as transcriptional co-repressors; however, we recently found that EVI1 directly activates GATA2 transcription, which is an important gene for the maintenance of hematopoietic stem cells. We show here that EVI1-activated GATA2 transcripts derive from exon 1S of GATA2, which is specifically activated in neural and hematopoietic cells. EVI1 was acetylated by the histone acetyltransferase p300/CBP association factor (P/CAF) in myeloid leukemia cells and hematopoietic progenitor cells. Acetylation at Lys(564), which is adjacent to the CtBP-binding consensus sequence of EVI1, was found to be important for transcriptional activation of GATA2. Mutation of Lys(564) to alanine (K564A) markedly reduced the ability of EVI1 to bind DNA and activate transcription of GATA2. Furthermore, we confirmed that Lys(564) in EVI1 was specifically acetylated in leukemia and primary hematopoietic cells by using an antibody directed against an acetylated Lys(564) EVI1 peptide. Moreover, co-transfection of P/CAF with EVI1 overcame the suppressive effect of the CtBP co-repressor and resulted in GATA2 transcriptional activation; nonetheless, CtBP2 was still included in the protein complex with EVI1 and P/CAF on the EVI1-binding site in the GATA2 promoter region. Thus, acetylation of EVI1 at Lys(564) by P/CAF enhances the DNA binding capacity of EVI1 and thereby contributes to the activation of GATA2.	[Shimahara, Akiko; Yamakawa, Norio; Nishikata, Ichiro; Morishita, Kazuhiro] Miyazaki Univ, Div Tumor & Cellular Biochem, Dept Med Sci, Fac Med, Miyazaki 8891692, Japan	University of Miyazaki	Shimahara, A (corresponding author), 5200 Kihara Kiyotale, Miyazaki 5200, Japan.	kmorishi@med.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research of priority areas from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Asou H, 1996, JPN J CANCER RES, V87, P269, DOI 10.1111/j.1349-7006.1996.tb00216.x; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Huang SM, 1999, ONCOGENE, V18, P4958, DOI 10.1038/sj.onc.1202889; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Hung HL, 2001, J BIOL CHEM, V276, P10715, DOI 10.1074/jbc.M007846200; Huo XF, 2005, J CELL MOL MED, V9, P103, DOI 10.1111/j.1582-4934.2005.tb00340.x; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Matsuo Y, 1991, Hum Cell, V4, P261; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Molloy D, 2006, VIROLOGY, V355, P115, DOI 10.1016/j.virol.2006.05.004; MORISHITA K, 1990, ONCOGENE, V5, P963; MORISHITA K, 1995, ONCOGENE, V10, P1961; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; OVAL J, 1990, BLOOD, V76, P1369; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	38	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16967	16977		10.1074/jbc.M110.102046	http://dx.doi.org/10.1074/jbc.M110.102046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363750	Green Published, hybrid			2022-12-25	WOS:000277982600060
J	Wong, CH; Iskandar, KB; Yadav, SK; Hirpara, JL; Loh, T; Pervaiz, S				Wong, Chew Hooi; Iskandar, Kartini Bte; Yadav, Sanjiv Kumar; Hirpara, Jayshree L.; Loh, Thomas; Pervaiz, Shazib			Simultaneous Induction of Non-Canonical Autophagy and Apoptosis in Cancer Cells by ROS-Dependent ERK and JNK Activation	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; N-TERMINAL KINASE; INTRACELLULAR SUPEROXIDE; HYDROGEN-PEROXIDE; PROTEIN-KINASE; JNK1-MEDIATED PHOSPHORYLATION; TUMOR-SUPPRESSOR; T-CELLS; DEATH; NECROSIS	Background: Chemotherapy-induced reduction in tumor load is a function of apoptotic cell death, orchestrated by intracellular caspases. However, the effectiveness of these therapies is compromised by mutations affecting specific genes, controlling and/or regulating apoptotic signaling. Therefore, it is desirable to identify novel pathways of cell death, which could function in tandem with or in the absence of efficient apoptotic machinery. In this regard, recent evidence supports the existence of a novel cell death pathway termed autophagy, which is activated upon growth factor deprivation or exposure to genotoxic compounds. The functional relevance of this pathway in terms of its ability to serve as a stress response or a truly death effector mechanism is still in question; however, reports indicate that autophagy is a specialized form of cell death under certain conditions. Methodology/Principal Findings: We report here the simultaneous induction of non-canonical autophagy and apoptosis in human cancer cells upon exposure to a small molecule compound that triggers intracellular hydrogen peroxide (H(2)O(2)) production. Whereas, silencing of beclin1 neither inhibited the hallmarks of autophagy nor the induction of cell death, Atg 7 or Ulk1 knockdown significantly abrogated drug-induced H(2)O(2)-mediated autophagy. Furthermore, we provide evidence that activated extracellular regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) are upstream effectors controlling both autophagy and apoptosis in response to elevated intracellular H(2)O(2). Interestingly, inhibition of JNK activity reversed the increase in Atg7 expression in this system, thus indicating that JNK may regulate autophagy by activating Atg7. Of note, the small molecule compound triggered autophagy and apoptosis in primary cells derived from patients with lymphoma, but not in non-transformed cells. Conclusions/Significance: Considering that loss of tumor suppressor beclin 1 is associated with neoplasia, the ability of this small molecule compound to engage both autophagic and apoptotic machineries via ROS production and subsequent activation of ERK and JNK could have potential translational implications.	[Wong, Chew Hooi; Iskandar, Kartini Bte; Yadav, Sanjiv Kumar; Hirpara, Jayshree L.; Pervaiz, Shazib] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Wong, Chew Hooi; Pervaiz, Shazib] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117595, Singapore; [Loh, Thomas] Natl Univ Hosp Syst, Dept Otorhinolaryngol, Singapore, Singapore; [Pervaiz, Shazib] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Pervaiz, Shazib] Singapore MIT Alliance, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Wong, CH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	phssp@nus.edu.sg	Pervaiz, Shazib/C-4188-2015; Loh, Thomas/GYU-2298-2022		National Medical Research Council, Singapore; Biomedical Research Council, Singapore; Ministry of Education (MOE-Tier 2), Singapore; Duke-NUS Graduate Medical School, Singapore	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education (MOE-Tier 2), Singapore(Ministry of Education, Singapore); Duke-NUS Graduate Medical School, Singapore(National University of Singapore)	This work is supported by grants to S. P. from the National Medical Research Council, Singapore, the Biomedical Research Council, Singapore, the Ministry of Education (MOE-Tier 2), Singapore, and research funds from the Duke-NUS Graduate Medical School, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BODE AM, 2003, SCI STKE, pRE2; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Clement MV, 2003, CELL DEATH DIFFER, V10, P1273, DOI 10.1038/sj.cdd.4401302; Clement MV, 1999, FREE RADICAL RES, V30, P247, DOI 10.1080/10715769900300271; Clement MV, 2005, ANTIOXID REDOX SIGN, V7, P456, DOI 10.1089/ars.2005.7.456; Clement MV, 2001, REDOX REP, V6, P211, DOI 10.1179/135100001101536346; Clement MV, 1998, FEBS LETT, V440, P13, DOI 10.1016/S0014-5793(98)01410-0; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Pervaiz S, 2002, METHOD ENZYMOL, V352, P150; Pervaiz S, 2007, INT J BIOCHEM CELL B, V39, P1297, DOI 10.1016/j.biocel.2007.04.007; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; SCARLATTI F, 2008, CELL DEATH DIFFER; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Temkin V, 2007, IMMUNOL REV, V220, P8, DOI 10.1111/j.1600-065X.2007.00560.x; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yano K, 2007, AUTOPHAGY, V3, P215, DOI 10.4161/auto.3739; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	56	201	212	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e9996	10.1371/journal.pone.0009996	http://dx.doi.org/10.1371/journal.pone.0009996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368806	Green Published, gold			2022-12-25	WOS:000276419900003
J	Godet, AN; Guergnon, J; Maire, V; Croset, A; Garcia, A				Godet, Angelique N.; Guergnon, Julien; Maire, Virginie; Croset, Amelie; Garcia, Alphonse			The Combinatorial PP1-Binding Consensus Motif (R/K)x V-(0,V-1)/IxFxx(R/K)x(R/K) Is a New Apoptotic Signature	PLOS ONE			English	Article							PROTEIN PHOSPHATASE-1; PEPTIDES; INSIGHTS; PP1	Background: Previous studies established that PP1 is a target for Bcl-2 proteins and an important regulator of apoptosis. The two distinct functional PP1 consensus docking motifs, R/Kx((0,1))V/IxF and FxxR/KxR/K, involved in PP1 binding and cell death were previously characterized in the BH1 and BH3 domains of some Bcl-2 proteins. Principal Findings: In this study, we demonstrate that DPT-AIF(1), a peptide containing the AIF(562-571) sequence located in a c-terminal domain of AIF, is a new PP1 interacting and cell penetrating molecule. We also showed that DPT-AIF(1) provoked apoptosis in several human cell lines. Furthermore, DPT-APAF(1) a bi-partite cell penetrating peptide containing APAF-1(122-131), a non penetrating sequence from APAF-1 protein, linked to our previously described DPT-sh1 peptide shuttle, is also a PP1-interacting death molecule. Both AIF(562-571) and APAF-1(122-131) sequences contain a common R/Kx(0,1) V/IxFxxR/KxR/K motif, shared by several proteins involved in control of cell survival pathways. This motif combines the two distinct PP1c consensus docking motifs initially identified in some Bcl-2 proteins. Interestingly DPT-AIF(2) and DPT-APAF(2) that carry a F to A mutation within this combinatorial motif, no longer exhibited any PP1c binding or apoptotic effects. Moreover the F to A mutation in DPT-AIF(2) also suppressed cell penetration. Conclusion: These results indicate that the combinatorial PP1c docking motif R/Kx((0,1))V/IxFxxR/KxR/K, deduced from AIF(562-571) and APAF-1(122-131) sequences, is a new PP1c-dependent Apoptotic Signature. This motif is also a new tool for drug design that could be used to characterize potential anti-tumour molecules.	[Godet, Angelique N.; Guergnon, Julien; Maire, Virginie; Croset, Amelie; Garcia, Alphonse] Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Godet, AN (corresponding author), Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	agarcia@pasteur.fr			Institut Pasteur; MRT (Ministere Recherche et Technologie), French Government; CANAM (Caisse Nationale de Maladie)	Institut Pasteur(European Commission); MRT (Ministere Recherche et Technologie), French Government; CANAM (Caisse Nationale de Maladie)	This work was supported by the Institut Pasteur. A.N.G. is a recipient of an MRT (Ministere Recherche et Technologie) fellowship from the French Government. A. C. was supported by Institut Pasteur. V. M. was supported by a fellowship grant from Institut Pasteur, Direction de Valorisation et Partenariats Industriels (DVPI). J.G. was supported by CANAM (Caisse Nationale de Maladie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya C, 2007, CELL BIOL INT, V31, P263, DOI 10.1016/j.cellbi.2006.11.007; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Cohen PTW, 2002, J CELL SCI, V115, P241; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Frank R, 1996, Methods Mol Biol, V66, P149; Garcia A, 2004, CR BIOL, V327, P93, DOI 10.1016/j.crvi.2004.01.001; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Gebrim LC, 2009, BIOLOGICALS, V37, P222, DOI 10.1016/j.biologicals.2009.01.010; Guergnon J, 2006, MOL PHARMACOL, V69, P1115, DOI 10.1124/mol.105.019364; Helps NR, 1998, FEBS LETT, V438, P131, DOI 10.1016/S0014-5793(98)01286-1; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Lin WJ, 2009, PEPTIDES, V30, P283, DOI 10.1016/j.peptides.2008.10.007; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Onishi J, 2008, J PEPT SCI, V14, P1032, DOI 10.1002/psc.1039; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Valle M, 1999, PROTEIN SCI, V8, P883	17	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9981	10.1371/journal.pone.0009981	http://dx.doi.org/10.1371/journal.pone.0009981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376316	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200052
J	Folli, F; Guzzi, V; Perego, L; Coletta, DK; Finzi, G; Placidi, C; La Rosa, S; Capella, C; Socci, C; Lauro, D; Tripathy, D; Jenkinson, C; Paroni, R; Orsenigo, E; Cighetti, G; Gregorini, L; Staudacher, C; Secchi, A; Bachi, A; Brownlee, M; Fiorina, P				Folli, Franco; Guzzi, Valeria; Perego, Lucia; Coletta, Dawn K.; Finzi, Giovanna; Placidi, Claudia; La Rosa, Stefano; Capella, Carlo; Socci, Carlo; Lauro, Davide; Tripathy, Devjit; Jenkinson, Christopher; Paroni, Rita; Orsenigo, Elena; Cighetti, Giuliana; Gregorini, Luisa; Staudacher, Carlo; Secchi, Antonio; Bachi, Angela; Brownlee, Michael; Fiorina, Paolo			Proteomics Reveals Novel Oxidative and Glycolytic Mechanisms in Type 1 Diabetic Patients' Skin Which Are Normalized by Kidney-Pancreas Transplantation	PLOS ONE			English	Article							GLYCOSYLATION END-PRODUCTS; AUTOXIDATIVE GLYCOSYLATION; ISLET TRANSPLANTATION; GLUCOSE AUTOXIDATION; POTENTIAL ROLE; PROTEIN; COMPLICATIONS; EXPRESSION; CELLS; HEAT-SHOCK-PROTEIN-27	Background: In type 1 diabetes (T1D) vascular complications such as accelerated atherosclerosis and diffused macro-/microangiopathy are linked to chronic hyperglycemia with a mechanism that is not yet well understood. End-stage renal disease (ESRD) worsens most diabetic complications, particularly, the risk of morbidity and mortality from cardiovascular disease is increased several fold. Methods and Findings: We evaluated protein regulation and expression in skin biopsies obtained from T1D patients with and without ESRD, to identify pathways of persistent cellular changes linked to diabetic vascular disease. We therefore examined pathways that may be normalized by restoration of normoglycemia with kidney-pancreas (KP) transplantation. Using proteomic and ultrastructural approaches, multiple alterations in the expression of proteins involved in oxidative stress (catalase, superoxide dismutase 1, Hsp27, Hsp60, ATP synthase delta chain, and flavin reductase), aerobic and anaerobic glycolysis (ACBP, pyruvate kinase muscle isozyme, and phosphoglycerate kinase 1), and intracellular signaling (stratifin-14-3-3, S100-calcyclin, cathepsin, and PPI rotamase) as well as endothelial vascular abnormalities were identified in T1D and T1D+ESRD patients. These abnormalities were reversed after KP transplant. Increased plasma levels of malondialdehyde were observed in T1D and T1D+ESRD patients, confirming increased oxidative stress which was normalized after KP transplant. Conclusions: Our data suggests persistent cellular changes of anti-oxidative machinery and of aerobic/anaerobic glycolysis are present in T1D and T1D+ESRD patients, and these abnormalities may play a key role in the pathogenesis of hyperglycemia-related vascular complications. Restoration of normoglycemia and removal of uremia with KP transplant can correct these abnormalities. Some of these identified pathways may become potential therapeutic targets for a new generation of drugs.	[Folli, Franco; Tripathy, Devjit; Jenkinson, Christopher] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Guzzi, Valeria; Perego, Lucia; Paroni, Rita; Gregorini, Luisa] Univ Milan, Dept Med, Milan, Italy; [Coletta, Dawn K.] Arizona State Univ, Sch Life Sci, Ctr Metab Biol, Tempe, AZ USA; [Finzi, Giovanna; Placidi, Claudia; La Rosa, Stefano; Capella, Carlo] Univ Insubria, Osped Circolo, Dept Pathol, Varese, Italy; [Finzi, Giovanna; Placidi, Claudia; La Rosa, Stefano; Capella, Carlo] Univ Insubria, Dept Human Morphol, Varese, Italy; [Socci, Carlo; Orsenigo, Elena; Staudacher, Carlo] Ist Sci San Raffaele, Dept Surg, I-20132 Milan, Italy; [Lauro, Davide; Cighetti, Giuliana] Univ Milan, Dept Clin Sci Luigi Sacco, Milan, Italy; [Secchi, Antonio] Ist Sci San Raffaele, Dept Med, I-20132 Milan, Italy; [Bachi, Angela] Univ Vita & Salute San Raffaele, Dept Oncol, Milan, Italy; [Brownlee, Michael] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Fiorina, Paolo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Childrens Hosp,Transplantat Res Ctr,Nephrol Div, Boston, MA 02115 USA	University of Texas System; University of Texas Health San Antonio; University of Milan; Arizona State University; Arizona State University-Tempe; Ospedale Circolo & Fondazione Macchi; University of Insubria; University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Luigi Sacco Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Yeshiva University; Yeshiva University; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard Medical School	Folli, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.	folli@uthscsa.edu; paolo.fiorina@childrens.harvard.edu	folli, franco/J-2795-2018; La+Rosa, Stefano/AFH-8608-2022; La+Rosa, Stefano/AAF-3366-2022; PARONI, RITA/AAC-6265-2020; Coletta, Dawn/G-6382-2016; Lauro, Davide/K-4683-2018; bachi, angela/B-3527-2015; socci, carlo/AAN-7338-2020; PARONI, RITA/C-2955-2012; CIGHETTI, GIULIANA MARIA/E-8593-2017; Fiorina, Paolo/B-4532-2019	folli, franco/0000-0001-9824-5222; La+Rosa, Stefano/0000-0003-1941-2403; La+Rosa, Stefano/0000-0003-1941-2403; PARONI, RITA/0000-0002-3186-8860; bachi, angela/0000-0003-4842-6556; PARONI, RITA/0000-0002-3186-8860; tripathy, devjit/0000-0003-2797-0659; Lauro, Davide/0000-0002-8597-4415; CIGHETTI, GIULIANA MARIA/0000-0002-3428-8634; Fiorina, Paolo/0000-0002-1093-7724; Coletta, Dawn/0000-0001-5819-5152	American Society of Transplantation - Juvenile Diabetes Research Foundation; Italian Ministry of Health and the Italian Ministry of University and Scientific Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079195] Funding Source: NIH RePORTER	American Society of Transplantation - Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Italian Ministry of Health and the Italian Ministry of University and Scientific Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Paolo Fiorina is a recipient of an American Society of Transplantation - Juvenile Diabetes Research Foundation (AST-JDRF) Faculty Grant and a JDRF-Career Development Award. This work was supported by grants from JDF (P. F.) and grants from the Italian Ministry of Health and the Italian Ministry of University and Scientific Research (F. F., L. G. and A. S.) (http://www.a-s-t.org/index2.cfm?Section = research_funding&Sub1Section=ast_grants&content=past_grant_recipients.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee M, 2003, J CLIN INVEST, V112, P1788, DOI 10.1172/JCI200320501; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; Cighetti G, 2009, FREE RADICAL BIO MED, V47, P307, DOI 10.1016/j.freeradbiomed.2009.05.007; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Eberl N, 2005, DIABETES-METAB RES, V21, P525, DOI 10.1002/dmrr.555; Fiorina P, 2004, DIABETES, V53, P2291, DOI 10.2337/diabetes.53.9.2291; Fiorina P, 2003, TRANSPLANTATION, V75, P1296, DOI 10.1097/01.TP.0000061788.32639.D9; Fiorina P, 2003, DIABETES CARE, V26, P1129, DOI 10.2337/diacare.26.4.1129; Fiorina P, 2001, DIABETES, V50, P496, DOI 10.2337/diabetes.50.3.496; Gruden G, 2008, DIABETES, V57, P1966, DOI 10.2337/db08-0009; Gulden E, 2008, FEBS LETT, V582, P2731, DOI 10.1016/j.febslet.2008.07.002; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205; Iori E, 2008, BBA-MOL BASIS DIS, V1782, P627, DOI 10.1016/j.bbadis.2008.08.012; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; La Rocca E, 2000, CELL TRANSPLANT, V9, P929, DOI 10.1177/096368970000900621; La Rocca E, 2001, KIDNEY INT, V60, P1964, DOI 10.1046/j.1523-1755.2001.00008.x; Lee JP, 1999, P NATL ACAD SCI USA, V96, P3251, DOI 10.1073/pnas.96.6.3251; Macaulay IC, 2005, J CLIN INVEST, V115, P3370, DOI 10.1172/JCI26885; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nathan DM, 2003, NEW ENGL J MED, V348, P761; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oliveira HR, 1999, AM J PHYSIOL-CELL PH, V276, pC507, DOI 10.1152/ajpcell.1999.276.2.C507; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; PROPERZI G, 1995, J PATHOL, V175, P243, DOI 10.1002/path.1711750213; Quintana FJ, 2008, NOVART FDN SYMP, V291, P137; Quintana FJ, 2008, NOVART FDN SYMP, V291, P111; Quintana Francisco J, 2008, Novartis Found Symp, V291, P101; Schalkwijk CG, 2006, FEBS LETT, V580, P1565, DOI 10.1016/j.febslet.2006.01.086; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tessari P, 2007, J PROTEOME RES, V6, P976, DOI 10.1021/pr060443n; Vidal BC, 2005, CLIN SCI, V109, P421, DOI 10.1042/CS20050085; Vlassara H, 2003, MT SINAI J MED, V70, P232; VLASSARA H, 1992, P NATL ACAD SCI USA, V89, P12043, DOI 10.1073/pnas.89.24.12043; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	44	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9923	10.1371/journal.pone.0009923	http://dx.doi.org/10.1371/journal.pone.0009923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360867	Green Published, gold, Green Submitted			2022-12-25	WOS:000276163100016
J	Klevebring, D; Bjursell, M; Emanuelsson, O; Lundeberg, J				Klevebring, Daniel; Bjursell, Magnus; Emanuelsson, Olof; Lundeberg, Joakim			In-Depth Transcriptome Analysis Reveals Novel TARs and Prevalent Antisense Transcription in Human Cell Lines	PLOS ONE			English	Article							HUMAN PROMOTERS; HUMAN GENOME; RNA-SEQ; DNA	Several recent studies have indicated that transcription is pervasive in regions outside of protein coding genes and that short antisense transcripts can originate from the promoter and terminator regions of genes. Here we investigate transcription of fragments longer than 200 nucleotides, focusing on antisense transcription for known protein coding genes and intergenic transcription. We find that roughly 12% to 16% of all reads that originate from promoter and terminator regions, respectively, map antisense to the gene in question. Furthermore, we detect a high number of novel transcriptionally active regions (TARs) that are generally expressed at a lower level than protein coding genes. We find that the correlation between RNA-seq data and microarray data is dependent on the gene length, with longer genes showing a better correlation. We detect high antisense transcriptional activity from promoter, terminator and intron regions of protein-coding genes and identify a vast number of previously unidentified TARs, including putative novel EGFR transcripts. This shows that in-depth analysis of the transcriptome using RNA-seq is a valuable tool for understanding complex transcriptional events. Furthermore, the development of new algorithms for estimation of gene expression from RNA-seq data is necessary to minimize length bias.	[Klevebring, Daniel; Bjursell, Magnus; Emanuelsson, Olof; Lundeberg, Joakim] Royal Inst Technol, AlbaNova Univ Ctr, Sch Biotechnol, Div Gen Technol, Stockholm, Sweden	Royal Institute of Technology	Klevebring, D (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	joakim.lundeberg@biotech.kth.se		Klevebring, Daniel/0000-0002-9810-3838	Swedish Scientific Council; Knut and Alice Wallenberg Foundation	Swedish Scientific Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Scientific Council, and the Knut and Alice Wallenberg Foundation.	Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; EBISUYA M, 2008, NAT CELL BIOL; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Havgaard JH, 2007, PLOS COMPUT BIOL, V3, P1896, DOI 10.1371/journal.pcbi.0030193; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KLEVEBRING D, 2009, J BIOMED BIOTECHNOL, P1; Lai CQ, 2008, DIABETES, V57, P809, DOI 10.2337/db07-1238; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261; LINDBERG J, 2009, GENOMICS; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mortazavi A, 2008, NAT METH; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	24	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9762	10.1371/journal.pone.0009762	http://dx.doi.org/10.1371/journal.pone.0009762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360838	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969500002
J	Leibler, JH; Carone, M; Silbergeld, EK				Leibler, Jessica H.; Carone, Marco; Silbergeld, Ellen K.			Contribution of Company Affiliation and Social Contacts to Risk Estimates of Between-Farm Transmission of Avian Influenza	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANT ENTEROCOCCI; SWINE-FEEDING OPERATION; LOW-PATHOGENICITY; VIRUS INFECTIONS; POULTRY FARMS; COMMERCIAL POULTRY; A VIRUSES; H5N1; H7N2; EPIDEMIC	Background: Models of between-farm transmission of pathogens have identified service vehicles and social groups as risk factors mediating the spread of infection. Because of high levels of economic organization in much of the poultry industry, we examined the importance of company affiliation, as distinct from social contacts, in a model of the potential spread of avian influenza among broiler poultry farms in a poultry-dense region in the United States. The contribution of company affiliation to risk of between-farm disease transmission has not been previously studied. Methodology/Principal Findings: We obtained data on the nature and frequency of business and social contacts through a national survey of broiler poultry growers in the United States. Daily rates of contact were estimated using Monte Carlo analysis. Stochastic modeling techniques were used to estimate the exposure risk posed by a single infectious farm to other farms in the region and relative risk of exposure for farms under different scenarios. The mean daily rate of vehicular contact was 0.82 vehicles/day. The magnitude of exposure risk ranged from <1% to 25% under varying parameters. Risk of between-farm transmission was largely driven by company affiliation, with farms in the same company group as the index farm facing as much as a 5-fold increase in risk compared to farms contracted with different companies. Employment of part-time workers contributed to significant increases in risk in most scenarios, notably for farms who hired day-laborers. Social visits were significantly less important in determining risk. Conclusions/Significance: Biosecurity interventions should be based on information on industry structure and company affiliation, and include part-time workers as potentially unrecognized sources of viral transmission. Modeling efforts to understand pathogen transmission in the context of industrial food animal production should consider company affiliation in addition to geospatial factors and pathogen characteristics. Restriction of social contacts among farmers may be less useful in reducing between-farm transmission.	[Leibler, Jessica H.; Silbergeld, Ellen K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Carone, Marco] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Leibler, JH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.	jleibler@jhsph.edu		Leibler, Jessica/0000-0002-0605-0928	Johns Hopkins Sommer Scholar program and the Johns Hopkins Center	Johns Hopkins Sommer Scholar program and the Johns Hopkins Center	This study was funded by the Johns Hopkins Sommer Scholar program and the Johns Hopkins Center for a Livable Future. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey BL, 2003, AVIAN DIS, V47, P1099, DOI 10.1637/0005-2086-47.s3.1099; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Bos MEH, 2007, VET RES, V38, P493, DOI 10.1051/vetres:2007008; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102; *CORP, 2008, CRYST BALL FUS ED RE; Davison S, 1999, J AM VET MED ASSOC, V214, P1164; *DEL DEP TRANSP, 2008, TRAFF SUMM TRAFF COU; *DELM POULTR IND I, 2009, DELM US FACTS; Dent JE, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-27; Dunn PA, 2003, AVIAN DIS, V47, P812, DOI 10.1637/0005-2086-47.s3.812; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; Gerba CP, 2005, J ENVIRON QUAL, V34, P42; *GOOG INC, 2007, GOOG EARTH 4 2; Graham JP, 2009, SCI TOTAL ENVIRON, V407, P2701, DOI 10.1016/j.scitotenv.2008.11.056; Gray GC, 2009, POULTRY SCI, V88, P880, DOI 10.3382/ps.2008-00335; Guan J, 2009, AVIAN DIS, V53, P26, DOI 10.1637/8381-062008-Reg.1; Jalvingh AW, 1999, PREV VET MED, V42, P271, DOI 10.1016/S0167-5877(99)00080-X; Jeong OM, 2009, J VET SCI, V10, P53, DOI 10.4142/jvs.2009.10.1.53; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Ladman BS, 2008, AVIAN DIS, V52, P623, DOI 10.1637/8282-031208-Reg.1; Leibler JH, 2009, ECOHEALTH, V6, P58, DOI 10.1007/s10393-009-0226-0; Lipatov AS, 2009, J INFECT DIS, V199, P717, DOI 10.1086/596740; Lu H, 2003, AVIAN DIS, V47, P1015, DOI 10.1637/0005-2086-47.s3.1015; MA W, 2009, ZOONOSES PUBLIC 0520; MARTINEZ SW, 1999, AER777 USDA EC RES S; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; *MICR CORP, 2007, MICR OFF EXC; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OIE, 2009, WAHID INT; Price LB, 2007, J OCCUP ENVIRON MED, V49, P748, DOI 10.1097/JOM.0b013e3180d09ec5; R Core Team, 2022, R LANG ENV STAT COMP; Rule Ana M, 2008, J Infect Public Health, V1, P33, DOI 10.1016/j.jiph.2008.08.001; Saito T, 2009, VET MICROBIOL, V133, P65, DOI 10.1016/j.vetmic.2008.06.020; Sanson RL, 2005, NEW ZEAL VET J, V53, P223, DOI 10.1080/00480169.2005.36550; Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x; Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P1040, DOI 10.1289/ehp.9770; Sawabe K, 2006, AM J TROP MED HYG, V75, P327, DOI 10.4269/ajtmh.2006.75.327; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; StataCorp, 2005, STAT STAT SOFTW REL; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Thomas ME, 2005, PREV VET MED, V69, P1, DOI 10.1016/j.prevetmed.2004.12.001; Tiensin T, 2007, AVIAN DIS, V51, P182, DOI 10.1637/7635-042806R.1; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1; Truscott J, 2007, P ROY SOC B-BIOL SCI, V274, P2287, DOI 10.1098/rspb.2007.0542; United States Department of Agriculture (USDA), 2007, CENS AGR; *US AN HLTH ASS, 2004, P ANN M US AN HLTH A; van der Goot JA, 2003, AVIAN DIS, V47, P939, DOI 10.1637/0005-2086-47.s3.939; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; Vieira AR, 2009, AVIAN DIS, V53, P55, DOI 10.1637/8364-051608-Reg.1; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Ziegler AF, 1999, AVIAN DIS, V43, P142, DOI 10.2307/1592774	57	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9888	10.1371/journal.pone.0009888	http://dx.doi.org/10.1371/journal.pone.0009888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360859	gold, Green Published, Green Submitted			2022-12-25	WOS:000275969500015
J	Tizon, B; Sahoo, S; Yu, H; Gauthier, S; Kumar, AR; Mohan, P; Figliola, M; Pawlik, M; Grubb, A; Uchiyama, Y; Bandyopadhyay, U; Cuervo, AM; Nixon, RA; Levy, E				Tizon, Belen; Sahoo, Susmita; Yu, Haung; Gauthier, Sebastien; Kumar, Asok R.; Mohan, Panaiyur; Figliola, Matthew; Pawlik, Monika; Grubb, Anders; Uchiyama, Yasuo; Bandyopadhyay, Urmi; Cuervo, Ana Maria; Nixon, Ralph A.; Levy, Efrat			Induction of Autophagy by Cystatin C: A Mechanism That Protects Murine Primary Cortical Neurons and Neuronal Cell Lines	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; ONSET ALZHEIMER-DISEASE; ENDOCYTIC PATHWAYS; GENE POLYMORPHISM; BETA-PROTEIN; CATHEPSIN-B; DEATH; INHIBITION; VACUOLES; BRAIN	Cystatin C (CysC) expression in the brain is elevated in human patients with epilepsy, in animal models of neurodegenerative conditions, and in response to injury, but whether up-regulated CysC expression is a manifestation of neurodegeneration or a cellular repair response is not understood. This study demonstrates that human CysC is neuroprotective in cultures exposed to cytotoxic challenges, including nutritional-deprivation, colchicine, staurosporine, and oxidative stress. While CysC is a cysteine protease inhibitor, cathepsin B inhibition was not required for the neuroprotective action of CysC. Cells responded to CysC by inducing fully functional autophagy via the mTOR pathway, leading to enhanced proteolytic clearance of autophagy substrates by lysosomes. Neuroprotective effects of CysC were prevented by inhibiting autophagy with beclin 1 siRNA or 3-methyladenine. Our findings show that CysC plays a protective role under conditions of neuronal challenge by inducing autophagy via mTOR inhibition and are consistent with CysC being neuroprotective in neurodegenerative diseases. Thus, modulation of CysC expression has therapeutic implications for stroke, Alzheimer's disease, and other neurodegenerative disorders.	[Tizon, Belen; Sahoo, Susmita; Gauthier, Sebastien; Kumar, Asok R.; Mohan, Panaiyur; Figliola, Matthew; Pawlik, Monika; Nixon, Ralph A.; Levy, Efrat] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Nixon, Ralph A.; Levy, Efrat] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Levy, Efrat] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Nixon, Ralph A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Yu, Haung] Columbia Univ, Dept Pathol, Taub Inst, New York, NY USA; [Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo, Japan; [Bandyopadhyay, Urmi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol & Med, Bronx, NY 10467 USA	Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Columbia University; Lund University; Skane University Hospital; Juntendo University; Yeshiva University; Albert Einstein College of Medicine	Tizon, B (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.	elevy@nki.rfmh.org	Bandyopadhyay, Urmi/A-3944-2015	Bandyopadhyay, Urmi/0000-0003-3438-8923; Gauthier, Sebastien/0000-0002-5692-9260; Grubb, Anders/0000-0002-0125-3662; Yu, Wai Haung/0000-0001-7186-6731; Cuervo, Ana Maria/0000-0002-0771-700X	National Institute on Aging (NIA) [AG017617]; National Institute on Neurological Disorders and Stroke (NINDS) [NS42029]; Alzheimer's Association [IIRG-07-59677]; Swedish Science Research Council [05196]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); Swedish Science Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by the National Institute on Aging (NIA) (AG017617), by the National Institute on Neurological Disorders and Stroke (NINDS) (NS42029), by the Alzheimer's Association IIRG-07-59677, and by the Swedish Science Research Council (05196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Bernstein HG, 1996, MOL CHEM NEUROPATHOL, V27, P225, DOI 10.1007/BF02815106; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; BRUNK UT, 1995, FREE RADICAL BIO MED, V19, P813, DOI 10.1016/0891-5849(95)02001-Q; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; GLAUMANN H, 1981, INT REV CYTOL, V73, P149, DOI 10.1016/S0074-7696(08)61288-7; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Guimaraes CA, 2003, J BIOL CHEM, V278, P41938, DOI 10.1074/jbc.M306547200; HAAN J, 1994, ACTA NEUROL SCAND, V89, P367; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.5115; HALL A, 1993, BIOCHEM J, V291, P123, DOI 10.1042/bj2910123; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HORNUNG JP, 1989, J COMP NEUROL, V283, P425, DOI 10.1002/cne.902830310; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kato T, 2006, P NATL ACAD SCI USA, V103, P6019, DOI 10.1073/pnas.0509789103; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; LAWRENCE BP, 1992, J CELL SCI, V102, P515; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; MARUYAMA K, 1990, STROKE, V21, P397, DOI 10.1161/01.STR.21.3.397; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; NITATORI T, 1995, J NEUROSCI, V15, P1001; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Noto D, 2005, INT J CARDIOL, V101, P213, DOI 10.1016/j.ijcard.2004.03.018; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Perry SW, 2004, J NEUROSCI RES, V78, P485, DOI 10.1002/jnr.20272; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pirttila TJ, 2005, NEUROBIOL DIS, V20, P241, DOI 10.1016/j.nbd.2005.03.006; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; SUN Q, 1989, EXP CELL RES, V180, P150, DOI 10.1016/0014-4827(89)90219-X; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; TAVERA C, 1992, BIOCHEM BIOPH RES CO, V182, P1082, DOI 10.1016/0006-291X(92)91842-E; Tizon B., 2006, HDB NEUROCHEMISTRY M; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; VINTERS HV, 1990, AM J PATHOL, V137, P233; Yamada Toshiyuki, 2002, Rinsho Byori, V50, P613; YASUHARA O, 1993, BRAIN RES, V628, P85, DOI 10.1016/0006-8993(93)90941-F; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	72	95	106	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9819	10.1371/journal.pone.0009819	http://dx.doi.org/10.1371/journal.pone.0009819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352108	gold, Green Published			2022-12-25	WOS:000275894400020
J	Arnot, CJ; Gay, NJ; Gangloff, M				Arnot, Christopher J.; Gay, Nicholas J.; Gangloff, Monique			Molecular Mechanism That Induces Activation of Spatzle, the Ligand for the Drosophila Toll Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CYTOKINE SPATZLE; IMMUNE-RESPONSE; INNATE IMMUNITY; HORSESHOE-CRAB; PROTEIN; EMBRYO; FRAGMENT; SYSTEM	The Drosophila Toll receptor is activated by an endogenous cytokine ligand Spatzle. Active ligand is generated in response to positional cues in embryonic dorso-ventral patterning and microbial pathogens in the insect immune response. Spatzle is secreted as a pro-protein and is processed into an active form by the serine endoproteases Easter and Spatzle-processing enzyme during dorso-ventral patterning and infection, respectively. Here, we provide evidence for the molecular mechanism of this activation process. We show that the Spatzle prodomain masks a predominantly hydrophobic region of Spatzle and that proteolysis causes a conformational change that exposes determinants that are critical for binding to the Toll receptor. We also gather that a conserved sequence motif in the prodomain presents features of an amphipathic helix likely to bind a hydrophobic cleft in Spatzle thereby occluding the putative Toll binding region. This mechanism of activation has a striking similarity to that of coagulogen, a clotting factor of the horseshoe crab, an invertebrate that has changed little in 400 million years. Taken together, our findings demonstrate that an ancient passive defense system has been adapted during evolution and converted for use in a critical pathway of innate immune signaling and embryonic morphogenesis.	[Arnot, Christopher J.; Gay, Nicholas J.; Gangloff, Monique] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk; mg308@cam.ac.uk		Gangloff, Monique/0000-0001-6131-0115	BBSRC [BB/G002797/1] Funding Source: UKRI; MRC [G1000133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G002797/1] Funding Source: Medline; Medical Research Council [G1000133] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; Eftink MR, 1996, BIOCHEMISTRY-US, V35, P8084, DOI 10.1021/bi9530090; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hoffmann A, 2008, J BIOL CHEM, V283, P32598, DOI 10.1074/jbc.M801815200; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Paoletti F, 2006, BIOCHEM SOC T, V34, P605, DOI 10.1042/BST0340605; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; PERMYAKOV EA, 1993, LUMINESCENT SPECTROS, P21; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Turcotte CL, 2002, DEV DYNAM, V224, P51, DOI 10.1002/dvdy.10081; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Wang Y, 2009, CELL MOL LIFE SCI, V66, P1595, DOI 10.1007/s00018-009-9028-3; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	28	52	55	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19502	19509		10.1074/jbc.M109.098186	http://dx.doi.org/10.1074/jbc.M109.098186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20378549	Green Published, hybrid			2022-12-25	WOS:000278727800060
J	Flegg, CP; Sharma, M; Medina-Palazon, C; Jamieson, C; Galea, M; Brocardo, MG; Mills, K; Henderson, BR				Flegg, Cameron P.; Sharma, Manisha; Medina-Palazon, Cahora; Jamieson, Cara; Galea, Melanie; Brocardo, Mariana G.; Mills, Kate; Henderson, Beric R.			Nuclear Export and Centrosome Targeting of the Protein Phosphatase 2A Subunit B56 alpha ROLE OF B56 alpha IN NUCLEAR EXPORT OF THE CATALYTIC SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; B56 REGULATORY SUBUNIT; BETA-CATENIN; LOCALIZES; FAMILY; IDENTIFICATION; ACCUMULATION; SEQUENCE; DOMAIN	Protein phosphatase (PP) 2A is a heterotrimeric enzyme regulated by specific subunits. The B56 (or B'/PR61/PPP2R5) class of B-subunits direct PP2A or its substrates to different cellular locations, and the B56 alpha, -beta, and -epsilon isoforms are known to localize primarily in the cytoplasm. Here we studied the pathways that regulate B56 alpha subcellular localization. We detected B56 alpha in the cytoplasm and nucleus, and at the nuclear envelope and centrosomes, and show that cytoplasmic localization is dependent on CRM1-mediated nuclear export. The inactivation of CRM1 by leptomycin B or by siRNA knockdown caused nuclear accumulation of ectopic and endogenous B56 alpha. Conversely, CRM1 overexpression shifted B56 alpha to the cytoplasm. We identified a functional nuclear export signal at the C terminus (NES; amino acids 451-469), and site-directed mutagenesis of the NES (L461A) caused nuclear retention of full-length B56 alpha. Active NESs were identified at similar positions in the cytoplasmic B56-beta and epsilon isoforms, but not in the nuclear-localized B56-delta or gamma isoforms. The transient expression of B56 alpha induced nuclear export of the PP2A catalytic (C) subunit, and this was blocked by the L461A NES mutation. In addition, B56 alpha co-located with the PP2A active (A) subunit at centrosomes, and its centrosome targeting involved sequences that bind to the A-subunit. Fluorescence Recovery after Photobleaching (FRAP) assays revealed dynamic and immobile pools of B56 alpha-GFP, which was rapidly exported from the nucleus and subject to retention at centrosomes. We propose that B56 alpha can act as a PP2A C-subunit chaperone and regulates PP2A activity at diverse subcellular locations.	[Flegg, Cameron P.; Sharma, Manisha; Medina-Palazon, Cahora; Jamieson, Cara; Galea, Melanie; Brocardo, Mariana G.; Mills, Kate; Henderson, Beric R.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead Hosp, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Henderson, BR (corresponding author), Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead Hosp, Darcy Rd,POB 412, Westmead, NSW 2145, Australia.	beric_henderson@sydney.edu.au	Galea, Melanie A/I-2236-2014	Brocardo, Mariana/0000-0002-3962-7308; Sharma, Manisha/0000-0003-1892-9865	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Cadot B, 2009, CANCER RES, V69, P6074, DOI 10.1158/0008-5472.CAN-08-2796; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; Gillingham AK, 2000, EMBO REP, V1, P524; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Johnson M, 2009, CELL SIGNAL, V21, P339, DOI 10.1016/j.cellsig.2008.11.004; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Tsuchiya A, 2007, ONCOGENE, V26, P1522, DOI 10.1038/sj.onc.1209962; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; VIRSHUP DM, 1989, EMBO J, V8, P3891, DOI 10.1002/j.1460-2075.1989.tb08568.x; Yamamoto H, 2001, J BIOL CHEM, V276, P26875, DOI 10.1074/jbc.M100443200	34	20	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18144	18154		10.1074/jbc.M109.093294	http://dx.doi.org/10.1074/jbc.M109.093294			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378546	Green Published, hybrid			2022-12-25	WOS:000278453900005
J	Fernandez-Sanchez, ME; Sechet, E; Margottin-Goguet, F; Rogge, L; Bianchi, E				Fernandez-Sanchez, Maria Elena; Sechet, Emmanuel; Margottin-Goguet, Florence; Rogge, Lars; Bianchi, Elisabetta			The Human COP9 Signalosome Protects Ubiquitin-conjugating Enzyme 3 (UBC3/Cdc34) from beta-Transducin Repeat-containing Protein (beta TrCP)-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-CYCLE; E3 LIGASE; OXIDATIVE STRESS; FISSION YEAST; DNA-DAMAGE; E2 ENZYME; CDC34; NEDD8; TRCP	The COP9 signalosome (CSN) is an essential multisubunit complex that regulates the activity of cullin-RING ubiquitin ligases by removing the ubiquitin-like peptide NEDD8 from cullins. Here, we demonstrate that the CSN can affect other components of the ubiquitination cascade. Down-regulation of human CSN4 or CSN5 induced proteasome-mediated degradation of the ubiquitin-conjugating enzyme UBC3/Cdc34. UBC3 was targeted for ubiquitination by the cullin-RING ubiquitin ligase SCF beta TrCP. This interaction required the acidic C-terminal extension of UBC3, which is absent in ubiquitin-conjugating enzymes of the UBCH5 family. Conversely, the UBC3 acidic domain was sufficient to impart sensitivity to SCF beta TrCP-mediated ubiquitination to UBCH5 enzymes. Our work indicates that the CSN is necessary to ensure the stability of selected ubiquitin-conjugating enzymes and uncovers a novel pathway of regulation of ubiquitination processes.	[Fernandez-Sanchez, Maria Elena; Sechet, Emmanuel; Rogge, Lars; Bianchi, Elisabetta] Inst Pasteur, Immunoregulat Unit, F-75724 Paris, France; [Fernandez-Sanchez, Maria Elena; Sechet, Emmanuel; Rogge, Lars; Bianchi, Elisabetta] CNRS, URA1961, F-75724 Paris, France; [Margottin-Goguet, Florence] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Margottin-Goguet, Florence] INSERM, U1016, F-75014 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bianchi, E (corresponding author), Inst Pasteur, Immunoregulat Unit, 25 Rue Dr Roux, F-75724 Paris, France.	ebianchi@pasteur.fr	Rogge, Lars/GYJ-6142-2022; Margottin-Goguet, Florence/F-9272-2013	Margottin-Goguet, Florence/0000-0002-3124-6690; Rogge, Lars/0000-0003-1262-9204; Fernandez Sanchez, Maria Elena/0000-0001-8083-8863	Canceropole, Ile-de-France	Canceropole, Ile-de-France(Region Ile-de-France)	This work was supported by Canceropole, Ile-de-France.	Asada S, 2008, INT J MOL MED, V22, P95; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Block K, 2001, J BIOL CHEM, V276, P41049, DOI 10.1074/jbc.M106453200; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gewurz BE, 2006, CURR BIOL, V16, pR932, DOI 10.1016/j.cub.2006.09.046; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Huang XH, 2009, J MOL BIOL, V391, P691, DOI 10.1016/j.jmb.2009.06.066; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian X, 2005, BIOCHEM J, V389, P389, DOI 10.1042/BJ20050297; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Raymond F, 2000, J CELL SCI, V113, P1687; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Semplici F, 2002, ONCOGENE, V21, P3978, DOI 10.1038/sj.onc.1205574; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Uchida S, 2009, CANCER RES, V69, P6438, DOI 10.1158/0008-5472.CAN-09-0869; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	54	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17390	17397		10.1074/jbc.M109.076661	http://dx.doi.org/10.1074/jbc.M109.076661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378537	Green Published, hybrid			2022-12-25	WOS:000278133400016
J	Denes, V; Pilichowska, M; Makarovskiy, A; Carpinito, G; Geck, P				Denes, V.; Pilichowska, M.; Makarovskiy, A.; Carpinito, G.; Geck, P.			Loss of a cohesin-linked suppressor APRIN (Pds5b) disrupts stem cell programs in embryonal carcinoma: an emerging cohesin role in tumor suppression	ONCOGENE			English	Article						APRIN; stem cells; differentiation; cancer; Pds5b; cohesins	PROSTATE-CANCER CELLS; DE-LANGE-SYNDROME; NEURAL DIFFERENTIATION; GENE-EXPRESSION; AT-HOOK; AS3; PROLIFERATION; PATTERNS; NEURONS; PROTEIN	Cohesins appear to have critical functions beyond mitotic cohesion. Our data on a cohesin-associated Pds5-paralog, APRIN, indicate a novel cohesin role in stem cell differentiation. APRIN/Pds5B is lost in many cancers and it is a putative tumor suppressor. Its mutations in the germ line, however, generate birth defects. We reasoned that as both cancer and birth defects share disrupted stem cell differentiation, the data suggest an APRIN/Pds5B cohesin function in stem cells. We used an embryonal carcinoma stem cell model and show here that (i) APRIN expression is precisely coordinated with stem cell differentiation; (ii) this coordination involves surface-contact and endocrine pathways; and (iii) APRIN/Pds5b coordination is critical in stem/progenitor exit decisions. APRIN knockdown disrupted Oct4, Nanog and SOX2 patterns, differentiation failed and the resulting immature proliferative cells did not progress beyond proneural progenitor phase. Furthermore, the phenotype-blocked progenitor exit (Mash-1(+)); failed E-cadherin exit (E-Cadh(low+));incomplete N-cadherin transition (N-Cadh(low+)); retained proliferative capacity (c-myc(+)); irregular stemness (SOX2(late++)) and lost response to contact and hormonal cues-shares similarities with cancer-initiating cells. The data suggest novel APRIN/Pds5B-linked cohesin roles in stem/progenitor programs and a new mechanism in tumor suppression. Oncogene (2010) 29, 3446-3452; doi:10.1038/onc.2010.100; published online 12 April 2010	[Denes, V.; Geck, P.] Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; [Pilichowska, M.] Tufts Med Ctr, Dept Pathol, Boston, MA USA; [Makarovskiy, A.; Carpinito, G.] Tufts Med Ctr, Dept Urol, Boston, MA USA	Tufts University; Tufts Medical Center; Tufts Medical Center	Geck, P (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cell Biol, Harrison Ave, Boston, MA 02111 USA.	peter.geck@tufts.edu			The Susan G Komen Breast Cancer Foundation [BCTR0403214, W81XWH-08-1-0575, W81XWH-09-1-0411]; Sanofi-Aventis [IST10257];  [DOD-DAMD17-01-1-0430];  [DOD-DAMD1703-1-0266]	The Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Sanofi-Aventis(Sanofi-Aventis); ; 	We are grateful to Grace Gill, Karina Meiri and Natasha Kreder for critical review of the paper. The technical assistance of Shu Ling Liang and Byung Kyu Kim is greatly appreciated. This work was supported by the following awards: DOD-DAMD17-01-1-0430 (PG); DOD-DAMD1703-1-0266 (PG); The Susan G Komen Breast Cancer Foundation BCTR0403214 (PG); W81XWH-08-1-0575 (PG); W81XWH-09-1-0411 (PG) and Sanofi-Aventis award IST10257 (AM).	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Cattaruzzi G, 2007, NUCLEIC ACIDS RES, V35, P1751, DOI 10.1093/nar/gkl1106; DuVall GA, 1996, J CLIN GASTROENTEROL, V22, P131, DOI 10.1097/00004836-199603000-00012; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Geck P, 1999, J STEROID BIOCHEM, V68, P41, DOI 10.1016/S0960-0760(98)00165-4; Geck P, 1997, J STEROID BIOCHEM, V63, P211, DOI 10.1016/S0960-0760(97)00122-2; Geck P, 2001, AM J HUM GENET, V69, P461, DOI 10.1086/321968; Geck P, 2000, P NATL ACAD SCI USA, V97, P10185, DOI 10.1073/pnas.97.18.10185; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harada H, 2001, INT J ONCOL, V18, P1003; Itoh F, 1997, TOHOKU J EXP MED, V182, P327, DOI 10.1620/tjem.182.327; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kumar D, 2004, GENE, V328, P187, DOI 10.1016/j.gene.2003.12.013; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Maffini M, 2008, J STEROID BIOCHEM, V108, P32, DOI 10.1016/j.jsbmb.2007.05.034; Maffini MV, 2002, ENDOCRINOLOGY, V143, P2708, DOI 10.1210/en.143.7.2708; Mani S, 2001, MOL CELL NEUROSCI, V17, P54, DOI 10.1006/mcne.2000.0931; MARUIWA M, 1988, VIRCHOWS ARCH A, V413, P463, DOI 10.1007/BF00716995; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; Murthy S, 2005, PROSTATE, V64, P362, DOI 10.1002/pros.20251; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Reis EM, 2005, CANCER RES, V65, P1693, DOI 10.1158/0008-5472.CAN-04-3506; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; SATO A, 1986, ACTA PATHOL JAPON, V36, P143; Seo MJ, 2005, GYNECOL ONCOL, V96, P621, DOI 10.1016/j.ygyno.2004.11.032; SMITH SC, 1987, J CELL PHYSIOL, V131, P74, DOI 10.1002/jcp.1041310112; SUGITA K, 1986, BRAIN DEV-JPN, V8, P541, DOI 10.1016/S0387-7604(86)80101-2; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teramoto S, 2005, ONCOL REP, V14, P1231; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Wei Y, 2002, DIFFERENTIATION, V70, P204, DOI 10.1046/j.1432-0436.2002.700409.x; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang Y, 2008, J GENET GENOMICS, V35, P267, DOI 10.1016/S1673-8527(08)60038-7; Zheng MZ, 2008, J CANCER RES CLIN, V134, P453, DOI 10.1007/s00432-007-0306-x	49	18	19	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2010	29	23					3446	3452		10.1038/onc.2010.100	http://dx.doi.org/10.1038/onc.2010.100			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20383194				2022-12-25	WOS:000278622700012
J	Alcazar-Roman, AR; Bolger, TA; Wente, SR				Alcazar-Roman, Abel R.; Bolger, Timothy A.; Wente, Susan R.			Control of mRNA Export and Translation Termination by Inositol Hexakisphosphate Requires Specific Interaction with Gle1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN DBP5; NUCLEAR-PORE COMPLEX; NUCLEOPORIN NUP214; POLY(A)(+) RNA; HUMAN HOMOLOG; YEAST; PATHWAY; CELLS; MRNP; HELICASE	The unidirectional translocation of messenger RNA (mRNA) through the aqueous channel of the nuclear pore complex (NPC) is mediated by interactions between soluble mRNA export factors and distinct binding sites on the NPC. At the cytoplasmic side of the NPC, the conserved mRNA export factors Gle1 and inositol hexakisphosphate (IP6) play an essential role in mRNA export by activating the ATPase activity of the DEAD-box protein Dbp5, promoting localized messenger ribonucleoprotein complex remodeling, and ensuring the directionality of the export process. In addition, Dbp5, Gle1, and IP6 are also required for proper translation termination. However, the specificity of the IP6-Gle1 interaction in vivo is unknown. Here, we characterize the biochemical interaction between Gle1 and IP6 and the relationship to Dbp5 binding and stimulation. We identify Gle1 residues required for IP6 binding and show that these residues are needed for IP6-dependent Dbp5 stimulation in vitro. Furthermore, we demonstrate that Gle1 is the primary target of IP6 for both mRNA export and translation termination in vivo. In Saccharomyces cerevisiae cells, the IP6-binding mutants recapitulate all of the mRNA export and translation termination defects found in mutants depleted of IP6. We conclude that Gle1 specifically binds IP6 and that this interaction is required for the full potentiation of Dbp5 ATPase activity during both mRNA export and translation termination.	[Alcazar-Roman, Abel R.; Bolger, Timothy A.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, U-3209 MRBIII, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu		Alcazar-Roman, Abel R./0000-0003-1668-1886	National Institutes of Health [R01-GM51219, F32-GM082065]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051219, R01GM051219, F32GM082065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM51219 (to S. R. W.) and F32-GM082065 (to T. A. B.).	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; DelPriore V, 1996, MOL BIOL CELL, V7, P1601, DOI 10.1091/mbc.7.10.1601; Dossani ZY, 2009, P NATL ACAD SCI USA, V106, P16251, DOI 10.1073/pnas.0902251106; Du J, 1998, GENETICS, V150, P987; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Fan JS, 2009, J MOL BIOL, V388, P1, DOI 10.1016/j.jmb.2009.03.004; Feng YC, 2001, P NATL ACAD SCI USA, V98, P875, DOI 10.1073/pnas.021558098; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mckee AE, 2007, CELL RES, V17, P581, DOI 10.1038/cr.2007.54; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Moon D, 2008, J MICROBIOL, V46, P422, DOI 10.1007/s12275-008-0177-0; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Sarmah B, 2009, EUKARYOT CELL, V8, P134, DOI 10.1128/EC.00279-08; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tuite MF, 2007, PRION, V1, P101, DOI 10.4161/pri.1.2.4665; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	53	63	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16683	16692		10.1074/jbc.M109.082370	http://dx.doi.org/10.1074/jbc.M109.082370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371601	Green Published, hybrid			2022-12-25	WOS:000277982600032
J	Gundlfinger, A; Breustedt, J; Sullivan, D; Schmitz, D				Gundlfinger, Anja; Breustedt, Joerg; Sullivan, David; Schmitz, Dietmar			Natural Spike Trains Trigger Short- and Long-Lasting Dynamics at Hippocampal Mossy Fiber Synapses in Rodents	PLOS ONE			English	Article							TERM POTENTIATION; SYNAPTIC PLASTICITY; UNIT-ACTIVITY; CA3; RECEPTORS; LTP; FACILITATION; INFORMATION; SEPARATION; PATTERNS	Background: Synapses exhibit strikingly different forms of plasticity over a wide range of time scales, from milliseconds to hours. Studies on synaptic plasticity typically use constant-frequency stimulation to activate synapses, whereas in vivo activity of neurons is irregular. Methodology/Principal Findings: Using extracellular and whole-cell electrophysiological recordings, we have here studied the synaptic responses at hippocampal mossy fiber synapses in vitro to stimulus patterns obtained from in vivo recordings of place cell firing of dentate gyrus granule cells in behaving rodents. We find that synaptic strength is strongly modulated on short-and long-lasting time scales during the presentation of the natural stimulus trains. Conclusions/Significance: We conclude that dynamic short- and long-term synaptic plasticity at the hippocampal mossy fiber synapse plays a prominent role in normal synaptic function.	[Gundlfinger, Anja; Breustedt, Joerg; Schmitz, Dietmar] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany; [Gundlfinger, Anja; Schmitz, Dietmar] Humboldt Univ, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Sullivan, David] Rutgers State Univ, Ctr Mol & Behav Neurobiol, Newark, NJ 07102 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Rutgers State University Newark; Rutgers State University New Brunswick	Gundlfinger, A (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	dietmar.schmitz@charite.de		Schmitz, Dietmar/0000-0003-2741-5241	Deutsche Forschungsgemeinschaft [SFB665, SFB618, GRK1123, EXC257]; Bundesministerium fur Bildung und Forschung [01GQ0410]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by the Deutsche Forschungsgemeinschaft (Grants SFB665, SFB618, GRK1123, EXC257 to D.S.) and the Bundesministerium fur Bildung und Forschung (Bernstein Center for Computational Neuroscience Berlin, Grant 01GQ0410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUZSAKI G, 1992, EPILEPSY RES, P281; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; deKay JGT, 2006, HIPPOCAMPUS, V16, P66, DOI 10.1002/hipo.20132; Dobrunz LE, 1999, NEURON, V22, P157, DOI 10.1016/S0896-6273(00)80687-X; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Frerking M, 2006, J NEUROPHYSIOL, V96, P2139, DOI 10.1152/jn.00243.2006; Gundlfinger A, 2007, J PHYSIOL-LONDON, V585, P853, DOI 10.1113/jphysiol.2007.143925; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Isaac JTR, 2009, J NEUROSCI, V29, P6840, DOI 10.1523/JNEUROSCI.0731-09.2009; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MIZUMORI SJY, 1989, J NEUROPHYSIOL, V61, P15, DOI 10.1152/jn.1989.61.1.15; Mori-Kawakami F, 2003, J PHYSIOL-LONDON, V553, P37, DOI 10.1113/jphysiol.2003.045948; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	38	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9961	10.1371/journal.pone.0009961	http://dx.doi.org/10.1371/journal.pone.0009961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376354	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000276418200035
J	Ray, HJ; Chu, P; Wu, TH; Lyons, CR; Murthy, AK; Guentzel, MN; Klose, KE; Arulanandam, BP				Ray, Heather J.; Chu, Ping; Wu, Terry H.; Lyons, C. Rick; Murthy, Ashlesh K.; Guentzel, M. Neal; Klose, Karl E.; Arulanandam, Bernard P.			The Fischer 344 Rat Reflects Human Susceptibility to Francisella Pulmonary Challenge and Provides a New Platform for Virulence and Protection Studies	PLOS ONE			English	Article							LIVE VACCINE STRAIN; NITRIC-OXIDE PRODUCTION; CD4(+) T-CELLS; INTRANASAL VACCINATION; MURINE MACROPHAGES; TULARENSIS-LVS; IFN-GAMMA; TULAREMIA; IMMUNITY; INFECTION	Background: The pathogenesis of Francisella tularensis, the causative agent of tularemia, has been primarily characterized in mice. However, the high degree of sensitivity of mice to bacterial challenge, especially with the human virulent strains of F. tularensis, limits this animal model for screening of defined attenuated vaccine candidates for protection studies. Methods and Findings: We analyzed the susceptibility of the Fischer 344 rat to pulmonary (intratracheal) challenge with three different subspecies (subsp) of F. tularensis that reflect different levels of virulence in humans, and characterized the bacterial replication profile in rat bone marrow-derived macrophages (BMDM). In contrast to the mouse, Fischer 344 rats exhibit a broader range of sensitivity to pulmonary challenge with the human virulent subsp. tularensis and holarctica. Unlike mice, Fischer rats exhibited a high degree of resistance to pulmonary challenge with LVS (an attenuated derivative of subsp. holarctica) and subsp. novicida. Within BMDM, subsp. tularensis and LVS showed minimal replication, subsp. novicida showed marginal replication, and subsp. holartica replicated robustly. The limited intramacrophage replication of subsp. tularensis and novicida strains was correlated with the induction of nitric oxide production. Importantly, Fischer 344 rats that survived pulmonary infection with subsp. novicida were markedly protected against subsequent pulmonary challenge with subsp. tularensis, suggesting that subsp. novicida may be a useful platform for the development of vaccines against subsp. tularensis. Conclusions: The Fischer 344 rat exhibits similar sensitivity to F. tularensis strains as that reported for humans, and thus the Fischer 344 ray may serve as a better animal model for tularemia vaccine development.	[Ray, Heather J.; Chu, Ping; Murthy, Ashlesh K.; Guentzel, M. Neal; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Ray, Heather J.; Chu, Ping; Murthy, Ashlesh K.; Guentzel, M. Neal; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Wu, Terry H.; Lyons, C. Rick] Univ New Mexico, Ctr Infect Dis & Immun, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of New Mexico; University of New Mexico's Health Sciences Center	Ray, HJ (corresponding author), Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.	Bernard.arulanandam@utsa.edu	Arulanandam, Bernard P/O-9501-2014	Ray, Heather/0000-0003-0292-8403	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200500040C, PO1 AI057986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986, T32AI007538] Funding Source: NIH RePORTER	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with Federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200500040C and Grant PO1 AI057986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY LSD, 1987, MICROB PATHOGENESIS, V2, P3, DOI 10.1016/0882-4010(87)90110-0; Barker JR, 2007, ANN NY ACAD SCI, V1105, P138, DOI 10.1196/annals.1409.010; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; CANONICO PG, 1975, INFECT IMMUN, V12, P42, DOI 10.1128/IAI.12.1.42-47.1975; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; COSTA DL, 1986, LAB ANIM SCI, V36, P256; DOWNS CM, 1949, J IMMUNOL, V63, P117; DOWNS CM, 1947, J IMMUNOL, V56, P217; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ELKINS KL, 1992, MICROB PATHOGENESIS, V13, P417, DOI 10.1016/0882-4010(92)90085-3; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Frank DW, 2007, ANN NY ACAD SCI, V1105, P67, DOI 10.1196/annals.1409.008; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; JEMSKI JV, 1981, INFECT IMMUN, V34, P766, DOI 10.1128/IAI.34.3.766-772.1981; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; KELLER R, 1992, INFECT IMMUN, V60, P3664, DOI 10.1128/IAI.60.9.3664-3672.1992; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Kmonickova E, 2007, NITRIC OXIDE-BIOL CH, V17, P160, DOI 10.1016/j.niox.2007.06.006; KOSTIALA AAI, 1975, IMMUNOLOGY, V28, P855; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Mahawar M, 2009, J BACTERIOL, V191, P4798, DOI 10.1128/JB.00212-09; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; Pierini LM, 2006, CELL MICROBIOL, V8, P1361, DOI 10.1111/j.1462-5822.2006.00719.x; Powell HJ, 2008, IMMUNOL CELL BIOL, V86, P515, DOI 10.1038/icb.2008.31; Rao KMK, 2000, J TOXICOL ENV HEAL B, V3, P27, DOI 10.1080/109374000281131; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Raymond CR, 2009, MICROB PATHOGENESIS, V46, P231, DOI 10.1016/j.micpath.2009.01.002; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; TARNVIK A, 1989, REV INFECT DIS, V11, P440; WEINBERG JB, 1995, BLOOD, V86, P1184; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	45	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9952	10.1371/journal.pone.0009952	http://dx.doi.org/10.1371/journal.pone.0009952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376351	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200028
J	Smith, SL; Trachtenberg, JT				Smith, Spencer L.; Trachtenberg, Joshua T.			The Refinement of Ipsilateral Eye Retinotopic Maps Is Increased by Removing the Dominant Contralateral Eye in Adult Mice	PLOS ONE			English	Article							VISUAL-CORTEX; MONOCULAR DEPRIVATION; RECEPTIVE-FIELDS; CORTICAL MAPS; EPHRIN-AS; PLASTICITY; ACUITY; CONTRAST	Background: Shortly after eye opening, initially disorganized visual cortex circuitry is rapidly refined to form smooth retinotopic maps. This process asymptotes long before adulthood, but it is unknown whether further refinement is possible. Prior work from our lab has shown that the retinotopic map of the non-dominant ipsilateral eye develops faster when the dominant contralateral eye is removed. We examined whether input from the contralateral eye might also limit the ultimate refinement of the ipsilateral eye retinotopic map in adults. In addition, we examined whether the increased refinement involved the recruitment of adjacent cortical area. Methodology/Principal Findings: By surgically implanting a chronic optical window over visual cortex in mice, we repeatedly measured the degree of retinotopic map refinement using quantitative intrinsic signal optical imaging over four weeks. We removed the contralateral eye and observed that the retinotopic map for the ipsilateral eye was further refined and the maximum magnitude of response increased. However, these changes were not accompanied by an increase in the area of responsive cortex. Conclusions/Significance: Since the retinotopic map was functionally refined to a greater degree without taking over adjacent cortical area, we conclude that input from the contralateral eye limits the normal refinement of visual cortical circuitry in mice. These findings suggest that the refinement capacity of cortical circuitry is normally saturated.	[Smith, Spencer L.; Trachtenberg, Joshua T.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Smith, SL (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	spencer.smith@wibr.ucl.ac.uk; jtrachtenberg@mednet.ucla.edu			NIH R01 [5R01EY016052]; Klingenstein Foundation; NIH NRSA [1F32EY016633]; A. P. Giannini Foundation; NATIONAL EYE INSTITUTE [R01EY016052, F32EY016633] Funding Source: NIH RePORTER	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. P. Giannini Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an NIH R01 (5R01EY016052, JTT), the Klingenstein Foundation (JTT), an NIH NRSA (1F32EY016633, SLS), and the A. P. Giannini Foundation (SLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Faguet J, 2009, J NEUROPHYSIOL, V101, P855, DOI 10.1152/jn.90893.2008; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; FREEMAN RD, 1980, J NEUROPHYSIOL, V43, P1645, DOI 10.1152/jn.1980.43.6.1645; Hirsch JA, 2006, TRENDS NEUROSCI, V29, P30, DOI 10.1016/j.tins.2005.11.001; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nicholas JJ, 1996, VISION RES, V36, P175, DOI 10.1016/0042-6989(95)00119-K; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Steeves JKE, 2004, VISION RES, V44, P943, DOI 10.1016/j.visres.2003.11.015; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273	20	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9925	10.1371/journal.pone.0009925	http://dx.doi.org/10.1371/journal.pone.0009925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369001	Green Submitted, Green Published, gold			2022-12-25	WOS:000276163100017
J	Zhang, BY; Cressman, R; Tao, Y				Zhang, Bo-Yu; Cressman, Ross; Tao, Yi			Cooperation and Stability through Periodic Impulses	PLOS ONE			English	Article							EVOLUTIONARILY STABLE STRATEGIES; GAMES	Basic games, where each individual chooses between two strategies, illustrate several issues that immediately emerge from the standard approach that applies strategic reasoning, based on rational decisions, to predict population behavior where no rationality is assumed. These include how mutual cooperation (which corresponds to the best outcome from the population perspective) can evolve when the only individually rational choice is to defect, illustrated by the Prisoner's Dilemma (PD) game, and how individuals can randomize between two strategies when neither is individually rational, illustrated by the Battle of the Sexes (BS) game that models male-female conflict over parental investment in offspring. We examine these questions from an evolutionary perspective where the evolutionary dynamics includes an impulsive effect that models sudden changes in collective population behavior. For the PD game, we show analytically that cooperation can either coexist with defection or completely take over the population, depending on the strength of the impulse. By extending these results for the PD game, we also show that males and females each evolve to a single strategy in the BS game when the impulsive effect is strong and that weak impulses stabilize the randomized strategies of this game.	[Zhang, Bo-Yu; Tao, Yi] Chinese Acad Sci, Inst Zool, Ctr Computat Biol & Evolut, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhang, Bo-Yu] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Cressman, Ross] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Normal University; Wilfrid Laurier University	Zhang, BY (corresponding author), Chinese Acad Sci, Inst Zool, Ctr Computat Biol & Evolut, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	rcressman@wlu.ca; yitao@ioz.ac.cn		Tao, Yi/0000-0002-0749-6614	National Basic Research Program (973) [2007CB109107]; Natural Sciences and Engineering Research Council of Canada	National Basic Research Program (973)(National Basic Research Program of China); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by The National Basic Research Program (973) (No. 2007CB109107) of the People's Republic of China and by an Individual Discovery Grant from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Dawkins R, 1976, SELFISH GENE; DEALESSI L, 1975, AM ECON REV, V65, P127; DOUTY CM, 1972, AM ECON REV, V62, P580; Echenique F, 2004, J ECON THEORY, V118, P61, DOI 10.1016/j.jet.2003.10.004; Frey Bruno S, 2009, CESIFO WORKING PAPER, V2551; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Korn R, 1999, MATH METHOD OPER RES, V50, P493, DOI 10.1007/s001860050083; Maynard Smith J., 1982, pi; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; SCHUSTER P, 1981, ANIM BEHAV, V29, P186, DOI 10.1016/S0003-3472(81)80165-0; SELTEN R, 1980, J THEOR BIOL, V84, P93, DOI 10.1016/S0022-5193(80)81038-1; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; SMITH JM, 1988, J THEOR BIOL, V130, P247, DOI 10.1016/S0022-5193(88)80100-0; Taylor PD, 2007, J EVOLUTION BIOL, V20, P301, DOI 10.1111/j.1420-9101.2006.01196.x; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Wang SC, 2008, J THEOR BIOL, V254, P384, DOI 10.1016/j.jtbi.2008.05.016	26	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9882	10.1371/journal.pone.0009882	http://dx.doi.org/10.1371/journal.pone.0009882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369003	Green Published, gold, Green Submitted			2022-12-25	WOS:000276163100004
J	Excoffon, KJDA; Gansemer, ND; Mobily, ME; Karp, PH; Parekh, KR; Zabner, J				Excoffon, Katherine J. D. A.; Gansemer, Nicholas D.; Mobily, Matthew E.; Karp, Philip H.; Parekh, Kalpaj R.; Zabner, Joseph			Isoform-Specific Regulation and Localization of the Coxsackie and Adenovirus Receptor in Human Airway Epithelia	PLOS ONE			English	Article							FIBROSIS TRANSMEMBRANE REGULATOR; HISTONE DEACETYLASE INHIBITOR; MEDIATED GENE-TRANSFER; CYSTIC-FIBROSIS; B VIRUS; BINDING AFFINITIES; TIGHT JUNCTIONS; APICAL SURFACE; CAR; DOMAIN	Adenovirus is an important respiratory pathogen. Adenovirus fiber from most serotypes co-opts the Coxsackie-Adenovirus Receptor (CAR) to bind and enter cells. However, CAR is a cell adhesion molecule localized on the basolateral membrane of polarized epithelia. Separation from the lumen of the airways by tight junctions renders airway epithelia resistant to inhaled adenovirus infection. Although a role for CAR in viral spread and egress has been established, the mechanism of initial respiratory infection remains controversial. CAR exists in several protein isoforms including two transmembrane isoforms that differ only at the carboxy-terminus (CAR(Ex7) and CAR(Ex8)). We found low-level expression of the CAR(Ex8) isoform in well-differentiated human airway epithelia. Surprisingly, in contrast to CAR(Ex7), CAR(Ex8) localizes to the apical membrane of epithelia where it augments adenovirus infection. Interestingly, despite sharing a similar class of PDZ-binding domain with CAR(Ex7), CAR(Ex8) differentially interacts with PICK1, PSD-95, and MAGI-1b. MAGI-1b appears to stoichiometrically regulate the degradation of CAR(Ex8) providing a potential mechanism for the apical localization of CAR(Ex8) in airway epithelial. In summary, apical localization of CAR(Ex8) may be responsible for initiation of respiratory adenoviral infections and this localization appears to be regulated by interactions with PDZ-domain containing proteins.	[Excoffon, Katherine J. D. A.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Gansemer, Nicholas D.; Mobily, Matthew E.; Karp, Philip H.; Zabner, Joseph] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Parekh, Kalpaj R.] Univ Iowa, Dept Cardiothorac Surg, Iowa City, IA USA	University System of Ohio; Wright State University Dayton; University of Iowa; University of Iowa	Excoffon, KJDA (corresponding author), Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.	joseph-zabner@uiowa.edu	Parekh, Kalpaj/E-4966-2012; Excoffon, Katherine/ABC-5037-2021	Parekh, Kalpaj/0000-0001-6869-5441; Excoffon, Katherine/0000-0003-3945-0298; Zabner, Joseph/0000-0002-9606-1339	NIH [HL51670-11]; Roy J. Carver Charitable Trust; NHLBI; CFF; NIDDK; National Heart, Lung and Blood Institute; NIDDK [DK54759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Charitable Trust; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CFF; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a PPG grant from the NIH (HL51670-11). The Gene Transfer Vector Core is supported by the Roy J. Carver Charitable Trust, the NHLBI, CFF, and NIDDK. The In Vitro Cell Models Core is supported by the National Heart, Lung and Blood Institute and NIDDK [DK54759]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Bernal RM, 2002, CLIN CANCER RES, V8, P1915; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dorner A, 2006, J MOL MED, V84, P842, DOI 10.1007/s00109-006-0076-y; Dorner A, 2004, J BIOL CHEM, V279, P18497, DOI 10.1074/jbc.M311754200; Excoffon KJDA, 2007, J VIROL, V81, P5573, DOI 10.1128/JVI.02562-06; Excoffon KJDA, 2005, AM J RESP CELL MOL, V32, P498, DOI 10.1165/rcmb.2005-0031OC; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Excoffon KJDA, 2003, J VIROL, V77, P2559, DOI 10.1128/JVI.77.4.2559-2567.2003; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; Goodfellow IG, 2005, J VIROL, V79, P12016, DOI 10.1128/JVI.79.18.12016-12024.2005; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kitazono M, 2001, CANCER RES, V61, P6328; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Pong RC, 2006, CANCER RES, V66, P8822, DOI 10.1158/0008-5472.CAN-05-4672; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Reimer D, 2007, INT J CANCER, V120, P2568, DOI 10.1002/ijc.22580; Segura-Pacheco Blanca, 2007, Genet Vaccines Ther, V5, P10, DOI 10.1186/1479-0556-5-10; Shaw CA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-42; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Thoelen I, 2001, BIOCHEM BIOPH RES CO, V287, P216, DOI 10.1006/bbrc.2001.5535; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Van't Hof W, 2001, HUM GENE THER, V12, P25, DOI 10.1089/104303401450933; Walters RW, 2001, J VIROL, V75, P7703, DOI 10.1128/JVI.75.16.7703-7711.2001; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Yanagawa B, 2004, J INFECT DIS, V189, P1431, DOI 10.1086/382598; Zabner J, 1996, GENE THER, V3, P458; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	45	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9909	10.1371/journal.pone.0009909	http://dx.doi.org/10.1371/journal.pone.0009909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361046	gold, Green Published			2022-12-25	WOS:000275969600015
J	Himer, L; Csoka, B; Selmeczy, Z; Koscso, B; Pocza, T; Pacher, P; Nemeth, ZH; Deitch, EA; Vizi, ES; Cronstein, BN; Hasko, G				Himer, Leonora; Csoka, Balazs; Selmeczy, Zsolt; Koscso, Balazs; Pocza, Timea; Pacher, Pal; Nemeth, Zoltan H.; Deitch, Edwin A.; Vizi, E. Sylvester; Cronstein, Bruce N.; Hasko, Gyoergy			Adenosine A(2A) receptor activation protects CD4(+) T lymphocytes against activation-induced cell death	FASEB JOURNAL			English	Article						inflammation; apoptosis; anergy	FAS-LIGAND EXPRESSION; VASOACTIVE-INTESTINAL-PEPTIDE; DEFICIENT MICE REVEALS; FACTOR-KAPPA-B; EXTRACELLULAR ADENOSINE; ADENYLATE-CYCLASE; DEAMINASE DEFICIENCY; MEDIATED ACTIVATION; DNA FRAGMENTATION; MOUSE THYMOCYTES	Activation-induced cell death (AICD) is initiated by T-cell receptor (TCR) restimulation of already activated and expanded peripheral T cells and is mediated through Fas/Fas ligand (FasL) interactions. Adenosine is a purine nucleoside signaling molecule, and its immunomodulatory effects are mediated by 4 G-protein-coupled receptors: A(1), A(2A), A(2B), and A(3). In this study, we investigated the role of A(2A) receptors in regulating CD4(+) T lymphocyte AICD. Our results showed that the selective A(2A) receptor agonist CGS21680 (EC50 = 15.2-32.6 nM) rescued mouse CD4(+) hybridomas and human Jurkat cells from AICD and that this effect was reversed by the selective A(2A) receptor antagonist ZM241385 (EC50 = 2.3 nM). CGS21680 decreased phosphatidylserine exposure on the membrane, as well as the cleavage of caspase-3, caspase-8 and poly(ADP-ribose) polymerase indicating that A2A receptor stimulation blocks the extrinsic apoptotic pathway. In addition, CGS21680 attenuated both Fas and FasL mRNA expression. This decrease in FasL expression was associated with decreased activation of the transcription factor systems NF-kappa B, NF-ATp, early growth response (Egr)-1, and Egr-3. The antiapoptotic effect of A(2A) receptor stimulation was mediated by protein kinase A. Together, these results demonstrate that A(2A) receptor activation suppresses the AICD of peripheral T cells.-Himer, L., Csoka, B., Selmeczy, Z., Koscso, B., Pocza, T., Pacher, P., Nemeth, Z. H., Deitch, E. A., Vizi, E. S., Cronstein, B. N., Hasko, G. Adenosine A(2A) receptor activation protects CD4(+) T lymphocytes against activation-induced cell death. FASEB J. 24, 2631-2640 (2010). www.fasebj.org	[Csoka, Balazs; Nemeth, Zoltan H.; Deitch, Edwin A.; Hasko, Gyoergy] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA; [Himer, Leonora; Selmeczy, Zsolt; Koscso, Balazs; Pocza, Timea; Vizi, E. Sylvester] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary; [Pacher, Pal] NIAAA, Sect Oxidat Stress Tissue Injury, Lab Physiol Studies, NIH, Bethesda, MD USA; [Nemeth, Zoltan H.] Morristown Mem Hosp, Dept Surg, Morristown, NJ USA; [Cronstein, Bruce N.] NYU, Sch Med, Dept Med, Div Clin Pharmacol, New York, NY USA; [Hasko, Gyoergy] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, H-4012 Debrecen, Hungary	Rutgers State University New Brunswick; Rutgers State University Medical Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Atlantic Health System; New York University; University of Debrecen	Hasko, G (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	haskoge@umdnj.edu	Cronstein, Bruce N/D-4678-2011; Pacher, Pal/B-6378-2008	Cronstein, Bruce N/0000-0002-4295-7383; Pacher, Pal/0000-0001-7036-8108; Csoka, Balazs/0000-0002-7562-1130; Koscso, Balazs/0000-0001-9676-2066	U.S. National Institutes of Health (NIH) [R01 GM66189]; NIH, National Institute on Alcohol Abuse and Alcoholism; OTKA [73110, 78275]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the U.S. National Institutes of Health (NIH; grant R01 GM66189), the Intramural Research Program of NIH, National Institute on Alcohol Abuse and Alcoholism, and the Hungarian Research Fund OTKA (73110 and 78275).	Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Apasov S, 2000, BLOOD, V95, P3859; Apasov SG, 1999, INT IMMUNOL, V11, P179, DOI 10.1093/intimm/11.2.179; Apasov SG, 2001, J CLIN INVEST, V108, P131, DOI 10.1172/JCI10360; Apasov SG, 2000, BRIT J PHARMACOL, V131, P43, DOI 10.1038/sj.bjp.0703532; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; Barbieri D, 1998, NEUROCHEM INT, V32, P493, DOI 10.1016/S0197-0186(97)00129-0; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Bshesh K, 2002, J LEUKOCYTE BIOL, V72, P1027; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Delgado M, 2001, J IMMUNOL, V166, P1028, DOI 10.4049/jimmunol.166.2.1028; Delgado M, 2000, J IMMUNOL, V165, P114, DOI 10.4049/jimmunol.165.1.114; Erdmann AA, 2005, BLOOD, V105, P4707, DOI 10.1182/blood-2004-04-1407; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Genestier L, 1998, J CLIN INVEST, V102, P322, DOI 10.1172/JCI2676; Gessi S, 2000, BRIT J PHARMACOL, V129, P2, DOI 10.1038/sj.bjp.0703045; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ishimaru N, 2001, J IMMUNOL, V167, P6031, DOI 10.4049/jimmunol.167.10.6031; Jacobson KA, 1999, APOPTOSIS, V4, P197, DOI 10.1023/A:1009666707307; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; Kiss I, 2006, EUR J IMMUNOL, V36, P1559, DOI 10.1002/eji.200535334; KIZAKI H, 1988, J IMMUNOL, V141, P1652; Koshiba M, 1997, J BIOL CHEM, V272, P25881, DOI 10.1074/jbc.272.41.25881; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li-Weber M, 1998, EUR J IMMUNOL, V28, P2373, DOI 10.1002/(SICI)1521-4141(199808)28:08<2373::AID-IMMU2373>3.0.CO;2-T; Li-Weber M, 2002, CELL DEATH DIFFER, V9, P1256, DOI 10.1038/sj.cdd.4401102; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Lukashev DE, 2003, BIOCHEM PHARMACOL, V65, P2081, DOI 10.1016/S0006-2952(03)00158-8; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nemeth ZH, 2003, J PHARMACOL EXP THER, V306, P1042, DOI 10.1124/jpet.103.052944; Nemeth ZH, 2007, FASEB J, V21, P2379, DOI 10.1096/fj.07-8213com; Norian LA, 1998, J IMMUNOL, V161, P1078; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Raskovalova T, 2007, CANCER RES, V67, P5949, DOI 10.1158/0008-5472.CAN-06-4249; Scheibner KA, 2009, AM J RESP CELL MOL, V40, P251, DOI 10.1165/rcmb.2008-0168OC; Seino KI, 1997, GASTROENTEROLOGY, V113, P1315, DOI 10.1053/gast.1997.v113.pm9322527; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; Sevigny CP, 2007, J IMMUNOL, V178, P4240, DOI 10.4049/jimmunol.178.7.4240; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; SHI YF, 1990, J IMMUNOL, V144, P3326; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Suarez A, 2002, J IMMUNOL, V169, P1159, DOI 10.4049/jimmunol.169.3.1159; SZONDY Z, 1994, BIOCHEM J, V304, P877, DOI 10.1042/bj3040877; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WESSELBORG S, 1993, J IMMUNOL, V150, P4338; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang J, 2004, CELL MOL IMMUNOL, V1, P186	63	58	60	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2631	2640		10.1096/fj.10-155192	http://dx.doi.org/10.1096/fj.10-155192			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371613	Green Published			2022-12-25	WOS:000285005400005
J	Kwon, RY; Temiyasathit, S; Tummala, P; Quah, CC; Jacobs, CR				Kwon, Ronald Y.; Temiyasathit, Sara; Tummala, Padmaja; Quah, Clarence C.; Jacobs, Christopher R.			Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells	FASEB JOURNAL			English	Article						mechanotransduction; fluid flow; osteocyte; osteoporosis	POLYCYSTIC KIDNEY-DISEASE; OSCILLATORY FLUID-FLOW; LEFT-RIGHT ASYMMETRY; INTRAFLAGELLAR TRANSPORT; MC3T3-E1 OSTEOBLASTS; SIGNALING PATHWAY; PROTEIN-KINASE; DETECT CHANGES; SHEAR-STRESS; OSTEOCYTES	Primary cilia are chemosensing and mechanosensing organelles that regulate remarkably diverse processes in a variety of cells. We previously showed that primary cilia play a role in mediating mechanosensing in bone cells through an unknown mechanism that does not involve extracellular Ca2+-dependent intracellular Ca2+ release, which has been implicated in all other cells that transduce mechanical signals via the cilium. Here, we identify a molecular mechanism linking primary cilia and bone cell mechanotransduction that involves adenylyl cyclase 6 (AC6) and cAMP. Intracellular cAMP was quantified in MLO-Y4 cells exposed to dynamic flow, and AC6 and primary cilia were inhibited using RNA interference. When exposed to flow, cells rapidly (<2 min) and transiently decreased cAMP production in a primary cilium-dependent manner. RT-PCR revealed differential expression of the membrane-bound isoforms of adenylyl cyclase, while immunostaining revealed one, AC6, preferentially localized to the cilium. Further studies showed that decreases in cAMP in response to flow were dependent on AC6 and Gd3+-sensitive channels but not intracellular Ca2+ release and that this response mediated flow-induced COX-2 gene expression. The signaling events identified provide important details of a novel early mechanosensing mechanism in bone and advances our understanding of how signal transduction occurs at the primary cilium.-Kwon, R. Y., Temiyasathit, S., Tummala, P., Quah, C. C., Jacobs, C. R. Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells. FASEB J. 24, 2859-2868 (2010). www.fasebj.org	[Kwon, Ronald Y.; Temiyasathit, Sara; Tummala, Padmaja; Quah, Clarence C.; Jacobs, Christopher R.] Bone & Joint Rehabil R&D Ctr, Dept Vet Affairs, Palo Alto, CA USA; [Kwon, Ronald Y.; Jacobs, Christopher R.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Temiyasathit, Sara; Jacobs, Christopher R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Jacobs, Christopher R.] Columbia Univ, Dept Biomed Engn, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Columbia University	Jacobs, CR (corresponding author), 351 Engn Terr,1210 Amsterdam Ave,Mail Code 8904, New York, NY 10027 USA.	crj2111@columbia.edu			Department of Veterans Affairs, the National Institutes of Health [AR045989, AR054156]; National Science Foundation; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR054156, R01AR045989] Funding Source: NIH RePORTER	Department of Veterans Affairs, the National Institutes of Health(US Department of Veterans Affairs); National Science Foundation(National Science Foundation (NSF)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Drs. Tim Stearns and Charlie Anderson for helpful discussions. This study was supported by the Department of Veterans Affairs, the National Institutes of Health (grants AR045989 and AR054156 to C.R.J.), a National Science Foundation Graduate Fellowship (to R.Y.K.), and a Department of Veterans Affairs Pre-Doctoral Associated Health Rehabilitation Research Fellowship (to S.T.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Chabardes D, 1999, CELL SIGNAL, V11, P651, DOI 10.1016/S0898-6568(99)00031-5; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Ishijima M, 2002, J BONE MINER RES, V17, P661, DOI 10.1359/jbmr.2002.17.4.661; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Johnston CA, 2004, J NEUROCHEM, V88, P1497, DOI 10.1046/j.1471-4159.2004.02285.x; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kwon RY, 2010, J BONE MINER RES, V25, P1798, DOI 10.1002/jbmr.74; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Masyuk AI, 2008, AM J PHYSIOL-GASTR L, V295, pG725, DOI 10.1152/ajpgi.90265.2008; Masyuk AI, 2006, GASTROENTEROLOGY, V131, P911, DOI 10.1053/j.gastro.2006.07.003; McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Phillips JA, 2008, MATRIX BIOL, V27, P609, DOI 10.1016/j.matbio.2008.05.003; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Raychowdhury MK, 2009, AM J PHYSIOL-RENAL, V296, pF87, DOI 10.1152/ajprenal.90509.2008; REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113; RODAN GA, 1975, SCIENCE, V189, P467, DOI 10.1126/science.168639; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ryder KD, 2001, J BONE MINER RES, V16, P240, DOI 10.1359/jbmr.2001.16.2.240; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Tan SD, 2007, BONE, V41, P745, DOI 10.1016/j.bone.2007.07.019; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Vezeridis PS, 2006, BIOCHEM BIOPH RES CO, V348, P1082, DOI 10.1016/j.bbrc.2006.07.146; Wadhwa S, 2002, BIOCHEM BIOPH RES CO, V297, P46, DOI 10.1016/S0006-291X(02)02124-1; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang JS, 2006, J BONE MINER RES, V21, P1729, DOI 10.1359/JBMR.060722; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289	59	97	101	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2859	2868		10.1096/fj.09-148007	http://dx.doi.org/10.1096/fj.09-148007			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371630	Green Published			2022-12-25	WOS:000285005400026
J	Liu, WY; Collodi, P				Liu, Weiyi; Collodi, Paul			Zebrafish dead end possesses ATPase activity that is required for primordial germ cell development	FASEB JOURNAL			English	Article						rescue; vasa; nanos1; TDRD7; miRNA	HELICASE ACTIVITY; BOX PROTEINS; RNA; VASA; GENE; EXPRESSION; HOMOLOG; COMPONENTS; APOBEC3G; PRODUCT	Zebrafish dead end (dnd) mRNA is specifically expressed in primordial germ cells (PGCs) and is required for PGC migration and survival. Previous studies have shown that zebrafish Dnd functions by protecting the 3'UTRs of nanos1 and TDRD7 from miR-430b-mediated RNA deadenylation. In this work, we demonstrate that zebrafish Dnd protein possesses Mg2+-dependent ATPase activity that is required for PGC formation. Michaelis-Menten analysis revealed that the ATPase has a k(cat) of 0.632 +/- 0.036/min under optimal conditions, and mapping studies using Dnd truncates showed that ATPase resides in the last 91 aa of the Dnd C terminus. Internal deletion and point mutagenesis analysis of this region were used to identify key amino acids required for ATPase activity. Rescue experiments conducted by injecting mRNAs encoding the Dnd ATPase mutants into embryos in which the endogenous dnd expression was inhibited demonstrated that the ATPase activity is required for normal zebrafish PGC survival. Real-time PCR analysis showed that the expression of PGC markers nanos1 and TDRD7 but not vasa were down-regulated when dnd mutant proteins lacking ATPase were expressed in the rescued embryos, indicating that the Dnd ATPase is involved in protecting nanos1 and TDRD7 transcripts.-Liu, W., Collodi, P. Zebrafish dead end possesses ATPase activity that is required for primordial germ cell development. FASEB J. 24, 2641-2650 (2010). www.fasebj.org	[Liu, Weiyi; Collodi, Paul] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Collodi, P (corresponding author), Purdue Univ, Dept Anim Sci, 915 W State St, W Lafayette, IN 47907 USA.	pcollodi@purdue.edu	liu, weiyi/G-2730-2012; liu, weiyi/B-2053-2014		National Institutes of Health [R01GM069384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Lisbeth Olsen (University of Bergen, Bergen, Norway) for the vasa: EGFP transgenic zebrafish and Ten-tsao Wong (Purdue University) for the pBSK-dnd3'UTR. This work was supported by a grant from the National Institutes of Health (R01GM069384).	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bhattacharya C, 2007, BIOCHEM BIOPH RES CO, V355, P194, DOI 10.1016/j.bbrc.2007.01.138; Bhattacharya C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002315; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Braat AK, 2001, GENESIS, V30, P183, DOI 10.1002/gene.1060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARTER SG, 1982, J BIOCHEM BIOPH METH, V7, P7, DOI 10.1016/0165-022X(82)90031-8; Chene P, 2002, NAT REV DRUG DISCOV, V1, P665, DOI 10.1038/nrd894; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Ikenishi K, 1997, DEV GROWTH DIFFER, V39, P625; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LEBEL D, 1980, J BIOL CHEM, V255, P1227; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Linger R, 2008, GENE CHROMOSOME CANC, V47, P247, DOI 10.1002/gcc.20526; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Sakowicz R, 1998, SCIENCE, V280, P292, DOI 10.1126/science.280.5361.292; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shen JP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702304200; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Tanaka SS, 2000, GENE DEV, V14, P841; Tourneur L, 2008, J BIOL CHEM, V283, P17929, DOI 10.1074/jbc.M802263200; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yoon C, 1997, DEVELOPMENT, V124, P3157; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	50	35	37	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2641	2650		10.1096/fj.09-148403	http://dx.doi.org/10.1096/fj.09-148403			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371629	Green Published			2022-12-25	WOS:000285005400006
J	Rossi, A; Schenone, S; Angelucci, A; Cozzi, M; Caracciolo, V; Pentimalli, F; Puca, A; Pucci, B; La Montagna, R; Bologna, M; Botta, M; Giordano, A				Rossi, Alessandra; Schenone, Silvia; Angelucci, Adriano; Cozzi, Martina; Caracciolo, Valentina; Pentimalli, Francesca; Puca, Andrew; Pucci, Biagio; La Montagna, Raffaele; Bologna, Mauro; Botta, Maurizio; Giordano, Antonio			New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells	FASEB JOURNAL			English	Article						tyrosine kinase inhibitors; apoptosis; cancer therapy; brain tumors; cdc2	ANTIPROLIFERATIVE ACTIVITY; BRAIN-TUMORS; CANCER CELLS; TYROSINE KINASES; CARCINOMA-CELLS; BCR-ABL; PHOSPHORYLATION; APOPTOSIS; CHEMOTHERAPY; THERAPY	Medulloblastoma is the most common malignant brain tumor in children, and despite improvements in the overall survival rate, it still lacks an effective treatment. Src plays an important role in cancer, and recently high Src activity was documented in medulloblastoma. In this report, we examined the effects of novel pyrazolo-[3,4-d]-pyrimidine derivative Src inhibitors in medulloblastoma. By MTS assay, we showed that the pyrimidine derivatives indicated as S7, S29, and SI163 greatly reduce the growth rate of medulloblastoma cells by inhibiting Src phosphorylation, compared with HT22 non-neoplastic nerve cells. These compounds also halt cells in the G2/M phase, and this effect likely occurs through the regulation of cdc2 and CDC25C phosphorylation, as shown by Western blot. Moreover, the exposure to pyrimidine derivatives induces apoptosis, assayed by the supravital propidium iodide assay, through modulation of the apoptotic proteins Bax and Bc12, and inhibits tumor growth in vivo in a mouse model. Notably, S7, S29, and SI163 show major inhibitory effects on medulloblastoma cell growth compared with the chemotherapeutic agents cisplatin and etoposide. In conclusion, our results suggest that S7, S29, and SI163 could be novel attractive candidates for the treatment of medulloblastoma or tumors characterized by high Src activity.-Rossi, A., Schenone, S., Angelucci, A., Cozzi, M., Caracciolo, V., Pentimalli, F., Puca, A., Pucci, B., La Montagna, R., Bologna, M., Botta, M., Giordano, A. New pyrazolo[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells. FASEB J. 24, 2881-2892 (2010). www.fasebj.org	[Rossi, Alessandra; Caracciolo, Valentina; Pentimalli, Francesca; Puca, Andrew; La Montagna, Raffaele; Giordano, Antonio] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Rossi, Alessandra; Cozzi, Martina; Giordano, Antonio] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Botta, Maurizio] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy; [Schenone, Silvia] Univ Genoa, Dept Pharmaceut Sci, Genoa, Italy; [Angelucci, Adriano; Bologna, Mauro] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Pentimalli, Francesca; Pucci, Biagio; Giordano, Antonio] CROM Ctr Oncol Res Mercogliano, Avellino, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena; University of Siena; University of Genoa; University of L'Aquila	Giordano, A (corresponding author), Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, BioLife Sci Bldg,Ste 333,1900 N 12th St, Philadelphia, PA 19122 USA.	giordano@temple.edu	pucci, biagio/AAA-9268-2020; Giordano, Antonio/F-1927-2010; Rossi, Alessandra/A-7823-2013; Pentimalli, Francesca/K-4936-2014; Angelucci, Adriano/B-7134-2013; Pucci, Biagio/AAS-7502-2021	pucci, biagio/0000-0003-4502-1748; Giordano, Antonio/0000-0002-5959-016X; Rossi, Alessandra/0000-0002-9527-4658; Pentimalli, Francesca/0000-0003-4740-6801; Angelucci, Adriano/0000-0002-8755-1889; BOLOGNA, Mauro/0000-0002-6306-6897	U.S. National Institutes of Health; Sbarro Health Research Organization; Human Health Foundation Onlus Spoleto, Italy; Teresa and Luigi de Beaumont Bonelli Foundation	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sbarro Health Research Organization; Human Health Foundation Onlus Spoleto, Italy; Teresa and Luigi de Beaumont Bonelli Foundation	This study was supported by U.S. National Institutes of Health grants and by the Sbarro Health Research Organization (http://www.shro.org), the Human Health Foundation Onlus Spoleto, Italy (http://www.hhfonlus.org), and the Teresa and Luigi de Beaumont Bonelli Foundation (to A.G.). The authors also thank Dr. A. Cuppone for assistance with flow cytometry analysis.	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Angelucci A, 2006, EUR J CANCER, V42, P2838, DOI 10.1016/j.ejca.2006.06.024; Banavali NK, 2009, PROTEINS, V74, P378, DOI 10.1002/prot.22153; Bennett JJ, 2004, FASEB J, V18, P1001, DOI 10.1096/fj.02-1080fje; Bondavalli F, 2002, J MED CHEM, V45, P4875, DOI 10.1021/jm0209580; Carraro F, 2006, J MED CHEM, V49, P1549, DOI 10.1021/jm050603r; Carraro F, 2004, J MED CHEM, V47, P1595, DOI 10.1021/jm034257u; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Courtneidge SA, 2002, BIOCHEM SOC T, V30, P11, DOI 10.1042/bst0300011; DAVIDPFEUTY T, 1990, J CELL BIOL, V111, P3097, DOI 10.1083/jcb.111.6.3097; de Groot J, 2009, J NEURO-ONCOL, V95, P151, DOI 10.1007/s11060-009-9916-2; Decleves X, 2006, CURR CANCER DRUG TAR, V6, P433, DOI 10.2174/156800906777723930; Donnini S, 2007, INT J CANCER, V120, P995, DOI 10.1002/ijc.22410; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; El Touny LH, 2006, PROSTATE, V66, P1542, DOI 10.1002/pros.20495; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guessous F, 2008, J CELL PHYSIOL, V217, P577, DOI 10.1002/jcp.21542; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Johnston DL, 2009, J NEURO-ONCOL, V94, P51, DOI 10.1007/s11060-009-9799-2; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Leskov KS, 2001, SEMIN RADIAT ONCOL, V11, P352, DOI 10.1053/srao.2001.26912; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Liao CH, 2005, J CELL BIOCHEM, V96, P155, DOI 10.1002/jcb.20540; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Manetti F, 2007, CHEMMEDCHEM, V2, P343, DOI 10.1002/cmdc.200600214; Mazoochi T, 2009, MOL HUM REPROD, V15, P155, DOI 10.1093/molehr/gap002; Mizenina OA, 2004, CELL CYCLE, V3, P796; Moasser MM, 1999, CANCER RES, V59, P6145; Nieder C, 2009, CLIN ONCOL-UK, V21, P515, DOI 10.1016/j.clon.2009.05.003; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Rossi A, 2009, INT J CANCER, V125, P235, DOI 10.1002/ijc.24331; Schenone S, 2004, EUR J MED CHEM, V39, P939, DOI 10.1016/j.ejmech.2004.07.010; Schenone S, 2004, BIOORG MED CHEM LETT, V14, P2511, DOI 10.1016/j.bmcl.2004.03.013; Schenone S, 2008, EUR J MED CHEM, V43, P2665, DOI 10.1016/j.ejmech.2008.01.034; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Spreafico A, 2008, FASEB J, V22, P1560, DOI 10.1096/fj.07-9873com; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Taylor RE, 2003, J CLIN ONCOL, V21, P1581, DOI 10.1200/JCO.2003.05.116; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Warren K, 2006, CANCER CHEMOTH PHARM, V58, P343, DOI 10.1007/s00280-005-0172-7; Xu NH, 2007, CELL CYCLE, V6, P1639, DOI 10.4161/cc.6.13.4385; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Zamai L, 2001, CYTOMETRY, V44, P57, DOI 10.1002/1097-0320(20010501)44:1<57::AID-CYTO1082>3.3.CO;2-F	53	26	26	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2881	2892		10.1096/fj.09-148593	http://dx.doi.org/10.1096/fj.09-148593			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354138	Green Published			2022-12-25	WOS:000285005400028
J	Sha, W; da Costa, KA; Fischer, LM; Milburn, MV; Lawton, KA; Berger, A; Jia, W; Zeisel, SH				Sha, Wei; da Costa, Kerry-Ann; Fischer, Leslie M.; Milburn, Michael V.; Lawton, Kay A.; Berger, Alvin; Jia, Wei; Zeisel, Steven H.			Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline	FASEB JOURNAL			English	Article						fatty liver; metabolomics; plasma; PEMT	N-METHYLTRANSFERASE GENE; COA DESATURASE ACTIVITY; NONALCOHOLIC FATTY; HOMOCYSTEINE CONCENTRATION; PARENTERAL-NUTRITION; OSMOTIC REGULATION; FOLATE CONTENT; DEFICIENCY; BETAINE; TRANSPORT	Choline is an essential nutrient, and deficiency causes liver and muscle dysfunction. Common genetic variations alter the risk of developing organ dysfunction when choline deficient, probably by causing metabolic inefficiencies that should be detectable even while ingesting a normal choline-adequate diet. We determined whether metabolomic profiling of plasma at baseline could predict whether humans will develop liver dysfunction when deprived of dietary choline. Fifty-three participants were fed a diet containing 550 mg choline/70 kg/d for 10 d and then fed <50 mg choline/70 kg/d for up to 42 d. Participants who developed organ dysfunction on this diet were repleted with a choline-adequate diet for >= 3 d. Plasma samples, obtained at baseline, end of depletion, and end of repletion, were used for targeted and nontargeted metabolomic profiling. Liver fat was assessed using magnetic resonance spectroscopy. Metabolomic profiling and targeted biochemical analyses were highly correlated for the analytes assessed by both procedures. In addition, we report relative concentration changes of other small molecules detected by the nontargeted metabolomic analysis after choline depletion. Finally, we show that metabolomic profiles of participants when they were consuming a control baseline diet could predict whether they would develop liver dysfunction when deprived of dietary choline.-Sha, W., da Costa, K., Fischer, L. M., Milburn, M. V., Lawton, K. A., Berger, A., Jia, W., Zeisel, S. H. Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB J. 24, 2962-2975 (2010). www.fasebj.org	[Zeisel, Steven H.] Univ N Carolina Chapel Hill, Nutr Res Inst, Kannapolis, NC 28081 USA; [Sha, Wei] Univ N Carolina Charlotte, Bioinformat Res Ctr, Kannapolis, NC USA; [Jia, Wei] Univ N Carolina Greensboro, Dept Nutr, Kannapolis, NC USA; [da Costa, Kerry-Ann; Fischer, Leslie M.; Zeisel, Steven H.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [da Costa, Kerry-Ann; Fischer, Leslie M.; Zeisel, Steven H.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Milburn, Michael V.; Lawton, Kay A.; Berger, Alvin] Metabolon Inc, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Metabolon	Zeisel, SH (corresponding author), Univ N Carolina Chapel Hill, Nutr Res Inst, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Berger, Alvin/AAE-5353-2022; Jia, Wei/AAN-5102-2020	Jia, Wei/0000-0002-3739-8994	Mead Johnson Nutritionals; Balchem; Egg Nutrition Research Center; National Institutes of Health [DK55865, DK56350, RR00046]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Mead Johnson Nutritionals; Balchem; Egg Nutrition Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Yunping Qiu for the PCA and PLS-DA analyses. W.S. performed the statistical computations for data analysis and was responsible for the preparation of the manuscript. K.D. supervised the sample collection and targeted analyses and assisted in the data interpretation and writing of the manuscript. L.M.F. oversaw recruitment of subjects into the study, compliance and safety monitoring. A.B., M.M., and K.L. were responsible for the metabolomic analyses; A.B. also participated in the interpretation of the data. W.J. supervised the PCA and PLS-DA analyses. S.H.Z. was responsible for the conceptualization, funding, implementation and design of the human study, participated in statistical analyses and data interpretation, and provided major input in the writing of the manuscript. There is no financial conflict of interest in relation to this study (S.H.Z. received grant support from Mead Johnson Nutritionals, Balchem, and the Egg Nutrition Research Center for studies other than those described in this paper; S.H.Z. serves on the scientific advisory boards of Metabolon, Inc. and Dupont). This study was funded by grants from the National Institutes of Health to S.H.Z. (DK55865, DK56350, RR00046).	ACARA M, 1979, AM J PHYSIOL, V236, pF112; Albright CD, 1998, J NUTR BIOCHEM, V9, P476, DOI 10.1016/S0955-2863(98)00047-3; Atkinson W, 2007, EUR J NUTR, V46, P446, DOI 10.1007/s00394-007-0684-5; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Barrett T., 2008, U.S. Patent, Patent No. [7,433,787, 7433787]; Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; BLUSZTAJN JK, 1985, BIOCHEM J, V232, P505, DOI 10.1042/bj2320505; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Buchman AL, 2001, JPEN-PARENTER ENTER, V25, P260, DOI 10.1177/0148607101025005260; Busby MG, 2004, J AM DIET ASSOC, V104, P1836, DOI 10.1016/j.jada.2004.09.027; CARTER AL, 1978, J NUTR, V108, P1748, DOI 10.1093/jn/108.11.1748; Cho E, 2006, AM J CLIN NUTR, V83, P905, DOI 10.1093/ajcn/83.4.905; Cui Z, 1996, J BIOL CHEM, V271, P2839, DOI 10.1074/jbc.271.5.2839; da Costa KA, 2006, FASEB J, V20, pA606; da Costa KA, 2005, AM J CLIN NUTR, V81, P440; da Costa KA, 2004, AM J CLIN NUTR, V80, P163; da Costa KA, 2006, AM J CLIN NUTR, V84, P88, DOI 10.1093/ajcn/84.1.88; DACOSTA KA, 1993, J BIOL CHEM, V268, P2100; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Dong H, 2007, J HEPATOL, V46, P915, DOI 10.1016/j.jhep.2006.12.012; Duarte IF, 2005, ANAL CHEM, V77, P5570, DOI 10.1021/ac050455c; Dzurik R, 2001, KIDNEY INT, V59, pS278; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ferrara F, 2005, DRUG EXP CLIN RES, V31, P109; Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; Griffin JL, 2004, PHYSIOL GENOMICS, V17, P140, DOI 10.1152/physiolgenomics.00158.2003; Horio M, 1997, AM J PHYSIOL-CELL PH, V272, pC804, DOI 10.1152/ajpcell.1997.272.3.C804; Jacobs A, 2009, TOXICOL LETT, V186, P32, DOI 10.1016/j.toxlet.2008.08.013; Jensen LJ, 2007, FASEB J, V21, pA519; Jun DW, 2009, EUR J GASTROEN HEPAT, V21, P667, DOI 10.1097/MEG.0b013e3283196adc; Kempson SA, 2004, PFLUG ARCH EUR J PHY, V449, P227, DOI 10.1007/s00424-004-1338-6; Keun HC, 2007, PHARMACOGENOMICS, V8, P731, DOI 10.2217/14622416.8.7.731; KIM YI, 1994, J NUTR, V124, P2197, DOI 10.1093/jn/124.11.2197; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Kovacic P, 2005, MED HYPOTHESES, V65, P90, DOI 10.1016/j.mehy.2005.01.031; Launay-Vacher V, 2006, NEPHRON PHYSIOL, V103, P97, DOI 10.1159/000092212; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Ma XZ, 2009, RADIOGRAPHICS, V29, P1253, DOI 10.1148/rg.295085186; Maddox JF, 2006, TOXICOL APPL PHARM, V212, P35, DOI 10.1016/j.taap.2005.06.021; MICHAEL UF, 1975, P SOC EXP BIOL MED, V150, P672, DOI 10.3181/00379727-150-39103; *NAT AC SCI US, 1998, DIET REF INT FOL THI, V1, P390; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; PONTREMOLI S, 1990, BIOCHEM BIOPH RES CO, V167, P373, DOI 10.1016/0006-291X(90)91775-N; Resseguie ME, 2007, FASEB J, V21, pA61; Romeo S, 2006, FASEB J, V20, P2180, DOI 10.1096/fj.06-1004ufm; Rubino FM, 2009, MASS SPECTROM REV, V28, P725, DOI 10.1002/mas.20207; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Savendahl L, 1997, AM J CLIN NUTR, V66, P622, DOI 10.1093/ajcn/66.3.622; SELHUB J, 1991, CANCER RES, V51, P16; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; SHEARD NF, 1986, AM J CLIN NUTR, V43, P219, DOI 10.1093/ajcn/43.2.219; SHEARD NF, 1994, J NUTR, V124, P738, DOI 10.1093/jn/124.5.738; Song JN, 2005, FASEB J, V19, pA1037; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Srimaroeng C, 2008, XENOBIOTICA, V38, P889, DOI [10.1080/00498250801927435, 10.1080/00498250801927435 ]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Urakami Y, 2004, PHARM RES-DORDR, V21, P976, DOI 10.1023/B:PHAM.0000029286.45788.ad; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; VARELAMOREIRAS G, 1992, J NUTR BIOCHEM, V3, P519, DOI 10.1016/0955-2863(92)90073-R; Wagner CA, 2000, AM J PHYSIOL-RENAL, V279, pF584, DOI 10.1152/ajprenal.2000.279.3.F584; Xu XR, 2009, FASEB J, V23, P4022, DOI 10.1096/fj.09-136507; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r34; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; ZEISEL SH, 1989, BIOCHEM J, V259, P725, DOI 10.1042/bj2590725; Zeisel SH, 2007, AM J CLIN NUTR, V86, P542, DOI 10.1093/ajcn/86.3.542; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zeisel SH, 2006, FASEB J, V20, P2181, DOI 10.1096/fj.06-1005ufm	75	83	89	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2962	2975		10.1096/fj.09-154054	http://dx.doi.org/10.1096/fj.09-154054			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371621	Green Published, Green Submitted			2022-12-25	WOS:000285005400035
J	Yang, KL; Moldovan, GL; D'Andrea, AD				Yang, Kailin; Moldovan, George-Lucian; D'Andrea, Alan D.			RAD18-dependent Recruitment of SNM1A to DNA Repair Complexes by a Ubiquitin-binding Zinc Finger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FANCONI-ANEMIA PATHWAY; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; POLYMERASE-ETA; PCNA; PROTEIN; DAMAGE; RAD18; CELLS; FAMILY	SNM1A is a member of the SNM1 family of nucleases required for cellular processing of interstrand DNA crosslinks (ICLs). Little is known about the molecular function of SNM1A, in terms of its recruitment to ICL lesions or its DNA damage processing activity. Here we show that SNM1A contains a functional PIP box (PCNA-interacting protein box) and a UBZ (ubiquitin binding zinc finger), required for assembly of SNM1A into nuclear focus. Moreover, RAD18-dependent monoubiquitination of PCNA is required for Mitomycin C and Ultraviolet Light inducible SNM1A nuclear focus assembly. Taken together, our results identify a novel RAD18-PCNA(Ub)-SNM1A pathway required for nuclear focus formation and ICL resistance.	[D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Yang, Kailin] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Leder Human Biol Program, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Yang, Kailin/D-7966-2013; Classen, Scott/AAY-8176-2020; Yang, Kailin/L-2205-2013	Yang, Kailin/0000-0001-5968-6738; George-Lucian, Moldovan/0000-0003-3825-149X	National Institutes of Health [R01DK43889, R01HL52725, P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725, R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK43889, R01HL52725, and P01CA092584 (to A. D. D.).	Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Hazrati A, 2008, DNA REPAIR, V7, P230, DOI 10.1016/j.dnarep.2007.09.013; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Hemphill AW, 2008, MOL GENET METAB, V94, P38, DOI 10.1016/j.ymgme.2007.11.012; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Richie CT, 2002, MOL CELL BIOL, V22, P8635, DOI 10.1128/MCB.22.24.8635-8647.2002; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	34	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19085	19091		10.1074/jbc.M109.100032	http://dx.doi.org/10.1074/jbc.M109.100032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20385554	hybrid, Green Published			2022-12-25	WOS:000278727800018
J	Sprehe, M; Fisk, JC; McEvoy, SM; Read, LK; Schumacher, MA				Sprehe, Mareen; Fisk, John C.; McEvoy, Sarah M.; Read, Laurie K.; Schumacher, Maria A.			Structure of the Trypanosoma brucei p22 Protein, a Cytochrome Oxidase Subunit II-specific RNA-editing Accessory Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL MESSENGER-RNAS; INDUCIBLE EXPRESSION SYSTEM; TYPE-1 TAT TRANSACTIVATOR; IN-VITRO INTERACTION; LAMIN-B RECEPTOR; GUIDE-RNA; CELLULAR-PROTEIN; SPLICING FACTOR; BINDING-PROTEIN; HUMAN P-32	Kinetoplastid RNA (k-RNA) editing is a complex process in the mitochondria of kinetoplastid protozoa, including Trypanosoma brucei, that involves the guide RNA-directed insertion and deletion of uridines from precursor-mRNAs to produce mature, translatable mRNAs. k-RNA editing is performed by multiprotein complexes called editosomes. Additional non-editosome components termed k-RNA-editing accessory factors affect the extent of editing of specific RNAs or classes of RNAs. The T. brucei p22 protein was identified as one such accessory factor. Here we show that p22 contributes to cell growth in the procyclic form of T. brucei and functions as a cytochrome oxidase subunit II-specific k-RNA-editing accessory factor. To gain insight into its functions, we solved the crystal structure of the T. brucei p22 protein to 2.0-angstrom resolution. The p22 structure consists of a six-stranded, antiparallel beta-sheet flanked by five alpha-helices. Three p22 subunits combine to form a tight trimer that is primarily stabilized by interactions between helical residues. One side of the trimer is strikingly acidic, while the opposite face is more neutral. Database searches show p22 is structurally similar to human p32, which has a number of functions, including regulation of RNA splicing. p32 interacts with a number of target proteins via its alpha 1 N-terminal helix, which is among the most conserved regions between p22 and p32. Co-immunoprecipitation studies showed that p22 interacts with the editosome and the k-RNA accessory protein, TbRGG2, and alpha 1 of p22 was shown to be important for the p22-TbRGG2 interaction. Thus, these combined studies suggest that p22 mediates its role in k-RNA editing by acting as an adaptor protein.	[Schumacher, Maria A.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; [Fisk, John C.; McEvoy, Sarah M.; Read, Laurie K.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA	University of Texas System; UTMD Anderson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schumacher, MA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, 1515 Holcombe Blvd, Houston, TX 77030 USA.	maschuma@mdanderson.org			National Institutes of Health [RO1 GM074815, RO1 AI061580, F32 AI07718501]; Office of science, Office of Basic Energy Sciences, Material Sciences Division, of the US Dept. of Energy at Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of science, Office of Basic Energy Sciences, Material Sciences Division, of the US Dept. of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM074815 (to M. A. S.), RO1 AI061580 (to L. K. R.), and F32 AI07718501 (to J.C.F.). The Advanced Light Source is supported by the Director, Office of science, Office of Basic Energy Sciences, Material Sciences Division, of the US Dept. of Energy under contract DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Aphasizheva I, 2004, J BIOL CHEM, V279, P24123, DOI 10.1074/jbc.M401234200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beatch MD, 2005, J VIROL, V79, P10807, DOI 10.1128/JVI.79.16.10807-10820.2005; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Berro R, 2006, J VIROL, V80, P3189, DOI 10.1128/JVI.80.7.3189-3204.2006; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruni R, 1996, P NATL ACAD SCI USA, V93, P10423, DOI 10.1073/pnas.93.19.10423; Bryant HE, 2000, J VIROL, V74, P11322, DOI 10.1128/JVI.74.23.11322-11328.2000; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Chattopadhyay C, 2004, NUCLEIC ACIDS RES, V32, P3632, DOI 10.1093/nar/gkh692; CORELL RA, 1993, NUCLEIC ACIDS RES, V21, P4313, DOI 10.1093/nar/21.18.4313; Corell RA, 1996, MOL CELL BIOL, V16, P1410; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Golden DE, 2005, RNA, V11, P29, DOI 10.1261/rna.7170705; Goulah CC, 2007, J BIOL CHEM, V282, P7181, DOI 10.1074/jbc.M609485200; Goulah CC, 2006, RNA, V12, P1545, DOI 10.1261/rna.90106; Hall KT, 2002, J VIROL, V76, P11612, DOI 10.1128/JVI.76.22.11612-11622.2002; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Hayman ML, 2001, NUCLEIC ACIDS RES, V29, P5216, DOI 10.1093/nar/29.24.5216; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Herwald H, 1996, J BIOL CHEM, V271, P13040, DOI 10.1074/jbc.271.22.13040; Horvath A, 2000, SCIENCE, V287, P1639, DOI 10.1126/science.287.5458.1639; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Joseph K, 1996, P NATL ACAD SCI USA, V93, P8552, DOI 10.1073/pnas.93.16.8552; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Klingbeil MM, 2004, P NATL ACAD SCI USA, V101, P4333, DOI 10.1073/pnas.0401400101; Klingbeil MM, 2001, PROTIST, V152, P255, DOI 10.1078/1434-4610-00066; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Lim BL, 1996, BIOCHEM BIOPH RES CO, V218, P260, DOI 10.1006/bbrc.1996.0046; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; LUO Y, 1994, J VIROL, V68, P3850, DOI 10.1128/JVI.68.6.3850-3856.1994; Mallick J, 2005, EXP CELL RES, V309, P250, DOI 10.1016/j.yexcr.2005.05.025; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Okagaki T, 2000, J CELL BIOL, V148, P653, DOI 10.1083/jcb.148.4.653; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Robles-Flores M, 2002, J BIOL CHEM, V277, P5247, DOI 10.1074/jbc.M109333200; Schmid B, 1996, EUR J BIOCHEM, V240, P721, DOI 10.1111/j.1432-1033.1996.0721h.x; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; Seytter T, 1998, YEAST, V14, P303, DOI 10.1002/(SICI)1097-0061(19980315)14:4<303::AID-YEA217>3.0.CO;2-N; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; Sheikh MA, 2008, PROTEINS, V71, P1563, DOI 10.1002/prot.21993; SIMOS G, 1994, FEBS LETT, V346, P225, DOI 10.1016/0014-5793(94)00479-X; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Stuart K, 2002, MOL MICROBIOL, V45, P591, DOI 10.1046/j.1365-2958.2002.03028.x; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Van den Brulle J, 1999, APPL ENVIRON MICROB, V65, P5222; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yanagida M, 2004, J BIOL CHEM, V279, P1607, DOI 10.1074/jbc.M305604200; YU L, 1995, J VIROL, V69, P3007, DOI 10.1128/JVI.69.5.3007-3016.1995; YU L, 1995, J VIROL, V69, P3017, DOI 10.1128/JVI.69.5.3017-3023.1995	94	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18899	18908		10.1074/jbc.M109.066597	http://dx.doi.org/10.1074/jbc.M109.066597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392699	Green Published, hybrid			2022-12-25	WOS:000278453900080
J	Li, A; Yu, YP; Lee, SC; Ishibashi, T; Lees-Miller, SP; Ausio, J				Li, Andra; Yu, Yaping; Lee, Sheng-Chun; Ishibashi, Toyotaka; Lees-Miller, Susan P.; Ausio, Juan			Phosphorylation of Histone H2A.X by DNA-dependent Protein Kinase Is Not Affected by Core Histone Acetylation, but It Alters Nucleosome Stability and Histone H1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; IONIZING-RADIATION; DAMAGE RESPONSE; CHROMATIN-STRUCTURE; GAMMA-H2AX FOCI; REPAIR; YEAST; COMPLEX; ATM; PK	Phosphorylation of the C-terminal end of histone H2A.X is the most characterized histone post-translational modification in DNA double-stranded breaks (DSB). DNA-dependent protein kinase (DNA-PK) is one of the three phosphatidylinositol 3 kinase-like family of kinase members that is known to phosphorylate histone H2A.X during DNA DSB repair. There is a growing body of evidence supporting a role for histone acetylation in DNA DSB repair, but the mechanism or the causative relation remains largely unknown. Using bacterially expressed recombinant mutants and stably and transiently transfected cell lines, we find that DNA-PK can phosphorylate Thr-136 in addition to Ser-139 both in vitro and in vivo. Furthermore, the phosphorylation reaction is not inhibited by the presence of H1, which in itself is a substrate of the reaction. We also show that, in contrast to previous reports, the ability of the enzyme to phosphorylate these residues is not affected by the extent of acetylation of the core histones. In vitro assembled nucleosomes and HeLa S3 native oligonucleosomes consisting of non-acetylated and acetylated histones are equally phosphorylated by DNA-PK. We demonstrate that the apparent differences in the extent of phosphorylation previously observed can be accounted for by the differential chromatin solubility under the MgCl2 concentrations required for the phosphorylation reaction in vitro. Finally, we show that although H2A.X does not affect nucleosome conformation, it has a de-stabilizing effect that is enhanced by the DNA-PK-mediated phosphorylation and results in an impaired histone H1 binding.	[Li, Andra; Ishibashi, Toyotaka; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Yu, Yaping; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Lee, Sheng-Chun] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei, Taiwan; [Lee, Sheng-Chun] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	University of Victoria; University of Calgary; National Taiwan University; Academia Sinica - Taiwan	Ausio, J (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055,Petch Bldg 220, Victoria, BC V8W 3P6, Canada.	jausio@uvic.ca	Ishibashi, Toyotaka/AAW-2687-2020	Ishibashi, Toyotaka/0000-0001-8015-2319; Lees-Miller, Susan/0000-0001-5809-2516	Canadian Institute of Health Research [MOP-97878, MOP-57718]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grants MOP-97878 (to S. P. L.-M.) and MOP-57718 (to J. A.).	Abbott DW, 2005, J BIOL CHEM, V280, P16437, DOI 10.1074/jbc.M500170200; Abbott DW, 2004, BIOCHEMISTRY-US, V43, P1352, DOI 10.1021/bi035859i; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Ausio J, 2001, BIOCHEM CELL BIOL, V79, P693, DOI 10.1139/bcb-79-6-693; AUSIO J, 1984, J MOL BIOL, V176, P77, DOI 10.1016/0022-2836(84)90383-8; Ausio J, 1998, METHODS, V15, P333, DOI 10.1006/meth.1998.0637; Ausio J, 2000, BIOPHYS CHEM, V86, P141, DOI 10.1016/S0301-4622(00)00144-7; BENNETZEN MV, 2010, MOL CELL PR IN PRESS; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; COSTES SV, 2010, MUTAT RES IN PRESS; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; DEMELER B, 2005, ULTRSCAN COMPREHENSI; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fink M, 2007, MOL CELL BIOL, V27, P3589, DOI 10.1128/MCB.02077-06; Gautier T, 2004, EMBO REP, V5, P715, DOI 10.1038/sj.embor.7400182; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Harvey AC, 2005, GENETICS, V170, P543, DOI 10.1534/genetics.104.038570; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Kysela B, 2005, P NATL ACAD SCI USA, V102, P1877, DOI 10.1073/pnas.0401179102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li A, 2005, BIOCHEM CELL BIOL, V83, P505, DOI 10.1139/O05-114; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maffey AH, 2007, MOL CELL ENDOCRINOL, V268, P10, DOI 10.1016/j.mce.2007.01.009; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Marino-Ramirez L, 2005, EXPERT REV PROTEOMIC, V2, P719, DOI 10.1586/14789450.2.5.719; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Moore JD, 2007, GENETICS, V176, P15, DOI 10.1534/genetics.106.063792; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2005, CELL CYCLE, V4, P568; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; PERRY M, 1982, J BIOL CHEM, V257, P7336; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; PINEIRO M, 1991, BIOCHEMISTRY-US, V30, P5805, DOI 10.1021/bi00237a025; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saperas N, 2006, FEBS J, V273, P4548, DOI 10.1111/j.1742-4658.2006.05461.x; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Siino JS, 2002, BIOCHEM BIOPH RES CO, V297, P1318, DOI 10.1016/S0006-291X(02)02383-5; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Vasireddy RS, 2010, CELL MOL LIFE SCI, V67, P291, DOI 10.1007/s00018-009-0181-5; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; YAGER TD, 1984, J BIOL CHEM, V259, P4212	64	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17778	17788		10.1074/jbc.M110.116426	http://dx.doi.org/10.1074/jbc.M110.116426			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356835	hybrid, Green Published			2022-12-25	WOS:000278133400056
J	Odegaard, ML; Joseph, JW; Jensen, MV; Lu, DH; Ilkayeva, O; Ronnebaum, SM; Becker, TC; Newgard, CB				Odegaard, Matthew L.; Joseph, Jamie W.; Jensen, Mette V.; Lu, Danhong; Ilkayeva, Olga; Ronnebaum, Sarah M.; Becker, Thomas C.; Newgard, Christopher B.			The Mitochondrial 2-Oxoglutarate Carrier Is Part of a Metabolic Pathway That Mediates Glucose- and Glutamine-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR ISOTOPOMER ANALYSIS; PANCREATIC BETA-CELLS; ISOCITRATE DEHYDROGENASE; REGULATORY ROLE; CHANNELS; ISLETS; SUPPRESSION; MECHANISMS; EXPRESSION; ADENOVIRUS	Glucose-stimulated insulin secretion from pancreatic islet beta-cells is dependent in part on pyruvate cycling through the pyruvate/isocitrate pathway, which generates cytosolic alpha-ketoglutarate, also known as 2-oxoglutarate (2OG). Here, we have investigated if mitochondrial transport of 2OG through the 2-oxoglutarate carrier (OGC) participates in control of nutrient-stimulated insulin secretion. Suppression of OGC in clonal pancreatic beta-cells (832/13 cells) and isolated rat islets by adenovirus-mediated delivery of small interfering RNA significantly decreased glucose-stimulated insulin secretion. OGC suppression also reduced insulin secretion in response to glutamine plus the glutamate dehydrogenase activator 2-amino-2-norbornane carboxylic acid. Nutrient-stimulated increases in glucose usage, glucose oxidation, glutamine oxidation, or ATP: ADP ratio were not affected by OGC knockdown, whereas suppression of OGC resulted in a significant decrease in the NADPH: NADP(+) ratio during stimulation with glucose but not glutamine + 2-amino-2-norbornane carboxylic acid. Finally, OGC suppression reduced insulin secretion in response to a membrane-permeant 2OG analog, dimethyl-2OG. These data reveal that the OGC is part of a mechanism of fuel-stimulated insulin secretion that is commonto glucose, amino acid, and organic acid secretagogues, involving flux through the pyruvate/isocitrate cycling pathway. Although the components of this pathway must remain intact for appropriate stimulus-secretion coupling, production of NADPH does not appear to be the universal second messenger signal generated by these reactions.	[Newgard, Christopher B.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Med Ctr, Duke Independence Pk Facil, Durham, NC 27704 USA; [Odegaard, Matthew L.; Jensen, Mette V.; Lu, Danhong; Ilkayeva, Olga; Ronnebaum, Sarah M.; Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27704 USA; [Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2G 1C5, Canada	Duke University; Duke University; University of Waterloo	Newgard, CB (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Med Ctr, Duke Independence Pk Facil, 4321 Med Pk Dr,Ste 200, Durham, NC 27704 USA.	newga002@mc.duke.edu		Ronnebaum, Sarah/0000-0003-4787-754X	National Institutes of Health [DK-42583, DK-58398]; Canadian Institute of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK-42583 and DK-58398 (to C.B.N.). This work was also supported by a Canadian Institute of Health Research grant (to J.W.J.).	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Fallon MJ, 2008, METABOLISM, V57, P1148, DOI 10.1016/j.metabol.2008.03.022; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kanao T, 2002, EUR J BIOCHEM, V269, P1926, DOI 10.1046/j.1432-1033.2002.02849.x; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Matschinsky F.M., 2001, HDB PHYSL 7, P125; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P493, DOI 10.1007/BF01108406; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572	36	58	59	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16530	16537		10.1074/jbc.M109.092593	http://dx.doi.org/10.1074/jbc.M109.092593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356834	Green Published, hybrid			2022-12-25	WOS:000277982600015
J	Gai, ZH; Wang, XY; Liu, XR; Tai, C; Tang, HZ; He, XF; Wu, G; Deng, ZX; Xu, P				Gai, Zhonghui; Wang, Xiaoyu; Liu, Xiaorui; Tai, Cui; Tang, Hongzhi; He, Xiaofei; Wu, Geng; Deng, Zixin; Xu, Ping			The Genes Coding for the Conversion of Carbazole to Catechol Are Flanked by IS6100 Elements in Sphingomonas sp Strain XLDN2-5	PLOS ONE			English	Article							CATABOLIC GENES; DIOXIN DIOXYGENASE; PLASMID PCAR3; DEGRADATION; SEQUENCE; CELLS; 1,9A-DIOXYGENASE; PAUCIMOBILIS; ORGANIZATION; EXPRESSION	Background: Carbazole is a recalcitrant compound with a dioxin-like structure and possesses mutagenic and toxic activities. Bacteria respond to a xenobiotic by recruiting exogenous genes to establish a pathway to degrade the xenobiotic, which is necessary for their adaptation and survival. Usually, this process is mediated by mobile genetic elements such as plasmids, transposons, and insertion sequences. Findings: The genes encoding the enzymes responsible for the degradation of carbazole to catechol via anthranilate were cloned, sequenced, and characterized from a carbazole-degrading Sphingomonas sp. strain XLDN2-5. The car gene cluster (carRAaBaBbCAc) and fdr gene were accompanied on both sides by two copies of IS6100 elements, and organized as IS6100::ISSsp1-ORF1-carRAaBaBbCAc-ORF8-IS6100-fdr-IS6100. Carbazole was converted by carbazole 1,9a-dioxygenase (CARDO, CarAaAcFdr), meta-cleavage enzyme (CarBaBb), and hydrolase (CarC) to anthranilate and 2-hydroxypenta-2,4-dienoate. The fdr gene encoded a novel ferredoxin reductase whose absence resulted in lower transformation activity of carbazole by CarAa and CarAc. The ant gene cluster (antRAcAdAbAa) which was involved in the conversion of anthranilate to catechol was also sandwiched between two IS6100 elements as IS6100-antRAcAdAbAa-IS6100. Anthranilate 1,2-dioxygenase (ANTDO) was composed of a reductase (AntAa), a ferredoxin (AntAb), and a two-subunit terminal oxygenase (AntAcAd). Reverse transcription-PCR results suggested that carAaBaBbCAc gene cluster, fdr, and antRAcAdAbAa gene cluster were induced when strain XLDN2-5 was exposed to carbazole. Expression of both CARDO and ANTDO in Escherichia coli required the presence of the natural reductases for full enzymatic activity. Conclusions/Significance: We predict that IS6100 might play an important role in the establishment of carbazole-degrading pathway, which endows the host to adapt to novel compounds in the environment. The organization of the car and ant genes in strain XLDN2-5 was unique, which showed strong evolutionary trail of gene recruitment mediated by IS6100 and presented a remarkable example of rearrangements and pathway establishments.	[Gai, Zhonghui] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gai, ZH (corresponding author), Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	pingxu@sjtu.edu.cn			National High Technology Research and Development Program of China [2007AA10Z401]; National Basic Research Program of China [2009CB118906]; National Natural Science Foundation of China [20977061, 20777051]; Shanghai Key Basic Research Program of China [09JC1407700]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Program of China	This work was partially supported by the grants from National High Technology Research and Development Program of China (grant number 2007AA10Z401), from National Basic Research Program of China (grant number 2009CB118906), and from National Natural Science Foundation of China (grant numbers 20977061 and 20777051). The authors also acknowledge the financial support from Shanghai Key Basic Research Program of China (grant number 09JC1407700). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud J, 1998, J BACTERIOL, V180, P3954, DOI 10.1128/JB.180.15.3954-3966.1998; Armengaud J, 1998, EUR J BIOCHEM, V253, P437, DOI 10.1046/j.1432-1327.1998.2530437.x; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Cai M, 2002, J BACTERIOL, V184, P4672, DOI 10.1128/JB.184.17.4672-4680.2002; Chang HK, 2003, J BACTERIOL, V185, P5871, DOI 10.1128/JB.185.19.5871-5881.2003; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dogra C, 2004, J BACTERIOL, V186, P2225, DOI 10.1128/JB.186.8.2225-2235.2004; Gai ZH, 2007, APPL ENVIRON MICROB, V73, P2832, DOI 10.1128/AEM.02704-06; Gai ZH, 2008, MICROBIOL-SGM, V154, P3804, DOI 10.1099/mic.0.2008/023176-0; HALL RM, 1994, J BACTERIOL, V176, P6286, DOI 10.1128/jb.176.20.6286-6294.1994; Herman PL, 2005, J BIOL CHEM, V280, P24759, DOI 10.1074/jbc.M500597200; Jha AM, 2002, MUTAT RES-FUND MOL M, V500, P97, DOI 10.1016/S0027-5107(01)00303-7; KATO K, 1994, J BACTERIOL, V176, P1197, DOI 10.1128/JB.176.4.1197-1200.1994; Kilbane JJ, 2002, BIOCHEM BIOPH RES CO, V297, P242, DOI 10.1016/S0006-291X(02)02183-6; Kirimura K, 1999, BIOSCI BIOTECH BIOCH, V63, P1563, DOI 10.1271/bbb.63.1563; Li L, 2006, APPL MICROBIOL BIOT, V73, P941, DOI 10.1007/s00253-006-0530-3; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MARTIN C, 1990, NATURE, V345, P739, DOI 10.1038/345739a0; Nagata Y, 1999, J IND MICROBIOL BIOT, V23, P380, DOI 10.1038/sj.jim.2900736; Nojiri H, 1999, J BACTERIOL, V181, P3105, DOI 10.1128/JB.181.10.3105-3113.1999; Nojiri H, 2001, J BACTERIOL, V183, P3663, DOI 10.1128/JB.183.12.3663-3679.2001; Ouchiyama N, 1998, J GEN APPL MICROBIOL, V44, P57, DOI 10.2323/jgam.44.57; PETERSON JA, 1990, J BIOL CHEM, V265, P6066; Pinyakong O, 2003, J GEN APPL MICROBIOL, V49, P1, DOI 10.2323/jgam.49.1; Providenti MA, 2006, APPL ENVIRON MICROB, V72, P2651, DOI 10.1128/AEM.72.4.2651-2660.2006; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Sambrook J, 2001, MOL CLONING LAB MANU; Sato SI, 1997, J BACTERIOL, V179, P4850, DOI 10.1128/jb.179.15.4850-4858.1997; Shepherd JM, 1998, BIOCHEM BIOPH RES CO, V247, P129, DOI 10.1006/bbrc.1998.8750; Shintani M, 2007, J BACTERIOL, V189, P2007, DOI 10.1128/JB.01486-06; SUNDIN GW, 1995, APPL ENVIRON MICROB, V61, P2891, DOI 10.1128/AEM.61.8.2891-2897.1995; Tauch A, 2002, PLASMID, V48, P117, DOI 10.1016/S0147-619X(02)00120-8; Urata M, 2006, APPL ENVIRON MICROB, V72, P3198, DOI 10.1128/AEM.72.5.3198-3205.2006; Wang X, 2007, APPL ENVIRON MICROB, V73, P6421, DOI 10.1128/AEM.01051-07; Zylstra GJ, 1997, J IND MICROBIOL BIOT, V19, P408, DOI 10.1038/sj.jim.2900475	35	17	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10018	10.1371/journal.pone.0010018	http://dx.doi.org/10.1371/journal.pone.0010018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368802	Green Published, gold, Green Submitted			2022-12-25	WOS:000276419900017
J	Twine, SM; Petit, MD; Fulton, KM; House, RV; Conlan, JW				Twine, Susan M.; Petit, Mireille D.; Fulton, Kelly M.; House, Robert V.; Conlan, J. Wayne			Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)	PLOS ONE			English	Article							TULAREMIA	Background: Francisella tularensis subspecies tularensis is the causative agent of a spectrum of diseases collectively known as tularemia. An attenuated live vaccine strain (LVS) has been shown to be efficacious in humans, but safety concerns have prevented its licensure by the FDA. Recently, F. tularensis LVS has been produced under Current Good Manufacturing Practice (CGMP guidelines). Little is known about the immunogenicity of this new vaccine preparation in comparison with extensive studies conducted with laboratory passaged strains of LVS. Thus, the aim of the current work was to evaluate the repertoire of antibodies produced in mouse strains vaccinated with the new LVS vaccine preparation. Methodology/Principal Findings: In the current study, we used an immunoproteomics approach to examine the repertoire of antibodies induced following successful immunization of BALB/c versus unsuccessful vaccination of C57BL/6 mice with the new preparation of F. tularensis LVS. Successful vaccination of BALB/c mice elicited antibodies to nine identified proteins that were not recognized by antisera from vaccinated but unprotected C57BL/6 mice. In addition, the CGMP formulation of LVS stimulated a greater repertoire of antibodies following vaccination compared to vaccination with laboratory passaged ATCC LVS strain. A total of 15 immunoreactive proteins were identified in both studies, however, 16 immunoreactive proteins were uniquely reactive with sera from the new formulation of LVS. Conclusions/Significance: This is the first report characterising the antibody based immune response of the new formulation of LVS in the widely used murine model of tularemia. Using two mouse strains, we show that successfully vaccinated mice can be distinguished from unsuccessfully vaccinated mice based upon the repertoire of antibodies generated. This opens the door towards downselection of antigens for incorporation into tularemia subunit vaccines. In addition, this work also highlights differences in the humoral immune response to vaccination with the commonly used laboratory LVS strain and the new vaccine formulation of LVS.	[Twine, Susan M.; Petit, Mireille D.; Fulton, Kelly M.; Conlan, J. Wayne] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [House, Robert V.] DynPort Vaccine Co LLC, Frederick, MD USA	National Research Council Canada	Twine, SM (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	susan.twine@nrc-cnrc.gc.ca		Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN26620050041C]; National Research Council	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Research Council	This work has been funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN26620050041C. This contract was awarded to the Dynport Vaccine Company, who administered funds. National Research Council was a subcontractor of this award. All research described was funded by NIH; no funding was received directly from Dynport Vaccine Company outside the NIH award. The Dynport Vaccine Company were in no way sponsors of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government.	Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Chen CS, 2005, J CREATIVE BEHAV, V39, P89, DOI 10.1002/j.2162-6057.2005.tb01252.x; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2008, MOL IMMUNOL, V45, P2962, DOI 10.1016/j.molimm.2008.01.022; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; CONLAN JW, 2004, EXPERT REV VACCINES, V3; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Cowley SC, 2003, J EXP MED, V198, P379, DOI 10.1084/jem.20030687; DIENST FT, 1963, J LA STATE MED SOC, V115, P14; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Gosselin EJ, 2005, HUM IMMUNOL, V66, P1039, DOI 10.1016/j.humimm.2005.08.240; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; Havlasova J, 2002, PROTEOMICS, V2, P857, DOI 10.1002/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; JANOVSKA S, 2007, IMMUNOL LETT, V13, P35; Kirimanjeswara GS, 2008, IMMUNOL REV, V225, P244, DOI 10.1111/j.1600-065X.2008.00689.x; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Macela A, 1996, FEMS IMMUNOL MED MIC, V13, P235, DOI 10.1111/j.1574-695X.1996.tb00243.x; MANSFIELD MA, 1995, ANAL BIOCHEM, V229, P140, DOI 10.1006/abio.1995.1391; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; OYSTON PC, 2005, ANTON LEEUW INT J G, V87, P77; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; SASLAW S, 1961, ARCH INTERN MED, V107; Shen H, 2004, VACCINE, V22, P2116, DOI 10.1016/j.vaccine.2003.12.003; SJOSTEDT A, 1992, IMMUNOLOGY, V76, P584; SJOSTEDT A, 2001, BERGERYS MANUAL SYST; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Titball RW, 2003, EXPERT OPIN BIOL TH, V3, P645, DOI 10.1517/14712598.3.4.645; Twine SM, 2005, J PROTEOME RES, V4, P1848, DOI 10.1021/pr050102u; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070; WAYNE CJ, 2007, ANN NY ACAD SCI, V1105, P25; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	38	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10000	10.1371/journal.pone.0010000	http://dx.doi.org/10.1371/journal.pone.0010000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368994	Green Published, Green Submitted, gold			2022-12-25	WOS:000276419900004
J	Becq, J; Churlaud, C; Deschavanne, P				Becq, Jennifer; Churlaud, Cecile; Deschavanne, Patrick			A Benchmark of Parametric Methods for Horizontal Transfers Detection	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; GENOMIC ISLANDS; ESCHERICHIA-COLI; SURROGATE METHODS; BACTERIAL; SIGNATURE; IDENTIFICATION; ACQUISITION; RESISTANCE; EVOLUTION	Horizontal gene transfer (HGT) has appeared to be of importance for prokaryotic species evolution. As a consequence numerous parametric methods, using only the information embedded in the genomes, have been designed to detect HGTs. Numerous reports of incongruencies in results of the different methods applied to the same genomes were published. The use of artificial genomes in which all HGT parameters are controlled allows testing different methods in the same conditions. The results of this benchmark concerning 16 representative parametric methods showed a great variety of efficiencies. Some methods work very poorly whatever the type of HGTs and some depend on the conditions or on the metrics used. The best methods in terms of total errors were those using tetranucleotides as criterion for the window methods or those using codon usage for gene based methods and the Kullback-Leibler divergence metric. Window methods are very sensitive but less specific and detect badly lone isolated gene. On the other hand gene based methods are often very specific but lack of sensitivity. We propose using two methods in combination to get the best of each category, a gene based one for specificity and a window based one for sensitivity.	[Becq, Jennifer] Univ Paris Diderot, Inst Natl Transfus Sanguine, UMR S 665, INSERM, Paris, France; [Churlaud, Cecile; Deschavanne, Patrick] Univ Paris Diderot, INSERM, UMR S 973, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Becq, J (corresponding author), Univ Paris Diderot, Inst Natl Transfus Sanguine, UMR S 665, INSERM, Paris, France.	patrick.deschavanne@univ-paris-diderot.fr			French Education and Research Ministry	French Education and Research Ministry	JB was supported by grants from the French Education and Research Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PATHOGENICITY ISLAND; Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Azad RK, 2005, PLOS COMPUT BIOL, V1, P461, DOI 10.1371/journal.pcbi.0010056; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Cortez Diego Q., 2005, In Silico Biology, V5, P581; Daubin V, 2001, Genome Inform, V12, P155; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Deschavanne P, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P161, DOI 10.1109/BIBE.2000.889603; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Doolittle WF, 1999, TRENDS CELL BIOL, V15, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Guindon S, 2001, MOL BIOL EVOL, V18, P1838, DOI 10.1093/oxfordjournals.molbev.a003972; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hamady M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-476; Hayes WS, 1998, GENOME RES, V8, P1154, DOI 10.1101/gr.8.11.1154; HOOPER SD, 2002, J MOL EVOL, P365; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Ip M, 2007, ANTIMICROB AGENTS CH, V51, P2690, DOI 10.1128/AAC.00258-07; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Koski LB, 2001, MOL BIOL EVOL, V18, P404, DOI 10.1093/oxfordjournals.molbev.a003816; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; LERAT E, 2005, PLOS BIOL; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Lio P, 2000, BIOINFORMATICS, V16, P932, DOI 10.1093/bioinformatics/16.10.932; Lio P, 1996, J THEOR BIOL, V183, P455, DOI 10.1006/jtbi.1996.0235; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Merkl R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-22; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Perriere G, 2002, NUCLEIC ACIDS RES, V30, P4548, DOI 10.1093/nar/gkf565; POPTSOVA M, 2007, BMC EVOLUTIONARY BIO; Ragan MA, 2006, TRENDS MICROBIOL, V14, P4, DOI 10.1016/j.tim.2005.11.004; Ragan MA, 2001, CURR OPIN GENET DEV, V11, P620, DOI 10.1016/S0959-437X(00)00244-6; Ragan MA, 2001, FEMS MICROBIOL LETT, V201, P187, DOI 10.1111/j.1574-6968.2001.tb10755.x; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; ROLFE R, 1959, P NATL ACAD SCI USA, V45, P1039, DOI 10.1073/pnas.45.7.1039; RUITING L, 1996, MOL BIOL EVOL, V13, P47; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; SUEOKA N, 1993, J MOL EVOL, P137; SUEOKA N, 1992, J MOL EVOL, P95; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P922, DOI 10.1093/nar/gki187; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; van Passel MWJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-163; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang B, 2001, J MOL EVOL, V53, P244, DOI 10.1007/s002390010214; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184	59	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9989	10.1371/journal.pone.0009989	http://dx.doi.org/10.1371/journal.pone.0009989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376325	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200059
J	Garbian, Y; Ovadia, O; Dadon, S; Mishmar, D				Garbian, Yael; Ovadia, Ofer; Dadon, Sarah; Mishmar, Dan			Gene Expression Patterns of Oxidative Phosphorylation Complex I Subunits Are Organized in Clusters	PLOS ONE			English	Article							STEADY-STATE LEVELS; MITOCHONDRIAL-DNA; TRANSCRIPTION; COEXPRESSION; EVOLUTION; GENOME	After the radiation of eukaryotes, the NUO operon, controlling the transcription of the NADH dehydrogenase complex of the oxidative phosphorylation system (OXPHOS complex I), was broken down and genes encoding this protein complex were dispersed across the nuclear genome. Seven genes, however, were retained in the genome of the mitochondrion, the ancient symbiote of eukaryotes. This division, in combination with the three-fold increase in subunit number from bacteria (N = similar to 14) to man (N = 45), renders the transcription regulation of OXPHOS complex I a challenge. Recently bioinformatics analysis of the promoter regions of all OXPHOS genes in mammals supported patterns of co-regulation, suggesting that natural selection favored a mechanism facilitating the transcriptional regulatory control of genes encoding subunits of these large protein complexes. Here, using real time PCR of mitochondrial (mtDNA)- and nuclear DNA (nDNA)-encoded transcripts in a panel of 13 different human tissues, we show that the expression pattern of OXPHOS complex I genes is regulated in several clusters. Firstly, all mtDNA-encoded complex I subunits (N = 7) share a similar expression pattern, distinct from all tested nDNA-encoded subunits (N = 10). Secondly, two sub-clusters of nDNA-encoded transcripts with significantly different expression patterns were observed. Thirdly, the expression patterns of two nDNA-encoded genes, NDUFA4 and NDUFA5, notably diverged from the rest of the nDNA-encoded subunits, suggesting a certain degree of tissue specificity. Finally, the expression pattern of the mtDNA-encoded ND4L gene diverged from the rest of the tested mtDNA-encoded transcripts that are regulated by the same promoter, consistent with post-transcriptional regulation. These findings suggest, for the first time, that the regulation of complex I subunits expression in humans is complex rather than reflecting global co-regulation.	[Garbian, Yael; Ovadia, Ofer; Dadon, Sarah; Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Garbian, Yael; Dadon, Sarah; Mishmar, Dan] Ben Gurion Univ Negev, Natl Inst Biotechnol NIBN, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Garbian, Y (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	dmishmar@bgu.ac.il	Ovadia, Ofer OO/C-8292-2012; Mishmar, Dan/AAJ-6109-2020	Mishmar, Dan/0000-0003-3488-8792; Ovadia, Ofer/0000-0002-4941-4947	Israel Science Foundation (ISF); Bikurah F.I.R.S.T. Foundation; Israeli Cancer Association	Israel Science Foundation (ISF)(Israel Science Foundation); Bikurah F.I.R.S.T. Foundation; Israeli Cancer Association	This work was supported by grants from the Israel Science Foundation (ISF), Bikurah F.I.R.S.T. Foundation and the Israeli Cancer Association awarded to D. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Duborjal H, 2002, GENOME RES, V12, P1901, DOI 10.1101/gr.194102; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; KING MP, 1993, J BIOL CHEM, V268, P10228; LABBE D, 1991, J BIOL CHEM, V266, P10844; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Legendre L, NUMERICAL ECOLOGY; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; TORRESBACETE J, 2009, J BIOL CHEM; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707	20	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9985	10.1371/journal.pone.0009985	http://dx.doi.org/10.1371/journal.pone.0009985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376309	gold, Green Submitted, Green Published			2022-12-25	WOS:000276418200055
J	Jennings, RM; Bucklin, A; Pierrot-Bults, A				Jennings, Robert M.; Bucklin, Ann; Pierrot-Bults, Annelies			Barcoding of Arrow Worms (Phylum Chaetognatha) from Three Oceans: Genetic Diversity and Evolution within an Enigmatic Phylum	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DNA; PHYLOGENIES; INFERENCE; ACCURATE; BRANCHES	Arrow worms (Phylum Chaetognatha) are abundant planktonic organisms and important predators in many food webs; yet, the classification and evolutionary relationships among chaetognath species remain poorly understood. A seemingly simple body plan is underlain by subtle variation in morphological details, obscuring the affinities of species within the phylum. Many species achieve near global distributions, spanning the same latitudinal bands in all ocean basins, while others present disjunct ranges, in some cases with the same species apparently found at both poles. To better understand how these complex evolutionary and geographic variables are reflected in the species makeup of chaetognaths, we analyze DNA barcodes of the mitochondrial cytochrome oxidase c subunit I (COI) gene, from 52 specimens of 14 species of chaetognaths collected mainly from the Atlantic Ocean. Barcoding analysis was highly successful at discriminating described species of chaetognaths across the phylum, and revealed little geographical structure. This barcode analysis reveals hitherto unseen genetic variation among species of arrow worms, and provides insight into some species relationships of this enigmatic group.	[Jennings, Robert M.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Bucklin, Ann] Univ Connecticut, Dept Marine Sci, Groton, CT USA; [Pierrot-Bults, Annelies] Zool Museum, Amsterdam, Netherlands	University of Massachusetts System; University of Massachusetts Boston; University of Connecticut	Jennings, RM (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	rob.jennings@umb.edu	Jennings, Robert/D-4393-2009	Jennings, Robert/0000-0003-4714-5824; Bucklin, Ann/0000-0003-3750-9348	NOAA's Office of Ocean Exploration [NA050AR4601079]; Russian Foundation for Basic Research [06-05-65187]; Alfred P. Sloan Foundation	NOAA's Office of Ocean Exploration(National Oceanic Atmospheric Admin (NOAA) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was partially funded by NOAA's Office of Ocean Exploration (Award No. NA050AR4601079). Funding to APB was provided by MAR-ECO (www.mar-eco.no).Samples collected by Ksenia Kosobokova and kindly contributed by her were supported by the Russian Foundation for Basic Research (Award No. 06-05-65187). The authors gratefully acknowledge the support of the Alfred P. Sloan Foundation. This study is a contribution from the Census of Marine Zooplankton (CMarZ, www.CMarZ.org), an ocean realm field project of the Census of Marine Life (www.coml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; BIERI R, 1991, P122; Bone Q, 1991, BIOL CHAETOGNATHS; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GHIRARDELLI E, 1968, ADV MAR BIOL, V6, P271; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Halanych KM, 1996, SYST BIOL, V45, P223, DOI 10.2307/2413616; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Matus DQ, 2006, CURR BIOL, V16, pR575, DOI 10.1016/j.cub.2006.07.017; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Papillon D, 2006, MOL PHYLOGENET EVOL, V38, P621, DOI 10.1016/j.ympev.2005.12.004; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Peijnenburg KTCA, 2005, MAR BIOL, V147, P1279, DOI 10.1007/s00227-005-0041-2; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Pierrot-Bults AC, 2008, DEEP-SEA RES PT II, V55, P137, DOI 10.1016/j.dsr2.2007.09.016; PIERROT-BULTS A C, 1976, Bulletin Zoologisch Museum Universiteit van Amsterdam, V5, P59; Pleijel F, 2008, MOL PHYLOGENET EVOL, V48, P369, DOI 10.1016/j.ympev.2008.03.024; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telford MJ, 1997, J MOL EVOL, V44, P135, DOI 10.1007/PL00006130; Telford MJ, 2004, NATURE, V431, P254, DOI 10.1038/431254b; TELFORD MJ, 1993, MOL BIOL EVOL, V10, P660; Tokioka T., 1965, Publications of the Seto Marine Biological Laboratory, V12, P335; VANDERSPOEL S, 1973, ZOOGEOGRAPHY DIVERSI; Vannier J, 2007, P ROY SOC B-BIOL SCI, V274, P627, DOI 10.1098/rspb.2006.3761; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529	38	28	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9949	10.1371/journal.pone.0009949	http://dx.doi.org/10.1371/journal.pone.0009949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376348	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200025
J	Krylova, EM; Sahling, H				Krylova, Elena M.; Sahling, Heiko			Vesicomyidae (Bivalvia): Current Taxonomy and Distribution	PLOS ONE			English	Article							COLD-SEEP COMMUNITIES; DEEP-SEA; HYDROTHERMAL VENT; EVOLUTIONARY RELATIONSHIPS; CLAMS; GULF	Vesicomyid bivalves are a consistent component of communities of sulphide-rich reducing environments distributed worldwide from 77 degrees N to 70 degrees S at depths from 100 to 9050 m. Up-to-now the taxonomy of the family has been uncertain. In this paper, the current state of vesicomyid taxonomy and distribution at the generic rank are considered. This survey is founded on a database including information both from literature sources and also unpublished data of the authors on all recent species of vesicomyids. We suggest that the Vesicomyidae is not a synonym of Kelliellidae, and is therefore a valid family name. We propose to divide the family Vesicomyidae into two subfamilies: Vesicomyinae and Pliocardiinae. The Vesicomyinae includes one genus, Vesicomya, which comprises small-sized bivalves characterized by non-reduced gut and the absence of subfilamental tissue in gills. Symbiosis with chemoautotrophic bacteria has, so far, not been proved for Vesicomya and the genus is not restricted to sulphide-rich reducing habitats. The subfamily Pliocardiinae currently contains about 15 genera with mostly medium or large body size, characterized by the presence of subfilamental tissue in the gills. The Pliocardiinae are highly specialized for sulphide-rich reducing environments, harbouring chemoautrophic bacteria in their gills. This is the first summary of the generic structure of the family Vesicomyidae that allow us to analyze the distribution of vesicomyids at the generic level. We recognize here five different distribution patterns that are related to the specific environmental demands. The general trends in the distribution patterns of the vesicomyids are an occurrence of the majority of genera in broad geographical ranges and the prevalence of near continental type of distribution.	[Krylova, Elena M.] PP Shirshov Oceanol Inst, Lab Ocean Benth Fauna, Moscow, Russia; [Sahling, Heiko] Univ Bremen, Dept Geosci, MARUM Ctr Marine Environm Sci, Bremen, Germany	Russian Academy of Sciences; Shirshov Institute of Oceanology; University of Bremen	Krylova, EM (corresponding author), PP Shirshov Oceanol Inst, Lab Ocean Benth Fauna, Moscow, Russia.	elenamkr@mail.ru	Krylova, Elena M./A-4418-2017; Sahling, Heiko/B-7701-2017	Krylova, Elena M./0000-0003-1341-1709; Sahling, Heiko/0000-0002-1022-9816	DFG [SA 13483-1]	DFG(German Research Foundation (DFG))	This study was partly funded through DFG-Research Center/Excellence Cluster "The Ocean in the Earth System". In addition, funding was provided by the "Deutsche Forschungsgemeinschaft" DFG project number SA 13483-1. Publishing costs will be published by CheSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2001, ZOOL J LINN SOC-LOND, V131, P199, DOI 10.1006/zjils.2000.0233; [Anonymous], 2000, SANTA BARBARA MUSEUM, P764; Barry JP, 1997, LIMNOL OCEANOGR, V42, P318, DOI 10.4319/lo.1997.42.2.0318; BELIAEV GM, 1959, DOKL AKAD NAUK SSSR+, V129, P658; BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; BERNARD F R, 1974, Allan Hancock Monographs in Marine Biology, V8, P1; BOSS K. J., 1967, BREVOIRA MUS COMP ZOOL [HARVARD], V266, P1; Boss K. J., 1970, Mitt. zool. Mus. Berl., V46, P67; BOSS KJ, 1980, MALACOLOGIA, V20, P161; BOSS KJ, 1968, B MAR SCI, V18, P731; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; CARNEY RS, 1994, GEO-MAR LETT, V14, P149, DOI 10.1007/BF01203726; Clarke A. H. Jr., 1962, Bulletin National Museum of Canada, VNo. 181, P1; COSEL VR, RECORDS MUS IN PRESS; COSEL VR, 2008, ZOOSYSTEMA, V30, P929; Dall W.H., 1908, B MUS COMP ZOOL HARV, V43, P415; Dall W.H., 1891, US NATL MUSEUM P, V14, P173, DOI [DOI 10.5479/SI.00963801.14-849.173, 10.5479/si.00963801.14-849.173]; Egorova E.N., 1998, Zoosystematica Rossica, V7, P245; Filatova Z. A., 1971, Trudy Inst Okeanol, V92, P46; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Gay A, 2007, MAR GEOL, V244, P68, DOI 10.1016/j.margeo.2007.06.003; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; HASHIMOTO J, 1993, ZOOL SCI, V10, P1063; Kanno S., 1998, RES REPORT SHINSHUSH, V1, P17; KEEN AM, 1969, TREATISE INVERTEBRAT, P663; Knudsen J, 1970, GALATHEA REP, V11, P7; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Krylova E.M., 2000, Ruthenica, V10, P76; Krylova Elena M., 2006, Archiv fuer Molluskenkunde, V135, P231; Krylova EM, 2006, J MOLLUS STUD, V72, P359, DOI 10.1093/mollus/eyl022; KRYLOVA EM, J MOLLUS ST IN PRESS; Mironov A.N., 1985, Trudy Instituta Okeanologii Akademii Nauk SSSR, V120, P70; Mironov A.N., 2002, BIOLOGIYA GIDROTERMA, P410; Mironov A.N., 2006, BIOGEOGRAPHY N ATLAN, P22; Okutani Takashi, 2000, Venus the Japanese Journal of Malacology, V59, P83; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Prashad B., 1932, Siboga Expeditie Leiden, V53c, P1; Sahling H, 2005, LIMNOL OCEANOGR, V50, P598, DOI 10.4319/lo.2005.50.2.0598; Sahling H, 2003, DEEP-SEA RES PT I, V50, P1391, DOI 10.1016/j.dsr.2003.08.004; Sahling H, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001978; SCARLATO O.A., 1981, BIVALVE MOLLUSCS LOW; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sibuet M, 2009, DEEP-SEA RES PT II, V56, P2156, DOI 10.1016/j.dsr2.2009.04.015; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thiele J, 1929, HDB SYSTEMATISCHEN W; Thiele J., 1931, VALDIVIA, V21, P159; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; von Cosel R, 2001, SARSIA, V86, P333, DOI 10.1080/00364827.2001.10425523; von Cosel R, 2009, DEEP-SEA RES PT II, V56, P2350, DOI 10.1016/j.dsr2.2009.04.016; WOODRING WP, 1938, US GEOLOGICAL SURVEY, V190, P1	51	98	107	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9957	10.1371/journal.pone.0009957	http://dx.doi.org/10.1371/journal.pone.0009957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376362	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200032
J	Spilman, P; Podlutskaya, N; Hart, MJ; Debnath, J; Gorostiza, O; Bredesen, D; Richardson, A; Strong, R; Galvan, V				Spilman, Patricia; Podlutskaya, Natalia; Hart, Matthew J.; Debnath, Jayanta; Gorostiza, Olivia; Bredesen, Dale; Richardson, Arlan; Strong, Randy; Galvan, Veronica			Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							APP TRANSGENIC MICE; LIFE-SPAN; MAMMALIAN PROTEIN; ALPHA-SYNUCLEIN; AUTOPHAGY; YEAST; TOR; INDUCTION; PATHWAY; EXPRESSION	Background: Reduced TOR signaling has been shown to significantly increase lifespan in a variety of organisms [1,2,3,4]. It was recently demonstrated that long-term treatment with rapamycin, an inhibitor of the mTOR pathway[5], or ablation of the mTOR target p70S6K[6] extends lifespan in mice, possibly by delaying aging. Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined. Methodology/Principal Findings: We used rapamycin administration and behavioral tools in a mouse model of AD as well as standard biochemical and immunohistochemical measures in brain tissue to provide answers for this question. Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of A beta(42), a major toxic species in AD[7], in the PDAPP transgenic mouse model. These data indicate that inhibition of the mTOR pathway can reduce A beta(42) levels in vivo and block or delay AD in mice. As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in A beta and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of A beta. Conclusions/Significance: Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease. Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.	[Spilman, Patricia; Gorostiza, Olivia; Bredesen, Dale] Buck Inst Age Res, Novato, CA USA; [Podlutskaya, Natalia; Galvan, Veronica] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Podlutskaya, Natalia; Richardson, Arlan; Strong, Randy; Galvan, Veronica] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Richardson, Arlan; Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Hart, Matthew J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX USA; [Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Buck Institute for Research on Aging; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of California System; University of California San Francisco	Spilman, P (corresponding author), Buck Inst Age Res, Novato, CA USA.	galvanv@uthscsa.edu		Debnath, Jayanta/0000-0002-8745-4069; Hart, Matthew/0000-0002-2683-480X	Alzheimer's Association [NIRG-DDC-120433]; NIA Interventions Testing Center [U01AG022307]; San Antonio Nathan Shock Aging Center [P30AG-13319]; Research and Development Service of the Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA126792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG022307, P30AG013319] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIA Interventions Testing Center; San Antonio Nathan Shock Aging Center; Research and Development Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIRG-DDC-120433 from the Alzheimer's Association to V. G. and by the NIA Interventions Testing Center (U01AG022307) to R. S. The authors also recognize the support of the San Antonio Nathan Shock Aging Center (P30AG-13319, A.R.) and the VA Neurodegeneration Research Center (REAP) from the Research and Development Service of the Department of Veterans Affairs (A.R., R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Galvan V, 2008, BEHAV BRAIN RES, V191, P246, DOI 10.1016/j.bbr.2008.03.035; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KOO EH, 1994, J BIOL CHEM, V269, P17386; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Menzies FM, 2006, AUTOPHAGY, V2, P224, DOI 10.4161/auto.2696; MIZUSHIMA N, 2009, CURR OPIN CELL BIOL, V22, P1; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myskiw JC, 2008, NEUROBIOL LEARN MEM, V89, P338, DOI 10.1016/j.nlm.2007.10.002; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roskam S, 2010, NEUROSCI BIOBEHAV R, V34, P487, DOI 10.1016/j.neubiorev.2009.10.006; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Saganich MJ, 2006, J NEUROSCI, V26, P13428, DOI 10.1523/JNEUROSCI.4180-06.2006; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhang JL, 2010, BEHAV BRAIN RES, V206, P202, DOI 10.1016/j.bbr.2009.09.013	50	731	773	0	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9979	10.1371/journal.pone.0009979	http://dx.doi.org/10.1371/journal.pone.0009979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376313	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200050
J	Tarazona-Santos, E; Fabbri, C; Yeager, M; Magalhaes, WC; Burdett, L; Crenshaw, A; Pettener, D; Chanock, SJ				Tarazona-Santos, Eduardo; Fabbri, Cristina; Yeager, Meredith; Magalhaes, Wagner C.; Burdett, Laurie; Crenshaw, Andrew; Pettener, Davide; Chanock, Stephen J.			Diversity in the Glucose Transporter-4 Gene (SLC2A4) in Humans Reflects the Action of Natural Selection along the Old-World Primates Evolution	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; HUMAN GENOME; RECOMBINATION HOTSPOTS; GLUCOSE-TRANSPORTER; POPULATION-GENETICS; HAPLOTYPE STRUCTURE; POSITIVE SELECTION; POLYMORPHISM; MODEL; ASSOCIATION	Background: Glucose is an important source of energy for living organisms. In vertebrates it is ingested with the diet and transported into the cells by conserved mechanisms and molecules, such as the trans-membrane Glucose Transporters (GLUTs). Members of this family have tissue specific expression, biochemical properties and physiologic functions that together regulate glucose levels and distribution. GLUT4-coded by SLC2A4 (17p13) is an insulin-sensitive transporter with a critical role in glucose homeostasis and diabetes pathogenesis, preferentially expressed in the adipose tissue, heart muscle and skeletal muscle. We tested the hypothesis that natural selection acted on SLC2A4. Methodology/Principal Findings: We re-sequenced SLC2A4 and genotyped 104 SNPs along a similar to 1 Mb region flanking this gene in 102 ethnically diverse individuals. Across the studied populations (African, European, Asian and Latin-American), all the eight common SNPs are concentrated in the N-terminal region upstream of exon 7 (similar to 3700 bp), while the C-terminal region downstream of intron 6 (similar to 2600 bp) harbors only 6 singletons, a pattern that is not compatible with neutrality for this part of the gene. Tests of neutrality based on comparative genomics suggest that: (1) episodes of natural selection (likely a selective sweep) predating the coalescent of human lineages, within the last 25 million years, account for the observed reduced diversity downstream of intron 6 and, (2) the target of natural selection may not be in the SLC2A4 coding sequence. Conclusions: We propose that the contrast in the pattern of genetic variation between the N-terminal and C-terminal regions are signatures of the action of natural selection and thus follow-up studies should investigate the functional importance of differnet regions of the SLC2A4 gene.	[Tarazona-Santos, Eduardo; Fabbri, Cristina; Magalhaes, Wagner C.; Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Tarazona-Santos, Eduardo; Magalhaes, Wagner C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Fabbri, Cristina; Pettener, Davide] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Bologna, Italy; [Yeager, Meredith; Burdett, Laurie; Crenshaw, Andrew] NCI, Intramural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA; [Yeager, Meredith; Burdett, Laurie; Crenshaw, Andrew] NCI, Core Genotype Facil, NIH, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal de Minas Gerais; University of Bologna; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tarazona-Santos, E (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	edutars@icb.ufmg.br	Tarazona-Santos, Eduardo/AAF-1110-2019; Yeager, Meredith/AAA-5322-2020; Fripp, Jurgen/A-8763-2011; Chetelat, Gael/G-2316-2015; Bourgeat, Pierrick T/A-1419-2010; Pettener, Davide/E-1576-2017; Magalhaes, Wagner CS/D-8822-2015; Salvado, Olivier/C-8910-2009; IBL, A/C-8408-2013	Fripp, Jurgen/0000-0001-9705-0079; Bourgeat, Pierrick T/0000-0002-2605-4766; Salvado, Olivier/0000-0002-2720-8739; Tarazona, Eduardo/0000-0003-3508-3160	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; University of Bologna; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); Fundacao de Amparo a Pesquisa de Minas Gerais (Brazil); Brazilian Ministry of Education (Agency for the Development of Graduate Education-CAPES)	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Bologna; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Ministry of Education (Agency for the Development of Graduate Education-CAPES)	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. CF and DP were supported by the University of Bologna, ET-S by NIH, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) and Fundacao de Amparo a Pesquisa de Minas Gerais (Brazil) and WCSM by Brazilian Ministry of Education (Agency for the Development of Graduate Education-CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; BANDELT HJ, 1995, GENETICS, V141, P743; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand-Miller Jennie, 2007, Curr Atheroscler Rep, V9, P479, DOI 10.1007/s11883-007-0064-x; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; FU YX, 1993, GENETICS, V133, P693; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hughes AL, 2008, GENOMICS, V92, P1, DOI 10.1016/j.ygeno.2008.03.005; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li N, 2003, GENETICS, V165, P2213; McDonald JH, 1998, MOL BIOL EVOL, V15, P377, DOI 10.1093/oxfordjournals.molbev.a025934; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Oshel KM, 2000, J BIOL CHEM, V275, P23666, DOI 10.1074/jbc.M001452200; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Suh SH, 2007, MOL CELLS, V23, P272; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tarazona-Santos E, 2005, GENES IMMUN, V6, P53, DOI 10.1038/sj.gene.6364149; Tarazona-Santos E, 2008, HUM MUTAT, V29, P623, DOI 10.1002/humu.20667; Teran-Garcia M, 2008, J APPL PHYSIOL, V105, P988, DOI 10.1152/japplphysiol.00070.2008; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang Z., 2007, HDB STAT GENETICS, V1, P377; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9827	10.1371/journal.pone.0009827	http://dx.doi.org/10.1371/journal.pone.0009827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352120	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894400027
J	Tissot, AC; Renhofa, R; Schmitz, N; Cielens, I; Meijerink, E; Ose, V; Jennings, GT; Saudan, P; Pumpens, P; Bachmann, MF				Tissot, Alain C.; Renhofa, Regina; Schmitz, Nicole; Cielens, Indulis; Meijerink, Edwin; Ose, Velta; Jennings, Gary T.; Saudan, Philippe; Pumpens, Paul; Bachmann, Martin F.			Versatile Virus-Like Particle Carrier for Epitope Based Vaccines	PLOS ONE			English	Article							INFLUENZA-A VACCINE; ADVANCED PROSTATE-CANCER; PHASE-I SAFETY; AUTOIMMUNE ARTHRITIS; EXTRACELLULAR DOMAIN; PRECLINICAL EFFICACY; ACTIVE IMMUNIZATION; COAT PROTEIN; PHAGE; IMMUNOGENICITY	Background: Recombinant proteins and in particular single domains or peptides are often poorly immunogenic unless conjugated to a carrier protein. Virus-like-particles are a very efficient means to confer high immunogenicity to antigens. We report here the development of virus-like-particles (VLPs) derived from the RNA bacteriophage AP205 for epitope-based vaccines. Methodology/Principal Findings: Peptides of angiotensin II, S. typhi outer membrane protein (D2), CXCR4 receptor, HIV1 Nef, gonadotropin releasing hormone (GnRH), Influenza A M2-protein were fused to either N-or C-terminus of AP205 coat protein. The A205-peptide fusions assembled into VLPs, and peptides displayed on the VLP were highly immunogenic in mice. GnRH fused to the C-terminus of AP205 induced a strong antibody response that inhibited GnRH function in vivo. Exposure of the M2-protein peptide at the N-terminus of AP205 resulted in a strong M2-specific antibody response upon immunization, protecting 100% of mice from a lethal influenza infection. Conclusions/Significance: AP205 VLPs are therefore a very efficient and new vaccine system, suitable for complex and long epitopes, of up to at least 55 amino acid residues in length. AP205 VLPs confer a high immunogenicity to displayed epitopes, as shown by inhibition of endogenous GnRH and protective immunity against influenza infection.	[Tissot, Alain C.; Schmitz, Nicole; Meijerink, Edwin; Jennings, Gary T.; Saudan, Philippe; Bachmann, Martin F.] Cytos Biotechnol AG, Zurich, Switzerland; [Renhofa, Regina; Cielens, Indulis; Ose, Velta; Pumpens, Paul] Latvian Biomed Res & Study Ctr, Riga, Latvia	Latvian Biomedical Research & Study Centre	Tissot, AC (corresponding author), Cytos Biotechnol AG, Zurich, Switzerland.	paul@biomed.lu.lv; martin.bachmann@cytos.com	Pumpens, Paul/A-2163-2008		Cytos Biotechnology AG	Cytos Biotechnology AG	The work was funded by Cytos Biotechnology AG. The authors of the manuscript were employees or collaborators of the funder at the time of performance of the work. The funding source supported financially the performance of the experiments. Data analysis and interpretation was performed exclusively by the authors.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Armstrong EP, 2007, J MANAGE CARE PHARM, V13, pS12; Bachmann MF, 1999, CURR OPIN IMMUNOL, V11, P332, DOI 10.1016/S0952-7915(99)80053-3; Bachmann MF, 2004, NAT REV DRUG DISCOV, V3, P81, DOI 10.1038/nrd1284; Chackerian B, 2004, J VIROL, V78, P4037, DOI 10.1128/JVI.78.8.4037-4047.2004; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Cielens I, 2000, FEBS LETT, V482, P261, DOI 10.1016/S0014-5793(00)02061-5; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Hsu CT, 2000, CANCER RES, V60, P3701; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Klovins J, 2002, J GEN VIROL, V83, P1523, DOI 10.1099/0022-1317-83-6-1523; Kozlovska TM, 1996, INTERVIROLOGY, V39, P9, DOI 10.1159/000150469; KOZLOVSKA TM, 1993, GENE, V137, P133, DOI 10.1016/0378-1119(93)90261-Z; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Labrie F, 2004, J ANDROL, V25, P305; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; Meinke A, 2005, VACCINE, V23, P2035, DOI 10.1016/j.vaccine.2005.01.005; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; O'Hagan DT, 2004, DRUG DISCOV TODAY, V9, P846, DOI 10.1016/S1359-6446(04)03234-9; Parkinson RJ, 2004, EUR UROL, V45, P171, DOI 10.1016/j.eururo.2003.10.007; Pumpens P, 2002, INTERVIROLOGY, V45, P24, DOI 10.1159/000050084; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; PUSHKO P, 1993, PROTEIN ENG, V6, P883, DOI 10.1093/protein/6.8.883; PUSHKO P, 1994, VIROLOGY, V202, P912, DOI 10.1006/viro.1994.1413; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Simms MS, 2000, BRIT J CANCER, V83, P443, DOI 10.1054/bjoc.2000.1315; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Spohn G, 2005, J IMMUNOL, V175, P6211, DOI 10.4049/jimmunol.175.9.6211; Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989; Spohn G, 2007, J IMMUNOL, V178, P7450, DOI 10.4049/jimmunol.178.11.7450; TALWAR GP, 1992, INT J IMMUNOPHARMACO, V14, P511, DOI 10.1016/0192-0561(92)90183-L; Tars K, 2000, ACTA CRYSTALLOGR D, V56, P398, DOI 10.1107/S0907444900001232; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	41	129	145	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9809	10.1371/journal.pone.0009809	http://dx.doi.org/10.1371/journal.pone.0009809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352110	gold, Green Submitted, Green Published			2022-12-25	WOS:000275894400014
J	Xu, JQ; Sato, S; Okuyama, S; Swan, RJ; Jacobsen, MT; Strunk, E; Ikezu, T				Xu, Jiqing; Sato, Shinji; Okuyama, Satoshi; Swan, Russell J.; Jacobsen, Michael T.; Strunk, Elena; Ikezu, Tsuneya			Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice	FASEB JOURNAL			English	Article						transgenic mouse model; neurodegeneartion; protein kinase; frontotemporal dementia; tauopathy; cyclin-dependent kinase 5	GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; MOUSE MODEL; DEPOSITION PRECEDES; AMYLOID DEPOSITION; TYROSINE KINASE; PROTEIN-KINASES; PHOSPHORYLATION	Tau-tubulin kinase-1 (TTBK1) phosphorylates microtubule-associated protein tau at specific serine/threonine residues found in paired helical filaments (PHFs), and its expression is up-regulated in the brain in Alzheimer disease, suggesting its role in tauopathy pathogenesis. To understand the effects of TTBK1 on tauopathy in vivo, we have developed bigenic mice overexpressing full-length TTBK1 and the P301L tau mutant. The bigenic mice show enhanced tau phosphorylation at multiple sites (AT8, 12E8, PHF-1, and pS422), tauC3-immunoreactive tau fragmentation, and accumulation of tau aggregates in cortical and hippocampal neurons at 12-13 mo of age. However, the phosphorylated tau aggregates were predominantly sarkosyl soluble and migrated in the light sucrose density fraction after discontinuous sucrose gradient ultracentrifugation, which suggests that they form small oligomers. The bigenic mice show significant locomotor dysfunction as determined by both rotorod and grip strength tests, as well as enhanced loss of motor neurons in the L4-L5 spinal cord. This neuronal dysfunction and degeneration was associated with increased levels of tau oligomers, cyclin-dependent protein kinase 5 activators p35 and p25, and pY216 phosphorylated glycogen synthase kinase 3-beta. These data suggest that TTBK1 up-regulation enhances tau phosphorylation and oligomerization, whose toxicity results in enhanced neurodegeneration and locomotor dysfunction in a tauopathy animal model.-Xu, J., Sato, S., Okuyama, S., Swan, R. J., Jacobsen, M. T., Strunk, E., Ikezu, T. Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice. FASEB J. 24, 2904-2915 (2010). www.fasebj.org	Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; Univ Nebraska Med Ctr, Ctr Neurodegenerat Disorders, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Ikezu, T (corresponding author), 985930 Nebraska Med Ctr, Omaha, NE 68198 USA.	tikezu@unmc.edu		Ikezu, Tsuneya/0000-0002-3979-8596	University of Nebraska Medical Center; John Douglas French Alzheimer's Foundation; Vada Oldfield Alzheimer's Research Awards	University of Nebraska Medical Center; John Douglas French Alzheimer's Foundation; Vada Oldfield Alzheimer's Research Awards	The authors thank D. Morgan for the consultation in spatial learning tests; A. Takashima for the consultation in sucrose gradient fractionation of tau oligomers; P. Davies (Albert Einstein College of Medicine, Bronx, NY, USA) for PHF-1 and TG2 antibodies; A. Delacourte (INSERM, Lille, France) and M. Hasegawa (University of Tokyo, Tokyo, Japan) for pS422 antibody; P. Schubert (Athena Neurosciences Inc., South San Francisco, CA, USA) for 12E8 antibody; L. Binder (Northwestern University, Chicago, IL, USA) and M. Novak (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for tau66, tauC3, and MN423 antibodies; A. LeBlanc (McGill University, Montreal, QC, Canada) for tauC6 antibody; J. Davis (University of Nebraska Medical Center, Omaha, NE, USA) for GSK3 antibodies; and M. Marquardt, K. Estes, and T. Smith for manuscript editing. This work was supported by University of Nebraska Medical Center Faculty Retention Fund (T.I.), John Douglas French Alzheimer's Foundation (S.S.), and Vada Oldfield Alzheimer's Research Awards (S.S. and T.I.).	Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; ARIOKA M, 1993, J NEUROCHEM, V60, P461, DOI 10.1111/j.1471-4159.1993.tb03173.x; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BRAAK H, 1995, ACTA NEUROPATHOL, V16, P278; Bussiere T, 1999, ACTA NEUROPATHOL, V97, P221, DOI 10.1007/s004010050978; Cho JH, 2004, J BIOL CHEM, V279, P54716, DOI 10.1074/jbc.M403364200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Evans DB, 2000, J BIOL CHEM, V275, P24977, DOI 10.1074/jbc.M000808200; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Imahori K, 1997, J BIOCHEM, V121, P179; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Ishizawa T, 2003, AM J PATHOL, V163, P1057, DOI 10.1016/S0002-9440(10)63465-7; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lippa CF, 1998, LANCET, V352, P1117, DOI 10.1016/S0140-6736(05)79757-9; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Sato S, 2008, J NEUROSCI, V28, P14511, DOI 10.1523/JNEUROSCI.3417-08.2008; Sayas CL, 2006, MOL BIOL CELL, V17, P1834, DOI 10.1091/mbc.E05-07-0688; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yusta B, 2002, J BIOL CHEM, V277, P24896, DOI 10.1074/jbc.M201358200	47	26	27	4	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2904	2915		10.1096/fj.09-150144	http://dx.doi.org/10.1096/fj.09-150144			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354135				2022-12-25	WOS:000285005400030
J	Zhang, S; Rattanatray, L; MacLaughlin, SM; Cropley, JE; Suter, CM; Molloy, L; Kleemann, D; Walker, SK; Muhlhausler, BS; Morrison, JL; McMillen, IC				Zhang, Song; Rattanatray, Leewen; MacLaughlin, Severence M.; Cropley, Jennifer E.; Suter, Catherine M.; Molloy, Laura; Kleemann, Dave; Walker, Simon K.; Muhlhausler, Beverly S.; Morrison, Janna L.; McMillen, I. Caroline			Periconceptional undernutrition in normal and overweight ewes leads to increased adrenal growth and epigenetic changes in adrenal IGF2/H19 gene in offspring	FASEB JOURNAL			English	Article						fetus; embryo; hypothalamo-pituitary axis; cortisol; DNA methylation	MESSENGER-RIBONUCLEIC-ACID; SHEEP FETUS; MATERNAL UNDERNUTRITION; LATE-GESTATION; FETAL SHEEP; RNA LEVELS; IGF-II; AXIS; EXPRESSION; CORTISOL	Adverse conditions in early life result in increased activation of the hypothalamo-pituitary-adrenal axis and in stress responsiveness in offspring. We have developed a model in which "donor" ewes are either normally nourished or overnourished prior to a period of dietary restriction, before transfer of the embryo at 6-7 d after conception to a ewe of normal weight and nutritional history. A moderate restriction of energy intake during the periconceptional period in both normal weight and overweight ewes resulted in increased adrenal mass in male and female lambs and an increased cortisol response to stress in female lambs. The increase in adrenal weight in lambs exposed to periconceptional undernutrition was associated with a decrease in the adrenal mRNA expression of IGF2 and decreased methylation in the proximal CTCF-binding site in the differentially methylated region of the IGF2/H19 gene. Thus, weight loss in both normal and overweight mothers during the periconceptional period results in epigenetic modification of IGF2 in the adrenal gland, adrenal overgrowth, and increased vulnerability to stress in offspring. Determining the appropriate approach to weight loss in the periconceptional period may therefore be important in overweight or obese women seeking to become pregnant.-Zhang, S., Rattanatray, L., MacLaughlin, S. M., Cropley, J. E., Suter, C. M., Molloy, L., Kleemann, D., Walker, S. K., Muhlhausler, B. S., Morrison, J. L., and McMillen, I. C. Periconceptional undernutrition in normal and overweight ewes leads to increased adrenal growth and epigenetic changes in adrenal IGF2/H19 gene in offspring. FASEB J. 24, 2772-2782 (2010). www.fasebj.org	[Zhang, Song; Rattanatray, Leewen; MacLaughlin, Severence M.; Muhlhausler, Beverly S.; Morrison, Janna L.; McMillen, I. Caroline] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, The Chancellery, Adelaide, SA 5005, Australia; [Rattanatray, Leewen] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Physiol, Adelaide, SA, Australia; [Cropley, Jennifer E.; Suter, Catherine M.; Molloy, Laura] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Suter, Catherine M.] Univ New S Wales, Kensington, NSW 2033, Australia; [Kleemann, Dave; Walker, Simon K.] S Australian Res & Dev Inst, Turretfield Res Ctr, Rosedale, SA, Australia	University of South Australia; University of Adelaide; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	McMillen, IC (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, The Chancellery, 160 Currie St, Adelaide, SA 5005, Australia.	caroline.mcmillen@unisa.edu.au	Morrison, Janna/B-8308-2009; McMillen, Isabella Caroline/N-5540-2019	Morrison, Janna/0000-0002-8602-8519; Muhlhausler, Beverly/0000-0002-9021-6790; Cropley, Jennifer/0000-0001-6078-2604	Brailsford Robertson Trust; National Health and Medical Research Council	Brailsford Robertson Trust; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors gratefully acknowledge the technical assistance provided by Laura O'Carroll, Pamela Sim, and Bernard Chuang during the course of this study. This study was supported by funding from the Brailsford Robertson Trust and from the National Health and Medical Research Council.	AFRC (Agricultural and Food Research Council), 1993, EN PROT REQ RUM ADV, P100; Bloomfield FH, 2004, ENDOCRINOLOGY, V145, P4278, DOI 10.1210/en.2004-0424; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Butler TG, 2002, J CLIN INVEST, V110, P783, DOI 10.1172/JCI200215563; Canny BJ, 1999, J ENDOCRINOL, V162, P215, DOI 10.1677/joe.0.1620215; Chadio SE, 2007, J ENDOCRINOL, V192, P495, DOI 10.1677/JOE-06-0172; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coulter CL, 2003, MOL CELL ENDOCRINOL, V206, P85, DOI 10.1016/S0303-7207(03)00214-4; de Vries A, 2007, J CLIN INVEST, V117, P1058, DOI 10.1172/JCI30982; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Edwards LJ, 2002, AM J PHYSIOL-REG I, V283, pR669, DOI 10.1152/ajpregu.00736.2001; Edwards LJ, 2002, BIOL REPROD, V66, P1562, DOI 10.1095/biolreprod66.5.1562; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gardner DS, 2006, J ENDOCRINOL, V190, P203, DOI 10.1677/joe.1.06751; HAN VKM, 1992, ENDOCRINOLOGY, V131, P3100, DOI 10.1210/en.131.6.3100; HAN VKM, 1988, J CLIN ENDOCR METAB, V66, P422, DOI 10.1210/jcem-66-2-422; Hawkins P, 2000, REPROD FERT DEVELOP, V12, P443, DOI 10.1071/RD99071; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Kakar MA, 2005, THERIOGENOLOGY, V64, P1090, DOI 10.1016/j.theriogenology.2004.12.017; LaCoursiere DY, 2005, AM J OBSTET GYNECOL, V192, P832, DOI 10.1016/j.ajog.2004.11.034; Levitt NS, 1996, NEUROENDOCRINOLOGY, V64, P412, DOI 10.1159/000127146; Lund TD, 2004, J NEUROENDOCRINOL, V16, P272, DOI 10.1111/j.0953-8194.2004.01167.x; MacLaughlin SM, 2007, ENDOCRINOLOGY, V148, P1911, DOI 10.1210/en.2006-0761; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; *MIN AGR FISH FOOD, 1984, EN ALL FEED SYST RUM; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Owen D, 2003, ENDOCRINOLOGY, V144, P2775, DOI 10.1210/en.2002-0145; PHAMHUUTRUNG MT, 1991, J STEROID BIOCHEM, V39, P903, DOI 10.1016/0960-0760(91)90348-9; Phillips DIW, 2007, J INTERN MED, V261, P453, DOI 10.1111/j.1365-2796.2007.01801.x; Phillips DIW, 2000, HYPERTENSION, V35, P1301, DOI 10.1161/01.HYP.35.6.1301; Phillips ID, 1996, J PHYSIOL-LONDON, V491, P871, DOI 10.1113/jphysiol.1996.sp021264; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Ross JT, 2007, ENDOCRINOLOGY, V148, P5424, DOI 10.1210/en.2006-1573; Ross JT, 2000, J NEUROENDOCRINOL, V12, P79; Ross JT, 2000, ENDOCRINOLOGY, V141, P2153, DOI 10.1210/en.141.6.2153; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sanchez C, 2009, STEM CELLS, V27, P375, DOI 10.1634/stemcells.2008-0546; Silva C, 2002, ANN NY ACAD SCI, V966, P68, DOI 10.1111/j.1749-6632.2002.tb04203.x; van Lier E, 2003, ANIM REPROD SCI, V79, P81, DOI 10.1016/S0378-4320(03)00083-6; Viau V, 1996, J NEUROSCI, V16, P1866; Warnes KE, 2004, BIOL REPROD, V71, P620, DOI 10.1095/biolreprod.103.025197; Weaver IC, 2004, NAT NEUROSCI, V7, P791; Whittle WL, 2001, BIOL REPROD, V64, P1019, DOI 10.1095/biolreprod64.4.1019; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	50	83	87	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2772	2782		10.1096/fj.09-154294	http://dx.doi.org/10.1096/fj.09-154294			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371620				2022-12-25	WOS:000285005400018
J	Tang, QY; Zhang, Z; Xia, JS; Ren, DJ; Logothetis, DE				Tang, Qiong-Yao; Zhang, Zhe; Xia, Jingsheng; Ren, Dejian; Logothetis, Diomedes E.			Phosphatidylinositol 4,5-Bisphosphate Activates Slo3 Currents and Its Hydrolysis Underlies the Epidermal Growth Factor-induced Current Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; POTASSIUM CHANNELS; KIR CHANNELS; ION CHANNELS; MOUSE SPERM; SIGNALING PATHWAYS; ACROSOME REACTION; PIP2; PH; SPERMATOZOA	The Slo3 gene encodes a high conductance potassium channel, which is activated by both voltage and intracellular alkalinization. Slo3 is specifically expressed in mammalian sperm cells, where it gives rise to pH-dependent outwardly rectifying K+ currents. Sperm Slo3 is the main current responsible for the capacitation-induced hyperpolarization, which is required for the ensuing acrosome reaction, an exocytotic process essential for fertilization. Here we show that in intact spermatozoa and in a heterologous expression system, the activation of Slo3 currents is regulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Depletion of endogenous PIP2 in inside-out macropatches from Xenopus oocytes inhibited heterologously expressed Slo3 currents. Whole-cell recordings of sperm Slo3 currents or of Slo3 channels co-expressed in Xenopus oocytes with epidermal growth factor receptor, demonstrated that stimulation by epidermal growth factor (EGF) could inhibit channel activity in a PIP2-dependent manner. High concentrations of PIP2 in the patch pipette not only resulted in a strong increase in sperm Slo3 current density but also prevented the EGF-induced inhibition of this current. Mutation of positively charged residues involved in channel-PIP2 interactions enhanced the EGF-induced inhibition of Slo3 currents. Overall, our results suggest that PIP2 is an important regulator for Slo3 activation and that receptor-mediated hydrolysis of PIP2 leads to inhibition of Slo3 currents both in native and heterologous expression systems.	[Tang, Qiong-Yao; Zhang, Zhe; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Xia, Jingsheng; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Virginia Commonwealth University; University of Pennsylvania	Logothetis, DE (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA.	delogothetis@vcu.edu	Tang, Qiong-Yao/G-6051-2012; Zhang, Zhe/C-2685-2011		National Institutes of Health [HL059949, HL090882]; discretionary institutional funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090882, R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); discretionary institutional funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL059949 and HL090882 (to D.E.L.).This work was also supported by discretionary institutional funds (to D.E.L.).	Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Breitbart H, 2003, CELL MOL BIOL, V49, P321; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Fujita A, 2000, J CELL SCI, V113, P103; Furuya S, 1993, Nihon Sanka Fujinka Gakkai Zasshi, V45, P1313; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jungnickel MK, 2007, DEV BIOL, V304, P116, DOI 10.1016/j.ydbio.2006.12.023; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; LAX Y, 1994, FEBS LETT, V339, P234, DOI 10.1016/0014-5793(94)80422-2; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOGOTHETIS DE, 2010, EUR J PHYSL IN PRESS; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lopes CMB, 2007, CHANNELS, V1, P124, DOI 10.4161/chan.4322; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; MURASE T, 1995, FEBS LETT, V360, P242, DOI 10.1016/0014-5793(95)00114-O; NagDas SK, 2002, BIOL REPROD, V67, P1058, DOI 10.1095/biolreprod67.4.1058; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Oliva-Hernandez J, 2008, THERIOGENOLOGY, V70, P1159, DOI 10.1016/j.theriogenology.2008.06.090; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tang QY, 2003, J MEMBRANE BIOL, V196, P185, DOI 10.1007/s00232-003-0637-8; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xie LH, 2007, PROG BIOPHYS MOL BIO, V94, P320, DOI 10.1016/j.pbiomolbio.2006.04.001; Xie LH, 2005, J GEN PHYSIOL, V126, P541, DOI 10.1085/jgp.200509380; Yang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006135; Zhang D, 2005, J ANDROL, V26, P643, DOI 10.2164/jandrol.05009; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang X, 2006, J GEN PHYSIOL, V128, P317, DOI 10.1085/jgp.200609552; Zhang X, 2006, J GEN PHYSIOL, V128, P301, DOI 10.1085/jgp.200609551	54	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19259	19266		10.1074/jbc.M109.100156	http://dx.doi.org/10.1074/jbc.M109.100156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392696	Green Published, hybrid			2022-12-25	WOS:000278727800035
J	Liu, Y; Karaca, M; Zhang, Z; Gioeli, D; Earp, HS; Whang, YE				Liu, Y.; Karaca, M.; Zhang, Z.; Gioeli, D.; Earp, H. S.; Whang, Y. E.			Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases	ONCOGENE			English	Article						androgen receptor; phosphorylation; Ack1 kinase; dasatinib; prostate cancer	RECURRENT PROSTATE-CANCER; ACTIVATION; RESISTANT; GROWTH; INTERLEUKIN-6; INDEPENDENCE; PROGRESSION; EXPRESSION; PATHWAY	Activation of androgen receptor (AR) may have a role in the development of castration-resistant prostate cancer. Two intracellular tyrosine kinases, Ack1 (activated cdc42-associated kinase) and Src, phosphorylate and enhance AR activity and promote prostate xenograft tumor growth in castrated animals. However, the upstream signals that activate these kinases and lead to AR activation are incompletely characterized. In this study, we investigated AR phosphorylation in response to non-androgen ligand stimulation using phospho-specific antibodies. Treatment of LNCaP and LAPC-4 cells with epidermal growth factor (EGF), heregulin, Gas6 (ligand binding to the Mer receptor tyrosine kinase and activating Ack1 downstream), interleukin (IL)-6 or bombesin stimulated cell proliferation in the absence of androgen. Treatment of LNCaP and LAPC-4 cells with EGF, heregulin or Gas6 induced AR phosphorylation at Tyr-267, whereas IL-6 or bombesin treatment did not. AR phosphorylation at Tyr-534 was induced by treatment with EGF, IL-6 or bombesin, but not by heregulin or Gas6. Small interfering RNA-mediated knockdown of Ack1 or Src showed that Ack1 mediates heregulin- and Gas6-induced AR Tyr-267 phosphorylation, whereas Src mediates Tyr-534 phosphorylation induced by EGF, IL-6 and bombesin. Dasatinib, a Src inhibitor, blocked EGF-induced Tyr-534 phosphorylation. In addition, we showed that dasatinib also inhibited Ack1 kinase. Dasatinib inhibited heregulin-induced Ack1 kinase activity and AR Tyr-267 phosphorylation. In addition, dasatinib inhibited heregulin-induced AR-dependent reporter activity. Dasatinib also inhibited heregulin-induced expression of endogenous AR target genes. Dasatinib inhibited Ack1-dependent colony formation and prostate xenograft tumor growth in castrated mice. Interestingly, Ack1 or Src knockdown or dasatinib did not inhibit EGF-induced AR Tyr-267 phosphorylation or EGF-stimulated AR activity, suggesting the existence of an additional tyrosine kinase that phosphorylates AR at Tyr-267. These data suggest that specific tyrosine kinases phosphorylate AR at distinct sites and that dasatinib may exert antitumor activity in prostate cancer through inhibition of Ack1. Oncogene (2010) 29, 3208-3216; doi: 10.1038/onc.2010.103; published online 12 April 2010	[Liu, Y.; Zhang, Z.; Earp, H. S.; Whang, Y. E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Karaca, M.; Whang, Y. E.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Gioeli, D.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Earp, H. S.; Whang, Y. E.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Earp, H. S.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Whang, YE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Campus Box 7295, Chapel Hill, NC 27599 USA.	ywhang@med.unc.edu	, Animal Studies Core/AAF-4432-2022; , Animal Studies Core/ADK-4234-2022; Whang, Young/AAK-7435-2021	Whang, Young/0000-0002-1621-6661	NIH [R01CA120921, R01CA120304, T32ES007017]; NATIONAL CANCER INSTITUTE [R01CA120921, R01CA120304, R01CA124706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Francis Lee of Bristol-Myers-Squibb for providing dasatinib, Charlene Ross and staff of the UNC Lineberger Animal Studies Facility for assistance in xenograft tumor experiments, Dominic Moore for statistical analysis and Nupam Mahajan for discussions and sharing unpublished papers. This study was supported by grants from NIH R01CA120921 (YEW), NIH R01CA120304 (HSE) and NIH T32ES007017 (MK).	Araujo J, 2009, J CLIN ONCOL, V27; Araujo J, 2009, INT J CANCER, V124, P1, DOI 10.1002/ijc.23998; Brave M, 2008, CLIN CANCER RES, V14, P352, DOI 10.1158/1078-0432.CCR-07-4175; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; Desai SJ, 2006, CANCER RES, V66, P10449, DOI 10.1158/0008-5472.CAN-06-2582; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gong J, 2006, ONCOGENE, V25, P2011, DOI 10.1038/sj.onc.1209231; Gregory CW, 2005, CLIN CANCER RES, V11, P1704, DOI 10.1158/1078-0432.CCR-04-1158; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Liu YB, 2005, CANCER RES, V65, P3404, DOI 10.1158/0008-5472.CAN-04-4292; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Pao-Chun L, 2009, J BIOL CHEM, V284, P34954, DOI 10.1074/jbc.M109.072660; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Wang Y, 2007, CURR CANCER DRUG TAR, V7, P591, DOI 10.2174/156800907781662248; Yang JC, 2009, CANCER RES, V69, P151, DOI 10.1158/0008-5472.CAN-08-0442; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	35	70	77	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 3	2010	29	22					3208	3216		10.1038/onc.2010.103	http://dx.doi.org/10.1038/onc.2010.103			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20383201	Green Accepted, Green Submitted			2022-12-25	WOS:000278321100004
J	Morita, YS; Yamaryo-Botte, Y; Miyanagi, K; Callaghan, JM; Patterson, JH; Crellin, PK; Coppel, RL; Billman-Jacobe, H; Kinoshita, T; McConville, MJ				Morita, Yasu S.; Yamaryo-Botte, Yoshiki; Miyanagi, Kana; Callaghan, Judy M.; Patterson, John H.; Crellin, Paul K.; Coppel, Ross L.; Billman-Jacobe, Helen; Kinoshita, Taroh; McConville, Malcolm J.			Stress-induced Synthesis of Phosphatidylinositol 3-Phosphate in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; BIOSYNTHESIS; PHOSPHOLIPIDS; GROWTH; TUBERCULOSIS; 4-PHOSPHATE; METABOLISM; 3-KINASES; KINASE; LIPIDS	Phosphoinositides play key roles in regulating membrane dynamics and intracellular signaling in eukaryotic cells. However, comparable lipid-based signaling pathways have not been identified in bacteria. Here we show that Mycobacterium smegmatis and other Actinomycetes bacteria can synthesize the phosphoinositide, phosphatidylinositol 3-phosphate (PI3P). This lipid was transiently labeled with [H-3]inositol. Sensitivity of the purified lipid to alkaline phosphatase, headgroup analysis by high-pressure liquid chromatography, and mass spectrometry demonstrated that it had the structure 1,2-[tuberculostearoyl, octadecenoyl]-sn-glycero 3-phosphoinositol 3-phosphate. Synthesis of PI3P was elevated by salt stress but not by exposure to high concentrations of non-ionic solutes. Synthesis of PI3P in a cell-free system was stimulated by the synthesis of CDP-diacylglycerol, a lipid substrate for phosphatidylinositol (PI) biosynthesis, suggesting that efficient cell-free PI3P synthesis is dependent on de novo PI synthesis. In vitro experiments further indicated that the rapid turnover of this lipid was mediated, at least in part, by a vanadate-sensitive phosphatase. This is the first example of de novo synthesis of PI3P in bacteria, and the transient synthesis in response to environmental stimuli suggests that some bacteria may have evolved similar lipid-mediated signaling pathways to those observed in eukaryotic cells.	[McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Billman-Jacobe, Helen] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Yamaryo-Botte, Yoshiki; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Yamaryo-Botte, Yoshiki; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Victorian Bioinformat Consortium, Dept Microbiol, Clayton, Vic 3800, Australia; [Miyanagi, Kana; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Miyanagi, Kana; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	University of Melbourne; University of Melbourne; Monash University; Monash University; Osaka University; Osaka University	Morita, YS (corresponding author), Osaka Univ, Dept Immunoregulat, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ymorita@biken.osaka-u.ac.jp	Coppel, Ross L/A-6626-2008; Kinoshita, Taroh/C-7353-2009	Coppel, Ross L/0000-0002-4476-9124; Morita, Yasu/0000-0002-4514-9242; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411; Crellin, Paul K/0000-0002-2017-4935; Billman-Jacobe, Helen/0000-0001-5713-4657	International Human Frontier Science Program; JSPS [KAKENHI 20590441]; National Health and Medical Research Council; Ministry of Education, Culture, Sports, Science, and Technology, Japan	International Human Frontier Science Program(Human Frontier Science Program); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the International Human Frontier Science Program and JSPS (Grant KAKENHI 20590441). To whom correspondence may be addressed: Dept. of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-8329; Fax: 81-6-6875-5233; E-mail: ymorita@biken.osaka-u.ac.jp.; Supported by a National Health and Medical Research Council project grant.; Supported by the Knowledge Cluster Initiative of Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; BREARLEY CA, 1997, SIGNALLING INOSITIDE, P1; BRENNAN P, 1968, BIOCHEM BIOPH RES CO, V30, P69, DOI 10.1016/0006-291X(68)90714-6; BRENNAN PJ, 1971, LIPIDS, V6, P401, DOI 10.1007/BF02531377; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cameroni E, 2006, J BIOL CHEM, V281, P38139, DOI 10.1074/jbc.M601060200; Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x; DOVE SK, 1999, SIGNAL TRANSDUCTION, P255; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falasca Marco, 2006, Archives of Physiology and Biochemistry, V112, P274, DOI 10.1080/13813450601094664; FINNERTY WR, 1979, ANN INTERN MED, V90, P631, DOI 10.7326/0003-4819-90-4-631; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; KATAOKA T, 1967, BIOCHIM BIOPHYS ACTA, V144, P681, DOI 10.1016/0005-2760(67)90058-6; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lemke LE, 1999, CANCER CHEMOTH PHARM, V44, P491, DOI 10.1007/s002800051123; LENNARZ WJ, 1962, J BIOL CHEM, V237, P664; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lymn JS, 2003, FEBS LETT, V555, P591, DOI 10.1016/S0014-5793(03)01350-4; Milne SB, 2005, J LIPID RES, V46, P1796, DOI 10.1194/jlr.D500010-JLR200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Ralton JE, 1998, J BIOL CHEM, V273, P4245, DOI 10.1074/jbc.273.7.4245; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; SAHA AK, 1989, J BACTERIOL, V171, P5103, DOI 10.1128/jb.171.9.5103-5110.1989; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spielman MA, 1934, J BIOL CHEM, V106, P87; TABAUD H, 1971, BIOCHIMIE, V53, P55, DOI 10.1016/S0300-9084(71)80083-4; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; YANO I, 1969, J BACTERIOL, V98, P124, DOI 10.1128/JB.98.1.124-130.1969	38	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16643	16650		10.1074/jbc.M110.119263	http://dx.doi.org/10.1074/jbc.M110.119263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20364020	hybrid, Green Published			2022-12-25	WOS:000277982600028
J	Diancourt, L; Passet, V; Nemec, A; Dijkshoorn, L; Brisse, S				Diancourt, Laure; Passet, Virginie; Nemec, Alexandr; Dijkshoorn, Lenie; Brisse, Sylvain			The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool	PLOS ONE			English	Article							UNITED-STATES HOSPITALS; MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANCE; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; CLINICAL STRAINS; SP-NOV; IDENTIFICATION; WIDESPREAD; DIVERSITY	Outbreaks of hospital infections caused by multidrug resistant Acinetobacter baumannii strains are of increasing concern worldwide. Although it has been reported that particular outbreak strains are geographically widespread, little is known about the diversity and phylogenetic relatedness of A. baumannii clonal groups. Sequencing of internal portions of seven housekeeping genes (total 2,976 nt) was performed in 154 A. baumannii strains covering the breadth of known diversity and including representatives of previously recognized international clones, and in 19 representatives of other Acinetobacter species. Restricted amounts of diversity and a star-like phylogeny reveal that A. baumannii is a genetically compact species that suffered a severe bottleneck in the recent past, possibly linked to a restricted ecological niche. A. baumannii is neatly demarcated from its closest relative (genomic species 13TU) and other Acinetobacter species. Multilocus sequence typing analysis demonstrated that the previously recognized international clones I to III correspond to three clonal complexes, each made of a central, predominant genotype and few single locus variants, a hallmark of recent clonal expansion. Whereas antimicrobial resistance was almost universal among isolates of these and a novel international clone (ST15), isolates of the other genotypes were mostly susceptible. This dichotomy indicates that antimicrobial resistance is a major selective advantage that drives the ongoing rapid clonal expansion of these highly problematic agents of nosocomial infections.	[Diancourt, Laure; Passet, Virginie; Brisse, Sylvain] Inst Pasteur Genotyping Pathogens & Publ Hlth, Paris, France; [Nemec, Alexandr] Natl Inst Publ Hlth, Lab Bacterial Genet, Prague, Czech Republic; [Dijkshoorn, Lenie] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institute of Public Health (SZU) - Czech Republic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Diancourt, L (corresponding author), Inst Pasteur Genotyping Pathogens & Publ Hlth, Paris, France.	sylvain.brisse@pasteur.fr	Nemec, Alexandr/C-4447-2008; Brisse, Sylvain/M-8723-2013	Nemec, Alexandr/0000-0003-0608-9598; Brisse, Sylvain/0000-0002-2516-2108	Institut Pasteur; Institut de Veille Sanitaire; Conny-Maeva Charitable Foundation; Grant Agency of the Czech Republic [310/08/1747]	Institut Pasteur(European Commission); Institut de Veille Sanitaire; Conny-Maeva Charitable Foundation; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	Platform Genotyping of Pathogens and Public Health is supported by Institut Pasteur and the Institut de Veille Sanitaire; this work received, in addition, financial support from a generous gift by the Conny-Maeva Charitable Foundation. AN was supported by grant 310/08/1747 of the Grant Agency of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Berlau J, 1999, J HOSP INFECT, V42, P201, DOI 10.1053/jhin.1999.0602; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; BOUVET PJM, 1987, ANN INST PASTEUR MIC, V138, P569, DOI 10.1016/0769-2609(87)90042-1; Brisse S, 2000, J CLIN MICROBIOL, V38, P3636, DOI 10.1128/JCM.38.10.3636-3645.2000; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Da Silva G, 2007, CLIN MICROBIOL INFEC, V13, P190, DOI 10.1111/j.1469-0691.2006.01628.x; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; DIJKSHOORN L, 1993, J CLIN MICROBIOL, V31, P702, DOI 10.1128/JCM.31.3.702-705.1993; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dijkshoorn Lenie, 2008, P1; Ecker JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hoffmann MS, 2010, INFECT CONT HOSP EP, V31, P196, DOI 10.1086/650379; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Janssen P, 1997, INT J SYST BACTERIOL, V47, P1179, DOI 10.1099/00207713-47-4-1179; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Nemec A, 1999, J MED MICROBIOL, V48, P287, DOI 10.1099/00222615-48-3-287; Nemec A, 2004, J MED MICROBIOL, V53, P1233, DOI 10.1099/jmm.0.45716-0; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Nemec A, 2007, J ANTIMICROB CHEMOTH, V60, P483, DOI 10.1093/jac/dkm231; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; ORSKOV F, 1983, J INFECT DIS, V148, P346, DOI 10.1093/infdis/148.2.346; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Post V, 2009, ANTIMICROB AGENTS CH, V53, P2667, DOI 10.1128/AAC.01407-08; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salerno A, 2007, J BACTERIOL, V189, P7808, DOI 10.1128/JB.00796-07; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; SEIFERT H, 1994, J CLIN MICROBIOL, V32, P82, DOI 10.1128/JCM.32.1.82-86.1994; SELTMANN G, 1995, ZBL BAKT-INT J MED M, V282, P372; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Spence RP, 2004, J CLIN MICROBIOL, V42, P832, DOI 10.1128/JCM.42.2.832-834.2004; Spratt Brian G, 2004, Methods Mol Biol, V266, P323; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TJERNBERG I, 1989, APMIS, V97, P595, DOI 10.1111/j.1699-0463.1989.tb00449.x; Turton JF, 2009, EUR J CLIN MICROBIOL, V28, P499, DOI 10.1007/s10096-008-0659-3; Turton JF, 2006, J CLIN MICROBIOL, V44, P2630, DOI 10.1128/JCM.00547-06; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; Van Dessel H, 2002, J HOSP INFECT, V51, P89, DOI 10.1053/jhin.2002.1212; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; VANEECHOUTTE M, 1995, J CLIN MICROBIOL, V33, P11; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wisplinghoff H, 2008, CLIN MICROBIOL INFEC, V14, P708, DOI 10.1111/j.1469-0691.2008.02010.x; Wisplinghoff H, 2007, J HOSP INFECT, V66, P174, DOI 10.1016/j.jhin.2007.02.016; Wisplinghoff H, 2000, CLIN INFECT DIS, V31, P690, DOI 10.1086/314040; Wroblewska MM, 2008, FEMS IMMUNOL MED MIC, V53, P140, DOI 10.1111/j.1574-695X.2008.00403.x	73	469	478	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10034	10.1371/journal.pone.0010034	http://dx.doi.org/10.1371/journal.pone.0010034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383326	Green Submitted, Green Published, gold			2022-12-25	WOS:000276454000008
J	Dalkic, E; Wang, XW; Wright, N; Chan, C				Dalkic, Ertugrul; Wang, Xuewei; Wright, Neil; Chan, Christina			Cancer-Drug Associations: A Complex System	PLOS ONE			English	Article							FDA APPROVED DRUGS; NETWORK; TARGETS	Background: Network analysis has been performed on large-scale medical data, capturing the global topology of drugs, targets, and disease relationships. A smaller-scale network is amenable to a more detailed and focused analysis of the individual members and their interactions in a network, which can complement the global topological descriptions of a network system. Analysis of these smaller networks can help address questions, i.e., what governs the pairing of the different cancers and drugs, is it driven by molecular findings or other factors, such as death statistics. Methodology/Principal Findings: We defined global and local lethality values representing death rates relative to other cancers vs. within a cancer. We generated two cancer networks, one of cancer types that share Food and Drug Administration (FDA) approved drugs (FDA cancer network), and another of cancer types that share clinical trials of FDA approved drugs (clinical trial cancer network). Breast cancer is the only cancer type with significant weighted degree values in both cancer networks. Lung cancer is significantly connected in the FDA cancer network, whereas ovarian cancer and lymphoma are significantly connected in the clinical trial cancer network. Correlation and linear regression analyses showed that global lethality impacts the drug approval and trial numbers, whereas, local lethality impacts the amount of drug sharing in trials and approvals. However, this effect does not apply to pancreatic, liver, and esophagus cancers as the sharing of drugs for these cancers is very low. We also collected mutation target information to generate cancer type associations which were compared with the cancer type associations derived from the drug target information. The analysis showed a weak overlap between the mutation and drug target based networks. Conclusions/Significance: The clinical and FDA cancer networks are differentially connected, with only breast cancer significantly connected in both networks. The networks of cancer-drug associations are moderately affected by the death statistics. A strong overlap does not exist between the cancer-drug associations and the molecular information. Overall, this analysis provides a systems level view of cancer drugs and suggests that death statistics (i.e. global vs. local lethality) have a differential impact on the number of approvals, trials and drug sharing.	[Dalkic, Ertugrul; Wang, Xuewei; Wright, Neil; Chan, Christina] Michigan State Univ, Ctr Syst Biol, E Lansing, MI 48824 USA; [Dalkic, Ertugrul; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, Cellular & Mol Biol Lab, E Lansing, MI 48824 USA; [Dalkic, Ertugrul; Chan, Christina] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Wang, Xuewei; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Wright, Neil] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Dalkic, E (corresponding author), Michigan State Univ, Ctr Syst Biol, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Wright, Neil/AAB-7092-2019; wang, xuewei/C-7773-2009	Wang, Xuewei/0000-0003-3679-7421	National Institutes of Health [R01GM079688-01, R21CA126136-01, R21RR024439, P42 ES004911]; Michigan Universities Commercialization Initiative (MUCI); Michigan State University Foundation; Center for Systems Biology; Michigan State University Quantitative Biology and Modeling Initiative Fellowship; NATIONAL CANCER INSTITUTE [R21CA126136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Universities Commercialization Initiative (MUCI); Michigan State University Foundation; Center for Systems Biology; Michigan State University Quantitative Biology and Modeling Initiative Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by the National Institutes of Health (R01GM079688-01, R21CA126136-01, R21RR024439, P42 ES004911), Michigan Universities Commercialization Initiative (MUCI) and the Michigan State University Foundation and the Center for Systems Biology. E. D. is supported in part by Michigan State University Quantitative Biology and Modeling Initiative Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2001, AM CANC SOC 2001 200; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Sakharkar MK, 2008, INT J BIOL SCI, V4, P15; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; TESTA JR, 1992, CANCER RES, V52, pS2702; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; YOKOTA J, 1986, LANCET, V1, P765	15	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10031	10.1371/journal.pone.0010031	http://dx.doi.org/10.1371/journal.pone.0010031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368808	Green Published, Green Submitted, gold			2022-12-25	WOS:000276419900022
J	Zhou, XX; Han, PW; Li, JM; Zhang, X; Huang, B; Ruan, HQ; Chen, C				Zhou, Xixi; Han, Peiwei; Li, Jiangmei; Zhang, Xu; Huang, Bo; Ruan, Hong-Qiang; Chen, Chang			ESNOQ, Proteomic Quantification of Endogenous S-Nitrosation	PLOS ONE			English	Article							NITROSYLATED PROTEINS; MASS-SPECTROMETRY; CELL-CULTURE; NITRIC-OXIDE; AMINO-ACIDS; SILAC; IDENTIFICATION; SITES	S-nitrosation is a post-translational protein modification and is one of the most important mechanisms of NO signaling. Endogenous S-nitrosothiol (SNO) quantification is a challenge for detailed functional studies. Here we developed an ESNOQ (Endogenous SNO Quantification) method which combines the stable isotope labeling by amino acids in cell culture (SILAC) technique with the detergent-free biotin-switch assay and LC-MS/MS. After confirming the accuracy of quantification in this method, we obtained an endogenous S-nitrosation proteome for LPS/IFN-gamma induced RAW264.7 cells. 27 S-nitrosated protein targets were confirmed and using our method we were able to obtain quantitative information on the level of S-nitrosation on each modified Cys. With this quantitative information, over 15 more S-nitrosated targets were identified than in previous studies. Based on the quantification results, we found that the S-nitrosation levels of different cysteines varied within one protein, providing direct evidence for differences in the sensitivity of cysteine residues to reactive nitrosative stress and that S-nitrosation is a site-specific modification. Gene ontology clustering shows that S-nitrosation targets in the LPS/IFN-gamma induced RAW264.7 cell model were functionally enriched in protein translation and glycolysis, suggesting that S-nitrosation may function by regulating multiple pathways. The ESNOQ method described here thus provides a solution for quantification of multiple endogenous S-nitrosation events, and makes it possible to elucidate the network of relationships between endogenous S-nitrosation targets involved in different cellular processes.	[Zhou, Xixi; Han, Peiwei; Li, Jiangmei; Zhang, Xu; Huang, Bo; Chen, Chang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Ruan, Hong-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, XX (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	changchen@moon.ibp.ac.cn	Zhou, Xixi/F-1760-2011; HUANG, Bo/ABG-2966-2021; huang, bo/B-4649-2008; Zhou, Xixi/F-6474-2013	Zhou, Xixi/0000-0003-4202-8821; huang, bo/0000-0001-5945-7601; chen, chang/0000-0003-1008-1062; , Xu/0000-0002-8103-8486	National Basic Research Program of China [2006CB911001, 2005CB522804]; National Natural Science Foundation of China [30270352, 30770512]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (2006CB911001, 2005CB522804), and the National Natural Science Foundation of China (30270352 and 30770512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gao CJ, 2005, NITRIC OXIDE-BIOL CH, V12, P121, DOI 10.1016/j.niox.2004.11.006; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Han P, 2008, RAPID COMMUN MASS SP, V22, P1137, DOI 10.1002/rcm.3476; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Sandau K, 1996, CELL SIGNAL, V8, P173, DOI 10.1016/0898-6568(95)02051-9; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; THOMPSON J, 1973, J EXP MED, V137, P10, DOI 10.1084/jem.137.1.10; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016	23	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10015	10.1371/journal.pone.0010015	http://dx.doi.org/10.1371/journal.pone.0010015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368813	Green Published, Green Submitted, gold			2022-12-25	WOS:000276419900015
J	Nishida, H; Motoyama, T; Suzuki, Y; Yamamoto, S; Aburatani, H; Osada, H				Nishida, Hiromi; Motoyama, Takayuki; Suzuki, Yutaka; Yamamoto, Shogo; Aburatani, Hiroyuki; Osada, Hiroyuki			Genome-Wide Maps of Mononucleosomes and Dinucleosomes Containing Hyperacetylated Histones of Aspergillus fumigatus	PLOS ONE			English	Article							HIGH-RESOLUTION; CHROMATIN-STRUCTURE; NUCLEOSOME; YEAST; TRANSCRIPTION; DEACETYLASES; NIDULANS; CODE	It is suggested that histone modifications and/or histone variants influence the nucleosomal DNA length. We sequenced both ends of mononucleosomal and dinucleosomal DNA fragments of the filamentous fungus Aspergillus fumigatus, after treatment with the histone deacetylase inhibitor trichostatin A (TSA). After mapping the DNA fragments to the genome, we identified >7 million mononucleosome positions and >7 million dinucleosome positions. We showed that the distributions of the lengths of the mononucleosomal DNA fragments after 15-min and 30-min treatments with micrococcal nuclease (MNase) showed a single peak at 168 nt and 160 nt, respectively. The distributions of the lengths of the dinucleosomal DNA fragments after 15-min-and 30-min-treatment with MNase showed a single peak at 321 nt and 306 nt, respectively. The nucleosomal DNA fragments obtained from the TSA-treated cells were significantly longer than those obtained from the untreated cells. On the other hand, most of the genes did not undergo any change after treatment. Between the TSA-treated and untreated cells, only 77 genes had >= 2-fold change in expression levels. In addition, our results showed that the locations where mononucleosomes were frequently detected were conserved between the TSA-treated cells and untreated cells in the gene promoters (lower density of the nucleosomes). However, these locations were less conserved in the bodies (higher density of the nucleosomes) of genes with >= 2-fold changes. Our findings indicate that TSA influences the nucleosome positions, especially of the regions with high density of the nucleosomes by elongation of the nucleosomal DNA. However, most of the nucleosome positions are conserved in the gene promoters, even after treatment with TSA, because of the low density of nucleosomes in the gene promoters.	[Nishida, Hiromi] Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan; [Motoyama, Takayuki; Osada, Hiroyuki] RIKEN, Chem Biol Core Facil, Adv Sci Inst, Wako, Saitama, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Yamamoto, Shogo; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	University of Tokyo; RIKEN; University of Tokyo; University of Tokyo	Nishida, H (corresponding author), Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan.	hnishida@iu.a.u-tokyo.ac.jp	Motoyama, Takayuki/D-2646-2017; Osada, Hiroyuki/AAY-6254-2020; Osada, Hiroyuki/N-4305-2014; Nishida, Hiromi/B-1635-2008		Institute for Fermentation, Osaka, Japan; Ministry of Education, Culture, Sports, Science and Technology [20221009]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research grant from the Institute for Fermentation, Osaka, Japan to HN, Grants-in-Aid for Scientific Research (S) 20221009 from the Ministry of Education, Culture, Sports, Science and Technology to HA, and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Gonzalez R, 1997, NUCLEIC ACIDS RES, V25, P3955, DOI 10.1093/nar/25.19.3955; Graessle S, 2000, BBA-GENE STRUCT EXPR, V1492, P120, DOI 10.1016/S0167-4781(00)00093-2; IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Nishida H., 2009, OPEN ACCESS BIOINFOR, V1, P1; Nishida H, 2009, BIOINFORMATICS, V25, P2295, DOI 10.1093/bioinformatics/btp413; Nishida H, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/379317; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Song JS, 2008, GENOME RES, V18, P1064, DOI 10.1101/gr.075374.107; Suzuki Yutaka, 2003, Methods Mol Biol, V221, P73; Tribus M, 2010, MOL BIOL CELL, V21, P345, DOI 10.1091/mbc.E09-08-0750; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	29	9	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9916	10.1371/journal.pone.0009916	http://dx.doi.org/10.1371/journal.pone.0009916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361043	Green Published, gold, Green Submitted			2022-12-25	WOS:000275969600017
J	Mroz, P; Huang, YY; Szokalska, A; Zhiyentayev, T; Janjua, S; Nifli, AP; Sherwood, ME; Ruzie, C; Borbas, KE; Fan, DZ; Krayer, M; Balasubramanian, T; Yang, E; Kee, HL; Kirmaier, C; Diers, JR; Bocian, DF; Holten, D; Lindsey, JS; Hamblin, MR				Mroz, Pawel; Huang, Ying-Ying; Szokalska, Angelika; Zhiyentayev, Timur; Janjua, Sahar; Nifli, Artemissia-Phoebe; Sherwood, Margaret E.; Ruzie, Christian; Borbas, K. Eszter; Fan, Dazhong; Krayer, Michael; Balasubramanian, Thiagarajan; Yang, Eunkyung; Kee, Hooi Ling; Kirmaier, Christine; Diers, James R.; Bocian, David F.; Holten, Dewey; Lindsey, Jonathan S.; Hamblin, Michael R.			Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy	FASEB JOURNAL			English	Article						multidrug resistance; melanosomes; electron microscopy	OVARIAN-CARCINOMA CELLS; MALIGNANT-MELANOMA; ANTITUMOR IMMUNITY; MELANOGENESIS; PHOTOSENSITIZERS; CANCER; OXYGEN; CYCLOPHOSPHAMIDE; SUBSTITUENTS; MELANOCYTES	Cutaneous malignant melanoma remains a therapeutic challenge, and patients with advanced disease have limited survival. Photodynamic therapy (PDT) has been successfully used to treat many malignancies, and it may show promise as an antimelanoma modality. However, high melanin levels in melanomas can adversely affect PDT effectiveness. Herein the extent of melanin contribution to melanoma resistance to PDT was investigated in a set of melanoma cell lines that markedly differ in the levels of pigmentation; 3 new bacteriochlorins successfully overcame the resistance. Cell killing studies determined that bacteriochlorins are superior at (LD50 approximate to 0.1 mu M) when compared with controls such as the FDA-approved Photofrin (LD50 approximate to 10 mu M) and clinically tested LuTex (LD50 approximate to 1 mu M). The melanin content affects PDT effectiveness, but the degree of reduction is significantly lower for bacteriochlorins than for Photofrin. Microscopy reveals that the least effective bacteriochlorin localizes predominantly in lysosomes, while the most effective one preferentially accumulates in mitochondria. Interestingly all bacteriochlorins accumulate in melanosomes, and subsequent illumination leads to melanosomal damage shown by electron microscopy. Fluorescent probes show that the most effective bacteriochlorin produces significantly higher levels of hydroxyl radicals, and this is consistent with the redox properties suggested by molecular-orbital calculations. The best in vitro performing bacteriochlorin was tested in vivo in a mouse melanoma model using spectrally resolved fluorescence imaging and provided significant survival advantage with 20% of cures (P<0.01).-Mroz, P., Huang, Y.-Y., Szokalska, A., Zhiyentayev, T., Janjua, S., Nifli, A.-P., Sherwood, M. E., Ruzie, C., Borbas, K. E., Fan, D., Krayer, M., Balasubramanian, T., Yang, E., Kee, H. L., Kirmaier, C., Diers, J. R., Bocian, D. F., Holten, D., Lindsey, J. S., Hamblin, M. R. Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy. FASEB J. 24, 3160-3170 (2010). www.fasebj.org	[Mroz, Pawel; Huang, Ying-Ying; Szokalska, Angelika; Zhiyentayev, Timur; Janjua, Sahar; Nifli, Artemissia-Phoebe; Sherwood, Margaret E.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Mroz, Pawel; Huang, Ying-Ying; Nifli, Artemissia-Phoebe; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Nanning, Peoples R China; [Szokalska, Angelika] Med Univ Warsaw, Dept Immunol, Ctr Biostruct, Warsaw, Poland; [Zhiyentayev, Timur] MIT, Dept Chem, Cambridge, MA 02139 USA; [Janjua, Sahar] Aga Khan Med Coll, Karachi, Pakistan; [Ruzie, Christian; Borbas, K. Eszter; Fan, Dazhong; Krayer, Michael; Lindsey, Jonathan S.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; [Balasubramanian, Thiagarajan] NIRvana Pharmaceut Inc, Raleigh, NC USA; [Yang, Eunkyung; Kee, Hooi Ling; Kirmaier, Christine; Holten, Dewey] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Diers, James R.; Bocian, David F.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Guangxi Medical University; Medical University of Warsaw; Massachusetts Institute of Technology (MIT); University of North Carolina; North Carolina State University; Washington University (WUSTL); University of California System; University of California Riverside; Harvard University; Massachusetts Institute of Technology (MIT)	Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, 40 Blossom St, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Mroz, Pawel/P-1258-2019; Muchowicz, Angelika/J-7494-2012; Huang, yingying/J-7329-2012; Lindsey, Jonathan S/J-7761-2012; Nifli, Artemissia-Phoebe/H-6171-2019; Hamblin, Mike/AAB-2511-2022; Huang, Ying-ying/G-3153-2011	Hamblin, Michael R/0000-0001-6431-4605; Muchowicz, Angelika/0000-0003-4707-1722; Huang, yingying/0000-0002-4038-0277; Nifli, Artemissia-Phoebe/0000-0002-8829-7894; Huang, Ying-ying/0000-0003-3066-6981; Krayer, Michael/0000-0002-1945-1181; Mroz, Pawel/0000-0003-3838-4743	NIH [R01GM36238, R01AI050875]; Burroughs-Wellcome fellowship; Jimmy V. NCSU Cancer Therapeutics Training Program; National Institute of Allergy and Infectious Diseases [R41AI072854]; Genzyme-Partners Translational Research; Foundation for Polish Science; International Union against Cancer; European Structural Fund; Division of Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-05ER15660, DE-FG02-05ER15661]; NATIONAL CANCER INSTITUTE [R01CA083882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI072854, R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome fellowship(Burroughs Wellcome Fund); Jimmy V. NCSU Cancer Therapeutics Training Program; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Genzyme-Partners Translational Research; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); International Union against Cancer; European Structural Fund; Division of Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (R01GM36238 to J.S.L. and R01AI050875 to M. R. H.), a Burroughs-Wellcome fellowship (to M. K.), and the Jimmy V. NCSU Cancer Therapeutics Training Program. P. M. and T. B. were supported by a grant (R41AI072854) from the National Institute of Allergy and Infectious Diseases to NIRvana Pharmaceuticals. P. M. was partly supported by Genzyme-Partners Translational Research Grant. A. S. was supported by the Foundation for Polish Science, the International Union against Cancer, and the European Structural Fund: Mazowieckie Stypendium Doktoranckie. Characterization of the photophysical and redox properties of the bacteriochlorins described herein was initially motivated by solar-energy studies and supported by grants from the Division of Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences of the U.S. Department of Energy to D. F. B. (DE-FG02-05ER15660) and D. H. (DE-FG02-05ER15661). The authors thank Pharmacyclics (Sunnyvale, CA, USA) for the gift of LuTex and loan of 730-nm laser and QLT (Vancouver, BC, Canada) for the gift of Photofrin.	Ashur I, 2009, J PHYS CHEM A, V113, P8027, DOI 10.1021/jp900580e; Biolo R, 1996, PHOTOCHEM PHOTOBIOL, V63, P224, DOI 10.1111/j.1751-1097.1996.tb03018.x; Borbas KE, 2008, ORG LETT, V10, P1931, DOI 10.1021/ol800436u; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Busetti A, 1999, BRIT J CANCER, V79, P821, DOI 10.1038/sj.bjc.6690131; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Chang SK, 2008, CLIN CANCER RES, V14, P4146, DOI 10.1158/1078-0432.CCR-07-4536; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Dellian M, 1996, INT J CANCER, V65, P246; Fan DZ, 2007, J ORG CHEM, V72, P5350, DOI 10.1021/jo070785s; GRADYUSHKO AT, 1970, PHOTOCHEM PHOTOBIOL, V11, P387, DOI 10.1111/j.1751-1097.1970.tb06011.x; HOLTEN D, 1976, PHOTOCHEM PHOTOBIOL, V23, P415, DOI 10.1111/j.1751-1097.1976.tb07275.x; Hong L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1475, DOI 10.1562/2006-03-14-RA-846; Kee HL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1125, DOI 10.1111/j.1751-1097.2007.00151.x; Kee HL, 2008, J PHOTOCH PHOTOBIO A, V200, P346, DOI 10.1016/j.jphotochem.2008.08.006; Kim HJ, 2005, J ORG CHEM, V70, P5475, DOI 10.1021/jo050467y; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Lapouge K, 1999, BIOCHEMISTRY-US, V38, P11115, DOI 10.1021/bi990723z; Liu WG, 2007, CLIN CANCER RES, V13, P2463, DOI 10.1158/1078-0432.CCR-06-1599; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P135, DOI 10.1562/2004-08-03-RA-259.1; Mazor O, 2005, PHOTOCHEM PHOTOBIOL, V81, P342, DOI 10.1562/2004-06-14-RA-199.1; Mennel S, 2007, OPHTHALMOLOGICA, V221, P216, DOI 10.1159/000101922; MROZ P, 2009, P SPIE, V7380; Mroz P, 2009, CANCER LETT, V282, P63, DOI 10.1016/j.canlet.2009.02.054; NAKAYASU M, 1977, J CELL PHYSIOL, V92, P49, DOI 10.1002/jcp.1040920107; *NAT COMPR CANC NE, 2009, NCCN CLIN PRACT GUID; Naylor MF, 2006, BRIT J DERMATOL, V155, P1287, DOI 10.1111/j.1365-2133.2006.07514.x; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; ORLOW SJ, 1993, J INVEST DERMATOL, V100, P55, DOI 10.1111/1523-1747.ep12354138; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Riley PA, 2003, PIGM CELL RES, V16, P548, DOI 10.1034/j.1600-0749.2003.00069.x; Ruzie C, 2008, J ORG CHEM, V73, P5806, DOI 10.1021/jo800736c; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Safaei R, 2005, CLIN CANCER RES, V11, P756; Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shao Y, 2006, PHYS CHEM CHEM PHYS, V8, P3172, DOI 10.1039/b517914a; Sheleg SV, 2004, PHOTODERMATOL PHOTO, V20, P21, DOI 10.1111/j.1600-0781.2004.00078.x; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2001, ARCH PATHOL LAB MED, V125, P1295; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; SOLCA FF, 1993, FEBS LETT, V322, P177, DOI 10.1016/0014-5793(93)81563-F; Su JF, 2008, J NANOSCI NANOTECHNO, V8, P1174, DOI 10.1166/jnn.2008.317; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Szakacs G, 2004, MOL INTERV, V4, P323, DOI 10.1124/mi.4.6.5; Taniguchi M, 2008, NEW J CHEM, V32, P947, DOI 10.1039/b717803d; Trachtenberg J, 2008, BJU INT, V102, P556, DOI 10.1111/j.1464-410X.2008.07753.x; WEBER G, 1957, T FARADAY SOC, V53, P646, DOI 10.1039/tf9575300646; Woodburn KW, 1998, J INVEST DERMATOL, V110, P746, DOI 10.1046/j.1523-1747.1998.00182.x; Yeung P F, 2001, IDrugs, V4, P351	58	78	80	0	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3160	3170		10.1096/fj.09-152587	http://dx.doi.org/10.1096/fj.09-152587			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20385618	Green Published			2022-12-25	WOS:000281446400006
J	Pastorino, S; Renganathan, H; Caliva, MJ; Filbert, EL; Opoku-Ansah, J; Sulzmaier, FJ; Gawecka, JE; Werlen, G; Shaw, AS; Ramos, JW				Pastorino, Sandra; Renganathan, Hemamalini; Caliva, Maisel J.; Filbert, Erin L.; Opoku-Ansah, John; Sulzmaier, Florian J.; Gawecka, Joanna E.; Werlen, Guy; Shaw, Andrey S.; Ramos, Joe W.			The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling	FASEB JOURNAL			English	Article						ERK MAP kinase; IL-2; proliferation; Jurkat T cells	MAP KINASE; ACTIVATION; PROLIFERATION; EXPRESSION; SELECTION; FAMILY; PHOSPHORYLATION; TRANSCRIPTION; SPECIFICITY; ASTROCYTES	PEA-15 is a death effector domain-containing phosphoprotein that binds ERK and restricts it to the cytoplasm. PEA-15 also binds to FADD and thereby blocks apoptosis induced by death receptors. Abnormal expression of PEA-15 is associated with type II diabetes and some cancers; however, its physiological function remains unclear. To determine the function of PEA-15 in vivo, we used C57BL/6 mice in which the PEA-15 coding region was deleted. We thereby found that PEA-15 regulates T-cell proliferation. PEA-15-null mice did not have altered thymic or splenic lymphocyte cellularity or differentiation. However, PEA-15 deficient T cells had increased CD3/CD28-induced nuclear translocation of ERK and increased activation of IL-2 transcription and secretion in comparison to control wild-type littermates. Indeed, activation of the T-cell receptor in wild-type mice caused PEA-15 release of ERK. In contrast, overexpression of PEA-15 in Jurkat T cells blocked nuclear translocation of ERK and IL-2 transcription. Finally, PEA-15-null T cells showed increased IL-2 dependent proliferation on stimulation. No differences in T cell susceptibility to apoptosis were found. Thus, PEA-15 is a novel player in T-cell homeostasis. As such this work may have far reaching implications in understanding how the immune response is controlled.-Pastorino, S., Renganathan, H., Caliva, M. J., Filbert, E. L., Opoku-Ansah, J., Sulzmaier, F. J., Gawecka, J. E., Werlen, G., Shaw, A. S., Ramos, J. W. The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling. FASEB J. 24, 2818-2828 (2010). www.fasebj.org	[Pastorino, Sandra; Renganathan, Hemamalini; Caliva, Maisel J.; Opoku-Ansah, John; Sulzmaier, Florian J.; Gawecka, Joanna E.; Ramos, Joe W.] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Nat Prod & Canc Biol Program, Honolulu, HI 96813 USA; [Filbert, Erin L.; Shaw, Andrey S.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Werlen, Guy] Rutgers State Univ, Canc Inst New Jersey, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; Washington University (WUSTL); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Howard Hughes Medical Institute; Washington University (WUSTL)	Ramos, JW (corresponding author), Univ Hawaii Manoa, Canc Res Ctr Hawaii, Nat Prod & Canc Biol Program, Biosci Bldg,Rm 241C,651 Ilalo St, Honolulu, HI 96813 USA.	jramos@crch.hawaii.edu	Ramos, Joe/G-4074-2010	Ramos, Joe/0000-0002-9708-2115	New Jersey Commission on Cancer Research [08-1089-CCR-EO]; National Cancer Institute of the NIH [CA03849]; NATIONAL CANCER INSTITUTE [R01CA093849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR018727] Funding Source: NIH RePORTER	New Jersey Commission on Cancer Research; National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank Dr. Herve Chneiweiss (Centre Paul Broca, Paris, France) for providing the original PEA-15<SUP>-/-</SUP> mice. The authors thank E. Collier for expert technical assistance and Dr. P. Hoffmann for helpful suggestions. The authors also thank Drs. Y. Shimizu and M. Matter for critically reviewing this manuscript. The authors thank the staff of the University of Hawaii at Manoa Centers of Biomedical Research Excellence (COBRE; P20RR018727) and Research Centers in Minority Institutions (RCMI; G12RR003061), National Center for Resource Resources, NIH flow cytometry core facility for excellent technical assistance. G.W. is supported by the New Jersey Commission on Cancer Research, grant 08-1089-CCR-EO. This work was supported by the National Cancer Institute of the NIH (CA03849 to J.W.R.). S.P. designed and performed experiments, analyzed the data, and wrote the manuscript; H.R., M.J.C., F.J.S., and E.L.F. designed and performed experiments and analyzed the data; J.E.G. and J.O-A. performed experiments; J.W.R., G.W., and A.S.S. designed experiments, analyzed the data and edited the manuscript. The authors declare that they have no competing financial interests.	Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Barnhart BC, 2003, ONCOGENE, V22, P8634, DOI 10.1038/sj.onc.1207103; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Budd RC, 2002, J CLIN INVEST, V109, P437, DOI 10.1172/JC1200215077; Chou FL, 2003, J BIOL CHEM, V278, P52587, DOI 10.1074/jbc.M309322200; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Kitsberg D, 1999, J NEUROSCI, V19, P8244; Krueger J, 2005, MOL BIOL CELL, V16, P3552, DOI 10.1091/mbc.E04-11-1007; Li YQ, 1999, IMMUNOLOGY, V96, P524; Luschen S, 2005, EXP CELL RES, V310, P33, DOI 10.1016/j.yexcr.2005.07.022; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PARK JH, 1993, BLOOD, V82, P2470; Ramos Joe W, 2005, Hawaii Med J, V64, P77; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Wang XQ, 2008, J IMMUNOL, V180, P6703, DOI 10.4049/jimmunol.180.10.6703; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	41	15	15	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2818	2828		10.1096/fj.09-144295	http://dx.doi.org/10.1096/fj.09-144295			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354143	Green Published			2022-12-25	WOS:000285005400022
J	Sako, D; Grinberg, AV; Liu, J; Davies, MV; Castonguay, R; Maniatis, S; Andreucci, AJ; Pobre, EG; Tomkinson, KN; Monnell, TE; Ucran, JA; Martinez-Hackert, E; Pearsall, RS; Underwood, KW; Seehra, J; Kumar, R				Sako, Dianne; Grinberg, Asya V.; Liu, June; Davies, Monique V.; Castonguay, Roselyne; Maniatis, Silas; Andreucci, Amy J.; Pobre, Eileen G.; Tomkinson, Kathleen N.; Monnell, Travis E.; Ucran, Jeffrey A.; Martinez-Hackert, Erik; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra			Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; BETA SUPERFAMILY; MYOSTATIN GENE; GROWTH; MUSCLE; MICE; DIFFERENTIATION; MUTATIONS; FAMILY; CATTLE	The single transmembrane domain serine/threonine kinase activin receptor type IIB (ActRIIB) has been proposed to bind key regulators of skeletal muscle mass development, including the ligands GDF-8 (myostatin) and GDF-11 (BMP-11). Here we provide a detailed kinetic characterization of ActRIIB binding to several low and high affinity ligands using a soluble activin receptor type IIB-Fc chimera (ActRIIB.Fc). We show that both GDF-8 and GDF-11 bind the extracellular domain of ActRIIB with affinities comparable with those of activin A, a known high affinity ActRIIB ligand, whereas BMP-2 and BMP-7 affinities for ActRIIB are at least 100-fold lower. Using site-directed mutagenesis, we demonstrate that ActRIIB binds GDF-11 and activin A in different ways such as, for example, substitutions in ActRIIB Leu(79) effectively abolish ActRIIB binding to activin A yet not to GDF-11. Native ActRIIB has four isoforms that differ in the length of the C-terminal portion of their extracellular domains. We demonstrate that the C terminus of the ActRIIB extracellular domain is crucial for maintaining biological activity of the ActRIIB.Fc receptor chimera. In addition, we show that glycosylation of ActRIIB is not required for binding to activin A or GDF-11. Together, our findings reveal binding specificity and activity determinants of the ActRIIB receptor that combine to effect specificity in the activation of distinct signaling pathways.	[Sako, Dianne; Grinberg, Asya V.; Liu, June; Davies, Monique V.; Castonguay, Roselyne; Andreucci, Amy J.; Pobre, Eileen G.; Tomkinson, Kathleen N.; Monnell, Travis E.; Ucran, Jeffrey A.; Martinez-Hackert, Erik; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra] Acceleron Pharma Inc, Cambridge, MA 02139 USA; [Maniatis, Silas] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Acceleron Pharma; Harvard University	Kumar, R (corresponding author), Acceleron Pharma Inc, 128 Sidney St, Cambridge, MA 02139 USA.	rkumar@acceleronpharma.com		Martinez-Hackert, Erik/0000-0002-6182-7023	Acceleron Pharma	Acceleron Pharma	We thank Tim Ahern, a medical writer supported by Acceleron Pharma, who provided editorial assistance during preparation of the manuscript. We also thank John Knopf and John Quisel for critical review of the manuscript and all members of Acceleron Pharma's Cell Biology and Protein Purification Groups for contributions in support of this work.	ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; del Re E, 2004, J BIOL CHEM, V279, P53126, DOI 10.1074/jbc.M408090200; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Goetschy JF, 1996, EUR J BIOCHEM, V241, P355, DOI 10.1111/j.1432-1033.1996.00355.x; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Greenwald J, 1998, BIOCHEMISTRY-US, V37, P16711, DOI 10.1021/bi981939o; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; HILDEN K, 1994, BLOOD, V83, P2163; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; MATHEWS LS, 1993, RECEPTOR, V3, P173; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Patel SR, 2005, TRENDS MOL MED, V11, P512, DOI 10.1016/j.molmed.2005.09.007; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	41	106	145	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21037	21048		10.1074/jbc.M110.114959	http://dx.doi.org/10.1074/jbc.M110.114959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20385559	Green Published, hybrid			2022-12-25	WOS:000279228600067
J	Petkova, MI; Pujol-Carrion, N; Arroyo, J; Garcia-Cantalejo, J; de la Torre-Ruiz, MA				Ivanova Petkova, Mima; Pujol-Carrion, Nuria; Arroyo, Javier; Garcia-Cantalejo, Jesus; Angeles de la Torre-Ruiz, Maria			Mtl1 Is Required to Activate General Stress Response through Tor1 and Ras2 Inhibition under Conditions of Glucose Starvation and Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; NUCLEAR-LOCALIZATION; BUDDING YEAST; GLYCOGEN ACCUMULATION; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; GROWTH CONTROL; CYCLIC-AMP	Mtl1 is a member of the cell wall integrity (CWI) pathway of Saccharomyces cerevisiae, which functions as a cell wall sensor for oxidative stress. Genome-wide transcriptional analysis revealed a cluster of genes that were down-regulated in the absence of Mtl1. Many of these genes were potentially regulated by the general stress response factor Msn2/Msn4. In response to rapamycin, caffeine, glucose starvation and oxidative stress provoked by H2O2, mtl1 presents a significant loss of viability as well as a deficiency in the transcriptional response mediated by Msn2/Msn4. The Mtl1 function was required (i) to induce ribosomal gene repression, (ii) to induce the general stress response driven by the transcription factor Msn2/Msn4, and (iii) to activate the CWI pathway in response to both glucose starvation and oxidative stress. We also detected higher cAMP levels in the mtl1 mutant than in wild type cells indicative of up-regulated RAS2-PKA activity. Disruption of TOR1, disruption of RAS2, or hyperactivation of Rho1 restored both the viability and the transcriptional function (both ribosomal and Msn2/Msn4-dependent gene expression) in the mtl1 mutant to almost wild type levels when cells were starved of glucose or stressed with H2O2. Taking our results together, we propose an essential role for Mtl1 in signaling oxidative stress and quiescence to the CWI pathway and to the general stress response through Rho1 and the inhibition of either the TOR1 or RAS2 functions. These mechanisms would be required to allow cells to adapt to both oxidative and nutritional stresses.	[Ivanova Petkova, Mima; Pujol-Carrion, Nuria; Angeles de la Torre-Ruiz, Maria] Univ Lleida, Fac Med, Dept Ciencies Med Basiques IRBLleida, Lleida 25008, Spain; [Arroyo, Javier] Univ Complutense, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; [Garcia-Cantalejo, Jesus] Univ Complutense, Univ Complutense Madrid, Unidad Genom Campus Moncloa, E-28040 Madrid, Spain	Universitat de Lleida; Complutense University of Madrid; Complutense University of Madrid	de la Torre-Ruiz, MA (corresponding author), Univ Lleida, Fac Med, Dept Ciencies Med Basiques IRBLleida, Lleida 25008, Spain.	madelatorre@cmb.udl.es	Ivanova Petkova, Mima/C-5594-2011; Arroyo, Javier/E-9308-2016; de la Torre, M Angeles/A-7357-2010; Carrión, Nuria Pujol/H-9929-2015	Arroyo, Javier/0000-0002-1971-1721; de la Torre, M Angeles/0000-0002-6111-1359; Carrión, Nuria Pujol/0000-0003-3345-2743; Garcia-Cantalejo, Jesus/0000-0001-6465-1273	Ministerio de Educacion y Ciencia (Spanish government) [BFU2009-11215, BIO2007-67821]; Comunidad de Madrid (Spain) [S-SAL-0246/2006]	Ministerio de Educacion y Ciencia (Spanish government)(Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid)	This work was supported by Ministerio de Educacion y Ciencia (Spanish government) Grants BFU2009-11215 and BIO2007-67821 and Comunidad de Madrid (Spain) Grant S-SAL-0246/2006.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen JCY, 2006, CURR GENET, V49, P281, DOI 10.1007/s00294-005-0055-9; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; de Bettignies G, 2001, GENETICS, V159, P1435; de la Torre-Ruiz MA, 2002, J BIOL CHEM, V277, P33468, DOI 10.1074/jbc.M203515200; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; FRANCOIS JM, 1992, EMBO J, V11, P87, DOI 10.1002/j.1460-2075.1992.tb05031.x; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Garreau H, 2000, MICROBIOL-UK, V146, P2113, DOI 10.1099/00221287-146-9-2113; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; HARDY TA, 1994, J BIOL CHEM, V269, P27907; Hasan R, 2002, MOL MICROBIOL, V45, P233, DOI 10.1046/j.1365-2958.2002.03011.x; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kaiser C., 1994, METHODS YEAST GENETI; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Matsumoto K, 1985, Yeast, V1, P25, DOI 10.1002/yea.320010104; Motizuki M, 2008, BBA-GEN SUBJECTS, V1780, P179, DOI 10.1016/j.bbagen.2007.10.003; Park JI, 2005, J BIOL CHEM, V280, P2529, DOI 10.1074/jbc.M407900200; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Reiling JH, 2008, MOL CELL, V29, P533, DOI 10.1016/j.molcel.2008.02.011; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; Serrano R, 2006, J BIOL CHEM, V281, P39785, DOI 10.1074/jbc.M604497200; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Steinboeck F, 2006, J BIOCHEM, V139, P741, DOI 10.1093/jb/mvj080; Swiegers JH, 2006, CURR GENET, V50, P161, DOI 10.1007/s00294-006-0084-z; TATCHELL K, 1985, P NATL ACAD SCI USA, V82, P3785, DOI 10.1073/pnas.82.11.3785; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	63	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19521	19531		10.1074/jbc.M109.085282	http://dx.doi.org/10.1074/jbc.M109.085282			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388713	hybrid, Green Published			2022-12-25	WOS:000278727800062
J	Wiebusch, L; Hagemeier, C				Wiebusch, L.; Hagemeier, C.			p53-and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress	ONCOGENE			English	Article						APC/C; p53; p21; Emi1; senescence; apoptosis	ANAPHASE-PROMOTING COMPLEX; NORMAL HUMAN FIBROBLASTS; DNA-DAMAGE-RESPONSE; HUMAN CANCER-CELLS; S-PHASE; TRANSCRIPTIONAL REPRESSION; ANTICANCER AGENTS; TUMOR-SUPPRESSION; UBIQUITIN LIGASE; DOWN-REGULATION	The long-term cellular response to DNA damage is controlled by the tumor suppressor p53. It results in cell-cycle arrest followed by DNA repair and, depending on the degree of damage inflicted, premature senescence or apoptotic cell death. Here we show that in normal diploid fibroblasts the ubiquitin ligase anaphase-promoting complex or cyclosome (APC/C)-Cdh1 becomes prematurely activated in G2 as part of the sustained long-term but not the rapid short-term response to genotoxic stress and results in the degradation of numerous APC/C substrates. Using HCT116 somatic knockout cells we show that mechanistically premature APC/C activation depends on p53 and its transcriptional target p21 that mediates the signal through downregulation of the APC/C inhibitor Emi1. Cdc14B is dispensable in this setting but might function redundantly. Our data suggest an unexpected role for the APC/C in executing a part of the p53-dependent DNA damage response that leads to premature senescence. Oncogene (2010) 29, 3477-3489; doi:10.1038/onc.2010.99; published online 12 April 2010	[Wiebusch, L.; Hagemeier, C.] Charite, Childrens Hosp, Mol Biol Lab, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wiebusch, L (corresponding author), Charite, Childrens Hosp, Mol Biol Lab, Ziegelstr 5-9, D-10117 Berlin, Germany.	lueder.wiebusch@charite.de; christian.hagemeier@charite.de	Wiebusch, Lüder/AAR-6668-2021	Wiebusch, Lüder/0000-0002-7210-6731	Deutsche Forschungsgemeinschaft (DFG) [HA1575/2-1, WI2043/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank Eli Berdougo, Philipp Haemmati, Christoph Hanski, Hans-Jurgen Heidebrecht, Prasad Jallepalli, Bert Vogelstein and Ralph Wasch for the generous supply of reagents. We acknowledge Matthias Truss for help with lentivirus production and Ralf Uecker for excellent technical assistance. This work was supported by Grants HA1575/2-1 and WI2043/2-2 from the Deutsche Forschungsgemeinschaft (DFG).	Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Andreassen PR, 2001, CANCER RES, V61, P7660; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Berdougo E, 2008, CELL CYCLE, V7, P1184, DOI 10.4161/cc.7.9.5792; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang BD, 1999, CANCER RES, V59, P3761; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Gillis LD, 2009, CELL CYCLE, V8, P253, DOI 10.4161/cc.8.2.7550; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; HARPER JW, 1993, CELL, V75, P805; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Janicke RU, 2007, CELL CYCLE, V6, P407; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kob R, 2009, CELL CYCLE, V8, P2041, DOI 10.4161/cc.8.13.8850; Kurose A, 2006, CELL PROLIFERAT, V39, P231, DOI 10.1111/j.1365-2184.2006.00380.x; Lee J, 2009, MOL BIOL CELL, V20, P1891, DOI 10.1091/mbc.E08-08-0818; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Matthew EM, 2007, CELL CYCLE, V6, P2571, DOI 10.4161/cc.6.20.5079; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Nayak BK, 2002, ONCOGENE, V21, P7226, DOI 10.1038/sj.onc.1205889; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; St Clair S, 2004, MOL CELL, V16, P725; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; WALDMAN T, 1995, CANCER RES, V55, P5187; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	60	54	62	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3477	3489		10.1038/onc.2010.99	http://dx.doi.org/10.1038/onc.2010.99			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20383190				2022-12-25	WOS:000278835400003
J	Shepherd, M; Sanguinetti, G; Cook, GM; Poole, RK				Shepherd, Mark; Sanguinetti, Guido; Cook, Gregory M.; Poole, Robert K.			Compensations for Diminished Terminal Oxidase Activity in Escherichia coli CYTOCHROME bd-II-MEDIATED RESPIRATION AND GLUTAMATE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN H-NS; ACID RESISTANCE; GENE-EXPRESSION; TRANSCRIPTIONAL RESPONSES; OXYGEN AVAILABILITY; CRYSTAL-STRUCTURE; ACTIVATOR APPY; QUINOL OXIDASE; SIGMA-FACTOR; LOW PH	Escherichia coli possesses cytochrome bo' (CyoABCDE), cytochrome bd-I (CydAB), and cytochrome bd-II (AppBC) quinol oxidases, all of which can catalyze the terminal step in the aerobic respiratory chain, the reduction of oxygen by ubiquinol. Although CydAB has a role in the generation of Delta pH, AppBC has been proposed to alleviate the accumulation of electrons in the quinone pool during respiratory stress via electroneutral ubiquinol oxidation. A cydB mutant strain exhibited lower respiration rates while maintaining a wild type growth rate. Transcriptomic analysis revealed a dramatic up-regulation of AppBC in the cydB strain, accompanied by the induction of genes involved in glutamate/gamma-aminobutyric acid (GABA) antiport, the GABA shunt, the glyoxylate shunt, respiration (including appBC), motility, and osmotic stress. Transcription factor modeling suggests that the underpinning regulation is largely controlled by H-NS, GadX, FlhDC, and AppY. The transcriptional adaptations imply that cydB cells contribute to the proton motive force via consumption of intracellular protons and glutamate/GABA antiport. Indeed, supplementation of culture medium with L-glutamate stimulates growth in a cydB strain. Phenotype analyses of the cydB strain confirm decreased motility and elevated acid resistance and also an elevated cytochrome d spectroscopic signal in cells grown at low pH. We propose a mechanism via which E. coli can compensate for the loss of cytochrome bd-I activity; cytochrome bd-II-mediated quinol oxidation prevents the accumulation of NADH, whereas GABA synthesis/antiport maintains the proton motive force for ATP production.	[Shepherd, Mark; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Edinburgh, Sch Informat, Edinburgh EH8 9AB, Midlothian, Scotland; [Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand	University of Sheffield; University of Edinburgh; University of Otago	Shepherd, M (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	m.shepherd@sheffield.ac.uk	Cook, Gregory/E-5665-2011	Shepherd, Mark/0000-0002-7472-2300	Biotechnology and Biological Sciences Research Council [BB/C514174/1, BB/F003463/1]; BBSRC [BB/F003463/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/C514174/1 and via Systems Biology of Microorganisms Grant BB/F003463/1 (to R. K. P.).	Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; Atlung T, 1997, J BACTERIOL, V179, P2141, DOI 10.1128/jb.179.7.2141-2146.1997; Atlung T, 1996, J BACTERIOL, V178, P3418, DOI 10.1128/jb.178.12.3418-3425.1996; Baba Tomoya, 2006, Mol Syst Biol, V2; BARTH M, 1995, J BACTERIOL, V177, P3455, DOI 10.1128/jb.177.12.3455-3464.1995; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Boulanger A, 2005, J BACTERIOL, V187, P3282, DOI 10.1128/JB.187.9.3282-3286.2005; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI [DOI 10.1128/jb.172.11.6333-6338.1990, 10.1128/jb.172.11.6333-6338.1990]; DASSA J, 1991, MOL GEN GENET, V229, P341, DOI 10.1007/BF00267454; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; DMELLO R, 1995, J BACTERIOL, V177, P867, DOI 10.1128/jb.177.3.867-870.1995; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; GENNIS RB, 1987, FEMS MICROBIOL LETT, V46, P387; Giangrossi M, 2005, J BIOL CHEM, V280, P21498, DOI 10.1074/jbc.M413255200; Gilberthorpe NJ, 2008, J BIOL CHEM, V283, P11146, DOI 10.1074/jbc.M708019200; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; IUCHI S, 1991, CELL, V66, P5, DOI 10.1016/0092-8674(91)90130-Q; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; King PW, 1999, J BACTERIOL, V181, P5250, DOI 10.1128/JB.181.17.5250-5256.1999; Kruse T, 2009, INT J PEPT RES THER, V15, P17, DOI 10.1007/s10989-008-9157-9; LOEWEN PC, 1993, BIOCHEMISTRY-US, V32, P10159, DOI 10.1021/bi00089a035; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; MCCANN MP, 1991, J BACTERIOL, V173, P4188, DOI 10.1128/jb.173.13.4188-4194.1991; MOROLLO AA, 1993, P NATL ACAD SCI USA, V90, P9983, DOI 10.1073/pnas.90.21.9983; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nagarajavel V, 2007, J BIOL CHEM, V282, P23622, DOI 10.1074/jbc.M702753200; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; POOLE RK, 1980, BIOCHIM BIOPHYS ACTA, V591, P471, DOI 10.1016/0005-2728(80)90177-2; PUUSTINEN A, 1989, FEBS LETT, V249, P163, DOI 10.1016/0014-5793(89)80616-7; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Ramseier TM, 1996, CURR MICROBIOL, V33, P270, DOI 10.1007/s002849900112; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; RIEBELING V, 1975, EUR J BIOCHEM, V55, P445, DOI 10.1111/j.1432-1033.1975.tb02181.x; Rowbury RJ, 1997, LETT APPL MICROBIOL, V24, P319, DOI 10.1046/j.1472-765X.1997.00065.x; SALERNO JC, 1989, FEBS LETT, V247, P101, DOI 10.1016/0014-5793(89)81249-9; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; SCHELLHORN HE, 1992, J BACTERIOL, V174, P4769, DOI 10.1128/JB.174.14.4769-4776.1992; SCHULTZ A, 1990, APPL ENVIRON MICROB, V56, P1; Soutourina OA, 2002, MICROBIOL-SGM, V148, P1543, DOI 10.1099/00221287-148-5-1543; Sturr MG, 1996, J BACTERIOL, V178, P1742, DOI 10.1128/jb.178.6.1742-1749.1996; Tramonti A, 2002, J BACTERIOL, V184, P2603, DOI 10.1128/JB.184.10.2603-2613.2002; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WIKSTROM, 1994, BIOCHIM BIOPHYS ACTA, V1187, P106; Yamamoto K, 2008, J BIOTECHNOL, V133, P196, DOI 10.1016/j.jbiotec.2007.08.002; YAMASHINO T, 1995, EMBO J, V14, P594, DOI 10.1002/j.1460-2075.1995.tb07035.x; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796	65	33	34	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18464	18472		10.1074/jbc.M110.118448	http://dx.doi.org/10.1074/jbc.M110.118448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392690	Green Published, hybrid			2022-12-25	WOS:000278453900040
J	Sutanto, MM; Ferguson, KK; Sakuma, H; Ye, HG; Brady, MJ; Cohen, RN				Sutanto, Maria M.; Ferguson, Kelly K.; Sakuma, Hiroya; Ye, Honggang; Brady, Matthew J.; Cohen, Ronald N.			The Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) Regulates Adipose Tissue Accumulation and Adipocyte Insulin Sensitivity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OB GENE-EXPRESSION; HIGH-FAT DIET; PLASMA LEPTIN; PPAR-GAMMA; TRANSCRIPTIONAL ACTIVITY; BODY-FAT; OBESITY; REPRESSION; THIAZOLIDINEDIONE; IDENTIFICATION	The silencing mediator of retinoid and thyroid hormone receptors (SMRT) serves as a corepressor for nuclear receptors and other factors. Recent evidence suggests that SMRT is an important regulator of metabolism, but its role in adipocyte function in vivo remains unclear. We generated heterozygous SMRT knock-out (SMRT+/-) mice to investigate the function of SMRT in the adipocyte and the regulation of adipocyte insulin sensitivity. We show that SMRT+/- mice are normal weight on a regular diet, but develop increased adiposity on a high-fat diet (HFD). The mechanisms underlying this phenotype are complex, but appear to be due to a combination of an increased number of smaller subcutaneous adipocytes as well as decreased leptin expression, resulting in greater caloric intake. In addition, adipogenesis of mouse embryonic fibroblasts (MEFs) derived from these mice was increased. However, adipocyte insulin sensitivity, measured by insulin-induced Akt phosphorylation and insulin-mediated suppression of lipolysis, was enhanced in SMRT+/- adipocytes. These finding suggest that SMRT regulates leptin expression and limits the ability of fat mass to expand with increased caloric intake, but that SMRT also negatively regulates adipocyte insulin sensitivity.	[Ferguson, Kelly K.; Sakuma, Hiroya; Ye, Honggang; Brady, Matthew J.; Cohen, Ronald N.] Univ Chicago, Sect Endocrinol Diabet & Metab, Dept Med, Chicago, IL 60637 USA; [Sutanto, Maria M.; Brady, Matthew J.; Cohen, Ronald N.] Univ Chicago, Comm Mol Metab & Nutr, Div Biol Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cohen, RN (corresponding author), Univ Chicago, Sect Endocrinol Diabet & Metab, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	roncohen@medicine.bsd.uchicago.edu	Ferguson, Kelly/C-3745-2019	Ferguson, Kelly/0000-0001-8467-3250	National Institutes of Health [NIDDK R01 DK078125]; Endocrine Society Bridge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK078125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society Bridge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant NIDDK R01 DK078125 and an Endocrine Society Bridge Grant.	Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DE VP, 1996, J CLIN INVEST, V98, P1004; Di Cosmo C, 2009, ENDOCRINOLOGY, V150, P4450, DOI 10.1210/en.2009-0209; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716; Gauthier MS, 2004, INT J OBESITY, V28, P1064, DOI 10.1038/sj.ijo.0802628; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jurczak MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE952, DOI 10.1152/ajpendo.00559.2006; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Kelly IE, 1999, DIABETES CARE, V22, P288, DOI 10.2337/diacare.22.2.288; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kolaczynski JW, 1996, DIABETES, V45, P1511, DOI 10.2337/diabetes.45.11.1511; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mori Y, 1999, DIABETES CARE, V22, P908, DOI 10.2337/diacare.22.6.908; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pohlenz J, 1999, THYROID, V9, P1001, DOI 10.1089/thy.1999.9.1001; Rocchini AP, 2002, NEW ENGL J MED, V346, P854, DOI 10.1056/NEJM200203143461112; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Sewter CP, 2002, DIABETES, V51, P718, DOI 10.2337/diabetes.51.3.718; Shimizu H, 1998, DIABETES CARE, V21, P1470, DOI 10.2337/diacare.21.9.1470; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; TRAYHURN P, 1995, FEBS LETT, V368, P488, DOI 10.1016/0014-5793(95)00719-P; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu JJ, 2006, CANCER RES, V66, P9316, DOI 10.1158/0008-5472.CAN-06-1902; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P6386, DOI 10.1073/pnas.94.12.6386	45	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18485	18495		10.1074/jbc.M110.107680	http://dx.doi.org/10.1074/jbc.M110.107680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20371609	Green Published, hybrid			2022-12-25	WOS:000278453900042
J	Vogel, M; Lawson, M; Sippl, W; Conrad, U; Roos, W				Vogel, Matthias; Lawson, Michael; Sippl, Wolfgang; Conrad, Udo; Roos, Werner			Structure and Mechanism of Sanguinarine Reductase, an Enzyme of Alkaloid Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID SUBSTITUTION MATRICES; IX-BETA REDUCTASE; BENZOPHENANTHRIDINE ALKALOIDS; PHYTOALEXIN BIOSYNTHESIS; METABOLISM; CALIFORNICA; INDUCTION; MOLECULES; DNA	Sanguinarine reductase is a plant enzyme that prevents the cytotoxic effects of benzophenanthridine alkaloids, which are the main phytoalexins of Papaveraceae. The enzyme catalyzes the reduction of sanguinarine, the most toxic benzophenanthridine, which re-enters the cytoplasm after its primary accumulation in the cell wall region has reached a threshold concentration. We present the sequence of the gene and protein of sanguinarine reductase isolated from cell cultures of Eschscholzia californica. High sequence similarities indicate that the enzyme evolved from a plant-specific branch of the ubiquitous Rossmann fold NAD(P)H/NAD(P)(+) binding reductases, with NADP-dependent epimerases or hydroxysteroid reductases as the most likely ancestors. Based on the x-ray structure of a close homolog, a three-dimensional model of the spatial conformation and catalytic site of sanguinarine reductase was established and used for in silico screening of known three-dimensional structures. Surprisingly, the enzyme shares high structural similarity with enzymes of human and bacterial origin, which have similar functions as the plant homologs but bear little amino acid sequence similarity. Using site-directed mutagenesis, a series of recombinant enzymes was generated and assayed to reveal the impact of individual amino acids and peptides in the catalytic process. It appears that relatively few innovations were required to generate this selective catalyst for alkaloid detoxication, notably an insertion of 13 amino acids and the generation of a novel catalytic triad of Cys-Asp-His were sufficient.	[Vogel, Matthias; Roos, Werner] Univ Halle Wittenberg, Dept Pharmaceut Biol, Mol Cell Biol Lab, D-06120 Halle, Saale, Germany; [Lawson, Michael; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Pharmaceut Chem, D-06120 Halle, Saale, Germany; [Conrad, Udo] Inst Plant Genet & Crop Plant Res, D-06446 Gatersleben, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Roos, W (corresponding author), Kurt Mothes Str 3, D-06120 Halle, Germany.	werner.roos@pharmazie.uni-halle.de	Sippl, Wolfgang/P-5944-2014	Sippl, Wolfgang/0000-0002-5985-9261	German Research Council (Deutsche Forschungsgemeinschaft)	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft).	Bartak P, 2003, J PHYS ORG CHEM, V16, P803, DOI 10.1002/poc.659; BLECHERT S, 1995, P NATL ACAD SCI USA, V92, P4099, DOI 10.1073/pnas.92.10.4099; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Faddeeva M D, 1997, Tsitologiia, V39, P181; Haider G, 1997, BIOCHEM BIOPH RES CO, V241, P606, DOI 10.1006/bbrc.1997.7842; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Herrmann S, 2003, THESIS M LUTHER U HA; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Klein M, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P229, DOI 10.1007/978-0-387-85498-4_11; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lukacik P, 2006, MOL CELL ENDOCRINOL, V248, P61, DOI 10.1016/j.mce.2005.12.007; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Pellegrini E, 2002, J PHYS CHEM A, V106, P1316, DOI 10.1021/jp0135050; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Roos W, 1998, PLANT PHYSIOL, V118, P349, DOI 10.1104/pp.118.2.349; Schmeller T, 1997, PHYTOCHEMISTRY, V44, P257, DOI 10.1016/S0031-9422(96)00545-6; SCHWARTZE W, 2007, THESIS M LUTHER U HA; Smith LJ, 2008, BIOCHEM J, V411, P475, DOI 10.1042/BJ20071495; TANAHASHI T, 1990, PHYTOCHEMISTRY, V29, P1113, DOI 10.1016/0031-9422(90)85414-B; Ulrichova J, 2001, TOXICOL LETT, V125, P125, DOI 10.1016/S0378-4274(01)00430-1; Viehweger K, 2006, PLANT CELL, V18, P1510, DOI 10.1105/tpc.105.035121; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Weiss D, 2006, PLANT CELL ENVIRON, V29, P291, DOI 10.1111/j.1365-3040.2005.01421.x; Wink M, 1998, J CHEM ECOL, V24, P1881, DOI 10.1023/A:1022315802264; ZENK MH, 1994, PURE APPL CHEM, V66, P2023, DOI 10.1351/pac199466102023; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	29	31	32	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18397	18406		10.1074/jbc.M109.088989	http://dx.doi.org/10.1074/jbc.M109.088989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378534	hybrid, Green Published			2022-12-25	WOS:000278453900033
J	Brillet, T; Baudin-Creuza, V; Vasseur, C; Domingues-Hamdi, E; Kiger, L; Wajcman, H; Pissard, S; Marden, MC				Brillet, Thomas; Baudin-Creuza, Veronique; Vasseur, Corinne; Domingues-Hamdi, Elisa; Kiger, Laurent; Wajcman, Henri; Pissard, Serge; Marden, Michael C.			alpha-Hemoglobin Stabilizing Protein (AHSP), a Kinetic Scheme of the Action of a Human Mutant, AHSP(V56G)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CHAINS; GENE; EXPRESSION; CHAPERONE; MECHANISM	A kinetic analysis has been made of the interaction of alpha-Hb chains with a mutant alpha-hemoglobin stabilizing protein, AHSP(V56G), which is the first case of an AHSP mutation associated with clinical symptoms of mild thalassemia syndrome. The chaperone AHSP is thought to protect nascent alpha chains until final binding to the partner beta-Hb. Rather than protecting alpha chains, the mutant chaperone is partially unfolded but recovers its secondary structure via interaction with alpha-Hb. For both AHSP(WT) and AHSP(V56G), the binding to alpha-Hb is quite rapid relative to the alpha-beta reaction, as expected because the chaperone binding must be quite competitive to complete the alpha chain folding process before alpha-Hb binds irreversibly to beta-Hb. The main kinetic difference is a dissociation rate of AHSP(V56G).alpha-Hb some four times faster relative to AHSP.alpha-Hb. Considering a role of protein folding, the AHSPV56G apparently does not bind long enough (0.5 s versus 2 s for the WT) to complete the structural modifications. The overall replacement reaction (AHSP.alpha-Hb + beta-Hb -> AHSP + alpha beta) can be quite long, especially if there is an excess of AHSP relative to beta-Hb monomers.	[Marden, Michael C.] Univ Paris 07, INSERM, U779, CHU Bicetre, F-94275 Le Kremlin Bicetre, France; [Wajcman, Henri; Pissard, Serge] Univ Paris 12, U955 Eq 11, INSERM, IMRB, F-94010 Creteil, France; [Wajcman, Henri; Pissard, Serge] Univ Paris 12, AP HP, Hop Henri Mondor, Serv Biochim & Genet, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Marden, MC (corresponding author), Univ Paris 07, INSERM, U779, CHU Bicetre, 11,78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	michael.marden@inserm.fr	Kiger, Laurent/Q-1686-2018; Pissard, Serge/F-8621-2010; BAUDIN-CREUZA, Véronique/K-7309-2017; Vasseur, Corinne/AAV-1384-2021; Marden, Michael C/G-3139-2012; Marden, Michael/AAA-5923-2020	BAUDIN-CREUZA, Véronique/0000-0003-1032-3236; Vasseur, Corinne/0000-0002-4422-7069; Marden, Michael C/0000-0002-5254-6385; 	Institut National de la Sante et de la Recherche Medicale (INSERM); Delegation Generale pour l'Armement (DGA); University of Paris 7, 11, and 12 (France)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Delegation Generale pour l'Armement (DGA); University of Paris 7, 11, and 12 (France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Delegation Generale pour l'Armement (DGA), and the University of Paris 7, 11, and 12 (France).	Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; dos Santos CO, 2008, AM J HEMATOL, V83, P103, DOI 10.1002/ajh.21041; dos Santos CO, 2004, EXP HEMATOL, V32, P157, DOI 10.1016/j.exphem.2003.11.002; dos Santos CO, 2005, BLOOD, V106, p1010A; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; GALANELLO R, 2003, BLOOD, V102; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; GERACI G, 1969, J BIOL CHEM, V244, P4664; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; MARDEN MC, 1988, BIOCHEMISTRY-US, V27, P1659, DOI 10.1021/bi00405a041; MCGOVERN P, 1976, J BIOL CHEM, V251, P7871; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; PARKHURST KM, 1992, INT J BIOCHEM, V24, P993, DOI 10.1016/0020-711X(92)90109-E; Pissard S, 2009, BLOOD, V114, P191, DOI 10.1182/blood.V114.22.462.462; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664	20	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17986	17992		10.1074/jbc.M109.098491	http://dx.doi.org/10.1074/jbc.M109.098491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371604	Green Published, hybrid			2022-12-25	WOS:000278133400074
J	Kosaka, N; Iguchi, H; Yoshioka, Y; Takeshita, F; Matsuki, Y; Ochiya, T				Kosaka, Nobuyoshi; Iguchi, Haruhisa; Yoshioka, Yusuke; Takeshita, Fumitaka; Matsuki, Yasushi; Ochiya, Takahiro			Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-DERIVED EXOSOMES; SMALL RNAS; DIAGNOSTIC BIOMARKERS; APOPTOTIC BODIES; PROSTATE-CANCER; SERUM; PLASMA	The existence of circulating microRNAs (miRNAs) in the blood of cancer patients has raised the possibility that miRNAs may serve as a novel diagnostic marker. However, the secretory mechanism and biological function of extracellular miRNAs remain unclear. Here, we show that miRNAs are released through a ceramide-dependent secretory machinery and that the secretory miRNAs are transferable and functional in the recipient cells. Ceramide, whose biosynthesis is regulated by neutral sphingomyelinase 2 (nSMase2), triggers secretion of small membrane vesicles called exosomes. The decreased activity of nSMase2 with a chemical inhibitor, GW4869, and a specific small interfering RNA resulted in the reduced secretion of miRNAs. Complementarily, overexpression of nSMase2 increased extracellular amounts of miRNAs. We also revealed that the endosomal sorting complex required for transport system is unnecessary for the release of miRNAs. Furthermore, a tumor-suppressive miRNA secreted via this pathway was transported between cells and exerted gene silencing in the recipient cells, thereby leading to cell growth inhibition. Our findings shed a ray of light on the physiological relevance of secretory miRNAs.	[Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Chuo Ku, Tokyo 1040045, Japan; [Iguchi, Haruhisa; Matsuki, Yasushi] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Konohana Ku, Osaka 5540022, Japan	National Cancer Center - Japan; Dainippon Sumitomo Pharmaceutical Company	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Chuo Ku, 1-1 Tsukiji,5 Chome, Tokyo 1040045, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Education, Culture, Sports, Science and Technology; National Institute of Biomedical Innovation (NiBio)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation)	This work was supported in part by a grant-in-aid for the third-term comprehensive 10-year strategy for cancer control, a grant-in-aid for scientific research on priority areas cancer from the Ministry of Education, Culture, Sports, Science and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; El-Hefnawy T, 2004, CLIN CHEM, V50, P564, DOI 10.1373/clinchem.2003.028506; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hasselmann DO, 2001, CLIN CHEM, V47, P1488; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mignot G, 2006, J CELL MOL MED, V10, P376, DOI 10.1111/j.1582-4934.2006.tb00406.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Rechavi O, 2009, GENE DEV, V23, P1971, DOI 10.1101/gad.1789609; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	29	1401	1467	3	220	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17442	17452		10.1074/jbc.M110.107821	http://dx.doi.org/10.1074/jbc.M110.107821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353945	hybrid, Green Published			2022-12-25	WOS:000278133400022
J	Martin, R; Durroux, T; Ciruela, F; Torres, M; Pin, JP; Sanchez-Prieto, J				Martin, Ricardo; Durroux, Thierry; Ciruela, Francisco; Torres, Magdalena; Pin, Jean-Philippe; Sanchez-Prieto, Jose			The Metabotropic Glutamate Receptor mGlu7 Activates Phospholipase C, Translocates Munc-13-1 Protein, and Potentiates Glutamate Release at Cerebrocortical Nerve Terminals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; KINASE-C; PHORBOL ESTERS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; CALCIUM-CHANNELS; RAT HIPPOCAMPUS; CA2+ CHANNELS; MICE LACKING; PLC-ETA	At synaptic boutons, metabotropic glutamate receptor 7 (mGlu7 receptor) serves as an autoreceptor, inhibiting glutamate release. In this response, mGlu7 receptor triggers pertussis toxin-sensitive G protein activation, reducing presynaptic Ca2+ influx and the subsequent depolarization evoked release. Here we report that receptor coupling to signaling pathways that potentiate release can be seen following prolonged exposure of nerve terminals to the agonist L-(+)-phosphonobutyrate, L-AP4. This novel mGlu7 receptor response involves an increase in the release induced by the Ca2+ ionophore ionomycin, suggesting a mechanism that is independent of Ca2+ channel activity, but dependent on the downstream exocytotic release machinery. The mGlu7 receptor-mediated potentiation resists exposure to pertussis toxin, but is dependent on phospholipase C, and increased phosphatidylinositol (4,5)-bisphosphate hydrolysis. Furthermore, the potentiation of release does not depend on protein kinase C, although it is blocked by the diacylglycerol-binding site antagonist calphostin C. We also found that activation of mGlu7 receptors translocate the active zone protein essential for synaptic vesicle priming, munc13-1, from soluble to particulate fractions. We propose that the mGlu7 receptor can facilitate or inhibit glutamate release through multiple pathways, thereby exerting homeostatic control of presynaptic function.	[Martin, Ricardo; Torres, Magdalena; Sanchez-Prieto, Jose] Univ Complutense Madrid, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain; [Durroux, Thierry; Pin, Jean-Philippe] CNRS, UMR 5203, Inst Genom Fonct, F-34000 Montpellier, France; [Ciruela, Francisco] Univ Barcelona, Fac Med, Dept Patol & Terapeut Expt, Unitat Farmacol, Barcelona 08907, Spain	Complutense University of Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Barcelona	Sanchez-Prieto, J (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain.	jsprieto@vet.ucm	Ciruela, F./A-5096-2013; Martín, Ricardo/J-1408-2018; Torres, Magdalena/E-6150-2017; Pin, Jean-Philippe/Y-6668-2019	Ciruela, F./0000-0003-0832-3739; Martín, Ricardo/0000-0002-7645-4901; Torres, Magdalena/0000-0002-3893-8569; Pin, Jean-Philippe/0000-0002-1423-345X; Durroux, Thierry/0000-0003-1091-6066; Sanchez-Prieto, Jose/0000-0002-8513-3501	Spanish Ministerio de Educacion y Ciencia [BFU2007-64154/BFI]; Instituto de Salud Carlos III [RD06/0026]; Comunidad de Madrid [S-BIO-0170/2006, SAF2008-01462]; Ministerio de Ciencia e Innovacion [CSD2008-00005]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Spanish Ministerio de Educacion y Ciencia Grant BFU2007-64154/BFI, Instituto de Salud Carlos III Grant RD06/0026, and Comunidad de Madrid Grants S-BIO-0170/2006 (to J.S.-P.) and SAF2008-01462, and Consolider-Ingenio CSD2008-00005 from the Ministerio de Ciencia e Innovacion (to F. C.).	Andrews-Zwilling YS, 2006, J BIOL CHEM, V281, P19720, DOI 10.1074/jbc.M601421200; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Bauer CS, 2007, J NEUROSCI, V27, P212, DOI 10.1523/JNEUROSCI.4201-06.2007; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Cockcroft S, 2006, TRENDS BIOCHEM SCI, V31, P4, DOI 10.1016/j.tibs.2005.11.003; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GEREAU RW, 1995, J NEUROSCI, V15, P6879; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HERRERO I, 1991, NEUROSCI LETT, V126, P41, DOI 10.1016/0304-3940(91)90366-2; Herrero I, 1996, EUR J NEUROSCI, V8, P700, DOI 10.1111/j.1460-9568.1996.tb01255.x; HERRERO I, 1992, J NEUROCHEM, V59, P1574, DOI 10.1111/j.1471-4159.1992.tb08478.x; Hwang JI, 2005, BIOCHEM J, V389, P181, DOI 10.1042/BJ20041677; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Ladera C, 2007, J NEUROCHEM, V103, P2314, DOI 10.1111/j.1471-4159.2007.04964.x; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Martin R, 2008, NEUROPHARMACOLOGY, V55, P464, DOI 10.1016/j.neuropharm.2008.04.011; Millan C, 2003, J BIOL CHEM, V278, P23955, DOI 10.1074/jbc.M211471200; Millan C, 2002, J BIOL CHEM, V277, P47796, DOI 10.1074/jbc.M207531200; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Pelkey KA, 2008, NEURON, V60, P980, DOI 10.1016/j.neuron.2008.11.018; Perroy J, 2000, J NEUROSCI, V20, P7896; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Sorensen SD, 2002, MOL PHARMACOL, V61, P1303, DOI 10.1124/mol.61.6.1303; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Zhang CS, 2008, J NEUROSCI, V28, P8604, DOI 10.1523/JNEUROSCI.0628-08.2008; Zhang YH, 2001, J NEUROPHYSIOL, V85, P362, DOI 10.1152/jn.2001.85.1.362	47	50	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17907	17917		10.1074/jbc.M109.080838	http://dx.doi.org/10.1074/jbc.M109.080838			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375012	Green Published, hybrid			2022-12-25	WOS:000278133400067
J	Yi, TF; Tan, KR; Cho, SG; Wang, Y; Luo, J; Zhang, WZ; Li, DL; Liu, MY				Yi, Tingfang; Tan, Kunrong; Cho, Sung-Gook; Wang, Ying; Luo, Jian; Zhang, Wenzheng; Li, Dali; Liu, Mingyao			Regulation of Embryonic Kidney Branching Morphogenesis and Glomerular Development by KISS1 Receptor (Gpr54) through NFAT2-and Sp1-mediated Bmp7 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS SUPPRESSOR GENE; ACTIVATED T-CELLS; HORMONE-RELEASING ACTIVITY; NUCLEAR FACTOR; TRANSCRIPTION FACTORS; DOWN-REGULATION; CANCER; KISSPEPTINS; PEPTIDE; LIGAND	G-protein-coupled receptor 54 (Gpr54, KISS1 receptor) plays critical roles in puberty regulation, tumor metastasis suppression, and vasoconstriction. Bone morphogenetic protein-7 (Bmp7) is required for kidney organogenesis. However, whether Gpr54 is involved in embryonic kidney development and how Bmp7 expression is regulated in the kidney are largely unknown. Here we report that Gpr54 deletion leads to kidney branching morphogenesis and glomerular development retardation in embryonic kidneys in vivo and in explanted kidneys in vitro. Gpr54 inactivation results in a high risk of low glomerular number in adult kidneys. Gpr54 is expressed in condensed mesenchyme at E12.5 and epithelial cells of proximal and distal tubules and collecting ducts at E17.5 and P0 mouse kidney. Deletion of Gpr54 decreases Bmp7 expression and Smad1 phosphorylation in the developing kidney. Using chromatin immunoprecipitation and luciferase assays, we demonstrate that Gpr54 regulates NFAT2- and Sp1-mediated Bmp7 transcription. Furthermore, we show that NFAT2 cooperates with Sp1 to promote Bmp7 transcription activation. Together, these data suggest that Gpr54 regulates Bmp7 expression through NFAT2 and Sp1 and plays an important role in embryonic kidney branching morphogenesis and glomerular development.	[Yi, Tingfang; Tan, Kunrong; Cho, Sung-Gook; Wang, Ying; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol,Dept Mol & Cellular Med, Houston, TX 77030 USA; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Zhang, Wenzheng] Univ Texas Hlth Sci Ctr, Dept Internal Med, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; East China Normal University; East China Normal University; University of Texas System; University of Texas Health Science Center Houston	Liu, MY (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	Luo, Jian/H-3362-2016	Luo, Jian/0000-0003-3583-0154; Cho, Sung-Gook/0000-0002-8791-9532; Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health (NCI) [1R01CA106479]; NATIONAL CANCER INSTITUTE [R01CA106479] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA106479 (NCI).	Adams D, 2007, DEV BIOL, V311, P679, DOI 10.1016/j.ydbio.2007.08.036; Alfonso-Jaume MA, 2004, BIOCHEM J, V380, P735, DOI 10.1042/BJ20031281; Bates CM, 2000, MOL GENET METAB, V71, P391, DOI 10.1006/mgme.2000.3072; Brailoiu GC, 2005, J COMP NEUROL, V481, P314, DOI 10.1002/cne.20350; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; CHEN J, 1994, P NATL ACAD SCI USA, V91, P2611, DOI 10.1073/pnas.91.7.2611; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colledge WH, 2004, TRENDS ENDOCRIN MET, V15, P448, DOI 10.1016/j.tem.2004.09.008; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Tassigny XD, 2008, ENDOCRINOLOGY, V149, P3926, DOI 10.1210/en.2007-1487; Dhar DK, 2004, INT J CANCER, V111, P868, DOI 10.1002/ijc.20357; Dittmer A, 2006, J BIOL CHEM, V281, P14563, DOI 10.1074/jbc.M510527200; Dressler GR, 2002, TRENDS CELL BIOL, V12, P390, DOI 10.1016/S0962-8924(02)02334-6; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Elliott WJ, 2007, NAT CLIN PRACT CARD, V4, P538, DOI 10.1038/ncpcardio0989; FULOP T, 1993, CELL SIGNAL, V5, P593, DOI 10.1016/0898-6568(93)90054-P; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Godin RE, 1998, DEVELOPMENT, V125, P3473; Godin RE, 1999, INT J DEV BIOL, V43, P405; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; GROBSTEIN C, 1955, ANN NY ACAD SCI, V60, P1095, DOI 10.1111/j.1749-6632.1955.tb40091.x; Ikeguchi M, 2004, CLIN CANCER RES, V10, P1379, DOI 10.1158/1078-0432.CCR-1519-02; Jena N, 1997, EXP CELL RES, V230, P28, DOI 10.1006/excr.1996.3411; Jiang Tao, 2005, Zhonghua Zhongliu Zazhi, V27, P229; Jiang Y, 2005, CLIN EXP METASTAS, V22, P369, DOI 10.1007/s10585-005-8186-4; Kazama I, 2008, J AM SOC NEPHROL, V19, P2181, DOI 10.1681/ASN.2007111212; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li DL, 2007, ENDOCRINOLOGY, V148, P4821, DOI 10.1210/en.2007-0154; Li DL, 2009, PEPTIDES, V30, P130, DOI 10.1016/j.peptides.2008.09.025; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Martinez G, 2002, INT J DEV BIOL, V46, P525; Marumo T, 2008, J AM SOC NEPHROL, V19, P1311, DOI 10.1681/ASN.2007091040; Masui T, 2004, BIOCHEM BIOPH RES CO, V315, P85, DOI 10.1016/j.bbrc.2004.01.021; Mitu GM, 2007, AM J PHYSIOL-RENAL, V293, pF1641, DOI 10.1152/ajprenal.00179.2007; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Navarro VM, 2005, ENDOCRINOLOGY, V146, P156, DOI 10.1210/en.2004-0836; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Nicolle G, 2007, ANN ONCOL, V18, P605, DOI 10.1093/annonc/mdl421; Ohta S, 2005, INT J CANCER, V114, P139, DOI 10.1002/ijc.20670; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Paralkar VM, 2002, J CELL PHYSIOL, V190, P207, DOI 10.1002/JCP.10048; Patel SR, 2005, TRENDS MOL MED, V11, P512, DOI 10.1016/j.molmed.2005.09.007; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qiao JZ, 1999, P NATL ACAD SCI USA, V96, P7330, DOI 10.1073/pnas.96.13.7330; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; Sanchez-Carbayo M, 2003, LAB INVEST, V83, P507, DOI 10.1097/01.LAB.0000064702.63200.94; Sanchez-Carbayo M, 2003, AM J PATHOL, V162, P609, DOI 10.1016/S0002-9440(10)63854-0; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Seminara SB, 2005, ENDOCRINOLOGY, V146, P1686, DOI 10.1210/en.2005-0070; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; Simon N, 1999, AM J PHYSIOL-RENAL, V276, pF382, DOI 10.1152/ajprenal.1999.276.3.F382; Stafford LJ, 2002, CANCER RES, V62, P5399; Sugimoto T, 2001, J AM SOC NEPHROL, V12, P1359, DOI 10.1681/ASN.V1271359; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Terao Y, 2004, BBA-GENE STRUCT EXPR, V1678, P102, DOI 10.1016/j.bbaexp.2004.02.005; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; van Adelsberg J, 1999, DEV GENET, V24, P299, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<299::AID-DVG13>3.0.CO;2-J; Wetzel P, 2006, KIDNEY INT, V70, P717, DOI 10.1038/sj.ki.5001653; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Zhang CG, 2008, J NEUROSCI, V28, P4423, DOI 10.1523/JNEUROSCI.5352-07.2008; Zhang J, 2007, CANCER, V109, P1478, DOI 10.1002/cncr.22554; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201	79	24	24	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17811	17820		10.1074/jbc.M110.130740	http://dx.doi.org/10.1074/jbc.M110.130740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375015	Green Published, hybrid			2022-12-25	WOS:000278133400059
J	March, C; Regueiro, V; Llobet, E; Moranta, D; Morey, P; Garmendia, J; Bengoechea, JA				March, Catalina; Regueiro, Veronica; Llobet, Enrique; Moranta, David; Morey, Pau; Garmendia, Junkal; Bengoechea, Jose A.			Dissection of Host Cell Signal Transduction during Acinetobacter baumannii - Triggered Inflammatory Response	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; NF-KAPPA-B; LIPOPOLYSACCHARIDE-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; HUMAN AIRWAY EPITHELIA; CIGARETTE-SMOKE; BETA-DEFENSINS; PATHOGEN RECOGNITION; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2	Infected airway epithelial cells up-regulate the expression of chemokines, chiefly IL-8, and antimicrobial molecules including beta-defensins (BD). Acinetobacter baumannii is a cause of hospital-acquired pneumonia. We examined whether A. baumannii induced the expressions of IL-8 and BD2 by airway epithelial cells and the receptors implicated in bacterial detection. A549 and human primary airway cells released IL-8 upon infection. A. baumannii-infected cells also increased the expression of BD2 which killed A. baummannii strains. IL-8 induction was via NF-kappa B and mitogen-activated kinases p38 and p44/42-dependent pathways. A. baumannii engaged Toll-like receptor (TLR) 2 and TLR4 pathways and A549 cells could use soluble CD14 as TLRs co-receptor. A. baumannii lipopolysaccharide stimulated IL-8 release by A549 cells and sCD14 facilitated the recognition of the lipopolysaccharide. Mass spectrometry analysis revealed that A. baumannii lipid A structure matches those with endotoxic potential. These results demonstrate that airway epithelial cells produce mediators important for A. baumannii clearance.	[March, Catalina; Regueiro, Veronica; Llobet, Enrique; Moranta, David; Morey, Pau; Garmendia, Junkal; Bengoechea, Jose A.] Fundacio Caubet CIMERA Illes Balears, Program Infect & Immun, Bunyola, Spain; [March, Catalina; Regueiro, Veronica; Llobet, Enrique; Moranta, David; Morey, Pau; Garmendia, Junkal; Bengoechea, Jose A.] Ctr Invest Biomed Red Enfermedades Resp, Area Mol Basis Microbial Pathogenesis, Bunyola, Spain; [Garmendia, Junkal] Inst Agrobiotecnol, Pamplona, Spain; [Bengoechea, Jose A.] Univ Illes Balears, Fac Biol, Area Microbiol, Palma de Mallorca, Spain; [Bengoechea, Jose A.] CSIC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC)	March, C (corresponding author), Fundacio Caubet CIMERA Illes Balears, Program Infect & Immun, Bunyola, Spain.	bengoechea@caubet-cimera.es	Mesquida, David Moranta/H-4958-2012; Garmendia, Juncal/G-4360-2011; Morey, Pau/I-2521-2018	Mesquida, David Moranta/0000-0001-9528-4920; Garmendia, Juncal/0000-0002-7440-2737; Morey, Pau/0000-0003-3597-5054; Bengoechea, Jose/0000-0002-9677-8751	Fondo de Investigacian Sanitaria [PI04/1854]	Fondo de Investigacian Sanitaria	This work has been funded by a grant from Fondo de Investigacian Sanitaria (PI04/1854) to J.A.B. CIBERES is an initiative from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayram H, 1998, AM J RESP CELL MOL, V18, P441, DOI 10.1165/ajrcmb.18.3.2882; Bengoechea JA, 1996, INFECT IMMUN, V64, P4891, DOI 10.1128/IAI.64.12.4891-4899.1996; Chen MZ, 2001, CHEST, V120, P1072, DOI 10.1378/chest.120.4.1072; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; EL HA, 2005, J LIPID RES, V46, P1773; Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jia HP, 2001, GENE, V263, P211; Karim M, 1991, J Pak Med Assoc, V41, P35; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Leone S, 2006, CARBOHYD RES, V341, P582, DOI 10.1016/j.carres.2006.01.016; Leone S, 2007, J LIPID RES, V48, P1045, DOI 10.1194/jlr.M600323-JLR200; Leung AS, 2006, CHEST, V129, P102, DOI 10.1378/chest.129.1.102; LOPPNOW H, 1995, INFECT IMMUN, V63, P1020, DOI 10.1128/IAI.63.3.1020-1026.1995; Martin TR, 1997, AM J RESP CRIT CARE, V155, P937, DOI 10.1164/ajrccm.155.3.9117029; McCray PB, 1997, AM J RESP CELL MOL, V16, P343, DOI 10.1165/ajrcmb.16.3.9070620; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Pathmanathan S, 2003, OCCUP ENVIRON MED, V60, P892, DOI 10.1136/oem.60.11.892; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Qiu HY, 2009, MICROBES INFECT, V11, P946, DOI 10.1016/j.micinf.2009.06.003; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Schulz C, 2002, SCAND J IMMUNOL, V56, P294, DOI 10.1046/j.1365-3083.2002.01137.x; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tirsoaga A, 2007, APPL ENVIRON MICROB, V73, P1803, DOI 10.1128/AEM.02452-06; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; VAN FH, 2007, INFECT IMMUN, V75, P5597; Vinogradov EV, 1997, EUR J BIOCHEM, V243, P122, DOI 10.1111/j.1432-1033.1997.0122a.x; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i	57	51	53	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10033	10.1371/journal.pone.0010033	http://dx.doi.org/10.1371/journal.pone.0010033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383325	Green Published, Green Submitted, gold			2022-12-25	WOS:000276454000007
J	Li, CH; Ohn, T; Ivanov, P; Tisdale, S; Anderson, P				Li, Chi Ho; Ohn, Takbum; Ivanov, Pavel; Tisdale, Sarah; Anderson, Paul			eIF5A Promotes Translation Elongation, Polysome Disassembly and Stress Granule Assembly	PLOS ONE			English	Article							INITIATION-FACTOR 5A; O-GLCNAC MODIFICATION; PROTEIN-SYNTHESIS; DEOXYHYPUSINE SYNTHASE; HYPUSINE MODIFICATION; GROWTH; EIF-5A; INVOLVEMENT; INHIBITOR; DEPLETION	Stress granules (SGs) are cytoplasmic foci at which untranslated mRNAs accumulate in cells exposed to environmental stress. We have identified ornithine decarboxylase (ODC), an enzyme required for polyamine synthesis, and eIF5A, a polyamine (hypusine)-modified translation factor, as proteins required for arsenite-induced SG assembly. Knockdown of deoxyhypusine synthase (DHS) or treatment with a deoxyhypusine synthase inhibitor (GC7) prevents hypusine modification of eIF5A as well as arsenite-induced polysome disassembly and stress granule assembly. Time-course analysis reveals that this is due to a slowing of stress-induced ribosome run-off in cells lacking hypusine-eIF5A. Whereas eIF5A only marginally affects protein synthesis under normal conditions, it is required for the rapid onset of stress-induced translational repression. Our results reveal that hypusine-eIF5A-facilitated translation elongation promotes arsenite-induced polysome disassembly and stress granule assembly in cells subjected to adverse environmental conditions.	[Li, Chi Ho; Ohn, Takbum; Ivanov, Pavel; Tisdale, Sarah; Anderson, Paul] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Li, CH (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu	Ivanov, Pavel/F-3339-2016; Ivanov, Pavel/AAZ-9197-2021	Ivanov, Pavel/0000-0002-7986-7760; Ivanov, Pavel/0000-0002-7986-7760	NIAID NIH HHS [R56 AI033600, AI065858, P01 AI065858, R01 AI033600, AI033600] Funding Source: Medline; NIAMS NIH HHS [AR0514732] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033600, R56AI033600, P01AI065858] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON P, 2008, TRENDS BIOCH SCI; BENNE R, 1978, J BIOL CHEM, V253, P3078; Cano VSP, 2008, FEBS J, V275, P44, DOI 10.1111/j.1742-4658.2007.06172.x; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Dias CAO, 2008, FEBS J, V275, P1874, DOI 10.1111/j.1742-4658.2008.06345.x; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hopkins MT, 2008, PLANT PHYSIOL, V148, P479, DOI 10.1104/pp.108.118869; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; KANG HA, 1994, J BIOL CHEM, V269, P3934; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Luchessi AD, 2009, J CELL PHYSIOL, V218, P480, DOI 10.1002/jcp.21619; Moore CC, 2008, J INFECT DIS, V198, P1407, DOI 10.1086/592222; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shi XP, 1996, BBA-MOL CELL RES, V1310, P119, DOI 10.1016/0167-4889(95)00165-4; STEINKASSERER A, 1995, GENOMICS, V25, P749, DOI 10.1016/0888-7543(95)80025-H; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Svensson KJ, 2008, CANCER RES, V68, P9291, DOI 10.1158/0008-5472.CAN-08-2340; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zhao YJ, 2007, EUR J PHARMACOL, V562, P236, DOI 10.1016/j.ejphar.2007.01.096; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	34	81	85	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9942	10.1371/journal.pone.0009942	http://dx.doi.org/10.1371/journal.pone.0009942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376341	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200018
J	Shao, W; Wu, J; Chen, J; Lee, DM; Tishkina, A; Harris, TJC				Shao, Wei; Wu, Johnny; Chen, Jeyla; Lee, Donghoon M.; Tishkina, Alisa; Harris, Tony J. C.			A Modifier Screen for Bazooka/PAR-3 Interacting Genes in the Drosophila Embryo Epithelium	PLOS ONE			English	Article							FUNCTIONAL GENOMIC SCREEN; CELL POLARITY; ADHERENS JUNCTIONS; PAR PROTEINS; ZONULA ADHERENS; E-CADHERIN; ESTABLISHMENT; REVEALS; APKC; CRUMBS	Background: The development and homeostasis of multicellular organisms depends on sheets of epithelial cells. Bazooka (Baz; PAR-3) localizes to the apical circumference of epithelial cells and is a key hub in the protein interaction network regulating epithelial structure. We sought to identify additional proteins that function with Baz to regulate epithelial structure in the Drosophila embryo. Methodology/Principal Findings: The baz zygotic mutant cuticle phenotype could be dominantly enhanced by loss of known interaction partners. To identify additional enhancers, we screened molecularly defined chromosome 2 and 3 deficiencies. 37 deficiencies acted as strong dominant enhancers. Using deficiency mapping, bioinformatics, and available single gene mutations, we identified 17 interacting genes encoding known and predicted polarity, cytoskeletal, transmembrane, trafficking and signaling proteins. For each gene, their loss of function enhanced adherens junction defects in zygotic baz mutants during early embryogenesis. To further evaluate involvement in epithelial polarity, we generated GFP fusion proteins for 15 of the genes which had not been found to localize to the apical domain previously. We found that GFP fusion proteins for Drosophila ASAP, Arf79F, CG11210, Septin 5 and Sds22 could be recruited to the apical circumference of epithelial cells. Nine of the other proteins showed various intracellular distributions, and one was not detected. Conclusions/Significance: Our enhancer screen identified 17 genes that function with Baz to regulate epithelial structure in the Drosophila embryo. Our secondary localization screen indicated that some of the proteins may affect epithelial cell polarity by acting at the apical cell cortex while others may act through intracellular processes. For 13 of the 17 genes, this is the first report of a link to baz or the regulation of epithelial structure.	[Shao, Wei; Wu, Johnny; Chen, Jeyla; Lee, Donghoon M.; Tishkina, Alisa; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Shao, W (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca		Lee, Donghoon/0000-0002-1078-6655	Canadian Institutes of Health Research (CIHR) [MOP-82829]; Natural Science and Engineering Research Council (NSERC) of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by Canadian Institutes of Health Research (CIHR) Operating grant number MOP-82829 to T. Harris (http://www.cihr-irsc.gc.ca/e/193.html). W. Shao was supported by a University of Toronto Connaught Scholarship and a Ning Po Residents Association Scholarship. J. Wu and J. Chen were supported by the Work-Study program at the University of Toronto. J. Chen was also awarded a Natural Science and Engineering Research Council (NSERC) of Canada Undergraduate Research Award. A. Tishkina was awarded a University of Toronto Excellence Award for Undergraduate Research. T. Harris holds a Tier 2 Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2002, GENE, V297, P69, DOI 10.1016/S0378-1119(02)00887-9; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Ayyub C, 2005, DEV DYNAM, V232, P865, DOI 10.1002/dvdy.20322; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Bayraktar J, 2006, J CELL SCI, V119, P711, DOI 10.1242/jcs.02789; Beers M, 2006, DEVELOPMENT, V133, P3745, DOI 10.1242/dev.02544; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2001, TRENDS GENET, V17, P511, DOI 10.1016/S0168-9525(01)02407-6; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Grawe F, 1996, DEVELOPMENT, V122, P951; Grusche FA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-14; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Magie Craig R., 2002, Development (Cambridge), V129, P3771; MCGILL MA, 2009, J CELL BIOL; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Pope KL, 2008, DEVELOPMENT, V135, P2227, DOI 10.1242/dev.019802; Raghu P, 2009, J CELL BIOL, V185, P129, DOI 10.1083/jcb.200807027; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zhang Y, 2004, CELL CYCLE, V3, P391	80	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9938	10.1371/journal.pone.0009938	http://dx.doi.org/10.1371/journal.pone.0009938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368978	Green Submitted, gold, Green Published			2022-12-25	WOS:000276418200015
J	Weisrock, DW; Rasoloarison, RM; Fiorentino, I; Ralison, JM; Goodman, SM; Kappeler, PM; Yoder, AD				Weisrock, David W.; Rasoloarison, Rodin M.; Fiorentino, Isabella; Ralison, Jose M.; Goodman, Steven M.; Kappeler, Peter M.; Yoder, Anne D.			Delimiting Species without Nuclear Monophyly in Madagascar's Mouse Lemurs	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENE TREES; MICROCEBUS; DNA; BIODIVERSITY; DIVERSITY; EVOLUTION; PATTERNS; LOCI; DELIMITATION	Background: Speciation begins when populations become genetically separated through a substantial reduction in gene flow, and it is at this point that a genetically cohesive set of populations attain the sole property of species: the independent evolution of a population-level lineage. The comprehensive delimitation of species within biodiversity hotspots, regardless of their level of divergence, is important for understanding the factors that drive the diversification of biota and for identifying them as targets for conservation. However, delimiting recently diverged species is challenging due to insufficient time for the differential evolution of characters-including morphological differences, reproductive isolation, and gene tree monophyly-that are typically used as evidence for separately evolving lineages. Methodology: In this study, we assembled multiple lines of evidence from the analysis of mtDNA and nDNA sequence data for the delimitation of a high diversity of cryptically diverged population-level mouse lemur lineages across the island of Madagascar. Our study uses a multi-faceted approach that applies phylogenetic, population genetic, and genealogical analysis for recognizing lineage diversity and presents the most thoroughly sampled species delimitation of mouse lemur ever performed. Conclusions: The resolution of a large number of geographically defined clades in the mtDNA gene tree provides strong initial evidence for recognizing a high diversity of population-level lineages in mouse lemurs. We find additional support for lineage recognition in the striking concordance between mtDNA clades and patterns of nuclear population structure. Lineages identified using these two sources of evidence also exhibit patterns of population divergence according to genealogical exclusivity estimates. Mouse lemur lineage diversity is reflected in both a geographically fine-scaled pattern of population divergence within established and geographically widespread taxa, as well as newly resolved patterns of microendemism revealed through expanded field sampling into previously poorly and well-sampled regions.	[Weisrock, David W.; Fiorentino, Isabella; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC USA; [Rasoloarison, Rodin M.; Kappeler, Peter M.] German Primate Ctr, Dept Behav Ecol & Sociobiol, Gottingen, Germany; [Rasoloarison, Rodin M.; Ralison, Jose M.] Univ Antananarivo, Dept Biol Anim, Antananarivo, Madagascar; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Vahatra, Antananarivo, Madagascar; [Yoder, Anne D.] Duke Univ, Duke Lemur Ctr, Durham, NC USA	Duke University; Deutsches Primatenzentrum (DPZ); University Antananarivo; Field Museum of Natural History (Chicago); Duke University	Weisrock, DW (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40536 USA.	dweis2@uky.edu	Weisrock, David W./G-3587-2015; Kappeler, Peter/B-6825-2012	Weisrock, David/0000-0002-6187-5623	National Science Foundation [DEB 0516276]; John D. and Catherine T. MacArthur Foundation; German Primate Center (DPZ); Deutsche Forschungsgemeinschaft [Ka 1082-8]; Volkswagen Foundation	National Science Foundation(National Science Foundation (NSF)); John D. and Catherine T. MacArthur Foundation; German Primate Center (DPZ); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This project was supported by grant DEB 0516276 from the National Science Foundation, and by funding from the John D. and Catherine T. MacArthur Foundation, the German Primate Center (DPZ), the Deutsche Forschungsgemeinschaft (grant Ka 1082-8), and the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS RM, 1994, J MOL EVOL, V38, P215; Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Andreone F, 2008, PLOS BIOL, V6, P943, DOI 10.1371/journal.pbio.0060118; Andriantompohavana Rambinintsoa, 2006, Occasional Papers Museum of Texas Tech University, V259, P1; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Caparroz R, 2009, AUK, V126, P359, DOI 10.1525/auk.2009.07183; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2005, EVOLUTION, V59, P24; Duminil J, 2006, MOL ECOL, V15, P3505, DOI 10.1111/j.1365-294X.2006.03040.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fichtel C, 2007, AM J PRIMATOL, V69, P611, DOI 10.1002/ajp.20363; Fredsted T, 2005, MOL ECOL, V14, P2363, DOI 10.1111/j.1365-294X.2005.02596.x; FU YX, 1993, GENETICS, V133, P693; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goodman S.M., 1997, FIELDIANA ZOOL, V87, P1; Groeneveld LF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-30; Groves CP, 2000, INT J PRIMATOL, V21, P943, DOI 10.1023/A:1005559012637; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heckman KL, 2007, MOL PHYLOGENET EVOL, V43, P353, DOI 10.1016/j.ympev.2007.03.005; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Hudson RR, 2003, EVOLUTION, V57, P182; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Kappeler P.M., 2005, Primate Report, V71, P3; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Louis EE, 2006, INT J PRIMATOL, V27, P347, DOI 10.1007/s10764-006-9036-1; Louis Edward E. Jr, 2008, Primate Conservation, V23, P19, DOI 10.1896/052.023.0103; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; Mayden R. L., 1997, V54, P381; Mayden RL, 1999, J NEMATOL, V31, P95; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Olivieri G, 2007, MOL PHYLOGENET EVOL, V43, P309, DOI 10.1016/j.ympev.2006.10.026; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pritchard JK, 2000, GENETICS, V155, P945; Radespiel U, 2008, AM J PRIMATOL, V70, P1033, DOI 10.1002/ajp.20592; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Thalmann U, 2007, FOLIA PRIMATOL, V78, P420, DOI 10.1159/000105153; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Weisrock DW, 2006, MOL ECOL, V15, P2489, DOI 10.1111/j.1365-294X.2006.02961.x; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wimmer B, 2002, BEHAV ECOL SOCIOBIOL, V52, P166, DOI 10.1007/s00265-002-0497-8; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yoder AD, 2000, P NATL ACAD SCI USA, V97, P11325, DOI 10.1073/pnas.200121897; Yoder AD, 2005, P NATL ACAD SCI USA, V102, P6587, DOI 10.1073/pnas.0502092102; Yoder AD, 2002, INT J PRIMATOL, V23, P1335, DOI 10.1023/A:1021187106641	69	119	119	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9883	10.1371/journal.pone.0009883	http://dx.doi.org/10.1371/journal.pone.0009883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360988	gold, Green Published, Green Submitted			2022-12-25	WOS:000276163200003
J	Chuykin, I; Lapidus, I; Popova, E; Vilianovich, L; Mosienko, V; Alenina, N; Binas, B; Chai, GX; Bader, M; Krivokharchenko, A				Chuykin, Ilya; Lapidus, Irina; Popova, Elena; Vilianovich, Larisa; Mosienko, Valentina; Alenina, Natalia; Binas, Bert; Chai, Guixuan; Bader, Michael; Krivokharchenko, Alexander			Characterization of Trophoblast and Extraembryonic Endoderm Cell Lineages Derived from Rat Preimplantation Embryos	PLOS ONE			English	Article							STEM-CELLS; GATA FACTORS; ES CELLS; MOUSE; DIFFERENTIATION; BLASTOCYSTS; LINES; GENERATION; TISSUES	Background: Previous attempts to isolate pluripotent cell lines from rat preimplantation embryo in mouse embryonic stem (ES) cell culture conditions (serum and LIF) were unsuccessful, however the resulting cells exhibited the expression of such traditional pluripotency markers as SSEA-1 and alkaline phosphatase. We addressed the question, which kind of cell lineages are produced from rat preimplantation embryo under "classical" mouse ES conditions. Results: We characterized two cell lines (C5 and B10) which were obtained from rat blastocysts in medium with serum and LIF. In the B10 cell line we found the expression of genes known to be expressed in trophoblast, Cdx-2, cytokeratin-7, and Hand-1. Also, B10 cells invaded the trophectodermal layer upon injection into rat blastocysts. In contrast to mouse Trophoblast Stem (TS) cells proliferation of B10 cells occurred independently of FGF4. Cells of the C5 line expressed traditional markers of extraembryonic-endoderm (XEN) cells, in particular, GATA-4, but also the pluripotency markers SSEA-1 and Oct-4. C5 cell proliferation exhibited dependence on LIF, which is not known to be required by mouse XEN cells. Conclusions: Our results confirm and extend previous findings about differences between blastocyst-derived cell lines of rat and mice. Our data show, that the B10 cell line represents a population of FGF4-independent rat TS-like cells. C5 cells show features that have recently become known as characteristic of rat XEN cells. Early passages of C5 and B10 cells contained both, TS and XEN cells. We speculate, that mechanisms maintaining self-renewal of cell lineages in rat preimplantation embryo and their in vitro counterparts, including ES, TS and XEN cells are different than in respective mouse lineages.	[Chuykin, Ilya; Lapidus, Irina; Popova, Elena; Vilianovich, Larisa; Mosienko, Valentina; Alenina, Natalia; Bader, Michael; Krivokharchenko, Alexander] Max Delbruck Ctr Mol Med, Berlin, Germany; [Binas, Bert] Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea; [Chai, Guixuan] HD Biosci Co Ltd, Shanghai, Peoples R China	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hanyang University	Chuykin, I (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	mbader@mdc-berlin.de	Mosienko, Valentina/AAN-5983-2020; Bader, Michael/K-2124-2013	Popova, Elena/0000-0002-3043-9650; Mosienko, Valentina/0000-0002-8562-532X; Bader, Michael/0000-0003-4780-4164	DAAD [A0890020, A0799669]; ESF [2007000003]; Russian fund for fundamental research and Helmholtz society [HRJRG 24]; European Union	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ESF(European Commission); Russian fund for fundamental research and Helmholtz society; European Union(European Commission)	I.C. and V. M. were supported by the grant of DAAD (A0890020 and A0799669). I. L. was supported by ESF (2007000003). This work was supported by a joint grant between the Russian fund for fundamental research and Helmholtz society (HRJRG 24) and by the EURATOOLS integrated project funded by the Sixth Framework Programme of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Galat V, 2009, STEM CELLS DEV, V18, P1309, DOI 10.1089/scd.2009.0115; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Krivokharchenko A, 2002, MOL REPROD DEV, V61, P460, DOI 10.1002/mrd.90001; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Li CL, 2009, CELL RES, V19, P173, DOI 10.1038/cr.2008.301; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Popova E, 2008, TRANSGENIC RES, V17, P955, DOI 10.1007/s11248-008-9189-0; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Shimosato D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-80; Sutherland A, 2003, DEV BIOL, V258, P241, DOI 10.1016/S0012-1606(03)00130-1; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844	31	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9794	10.1371/journal.pone.0009794	http://dx.doi.org/10.1371/journal.pone.0009794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369002	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000276163100002
J	Simmen, B; Bayart, F; Rasamimanana, H; Zahariev, A; Blanc, S; Pasquet, P				Simmen, Bruno; Bayart, Francoise; Rasamimanana, Hanta; Zahariev, Alexandre; Blanc, Stephane; Pasquet, Patrick			Total Energy Expenditure and Body Composition in Two Free-Living Sympatric Lemurs	PLOS ONE			English	Article							RING-TAILED LEMURS; PROPITHECUS-VERREAUXI-COQUERELI; FIELD METABOLIC-RATE; EULEMUR-FULVUS; VARECIA-VARIEGATA; HAPALEMUR-GRISEUS; BASAL-METABOLISM; MOUSE LEMUR; PRIMATE; WILD	Background: Evolutionary theories that account for the unusual socio-ecological traits and life history features of group-living prosimians, compared with other primates, predict behavioral and physiological mechanisms to conserve energy. Low energy output and possible fattening mechanisms are expected, as either an adaptive response to drastic seasonal fluctuations of food supplies in Madagascar, or persisting traits from previously nocturnal hypometabolic ancestors. Free ranging ring-tailed lemurs (Lemur catta) and brown lemurs (Eulemur sp.) of southern Madagascar have different socio-ecological characteristics which allow a test of these theories: Both gregarious primates have a phytophagous diet but different circadian activity rhythms, degree of arboreality, social systems, and slightly different body size. Methodology and Results: Daily total energy expenditure and body composition were measured in the field with the doubly labeled water procedure. High body fat content was observed at the end of the rainy season, which supports the notion that individuals need to attain a sufficient physical condition prior to the long dry season. However, ring-tailed lemurs exhibited lower water flux rates and energy expenditure than brown lemurs after controlling for body mass differences. The difference was interpreted to reflect higher efficiency for coping with seasonally low quality foods and water scarcity. Daily energy expenditure of both species was much less than the field metabolic rates predicted by various scaling relationships found across mammals. Discussion: We argue that low energy output in these species is mainly accounted for by low basal metabolic rate and reflects adaptation to harsh, unpredictable environments. The absence of observed sex differences in body weight, fat content, and daily energy expenditure converge with earlier investigations of physical activity levels in ring-tailed lemurs to suggest the absence of a relationship between energy constraints and the evolution of female dominance over males among lemurs. Nevertheless, additional seasonal data are required to provide a definitive conclusion.	[Simmen, Bruno; Bayart, Francoise; Pasquet, Patrick] CNRS, UMR 7206, Brunoy, France; [Simmen, Bruno; Bayart, Francoise; Pasquet, Patrick] Museum Natl Hist Nat, Brunoy, France; [Rasamimanana, Hanta] Univ Antananarivo, Ecole Normale Super, Antananarivo, Madagascar; [Zahariev, Alexandre; Blanc, Stephane] Univ Strasbourg, Strasbourg, France; [Zahariev, Alexandre; Blanc, Stephane] CNRS, Inst Pluridisciplinaire Hubert Curien, UMR 7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); University Antananarivo; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Simmen, B (corresponding author), CNRS, UMR 7206, Brunoy, France.	simmen@mnhn.fr	Simmen, Bruno/G-9916-2014	Patrick, Pasquet/0000-0002-7017-3068; Simmen, Bruno/0000-0002-5867-1646	National Museum of Natural History in Paris; CNRS [7206]	National Museum of Natural History in Paris; CNRS(Centre National de la Recherche Scientifique (CNRS))	The study was funded by a BQR from the National Museum of Natural History in Paris and by CNRS (UMR 7206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; Blanc S, 2005, J MED PRIMATOL, V34, P130, DOI 10.1111/j.1600-0684.2005.00106.x; Campbell JL, 2000, AM J PRIMATOL, V52, P133, DOI 10.1002/1098-2345(200011)52:3<133::AID-AJP2>3.0.CO;2-#; Campbell JL, 2004, AM J PRIMATOL, V64, P323, DOI 10.1002/ajp.20081; Clutton-Brock T. H, 1977, P557; DANIELS HL, 1984, J MAMMAL, V65, P584, DOI 10.2307/1380841; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Donati G, 2009, ANIM BEHAV, V77, P317, DOI 10.1016/j.anbehav.2008.09.033; Drack S, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P83; Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039; Ganzhorn Jorg U., 2003, P132; Garcia C, 2004, J MED PRIMATOL, V33, P146, DOI 10.1111/j.1600-0684.2004.00064.x; Genoud M, 1997, AM J PRIMATOL, V41, P229, DOI 10.1002/(SICI)1098-2345(1997)41:3<229::AID-AJP5>3.0.CO;2-Z; Goodman SM, 1997, REV ECOL-TERRE VIE, V52, P321; Goodman Steven M., 2006, P3, DOI 10.1007/978-0-387-34126-2_1; Hayes M, 2005, INT J OBESITY, V29, P151, DOI 10.1038/sj.ijo.0802842; Hladik A., 1980, P3; Hladik C.-M., 1981, P215; Jolly A., 1966, LEMUR BEHAV MADAGASC; Jolly A., 1984, FEMALE PRIMATES STUD, P197; Jolly Alison, 2006, P3; KAPPELER PM, 1991, FOLIA PRIMATOL, V57, P132, DOI 10.1159/000156575; KARASOV WH, 1992, AM ZOOL, V32, P238, DOI 10.1093/icb/32.2.238; Kleiber M., 1961, FIRE LIFE, DOI DOI 10.1002/JPS.2600510525; KODAMA AM, 1970, J APPL PHYSIOL, V29, P260, DOI 10.1152/jappl.1970.29.2.260; Koyama N, 2008, PRIMATES, V49, P9, DOI 10.1007/s10329-007-0051-4; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; MILTON K, 1976, NATURE, V259, P459, DOI 10.1038/259459a0; MILTON K, 1979, J MAMMAL, V60, P373, DOI 10.2307/1379809; Milton K., 1980, FORAGING STRATEGIES; NAGY KA, 1979, ECOLOGY, V60, P475, DOI 10.2307/1936066; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; OVERDORFF DJ, 1993, INT J PRIMATOL, V14, P721, DOI 10.1007/BF02192188; Overdorff DJ, 1996, AM J PHYS ANTHROPOL, V100, P487; Pereira ME, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P93; PEREIRA ME, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P205; Perret M, 1998, COMP BIOCHEM PHYS A, V119, P981, DOI 10.1016/S1095-6433(98)00015-4; Pinkus Susan, 2006, P119, DOI 10.1007/978-0-387-34126-2_9; Power RA, 2001, COMPARATIVE MED, V51, P218; Pride E, 2005, BEHAV ECOL, V16, P550, DOI 10.1093/beheco/ari025; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; RASAMIMANANA H, 2004, THESIS NATL MUSEUM N; Rasamimanana Hantanirina, 2006, P271, DOI 10.1007/978-0-387-34126-2_16; RASAMIMANANA HR, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P123; Richard AF, 2000, J HUM EVOL, V39, P381, DOI 10.1006/jhev.2000.0427; RICHARD AF, 1987, AM J PRIMATOL, V12, P309, DOI 10.1002/ajp.1350120308; RICHARD AF, 1991, ANNU REV ECOL SYST, V22, P145, DOI 10.1146/annurev.es.22.110191.001045; Roeder JJ, 2002, AGGRESSIVE BEHAV, V28, P62, DOI 10.1002/ab.90006; Sapolsky RM, 1998, AM J PRIMATOL, V44, P155, DOI 10.1002/(SICI)1098-2345(1998)44:2&lt;155::AID-AJP6&gt;3.0.CO;2-V; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Sauther ML, 1998, FOLIA PRIMATOL, V69, P309; Schmid J, 2000, J COMP PHYSIOL B, V170, P633, DOI 10.1007/s003600000146; Schmid J, 1996, AM J PRIMATOL, V38, P169, DOI 10.1002/(SICI)1098-2345(1996)38:2<169::AID-AJP5>3.0.CO;2-X; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; Simmen B, 2003, INT J PRIMATOL, V24, P948; Simmen B, 2007, INT J PRIMATOL, V28, P1253, DOI 10.1007/s10764-007-9217-6; Simmen Bruno, 2006, P55, DOI 10.1007/978-0-387-34126-2_5; Speakman J.R., 1997, DOUBLY LABELLED WATE; Sussman R.W., 1974, P75; vanSchaik CP, 1996, ETHOLOGY, V102, P915; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Wright PC, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P121, DOI 10.1007/1-4020-3833-X_7	68	39	41	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9860	10.1371/journal.pone.0009860	http://dx.doi.org/10.1371/journal.pone.0009860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360848	gold, Green Published, Green Submitted			2022-12-25	WOS:000275969500006
J	Davenport, CF; Tummler, B				Davenport, Colin F.; Tuemmler, Burkhard			Abundant Oligonucleotides Common to Most Bacteria	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; A-TRACT; DINUCLEOTIDE STEPS; BENT DNA; EVOLUTIONARY IMPLICATIONS; NUCLEOSOME ORGANIZATION; GENOMES; SEQUENCES; CHROMOSOMES; SIGNATURES	Background: Bacteria show a bias in their genomic oligonucleotide composition far beyond that dictated by G+C content. Patterns of over-and underrepresented oligonucleotides carry a phylogenetic signal and are thus diagnostic for individual species. Patterns of short oligomers have been investigated by multiple groups in large numbers of bacteria genomes. However, global distributions of the most highly overrepresented mid-sized oligomers have not been assessed across all prokaryotes to date. We surveyed overrepresented mid-length oligomers across all prokaryotes and normalised for base composition and embedded oligomers using zero and second order Markov models. Principal Findings: Here we report a presumably ancient set of oligomers conserved and overrepresented in nearly all branches of prokaryotic life, including Archaea. These oligomers are either adenine rich homopurines with one to three guanine nucleosides, or homopyridimines with one to four cytosine nucleosides. They do not show a consistent preference for coding or non-coding regions or aggregate in any coding frame, implying a role in DNA structure and as polypeptide binding sites. Structural parameters indicate these oligonucleotides to be an extreme and rigid form of B-DNA prone to forming triple stranded helices under common physiological conditions. Moreover, the narrow minor grooves of these structures are recognised by DNA binding and nucleoid associated proteins such as HU. Conclusion: Homopurine and homopyrimidine oligomers exhibit distinct and unusual structural features and are present at high copy number in nearly all prokaryotic lineages. This fact suggests a non-neutral role of these oligonucleotides for bacterial genome organization that has been maintained throughout evolution.	[Davenport, Colin F.; Tuemmler, Burkhard] Hannover Med Sch, Hannover, Lower Saxony, Germany	Hannover Medical School	Davenport, CF (corresponding author), Hannover Med Sch, Hannover, Lower Saxony, Germany.	davenport.colin@mh-hannover.de		Davenport, Colin/0000-0002-4764-6963	Deutsche Forschungsgemeinschaft [653/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grant 653/3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P865, DOI 10.1093/bioinformatics/16.10.865; BEUTEL BA, 1992, J MOL BIOL, V228, P803, DOI 10.1016/0022-2836(92)90865-H; Bohlin J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000057; BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; Chor B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r108; Cohanim AB, 2009, NUCLEIC ACIDS RES, V37, P6466, DOI 10.1093/nar/gkp689; Coker C, 2000, J BACTERIOL, V182, P2649, DOI 10.1128/JB.182.9.2649-2653.2000; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davenport CF, 2009, ENVIRON MICROBIOL, V11, P1092, DOI 10.1111/j.1462-2920.2008.01839.x; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; ELHASSAN MA, 1995, J MOL BIOL, V251, P648, DOI 10.1006/jmbi.1995.0462; ElHassan MA, 1996, ENDEAVOUR, V20, P61, DOI 10.1016/0160-9327(96)10016-8; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; Fofanov Y, 2004, BIOINFORMATICS, V20, P2421, DOI 10.1093/bioinformatics/bth266; Greenwood P. E., 1996, GUIDE CHISQUARED TES; Hampson S, 2002, BIOINFORMATICS, V18, P513, DOI 10.1093/bioinformatics/18.4.513; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HARAN TE, 1989, BIOCHEMISTRY-US, V28, P2763, DOI 10.1021/bi00433a003; HOEBEKE M, RMES FINDING EXCEPTI; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karlin S, 1996, NUCLEIC ACIDS RES, V24, P4263, DOI 10.1093/nar/24.21.4263; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEROY JL, 1988, BIOCHEMISTRY-US, V27, P8894, DOI 10.1021/bi00425a004; Mrazek J, 2002, NUCLEIC ACIDS RES, V30, P4216, DOI 10.1093/nar/gkf534; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P5127, DOI 10.1073/pnas.0700429104; NADEAU JG, 1989, P NATL ACAD SCI USA, V86, P2622, DOI 10.1073/pnas.86.8.2622; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; ORNSTEIN RL, 1978, BIOPOLYMERS, V17, P2341, DOI 10.1002/bip.1978.360171005; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; R Core Team, 2022, R LANG ENV STAT COMP; RAJAGOPAL P, 1989, NATURE, V339, P637, DOI 10.1038/339637a0; Reva ON, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-90; Roberts RW, 1996, P NATL ACAD SCI USA, V93, P4320, DOI 10.1073/pnas.93.9.4320; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sandstrom K, 2002, J MOL BIOL, V315, P737, DOI 10.1006/jmbi.2001.5249; Schbath S, 2000, J COMPUT BIOL, V7, P193, DOI 10.1089/10665270050081469; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Tolstorukov MY, 2005, NUCLEIC ACIDS RES, V33, P3907, DOI 10.1093/nar/gki699; van Passel MWJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-26; Wang YW, 2005, GENE, V346, P173, DOI 10.1016/j.gene.2004.10.021; WATERHOUSE AM, 2009, JALVIEW VERSION 2 MU; Woods KK, 2004, J AM CHEM SOC, V126, P15330, DOI 10.1021/ja045207x	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9841	10.1371/journal.pone.0009841	http://dx.doi.org/10.1371/journal.pone.0009841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352124	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894400034
J	Flier, SN; Tanjore, H; Kokkotou, EG; Sugimoto, H; Zeisberg, M; Kalluri, R				Flier, Sarah N.; Tanjore, Harikrishna; Kokkotou, Efi G.; Sugimoto, Hikaru; Zeisberg, Michael; Kalluri, Raghu			Identification of Epithelial to Mesenchymal Transition as a Novel Source of Fibroblasts in Intestinal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; BONE MORPHOGENIC PROTEIN-7; TNF-ALPHA THERAPY; CROHNS-DISEASE; SUBEPITHELIAL MYOFIBROBLASTS; RENAL FIBROBLASTS; MOUSE MODELS; TGF-BETA; KIDNEY; TRANSFORMATION	Intestinal fibrosis is a major complication of Crohn disease (CD), but the precise mechanism by which it occurs is incompletely understood. As a result, specific therapies to halt or even reverse fibrosis have not been explored. Here, we evaluated the contribution of epithelial to mesenchymal transition (EMT) to intestinal fibrosis associated with a mouse model of CD and also human inflammatory bowel disease. Mice administered intrarectal 2,4,6-trinitrobenzene sulfonic acid (TNBS) develop inflammation and fibrosis that resembles CD both histologically and by immunologic profile. We utilized this model to molecularly probe the contribution of EMT to intestinal fibrosis. Additionally, we utilized double-transgenic VillinCre; R26Rosa-lox-STOP-lox-LacZ mice, in which removal of the STOP cassette by Cre recombinase in villin(+) intestinal epithelial cells activates permanent LacZ expression, to lineage trace epithelial cells that might undergo EMT upon TNBS administration. TNBS-induced fibrosis is associated with the presence of a significant number of cells that express both epithelial and mesenchymal markers. In the lineage tagged transgenic mice, the appearance of LacZ(+) cells that also express the fibroblast marker FSP1 unequivocally demonstrates EMT. Transforming growth factor (TGF)-beta 1, a known inducer of EMT in epithelial cells, induces EMT in rat intestinal epithelial cells in vitro, and bone morphogenic protein-7, an antagonist of TGF-beta 1, inhibits EMT and fibrosis both in vitro and in the TNBS-treated mice. Our study demonstrates that EMT contributes to intestinal fibrosis associated with the TNBS-induced model of Crohn colitis and that inhibition of TGF-beta 1 with recombinant human bone morphogenic protein-7 prevents this process and prevents fibrosis.	[Kalluri, Raghu] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci,Dept Med,Div Matrix Biol, Boston, MA 02215 USA; [Flier, Sarah N.; Kokkotou, Efi G.] Beth Israel Deaconess Med Ctr, Dept Med, Dept Gastroenterol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Mit Div Hlth Sci & Technol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University	Kalluri, R (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci,Dept Med,Div Matrix Biol, 3 Blackfan Circle,Rm 11090, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X	National Institutes of Health [DK62987, DK55001, AA13913, DK080058, CA125550, DK61688, T32DK07760, 5K08DK074558, R03DK081687]; Harvard Digestive Diseases Center; Beth Israel Deaconess Medical Center for the Division of Matrix Biology; NATIONAL CANCER INSTITUTE [R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080058, R01DK062987, K08DK074558, R03DK081687, R01DK061688, T32DK007760, R01DK055001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Beth Israel Deaconess Medical Center for the Division of Matrix Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62987, DK55001, AA13913, DK080058 (to E. G. K.), and CA125550 and DK61688 (to R. K.). This work was also supported by a research fund from the Beth Israel Deaconess Medical Center for the Division of Matrix Biology.; Supported by National Institutes of Health Grant T32DK07760.; Supported by National Institutes of Health Grants 5K08DK074558 and R03DK081687 and by a grant from the Harvard Digestive Diseases Center Pilot and Feasibility Awards Program.	Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004; Bataille F, 2008, INFLAMM BOWEL DIS, V14, P1514, DOI 10.1002/ibd.20590; Cook SD, 1996, CLIN ORTHOP RELAT R, P29, DOI 10.1097/00003086-199603000-00005; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; FIOCCHI C, 1997, AM J PHYSIOL, V273, P769; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Froehlich F, 2007, DIGESTION, V76, P113, DOI 10.1159/000111025; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hay ED, 1995, ACTA ANAT, V154, P8; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Lichtenstein GR, 2006, AM J GASTROENTEROL, V101, P1030, DOI 10.1111/j.1572-0241.2006.00463.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Schuppan D, 2001, SEMIN LIVER DIS, V21, P351, DOI 10.1055/s-2001-17556; Sorrentino D, 2007, DIGESTION, V75, P22, DOI 10.1159/000101563; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2006, NEPHROL DIAL TRANSPL, V21, P568, DOI 10.1093/ndt/gfk010; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	48	190	198	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20202	20212		10.1074/jbc.M110.102012	http://dx.doi.org/10.1074/jbc.M110.102012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20363741	hybrid, Green Published			2022-12-25	WOS:000279012000055
J	Smythies, LE; Shen, RZ; Bimczok, D; Novak, L; Clements, RH; Eckhoff, DE; Bouchard, P; George, MD; Hu, WK; Dandekar, S; Smith, PD				Smythies, Lesley E.; Shen, Ruizhong; Bimczok, Diane; Novak, Lea; Clements, Ronald H.; Eckhoff, Devin E.; Bouchard, Phillipe; George, Michael D.; Hu, William K.; Dandekar, Satya; Smith, Phillip D.			Inflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced I kappa B alpha Expression and NF-kappa B Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BRUTONS TYROSINE KINASE; DOWN-REGULATION; CD14; GUT; ACTIVATION; CELLS; MONOCYTES; PATHWAY; STROMA	Human intestinal macrophages contribute to tissue homeostasis in noninflamed mucosa through profound down-regulation of pro-inflammatory cytokine release. Here, we show that this down-regulation extends to Toll-like receptor (TLR)-induced cytokine release, as intestinal macrophages expressed TLR3-TLR9 but did not release cytokines in response to TLR-specific ligands. Likely contributing to this unique functional profile, intestinal macrophages expressed markedly down-regulated adapter proteins MyD88 and Toll interleukin receptor 1 domain-containing adapter-inducing interferon, which together mediate all TLR MyD88-dependent and -independent NF-kappa B signaling, did not phosphorylate NF-kappa B p65 or Smadinduced I kappa B alpha, and did not translocate NF-kappa B into the nucleus. Importantly, transforming growth factor-beta released from intestinal extracellular matrix (stroma) induced identical down-regulation in the NF-kappa B signaling and function of blood monocytes, the exclusive source of intestinal macrophages. Our findings implicate stromal transforming growth factor-beta-induced dysregulation of NF-kappa B proteins and Smad signaling in the differentiation of pro-inflammatory blood monocytes into noninflammatory intestinal macrophages.	[Smythies, Lesley E.; Shen, Ruizhong; Bimczok, Diane; Bouchard, Phillipe; Smith, Phillip D.] Univ Alabama Birmingham, Dept Med Gastroenterol, Birmingham, AL 35294 USA; [Novak, Lea] Univ Alabama Birmingham, Dept Pathol & Surg, Birmingham, AL 35294 USA; [Clements, Ronald H.] Univ Alabama Birmingham, Dept Gastrointestinal, Birmingham, AL 35294 USA; [Eckhoff, Devin E.] Univ Alabama Birmingham, Dept Transplantat, Birmingham, AL 35294 USA; [George, Michael D.; Hu, William K.; Dandekar, Satya] Univ Calif Davis, Dept Med Microbiol, Davis, CA 95616 USA; [Smith, Phillip D.] Vet Adm Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smythies, LE (corresponding author), Univ Alabama Birmingham, Dept Med, 1530 3rd Ave S,SHEL 606, Birmingham, AL 35294 USA.	lesmy@uab.edu; pdsmith@uab.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083027, R21AI083539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054495, R01DK061297, R01DK047322, R01DK043183, R24DK064400, R21DK074033] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000372] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-20136, C06 RR020136] Funding Source: Medline; NIAID NIH HHS [AI-83027, AI-83539, P01 AI083027, R21 AI083539] Funding Source: Medline; NIDDK NIH HHS [R01 DK047322, R01 DK043183, R01 DK061297, DK-61297, DK-47322, DK-64400, DK-54495, R24 DK064400, DK-74033, DK-43183, R21 DK074033, R01 DK054495] Funding Source: Medline; CSRD VA [I01 CX000372] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CSRD VA		Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Imai K, 2000, INFECT IMMUN, V68, P2418, DOI 10.1128/IAI.68.5.2418-2423.2000; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li L, 1999, GASTROENTEROLOGY, V116, P1043, DOI 10.1016/S0016-5085(99)70007-7; Maheshwari A, 2006, J LEUKOCYTE BIOL, V80, P1111, DOI 10.1189/jlb.0306230; MAI UEH, 1991, J CLIN INVEST, V87, P894, DOI 10.1172/JCI115095; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Meng G, 2000, J INFECT DIS, V182, P785, DOI 10.1086/315790; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2005, GASTROENTEROLOGY, V129, P1420, DOI 10.1053/j.gastro.2005.09.005; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rugtveit J, 1997, CLIN EXP IMMUNOL, V110, P104, DOI 10.1046/j.1365-2249.1997.5071404.x; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Schenk M, 2005, J IMMUNOL, V174, P517, DOI 10.4049/jimmunol.174.1.517; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Smith PD, 1997, J IMMUNOL METHODS, V202, P1, DOI 10.1016/S0022-1759(96)00204-9; Smith PD, 2001, J IMMUNOL, V167, P2651, DOI 10.4049/jimmunol.167.5.2651; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Smith PD, 2009, MUCOSAL IMMUNOL, V2, P378, DOI 10.1038/mi.2009.94; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; SMYTHIES LE, 2006, CURR PROTOC IMMUNO B, P1; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; WAHL LM, 2006, CURR PROTOCOL IMMUNO, P1; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270; ZHANG DE, 1994, J BIOL CHEM, V269, P11425	41	134	135	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19593	19604		10.1074/jbc.M109.069955	http://dx.doi.org/10.1074/jbc.M109.069955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388715	Green Published, hybrid			2022-12-25	WOS:000278727800069
J	Sammels, E; Devogelaere, B; Mekahli, D; Bultynck, G; Missiaen, L; Parys, JB; Cai, YQ; Somlo, S; De Smedt, H				Sammels, Eva; Devogelaere, Benoit; Mekahli, Djalila; Bultynck, Geert; Missiaen, Ludwig; Parys, Jan B.; Cai, Yiqiang; Somlo, Stefan; De Smedt, Humbert			Polycystin-2 Activation by Inositol 1,4,5-Trisphosphate-induced Ca2+ Release Requires Its Direct Association with the Inositol 1,4,5-Trisphosphate Receptor in a Signaling Microdomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; ENDOPLASMIC-RETICULUM; EPITHELIAL-CELLS; LIGAND-BINDING; CHANNEL; CALCIUM; TRPP2; COMPLEX; DOMAIN; GENE	Autosomal dominant polycystic kidney disease is characterized by the loss-of-function of a signaling complex involving polycystin-1 and polycystin-2 (TRPP2, an ion channel of the TRP superfamily), resulting in a disturbance in intracellular Ca2+ signaling. Here, we identified the molecular determinants of the interaction between TRPP2 and the inositol 1,4,5-trisphosphate receptor (IP3R), an intracellular Ca2+ channel in the endoplasmic reticulum. Glutathione S-transferase pulldown experiments combined with mutational analysis led to the identification of an acidic cluster in the C-terminal cytoplasmic tail of TRPP2 and a cluster of positively charged residues in the N-terminal ligand-binding domain of the IP3R as directly responsible for the interaction. To investigate the functional relevance of TRPP2 in the endoplasmic reticulum, we re-introduced the protein in TRPP2(-/-) mouse renal epithelial cells using an adenoviral expression system. The presence of TRPP2 resulted in an increased agonist-induced intracellular Ca2+ release in intact cells and IP3-induced Ca2+ release in permeabilized cells. Using pathological mutants of TRPP2, R740X and D509V, and competing peptides, we demonstrated that TRPP2 amplified the Ca2+ signal by a local Ca2+-induced Ca2+-release mechanism, which only occurred in the presence of the TRPP2-IP3R interaction, and not via altered IP3R channel activity. Moreover, our results indicate that this interaction was instrumental in the formation of Ca2+ microdomains necessary for initiating Ca2+-induced Ca2+ release. The data strongly suggest that defects in this mechanism may account for the altered Ca2+ signaling associated with pathological TRPP2 mutations and therefore contribute to the development of autosomal dominant polycystic kidney disease.	[Sammels, Eva; Devogelaere, Benoit; Mekahli, Djalila; Bultynck, Geert; Missiaen, Ludwig; Parys, Jan B.; De Smedt, Humbert] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, B-3000 Louvain, Belgium; [Cai, Yiqiang; Somlo, Stefan] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06510 USA	KU Leuven; Yale University	De Smedt, H (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, Campus Gasthuisberg O&N1,Herestr 49 Bus 802, B-3000 Louvain, Belgium.	humbert.desmedt@med.kuleuven.be		Parys, Jan/0000-0002-3591-4967; Mekahli, Djalila/0000-0003-0954-6088; Bultynck, Geert/0000-0002-5968-4828	K.U. Leuven [GOA/09/012]; Flemish National Science Foundation [G.0210.03]; Interuniversity Attraction Poles Programme [P6/28]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328, P30DK079310] Funding Source: NIH RePORTER	K.U. Leuven(KU Leuven); Flemish National Science Foundation; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grant GOA/09/012 from the Concerted Actions of the K.U. Leuven (to L. M., H. D. S., and J. B. P.), Grant G.0210.03 from the Flemish National Science Foundation (to H. D. S. and J. B. P.), and Grant P6/28 from the Interuniversity Attraction Poles Programme (to H. D. S., L. M., and J. B. P.).	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Devogelaere B, 2008, CELL CALCIUM, V43, P17, DOI 10.1016/j.ceca.2007.04.005; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; GABOW PA, 1997, DIS KIDNEY, P521; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, J AM SOC NEPHROL, V20, P1188, DOI 10.1681/ASN.2009010014; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kottgen M, 2005, PFLUG ARCH EUR J PHY, V451, P286, DOI 10.1007/s00424-005-1417-3; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Miyagi K, 2009, J BIOL CHEM, V284, P34400, DOI 10.1074/jbc.M109.015149; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; RICHARDSON A, 1993, J BIOL CHEM, V268, P11528; Schumann F, 2009, J BIOL CHEM, V284, P24372, DOI 10.1074/jbc.M109.025635; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 2007, CELL SIGNAL, V19, P444, DOI 10.1016/j.cellsig.2006.09.005; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106	46	82	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18794	18805		10.1074/jbc.M109.090662	http://dx.doi.org/10.1074/jbc.M109.090662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375013	Green Published, hybrid			2022-12-25	WOS:000278453900070
J	Feltham, R; Moulin, M; Vince, JE; Mace, PD; Wong, WWL; Anderton, H; Day, CL; Vaux, DL; Silke, J				Feltham, Rebecca; Moulin, Maryline; Vince, James E.; Mace, Peter D.; Wong, Wendy Wei-Lynn; Anderton, Holly; Day, Catherine L.; Vaux, David L.; Silke, John			Tumor Necrosis Factor (TNF) Signaling, but Not TWEAK (TNF-like Weak Inducer of Apoptosis)-triggered cIAP1 (Cellular Inhibitor of Apoptosis Protein 1) Degradation, Requires cIAP1 RING Dimerization and E2 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRAF2; ACTIVATION; ALPHA; COMPLEX; UBIQUITINATION; DOMAIN; SURVIVAL; C-IAP1; CELLS	Cellular inhibitor of apoptosis (cIAP) proteins, cIAP1 and cIAP2, are important regulators of tumor necrosis factor (TNF) superfamily (SF) signaling and are amplified in a number of tumor types. They are targeted by IAP antagonist compounds that are undergoing clinical trials. IAP antagonist compounds trigger cIAP autoubiquitylation and degradation. The TNFSF member TWEAK induces lysosomal degradation of TRAF2 and cIAPs, leading to elevated NIK levels and activation of non-canonical NF-kappa B. To investigate the role of the ubiquitin ligase RING domain of cIAP1 in these pathways, we used cIAP-deleted cells reconstituted with cIAP1 point mutants designed to interfere with the ability of the RING to dimerize or to interact with E2 enzymes. We show that RING dimerization and E2 binding are required for IAP antagonists to induce cIAP1 degradation and protect cells from TNF-induced cell death. The RING functions of cIAP1 are required for full TNF-induced activation of NF-kappa B, however, delayed activation of NF-kappa B still occurs in cIAP1 and -2 double knock-out cells. The RING functions of cIAP1 are also required to prevent constitutive activation of non-canonical NF-kappa B by targeting NIK for proteasomal degradation. However, in cIAP double knock-out cells TWEAK was still able to increase NIK levels demonstrating that NIK can be regulated by cIAP-independent pathways. Finally we show that, unlike IAP antagonists, TWEAK was able to induce degradation of cIAP1 RING mutants. These results emphasize the critical importance of the RING of cIAP1 in many signaling scenarios, but also demonstrate that in some pathways RING functions are not required.	[Feltham, Rebecca; Moulin, Maryline; Wong, Wendy Wei-Lynn; Anderton, Holly; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Vince, James E.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Mace, Peter D.; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	La Trobe University; University of Lausanne; University of Otago	Silke, J (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia.	j.silke@latrobe.edu.au	Silke, John/B-7622-2008; Vaux, David L/C-7249-2013; Wong, W. Wei-Lynn/A-6851-2015	Silke, John/0000-0002-7611-5774; Vaux, David L/0000-0003-2703-1651; Wong, W. Wei-Lynn/0000-0003-3155-1211; Day, Catherine/0000-0003-1571-4367; Anderton, Holly/0000-0003-3913-9686; Moulin, Maryline/0000-0002-1851-8727; Mace, Peter/0000-0003-2175-9537; Feltham, Rebecca/0000-0001-8376-6869	Human Frontiers Science Program Fellowship; Marsden Fund (New Zealand); Leukemia and Lymphoma Society; National Health and Medical Research Council [461221, 433013, 541901, 541902]	Human Frontiers Science Program Fellowship(Human Frontier Science Program); Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a Human Frontiers Science Program Fellowship.; Supported by the Marsden Fund (New Zealand).; Australian Fellow, funded by the Leukemia and Lymphoma Society and National Health and Medical Research Council Grant 461221.; Supported by National Health and Medical Research Council Grants 433013, 541901, and 541902.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang LQ, 2009, J MOL BIOL, V389, P495, DOI 10.1016/j.jmb.2009.04.054	52	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17525	17536		10.1074/jbc.M109.087635	http://dx.doi.org/10.1074/jbc.M109.087635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356846	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000278133400031
J	Kusama, N; Harding, AMS; Benson, CJ				Kusama, Nobuyoshi; Harding, Anne Marie S.; Benson, Christopher J.			Extracellular Chloride Modulates the Desensitization Kinetics of Acid-sensing Ion Channel 1a (ASIC1a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPREADING DEPRESSION; SENSORY NEURONS; ISCHEMIA; CONTRIBUTES; SUBUNITS; MUSCLE; ANIONS; PH; AMYGDALA; CURRENTS	Acid-sensing ion channels (ASICs) are sodium channels gated by extracellular protons. The recent crystallization of ASIC1a identified potential binding sites for Cl- in the extracellular domain that are highly conserved between ASIC isoforms. However, the significance of Cl- binding is unknown. We investigated the effect of Cl- substitution on heterologously expressed ASIC1a current and H+-gated currents from hippocampal neurons recorded by whole-cell patch clamp. Replacement of extracellular Cl- with the impermeable and inert anion methanesulfonate (MeSO3-) caused ASIC1a currents to desensitize at a faster rate and attenuated tachyphylaxis. However, peak current amplitude, pH sensitivity, and selectivity were unchanged. Other anions, including Br-, I-, and thiocyanate, also altered the kinetics of desensitization and tachyphylaxis. Mutation of the residues that form the Cl--binding site in ASIC1a abolished the modulatory effects of anions. The results of anion substitution on native ASIC channels in hippocampal neurons mirrored those in heterologously expressed ASIC1a and altered acid-induced neuronal death. Anion modulation of ASICs provides new insight into channel gating and may prove important in pathological brain conditions associated with changes in pH and Cl-.	[Kusama, Nobuyoshi; Harding, Anne Marie S.; Benson, Christopher J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Benson, CJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	chris-benson@uiowa.edu		Benson, Christopher/0000-0001-6600-8193	National Institutes of Health [HL076419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL076419 (to C. J. B.).	Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; ARMSTRONG CM, 1991, P NATL ACAD SCI USA, V88, P6528, DOI 10.1073/pnas.88.15.6528; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; DANI JA, 1983, J GEN PHYSIOL, V81, P255, DOI 10.1085/jgp.81.2.255; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gitterman DP, 2005, J PHYSIOL-LONDON, V562, P759, DOI 10.1113/jphysiol.2004.075069; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HILLE B, 1992, IONIC CHANNELS EXCIT, P261; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; KAO CY, 1968, J PHYSIOL-LONDON, V198, P291, DOI 10.1113/jphysiol.1968.sp008607; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; Naves LA, 2005, BRAZ J MED BIOL RES, V38, P1561, DOI 10.1590/S0100-879X2005001100001; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	37	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17425	17431		10.1074/jbc.M109.091561	http://dx.doi.org/10.1074/jbc.M109.091561			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385551	hybrid, Green Published			2022-12-25	WOS:000278133400020
J	Sim, L; Willemsma, C; Mohan, S; Naim, HY; Pinto, BM; Rose, DR				Sim, Lyann; Willemsma, Carly; Mohan, Sankar; Naim, Hassan Y.; Pinto, B. Mario; Rose, David R.			Structural Basis for Substrate Selectivity in Human Maltase-Glucoamylase and Sucrase-Isomaltase N-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDASE INHIBITORS; PROTEIN; GLUCOSIDASE; TRANSPORT; SALACINOL; ANALOGS; BINDING	Human maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI) are small intestinal enzymes that work concurrently to hydrolyze the mixture of linear alpha-1,4- and branched alpha-1,6-oligosaccharide substrates that typically make up terminal starch digestion products. MGAM and SI are each composed of duplicated catalytic domains, N- and C-terminal, which display overlapping substrate specificities. The N-terminal catalytic domain of human MGAM (ntMGAM) has a preference for short linear alpha-1,4-oligosaccharides, whereas N-terminal SI (ntSI) has a broader specificity for both alpha-1,4- and alpha-1,6-oligosaccharides. Here we present the crystal structure of the human ntSI, in apo form to 3.2 angstrom and in complex with the inhibitor kotalanol to 2.15 angstrom resolution. Structural comparison with the previously solved structure of ntMGAM reveals key active site differences in ntSI, including a narrow hydrophobic +1 subsite, which may account for its additional substrate specificity for alpha-1,6 substrates.	[Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Sim, Lyann; Willemsma, Carly; Rose, David R.] Univ Toronto, Dept Med Biophys, Toronto, ON M56 2M9, Canada; [Sim, Lyann; Willemsma, Carly; Rose, David R.] Univ Toronto, Ontario Canc Inst, Toronto, ON M56 2M9, Canada; [Mohan, Sankar; Pinto, B. Mario] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Naim, Hassan Y.] Univ Vet Med, Dept Physiol Chem, D-3059 Hannover, Germany	University of Waterloo; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Simon Fraser University; University of Veterinary Medicine Hannover, Foundation	Rose, DR (corresponding author), Univ Waterloo, Dept Biol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	drrose@uwaterloo.ca	Mohan, Sankar/A-7669-2011		Canadian Institutes for Health Research (CIHR) [FRN79400]; Heart and Stroke Foundation of Ontario [NA-6305]; Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation (NSF); NIGMS, National Institutes of Health (NIH), under NSF [DMR-0225180]; National Center for Research Resources, National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation (NSF)(National Science Foundation (NSF)); NIGMS, National Institutes of Health (NIH), under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant FRN79400 and Heart and Stroke Foundation of Ontario Grant NA-6305.; Recipient of funding through a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC).; The pMT-TEVA vector was a generous gift from Dr. Peter L. Davies (Department of Biochemistry, Queens University, Kingston, Ontario, Canada). This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation (NSF) and NIGMS, National Institutes of Health (NIH), under NSF award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Center for Research Resources, National Institutes of Health Grant RR-01646.	Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; Coutinho PM, 1997, CARBOHYD RES, V297, P309, DOI 10.1016/S0008-6215(96)00283-2; COWELL GM, 1986, BIOCHEM J, V237, P455, DOI 10.1042/bj2370455; DAHLQVIST A, 1964, ANAL BIOCHEM, V7, P18, DOI 10.1016/0003-2697(64)90115-0; DANIELSEN EM, 1994, BIOCHEMISTRY-US, V33, P1599, DOI 10.1021/bi00172a041; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DOWD MK, 1994, BIOPOLYMERS, V34, P625, DOI 10.1002/bip.360340505; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; GRAY GM, 1979, J BIOL CHEM, V254, P6038; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; HEYMANN H, 1995, BIOL CHEM H-S, V376, P249; JASCUR T, 1991, BIOCHEMISTRY-US, V30, P1908, DOI 10.1021/bi00221a025; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Mohan S, 2007, CARBOHYD RES, V342, P1551, DOI 10.1016/j.carres.2007.05.014; Mohan S, 2009, COLLECT CZECH CHEM C, V74, P1117, DOI 10.1135/cccc2009024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Rossi EJ, 2006, FEBS J, V273, P2673, DOI 10.1111/j.1742-4658.2006.05283.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scotter AJ, 2006, PROTEIN EXPRES PURIF, V47, P374, DOI 10.1016/j.pep.2005.10.028; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, BIOCHEMISTRY-US, V49, P443, DOI 10.1021/bi9016457; VANBEERS EH, 1995, CRIT REV BIOCHEM MOL, V30, P197, DOI 10.3109/10409239509085143; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	36	140	144	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17763	17770		10.1074/jbc.M109.078980	http://dx.doi.org/10.1074/jbc.M109.078980			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356844	hybrid, Green Published			2022-12-25	WOS:000278133400054
J	Wang, Z; Pedersen, E; Basse, A; Lefever, T; Peyrollier, K; Kapoor, S; Mei, Q; Karlsson, R; Chrostek-Grashoff, A; Brakebusch, C				Wang, Z.; Pedersen, E.; Basse, A.; Lefever, T.; Peyrollier, K.; Kapoor, S.; Mei, Q.; Karlsson, R.; Chrostek-Grashoff, A.; Brakebusch, C.			Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo	ONCOGENE			English	Article						Rac1; tumor; Pak	ACTIVATOR TIAM1; ERK; PHOSPHORYLATION; PROLIFERATION; REQUIREMENT; DELETION; PAK	Rac1 has a role in proliferation and survival of tumor cells in vitro. The exact effects of Rac1 on growth, apoptosis and corresponding signaling pathways during tumorigenesis in vivo, however, have not been explored yet. Using mice with a keratinocyte-restricted deletion of the Rac1 gene, we found that Rac1 is essential for DMBA/TPA-induced skin tumor formation. This corresponded to a decreased keratinocyte hyperproliferation, although apoptosis was not detectably altered. Activated Rac1 promoted Erk-dependent hyperproliferation by Pak1-mediated Mek activation independent of Mek1 phosporylation at serine 298. Rac1 was furthermore required for Pak2-dependent hyperactivation of Akt, which under in vivo condition was restricted to the suprabasal cell layers corresponding to a suprabasal-specific expression of Pak2. It is surprising that none of these signaling pathways was altered in untreated Rac1-deficient skin, indicating a hyperproliferation- specific function of Rac1 in vivo. These data suggest that blocking of Rac1 function might allow tumor-specific growth repression, as Rac1 is not required for normal growth and growth signaling controlling pathways in skin in vivo. Oncogene (2010) 29, 3362-3373; doi:10.1038/onc.2010.95; published online 12 April 2010	[Wang, Z.; Pedersen, E.; Basse, A.; Lefever, T.; Peyrollier, K.; Kapoor, S.; Karlsson, R.; Brakebusch, C.] Univ Copenhagen, Inst Biomed, BRIC, DK-2200 Copenhagen, Denmark; [Wang, Z.; Mei, Q.] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Lefever, T.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Chrostek-Grashoff, A.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA USA	University of Copenhagen; Air Force Military Medical University; Ghent University; University of Virginia	Brakebusch, C (corresponding author), Univ Copenhagen, Inst Biomed, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	cord.brakebusch@bric.dk	Basse, Astrid L/M-4630-2014	Basse, Astrid L/0000-0002-6532-9232; Brakebusch, Cord/0000-0002-9342-1634	Danish Cancer Foundation; Novo Nordisk Foundation	Danish Cancer Foundation(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank Dr Peter Staller and Dr Chris Marshall for advice, Dr Anders Lund for providing the plasmids, Volkan Turan for excellent technical help, Anna Fossum for FACS, and Sahar Abelechian and Anita Friismose for help with mouse handling. This work was supported by the Danish Cancer Foundation and the Novo Nordisk Foundation.	Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Espina C, 2008, AM J PATHOL, V172, P156, DOI 10.2353/ajpath.2008.070561; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Maruta Hiroshi, 2002, Methods Mol Biol, V189, P75; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	24	86	87	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3362	3373		10.1038/onc.2010.95	http://dx.doi.org/10.1038/onc.2010.95			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20383193				2022-12-25	WOS:000278622700005
J	Cen, S; Peng, ZG; Li, XY; Li, ZR; Ma, J; Wang, YM; Fan, B; You, XF; Wang, YP; Liu, F; Shao, RG; Zhao, LX; Yu, LY; Jiang, JD				Cen, Shan; Peng, Zong-Gen; Li, Xiao-Yu; Li, Zhuo-Rong; Ma, Jing; Wang, Yue-Ming; Fan, Bo; You, Xue-Fu; Wang, Yu-Ping; Liu, Fei; Shao, Rong-Guang; Zhao, Li-Xun; Yu, Liyan; Jiang, Jian-Dong			Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL VIF PROTEIN; SOR GENE; TYPE-1 VIF; LYMPHOCYTES; INFECTIVITY	APOBEC3G (hA3G) is a host inhibitor for human immunodeficiency virus, type 1 (HIV-1). However, HIV-1 Vif binds hA3G and induces its degradation. We have established a screening system to discover inhibitors that protect hA3G from Vif-mediated degradation. Through screening, compounds IMB-26 and IMB-35 were identified to be specific inhibitors for the degradation of hA3G by Vif. The inhibitors suppressed HIV-1 replication in hA3G-containing cells but not in those without hA3G. The anti-HIV effect correlated with the endogenous hA3G level. HIV-1 particles from hA3G(+) cells treated with IMB-26/35 contained a hA3G level higher than that from those without IMB-26/35 treatment and showed decreased infectivity. IMB26/35 bound directly to the hA3G protein, suppressed Vif/hA3G interaction, and therefore protected hA3G from Vif-mediated degradation. The compounds were safe with an anti-HIV therapeutic index >200 in vitro. LD50 of IMB-26 in mice was >1000 mg/kg (intraperitoneally). Therefore, IMB-26 and IMB-35 are novel anti-HIV leads working through specific stabilization of hA3G.	[Wang, Yu-Ping; Liu, Fei; Shao, Rong-Guang; Zhao, Li-Xun; Yu, Liyan; Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Med Biotechnol, Dept Virol, Beijing 100050, Peoples R China; [Cen, Shan; Li, Xiao-Yu; Ma, Jing] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Cen, Shan; Li, Xiao-Yu; Ma, Jing] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Lady Davis Institute; McGill University; McGill University	Yu, LY (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Dept Virol, Beijing 100050, Peoples R China.	yuliyan_2000@yahoo.com; jiang.jdong@163.com	yu, liyan/GYD-2950-2022; LIU, FEI/H-2783-2013; Wang, Yueming/B-4658-2015; Peng, Zong-Gen/GVU-2327-2022	yu, liyan/0000-0002-8861-9806; Peng, Zong-Gen/0000-0001-7662-6892	Bill & Melinda Gates Foundation; NIH [GC10577]; Ministry of Science and Technology [2009ZX09301-003]; National S&T Major Special Project on Major New Drug Innovation [2009ZX09103-138, 2009ZX09303-005]; National Natural Science Foundation of China [30973569]; Canadian Institutes of Health Research [HVI-93435]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National S&T Major Special Project on Major New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Grand Challenges in Global Health Initiatives of the Bill & Melinda Gates Foundation and Foundation of NIH (GC10577 to J.-D.J.), 11th 5-year New Drug R& D Program of the Ministry of Science and Technology (2009ZX09301-003 to J.-D.J.), National S&T Major Special Project on Major New Drug Innovation (2009ZX09103-138 and 2009ZX09303-005 to S.C.), National Natural Science Foundation of China (30973569), and Canadian Institutes of Health Research Grant HVI-93435 (to S.C.).	Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Hu K, 2005, J VIROL METHODS, V128, P93, DOI 10.1016/j.jviromet.2005.04.012; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Rose KM, 2005, AIDS RES HUM RETROV, V21, P611, DOI 10.1089/aid.2005.21.611; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; SODROSKI J, 1986, SCIENCE, V231, P1549, DOI 10.1126/science.3006244; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	20	84	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16546	16552		10.1074/jbc.M109.085308	http://dx.doi.org/10.1074/jbc.M109.085308			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363737	Green Published, hybrid			2022-12-25	WOS:000277982600017
J	Rosenberg, MS				Rosenberg, Michael S.			A Generalized Formula for Converting Chi-Square Tests to Effect Sizes for Meta-Analysis	PLOS ONE			English	Article							FITNESS	The common formula used for converting a chi-square test into a correlation coefficient for use as an effect size in meta-analysis has a hidden assumption which may be violated in specific instances, leading to an overestimation of the effect size. A corrected formula is provided.	[Rosenberg, Michael S.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA; [Rosenberg, Michael S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Rosenberg, MS (corresponding author), Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA.	msr@asu.edu	Rohlf, F J/A-8710-2008; Rosenberg, Michael S/A-4621-2008	Rosenberg, Michael S/0000-0001-7882-2467	National Evolutionary Synthesis Center (NESCent; NSF) [EF-0905606]; National Science Foundation (NSF) [DBI-0542599]	National Evolutionary Synthesis Center (NESCent; NSF)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation (NSF)(National Science Foundation (NSF))	Supported by the National Evolutionary Synthesis Center (NESCent; http://www.nescent.org; NSF #EF-0905606), and the National Science Foundation (NSF; #DBI-0542599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Britten HB, 1996, EVOLUTION, V50, P2158, DOI 10.1111/j.1558-5646.1996.tb03606.x; Cohen J., 1965, HDB CLIN PSYCHOL, P95; Cooper H. M., 1998, SYNTHESIZING RES GUI, V3rd; Hedges L.V., 1985, STAT METHODS META AN; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Koricheva J, HDB METAANA IN PRESS; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; ROSENBERG MS, HDB METAANALYSIS ECO; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rosenthal R., 2008, ESSENTIALS BEHAV RES; ROSENTHAL R, 2000, CONTRAST EFFECT SIZE; Rosenthal R, 1978, BEHAVIORAL BRAIN SCI, V3, P377; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231	16	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10059	10.1371/journal.pone.0010059	http://dx.doi.org/10.1371/journal.pone.0010059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383281	Green Published, gold, Green Submitted			2022-12-25	WOS:000276454000018
J	Sittig, LJ; Redei, EE				Sittig, Laura J.; Redei, Eva E.			Paternal Genetic Contribution Influences Fetal Vulnerability to Maternal Alcohol Consumption in a Rat Model of Fetal Alcohol Spectrum Disorder	PLOS ONE			English	Article							ETHANOL TERATOGENESIS; BIRTH-WEIGHT; PREGNANCY; HORMONE; GROWTH; MICE; ADRENALECTOMY; DEFICIENCY; DOMINANCE; DIAGNOSIS	Background: Fetal alcohol exposure causes in the offspring a collection of permanent physiological and neuropsychological deficits collectively termed Fetal Alcohol Spectrum Disorder (FASD). The timing and amount of exposure cannot fully explain the substantial variability among affected individuals, pointing to genetic influences that mediate fetal vulnerability. However, the aspects of vulnerability that depend on the mother, the father, or both, are not known. Methodology/Principal Findings: Using the outbred Sprague-Dawley (SD) and inbred Brown Norway (BN) rat strains as well as their reciprocal crosses, we administered ethanol (E), pair-fed (PF), or control (C) diets to the pregnant dams. The dams' plasma levels of free thyroxine (fT4), triiodothyronine (T3), free T3 (fT3), and thyroid stimulating hormone (TSH) were measured to elucidate potential differences in maternal thyroid hormonal environment, which affects specific aspects of FASD. We then compared alcohol-exposed, pair fed, and control offspring of each fetal strain on gestational day 21 (G21) to identify maternal and paternal genetic effects on bodyweight and placental weight of male and female fetuses. Conclusions: SD and BN dams exhibited different baseline hypothalamic-pituitary-thyroid function. Moreover, the thyroid function of SD dams was more severely affected by alcohol consumption while that of BN dams was relatively resistant. This novel finding suggests that genetic differences in maternal thyroid function are one source of maternal genetic effects on fetal vulnerability to FASD. The fetal vulnerability to decreased bodyweight after alcohol exposure depended on the genetic contribution of both parents, not only maternal contribution as previously thought. In contrast, the effect of maternal alcohol consumption on placental weight was consistent and not strain-dependent. Interestingly, placental weight in fetuses with different paternal genetic contributions exhibited opposite responses to caloric restriction (pair feeding). In summary, these novel findings demonstrate both maternal and paternal genetic contributions to in utero vulnerability to alcohol, refining our understanding of the genetically-based heterogeneity seen in human FASD.	[Sittig, Laura J.; Redei, Eva E.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Asher Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Sittig, LJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Asher Ctr, Chicago, IL 60611 USA.	e-redei@northwestern.edu		Sittig, Laura/0000-0001-5912-9528	NIH [AA013452]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017978, R01AA013452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was funded by grant NIH AA013452 to EER (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum AE, 2005, ENDOCRINOLOGY, V146, P870, DOI 10.1210/en.2004-0948; Bradford G E, 1979, J Anim Sci, V49 Suppl 2, P66; Burd L, 2007, J MATERN-FETAL NEO M, V20, P361, DOI 10.1080/14767050701298365; Chan SY, 2009, NAT CLIN PRACT ENDOC, V5, P45, DOI 10.1038/ncpendmet1026; CHASNOFF IJ, 1985, ACTA GENET MED GEMEL, V34, P229, DOI 10.1017/S0001566000004797; Das SC, 2006, INDIAN J MED RES, V124, P535; Das UG, 2004, ALCOHOL CLIN EXP RES, V28, P1598, DOI 10.1097/01.ALC.0000141816.14776.97; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; GILLIAM DM, 1990, ALCOHOL CLIN EXP RES, V14, P539, DOI 10.1111/j.1530-0277.1990.tb01196.x; Gilliam DM, 1997, ALCOHOL CLIN EXP RES, V21, P28; Guerri C, 2009, ALCOHOL ALCOHOLISM, V44, P108, DOI 10.1093/alcalc/agn105; GUNDOGAN F, 2009, ALCOHOL CLIN EXP RES; Hager R, 2009, EVOLUTION, V63, P1118, DOI 10.1111/j.1558-5646.2009.00638.x; HAYCOCK PC, 2009, BIOL REPROD; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Jacobson SW, 2006, J PEDIATR-US, V148, P30, DOI 10.1016/j.jpeds.2005.08.023; Kelly SJ, 2009, DEV DISABIL RES REV, V15, P200, DOI 10.1002/ddrr.69; Le Clair C, 2009, CAN J PHYSIOL PHARM, V87, P161, DOI [10.1139/Y09-006, 10.1139/y09-006]; Leamy LJ, 2008, HEREDITY, V101, P518, DOI 10.1038/hdy.2008.79; Lindsay RS, 2002, HUM GENET, V110, P503, DOI 10.1007/s00439-002-0718-2; Manning MA, 2007, NEUROSCI BIOBEHAV R, V31, P230, DOI 10.1016/j.neubiorev.2006.06.016; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Mantey C, 2005, J HERED, V96, P329, DOI 10.1093/jhered/esi044; Moeller LC, 2007, ENDOCRINOLOGY, V148, P4727, DOI 10.1210/en.2007-0236; Rasmussen SA, 2009, BIRTH DEFECTS RES A, V85, P82, DOI 10.1002/bdra.20506; RIIKONEN RS, 1994, PEDIATR NEUROL, V11, P332, DOI 10.1016/0887-8994(94)90012-4; Risnes KR, 2009, AM J EPIDEMIOL, V170, P622, DOI 10.1093/aje/kwp182; ROSENBERG MJ, ALCOHOL; Sinha P, 1997, ENDOCRINOLOGY, V138, P4792, DOI 10.1210/en.138.11.4792; Spencer HG, 2009, GENETICA, V136, P285, DOI 10.1007/s10709-008-9300-8; STREISSGUTH AP, 1993, AM J MED GENET, V47, P857, DOI 10.1002/ajmg.1320470612; Swerdlow NR, 2008, PHARMACOL BIOCHEM BE, V88, P280, DOI 10.1016/j.pbb.2007.08.013; WEINBERG J, 1984, NEUROBEH TOXICOL TER, V6, P261; Wilcoxon JS, 2005, MOL PSYCHIATR, V10, P961, DOI 10.1038/sj.mp.4001694; Wilcoxon JS, 2004, AM J PHYSIOL-ENDOC M, V287, pE318, DOI 10.1152/ajpendo.00022.2004; Wilcoxon JS, 2003, AM J PHYSIOL-ENDOC M, V285, pE31, DOI 10.1152/ajpendo.00552.2002	37	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10058	10.1371/journal.pone.0010058	http://dx.doi.org/10.1371/journal.pone.0010058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383339	gold, Green Published, Green Submitted			2022-12-25	WOS:000276454000017
J	Chigurupati, S; Mughal, MR; Chan, SL; Arumugam, TV; Baharani, A; Tang, SC; Yu, QS; Holloway, HW; Wheeler, R; Poosala, S; Greig, NH; Mattson, MP				Chigurupati, Srinivasulu; Mughal, Mohamed R.; Chan, Sic L.; Arumugam, Thiruma V.; Baharani, Akanksha; Tang, Sung-Chun; Yu, Qian-Sheng; Holloway, Harold W.; Wheeler, Ross; Poosala, Suresh; Greig, Nigel H.; Mattson, Mark P.			A Synthetic Uric Acid Analog Accelerates Cutaneous Wound Healing in Mice	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; GROWTH-FACTOR; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; NITRIC-OXIDE; GLUTATHIONE; PROTECTS; DAMAGE; ALPHA; EGF	Wound healing is a complex process involving intrinsic dermal and epidermal cells, and infiltrating macrophages and leukocytes. Excessive oxidative stress and associated inflammatory processes can impair wound healing, and antioxidants have been reported to improve wound healing in animal models and human subjects. Uric acid (UA) is an efficient free radical scavenger, but has a very low solubility and poor tissue penetrability. We recently developed novel UA analogs with increased solubility and excellent free radical-scavenging properties and demonstrated their ability to protect neural cells against oxidative damage. Here we show that the uric acid analog (6, 8 dithio-UA, but not equimolar concentrations of UA or 1, 7 dimethyl-UA) modified the behaviors of cultured vascular endothelial cells, keratinocytes and fibroblasts in ways consistent with enhancement of the wound healing functions of all three cell types. We further show that 6, 8 dithio-UA significantly accelerates the wound healing process when applied topically (once daily) to full-thickness wounds in mice. Levels of Cu/Zn superoxide dismutase were increased in wound tissue from mice treated with 6, 8 dithio-UA compared to vehicle-treated mice, suggesting that the UA analog enhances endogenous cellular antioxidant defenses. These results support an adverse role for oxidative stress in wound healing and tissue repair, and provide a rationale for the development of UA analogs in the treatment of wounds and for modulation of angiogenesis in other pathological conditions.	[Chigurupati, Srinivasulu; Mughal, Mohamed R.; Arumugam, Thiruma V.; Tang, Sung-Chun; Yu, Qian-Sheng; Holloway, Harold W.; Greig, Nigel H.; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Chigurupati, Srinivasulu; Poosala, Suresh] NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Wheeler, Ross] Univ Cent Florida, Dept Pathol & Med Educ, Orlando, FL 32816 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; University of Central Florida; Johns Hopkins University	Chigurupati, S (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Arumugam, Thiruma Valavan/B-4898-2011; Mattson, Mark P/F-6038-2012; Arumugam, Thiruma/AAG-6958-2019	Tang, Sung-Chun/0000-0003-3731-5973; Arumugam, Thiruma/0000-0002-3377-0939	National Institute on Aging, National Institutes of Helath (NIH); NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Helath (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging Intramural Research Program of the National Institutes of Helath (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva R, 2005, BIOCHEM BIOPH RES CO, V333, P404, DOI 10.1016/j.bbrc.2005.05.119; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; CUTLER RG, 1984, ARCH GERONTOL GERIAT, V3, P321, DOI 10.1016/0167-4943(84)90033-5; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Gilman Thomas, 2004, Int J Low Extrem Wounds, V3, P125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Ha XQ, 2003, CHINESE MED J-PEKING, V116, P1029; Haberman F, 2007, NEUROMOL MED, V9, P315, DOI 10.1007/s12017-007-8010-1; HEBDA PA, 1990, J INVEST DERMATOL, V95, P626, DOI 10.1111/1523-1747.ep12513528; HOCKEL M, 1987, J CELL PHYSIOL, V133, P1, DOI 10.1002/jcp.1041330102; Hong JP, 2006, ANN PLAS SURG, V56, P394, DOI 10.1097/01.sap.0000198731.12407.0c; Hooper DC, 1997, P NATL ACAD SCI USA, V94, P2528, DOI 10.1073/pnas.94.6.2528; Keller JN, 1998, J NEUROSCI, V18, P687; Khanolkar MP, 2008, QJM-INT J MED, V101, P685, DOI 10.1093/qjmed/hcn027; Kumin A, 2007, J CELL BIOL, V179, P747, DOI 10.1083/jcb.200706090; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004; MERRELL JG, 2009, CLIN EXP PH IN PRESS; Milne Catherine T, 2008, Adv Nurse Pract, V16, P53; Mudge BP, 2002, WOUND REPAIR REGEN, V10, P52, DOI 10.1046/j.1524-475X.2002.10803.x; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; SEN CK, 2008, BIOCH BIOPH IN PRESS; Senel O, 1997, ANN PLAS SURG, V39, P516; Serarslan G, 2007, CLIN EXP DERMATOL, V32, P709, DOI 10.1111/j.1365-2230.2007.02470.x; Shukla A, 1997, FREE RADICAL RES, V26, P93, DOI 10.3109/10715769709097788; Soneja A, 2005, PHARMACOL REP, V57, P108; STEED DL, 1992, DIABETES CARE, V15, P1598, DOI 10.2337/diacare.15.11.1598; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Ucuzian AA, 2007, WORLD J SURG, V31, P654, DOI 10.1007/s00268-006-0763-4; Weinberger Abraham, 1995, Current Opinion in Rheumatology, V7, P359, DOI 10.1097/00002281-199507000-00017; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Williams DT, 2003, CRIT CARE MED, V31, pS547, DOI 10.1097/01.CCM.0000081430.34066.1D; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1	40	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10044	10.1371/journal.pone.0010044	http://dx.doi.org/10.1371/journal.pone.0010044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386608	Green Published, gold, Green Submitted			2022-12-25	WOS:000276420400015
J	Swisher, KD; Parker, R				Swisher, Kylie D.; Parker, Roy			Localization to, and Effects of Pbp1, Pbp4, Lsm12, Dhh1, and Pab1 on Stress Granules in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA; P-BODIES; POLY(A)-BINDING PROTEIN; PROCESSING BODIES; IN-VIVO; YEAST; TRANSLATION; HELICASE; IDENTIFICATION; RAP55	The regulation of translation and mRNA degradation in eukaryotic cells involves the formation of cytoplasmic mRNP granules referred to as P-bodies and stress granules. The yeast Pbp1 protein and its mammalian ortholog, Ataxin-2, localize to stress granules and promote their formation. In Saccharomyces cerevisiae, Pbp1 also interacts with the Pab1, Lsm12, Pbp4, and Dhh1 proteins. In this work, we determined whether these Pbp1 interacting proteins also accumulated in stress granules and/or could affect their formation. These experiments revealed the following observations. First, the Lsm12, Pbp4, and Dhh1 proteins all accumulate in stress granules, whereas only the Dhh1 protein is a constitutive P-body component. Second, deletion or over-expression of the Pbp4 and Lsm12 proteins did not dramatically affect the formation of stress granules or P-bodies. In contrast, Pbp1 and Dhh1 over-expression inhibits cell growth, and for Dhh1, leads to the accumulation of stress granules. Finally, a strain lacking the Pab1 protein was reduced at forming stress granules, although they could still be detected. This indicates that Pab1 affects, but is not absolutely required for, stress granule formation. These observations offer new insight into the function of stress granule components with roles in stress granule assembly and mRNP regulation.	[Swisher, Kylie D.; Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ USA	University of Arizona	Parker, R (corresponding author), Univ Arizona, Howard Hughes Med Inst, Tucson, AZ USA.	rrparker@email.arizona.edu			Howard Hughes Medical Institute; National Institutes of Health [5R37GM45443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (www.hhmi.org) and the National Institutes of Health (5R37GM45443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Balagopal V, 2009, GENETICS, V181, P93, DOI 10.1534/genetics.108.092601; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 2004, MOL CELL BIOL, V24, P4196, DOI 10.1128/MCB.24.10.4196-4206.2004; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rajyaguru P, 2009, TRENDS CELL BIOL, V19, P24, DOI 10.1016/j.tcb.2008.11.001; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tritschler F, 2009, MOL CELL, V33, P661, DOI 10.1016/j.molcel.2009.02.014; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706	38	89	90	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10006	10.1371/journal.pone.0010006	http://dx.doi.org/10.1371/journal.pone.0010006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368989	Green Published, gold, Green Submitted			2022-12-25	WOS:000276419900009
J	Chiriac, A; Nelson, TJ; Faustino, RS; Behfar, A; Terzic, A				Chiriac, Anca; Nelson, Timothy J.; Faustino, Randolph S.; Behfar, Atta; Terzic, Andre			Cardiogenic Induction of Pluripotent Stem Cells Streamlined Through a Conserved SDF-1/VEGF/BMP2 Integrated Network	PLOS ONE			English	Article							REGULATORY NETWORKS; PROGENITOR CELLS; SMOOTH-MUSCLE; DIFFERENTIATION; CARDIOMYOCYTE; MULTIPOTENT; LINEAGE; GROWTH; NOISE; STOCHASTICITY	Background: Pluripotent stem cells produce tissue-specific lineages through programmed acquisition of sequential gene expression patterns that function as a blueprint for organ formation. As embryonic stem cells respond concomitantly to diverse signaling pathways during differentiation, extraction of a pro-cardiogenic network would offer a roadmap to streamline cardiac progenitor output. Methods and Results: To resolve gene ontology priorities within precursor transcriptomes, cardiogenic subpopulations were here generated according to either growth factor guidance or stage-specific biomarker sorting. Innate expression profiles were independently delineated through unbiased systems biology mapping, and cross-referenced to filter transcriptional noise unmasking a conserved progenitor motif (55 up- and 233 down-regulated genes). The streamlined pool of 288 genes organized into a core biological network that prioritized the "Cardiovascular Development'' function. Recursive in silico deconvolution of the cardiogenic neighborhood and associated canonical signaling pathways identified a combination of integrated axes, CXCR4/SDF-1, Flk-1/VEGF and BMP2r/BMP2, predicted to synchronize cardiac specification. In vitro targeting of the resolved triad in embryoid bodies accelerated expression of Nkx2.5, Mef2C and cardiac-MHC, enhanced beating activity, and augmented cardiogenic yield. Conclusions: Transcriptome-wide dissection of a conserved progenitor profile thus revealed functional highways that coordinate cardiogenic maturation from a pluripotent ground state. Validating the bioinformatics algorithm established a strategy to rationally modulate cell fate, and optimize stem cell-derived cardiogenesis.	[Chiriac, Anca] Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Med, Rochester, MN 55905 USA; Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Med Genet, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Chiriac, A (corresponding author), Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Med, Rochester, MN 55905 USA.	terzic.andre@mayo.edu		Behfar, Atta/0000-0003-3775-5784; Nelson, Timothy/0000-0002-3862-7023	National Institutes of Health [R01HL083439, T32HL007111]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007111, R01HL083439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (R01HL083439, T32HL007111), Marriott Individualized Medicine Program, Asper Foundation, Marriott Heart Disease Research Program, Mayo Graduate School, and Mayo Clinic Clinician-Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Arrell DK, 2007, CLIN PHARMACOL THER, V82, P316, DOI 10.1038/sj.clpt.6100310; Arrell DK, 2008, STEM CELLS, V26, P387, DOI 10.1634/stemcells.2007-0599; Arrell DK, 2009, J PROTEOME RES, V8, P4823, DOI 10.1021/pr900561g; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Behfar A, 2008, J MOL CELL CARDIOL, V45, P523, DOI 10.1016/j.yjmcc.2008.09.122; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Braam SR, 2009, TRENDS PHARMACOL SCI, V30, P536, DOI 10.1016/j.tips.2009.07.001; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen Y, 2006, AM J PHYSIOL-HEART C, V291, pH1653, DOI 10.1152/ajpheart.00363.2005; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; CHUNG S, 2008, ANN NY ACAD SCI, V1147, P255; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Faustino RS, 2008, J CARDIOVASC TRANSL, V1, P120, DOI 10.1007/s12265-008-9019-z; Faustino RS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r6; Faustino RS, 2008, CTS-CLIN TRANSL SCI, V1, P174, DOI 10.1111/j.1752-8062.2008.00038.x; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Horton RE, 2009, REGEN MED, V4, P721, DOI 10.2217/RME.09.48; Huang FQ, 2008, NAT PROTOC, V3, P1848, DOI 10.1038/nprot.2008.185; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Leschik J, 2008, NAT PROTOC, V3, P1381, DOI 10.1038/nprot.2008.116; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Misra R P, 2001, BMC Biotechnol, V1, P12, DOI 10.1186/1472-6750-1-12; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nelson TJ, 2008, CLIN PHARMACOL THER, V84, P620, DOI 10.1038/clpt.2008.146; Nelson TJ, 2008, STEM CELLS, V26, P1464, DOI 10.1634/stemcells.2007-0808; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Nelson TJ, 2009, CTS-CLIN TRANSL SCI, V2, P222, DOI 10.1111/j.1752-8062.2009.00096.x; Nelson TJ, 2009, DIFFERENTIATION, V77, P248, DOI 10.1016/j.diff.2008.10.012; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Penn MS, 2009, CIRC RES, V104, P1133, DOI 10.1161/CIRCRESAHA.109.198929; Perez-Terzic C, 2003, CIRC RES, V92, P444, DOI 10.1161/01.RES.0000059415.25070.54; PEREZTERZIC C, 2007, NAT CLIN PRACT CARD, V4, pE68; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Zlatkovic J, 2009, PROTEOMICS, V9, P1314, DOI 10.1002/pmic.200800718	65	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9943	10.1371/journal.pone.0009943	http://dx.doi.org/10.1371/journal.pone.0009943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376342	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200019
J	Venturi, V; Bertani, I; Kerenyi, A; Netotea, S; Pongor, S				Venturi, Vittorio; Bertani, Iris; Kerenyi, Adam; Netotea, Sergiu; Pongor, Sandor			Co-Swarming and Local Collapse: Quorum Sensing Conveys Resilience to Bacterial Communities by Localizing Cheater Mutants in Pseudomonas aeruginosa	PLOS ONE			English	Article							SOCIAL EVOLUTION; COOPERATION	Background: Members of swarming bacterial consortia compete for nutrients but also use a co-operation mechanism called quorum sensing (QS) that relies on chemical signals as well as other secreted products ("public goods'') necessary for swarming. Deleting various genes of this machinery leads to cheater mutants impaired in various aspects of swarming cooperation. Methodology/Principal Findings: Pairwise consortia made of Pseudomonas aeruginosa, its QS mutants as well as B. cepacia cells show that a interspecies consortium can "combine the skills'' of its participants so that the strains can cross together barriers that they could not cross alone. In contrast, deleterious mutants are excluded from consortia either by competition or by local population collapse. According to modeling, both scenarios are the consequence of the QS signalling mechanism itself. Conclusion/Significance: The results indirectly explain why it is an advantage for bacteria to maintain QS systems that can cross-talk among different species, and conversely, why certain QS mutants which can be abundant in isolated niches, cannot spread and hence remain localized.	[Venturi, Vittorio; Bertani, Iris; Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Kerenyi, Adam; Netotea, Sergiu] Hungarian Acad Sci, Biol Res Ctr, H-6701 Szeged, Hungary	International Center for Genetic Engineering & Biotechnology (ICGEB); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Venturi, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	venturi@icgeb.org; pongor@icgeb.org	Venturi, Vittorio/AAO-3069-2021	Bertani, Iris/0000-0003-0378-7796; Venturi, Vittorio/0000-0003-4307-5697	Italian Cystic Fibrosis Research Foundation [9/2007]; Hungarian National Office for Research and Technology (NKTH) [TAMOP-4.2.2-08/1/2008-008]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Hungarian National Office for Research and Technology (NKTH)(National Office for Research and Technology)	I. B. was supported by a fellowship from the Italian Cystic Fibrosis Research Foundation (Project FFC#9/2007) with the contribution of the Delegazione FFC di Belluno. The work at BRC Szeged was partly supported by a grant no TAMOP-4.2.2-08/1/2008-008 from the Hungarian National Office for Research and Technology (NKTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Netotea S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-6; Paulsson J, 2002, GENETICS, V161, P1373; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Steindler L, 2009, APPL ENVIRON MICROB, V75, P5131, DOI 10.1128/AEM.02914-08; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Szathmary E, 1995, MAJOR TRANSITIONS EV; Venturi V, 2009, HFSP J, V3, P105, DOI 10.2976/1.3065673; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	25	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9998	10.1371/journal.pone.0009998	http://dx.doi.org/10.1371/journal.pone.0009998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376321	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200063
J	Zhao, RM; Leung, E; Gruner, S; Schapira, M; Houry, WA				Zhao, Rongmin; Leung, Elisa; Gruner, Stefan; Schapira, Matthieu; Houry, Walid A.			Tamoxifen Enhances the Hsp90 Molecular Chaperone ATPase Activity	PLOS ONE			English	Article							PROTEIN; CANCER; INHIBITOR; THERAPY; GROWTH; CELLS	Background: Hsp90 is an essential molecular chaperone that is also a novel anti-cancer drug target. There is growing interest in developing new drugs that modulate Hsp90 activity. Methodology/Principal Findings: Using a virtual screening approach, 4-hydroxytamoxifen, the active metabolite of the anti-estrogen drug tamoxifen, was identified as a putative Hsp90 ligand. Surprisingly, while all drugs targeting Hsp90 inhibit the chaperone ATPase activity, it was found experimentally that 4-hydroxytamoxifen and tamoxifen enhance rather than inhibit Hsp90 ATPase. Conclusions/Significance: Hence, tamoxifen and its metabolite are the first members of a new pharmacological class of Hsp90 activators.	[Zhao, Rongmin; Leung, Elisa; Gruner, Stefan; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto	Zhao, RM (corresponding author), Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada.	matthieu.schapira@utoronto.ca; walid.houry@utoronto.ca		Zhao, Rongmin/0000-0003-1300-5882	Canadian Institutes of Health Research [MOP-93778]; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported, in part, by a grant from the Canadian Institutes of Health Research (MOP-93778) to WAH and public and private funding to the Structural Genomics Consortium. The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck, the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Agatsuma T, 2002, BIOORGAN MED CHEM, V10, P3445, DOI 10.1016/S0968-0896(02)00260-2; An Jianghong, 2004, Genome Inform, V15, P31; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Dunn FB, 2002, J NATL CANCER I, V94, P1194; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Mosser DD, 2004, BIOCHEMISTRY-US, V43, P8107, DOI 10.1021/bi0493766; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Totrov M, 1997, PROTEINS, P215; Vilenchik M, 2004, CHEM BIOL, V11, P787, DOI 10.1016/j.chembiol.2004.04.008; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Workman P, 2002, CANCER DETECT PREV, V26, P405, DOI 10.1016/S0361-090X(02)00126-5; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9934	10.1371/journal.pone.0009934	http://dx.doi.org/10.1371/journal.pone.0009934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376192	Green Published, gold			2022-12-25	WOS:000276418200011
J	Hesselmann, G; Sadaghiani, S; Friston, KJ; Kleinschmidt, A				Hesselmann, Guido; Sadaghiani, Sepideh; Friston, Karl J.; Kleinschmidt, Andreas			Predictive Coding or Evidence Accumulation? False Inference and Neuronal Fluctuations	PLOS ONE			English	Article							ONGOING ACTIVITY FLUCTUATIONS; VISUAL-CORTEX; DECISION-MAKING; PERCEPTION; VARIABILITY; RESPONSES; SYSTEMS; NOISE; BIAS	Perceptual decisions can be made when sensory input affords an inference about what generated that input. Here, we report findings from two independent perceptual experiments conducted during functional magnetic resonance imaging (fMRI) with a sparse event-related design. The first experiment, in the visual modality, involved forced-choice discrimination of coherence in random dot kinematograms that contained either subliminal or periliminal motion coherence. The second experiment, in the auditory domain, involved free response detection of (non-semantic) near-threshold acoustic stimuli. We analysed fluctuations in ongoing neural activity, as indexed by fMRI, and found that neuronal activity in sensory areas (extrastriate visual and early auditory cortex) biases perceptual decisions towards correct inference and not towards a specific percept. Hits (detection of near-threshold stimuli) were preceded by significantly higher activity than both misses of identical stimuli or false alarms, in which percepts arise in the absence of appropriate sensory input. In accord with predictive coding models and the free-energy principle, this observation suggests that cortical activity in sensory brain areas reflects the precision of prediction errors and not just the sensory evidence or prediction errors per se.	[Hesselmann, Guido; Sadaghiani, Sepideh; Kleinschmidt, Andreas] INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Hesselmann, Guido; Sadaghiani, Sepideh; Kleinschmidt, Andreas] CEA, Direct Sci Vivant, Inst Imagerie Biomed NeuroSpin, Gif Sur Yvette, France; [Hesselmann, Guido] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sadaghiani, Sepideh] Univ Tubingen, Int Max Planck Res Sch Neural & Behav Sci, Tubingen, Germany; [Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Weizmann Institute of Science; Eberhard Karls University of Tubingen; Max Planck Society; University of London; University College London	Hesselmann, G (corresponding author), INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	andreas.kleinschmidt@cea.fr	Hesselmann, Guido/I-2880-2016; Friston, Karl/D-9230-2011	Hesselmann, Guido/0000-0002-8873-7212; Friston, Karl/0000-0001-7984-8909; Lauwereyns, Jan/0000-0003-0551-2550; Sadaghiani, Sepideh/0000-0001-8800-3959	Agence Nationale de la Recherche (SPONTACT; France); Friedrich-Ebert Foundation (Germany); Minerva fellowship (Max Planck Society)	Agence Nationale de la Recherche (SPONTACT; France)(French National Research Agency (ANR)); Friedrich-Ebert Foundation (Germany); Minerva fellowship (Max Planck Society)(Max Planck Society)	This fMRI experiment was part of a general research program on functional neuroimaging of the human brain which was sponsored by the Atomic Energy Commission (principal investigator Denis Le Bihan). This work was funded by the Agence Nationale de la Recherche (SPONTACT; France). S. S. is supported by the Friedrich-Ebert Foundation (Germany). G. H. is supported by a Minerva fellowship (Max Planck Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Deco G, 2008, TRENDS NEUROSCI, V31, P591, DOI 10.1016/j.tins.2008.08.007; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000211; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; Kroener S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006507; Laufs H, 2008, HUM BRAIN MAPP, V29, P762, DOI 10.1002/hbm.20600; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028	25	79	79	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9926	10.1371/journal.pone.0009926	http://dx.doi.org/10.1371/journal.pone.0009926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369004	gold, Green Published, Green Submitted			2022-12-25	WOS:000276163100018
J	Johnson, AR; Craciunescu, CN; Guo, Z; Teng, YW; Thresher, RJ; Blusztajn, JK; Zeisel, SH				Johnson, Amy R.; Craciunescu, Corneliu N.; Guo, Zhong; Teng, Ya-Wen; Thresher, Randy J.; Blusztajn, Jan K.; Zeisel, Steven H.			Deletion of murine choline dehydrogenase results in diminished sperm motility	FASEB JOURNAL			English	Article						betaine; mitochondria	RAT-LIVER MITOCHONDRIA; PRESSURE LIQUID-CHROMATOGRAPHY; S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; BETAINE ALDEHYDE; OXIDATION; OXIDASE; INFERTILITY; ASSAY; ADENOSYLMETHIONINE	Choline dehydrogenase (CHDH) catalyzes the conversion of choline to betaine, an important methyl donor and organic osmolyte. We have previously identified single nucleotide polymorphisms (SNPs) in the human CHDH gene that, when present, seem to alter the activity of the CHDH enzyme. These SNPs occur frequently in humans. We created a Chdh(-/-) mouse to determine the functional effects of mutations that result in decreased CHDH activity. Chdh deletion did not affect fetal viability or alter growth or survival of these mice. Only one of eleven Chdh(-/-) males was able to reproduce. Loss of CHDH activity resulted in decreased testicular betaine and increased choline and PCho concentrations. Chdh(-/-) and Chdh(-/-) mice produced comparable amounts of sperm; the impaired fertility was due to diminished sperm motility in the Chdh(-/-) males. Transmission electron microscopy revealed abnormal mitochondrial morphology in Chdh(-/-) sperm. ATP content, total mitochondrial dehydrogenase activity and inner mitochondrial membrane polarization were all significantly reduced in sperm from Chdh(-/-) animals. Mitochondrial changes were also detected in liver, kidney, heart, and testis tissues. We suggest that men who have SNPs in CHDH that decrease the activity of the CHDH enzyme could have decreased sperm motility and fertility.-Johnson, A. R., Craciunescu, C. N., Guo, Z., Teng, Y.-W., Thresher, R. J., Blusztajn, J. K., Zeisel, S. H. Deletion of murine choline dehydrogenase results in diminished sperm motility. FASEB J. 24, 2752-2761 (2010). www.fasebj.org	[Johnson, Amy R.; Craciunescu, Corneliu N.; Guo, Zhong; Teng, Ya-Wen; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Inst Nutr Res, Dept Nutr, Chapel Hill, NC USA; [Thresher, Randy J.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Blusztajn, Jan K.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Boston University	Zeisel, SH (corresponding author), UNC Nutr Res Inst, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Ariel, Pablo/AGJ-4118-2022	/0000-0001-8438-3122	National Institutes of Health [AG09525, DK55865, DK56350]; Balchem Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055865, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Balchem Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Deborah O'Brien for her guidance with the sperm techniques, Drs. Neil Kowall and Virginia Godfrey for their histology expertise, and Sergei Baranov (Kristal Lab) for the mitochondrial respiration data. This work is supported by grants from the National Institutes of Health to S.H.Z. (AG09525, DK55865, DK56350). A.R.J. is supported by a scholarship from the Balchem Corporation. A.R.J. conducted all experiments unless otherwise noted and wrote the manuscript. C.N.C. established the Chdh animal colony and assisted with experiments. Z.G. performed all choline metabolite analyses. Y.-W.T. performed urinalysis and liver histology studies. R.J.T. generated the Chdh chimeric mice. J.K.B. contributed to the experimental design. S.H.Z. developed the idea for these studies, contributed to the experimental design, assisted with data analysis, and helped write the manuscript. All authors reviewed and approved the manuscript.	Adham IM, 2001, MOL HUM REPROD, V7, P513, DOI 10.1093/molehr/7.6.513; Alfie ME, 1999, HYPERTENSION, V33, P1436, DOI 10.1161/01.HYP.33.6.1436; Bodrova ME, 1998, FEBS LETT, V435, P269, DOI 10.1016/S0014-5793(98)01072-2; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Chern MK, 2000, BIOCHEM PHARMACOL, V60, P1629, DOI 10.1016/S0006-2952(00)00469-X; Cohen G, 1999, ANN NY ACAD SCI, V893, P273, DOI 10.1111/j.1749-6632.1999.tb07835.x; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; da Costa KA, 2006, FASEB J, V20, pA606; DERIDDER JJ, 1973, BIOCHIM BIOPHYS ACTA, V291, P557, DOI 10.1016/0005-2736(73)90507-5; DERIDDER JJM, 1975, BIOCHIM BIOPHYS ACTA, V408, P112, DOI 10.1016/0005-2728(75)90003-1; Devin A, 1997, J BIOENERG BIOMEMBR, V29, P579, DOI 10.1023/A:1022435102552; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; GARCIAPEREZ A, 1991, J MEMBRANE BIOL, V119, P1, DOI 10.1007/BF01868535; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; GLUECK CJ, 1995, AM J CARDIOL, V75, P132, DOI 10.1016/S0002-9149(00)80061-2; GROSSMAN EB, 1989, AM J PHYSIOL, V256, pF107; HAUBRICH DR, 1981, BIOCHEM PHARMACOL, V30, P2993, DOI 10.1016/0006-2952(81)90265-3; Huang SB, 2003, BIOCHEM BIOPH RES CO, V309, P344, DOI 10.1016/j.bbrc.2003.08.010; IKUTA S, 1977, J BIOCHEM-TOKYO, V82, P157, DOI 10.1093/oxfordjournals.jbchem.a131664; IKUTA S, 1977, J BIOCHEM-TOKYO, V82, P1741, DOI 10.1093/oxfordjournals.jbchem.a131872; Jacobsen DW, 1996, AM J CLIN NUTR, V64, P641, DOI 10.1093/ajcn/64.4.641; KAGAWA T, 1965, J BIOL CHEM, V240, P1836; Kelly TLJ, 2005, BIOL REPROD, V72, P667, DOI 10.1095/biolreprod.104.035238; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Lawson-Yuen A, 2006, MOL GENET METAB, V88, P201, DOI 10.1016/j.ymgme.2006.02.004; LIN CS, 1986, J PROTEIN CHEM, V5, P193, DOI 10.1007/BF01025488; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maconochie N, 2004, BRIT MED J, V329, P196, DOI 10.1136/bmj.38163.620972.AE; Mann PJG, 1937, BIOCHEM J, V31, P869, DOI 10.1042/bj0310869; Melenovsky V, 2003, AM HEART J, V146, P110, DOI 10.1016/S0002-8703(03)00122-4; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Nasr-Esfahani MH, 2002, J ASSIST REPROD GEN, V19, P477, DOI 10.1023/A:1020310503143; OHTAFUKUYAMA M, 1980, J BIOCHEM-TOKYO, V88, P197; Olthof MR, 2005, CURR DRUG METAB, V6, P15, DOI 10.2174/1389200052997366; POMFRET EA, 1989, ANAL BIOCHEM, V180, P85, DOI 10.1016/0003-2697(89)90091-2; Rajapakse N, 2001, BRAIN RES PROTOC, V8, P176, DOI 10.1016/S1385-299X(01)00108-8; ROZWADOWSKI KL, 1991, J BACTERIOL, V173, P472, DOI 10.1128/jb.173.2.472-478.1991; Schwahn BC, 2004, BIOCHEM J, V382, P831, DOI 10.1042/BJ20030822; Schwahn BC, 2003, FASEB J, V17, P512, DOI 10.1096/fj.02-0456fje; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; Sipila P, 2009, REPRODUCTION, V137, P379, DOI 10.1530/REP-08-0132; Steenge GR, 2003, J NUTR, V133, P1291; STOREY BT, 1975, FERTIL STERIL, V26, P1257; SVANBORG A, 1961, ACTA MED SCAND, V169, P43; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; Turner RM, 2003, J ANDROL, V24, P790; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; WENDEL U, 1984, EUR J PEDIATR, V142, P147, DOI 10.1007/BF00445602; *WHO, 1990, PROGR RES 1989 1990, P15; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Yeung CH, 2004, J ANDROL, V25, P216; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zeisel SH, 2003, J NUTR, V133, P1302; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; ZHANG J, 1992, BIOCHIM BIOPHYS ACTA, V1117, P333, DOI 10.1016/0304-4165(92)90033-Q	59	49	53	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2752	2761		10.1096/fj.09-153718	http://dx.doi.org/10.1096/fj.09-153718			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20371614	Green Published, Green Submitted			2022-12-25	WOS:000285005400016
J	Takanaga, H; Frommer, WB				Takanaga, Hitomi; Frommer, Wolf B.			Facilitative plasma membrane transporters function during ER transit	FASEB JOURNAL			English	Article						endoplasmic reticulum; uniporter; sodium-cotransporter; fluoresecence resonance energy transfer; sensor	ENDOPLASMIC-RETICULUM MEMBRANE; GLUCOSE-RELEASE; GLUCOSE-6-PHOSPHATASE SYSTEM; GLUT2-NULL HEPATOCYTES; GLUT1; PROTEIN; CELLS; RAT; EXPRESSION; SENSORS	Although biochemical studies suggested a high permeability of the endoplasmic reticulum (ER) membrane for small molecules, proteomics identified few specialized ER transporters. To test functionality of transporters during ER passage, we tested whether glucose transporters (GLUTs, SGLTs) destined for the plasma membrane are active during ER transit. HepG2 cells were characterized by low-affinity ER transport activity, suggesting that ER uptake is protein mediated. The much-reduced capacity of HEK293T cells to take up glucose across the plasma membrane correlated with low ER transport. Ectopic expression of GLUT1, -2, -4, or -9 induced GLUT isoform-specific ER transport activity in HEK293T cells. In contrast, the Na+-glucose cotransporter SGLT1 mediated efficient plasma membrane glucose transport but no detectable ER uptake, probably because of lack of a sufficient sodium gradient across the ER membrane. In conclusion, we demonstrate that GLUTs are sufficient for mediating ER glucose transport en route to the plasma membrane. Because of the low volume of the ER, trace amounts of these uniporters contribute to ER solute import during ER transit, while uniporters and cation-coupled transporters carry out export from the ER, together potentially explaining the low selectivity of ER transport. Expression levels and residence time of transporters in the ER, as well as their coupling mechanisms, could be key determinants of ER permeability.-Takanaga, H., Frommer, W. B. Facilitative plasma membrane transporters function during ER transit. FASEB J. 24, 2849-2858 (2010). www.fasebj.org	[Takanaga, Hitomi; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA	Carnegie Institution for Science	Frommer, WB (corresponding author), 260 Panama St, Stanford, CA 94305 USA.	wfrommer@carnegiescience.edu	Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115	U.S. National Institutes of Health (NIDDK) [1RO1DK079109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Oliver Schweissgut (Siegen, Germany) for writing the Matlab script for the baseline correction. The authors thank Li-Qing Chen (Carnegie Institution for Science, Stanford, CA, USA) for carrying out the RT-PCR. This work was funded by a grant from the U.S. National Institutes of Health to W.B.F. (NIDDK; 1RO1DK079109).	ARION WJ, 1980, J BIOL CHEM, V255, P396; Brockmann K, 2001, ANN NEUROL, V50, P476, DOI 10.1002/ana.1222; Burcelin R, 2000, DIABETES, V49, P1643, DOI 10.2337/diabetes.49.10.1643; Burcelin R, 2000, J BIOL CHEM, V275, P10930, DOI 10.1074/jbc.275.15.10930; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Chandra P, 2004, PHARM RES-DORDR, V21, P719, DOI 10.1023/B:PHAM.0000026420.79421.8f; Chen SY, 2008, FASEB J, V22, P2206, DOI 10.1096/fj.07-104851; Csala M, 2006, FEBS LETT, V580, P2160, DOI 10.1016/j.febslet.2006.03.050; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Deuschle K, 2005, CYTOM PART A, V64A, P3, DOI 10.1002/cyto.a.20119; Eskandari S, 2005, J MEMBRANE BIOL, V204, P23, DOI 10.1007/s00232-005-0743-x; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Fehr M, 2005, BIOCHEM SOC T, V33, P287, DOI 10.1042/BST0330287; Fehr M, 2004, J FLUORESC, V14, P603, DOI 10.1023/B:JOFL.0000039347.94943.99; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Foster JA, 2002, EXP BIOL MED, V227, P601, DOI 10.1177/153537020222700807; Gao BB, 2008, MOL CELL PROTEOMICS, V7, P2399, DOI 10.1074/mcp.M800104-MCP200; Guerra G, 2007, BBA-BIOMEMBRANES, V1768, P2383, DOI 10.1016/j.bbamem.2007.04.029; Guillam MT, 1998, P NATL ACAD SCI USA, V95, P12317, DOI 10.1073/pnas.95.21.12317; Hirayama BA, 1996, AM J PHYSIOL-GASTR L, V270, pG919, DOI 10.1152/ajpgi.1996.270.6.G919; HOOPER G, 1976, J GEN PHYSIOL, V67, P469, DOI 10.1085/jgp.67.4.469; Hosokawa M, 2002, AM J PHYSIOL-ENDOC M, V282, pE794, DOI 10.1152/ajpendo.00374.2001; Kasahara T, 1996, BIOCHEM J, V315, P177, DOI 10.1042/bj3150177; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; LI YX, 1995, AM J PHYSIOL-CELL PH, V269, pC1079, DOI 10.1152/ajpcell.1995.269.5.C1079; Lippincott-Schwartz J, 2000, BIOPHYS J, V78, p138A; Lizak B, 2008, MOL MEMBR BIOL, V25, P95, DOI 10.1080/09687680701670481; Matern D, 2002, EUR J PEDIATR, V161, pS10, DOI 10.1007/s00431-002-0998-5; Mechin MC, 2000, PROTEINS, V41, P164, DOI 10.1002/1097-0134(20001101)41:2<164::AID-PROT20>3.0.CO;2-2; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pascual JM, 2008, J BIOL CHEM, V283, P16732, DOI 10.1074/jbc.M801403200; Santer R, 2002, HUM GENET, V110, P21, DOI 10.1007/s00439-001-0638-6; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Wong HY, 2007, MOL GENET METAB, V90, P193, DOI 10.1016/j.ymgme.2006.09.002	39	51	53	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2849	2858		10.1096/fj.09-146472	http://dx.doi.org/10.1096/fj.09-146472			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354141	Green Published, hybrid			2022-12-25	WOS:000285005400025
J	Wang, SB; Dale, GL; Song, P; Viollet, B; Zou, MH				Wang, Shaobin; Dale, George L.; Song, Ping; Viollet, Benoit; Zou, Ming-hui			AMPK alpha 1 Deletion Shortens Erythrocyte Life Span in Mice ROLE OF OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RED-CELL MEMBRANE; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; HEMOLYTIC-ANEMIA; IN-VIVO; EXPRESSION; SURVIVAL; BLOOD	AMP-activated protein kinase (AMPK) is an energy sensor essential for maintaining cellular energy homeostasis. Here, we report that AMPK alpha 1 is the predominant isoform of AMPK in murine erythrocytes and mice globally deficient in AMPK alpha 1 (AMPK alpha 1(-/-)), but not in those lacking AMPK alpha 2, and the mice had markedly enlarged spleens with dramatically increased proportions of Ter119-positive erythroid cells. Blood tests revealed significantly decreased erythrocyte and hemoglobin levels with increased reticulocyte counts and elevated plasma erythropoietin concentrations in AMPK alpha 1(-/-) mice. The life span of erythrocytes from AMPK alpha 1(-/-) mice was less than that in wild-type littermates, and the levels of reactive oxygen species and oxidized proteins were significantly increased in AMPK alpha 1(-/-) erythrocytes. In keeping with the elevated oxidative stress, treatment of AMPK alpha 1(-/-) mice with the antioxidant, tempol, resulted in decreased reticulocyte counts and improved erythrocyte survival. Furthermore, the expression of Foxo3 and reactive oxygen species scavenging enzymes was significantly decreased in erythroblasts from AMPK alpha 1(-/-) mice. Collectively, these results establish an essential role for AMPK alpha 1 in regulating oxidative stress and life span in erythrocytes.	[Zou, Ming-hui] Univ Oklahoma, Sect Endocrinol & Diabet, Dept Med, Hlth Sci Ctr,Div Hematol, Oklahoma City, OK 73104 USA; [Wang, Shaobin; Song, Ping; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Div Endocrinol & Diabet, Oklahoma City, OK 73104 USA; [Wang, Shaobin; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Viollet, Benoit] Inst Cochin, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] INSERM, Paris U567, F-75654 Paris 13, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Zou, MH (corresponding author), Univ Oklahoma, Sect Endocrinol & Diabet, Dept Med, Hlth Sci Ctr,Div Hematol, BSEB 325, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Song, Ping/D-6972-2011; wang, shaobin/D-7168-2011; wang, shaobin/L-8539-2015; Song, Ping/N-8456-2018; wang, shaobin/A-2415-2015; Wang, Shaobin/C-5507-2008	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Song, Ping/0000-0002-2654-6162; Song, Ping/0000-0002-6143-4270; wang, shaobin/0000-0002-0931-7210; Wang, Shaobin/0000-0002-1751-9162	National Institutes of Health [HL079584, HL074399, HL080499, HL089920, HL096032]; American Diabetes Association; Juvenile Diabetes Research Foundation; Oklahoma Center for Advancement of Science and Technology; Travis Endowed Chair in Endocrinology, University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL105157, R01HL096032, R01HL080499, R01HL089920, R01HL079584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oklahoma Center for Advancement of Science and Technology; Travis Endowed Chair in Endocrinology, University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL074399, HL080499, HL089920, and HL096032. This work was also supported by research awards from the American Diabetes Association, Juvenile Diabetes Research Foundation, Oklahoma Center for Advancement of Science and Technology, and a Travis Endowed Chair in Endocrinology, University of Oklahoma Health Sciences Center.	An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; BEUTLER E, 2005, WILLIAMS HEMATOLOGY, P405; Bogdanova A, 2007, BLOOD, V110, P762, DOI 10.1182/blood-2006-12-063602; Bratosin D, 1997, CR ACAD SCI III-VIE, V320, P811, DOI 10.1016/S0764-4469(97)85017-2; Castro L, 2001, NUTRITION, V17, P161, DOI 10.1016/S0899-9007(00)00570-0; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; HEBBEL RP, 1990, BLOOD, V76, P1015; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; ITANO HA, 1975, NATURE, V256, P665, DOI 10.1038/256665a0; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; McMullin MF, 1999, J CLIN PATHOL, V52, P241, DOI 10.1136/jcp.52.4.241; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MOHANDAS N, 1979, SEMIN HEMATOL, V16, P95; MOHANDAS N, 1980, J CLIN INVEST, V66, P563, DOI 10.1172/JCI109888; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; SUZUKI T, 1987, BLOOD, V70, P791; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; TURGEON ML, 2005, CLIN HEMATOLOGY THEO, P455; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2007, PROSTAG OTH LIPID M, V82, P119, DOI 10.1016/j.prostaglandins.2006.05.005	50	80	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19976	19985		10.1074/jbc.M110.102467	http://dx.doi.org/10.1074/jbc.M110.102467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20392689	Green Published, hybrid			2022-12-25	WOS:000279012000031
J	Bobkova, EV; Weber, MJ; Xu, ZW; Zhang, YL; Jung, J; Blume-Jensen, P; Northrup, A; Kunapuli, P; Andersen, JN; Kariv, I				Bobkova, Ekaterina V.; Weber, Michael J.; Xu, Zangwei; Zhang, Yan-Ling; Jung, Joon; Blume-Jensen, Peter; Northrup, Alan; Kunapuli, Priya; Andersen, Jannik N.; Kariv, Ilona			Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism of Action by Ultrahigh Throughput Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC COLORECTAL-CANCER; PIF-BINDING POCKET; PROTEIN-KINASE; DRUG DISCOVERY; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; DOMAIN; ASSAYS; STABILITY	The phosphoinositide 3-kinase/AKT signaling pathway plays a key role in cancer cell growth, survival, and angiogenesis. Phosphoinositide-dependent protein kinase-1 (PDK1) acts at a focal point in this pathway immediately downstream of phosphoinositide 3-kinase and PTEN, where it phosphorylates numerous AGC kinases. The PDK1 kinase domain has at least three ligand-binding sites: the ATP-binding pocket, the peptide substrate-binding site, and a groove in the N-terminal lobe that binds the C-terminal hydrophobic motif of its kinase substrates. Based on the unique PDK1 substrate recognition system, ultra-high throughput TR-FRET and Alphascreen (R) screening assays were developed using a biotinylated version of the PDK1-tide substrate containing the activation loop of AKT fused to a pseudo-activated hydrophobic motif peptide. Using full-length PDK1, K-m values were determined as 5.6 mu M for ATP and 40 nM for the fusion peptide, revealing 50-fold higher affinity compared with the classical AKT(Thr-308)-tide. Kinetic and biophysical studies confirmed the PDK1 catalytic mechanism as a rapid equilibrium random bireactant reaction. Following an ultrahigh throughput screen of a large library, 2,000 compounds were selected from the reconfirmed hits by computational analysis with a focus on novel scaffolds. ATP-competitive hits were deconvoluted by dose-response studies at 1 x and 10 x K-m concentrations of ATP, and specificity of binding was assessed in thermal shift assay. Inhibition studies using fusion PDK1-tide1 substrate versus AKT(Thr-308)-tide and kinase selectivity profiling revealed a novel selective alkaloid scaffold that evidently binds to the PDK1-interacting fragment pocket. Molecular modeling suggests a structural paradigm for the design of inhibitory versus activating allosteric ligands of PDK1.	[Bobkova, Ekaterina V.; Xu, Zangwei; Zhang, Yan-Ling; Jung, Joon; Blume-Jensen, Peter; Northrup, Alan; Andersen, Jannik N.; Kariv, Ilona] Merck Res Labs, Boston, MA 02115 USA; [Weber, Michael J.; Kunapuli, Priya] Merck Res Labs, N Wales, PA 19454 USA	Merck & Company; Merck & Company	Bobkova, EV (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ebobkova@burnham.org		Andersen, Jannik/0000-0003-4528-2120				Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Boyle R. G., 2005, PCT Int. Appl., Patent No. [2005028474, WO 2005028474 A2]; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Engel M, 2006, EMBO J, V25, P5469, DOI 10.1038/sj.emboj.7601416; Fang L, 2008, J CHEM INF MODEL, V48, P2030, DOI 10.1021/ci800104s; Gao XX, 2006, J BIOL CHEM, V281, P21670, DOI 10.1074/jbc.M602448200; GOULET JL, 2003, Patent No. 2003011285; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Harris TK, 2003, IUBMB LIFE, V55, P117, DOI 10.1080/1521654031000115951; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Komander D, 2004, STRUCTURE, V12, P215, DOI 10.1016/j.str.2004.01.005; KOZINA E, 2008, Patent No. 2008112217; Lind K. E., 2008, Patent No. 2008005457; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Segel I. H., 1993, ENZYME KINETICS BEHA, P274; Stockman BJ, 2009, CHEM BIOL DRUG DES, V73, P179, DOI 10.1111/j.1747-0285.2008.00768.x; Stroba A, 2009, J MED CHEM, V52, P4683, DOI 10.1021/jm9001499; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356; YOUNG J, 2007, Patent No. 2007145957; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	38	43	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18838	18846		10.1074/jbc.M109.089946	http://dx.doi.org/10.1074/jbc.M109.089946			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385558	Green Published, hybrid			2022-12-25	WOS:000278453900074
J	Lowe, EC; Bydder, S; Hartshorne, RS; Tape, HLU; Dridge, EJ; Debieux, CM; Paszkiewicz, K; Singleton, I; Lewis, RJ; Santini, JM; Richardson, DJ; Butler, CS				Lowe, Elisabeth C.; Bydder, Sarah; Hartshorne, Robert S.; Tape, Hannah L. U.; Dridge, Elizabeth J.; Debieux, Charles M.; Paszkiewicz, Konrad; Singleton, Ian; Lewis, Richard J.; Santini, Joanne M.; Richardson, David J.; Butler, Clive S.			Quinol-cytochrome c Oxidoreductase and Cytochrome c(4) Mediate Electron Transfer during Selenate Respiration in Thauera selenatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL SULFIDE DEHYDROGENASE; NITRITE REDUCTASE GENES; NITRATE REDUCTASE; REDOX CENTERS; ETHYLBENZENE DEHYDROGENASE; THIOBACILLUS-FERROOXIDANS; RHODOVULUM-SULFIDOPHILUM; THIOCAPSA-ROSEOPERSICINA; IDEONELLA-DECHLORATANS; PSEUDOMONAS-STUTZERI	Selenatereductase(SER) from Thaueraselenatis is a periplasmic enzyme that has been classified as a type II molybdoenzyme. The enzyme comprises three subunits SerABC, where SerC is an unusual b-heme cytochrome. In the present work the spectropotentiometric characterization of the SerC component and the identification of redox partners to SER are reported. The mid-point redox potential of the b-heme was determined by optical titration (E-m + 234 +/- 10 mV). A profile of periplasmic c-type cytochromes expressed in T. selenatis under selenate respiring conditions was undertaken. Two c-type cytochromes were purified (similar to 24 and similar to 6 kDa), and the 24-kDa protein (cytc-Ts4) was shown to donate electrons to SerABC in vitro. Protein sequence of cytc-Ts4 was obtained by N-terminal sequencing and liquid chromatography-tandem mass spectrometry analysis, and based upon sequence similarities, was assigned as a member of cytochrome c(4) family. Redox potentiometry, combined with UV-visible spectroscopy, showed that cytc-Ts4 is a diheme cytochrome with a redox potential of + 282 +/- 10 mV, and both hemes are predicted to have His-Met ligation. To identify the membrane-bound electron donors to cytc-Ts4, growth of T. selenatis in the presence of respiratory inhibitors was monitored. The specific quinol-cytochrome c oxidoreductase (QCR) inhibitors myxothiazol and antimycin A partially inhibited selenate respiration, demonstrating that some electron flux is via the QCR. Electron transfer via a QCR and a diheme cytochrome c(4) is a novel route for a member of the DMSO reductase family of molybdoenzymes.	[Lowe, Elisabeth C.; Tape, Hannah L. U.; Dridge, Elizabeth J.; Debieux, Charles M.; Paszkiewicz, Konrad; Butler, Clive S.] Univ Exeter, Sch Biosci, Ctr Biocatalysis, Exeter EX4 4QD, Devon, England; [Bydder, Sarah] La Trobe Univ, Dept Microbiol, Bundoora, Vic 3086, Australia; [Hartshorne, Robert S.; Richardson, David J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Singleton, Ian] Newcastle Univ, Inst Res Environm & Sustainabil, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lewis, Richard J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Santini, Joanne M.] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England	University of Exeter; La Trobe University; University of East Anglia; Newcastle University - UK; Newcastle University - UK; University of London; Birkbeck University London; University College London	Butler, CS (corresponding author), Univ Exeter, Sch Biosci, Ctr Biocatalysis, Stocker Rd, Exeter EX4 4QD, Devon, England.	c.s.butler@exeter.ac.uk	Singleton, Ian/G-1174-2010; Richardson, David J/E-2275-2011	Lowe, Elisabeth/0000-0001-9812-0614; Singleton, Ian/0000-0002-3866-668X; lewis, richard/0000-0003-2641-8643	Biotechnology and Biological Sciences Research Council (BBSRC) [P17219, BBS/B/10110]; BBSRC/Engineering and Physical Sciences Research Council [BB/D00781X/1]; Systems Biology Theme, University of Exeter; La Trobe University; BBSRC [BB/D00781X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00781X/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); Systems Biology Theme, University of Exeter; La Trobe University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in part by Biotechnology and Biological Sciences Research Council (BBSRC) Grants P17219 and BBS/B/10110 (to C. S. B. and D. J. R.) and BBSRC/Engineering and Physical Sciences Research Council (life science interface) Grant BB/D00781X/1 (to C. S. B., R. J. L., and D. J. R.). Sequencing of the T. selenatis genome was funded by the Systems Biology Theme, University of Exeter.; A recipient of a BBSRC Agri-food committee studentship.; Supported by a La Trobe University postgraduate award.	Abergel C, 2003, STRUCTURE, V11, P547, DOI 10.1016/S0969-2126(03)00072-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backlund AS, 2009, APPL ENVIRON MICROB, V75, P2439, DOI 10.1128/AEM.01325-08; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BOHLIN J, 2009, MICROBIOL R IN PRESS; Branca RMM, 2007, J MASS SPECTROM, V42, P1569, DOI 10.1002/jms.1337; Branca RMM, 2007, ARCH BIOCHEM BIOPHYS, V467, P174, DOI 10.1016/j.abb.2007.07.031; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; Cavazza C, 1996, EUR J BIOCHEM, V242, P308, DOI 10.1111/j.1432-1033.1996.0308r.x; CHRISTENSEN HEM, 1994, GENE, V144, P139, DOI 10.1016/0378-1119(94)90219-4; CRASKE A, 1986, EUR J BIOCHEM, V158, P429, DOI 10.1111/j.1432-1033.1986.tb09771.x; Creevey NL, 2008, BIOCHEMISTRY-US, V47, P3770, DOI 10.1021/bi702444r; Danielsson H, 2003, APPL ENVIRON MICROB, V69, P5585, DOI 10.1128/AEM.69.9.5585-5592.2003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dridge EJ, 2007, BIOCHEM J, V408, P19, DOI 10.1042/BJ20070669; Dutton P L, 1978, Methods Enzymol, V54, P411; Etchebehere C, 2005, APPL ENVIRON MICROB, V71, P5642, DOI 10.1128/AEM.71.9.5642-5645.2005; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; Johnson HA, 2001, J BACTERIOL, V183, P4536, DOI 10.1128/JB.183.15.4536-4542.2001; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Kadziola A, 1997, STRUCTURE, V5, P203, DOI 10.1016/S0969-2126(97)00179-2; Karlsson J, 2005, PROTEIN EXPRES PURIF, V41, P306, DOI 10.1016/j.pep.2005.02.002; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Krafft T, 2000, DNA Seq, V10, P365, DOI 10.3109/10425170009015604; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACY JM, 1993, INT J SYST BACTERIOL, V43, P135, DOI 10.1099/00207713-43-1-135; Magalon A, 1998, J BIOL CHEM, V273, P10851, DOI 10.1074/jbc.273.18.10851; Maher MJ, 2004, INORG CHEM, V43, P402, DOI 10.1021/ic035136n; Martinez-Espinosa RM, 2007, FEMS MICROBIOL LETT, V276, P129, DOI 10.1111/j.1574-6968.2007.00887.x; McCrindle SL, 2005, ADV MICROB PHYSIOL, V50, P147, DOI 10.1016/S0065-2911(05)50004-3; McDevitt CA, 2002, BIOCHEMISTRY-US, V41, P15234, DOI 10.1021/bi026221u; McDevitt CA, 2002, MOL MICROBIOL, V44, P1575, DOI 10.1046/j.1365-2958.2002.02978.x; McEwan AG, 2002, GEOMICROBIOL J, V19, P3, DOI 10.1080/014904502317246138; MOIR JWB, 1993, EUR J BIOCHEM, V212, P377, DOI 10.1111/j.1432-1033.1993.tb17672.x; MONOD J., 1942, Research on the Glowth of Bacterial Cultures.; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ohmine M, 2009, BIOCHEMISTRY-US, V48, P9132, DOI 10.1021/bi901202m; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; PETTIGREW GW, 1988, BIOCHEM J, V252, P427, DOI 10.1042/bj2520427; Potter L, 2001, ADV MICROB PHYSIOL, V45, P51, DOI 10.1016/S0065-2911(01)45002-8; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Ridley H, 2006, APPL ENVIRON MICROB, V72, P5173, DOI 10.1128/AEM.00568-06; Roldan MD, 1998, J BIOL CHEM, V273, P28785, DOI 10.1074/jbc.273.44.28785; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Schroder I, 1997, J BIOL CHEM, V272, P23765, DOI 10.1074/jbc.272.38.23765; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Song BK, 2003, FEMS MICROBIOL ECOL, V43, P349, DOI 10.1111/j.1574-6941.2003.tb01075.x; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; SWANK RT, 1969, BIOCHIM BIOPHYS ACTA, V180, P473, DOI 10.1016/0005-2728(69)90026-7; THIERBACH G, 1981, BIOCHIM BIOPHYS ACTA, V638, P282, DOI 10.1016/0005-2728(81)90238-3; VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZWIETERING MH, 1992, J APPL BACTERIOL, V72, P139, DOI 10.1111/j.1365-2672.1992.tb01815.x	54	34	34	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18433	18442		10.1074/jbc.M110.115873	http://dx.doi.org/10.1074/jbc.M110.115873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388716	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000278453900037
J	Luo, DH; Wei, N; Doan, DN; Paradkar, PN; Chong, YW; Davidson, AD; Kotaka, M; Lescar, J; Vasudevan, SG				Luo, Dahai; Wei, Na; Doan, Danny N.; Paradkar, Prasad N.; Chong, Yuwen; Davidson, Andrew D.; Kotaka, Masayo; Lescar, Julien; Vasudevan, Subhash G.			Flexibility between the Protease and Helicase Domains of the Dengue Virus NS3 Protein Conferred by the Linker Region and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; HELICASE/NUCLEOSIDE TRIPHOSPHATASE; CATALYTIC DOMAIN; REPLICATION; ASSOCIATION; PREDICTION; RESOLUTION; SYSTEM; NS2B	The dengue virus (DENV) NS3 protein is essential for viral polyprotein processing and RNA replication. It contains an N-terminal serine protease region (residues 1-168) joined to an RNA helicase (residues 180-618) by an 11-amino acid linker (169-179). The structure at 3.15 angstrom of the soluble NS3 protein from DENV4 covalently attached to 18 residues of the NS2B cofactor region (NS2B(18)NS3) revealed an elongated molecule with the protease domain abutting subdomains I and II of the helicase (Luo, D., Xu, T., Hunke, C., Gruber, G., Vasudevan, S. G., and Lescar, J. (2008) J. Virol. 82, 173-183). Unexpectedly, using similar crystal growth conditions, we observed an alternative conformation where the protease domain has rotated by similar to 161 degrees with respect to the helicase domain. We report this new crystal structure bound to ADP-Mn2+ refined to a resolution of 2.2 angstrom. The biological significance for interdomain flexibility conferred by the linker region was probed by either inserting a Gly residue between Glu(173) and Pro174 or replacing Pro174 with a Gly residue. Both mutations resulted in significantly lower ATPase and helicase activities. We next increased flexibility in the linker by introducing a Pro(176) to Gly mutation in a DENV2 replicon system. A 70% reduction in luciferase reporter signal and a similar reduction in the level of viral RNA synthesis were observed. Our results indicate that the linker region has evolved to an optimum length to confer flexibility to the NS3 protein that is required both for polyprotein processing and RNA replication.	[Luo, Dahai; Kotaka, Masayo; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Wei, Na; Doan, Danny N.; Paradkar, Prasad N.; Chong, Yuwen; Vasudevan, Subhash G.] Duke Natl Univ Singapore Grad Med Sch, Program Emerging Infect Dis, Singapore 637551, Singapore; [Davidson, Andrew D.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Lescar, Julien] CNRS, UMR 6098, F-13288 Marseille, France	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Bristol; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Vasudevan, SG (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore.	subhash.vasudevan@duke-nus.edu.sg	Paradkar, Prasad/ABA-5851-2020; Luo, Dahai/J-6022-2012; Kotaka, Masayo/C-4483-2009	Paradkar, Prasad/0000-0002-6553-2214; Luo, Dahai/0000-0001-7637-7275; Kotaka, Masayo/0000-0001-9692-3843; Vasudevan, Subhash/0000-0002-5083-3831	Biomedical Research Council [06/1/22/19/447, 09/1/22/19/599]; CNRS; Agency for Sciences, Technology and Research, Singapore; Ministry of Health, Singapore;  [ARC5/07]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agency for Sciences, Technology and Research, Singapore; Ministry of Health, Singapore(Ministry of Health-Singapore); 	Recipient of Biomedical Research Council Grants 06/1/22/19/447 and 09/1/22/19/599, an ARC5/07 grant, and an Action Thematique d'Incitation sur Programme from the CNRS.; Recipient of support from the Duke-National University of Singapore Signature Research Program (funded by the Agency for Sciences, Technology and Research, Singapore, and the Ministry of Health, Singapore).	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804; Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DeLano WL, 2002, PYMOL USERS MANUAL; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055; Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Westaway EG, 1999, VIROLOGY, V258, P108, DOI 10.1006/viro.1999.9683; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Xu T., 2006, NOVART FDN SYMP, V277, P251; Xu T., 2006, NOVART FDN SYMP, V277, P97; Xu Ting, 2006, Novartis Found Symp, V277, P87, DOI 10.1002/0470058005.ch7; Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018; Yan YW, 1998, PROTEIN SCI, V7, P837; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200	43	115	121	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18817	18827		10.1074/jbc.M109.090936	http://dx.doi.org/10.1074/jbc.M109.090936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375022	Green Published, hybrid			2022-12-25	WOS:000278453900072
J	Wu, N; Siow, YL; Karmin, O				Wu, Nan; Siow, Yaw L.; Karmin, O.			Ischemia/Reperfusion Reduces Transcription Factor Sp1-mediated Cystathionine beta-Synthase Expression in the Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; DNA-BINDING ACTIVITY; HYDROGEN-SULFIDE; SP1 PHOSPHORYLATION; GENE-TRANSCRIPTION; CARDIOVASCULAR-DISEASE; SERUM HOMOCYSTEINE; PROTEIN; ACTIVATION; RAT	Cystathionine beta-synthase (CBS) is a key enzyme that catalyzes the rate-limiting step for homocysteine (Hcy) metabolism via the trans-sulfuration pathway and is also responsible for the production of H2S through the desulfhydration reaction. Our recent studies demonstrate that renal ischemia/reperfusion decreased the CBS activity leading to Hcy accumulation and H2S reduction in the kidney, which in turn contributed to kidney injury. Both Hcy and H2S play important roles in physiological and pathological processes. In this study we investigated the molecular mechanism by which CBS activity was regulated in the kidney. The left kidney of Sprague-Dawley rat was subjected to 45 min of ischemia followed by 6 h of reperfusion. Ischemia/reperfusion caused a significant decrease in CBS mRNA and protein levels in the kidney. As a consequence, there was a marked reduction in the CBS enzyme activity. Transfection of kidney proximal tubular cells with transcription factor (Sp1) small interfering RNA caused a marked reduction in CBS mRNA, indicating a pivotal role for Sp1 in regulating CBS expression in kidney cells. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay detected a lower Sp1 activity in kidneys subjected to ischemia/reperfusion as compared with that in a sham-operated group. ERK-mediated phosphorylation of Sp1 was responsible for a decreased transcriptional activity of Sp1 in the kidney upon ischemia/reperfusion. These results suggest that reduced kidney CBS gene expression during ischemia/reperfusion is mediated via a decrease in Sp1 transcriptional activity. Regulation of CBS-mediated Hcy and H2S homeostasis may offer a renal protective effect against ischemia/reperfusion injury.	[Wu, Nan; Siow, Yaw L.; Karmin, O.] Univ Manitoba, Lab Integrat Biol, Dept Anim Sci, Dept Physiol,St Boniface Hosp Res Ctr, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Karmin, O (corresponding author), Univ Manitoba, Lab Integrat Biol, Dept Anim Sci, Dept Physiol,St Boniface Hosp Res Ctr, 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	karmino@sbrc.ca		Siow, Yaw/0000-0001-6623-2881; O, Karmin/0000-0002-2163-9458	Natural Sciences and Engineering Research Council of Canada; St. Boniface Hospital & Research Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); St. Boniface Hospital & Research Foundation	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the St. Boniface Hospital & Research Foundation.	Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Au-Yeung KKW, 2004, CIRC RES, V94, P28, DOI 10.1161/01.RES.0000108264.67601.2C; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Distrutti E, 2008, HEPATOLOGY, V47, P659, DOI 10.1002/hep.22037; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Eto K, 2002, J BIOL CHEM, V277, P42680, DOI 10.1074/jbc.M205835200; Francis ME, 2004, KIDNEY INT, V66, P303, DOI 10.1111/j.1523-1755.2004.00732.x; Friedman AN, 2001, J AM SOC NEPHROL, V12, P2181, DOI 10.1681/ASN.V12102181; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; Ge YB, 2001, J BIOL CHEM, V276, P43570, DOI 10.1074/jbc.M104930200; House JD, 1997, BIOCHEM J, V328, P287; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kraus JP, 1998, GENOMICS, V52, P312, DOI 10.1006/geno.1998.5437; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; Liao MJ, 2008, MOL ENDOCRINOL, V22, P1449, DOI 10.1210/me.2008-0035; Maclean KN, 2004, J BIOL CHEM, V279, P8558, DOI 10.1074/jbc.M310211200; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Majumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M511223200; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V270, P947, DOI 10.1006/bbrc.2000.2522; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Prathapasinghe GA, 2007, AM J PHYSIOL-RENAL, V292, pF1354, DOI 10.1152/ajprenal.00301.2006; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Roper MD, 1996, MAMM GENOME, V7, P754, DOI 10.1007/s003359900226; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; WEINBERG JM, 1991, KIDNEY INT, V39, P476, DOI 10.1038/ki.1991.58; Woo CWH, 2008, J BIOL CHEM, V283, P1282, DOI 10.1074/jbc.M707886200; Woo CWH, 2006, BBA-MOL BASIS DIS, V1762, P656, DOI 10.1016/j.bbadis.2006.05.012; Woo CWH, 2006, ARTERIOSCL THROM VAS, V26, P1043, DOI 10.1161/01.ATV.0000214981.58499.32; Woo CWH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1002, DOI 10.1152/ajpendo.00518.2004; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Xu ZB, 2009, AM J PHYSIOL-RENAL, V297, pF27, DOI 10.1152/ajprenal.00096.2009; Yi F, 2008, AM J NEPHROL, V28, P254, DOI 10.1159/000110876; Yun SS, 2002, J BIOL CHEM, V277, P34808, DOI 10.1074/jbc.M205417200; Zhu T, 2002, CLIN EXP PHARMACOL P, V29, P852, DOI 10.1046/j.1440-1681.2002.03736.x; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200	55	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18225	18233		10.1074/jbc.M110.132142	http://dx.doi.org/10.1074/jbc.M110.132142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392694	hybrid, Green Published			2022-12-25	WOS:000278453900014
J	Doyle, K; Fitzpatrick, FA				Doyle, Kelly; Fitzpatrick, F. A.			Redox Signaling, Alkylation (Carbonylation) of Conserved Cysteines Inactivates Class I Histone Deacetylases 1, 2, and 3 and Antagonizes Their Transcriptional Repressor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION PRODUCT; KAPPA-B KINASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDINS; PROTEIN CARBONYLATION; GROWTH-INHIBITION; COVALENT MODIFICATION; OXIDATIVE STRESS; INFLAMMATION; MECHANISM	Cells use redox signaling to adapt to oxidative stress. For instance, certain transcription factors exist in a latent state that may be disrupted by oxidative modifications that activate their transcription potential. We hypothesized that DNA-binding sites (response elements) for redox-sensitive transcription factors may also exist in a latent state, maintained by co-repressor complexes containing class I histone deacetylase (HDAC) enzymes, and that HDAC inactivation by oxidative stress may antagonize deacetylase activity and unmask electrophile-response elements, thus activating transcription. Electrophiles suitable to test this hypothesis include reactive carbonyl species, often derived from peroxidation of arachidonic acid. We report that alpha,beta-unsaturated carbonyl compounds, e.g. the cyclopentenone prostaglandin, 15-deoxy-Delta 12,14-PGJ(2) (15d-PGJ(2)), and 4-hydroxy-2-nonenal (4HNE), alkylate (carbonylate), a subset of class I HDACs including HDAC1, -2, and -3, but not HDAC8. Covalent modification at two conserved cysteine residues, corresponding to Cys(261) and Cys(273) in HDAC1, coincided with attenuation of histone deacetylase activity, changes in histone H3 and H4 acetylation patterns, derepression of a LEF1 center dot beta-catenin model system, and transcription of HDAC-repressed genes, e. g. heme oxygenase-1 (HO-1), Gadd45, and HSP70. Identification of particular class I HDACs as components of the redox/electrophile-responsive proteome offers a basis for understanding how cells stratify their responses to varying degrees of pathophysiological oxidative stress associated with inflammation, cancer, and metabolic syndrome.	[Doyle, Kelly; Fitzpatrick, F. A.] Univ Utah, Sch Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Fitzpatrick, FA (corresponding author), Kansas City Univ Med & Biosci, Dept Pharmacol & Microbiol, SEP 429,1750 Independence Ave, Kansas City, MO 64106 USA.	ffitzpatrick@kcumb.edu			National Institutes of Health [R01 AI 26730]; Dee Glen and Ida Smith Chair for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dee Glen and Ida Smith Chair for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 26730 (to F. A. F.). This work was also supported by the Dee Glen and Ida Smith Chair for Cancer Research.	Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Cattaruzza M, 2008, CIRC RES, V102, P273, DOI 10.1161/CIRCRESAHA.108.172148; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Courey AJ, 2001, GENE DEV, V15, P2786; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Jepsen K, 2002, J CELL SCI, V115, P689; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Lu CB, 2002, J BIOL CHEM, V277, P24368, DOI 10.1074/jbc.M201924200; McCulloch MWB, 2009, BIOORGAN MED CHEM, V17, P2189, DOI 10.1016/j.bmc.2008.10.077; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P500; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P506; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; NOYORI R, 1993, SCIENCE, V259, P44, DOI 10.1126/science.8418493; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; ROBERTS LJ, 1985, PROSTAGLANDINS, V30, P383, DOI 10.1016/0090-6980(85)90114-5; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun JM, 2003, METHODS, V31, P12, DOI 10.1016/S1046-2023(03)00083-5; Suzuki M, 1997, J AM CHEM SOC, V119, P2376, DOI 10.1021/ja9628359; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Valacchi G, 2005, ANTIOXID REDOX SIGN, V7, P25, DOI 10.1089/ars.2005.7.25; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; Wang DF, 2005, J MED CHEM, V48, P6936, DOI 10.1021/jm0505011; West JD, 2006, CHEM RES TOXICOL, V19, P173, DOI 10.1021/tx050321u; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	65	110	112	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17417	17424		10.1074/jbc.M109.089250	http://dx.doi.org/10.1074/jbc.M109.089250			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385560	Green Published, hybrid			2022-12-25	WOS:000278133400019
J	Goncalves, S; Borges, N; Esteves, AM; Victor, BL; Soares, CM; Santos, H; Matias, PM				Goncalves, Susana; Borges, Nuno; Esteves, Ana M.; Victor, Bruno L.; Soares, Claudio M.; Santos, Helena; Matias, Pedro M.			Structural Analysis of Thermus thermophilus HB27 Mannosyl-3-phosphoglycerate Synthase Provides Evidence for a Second Catalytic Metal Ion and New Insight into the Retaining Mechanism of Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENETIC-CHARACTERIZATION; DIFFRACTION DATA; MANNOSYLGLYCERATE; ROTATION; DONOR; CLASSIFICATION; IDENTIFICATION; BIOSYNTHESIS; EFFICIENT	Mannosyl-3-phosphoglycerate synthase is a glycosyltransferase involved in the two-step synthetic pathway of mannosylglycerate, a compatible solute that accumulates in response to salt and/or heat stresses in many microorganisms thriving in hot environments. The three-dimensional structure of mannosyl-3-phosphoglycerate synthase from Thermus thermophilus HB27 in its binary complex form, with GDP-alpha-D-mannose and Mg2+, shows a second metal binding site, about 6 angstrom away from the mannose moiety. Kinetic and mutagenesis studies have shown that this metal site plays a role in catalysis. Additionally, Asp(167) in the DXD motif is found within van der Waals contact distance of the C1' atom in the mannopyranose ring, suggesting its action as a catalytic nucleophile, either in the formation of a glycosylenzyme intermediate according to the double-displacement S(N)2 reaction mechanism or in the stabilization of the oxocarbenium ion-like intermediate according to the D-N*A(Nss) (S(N)i-like) reaction mechanism. We propose that either mechanism may occur in retaining glycosyltransferases with a GT-A fold, and, based on the gathered structural information, we identified an extended structural signature toward a common scaffold between the inverting and retaining glycosyltransferases.	[Goncalves, Susana; Borges, Nuno; Esteves, Ana M.; Victor, Bruno L.; Soares, Claudio M.; Santos, Helena; Matias, Pedro M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal	Universidade Nova de Lisboa	Matias, PM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Apartado 127, P-2781901 Oeiras, Portugal.	matias@itqb.unl.pt	Victor, Bruno L./L-2649-2016; Da Silva Esteves, Ana Maria/N-9216-2019; Soares, Claudio M/E-2675-2012; Matias, Pedro M/B-7180-2008; Borges, Nuno/Q-3515-2019; Borges, Nuno/A-1427-2011; Santos, Helena/B-9141-2011; da Silva Esteves, Ana Maria/O-9427-2014	Victor, Bruno L./0000-0002-6472-5700; Da Silva Esteves, Ana Maria/0000-0002-4932-4431; Soares, Claudio M/0000-0003-1154-556X; Matias, Pedro M/0000-0001-6170-451X; Borges, Nuno/0000-0002-3277-8517; Borges, Nuno/0000-0002-3277-8517; Santos, Helena/0000-0002-8050-9485; da Silva Esteves, Ana Maria/0000-0002-4932-4431	Diamond Light Source [226716]; Fundacao para a Ciencia e Tecnologia [PTDC/QUI/71142/2006, SFRH/BPD/29708/2006, SFRH/BD/23222/2005]	Diamond Light Source; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was carried out with the support of the Diamond Light Source, funded by Seventh Framework Programme Grant 226716, and Fundacao para a Ciencia e Tecnologia Grants PTDC/QUI/71142/2006, SFRH/BPD/29708/2006, and SFRH/BD/23222/2005.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Alarico S, 2007, EXTREMOPHILES, V11, P833, DOI 10.1007/s00792-007-0106-x; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borges N, 2004, J BIOL CHEM, V279, P9892, DOI 10.1074/jbc.M312186200; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bulter T, 1999, GLYCOCONJUGATE J, V16, P147, DOI 10.1023/A:1026444726698; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Empadinhas N, 2003, APPL ENVIRON MICROB, V69, P3272, DOI 10.1128/AEM.69.6.3272-3279.2003; Empadinhas N, 2001, J BIOL CHEM, V276, P43580, DOI 10.1074/jbc.M108054200; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faria TQ, 2008, CARBOHYD RES, V343, P3025, DOI 10.1016/j.carres.2008.08.030; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Goncalves S, 2009, ACTA CRYSTALLOGR F, V65, P1014, DOI 10.1107/S1744309109032576; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martins LO, 1999, J BIOL CHEM, V274, P35407, DOI 10.1074/jbc.274.50.35407; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0; Sa-Moura B, 2008, ACTA CRYSTALLOGR F, V64, P760, DOI 10.1107/S1744309108021490; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Santos H, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P86; Santos Helena, 2008, P9; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TOM DH, 1999, ANGEW CHEM INT EDIT, V38, P750; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	59	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17857	17868		10.1074/jbc.M109.095976	http://dx.doi.org/10.1074/jbc.M109.095976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356840	Green Published, hybrid			2022-12-25	WOS:000278133400063
J	Hervas-Aguilar, A; Galindo, A; Penalva, MA				Hervas-Aguilar, America; Galindo, Antonio; Penalva, Miguel A.			Receptor-independent Ambient pH Signaling by Ubiquitin Attachment to Fungal Arrestin-like PalF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; TRANSCRIPTION FACTOR; ESCRT MACHINERY; CANDIDA-ALBICANS; GENE-EXPRESSION; RIM101 PATHWAY; BETA-ARRESTIN; CELL-SURFACE; PROTEIN	The seven-transmembrane receptor PalH and its coupled, positive-acting arrestin-like protein PalF are key components of a molecular sensor that in Aspergillus nidulans and other ascomycete fungi mediates activation of an intracellular signaling cascade by alkaline ambient pH. PalF is ubiquitinated in an alkaline pH-and PalH-dependent manner. We show here that PalF assists the plasma membrane localization of PalH and that PalF overexpression slightly hypersensitizes the pathway to alkaline pH but does not bypass the need for the ambient pH signal receptor in signaling. In contrast, covalent attachment of Ub to PalF activates the signaling pathway under acidic pH conditions in which the pathway is normally inactive, demonstrating a positive role for ubiquitination. We further show that PalF acts upstream of, or in concert with, the Bro1 domain-containing pH signaling protein PalC, which is normally recruited to cortical structures likely to represent active pH signaling foci under neutral/alkaline pH conditions. In agreement with its pathway-activating consequences, expression of PalF-Ub also promotes PalC cortical recruitment under acidic conditions. Notably, our data establish that expression of PalF-Ub, at approximately physiological levels, in a null palH background leads to a considerable degree of signaling even in the complete absence of the receptor. Thus PalF ubiquitination is a key, perhaps the sole, molecular trigger required for transmitting the alkaline pH signal to the downstream elements of the pathway.	[Hervas-Aguilar, America; Galindo, Antonio; Penalva, Miguel A.] CSIC, Ctr Invest Biol, Dept Mol & Cellular Med, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Penalva, MA (corresponding author), Ramiro de Maeztu 9, Madrid 28040, Spain.	penalva@cib.csic.es	Galindo, Antonio/A-9991-2018; Penalva, Miguel A/G-2295-2015	Galindo, Antonio/0000-0002-1108-652X; Penalva, Miguel A/0000-0002-3102-2806	Direccion General de Investigacion (Spain) [BIO2009-7281]; Comunidad de Madrid [SAL/0246/2006]	Direccion General de Investigacion (Spain)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Grant BIO2009-7281 from Direccion General de Investigacion (Spain) and by Comunidad de Madrid Grant SAL/0246/2006 (to M. A. P.).	Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Calcagno-Pizarelli AM, 2007, EUKARYOT CELL, V6, P2365, DOI 10.1128/EC.00275-07; Castrejon F, 2006, EUKARYOT CELL, V5, P507, DOI 10.1128/EC.5.3.507-517.2006; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Galindo A, 2007, TRAFFIC, V8, P1346, DOI 10.1111/j.1600-0854.2007.00620.x; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hervas-Aguilar A, 2007, J BIOL CHEM, V282, P34735, DOI 10.1074/jbc.M706723200; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; OREJAS M, 1995, GENE DEV, V9, P1622, DOI 10.1101/gad.9.13.1622; Pantazopoulou A, 2009, MOL BIOL CELL, V20, P4335, DOI 10.1091/mbc.E09-03-0254; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penas MM, 2007, EUKARYOT CELL, V6, P960, DOI 10.1128/EC.00047-07; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rodriguez-Galan O, 2009, J BIOL CHEM, V284, P4404, DOI 10.1074/jbc.M808645200; Serrano R, 2006, J BIOL CHEM, V281, P39785, DOI 10.1074/jbc.M604497200; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666	36	47	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18095	18102		10.1074/jbc.M110.114371	http://dx.doi.org/10.1074/jbc.M110.114371			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368671	Green Published, hybrid			2022-12-25	WOS:000278133400084
J	Kunii, S; Morimoto, K; Nagai, K; Saito, T; Sato, K; Tonomura, B				Kunii, Saori; Morimoto, Koichi; Nagai, Kouhei; Saito, Takuya; Sato, Kenji; Tonomura, Ben'ichiro			Actinidain-hydrolyzed Type I Collagen Reveals a Crucial Amino Acid Sequence in Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; BINDING-SITES; C-TELOPEPTIDE; FIBRILLOGENESIS; INVITRO; CONFORMATION; PROTEIN; ENZYME; STABILIZE; PEPTIDES	We investigated the ability of type I collagen telopeptides to bind neighboring collagen molecules, which is thought to be the initial event in fibrillogenesis. Limited hydrolysis by actinidain protease produced monomeric collagen, which consisted almost entirely of alpha 1 and alpha 2 chains. As seen with ultrahigh resolution scanning electron microscopy, actinidain-hydrolyzed collagen exhibited unique self-assembly, as if at an intermediate stage, and formed a novel suprastructure characterized by poor fibrillogenesis. Then, the N- and C-terminal sequences of chicken type I collagen hydrolyzed by actinidain or pepsin were determined by Edman degradation and de novo sequence analysis with matrix-assisted laser desorption ionization-tandem time-of-flight mass spectrometry, respectively. In the C-telopeptide region of the alpha 1 chain, pepsin cleaved between Asp(1035) and Phe(1036), and actinidain between Gly(1032) and Gly(1033). Thus, the actinidain-hydrolyzed alpha 1 chain is shorter at the C terminus by three residues, Gly(1033), Phe(1034), and Asp(1035). In the alpha 2 chain, both proteases cleaved between Glu(1030) and Val(1031). We demonstrated that a synthetic nonapeptide mimicking the alpha 1 C-terminal sequence including GFD weakly inhibited the self-assembly of pepsin-hydrolyzed collagen, whereas it remarkably accelerated that of actinidain-hydrolyzed collagen. We conclude that the specific GFD sequence of the C-telopeptide of the alpha 1 chain plays a crucial role in stipulating collagen suprastructure and in subsequent fibril formation.	Kinki Univ, Dept Biotechnol Sci, Wakayama 6496493, Japan; [Nagai, Kouhei] St Marianna Univ, Sch Med, Grad Sch Med, Kawasaki Ku, Kanagawa 2168511, Japan; [Sato, Kenji] Kyoto Prefectural Univ, Div Appl Life Sci, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan	Kindai University (Kinki University); Saint Marianna University; Kyoto Prefectural University		morimoto@waka.kindai.ac.jp	Morimoto, Koichi/ABI-2606-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [16500307]; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by Grant-in-aid for Scientific Research 16500307 (to K. M.), a grant-in-aid for the 21st Century COE Program "Centers of Excellence" of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Wakayama Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence of the Japan Science and Technology Agency.	Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Cabral WA, 2002, J BIOL CHEM, V277, P4215, DOI 10.1074/jbc.M109048200; CAPALDI MJ, 1982, BIOPOLYMERS, V21, P2291, DOI 10.1002/bip.360211115; CARNE A, 1978, BIOCHEM J, V173, P73, DOI 10.1042/bj1730073; Chung HJ, 2008, J BIOL CHEM, V283, P25879, DOI 10.1074/jbc.M804272200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; GELMAN RA, 1979, J BIOL CHEM, V254, P180; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; HELSETH DL, 1979, BIOPOLYMERS, V18, P3005, DOI 10.1002/bip.1979.360181208; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; HULMES DJS, 1980, INT J BIOL MACROMOL, V2, P338, DOI 10.1016/0141-8130(80)90015-X; JONES EY, 1987, BIOPOLYMERS, V26, P463, DOI 10.1002/bip.360260403; Kadler KE, 1996, BIOCHEM J, V316, P1; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b; Malone JP, 2004, PROTEINS, V54, P206, DOI 10.1002/prot.10526; MCDOWALL MA, 1970, EUR J BIOCHEM, V14, P214, DOI 10.1111/j.1432-1033.1970.tb00280.x; Morimoto K, 2004, BIOSCI BIOTECH BIOCH, V68, P861, DOI 10.1271/bbb.68.861; Morimoto K, 2006, J BIOCHEM, V139, P1065, DOI 10.1093/jb/mvj106; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; Nagai K, 2008, ELECTROPHORESIS, V29, P672, DOI 10.1002/elps.200700461; Nakayama T, 2006, VIROLOGY, V350, P484, DOI 10.1016/j.virol.2006.03.004; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Paige MF, 1998, BIOPHYS J, V74, P3211, DOI 10.1016/S0006-3495(98)78027-0; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Slatter DA, 2003, J MOL BIOL, V329, P175, DOI 10.1016/S0022-2836(03)00380-2; SNOWDEN JM, 1979, BIOCHIM BIOPHYS ACTA, V580, P372, DOI 10.1016/0005-2795(79)90149-1; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Veis A., 1994, EXTRACELLULAR MATRIX, P15, DOI DOI 10.1016/B978-0-12-775170-2.50007-X; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172	37	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17465	17470		10.1074/jbc.M110.110759	http://dx.doi.org/10.1074/jbc.M110.110759			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20392700	Green Published, hybrid			2022-12-25	WOS:000278133400024
J	Timofeev, O; Cizmecioglu, O; Settele, F; Kempf, T; Hoffmann, I				Timofeev, Oleg; Cizmecioglu, Onur; Settele, Florian; Kempf, Tore; Hoffmann, Ingrid			Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G(2)/M Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK-ACTIVATING KINASE; HUMAN CYCLIN-A; CELL-CYCLE; S-PHASE; DEPENDENT PHOSPHORYLATION; DNA-DAMAGE; IN-VIVO; T-LOOP; MITOSIS; COMPLEX	Progression through mitosis requires the coordinated regulation of Cdk1 kinase activity. Activation of Cdk1 is a multistep process comprising binding of Cdk1 to cyclin B, relocation of cyclin-kinase complexes to the nucleus, activating phosphorylation of Cdk1 on Thr(161) by the Cdk-activating kinase (CAK; Cdk7 in metazoans), and removal of inhibitory Thr(14) and Tyr(15) phosphorylations. This dephosphorylation is catalyzed by the dual specific Cdc25 phosphatases, which occur in three isoforms in mammalian cells, Cdc25A, -B, and -C. We find that expression of Cdc25A leads to an acceleratedG(2)/Mphase transition. In Cdc25A-overexpressing cells, Cdk1 exhibits high kinase activity despite being phosphorylated on Tyr(15). In addition, Tyr(15)-phosphorylated Cdk1 binds more cyclinBin Cdc25A-overexpressing cells compared with control cells. Consistent with this observation, we demonstrate that in human transformed cells, Cdc25A and Cdc25B, but not Cdc25C phosphatases have an effect on timing and efficiency of cyclin-kinase complex formation. Overexpression of Cdc25A or Cdc25B promotes earlier assembly and activation of Cdk1-cyclin B complexes, whereas repression of these phosphatases by short hairpin RNA has a reverse effect, leading to a substantial decrease in amounts of cyclin B-bound Cdk1 in G(2) and mitosis. Importantly, we find that Cdc25A overexpression leads to an activation of Cdk7 and increase in Thr161 phosphorylation of Cdk1. In conclusion, our data suggest that complex assembly and dephosphorylation of Cdk1 at G(2)/M is tightly coupled and regulated by Cdc25 phosphatases.	[Timofeev, Oleg; Cizmecioglu, Onur; Settele, Florian; Kempf, Tore; Hoffmann, Ingrid] German Canc Res Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Hoffmann, I (corresponding author), German Canc Res Ctr, F045,Neuenheimer Feld 242, D-69120 Heidelberg, Germany.	ingrid.hoffmann@dkfz.de	Cizmecioglu, Onur/AAA-6289-2020; Cizmecioglu, Onur/AAF-5874-2020	Cizmecioglu, Onur/0000-0002-7608-6950; Timofeev, Oleg/0000-0002-3114-6403	Deutsche Krebshilfe [107058]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe Grant 107058 (to I.H.).	ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Coulonval K, 2003, J BIOL CHEM, V278, P52052, DOI 10.1074/jbc.M307012200; Crasta K, 2006, EMBO J, V25, P2551, DOI 10.1038/sj.emboj.7601136; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Garrett S, 2001, MOL CELL BIOL, V21, P88, DOI 10.1128/MCB.21.1.88-99.2001; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; Lammer C, 1998, J CELL SCI, V111, P2445; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mitra J, 2004, ONCOGENE, V23, P3361, DOI 10.1038/sj.onc.1207446; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; PINES J, 1992, CIBA F SYMP, V170, P187; POON RYC, 1994, J CELL SCI, V107, P2789; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Rudolph J, 2001, ANAL BIOCHEM, V289, P43, DOI 10.1006/abio.2000.4906; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Timofeev O, 2009, FEBS LETT, V583, P841, DOI 10.1016/j.febslet.2009.01.044; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093	48	98	103	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16978	16990		10.1074/jbc.M109.096552	http://dx.doi.org/10.1074/jbc.M109.096552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360007	hybrid, Green Published			2022-12-25	WOS:000277982600061
J	Xu, LH; Fushinobu, S; Takamatsu, S; Wakagi, T; Ikeda, H; Shoun, H				Xu, Lian-Hua; Fushinobu, Shinya; Takamatsu, Satoshi; Wakagi, Takayoshi; Ikeda, Haruo; Shoun, Hirofumi			Regio- and Stereospecificity of Filipin Hydroxylation Sites Revealed by Crystal Structures of Cytochrome P450 105P1 and 105D6 from Streptomyces avermitilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYENE ANTIBIOTICS; DIOXYGEN COMPLEX; WILD-TYPE; CONFIGURATION; BIOSYNTHESIS; ACTIVATION; MOLECULES; MECHANISM; P450ERYF; NADH	The polyene macrolide antibiotic filipin is widely used as a probe for cholesterol and a diagnostic tool for type C Niemann-Pick disease. Two position-specific P450 enzymes are involved in the post-polyketide modification of filipin during its biosynthesis, thereby providing molecular diversity to the "filipin complex." CYP105P1 and CYP105D6 from Streptomyces avermitilis, despite their high sequence similarities, catalyze filipin hydroxylation at different positions, C26 and C1', respectively. Here, we determined the crystal structure of the CYP105P1-filipin I complex. The distal pocket of CYP105P1 has the second largest size among P450 hydroxylases that act on macrolide substrates. Compared with previously determined substrate-free structures, the FG helices showed significant closing motion on substrate binding. The long BC loop region adopts a unique extended conformation without a B' helix. The binding site is essentially hydrophobic, but numerous water molecules are involved in recognizing the polyol side of the substrate. Therefore, the distal pocket of CYP105P1 provides a specific environment for the large filipin substrate to bind with its pro-S side of position C26 directed toward the heme iron. The ligand-free CYP105D6 structure was also determined. A small sub-pocket accommodating the long alkyl side chain of filipin I was observed in the CYP105P1 structure but was absent in the CYP105D6 structure, indicating that filipin cannot bind to CYP105D6 with a similar orientation due to steric hindrance. This observation can explain the strict regiospecificity of these enzymes.	[Xu, Lian-Hua; Fushinobu, Shinya; Wakagi, Takayoshi; Shoun, Hirofumi] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Takamatsu, Satoshi; Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Kanagawa 2288555, Japan	University of Tokyo; Kitasato University	Shoun, H (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahshoun@mail.ecc.u-tokyo.ac.jp	Wakagi, Takayoshi/AAJ-4145-2021; Takamatsu, Satoshi/AAW-5197-2020; Fushinobu, Shinya/E-4987-2011	Takamatsu, Satoshi/0000-0001-5620-6196; Fushinobu, Shinya/0000-0003-1346-6435	Japan Society for the Promotion of Science [20248009, 20310122]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research 20248009 (to H. S.) and 20310122 (to H. I.) from the Japan Society for the Promotion of Science.	BERGY ME, 1968, BIOCHEMISTRY-US, V7, P653, DOI 10.1021/bi00842a021; BUTLER JD, 1987, P NATL ACAD SCI USA, V84, P556, DOI 10.1073/pnas.84.2.556; BUTLER JD, 1992, J BIOL CHEM, V267, P23797; Chen L, 2009, FEMS MICROBIOL LETT, V298, P199, DOI 10.1111/j.1574-6968.2009.01721.x; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; EDWARDS DMF, 1989, J ANTIBIOT, V42, P322, DOI 10.7164/antibiotics.42.322; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fjaervik E, 2005, APPL MICROBIOL BIOT, V67, P436, DOI 10.1007/s00253-004-1802-4; Gimpl G, 2007, BIOSCIENCE REP, V27, P335, DOI 10.1007/s10540-007-9060-1; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; Ho WW, 2008, BIOCHEMISTRY-US, V47, P2071, DOI 10.1021/bi702240k; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; McLean KJ, 2005, BIOCHEM SOC T, V33, P796, DOI 10.1042/BST0330796; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; Omura S., 2002, MACROLIDE ANTIBIOTIC; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Oshima R, 2004, J MOL BIOL, V342, P207, DOI 10.1016/j.jmb.2004.07.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PANDEY RC, 1970, J ANTIBIOT, V23, P414, DOI 10.7164/antibiotics.23.414; PANDEY RC, 1972, J AM CHEM SOC, V94, P4306, DOI 10.1021/ja00767a045; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Poulos TL, 2007, DRUG METAB REV, V39, P557, DOI 10.1080/03602530701498240; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Richardson TI, 1996, J ORG CHEM, V61, P4219, DOI 10.1021/jo960218x; ROSE IA, 1980, P NATL ACAD SCI-BIOL, V77, P2439, DOI 10.1073/pnas.77.5.2439; RYCHNOVSKY SD, 1995, ANGEW CHEM INT EDIT, V34, P1227, DOI 10.1002/anie.199512271; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Sugimoto H, 2008, BIOCHEMISTRY-US, V47, P4017, DOI 10.1021/bi7023767; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volpon L, 2000, FEBS LETT, V478, P137, DOI 10.1016/S0014-5793(00)01824-X; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008; WHITFIELD GB, 1955, J AM CHEM SOC, V77, P4799, DOI 10.1021/ja01623a032; Xu LH, 2009, J BACTERIOL, V191, P1211, DOI 10.1128/JB.01276-08; Xue YQ, 2001, METAB ENG, V3, P15, DOI 10.1006/mben.2000.0167; Yasutake Y, 2007, BIOCHEM BIOPH RES CO, V361, P876, DOI 10.1016/j.bbrc.2007.07.062; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200; Zhao B, 2005, J BIOL CHEM, V280, P42188, DOI 10.1074/jbc.M509220200	50	48	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16844	16853		10.1074/jbc.M109.092460	http://dx.doi.org/10.1074/jbc.M109.092460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20375018	hybrid, Green Published			2022-12-25	WOS:000277982600048
J	Bottova, I; Sauder, U; Olivieri, V; Hehl, AB; Sonda, S				Bottova, Iveta; Sauder, Ursula; Olivieri, Vesna; Hehl, Adrian B.; Sonda, Sabrina			The P-glycoprotein Inhibitor GF120918 Modulates Ca2+-Dependent Processes and Lipid Metabolism in Toxoplasma Gondii	PLOS ONE			English	Article							REGULATORY VOLUME DECREASE; MULTIDRUG-RESISTANCE; HOST-CELLS; APICOMPLEXAN PARASITES; NEOSPORA-CANINUM; IN-VITRO; INTRACELLULAR CALCIUM; SUBCELLULAR-LOCALIZATION; EXPRESSION ANALYSIS; GLIDING MOTILITY	Up-regulation of the membrane-bound efflux pump P-glycoprotein (P-gp) is associated with the phenomenon of multidrug-resistance in pathogenic organisms, including protozoan parasites. In addition, P-gp plays a role in normal physiological processes, however our understanding of these P-gp functions remains limited. In this study we investigated the effects of the P-gp inhibitor GF120918 in Toxoplasma gondii, a model apicomplexan parasite and an important human pathogen. We found that GF120918 treatment severely inhibited parasite invasion and replication. Further analyses of the molecular mechanisms involved revealed that the P-gp inhibitor modulated parasite motility, microneme secretion and egress from the host cell, all cellular processes known to depend on Ca2+ signaling in the parasite. In support of a potential role of P-gp in Ca2+-mediated processes, immunoelectron and fluorescence microscopy showed that T. gondii Pgp was localized in acidocalcisomes, the major Ca2+ storage in the parasite, at the plasma membrane, and in the intravacuolar tubular network. In addition, metabolic labeling of extracellular parasites revealed that inhibition or down-regulation of T. gondii P-gp resulted in aberrant lipid synthesis. These results suggest a crucial role of T. gondii P-gp in essential processes of the parasite biology and further validate the potential of P-gp activity as a target for drug development.	[Bottova, Iveta; Hehl, Adrian B.; Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Sauder, Ursula; Olivieri, Vesna] Univ Basel, Biozentrum, Basel, Switzerland	University of Zurich; University of Basel	Bottova, I (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	sabrina.sonda@vetparas.uzh.ch		Hehl, Adrian/0000-0002-2110-4445	Marie Heim-Voegtlin Foundation; Fondation Pierre Mercier pour la Science; Swiss National Science Foundation [3100A0-112327]; SBF (Staatssekretariat fur Bildung und Forschung) [C03.0007]	Marie Heim-Voegtlin Foundation; Fondation Pierre Mercier pour la Science; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SBF (Staatssekretariat fur Bildung und Forschung)	This work was supported by grants of the Marie Heim-Voegtlin Foundation and Fondation Pierre Mercier pour la Science to SS and of the Swiss National Science Foundation (Grant nr. 3100A0-112327) and grant C03.0007 (COST Action 857) from the SBF (Staatssekretariat fur Bildung und Forschung) to ABH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; Austin C, 2000, CIRC RES, V86, P355, DOI 10.1161/01.RES.86.3.355; Bardelmeijer HA, 2004, INVEST NEW DRUG, V22, P219, DOI 10.1023/B:DRUG.0000026248.45084.21; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottova I, 2009, J BIOL CHEM, V284, P17438, DOI 10.1074/jbc.M809420200; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Charron AJ, 2002, J CELL SCI, V115, P3049; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Drozdowicz YM, 2003, J BIOL CHEM, V278, P1075, DOI 10.1074/jbc.M209436200; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Ernest S, 1999, J AM SOC NEPHROL, V10, P2306; Evers R, 2000, BRIT J CANCER, V83, P366, DOI 10.1054/bjoc.2000.1260; Ford JM, 1996, EUR J CANCER, V32A, P991, DOI 10.1016/0959-8049(96)00047-0; Fritz F, 1999, BIOCHEMISTRY-US, V38, P4214, DOI 10.1021/bi981929n; Fuchs N, 1998, J PARASITOL, V84, P753, DOI 10.2307/3284583; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hemphill A, 1996, INFECT IMMUN, V64, P4279, DOI 10.1128/IAI.64.10.4279-4287.1996; Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGH KP, 1994, TRANSPLANTATION, V57, P1689, DOI 10.1097/00007890-199457120-00001; Hoff EF, 2002, TRENDS PARASITOL, V18, P251, DOI 10.1016/S1471-4922(02)02240-7; Hoffman MM, 1997, BIOCHEMISTRY-US, V36, P11153, DOI 10.1021/bi970530g; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; HYAFIL F, 1993, CANCER RES, V53, P4595; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Lavine MD, 2008, EUKARYOT CELL, V7, P131, DOI 10.1128/EC.00301-07; Lefurgey A, 2005, J EUKARYOT MICROBIOL, V52, P277, DOI 10.1111/j.1550-7408.2005.00030.x; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Luo SH, 2005, MOL MICROBIOL, V55, P1034, DOI 10.1111/j.1365-2958.2004.04464.x; Maier P, 2006, RADIAT RES, V166, P463, DOI 10.1667/RR0550.1; McAllister MM, 1996, J PARASITOL, V82, P354, DOI 10.2307/3284181; MESTDAGH N, 1994, BIOCHEM PHARMACOL, V48, P709, DOI 10.1016/0006-2952(94)90048-5; Miranda K, 2008, EXP PARASITOL, V118, P2, DOI 10.1016/j.exppara.2007.07.009; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nagamune Kisaburo, 2008, V47, P70; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Persson EK, 2007, J IMMUNOL, V179, P8357, DOI 10.4049/jimmunol.179.12.8357; Robert J, 1998, Expert Opin Investig Drugs, V7, P929, DOI 10.1517/13543784.7.6.929; Rodrigues AC, 2009, EUR J PHARM SCI, V37, P486, DOI 10.1016/j.ejps.2009.04.006; Sauvage V, 2004, MOL BIOCHEM PARASIT, V134, P89, DOI 10.1016/j.molbiopara.2003.08.015; Sauvage V, 2006, MOL BIOCHEM PARASIT, V147, P177, DOI 10.1016/j.molbiopara.2006.02.008; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schmid A, 2009, MOL BIOCHEM PARASIT, V163, P54, DOI 10.1016/j.molbiopara.2008.09.010; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; Silverman JA, 1997, ANTIMICROB AGENTS CH, V41, P1859, DOI 10.1128/AAC.41.9.1859; SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Sulova Z, 2005, BIOCHEM BIOPH RES CO, V335, P777, DOI 10.1016/j.bbrc.2005.07.144; Tamai I, 2000, J PHARM SCI-US, V89, P1371, DOI 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D; TSURUO T, 1984, CANCER RES, V44, P5095; UEDA K, 1992, J BIOL CHEM, V267, P24248; Valverde MA, 1996, EMBO J, V15, P4460, DOI 10.1002/j.1460-2075.1996.tb00823.x; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Wallstab A, 1999, BRIT J CANCER, V79, P1053, DOI 10.1038/sj.bjc.6690169; Ward KW, 2004, J PHARMACOL EXP THER, V310, P703, DOI 10.1124/jpet.104.068288; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Witherspoon SM, 1996, CLIN CANCER RES, V2, P7; Zhang Y, 2003, ADV DRUG DELIVER REV, V55, P31, DOI 10.1016/S0169-409X(02)00170-9	69	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10062	10.1371/journal.pone.0010062	http://dx.doi.org/10.1371/journal.pone.0010062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386707	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000276482000008
J	Fendel, R; Brandts, C; Rudat, A; Kreidenweiss, A; Steur, C; Appelmann, I; Ruehe, B; Schroder, P; Berdel, WE; Kremsner, PG; Mordmuller, B				Fendel, Rolf; Brandts, Christian; Rudat, Annika; Kreidenweiss, Andrea; Steur, Claudia; Appelmann, Iris; Ruehe, Bettina; Schroeder, Paul; Berdel, Wolfgang E.; Kremsner, Peter G.; Mordmueller, Benjamin			Hemolysis Is Associated with Low Reticulocyte Production Index and Predicts Blood Transfusion in Severe Malarial Anemia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; AFRICAN CHILDREN; INFECTED ERYTHROCYTES; CELL DEFORMABILITY; OXIDATIVE STRESS; RED-CELLS; PHAGOCYTOSIS; ERYTHROPOIESIS; CLEARANCE; ERYTHROPHAGOCYTOSIS	Background: Falciparum Malaria, an infectious disease caused by the apicomplexan parasite Plasmodium falciparum, is among the leading causes of death and morbidity attributable to infectious diseases worldwide. In Gabon, Central Africa, one out of four inpatients have severe malarial anemia (SMA), a life-threatening complication if left untreated. Emerging drug resistant parasites might aggravate the situation. This case control study investigates biomarkers of enhanced hemolysis in hospitalized children with either SMA or mild malaria (MM). Methods and Findings: Ninety-one children were included, thereof 39 SMA patients. Strict inclusion criteria were chosen to exclude other causes of anemia. At diagnosis, erythrophagocytosis (a direct marker for extravascular hemolysis, EVH) was enhanced in SMA compared to MM patients (5.0 arbitrary units (AU) (interquartile range (IR): 2.2-9.6) vs. 2.1 AU (IR: 1.3-3.9), p<0.01). Furthermore, indirect markers for EVH, (i.e. serum neopterin levels, spleen size enlargement and monocyte pigment) were significantly increased in SMA patients. Markers for erythrocyte ageing, such as CD35 (complement receptor 1), CD55 (decay acceleration factor) and phosphatidylserine exposure (annexin-V-binding) were investigated by flow cytometry. In SMA patients, levels of CD35 and CD55 on the red blood cell surface were decreased and erythrocyte removal markers were increased when compared to MM or reconvalescent patients. Additionally, intravascular hemolysis (IVH) was quantified using several indirect markers (LDH, alpha-HBDH, haptoglobin and hemopexin), which all showed elevated IVH in SMA. The presence of both IVH and EVH predicted the need for blood transfusion during antimalarial treatment (odds ratio 61.5, 95% confidence interval (CI): 8.9-427). Interestingly, this subpopulation is characterized by a significantly lowered reticulocyte production index (RPI, p<0.05). Conclusions: Our results show the multifactorial pathophysiology of SMA, whereby EVH and IVH play a particularly important role. We propose a model where removal of infected and non-infected erythrocytes of all ages (including reticulocytes) by EVH and IVH is a main mechanism of SMA. Further studies are underway to investigate the mechanism and extent of reticulocyte removal to identify possible interventions to reduce the risk of SMA development.	[Fendel, Rolf; Brandts, Christian; Rudat, Annika; Kreidenweiss, Andrea; Steur, Claudia; Appelmann, Iris; Ruehe, Bettina; Schroeder, Paul; Kremsner, Peter G.; Mordmueller, Benjamin] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Fendel, Rolf; Kreidenweiss, Andrea; Kremsner, Peter G.; Mordmueller, Benjamin] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Fendel, Rolf] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Brandts, Christian; Rudat, Annika; Appelmann, Iris; Berdel, Wolfgang E.] Univ Munster, Dept Med, Munster, Germany; [Brandts, Christian] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany	Eberhard Karls University of Tubingen; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Munster; Goethe University Frankfurt	Fendel, R (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	benjamin.mordmueller@uni-tuebingen.de	Mordmüller, Benjamin/A-5749-2010; Fendel, Rolf/K-3985-2013	Mordmüller, Benjamin/0000-0001-9101-2768; Fendel, Rolf/0000-0003-4716-0311; Kreidenweiss, Andrea/0000-0002-5025-7221; Brandts, Christian H./0000-0003-1732-2535	Deutsche Forschungsgemeinschaft [DFG MO 1071/4-1, BR 1945/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a grant (DFG MO 1071/4-1 and BR 1945/6-1) from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akech SO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-256; [Anonymous], 2008, WORLD MAL REP 2008; Ayi K, 2005, INFECT IMMUN, V73, P2559, DOI 10.1128/IAI.73.4.2559-2563.2005; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Casals-Pascual C, 2006, CURR MOL MED, V6, P155, DOI 10.2174/156652406776055159; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; COLEBUNDERS R, 1991, J INFECT DIS, V164, P450, DOI 10.1093/infdis/164.3.450; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Craig ML, 2005, J IMMUNOL, V174, P3059, DOI 10.4049/jimmunol.174.5.3059; DAVIS TME, 1990, J CLIN INVEST, V86, P793, DOI 10.1172/JCI114776; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; Dondorp AM, 2003, REDOX REP, V8, P292, DOI 10.1179/135100003225002934; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Fendel R, 2007, CYTOM PART A, V71A, P258, DOI 10.1002/cyto.a.20360; Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Helbok R, 2006, AM J TROP MED HYG, V75, P443, DOI 10.4269/ajtmh.2006.75.443; Helegbe GK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-165; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; Kremsner PG, 2009, J INFECT DIS, V199, P142, DOI 10.1086/595295; KREMSNER PG, 1995, ANTIMICROB AGENTS CH, V39, P1603, DOI 10.1128/AAC.39.7.1603; Kremsner PG, 2000, LANCET, V355, P40, DOI 10.1016/S0140-6736(99)04761-3; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Mahaffy JM, 1998, J THEOR BIOL, V190, P135, DOI 10.1006/jtbi.1997.0537; Mandal D, 2002, FEBS LETT, V513, P184, DOI 10.1016/S0014-5793(02)02294-9; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; McQueen PG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000149; Metzger WG, 1995, T ROY SOC TROP MED H, V89, P637, DOI 10.1016/0035-9203(95)90423-9; Moore A, 2001, LANCET, V358, P657, DOI 10.1016/S0140-6736(01)05783-X; Mordmuller B, 1998, CLIN INFECT DIS, V26, P850, DOI 10.1086/513926; Mordmuller BG, 1997, EUR CYTOKINE NETW, V8, P29; NEWTON CRJC, 1992, LANCET, V340, P917, DOI 10.1016/0140-6736(92)93334-J; Nuchsongsin F, 2007, AM J TROP MED HYG, V77, P617, DOI 10.4269/ajtmh.2007.77.617; Nyakoe NK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-7; Owuor B, 2008, MOL MED, V14, P89, DOI 10.2119/2007-00093.Owuor; OYAKHIROME S, 2010, AM J TROP M IN PRESS; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Riley RS, 2001, J CLIN LAB ANAL, V15, P267, DOI 10.1002/jcla.1039; Safeukui I, 2008, BLOOD, V112, P2520, DOI 10.1182/blood-2008-03-146779; Team RDC, 2019, R LANG ENV STAT COMP; Waitumbi JN, 2004, J INFECT DIS, V190, P1183, DOI 10.1086/423140; Waitumbi JN, 2000, BLOOD, V95, P1481, DOI 10.1182/blood.V95.4.1481.004k15_1481_1486; Wiesner J, 1997, EUR J IMMUNOL, V27, P2708, DOI 10.1002/eji.1830271034	47	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10038	10.1371/journal.pone.0010038	http://dx.doi.org/10.1371/journal.pone.0010038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386613	Green Published, gold, Green Submitted			2022-12-25	WOS:000276420400010
J	Krill, AM; Kirst, M; Kochian, LV; Buckler, ES; Hoekenga, OA				Krill, Allison M.; Kirst, Matias; Kochian, Leon V.; Buckler, Edward S.; Hoekenga, Owen A.			Association and Linkage Analysis of Aluminum Tolerance Genes in Maize	PLOS ONE			English	Article							ACID-SOIL TOLERANCE; GENOTYPIC DIFFERENCES; MALATE TRANSPORTERS; ROOT ELONGATION; COMPLEX TRAITS; RESISTANCE; TOXICITY; INHIBITION; EXUDATION; SELECTION	Background: Aluminum (Al) toxicity is a major worldwide constraint to crop productivity on acidic soils. Al becomes soluble at low pH, inhibiting root growth and severely reducing yields. Maize is an important staple food and commodity crop in acidic soil regions, especially in South America and Africa where these soils are very common. Al exclusion and intracellular tolerance have been suggested as two important mechanisms for Al tolerance in maize, but little is known about the underlying genetics. Methodology: An association panel of 282 diverse maize inbred lines and three F-2 linkage populations with approximately 200 individuals each were used to study genetic variation in this complex trait. Al tolerance was measured as net root growth in nutrient solution under Al stress, which exhibited a wide range of variation between lines. Comparative and physiological genomics-based approaches were used to select 21 candidate genes for evaluation by association analysis. Conclusions: Six candidate genes had significant results from association analysis, but only four were confirmed by linkage analysis as putatively contributing to Al tolerance: Zea mays AltSB like (ZmASL), Zea mays aluminum-activated malate transporter2 (ALMT2), S-adenosyl-L-homocysteinase (SAHH), and Malic Enzyme (ME). These four candidate genes are high priority subjects for follow-up biochemical and physiological studies on the mechanisms of Al tolerance in maize. Immediately, elite haplotype-specific molecular markers can be developed for these four genes and used for efficient marker-assisted selection of superior alleles in Al tolerance maize breeding programs.	[Krill, Allison M.; Kochian, Leon V.; Buckler, Edward S.; Hoekenga, Owen A.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Krill, Allison M.; Buckler, Edward S.; Hoekenga, Owen A.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Kirst, Matias; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Kirst, Matias] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Kochian, Leon V.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA	United States Department of Agriculture (USDA); Cornell University; Cornell University; State University System of Florida; University of Florida; Cornell University	Krill, AM (corresponding author), USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	Owen.Hoekenga@ars.usda.gov	Kochian, Leon/ABH-6148-2020; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Kochian, Leon/0000-0003-3416-089X; Buckler, Edward/0000-0002-3100-371X; Hoekenga, Owen/0000-0003-4427-2000	National Science Foundation (NSF) [0419435, 0453331]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Base Funds	National Science Foundation (NSF)(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Base Funds(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research described here was supported in part by an award from the National Science Foundation (NSF) Plant Genome Research Program (http://www.nsf.gov/dir/index.jsp?org=BIO; DBI # 0419435) to LVK, OAH, and ESB. Ms. Pleiman (Ball State University) and Mr. Thornblade (Hamilton College) were interns supported by an award from NSF Plant Genome Research Research Experience for Undergraduates (DBI # 0453331) to the Boyce Thompson Institute for Plant Research (G. Jander) and Cornell University (T. Owens). The research was also supported in part by United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Base Funds to LVK and ESB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Delhaize E, 2007, FEBS LETT, V581, P2255, DOI 10.1016/j.febslet.2007.03.057; Detarsio E, 2008, PLANT MOL BIOL, V68, P355, DOI 10.1007/s11103-008-9375-8; EDMEADES G, 1995, PHYSL STRESS RESISTA; Eticha D, 2005, PLANT CELL ENVIRON, V28, P1410, DOI 10.1111/j.1365-3040.2005.01375.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fontecha G, 2007, THEOR APPL GENET, V114, P249, DOI 10.1007/s00122-006-0427-7; Fu Y, 2005, P NATL ACAD SCI USA, V102, P12282, DOI 10.1073/pnas.0503394102; Garvin D. F., 2003, Handbook of soil acidity, P387; GRANADOS G, 1993, CROP SCI, V33, P936, DOI 10.2135/cropsci1993.0011183X003300050012x; HALL T, BIOLIGN 4 0 7 COMPUT; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Jones DL, 2006, PLANT CELL ENVIRON, V29, P1309, DOI 10.1111/j.1365-3040.2006.01509.x; JONES DL, 1995, PLANTA, V197, P672; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kollmeier M, 2000, PLANT PHYSIOL, V122, P945, DOI 10.1104/pp.122.3.945; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; Li CH, 2008, PLANTA, V228, P125, DOI 10.1007/s00425-008-0724-2; Ligaba A, 2006, PLANT PHYSIOL, V142, P1294, DOI 10.1104/pp.106.085233; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Magalhaes JV, 2004, GENETICS, V167, P1905, DOI 10.1534/genetics.103.023580; Magnavaca R., 1987, Genetic aspects of plant mineral nutrition, 16-20 June, 1985, Madison, USA, P255; Maron LG, 2008, NEW PHYTOL, V179, P116, DOI 10.1111/j.1469-8137.2008.02440.x; MASON PA, 2005, THESIS CORNELL U ITH; Ninamango-Cardenas FE, 2003, EUPHYTICA, V130, P223, DOI 10.1023/A:1022867416513; Pandey S., 2007, Plant Breeding Reviews, V28, P59; PANDEY S, 1994, CROP SCI, V34, P1511, DOI 10.2135/cropsci1994.0011183X003400060018x; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; Pineros MA, 2005, PLANT PHYSIOL, V137, P231, DOI 10.1104/pp.104.047357; Pineros MA, 2008, PLANT PHYSIOL, V147, P2131, DOI 10.1104/pp.108.119636; Pineros MA, 2008, PLANT J, V53, P352, DOI 10.1111/j.1365-313X.2007.03344.x; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; RAO IM, 1993, BIOSCIENCE, V43, P454, DOI 10.2307/1311905; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; RYAN PR, 1992, PLANT PHYSIOL, V99, P1193, DOI 10.1104/pp.99.3.1193; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sibov ST, 1999, GENOME, V42, P475, DOI 10.1139/gen-42-3-475; *SOFTB INC, PRED PROT SEC STRUCT; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; UEXKULL HR, 1995, PLANT SOIL INTERACTI, P5; UrreaGomez R, 1996, AGRON J, V88, P806, DOI 10.2134/agronj1996.00021962008800050020x; Vargas-Duque J, 1994, CROP SCI, V34, P50; Wang JK, 2007, THEOR APPL GENET, V115, P87, DOI 10.1007/s00122-007-0545-x; Welcker C, 2005, CROP SCI, V45, P2405, DOI 10.2135/cropsci2004.0606; Weretilnyk EA, 2001, PLANT PHYSIOL, V125, P856, DOI 10.1104/pp.125.2.856; Whitt Sr, 2003, METH MOL B, V236, P123; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yang JL, 2008, PLANT PHYSIOL, V146, P602, DOI 10.1104/pp.107.111989; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	59	68	74	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9958	10.1371/journal.pone.0009958	http://dx.doi.org/10.1371/journal.pone.0009958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376361	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200033
J	Saito, K; Hatsugai, N; Horikawa, K; Kobayashi, K; Matsu-ura, T; Mikoshiba, K; Nagai, T				Saito, Kenta; Hatsugai, Noriyuki; Horikawa, Kazuki; Kobayashi, Kentaro; Matsu-ura, Toru; Mikoshiba, Katsuhiko; Nagai, Takeharu			Auto-Luminescent Genetically-Encoded Ratiometric Indicator for Real-Time Ca2+ Imaging at the Single Cell Level	PLOS ONE			English	Article							FLUORESCENT INDICATORS; PROTEIN; AEQUORIN; RESISTANCE; CALCIUM	Background: Efficient bioluminescence resonance energy transfer (BRET) from a bioluminescent protein to a fluorescent protein with high fluorescent quantum yield has been utilized to enhance luminescence intensity, allowing single-cell imaging in near real time without external light illumination. Methodology/Principal Findings: We applied BRET to develop an autoluminescent Ca2+ indicator, BRAC, which is composed of Ca2+-binding protein, calmodulin, and its target peptide, M13, sandwiched between a yellow fluorescent protein variant, Venus, and an enhanced Renilla luciferase, RLuc8. Adjusting the relative dipole orientation of the luminescent protein's chromophores improved the dynamic range of BRET signal change in BRAC up to 60%, which is the largest dynamic range among BRET-based indicators reported so far. Using BRAC, we demonstrated successful visualization of Ca2+ dynamics at the single-cell level with temporal resolution at 1 Hz. Moreover, BRAC signals were acquired by ratiometric imaging capable of canceling out Ca2+-independent signal drifts due to change in cell shape, focus shift, etc. Conclusions/Significance: The brightness and large dynamic range of BRAC should facilitate high-sensitive Ca2+ imaging not only in single live cells but also in small living subjects.	[Saito, Kenta; Hatsugai, Noriyuki; Horikawa, Kazuki; Kobayashi, Kentaro; Nagai, Takeharu] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Hatsugai, Noriyuki] Hokkaido Univ, Res Ctr Cooperat Projects, Kita Ku, Sapporo, Hokkaido, Japan; [Matsu-ura, Toru; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Nagai, Takeharu] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	Hokkaido University; Hokkaido University; RIKEN; Japan Science & Technology Agency (JST)	Saito, K (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Kita 20,Nishi 10, Sapporo, Hokkaido, Japan.	tnagai@es.hokudai.ac.jp	Saito, Kenta/G-2443-2010; Matsu-ura, Toru/P-3461-2017; Mikoshiba, Katsuhiko/N-7943-2015; Hatsugai, Noriyuki/O-9156-2015	Saito, Kenta/0000-0003-4147-255X; Matsu-ura, Toru/0000-0002-9876-3086; Hatsugai, Noriyuki/0000-0002-5708-4263; Nagai, Takeharu/0000-0003-2650-9895; Horikawa, Kazuki/0000-0002-9285-4171	Ministry of Labor, Health and Welfare of Japan; Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency	Ministry of Labor, Health and Welfare of Japan; Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency	This work was partly supported by grants from Scientific Research on Advanced Medical Technology of the Ministry of Labor, Health and Welfare of Japan, and Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Dacres H, 2009, ANAL BIOCHEM, V385, P194, DOI 10.1016/j.ab.2008.10.040; De A, 2009, FASEB J, V23, P2702, DOI 10.1096/fj.08-118919; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hoshino H, 2007, NAT METHODS, V4, P637, DOI 10.1038/NMETH1069; Kaihara A, 2008, ANAL SCI, V24, P1405, DOI 10.2116/analsci.24.1405; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim SB, 2009, ANAL CHEM, V81, P67, DOI 10.1021/ac801658y; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; SHIMOMURA O, 1993, BIOCHEM J, V296, P549, DOI 10.1042/bj2960549; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P159, DOI 10.1142/9789812773647_0005; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	21	47	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9935	10.1371/journal.pone.0009935	http://dx.doi.org/10.1371/journal.pone.0009935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376337	Green Published, gold			2022-12-25	WOS:000276418200012
J	Ravoori, M; Czaplinska, AJ; Sikes, C; Han, L; Johnson, EM; Qiao, W; Ng, C; Cody, DD; Murphy, WA; Do, KA; Navone, NM; Kundra, V				Ravoori, Murali; Czaplinska, Aneta J.; Sikes, Charles; Han, Lin; Johnson, Evan M.; Qiao, Wei; Ng, Chaan; Cody, Dianna D.; Murphy, William A., Jr.; Do, Kim-Anh; Navone, Nora M.; Kundra, Vikas			Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo mu CT and Non-Destructive Ex Vivo mu CT and DXA in a Mouse Model	PLOS ONE			English	Article							METASTASIS; GROWTH; CELLS; TOMOGRAPHY; ESTABLISHMENT; OSTEOCLASTS; RESOLUTION; INJECTION; RECEPTOR; THERAPY	Background: To compare nondestructive in vivo and ex vivo micro-computed tomography (mu CT) and ex vivo dual-energy-X-ray-absorptiometry (DXA) in characterizing mineralized cortical and trabecular bone response to prostate cancer involving the skeleton in a mouse model. Methodology/Principal Findings: In vivo mu CT was performed before and 10 weeks after implantation of human prostate cancer cells (MDA-PCa-2b) or vehicle into SCID mouse femora. After resection, femora were imaged by nondestructive ex vivo specimen mu CT at three voxel sizes (31 mu, 16 mu, 8 mu) and DXA, and then sectioned for histomorphometric analysis of mineralized bone. Bone mineral density (BMD), trabecular parameters (number, TbN; separation, TbSp; thickness, TbTh) and mineralized bone volume/total bone volume (BV/TV) were compared and correlated among imaging methods and histomorphometry. Statistical tests were considered significant if P<0.05. Ten weeks post inoculation, diaphyseal BMD increased in the femur with tumor compared to the opposite femur by all modalities (p<0.005, n = 11). Diaphyseal BMD by in vivo mu CT correlated with ex vivo 31 and 16 mu m mu CT and histomorphometry BV/TV (r = 0.91-0.94, P<0.001, n = 11). DXA BMD correlated less with bone histomorphometry (r = 0.73, P<0.001, n = 11) and DXA did not distinguish trabeculae from cortex. By in vivo and ex vivo mu CT, trabecular BMD decreased (P<0.05, n = 11) as opposed to the cortex. Unlike BMD, trabecular morphologic parameters were threshold-dependent and when using "fixed-optimal-thresholds," all except TbTh demonstrated trabecular loss with tumor and correlated with histomorphometry (r = 0.73-0.90, P>0.05, n = 11). Conclusions/Significance: Prostate cancer involving the skeleton can elicit a host bone response that differentially affects the cortex compared to trabeculae and that can be quantified noninvasively in vivo and nondestructively ex vivo.	[Ravoori, Murali; Han, Lin; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Czaplinska, Aneta J.; Sikes, Charles; Navone, Nora M.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol Res, Houston, TX 77030 USA; [Johnson, Evan M.; Cody, Dianna D.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Qiao, Wei; Do, Kim-Anh] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Ng, Chaan; Murphy, William A., Jr.; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ravoori, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA.	vkundra@mdanderson.org		Copeland, Margaret/0000-0002-9664-9335	National Institutes of Health/National Cancer Institute [P50 CA090270]; University of Texas M. D. Anderson Cancer Center Prostate Cancer Research Program; UT MDACC Core [P30CA16672]; NATIONAL CANCER INSTITUTE [P50CA140388, P30CA016672, P50CA090270] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas M. D. Anderson Cancer Center Prostate Cancer Research Program; UT MDACC Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute P50 CA090270, University of Texas M. D. Anderson Cancer Center Prostate Cancer Research Program, UT MDACC Core grant P30CA16672 and John S. Dunn, Sr., Distinguished Chair in Diagnostic Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Imran, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000689; American Cancer Society, 2009, CANC FACTS FIG 2009; AVIOLI, 1998, METABOLIC BONE DIS C; Barou O, 2002, INVEST RADIOL, V37, P40, DOI 10.1097/00004424-200201000-00008; Bauer JS, 2007, AM J ROENTGENOL, V188, P1294, DOI 10.2214/AJR.06.1006; BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Cho MH, 2005, PHYSIOL MEAS, V26, P667, DOI 10.1088/0967-3334/26/5/008; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; DAMBACHER MA, 2004, J MINER STOFFWECHS, V11, P13; Degeorges A, 1999, CANCER RES, V59, P2787; Dong Z, 2005, AM J PATHOL, V166, P1173, DOI 10.1016/S0002-9440(10)62337-1; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; GOLDSTEIN SA, 1990, MECH REMODELING PROP, P61; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Henry MD, 2005, PROSTATE, V65, P347, DOI 10.1002/pros.20300; JACOBS SC, 1983, UROLOGY, V21, P337, DOI 10.1016/0090-4295(83)90147-4; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; KESSLER RM, 1984, J COMPUT ASSIST TOMO, V8, P514, DOI 10.1097/00004728-198406000-00028; KINNEY JH, 1995, J BONE MINER RES, V10, P264; Kundra V, 2007, PROSTATE, V67, P50, DOI 10.1002/pros.20494; Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4; Navone NM, 1997, CLIN CANCER RES, V3, P2493; Navone NM, 2000, CLIN CANCER RES, V6, P1190; Nemeth JA, 1999, CANCER RES, V59, P1987; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Peyrin F, 1998, Technol Health Care, V6, P391; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; RUEGSEGGER, 1995, OSTEOPOROSIS INT, V5, P287; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; THALMANN GN, 1994, CANCER RES, V54, P2577; Uchiyama T, 1997, CALCIFIED TISSUE INT, V61, P493, DOI 10.1007/s002239900373; Uehara H, 2003, J NATL CANCER I, V95, P458, DOI 10.1093/jnci/95.6.458; Williams SA, 2007, JNCI-J NATL CANCER I, V99, P376, DOI 10.1093/jnci/djk065; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yang M, 1999, CANCER RES, V59, P781; Yonou H, 2004, PROSTATE, V58, P406, DOI 10.1002/pros.10349; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y	40	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9854	10.1371/journal.pone.0009854	http://dx.doi.org/10.1371/journal.pone.0009854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360964	Green Submitted, Green Published, gold			2022-12-25	WOS:000276163100003
J	Zvuloni, A; van Woesik, R; Loya, Y				Zvuloni, Assaf; van Woesik, Robert; Loya, Yossi			Diversity Partitioning of Stony Corals Across Multiple Spatial Scales Around Zanzibar Island, Tanzania	PLOS ONE			English	Article							SPECIES-DIVERSITY; SCLERACTINIAN CORALS; REEF; COMMUNITIES; PATTERNS; CONSERVATION; BIODIVERSITY; BUTTERFLIES; COMPETITION; RICHNESS	Background: The coral reefs of Zanzibar Island (Unguja, Tanzania) encompass a considerable proportion of the global coral-reef diversity and are representative of the western Indian Ocean region. Unfortunately, these reefs have been recently subjected to local and regional disturbances. The objectives of this study were to determine whether there are potentially non-random processes forcing the observed coral diversity patterns, and highlight where and at which spatial scales these processes might be most influential. Methodology/Principal Findings: A hierarchical (nested) sampling design was employed across three spatial scales, ranging from transects (<= 20 m), stations (<100 m), to sites (<1000 m), to examine coral diversity patterns. Two of the four sites, Chumbe and Mnemba, were located within Marine Protected Areas (MPAs), while the other two sites, Changuu and Bawe, were not protected. Additive partitioning of coral diversity was used to separate regional (total) diversity (gamma) into local alpha diversity and among-sample beta diversity components. Individual-based null models were used to identify deviations from random distribution across the three spatial scales. We found that Chumbe and Mnemba had similar diversity components to those predicted by the null models. However, the diversity at Changuu and Bawe was lower than expected at all three spatial scales tested. Consequently, the relative contribution of the among-site diversity component was significantly greater than expected. Applying partitioning analysis for each site separately revealed that the within-transect diversity component in Changuu was significantly lower than the null expectation. Conclusions/Significance: The non-random outcome of the partitioning analyses helped to identify the among-sites scale (i.e., 10's of kilometers) and the within-transects scale (i.e., a few meters; especially at Changuu) as spatial boundaries within which to examine the processes that may interact and disproportionately differentiate coral diversity. In light of coral community compositions and diversity patterns we strongly recommend that Bawe be declared a MPA.	[Zvuloni, Assaf; Loya, Yossi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Zvuloni, Assaf] Interuniv Inst Marine Sci Eilat, H Steinitz Marine Biol Lab, Elat, Israel; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Tel Aviv University; Florida Institute of Technology	Zvuloni, A (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	zvolonia@post.tau.ac.il	Loya, Yossi/J-3039-2012; Loya, Joseph/AAJ-9014-2020	Loya, Yossi/0000-0001-6870-9444; 	World Bank and the Global Environmental Facility (GEF); Coral Bleaching and Local Environmental Responses working group; Raynor Chair for Environmental Conservation Research	World Bank and the Global Environmental Facility (GEF); Coral Bleaching and Local Environmental Responses working group; Raynor Chair for Environmental Conservation Research	This work was supported by the World Bank and the Global Environmental Facility (GEF) through the Coral Reef Targeted Research and Capacity Building for Management program, Coral Bleaching and Local Environmental Responses working group, (RvW and YL) and the Raynor Chair for Environmental Conservation Research to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AH, 2003, MAR ECOL PROG SER, V252, P289, DOI 10.3354/meps252289; Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bjork M, 1995, AMBIO, V24, P502; Brown KS, 2000, BIOTROPICA, V32, P934, DOI 10.1646/0006-3606(2000)032[0934:AFBIFL]2.0.CO;2; BUSS LW, 1979, AM NAT, V113, P223, DOI 10.1086/283381; Carlon DB, 2002, J EXP MAR BIOL ECOL, V268, P33, DOI 10.1016/S0022-0981(01)00369-0; Clarke KR, 1994, CHANGE MARINE COMMUN; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Done TJ, 1983, CORAL ZONATION ITS N, P107; DULVY NK, 1995, AMBIO, V24, P358; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; GAUDIAN G, 1990, ZANZIBAR ENV STUDY S, V9; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guard M, 1997, MAR POLLUT BULL, V34, P758, DOI 10.1016/S0025-326X(97)00095-7; Hillebrand H, 2002, OECOLOGIA, V132, P479, DOI 10.1007/s00442-002-0988-3; Houk P, 2010, MAR ECOL-EVOL PERSP, V31, P318, DOI 10.1111/j.1439-0485.2009.00301.x; Hubbell Stephen P., 2001, V32, pi; Jiddawi N, 1997, P NAT C COR REEFS, P22; Johnstone RW, 1998, AMBIO, V27, P700; Karlson RH, 2004, NATURE, V429, P867, DOI 10.1038/nature02685; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LANG J, 1973, B MAR SCI, V23, P260; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; LOYA Y, 1972, MAR BIOL, V13, P100, DOI 10.1007/BF00366561; Mbije NE, 2002, AMBIO, V31, P609, DOI 10.1639/0044-7447(2002)031[0609:PITDAA]2.0.CO;2; MCCLANAHAN TR, 1994, CORAL REEFS, V13, P231, DOI 10.1007/BF00303637; McClanahan TR, 1999, BIOL CONSERV, V89, P161, DOI 10.1016/S0006-3207(98)00123-2; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; MUHANDO C, 1998, CORAL REEFS VALUES T, P15; Muhando CA, 2002, AMBIO, V31, P558, DOI 10.1639/0044-7447(2002)031[0558:EEOTDO]2.0.CO;2; MUHANDO CA, 1997, P NAT C COR REEFS; Mundy C, 2000, MAR ECOL PROG SER, V198, P109, DOI 10.3354/meps198109; NGOILE MAK, 1988, ECOLOGY BIOPRODUCTIV, P93; NGOILE MAK, 1990, ZNZ ENV STUDY SER, V9; Nzali LM, 1998, AMBIO, V27, P717; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Semmens BX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008895; Smith LD, 1999, J EXP MAR BIOL ECOL, V235, P147, DOI 10.1016/S0022-0981(98)00178-6; Srivastava DS, 1999, J ANIM ECOL, V68, P1, DOI 10.1046/j.1365-2656.1999.00266.x; Summerville KS, 2003, CONSERV BIOL, V17, P1045, DOI 10.1046/j.1523-1739.2003.02059.x; THOMAS CD, 1985, BIOL CONSERV, V33, P95, DOI 10.1016/0006-3207(85)90098-9; *UNEP, 1989, UNEP REG SEAS REP; van Woesik R., 2002, Comments on Theoretical Biology, V7, P201, DOI 10.1080/08948550214054; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veron J. E. N., 2000, CORALS WORLD, V2; VERON JEN, 1995, CORALS SPACE TIME BI; WAGNER GM, 1997, P NAT C COR REEFS ZA, P38; Weiher E., 1999, ECOLOGICAL ASSEMBLY; WELLINGTON GM, 1982, ECOL MONOGR, V52, P223, DOI 10.2307/2937329; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3; Zvuloni A, 2008, LIMNOL OCEANOGR-METH, V6, P144, DOI 10.4319/lom.2008.6.144	58	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9941	10.1371/journal.pone.0009941	http://dx.doi.org/10.1371/journal.pone.0009941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360956	Green Published, gold, Green Submitted			2022-12-25	WOS:000276163100023
J	Davis, JL; Worodria, W; Kisembo, H; Metcalfe, JZ; Cattamanchi, A; Kawooya, M; Kyeyune, R; den Boon, S; Powell, K; Okello, R; Yoo, S; Huang, L				Davis, J. Lucian; Worodria, William; Kisembo, Harriet; Metcalfe, John Z.; Cattamanchi, Adithya; Kawooya, Michael; Kyeyune, Rachel; den Boon, Saskia; Powell, Krista; Okello, Richard; Yoo, Samuel; Huang, Laurence			Clinical and Radiographic Factors Do Not Accurately Diagnose Smear-Negative Tuberculosis in HIV-infected Inpatients in Uganda: A Cross-Sectional Study	PLOS ONE			English	Article							ACID-FAST BACILLI; CHEST-X-RAY; PULMONARY TUBERCULOSIS; FLUORESCENCE MICROSCOPY; RECORDING-SYSTEM; SPUTUM SMEARS; SENSITIVITY; PERFORMANCE; SPECIFICITY; OPPORTUNITY	Background: Although World Health Organization guidelines recommend clinical judgment and chest radiography for diagnosing tuberculosis in HIV-infected adults with unexplained cough and negative sputum smears for acid-fast bacilli, the diagnostic performance of this approach is unknown. Therefore, we sought to assess the accuracy of symptoms, physical signs, and radiographic findings for diagnosing tuberculosis in this population in a low-income country with a high incidence of tuberculosis. Methodology: We performed a cross-sectional study enrolling consecutive HIV-infected inpatients with unexplained cough and negative sputum smears for acid-fast bacilli at Mulago Hospital in Kampala, Uganda. Trained medical officers prospectively collected data on standard symptoms and signs of systemic respiratory illness, and two radiologists interpreted chest radiographs in a standardized fashion. We calculated positive-and negative-likelihood ratios of these factors for diagnosing pulmonary tuberculosis (defined when mycobacterial cultures of sputum or bronchoalveolar lavage fluid were positive). We used both conventional and novel regression techniques to develop multivariable prediction models for pulmonary tuberculosis. Principal Findings: Among 202 enrolled HIV-infected adults with negative sputum smears for acid-fast bacilli, 72 (36%) had culture-positive pulmonary tuberculosis. No single factor, including respiratory symptoms, physical findings, CD4+ T-cell count, or chest radiographic abnormalities, substantially increased or decreased the likelihood of pulmonary tuberculosis. After exhaustive testing, we were also unable to identify any combination of factors which reliably predicted bacteriologically confirmed tuberculosis. Conclusions and Significance: Clinical and radiographic criteria did not help diagnose smear-negative pulmonary tuberculosis among HIV-infected patients with unexplained cough in a low-income setting. Enhanced diagnostic methods for smear-negative tuberculosis are urgently needed.	[Davis, J. Lucian; Metcalfe, John Z.; Cattamanchi, Adithya; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Davis, J. Lucian; Metcalfe, John Z.; Cattamanchi, Adithya; Powell, Krista; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Davis, J. Lucian; Metcalfe, John Z.; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Francis J Curry Natl TB Ctr, San Francisco, CA USA; [Kisembo, Harriet; Kawooya, Michael; Okello, Richard] Makerere Univ, Dept Radiol, Mulago Hosp, Kampala, Uganda; [Worodria, William; Yoo, Samuel] Makerere Univ, Dept Med, Mulago Hosp, Kampala, Uganda; [Davis, J. Lucian; Worodria, William; Cattamanchi, Adithya; Kyeyune, Rachel; den Boon, Saskia; Yoo, Samuel; Huang, Laurence] Makerere Univ, Univ California San Francisco Res Collaborat, Mulago Hosp, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital	Davis, JL (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	lucian.davis@ucsf.edu	Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Metcalfe, John/0000-0002-2279-7036	National Institutes of Health [K23 HL094141, K23 AI080147, K24 HL087713, R01HL090335]; National Center for Research Resources [KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, K23HL094141, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Foundation for Innovative New Diagnostics (www.finddiagnostics.org) provided some funding which supported this study. In addition, the following authors have received support for this research from the National Institutes of Health (www.nih.gov): Adithya Cattamanchi, K23 HL094141; J. Lucian Davis, K23 AI080147; Laurence Huang, K24 HL087713, R01HL090335. This work was also supported by the National Center for Research Resources (KL2 RR024130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript for this study.	[Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Bock NN, 1996, AM J RESP CRIT CARE, V154, P1468, DOI 10.1164/ajrccm.154.5.8912766; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cambanis A, 2007, INT J TUBERC LUNG D, V11, P40; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi A, 2008, J CLIN MICROBIOL, V46, P3325, DOI 10.1128/JCM.01175-08; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Cummings P, 2003, ARCH PEDIAT ADOL MED, V157, P321, DOI 10.1001/archpedi.157.4.321; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; El-Solh AA, 1999, CHEST, V116, P968, DOI 10.1378/chest.116.4.968; ElSolh A, 1997, AM J RESP CRIT CARE, V155, P1711, DOI 10.1164/ajrccm.155.5.9154881; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Harries AD, 1998, INT J TUBERC LUNG D, V2, P999; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; McGee S, 2002, J GEN INTERN MED, V17, P646; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Newman TB, 2009, EVIDENCE-BASED DIAGNOSIS, P1, DOI 10.1017/CBO9780511759512; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Samb B, 1997, INT J TUBERC LUNG D, V1, P25; Selwyn PA, 1998, AIDS, V12, P885, DOI 10.1097/00002030-199808000-00011; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Shea YR, 2009, J CLIN MICROBIOL, V47, P1553, DOI 10.1128/JCM.00348-09; Sinisi SE, 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1069; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Were W, 2009, INT J TUBERC LUNG D, V13, P47; *WHO, 2005, INT MAN AD AD ILLN G; Wilkinson D, 2000, INT J TUBERC LUNG D, V4, P513; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; Wisnivesky JP, 2000, ARCH INTERN MED, V160, P2471, DOI 10.1001/archinte.160.16.2471	43	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9859	10.1371/journal.pone.0009859	http://dx.doi.org/10.1371/journal.pone.0009859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361038	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600001
J	Han, J; Goldstein, LA; Hou, W; Froelich, CJ; Watkins, SC; Rabinowich, H				Han, Jie; Goldstein, Leslie A.; Hou, Wen; Froelich, Christopher J.; Watkins, Simon C.; Rabinowich, Hannah			Deregulation of Mitochondrial Membrane Potential by Mitochondrial Insertion of Granzyme B and Direct Hax-1 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HS1-ASSOCIATED PROTEIN X-1; CYTOTOXIC T-LYMPHOCYTES; CYTOCHROME-C RELEASE; CELL-DEATH; PERMEABILITY TRANSITION; CYCLOPHILIN-D; CYTOSOLIC DELIVERY; APOPTOTIC EVENTS; EBNA-LP; BAX	The cytoplasm and the nucleus have been identified as activity sites for granzyme B (GrB) following its delivery from cytotoxic lymphocyte granules into target cells. Here we report on the ability of exogenous GrB to insert into and function within a proteinase K-resistant mitochondrial compartment. We identified Hax-1 (HS-1-associated protein X-1), a mitochondrial protein involved in the maintenance of mitochondrial membrane potential, as a GrB substrate within the mitochondrion. GrB cleaves Hax-1 into two major fragments: an N-terminal fragment that localizes to mitochondria and a C-terminal fragment that localizes to the cytosol after being released from GrB-treated mitochondria. The N-terminal Hax-1 fragment major cellular impact is on the regulation of mitochondrial polarization. Overexpression of wild-type Hax-1 or its uncleavable mutant form protects the mitochondria against GrB or valinomycin-mediated depolarization. The N-terminal Hax-1 fragment functions as a dominant negative form of Hax-1, mediating mitochondrial depolarization in a cyclophilin D-dependent manner. Thus, induced expression of the N-terminal Hax-1 fragment results in mitochondrial depolarization and subsequent lysosomal degradation of such altered mitochondria. This study is the first to demonstrate GrB activity within the mitochondrion and to identify Hax-1 cleavage as a novel mechanism for GrB-mediated mitochondrial depolarization.	[Rabinowich, Hannah] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Han, Jie; Goldstein, Leslie A.; Hou, Wen; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Froelich, Christopher J.] Evanston NW Res Inst, Evanston, IL 60201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavil Rm G17C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [RO1 CA109285, RO1 CA111786]; NATIONAL CANCER INSTITUTE [R01CA109285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109285 and RO1 CA111786 (to H. R.).	Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Besenicar MP, 2008, BIOCHEM BIOPH RES CO, V371, P391, DOI 10.1016/j.bbrc.2008.04.071; Bots M, 2006, J CELL SCI, V119, P5011, DOI 10.1242/jcs.03239; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Galluzzi L, 2007, NAT CELL BIOL, V9, P487, DOI 10.1038/ncb0507-487; Goping IS, 2008, BLOOD, V111, P2142, DOI 10.1182/blood-2007-08-105221; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; HANNA WL, 1993, PROTEIN EXPRES PURIF, V4, P398, DOI 10.1006/prep.1993.1052; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Kawaguchi Y, 2000, J VIROL, V74, P10104, DOI 10.1128/JVI.74.21.10104-10111.2000; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Matsuda G, 2003, MICROBIOL IMMUNOL, V47, P91, DOI 10.1111/j.1348-0421.2003.tb02790.x; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Waterhouse NJ, 2006, IMMUNOL CELL BIOL, V84, P72, DOI 10.1111/j.1440-1711.2005.01416.x; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005; ZHAO W, 2010, P NATL ACAD IN PRESS; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	53	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22461	22472		10.1074/jbc.M109.086587	http://dx.doi.org/10.1074/jbc.M109.086587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20388708	hybrid, Green Published			2022-12-25	WOS:000279702200058
J	Castegna, A; Scarcia, P; Agrimi, G; Palmieri, L; Rottensteiner, H; Spera, I; Germinario, L; Palmieri, F				Castegna, Alessandra; Scarcia, Pasquale; Agrimi, Gennaro; Palmieri, Luigi; Rottensteiner, Hanspeter; Spera, Iolanda; Germinario, Lucrezia; Palmieri, Ferdinando			Identification and Functional Characterization of a Novel Mitochondrial Carrier for Citrate and Oxoglutarate in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL BETA-OXIDATION; RAT-LIVER MITOCHONDRIA; BACTERIAL EXPRESSION; TRANSPORT PROTEIN; FATTY-ACIDS; TRICARBOXYLATE CARRIER; BOVINE MITOCHONDRIA; CYTOSOLIC SOURCES; GENE DISRUPTION; COMPLEX-I	Mitochondrial carriers are a family of transport proteins that shuttle metabolites, nucleotides, and coenzymes across the mitochondrial membrane. The function of only a few of the 35 Saccharomyces cerevisiae mitochondrial carriers still remains to be uncovered. In this study, we have functionally defined and characterized the S. cerevisiae mitochondrial carrier Yhm2p. The YHM2 gene was overexpressed in S. cerevisiae, and its product was purified and reconstituted into liposomes. Its transport properties, kinetic parameters, and targeting to mitochondria show that Yhm2p is a mitochondrial transporter for citrate and oxoglutarate. Reconstituted Yhm2p also transported oxaloacetate, succinate, and fumarate to a lesser extent, but virtually not malate and isocitrate. Yhm2p catalyzed only a counter-exchange transport that was saturable and inhibited by sulfhydryl-blocking reagents but not by 1,2,3-benzenetricarboxylate (a powerful inhibitor of the citrate/malate carrier). The physiological role of Yhm2p is to increase the NADPH reducing power in the cytosol (required for biosynthetic and antioxidant reactions) and probably to act as a key component of the citrate-oxoglutarate NADPH redox shuttle between mitochondria and cytosol. This protein function is based on observations documenting a decrease in the NADPH/NADP(+) and GSH/GSSG ratios in the cytosol of Delta YHM2 cells as well as an increase in the NADPH/NADP(+) ratio in their mitochondria compared with wildtype cells. Our proposal is also supported by the growth defect displayed by the Delta YHM2strain and more so by the Delta YHM2 Delta ZWF1 strain upon H2O2 exposure, implying that Yhm2p has an antioxidant function.	[Castegna, Alessandra; Scarcia, Pasquale; Agrimi, Gennaro; Palmieri, Luigi; Spera, Iolanda; Germinario, Lucrezia; Palmieri, Ferdinando] Univ Bari, Biochem & Mol Biol Lab, Dept Pharmacobiol, I-70125 Bari, Italy; [Rottensteiner, Hanspeter] Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany; [Palmieri, Luigi; Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Ruhr University Bochum; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	castegna, alessandra/AAH-6668-2020; castegna, alessandra/M-5106-2013; Scarcia, Pasquale/A-8830-2010; Scarcia, Pasquale/O-9550-2019; Agrimi, Gennaro/D-4001-2018	Scarcia, Pasquale/0000-0001-6216-0411; Scarcia, Pasquale/0000-0001-6216-0411; Agrimi, Gennaro/0000-0002-5219-4412; CASTEGNA, Alessandra/0000-0003-0235-6847	Ministero dell'Universita e della Ricerca; Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet [RBRN07BMCT_009]	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet	This work was supported by grants from the Ministero dell'Universita e della Ricerca, the Center of Excellence in Genomics, Apulia Region, the University of Bari, and the Italian Human ProteomeNet No. RBRN07BMCT_009.	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BISACCIA F, 1989, BIOCHIM BIOPHYS ACTA, V977, P171, DOI 10.1016/S0005-2728(89)80068-4; Cho JH, 1998, MOL CELL BIOL, V18, P5712, DOI 10.1128/MCB.18.10.5712; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; DAUM G, 1982, J BIOL CHEM, V257, P3075; ElMoualij B, 1997, YEAST, V13, P573, DOI 10.1002/(SICI)1097-0061(199705)13:6<573::AID-YEA107>3.0.CO;2-I; EVANS CT, 1983, EUR J BIOCHEM, V130, P195; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Henke B, 1998, J BIOL CHEM, V273, P3702, DOI 10.1074/jbc.273.6.3702; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; HOEK JB, 1974, ALCOHOL ALDEHYDE MET, P351; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; Marobbio CMT, 2008, J BIOL CHEM, V283, P28445, DOI 10.1074/jbc.M804637200; Minard KI, 1999, J BIOL CHEM, V274, P3402, DOI 10.1074/jbc.274.6.3402; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Minard KL, 2001, FREE RADICAL BIO MED, V31, P832, DOI 10.1016/S0891-5849(01)00666-9; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1972, EUR J BIOCHEM, V26, P587, DOI 10.1111/j.1432-1033.1972.tb01801.x; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Palmieri L, 1999, J BIOL CHEM, V274, P22184, DOI 10.1074/jbc.274.32.22184; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Schafer H, 2001, ELECTROPHORESIS, V22, P2955, DOI 10.1002/1522-2683(200108)22:14<2955::AID-ELPS2955>3.0.CO;2-U; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; STJOHN PA, 1986, J NEUROSCI, V6, P1492; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677; Visser WF, 2006, BIOCHEM BIOPH RES CO, V348, P1224, DOI 10.1016/j.bbrc.2006.07.049; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; WILLIAMSON JR, 1980, FEBS LETT, V117, P73	51	91	95	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17359	17370		10.1074/jbc.M109.097188	http://dx.doi.org/10.1074/jbc.M109.097188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371607	Green Published, hybrid			2022-12-25	WOS:000278133400013
J	Clouet-d'Orval, B; Rinaldi, D; Quentin, Y; Carpousis, AJ				Clouet-d'Orval, Beatrice; Rinaldi, Dana; Quentin, Yves; Carpousis, Agamemnon J.			Euryarchaeal beta-CASP Proteins with Homology to Bacterial RNase J Have 5 '- to 3 '-Exoribonuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX C/D RNA; ESCHERICHIA-COLI; MESSENGER-RNA; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; PYROCOCCUS-FURIOSUS; ARCHAEAL EXOSOME; LACTAMASE FOLD; GUIDE RNAS; TRANSLATION	In the Archaea only a handful of ribonucleases involved in RNA processing and degradation have been characterized. One potential group of archaeal ribonucleases are homologues of the bacterial RNase J family, which have a beta-CASP metallo-beta-lactamase fold. Here we show that beta-CASP proteins encoded in the genomes of the hyperthermophilic Euryarchaeota Pyrococcus abyssi and Thermococcus kodakaraensis are processive exoribonucleases with a 5' end dependence and a 5' to 3' directionality. We named these enzymes Pab-RNase J and Tk-RNase J, respectively. RNAs with 5'-monophosphate or 5'-hydroxyl ends are preferred substrates of Pab-RNase J, whereas circularized RNA is resistant to Pab-RNase J activity. Degradation of a 3' end-labeled synthetic RNA in which an internal nucleoside is substituted by three ethylene glycol units generates intermediates demonstrating 5' to 3' directionality. The substitution of conserved residues in Pab-RNase J predicted to be involved in the coordination of metal ions demonstrates their importance for ribonuclease activity, although the detailed geometry of the catalytic site is likely to differ from bacterial RNase J. This is the first identification of a 5'-exoribonuclease encoded in the genomes of the Archaea. Phylogenetic analysis shows that euryarchaeal RNase J has been inherited vertically, suggesting an ancient origin predating the separation of the Bacteria and the Archaea.	[Clouet-d'Orval, Beatrice] CNRS, Lab Microbiol & Genet Mol, UMR 5100, F-31062 Toulouse, France; Univ Toulouse 3, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Clouet-d'Orval, B (corresponding author), CNRS, Lab Microbiol & Genet Mol, UMR 5100, 118 Route Narbonne, F-31062 Toulouse, France.	beatrice.clouet-dorval@ibcg.biotoul.fr	Carpousis, Agamemnon/S-2098-2019	Carpousis, Agamemnon/0000-0002-1774-2102; Quentin, Yves/0000-0001-8248-0586; Clouet-d'Orval, Beatrice/0000-0002-3591-8538	CNRS; Agence Nationale de la Recherche (ANR) [BLAN08-1_329396]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the CNRS with additional funding from the Agence Nationale de la Recherche (ANR) (Grant BLAN08-1_329396).	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Bortolin ML, 2003, NUCLEIC ACIDS RES, V31, P6524, DOI 10.1093/nar/gkg860; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; BROWN JW, 1985, J BACTERIOL, V162, P909, DOI 10.1128/JB.162.3.909-917.1985; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; Condon C, 1997, J MOL BIOL, V268, P235, DOI 10.1006/jmbi.1997.0971; d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; French SL, 2007, MOL BIOL EVOL, V24, P893, DOI 10.1093/molbev/msm007; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hasenohrl D, 2008, P NATL ACAD SCI USA, V105, P2146, DOI 10.1073/pnas.0708894105; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Kanai A, 2003, BIOCHEM J, V372, P253, DOI 10.1042/BJ20021968; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Portnoy V, 2006, NUCLEIC ACIDS RES, V34, P5923, DOI 10.1093/nar/gkl763; Ramos CRR, 2006, J BIOL CHEM, V281, P6751, DOI 10.1074/jbc.M512495200; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Tang TH, 2002, NUCLEIC ACIDS RES, V30, P921, DOI 10.1093/nar/30.4.921; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; Viswanathan M, 1998, J BIOL CHEM, V273, P35126, DOI 10.1074/jbc.273.52.35126; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08; Zhang J, 2009, RNA, V15, P1909, DOI 10.1261/rna.1715209	49	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17574	17583		10.1074/jbc.M109.095117	http://dx.doi.org/10.1074/jbc.M109.095117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375016	Green Published, hybrid			2022-12-25	WOS:000278133400036
J	de Jong, SJ; Albrecht, JC; Schmidt, M; Muller-Fleckenstein, I; Biesinger, B				de Jong, Sarah Jill; Albrecht, Jens-Christian; Schmidt, Monika; Mueller-Fleckenstein, Ingrid; Biesinger, Brigitte			Activation of Noncanonical NF-kappa B Signaling by the Oncoprotein Tio	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-CELLS; HERPESVIRUS-SAIMIRI; GROWTH TRANSFORMATION; MULTIPLE-MYELOMA; TRANSCRIPTION FACTORS; KINASE INHIBITOR; TARGET GENES; IKK-ALPHA; PATHWAY; PROTEIN	NF-kappa B transcription factors are key regulators of cellular proliferation and frequently contribute to oncogenesis. The herpes-viral oncoprotein Tio, which promotes growth transformation of human T cells in a recombinant herpesvirus saimiri background, potently induces canonical NF-kappa B signaling through membrane recruitment of the ubiquitin ligase tumor necrosis factor receptor-associated factor 6 (TRAF6). Here, we show that, in addition to Tio-TRAF6 interaction, the Tio-induced canonical NF-kappa B signal requires the presence of the regulatory subunit of the inhibitor of kappa B kinase (IKK) complex, NF-kappa B essential modulator (NEMO), and the activity of its key kinase, IKK beta, to up-regulate expression of endogenous cellular inhibitor of apoptosis 2 (cIAP2) and interleukin 8 (IL-8) proteins. Dependent on TRAF6 and NEMO, Tio enhances the expression of the noncanonical NF-kappa B proteins, p100 and RelB. Independent of TRAF6 and NEMO, Tio mediates stabilization of the noncanonical kinase, NF-kappa B-inducing kinase (NIK). Concomitantly, Tio induces efficient processing of the p100 precursor molecule to its active form, p52, as well as DNA binding of nuclear p52 and RelB. In human T cells transformed by infection with a Tio-recombinant virus, sustained expression of p100, RelB, and cIAP2 depends on IKK beta activity, yet processing to p52 remains largely unaffected by IKK beta inhibition. However, long term inhibition of IKK beta disrupts the continuous growth of the transformed cells and induces cell death. Hence, the Tio oncoprotein triggers noncanonical NF-kappa B signaling through NEMO-dependent up-regulation of p100 precursor and RelB, as well as through NEMO-independent generation of p52 effector.	[de Jong, Sarah Jill; Albrecht, Jens-Christian; Schmidt, Monika; Mueller-Fleckenstein, Ingrid; Biesinger, Brigitte] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Biesinger, B (corresponding author), Schlossgarten 4, D-91054 Erlangen, Germany.	brigitte.biesinger@viro.med.uni-erlangen.de			DFG [BI465/5-1, GRK 1071]	DFG(German Research Foundation (DFG))	This work was supported by DFG Grants BI465/5-1 and GRK 1071.	Albrecht JC, 2005, J VIROL, V79, P10507, DOI 10.1128/JVI.79.16.10507-10513.2005; Albrecht JC, 2004, J VIROL, V78, P9814, DOI 10.1128/JVI.78.18.9814-9819.2004; Albrecht JC, 1999, J VIROL, V73, P4631, DOI 10.1128/JVI.73.6.4631-4639.1999; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; BIESINGER B, 1995, J BIOL CHEM, V270, P4729, DOI 10.1074/jbc.270.9.4729; BIESINGER B, 1992, P NATL ACAD SCI USA, V89, P3116, DOI 10.1073/pnas.89.7.3116; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Britanova LV, 2008, BIOCHEM BIOPH RES CO, V365, P583, DOI 10.1016/j.bbrc.2007.10.200; Cesarman E, 2007, CURR TOP MICROBIOL, V312, P263; Duboise SM, 1998, J VIROL, V72, P1308, DOI 10.1128/JVI.72.2.1308-1313.1998; Eliopoulos AG, 2003, ONCOGENE, V22, P7557, DOI 10.1038/sj.onc.1207120; FALK LA, 1974, INT J CANCER, V14, P473, DOI 10.1002/ijc.2910140407; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Glanz A, 2008, IMMUNOL CELL BIOL, V86, P622, DOI 10.1038/icb.2008.43; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Heck E, 2006, J VIROL, V80, P9934, DOI 10.1128/JVI.01112-06; Heinemann S, 2006, J BIOL CHEM, V281, P8565, DOI 10.1074/jbc.M510891200; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lee H, 1999, J VIROL, V73, P3913, DOI 10.1128/JVI.73.5.3913-3919.1999; LOMBARDI L, 1995, NUCLEIC ACIDS RES, V23, P2328, DOI 10.1093/nar/23.12.2328; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Murata T, 2004, BIOORG MED CHEM LETT, V14, P4019, DOI 10.1016/j.bmcl.2004.05.041; Packham G, 2008, BRIT J HAEMATOL, V143, P3, DOI 10.1111/j.1365-2141.2008.07284.x; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Sanda T, 2006, LEUKEMIA, V20, P590, DOI 10.1038/sj.leu.2404129; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Sorokina EM, 2004, J BIOL CHEM, V279, P13469, DOI 10.1074/jbc.M305250200; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Wies E, 2009, J BIOL CHEM, V284, P8525, DOI 10.1074/jbc.M809252200; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	44	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16495	16503		10.1074/jbc.M110.102848	http://dx.doi.org/10.1074/jbc.M110.102848			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353939	Green Published, hybrid			2022-12-25	WOS:000277982600011
J	Kelly, SE; Di Benedetto, A; Greco, A; Howard, CM; Sollars, VE; Primerano, DA; Valluri, JV; Claudio, PP				Kelly, Sarah E.; Di Benedetto, Altomare; Greco, Adelaide; Howard, Candace M.; Sollars, Vincent E.; Primerano, Donald A.; Valluri, Jagan V.; Claudio, Pier Paolo			Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications	PLOS ONE			English	Article							MAMMARY STEM-CELLS; PROSTATE-CANCER; BREAST-CANCER; IN-VITRO; PROSPECTIVE IDENTIFICATION; SIDE POPULATION; OSTEOSARCOMA; CARCINOGENESIS; MECHANISM; CAPACITY	Cancer stem cells (CSCs) are considered a subset of the bulk tumor responsible for initiating and maintaining the disease. Several surface cellular markers have been recently used to identify CSCs. Among those is CD133, which is expressed by hematopoietic progenitor cells as well as embryonic stem cells and various cancers. We have recently isolated and cultured CD133 positive [CD133(+)] cells from various cancer cell lines using a NASA developed Hydrodynamic Focusing Bioreactor (HFB) (Celdyne, Houston, TX). For comparison, another bioreactor, the rotary cell culture system (RCCS) manufactured by Synthecon (Houston, TX) was used. Both the HFB and the RCCS bioreactors simulate aspects of hypogravity. In our study, the HFB increased CD133(+) cell growth from various cell lines compared to the RCCS vessel and to normal gravity control. We observed a (+) 15-fold proliferation of the CD133(+) cellular fraction with cancer cells that were cultured for 7-days at optimized conditions. The RCCS vessel instead yielded a (2) 4.8-fold decrease in the CD133(+) cellular fraction respect to the HFB after 7-days of culture. Interestingly, we also found that the hypogravity environment of the HFB greatly sensitized the CD133(+) cancer cells, which are normally resistant to chemo treatment, to become susceptible to various chemotherapeutic agents, paving the way to less toxic and more effective chemotherapeutic treatment in patients. To be able to test the efficacy of cytotoxic agents in vitro prior to their use in clinical setting on cancer cells as well as on cancer stem cells may pave the way to more effective chemotherapeutic strategies in patients. This could be an important advancement in the therapeutic options of oncologic patients, allowing for more targeted and personalized chemotherapy regimens as well as for higher response rates.	[Kelly, Sarah E.; Di Benedetto, Altomare; Greco, Adelaide; Howard, Candace M.; Sollars, Vincent E.; Primerano, Donald A.; Claudio, Pier Paolo] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Di Benedetto, Altomare] Univ Aquila, Fac Sci, Dept Basic & Appl Biol, I-67100 Laquila, Italy; [Greco, Adelaide] Adv Biotechnol Scarl, CEINGE, Naples, Italy; [Greco, Adelaide] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy; [Greco, Adelaide] CNR, IBB, I-80125 Naples, Italy; [Valluri, Jagan V.] Marshall Univ, Dept Biol, Huntington, WV USA; [Claudio, Pier Paolo] Marshall Univ, Dept Surg, Joan C Edwards Sch Med, Huntington, WV USA	Marshall University; University of L'Aquila; CEINGE Biotecnologie Avanzate; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Marshall University; Marshall University	Kelly, SE (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	claudiop@marshall.edu	Sollars, Vincent/R-3769-2019; Claudio, Pier Paolo/AAW-7282-2021; Greco, Adelaide/C-7679-2018	Claudio, Pier Paolo/0000-0001-7790-1622; Greco, Adelaide/0000-0001-6841-1963; Sollars, Vincent/0000-0002-5602-3610; Howard, Candace/0000-0001-6537-3551	Cell Differentiation and Development Center (CDDC) at Marshall University [NIH-CA138510, NIH-CA140024, NIH-COBRE 5P20RR020180]; West Virginia NASA Space Grant Consortium [WV-INBRE 5P20RR016477]; NATIONAL CANCER INSTITUTE [R03CA140024] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477, P20RR020180] Funding Source: NIH RePORTER	Cell Differentiation and Development Center (CDDC) at Marshall University; West Virginia NASA Space Grant Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was performed with funds received in part by the Cell Differentiation and Development Center (CDDC) at Marshall University, NIH-CA138510, NIH-CA140024, NIH-COBRE 5P20RR020180 (to P. P. C.); West Virginia NASA Space Grant Consortium (to S. K. and J.V.V.); WV-INBRE 5P20RR016477 (to D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Romaih K, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-14; BADHWAR GD, 1992, ADV SPACE RES-SERIES, V12, P195, DOI 10.1016/0273-1177(92)90108-A; Baisden DL, 2008, AVIAT SPACE ENVIR MD, V79, P629, DOI 10.3357/ASEM.2314.2008; Barr YR, 2007, AVIAT SPACE ENVIR MD, V78, pA26; Berend KR, 2001, J SURG ONCOL, V78, P162, DOI 10.1002/jso.1142; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2006, MOL INTERV, V6, P140, DOI 10.1124/mi.6.3.5; Dicello JF, 2003, HEALTH PHYS, V85, P94, DOI 10.1097/00004032-200307000-00017; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Fan XL, 2007, SEMIN CANCER BIOL, V17, P214, DOI 10.1016/j.semcancer.2006.04.002; Farnie G, 2006, Ernst Schering Found Symp Proc, P141; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Grun B, 2009, CELL PROLIFERAT, V42, P219, DOI 10.1111/j.1365-2184.2008.00579.x; Guo W, 2006, PEDIATR RES, V59, p59R, DOI 10.1203/01.pdr.0000203592.04530.06; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Kelly K, 2008, CELL RES, V18, P528, DOI 10.1038/cr.2008.50; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Lawrenson K, 2009, CELL PROLIFERAT, V42, P385, DOI 10.1111/j.1365-2184.2009.00604.x; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lin TL, 2007, PEDIATR RES, V62, P239, DOI 10.1203/PDR.0b013e3181515124; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Mihailova M, 2006, ANN NY ACAD SCI, V1091, P470, DOI 10.1196/annals.1378.089; Mitteregger R, 1999, INT J ARTIF ORGANS, V22, P816, DOI 10.1177/039139889902201207; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Okamoto OK, 2008, EXPERT REV MOL DIAGN, V8, P387, DOI 10.1586/14737159.8.4.387; Panagiotakos G, 2007, CURR NEUROL NEUROSCI, V7, P215, DOI 10.1007/s11910-007-0033-3; Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702; RAJAN P, 2008, STEM CELL REV; REEDIJK J, 1985, PHARM WEEKBLAD, V7, P173, DOI 10.1007/BF02307573; REN C, 2008, GENE THER; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakai S, 2009, J ORTHOP RES, V27, P517, DOI 10.1002/jor.20566; SARTIANO GP, 1979, J ANTIBIOT, V32, P1038, DOI 10.7164/antibiotics.32.1038; Schuetze Scott M, 2007, J Natl Compr Canc Netw, V5, P449; Shipitsin M, 2008, LAB INVEST, V88, P459, DOI 10.1038/labinvest.2008.14; Singh SK, 2003, CANCER RES, V63, P5821; Soltysova A, 2005, NEOPLASMA, V52, P435; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Tysnes BB, 2007, BBA-REV CANCER, V1775, P283, DOI 10.1016/j.bbcan.2007.01.001; Villanueva I, 2009, BIOTECHNOL BIOENG, V102, P1242, DOI 10.1002/bit.22134; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; WHITMORE PJ, 1981, J AEROSOL SCI, V12, P1, DOI 10.1016/0021-8502(81)90003-3; Williams JR, 1999, MUTAT RES-FUND MOL M, V430, P255, DOI 10.1016/S0027-5107(99)00137-2; WODINSKY I, 1968, CANCER CHEMOTH REP, V52, P251; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465; Zalupski MM, 2004, CANCER-AM CANCER SOC, V100, P818, DOI 10.1002/cncr.20021	60	45	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10035	10.1371/journal.pone.0010035	http://dx.doi.org/10.1371/journal.pone.0010035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386701	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482000006
J	Poulain, P; Gelly, JC; Flatters, D				Poulain, Pierre; Gelly, Jean-Christophe; Flatters, Delphine			Detection and Architecture of Small Heat Shock Protein Monomers	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; C-TERMINAL EXTENSION; FUNCTIONAL ELEMENT; A-CRYSTALLIN; IXI/V MOTIF; CHAPERONE; DOMAIN; IDENTIFICATION; SUPERFAMILY; FLEXIBILITY	Background: Small Heat Shock Proteins (sHSPs) are chaperone-like proteins involved in the prevention of the irreversible aggregation of misfolded proteins. Although many studies have already been conducted on sHSPs, the molecular mechanisms and structural properties of these proteins remain unclear. Here, we propose a better understanding of the architecture, organization and properties of the sHSP family through structural and functional annotations. We focused on the Alpha Crystallin Domain (ACD), a beta sandwich fold that is the hallmark of the sHSP family. Methodology/Principal Findings: We developed a new approach for detecting sHSPs and delineating ACDs based on an iterative Hidden Markov Model algorithm using a multiple alignment profile generated from structural data on ACD. Using this procedure on the UniProt databank, we found 4478 sequences identified as sHSPs, showing a very good coverage with the corresponding PROSITE and Pfam profiles. ACD was then delimited and structurally annotated. We showed that taxonomic-based groups of sHSPs (animals, plants, bacteria) have unique features regarding the length of their ACD and, more specifically, the length of a large loop within ACD. We detailed highly conserved residues and patterns specific to the whole family or to some groups of sHSPs. For 96% of studied sHSPs, we identified in the C-terminal region a conserved I/V/L-X-I/V/L motif that acts as an anchor in the oligomerization process. The fragment defined from the end of ACD to the end of this motif has a mean length of 14 residues and was named the C-terminal Anchoring Module (CAM). Conclusions/Significance: This work annotates structural components of ACD and quantifies properties of several thousand sHSPs. It gives a more accurate overview of the architecture of sHSP monomers.	[Poulain, Pierre] INSERM, UMR S 665, DSIMB, Paris, France; Univ Paris 07, INTS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Poulain, P (corresponding author), INSERM, UMR S 665, DSIMB, Paris, France.	pierre.poulain@univ-paris-diderot.fr; delphine.flatters@univ-paris-diderot.fr	Gelly, Jean-Christophe/A-9321-2010; Poulain, Pierre/A-8287-2009	Gelly, Jean-Christophe/0000-0001-5138-361X; Poulain, Pierre/0000-0003-4177-3619	French Ministry of Research; Paris Diderot - Paris 7 University; National Institute for Blood Transfusion (INTS); Institute for Health and Medical Care (INSERM)	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Paris Diderot - Paris 7 University; National Institute for Blood Transfusion (INTS); Institute for Health and Medical Care (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Financial support was provided by grants from the French Ministry of Research, the Paris Diderot - Paris 7 University, the National Institute for Blood Transfusion (INTS) and the Institute for Health and Medical Care (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bernardes JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-435; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DEJONG WW, 1988, J BIOL CHEM, V263, P5141; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; DELANO WL, 2010, POYMOL MOL GRAPHICS; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; Fu XM, 2006, BIOCHEMISTRY-MOSCOW+, V71, pS83, DOI 10.1134/S0006297906130141; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Goldstein P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-335; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hilario E, 2006, ACTA CRYSTALLOGR F, V62, P446, DOI 10.1107/S174430910601219X; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lindner RA, 2000, EUR J BIOCHEM, V267, P1923, DOI 10.1046/j.1432-1327.2000.01188.x; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Munchbach M, 1999, J BACTERIOL, V181, P83; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Pasta SY, 2004, MOL VIS, V10, P655; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; *R DEV COR TEAM, 2010, LANG ENV STATISTICAL; Saji H, 2008, PROTEINS, V71, P771, DOI 10.1002/prot.21762; Scheeff ED, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-410; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters ER, 1999, P NATL ACAD SCI USA, V96, P14394, DOI 10.1073/pnas.96.25.14394; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021	58	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e9990	10.1371/journal.pone.0009990	http://dx.doi.org/10.1371/journal.pone.0009990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383329	Green Published, Green Submitted, gold			2022-12-25	WOS:000276454000003
J	Colson, P; Richet, H; Desnues, C; Balique, F; Moal, V; Grob, JJ; Berbis, P; Lecoq, H; Harle, JR; Berland, Y; Raoult, D				Colson, Philippe; Richet, Herve; Desnues, Christelle; Balique, Fanny; Moal, Valerie; Grob, Jean-Jacques; Berbis, Philippe; Lecoq, Herve; Harle, Jean-Robert; Berland, Yvon; Raoult, Didier			Pepper Mild Mottle Virus, a Plant Virus Associated with Specific Immune Responses, Fever, Abdominal Pains, and Pruritus in Humans	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; FRANKLINIELLA-OCCIDENTALIS; ELECTRON-MICROSCOPY; VIRAL COMMUNITY; INFECTING VIRUS; INSECT VECTOR; COAT PROTEIN; LUNG CANCER; HUMAN FECES; VACCINE	Background: Recently, metagenomic studies have identified viable Pepper mild mottle virus (PMMoV), a plant virus, in the stool of healthy subjects. However, its source and role as pathogen have not been determined. Methods and Findings: 21 commercialized food products containing peppers, 357 stool samples from 304 adults and 208 stool samples from 137 children were tested for PMMoV using real-time PCR, sequencing, and electron microscopy. Anti-PMMoV IgM antibody testing was concurrently performed. A case-control study tested the association of biological and clinical symptoms with the presence of PMMoV in the stool. Twelve (57%) food products were positive for PMMoV RNA sequencing. Stool samples from twenty-two (7.2%) adults and one child (0.7%) were positive for PMMoV by real-time PCR. Positive cases were significantly more likely to have been sampled in Dermatology Units (p<10(-6)), to be seropositive for anti-PMMoV IgM antibodies (p = 0.026) and to be patients who exhibited fever, abdominal pains, and pruritus (p = 0.045, 0.038 and 0.046, respectively). Conclusions: Our study identified a local source of PMMoV and linked the presence of PMMoV RNA in stool with a specific immune response and clinical symptoms. Although clinical symptoms may be imputable to another cofactor, including spicy food, our data suggest the possibility of a direct or indirect pathogenic role of plant viruses in humans.	[Colson, Philippe; Richet, Herve; Desnues, Christelle; Balique, Fanny; Raoult, Didier] Univ Aix Marseille 2, URMITE, CNRS, UMR 6236,IRD 3R198,Fac Med & Pharm, Marseille, France; [Colson, Philippe; Raoult, Didier] CHU Timone, Marseille, France; [Moal, Valerie; Berland, Yvon] Ctr Hosp Univ Concept, Ctr Nephrol & Transplantat Renale, Marseille, France; [Grob, Jean-Jacques] Ctr Hosp Univ St Marguerite, Serv Dermatol, Marseille, France; [Berbis, Philippe] Ctr Hosp Univ Nord, Serv Dermatol, Marseille, France; [Balique, Fanny; Lecoq, Herve] INRA, UR 407, Unite Pathol Vegetale, F-84143 Montfavet, France; [Harle, Jean-Robert] Ctr Hosp Univ Concept, Serv Med Interne, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Colson, P (corresponding author), Univ Aix Marseille 2, URMITE, CNRS, UMR 6236,IRD 3R198,Fac Med & Pharm, Marseille, France.	didier.raoult@gmail.com	Desnues, Christelle/ABG-2910-2021; RAOULT, Didier/A-8434-2008; Desnues, Christelle/B-1383-2010; Colson, Philippe/P-6355-2014	Desnues, Christelle/0000-0002-2178-0355; RAOULT, Didier/0000-0002-0633-5974; Desnues, Christelle/0000-0002-2178-0355; Colson, Philippe/0000-0001-6285-0308; Grob, Jean-Jacques/0000-0002-0667-153X	French Centre National de la Recherche Scientifique (CNRS)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	Recurrent funding by the French Centre National de la Recherche Scientifique (CNRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTHWELL PW, 1960, LANCET, V1, P657; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brennan FR, 1999, J VIROL, V73, P930, DOI 10.1128/JVI.73.2.930-938.1999; Chikhi-Brachet R, 2002, J CLIN MICROBIOL, V40, P4266, DOI 10.1128/JCM.40.11.4266-4272.2002; Colson P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-21; Curry A, 2006, MICRON, V37, P91, DOI 10.1016/j.micron.2005.10.001; de Medeiros RB, 2005, P NATL ACAD SCI USA, V102, P1175, DOI 10.1073/pnas.0406668102; Denno Donna M., 2007, Animal Health Research Reviews, V8, P69, DOI 10.1017/S1466252307001302; FAUQUET CM, VIRUS TAXONOMY; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Florindo MI, 2002, BRAZ J MED BIOL RES, V35, P827, DOI 10.1590/S0100-879X2002000700011; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Hamada H, 2007, VIRUS GENES, V34, P205, DOI 10.1007/s11262-006-0049-9; Harrison BD, 1999, PHILOS T ROY SOC B, V354, P521, DOI 10.1098/rstb.1999.0403; HWANG DJ, 1994, P NATL ACAD SCI USA, V91, P9067, DOI 10.1073/pnas.91.19.9067; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; KATSILAMBROS L, 1960, LANCET, V2, P934; KITAJIMA EW, 1983, INTERVIROLOGY, V19, P129, DOI 10.1159/000149347; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; LECLAIR RA, 1967, AM REV RESPIR DIS, V95, P510; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Modelska A, 1998, P NATL ACAD SCI USA, V95, P2481, DOI 10.1073/pnas.95.5.2481; Musher DM, 2004, NEW ENGL J MED, V351, P2417, DOI 10.1056/NEJMra041837; Near KA, 2002, INFECT IMMUN, V70, P692, DOI 10.1128/IAI.70.2.692-701.2002; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Pascual DW, 2007, P NATL ACAD SCI USA, V104, P10757, DOI 10.1073/pnas.0704516104; Raoult D, 2010, FUTURE MICROBIOL, V5, P135, DOI 10.2217/FMB.09.119; Rogers SO, 2004, MED HYPOTHESES, V63, P773, DOI 10.1016/j.mehy.2004.04.004; ROSARIO K, 2009, APPL ENV MICROBIOL; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; WETTER C, 1984, PHYTOPATHOLOGY, V74, P405, DOI 10.1094/Phyto-74-405; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Yusibov Vidadi, 2006, Drugs R D, V7, P203, DOI 10.2165/00126839-200607040-00001; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; 2006, ICTVDB UNIVERSAL VIR	36	105	118	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10041	10.1371/journal.pone.0010041	http://dx.doi.org/10.1371/journal.pone.0010041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386604	Green Published, gold, Green Submitted			2022-12-25	WOS:000276420400012
J	Beermann, ML; Ardelt, M; Girgenrath, M; Miller, JB				Beermann, Mary Lou; Ardelt, Magdalena; Girgenrath, Mahasweta; Miller, Jeffrey Boone			Prdm1 (Blimp-1) and the Expression of Fast and Slow Myosin Heavy Chain Isoforms during Avian Myogenesis In Vitro	PLOS ONE			English	Article							CHICK LIMB BUD; MUSCLE-FIBERS; CLONAL ANALYSIS; CELL LINEAGES; HEDGEHOG; ZEBRAFISH; SPECIFICATION; DIFFERENTIATION; REQUIREMENTS; DIVERSITY	Background: Multiple types of fast and slow skeletal muscle fibers form during early embryogenesis in vertebrates. In zebrafish, formation of the earliest slow myofibers in fin muscles requires expression of the zinc-finger transcriptional repressor Prdm1 (also known as Blimp1). To further understand how the role of Prdm1 in early myogenesis may vary through evolution and during development, we have now analyzed Prdm1 expression in the diverse types of myotubes that form in culture from somitic, embryonic, and fetal chicken myoblasts. Principal Findings: In cultures of somitic, embryonic limb, and fetal limb chicken cells, we found that Prdm1 was expressed in all of the differentiated muscle cells that formed, including those that expressed only fast myosin heavy chain isoforms, as well as those that co-expressed both fast and slow myosin heavy chain isoforms. Prdm1 was also expressed in Pax7-positive myoblasts, as well as in non-myogenic cells in the cultures. Furthermore, though all differentiated cells in control somite cultures co-expressed fast and slow myosin heavy chains, antisense knockdown of Prdm1 expression inhibited the formation of these co-expressing cells in somite cultures. Conclusions: In chicken myogenic cell cultures, Prdm1 was expressed in most Pax7-positive myoblasts and in all differentiated muscle cells, irrespective of the developmental stage of cell donor or the pattern of fast and slow myosin heavy chains expressed in the differentiated cells that were formed. Thus, Prdm1 was expressed in myogenic cells prior to terminal differentiation; and, after differentiation, Prdm1 expression was not limited to cells that expressed slow myosin heavy chain isoforms. In addition, Prdm1 appeared to be required for differentiation of the somitic myocytes, which are the earliest myocytes to form in the avian embryo.	[Beermann, Mary Lou; Ardelt, Magdalena; Miller, Jeffrey Boone] Boston Biomed Res Inst, Neuromuscular Biol & Dis Grp, Watertown, MA USA; [Beermann, Mary Lou; Miller, Jeffrey Boone] Boston Biomed Res Inst, Senator Paul D Wellstone Muscular Dystrophy Coope, Watertown, MA USA; [Girgenrath, Mahasweta] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Miller, Jeffrey Boone] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Boston Biomedical Research Institute; Boston Biomedical Research Institute; Boston University; Harvard University; Harvard Medical School	Beermann, ML (corresponding author), Boston Biomed Res Inst, Neuromuscular Biol & Dis Grp, Watertown, MA USA.	miller@bbri.org		Miller, Jeffrey/0000-0001-5273-2201	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2006-35206-16622]; National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health [2R01HL064641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064641] Funding Source: NIH RePORTER	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by Competitive Grant #2006-35206-16622 to J.B.M. from the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov) and by grant 2R01HL064641 to J.B.M. from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health (www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; BONNER PH, 1974, DEV BIOL, V37, P317, DOI 10.1016/0012-1606(74)90152-3; Bren-Mattison Y, 2002, DEV BIOL, V242, P130, DOI 10.1006/dbio.2001.0528; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Christ B, 2002, INT J DEV BIOL, V46, P905; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; DIMARIO JX, 1993, NATURE, V362, P165, DOI 10.1038/362165a0; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Ha AS, 2003, GENE EXPR PATTERNS, V3, P297, DOI 10.1016/S1567-133X(03)00042-5; Hammond KL, 2009, EVOL DEV, V11, P27, DOI 10.1111/j.1525-142X.2008.00300.x; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Ingham PW, 2005, EXP CELL RES, V306, P336, DOI 10.1016/j.yexcr.2005.03.019; John SA, 2009, EXP CELL RES, V315, P1077, DOI 10.1016/j.yexcr.2008.11.015; KELLY AM, 1986, MED SCI SPORT EXER, V18, P292, DOI 10.1249/00005768-198606000-00007; Li Xiaopeng, 2004, BMC Developmental Biology, V4, P1; Liew HP, 2008, DEV BIOL, V324, P226, DOI 10.1016/j.ydbio.2008.09.020; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Meves Friedr., 1909, Anatomischer Anzeiger, V34; MILLER JB, 1989, DEV BIOL, V136, P393, DOI 10.1016/0012-1606(89)90265-0; MILLER JB, 1986, J CELL BIOL, V103, P2197, DOI 10.1083/jcb.103.6.2197; MILLER JB, 1989, J BIOL CHEM, V264, P13122; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; MILLER JB, 1985, J CELL BIOL, V101, P1643, DOI 10.1083/jcb.101.5.1643; MILLER JB, 1986, P NATL ACAD SCI USA, V83, P3860, DOI 10.1073/pnas.83.11.3860; PAGE S, 1992, DEV BIOL, V154, P118, DOI 10.1016/0012-1606(92)90053-J; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Sacks LD, 2003, DEVELOPMENT, V130, P3391, DOI 10.1242/dev.00541; SEED J, 1984, DEV BIOL, V106, P389, DOI 10.1016/0012-1606(84)90237-9; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Stockdale FE, 2002, RES PRO CEL, V38, P199; STOCKDALE FE, 1987, DEV BIOL, V123, P1, DOI 10.1016/0012-1606(87)90420-9; VANSWEARINGEN J, 1995, DEV BIOL, V170, P321, DOI 10.1006/dbio.1995.1218; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Vishnudas VK, 2009, HUM MOL GENET, V18, P4467, DOI 10.1093/hmg/ddp399; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wilm TP, 2005, DEVELOPMENT, V132, P393, DOI 10.1242/dev.01572	42	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9951	10.1371/journal.pone.0009951	http://dx.doi.org/10.1371/journal.pone.0009951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376350	gold, Green Published			2022-12-25	WOS:000276418200027
J	Golding, J; Steer, C; Pembrey, M				Golding, Jean; Steer, Colin; Pembrey, Marcus			Parental and Grandparental Ages in the Autistic Spectrum Disorders: A Birth Cohort Study	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; PATERNAL AGE; MOUSE; CHECKLIST; CHILDREN; OOCYTES	Background: A number of studies have assessed ages of parents of children with autistic spectrum disorders (ASD), and reported both maternal and paternal age effects. Here we assess relationships with grandparental ages. Methods and Findings: We compared the parental and grandparental ages of children in the population-based Avon Longitudinal Study of Parents and Children (ALSPAC), according to their scores in regard to 4 autistic trait measures and whether they had been given a diagnosis of ASD. Mean maternal and paternal ages of ASD cases were raised, but this appears to be secondary to a maternal grandmother age effect (P = 0.006): OR = 1.66[95% CI 1.16, 2.37] for each 10-year increase in the grandmother's age at the birth of the mother. Trait measures also revealed an association between the maternal grandmother's age and the major autistic trait-the Coherence Scale (regression coefficient b = 0.142, [95% CI = 0.057, 0.228] P = 0.001). After allowing for confounders the effect size increased to b = 0.217[95% CI 0.125, 0.308](P<0.001) for each 10 year increase in age. Conclusions: Although the relationship between maternal grandmother's age and ASD and a major autistic trait was unexpected, there is some biological plausibility, for the maternal side at least, given that the timing of female meiosis I permits direct effects on the grandchild's genome during the grandmother's pregnancy. An alternative explanation is the meiotic mismatch methylation (3 M) hypothesis, presented here for the first time. Nevertheless the findings should be treated as hypothesis generating pending corroborative results from other studies.	[Golding, Jean; Steer, Colin; Pembrey, Marcus] Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Bristol	Golding, J (corresponding author), Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England.	jean.golding@bristol.ac.uk		Golding, Jean/0000-0003-2826-3307	The UK Medical Research Council (MRC); Wellcome Trust; MRC; Medical Research Council [G0400085, G9815508] Funding Source: researchfish; MRC [G0400085] Funding Source: UKRI	The UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. The statistical analyses for this paper were specifically funded by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Buss A., 1984, TEMPERAMENT EARLY DE; Chawarska K, 2007, J AUTISM DEV DISORD, V37, P62, DOI 10.1007/s10803-006-0330-8; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Fujino Y, 1996, HUM REPROD, V11, P1480; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hulten MA, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-21; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; JAGIELLO G, 1976, CHROMOSOMA, V58, P377, DOI 10.1007/BF00292845; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Levy Y, 2009, J CHILD PSYCHOL PSYC, V50, P657, DOI 10.1111/j.1469-7610.2008.01986.x; Lopes FL, 2009, HUM MOL GENET, V18, P2032, DOI 10.1093/hmg/ddp127; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; STEER C, TRAITS CONTRIB UNPUB; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095	33	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9939	10.1371/journal.pone.0009939	http://dx.doi.org/10.1371/journal.pone.0009939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580AG	20376340	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200016
J	Morrill, JC; Ikegami, T; Yoshikawa-Iwata, N; Lokugamage, N; Won, S; Terasaki, K; Zamoto-Niikura, A; Peters, CJ; Makino, S				Morrill, John C.; Ikegami, Tetsuro; Yoshikawa-Iwata, Naoko; Lokugamage, Nandadeva; Won, Sungyong; Terasaki, Kaori; Zamoto-Niikura, Aya; Peters, C. J.; Makino, Shinji			Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA	PLOS ONE			English	Article							GLYCOSAMINOGLYCAN-BINDING VARIANTS; ENCEPHALITIS-VIRUS; JAPANESE ENCEPHALITIS; VIRAL-RNA; EXPRESSION; DETERMINANTS; VACCINE; PROTEIN; NSS; LACKING	Background: Rift Valley fever virus (RVFV), a member of the genus Phlebovirus within the family Bunyaviridae, is a negative-stranded RNA virus with a tripartite genome. RVFV is transmitted by mosquitoes and causes fever and severe hemorrhagic illness among humans, while in livestock it causes fever and high abortion rates. Methodology/Principal Findings: Sequence analysis showed that a wild-type RVFV ZH501 preparation consisted of two major viral subpopulations, with a single nucleotide heterogeneity at nucleotide 847 of M segment (M847); one had a G residue at M847 encoding glycine in a major viral envelope Gn protein, while the other carried A residue encoding glutamic acid at the corresponding site. Two ZH501-derived viruses, rZH501-M847-G and rZH501-M847-A, carried identical genomic sequences, except that the former and the latter had G and A, respectively, at M847 were recovered by using a reverse genetics system. Intraperitoneal inoculation of rZH501-M847-A into mice caused a rapid and efficient viral accumulation in the sera, livers, spleens, kidneys and brains, and killed most of the mice within 8 days, whereas rZH501-M847-G caused low viremia titers, did not replicate as efficiently as did rZH501-M847-A in these organs, and had attenuated virulence to mice. Remarkably, as early as 2 days postinfection with rZH501-M847-G, the viruses carrying A at M847 emerged and became the major virus population thereafter, while replicating viruses retained the input A residue at M847 in rZH501-M847-A-infected mice. Conclusions/Significance: These data demonstrated that the single nucleotide substitution in the Gn protein substantially affected the RVFV mouse virulence and that a virus population carrying the virulent viral genotype quickly emerged and became the major viral population within a few days in mice that were inoculated with the attenuated virus.	[Morrill, John C.; Ikegami, Tetsuro; Yoshikawa-Iwata, Naoko; Lokugamage, Nandadeva; Won, Sungyong; Terasaki, Kaori; Zamoto-Niikura, Aya; Peters, C. J.; Makino, Shinji] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ikegami, Tetsuro; Peters, C. J.] Univ Texas Med Branch Galveston, Dept Pathol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Morrill, JC (corresponding author), Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	cjpeters@utmb.edu; shmakino@utmb.edu	Ikegami, Tetsuro/H-1329-2013; Ibrahim, Essam Hassan/G-1960-2018; Makino, Shinji/E-8014-2015	Ikegami, Tetsuro/0000-0001-8318-2783; Ibrahim, Essam Hassan/0000-0003-0130-2257; Makino, Shinji/0000-0002-7831-1576	Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, National Institutes of Health (NIH) [U54 AI057156]; NIH-NIAID [NIH-NIAID-DMID-02-24]; James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062636, U54AI057156] Funding Source: NIH RePORTER	Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants through the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, National Institutes of Health (NIH) grant number U54 AI057156, and by NIH-NIAID-DMID-02-24 Collaborative Grant on Emerging Viral Diseases. TI, SW, and KT were supported by the James W. McLaughlin Fellowship Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GW, 1987, MICROB PATHOGENESIS, V2, P283, DOI 10.1016/0882-4010(87)90126-4; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; BESSELAAR TG, 1991, ARCH VIROL, V121, P111, DOI 10.1007/BF01316748; Billecocq A, 2008, VIROLOGY, V378, P377, DOI 10.1016/j.virol.2008.05.033; Bird BH, 2008, J VIROL, V82, P2681, DOI 10.1128/JVI.02501-07; Bird BH, 2007, VIROLOGY, V362, P10, DOI 10.1016/j.virol.2007.01.046; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Briones C, 2006, GENE, V384, P129, DOI 10.1016/j.gene.2006.07.037; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; HARRINGTON DG, 1980, AM J VET RES, V41, P1559; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; KEEGAN K, 1986, J VIROL, V58, P263, DOI 10.1128/JVI.58.2.263-270.1986; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P8098, DOI 10.1073/pnas.85.21.8098; Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; Morrill JC, 1997, AM J VET RES, V58, P1104; MORVAN J, 1992, RES VIROLOGY, V143, P407, DOI 10.1016/S0923-2516(06)80134-2; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Nguku P., 2007, Morbidity and Mortality Weekly Report, V56, P73; NIKLASSON BS, 1984, ACTA PATH MICRO IM C, V92, P197; Peters C. J., 1981, Rift Valley fever. Proceedings of a Workshop on Rift Valley fever, Herzlia, Israel, March 18-21, 1980., P21; PETERS CJ, 1986, ANTIVIR RES, V6, P285, DOI 10.1016/0166-3542(86)90024-0; PETERS CJ, 1988, ARCH VIROL, V99, P31, DOI 10.1007/BF01311021; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; SALUZZO JF, 1990, VACCINE, V8, P369, DOI 10.1016/0264-410X(90)90096-5; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; SCHMALJOHN CS, 1989, VIROLOGY, V170, P184, DOI 10.1016/0042-6822(89)90365-6; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Sironen T, 2008, J GEN VIROL, V89, P1309, DOI 10.1099/vir.0.83662-0; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Vialat P, 2000, J VIROL, V74, P1538, DOI 10.1128/JVI.74.3.1538-1543.2000; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wang EY, 2003, J VIROL, V77, P1204, DOI 10.1128/JVI.77.2.1204-1210.2003; WON A, 2007, J VIROL IN PRESS, V81; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06	47	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9986	10.1371/journal.pone.0009986	http://dx.doi.org/10.1371/journal.pone.0009986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376320	Green Published, gold, Green Submitted			2022-12-25	WOS:000276418200056
J	Ye, JJ; Huang, CT; Shie, SS; Huang, PY; Su, LH; Chiu, CH; Leu, HS; Chiang, PC				Ye, Jung-Jr; Huang, Ching-Tai; Shie, Shian-Sen; Huang, Po-Yen; Su, Lin-Hui; Chiu, Cheng-Hsun; Leu, Hsieh-Shong; Chiang, Ping-Cherng			Multidrug Resistant Acinetobacter baumannii: Risk Factors for Appearance of Imipenem Resistant Strains on Patients Formerly with Susceptible Strains	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; CARBAPENEM RESISTANCE; ANTIBIOTIC-RESISTANCE; HOSPITAL OUTBREAK; IN-VITRO; ACQUISITION; INFECTIONS; EPIDEMIOLOGY; SULBACTAM	Background: Multidrug resistant Acinetobacter baumannii (MDRAB) is an important nosocomial pathogen usually susceptible to carbapenems; however, growing number of imipenem resistant MDRAB (IR-MDRAB) poses further clinical challenge. The study was designed to identify the risk factors for appearance of IR-MDRAB on patients formerly with imipenem susceptible MDRAB (IS-MDRAB) and the impact on clinical outcomes. Methodology/Principal Findings: A retrospective case control study was carried out for 209 consecutive episodes of IS-MDRAB infection or colonization from August 2001 to March 2005. Forty-nine (23.4%) episodes with succeeding clinical isolates of IR-MDRAB were defined as the cases and 160 (76.6%) with all subsequent clinical isolates of IS-MDRAB were defined as the controls. Quantified antimicrobial selective pressure, "time at risk'', severity of illness, comorbidity, and demographic data were incorporated for multivariate analysis, which revealed imipenem or meropenem as the only significant independent risk factor for the appearance of IR-MDRAB (adjusted OR, 1.18; 95% CI, 1.09 to 1.27). With selected cases and controls matched to exclude exogenous source of IR-MDRAB, multivariate analysis still identified carbapenem as the only independent risk factor (adjusted OR, 1.48; 95% CI, 1.14 to 1.92). Case patients had a higher crude mortality rate compared to control patients (57.1% vs. 31.3%, p = 0.001), and the mortality of case patients was associated with shorter duration of "time at risk'', i.e., faster appearance of IR-MDRAB (adjusted OR, 0.9; 95% CI, 0.83 to 0.98). Conclusions/Significance: Judicious use of carbapenem with deployment of antibiotics stewardship measures is critical for reducing IR-MDRAB and the associated unfavorable outcome.	[Ye, Jung-Jr; Huang, Ching-Tai; Shie, Shian-Sen; Huang, Po-Yen; Leu, Hsieh-Shong; Chiang, Ping-Cherng] Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan; [Su, Lin-Hui] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Pathol, Div Clin Pathol, Tao Yuan, Taiwan; [Chiu, Cheng-Hsun] Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Ye, JJ (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan.	chingtaihuang@gmail.com	Chuang, shengHao/C-8217-2012					Abbo A, 2005, EMERG INFECT DIS, V11, P22, DOI 10.3201/eid1101.040001; Afzal-Shah M, 1998, J ANTIMICROB CHEMOTH, V41, P576, DOI 10.1093/jac/41.5.576; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Cisneros JM, 2005, CLIN MICROBIOL INFEC, V11, P874, DOI 10.1111/j.1469-0691.2005.01256.x; *CLSI, 2001, PERF STAND ANT DISK; Corbella X, 2000, J CLIN MICROBIOL, V38, P4086, DOI 10.1128/JCM.38.11.4086-4095.2000; COURCOL RJ, 1989, J ANTIMICROB CHEMOTH, V23, P441, DOI 10.1093/jac/23.3.441; El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; GO ES, 1994, LANCET, V344, P1329, DOI 10.1016/S0140-6736(94)90694-7; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Hsueh PR, 2001, MICROB DRUG RESIST, V7, P373, DOI 10.1089/10766290152773383; Hsueh PR, 2002, EMERG INFECT DIS, V8, P827; Kiffer CRV, 2005, DIAGN MICR INFEC DIS, V52, P317, DOI 10.1016/j.diagmicrobio.2005.03.003; Kim YA, 2008, SCAND J INFECT DIS, V40, P234, DOI 10.1080/00365540701633004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Ko WC, 2004, J ANTIMICROB CHEMOTH, V53, P393, DOI 10.1093/jac/dkh080; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Paterson DL, 2002, CLIN INFECT DIS, V34, P1564, DOI 10.1086/340532; Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; SCHRECKENBERGER PC, 2003, MANNUAL CLIN MICROBI; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x	26	46	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9947	10.1371/journal.pone.0009947	http://dx.doi.org/10.1371/journal.pone.0009947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20369056	Green Submitted, gold, Green Published			2022-12-25	WOS:000276418200023
J	Tsuji, T; Du, W; Nishioka, T; Chen, LH; Yamamoto, D; Chen, CY				Tsuji, Takanori; Du, Wei; Nishioka, Takashi; Chen, Lihua; Yamamoto, Daisuke; Chen, Chang Yan			Phellinus Linteus Extract Sensitizes Advanced Prostate Cancer Cells to Apoptosis in Athymic Nude Mice	PLOS ONE			English	Article							PATHWAYS; POLYSACCHARIDES; MUSHROOMS; GROWTH	Phellinus linteus (PL) mushroom possesses anti-tumor property. We previously reported that the treatment with PL caused cultured human prostate cancer cells to undergo apoptosis. To further studying the mechanisms of PL-mediated apoptosis, we performed xenograft assay, together with in vitro assays, to evaluate the effect of PL on the genesis and progression of the tumors formed from the inoculation of prostate cancer PC3 or DU145 cells. After the inoculation, nude mice were injected with PL every two days for 12 days. Although PL treatment did not prevent the formation of the inoculated tumors, the growth rate of the tumors after PL treatment was dramatically attenuated. We then tested the effect of PL on the tumors 12 days after the inoculation. After inoculated tumors reached a certain size, PL was administrated to the mice by subcutaneous injection. The histochemistry or immunochemistry analysis showed that apoptosis occurred with the activation of caspase 3 in the tumors formed by inoculating prostate cancer DU145 or PC3 cells. The data was in a good agreement with that from cultured cells. Thus, our in vivo study suggests that PL not only is able to attenuate tumor growth, but also to cause tumor regression by inducing apoptosis.	[Tsuji, Takanori; Du, Wei; Nishioka, Takashi; Chen, Lihua; Yamamoto, Daisuke; Chen, Chang Yan] Harvard Univ, Sch Med, Dept Radiat Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsuji, T (corresponding author), Harvard Univ, Sch Med, Dept Radiat Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	cchen6@bidmc.harvard.edu		Nishioka, Takashi/0000-0002-1144-3881	JCRT Foundation	JCRT Foundation	This work is supported by funding from JCRT Foundation to CYC. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers AT, 1999, P SOC EXP BIOL MED, V221, P281, DOI 10.1046/j.1525-1373.1999.d01-86.x; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; CHIHARA G, 1969, Nature (London), V222, P687; Collins L, 2006, BRIT J CANCER, V95, P282, DOI 10.1038/sj.bjc.6603277; Guo JJ, 2007, MOL CARCINOGEN, V46, P144, DOI 10.1002/mc.20275; Han SB, 1999, IMMUNOPHARMACOLOGY, V41, P157, DOI 10.1016/S0162-3109(98)00063-0; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Song KS, 1995, CHEM PHARM BULL, V43, P2105, DOI 10.1248/cpb.43.2105; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Zhu T, 2007, BRIT J CANCER, V96, P583, DOI 10.1038/sj.bjc.6603595	16	20	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9885	10.1371/journal.pone.0009885	http://dx.doi.org/10.1371/journal.pone.0009885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360989	gold, Green Published, Green Submitted			2022-12-25	WOS:000276163200004
J	Zhou, X; Sumazin, P; Rajbhandari, P; Califano, A				Zhou, Xiang; Sumazin, Pavel; Rajbhandari, Presha; Califano, Andrea			A Systems Biology Approach to Transcription Factor Binding Site Prediction	PLOS ONE			English	Article							EXPECTATION MAXIMIZATION; REGULATORY ELEMENTS; GENE-EXPRESSION; HUMAN GENOME; B-CELLS; DISCOVERY; IDENTIFICATION; VERTEBRATE; SEQUENCE; MOTIFS	Background: The elucidation of mammalian transcriptional regulatory networks holds great promise for both basic and translational research and remains one the greatest challenges to systems biology. Recent reverse engineering methods deduce regulatory interactions from large-scale mRNA expression profiles and cross-species conserved regulatory regions in DNA. Technical challenges faced by these methods include distinguishing between direct and indirect interactions, associating transcription regulators with predicted transcription factor binding sites (TFBSs), identifying non-linearly conserved binding sites across species, and providing realistic accuracy estimates. Methodology/Principal Findings: We address these challenges by closely integrating proven methods for regulatory network reverse engineering from mRNA expression data, linearly and non-linearly conserved regulatory region discovery, and TFBS evaluation and discovery. Using an extensive test set of high-likelihood interactions, which we collected in order to provide realistic prediction-accuracy estimates, we show that a careful integration of these methods leads to significant improvements in prediction accuracy. To verify our methods, we biochemically validated TFBS predictions made for both transcription factors (TFs) and co-factors; we validated binding site predictions made using a known E2F1 DNA-binding motif on E2F1 predicted promoter targets, known E2F1 and JUND motifs on JUND predicted promoter targets, and a de novo discovered motif for BCL6 on BCL6 predicted promoter targets. Finally, to demonstrate accuracy of prediction using an external dataset, we showed that sites matching predicted motifs for ZNF263 are significantly enriched in recent ZNF263 ChIP-seq data. Conclusions/Significance: Using an integrative framework, we were able to address technical challenges faced by state of the art network reverse engineering methods, leading to significant improvement in direct-interaction detection and TFBS-discovery accuracy. We estimated the accuracy of our framework on a human B-cell specific test set, which may help guide future methodological development.	[Zhou, Xiang; Califano, Andrea] Columbia Univ, Dept Biomed Informat DBMI, New York, NY 10027 USA; [Sumazin, Pavel; Rajbhandari, Presha; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, New York, NY USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Zhou, X (corresponding author), Columbia Univ, Dept Biomed Informat DBMI, New York, NY 10027 USA.	califano@c2b2.columbia.edu	Califano, Andrea/F-7239-2012; Sumazin, Pavel/AAE-6607-2020	Sumazin, Pavel/0000-0002-1215-4977; Califano, Andrea/0000-0003-4742-3679	National Center: Multi-Scale Study - Cellular Networks [U54-CA121852-05]; National Centers for Biomedical Computing NIH Roadmap; Multi-Scale Study - Cellular Networks [U54-CA121852-05]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER	National Center: Multi-Scale Study - Cellular Networks; National Centers for Biomedical Computing NIH Roadmap; Multi-Scale Study - Cellular Networks; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Center: Multi-Scale Study - Cellular Networks (RMI) grant (U54-CA121852-05) from the National Centers for Biomedical Computing NIH Roadmap initiative. XZ is supported by Multi-Scale Study - Cellular Networks (RMI) grant (U54-CA121852-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aach J, 2000, GENOME RES, V10, P431, DOI 10.1101/gr.10.4.431; BAILEY TL, 1993, MACH LEARN, V21, P51; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Blanchette M, 2001, Bioinformatics, V17 Suppl 1, pS30; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Brazma A, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P34; Califano A, 2000, BIOINFORMATICS, V16, P341, DOI 10.1093/bioinformatics/16.4.341; CARRO M, 2009, NATURE; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; KAWAMATA N, 1994, BIOCHEM BIOPH RES CO, V204, P366, DOI 10.1006/bbrc.1994.2468; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; SADLER JR, 1983, NUCLEIC ACIDS RES, V11, P2221, DOI 10.1093/nar/11.7.2221; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100114; Smith DR, 2005, WORD IMAGE, V21, P1, DOI 10.1080/0266628052000307175; Sosinsky A, 2007, P NATL ACAD SCI USA, V104, P6305, DOI 10.1073/pnas.0701614104; Sumazin P, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bth471; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; XIE D, 2008, GENOME RES; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; YOSEPH B, 2001, P 1 INT WORKSH ALG B; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu Z, 2002, J MOL BIOL, V318, P71, DOI 10.1016/S0022-2836(02)00026-8	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9878	10.1371/journal.pone.0009878	http://dx.doi.org/10.1371/journal.pone.0009878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360861	Green Submitted, gold, Green Published			2022-12-25	WOS:000275969600003
J	Mathew, R; Jia, WW; Sharma, A; Zhao, YJ; Clarke, LE; Cheng, XA; Wang, HY; Salli, U; Vrana, KE; Robertson, GP; Zhu, JY; Wang, SW				Mathew, Renjith; Jia, Wenwen; Sharma, Arati; Zhao, Yuanjun; Clarke, Loren E.; Cheng, Xiang; Wang, Huayan; Salli, Ugur; Vrana, Kent E.; Robertson, Gavin P.; Zhu, Jiyue; Wang, Shuwen			Robust activation of the human but not mouse telomerase gene during the induction of pluripotency	FASEB JOURNAL			English	Article						pluripotent stem cells; reprogramming; promoter	REVERSE-TRANSCRIPTASE; STEM-CELLS; LIFE-SPAN; CATALYTIC SUBUNIT; HTERT GENE; HUMAN FIBROBLASTS; DNA METHYLATION; EXPRESSION; PROTEIN; LENGTH	Pluripotent stem cells (PSCs) express telomerase and have unlimited proliferative potential. To study telomerase activation during reprogramming, 3 classes of embryonic stem cell (ESC)-like clones were isolated from mouse fibroblasts containing a transgenic hTERT reporter. Class I expressed few pluripotency markers, whereas class II contained many, but not Oct4, Nanog, and Sox2. Neither class of cells differentiated efficiently. Class III cells, the fully reprogrammed induced PSCs (iPSCs), expressed all pluripotency markers, formed teratomas indistinguishable from those of mESCs, and underwent efficient osteogenic differentiation in vitro. Interestingly, whereas the endogenous mTERT gene expression was only moderately increased during reprogramming, the hTERT promoter was strongly activated in class II cells and was further elevated in class III cells. Treatment of class II cells with chemical inhibitors of MEKs and glycogen synthase kinase 3 resulted in their further reprogramming into class III cells, accompanied by a strong activation of hTERT promoter. In reprogrammed human cells, the endogenous telomerase level, although variable among different clones, was dramatically elevated. Only in cells with the highest telomerase were telomeres restored to the lengths in hESCs. Our data, for the first time, demonstrated that the hTERT promoter was strongly activated in discrete steps, revealing a critical difference in human and mouse cell reprogramming. Because telomere elongation is crucial for self-renewal of hPSCs and replicative aging of their differentiated progeny, these findings have important implications in the generation and applications of iPSCs.-Mathew, R., Jia, W., Sharma, A., Zhao, Y., Clarke, L. E., Cheng, X., Wang, H., Salli, U., Vrana, K. E., Robertson, G. P., Zhu, J., Wang, S. Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J. 24, 2702-2715 (2010). www.fasebj.org	[Mathew, Renjith; Jia, Wenwen; Zhao, Yuanjun; Wang, Huayan; Zhu, Jiyue; Wang, Shuwen] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA; [Sharma, Arati; Salli, Ugur; Vrana, Kent E.; Robertson, Gavin P.] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Clarke, Loren E.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Jia, Wenwen; Cheng, Xiang] NW Univ Agr & Forestry, Anim Med Coll, Natl Stem Cell Engn & Technol Ctr, Shaanxi Branch, Yangling, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwest A&F University - China	Wang, SW (corresponding author), 500 Univ Dr,C4605, Hershey, PA 17033 USA.	sqw10@psu.edu	Mathew, Renjith/N-4285-2013; zhu, ji/HDM-1538-2022; cheng, xiang/C-9987-2016; Robertson, Gavin P./A-6106-2017	Vrana, Kent/0000-0003-4902-7733; cheng, xiang/0000-0001-5315-9830; Robertson, Gavin P./0000-0003-0152-2997; sharma, arati/0000-0001-7178-949X	National Institutes of Health (NIH) [GM071725-S1, R03 CA142060-01, CA-127892-01A, GM38931-S1]; Penn State Cancer Institute Experimental Therapeutic research initiative; Dean's feasibility; Chinese National Natural Science Foundation [30871786]; Chinese National Programs for Fundamental Research and Development (973 plan) [2009CB941002]; NATIONAL CANCER INSTITUTE [R01CA127892, R03CA142060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071725, R01GM038931] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State Cancer Institute Experimental Therapeutic research initiative; Dean's feasibility; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese National Programs for Fundamental Research and Development (973 plan)(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. James Thomson (University of Wisconsin, Madison, WI, USA) for the generous gift of hiPSC clones. The authors are also grateful to the Carrel Laboratory at Penn State College of Medicine for their technical help with pyrosequencing. The work was supported in part by National Institutes of Health (NIH) grant GM071725-S1 (J.Z.), a Penn State Cancer Institute Experimental Therapeutic research initiative (J.Z.), and a Dean's feasibility grant (S.W.). J.Z. was a research scholar of the American Cancer Society (RSG-04-197-01-MGO). A.S., G.P.R., and K.E.V. were supported by NIH grants R03 CA142060-01, CA-127892-01A, and GM38931-S1, respectively. H.W. was supported by grants from the Chinese National Natural Science Foundation (30871786) and the Chinese National Programs for Fundamental Research and Development (973 plan, 2009CB941002).	Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Armanios M, 2005, COLD SH Q B, V70, P205, DOI 10.1101/sqb.2005.70.030; Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; Bekaert S, 2004, DEV BIOL, V274, P15, DOI 10.1016/j.ydbio.2004.06.023; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blackburn EH, 2000, COLD SPRING HARB SYM, V65, P253, DOI 10.1101/sqb.2000.65.253; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; CHADENEAU C, 1995, ONCOGENE, V11, P893; Clark AJ, 2003, NAT CELL BIOL, V5, P535, DOI 10.1038/ncb992; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Dessain SK, 2000, CANCER RES, V60, P537; Devereux TR, 1999, CANCER RES, V59, P6087; Forsyth NR, 2005, MECH AGEING DEV, V126, P685, DOI 10.1016/j.mad.2005.01.003; Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Greider CW, 1999, TRENDS GENET, V15, P109, DOI 10.1016/S0168-9525(98)01681-3; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Gunes C, 2000, CANCER RES, V60, P2116; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herzig M, 2002, BBA-REV CANCER, V1602, P97, DOI 10.1016/S0304-419X(02)00039-2; Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kozik A, 1998, MOL REPROD DEV, V51, P98, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;98::AID-MRD12&gt;3.0.CO;2-Q; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu KB, 2001, J IMMUNOL, V166, P4826, DOI 10.4049/jimmunol.166.8.4826; Liu L, 2004, GENE CHROMOSOME CANC, V41, P26, DOI 10.1002/gcc.20058; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ulaner GA, 1998, CANCER RES, V58, P4168; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wang SW, 2004, J BIOL CHEM, V279, P55401, DOI 10.1074/jbc.M411352200; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Wright WE, 1996, DEV GENET, V18, P173; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao YJ, 2009, GENE CHROMOSOME CANC, V48, P963, DOI 10.1002/gcc.20698; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	72	37	41	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2702	2715		10.1096/fj.09-148973	http://dx.doi.org/10.1096/fj.09-148973			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354136	Green Published			2022-12-25	WOS:000285005400012
J	Okada, H; Zhang, WZ; Peterhoff, C; Hwang, JC; Nixon, RA; Ryu, SH; Kim, TW				Okada, Hirokazu; Zhang, Wenzhu; Peterhoff, Corrinne; Hwang, Jeremy C.; Nixon, Ralph A.; Ryu, Sung H.; Kim, Tae-Wan			Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing	FASEB JOURNAL			English	Article						protein trafficking; Alzheimer's disease; endosome; trans-Golgi network; retromer	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE PATHOGENESIS; TRANS-GOLGI NETWORK; GGA PROTEINS; CLEAVING ENZYME; CYTOSOLIC DOMAIN; VHS DOMAIN; TRAFFICKING; RETROMER	The beta-site APP cleaving enzyme-1 (BACE1) mediates the first cleavage of the beta-amyloid precursor protein (APP) to yield the amyloid beta-peptide (A beta), a key pathogenic agent in Alzheimer's disease (AD). Using a proteomic approach based on in-cell chemical cross-linking and tandem affinity purification (TAP), we herein identify sorting nexin 6 (SNX6) as a BACE1-associated protein. SNX6, a PX domain protein, is a putative component of retromer, a multiprotein cargo complex that mediates the retrograde trafficking of the cation-independent mannose-6-phosphate receptor (CI-MPR) and sortilin. RNA interference suppression of SNX6 increased BACE1-dependent secretion of soluble APP (sAPP beta) and cell-associated fragments (C99), resulting in increased A beta secretion. Furthermore, SNX6 reduction led to elevated steady-state BACE1 levels as well as increased retrograde transport of BACE1 in the endocytic pathway, suggesting that SNX6 modulates the retrograde trafficking and basal levels of BACE1, thereby regulating BACE1-mediated APP processing and A beta biogenesis. Our study identifies a novel cellular pathway by which SNX6 negatively modulates BACE1-mediated cleavage of APP.-Okada, H., Zhang, W., Peterhoff, C., Hwang, J. C., Nixon, R. A., Ryu, S. H., Kim, T.-W. Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing. FASEB J. 24, 2783-2794 (2010). www.fasebj.org	[Zhang, Wenzhu; Kim, Tae-Wan] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Okada, Hirokazu; Hwang, Jeremy C.; Kim, Tae-Wan] Columbia Univ, Med Ctr, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; [Kim, Tae-Wan] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Peterhoff, Corrinne; Nixon, Ralph A.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Ryu, Sung H.] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea; [Ryu, Sung H.] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea	Columbia University; Columbia University; Columbia University; Nathan Kline Institute for Psychiatric Research; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, TW (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, 630 W 168th St,P&S 12-430, New York, NY 10032 USA.	twk16@columbia.edu		Okada, Hirokazu/0000-0002-1065-2470; Ryu, Sung Ho/0000-0003-0913-3048	U.S. National Institutes of Health [AG-09702]; American Health Assistance Foundation	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation)	This study was supported by an Alzheimer's Disease Research Center grant from the U.S. National Institutes of Health (AG-09702) and by the American Health Assistance Foundation to T.-W.K. The authors thank G. Finan for critical reading of the manuscript, I.S. Kim for technical assistance with molecular biology, and A. Zenobia Moore for assistance with cell culture.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Huse JT, 2001, TRAFFIC, V2, P75, DOI 10.1034/j.1600-0854.2001.020201.x; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee EB, 2003, J BIOL CHEM, V278, P4458, DOI 10.1074/jbc.M210105200; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	48	77	86	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2783	2794		10.1096/fj.09-146357	http://dx.doi.org/10.1096/fj.09-146357			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354142	Green Published			2022-12-25	WOS:000285005400019
J	Harper, MT; Poole, AW				Harper, Matthew T.; Poole, Alastair W.			Protein Kinase C theta Negatively Regulates Store-independent Ca2+ Entry and Phosphatidylserine Exposure Downstream of Glycoprotein VI in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CURRENTS; THROMBUS FORMATION; CALCIUM-ENTRY; IN-VIVO; INFARCT VOLUME; PKC-THETA; KEY ROLE; CHANNEL; ACTIVATION; MEMBRANE	Platelet activation must be tightly controlled to provide an effective, but not excessive, response to vascular injury. Cytosolic calcium is a critical regulator of platelet function, including granule secretion, integrin activation, and phosphatidylserine (PS) exposure. Here we report that the novel protein kinase C isoform, PKC theta, plays an important role in negatively regulating Ca2+ signaling downstream of the major collagen receptor, glycoprotein VI (GPVI). This limits PS exposure and so may prevent excessive platelet procoagulant activity. Stimulation of GPVI resulted in significantly higher and more sustained Ca2+ signals in PKC theta(-/-) platelets. PKC theta acts at multiple distinct sites. PKC theta limits secretion, reducing autocrine ADP signaling that enhances Ca2+ release from intracellular Ca2+ stores. PKC theta thereby indirectly regulates activation of store-operated Ca2+ entry. However, PKC theta also directly and negatively regulates store-independent Ca2+ entry. This pathway, activated by the diacylglycerol analogue, 1-oleoyl-2-acetyl-sn-glycerol, was enhanced in PKC theta(-/-) platelets, independently of ADP secretion. Moreover, LOE-908, which blocks 1-oleoyl-2-acetyl-sn-glycerol-induced Ca2+ entry but not store-operated Ca2+ entry, blocked the enhanced GPVI-dependent Ca2+ signaling and PS exposure seen in PKC theta(-/-) platelets. We propose that PKC theta normally acts to restrict store-independent Ca2+ entry during GPVI signaling, which results in reduced PS exposure, limiting platelet procoagulant activity during thrombus formation.	[Harper, Matthew T.; Poole, Alastair W.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Univ Walk, Bristol BS8 1TD, Avon, England.	a.poole@bris.ac.uk	Harper, Matthew T/G-5630-2013	Harper, Matthew T/0000-0002-4740-637X; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [RG/05/015]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation Programme Grant RG/05/015.	Arachiche A, 2009, ARTERIOSCL THROM VAS, V29, P1883, DOI 10.1161/ATVBAHA.109.190926; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Carter RN, 2006, J PHYSIOL-LONDON, V576, P151, DOI 10.1113/jphysiol.2006.113886; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Christensen T, 2005, BASIC CLIN PHARMACOL, V96, P316, DOI 10.1111/j.1742-7843.2005.pto960407.x; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003277; Harper AGS, 2009, CELL CALCIUM, V45, P413, DOI 10.1016/j.ceca.2009.02.003; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Harper MT, 2009, BLOOD, V114, P489, DOI 10.1182/blood-2009-03-208454; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; KRAUTWURST D, 1993, MOL PHARMACOL, V43, P655; KRAUTWURST D, 1994, N-S ARCH PHARMACOL, V349, P301; Kuijpers MJE, 2008, MICROCIRCULATION, V15, P269, DOI 10.1080/10739680701653517; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liu DY, 2008, ARTERIOSCL THROM VAS, V28, P746, DOI 10.1161/ATVBAHA.108.162222; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; SAGE SO, 1989, BIOCHEM J, V258, P923, DOI 10.1042/bj2580923; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; SMEETS EF, 1993, THROMB HAEMOSTASIS, V70, P1024; Solum NO, 1999, ARTERIOSCL THROM VAS, V19, P2841, DOI 10.1161/01.ATV.19.12.2841; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Tatlisumak T, 2000, J NEUROL SCI, V178, P107, DOI 10.1016/S0022-510X(00)00380-4; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Vorndran C, 1995, BIOPHYS J, V69, P2112, DOI 10.1016/S0006-3495(95)80082-2; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	40	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19865	19873		10.1074/jbc.M109.085654	http://dx.doi.org/10.1074/jbc.M109.085654			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20388711	Green Published, hybrid			2022-12-25	WOS:000279012000019
J	Jones, KL; Roche, M; Gantier, MP; Begum, NA; Honjo, T; Caradonna, S; Williams, BRG; Mak, J				Jones, Kate L.; Roche, Michael; Gantier, Michael P.; Begum, Nasim A.; Honjo, Tasuku; Caradonna, Salvatore; Williams, Bryan R. G.; Mak, Johnson			X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; REPAIR ENZYME; IN-VIVO; REVERSE TRANSCRIPTION; MITOCHONDRIAL FORMS; CYCLE REGULATION; VIRAL PARTICLES; MUTATION-RATE; ABASIC SITES	It has been assumed that R5 and X4 HIV utilize similar strategies to support viral cDNA synthesis post viral entry. In this study, we provide evidence to show that R5 and X4 HIV have distinct requirements for host cell uracil DNA glycosylase (UNG2) during the early stage of infection. UNG2 has been previously implicated in HIV infection, but its precise role remains controversial. In this study we show that, although UNG2 is highly expressed in different cell lines, UNG2 levels are low in the natural host cells of HIV. Short interfering RNA knockdown of endogenous UNG2 in primary cells showed that UNG2 is required for R5 but not X4 HIV infection and that this requirement is bypassed when HIV enters the target cell via vesicular stomatitis virus envelope-glycoprotein-mediated endocytosis. We also show that short interfering RNA knockdown of UNG2 in virus-producing primary cells leads to defective R5 HIV virions that are unable to complete viral cDNA synthesis. Quantitative PCR analysis revealed that endogenous UNG2 levels are transiently up-regulated post HIV infection, and this increase in UNG2 mRNA is similar to 10-20 times higher in R5 versus X4 HIV-infected cells. Our data show that both virion-associated UNG2 and HIV infection-induced UNG2 expression are critical for reverse transcription during R5 but not X4 HIV infection. More importantly, we have made the novel observation that R5 and X4 HIV have distinct host cell factor requirements and differential capacities to induce gene expression during the early stages of infection. These differences may result from activation of distinct signaling cascades and/or infection of divergent T-lymphocyte subpopulations.	[Jones, Kate L.; Roche, Michael; Mak, Johnson] Burnet Inst, Ctr Virol, Melbourne, Vic 3004, Australia; [Jones, Kate L.; Mak, Johnson] Monash Univ, Dept Biochem, Clayton, Vic 3168, Australia; [Roche, Michael; Mak, Johnson] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Gantier, Michael P.; Williams, Bryan R. G.] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Begum, Nasim A.; Honjo, Tasuku] Kyoto Univ, Dept Med Chem, Kyoto 6068501, Japan; [Caradonna, Salvatore] Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA	Burnet Institute; Monash University; Monash University; Monash University; Kyoto University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mak, J (corresponding author), Burnet Inst, Ctr Virol, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	mak@burnet.edu.au	Gantier, Michael/H-7954-2019; mak, johnson/S-2457-2019; Williams, Bryan R. G./A-5021-2009; mak, johnson/H-4605-2014; Gantier, Michael/B-7512-2011; Caradonna, Salvatore/AFU-8514-2022; Honjo, Tasuku/N-4470-2016	Gantier, Michael/0000-0003-3740-698X; mak, johnson/0000-0002-5229-5707; Williams, Bryan R. G./0000-0002-4969-1151; mak, johnson/0000-0002-5229-5707; Gantier, Michael/0000-0003-3740-698X; Caradonna, Salvatore/0000-0002-2104-581X; Begum, Nasim/0000-0001-7177-188X; Roche, Michael/0000-0001-8819-0096				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; APRELIKOVA ON, 1982, FEBS LETT, V137, P193, DOI 10.1016/0014-5793(82)80347-5; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Briant L, 1996, J IMMUNOL, V156, P3994; CARADONNA S, 1987, J VIROL, V61, P3040, DOI 10.1128/JVI.61.10.3040-3047.1987; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Fischer JA, 2006, CANCER RES, V66, P8829, DOI 10.1158/0008-5472.CAN-06-0540; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Haug T, 1998, NUCLEIC ACIDS RES, V26, P1449, DOI 10.1093/nar/26.6.1449; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jones Kate L., 2005, Current Pharmacogenomics, V3, P97, DOI 10.2174/1570160054022962; Jones KL, 2008, NUCLEIC ACIDS RES, V36, P1578, DOI 10.1093/nar/gkm1149; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kariko K, 2004, CELLS TISSUES ORGANS, V177, P132, DOI 10.1159/000079987; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; LERNER DL, 1995, P NATL ACAD SCI USA, V92, P7480, DOI 10.1073/pnas.92.16.7480; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; McGeehan JE, 2001, CURR PROTEIN PEPT SC, V2, P325, DOI 10.2174/1389203013380964; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; NAGELHUS TA, 1995, EXP CELL RES, V220, P292, DOI 10.1006/excr.1995.1318; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Payne SL, 2001, CURR PROTEIN PEPT SC, V2, P381, DOI 10.2174/1389203013381008; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; Priet S, 2003, VIROLOGY, V307, P283, DOI 10.1016/S0042-6822(02)00073-9; PU WT, 1992, NUCLEIC ACIDS RES, V20, P771, DOI 10.1093/nar/20.4.771; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; SchmidAntomarchi H, 1996, EUR J IMMUNOL, V26, P717, DOI 10.1002/eji.1830260331; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; SLUPPHAUG G, 1991, NUCLEIC ACIDS RES, V19, P5131, DOI 10.1093/nar/19.19.5131; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Studebaker AW, 2001, CURR PROTEIN PEPT SC, V2, P371, DOI 10.2174/1389203013380946; Turelli P, 1997, J VIROL, V71, P4522, DOI 10.1128/JVI.71.6.4522-4530.1997; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; van Rij RP, 2000, J CLIN INVEST, V106, P1569, DOI 10.1172/JCI7953C1; Verani Alessia, 2002, Current Molecular Medicine (Hilversum), V2, P691, DOI 10.2174/1566524023361862; VILPO JA, 1988, MUTAT RES, V193, P207, DOI 10.1016/0167-8817(88)90031-4; Willetts KE, 1999, J VIROL, V73, P1682, DOI 10.1128/JVI.73.2.1682-1688.1999; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zaitseva M, 2003, BBA-BIOMEMBRANES, V1614, P51, DOI 10.1016/S0005-2736(03)00162-7	79	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18603	18614		10.1074/jbc.M109.090126	http://dx.doi.org/10.1074/jbc.M109.090126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20371602	Green Published, hybrid			2022-12-25	WOS:000278453900054
J	Liu, N; Li, H; Li, SX; Shen, MY; Xiao, N; Chen, YF; Wang, Y; Wang, WC; Wang, R; Wang, QA; Sun, JH; Wang, P				Liu, Ning; Li, Hui; Li, Shuangxi; Shen, Mingyue; Xiao, Ning; Chen, Yunfei; Wang, Yan; Wang, Weichao; Wang, Rui; Wang, Qian; Sun, Jianhua; Wang, Ping			The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; PHOSPHORYLATION-DEPENDENT DEGRADATION; C-MYC; TRANSCRIPTION FACTORS; MEDIATED PROTEOLYSIS; CELL-PROLIFERATION; EPITHELIAL-CELLS; LIPID-METABOLISM; PROSTATE-CANCER; BREAST-CANCER	The proproliferative transcription factor KLF5 plays an important role in promoting cell proliferation and tumorigenesis. KLF5 is a short-lived protein that can be rapidly degraded through the ubiquitin-proteasome pathway in cancer cells. However, the mechanisms regulating protein stability remain poorly understood. In this study, the tumor suppressor Fbw7, a component of the SCF complex (SCFFbw7) E3 ubiquitin ligase, specifically promoted the degradation and ubiquitination of KLF5 but had little effect on the stability of KLF4. Fbw7 interacted with KLF5 in a CDC4 phosphodegron (CPD)-dependent manner. Three CPDs were found in the KLF5 protein. Simultaneous mutation of these CPDs significantly abolished Fbw7-mediated ubiquitination and degradation. Furthermore, Fbw7 deficiency dramatically delayed KLF5 turnover and led to the accumulation of KLF5 protein in cancer cells. Glycogen synthase kinase-3 beta could phosphorylate and promote Fbw7-mediated KLF5 degradation. More importantly, Fbw7 negatively regulated the biological activity of KLF5 in gene regulation and cell proliferation. Taken together, these data indicate that Fbw7 is a key negative regulator controlling KLF5-mediated cell proliferation and suggest an additional mechanism linking the loss of Fbw7 function to tumorigenesis.	[Wang, Ping] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	East China Normal University; East China Normal University	Wang, P (corresponding author), E China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	pwang@bio.ecnu.edu.cn		Liu, Ning/0000-0002-7009-9187	Research Platform of Cell Signaling Networks of the Science and Technology Commission of Shanghai Municipality [06DZ22923]; National Natural Science Foundation of China [30800587, 30971521]; National Basic Research Program of China [2010CB529704]	Research Platform of Cell Signaling Networks of the Science and Technology Commission of Shanghai Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by Grant 06DZ22923 from the Research Platform of Cell Signaling Networks of the Science and Technology Commission of Shanghai Municipality, Grants 30800587 and 30971521 from the National Natural Science Foundation of China, and 973 Program Grant 2010CB529704 from the National Basic Research Program of China.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bialkowska AB, 2009, MOL CANCER THER, V8, P563, DOI 10.1158/1535-7163.MCT-08-0767; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2009, INT J CANCER, V124, P2829, DOI 10.1002/ijc.24266; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; McConnell BB, 2008, GASTROENTEROLOGY, V134, P1007, DOI 10.1053/j.gastro.2008.01.013; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rajagopalan H, 2004, CELL CYCLE, V3, P693; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Usui S, 2004, J BIOL CHEM, V279, P12300, DOI 10.1074/jbc.M305025200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200; Ziemer LT, 2001, MOL CELL BIOL, V21, P562, DOI 10.1128/MCB.21.2.562-574.2001	53	91	96	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18858	18867		10.1074/jbc.M109.099440	http://dx.doi.org/10.1074/jbc.M109.099440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388706	hybrid, Green Published			2022-12-25	WOS:000278453900076
J	Kim, EM; Shin, EJ; Choi, JH; Son, HJ; Park, IS; Joh, TH; Hwang, O				Kim, Eun-Mee; Shin, Eun-Jung; Choi, Ji Hyun; Son, Hyo Jin; Park, Il-Seon; Joh, Tong H.; Hwang, Onyou			Matrix Metalloproteinase-3 Is Increased and Participates in Neuronal Apoptotic Signaling Downstream of Caspase-12 during Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; CELL-DEATH; PARKINSONS-DISEASE; INTRINSIC PATHWAY; TUMOR PROGRESSION; OXIDATIVE STRESS; NERVOUS-SYSTEM; ACTIVATION; STROMELYSIN; TIMP-1	Although endoplasmic reticulum (ER) stress-induced apoptosis has been associated with pathogenesis of neurodegenerative diseases, the cellular components involved have not been well delineated. The present study shows that matrix metalloproteinase (MMP)-3 plays a role in the ER stress-induced apoptosis. ER stress induced by brefeldin A (BFA) or tunicamycin (TM) increases gene expression of MMP-3, selectively among various MMP subtypes, and the active form of MMP-3 (actMMP-3) in the brain-derived CATH. a cells. Pharmacological inhibition of enzyme activity, small interference RNA-mediated gene knockdown, and gene knock-out of MMP-3 all provide protection against ER stress. MMP-3 acts downstream of caspase-12, because both pharmacological inhibition and gene knockdown of caspase-12 attenuate the actMMP-3 increase, but inhibition and knock-out of MMP-3 do not alter caspase-12. Furthermore, independently of the increase in the protein level, the catalytic activity of MMP-3 enzyme can be increased via lowering of its endogenous inhibitor protein TIMP-1. Caspase-12 causes liberation of MMP-3 enzyme activity by degrading TIMP-1 that is already bound to actMMP-3. TIMP-1 is decreased in response to ER stress, and TIMP-1 overexpression leads to cell protection and a decrease in MMP-3 activity. Taken together, actMMP-3 protein level and catalytic activity are increased following caspase-12 activation during ER stress, and this in turn plays a role in the downstream apoptotic signaling in neuronal cells. MMP-3 and TIMP-1 may therefore serve as cellular targets for therapy against neurodegenerative diseases.	[Kim, Eun-Mee; Shin, Eun-Jung; Choi, Ji Hyun; Son, Hyo Jin; Hwang, Onyou] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea; [Hwang, Onyou] Asan Inst Life Sci, Ctr Brain Res, Seoul 138736, South Korea; [Park, Il-Seon] Chosun Univ, Res Ctr Proteineous Mat, Kwangju 501759, South Korea; [Park, Il-Seon] Chosun Univ, Dept Biomat Engn, Kwangju 501759, South Korea; [Joh, Tong H.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	University of Ulsan; Chosun University; Chosun University; Cornell University	Hwang, O (corresponding author), Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, 388-1 Pungnap Dong, Seoul 138736, South Korea.	oyhwang@amc.seoul.kr			Ministry of Education, Science, and Technology, Republic of Korea [2009K001251]	Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Brain Research Center 21st Century Frontier Research Program of the Ministry of Education, Science, and Technology, Republic of Korea Grant 2009K001251 (to O.H.).	Aoki T, 2007, STROKE, V38, P2337, DOI 10.1161/STROKEAHA.107.481838; Arboleda G, 2005, J MOL NEUROSCI, V27, P65, DOI 10.1385/JMN:27:1:065; Boulday G, 2004, ANN NY ACAD SCI, V1030, P28, DOI 10.1196/annals.1329.004; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; Choi HJ, 2000, MOL PHARMACOL, V58, P633, DOI 10.1124/mol.58.3.633; Choi HJ, 2003, J NEUROCHEM, V86, P143, DOI 10.1046/j.1471-4159.2003.01808.x; Crocker SJ, 2004, J NEUROSCI RES, V75, P1, DOI 10.1002/jnr.10836; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fujita E, 2002, CELL DEATH DIFFER, V9, P1108, DOI 10.1038/sj.cdd.4401080; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; HAMMANI K, 1992, GENE, V120, P321, DOI 10.1016/0378-1119(92)90116-7; Han JM, 2007, J PHARMACOL EXP THER, V321, P249, DOI 10.1124/jpet.106.110866; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hornebeck W, 2005, BIOCHIMIE, V87, P377, DOI 10.1016/j.biochi.2004.09.022; Hwang O, 2001, MOL PHARMACOL, V59, P1249, DOI 10.1124/mol.59.5.1249; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kim YS, 2005, J NEUROSCI, V25, P3701, DOI 10.1523/JNEUROSCI.4346-04.2005; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Mao WK, 2006, AM J PHYSIOL-CELL PH, V290, pC1373, DOI 10.1152/ajpcell.00369.2005; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Mudgett JS, 1998, ARTHRITIS RHEUM-US, V41, P110, DOI 10.1002/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Murphy G, 1995, ACTA ORTHOP SCAND, V66, P55, DOI 10.3109/17453679509157648; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SURI C, 1993, J NEUROSCI, V13, P1280; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Tan HK, 2003, MOL CELL NEUROSCI, V22, P98, DOI 10.1016/S1044-7431(02)00024-6; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Thorne M, 2009, J NEUROIMMUNOL, V211, P92, DOI 10.1016/j.jneuroim.2009.04.003; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P553, DOI 10.1089/ars.2006.1524; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	43	55	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16444	16452		10.1074/jbc.M109.093799	http://dx.doi.org/10.1074/jbc.M109.093799			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20368330	Green Published, hybrid			2022-12-25	WOS:000277982600006
J	Dutta, NK; Mehra, S; Kaushal, D				Dutta, Noton K.; Mehra, Smriti; Kaushal, Deepak			A Mycobacterium tuberculosis Sigma Factor Network Responds to Cell-Envelope Damage by the Promising Anti-Mycobacterial Thioridazine	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; ANTITUBERCULAR ACTIVITY; DRUG-RESISTANCE; MUTANT LACKING; MACROPHAGES; PERSISTENCE; REVERSAL; STRESS; VIVO	Background: Novel therapeutics are urgently needed to control tuberculosis (TB). Thioridazine (THZ) is a candidate for the therapy of multidrug and extensively drug-resistant TB. Methodology/Principal Findings: We studied the impact of THZ on Mycobacterium tuberculosis (Mtb) by analyzing gene expression profiles after treatment at the minimal inhibitory (1x MIC) or highly inhibitory (4x MIC) concentrations between 1-6 hours. THZ modulated the expression of genes encoding membrane proteins, efflux pumps, oxido-reductases and enzymes involved in fatty acid metabolism and aerobic respiration. The Rv3160c-Rv3161c operon, a multi-drug transporter and the Rv3614c/3615c/3616c regulon, were highly induced in response to THZ. A significantly high number of Mtb genes co-expressed with sigma(B) (the sigma(B) regulon) was turned on by THZ treatment. sigma(B) has recently been shown to protect Mtb from envelope-damage. We hypothesized that THZ damages the Mtb cell-envelope, turning on the expression of the sigma(B) regulon. Consistent with this hypothesis, we present electron-microscopy data which shows that THZ modulates cell-envelope integrity. Moreover, the Mtb mutants in sigma(H) and sigma(E), two alternate stress response sigma factors that induce the expression of sB, exhibited higher sensitivity to THZ, indicating that the presence and expression of sigma(B) allows Mtb to resist the impact of THZ. Conditional induction of sigma(B) levels increased the survival of Mtb in the presence of THZ. Conclusions/Significance: THZ targets different pathways and can thus be used as a multi-target inhibitor itself as well as provide strategies for multi-target drug development for combination chemotherapy. Our results show that the Mtb sigma factor network comprising of sigma(H), sigma(E) and sigma(B) plays a crucial role in protecting the pathogen against cell-envelope damage.	[Dutta, Noton K.; Mehra, Smriti; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA USA; [Mehra, Smriti; Kaushal, Deepak] Tulane Natl Primate Res Ctr, DNA Microarray & Express Core, Covington, LA USA; [Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Dutta, NK (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA USA.	dkaushal@tulane.edu	Dutta, Noton K./K-5202-2012	Dutta, Noton K./0000-0002-5066-3342	NIH [R21RR026006, P20RR020159, P51RR164]; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Vaccine Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159, R21RR026006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Vaccine Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH (http://www.ncrr.nih.gov/) grants R21RR026006, P20RR020159 and P51RR164, with support from the Tulane Research Enhancement Fund (http://tulane.edu/news/newwave/20-million-fund-supports-research.cfm), Tulane Center for Infectious Diseases (http://tulane.edu/cid/) and the Louisiana Vaccine Center (http://www.louisianavc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L, 2008, CURR DRUG TARGETS, V9, P816, DOI 10.2174/138945008785747798; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Ando M, 2003, INFECT IMMUN, V71, P7170, DOI 10.1128/IAI.71.12.7170-7172.2003; ANDREW MB, 2008, ANTIMICROB AGENTS CH, V52, P3604; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bate AB, 2007, BIOORG MED CHEM LETT, V17, P1346, DOI 10.1016/j.bmcl.2006.11.091; Bishai WR, 1999, INFECT IMMUN, V67, P4931, DOI 10.1128/IAI.67.9.4931-4934.1999; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Dutta NK, 2009, J MED MICROBIOL, V58, P1667, DOI 10.1099/jmm.0.014027-0; Dutta NK, 2007, INT J ANTIMICROB AG, V30, P336, DOI 10.1016/j.ijantimicag.2007.04.016; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Gomez JE, 1997, TUBERCLE LUNG DIS, V78, P175, DOI 10.1016/S0962-8479(97)90024-1; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Haydel SE, 2006, J BACTERIOL, V188, P150, DOI 10.1128/JB.188.1.150-159.2006; Jensen-Cain DM, 2001, MICROB PATHOGENESIS, V30, P271, DOI 10.1006/mpat.2001.0431; JOANNA CB, 2003, ANTIMICROB AGENTS CH, V47, P2903; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; Kristiansen J. E., 1991, ASM News (Washington), V57, P135; Kristiansen JE, 2007, J ANTIMICROB CHEMOTH, V59, P1271, DOI 10.1093/jac/dkm071; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI [10.1128/jb.174.12.3843-3849.1992, :10.1128/jb.174.12.3843-3849.1992, DOI 10.1128/JB.174.12.3843-3849.1992]; Manca C, 1999, J IMMUNOL, V162, P6740; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Manganelli R, 2010, MOL MICROBIOL, V75, P538, DOI 10.1111/j.1365-2958.2009.07009.x; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Martins M, 2007, IN VIVO, V21, P771; Martins M, 2007, INT J ANTIMICROB AG, V29, P338, DOI 10.1016/j.ijantimicag.2006.10.013; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Molnar J, 2006, CURR DRUG TARGETS, V7, P789, DOI 10.2174/138945006777709584; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; PREDICH M, 1995, MOL MICROBIOL, V15, P355, DOI 10.1111/j.1365-2958.1995.tb02249.x; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; RATNAKAR P, 1992, FEMS MICROBIOL LETT, V97, P73; Raviglione MC, 2007, B WORLD HEALTH ORGAN, V85, P327, DOI 10.2471/BLT.06.038513; Reddy MV, 1996, J ANTIMICROB CHEMOTH, V37, P196, DOI 10.1093/jac/37.1.196; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Viveiros M, 2001, INT J ANTIMICROB AG, V17, P225, DOI 10.1016/S0924-8579(00)00343-5; Waddell SJ, 2004, TUBERCULOSIS, V84, P263, DOI 10.1016/j.tube.2003.12.005; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Xie ZF, 2005, ANTIMICROB AGENTS CH, V49, P4778, DOI 10.1128/AAC.49.11.4778-4780.2005; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200; 2008, TUBERCUL EDINB, V88, P164	58	62	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10069	10.1371/journal.pone.0010069	http://dx.doi.org/10.1371/journal.pone.0010069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386700	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482000009
J	Aumakhan, B; Gaydos, CA; Quinn, TC; Beyrer, C; Benning, L; Minkoff, H; Merenstein, DJ; Cohen, M; Greenblatt, R; Nowicki, M; Anastos, K; Gange, SJ				Aumakhan, Bulbulgul; Gaydos, Charlotte A.; Quinn, Thomas C.; Beyrer, Chris; Benning, Lorie; Minkoff, Howard; Merenstein, Daniel J.; Cohen, Mardge; Greenblatt, Ruth; Nowicki, Marek; Anastos, Kathryn; Gange, Stephen J.			Clinical Reactivations of Herpes Simplex Virus Type 2 Infection and Human Immunodeficiency Virus Disease Progression Markers	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; WOMENS INTERAGENCY HIV; GENITAL HERPES; T-LYMPHOCYTES; VIRAL SYNERGY; RNA LEVELS; THERAPY; HSV-2; ACYCLOVIR; RISK	Background: The natural history of HSV-2 infection and role of HSV-2 reactivations in HIV disease progression are unclear. Methods: Clinical symptoms of active HSV-2 infection were used to classify 1,938 HIV/HSV-2 co-infected participants of the Women's Interagency HIV Study (WIHS) into groups of varying degree of HSV-2 clinical activity. Differences in plasma HIV RNA and CD4+ T cell counts between groups were explored longitudinally across three study visits and cross-sectionally at the last study visit. Results: A dose dependent association between markers of HIV disease progression and degree of HSV-2 clinical activity was observed. In multivariate analyses after adjusting for baseline CD4+ T cell levels, active HSV-2 infection with frequent symptomatic reactivations was associated with 21% to 32% increase in the probability of detectable plasma HIV RNA (trend p=0.004), an average of 0.27 to 0.29 log10 copies/ml higher plasma HIV RNA on a continuous scale (trend p<0.001) and 51 to 101 reduced CD4+ T cells/mm(3) over time compared to asymptomatic HSV-2 infection (trend p<0.001). Conclusions: HIV induced CD4+ T cell loss was associated with frequent symptomatic HSV-2 reactivations. However, effect of HSV-2 reactivations on HIV disease progression markers in this population was modest and appears to be dependent on the frequency and severity of reactivations. Further studies will be necessary to determine whether HSV-2 reactivations contribute to acceleration of HIV disease progression.	[Aumakhan, Bulbulgul; Beyrer, Chris; Benning, Lorie; Gange, Stephen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Gaydos, Charlotte A.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Quinn, Thomas C.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Minkoff, Howard] Maimonides Hosp, Brooklyn, NY 11219 USA; [Minkoff, Howard] SUNY Downstate, Brooklyn, NY USA; [Merenstein, Daniel J.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Cohen, Mardge] Cook Cty Med Ctr, Chicago, IL USA; [Greenblatt, Ruth] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA; [Greenblatt, Ruth] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Nowicki, Marek] Univ So Calif, Los Angeles, CA USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Maimonides Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Georgetown University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; Yeshiva University; Albert Einstein College of Medicine	Aumakhan, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	baumakhan@hivresearch.org	Gaydos, Charlotte A./E-9937-2010; Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X	National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources [UL1 RR024131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000358, ZIAAI000361, U01AI034993, U01AI035004, U01AI031834, U01AI034989, U01AI042590, U01AI034994] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript was collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/ Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington, DC Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli N, 2006, AIDS, V20, P1051, DOI 10.1097/01.aids.0000222078.75867.77; ASHLEY R, 1991, ANN INTERN MED, V115, P520, DOI 10.7326/0003-4819-115-7-520; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Ashley RL, 1999, CLIN MICROBIOL REV, V12, P1; Ashley RL, 1998, J CLIN MICROBIOL, V36, P294, DOI 10.1128/JCM.36.1.294-295.1998; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Barbour JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001080; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cheng RG, 2009, LANCET INFECT DIS, V9, P74, DOI 10.1016/S1473-3099(09)70002-7; Chretien F., 1997, Archives d'Anatomie et de Cytologie Pathologiques, V45, P153; Cowan FM, 2008, SEX TRANSM INFECT, V84, P548, DOI 10.1136/sti.2008.031153; Delany-Moretlwe Sinead, 2009, Curr Infect Dis Rep, V11, P135, DOI 10.1007/s11908-009-0020-8; DUNNE EF, 2008, J ACQUIR IMMUNE DEFI; Greenblatt RM, 1999, SEX TRANSM DIS, V26, P143, DOI 10.1097/00007435-199903000-00004; Haanpaa M, 2004, ACTA OBSTET GYN SCAN, V83, P946, DOI 10.1111/j.0001-6349.2004.00500.x; Harandi AM, 2001, J GEN VIROL, V82, P845, DOI 10.1099/0022-1317-82-4-845; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Koelle DM, 2000, J ANTIMICROB CHEMOTH, V45, P1, DOI 10.1093/jac/45.suppl_4.1; LINGAPPA JR, 2010, LANCET; Lisco A, 2009, LANCET INFECT DIS, V9, P522, DOI 10.1016/S1473-3099(09)70209-9; Milligan GN, 1998, J IMMUNOL, V160, P6093; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Posavad CM, 1997, P NATL ACAD SCI USA, V94, P10289, DOI 10.1073/pnas.94.19.10289; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tran THC, 2004, AM J OPHTHALMOL, V137, P872, DOI 10.1016/j.ajo.2003.12.036; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	33	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9973	10.1371/journal.pone.0009973	http://dx.doi.org/10.1371/journal.pone.0009973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376310	Green Submitted, Green Published, gold			2022-12-25	WOS:000276418200046
J	Ju, DH; Wang, XG; Ha, SW; Fu, JJ; Xie, YM				Ju, Donghong; Wang, Xiaogang; Ha, Seung-Wook; Fu, Jiejun; Xie, Youming			Inhibition of Proteasomal Degradation of Rpn4 Impairs Nonhomologous End-Joining Repair of DNA Double-Strand Breaks	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; S-PHASE; ATAXIA-TELANGIECTASIA; TRANSCRIPTION FACTOR; FEEDBACK-CIRCUIT; RNA INTERFERENCE; STRESS-RESPONSE; YEAST; EXPRESSION	Background: The proteasome homeostasis in Saccharomyces cerevisiae is regulated by a negative feedback circuit in which the transcription factor Rpn4 induces the proteasome genes and is rapidly degraded by the assembled proteasome. The integrity of the Rpn4-proteasome feedback loop is critical for cell viability under stressed conditions. We have demonstrated that inhibition of Rpn4 degradation sensitizes cells to DNA damage, particularly in response to high doses of DNA damaging agents. The underlying mechanism, however, remains unclear. Methodology/Principal Findings: Using yeast genetics and biochemical approach we show that inhibition of Rpn4 degradation displays a synthetic growth defect with deletion of the MEC1 checkpoint gene and sensitizes several checkpoint mutants to DNA damage. In addition, inhibition of Rpn4 degradation leads to a defect in repair of double-strand breaks (DSBs) by nonhomologous end-joining (NHEJ). The expression levels of several key NHEJ genes are downregulated and the recruitment of Yku70 to a DSB is reduced by inhibition of Rpn4 degradation. We find that Rpn4 and the proteasome are recruited to a DSB, suggesting their direct participation in NHEJ. Inhibition of Rpn4 degradation may result in a concomitant delay of release of Rpn4 and the proteasome from a DSB. Conclusion/Significance: This study provides the first evidence for the role of proteasomal degradation of Rpn4 in NHEJ.	[Ju, Donghong; Wang, Xiaogang; Ha, Seung-Wook; Fu, Jiejun; Xie, Youming] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA; [Xie, Youming] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Ju, DH (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA.	xiey@karmanos.org			National Science Foundation [MCB-0816974]; Div Of Molecular and Cellular Bioscience [0816974] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grant MCB-0816974 to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CY, 2008, DNA REPAIR, V7, P1531, DOI 10.1016/j.dnarep.2008.05.008; Clikeman JA, 2001, GENETICS, V157, P579; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Foss EJ, 2001, GENETICS, V157, P567; Fujimuro M, 1998, FEBS LETT, V423, P149, DOI 10.1016/S0014-5793(98)00084-2; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Guo N, 2008, YEAST, V25, P631, DOI 10.1002/yea.1614; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hausmann S, 2008, J BIOL CHEM, V283, P31706, DOI 10.1074/jbc.M806127200; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jessulat M, 2008, ARCH BIOCHEM BIOPHYS, V469, P157, DOI 10.1016/j.abb.2007.11.001; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2006, J BIOL CHEM, V281, P10657, DOI 10.1074/jbc.M513790200; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; Ju DD, 2007, BBA-MOL CELL RES, V1773, P1672, DOI 10.1016/j.bbamcr.2007.04.012; Ju DH, 2010, INT J BIOCHEM CELL B, V42, P282, DOI 10.1016/j.biocel.2009.11.003; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Lundgren J, 2003, MOL CELL BIOL, V23, P5320, DOI 10.1128/MCB.23.15.5320-5330.2003; Majka J, 2007, CELL CYCLE, V6, P1157, DOI 10.4161/cc.6.10.4221; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; NELSON MK, 1993, GENETICS, V134, P159; Owsianik G, 2002, MOL MICROBIOL, V43, P1295, DOI 10.1046/j.1365-2958.2002.02823.x; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; SIKORSKI RS, 1989, GENETICS, V122, P19; Teixeira MC, 2008, BIOCHEM BIOPH RES CO, V367, P249, DOI 10.1016/j.bbrc.2007.12.056; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Wilson TE, 2002, GENETICS, V162, P677; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xu HM, 2008, BREAST CANCER RES TR, V107, P267, DOI 10.1007/s10549-007-9553-4; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9877	10.1371/journal.pone.0009877	http://dx.doi.org/10.1371/journal.pone.0009877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376190	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200007
J	Genesca, M; McChesney, MB; Miller, CJ				Genesca, Meritxell; McChesney, Michael B.; Miller, Christopher J.			Depo-Provera (R) Treatment Does Not Abrogate Protection from Intravenous SIV Challenge in Female Macaques Immunized with an Attenuated AIDS Virus	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS-INDUCED PROTECTION; RHESUS MACAQUES; PATHOGENIC SIVMAC239; INTRAVAGINAL CHALLENGE; DISEASE PROGRESSION; VAGINAL CHALLENGE; VIRAL REPLICATION; SEX-HORMONES; DEPO-PROVERA	Background: In a previous study, progesterone treatment of female monkeys immunized with live, attenuated SHIV89.6 abrogated the generally consistent protection from vaginal simian immunodeficiency virus (SIV) challenge. The mechanisms responsible for the loss of protection remain to be defined. The objective of the present study was to determine whether Depo-Provera (R) administration alters protection from intravenous SIV challenge in SHIV-immunized female macaques. Methods and Findings: Two groups of female macaques were immunized with attenuated SHIV89.6 and then challenged intravenously with SIVmac239. Four weeks before challenge, one animal group was treated with Depo-Provera (R), a commonly used injectable contraceptive progestin. As expected, SHIV-immunized monkeys had significantly lower peak and set-point plasma viral RNA levels compared to naive controls, but in contrast to previously published findings with vaginal SIV challenge, the Depo-Provera (R) SHIV-immunized animals controlled SIV replication to a similar, or even slightly greater, degree than did the untreated SHIV-immunized animals. Control of viral replication from week 4 to week 20 after challenge was more consistent in the progesterone-treated, SHIV-immunized animals than in untreated, SHIV-immunized animals. Although levels of interferon-gamma production were similar, the SIV-specific CD8(+) T cells of progesterone-treated animals expressed more functions than the anti-viral CD8(+) T cells from untreated animals. Conclusions: Depo-Provera (R) did not diminish the control of viral replication after intravenous SIV challenge in female macaques immunized with a live-attenuated lentivirus. This result contrasts with the previously reported effect of DepoProvera (R) on protection from vaginal SIV challenge and strongly implies that the decreased protection from vaginal challenge is due to effects of progesterone on the genital tract rather than to systemic effects. Further, these results demonstrate that the effects of hormonal contraceptives on vaccine efficacy need to be considered in the context of testing and use of an AIDS vaccine.	[Genesca, Meritxell; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Genesca, Meritxell; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Med, Div Infect Dis, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Genesca, M (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu	Genescà, Meritxell/AFT-2336-2022	Genescà, Meritxell/0000-0001-6413-3812	National Institutes of Health (NIH) [RR00169, AI066314, AI44480]; James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044480, P01AI066314] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants RR00169, AI066314, AI44480 and a gift from the James B. Pendleton Charitable Trust. These agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed are solely those of the authors.	Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600; Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Asin SN, 2008, AIDS RES HUM RETROV, V24, P701, DOI 10.1089/aid.2007.0108; Baeten JM, 2007, CLIN INFECT DIS, V45, P360, DOI 10.1086/519432; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Bulterys M, 2007, AIDS, V21, P97, DOI 10.1097/QAD.0b013e3280117cb5; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Genesca M, 2007, J MED PRIMATOL, V36, P266, DOI 10.1111/j.1600-0684.2007.00244.x; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Liang J, 2006, INT IMMUNOPHARMACOL, V6, P830, DOI 10.1016/j.intimp.2005.12.002; MANNEL DN, 1990, IMMUNOL LETT, V26, P89, DOI 10.1016/0165-2478(90)90181-O; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Mauck C, 2005, JAIDS-J ACQ IMM DEF, V38, pS11, DOI 10.1097/01.qai.0000167026.95406.93; McChesney MB, 1998, J VIROL, V72, P10029, DOI 10.1128/JVI.72.12.10029-10035.1998; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Munoz LDA, 2007, J INFECT DIS, V195, P1294, DOI 10.1086/513434; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Pantaleo G, 2008, LANCET INFECT DIS, V8, P82, DOI 10.1016/S1473-3099(07)70266-9; Stone M, 2009, VIROLOGY, V392, P260, DOI 10.1016/j.virol.2009.06.052; Stringer EM, 2009, AIDS, V23, P1377, DOI 10.1097/QAD.0b013e32832cbca8; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4	27	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9814	10.1371/journal.pone.0009814	http://dx.doi.org/10.1371/journal.pone.0009814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352116	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400016
J	Han, XB; Kitamoto, S; Wang, HW; Boisvert, WA				Han, Xinbing; Kitamoto, Shiro; Wang, Hongwei; Boisvert, William A.			Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice	FASEB JOURNAL			English	Article						macrophage-specific retroviral transduction; foam cell formation; cholesterol efflux; inflammation; apoptosis	FOAM-CELL-FORMATION; SCAVENGER RECEPTOR-A; E-DEFICIENT MICE; E KNOCKOUT MICE; CHOLESTEROL EFFLUX; INHIBITS ATHEROSCLEROSIS; LIPOPROTEIN METABOLISM; DENSITY-LIPOPROTEINS; TRANSGENIC MICE; GENE-TRANSFER	In atherogenesis, macrophage foam cell formation is modulated by pathways involving both the uptake and efflux of cholesterol. We recently showed that interleukin-10 (IL-10) modulates lipid metabolism by enhancing both uptake and efflux of cholesterol in macrophages. However, the mechanistic details of these properties in vivo have been unclear. Thus, the purpose of this study was to determine whether expression of IL-10 in macrophages would alter susceptibility to atherosclerosis and whether IL-10 exerts its antiatherosclerotic properties by modulating lipid metabolism in macrophages. We utilized a macrophage-specific retroviral vector that allows long-term in vivo expression of IL-10 in macrophages through transplantation of retrovirally transduced bone marrow cells (BMCs). IL-10 expressed by macrophages derived from transduced BMCs inhibited atherosclerosis in LDLR-/- mice by reducing cholesteryl ester accumulation in atherosclerotic sites. Experiments with primary macrophages indicated that macrophage source of IL-10 stimulated both the uptake (by up-regulating scavenger receptors) and efflux of cholesterol (by activating the PPAR gamma-LXR-ABCA1/ABCG1 pathway), thereby reducing inflammation and apoptosis in atherosclerosis. These findings indicate that BMC-transduced macrophage IL-10 production can act as a strong antiatherogenic agent, and they highlight a novel antiatherosclerotic therapy using a simple, yet effective, stem cell transduction system that facilitates long-term expression of IL-10 in macrophages.-Han, X., Kitamoto, S., Wang, H., Boisvert, W. A. Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. FASEB J. 24, 2869-2880 (2010). www.fasebj.org	[Boisvert, William A.] Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96813 USA; [Han, Xinbing; Kitamoto, Shiro; Wang, Hongwei; Boisvert, William A.] Harvard Univ, Sch Med, Brigham Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02138 USA	University of Hawaii System; Harvard University; Brigham & Women's Hospital	Boisvert, WA (corresponding author), Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, 651 Ilalo St,BSB 311-C, Honolulu, HI 96813 USA.	wab@hawaii.edu			National Institutes of Health [HL075677]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank E. Raines (University of Washington, Seattle, WA, USA) for providing the CD68S-containing retroviral vector, as well as for valuable comments. The authors are grateful to D. Ahl for assistance with BMT. This study was supported by National Institutes of Health grant HL075677 (to W.A.B.).	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; de Winther MPJ, 1999, ATHEROSCLEROSIS, V144, P315, DOI 10.1016/S0021-9150(98)00332-3; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Gough PJ, 2003, BLOOD, V101, P485, DOI 10.1182/blood-2002-07-2131; Halvorsen B, 2005, J LIPID RES, V46, P211, DOI 10.1194/jlr.M400324-JLR200; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; Herijgers N, 2000, J LIPID RES, V41, P1402; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Klappacher GW, 2002, CURR OPIN LIPIDOL, V13, P305, DOI 10.1097/00041433-200206000-00011; KRUTH HS, 1984, AM J PATHOL, V114, P201; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Liu Y, 2006, ATHEROSCLEROSIS, V188, P19, DOI 10.1016/j.atherosclerosis.2005.10.029; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 1999, ARTERIOSCL THROM VAS, V19, P611, DOI 10.1161/01.ATV.19.3.611; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Pinderski LJ, 2002, CIRC RES, V90, P1064, DOI 10.1161/01.RES.0000018941.10726.FA; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Roselaar SE, 1996, ARTERIOSCL THROM VAS, V16, P1013, DOI 10.1161/01.ATV.16.8.1013; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Teupser D, 1999, ARTERIOSCL THROM VAS, V19, P1299, DOI 10.1161/01.ATV.19.5.1299; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; von der Thusen JH, 2001, FASEB J, V15, P2730, DOI 10.1096/fj.01-0483fje; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Yoshioka T, 2004, GENE THER, V11, P1772, DOI 10.1038/sj.gt.3302348; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216	44	94	104	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2869	2880		10.1096/fj.09-148155	http://dx.doi.org/10.1096/fj.09-148155			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20354139	Green Published			2022-12-25	WOS:000285005400027
J	Yi, Y; Kamata-Sakurai, M; Denda-Nagai, K; Itoh, T; Okada, K; Ishii-Schrade, K; Iguchi, A; Sugiura, D; Irimura, T				Yi, Yuri; Kamata-Sakurai, Mika; Denda-Nagai, Kaori; Itoh, Tomoko; Okada, Kyoko; Ishii-Schrade, Katrin; Iguchi, Akihiro; Sugiura, Daisuke; Irimura, Tatsuro			Mucin 21/Epiglycanin Modulates Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MAMMARY ADENOCARCINOMA; SIALOMUCIN COMPLEX; CARCINOMA-CELLS; EPISIALIN MUC1; CANCER CELL; EPIGLYCANIN; GLYCOPROTEIN; TA3; SURFACE; OVEREXPRESSION	The molecular structure of mouse Mucin 21 (Muc21)/epiglycanin is proposed to have 98 tandem repeats of 15 amino acids and three exceptional repeats with 12 or 13 amino acids each, followed by a stem domain, a transmembrane domain, and a cytoplasmic tail. A cDNA of Muc21 having 84 tandem repeats of 15 amino acids was constructed and transfected using a Venus vector into HEK 293T cells. The fluorescent cells, which were considered to express Muc21, were nonadherent. This anti-adhesion effect was lessened when constructs with smaller numbers of tandem repeats were used, suggesting that the tandem repeat domain plays a crucial role. Cells expressing Muc21 were significantly less adherent to each other and to extracellular matrix components than control cells. Antibody binding to the cell surface integrin subunits alpha 5, alpha 6, and beta 1 was reduced in Muc21 transfectants in a tandem repeat-dependent manner, whereas equal amounts of proteins were detected by Western blot analysis. Muc21 was expressed as a large glycoprotein that was highly glycosylated with O-glycans at the cell surface, as detected by flow cytometry, Western blotting, and lectin blotting. Although at least a portion of Muc21 was glycosylated with sialylated glycans, removal of sialic acid did not influence the prevention of adhesion.	[Yi, Yuri; Kamata-Sakurai, Mika; Denda-Nagai, Kaori; Itoh, Tomoko; Okada, Kyoko; Ishii-Schrade, Katrin; Iguchi, Akihiro; Sugiura, Daisuke; Irimura, Tatsuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo 1130033, Japan	University of Tokyo	Irimura, T (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	irimura@mol.f.u-tokyo.ac.jp		Sugiura, Daisuke/0000-0002-3865-3889; Denda-Nagai, Kaori/0000-0001-8325-3289				ARDMAN B, 1992, P NATL ACAD SCI USA, V89, P5001, DOI 10.1073/pnas.89.11.5001; Chervenak JL, 2000, BIOL REPROD, V63, P294, DOI 10.1095/biolreprod63.1.294; CODINGTON JF, 1979, J NATL CANCER I, V63, P153; CODINGTON JF, 1975, CARBOHYD RES, V40, P171, DOI 10.1016/S0008-6215(00)82679-8; CODINGTON JF, 1972, BIOCHEMISTRY-US, V11, P2559, DOI 10.1021/bi00764a001; CODINGTON JF, 1992, GLYCOBIOLOGY, V2, P173, DOI 10.1093/glycob/2.3.173; COOPER AG, 1979, JNCI-J NATL CANCER I, V63, P163; FRIBERG S, 1972, JNCI-J NATL CANCER I, V48, P1463; FUNG PYS, 1991, CANCER RES, V51, P1170; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; HAUSCHKA TS, 1971, JNCI-J NATL CANCER I, V47, P343; Itoh Y, 2008, GLYCOBIOLOGY, V18, P74, DOI 10.1093/glycob/cwm118; Kalra AV, 2009, EUR J CANCER, V45, P164, DOI 10.1016/j.ejca.2008.10.008; KEMPERMAN H, 1994, J CELL BIOL, V127, P2071, DOI 10.1083/jcb.127.6.2071; KLEIN G, 1951, EXP CELL RES, V2, P291, DOI 10.1016/0014-4827(51)90097-3; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; Komatsu M, 1999, CANCER RES, V59, P2229; LIGTENBERG MJL, 1992, CANCER RES, V52, P2318; MILLER SC, 1977, J CELL BIOL, V72, P511, DOI 10.1083/jcb.72.3.511; MILLER SC, 1982, J NATL CANCER I, V68, P981; Nagy P, 2005, CANCER RES, V65, P473; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565	24	21	22	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21233	21240		10.1074/jbc.M109.082875	http://dx.doi.org/10.1074/jbc.M109.082875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20388707	hybrid, Green Published			2022-12-25	WOS:000279516100008
J	Leugers, CJ; Lee, G				Leugers, Chad J.; Lee, Gloria			Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; CELL-CYCLE REENTRY; ALZHEIMERS-DISEASE; PC12 CELLS; LIPID RAFTS; PHOSPHORYLATES TAU; AXONAL-TRANSPORT; IN-VIVO; C-FOS	Microtubule-associated protein Tau is known to bind to and stabilize microtubules, thereby regulating microtubule dynamics. However, recent evidence has indicated that Tau can also interact with various components of intracellular signaling pathways, leading to the possibility that Tau might have a role in signal transduction. Here we provide evidence that during growth factor stimulation of neuronal cells, Tau has functions in advance of the neurite elongation stage. Using Tau-depleted neuronal cell lines, we demonstrate that Tau is required for neurite initiation in a manner that does not involve its microtubule binding function. In addition, we demonstrate that Tau potentiates AP-1 transcription factor activation in response to nerve growth factor (NGF). The effect of Tau on AP-1 activation is mediated through its ability to potentiate the activation of mitogen-activated protein kinase (MAPK), which occurs in response to both NGF and epidermal growth factor. Phosphorylation of Tau at Thr-231 also occurs in response to NGF and is required for Tau to impact on MAPK signaling, whereas the ability of Tau to bind to microtubules is not required. Together, these findings indicate a new functional role for Tau in early neuronal development independent of its established role in microtubule stabilization.	[Leugers, Chad J.; Lee, Gloria] Univ Iowa, Roy J & Lucille Carver Coll Med, Program Neurosci, Iowa City, IA 52242 USA; [Lee, Gloria] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Lee, G (corresponding author), 500 Newton Rd,B191 ML, Iowa City, IA 52242 USA.	gloria-lee@uiowa.edu	Lee, Gloria/F-5965-2011	Lee, Gloria/0000-0002-8633-1534	National Institutes of Health, NIA [AG 017753]; NATIONAL INSTITUTE ON AGING [R01AG017753] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG 017753 from the NIA.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; ANDERSON AJ, 1994, EXP NEUROL, V125, P286, DOI 10.1006/exnr.1994.1031; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BLANCHARD BJ, 1994, BIOCHEM BIOPH RES CO, V200, P187, DOI 10.1006/bbrc.1994.1432; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Delobel P, 2006, AM J PATHOL, V168, P878, DOI 10.2353/ajpath.2006.050540; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Dubey M, 2008, CELL MOTIL CYTOSKEL, V65, P89, DOI 10.1002/cm.20243; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Garcia-Sierra F, 2003, J ALZHEIMERS DIS, V5, P65, DOI 10.3233/JAD-2003-5201; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Golub T, 2004, CURR OPIN NEUROBIOL, V14, P542, DOI 10.1016/j.conb.2004.08.003; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hall GF, 1997, P NATL ACAD SCI USA, V94, P4733, DOI 10.1073/pnas.94.9.4733; HANEMAAIJER R, 1991, J NEUROSCI RES, V30, P163, DOI 10.1002/jnr.490300117; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Hernandez-Hernandez O, 2006, J NEUROSCI RES, V84, P841, DOI 10.1002/jnr.20989; Hoerndli FJ, 2007, EUR J NEUROSCI, V26, P60, DOI 10.1111/j.1460-9568.2007.05618.x; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Jenkins SM, 1998, NEUROREPORT, V9, P67, DOI 10.1097/00001756-199801050-00014; Jicha GA, 1997, J NEUROCHEM, V69, P2087; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kleijn M, 1998, J BIOL CHEM, V273, P5536, DOI 10.1074/jbc.273.10.5536; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; LEGER JG, 1994, J CELL SCI, V107, P3403; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Marcus DL, 1998, NEUROBIOL AGING, V19, P393, DOI 10.1016/S0197-4580(98)00077-3; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; RODER HM, 1993, BIOCHEM BIOPH RES CO, V193, P639, DOI 10.1006/bbrc.1993.1672; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P92, DOI 10.1111/j.1601-183X.2007.00377.x; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sharma VM, 2007, J CELL SCI, V120, P748, DOI 10.1242/jcs.03378; SONG JS, 1995, J PROTEIN CHEM, V14, P95, DOI 10.1007/BF01888367; Souter S, 2009, J CELL BIOCHEM, V108, P555, DOI 10.1002/jcb.22287; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Sui Z, 2006, BIOCHEM BIOPH RES CO, V345, P1643, DOI 10.1016/j.bbrc.2006.05.087; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200	87	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19125	19134		10.1074/jbc.M110.105387	http://dx.doi.org/10.1074/jbc.M110.105387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20375017	Green Published, hybrid			2022-12-25	WOS:000278727800022
J	Chou, ST; Yen, YC; Lee, CM; Chen, MS				Chou, Sung-Tau; Yen, Yi-Chen; Lee, Chin-Mei; Chen, Mei-Shya			Pro-apoptotic Role of Cdc25A ACTIVATION OF CYCLIN B1/Cdc2 BY THE Cdc25A C-TERMINAL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; CELL-CYCLE; BETA-TRCP; ACTIVATION; PHOSPHORYLATION; DEGRADATION; PHOSPHATASE; CHECKPOINT; INACTIVATION; PROTEOLYSIS	Cdc25A is a dual specificity protein phosphatase that activates cyclin/cyclin-dependent protein kinase (Cdk) complexes by removing inhibitory phosphates from conserved threonine and tyrosine in Cdks. To address how Cdc25A promotes apoptosis, Jurkat cells were treated with staurosporine, an apoptosis inducer. Upon staurosporine treatment, a Cdc25A C-terminal 37-kDa fragment, designated C37, was generated by caspase cleavage at Asp-223. Thr-507 in C37 became dephosphorylated, which prevented 14-3-3 binding, as shown previously. C37 exhibited higher phosphatase activity than full-length Cdc25A. C37 with alanine substitution for Thr-507 (C37/T507A) that imitated the cleavage product during staurosporine treatment interacted with Cdc2, Cdk2, cyclin A, and cyclin B1 and markedly activated cyclin B1/Cdc2. The dephosphorylation of Thr-507 might expose the Cdc2/Cdk2-docking site in C37. C37/T507A also induced apoptosis in Jurkat and K562 cells, resulting from activating cyclin B1/Cdc2 but not Cdk2. Thus, this study reveals that Cdc25A is a pro-apoptotic protein that amplifies staurosporine-induced apoptosis through the activation of cyclin B1/Cdc2 by its C-terminal domain.	[Chou, Sung-Tau; Yen, Yi-Chen; Lee, Chin-Mei; Chen, Mei-Shya] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Chen, MS (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	mschen@gate.sinica.edu.tw		Lee, Chin-Mei/0000-0003-3870-4268	National Institutes of Health [CA-094-PP-13, CA-095-PP-19, CA-096-PP-21]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants CA-094-PP-13, CA-095-PP-19, and CA-096-PP-21.	Andreau K, 2004, J BIOL CHEM, V279, P55937, DOI 10.1074/jbc.M406411200; Berndtsson M, 2005, FEBS LETT, V579, P3090, DOI 10.1016/j.febslet.2005.04.067; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Jackson JR, 2000, CANCER RES, V60, P566; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mazars A, 2009, CELL DEATH DIFFER, V16, P208, DOI 10.1038/cdd.2008.142; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Saha P, 1997, MOL CELL BIOL, V17, P4338, DOI 10.1128/MCB.17.8.4338; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Sohn R, 2005, BIOCHEMISTRY-US, V44, P16563, DOI 10.1021/bi0516879; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	35	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17833	17845		10.1074/jbc.M109.078386	http://dx.doi.org/10.1074/jbc.M109.078386			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368335	Green Published, hybrid			2022-12-25	WOS:000278133400061
J	Shadrick, WR; Julin, DA				Shadrick, William R.; Julin, Douglas A.			Kinetics of DNA Unwinding by the RecD2 Helicase from Deinococcus radiodurans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; BACTERIOPHAGE-T4 DDA HELICASE; MONOMERIC MOLECULAR MOTOR; ESCHERICHIA-COLI RECBCD; VIRUS NS3 HELICASE; PCRA HELICASE; STEP-SIZE; IN-VITRO; TRANSLOCATION; MECHANISM	RecD2 from Deinococcus radiodurans is a superfamily 1DNA helicase that is homologous to the Escherichia coli RecD protein but functions outside the context of RecBCD enzyme. We report here on the kinetics of DNA unwinding by RecD2 under single and multiple turnover conditions. There is little unwinding of 20-bp substrates by preformed RecD2-dsDNA complexes when excess ssDNA is present to trap enzyme molecules not bound to the substrate. A shorter 12-bp substrate is unwound rapidly under single turnover conditions. The 12-bp unwinding reaction could be simulated with a mechanism in which the DNA is unwound in two kinetic steps with rate constant of k(unw) = 5.5 s(-1) and a dissociation step from partially unwound DNA of k(off) = 1.9 s(-1). These results indicate a kinetic step size of about 3-4 bp, unwinding rate of about 15-20 bp/s, and low processivity (p = 0.74). The reaction time courses with 20-bp substrates, determined under multiple turnover conditions, could be simulated with a four-step mechanism and rate constant values very similar to those for the 12-bp substrate. The results indicate that the faster unwinding of a DNA substrate with a forked end versus only a 5'-terminal single-stranded extension can be accounted for by a difference in the rate of enzyme binding to the DNA substrates. Analysis of reactions done with different RecD2 concentrations indicates that the enzyme forms an inactive dimer or other oligomer at high enzyme concentrations. RecD2 oligomers can be detected by glutaraldehyde cross-linking but not by size exclusion chromatography.	[Shadrick, William R.; Julin, Douglas A.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Julin, DA (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	djulin@umd.edu						Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Cao Z, 2010, DNA REPAIR, V9, P66, DOI 10.1016/j.dnarep.2009.10.009; Chen HW, 1997, J BIOL CHEM, V272, P10072; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Montague M, 2009, J MOL EVOL, V69, P360, DOI 10.1007/s00239-009-9290-x; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Servinsky MD, 2007, J BACTERIOL, V189, P5101, DOI 10.1128/JB.00409-07; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wu CG, 2008, J MOL BIOL, V382, P312, DOI 10.1016/j.jmb.2008.07.012; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhou Q, 2007, FEMS MICROBIOL LETT, V271, P118, DOI 10.1111/j.1574-6968.2007.00703.x	41	13	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17292	17300		10.1074/jbc.M110.111427	http://dx.doi.org/10.1074/jbc.M110.111427			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360003	hybrid, Green Published			2022-12-25	WOS:000278133400006
J	Vivona, S; Liu, CW; Strop, P; Rossi, V; Filippini, F; Brunger, AT				Vivona, Sandro; Liu, Corey W.; Strop, Pavel; Rossi, Valeria; Filippini, Francesco; Brunger, Axel T.			The Longin SNARE VAMP7/TI-VAMP Adopts a Closed Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; COATED VESICLES; COMPLEX; PROTEIN; YKT6; SYNTAXIN-1; ARCHITECTURE; MECHANISM	SNARE protein complexes are key mediators of exocytosis by juxtaposing opposing membranes, leading to membrane fusion. SNAREs generally consist of one or two core domains that can form a four-helix bundle with other SNARE core domains. Some SNAREs, such as syntaxin target-SNAREs and longin vesicular-SNAREs, have independent, folded N-terminal domains that can interact with their respective SNARE core domains and thereby affect the kinetics of SNARE complex formation. This autoinhibition mechanism is believed to regulate the role of the longin VAMP7/TI-VAMP in neuronal morphogenesis. Here we use nuclear magnetic resonance spectroscopy to study the longin-SNARE core domain interaction for VAMP7. Using complete backbone resonance assignments, chemical shift perturbations analysis, and hydrogen/deuterium exchange experiments, we conclusively show that VAMP7 adopts a preferentially closed conformation in solution. Taken together, the closed conformation of longins is conserved, in contrast to the syntaxin family of SNAREs for which mixtures of open and closed states have been observed. This may indicate different regulatory mechanisms for SNARE complexes containing syntaxins and longins, respectively.	[Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Vivona, Sandro; Rossi, Valeria; Filippini, Francesco] Univ Padua, Dept Biol, Mol Biol & Bioinformat Unit MOLBINFO, I-35131 Padua, Italy; [Liu, Corey W.] Stanford Univ, Sch Med, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Padua; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu	Filippini, Francesco/AAH-2897-2021	Brunger, Axel/0000-0001-5121-2036; FILIPPINI, FRANCESCO/0000-0001-5672-0726	National Institutes of Health [RO1-MH63105]; MIUR [PRIN2005]; Padua University [CPDA077345/07]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIUR(Ministry of Education, Universities and Research (MIUR)); Padua University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-MH63105 (to A. T. B.). This work was also supported by grants from the MIUR-PRIN2005 and the Padua University (PRAT2007 Project CPDA077345/07) (to F. F.).	Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Goddard T. D, 2007, SPARKY 3; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Hasegawa H, 2004, J CELL SCI, V117, P4495, DOI 10.1242/jcs.01314; Hasegawa H, 2003, MOL BIOL CELL, V14, P698, DOI 10.1091/mbc.E02-09-0556; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kinch LN, 2006, PROTEIN SCI, V15, P2669, DOI 10.1110/ps.062419006; Liu Wei, 2009, Front Neuroenergetics, V1, P5, DOI 10.3389/neuro.14.005.2009; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pylypenko O, 2008, J MOL BIOL, V377, P1334, DOI 10.1016/j.jmb.2008.01.099; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Vedovato M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-510; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Wen WY, 2010, MOL CELL, V37, P383, DOI 10.1016/j.molcel.2010.01.024; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	39	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17965	17973		10.1074/jbc.M110.120972	http://dx.doi.org/10.1074/jbc.M110.120972			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378544	Green Published, hybrid			2022-12-25	WOS:000278133400072
J	Bohme, S; Meyer, S; Kruger, A; Steinhoff, HJ; Wittinghofer, A; Klare, JP				Boehme, Sabine; Meyer, Simon; Krueger, Andre; Steinhoff, Heinz-Juergen; Wittinghofer, Alfred; Klare, Johann P.			Stabilization of G Domain Conformations in the tRNA-modifying MnmE-GidA Complex Observed with Double Electron Electron Resonance Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; GENE; MTO1; BIOMACROMOLECULES; EXPRESSION; INSIGHTS; POSITION; MUTANTS; CODES	MnmE is a GTP-binding protein conserved between bacteria and eukarya. It is a dimeric three-domain protein where the two G domains have to approach each other for activation of the potassium-stimulated GTPase reaction. Together with GidA, in a heterotetrameric alpha(2)beta(2) complex, it is involved in the modification of the wobble uridine base U34 of the first anticodon position of particular tRNAs. Here we show, using various spin-labeled MnmE mutants and EPR spectroscopy, that GidA binding induces large conformational and dynamic changes in MnmE. It stimulates the GTPase reaction by stabilizing the GTP-bound conformation in a potassium-independent manner. Surprisingly, GidA binding influences not only the GTP-but also the GDP-bound conformation. Thus GidA is a new type of regulator for a G protein activated by dimerization.	[Meyer, Simon; Krueger, Andre; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; [Boehme, Sabine; Steinhoff, Heinz-Juergen; Klare, Johann P.] Univ Osnabruck, Dept Phys, D-49076 Osnabruck, Germany	Max Planck Society; University Osnabruck	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de; jklare@uos.de	Klare, Johann P./C-1428-2009; Steinhoff, Heinz-Juergen/H-3791-2014	Klare, Johann P./0000-0002-5761-5968; Steinhoff, Heinz-Juergen/0000-0002-5888-0157	Fond der Chemischen Industrie; International Max-Planck Research School; Deutsche Forschungsgemeinschaft [STE640/7-2]; Graduate College [612]	Fond der Chemischen Industrie(Fonds der Chemischen Industrie); International Max-Planck Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate College	This work was supported by funds from the Fond der Chemischen Industrie (to S.M.) and the International Max-Planck Research School (to S.M.), Deutsche Forschungsgemeinschaft Grant STE640/7-2 (to S.B., J.P.K., and H.-J.S.), and Graduate College Grant 612 (to S.B.).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AGRIS PF, 1992, J AM CHEM SOC, V114, P2652, DOI 10.1021/ja00033a044; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Cabedo H, 1999, EMBO J, V18, P7063, DOI 10.1093/emboj/18.24.7063; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Martin RE, 1998, ANGEW CHEM INT EDIT, V37, P2834, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2833::AID-ANIE2833>3.0.CO;2-7; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; Meyer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000212; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Sakamoto K, 1996, BIOCHEMISTRY-US, V35, P6533, DOI 10.1021/bi9526490; Schiemann O, 2007, Q REV BIOPHYS, V40, P1, DOI 10.1017/S003358350700460X; Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Steinhoff HJ, 2004, BIOL CHEM, V385, P913, DOI 10.1515/BC.2004.119; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Villarroya M, 2008, MOL CELL BIOL, V28, P7514, DOI 10.1128/MCB.00946-08; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; YOKOYAMA S, 1995, STRUCTURE BIOSYNTHES, P207; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	37	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16991	17000		10.1074/jbc.M109.096131	http://dx.doi.org/10.1074/jbc.M109.096131			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353943	hybrid, Green Published			2022-12-25	WOS:000277982600062
J	Brower, CS; Veiga, L; Jones, RH; Varshavsky, A				Brower, Christopher S.; Veiga, Lucia; Jones, Richard H.; Varshavsky, Alexander			Mouse Dfa Is a Repressor of TATA-box Promoters and Interacts with the Abt1 Activator of Basal Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; BIDIRECTIONAL PROMOTER; HUMAN GENOME; GENE ORGANIZATION; UBIQUITIN LIGASE; PATHWAY; IDENTIFICATION; PROTEIN; EXPRESSION; SPERMATOGENESIS	Our study of the mouse Ate1 arginyltransferase, a component of the N-end rule pathway, has shown that Ate1 pre-mRNA is produced from a bidirectional promoter that also expresses, in the opposite direction, a previously uncharacterized gene (Hu, R. G., Brower, C. S., Wang, H., Davydov, I. V., Sheng, J., Zhou, J., Kwon, Y. T., and Varshavsky, A. (2006) J. Biol. Chem. 281, 32559-32573). In this work, we began analyzing this gene, termed Dfa (divergent from Ate1). Mouse Dfa was found to be transcribed from both the bidirectional PAte1/Dfa promoter and other nearby promoters. The resulting transcripts are alternatively spliced, yielding a complex set of Dfa mRNAs that are present largely, although not exclusively, in the testis. A specific Dfa mRNA encodes, via its 3'-terminal exon, a 217-residue protein termed Dfa(A). Other Dfa mRNAs also contain this exon. Dfa(A) is sequelogous (similar in sequence) to a region of the human/mouse HTEX4 protein, whose physiological function is unknown. We produced an affinity-purified antibody to recombinant mouse Dfa(A) that detected a 35-kDa protein in the mouse testis and in several cell lines. Experiments in which RNA interference was used to down-regulate Dfa indicated that the 35-kDa protein was indeed Dfa(A). Furthermore, Dfa(A) was present in the interchromatin granule clusters and was also found to bind to the Ggnbp1 gametogenetin-binding protein-1 and to the Abt1 activator of basal transcription that interacts with the TATA-binding protein. Given these results, RNA interference was used to probe the influence of Dfa levels in luciferase reporter assays. We found that Dfa(A) acts as a repressor of TATA-box transcriptional promoters.	[Brower, Christopher S.; Veiga, Lucia; Jones, Richard H.; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Jones, Richard/0000-0002-7570-2141	National Institutes of Health [GM31530, DK39520]; March of Dimes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK039520, R37DK039520, R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31530 and DK39520 (to A. V.). This work was also supported by a grant from the March of Dimes Foundation.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Aihara T, 2009, BIOL REPROD, V80, P762, DOI 10.1095/biolreprod.108.074013; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Coriton O, 2000, MAMM GENOME, V11, P1127, DOI 10.1007/s003350010213; Elnitski L, 2005, CURR PROTOC BIOINFOR, P1041, DOI DOI 10.4.1-10.4.12; Elnitski L, 2003, CURR PROTOC BIOINFOR; Emoto M, 2005, GENE, V357, P47, DOI 10.1016/j.gene.2005.05.009; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lepourcelet M, 1998, IMMUNOGENETICS, V47, P491, DOI 10.1007/s002510050388; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Lu BS, 2003, J BIOL CHEM, V278, P16289, DOI 10.1074/jbc.M211023200; Meier-Noorden M, 2004, GENE, V338, P197, DOI 10.1016/j.gene.2004.05.006; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Oda T, 2000, MOL CELL BIOL, V20, P1407, DOI 10.1128/MCB.20.4.1407-1418.2000; Patton J, 2006, GENE, V369, P35, DOI 10.1016/j.gene.2005.10.009; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Prioleau MN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000454; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Saleh A, 2004, IMMUNITY, V21, P55, DOI 10.1016/j.immuni.2004.06.005; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Travers MT, 2005, GENOMICS, V85, P71, DOI 10.1016/j.ygeno.2004.10.001; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2008, NAT STRUCT MOL BIOL, V15, P1238, DOI 10.1038/nsmb1208-1238; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang IF, 2006, EXP CELL RES, V312, P3796, DOI 10.1016/j.yexcr.2006.07.028; West AB, 2003, J MOL BIOL, V326, P11, DOI 10.1016/S0022-2836(02)01376-1; Whitehouse C, 2004, GENE, V326, P87, DOI 10.1016/j.gene.2003.10.008; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang J, 2005, FEBS LETT, V579, P559, DOI 10.1016/j.febslet.2004.10.112; Zhou Y, 2005, MOL REPROD DEV, V70, P301, DOI 10.1002/mrd.20214	55	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17218	17234		10.1074/jbc.M110.118638	http://dx.doi.org/10.1074/jbc.M110.118638			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356838	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000277982600084
J	Klink, BU; Barden, S; Heidler, TV; Borchers, C; Ladwein, M; Stradal, TEB; Rottner, K; Heinz, DW				Klink, Bjoern U.; Barden, Stephan; Heidler, Thomas V.; Borchers, Christina; Ladwein, Markus; Stradal, Theresia E. B.; Rottner, Klemens; Heinz, Dirk W.			Structure of Shigella IpgB2 in Complex with Human RhoA IMPLICATIONS FOR THE MECHANISM OF BACTERIAL GUANINE NUCLEOTIDE EXCHANGE FACTOR MIMICRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIFFRACTION DATA; STRESS FIBERS; PROTEIN; GTPASES; BINDING; ACTIVATION; MEMBRANE; FAMILY; GDP	A common theme in bacterial pathogenesis is the manipulation of eukaryotic cells by targeting the cytoskeleton. This is in most cases achieved either by modifying actin, or indirectly via activation of key regulators controlling actin dynamics such as Rho-GTPases. A novel group of bacterial virulence factors termed the WXXXE family has emerged as guanine nucleotide exchange factors (GEFs) for these GTPases. The precise mechanism of nucleotide exchange, however, has remained unclear. Here we report the structure of the WXXXE-protein IpgB2 from Shigella flexneri and its complex with human RhoA. We unambiguously identify IpgB2 as a bacterial RhoA-GEF and dissect the molecular mechanism of GDP release, an essential prerequisite for GTP binding. Our observations uncover that IpgB2 induces conformational changes on RhoA mimicking DbI-but not DOCK family GEFs. We also show that dissociation of the GDP.Mg2+ complex is preceded by the displacement of the metal ion to the alpha-phosphate of the nucleotide, diminishing its affinity to the GTPase. These data refine our understanding of the mode of action not only of WXXXE GEFs but also of mammalian GEFs of the DH/PH family.	[Heinz, Dirk W.] Helmholtz Zentrum Infekt Forsch, Div Struct Biol, D-38124 Braunschweig, Germany; [Ladwein, Markus; Rottner, Klemens] Helmholtz Zentrum Infekt Forsch, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany; [Borchers, Christina; Stradal, Theresia E. B.] Helmholtz Zentrum Infekt Forsch, Signaling & Motil Grp, D-38124 Braunschweig, Germany; [Stradal, Theresia E. B.] Univ Munster, Inst Gen Zool & Genet, D-48149 Munster, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Munster	Heinz, DW (corresponding author), Helmholtz Zentrum Infekt Forsch, Div Struct Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany.	dirk.heinz@helmholtz-hzi.de		Barden, Stephan/0000-0003-2118-3371; Stradal, Theresia/0000-0002-0352-9474; Rottner, Klemens/0000-0003-4244-4198	Deutsche Forschungsgemeinschaft [SFB621, SPP1150]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded in part by the Deutsche Forschungsgemeinschaft (Grants SFB621 to K. R. and SPP1150 to T. E. B. S.).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; ARBELOA A, 2009, CELL MICROB IN PRESS; Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Arbeloa A, 2009, J MED MICROBIOL, V58, P988, DOI 10.1099/jmm.0.010231-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boquet P, 2003, TRENDS CELL BIOL, V13, P238, DOI 10.1016/S0962-8924(03)00037-0; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Bulgin RR, 2009, CELL MICROBIOL, V11, P217, DOI 10.1111/j.1462-5822.2008.01248.x; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Diacovich L, 2009, J BIOL CHEM, V284, P33151, DOI 10.1074/jbc.M109.034975; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; EBERTH A, 2009, CURR PROTOC CELL BIO, pCH4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freymann DM, 1999, NAT STRUCT BIOL, V6, P793, DOI 10.1038/11572; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; HAUSLER LC, 2004, THESIS RUHR U BOCHUM; Hayward RD, 2006, CELL, V124, P15, DOI 10.1016/j.cell.2005.12.024; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; Shames SR, 2009, INT J BIOCHEM CELL B, V41, P380, DOI 10.1016/j.biocel.2008.08.013; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	55	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17197	17208		10.1074/jbc.M110.107953	http://dx.doi.org/10.1074/jbc.M110.107953			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363740	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000277982600082
J	Limpert, AS; Carter, BD				Limpert, Allison S.; Carter, Bruce D.			Axonal Neuregulin 1 Type III Activates NF-kappa B in Schwann Cells during Myelin Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PERIPHERAL-NERVE; CANCER-CELLS; KINASE; RECEPTOR; PATHWAY; GROWTH; PROLIFERATION; AKT; DIFFERENTIATION	The formation of myelin requires a series of complex signaling events initiated by the axon to surrounding glial cells, which ultimately respond by tightly wrapping the axon with layers of specialized plasma membrane thereby allowing for saltatory conduction. Activation of the transcription factor NF-kappa B in Schwann cells has been suggested to be critical for these cells to differentiate into a myelinating phenotype; however, the mechanisms by which it is activated have yet to be elucidated. Here, we demonstrate that axonal membranes are sufficient to promote NF-kappa B activation in cultured Schwann cells and identify neuregulin 1 (NRG1), specifically the membrane-bound type III isoform, as the signal responsible for activating this transcription factor. Surprisingly, neither membrane-bound type I nor the soluble NRG1 EGF domain could activate NF-kappa B, indicating that type III induces a qualitatively unique signal. The transcriptional activity of NF-kappa B was significantly enhanced by treatment with forskolin, indicating these two signals converge for maximal activation. Both ErbB2 and -3 receptors were required for transducing the NRG1 signal, because gene deletion of ErbB3 in Schwann cells or treatment with the ErbB2 selective inhibitor, PKI-166, prevented the stimulation of NF-kappa B by axonal membranes. Finally, PKI-166 blocked the activation of the transcription factor in myelinating neuron/Schwann cell co-cultures and in vivo, in developing sciatic nerves. Taken together, these data establish NRG1 type III as the activator of NF-kappa B during myelin formation.	[Carter, Bruce D.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 625 Light Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu			National Institutes of Health [NS048249]; Muscular Dystrophy Association [MDA115761]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064278, R01NS048249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS048249 (to B.D.C.). This work was also supported by Muscular Dystrophy Association Grant MDA115761 (to A.S.L.).	Baseia Iuri Goulart, 2002, Acta Bot. Bras., V16, P01; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Cho HH, 2008, FEBS LETT, V582, P616, DOI 10.1016/j.febslet.2008.01.029; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Crovello CS, 1998, J BIOL CHEM, V273, P26954, DOI 10.1074/jbc.273.41.26954; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grinspan JB, 1996, J NEUROSCI, V16, P6107; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Kirillova I, 1999, CELL GROWTH DIFFER, V10, P819; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; LEVI ADO, 1995, J NEUROSCI, V15, P1329; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mattson MP, 2003, NAT NEUROSCI, V6, P105, DOI 10.1038/nn0203-105; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ozes ON, 1999, NATURE, V401, P82; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; PODUSLO JF, 1995, J NEUROCHEM, V65, P149; Qu SM, 2006, GENESIS, V44, P477, DOI 10.1002/dvg.20243; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; SALZER JL, 1980, J CELL BIOL, V84, P753, DOI 10.1083/jcb.84.3.753; Sweeney C, 2000, J BIOL CHEM, V275, P19803, DOI 10.1074/jbc.C901015199; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Walikonis RS, 1998, J BIOL CHEM, V273, P9070, DOI 10.1074/jbc.273.15.9070; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; WHITE FV, 1983, EXP CELL RES, V148, P183, DOI 10.1016/0014-4827(83)90198-2; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	50	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16614	16622		10.1074/jbc.M109.098780	http://dx.doi.org/10.1074/jbc.M109.098780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360002	Green Published, hybrid			2022-12-25	WOS:000277982600025
J	Singarapu, KK; Radek, JT; Tonelli, M; Markley, JL; Lan, Q				Singarapu, Kiran K.; Radek, James T.; Tonelli, Marco; Markley, John L.; Lan, Que			Differences in the Structure and Dynamics of the Apo- and Palmitate-ligated Forms of Aedes aegypti Sterol Carrier Protein 2 (AeSCP-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YELLOW-FEVER MOSQUITO; FATTY-ACID-BINDING; BACKBONE DYNAMICS; NMR; GENE; PROGRAM; EXPRESSION; DATABASE; REVEALS; DOMAIN	Sterol carrier protein-2 (SCP-2) is a nonspecific lipid-binding protein expressed ubiquitously in most organisms. Knockdown of SCP-2 expression in mosquitoes has been shown to result in high mortality in developing adults and significantly lowered fertility. Thus, it is of interest to determine the structure of mosquito SCP-2 and to identify its mechanism of lipid binding. We report here high quality three-dimensional solution structures of SCP-2 from Aedes aegypti determined by NMR spectroscopy in its ligand-free state (AeSCP-2) and in complex with palmitate. Both structures have a similar mixed alpha/beta fold consisting of a five-stranded beta-sheet and four alpha-helices arranged on one side of the beta-sheet. Ligand-free AeSCP-2 exhibited regions of structural heterogeneity, as evidenced by multiple two-dimensional N-15 heteronuclear single-quantum coherence peaks for certain amino acids; this heterogeneity disappeared upon complex formation with palmitate. The binding of palmitate to AeSCP-2 was found to decrease the backbone mobility of the protein but not to alter its secondary structure. Complex formation is accompanied by chemical shift differences and a loss of mobility for residues in the loop between helix alpha I and strand beta A. The structural differences between the alpha I and beta A of the mosquito and the vertebrate SCP-2s may explain the differential specificity (insect versus vertebrate) of chemical inhibitors of the mosquito SCP-2.	[Singarapu, Kiran K.; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Singarapu, Kiran K.; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Radek, James T.; Lan, Que] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA.	markley@nmrfam.wisc.edu; qlan@entomology.wisc.edu	Singarapu, Kiran/AAU-3435-2020		National Institutes of Health [5R01AI067422, P41 RR02301, P41 GM66326]; United States Armed Force Pest Management Board [W913M-05-1-0006]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Armed Force Pest Management Board; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AI067422 (to Q. L.) and P41 RR02301 (to J. L. M.). This work was also supported by Grant W913M-05-1-0006 from the Deployed War Fighter Protection Research Program administered by the United States Armed Force Pest Management Board. NMR data were collected at the National Magnetic Resonance Facility (Madison, WI) and supported by National Institutes of Health Grants P41 RR02301 and P41 GM66326 (to J. L. M.).	Atshaves BP, 2007, AM J PHYSIOL-GASTR L, V292, pG939, DOI 10.1152/ajpgi.00308.2006; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dyer DH, 2008, J LIPID RES, V49, P644, DOI 10.1194/jlr.M700460-JLR200; Dyer DH, 2009, MOL CELL BIOCHEM, V326, P67, DOI 10.1007/s11010-008-0007-z; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferdinandusse S, 2006, AM J HUM GENET, V78, P1046, DOI 10.1086/503921; Filipp FV, 2007, BIOCHEMISTRY-US, V46, P7980, DOI 10.1021/bi6025616; Fuchs M, 2001, J BIOL CHEM, V276, P48058, DOI 10.1074/jbc.M106732200; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Garcia FL, 2000, J MOL BIOL, V295, P595, DOI 10.1006/jmbi.1999.3355; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Hodsdon ME, 1996, J MOL BIOL, V264, P585, DOI 10.1006/jmbi.1996.0663; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kannenberg F, 1999, J BIOL CHEM, V274, P35455, DOI 10.1074/jbc.274.50.35455; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim MS, 2005, J LIPID RES, V46, P650, DOI 10.1194/jlr.M400389-JLR200; Ko MH, 2007, J BIOL CHEM, V282, P19742, DOI 10.1074/jbc.M611426200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x; Larson RT, 2010, J MED ENTOMOL, V47, P249, DOI 10.1603/ME09160; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lucke C, 2001, BIOCHEM J, V354, P259, DOI 10.1042/0264-6021:3540259; Lucke C, 1996, STRUCTURE, V4, P785, DOI 10.1016/S0969-2126(96)00086-X; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; OHBA T, 1994, GENOMICS, V24, P370, DOI 10.1006/geno.1994.1630; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stolowich NJ, 1997, BIOCHEMISTRY-US, V36, P1719, DOI 10.1021/bi962317a; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; SZYPERSKI T, 1993, FEBS LETT, V335, P18, DOI 10.1016/0014-5793(93)80431-S; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	48	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17046	17053		10.1074/jbc.M110.101154	http://dx.doi.org/10.1074/jbc.M110.101154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356842	hybrid, Green Published			2022-12-25	WOS:000277982600068
J	von Roretz, C; Gallouzi, IE				von Roretz, Christopher; Gallouzi, Imed-Eddine			Protein Kinase RNA/FADD/Caspase-8 Pathway Mediates the Proapoptotic Activity of the RNA-binding Protein Human Antigen R (HuR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; MESSENGER-RNA; TRANSLATIONAL CONTROL; PROTHYMOSIN-ALPHA; IN-VIVO; PKR; APOPTOSIS; DEATH; ACTIVATION; STRESS	The RNA-binding protein human antigen R (HuR) has been implicated in apoptosis in multiple ways. Several studies have shown that in response to a variety of stresses HuR promotes the expression of proapoptotic mRNAs, whereas others reported its regulatory effect on antiapoptotic messages. We recently showed that in response to severe stress, HuR is cleaved to generate two cleavage products (CPs), HuR-CP1 (24 kDa) and HuR-CP2 (8 kDa), by which it promotes apoptotic cell death. Here, we show that this cleavage event is dependent on protein kinase RNA (PKR). Surprisingly, although in response to the apoptotic inducer staurosporine PKR itself is not phosphorylated, PKR triggers the cleavage of HuR via its downstream effector FADD that in turn activates the caspase-8/caspase-3 pathway. This effect, however, does not require the phosphorylation of the eukaryotic translation initiation factor 2 alpha. Additionally, we observed that these HuR-CPs are sufficient to trigger cell death in the absence of activation of the PKR pathway. Therefore, our results support a model whereby in response to lethal stress, PKR, without being phosphorylated, activates the FADD/caspase-8/caspase-3 pathway to trigger HuR cleavage, and the HuR-CPs are then capable of promoting apoptosis.	[Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 904,3655 Promenade Sir William O, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca			National Cancer Institute of Canada (NCIC) [016247, 018125]; Canadian Institutes of Health Research; Tier II Canada Research Chair	National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Tier II Canada Research Chair	This work was supported in part by National Cancer Institute of Canada (NCIC) Operating Grants 016247 and 018125 (to I.-E.G.).; Recipient of a Canadian Institutes of Health Research doctoral research award.; Recipient of a Tier II Canada Research Chair. To whom correspondence should be addressed: Dept. of Biochemistry, McGill University, McIntyre Bldg., Rm. 904, 3655 Promenade Sir William Osler, Montreal, Quebec H3G 1Y6, Canada. Fax: 1-514-398-7384; E-mail: imed.gallouzi@mcgill.ca.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; BEAUCHAMP P, 2010, CELL DEATH IN PRESS; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; CASILLAS AM, 1993, BIOCHEM J, V290, P545, DOI 10.1042/bj2900545; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Donze O, 2004, EMBO J, V23, P564, DOI 10.1038/sj.emboj.7600078; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Peters GA, 2009, BIOCHEMISTRY-US, V48, P7441, DOI 10.1021/bi900433y; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Vaishnav D, 2003, BIOCHEM BIOPH RES CO, V307, P855, DOI 10.1016/S0006-291X(03)01287-7; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; van der Giessen K, 2007, MOL BIOL CELL, V18, P2619, DOI 10.1091/mbc.E07-02-0167; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16806	16813		10.1074/jbc.M109.087320	http://dx.doi.org/10.1074/jbc.M109.087320			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353946	Green Published, hybrid			2022-12-25	WOS:000277982600044
J	Yori, JL; Johnson, E; Zhou, GJ; Jain, MK; Keri, RA				Yori, Jennifer L.; Johnson, Emhonta; Zhou, Guangjin; Jain, Mukesh K.; Keri, Ruth A.			Kruppel-like Factor 4 Inhibits Epithelial-to-Mesenchymal Transition through Regulation of E-cadherin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR KLF4; TUMOR-CELL INVASION; BREAST-CANCER; MEDIATED ADHESION; STEM-CELLS; NUCLEAR-LOCALIZATION; DOWN-REGULATION; MAMMARY-GLAND; GOBLET CELLS; P120 CATENIN	The Kruppel-like factor 4 (KLF4) is a transcriptional regulator of proliferation and differentiation in epithelial cells, both during development and tumorigenesis. Although KLF4 functions as a tumor suppressor in several tissues, including the colon, the role of KLF4 in breast cancer is less clear. Here, we show that KLF4 is necessary for maintenance of the epithelial phenotype in non-transformed MCF-10A mammary epithelial cells. KLF4 silencing led to alterations in epithelial cell morphology and migration, indicative of an epithelial-to-mesenchymal transition. Consistent with these changes, decreased levels of KLF4 also resulted in the loss of E-cadherin protein and mRNA. Promoter/reporter analyses revealed decreased E-cadherin promoter activity with KLF4 silencing, while chromatin immuno-precipitation identified endogenous KLF4 binding to the GC-rich/E-box region of this promoter. Furthermore, forced expression of KLF4 in the highly metastatic MDA-MB-231 breast tumor cell line was sufficient to restore E-cadherin expression and suppress migration and invasion. These findings identify E-cadherin as a novel transcriptional target of KLF4. The clear requirement for KLF4 to maintain E-cadherin expression and prevent epithelial-to-mesenchymal transition in mammary epithelial cells supports a metastasis suppressive role for KLF4 in breast cancer.	[Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Div Gen Med Sci, Cleveland, OH 44106 USA; [Zhou, Guangjin; Jain, Mukesh K.; Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst & Univ Hosp, Harrington McLaughlin Heart & Vasc Inst,Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	zhou, guangjin/F-9031-2011; Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [CA090398, HL075427, HL086548]; Susan G. Komen Foundation [BCTR0601083]; Case Comprehensive Cancer Center [P30 CA043703]; Dept. of Defense [DAMD17-03-1-0302]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA090398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075427, R01HL086548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Case Comprehensive Cancer Center; Dept. of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA090398 (to R. A. K.), CURE supplement to Grant CA090398 (to E. J.), and Grants HL075427 and HL086548 (to M. K. J.). This work was also supported by the Susan G. Komen Foundation (Grant BCTR0601083 to R. A. K.) and by the Case Comprehensive Cancer Center core facilities (Grant P30 CA043703).; Recipient of a Dept. of Defense pre-doctoral fellowship (DAMD17-03-1-0302).	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Bennett HL, 2008, ONCOGENE, V27, P2693, DOI 10.1038/sj.onc.1210928; Boecker W, 2002, J PATHOL, V198, P458, DOI 10.1002/path.1241; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DUYEN TD, 2000, INT J BIOCHEM CELL B, V32, P1103; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Foster KW, 2000, CANCER RES, V60, P6488; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Imbalzano KM, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-7; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Johnson E, 2004, J BIOL CHEM, V279, P31041, DOI 10.1074/jbc.M400024200; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Knudsen KA, 2005, J CELL BIOCHEM, V95, P488, DOI 10.1002/jcb.20419; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mbalaviele G, 1996, CANCER RES, V56, P4063; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Miller KA, 2001, J BIOL CHEM, V276, P42863, DOI 10.1074/jbc.M108130200; Mo YY, 1996, CANCER RES, V56, P2633; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Paccione RJ, 2008, MOL CANCER THER, V7, P2894, DOI 10.1158/1535-7163.MCT-08-0450; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THOMPSON EW, 1994, CLIN EXP METASTAS, V12, P181, DOI 10.1007/BF01753886; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yancy Haile F, 2007, J Carcinog, V6, P8; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	84	122	130	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16854	16863		10.1074/jbc.M110.114546	http://dx.doi.org/10.1074/jbc.M110.114546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356845	Green Published, hybrid			2022-12-25	WOS:000277982600049
J	Jewett, A; Arasteh, A; Tseng, HC; Behel, A; Arasteh, H; Yang, W; Cacalano, NA; Paranjpe, A				Jewett, Anahid; Arasteh, Aida; Tseng, Han-Ching; Behel, Armin; Arasteh, Hobie; Yang, Wendy; Cacalano, Nicholas A.; Paranjpe, Avina			Strategies to Rescue Mesenchymal Stem Cells (MSCs) and Dental Pulp Stem Cells (DPSCs) from NK Cell Mediated Cytotoxicity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ORAL TUMOR-CELLS; CLASS-I ANTIGENS; FACTOR-KAPPA-B; STROMAL CELLS; BONE-MARROW; TNF-ALPHA; PROLIFERATION; IMMUNOSUPPRESSION; SECRETION	Background: The aim of this paper is to study the function of allogeneic and autologous NK cells against Dental Pulp Stem Cells (DPSCs) and Mesenchymal Stem Cells (MSCs) and to determine the function of NK cells in a three way interaction with monocytes and stem cells. Methodology/Principal Findings: We demonstrate here that freshly isolated untreated or IL-2 treated NK cells are potent inducers of cell death in DPSCs and MSCs, and that anti-CD16 antibody which induces functional split anergy and apoptosis in NK cells inhibits NK cell mediated lysis of DPSCs and MSCs. Monocytes co-cultured with either DPSCs or MSCs decrease lysis of stem cells by untreated or IL-2 treated NK cells. Monocytes also prevent NK cell apoptosis thereby raising the overall survival and function of NK cells, DPSCs or MSCs. Both total population of monocytes and those depleted of CD16(+) subsets were able to prevent NK cell mediated lysis of MSCs and DPSCs, and to trigger an increased secretion of IFN-gamma by IL-2 treated NK cells. Protection of stem cells from NK cell mediated lysis was also seen when monocytes were sorted out from stem cells before they were added to NK cells. However, this effect was not specific to monocytes since the addition of T and B cells to stem cells also protected stem cells from NK cell mediated lysis. NK cells were found to lyse monocytes, as well as T and B cells. Conclusion/Significance: By increasing the release of IFN-gamma and decreasing the cytotoxic function of NK cells monocytes are able to shield stem cells from killing by the NK cells, resulting in an increased protection and differentiation of stem cells. More importantly studies reported in this paper indicate that anti-CD16 antibody can be used to prevent NK cell induced rejection of stem cells.	[Jewett, Anahid; Arasteh, Aida; Tseng, Han-Ching; Behel, Armin; Arasteh, Hobie; Yang, Wendy; Paranjpe, Avina] Univ Calif Los Angeles, Sch Med & Dent, Div Oral Biol & Med, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA; [Cacalano, Nicholas A.] Univ Calif Los Angeles, Sch Med & Dent, Dept Radiat Oncol, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Jewett, A (corresponding author), Univ Calif Los Angeles, Sch Med & Dent, Div Oral Biol & Med, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA.	ajewett@ucla.edu			University of California Los Angeles Academic Senate	University of California Los Angeles Academic Senate(University of California System)	Funding was received from the University of California Los Angeles Academic Senate grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ALGE DL, J TISSUE ENG REGEN M, V4, P73; Cacalano N, 2008, APOPTOSIS, V13, P1439, DOI 10.1007/s10495-008-0270-1; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Jewett A, 2006, J DENT RES, V85, P1061, DOI 10.1177/154405910608501201; Jewett A, 2006, CANCER IMMUNOL IMMUN, V55, P1052, DOI 10.1007/s00262-005-0093-7; Jewett A, 2006, CLIN CANCER RES, V12, P1994, DOI 10.1158/1078-0432.CCR-05-2306; Jewett A, 1996, J IMMUNOL, V156, P907; Jewett A, 2003, HUM IMMUNOL, V64, P505, DOI 10.1016/S0198-8859(03)00039-9; JEWETT A, 1995, CELL IMMUNOL, V160, P91, DOI 10.1016/0008-8749(95)80013-9; JEWETT A, 1995, J CLIN IMMUNOL, V15, P35, DOI 10.1007/BF01489488; Jewett A, 1997, J IMMUNOL, V159, P4815; Jewett A, 2000, CLIN IMMUNOL, V96, P19, DOI 10.1006/clim.2000.4871; Jewett A, 2008, CANCER IMMUNOL IMMUN, V57, P1053, DOI 10.1007/s00262-007-0437-6; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nasef A, 2008, CELL IMMUNOL, V253, P16, DOI 10.1016/j.cellimm.2008.06.002; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; PARANJPE A, 2009, TOXICOL SCI; Paranjpe A, 2007, FREE RADICAL BIO MED, V43, P1394, DOI 10.1016/j.freeradbiomed.2007.07.011; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Vuk-Pavlovic S, 2008, BLOOD CELL MOL DIS, V40, P94, DOI 10.1016/j.bcmd.2007.06.025; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhao ZG, 2008, IMMUNOL INVEST, V37, P726, DOI 10.1080/08820130802349940	31	48	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9874	10.1371/journal.pone.0009874	http://dx.doi.org/10.1371/journal.pone.0009874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360990	Green Submitted, gold, Green Published			2022-12-25	WOS:000276163200001
J	Higuchi, A; Takahashi, K; Hirashima, M; Kawakita, T; Tsubota, K				Higuchi, Akihiro; Takahashi, Kazuhiko; Hirashima, Masaki; Kawakita, Tetsuya; Tsubota, Kazuo			Selenoprotein P Controls Oxidative Stress in Cornea	PLOS ONE			English	Article							DRY EYE; CELL-DEATH; GLUTATHIONE-PEROXIDASE; SERUM APPLICATION; EPITHELIAL-CELLS; LACRIMAL GLAND; SELENIUM; PROTEIN; SELENOCYSTEINE; HYDROPEROXIDE	The ocular surface is always attacked by oxidative stress, and cornea epithelial cells are supposed to have their own recovery system against oxidative stress. Therefore we hypothesized that tears supply key molecules for preventing oxidative stress in cornea. The potential target key molecule we focused is selenoprotein P (SeP). SeP is a carrier of selenium, which is an essential trace element for many animals, for oxidative stress metabolism in the organism, and was extremely expressed in lacrimal gland. An experiment was performed with SeP eye drops in a rat dry eye model, prepared by removing the lacrimal glands. The anticipated improvement in corneal dry eye index and the suppression of oxidative stress markers were observed in SeP eye drop group. Furthermore, the concentration of SeP was significantly higher in dry eye patients compared with normal volunteers. Collectively, we concluded that tear SeP is a key molecule to protect the ocular surface cells against environmental oxidative stress.	[Higuchi, Akihiro; Tsubota, Kazuo] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Takahashi, Kazuhiko] Hokkaido Pharmaceut Univ, Sch Pharm, Dept Nutr Biochem, Sapporo, Hokkaido, Japan; [Hirashima, Masaki] Chemoserotherapeut Res Inst, Res Dept 1, Kumamoto, Japan; [Kawakita, Tetsuya; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Keio University; Keio University	Higuchi, A (corresponding author), Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan.	ahiguchi@sc.itc.keio.ac.jp			Kowa Company, Ltd.	Kowa Company, Ltd.	The study reported in the present article was supported by grants from Kowa Company, Ltd. (4-14-3 Nihonbashihoncho, Chuo-Ku, Tokyo, Japan). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulah R, 2005, J TRACE ELEM MED BIO, V19, P141, DOI 10.1016/j.jtemb.2005.09.003; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; AUGUSTIN AJ, 1995, GRAEF ARCH CLIN EXP, V233, P694, DOI 10.1007/BF00164671; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Cekic O, 2002, AM J OPHTHALMOL, V134, P75, DOI 10.1016/S0002-9394(02)01472-1; Craig JP, 2000, EYE, V14, P635, DOI 10.1038/eye.2000.156; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Higuchi A, 2006, BRIT J OPHTHALMOL, V90, P760, DOI 10.1136/bjo.2005.088203; Higuchi A, 2007, CURR EYE RES, V32, P83, DOI 10.1080/02713680601147690; Hirashima M, 2003, BIOL PHARM BULL, V26, P794; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; KUIZENGA A, 1991, INVEST OPHTH VIS SCI, V32, P381; Lemp Michael A., 1995, CLAO Journal, V21, P221; MCKEEHAN WL, 1976, P NATL ACAD SCI USA, V73, P2023, DOI 10.1073/pnas.73.6.2023; Modis L, 1998, GRAEF ARCH CLIN EXP, V236, P86, DOI 10.1007/s004170050047; MOTSENBOCKER MA, 1982, BIOCHIM BIOPHYS ACTA, V719, P147, DOI 10.1016/0304-4165(82)90318-X; Nakamura S, 2003, INVEST OPHTH VIS SCI, V44, P4682, DOI 10.1167/iovs.03-0198; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; Saito Y, 2004, BIOCHEM J, V381, P841, DOI 10.1042/BJ20040328; Saito Y, 2002, EUR J BIOCHEM, V269, P5746, DOI 10.1046/j.1432-1033.2002.03298.x; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Sharif NA, 1998, INVEST OPHTH VIS SCI, V39, P2562; Shimmura S, 2003, BRIT J OPHTHALMOL, V87, P1279, DOI 10.1136/bjo.87.10.1279; Shisler JL, 1998, SCIENCE, V279, P102, DOI 10.1126/science.279.5347.102; Tsubota K, 2000, INT OPHTHALMOL CLIN, V40, P113, DOI 10.1097/00004397-200010000-00009; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; UBELS JL, 1986, INVEST OPHTH VIS SCI, V27, P1261; Wilson SE, 1999, INVEST OPHTH VIS SCI, V40, P2185; ZUCLICH JA, 1976, INVEST OPHTH VISUAL, V15, P760	36	51	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9911	10.1371/journal.pone.0009911	http://dx.doi.org/10.1371/journal.pone.0009911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360971	Green Published, gold, Green Submitted			2022-12-25	WOS:000276163100006
J	Bob, NS; Diop, BM; Renaud, F; Marrama, L; Durand, P; Tall, A; Ka, B; Ekala, MT; Bouchier, C; Mercereau-Puijalon, O; Jambou, R				Bob, Ndeye Sakha; Diop, Bernard Marcel; Renaud, Francois; Marrama, Laurence; Durand, Patrick; Tall, Adama; Ka, Boubacar; Ekala, Marie Therese; Bouchier, Christiane; Mercereau-Puijalon, Odile; Jambou, Ronan			Parasite Polymorphism and Severe Malaria in Dakar (Senegal): A West African Urban Area	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; GENETIC DIVERSITY; MICROSATELLITE; TRANSMISSION; POPULATION; LINKAGE; EPIDEMIOLOGY; PATTERNS; MARKERS; ALLELE	Background: Transmission of malaria in West African urban areas is low and healthcare facilities are well organized. However, malaria mortality remains high. We conducted a survey in Dakar with the general objective to establish who died from severe malaria (SM) in urban areas (particularly looking at the age-groups) and to compare parasite isolates associated with mild or severe malaria. Methodology/Principal Findings: The current study included mild-(MM) and severe malaria (SM) cases, treated in dispensaries (n = 2977) and hospitals (n = 104), We analysed Pfdhfr/Pfcrt-exon2 and nine microsatellite loci in 102 matched cases of SM and MM. Half of the malaria cases recorded at the dispensaries and 87% of SM cases referred to hospitals, occurred in adults, although adults only accounted for 26% of all dispensary consultations. This suggests that, in urban settings, whatever the reason for this adult over-representation, health-workers are forced to take care of increasing numbers of malaria cases among adults. Inappropriate self treatment and mutations in genes associated with drug resistance were found associated with SM in adults. SM was also associated with a specific pool of isolates highly polymorphic and different from those associated with MM. Conclusion: In this urban setting, adults currently represent one of the major groups of patients attending dispensaries for malaria treatment. For these patients, despite the low level of transmission, SM was associated with a specific and highly polymorphic pool of parasites which may have been selected by inappropriate treatment.	[Bob, Ndeye Sakha; Marrama, Laurence; Tall, Adama; Jambou, Ronan] Inst Pasteur, Dakar, Senegal; [Diop, Bernard Marcel] CHU Fann, Clin Malad Infectieuses, Dakar, Senegal; [Renaud, Francois; Durand, Patrick] CNRS, IRD, GEMI, UMR 2724, Montpellier, France; [Ka, Boubacar] Hop Principal Dakar, Dakar, Senegal; [Ekala, Marie Therese; Mercereau-Puijalon, Odile] Inst Pasteur, CNRS, URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bob, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	rjambou@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020; JAMBOU, RONAN/CAG-3718-2022		Louis D. Foundation; Ministere francais des Affaires etrangeres; European Commission [QLK2-CT20021-1503-ResMalChip]; FSP-RAI	Louis D. Foundation; Ministere francais des Affaires etrangeres; European Commission(European CommissionEuropean Commission Joint Research Centre); FSP-RAI	This study was supported by the Louis D. Foundation (Academies des Sciences, Paris, France), the Ministere francais des Affaires etrangeres (Fond Solidarite Prioritaire, FSP-RAI) and the European Commission (contract QLK2-CT20021-1503-ResMalChip) project. NS Bob was supported by a grant from FSP-RAI. The funders had no role in study design data collection and analysis, decision to publish or preparation of this manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Ariey F, 2001, J INFECT DIS, V184, P237, DOI 10.1086/322012; CONTAMIN H, 1995, J CLIN MICROBIOL, V33, P944, DOI 10.1128/JCM.33.4.944-951.1995; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Diallo S, 2000, Sante, V10, P221; Diallo S, 1998, B SOC PATHOL EXOT, V91, P208; Durand P, 2003, AM J TROP MED HYG, V68, P345, DOI 10.4269/ajtmh.2003.68.345; Durand R, 2008, TROP MED INT HEALTH, V13, P1392, DOI 10.1111/j.1365-3156.2008.02156.x; Faye O., 1995, Cahiers d'Etudes et de Recherches Francophones/Sante, V5, P299; Ferreira MU, 2002, J CLIN MICROBIOL, V40, P1854, DOI 10.1128/JCM.40.5.1854-1857.2002; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Henry M, 2006, AM J TROP MED HYG, V75, P146, DOI 10.4269/ajtmh.2006.75.146; Ibrahim ML, 2007, MICROBES INFECT, V9, P599, DOI 10.1016/j.micinf.2007.02.003; Konate L, 1999, T ROY SOC TROP MED H, V93, pS21, DOI 10.1016/S0035-9203(99)90323-1; Leclerc MC, 2002, MICROBES INFECT, V4, P685, DOI 10.1016/S1286-4579(02)01587-3; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; Ndiaye P, 2006, Med Trop (Mars), V66, P74; NEI M, 1985, MOL BIOL EVOL, V2, P189; Niang M, 2008, J ANTIMICROB CHEMOTH, V62, P921, DOI 10.1093/jac/dkn299; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; Nzila AM, 2002, INT J PARASITOL, V32, P1469, DOI 10.1016/S0020-7519(02)00164-9; Pages F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-178; Prothero RM, 2001, HEALTH RISK SOC, V3, P19, DOI 10.1080/713670171; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; Schleiermacher D, 2001, AM J TROP MED HYG, V64, P303, DOI 10.4269/ajtmh.2001.64.303; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Soumare M, 2008, Bull Soc Pathol Exot, V101, P20; Soumare M, 2005, MED MALADIES INFECT, V35, P383, DOI 10.1016/j.medmal.2005.03.009; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; TRAORE S, 1996, MIGRATIONS AFRIQUE O; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; United Nations, 2004, WORLD URB PROSP 2003; World Health Organization, 2008, WORLD MAL REP	37	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9817	10.1371/journal.pone.0009817	http://dx.doi.org/10.1371/journal.pone.0009817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352101	Green Published, gold			2022-12-25	WOS:000275894400019
J	House, JS; Zhu, SY; Ranjan, R; Linder, K; Smart, RC				House, John S.; Zhu, Songyun; Ranjan, Rakesh; Linder, Keith; Smart, Robert C.			C/EBP alpha and C/EBP beta Are Required for Sebocyte Differentiation and Stratified Squamous Differentiation in Adult Mouse Skin	PLOS ONE			English	Article							ENHANCER-BINDING-PROTEIN; TRANSCRIPTION FACTORS C/EBP; SEBACEOUS GLAND; STEM-CELLS; GENE-EXPRESSION; MAMMARY-GLAND; GROWTH ARREST; ONCOGENIC RAS; IN-VIVO; C-MYC	C/EBP alpha and C/EBP beta are bZIP transcription factors that are highly expressed in the interfollicular epidermis and sebaceous glands of skin and yet germ line deletion of either family member alone has only mild or no effect on keratinocyte biology and their role in sebocyte biology has never been examined. To address possible functional redundancies and reveal functional roles of C/EBP alpha and C/EBP beta in postnatal skin, mouse models were developed in which either family member could be acutely ablated alone or together in the epidermis and sebaceous glands of adult mice. Acute removal of either C/EBP alpha or C/EBP beta alone in adult mouse skin revealed modest to no discernable changes in epidermis or sebaceous glands. In contrast, co-ablation of C/EBP alpha and C/EBP beta in postnatal epidermis resulted in disruption of stratified squamous differentiation characterized by hyperproliferation of basal and suprabasal keratinocytes and a defective basal to spinous keratinocyte transition involving an expanded basal compartment and a diminished and delayed spinous compartment. Acute co-ablation of C/EBP alpha and C/EBP beta in sebaceous glands resulted in severe morphological defects, and sebocyte differentiation was blocked as determined by lack of sebum production and reduced expression of stearoyl-CoA desaturase (SCD3) and melanocortin 5 receptor (MC5R), two markers of terminal sebocyte differentiation. Specialized sebocytes of Meibomian glands and preputial glands were also affected. Our results indicate that in adult mouse skin, C/EBP alpha and C/EBP beta are critically involved in regulating sebocyte differentiation and epidermal homeostasis involving the basal to spinous keratinocyte transition and basal cell cycle withdrawal.	[House, John S.; Zhu, Songyun; Ranjan, Rakesh; Smart, Robert C.] N Carolina State Univ, Dept Environm & Mol Toxicol, Cell Signaling & Canc Grp, Raleigh, NC 27695 USA; [Linder, Keith] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	House, JS (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Cell Signaling & Canc Grp, Raleigh, NC 27695 USA.	rcsmart@ncsu.edu	House, John S/A-1933-2013	House, John S/0000-0002-8447-7871; Smart, Robert/0000-0002-6767-6756	National Cancer Institute [CA046637]; National Institute of Environmental Health Sciences [ES012473, ES007046]; NATIONAL CANCER INSTITUTE [R29CA046637, R01CA046637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046, R01ES012473] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Cancer Institute (CA046637), a grant from the National Institute of Environmental Health Sciences (ES012473) and a training grant from the National Institute of Environmental Health Sciences (ES007046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2003, AM J PATHOL, V163, P2173, DOI 10.1016/S0002-9440(10)63574-2; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Butovich IA, 2008, CURR EYE RES, V33, P405, DOI 10.1080/02713680802018419; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Chen WC, 2003, J INVEST DERMATOL, V121, P441, DOI 10.1046/j.1523-1747.2003.12411.x; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; DOUGHERTY JM, 1986, INVEST OPHTH VIS SCI, V27, P486; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; LOPEZ RG, 2009, NAT CELL BIOL; Maytin EV, 1999, DEV BIOL, V216, P164, DOI 10.1006/dbio.1999.9460; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; NATSUKA S, 1992, BLOOD, V79, P460; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Shim M, 2005, CANCER RES, V65, P861; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STEWART ME, 1992, SEMIN DERMATOL, V11, P100; Swart GWM, 1997, BIOL CHEM, V378, P373, DOI 10.1515/bchm.1997.378.5.373; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	45	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9837	10.1371/journal.pone.0009837	http://dx.doi.org/10.1371/journal.pone.0009837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352127	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894400032
J	Sitkiewicz, I; Green, NM; Guo, N; Bongiovanni, AM; Witkin, SS; Musser, JM				Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Bongiovanni, Ann M.; Witkin, Steven S.; Musser, James M.			Adaptation of Group A Streptococcus to Human Amniotic Fluid	PLOS ONE			English	Article							BACTERIAL-GROWTH INHIBITION; CHEMICALLY-DEFINED MEDIUM; GROUP-B STREPTOCOCCUS; HUMAN BLOOD; EPITHELIAL-CELLS; GENE-EXPRESSION; PYOGENES; VIRULENCE; TRANSCRIPTOME; INFECTIONS	Background: For more than 100 years, group A Streptococcus has been identified as a cause of severe and, in many cases, fatal infections of the female urogenital tract. Due to advances in hospital hygiene and the advent of antibiotics, this type of infection has been virtually eradicated. However, within the last three decades there has been an increase in severe intra-and post-partum infections attributed to GAS. Methodology: We hypothesized that GAS alters its transcriptome to survive in human amniotic fluid (AF) and cause disease. To identify genes that were up or down regulated in response to growth in AF, GAS was grown in human AF or standard laboratory media (THY) and samples for expression microarray analysis were collected during mid-logarithmic, late-logarithmic, and stationary growth phases. Microarray analysis was performed using a custom Affymetrix chip and normalized hybridization values derived from three biological replicates were collected at each growth point. Ratios of AF/THY above a 2-fold change and P-value <0.05 were considered significant. Principal Findings: The majority of changes in the GAS transcriptome involved down regulation of multiple adhesins and virulence factors and activation of the stress response. We observed significant changes in genes involved in the arginine deiminase pathway and in the nucleotide de novo synthesis pathway. Conclusions/Significance: Our work provides new insight into how pathogenic bacteria respond to their environment to establish infection and cause disease.	[Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Musser, James M.] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA; [Bongiovanni, Ann M.; Witkin, Steven S.; Musser, James M.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University	Sitkiewicz, I (corresponding author), Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmhs.org	Witkin, Steven/AAF-3812-2019; Witkin, Steven/AAW-8602-2021; Sitkiewicz, Izabela/G-5058-2011	Witkin, Steven/0000-0002-3502-3929; Sitkiewicz, Izabela/0000-0001-8228-9917; Bongiovanni, Ann Marie/0000-0001-9801-570X	Methodist Hospital Research Institute	Methodist Hospital Research Institute	The project was internally funded by The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 2004, J KOREAN MED SCI, V19, P333, DOI 10.3346/jkms.2004.19.3.333; BECK A, 1969, J BACTERIOL, V100, P1204, DOI 10.1128/JB.100.3.1204-1207.1969; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chuang I, 2002, CLIN INFECT DIS, V35, P665, DOI 10.1086/342062; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Degnan BA, 1998, INFECT IMMUN, V66, P3050, DOI 10.1128/IAI.66.7.3050-3058.1998; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; Eidelman Arthur I, 2002, J Perinatol, V22, P467, DOI 10.1038/sj.jp.7210774; EVANS HE, 1977, OBSTET GYNECOL, V49, P35; GALASK RP, 1970, AM J OBSTET GYNECOL, V106, P59, DOI 10.1016/0002-9378(70)90126-2; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Green NM, 2005, J CLIN MICROBIOL, V43, P4083, DOI 10.1128/JCM.43.8.4083-4091.2005; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Kreikemeyer B, 2002, MICROBIOL-SGM, V148, P1501, DOI 10.1099/00221287-148-5-1501; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; LARSEN B, 1974, AM J OBSTET GYNECOL, V119, P492, DOI 10.1016/0002-9378(74)90207-5; LARSEN B, 1974, AM J OBSTET GYNECOL, V119, P497, DOI 10.1016/0002-9378(74)90208-7; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Modena Alberto Bacchi, 2004, Acta Biomed, V75 Suppl 1, P11; Mylvaganam H, 2009, CLIN MICROBIOL INFEC, V15, P245, DOI 10.1111/j.1469-0691.2008.02664.x; Nair S, 2003, MICROBIOL-SGM, V149, P407, DOI 10.1099/mic.0.25783-0; Nilsson S, 2004, J PROTEOME RES, V3, P884, DOI 10.1021/pr0499545; Olsen RJ, 2010, P NATL ACAD SCI USA, V107, P888, DOI 10.1073/pnas.0911811107; Pasteur L., 1879, B ACAD NATL MED, VVIII, P271; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; PIERCE WILLIAM A., 1955, JOUR BACT, V69, P230; Pinho MD, 2006, J CLIN MICROBIOL, V44, P841, DOI 10.1128/JCM.44.3.841-846.2006; POMMERENKE W T, 1953, Ann Ostet Ginecol, V75, P891; Purushothaman SS, 2004, INDIAN J MED RES, V119, P44; Quivey RG, 2001, CRIT REV ORAL BIOL M, V12, P301, DOI 10.1177/10454411010120040201; Robertson GT, 2002, J BACTERIOL, V184, P3508, DOI 10.1128/JB.184.13.3508-3520.2002; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Shelburne SA, 2005, P NATL ACAD SCI USA, V102, P16037, DOI 10.1073/pnas.0505839102; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sitkiewicz I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006114; SOZANSKII A, 1961, B EXP BIOL MED+, V51, P323, DOI 10.1007/BF00783508; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Steiner K, 2002, INFECT IMMUN, V70, P3627, DOI 10.1128/IAI.70.7.3627-3636.2002; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tran SH, 2003, AM J OBSTET GYNECOL, V189, P746, DOI 10.1067/S0002-9378(03)00767-1; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Voyich JM, 2003, P NATL ACAD SCI USA, V100, P1996, DOI 10.1073/pnas.0337370100	52	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9785	10.1371/journal.pone.0009785	http://dx.doi.org/10.1371/journal.pone.0009785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352104	gold, Green Submitted, Green Published			2022-12-25	WOS:000275894400009
J	Peng, C; Cho, YY; Zhu, F; Xu, YM; Wen, WH; Ma, WY; Bode, AM; Dong, ZG				Peng, Cong; Cho, Yong-Yeon; Zhu, Feng; Xu, Yan-Ming; Wen, Weihong; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang			RSK2 mediates NF-kappa B activity through the phosphorylation of I kappa B alpha in the TNF-R1 pathway	FASEB JOURNAL			English	Article						apoptosis; cell survival; serine/threonine kinases; tumor promoter	RIBOSOMAL S6 KINASE; INDUCED APOPTOSIS; TARGETING DEATH; CELL-SURVIVAL; MAPK PATHWAY; DOCKING SITE; HISTONE H3; ACTIVATION; PROTEIN; IDENTIFICATION	The ribosomal S6 kinase 2 (RSK2) is a well-known serine/threonine kinase and a member of the p90 ribosomal S6 kinase (p90RSK) family of proteins. It is activated downstream of the MEK/ERKs cascade by mitogenic stimuli such as EGF or TPA. Here, we show that RSK2 is activated by treatment with tumor necrosis factor-alpha (TNF-alpha) and directly phosphorylates I kappa B alpha at Ser-32, leading to I kappa B alpha degradation. The phosphorylation of I kappa B alpha promotes the activation and translocation of the nuclear factor-kappa B (NF-kappa B) subunits p65 and p50 to the nucleus. The net result is an increased NF-kappa B activity, which serves as a mechanism for RSK2 blockade of TNF-alpha-induced apoptosis and enhanced cell survival.-Peng, C., Cho, Y.-Y., Zhu, F., Xu, Y.-M., Wen, W., Ma, W.-Y., Bode, A. M., Dong, Z. RSK2 mediates NF-kappa B activity through the phosphorylation of I kappa B alpha in the TNF-R1 pathway. FASEB J. 24, 3490-3499 (2010). www.fasebj.org	[Peng, Cong; Cho, Yong-Yeon; Zhu, Feng; Xu, Yan-Ming; Wen, Weihong; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/G-3567-2010; Cho, Yong-Yeon/AAD-4263-2020; peng, cong/A-9454-2012; ZHU, Feng/C-1303-2010; 温, 家琦/GYV-3177-2022	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	Hormel Foundation; U.S. National Institutes of Health [CA077646, CA111536, CA120388, R37CA081064, ES016548]; NATIONAL CANCER INSTITUTE [R01CA077646, R01CA120388, R01CA111536, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation and U.S. National Institutes of Health grants CA077646, CA111536, CA120388, R37CA081064, and ES016548.	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen NY, 2001, CANCER RES, V61, P3908; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Choi HS, 2009, MOL CELL BIOL, V29, P2168, DOI 10.1128/MCB.01508-08; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kwon B, 2003, EXP MOL MED, V35, P8, DOI 10.1038/emm.2003.2; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mahadevan Louis C, 2004, Novartis Found Symp, V259, P102; Merienne K, 2000, ONCOGENE, V19, P4221, DOI 10.1038/sj.onc.1203712; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; She QB, 2002, CANCER RES, V62, P1343; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Swanson KD, 1999, J BIOL CHEM, V274, P3385, DOI 10.1074/jbc.274.6.3385; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Vik TA, 1997, BIOCHEM BIOPH RES CO, V235, P398, DOI 10.1006/bbrc.1997.6794; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang P, 2004, INVEST OPHTH VIS SCI, V45, P2438, DOI 10.1167/iovs.03-0805; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	47	37	39	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3490	3499		10.1096/fj.09-151290	http://dx.doi.org/10.1096/fj.09-151290			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20385620	Green Published			2022-12-25	WOS:000281446400036
J	McMahon, M; Ayllon, V; Panov, KI; O'Connor, R				McMahon, Mary; Ayllon, Veronica; Panov, Kostya I.; O'Connor, Rosemary			Ribosomal 18 S RNA Processing by the IGF-I-responsive WDR3 Protein Is Integrated with p53 Function in Cancer Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOPROTEIN MDM2; TRANSCRIPTION; GROWTH; GENE; BIOGENESIS; ACTIVATION; BINDING; CYCLE; STABILIZATION; TRANSLOCATION	Insulin-like growth factor-I (IGF-I) signaling is strongly associated with cell growth and regulates the rate of synthesis of the rRNA precursor, the first and the key stage of ribosome biogenesis. In a screen for mediators of IGF-I signaling in cancer, we recently identified several ribosome-related proteins, including NEP1 (nucleolar essential protein 1) and WDR3 (WD repeat 3), whose homologues in yeast function in ribosome processing. The WDR3 gene and its locus on chromosome 1p12-13 have previously been linked with malignancy. Here we show that IGF-I induces expression of WDR3 in transformed cells. WDR3 depletion causes defects in ribosome biogenesis by affecting 18 S rRNA processing and also causes a transient down-regulation of precursor rRNA levels with moderate repression of RNA polymerase I activity. Suppression of WDR3 in cells expressing functional p53 reduced proliferation and arrested cells in the G(1) phase of the cell cycle. This was associated with activation of p53 and sequestration of MDM2 by ribosomal protein L11. Cells lacking functional p53 did not undergo cell cycle arrest upon suppression of WDR3. Overall, the data indicate that WDR3 has an essential function in 40 S ribosomal subunit synthesis and in ribosomal stress signaling to p53-mediated regulation of cell cycle progression in cancer cells.	[McMahon, Mary; Ayllon, Veronica; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland; [Panov, Kostya I.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland	University College Cork; Queens University Belfast	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland.	r.oconnor@ucc.ie	Ayllon, Veronica/L-7069-2014; O'Connor, Rosemary/B-7902-2014; McMahon, Mary/ABC-3576-2021	Ayllon, Veronica/0000-0002-7322-9282; O'Connor, Rosemary/0000-0002-0687-3422; McMahon, Mary/0000-0001-5548-2949; Panov, Konstantin/0000-0003-1375-7814	Science Foundation Ireland; Irish Research Council for Science, Engineering, and Technology; Health Research Board	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board	This work was supported by Science Foundation Ireland, the Irish Research Council for Science, Engineering, and Technology, and the Health Research Board.	Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Claudio JO, 1999, GENOMICS, V59, P85, DOI 10.1006/geno.1999.5858; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Eschrich D, 2002, CURR GENET, V40, P326, DOI 10.1007/s00294-001-0269-4; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mertens F, 1997, CANCER RES, V57, P2765; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Panov KI, 2001, MOL CELL BIOL, V21, P2641, DOI 10.1128/MCB.21.8.2641-2649.2001; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Steilen-Gimbel H, 1999, GENE CHROMOSOME CANC, V26, P270, DOI 10.1002/(SICI)1098-2264(199911)26:3<270::AID-GCC14>3.0.CO;2-W; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Tu X, 2002, J BIOL CHEM, V277, P44357, DOI 10.1074/jbc.M208001200; Turner AJ, 2009, MOL CELL BIOL, V29, P3007, DOI 10.1128/MCB.00029-09; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wu A, 2005, J BIOL CHEM, V280, P2863, DOI 10.1074/jbc.M406138200; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	45	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18309	18318		10.1074/jbc.M110.108555	http://dx.doi.org/10.1074/jbc.M110.108555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392698	hybrid, Green Published			2022-12-25	WOS:000278453900024
J	Roger, S; Gillet, L; Baroja-Mazo, A; Surprenant, A; Pelegrin, P				Roger, Sebastien; Gillet, Ludovic; Baroja-Mazo, Alberto; Surprenant, Annmarie; Pelegrin, Pablo			C-terminal Calmodulin-binding Motif Differentially Controls Human and Rat P2X(7) Receptor Current Facilitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; OF-FUNCTION; NUCLEOTIDE RECEPTOR; EXTRACELLULAR ATP; PORE FORMATION; ION-CHANNEL; POLYMORPHISM; GENE; EXPRESSION; RELEASE	P2X(7) receptors (P2X(7)R) are ATP-gated calcium-permeable cationic channels structurally unique among the P2X family by their much longer intracellular C-terminal tail. P2X(7)Rs show several unusual biophysical properties, in particular marked facilitation of currents and leftward shift in agonist affinity in response to repeated or prolonged agonist applications. We previously found the facilitation at rat P2X(7)R resulted from a Ca2+-calmodulin-dependent process and a distinct calcium-independent process. However, P2X(7)Rs show striking species differences; thus, this study compared the properties of ATP-evoked facilitation of currents in HEK293 cells transiently expressing the human or rat P2X(7)R as well as rat/human, human/rat chimeric, and mutated P2X(7)Rs. Facilitation at the human P2X(7)R was 5-fold slower than at the rat P2X(7)R. Facilitation did not resulting from an increase of receptor addressing the plasma membrane. We found the human P2X(7)R shows only calcium-independent facilitation with no evidence for calmodulin-dependent processes, nor does it contain the novel 1-5-16 calmodulin binding domain present in the C terminus of rat P2X(7)R. Replacement of three critical residues of this binding domain from the rat into the human P2X(7)R (T541I, C552S, and G559V) reconstituted the Ca2+-calmodulin-dependent facilitation, leaving the calcium-independent facilitation unaltered. The leftward shift in the ATP concentration-response curve with repeated agonist applications appears to be a property of the calcium-independent facilitation process because it was not altered in any of the chimeric or mutated P2X(7)Rs. The absence of Ca2+-dependent facilitation at the human P2X(7)R may represent a protective adaptation of the innate immune response in which P2X(7)R plays significant roles.	[Roger, Sebastien; Gillet, Ludovic] Univ Tours, INSERM, U921, F-37032 Tours, France; [Surprenant, Annmarie; Pelegrin, Pablo] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Baroja-Mazo, Alberto; Pelegrin, Pablo] Univ Hosp Virgen Arrixaca FFIS, Inflammat & Expt Surg Grp, Murcia 30120, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Manchester	Roger, S (corresponding author), Univ Tours, INSERM, U921, 10 Blvd Tonnelle, F-37032 Tours, France.	sebastien.roger@univ-tours.fr	Baroja-Mazo, Alberto/E-6270-2016; Pelegrin, Pablo/M-2007-2014	Baroja-Mazo, Alberto/0000-0001-5212-5006; Pelegrin, Pablo/0000-0002-9688-1804; Roger, Sebastien/0000-0002-9852-5248; Gillet, Ludovic/0000-0002-4990-6212	Biotechnology and Biological Sciences Research Council; French Foreign and European Ministry and the French Embassy in the United Kingdom; Isciii Grants [EMER07/049, PFIS0009/120]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French Foreign and European Ministry and the French Embassy in the United Kingdom; Isciii Grants	This work was supported by the Biotechnology and Biological Sciences Research Council, the "Partenariat Hubert Curien-Alliance" from the French Foreign and European Ministry and the French Embassy in the United Kingdom, and Isciii Grants EMER07/049 (to A. B.-M.) and PFIS0009/120 (to P. P.).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Alcaraz L, 2003, BIOORG MED CHEM LETT, V13, P4043, DOI 10.1016/j.bmcl.2003.08.033; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Dardano A, 2009, J CLIN ENDOCR METAB, V94, P695, DOI 10.1210/jc.2008-1322; Denlinger LC, 2005, J IMMUNOL, V174, P4424, DOI 10.4049/jimmunol.174.7.4424; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hibell AD, 2000, BRIT J PHARMACOL, V130, P167, DOI 10.1038/sj.bjp.0703302; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Romagnoli R, 2008, EXPERT OPIN THER TAR, V12, P647, DOI 10.1517/14728222.12.5.647 ; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Young MT, 2006, BRIT J PHARMACOL, V149, P261, DOI 10.1038/sj.bjp.0706880; Young MT, 2007, MOL PHARMACOL, V71, P92, DOI 10.1124/mol.106.030163; Zhang XF, 2005, BRAIN RES, V1052, P63, DOI 10.1016/j.brainres.2005.06.022; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	51	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17514	17524		10.1074/jbc.M109.053082	http://dx.doi.org/10.1074/jbc.M109.053082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378545	Green Published, hybrid			2022-12-25	WOS:000278133400030
J	Wang, XF; Lee, J; Di Jeso, B; Treglia, AS; Comoletti, D; Dubi, N; Taylor, P; Arvan, P				Wang, Xiaofan; Lee, Jaemin; Di Jeso, Bruno; Treglia, A. Sonia; Comoletti, Davide; Dubi, Noga; Taylor, Palmer; Arvan, Peter			Cis and Trans Actions of the Cholinesterase-like Domain within the Thyroglobulin Dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISSENSE MUTATION G2320R; ENDOPLASMIC-RETICULUM; HUMAN ACETYLCHOLINESTERASE; CONGENITAL HYPOTHYROIDISM; GOITROUS HYPOTHYROIDISM; THYROID PEROXIDASE; GENE; TRAFFICKING; SECRETION; PROTEINS	Thyroglobulin (Tg, precursor for thyroid hormone synthesis) is a large secreted glycoprotein composed of upstream regions I-II-III, followed by the similar to 570 residue cholinesterase-like (ChEL) domain. ChEL has two identified functions: 1) homodimerization, and 2) binding to I-II-III that facilitates I-II-III oxidative maturation required for intracellular protein transport. Like its homologs in the acetylcholinesterase (AChE) family, ChEL possesses two carboxyl-terminal alpha-helices. We find that a Tg-AChE chimera (swapping AChE in place of ChEL) allows for dimerization with monomeric AChE, proving exposure of the carboxyl-terminal helices within the larger context of Tg. Further, we establish that perturbing trans-helical interaction blocks homodimerization of the Tg ChEL domain. Additionally, ChEL can associate with neuroligins (a related family of cholinesterase-like proteins), demonstrating potential for Tg cross-dimerization between non-identical partners. Indeed, when mutant rdw-Tg (Tg-G2298R, defective for protein secretion) is co-expressed with wild-type Tg, the two proteins cross-dimerize and secretion of rdw-Tg is partially restored. Moreover, we find that AChE and soluble neuroligins also can bind to the upstream Tg regions I-II-III; however, they cannot rescue secretion, because they cannot facilitate oxidative maturation of I-II-III. These data suggest that specific properties of distinct Tg ChEL mutants may result in distinct patterns of Tg monomer folding, cross-dimerization with wild-type Tg, and variable secretion behavior in heterozygous patients.	[Wang, Xiaofan; Lee, Jaemin; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48109 USA; [Lee, Jaemin; Arvan, Peter] Univ Michigan, Program Cell & Mol Biol, Med Ctr, Ann Arbor, MI 48109 USA; [Di Jeso, Bruno; Treglia, A. Sonia] Univ Lecce, Fac Sci MFN, Dipartimento Sci & Tecnol Biol & Ambientali, I-73100 Lecce, Italy; [Comoletti, Davide; Dubi, Noga; Taylor, Palmer] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Salento; University of California System; University of California San Diego	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	di jeso, bruno/0000-0001-8713-5984; Lee, Jaemin/0000-0002-0224-7141	National Institutes of Health [R01-DK40344, P42-ES010337, R37-GM18360]; Ministero dell'Universita e della Ricerca [2006069102_004]; University of Michigan Diabetes Research and Training Center [NIH5P60 DK20572]; University of Michigan Cancer Center Core laboratories [P30 CA46592]; University of Michigan; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Michigan Diabetes Research and Training Center(University of Michigan System); University of Michigan Cancer Center Core laboratories; University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK40344 (to P. A.) and P42-ES010337 and R37-GM18360 (to P. T.). This work was also supported by the Ministero dell'Universita e della Ricerca PRIN 2006069102_004 (to B. D. J.), by University of Michigan Diabetes Research and Training Center Grant NIH5P60 DK20572 for the Molecular Biology and Sequencing Cores, and by the University of Michigan Cancer Center Core laboratories (Grant P30 CA46592). This work was performed in partial fulfillment of the requirements for Ph.D. (for J. L.) in the Cellular and Molecular Biology program at the University of Michigan.	Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; Caputo M, 2007, CLIN ENDOCRINOL, V67, P351, DOI 10.1111/j.1365-2265.2007.02889.x; Caron P, 2003, J CLIN ENDOCR METAB, V88, P3546, DOI 10.1210/jc.2002-021744; Comoletti D, 2008, CHEM-BIOL INTERACT, V175, P150, DOI 10.1016/j.cbi.2008.04.040; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; De Jaco A, 2008, CHEM-BIOL INTERACT, V175, P349, DOI 10.1016/j.cbi.2008.04.023; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; Di Jeso B, 1998, EUR J BIOCHEM, V252, P583, DOI 10.1046/j.1432-1327.1998.2520583.x; DIJESO B, 2004, THYROID, P77; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Gilbert MM, 2005, FRONT BIOSCI-LANDMRK, V10, P2177, DOI 10.2741/1689; Hishinuma A, 2000, ENDOCRINOLOGY, V141, P4050, DOI 10.1210/en.141.11.4050; KEREM A, 1993, J BIOL CHEM, V268, P180; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kitanaka S, 2006, J HUM GENET, V51, P379, DOI 10.1007/s10038-006-0360-2; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Menon S, 2007, J BIOL CHEM, V282, P6183, DOI 10.1074/jbc.M608863200; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; MORI N, 1987, P NATL ACAD SCI USA, V84, P2813, DOI 10.1073/pnas.84.9.2813; Pardo V, 2008, THYROID, V18, P783, DOI 10.1089/thy.2007.0321; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Renault L, 2005, CHEM-BIOL INTERACT, V157, P339, DOI 10.1016/j.cbi.2005.10.100; Rivolta CM, 2006, CLIN CHIM ACTA, V374, P8, DOI 10.1016/j.cca.2006.05.043; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; Srivatsan M, 2006, BIOINFORMATION, V1, P281, DOI 10.6026/97320630001281; SWILLENS S, 1986, BIOCHEM BIOPH RES CO, V137, P142, DOI 10.1016/0006-291X(86)91187-3; TARGOVNIK HM, 2010, MOL CELL EN IN PRESS; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; Veneziani BM, 1999, BIOCHIMIE, V81, P517, DOI 10.1016/S0300-9084(99)80104-7; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	46	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17564	17573		10.1074/jbc.M110.111641	http://dx.doi.org/10.1074/jbc.M110.111641			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353937	Green Published, hybrid			2022-12-25	WOS:000278133400035
J	Kozlov, AG; Cox, MM; Lohman, TM				Kozlov, Alexander G.; Cox, Michael M.; Lohman, Timothy M.			Regulation of Single-stranded DNA Binding by the C Termini of Escherichia coli Single-stranded DNA-binding (SSB) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 32 PROTEIN; NEGATIVE COOPERATIVITY; BACTERIOPHAGE T7; NUCLEIC-ACIDS; OLIGONUCLEOTIDE INTERACTIONS; DEINOCOCCUS-RADIODURANS; LIMITED PROTEOLYSIS; CRYSTAL-STRUCTURE; TETRAMER BINDING; MODE TRANSITIONS	The homotetrameric Escherichia coli single-stranded DNA-binding (SSB) protein plays a central role in DNA replication, repair, and recombination. In addition to its essential activity of binding to transiently formed single-stranded (ss) DNA, SSB also binds an array of partner proteins and recruits them to their sites of action using its four intrinsically disordered C-terminal tails. Here we show that the binding of ssDNA to SSB is inhibited by the SSB C-terminal tails, specifically by the last 8 highly acidic amino acids that comprise the binding site for its multiple partner proteins. We examined the energetics of ssDNA binding to short oligodeoxynucleotides and find that at moderate salt concentration, removal of the acidic C-terminal ends increases the intrinsic affinity for ssDNA and enhances the negative cooperativity between ssDNA binding sites, indicating that the C termini exert an inhibitory effect on ssDNA binding. This inhibitory effect decreases as the salt concentration increases. Binding of ssDNA to approximately half of the SSB subunits relieves the inhibitory effect for all of the subunits. The inhibition by the C termini is due primarily to a less favorable entropy change upon ssDNA binding. These observations explain why ssDNA binding to SSB enhances the affinity of SSB for its partner proteins and suggest that the C termini of SSB may interact, at least transiently, with its ssDNA binding sites. This inhibition and its relief by ssDNA binding suggest a mechanism that enhances the ability of SSB to selectively recruit its partner proteins to sites on DNA.	[Kozlov, Alexander G.; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Lohman, TM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231,660 S Euclid Ave, St Louis, MO 63110 USA.	lohman@biochem.wustl.edu			National Institutes of Health [GM30498, GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335, R01GM030498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM30498 (to T. M. L.) and GM32335 (to M. M. C.).	Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; BUJALOWSKI W, 1989, J MOL BIOL, V207, P269, DOI 10.1016/0022-2836(89)90455-5; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1989, J MOL BIOL, V207, P249, DOI 10.1016/0022-2836(89)90454-3; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1991, J BIOL CHEM, V266, P1616; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; FERRARI ME, 1994, J MOL BIOL, V236, P106, DOI 10.1006/jmbi.1994.1122; FERRARI ME, 1994, BIOCHEMISTRY-US, V33, P12896, DOI 10.1021/bi00209a022; GRAY DM, 1992, METHOD ENZYMOL, V211, P389; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HOSODA J, 1978, J BIOL CHEM, V253, P7547; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; Kozlov AG, 1998, J MOL BIOL, V278, P999, DOI 10.1006/jmbi.1998.1738; Kozlov AG, 1999, BIOCHEMISTRY-US, V38, P7388, DOI 10.1021/bi990309z; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P424; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, BIOCHEMISTRY-US, V33, P6167, DOI 10.1021/bi00186a016; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lohman TM., 1990, BIOL NONSPECIFIC DNA, P131; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MicroCal, 2004, ITC DAT AN OR TUT GU; MOISE H, 1976, NATURE, V259, P455, DOI 10.1038/259455a0; OVERMAN LB, 1994, J MOL BIOL, V236, P165, DOI 10.1006/jmbi.1994.1126; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; SANCAR A, 1981, P NATL ACAD SCI-BIOL, V78, P4274, DOI 10.1073/pnas.78.7.4274; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	52	67	73	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17246	17252		10.1074/jbc.M110.118273	http://dx.doi.org/10.1074/jbc.M110.118273			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360609	Green Published, hybrid			2022-12-25	WOS:000277982600086
J	Oh, M; Dey, A; Gerard, RD; Hill, JA; Rothermel, BA				Oh, Misook; Dey, Asim; Gerard, Robert D.; Hill, Joseph A.; Rothermel, Beverly A.			The CCAAT/Enhancer Binding Protein beta (C/EBP beta) Cooperates with NFAT to Control Expression of the Calcineurin Regulatory Protein RCAN1-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION-1; ENDOTHELIAL GROWTH-FACTOR; CARDIAC-HYPERTROPHY; TRANSCRIPTION FACTORS; NUCLEAR FACTOR; DIFFERENTIAL ACTIVATION; INHIBITOR DSCR1; GENE-EXPRESSION; TUMOR-GROWTH; PROLIFERATION	Regulator of calcineurin 1 (RCAN1) inhibits the protein phosphatase calcineurin and is required for appropriate immune responses, synaptic plasticity, vascular tone, angiogenesis, and cardiac remodeling. Expression of the RCAN1-4 isoform is under the control of the calcineurin-responsive transcription factor NFAT. Typically, NFATs act in cooperation with other transcription factors to achieve maximal activation of gene expression. In this study, we identify the CCAAT/enhancer binding protein beta (C/EBP beta) as an NFAT binding partner that cooperates with NFAT to regulate RCAN1-4 expression. Numerous C/EBP beta binding sites are conserved in the RCAN1-4 proximal promoter. Overexpression of C/EBP beta increased activity of both the endogenous mouse Rcan1-4 gene and a human RCAN1-4 luciferase reporter. Binding of C/EBP beta to multiple sites in the promoter was verified using electrophoretic mobility shift assays and chromatin immunoprecipitation. Adirect interaction between C/EBP beta and NFAT was demonstrated by co-immunoprecipitation of proteins and complex formation at NFAT-C/EBP beta composite sites. Depletion of endogenous C/EBP beta decreased maximal activation of RCAN1-4 expression by calcineurin, whereas inhibition of calcineurin did not alter the ability of C/EBP beta to activate RCAN1-4 expression. Together, these findings suggest that calcineurin/NFAT activation of RCAN1-4 expression is in part dependent upon C/EBP beta, whereas activation by C/EBP beta is not dependent on calcineurin and may provide a calcineurin-independent pathway for regulating RCAN1-4 expression. Importantly, nuclear localization, C/EBP beta DNA binding activity and occupancy of the Rcan1-4 promoter increased in mouse models of heart failure demonstrating in vivo activation of this pathway to regulate Rcan1-4 expression and ultimately shape the dynamics of calcineurin-dependent signaling.	[Oh, Misook; Dey, Asim; Gerard, Robert D.; Hill, Joseph A.; Rothermel, Beverly A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rothermel, BA (corresponding author), 5323 Harry Hines Blvd,NB11-200, Dallas, TX 75390 USA.	beverly.rothermel@utsouthwestern.edu			National Institute of Health [HL072016, HL097768, HL075173, HL080144, HL090842]; American Heart Association [0655202Y, 0970518N, 0640084N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080144, R01HL072016, R01HL097768, R01HL075173, R01HL090842] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL072016 and HL097768 (to B. A. R.) and HL075173, HL080144, and HL090842 (to J. A. H.). This work was also supported by American Heart Association Grants 0655202Y (to B. A. R.), 0970518N, and 0640084N (to J. A. H.).	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hill JA, 2002, J BIOL CHEM, V277, P10251, DOI 10.1074/jbc.M110722200; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Tremblay JJ, 2002, ENDOCRINOLOGY, V143, P3935, DOI 10.1210/en.2002-220413; Van Riper D, 2008, ARCH BIOCHEM BIOPHYS, V472, P43, DOI 10.1016/j.abb.2008.01.029; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Wu H, 2007, J BIOL CHEM, V282, P30673, DOI 10.1074/jbc.M703622200; Yan SF, 1997, J BIOL CHEM, V272, P4287, DOI 10.1074/jbc.272.7.4287; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang TTC, 2006, J BIOL CHEM, V281, P11541, DOI 10.1074/jbc.M511214200; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; Zhang F, 2003, J BIOL CHEM, V278, P44246, DOI 10.1074/jbc.M305564200; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	39	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16623	16631		10.1074/jbc.M109.098236	http://dx.doi.org/10.1074/jbc.M109.098236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371871	Green Published, hybrid			2022-12-25	WOS:000277982600026
J	Zhang, AS; Gao, JW; Koeberl, DD; Enns, CA				Zhang, An-Sheng; Gao, Junwei; Koeberl, Dwight D.; Enns, Caroline A.			The Role of Hepatocyte Hemojuvelin in the Regulation of Bone Morphogenic Protein-6 and Hepcidin Expression in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1Q-LINKED JUVENILE HEMOCHROMATOSIS; DISEASE TYPE-II; IRON-METABOLISM; SOLUBLE HEMOJUVELIN; GENE-THERAPY; MOUSE-LIVER; NEOGENIN; OVERLOAD; STORAGE; BMP6	Both hemojuvelin (HJV) and bone morphogenic protein-6 (BMP6) are essential for hepcidin expression. Hepcidin is the key peptide hormone in iron homeostasis, and is secreted predominantly by hepatocytes. HJV expression is detected in hepatocytes, as well as in skeletal and heart muscle. HJV binds BMP6 and increases hepcidin expression presumably by acting as a BMP co-receptor. We characterized the role of hepatocyte HJV in the regulation of BMP6 and hepcidin expression. In HJV-null (Hjv(-/-)) mice that have severe iron overload and marked suppression of hepcidin expression, we detected 4-fold higher hepatic BMP6 mRNA than in wild-type counterparts. These results indicate that Hjv(-/-) mice do not lack BMP6. Furthermore, iron depletion in Hjv(-/-) mice decreased hepatic BMP6 mRNA. Expression of HJV in hepatocytes of Hjv(-/-) mice using an AAV2/8 vector, increased hepatic hepcidin mRNA by 65-fold and phosphorylated Smad1/5/8 in the liver by about 2.5-fold. However, no significant change in BMP6 mRNA was detected in either the liver or the small intestine of these animals. Our results revealed a close correlation of hepatic BMP6 mRNA expression with hepatic iron-loading. Together, our data indicate that the regulation of hepatic BMP6 expression by iron is independent of HJV, and that expression of HJV in hepatocytes plays an essential role in hepcidin expression by potentiating the BMP6-mediated signaling.	[Zhang, An-Sheng; Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Koeberl, Dwight D.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA	Oregon Health & Science University; Duke University	Zhang, AS (corresponding author), OR Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [DK080765]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080765, T32DK067864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080765 (to A.-S.Z.).	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Ganz T, 2008, CELL METAB, V7, P288, DOI 10.1016/j.cmet.2008.03.008; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Harding CO, 2006, GENE THER, V13, P457, DOI 10.1038/sj.gt.3302678; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Krijt J, 2010, PHYSIOL RES, V59, P53, DOI 10.33549/physiolres.931706; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Sun B, 2007, AM J HUM GENET, V81, P1042, DOI 10.1086/522236; Sun BD, 2005, MOL THER, V11, P57, DOI 10.1016/j.ymthe.2004.10.004; TORRANCE JD, 1968, S AFR J MED SCI, V3, P9; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	33	63	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16416	16423		10.1074/jbc.M110.109488	http://dx.doi.org/10.1074/jbc.M110.109488			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363739	Green Published, hybrid			2022-12-25	WOS:000277982600003
J	Chen, YC; Zhang, XW; Niu, XH; Xin, DQ; Zhao, WP; Na, YQ; Mao, ZB				Chen, Y. C.; Zhang, X. W.; Niu, X. H.; Xin, D. Q.; Zhao, W. P.; Na, Y. Q.; Mao, Z. B.			Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer	ONCOGENE			English	Article						HBP1; MIF; cancer	RETINOBLASTOMA PROTEIN; PROGENITOR CELLS; FACTOR HBP1; EXPRESSION; GROWTH; GENE; ADENOCARCINOMA; CARCINOMA; EFFECTORS; PATHWAY	Macrophage migration inhibitory factor (MIF) is a well-described proinflammatory mediator. MIF overexpression has been observed in many tumors and is implicated in oncogenic transformation and tumor progression. However, the molecular mechanisms responsible for regulating MIF expression remain poorly understood. In this study, we showed that the transcriptional repressor HBP1 (HMG box-containing protein 1) negatively regulates MIF expression. We first identified a large high-affinity HBP1 DNA-binding element at positions -811 to -792 from the transcriptional start site within the MIF promoter by computer analysis. Reporter analyses showed that this element was required for HBP1-mediated transcriptional repression. Furthermore, HBP1 associated with the MIF promoter in vivo and repressed endogenous MIF gene expression. Consistent with HBP1-mediated repression of MIF, low levels of HBP1 expression were associated with high levels of MIF expression in prostate cancer samples. Importantly, HBP1-mediated repression of MIF inhibited tumorigenic growth and invasion, and the repressive effect of HBP1 on tumorigenic growth and invasion could be partially rescued by the addition of recombinant MIF to the culture medium. Finally, prostate tumor samples with low HBP1 and high MIF expression were associated with a significant decrease in relapse-free survival. Taken together, these results indicated that HBP1 directly inhibited MIF gene transcription, and suggested that the loss of HBP1 expression or activity may contribute to the upregulation of MIF expression in prostate tumor tissue. Oncogene (2010) 29, 3067-3078; doi: 10.1038/onc.2010.97; published online 12 April 2010	[Zhang, X. W.; Mao, Z. B.] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China; [Chen, Y. C.; Niu, X. H.; Xin, D. Q.; Na, Y. Q.] Peking Univ, Peking Univ Hosp 1, Dept Urol, Beijing 100083, Peoples R China; [Chen, Y. C.; Niu, X. H.; Xin, D. Q.; Na, Y. Q.] Peking Univ, Inst Urol, Beijing 100083, Peoples R China; [Zhao, W. P.] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China	Peking University; Peking University; Peking University; Zhejiang University	Mao, ZB (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 XueyuanRd, Beijing 100083, Peoples R China.	zbmao@bjmu.edu.cn			National Science Foundation of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Our work has been funded by the National Science Foundation of China. Most parts of this research were completed in Dr Mao's laboratory. Dr Mao was the corresponding author.	Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; Bini L, 1997, ELECTROPHORESIS, V18, P2832, DOI 10.1002/elps.1150181519; Gartel AL, 1998, ONCOGENE, V17, P3463, DOI 10.1038/sj.onc.1202240; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Kamimura A, 2000, CANCER, V89, P334, DOI 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N; Lavender P, 1997, ONCOGENE, V14, P2721, DOI 10.1038/sj.onc.1201243; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin KM, 2001, LEUKEMIA, V15, P601, DOI 10.1038/sj.leu.2402071; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lu XF, 2005, J BIOL CHEM, V280, P22606, DOI 10.1074/jbc.M412073200; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Mitchell RA, 2004, CELL SIGNAL, V16, P13, DOI 10.1016/j.cellsig.2003.07.002; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; Ren Y, 2003, INT J CANCER, V107, P22, DOI 10.1002/ijc.11287; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shih HH, 1998, MOL CELL BIOL, V18, P4732, DOI 10.1128/MCB.18.8.4732; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Walsh PC, 2002, CAMPBELLS UROLOGY; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	27	45	50	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 27	2010	29	21					3067	3078		10.1038/onc.2010.97	http://dx.doi.org/10.1038/onc.2010.97			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20383199				2022-12-25	WOS:000278133100004
J	Odgren, PR; Pratt, CH; MacKay, CA; Mason-Savas, A; Curtain, M; Shopland, L; Ichicki, T; Sundberg, JP; Donahue, LR				Odgren, Paul R.; Pratt, Craig H.; MacKay, Carole A.; Mason-Savas, April; Curtain, Michelle; Shopland, Lindsay; Ichicki, Tsutomu; Sundberg, John P.; Donahue, Leah Rae			Disheveled Hair and Ear (Dhe), a Spontaneous Mouse Lmna Mutation Modeling Human Laminopathies	PLOS ONE			English	Article							LINKAGE TESTING STOCK; A-TYPE LAMINS; NUCLEAR-ENVELOPE; RESTRICTIVE DERMOPATHY; MUSCULAR-DYSTROPHY; IN-VITRO; EXPRESSION; PROTEINS; MICE; RAT	Background: Investigations of naturally-occurring mutations in animal models provide important insights and valuable disease models. Lamins A and C, along with lamin B, are type V intermediate filament proteins which constitute the proteinaceous boundary of the nucleus. LMNA mutations in humans cause a wide range of phenotypes, collectively termed laminopathies. To identify the mutation and investigate the phenotype of a spontaneous, semi-dominant mutation that we have named Disheveled hair and ear (Dhe), which causes a sparse coat and small external ears in heterozygotes and lethality in homozygotes by postnatal day 10. Findings: Genetic mapping identified a point mutation in the Lmna gene, causing a single amino acid change, L52R, in the coiled coil rod domain of lamin A and C proteins. Cranial sutures in Dhe/+ mice failed to close. Gene expression for collagen types I and III in sutures was deficient. Skulls were small and disproportionate. Skeletons of Dhe/+ mice were hypomineralized and total body fat was deficient in males. In homozygotes, skin and oral mucosae were dysplastic and ulcerated. Nuclear morphometry of cultured cells revealed gene dose-dependent blebbing and wrinkling. Conclusion: Dhe mice should provide a useful new model for investigations of the pathogenesis of laminopathies.	[Odgren, Paul R.; MacKay, Carole A.; Mason-Savas, April] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Pratt, Craig H.; Shopland, Lindsay] Inst Mol Biophys, Bar Harbor, ME USA; [Curtain, Michelle; Donahue, Leah Rae] Genet Resource Sci, Bar Harbor, ME USA; [Pratt, Craig H.; Curtain, Michelle; Shopland, Lindsay; Ichicki, Tsutomu; Sundberg, John P.; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Odgren, PR (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	LeahRae.Donahue@jax.org		Pratt, Herb/0000-0002-4964-8292	National Institute of Dental and Craniofacial Research [DE 007444]; National Center for Research Resources [RR01183]; National Eye Institute [EY015073]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR49288]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE007444] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was made possible by grants DE 007444 to PRO from the National Institute of Dental and Craniofacial Research; RR01183 from the National Center for Research Resources and EY015073 from the National Eye Institute to LRD; AR49288 from National Institute of Arthritis and Musculoskeletal and Skin Diseases to JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; BAUSCHATZ JDG, 2001, PRELIMINARY SKULL CH; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; DECAUDAIN A, 2007, J CLIN ENDOCRINOL ME; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Jacob KN, 2006, MOL GENET METAB, V87, P289, DOI 10.1016/j.ymgme.2005.10.018; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kosho T, 2007, AM J MED GENET A, V143A, P2598, DOI 10.1002/ajmg.a.31983; Lenton KA, 2005, CURR TOP DEV BIOL, V66, P287, DOI 10.1016/S0070-2153(05)66009-7; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; Marks SC, 1999, DEV DYNAM, V215, P117; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nagano A, 2000, CURR OPIN NEUROL, V13, P533, DOI 10.1097/00019052-200010000-00005; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Odgren PR, 2006, CONNECT TISSUE RES, V47, P229, DOI 10.1080/03008200600860086; Odgren PR, 1996, PROTEINS, V24, P467, DOI 10.1002/(SICI)1097-0134(199604)24:4<467::AID-PROT6>3.0.CO;2-B; ODGREN PR, 2003, EPICENTRE FORUM, V10, P6; OPPERMAN LA, 1995, J BONE MINER RES, V10, P1978; Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; SEYMOUR R, 2004, HDB EXPT ANIMALS LAB, P495; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TAYLOR BA, 1993, GENOMICS, V16, P380, DOI 10.1006/geno.1993.1201; TAYLOR BA, 1989, GENOMICS, V5, P221, DOI 10.1016/0888-7543(89)90050-5; Vantyghem MC, 2007, CLIN ENDOCRINOL, V67, P247, DOI 10.1111/j.1365-2265.2007.02870.x; VERLOES A, 1992, AM J MED GENET, V43, P539, DOI 10.1002/ajmg.1320430308; Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105; Xu J, 2000, J CELL BIOCHEM, V77, P103, DOI 10.1002/(SICI)1097-4644(20000401)77:1<103::AID-JCB11>3.0.CO;2-G; Yang MH, 2006, BLOOD, V107, P2262, DOI 10.1182/blood-2005-08-3365; YOUNG L W, 1971, Birth Defects Original Article Series, V7, P291; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	39	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9959	10.1371/journal.pone.0009959	http://dx.doi.org/10.1371/journal.pone.0009959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376364	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200034
J	Southgate, TD; McGinn, OJ; Castro, FV; Rutkowski, AJ; Al-Muftah, M; Marinov, G; Smethurst, GJ; Shaw, D; Ward, CM; Miller, CJ; Stern, PL				Southgate, Thomas D.; McGinn, Owen J.; Castro, Fernanda V.; Rutkowski, Andrzej J.; Al-Muftah, Mariam; Marinov, Georgi; Smethurst, Graeme J.; Shaw, David; Ward, Christopher M.; Miller, Crispin J.; Stern, Peter L.			CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; TROPHOBLAST GLYCOPROTEIN; ANTIGEN-EXPRESSION; TUMOR-GROWTH; PROTEIN; CARCINOMA; ADHESION; CANCER; CXCL12; DIFFERENTIATION	5T4 oncofetal molecules are highly expressed during development and upregulated in cancer while showing only low levels in some adult tissues. Upregulation of 5T4 expression is a marker of loss of pluripotency in the early differentiation of embryonic stem (ES) cells and forms an integrated component of an epithelial-mesenchymal transition, a process important during embryonic development and metastatic spread of epithelial tumors. Investigation of the transcriptional changes in early ES differentiation showed upregulation of CXCL12 and down-regulation of a cell surface protease, CD26, which cleaves this chemokine. CXCL12 binds to the widely expressed CXCR4 and regulates key aspects of development, stem cell motility and tumour metastasis to tissues with high levels of CXCL12. We show that the 5T4 glycoprotein is required for optimal functional cell surface expression of the chemokine receptor CXCR4 and CXCL12 mediated chemotaxis in differentiating murine embryonic stem cells and embryo fibroblasts (MEF). Cell surface expression of 5T4 and CXCR4 molecules is colocalized in differentiating ES cells and MEF. By contrast, differentiating ES and MEF derived from 5T4 knockout (KO) mice show only intracellular CXCR4 expression but infection with adenovirus encoding mouse 5T4 restores CXCL12 chemotaxis and surface co-localization with 5T4 molecules. A series of chimeric constructs with interchanged domains of 5T4 and the glycoprotein CD44 were used to map the 5T4 sequences relevant for CXCR4 membrane expression and function in 5T4KO MEF. These data identified the 5T4 transmembrane domain as sufficient and necessary to enable CXCR4 cell surface expression and chemotaxis. Furthermore, some monoclonal antibodies against m5T4 can inhibit CXCL12 chemotaxis of differentiating ES cells and MEF which is not mediated by simple antigenic modulation. Collectively, these data support a molecular interaction of 5T4 and CXCR4 occurring at the cell surface which directly facilitates the biological response to CXCL12. The regulation of CXCR4 surface expression by 5T4 molecules is a novel means to control responses to the chemokine CXCL12 for example during embryogenesis but can also be selected to advantage the spread of a 5T4 positive tumor from its primary site.	[Southgate, Thomas D.; McGinn, Owen J.; Castro, Fernanda V.; Rutkowski, Andrzej J.; Al-Muftah, Mariam; Marinov, Georgi; Smethurst, Graeme J.; Shaw, David; Ward, Christopher M.; Stern, Peter L.] Univ Manchester, Paterson Inst Canc Res, Immunol Grp, Manchester, Lancs, England; [Rutkowski, Andrzej J.; Smethurst, Graeme J.; Miller, Crispin J.] Univ Manchester, Paterson Inst Canc Res, Appl Computat Biol & Bioinformat Grp, Manchester, Lancs, England	Paterson Institute for Cancer Research; University of Manchester; Paterson Institute for Cancer Research; University of Manchester	Southgate, TD (corresponding author), Univ Manchester, Paterson Inst Canc Res, Immunol Grp, Manchester, Lancs, England.	pstern@picr.man.ac.uk		Miller, Crispin/0000-0003-4341-1283; Ward, Christopher/0000-0001-7389-4488	Cancer Research UK [R108032Q]	Cancer Research UK(Cancer Research UK)	Work was funded by Cancer Research UK (www.cancerresearchuk.org) Grant No. R108032Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awan A, 2002, BIOCHEM BIOPH RES CO, V290, P1030, DOI 10.1006/bbrc.2001.6288; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barrow KM, 2005, DEV DYNAM, V233, P1535, DOI 10.1002/dvdy.20482; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CARSBERG CJ, 1995, J CELL SCI, V108, P2905; Carsberg CJ, 1996, INT J CANCER, V68, P84, DOI 10.1002/(SICI)1097-0215(19960927)68:1<84::AID-IJC15>3.0.CO;2-6; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths RW, 2005, BRIT J CANCER, V93, P670, DOI 10.1038/sj.bjc.6602776; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hildinger M, 1998, GENE THER, V5, P1575, DOI 10.1038/sj.gt.3300759; HOLE N, 1988, BRIT J CANCER, V57, P239, DOI 10.1038/bjc.1988.53; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; King KW, 1999, BBA-GENE STRUCT EXPR, V1445, P257, DOI 10.1016/S0167-4781(99)00055-X; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOFUKU Y, 2009, J BIOL CHEM; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese Adriano, 2006, V327, P139; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Mulder WMC, 1997, CLIN CANCER RES, V3, P1923; Mulryan K, 2002, MOL CANCER THER, V1, P1129; MYERS KA, 1994, J BIOL CHEM, V269, P9319; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Shaw DM, 2002, BIOCHEM J, V363, P137, DOI 10.1042/0264-6021:3630137; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; SMETHURST G, 2006, MICROARRAY ANAL MOUS; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; SOUTHALL PJ, 1990, BRIT J CANCER, V61, P89, DOI 10.1038/bjc.1990.20; SOUTHGATE TD, 2001, CURR PROTOC NEUROSCI, pCH4; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Starzynska T, 1998, EUR J GASTROEN HEPAT, V10, P479, DOI 10.1097/00042737-199806000-00008; STARZYNSKA T, 1994, BRIT J CANCER, V69, P899, DOI 10.1038/bjc.1994.173; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Ward CM, 2006, EXP CELL RES, V312, P1713, DOI 10.1016/j.yexcr.2006.02.006; Ward CM, 2003, J CELL SCI, V116, P4533, DOI 10.1242/jcs.00767; Woods AM, 2002, BIOCHEM J, V366, P353, DOI 10.1042/BJ20020104; WRIGLEY E, 1995, INT J GYNECOL CANCER, V5, P269, DOI 10.1046/j.1525-1438.1995.05040269.x; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhang J, 2005, CARCINOGENESIS, V26, P2069, DOI 10.1093/carcin/bgi183; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	66	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9982	10.1371/journal.pone.0009982	http://dx.doi.org/10.1371/journal.pone.0009982			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376365	Green Published, Green Submitted, gold			2022-12-25	WOS:000276418200053
J	Slominski, AT; Janjetovic, Z; Fuller, BE; Zmijewski, MA; Tuckey, RC; Nguyen, MN; Sweatman, T; Li, W; Zjawiony, J; Miller, D; Chen, TC; Lozanski, G; Holick, MF				Slominski, Andrzej T.; Janjetovic, Zorica; Fuller, Brian E.; Zmijewski, Michal A.; Tuckey, Robert C.; Nguyen, Minh N.; Sweatman, Trevor; Li, Wei; Zjawiony, Jordan; Miller, Duane; Chen, Tai C.; Lozanski, Gerard; Holick, Michael F.			Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity	PLOS ONE			English	Article							KAPPA-B ACTIVITY; ERYTHROID-DIFFERENTIATION; D ANALOGS; LEUKEMIA; RECEPTOR; INDUCTION; PATHWAY; SYSTEM; D3; PROLIFERATION	Background: Cytochrome P450scc metabolizes vitamin D3 to 20-hydroxyvitamin D3 (20(OH) D3) and 20,23(OH)(2)D3, as well as 1-hydroxyvitamin D3 to 1 alpha,20-dihydroxyvitamin D3 (1,20(OH)(2)D3). It also cleaves the side chain of 7-dehydrocholesterol producing 7-dehydropregnenolone (7DHP), which can be transformed to 20(OH)7DHP. UVB induces transformation of the steroidal 5,7-dienes to pregnacalciferol (pD) and a lumisterol-like compounds (pL). Methods and Findings: To define the biological significance of these P450scc-initiated pathways, we tested the effects of their 5,7-diene precursors and secosteroidal products on leukemia cell differentiation and proliferation in comparison to 1 alpha,25-dihydroxyvitamin D3 (1,25(OH)(2)D3). These secosteroids inhibited proliferation and induced erythroid differentiation of K562 human chronic myeloid and MEL mouse leukemia cells with 20(OH)D3 and 20,23(OH)(2)D3 being either equipotent or slightly less potent than 1,25(OH)(2)D3, while 1,20(OH)(2)D3, pD and pL compounds were slightly or moderately less potent. The compounds also inhibited proliferation and induced monocytic differentiation of HL-60 promyelocytic and U937 promonocytic human leukemia cells. Among them 1,25(OH)(2)D3 was the most potent, 20(OH)D3, 20,23(OH)(2)D3 and 1,20(OH)(2)D3 were less active, and pD and pL compounds were the least potent. Since it had been previously proven that secosteroids without the side chain (pD) have no effect on systemic calcium levels we performed additional testing in rats and found that 20(OH)D3 had no calcemic activity at concentration as high as 1 mg/kg, whereas, 1,20(OH)(2)D3 was slightly to moderately calcemic and 1,25(OH)(2)D3 had strong calcemic activity. Conclusions: We identified novel secosteroids that are excellent candidates for anti-leukemia therapy with 20(OH)D3 deserving special attention because of its relatively high potency and lack of calcemic activity.	[Slominski, Andrzej T.; Janjetovic, Zorica; Fuller, Brian E.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Zmijewski, Michal A.] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol Enzymol, PL-80952 Gdansk, Poland; [Zmijewski, Michal A.] Med Univ Gdansk, Gdansk, Poland; [Tuckey, Robert C.; Nguyen, Minh N.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia; [Sweatman, Trevor] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Sweatman, Trevor] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Li, Wei; Miller, Duane] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Zjawiony, Jordan] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA; [Zjawiony, Jordan] Univ Mississippi, Sch Pharm, Pharmaceut Sci Res Inst, University, MS 38677 USA; [Chen, Tai C.; Holick, Michael F.] Boston Univ, Sch Med, Dept Med, Div Endocrinol, Boston, MA 02118 USA; [Lozanski, Gerard] Ohio State Univ, Dept Pathol & Lab Med, Columbus, OH 43210 USA	University of Tennessee System; University of Tennessee Health Science Center; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Western Australia; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Mississippi; University of Mississippi; Boston University; University System of Ohio; Ohio State University	Slominski, AT (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.	aslominski@uthsc.edu	Tuckey, Robert/H-5983-2014	Holick, Michael/0000-0001-6023-9062; Zmijewski, Michal/0000-0003-2206-3531; Li, Wei/0000-0002-9522-4474; Tuckey, Robert/0000-0002-5022-4729; Slominski, Andrzej/0000-0001-8963-3995; Zjawiony, Jordan/0000-0001-5242-2799; Chen, Tai/0000-0002-5704-5694	NIH [R01A052190]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH grant R01A052190 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2000, LEUKEMIA, V14, P2176, DOI 10.1038/sj.leu.2401950; Bar M, 2007, J INVEST DERMATOL, V127, P206, DOI 10.1038/sj.jid.5700493; Bikle DD, 2007, CURR OPIN RHEUMATOL, V19, P383, DOI 10.1097/BOR.0b013e32818e9d58; BIKLE DD, 1986, J CLIN INVEST, V78, P557, DOI 10.1172/JCI112609; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Fabiani R, 2006, J NUTR, V136, P614, DOI 10.1093/jn/136.3.614; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; GALLAGHER R, 1979, BLOOD, V54, P713; Guryev O, 2003, P NATL ACAD SCI USA, V100, P14754, DOI 10.1073/pnas.2336107100; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOLICK MF, 1975, J BIOL CHEM, V250, P226; HOLICK MF, 1978, FED PROC, V37, P2567; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; James SY, 1999, GEN PHARMACOL, V32, P143, DOI 10.1016/S0306-3623(98)00098-6; Janjetovic Z, 2010, J CELL PHYSIOL, V223, P36, DOI 10.1002/jcp.21992; Janjetovic Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005988; Kamradt J, 2003, RECENT RESULTS CANC, V164, P259; Mahdavi M, 2007, ARCH PHARM RES, V30, P177, DOI 10.1007/BF02977692; Masuda S, 2006, MOL CANCER THER, V5, P797, DOI 10.1158/1535-7163.MCT-05-0539; MEYSKENS FL, 1995, LEUKEMIA RES, V19, P605, DOI 10.1016/0145-2126(95)00032-J; Mukai H, 2006, NEUROENDOCRINOLOGY, V84, P255, DOI 10.1159/000097747; Munker R, 1996, BLOOD, V88, P2201, DOI 10.1182/blood.V88.6.2201.bloodjournal8862201; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nakagawa K, 2005, CARCINOGENESIS, V26, P1044, DOI 10.1093/carcin/bgi049; NILSSON K, 1974, INT J CANCER, V13, P808, DOI 10.1002/ijc.2910130609; Pisarchik A V, 2001, Mol Gen Mikrobiol Virusol, P15; Qiao SJ, 2009, ENDOCRINOLOGY, V150, P4163, DOI 10.1210/en.2009-0195; REDDY PMS, 1993, MOL CELL BIOL, V13, P1093, DOI 10.1128/MCB.13.2.1093; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Schwartz GG, 2006, J NATL CANCER I, V98, P428, DOI 10.1093/jnci/djj127; Sicinski RR, 1998, J MED CHEM, V41, P4662, DOI 10.1021/jm9802618; Slominski A, 2005, CHEM BIOL, V12, P931, DOI 10.1016/j.chembiol.2005.06.010; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; Slominski A, 2006, J CELL PHYSIOL, V206, P780, DOI 10.1002/jcp.20530; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004309; Spina CS, 2007, J STEROID BIOCHEM, V103, P757, DOI 10.1016/j.jsbmb.2006.12.040; Spina CS, 2006, ANTICANCER RES, V26, P2515; Srivastava MD, 2004, LEUKEMIA LYMPHOMA, V45, P2119, DOI 10.1080/1042819032000159924; TANG E, 2010, J STEROID B IN PRESS; Teplyuk NM, 2009, J CELL BIOCHEM, V107, P144, DOI 10.1002/jcb.22108; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; TUCKEY RC, 2008, J STEROID BIOCH MOL; TUCKEY RC, 2008, INT J BIOCH CELL BIO; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Wu-Wong JR, 2006, LEUKEMIA LYMPHOMA, V47, P727, DOI 10.1080/10428190500398898; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72; Zmijewski MA, 2009, STEROIDS, V74, P218, DOI 10.1016/j.steroids.2008.10.017; Zmijewski MA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1570, DOI 10.1039/b809005j	54	125	126	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9907	10.1371/journal.pone.0009907	http://dx.doi.org/10.1371/journal.pone.0009907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360850	Green Published, Green Submitted, gold			2022-12-25	WOS:000275969600013
J	De Toni-Costes, F; Despeaux, M; Bertrand, J; Bourogaa, E; Ysebaert, L; Payrastre, B; Racaud-Sultan, C				De Toni-Costes, Fabienne; Despeaux, Mathieu; Bertrand, Jessica; Bourogaa, Ezzeddine; Ysebaert, Loic; Payrastre, Bernard; Racaud-Sultan, Claire			A New alpha(5)beta(1) Integrin-Dependent Survival Pathway Through GSK3 beta Activation in Leukemic Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN PHOSPHATASE 2A; FACTOR-KAPPA-B; ACUTE MYELOID-LEUKEMIA; FOCAL ADHESION KINASE; SIGNALING PATHWAYS; COLORECTAL-CANCER; APOPTOSIS; GROWTH; RECEPTOR	Background: Cell survival mediated by integrin engagement has been implicated in cell adhesion-mediated drug resistance. We have recently demonstrated that the activation of glycogen synthase kinase 3 beta (GSK3 beta) is a new pathway supporting the chemoresistance of leukemic cells adhered to fibronectin. Methodology and Principal Findings: We show here that in conditions of serum starvation, the fibronectin receptor alpha(5)beta(1) integrin, but not alpha(4)beta(1), induced activation of GSK3 beta through Ser-9 dephosphorylation in adherent U937 cells. The GSK3 beta-dependent survival pathway occurred in adherent leukemic cells from patients but not in the HL-60 and KG1 cell lines. In adhesion, activated GSK3 beta was found in the cytosol/plasma membrane compartment and was co-immunoprecipitated with alpha(5) integrin, the phosphatase PP2A and the scaffolding protein RACK1. PP2A and its regulatory subunit B' regulated the Ser-9 phosphorylation of GSK3 beta. In adherent leukemic cells, alpha(5)beta(1) integrin but not alpha(4)beta(1) upregulated the resistance to TNF alpha-induced apoptosis. Both extrinsic and intrinsic apoptotic pathways were under the control of alpha(5)beta(1) and GSK3 beta. Conclusions and Significance: Our data show that, upon serum starvation, alpha(5)beta(1) integrin engagement could regulate specific pro-survival functions through the activation of GSK3 beta.	[De Toni-Costes, Fabienne; Despeaux, Mathieu; Bertrand, Jessica; Bourogaa, Ezzeddine; Ysebaert, Loic; Payrastre, Bernard; Racaud-Sultan, Claire] Fac Med Toulouse, INSERM, U563, F-31073 Toulouse, France; [De Toni-Costes, Fabienne; Despeaux, Mathieu; Bertrand, Jessica; Bourogaa, Ezzeddine; Ysebaert, Loic; Payrastre, Bernard; Racaud-Sultan, Claire] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France; [Ysebaert, Loic] Hop Purpan, CHU Toulouse, Serv Hematol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	De Toni-Costes, F (corresponding author), Fac Med Toulouse, INSERM, U563, U317, F-31073 Toulouse, France.	claire.racaud@inserm.fr	Payrastre, Bernard/M-5295-2014; Ysebaert, Loic/H-1554-2016	Ysebaert, Loic/0000-0001-8478-5623; Racaud-Sultan, Claire/0000-0002-6549-1088; , Bernard/0000-0002-8693-0190	Association de Recherche contre le Cancer [Nu3638, Nu8407]; Institut National du Cancer [Nu07/3D1616/IABC-23-8/NC-NG]; Conseil Regional de Midi-Pyrenees; DGRSRT/INSERM Franco-Tunisian cooperation	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Conseil Regional de Midi-Pyrenees(Region Occitanie); DGRSRT/INSERM Franco-Tunisian cooperation	Financial support was obtained from the Association de Recherche contre le Cancer (Nu3638, Nu8407), the Institut National du Cancer (Nu07/3D1616/IABC-23-8/NC-NG), the Conseil Regional de Midi-Pyrenees and the DGRSRT/INSERM Franco-Tunisian cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Ayala F, 2009, LEUKEMIA, V23, P2233, DOI 10.1038/leu.2009.175; Bao Wenjie, 2002, Biological Procedures Online, V4, P81, DOI 10.1251/bpo37; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Chetoui N, 2006, MOL IMMUNOL, V43, P1687, DOI 10.1016/j.molimm.2005.09.010; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kapur R, 2001, BLOOD, V97, P1975, DOI 10.1182/blood.V97.7.1975; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Liao XB, 2003, MOL CANCER THER, V2, P1215; Mourtacla-Maarabouni M, 2005, J LEUKOCYTE BIOL, V78, P503, DOI 10.1189/jlb.0205070; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tcherkasowa AE, 2002, J IMMUNOL, V169, P5161, DOI 10.4049/jimmunol.169.9.5161; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Viquez NM, 2006, J NEUROSCI, V26, P9293, DOI 10.1523/JNEUROSCI.1740-06.2006	37	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9807	10.1371/journal.pone.0009807	http://dx.doi.org/10.1371/journal.pone.0009807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352103	Green Submitted, gold, Green Published			2022-12-25	WOS:000275894400013
J	Harris, HJ; Davis, C; Mullins, JGL; Hu, K; Goodall, M; Farquhar, MJ; Mee, CJ; McCaffrey, K; Young, S; Drummer, H; Balfe, P; McKeating, JA				Harris, Helen J.; Davis, Christopher; Mullins, Jonathan G. L.; Hu, Ke; Goodall, Margaret; Farquhar, Michelle J.; Mee, Christopher J.; McCaffrey, Kitty; Young, Stephen; Drummer, Heidi; Balfe, Peter; McKeating, Jane A.			Claudin Association with CD81 Defines Hepatitis C Virus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEINS; RECEPTOR CLASS-B; SCAVENGER-RECEPTOR; TETRASPANIN SUPERFAMILY; CELL ENTRY; IN-VITRO; INFECTION; CHOLESTEROL; CORECEPTOR; EXPRESSION	Viruses initiate infection by attaching to molecules or receptors at the cell surface. Hepatitis C virus (HCV) enters cells via a multistep process involving tetraspanin CD81, scavenger receptor class B member I, and the tight junction proteins Claudin-1 and Occludin. CD81 and scavenger receptor class B member I interact with HCV-encoded glycoproteins, suggesting an initial role in mediating virus attachment. In contrast, there are minimal data supporting Claudin-1 association with HCV particles, raising questions as to its role in the virus internalization process. In the present study we demonstrate a relationship between receptor active Claudins and their association and organization with CD81 at the plasma membrane by fluorescence resonance energy transfer and stoichiometric imaging methodologies. Mutation of residues 32 and 48 in the Claudin-1 first extracellular loop ablates CD81 association and HCV receptor activity. Furthermore, mutation of the same residues in the receptor-inactive Claudin-7 molecule enabled CD81 complex formation and virus entry, demonstrating an essential role for Claudin-CD81 complexes in HCV infection. Importantly, Claudin-1 associated with CD81 at the basolateral membrane of polarized HepG2 cells, whereas tight junction-associated pools of Claudin-1 demonstrated a minimal association with CD81. In summary, we demonstrate an essential role for Claudin-CD81 complexes in HCV infection and their localization at the basolateral surface of polarized hepatoma cells, consistent with virus entry into the liver via the sinusoidal blood and association with basal expressed forms of the receptors.	[Harris, Helen J.; Davis, Christopher; Hu, Ke; Goodall, Margaret; Farquhar, Michelle J.; Mee, Christopher J.; Young, Stephen; Balfe, Peter; McKeating, Jane A.] Univ Birmingham, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Mullins, Jonathan G. L.] Swansea Univ, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; [McCaffrey, Kitty; Drummer, Heidi] Burnet Inst, Melbourne, Vic 3001, Australia	University of Birmingham; Swansea University; Burnet Institute	Balfe, P (corresponding author), Univ Birmingham, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	p.balfe@bham.ac.uk		Balfe, Peter/0000-0002-6246-0876; Drummer, Heidi/0000-0002-0042-6277; Mullins, Jonathan/0000-0003-0144-2962; McKeating, Jane/0000-0002-7229-5886; Mee, Christopher/0000-0002-6359-2694; McCaffrey, Kathleen/0000-0002-6544-2649; davis, chris/0000-0002-7317-3266	Medical Research Council [G0801976, G0400802] Funding Source: Medline; MRC [G0400802, G0801976] Funding Source: UKRI; Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barth H, 2008, J VIROL, V82, P3466, DOI 10.1128/JVI.02478-07; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Timpe JM, 2008, GUT, V57, P1728, DOI 10.1136/gut.2007.141630; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	57	160	169	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21092	21102		10.1074/jbc.M110.104836	http://dx.doi.org/10.1074/jbc.M110.104836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20375010	Green Published, hybrid			2022-12-25	WOS:000279228600072
J	Gahring, LC; Vasquez-Opazo, GA; Rogers, SW				Gahring, Lorise C.; Vasquez-Opazo, Gustavo A.; Rogers, Scott W.			Choline Promotes Nicotinic Receptor alpha 4+beta 2 Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HIPPOCAMPAL SLICES; ACETYLCHOLINE-RECEPTORS; DIETARY CHOLINE; BINDING-SITES; DIFFERENTIAL DEVELOPMENT; BRAIN-DEVELOPMENT; MAMMALIAN-CELLS; IN-VIVO; EXPRESSION; EXPOSURE	Neuronal nicotinic acetylcholine receptors ( nAChR) composed of alpha 4 + beta 2 subunits, the high affinity nicotine-binding site in the mammalian brain, up-regulate in response to chronic nicotine exposure. The identities of endogenous mediators of this process are unknown. We find that choline also up-regulates alpha 4 + beta 2 nAChRs stably expressed by HEK293 cells as measured by increased [H-3] epibatidine density. Choline-mediated up-regulation is dose-dependent and corresponds with an increase in beta 2 subunit protein expression. The choline kinase inhibitor hemicholinium-3 inhibits similar to 60% of choline-mediated up-regulation revealing both an HC3-dependent and -independent pathway. Furthermore, choline-mediated up-regulation is not additive with up-regulation agents such as nicotine, but it is additive with weaker promoters of the up-regulation process. When co-applied with the pro-inflammatory cytokine tumor necrosis factor alpha, choline- mediated up- regulation is increased further through a mechanism that includes an increase in both alpha 4 and beta 2 protein expression, and this is inhibited by the p38 MAPK inhibitor SB202190. These findings extend the view that up- regulation of alpha 4 + beta 2 nAChRs is a normal physiological response to altered metabolic and inflammatory conditions.	[Rogers, Scott W.] Univ Utah, Sch Med, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, Salt Lake City, UT 84132 USA; [Gahring, Lorise C.; Vasquez-Opazo, Gustavo A.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Univ Utah, Sch Med, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, 2C132,30 North 1900 East, Salt Lake City, UT 84132 USA.	Scott.Rogers@hsc.utah.edu			National Institutes of Health [AG017517, AG029838, DA025057]; Veterans Affairs Merit award; NATIONAL INSTITUTE ON AGING [R01AG029838, R01AG017517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG017517 (to S.W.R.), AG029838 (to L.C.G.), and DA025057 (to L.C.G. and S.W.R.). This work was also supported by a Veterans Affairs Merit award (to L.C.G.).	ABREUVILLACA Y, 2010, BEHAV BRAIN RES; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 2005, J PHARMACOL EXP THER, V313, P740, DOI 10.1124/jpet.104.081232; Alkondon M, 2006, J PHARMACOL EXP THER, V318, P268, DOI 10.1124/jpet.106.103135; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; BURT AM, 1977, J NEUROCHEM, V28, P961, DOI 10.1111/j.1471-4159.1977.tb10657.x; Campos J, 2003, CURR MED CHEM, V10, P1095, DOI 10.2174/0929867033457539; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Cermak JM, 1998, FASEB J, V12, P349, DOI 10.1096/fasebj.12.3.349; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Corringer PJ, 2006, J PHYSIOL-PARIS, V99, P162, DOI 10.1016/j.jphysparis.2005.12.012; COUTCHER JB, 1992, J PHARMACOL EXP THER, V262, P1128; Detopoulou P, 2008, AM J CLIN NUTR, V87, P424, DOI 10.1093/ajcn/87.2.424; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2005, J NEUROIMMUNOL, V166, P88, DOI 10.1016/j.jneuroim.2005.05.007; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Guseva MV, 2006, PHARMACOL BIOCHEM BE, V84, P26, DOI 10.1016/j.pbb.2006.04.002; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; HAPPE HK, 1993, J NEUROCHEM, V60, P1191, DOI 10.1111/j.1471-4159.1993.tb03277.x; Harkness PC, 2002, J NEUROSCI, V22, P10172; Janardhan S, 2006, CURR MED CHEM, V13, P1169, DOI 10.2174/092986706776360923; Klein J, 2002, J NEUROCHEM, V80, P843, DOI 10.1046/j.0022-3042.2001.00754.x; KLEIN J, 1993, NEUROCHEM INT, V22, P293, DOI 10.1016/0197-0186(93)90058-D; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P749, DOI 10.1081/DDC-120005622; Lopez-Hernandez GY, 2004, J BIOL CHEM, V279, P38007, DOI 10.1074/jbc.M403537200; MANDELZYS A, 1995, J NEUROPHYSIOL, V74, P1212, DOI 10.1152/jn.1995.74.3.1212; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; MARKS MJ, 1985, PHARMACOL BIOCHEM BE, V22, P283, DOI 10.1016/0091-3057(85)90392-2; Matsumoto Mitsuru, 1999, Journal of Medical Investigation, V46, P141; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Melnick M, 2001, ANAT RECORD, V262, P318, DOI 10.1002/1097-0185(20010301)262:3<318::AID-AR1023>3.0.CO;2-3; Michel V, 2006, EXP BIOL MED, V231, P490; Montoya DAC, 2000, DEV BRAIN RES, V123, P25, DOI 10.1016/S0165-3806(00)00075-4; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG862, DOI 10.1152/ajpgi.1998.275.4.G862; Rodriguez-Gonzalez Agustin, 2003, Prog Cell Cycle Res, V5, P191; Sallette J, 2004, J BIOL CHEM, V279, P18767, DOI 10.1074/jbc.M308260200; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Sanders Lisa M, 2007, Nutr Today, V42, P181, DOI 10.1097/01.NT.0000286155.55343.fa; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; Slotkin TA, 2005, NEUROPSYCHOPHARMACOL, V30, P129, DOI 10.1038/sj.npp.1300544; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; ZAHALKA EA, 1993, BRAIN RES, V601, P221, DOI 10.1016/0006-8993(93)91714-4; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976	60	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19793	19801		10.1074/jbc.M110.108803	http://dx.doi.org/10.1074/jbc.M110.108803			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20392695	Green Published, hybrid			2022-12-25	WOS:000279012000012
J	Liu, Q; Moldoveanu, T; Sprules, T; Matta-Camacho, E; Mansur-Azzam, N; Gehring, K				Liu, Qian; Moldoveanu, Tudor; Sprules, Tara; Matta-Camacho, Edna; Mansur-Azzam, Nura; Gehring, Kalle			Apoptotic Regulation by MCL-1 through Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BH3-ONLY PROTEINS; DIPOLAR COUPLINGS; DOWN-REGULATION; BH3 DOMAINS; BCL-2; FAMILY; NMR; INHIBITOR; DEATH	Myeloid cell leukemia 1 (MCL-1), an anti-apoptotic BCL-2 family member active in the preservation of mitochondrial integrity during apoptosis, has fundamental roles in development and hematopoiesis and is dysregulated in human cancers. It bears a unique, intrinsically unstructured, N-terminal sequence, which leads to its instability in cells and hinders protein production and structural characterization. Here, we present collective data from NMR spectroscopy and titration calorimetry to reveal the selectivity of MCL-1 in binding BCL-2 homology 3 (BH3) ligands of interest for mammalian biology. The N-terminal sequence weakens the BH3 interactions but does not affect selectivity. Its removal by calpain-mediated limited proteolysis results in a stable BCL-2-like core domain of MCL-1 (cMCL-1). This core is necessary and sufficient for BH3 ligand binding. Significantly, we also characterized the in vitro protein-protein interaction between cMCL-1 and activated BID by size exclusion chromatography and NMR titrations. This interaction occurs in a very slow manner in solution but is otherwise similar to the interaction between cMCL-1 and BID-BH3 peptides. We also present the solution structure of complex cMCL-1.hBID-BH3, which completes the family portrait of MCL-1 complexes and may facilitate drug discovery against human tumors.	[Liu, Qian; Moldoveanu, Tudor; Sprules, Tara; Matta-Camacho, Edna; Mansur-Azzam, Nura; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Liu, Qian; Sprules, Tara; Matta-Camacho, Edna; Gehring, Kalle] McGill Univ, Grp Rech GRASP, Montreal, PQ H3G 1Y6, Canada; [Sprules, Tara; Gehring, Kalle] McGill Univ, Quebec Eastern Canada High Field NMR Facil, Montreal, PQ H3A 2A7, Canada	McGill University; McGill University; McGill University	Gehring, K (corresponding author), 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@mcgill.ca	Moldoveanu, Tudor/N-8173-2018; Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Moldoveanu, Tudor/0000-0003-0791-318X; Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-81277] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Germain M, 2007, J BIOL CHEM, V282, P32233, DOI 10.1074/jbc.M706408200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PENG JW, 1994, METHOD ENZYMOL, V239, P563; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Wei MC, 2000, GENE DEV, V14, P2060; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yao Y, 2009, BIOCHEMISTRY-US, V48, P8704, DOI 10.1021/bi901171n; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	49	52	53	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19615	19624		10.1074/jbc.M110.105452	http://dx.doi.org/10.1074/jbc.M110.105452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392693	Green Published, hybrid			2022-12-25	WOS:000278727800071
J	McIntosh, AL; Huang, HA; Atshaves, BP; Wellberg, E; Kuklev, DV; Smith, WL; Kier, AB; Schroeder, F				McIntosh, Avery L.; Huang, Huan; Atshaves, Barbara P.; Wellberg, Elizabeth; Kuklev, Dmitry V.; Smith, William L.; Kier, Ann B.; Schroeder, Friedhelm			Fluorescent n-3 and n-6 Very Long Chain Polyunsaturated Fatty Acids THREE-PHOTON IMAGING IN LIVING CELLS EXPRESSING LIVER FATTY ACID-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-CELL-FIBROBLASTS; BINDING PROTEIN GENE; CULTURED PRIMARY HEPATOCYTES; ACTIVATED RECEPTOR-ALPHA; L-FABP; ARACHIDONIC-ACID; PARINARIC ACID; LIVING CELLS; MICE LACKING; LIVER	Despite the considerable beneficial effects of n-3 and n-6 very long chain polyunsaturated fatty acids (VLC-PUFAs), very little is known about the factors that regulate their uptake and intracellular distribution in living cells. This issue was addressed in cells expressing liver-type fatty acid-binding protein (L-FABP) by real time multiphoton laser scanning microscopy of novel fluorescent VLC-PUFAs containing a conjugated tetraene fluorophore near the carboxyl group and natural methylene-interrupted n-3 or n-6 grouping. The fluorescent VLC-PUFAs mimicked many properties of their native nonfluorescent counterparts, including uptake, distribution, and metabolism in living cells. The unesterified fluorescent VLC-PUFAs distributed either equally in nuclei versus cytoplasm (22-carbon n-3 VLC-PUFA) or preferentially to cytoplasm (20-carbon n-3 and n-6 VLC-PUFAs). L-FABP bound fluorescent VLC-PUFA with affinity and specificity similar to their nonfluorescent natural counterparts. Regarding n-3 and n-6 VLC-PUFA, L-FABP expression enhanced uptake into the cell and cytoplasm, selectively altered the pattern of fluorescent n-6 and n-3 VLC-PUFA distribution in cytoplasm versus nuclei, and preferentially distributed fluorescent VLC-PUFA into nucleoplasm versus nuclear envelope, especially for the 22-carbon n-3 VLC-PUFA, correlating with its high binding by L-FABP. Multiphoton laser scanning microscopy data showed for the first time VLC-PUFA in nuclei of living cells and suggested a model, whereby L-FABP facilitated VLC-PUFA targeting to nuclei by enhancing VLC-PUFA uptake and distribution into the cytoplasm and nucleoplasm.	[McIntosh, Avery L.; Huang, Huan; Wellberg, Elizabeth; Schroeder, Friedhelm] Texas A&M Univ, Texas Vet Med Ctr, Dept Physiol & Pharmacol, College Stn, TX 77843 USA; [Kier, Ann B.] Texas A&M Univ, Texas Vet Med Ctr, Dept Pathobiol, College Stn, TX 77843 USA; [Atshaves, Barbara P.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Kuklev, Dmitry V.; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Michigan State University; University of Michigan System; University of Michigan	Schroeder, F (corresponding author), Texas A&M Univ, Texas Vet Med Ctr, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.	fschroeder@cvm.tamu.edu	Wellberg, Elizabeth/AFQ-6450-2022		National Institutes of Health, USPHS [DK41402, GM31651, DK70965, DK22042]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041402, R56DK070965, R01DK070965, R37DK022042, R01DK022042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031651] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41402 (to F. S. and A. B. K.), GM31651 (to F. S. and A. B. K.), DK70965 (to B. P. A.), and DK22042 (to W. L. S.) from USPHS.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Atshaves BP, 2010, LIPIDS, V45, P97, DOI 10.1007/s11745-009-3379-2; Atshaves BP, 2005, AM J PHYSIOL-CELL PH, V288, pC543, DOI 10.1152/ajpcell.00359.2004; Atshaves BP, 2004, MOL CELL BIOCHEM, V259, P115, DOI 10.1023/B:MCBI.0000021357.97765.f2; Atshaves BP, 2004, J BIOL CHEM, V279, P30954, DOI 10.1074/jbc.M313571200; Atshaves BP, 1999, J LIPID RES, V40, P610; Atshaves BP, 2002, AM J PHYSIOL-CELL PH, V283, pC688, DOI 10.1152/ajpcell.00586.2001; ATSHAVES BP, 2010, J NUTR BIOC IN PRESS; BORDEWICK U, 1989, BIOL CHEM H-S, V370, P229, DOI 10.1515/bchm3.1989.370.1.229; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Bradbury MW, 2004, ADV MOL CEL, V33, P47; Chao H, 2003, J LIPID RES, V44, P72, DOI 10.1194/jlr.M200191-JLR200; Chen CT, 2008, PROSTAG LEUKOTR ESS, V79, P85, DOI 10.1016/j.plefa.2008.09.003; Chuang S, 2009, J MED CHEM, V52, P5344, DOI 10.1021/jm801349e; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Ek BA, 1997, BBA-LIPID LIPID MET, V1346, P75, DOI 10.1016/S0005-2760(97)00021-0; Fraser H, 1997, MOL CELL BIOCHEM, V167, P51; Frolov A, 1997, BIOCHEMISTRY-US, V36, P6545, DOI 10.1021/bi970205t; Golovko MY, 2006, J LIPID RES, V47, P1289, DOI 10.1194/jlr.M600029-JLR200; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Heyliger CE, 1996, MOL CELL BIOCHEM, V155, P113; Heyliger CE, 1997, MOL CELL BIOCHEM, V176, P281, DOI 10.1023/A:1006817632484; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; JEFFERSON JR, 1990, J BIOL CHEM, V265, P11062; Jolly CA, 1997, ARCH BIOCHEM BIOPHYS, V341, P112, DOI 10.1006/abbi.1997.9957; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Kuklev DV, 2004, CHEM PHYS LIPIDS, V131, P215, DOI 10.1016/j.chemphyslip.2004.06.001; Kuklev DV, 2004, CHEM PHYS LIPIDS, V130, P145, DOI 10.1016/j.chemphyslip.2004.02.006; Lawrence JW, 2000, J LIPID RES, V41, P1390; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; McArthur MJ, 1999, J LIPID RES, V40, P1371; McGuire SO, 1997, LIPIDS, V32, P219, DOI 10.1007/s11745-997-0028-x; Morris DH, 2007, FLAX HLTH NUTR PRIME, P22; Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244, DOI 10.1152/ajpgi.1998.275.2.G244; Murphy EJ, 1996, ARCH BIOCHEM BIOPHYS, V335, P267, DOI 10.1006/abbi.1996.0507; Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0; Murphy EJ, 1999, BBA-MOL CELL BIOL L, V1436, P413, DOI 10.1016/S0005-2760(98)00150-7; NEMECZ G, 1991, ARCH BIOCHEM BIOPHYS, V286, P300, DOI 10.1016/0003-9861(91)90044-J; Norris AW, 2002, J LIPID RES, V43, P646; Paulussen R J, 1990, Subcell Biochem, V16, P175; PROWS DR, 1995, LIPIDS, V30, P907, DOI 10.1007/BF02537481; RAZA H, 1989, BIOCHEM BIOPH RES CO, V161, P448, DOI 10.1016/0006-291X(89)92619-3; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SAMUEL D, 1976, EUR J BIOCHEM, V64, P583, DOI 10.1111/j.1432-1033.1976.tb10338.x; Schaffer JE, 1995, TRENDS CARDIOVAS MED, V5, P218, DOI 10.1016/1050-1738(95)00102-6; SCHROEDER F, 1993, MOL CELL BIOCHEM, V123, P73, DOI 10.1007/BF01076477; Schroeder F, 2001, MOL CELL BIOCHEM, V219, P127, DOI 10.1023/A:1010851130136; Schroeder F, 1998, CHEM PHYS LIPIDS, V92, P1, DOI 10.1016/S0009-3084(98)00003-6; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Weisiger RA, 1996, COMP BIOCHEM PHYS B, V115, P319, DOI 10.1016/S0305-0491(96)00179-4; Wolfrum C, 2000, BIOCHEMISTRY-US, V39, P1469, DOI 10.1021/bi991638u; Yan J, 2009, J LIPID RES, V50, P2445, DOI 10.1194/jlr.M900177-JLR200	63	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18693	18708		10.1074/jbc.M109.079897	http://dx.doi.org/10.1074/jbc.M109.079897			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382741	hybrid, Green Published			2022-12-25	WOS:000278453900062
J	Fulcher, AJ; Dias, MM; Jans, DA				Fulcher, Alex James; Dias, Manisha M.; Jans, David A.			Binding of p110 Retinoblastoma Protein Inhibits Nuclear Import of Simian Virus SV40 Large Tumor Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-T-ANTIGEN; ADENOVIRUS E1A PROTEINS; II SITE FLANKING; LOCALIZATION SEQUENCE; CELL-CYCLE; GENE-PRODUCT; DNA-BINDING; JC VIRUS; NUCLEOCYTOPLASMIC TRANSPORT; QUANTITATIVE-ANALYSIS	Nuclear import of the simian virus 40 large tumor antigen (T-ag) is dependent on its nuclear localization signal (NLS) within amino acids 126-132 that is recognized by the importin alpha/beta 1 heterodimer, as well as a protein kinase CK2 site at serine 112 upstream of the NLS, which enhances the interaction similar to 50-fold. Here we show for the first time that T-ag nuclear import is negatively regulated by N-terminal sequences (amino acids 102-110), which represent the binding site (BS) for the retinoblastoma (Rb) tumor suppressor protein (p110(Rb)). Quantitative confocal laser scanning microscopic analysis of the transport properties of T-ag constructs with or without Rb binding site mutations in living transfected cells or in a reconstituted nuclear transport system indicates that the presence of the RbBS significantly reduces nuclear accumulation of T-ag. A number of approaches, including the analysis of T-ag nuclear import in an isogenic cell pair with and without functional p110(Rb) implicate p110(Rb) binding as being responsible for the reduced nuclear accumulation, with the Ser(106) phosphorylation site within the RbBS appearing to enhance the inhibitory effect. Immunoprecipitation experiments confirmed association of T-ag and p110(Rb) and dependence thereof on negative charge at Ser(106). The involvement of p110(Rb) in modulating T-ag nuclear transport has implications for the regulation of nuclear import of other proteins from viruses of medical significance that interact with p110(Rb), and how this may relate to transformation.	Monash Univ, Dept Biochem & Mol Biol, Nucl Signaling Lab, Clayton, Vic 3800, Australia; [Jans, David A.] ARC Ctr Excellence Biotechnol & Dev, Melbourne, Vic 3000, Australia	Monash University	Jans, DA (corresponding author), Dept Biochem & Mol Biol, Nucl Signaling Lab, Monash Univ Bldg 77, Monash, Vic 3800, Australia.	david.jans@med.monash.edu.au		Jans, David/0000-0001-5115-4745	NHMRC (National Health and Medical Research Council) [ID 143710, 384109]	NHMRC (National Health and Medical Research Council)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported, in whole or in part, by the NHMRC (National Health and Medical Research Council) (ID 143710 and 384109).	Alvisi G, 2006, BIOCHEMISTRY-US, V45, P6866, DOI 10.1021/bi060086u; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; BOLLAG B, 1989, J VIROL, V63, P863, DOI 10.1128/JVI.63.2.863-872.1989; Briggs LJ, 1998, J BIOL CHEM, V273, P22745, DOI 10.1074/jbc.273.35.22745; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHERINGTON V, 1988, MOL CELL BIOL, V8, P1380, DOI 10.1128/MCB.8.3.1380; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; DAVIES R, 1993, J VIROL, V67, P2521, DOI 10.1128/JVI.67.5.2521-2528.1993; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; Ferecatu I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-50; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; FRIEDRICH TD, 1993, ONCOGENE, V8, P1673; FULCHER AJ, 2009, FASEB J IN PRESS; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; HAGGERTY S, 1989, J VIROL, V63, P2180, DOI 10.1128/JVI.63.5.2180-2190.1989; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Harris KF, 1996, J VIROL, V70, P2378, DOI 10.1128/JVI.70.4.2378-2386.1996; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; HERRMANN CH, 1991, J VIROL, V65, P5848, DOI 10.1128/JVI.65.11.5848-5859.1991; Hu W, 2005, J CELL BIOCHEM, V95, P782, DOI 10.1002/jcb.20439; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; JANS DA, 1995, J BIOL CHEM, V270, P17064, DOI 10.1074/jbc.270.29.17064; JANS DA, 1994, ONCOGENE, V9, P2961; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KALDERON D, 1984, VIROLOGY, V139, P109, DOI 10.1016/0042-6822(84)90334-9; Kuusisto HV, 2008, INT J CANCER, V123, P2965, DOI 10.1002/ijc.23884; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Mohr S, 2008, J VIROL, V82, P10625, DOI 10.1128/JVI.01187-08; ORDENES GE, 1989, J CELL SCI, V93, P525; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Poon IKH, 2005, J VIROL, V79, P1339, DOI 10.1128/JVI.79.2.1339-1341.2005; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; SCHEIDTMANN KH, 1982, J VIROL, V44, P116, DOI 10.1128/JVI.44.1.116-133.1982; SCHEIDTMANN KH, 1984, J VIROL, V50, P1; SLADEK TL, 1992, J VIROL, V66, P1059, DOI 10.1128/JVI.66.2.1059-1065.1992; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; Yen A, 1998, EXP CELL RES, V241, P324, DOI 10.1006/excr.1998.4007	59	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17744	17753		10.1074/jbc.M109.055491	http://dx.doi.org/10.1074/jbc.M109.055491			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356831	hybrid, Green Published			2022-12-25	WOS:000278133400052
J	Valiron, O; Arnal, I; Caudron, N; Job, D				Valiron, Odile; Arnal, Isabelle; Caudron, Nicolas; Job, Didier			GDP-Tubulin Incorporation into Growing Microtubules Modulates Polymer Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOWLY HYDROLYZABLE ANALOG; DYNAMIC INSTABILITY; GUANOSINE DIPHOSPHATE; GTP HYDROLYSIS; INDIVIDUAL MICROTUBULES; PROTOFILAMENT NUMBERS; STRUCTURAL-CHANGES; ASSEMBLY DYNAMICS; KINETIC-ANALYSIS; ALPHA-TUBULIN	Microtubule growth proceeds through the endwise addition of nucleotide-bound tubulin dimers. The microtubule wall is composed of GDP-tubulin subunits, which are thought to come exclusively from the incorporation of GTP-tubulin complexes at microtubule ends followed by GTP hydrolysis within the polymer. The possibility of a direct GDP-tubulin incorporation into growing polymers is regarded as hardly compatible with recent structural data. Here, we have examined GTP-tubulin and GDP-tubulin incorporation into polymerizing microtubules using a minimal assembly system comprised of nucleotide-bound tubulin dimers, in the absence of free nucleotide. We find that GDP-tubulin complexes can efficiently co-polymerize with GTP-tubulin complexes during microtubule assembly. GDP-tubulin incorporation into microtubules occurs with similar efficiency during bulk microtubule assembly as during microtubule growth from seeds or centrosomes. Microtubules formed from GTP-tubulin/GDP-tubulin mixtures display altered microtubule dynamics, in particular a decreased shrinkage rate, apparently due to intrinsic modifications of the polymer disassembly properties. Thus, although microtubules polymerized from GTP-tubulin/GDP-tubulin mixtures or from homogeneous GTP-tubulin solutions are both composed of GDP-tubulin subunits, they have different dynamic properties, and this may reveal a novel form of microtubule "structural plasticity."	[Valiron, Odile; Arnal, Isabelle; Caudron, Nicolas; Job, Didier] Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, U836, F-38042 Grenoble 9, France; [Arnal, Isabelle] Univ Rennes 1, Inst Federatif Rech 140, CNRS, UMR 6026, F-35042 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Valiron, O (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, U836, Batiment Edmond J Safra,Site Sante Tronche,BP 170, F-38042 Grenoble 9, France.	odile.valiron@ujf-grenoble.fr	Arnal, Isabelle/X-6559-2019	Arnal, Isabelle/0000-0001-6149-8189	La Ligue Nationale Contre le Cancer; Agence Nationale de la Recherce [ANR-07-PCVI-0012]	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherce(French National Research Agency (ANR))	This work was supported by grants from La Ligue Nationale Contre le Cancer (to O. V. and D. J.) and Agence Nationale de la Recherce Grant ANR-07-PCVI-0012 (to I. A.).	Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; BAYLEY PM, 1986, FEBS LETT, V205, P230, DOI 10.1016/0014-5793(86)80903-6; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CARLIER MF, 1989, INT REV CYTOL, V115, P139; CARLIER MF, 1978, BIOCHEMISTRY-US, V17, P1908, DOI 10.1021/bi00603a017; Carlier MF, 1997, BIOPHYS J, V73, P418, DOI 10.1016/S0006-3495(97)78081-0; Caudron N, 2000, J MOL BIOL, V297, P211, DOI 10.1006/jmbi.2000.3554; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Fanara P, 1999, EMBO J, V18, P565, DOI 10.1093/emboj/18.3.565; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; HAMEL E, 1986, BIOCHEMISTRY-US, V25, P7054, DOI 10.1021/bi00370a045; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; JAMESON L, 1980, J BIOL CHEM, V255, P2284; JOB D, 1985, J CELL BIOL, V101, P1680, DOI 10.1083/jcb.101.5.1680; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mozziconacci J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003821; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; NICKERSON JA, 1978, BIOCHEM BIOPH RES CO, V85, P820, DOI 10.1016/0006-291X(78)91236-6; OBRIEN ET, 1989, BIOCHEMISTRY-US, V28, P1413, DOI 10.1021/bi00429a070; PATURLE L, 1989, BIOCHEMISTRY-US, V28, P2698, DOI 10.1021/bi00432a050; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WADE RH, 1990, J MOL BIOL, V212, P775, DOI 10.1016/0022-2836(90)90236-F; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEHLAND J, 1987, J CELL SCI, V88, P185; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007291; ZACKROFF RV, 1980, J MOL BIOL, V139, P641, DOI 10.1016/0022-2836(80)90053-4	44	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17507	17513		10.1074/jbc.M109.099515	http://dx.doi.org/10.1074/jbc.M109.099515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371874	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-25	WOS:000278133400029
J	Czubryt, MP; Lamoureux, L; Ramjiawan, A; Abrenica, B; Jangamreddy, J; Swan, K				Czubryt, Michael P.; Lamoureux, Lise; Ramjiawan, Angela; Abrenica, Bernard; Jangamreddy, Jaganmohan; Swan, Kristin			Regulation of Cardiomyocyte Glut4 Expression by ZAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; ACTIVATED-RECEPTOR-GAMMA; ZINC-FINGER PROTEIN; MEF2 TRANSCRIPTION FACTOR; II HISTONE DEACETYLASES; TUMOR-SUPPRESSOR GENE; CARDIAC-HYPERTROPHY; MUSCLE DIFFERENTIATION; GLUCOSE-TRANSPORTER; SKELETAL-MUSCLE	The transcription factor ZAC1 is expressed in a variety of tissues including the developing heart, but its physiological role is unclear. We examined the role of ZAC1 in regulating expression of the insulin-responsive glucose transporter GLUT4 and whether ZAC1 expression is altered in cardiomyocyte hypertrophy. We demonstrated expression of Zac1 mRNA and protein in rat cardiomyocytes by PCR and Western blotting, respectively. Using a combination of chromatin immunoprecipitation and luciferase assays, we showed that ZAC1 regulates Glut4 expression via a specific binding site in the Glut4 promoter. Overexpression of ZAC1 increased Glut4 mRNA and protein expression and resulted in increased glucose uptake in cardiomyocytes as determined by a fluorescent analog uptake assay. Induction of hypertrophy by phenylephrine or isoproterenol resulted in increased Zac1 expression. We identified a novel putative promoter in the Zac1 gene and demonstrated increased binding of MEF2 to this promoter in response to hypertrophic stimulation. MEF2 regulated transactivation of the Zac1 promoter and ZAC1 protein expression. This work identifies ZAC1 as a novel and previously unknown regulator of cardiomyocyte Glut4 expression and glucose uptake. Our results also implicate MEF2 as a regulator of ZAC1 expression in response to induction of hypertrophy.	Univ Manitoba, St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada; Univ Manitoba, Dept Physiol, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Czubryt, MP (corresponding author), 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	mczubryt@sbrc.ca	Reddy, Jaganmohan/R-9379-2019; Jangamreddy, Jaganmohan Reddy/J-8085-2013	Jangamreddy, Jaganmohan Reddy/0000-0001-6105-1213; Czubryt, Michael/0000-0003-4897-9804	University of Manitoba; Manitoba Medical Services Foundation; Canadian Institutes of Health Research [ROP 83898]	University of Manitoba; Manitoba Medical Services Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the University of Manitoba Research Grants program, the Manitoba Medical Services Foundation, and the Canadian Institutes of Health Research (ROP 83898).	Abdollahi A, 2003, J BIOL CHEM, V278, P6041, DOI 10.1074/jbc.M210361200; ADACHI S, 1994, J MOL CELL CARDIOL, V26, P789, DOI 10.1006/jmcc.1994.1096; Alam S, 2005, DEV DYNAM, V234, P772, DOI 10.1002/dvdy.20577; Armstrong MT, 2000, DEV DYNAM, V219, P226, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1049>3.3.CO;2-S; Arthur EI, 1997, EUR J HUM GENET, V5, P417, DOI 10.1159/000484801; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Bilanges B, 2001, ONCOGENE, V20, P1246, DOI 10.1038/sj.onc.1204237; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chen SL, 2000, GENE DEV, V14, P1209; Chiu LL, 2005, HIGH ALT MED BIOL, V6, P256, DOI 10.1089/ham.2005.6.256; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Galuska D, 1998, ADV EXP MED BIOL, V441, P73; Hashimoto T, 2004, J APPL PHYSIOL, V97, P843, DOI 10.1152/japplphysiol.01193.2003; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Huang CY, 2002, CELL BIOL INT, V26, P737, DOI 10.1006/cbir.2002.0919; Huang SM, 2000, MOL CELL BIOL, V20, P1855, DOI 10.1128/MCB.20.5.1855-1867.2000; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Ma D, 2004, J CLIN INVEST, V114, P339, DOI 10.1172/jci200419876; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Minakawa M, 2003, EUR J CARDIO-THORAC, V24, P493, DOI 10.1016/S1010-7940(03)00410-X; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Naya FJ, 1999, DEVELOPMENT, V126, P2045; *NIH, 1996, PUBL NIH, V8523; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Rauch C, 2005, AM J PHYSIOL-CELL PH, V288, pC593, DOI 10.1152/ajpcell.00346.2004; Rodriguez-Henche N, 2002, BBA-GENE STRUCT EXPR, V1576, P157, DOI 10.1016/S0167-4781(02)00303-2; Sale MM, 2004, DIABETES, V53, P830, DOI 10.2337/diabetes.53.3.830; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; TURNER JD, 1988, AM J PHYSIOL, V255, pE513, DOI 10.1152/ajpendo.1988.255.4.E513; Valente T, 2005, DEV DYNAM, V233, P667, DOI 10.1002/dvdy.20373; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Varrault A, 2001, J BIOL CHEM, V276, P18653, DOI 10.1074/jbc.C100095200; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16942	16950		10.1074/jbc.M109.097246	http://dx.doi.org/10.1074/jbc.M109.097246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363751	Green Published, hybrid			2022-12-25	WOS:000277982600057
J	Azcutia, V; Abu-Taha, M; Romacho, T; Vazquez-Bella, M; Matesanz, N; Luscinskas, FW; Rodriguez-Manas, L; Sanz, MJ; Sanchez-Ferrer, CF; Peiro, C				Azcutia, Veronica; Abu-Taha, May; Romacho, Tania; Vazquez-Bella, Marta; Matesanz, Nuria; Luscinskas, Francis W.; Rodriguez-Manas, Leocadio; Jesus Sanz, Maria; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion			Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo	PLOS ONE			English	Article							FACTOR-KAPPA-B; LEUKOCYTE ADHESION; MOLECULE-1 VCAM-1; DIABETES-MELLITUS; HYPERGLYCEMIA; EXPRESSION; PROTEIN; ACTIVATION; ICAM-1; COMPLICATIONS	Background: Hyperglycemia is acknowledged as an independent risk factor for developing diabetes-associated atherosclerosis. At present, most therapeutic approaches are targeted at a tight glycemic control in diabetic patients, although this fails to prevent macrovascular complications of the disease. Indeed, it remains highly controversial whether or not the mere elevation of extracellular D-glucose can directly promote vascular inflammation, which favors early proatherosclerotic events. Methods and Findings: In the present work, increasing extracellular D-glucose from 5.5 to 22 mmol/L was neither sufficient to induce intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression, analyzed by flow cytometry, nor to promote leukocyte adhesion to human umbilical vein endothelial cells (HUVEC) in vitro, measured by flow chamber assays. Interestingly, the elevation of D-glucose levels potentiated ICAM-1 and VCAM-1 expression and leukocyte adhesion induced by a pro-inflammatory stimulus, such as interleukin (IL)-1 beta (5 ng/mL). In HUVEC, high D-glucose augmented the activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) and nuclear transcription factor-kappa B (NF-kappa B) elicited by IL-1 beta, measured by Western blot and electromobility shift assay (EMSA), respectively, but had no effect by itself. Both ERK 1/2 and NF-kappa B were necessary for VCAM-1 expression, but not for ICAM-1 expression. In vivo, leukocyte trafficking was evaluated in the rat mesenteric microcirculation by intravital microscopy. In accordance with the in vitro data, the acute intraperitoneal injection of D-glucose increased leukocyte rolling flux, adhesion and migration, but only when IL-1 beta was co-administered. Conclusions: These results indicate that the elevation of extracellular D-glucose levels is not sufficient to promote vascular inflammation, and they highlight the pivotal role of a pro-inflammatory environment in diabetes, as a critical factor conditioning the early pro-atherosclerotic actions of hyperglycemia.	[Azcutia, Veronica; Romacho, Tania; Vazquez-Bella, Marta; Matesanz, Nuria; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Madrid, Spain; [Abu-Taha, May; Jesus Sanz, Maria] Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain; [Luscinskas, Francis W.] Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Luscinskas, Francis W.] Harvard Univ, Sch Med, Boston, MA USA; [Rodriguez-Manas, Leocadio] Hosp Univ Getafe, Serv Geriatria, Madrid, Spain; [Rodriguez-Manas, Leocadio] Hosp Univ Getafe, Unidad Invest, Madrid, Spain	Autonomous University of Madrid; University of Valencia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Hospital Universitario de Getafe; Hospital Universitario de Getafe	Azcutia, V (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Madrid, Spain.	concha.peiro@uam.es	Azcutia, Veronica/A-7704-2017; Romacho, Tania/AAB-3306-2021; Romacho, Tania/B-2663-2016; Peiro, Concepcion/B-9545-2017; Azcutia, Veronica/AAW-2443-2020; Abu Taha, May/AAA-3460-2019	Azcutia, Veronica/0000-0003-2160-5175; Romacho, Tania/0000-0002-0962-7163; Romacho, Tania/0000-0002-0962-7163; Peiro, Concepcion/0000-0002-9690-7816; Azcutia, Veronica/0000-0003-2160-5175; Rodriguez-Manas, Leocadio/0000-0002-6551-1333; Sanz, Maria Jesus/0000-0002-8885-294X; Matesanz, Nuria/0000-0002-5756-3424; Luscinskas, Francis/0000-0001-7100-4103; Abu Taha, May/0000-0002-5862-4348	Ministerio de Educacion y Ciencia [SAF2008-00942, SAF2008-01291, SAF2008-03477]; Instituto de Salud Carlos III [RETICEF RD06/0013]; Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Farmacologia/Laboratorios Almirall; Universidad Autonoma de Madrid; Ministerio de Asuntos Exteriores; Ministerio de Ciencia e Innovacion	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Farmacologia/Laboratorios Almirall(Almirall); Universidad Autonoma de Madrid; Ministerio de Asuntos Exteriores; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from Ministerio de Educacion y Ciencia (SAF2008-00942, SAF2008-01291 and SAF2008-03477); Instituto de Salud Carlos III (RETICEF RD06/0013); Fundacion de Investigacion Medica Mutua Madrilena; and Sociedad Espanola de Farmacologia/Laboratorios Almirall. V.A., M.A.-T., and T.R. are recipients of grants from Universidad Autonoma de Madrid, Ministerio de Asuntos Exteriores, and Ministerio de Ciencia e Innovacion, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altannavch TS, 2004, PHYSIOL RES, V53, P77; Alvarez A, 2004, BLOOD, V104, P402, DOI 10.1182/blood-2003-08-2974; Booth G, 2001, AM J PHYSIOL-ENDOC M, V280, pE848, DOI 10.1152/ajpendo.2001.280.6.E848; Borch-Johnsen K, 1999, LANCET, V354, P617; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Dilley RJ, 2008, J HYPERTENS, V26, P396, DOI 10.1097/HJH.0b013e3282f4e35d; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fogelstrand L, 2004, DIABETOLOGIA, V47, P1948, DOI 10.1007/s00125-004-1553-x; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gao L, 2006, J PHARMACOL EXP THER, V318, P53, DOI 10.1124/jpet.106.101444; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Harari OA, 2006, CIRC RES, V98, P1134, DOI 10.1161/01.RES.0000220105.85182.28; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jager A, 2000, DIABETES, V49, P485, DOI 10.2337/diabetes.49.3.485; Kado S, 2001, LIFE SCI, V68, P727, DOI 10.1016/S0024-3205(00)00968-1; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kirpichnikov D, 2001, TRENDS ENDOCRIN MET, V12, P225, DOI 10.1016/S1043-2760(01)00391-5; Lafuente N, 2008, J HYPERTENS, V26, P478, DOI 10.1097/HJH.0b013e3282f331fb; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liu WL, 2000, AM J PHYSIOL-ENDOC M, V279, pE782, DOI 10.1152/ajpendo.2000.279.4.E782; Lu HF, 2004, ENDOCRINOLOGY, V145, P4934, DOI 10.1210/en.2004-0737; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marfella R, 2000, CIRCULATION, V101, P2247, DOI 10.1161/01.CIR.101.19.2247; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Munoz C, 1996, J IMMUNOL, V157, P3587; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Otsuki M, 1997, DIABETES, V46, P2096, DOI 10.2337/diabetes.46.12.2096; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Peiro C, 2003, BRIT J PHARMACOL, V140, P681, DOI 10.1038/sj.bjp.0705483; Peiro C, 2007, J HYPERTENS, V25, P2421, DOI 10.1097/HJH.0b013e3282f0143c; Piconi L, 2004, J THROMB HAEMOST, V2, P1453, DOI 10.1111/j.1538-7836.2004.00835.x; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Rasmussen LM, 2002, SCAND J CLIN LAB INV, V62, P485; Ray KK, 2007, EUR HEART J, V28, P806, DOI 10.1093/eurheartj/ehm010; Razani B, 2009, NAT MED, V15, P372, DOI 10.1038/nm0409-372; RIM JA, 1994, DIABETES, V43, P1103; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tschope C, 2005, FASEB J, V19, P2057, DOI 10.1096/fj.05-4095fje; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje; WEBER C, 1994, ARTERIOSCLER THROMB, V14, P1665, DOI 10.1161/01.ATV.14.10.1665; Xin XP, 2004, LAB INVEST, V84, P1451, DOI 10.1038/labinvest.3700178; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007	50	50	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10091	10.1371/journal.pone.0010091	http://dx.doi.org/10.1371/journal.pone.0010091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386708	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482000019
J	Ramakrishna, M; Williams, LH; Boyle, SE; Bearfoot, JL; Sridhar, A; Speed, TP; Gorringe, KL; Campbell, IG				Ramakrishna, Manasa; Williams, Louise H.; Boyle, Samantha E.; Bearfoot, Jennifer L.; Sridhar, Anita; Speed, Terence P.; Gorringe, Kylie L.; Campbell, Ian G.			Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis	PLOS ONE			English	Article							PANCREATIC-CANCER; PROGNOSTIC MARKER; DNA; KINASE; AMPLIFICATION; ABNORMALITIES; ONCOGENE; PATTERNS; ECT2; PROTEINS	Ovarian cancer is a disease characterised by complex genomic rearrangements but the majority of the genes that are the target of these alterations remain unidentified. Cataloguing these target genes will provide useful insights into the disease etiology and may provide an opportunity to develop novel diagnostic and therapeutic interventions. High resolution genome wide copy number and matching expression data from 68 primary epithelial ovarian carcinomas of various histotypes was integrated to identify genes in regions of most frequent amplification with the strongest correlation with expression and copy number. Regions on chromosomes 3, 7, 8, and 20 were most frequently increased in copy number (>40% of samples). Within these regions, 703/1370 (51%) unique gene expression probesets were differentially expressed when samples with gain were compared to samples without gain. 30% of these differentially expressed probesets also showed a strong positive correlation (r >= 0.6) between expression and copy number. We also identified 21 regions of high amplitude copy number gain, in which 32 known protein coding genes showed a strong positive correlation between expression and copy number. Overall, our data validates previously known ovarian cancer genes, such as ERBB2, and also identified novel potential drivers such as MYNN, PUF60 and TPX2.	[Ramakrishna, Manasa; Boyle, Samantha E.; Bearfoot, Jennifer L.; Sridhar, Anita; Gorringe, Kylie L.; Campbell, Ian G.] Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia; [Ramakrishna, Manasa; Bearfoot, Jennifer L.; Gorringe, Kylie L.; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Williams, Louise H.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Ramakrishna, M (corresponding author), Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia.	kylie.gorringe@petermac.org	Gorringe, Kylie L/H-3264-2019; campbell, Ian G/F-6006-2011; Speed, Terence P/B-8085-2009	Gorringe, Kylie L/0000-0001-5681-2022; Speed, Terence P/0000-0002-5403-7998; Campbell, Ian/0000-0002-7773-4155	Cancer Council Victoria Postgraduate Scholarship; National Health and Medical Research Council (NHMRC) of Australia [566603]	Cancer Council Victoria Postgraduate Scholarship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	MR is supported by the Cancer Council Victoria Postgraduate Scholarship. This work is funded by a grant from the National Health and Medical Research Council (NHMRC) of Australia (ID: 566603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Alliel PM, 2000, BIOCHEM BIOPH RES CO, V273, P385, DOI 10.1006/bbrc.2000.2862; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bodmer W, 2003, GYNECOL ONCOL, V88, pS22, DOI 10.1006/gyno.2002.6678; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Fujimoto T, 2009, FEBS LETT, V583, P568, DOI 10.1016/j.febslet.2008.12.063; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; Gray JW, 2003, GYNECOL ONCOL, V88, pS16, DOI 10.1006/gyno.2002.6677; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Gyorffy B, 2008, INT J GYNECOL CANCER, V18, P1215, DOI 10.1111/j.1525-1438.2007.01169.x; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hyman E, 2002, CANCER RES, V62, P6240; Israeli O, 2005, CANCER GENET CYTOGEN, V160, P35, DOI 10.1016/j.cancergencyto.2004.11.011; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Katoh Y, 2009, J BIOL CHEM, V284, P27646, DOI 10.1074/jbc.M109.034884; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; Lukasiewicz KB, 2009, ENVIRON MOL MUTAGEN, V50, P602, DOI 10.1002/em.20533; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; R Core Team, 2022, R LANG ENV STAT COMP; Ran YL, 2008, CLIN CANCER RES, V14, P6538, DOI 10.1158/1078-0432.CCR-08-0476; Sakamoto K, 2008, J CELL SCI, V121, P1613, DOI 10.1242/jcs.023119; SANTARIUS T, NAT REV CANC, V10, P59; Storlazzi CT, 2003, GENE CHROMOSOME CANC, V37, P195, DOI 10.1002/gcc.10210; Taetle R, 1999, GENE CHROMOSOME CANC, V25, P290, DOI 10.1002/(SICI)1098-2264(199907)25:3<290::AID-GCC12>3.3.CO;2-7; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Watanabe T, 2002, JPN J CANCER RES, V93, P1114, DOI 10.1111/j.1349-7006.2002.tb01213.x; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang L, 2005, CANCER RES, V65, P925; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhao S, 2008, DNA CELL BIOL, V27, P159, DOI 10.1089/dna.2007.0634; Zorn KK, 2003, CLIN CANCER RES, V9, P4811; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	69	86	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9983	10.1371/journal.pone.0009983	http://dx.doi.org/10.1371/journal.pone.0009983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386695	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482000004
J	Wang, Y; Coffey, RJ; Osheroff, N; Neufeld, KL				Wang, Yang; Coffey, Robert J.; Osheroff, Neil; Neufeld, Kristi L.			Topoisomerase II alpha Binding Domains of Adenomatous Polyposis Coli Influence Cell Cycle Progression and Aneuploidy	PLOS ONE			English	Article							HL-60 LEUKEMIA-CELLS; WNT SIGNALING PATHWAY; BETA-CATENIN; CHROMOSOMAL INSTABILITY; GENETIC INSTABILITY; REDUCED EXPRESSION; MESSENGER-RNA; APC; PROTEIN; RESISTANCE	Background: Truncating mutations in the tumor suppressor gene APC (Adenomatous Polyposis Coli) are thought to initiate the majority of colorectal cancers. The 15- and 20-amino acid repeat regions of APC bind beta-catenin and have been widely studied for their role in the negative regulation of canonical Wnt signaling. However, functions of APC in other important cellular processes, such as cell cycle control or aneuploidy, are only beginning to be studied. Our previous investigation implicated the 15- amino acid repeat region of APC (M2-APC) in the regulation of the G2/M cell cycle transition through interaction with topoisomerase II alpha (topo II alpha). Methodology/Principal Findings: We now demonstrate that the 20-amino acid repeat region of APC (M3-APC) also interacts with topo II alpha in colonic epithelial cells. Expression of M3-APC in cells with full-length endogenous APC causes cell accumulation in G2. However, cells with a mutated topo II alpha isoform and lacking topo II beta did not arrest, suggesting that the cellular consequence of M2- or M3-APC expression depends on functional topoisomerase II. Both purified recombinant M2- and M3-APC significantly enhanced the activity of topo II alpha. Of note, although M3-APC can bind beta-catenin, the G2 arrest did not correlate with beta-catenin expression or activity, similar to what was seen with M2- APC. More importantly, expression of either M2- or M3-APC also led to increased aneuploidy in cells with full-length endogenous APC but not in cells with truncated endogenous APC that includes the M2- APC region. Conclusions/Significance: Together, our data establish that the 20-amino acid repeat region of APC interacts with topo II alpha to enhance its activity in vitro, and leads to G2 cell cycle accumulation and aneuploidy when expressed in cells containing full-length APC. These findings provide an additional explanation for the aneuploidy associated with many colon cancers that possess truncated APC.	[Wang, Yang; Neufeld, Kristi L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	University of Kansas; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Wang, Y (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	klneuf@ku.edu	Wang, Yang/O-2300-2013	Wang, Yang/0000-0003-2801-8416; Neufeld, Kristi/0000-0003-3653-9385	NIH [RO1 CA10922]; GI Special Program of Research Excellence [CA95103]; NCI [RO1 CA46413, GM33944]; Higuchi Biosciences Center; J.R. Inez Jay Award; KUCC Pilot Project Award; NATIONAL CANCER INSTITUTE [R01CA046413, R01CA109220, P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GI Special Program of Research Excellence; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Higuchi Biosciences Center; J.R. Inez Jay Award; KUCC Pilot Project Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by NIH RO1 CA10922 (Y. W. and K. L. N.), GI Special Program of Research Excellence CA95103 (R. J. C), NCI RO1 CA46413 (R. J. C), GM33944 (N. O.), Higuchi Biosciences Center J.R. & Inez Jay Award (Y. W. and K. L. N.), and the KUCC Pilot Project Award (Y. W. and K. L. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bhattacharjee RN, 1996, BIOCHEM BIOPH RES CO, V220, P192, DOI 10.1006/bbrc.1996.0379; Cardoso J, 2006, CANCER RES, V66, P2514, DOI 10.1158/0008-5472.CAN-05-2407; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fortune JM, 2000, METH MOL B, V95, P275; GORBSKY GJ, 1994, CANCER RES, V54, P1042; Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660; HARKER WG, 1989, CANCER RES, V49, P4542; HARKER WG, 1991, BIOCHEMISTRY-US, V30, P9953, DOI 10.1021/bi00105a020; HARKER WG, 1995, CANCER RES, V55, P4962; HARKER WG, 1995, CANCER RES, V55, P1707; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Heinen CD, 2002, GASTROENTEROLOGY, V123, P751, DOI 10.1053/gast.2002.35382; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Jaiswal AS, 2004, J CELL BIOCHEM, V93, P345, DOI 10.1002/jcb.20156; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kingma PS, 1997, BIOCHEMISTRY-US, V36, P5934, DOI 10.1021/bi970507v; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kleivi K, 2004, CANCER GENET CYTOGEN, V155, P119, DOI 10.1016/j.cancergencyto.2004.03.014; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; *NCI, 2001, NCI NCBIS SKY M FISH; Neufeld KL, 2009, ADV EXP MED BIOL, V656, P13, DOI 10.1007/978-1-4419-1145-2_2; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; QUIRKE P, 1988, GUT, V29, P603, DOI 10.1136/gut.29.5.603; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; Sugimoto K, 2008, ONCOGENE, V27, P3091, DOI 10.1038/sj.onc.1210978; SVENDSEN LB, 1993, DAN MED BULL, V40, P546; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang Y, 2008, MOL BIOL CELL, V19, P4076, DOI 10.1091/mbc.E07-12-1296; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e9994	10.1371/journal.pone.0009994	http://dx.doi.org/10.1371/journal.pone.0009994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368985	gold, Green Published, Green Submitted			2022-12-25	WOS:000276419900002
J	van Es, ACGM; van der Grond, J; ten Dam, VH; de Craen, AJM; Blauw, GJ; Westendorp, RGJ; Admiraal-Behloul, F; van Buchem, MA				van Es, Adriaan C. G. M.; van der Grond, Jeroen; ten Dam, V. Hester; de Craen, Anton J. M.; Blauw, Gerard J.; Westendorp, Rudi G. J.; Admiraal-Behloul, Faiza; van Buchem, Mark A.		PROSPER Study Grp	Associations between Total Cerebral Blood Flow and Age Related Changes of the Brain	PLOS ONE			English	Article							WHITE-MATTER LESIONS; INTERNAL CAROTID-ARTERY; CONTRAST MR-ANGIOGRAPHY; VOLUME MEASUREMENT; VASCULAR DEMENTIA; ELDERLY-PEOPLE; LEUKOARAIOSIS; HYPERINTENSITIES; ATROPHY; DISEASE	Background and Purpose: Although total cerebral blood flow (tCBF) is known to be related to age, less is known regarding the associations between tCBF and the morphologic changes of the brain accompanying cerebral aging. The purpose of this study was to investigate whether total cerebral blood flow (tCBF) is related to white matter hyperintensity (WMH) volume and/or cerebral atrophy. Furthermore, we investigate whether tCBF should be expressed in mL/min, as was done in all previous MR studies, or in mL/100 mL/min, which yielded good results in precious SPECT, PET and perfusion MRI studies investigating regional cerebral blood flow. Materials and Methods: Patients were included from the nested MRI sub-study of the PROSPER study. Dual fast spin echo and FLAIR images were obtained in all patients. In addition, single slice phase contrast MR angiography was used for flow measurements in the internal carotids and vertebral arteries. tCBF was expressed in both mL/min and mL/100 mL/min. Results: We found a significant correlation between tCBF in mL/min and both age (r = -.124; p = p <=.001) and parenchymal volume (r = 0.430; p <=.001). We found no association between tCBF in mL/min and %-atrophy (r = -.077; p <=.103) or total WMH volume (r = -.069; p =.148). When tCBF was expressed in mL/100 mL/min the correlation between tCBF and age was no longer found (r = -.001; p =.985). Multivariate regression analyses corrected for age showed a significant correlation between tCBF in mL/100 mL/min and WMH volume (r = -.106; p =.044). No significant association between tCBF in mL/100 mL/min and %- atrophy was found. Conclusion: From this study we conclude that, when evaluating tCBF alterations due to various pathologies, tCBF should in mL/100 mL/min instead of mL/min. Furthermore, changes or differences in WMH volume should be accounted for.	[van Es, Adriaan C. G. M.; Admiraal-Behloul, Faiza] Leiden Univ, Med Ctr, Dept Radiol, Sect Image Proc LKEB, Leiden, Netherlands; [ten Dam, V. Hester; de Craen, Anton J. M.; Blauw, Gerard J.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gen Internal Med, Sect Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Es, ACGM (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Sect Image Proc LKEB, Leiden, Netherlands.	A.C.G.M.van_Es@LUMC.nl	Blauw, Gerard/GWD-1079-2022; van Buchem, Mark/AAC-9843-2022; Blauw, Gerard/AAW-7904-2021; Sweeney, Brian J/D-2569-2013	van Buchem, Mark/0000-0003-1881-1998; 	Leiden University Medical Center	Leiden University Medical Center	The study was funded with internal funds from the Leiden University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascher E, 2003, J VASC SURG, V37, P769, DOI 10.1067/mva.2003.231; Bakker CJG, 1995, MAGN RESON IMAGING, V13, P959, DOI 10.1016/0730-725X(95)02005-E; Bisschops RHC, 2004, J NEUROL, V251, P1481, DOI 10.1007/s00415-004-0569-y; BOTS ML, 1993, LANCET, V341, P1232, DOI 10.1016/0140-6736(93)91144-B; Buijs PC, 1998, RADIOLOGY, V209, P667, DOI 10.1148/radiology.209.3.9844657; de Leeuw FE, 1999, ANN NEUROL, V46, P827, DOI 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO;2-H; de Leeuw FE, 2000, STROKE, V31, P425, DOI 10.1161/01.STR.31.2.425; DeCarli C, 1999, STROKE, V30, P529, DOI 10.1161/01.STR.30.3.529; den Heijer T, 2003, NEUROBIOL AGING, V24, P307, DOI 10.1016/S0197-4580(02)00088-X; Firbank MJ, 2004, AM J GERIAT PSYCHIAT, V12, P606, DOI 10.1176/appi.ajgp.12.6.606; Hatazawa J, 1997, STROKE, V28, P1944, DOI 10.1161/01.STR.28.10.1944; Hendrikse J, 2005, RADIOLOGY, V235, P184, DOI 10.1148/radiol.2351031799; Hendrikse J, 2003, NEUROSURGERY, V53, P858, DOI 10.1227/01.NEU.0000083552.45265.46; Ho SSY, 2000, STROKE, V31, P1342, DOI 10.1161/01.STR.31.6.1342; ISAKA Y, 1994, STROKE, V25, P375, DOI 10.1161/01.STR.25.2.375; Isaka Y, 1997, STROKE, V28, P354, DOI 10.1161/01.STR.28.2.354; Kato T, 2002, AM J NEURORADIOL, V23, P1346; KAWAMURA J, 1991, STROKE, V22, P609, DOI 10.1161/01.STR.22.5.609; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Marstrand JR, 2002, STROKE, V33, P972, DOI 10.1161/01.STR.0000012808.81667.4B; MEGURO K, 1990, ANN NEUROL, V28, P378, DOI 10.1002/ana.410280313; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Rutgers DR, 2000, STROKE, V31, P3021, DOI 10.1161/01.STR.31.12.3021; Sakakibara R, 1999, J NEUROL NEUROSUR PS, V67, P658, DOI 10.1136/jnnp.67.5.658; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Sullivan EV, 2004, NEUROBIOL AGING, V25, P185, DOI 10.1016/S0197-4580(03)00044-7; Swan GE, 2000, NEUROLOGY, V54, P2108, DOI 10.1212/WNL.54.11.2108; TarvonenSchroder S, 1996, J NEUROL NEUROSUR PS, V60, P431, DOI 10.1136/jnnp.60.4.431; van der Flier WM, 2004, NEUROLOGY, V62, P1862, DOI 10.1212/01.WNL.0000125337.65553.8A; van der Geest RJ, 1998, J COMPUT ASSIST TOMO, V22, P904, DOI 10.1097/00004728-199811000-00013; van Gijn J, 1998, NEUROLOGY, V51, pS3, DOI 10.1212/WNL.51.3_Suppl_3.S3; WASSERMAN BA, 1995, RADIOLOGY, V194, P681, DOI 10.1148/radiology.194.3.7862962; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7; Yamauchi H, 1999, NEUROLOGY, V53, P1833, DOI 10.1212/WNL.53.8.1833; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009	38	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9825	10.1371/journal.pone.0009825	http://dx.doi.org/10.1371/journal.pone.0009825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352115	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400025
J	Del Genio, CI; Kim, H; Toroczkai, Z; Bassler, KE				Del Genio, Charo I.; Kim, Hyunju; Toroczkai, Zoltan; Bassler, Kevin E.			Efficient and Exact Sampling of Simple Graphs with Given Arbitrary Degree Sequence	PLOS ONE			English	Article								Uniform sampling from graphical realizations of a given degree sequence is a fundamental component in simulation-based measurements of network observables, with applications ranging from epidemics, through social networks to Internet modeling. Existing graph sampling methods are either link-swap based (Markov-Chain Monte Carlo algorithms) or stub-matching based (the Configuration Model). Both types are ill-controlled, with typically unknown mixing times for link-swap methods and uncontrolled rejections for the Configuration Model. Here we propose an efficient, polynomial time algorithm that generates statistically independent graph samples with a given, arbitrary, degree sequence. The algorithm provides a weight associated with each sample, allowing the observable to be measured either uniformly over the graph ensemble, or, alternatively, with a desired distribution. Unlike other algorithms, this method always produces a sample, without backtracking or rejections. Using a central limit theorem-based reasoning, we argue, that for large N, and for degree sequences admitting many realizations, the sample weights are expected to have a lognormal distribution. As examples, we apply our algorithm to generate networks with degree sequences drawn from power-law distributions and from binomial distributions.	[Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Dept Phys, Houston, TX 77004 USA; [Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Texas Ctr Superconduct TcSUH, Houston, TX USA; [Kim, Hyunju; Toroczkai, Zoltan] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat ICeN, Notre Dame, IN 46556 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Notre Dame	Del Genio, CI (corresponding author), Univ Houston, Dept Phys, Houston, TX 77004 USA.	Kevin.E.Bassler@mail.uh.edu	Toroczkai, Zoltan/AAC-8446-2019; del Genio, Charo I/F-7249-2010	Toroczkai, Zoltan/0000-0002-6602-2849; del Genio, Charo I/0000-0001-9958-017X	National Science Foundation (NSF) [DMR-0908286]; Norman Hackerman Advanced Research Program [95921]; NSF [BCS-0826958]; Defense Threat Reduction Agency (DTRA) [HDTRA 201473-35045]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Norman Hackerman Advanced Research Program; NSF(National Science Foundation (NSF)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	CIDG and KEB are supported by the National Science Foundation (NSF) through grant DMR-0908286 and by the Norman Hackerman Advanced Research Program through grant 95921. HK and ZT are supported in part by the NSF BCS-0826958 and by the Defense Threat Reduction Agency (DTRA) through HDTRA 201473-35045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Bianconi G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016114; Bianconi G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036114; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Burda Z, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046118; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; COCHRAN W. G, 1977, SAMPLING TECHNIQUES, V3rd; Cooper C, 2007, COMB PROBAB COMPUT, V16, P557, DOI 10.1017/S0963548306007978; ERDOS P, 1960, MAT LAPOK, V11, P477; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Havel V., 1955, CASOPIS PROPESTOV MA, V80, P477, DOI DOI 10.21136/CPM.1955.108220; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kim H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/39/392001; KOREN M, 1976, J COMB THEORY B, V21, P235, DOI 10.1016/S0095-8956(76)80007-X; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman M., 1999, MONTE CARLO METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; TAYLOR R, 1982, SIAM J ALGEBRA DISCR, V3, P114, DOI 10.1137/0603011; Tripathi A, 2003, DISCRETE MATH, V265, P417, DOI 10.1016/S0012-365X(02)00886-5; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45	28	113	113	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10012	10.1371/journal.pone.0010012	http://dx.doi.org/10.1371/journal.pone.0010012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386694	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482000005
